data_2k7n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k7n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 24.5 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 N-CA-C 110.789 -0.504 . . . . 62.51 110.789 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 53.1 Cg_endo -69.55 -5.37 15.92 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.499 2.133 . . . . 72.42 112.116 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.643 HD22 HG13 ' A' ' 24' ' ' VAL . 4.7 t-20 -130.99 142.17 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.081 -0.963 . . . . 73.24 109.449 -175.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 164' ' ' PRO . 21.8 m -135.54 157.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.981 -0.377 . . . . 75.15 109.981 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 22' ' ' ILE . 50.8 p90 -121.06 130.46 53.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.267 0.556 . . . . 74.52 110.754 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -111.15 102.17 10.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.501 -0.772 . . . . 74.11 109.806 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.86 110.65 17.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.22 -0.659 . . . . 74.53 109.22 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.498 HG21 ' HE2' ' A' ' 53' ' ' PHE . 72.1 p -99.81 -179.7 4.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.149 -0.478 . . . . 74.34 110.719 -175.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 p -69.27 -16.88 63.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.091 -0.504 . . . . 62.21 110.878 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.412 ' HE2' HG23 ' A' ' 142' ' ' VAL . 4.4 mmt -94.83 -41.05 9.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 70.13 111.019 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -176.78 -127.49 1.05 Allowed Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.639 -0.791 . . . . 74.42 111.717 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 15' ' ' TYR . 19.6 tt -135.7 137.94 48.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.888 0.375 . . . . 73.23 110.188 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -122.41 108.75 22.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.191 -0.67 . . . . 75.11 109.191 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.643 HG13 HD22 ' A' ' 13' ' ' ASN . 39.5 t -98.03 131.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.334 -0.617 . . . . 74.53 109.334 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 25' ' ' LEU . 4.6 pp -146.99 159.26 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.119 0.485 . . . . 73.34 110.793 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -125.61 164.12 21.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.698 -0.683 . . . . 72.33 110.604 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -110.34 159.29 17.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.275 -0.875 . . . . 70.44 109.128 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.679 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.2 m-85 -86.46 88.79 7.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.398 0.618 . . . . 75.3 111.536 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.543 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 34.0 m95 -79.91 -3.59 48.76 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.416 -0.957 . . . . 72.11 108.416 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.82 -41.2 26.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 74.31 111.135 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.415 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 12.0 t60 -132.2 -17.33 2.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.658 -0.417 . . . . 73.52 111.774 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.91 88.62 31.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.779 -0.368 . . . . 75.42 111.024 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 31' ' ' HIS . 11.1 Cg_exo -71.15 -17.17 31.62 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.83 2.353 . . . . 65.42 112.694 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 7.5 mptt -90.31 -54.75 3.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.084 0.469 . . . . 74.42 110.475 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.7 m -55.38 -44.11 75.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 74.53 111.646 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -64.48 -37.6 88.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.371 . . . . 71.11 110.844 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.933 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -73.77 -38.92 64.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 74.53 110.53 -178.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.91 -58.71 7.38 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.386 0.429 . . . . 75.32 110.902 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.599 ' HD1' ' HH ' ' A' ' 48' ' ' TYR . 65.6 m-85 -61.83 -43.79 98.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.33 111.076 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.08 93.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 74.23 111.393 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -59.44 -45.19 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.31 111.429 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 47' ' ' TYR . 3.9 mm? -73.45 -23.34 60.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.736 0.303 . . . . 74.32 111.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.9 -48.71 52.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.386 . . . . 75.23 110.874 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -12.74 60.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.922 0.392 . . . . 74.11 111.022 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -52.35 9.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.839 -0.8 . . . . 75.23 108.839 172.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.92 45.84 0.93 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.675 -0.97 . . . . 64.44 110.675 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -88.86 -33.65 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.881 0.372 . . . . 70.42 111.368 -176.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.599 ' HH ' ' HD1' ' A' ' 39' ' ' PHE . 85.2 m-85 -71.94 -14.69 61.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.329 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -74.95 10.64 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 65.13 111.123 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.16 24.95 1.9 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.865 -0.607 . . . . 72.32 111.63 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.729 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 43.1 p -115.33 160.43 19.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.683 0.278 . . . . 72.32 111.082 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.9 ptpt -139.64 164.05 30.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.372 -0.377 . . . . 74.45 110.006 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.2 m-85 -82.24 117.68 22.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.831 -0.803 . . . . 74.44 108.831 173.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.83 -27.06 14.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.413 -0.358 . . . . 72.24 110.76 -169.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 30.5 mmt180 -132.02 116.68 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.517 -0.31 . . . . 73.31 110.564 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.52 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -127.28 94.25 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.007 -0.738 . . . . 62.23 109.007 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.8 mt -106.35 125.2 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.245 -0.434 . . . . 72.54 110.07 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.5 mtpt -60.27 130.79 48.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.223 0.327 . . . . 75.53 111.41 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 58.38 28.07 16.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.462 -0.79 . . . . 65.11 111.424 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.758 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -128.64 -87.52 0.55 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 72.12 109.86 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.727 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.7 ptt? -161.28 157.82 26.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 55.41 110.031 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.529 HD12 ' HA3' ' A' ' 143' ' ' GLY . 50.6 mt -128.62 102.07 7.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.613 -0.721 . . . . 73.42 109.682 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 23.5 tm0? -80.56 126.35 31.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 75.5 110.007 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.58 137.04 9.58 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.978 -0.63 . . . . 71.03 112.402 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.729 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 131.04 -137.47 9.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.071 -0.585 . . . . 70.41 112.12 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 4.5 t0 48.07 83.33 0.22 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 123.901 0.881 . . . . 73.13 112.241 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.26 -19.56 33.59 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.73 2.287 . . . . 73.14 111.498 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' HG21 ' A' ' 70' ' ' THR . 34.5 p -82.58 -34.55 27.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.144 -0.935 . . . . 71.11 111.534 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 76.22 28.0 60.92 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.102 -0.571 . . . . 74.22 111.835 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.57 HG21 ' OG1' ' A' ' 68' ' ' THR . 11.5 t -117.66 -17.48 9.91 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.101 0.408 . . . . 71.34 112.101 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.94 25.59 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 119.87 -1.157 . . . . 74.4 113.631 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.549 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.97 -7.36 6.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.336 0.568 . . . . 73.52 111.877 178.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 70.9 -163.87 53.64 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.182 -0.532 . . . . 72.21 113.342 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.12 -88.05 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.683 -0.567 . . . . 64.44 111.683 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . . . 59.87 33.08 21.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.278 0.561 . . . . 74.03 111.934 173.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 t -78.83 0.66 26.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 70.51 111.686 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.8 pt -74.01 -29.76 26.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.722 -0.391 . . . . 70.35 111.254 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 75' ' ' ALA . 23.1 p90 -108.05 1.73 22.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.3 0.572 . . . . 75.01 111.107 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -77.58 2.09 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.341 -0.845 . . . . 72.23 113.39 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -92.37 -170.39 2.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.851 0.358 . . . . 72.14 110.505 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.44 163.65 13.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.621 -0.511 . . . . 74.41 109.621 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 57.6 t80 -110.33 156.02 21.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.103 -0.239 . . . . 73.55 111.091 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.13 158.14 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.161 0.913 . . . . 73.22 112.16 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -75.22 106.76 6.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.299 -0.864 . . . . 73.04 110.838 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.5 21.37 9.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 74.24 109.354 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 HD23 ' OG1' ' A' ' 127' ' ' THR . 38.2 mt -59.32 97.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -0.999 . . . . 75.51 111.551 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -168.22 85.45 0.72 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 73.34 109.961 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.41 93.7 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.59 2.193 . . . . 72.03 111.947 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.61 -26.4 66.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.698 0.761 . . . . 64.45 109.65 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -83.12 177.75 8.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.899 -1.046 . . . . 70.33 108.808 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -133.8 159.86 39.34 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.907 -0.717 . . . . 73.43 110.541 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 118' ' ' PRO . 1.2 p90 -70.46 77.18 0.57 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.315 -0.857 . . . . 72.3 110.829 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -68.49 -40.59 80.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.945 -1.025 . . . . 75.3 111.421 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.66 -146.92 4.85 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.0 -0.619 . . . . 73.52 111.949 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.89 145.78 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.783 0.325 . . . . 53.34 110.751 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.09 24.3 6.34 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.67 -0.776 . . . . 74.23 111.535 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.2 mm -88.18 112.42 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.565 -0.532 . . . . 74.32 109.565 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 114' ' ' VAL . 3.3 tm? -85.45 121.76 28.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.987 -0.551 . . . . 74.21 109.594 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . . . -126.69 163.52 23.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.125 0.488 . . . . 75.34 111.186 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.533 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 28.1 ttt -91.62 134.16 34.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.483 -0.781 . . . . 73.45 109.939 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -96.5 151.24 19.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.132 0.492 . . . . 72.54 110.979 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.4 p-10 -155.84 159.38 39.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 74.3 110.581 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.62 -13.45 22.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.244 0.545 . . . . 73.32 110.808 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.462 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -162.58 -179.99 37.51 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.224 -1.55 . . . . 75.32 109.224 176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.63 -50.69 12.94 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.737 2.292 . . . . 72.0 112.063 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.89 19.56 15.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 75.02 110.367 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.3 m -101.08 51.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.317 -0.994 . . . . 73.02 108.317 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.533 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 42.3 m-80 -77.37 134.84 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.421 -1.263 . . . . 74.25 110.375 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.57 -157.21 10.09 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.745 -0.74 . . . . 71.01 112.506 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -95.7 8.99 41.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.162 0.506 . . . . 70.42 111.166 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 6.3 pt20 -90.8 158.6 16.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.871 -0.604 . . . . 72.3 111.328 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . 50.9 p90 -142.17 176.45 8.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.02 -0.536 . . . . 73.13 109.971 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 51.1 p90 -159.54 152.04 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 72.24 110.608 173.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.691 HG21 HD21 ' A' ' 98' ' ' LEU . 19.3 t -110.93 142.78 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.288 -0.634 . . . . 64.52 109.288 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.7 p -97.39 130.09 44.56 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.771 0.319 . . . . 74.32 110.154 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 62' ' ' ILE . 57.0 mt -86.22 -6.69 58.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.06 0.457 . . . . 72.45 110.957 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.19 166.88 14.33 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.805 -0.634 . . . . 72.24 109.794 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 92' ' ' PHE . 32.2 Cg_exo -59.41 106.63 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.591 2.194 . . . . 74.41 112.043 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.483 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.1 p -94.02 103.42 15.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.62 -0.718 . . . . 72.22 111.793 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.19 3.6 30.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.651 0.739 . . . . 73.3 110.255 176.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.483 ' CZ2' HG22 ' A' ' 119' ' ' THR . 1.2 p90 -93.71 -3.7 51.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.995 -1.002 . . . . 74.41 111.295 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.19 16.53 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.549 -0.296 . . . . 73.3 111.207 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.75 -38.9 57.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.281 -0.872 . . . . 75.3 111.552 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.12 22.48 10.39 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.608 -0.806 . . . . 64.02 112.083 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -118.4 -26.49 6.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.061 0.458 . . . . 74.22 110.135 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -137.34 128.09 27.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 73.23 110.486 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.405 ' OG1' HD23 ' A' ' 86' ' ' LEU . 21.5 m -68.73 120.71 15.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.433 . . . . 75.53 110.669 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.21 117.58 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.547 0.203 . . . . 75.25 111.547 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 47.9 m-85 -158.77 77.04 0.75 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.511 0.507 . . . . 73.03 110.698 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.34 163.24 35.45 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.116 -0.564 . . . . 52.2 112.285 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.679 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 78.3 mtm180 -142.31 127.14 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.028 -0.36 . . . . 72.35 110.028 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -87.06 142.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 75.34 110.686 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 43.6 t -145.77 147.72 32.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 64.35 110.773 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.705 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.3 tt0 48.41 34.04 4.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.568 0.747 . . . . 75.34 112.567 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 139' ' ' VAL . . . -163.45 16.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.061 -1.066 . . . . 74.23 112.407 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 tp -73.18 -31.74 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.159 -0.311 . . . . 62.53 110.159 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.93 95.49 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.982 -0.847 . . . . 71.11 110.982 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.445 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 81.8 mmm -68.61 -48.85 63.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.098 -0.334 . . . . 75.31 110.098 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.472 HG12 HD11 ' A' ' 62' ' ' ILE . 85.7 t -56.33 -30.23 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 73.22 110.532 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.72 -52.83 11.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.815 -0.63 . . . . 72.31 110.97 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -14.43 60.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.051 -0.522 . . . . 75.1 111.305 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.412 HG23 ' HE2' ' A' ' 20' ' ' MET . 46.4 t -93.52 -33.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.077 0.465 . . . . 73.2 110.382 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.529 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -82.8 -22.03 58.6 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.595 -0.812 . . . . 61.11 113.0 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ptp -84.33 -13.26 52.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.853 -0.339 . . . . 74.45 111.659 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 74.42 111.256 -177.695 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.439 -0.578 . . . . 75.43 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -127.21 165.4 19.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.141 -0.481 . . . . 73.11 110.721 -175.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 162' ' ' ALA . 4.0 mp -86.76 105.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.617 -0.72 . . . . 74.41 109.102 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.539 HG21 ' HD2' ' A' ' 161' ' ' LYS . 25.1 mm -70.46 -56.37 11.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.562 -0.744 . . . . 73.14 110.673 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.539 ' HD2' HG21 ' A' ' 160' ' ' ILE . 2.5 mptm? -133.34 128.04 34.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 70.13 110.147 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . . . -131.27 123.99 29.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.864 0.364 . . . . 72.42 110.672 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.22 143.24 32.84 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.89 -0.596 . . . . 63.53 109.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.837 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 74.4 Cg_endo -78.47 124.58 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.198 1.932 . . . . 64.02 112.241 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 115.522 -0.763 . . . . 73.33 109.234 -178.79 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.1 m-20 . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 121.32 0.581 . . . . 71.43 110.189 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.16 146.08 4.48 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.256 -0.884 . . . . 73.23 111.638 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.25 -167.38 39.86 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.359 -0.924 . . . . 73.33 111.864 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -79.38 167.21 21.18 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.605 -0.516 . . . . 74.43 109.605 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.407 ' O ' HG12 ' A' ' 191' ' ' ILE . 92.4 m-85 -114.06 103.62 55.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.142 0.496 . . . . 75.43 110.32 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.659 ' HB2' HD12 ' A' ' 90' ' ' LEU . 73.0 Cg_endo -79.87 -11.68 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.707 2.271 . . . . 74.32 112.069 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.69 -20.0 40.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.41 -0.814 . . . . 63.2 111.336 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.423 HG13 HG12 ' A' ' 193' ' ' VAL . 18.4 pt -87.9 -13.6 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.0 0.428 . . . . 71.31 110.969 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.1 m170 68.85 29.83 4.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.34 -0.846 . . . . 74.43 112.456 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.423 HG12 HG13 ' A' ' 191' ' ' ILE . 4.2 p -130.81 148.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.803 -0.443 . . . . 71.34 109.803 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.48 124.53 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.953 0.406 . . . . 63.21 111.831 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.588 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -163.29 152.31 14.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 71.11 109.174 175.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.408 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 52.8 m-85 -117.67 146.01 37.75 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.624 0.25 . . . . 64.41 111.217 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 36.2 Cg_endo -66.0 -59.63 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.643 2.229 . . . . 75.12 112.191 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.2 pt? -143.98 38.87 1.33 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.769 0.285 . . . . 74.33 111.769 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.2 m-20 76.43 -19.23 0.43 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.75 1.019 . . . . 73.22 113.75 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -60.37 -23.09 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.728 0.64 . . . . 72.22 112.728 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 -13.37 60.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.241 -0.981 . . . . 63.13 112.955 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.408 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 24.8 ptt180 -110.71 -24.16 10.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.081 0.441 . . . . 75.44 111.261 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.362 -0.828 . . . . 71.34 110.394 176.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 31.0 Cg_endo . . . . . 0 N--CA 1.459 -0.554 0 N-CA-C 110.787 -0.505 . . . . 72.23 110.787 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.27 -39.94 35.2 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.592 2.195 . . . . 75.23 112.67 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.414 HD22 HG22 ' A' ' 24' ' ' VAL . 26.2 t-20 -134.0 150.88 51.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 71.33 110.031 -173.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.538 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.0 m -129.23 141.65 46.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 75.14 110.498 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' HA ' HG11 ' A' ' 24' ' ' VAL . 24.1 m-85 -96.93 124.86 41.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 73.01 110.67 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 162' ' ' ALA . 27.7 mt -112.22 100.56 8.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.564 -0.289 . . . . 74.11 110.23 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.838 ' HB2' ' HG2' ' A' ' 161' ' ' LYS . 35.8 mt-10 -82.48 110.76 17.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.233 -0.654 . . . . 72.33 109.233 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -105.57 177.76 4.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.185 0.516 . . . . 72.1 111.899 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 9.9 p -71.97 -19.26 61.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 74.22 110.611 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.1 mmt -92.4 -38.78 11.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.823 -0.626 . . . . 63.23 110.833 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -178.66 -126.51 1.01 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.909 -0.663 . . . . 71.51 111.448 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.03 137.2 38.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.796 -0.446 . . . . 74.13 109.796 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.621 HG12 HG22 ' A' ' 139' ' ' VAL . 3.9 mp -139.02 130.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.721 -0.672 . . . . 74.33 109.227 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 133' ' ' CYS . 2.2 m -118.94 151.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.019 -0.672 . . . . 74.13 110.664 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -145.96 161.45 40.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 75.32 110.22 176.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -129.77 164.19 24.59 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.149 -0.932 . . . . 74.41 109.439 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.03 162.97 12.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.025 -0.361 . . . . 71.3 110.025 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.43 ' HH ' ' HB2' ' A' ' 189' ' ' PRO . 10.1 m-85 -86.39 101.75 13.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.325 0.583 . . . . 74.25 111.72 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.517 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -82.82 -1.68 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.223 -0.898 . . . . 74.45 110.184 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -68.87 -67.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 65.1 111.362 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -124.2 11.08 8.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 64.4 111.521 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.88 59.78 47.03 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.477 -0.329 . . . . 72.33 111.465 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 16.6 Cg_exo -67.53 -46.46 2.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.476 2.117 . . . . 55.13 111.975 -177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -63.91 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 74.31 110.307 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.535 ' HG1' ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -67.13 -41.04 86.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.391 -0.822 . . . . 75.25 110.495 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.517 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 18.5 t -58.52 -48.19 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 72.54 110.533 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.38 -34.61 78.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 72.24 111.275 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' HD21 ' A' ' 42' ' ' LEU . 6.7 t30 -54.69 -52.36 62.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 73.54 110.407 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.538 ' HE1' HG21 ' A' ' 14' ' ' VAL . 27.4 t80 -67.71 -44.84 76.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.201 0.524 . . . . 70.44 109.911 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -55.52 -44.58 76.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.306 -0.861 . . . . 74.24 112.087 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.5 mt-10 -69.77 -38.78 76.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.11 -0.236 . . . . 75.11 111.19 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 38' ' ' ASN . 4.0 mm? -65.14 -26.92 68.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 73.31 110.395 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.93 -45.2 64.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.973 -0.558 . . . . 72.23 109.873 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.6 mtp180 -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 75.45 111.063 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 9.1 mpt_? -73.01 -40.46 65.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.012 -0.366 . . . . 74.04 110.012 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 30.03 6.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.655 -0.784 . . . . 61.24 112.479 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -76.88 -17.01 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 74.41 111.385 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -74.3 -17.22 60.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.132 0.419 . . . . 73.22 112.132 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -71.19 -8.52 54.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.058 0.456 . . . . 73.21 110.606 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -122.69 31.21 4.87 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.942 -0.647 . . . . 64.43 111.951 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.811 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 73.4 p -112.11 154.3 25.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 71.02 111.155 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.82 157.46 43.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 74.4 109.948 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.56 ' CD1' ' HA3' ' A' ' 64' ' ' GLY . 97.9 m-85 -89.59 121.58 31.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 72.43 109.642 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -104.89 -35.6 7.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.53 -0.304 . . . . 72.34 111.803 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -113.41 112.96 24.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.686 -0.405 . . . . 73.03 110.356 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.623 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -125.99 94.33 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.179 -0.674 . . . . 75.43 109.179 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.818 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 24.2 mt -96.47 122.05 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.742 -0.663 . . . . 64.34 109.408 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.4 mtpt -53.49 120.93 6.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.525 0.516 . . . . 74.34 111.554 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 54.9 41.14 32.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.385 -0.825 . . . . 65.05 111.329 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.818 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 8.5 t80 -133.23 -80.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.775 -0.648 . . . . 74.41 109.46 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.684 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.6 ptt? -161.23 157.49 25.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.395 -0.82 . . . . 74.03 110.085 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.623 HG23 HG13 ' A' ' 56' ' ' ILE . 49.8 mt -127.11 101.39 7.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.409 -0.589 . . . . 75.31 109.409 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 37.7 tt0 -83.84 121.38 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.839 -0.619 . . . . 65.15 110.139 -177.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.56 ' HA3' ' CD1' ' A' ' 53' ' ' PHE . . . -142.93 151.35 23.09 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.519 -0.848 . . . . 21.43 112.719 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 135.14 -148.93 19.78 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.548 -0.834 . . . . 75.45 112.051 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 t70 59.67 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 O-C-N 124.376 0.692 . . . . 72.03 111.145 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.9 Cg_endo -64.53 -20.59 65.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.042 2.495 . . . . 71.34 112.445 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.522 ' OG1' HG23 ' A' ' 70' ' ' THR . 9.9 p -82.52 -27.56 31.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 75.34 111.422 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.17 26.59 68.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.91 -0.662 . . . . 72.04 111.685 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.522 HG23 ' OG1' ' A' ' 68' ' ' THR . 14.7 t -118.54 -24.09 6.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.487 0.185 . . . . 62.02 111.215 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.79 9.35 43.38 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 72.24 113.253 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HG3' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -150.38 21.77 0.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 75.04 110.718 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.5 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -103.7 -176.15 25.91 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.748 -0.739 . . . . 74.13 112.234 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 110' ' ' SER . . . 83.37 161.27 31.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.578 -0.82 . . . . 62.01 111.645 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.98 16.3 4.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.094 0.473 . . . . 75.15 111.567 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -68.65 -12.55 61.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.552 . . . . 74.15 110.941 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.599 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.2 pt -64.55 -39.44 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.367 -0.378 . . . . 72.13 110.369 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.599 ' N ' HG13 ' A' ' 77' ' ' ILE . 95.5 m-85 -75.02 -32.93 61.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.662 -0.496 . . . . 75.03 109.662 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.37 8.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.548 -0.834 . . . . 73.42 112.93 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -171.2 2.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.982 -0.377 . . . . 71.1 109.982 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -70.93 164.27 25.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 64.32 110.577 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -99.22 143.0 29.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 72.34 109.642 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 106' ' ' ASP . 35.1 tt0 -58.87 147.26 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.634 0.584 . . . . 71.35 110.726 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -67.33 125.3 25.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.741 0.781 . . . . 55.24 110.611 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.535 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 14.8 tp10 -117.77 29.36 7.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.644 -1.162 . . . . 74.14 108.361 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -49.61 100.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.72 -1.127 . . . . 75.24 111.175 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.64 78.69 9.83 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.066 -0.516 . . . . 73.42 111.128 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.66 66.4 2.3 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.56 2.173 . . . . 74.01 111.638 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.99 -23.55 59.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.053 0.93 . . . . 63.34 109.436 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -89.13 166.42 13.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.462 -1.244 . . . . 74.53 108.879 174.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -113.71 141.58 47.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.278 -0.569 . . . . 74.41 110.836 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.96 70.42 0.76 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.968 . . . . 71.12 109.801 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 193' ' ' VAL . 37.1 p -62.7 -40.89 98.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.091 . . . . 63.13 111.765 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.81 -144.73 4.09 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.761 -0.733 . . . . 75.53 111.911 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.05 144.02 27.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.798 0.332 . . . . 70.04 110.523 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.65 22.08 6.19 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.829 -0.7 . . . . 73.2 111.706 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 mm -88.39 114.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.442 -0.577 . . . . 73.43 109.442 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.74 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -89.86 120.28 30.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.956 -0.565 . . . . 75.55 109.746 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -128.33 160.92 30.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.948 -0.569 . . . . 64.54 110.257 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.648 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 39.0 ttp -91.06 143.16 26.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.601 -0.518 . . . . 71.35 109.601 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.3 114.4 26.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.274 0.559 . . . . 43.32 110.975 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 2.9 p-10 -115.7 149.93 37.63 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.283 -0.871 . . . . 74.41 109.897 175.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -83.84 -28.01 28.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.258 -0.883 . . . . 64.45 111.285 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.37 -108.89 0.32 Allowed Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 120.912 -0.661 . . . . 43.45 112.147 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.06 89.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.892 2.395 . . . . 65.35 112.009 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 3.3 p30 48.1 31.11 2.35 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.878 -1.055 . . . . 64.25 111.898 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.438 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 1.3 m -85.38 52.25 2.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.292 0.567 . . . . 71.2 109.996 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.5 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 19.0 m-80 -91.26 173.82 7.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.303 -0.862 . . . . 75.02 109.032 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.39 -96.71 0.13 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.353 -1.403 . . . . 75.54 114.234 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.508 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 46.9 t -126.87 12.19 7.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.391 0.615 . . . . 73.44 110.448 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.648 ' O ' ' HG3' ' A' ' 100' ' ' MET . 18.9 mp0 -101.14 147.04 26.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 74.4 109.474 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -147.21 176.09 10.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.809 0.338 . . . . 73.2 110.906 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.4 p90 -160.46 152.52 20.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.98 0.419 . . . . 74.11 110.202 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.662 HG21 HD21 ' A' ' 98' ' ' LEU . 18.5 t -112.91 138.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.786 -0.643 . . . . 71.23 109.268 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.9 p -93.3 125.47 37.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.058 0.456 . . . . 73.22 109.999 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD22 ' CD1' ' A' ' 62' ' ' ILE . 54.4 mt -85.29 -6.46 59.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.59 -0.732 . . . . 75.03 110.357 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.41 161.14 34.78 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.338 -0.846 . . . . 74.3 109.997 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.43 113.7 2.38 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.644 2.229 . . . . 75.12 112.224 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.2 p -105.31 103.57 13.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.102 -0.499 . . . . 74.54 110.938 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -99.78 13.84 32.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.862 0.839 . . . . 64.14 109.479 -177.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.735 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -111.05 3.85 18.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.673 -1.149 . . . . 74.04 110.748 -178.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -113.29 6.4 17.34 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.272 -0.422 . . . . 72.01 111.642 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.05 -31.72 43.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.536 -0.757 . . . . 70.04 112.132 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -125.51 20.49 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.496 -0.859 . . . . 73.1 111.691 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.71 -31.25 5.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 74.13 110.656 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.405 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 35.1 m80 -142.27 141.14 32.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 72.41 111.04 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.1 m -78.32 111.08 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 74.4 110.277 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 99' ' ' ALA . 38.6 mt -98.99 122.82 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.42 110.71 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 35' ' ' THR . 5.5 p90 -159.71 73.31 0.55 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.689 0.757 . . . . 73.4 110.898 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.74 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.49 156.66 28.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.292 -1.432 . . . . 72.01 113.802 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.419 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.9 mtm180 -134.77 122.32 21.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.504 0.321 . . . . 75.13 110.282 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -83.64 138.69 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.036 0.446 . . . . 65.23 110.66 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.534 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 41.1 t -139.86 157.66 45.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.253 -0.43 . . . . 71.14 109.907 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.4 pt20 36.86 42.77 0.24 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.252 1.021 . . . . 73.3 113.18 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.76 17.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.455 -0.879 . . . . 74.42 112.509 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.497 ' H ' ' HB3' ' A' ' 184' ' ' ASP . 11.3 tp -74.34 -34.51 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.387 -0.227 . . . . 74.04 110.387 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.28 95.33 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.736 -0.745 . . . . 63.11 111.367 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 142' ' ' VAL . 75.6 mmm -70.31 -50.79 35.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 110.114 -0.328 . . . . 75.14 110.114 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.621 HG22 HG12 ' A' ' 23' ' ' ILE . 86.3 t -55.96 -30.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.043 0.449 . . . . 74.21 110.699 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.531 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.8 t30 -70.48 -53.32 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.991 -0.55 . . . . 74.21 110.521 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.39 61.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.35 -0.386 . . . . 72.11 111.225 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 138' ' ' MET . 50.6 t -83.47 -34.85 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.225 0.536 . . . . 63.23 109.733 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -79.53 -21.51 66.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.622 -0.799 . . . . 71.03 112.624 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 56.4 mtm -82.52 -23.96 34.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.944 0.35 . . . . 73.4 111.944 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.488 0.661 . . . . 71.24 110.196 178.647 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 53' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.688 0.756 . . . . 74.23 111.725 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -122.93 163.77 19.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.069 -0.969 . . . . 73.03 109.67 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 159' ' ' ILE . 3.6 mp -90.25 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.815 -1.18 . . . . 72.44 107.815 170.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 19' ' ' SER . 32.2 mm -67.07 -53.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.693 -0.685 . . . . 75.12 110.618 -173.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.838 ' HG2' ' HB2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -142.06 132.56 25.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.606 -0.724 . . . . 64.44 110.018 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' A' ' 48' ' ' TYR . . . -133.46 146.15 50.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.787 0.327 . . . . 74.35 110.625 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.413 ' HE1' ' HB2' ' A' ' 161' ' ' LYS . 85.0 m-85 -148.37 140.7 14.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 75.01 109.822 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.447 ' HD3' ' OH ' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -78.15 132.49 11.54 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.186 1.924 . . . . 65.34 111.579 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.452 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 49.5 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 61.02 111.249 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 19.2 m-20 . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.523 0.678 . . . . 74.22 111.445 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 158.67 140.86 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.654 -1.157 . . . . 65.52 110.463 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.31 -169.81 40.57 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.233 -0.984 . . . . 74.22 111.97 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.76 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -75.34 166.67 23.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 110.153 -0.314 . . . . 71.24 110.153 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.97 100.03 11.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.482 -0.562 . . . . 70.31 109.482 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 5.5 Cg_exo -79.55 -9.75 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.666 2.244 . . . . 64.42 112.188 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.4 ' HB2' HH11 ' A' ' 131' ' ' ARG . 37.0 tt0 -74.17 -32.43 63.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.407 0.622 . . . . 75.21 109.63 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 pt -85.69 162.33 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.445 -0.946 . . . . 74.13 108.445 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -114.97 41.39 2.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.89 0.376 . . . . 74.32 111.25 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.713 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.6 p -109.57 -174.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.318 -0.623 . . . . 65.14 109.318 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.713 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -115.84 114.38 24.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.646 0.26 . . . . 75.14 111.064 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.577 HE21 ' HB2' ' A' ' 187' ' ' ALA . 3.7 pm0 -155.12 152.97 30.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.46 -0.571 . . . . 70.41 109.46 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -121.39 139.82 30.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.545 -0.298 . . . . 74.34 110.402 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.76 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 19.7 Cg_endo -58.31 -57.9 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.937 2.424 . . . . 74.54 111.99 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.12 23.85 4.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 75.11 109.873 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.474 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 30.2 m-20 69.55 9.5 7.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.36 -0.836 . . . . 75.1 112.169 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.9 ptm -53.0 -40.33 63.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 72.44 112.002 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.38 61.95 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.855 -0.688 . . . . 72.3 113.318 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.474 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 19.6 mtp180 -94.84 -3.68 48.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.827 0.346 . . . . 75.41 110.685 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 4.2 tppp? . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.604 -1.18 . . . . 75.32 112.142 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo . . . . . 0 N--CA 1.465 -0.199 0 CA-C-O 120.631 0.179 . . . . 72.13 111.931 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 32.1 Cg_endo -65.15 -22.48 61.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.928 2.419 . . . . 71.32 113.052 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -124.21 138.97 54.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.055 0.455 . . . . 75.03 110.936 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 164' ' ' PRO . 20.9 m -128.99 157.35 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.778 -0.646 . . . . 74.22 109.418 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.622 ' CB ' HG12 ' A' ' 24' ' ' VAL . 55.4 p90 -115.14 132.12 56.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.367 0.603 . . . . 75.12 111.551 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -110.32 109.13 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.086 -0.961 . . . . 75.23 110.25 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.13 112.39 23.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.19 -0.671 . . . . 74.02 109.19 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -104.68 178.89 4.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.97 0.414 . . . . 74.43 110.682 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 160' ' ' ILE . 12.9 p -80.44 -6.13 57.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.292 0.568 . . . . 75.24 110.463 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mmm -98.83 -41.58 7.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 74.25 109.565 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.552 ' HA3' ' HE3' ' A' ' 138' ' ' MET . . . -174.01 -134.13 1.8 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.1 -0.8 . . . . 62.12 111.1 177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.73 130.72 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.958 -0.756 . . . . 65.34 108.958 177.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 139' ' ' VAL . 4.8 mp -132.15 124.9 53.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.122 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' A' ' 15' ' ' TYR . 3.2 m -106.48 146.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.272 -0.571 . . . . 70.4 109.767 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.47 162.01 37.62 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.982 0.42 . . . . 74.21 110.14 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -135.14 165.14 26.09 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.709 -0.678 . . . . 73.12 110.767 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.65 166.86 10.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.806 -0.634 . . . . 74.55 110.237 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -87.0 96.23 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.327 0.584 . . . . 71.44 111.635 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.441 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 42.0 m95 -88.82 1.9 54.49 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.256 -0.884 . . . . 73.32 109.511 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -74.11 -50.2 20.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 72.44 111.324 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -137.97 8.63 2.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 75.41 111.426 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.84 85.54 57.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 74.12 110.503 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.07 -11.58 21.35 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.184 2.59 . . . . 71.14 113.002 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.66 -48.88 3.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 73.4 111.55 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -35.93 73.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 65.2 111.194 -175.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -54.81 -53.22 58.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.816 -0.629 . . . . 75.24 111.609 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 6.0 mtmp? -81.81 -23.63 36.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.993 -0.549 . . . . 74.3 111.188 -172.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.494 ' O ' HD22 ' A' ' 42' ' ' LEU . 4.3 m-20 -52.06 -47.02 65.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.551 0.691 . . . . 70.25 109.221 171.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HZ ' ' HB2' ' A' ' 100' ' ' MET . 19.2 m-85 -77.08 -49.57 15.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.378 -0.828 . . . . 74.32 110.834 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -57.25 -35.64 69.99 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.694 0.628 . . . . 63.5 112.694 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 49.0 mt-10 -88.0 -15.32 36.78 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.062 -0.399 . . . . 73.21 111.314 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 38' ' ' ASN . 2.4 mm? -75.03 -20.87 59.4 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.031 -0.667 . . . . 73.31 109.299 164.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' HE1' ' A' ' 48' ' ' TYR . . . -74.52 -41.83 59.97 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.708 -0.678 . . . . 75.35 110.949 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.799 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 1.3 ptp180 -67.79 -27.36 66.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.754 0.311 . . . . 75.01 110.552 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.52 -39.17 77.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.687 -0.857 . . . . 73.02 108.687 172.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.89 15.42 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.633 -0.712 . . . . 74.24 111.477 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.584 ' HD2' ' HG3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -72.79 -20.08 61.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 53.32 110.512 -173.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.528 ' HE1' ' HA ' ' A' ' 43' ' ' ALA . 78.0 m-85 -62.53 -28.54 69.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.811 -0.632 . . . . 74.14 111.177 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 29.1 m-80 -72.73 91.0 1.44 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.963 0.887 . . . . 75.53 109.47 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.56 11.68 3.61 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 113.896 -1.502 . . . . 64.12 112.009 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 70.2 p -99.83 154.42 18.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 72.01 110.569 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -130.69 155.86 45.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.471 -0.331 . . . . 74.33 110.722 -176.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.8 m-85 -81.75 109.51 16.22 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.944 -0.762 . . . . 75.02 108.944 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 -37.96 12.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.106 -0.497 . . . . 73.44 111.676 -171.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 17.0 mmt180 -112.12 114.14 26.81 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 75.14 109.239 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.19 89.21 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.06 -0.718 . . . . 64.31 109.06 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -93.9 125.17 46.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.989 -0.745 . . . . 72.4 108.989 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 12.4 ptmm? -53.41 135.56 39.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.507 0.505 . . . . 75.34 110.946 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 42.68 37.01 0.91 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.213 0.946 . . . . 64.43 112.412 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' N ' ' HB2' ' A' ' 116' ' ' LEU . 2.7 m-85 -134.4 -80.44 0.45 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.066 -0.515 . . . . 73.54 111.398 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.46 155.83 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 75.12 111.065 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 20.8 mt -132.3 106.36 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 75.43 110.004 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.433 ' OE1' ' HG2' ' A' ' 55' ' ' ARG . 44.4 tt0 -83.81 128.77 34.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.06 -0.348 . . . . 73.14 110.06 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.67 132.84 7.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.64 -0.79 . . . . 62.53 112.592 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 152.81 -112.79 0.55 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.55 -0.833 . . . . 75.41 113.452 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 31.09 73.14 0.5 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 74.43 113.364 -170.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HG3' ' HD2' ' A' ' 47' ' ' TYR . 72.9 Cg_endo -78.84 -16.29 12.9 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.049 1.833 . . . . 71.13 111.543 174.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 p -105.18 -57.34 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.715 -0.675 . . . . 74.51 111.177 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.13 0.02 41.18 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.826 -0.702 . . . . 65.23 112.06 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 t -80.95 -6.78 59.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.293 0.568 . . . . 75.31 110.687 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.41 -25.51 26.72 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.624 -0.798 . . . . 65.33 112.55 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.21 -32.24 13.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 72.24 111.414 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -161.45 15.34 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.625 -0.797 . . . . 73.23 111.58 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.61 -84.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.02 -0.61 . . . . 73.33 112.101 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 60.73 39.37 17.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.225 0.536 . . . . 52.24 111.272 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m -55.78 -29.27 59.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.159 -0.928 . . . . 74.21 112.439 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.481 HG22 ' HD1' ' A' ' 78' ' ' TYR . 7.9 tt -73.95 -41.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.207 0.447 . . . . 74.24 112.207 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' HD1' HG22 ' A' ' 77' ' ' ILE . 43.8 p90 -108.02 -8.69 15.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.338 -0.545 . . . . 75.52 112.215 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.12 -101.14 1.43 Allowed Glycine 0 C--N 1.329 0.169 0 C-N-CA 121.138 -0.553 . . . . 74.11 113.254 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -69.12 163.78 24.04 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.518 -0.549 . . . . 72.3 109.518 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.577 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 1.6 mp0 -58.75 174.06 0.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.683 0.754 . . . . 74.1 112.257 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -116.88 155.73 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.088 -0.96 . . . . 73.12 109.424 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.55 159.42 8.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.522 0.514 . . . . 75.0 110.555 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.528 0.68 . . . . 72.43 111.688 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -91.48 13.41 17.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.078 -0.965 . . . . 74.41 109.788 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.12 106.32 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.644 -0.707 . . . . 75.31 110.738 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -164.92 71.01 1.45 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 73.2 109.882 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -76.29 81.44 2.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.395 2.063 . . . . 75.01 113.094 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.96 -18.13 41.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.686 0.755 . . . . 75.24 109.793 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 2.9 pp -87.55 177.27 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.105 -0.952 . . . . 74.44 108.819 173.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.65 ' HD2' ' HA ' ' A' ' 192' ' ' HIS . 2.9 tmtm? -137.23 135.37 37.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.838 0.351 . . . . 75.12 110.425 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER -63.98 89.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.916 0.865 . . . . 73.12 109.977 173.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 193' ' ' VAL . 16.4 p -71.72 -51.01 25.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.602 -1.181 . . . . 74.15 111.083 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -147.85 -132.9 2.27 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.615 -0.802 . . . . 75.44 111.998 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.16 147.06 24.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.824 0.345 . . . . 45.35 110.852 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.2 20.98 8.3 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.751 -0.738 . . . . 53.22 111.582 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -87.05 111.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.387 -0.597 . . . . 71.25 109.387 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.715 HD22 HG21 ' A' ' 114' ' ' VAL . 3.1 tm? -88.15 118.74 27.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.721 -0.672 . . . . 71.44 109.809 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.63 173.83 9.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.005 -0.543 . . . . 54.34 111.512 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.514 ' HB2' ' HZ ' ' A' ' 39' ' ' PHE . 25.2 ttt -101.25 128.59 47.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.335 -0.848 . . . . 65.23 109.982 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -90.76 114.55 26.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.612 0.72 . . . . 71.33 110.991 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.462 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 3.9 p-10 -121.1 160.39 23.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.953 -1.021 . . . . 75.42 110.244 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.61 -25.31 16.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.152 -0.476 . . . . 62.21 110.832 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -152.75 -176.98 25.9 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.889 -1.285 . . . . 75.32 109.889 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.16 -53.72 5.98 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.338 2.692 . . . . 62.14 112.475 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.415 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 3.8 p30 -116.83 16.97 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.164 0.507 . . . . 73.33 110.671 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -92.73 53.55 2.06 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 75.32 108.261 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 106' ' ' ASP . 36.2 m-80 -87.04 107.81 18.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.641 -1.163 . . . . 74.22 110.281 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.88 -166.01 34.41 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.195 -0.762 . . . . 73.23 111.195 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m -100.22 67.12 1.35 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.908 -0.775 . . . . 72.23 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 69.2 mt-30 -124.83 147.76 48.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.111 -0.95 . . . . 72.44 110.174 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -120.4 155.81 32.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.427 -0.351 . . . . 71.24 110.919 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -153.76 141.74 20.26 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.111 -0.495 . . . . 75.23 110.37 168.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.715 HG21 HD22 ' A' ' 98' ' ' LEU . 15.9 t -110.94 142.43 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.602 -0.726 . . . . 74.54 109.424 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.58 127.04 41.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.382 . . . . 72.44 110.131 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 62' ' ' ILE . 65.3 mt -84.54 -9.03 58.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.773 -0.649 . . . . 71.53 109.859 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.0 157.7 31.96 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.107 -0.952 . . . . 71.51 109.556 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.412 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 27.5 Cg_exo -62.56 115.66 3.04 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.536 2.157 . . . . 52.53 112.264 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 p -105.77 106.92 17.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.006 0.431 . . . . 74.41 110.33 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp0? -97.34 20.71 11.13 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.381 0.61 . . . . 72.02 111.089 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -123.81 -1.77 8.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.314 -0.857 . . . . 75.31 110.337 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.669 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 97.9 mt -105.8 3.86 29.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.914 -0.584 . . . . 75.22 111.14 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.44 -23.68 67.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.455 -0.793 . . . . 74.42 111.134 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.29 18.4 7.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.686 -0.768 . . . . 70.21 111.504 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -115.49 -35.84 4.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.112 0.482 . . . . 73.35 109.708 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.462 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 54.0 m80 -141.59 132.66 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 74.53 109.093 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.7 t -74.78 147.14 41.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 64.31 110.302 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 99' ' ' ALA . 43.3 mt -123.97 119.57 57.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.004 -0.544 . . . . 75.4 110.388 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -156.32 72.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.447 . . . . 71.3 110.198 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -166.17 165.6 38.27 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.249 -0.74 . . . . 63.43 111.249 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -152.97 132.01 12.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 74.31 111.084 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 96' ' ' GLY . 5.2 p -79.94 144.6 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.856 . . . . 74.31 110.716 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.55 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 42.7 t -139.23 151.99 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.175 -0.466 . . . . 62.12 109.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.473 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.4 tt0 45.42 42.15 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.59 0.556 . . . . 73.41 111.893 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 27.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.206 -0.997 . . . . 62.22 112.397 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.407 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.3 tp -81.92 -31.19 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.898 -0.408 . . . . 75.41 109.898 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.85 91.72 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.786 -0.721 . . . . 74.2 111.39 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.552 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 69.8 mmm -68.28 -49.58 59.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.233 -0.284 . . . . 64.15 110.233 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.408 HG21 HG12 ' A' ' 23' ' ' ILE . 95.0 t -55.84 -30.53 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.251 0.548 . . . . 74.52 110.502 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.12 -52.62 22.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.717 -0.674 . . . . 74.42 110.709 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.3 OUTLIER -72.92 -14.73 61.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 74.45 111.481 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 138' ' ' MET . 63.6 t -89.95 -35.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.98 0.419 . . . . 74.11 110.492 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -81.33 -11.83 82.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 63.3 112.867 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 ptp -95.67 0.65 52.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.573 0.225 . . . . 75.25 111.235 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 142' ' ' VAL . 32.5 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.478 0.656 . . . . 74.24 111.958 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 107.618 -1.253 . . . . 71.52 107.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 2.3 mppt? -128.48 156.01 43.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.027 -0.669 . . . . 73.14 111.877 -166.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.33 104.23 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.694 -1.139 . . . . 75.51 108.199 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.567 HG23 ' HD3' ' A' ' 161' ' ' LYS . 32.2 mm -69.37 -58.36 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 73.51 110.6 -174.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.592 ' HB3' ' HE1' ' A' ' 163' ' ' TYR . 3.9 mppt? -132.13 139.4 48.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.73 -0.668 . . . . 71.24 110.131 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 48' ' ' TYR . . . -138.92 127.3 22.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 75.24 110.69 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.592 ' HE1' ' HB3' ' A' ' 161' ' ' LYS . 42.6 m-85 -140.22 155.06 70.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.877 -0.786 . . . . 72.1 108.877 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.7 Cg_exo -71.86 138.28 31.18 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.709 1.606 . . . . 72.32 110.364 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 73.02 111.152 -171.763 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER . . . . . 0 CA--C 1.503 -0.851 0 CA-C-O 122.008 0.908 . . . . 74.44 111.857 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 140.17 142.41 4.19 Favored Glycine 0 N--CA 1.426 -2.026 0 CA-C-N 113.82 -1.536 . . . . 73.22 111.263 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 172.06 54.1 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.691 -0.766 . . . . 63.41 111.656 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.777 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -66.36 148.59 51.64 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.848 -0.427 . . . . 62.03 109.848 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -80.1 107.18 6.29 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.372 -0.377 . . . . 73.32 110.185 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 5.3 Cg_exo -79.97 -5.84 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.762 2.308 . . . . 74.12 111.594 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.65 -22.29 60.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 74.22 110.446 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.0 pt -97.16 172.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.268 -0.641 . . . . 75.31 109.268 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.65 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 63.9 m170 -121.24 27.4 8.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 72.54 111.111 -175.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.0 p -111.87 167.22 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.936 -0.574 . . . . 74.22 110.144 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -89.22 108.68 19.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.924 0.392 . . . . 61.32 111.375 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -152.2 150.11 29.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.241 -0.651 . . . . 74.54 109.241 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -127.08 151.68 74.65 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.678 -0.237 . . . . 73.31 110.955 -173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.777 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 38.2 Cg_endo -66.38 -70.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.59 2.193 . . . . 75.14 111.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.428 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.9 pt? -114.99 16.41 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.033 0.444 . . . . 73.44 110.236 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.582 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 11.2 m-20 70.17 7.57 6.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.35 -0.841 . . . . 74.31 113.127 171.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.8 -31.18 71.38 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.884 0.327 . . . . 74.31 111.884 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.14 -1.14 87.6 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.808 -0.711 . . . . 50.12 112.907 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.582 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 69.8 mtp180 -80.98 -21.52 40.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 74.41 111.145 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.522 -0.763 . . . . 75.41 111.583 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 13.3 Cg_exo . . . . . 0 CA--C 1.531 0.348 0 CA-C-O 120.747 0.228 . . . . 73.4 112.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.5 -2.16 11.36 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.083 2.522 . . . . 74.34 112.886 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.548 HD22 HG12 ' A' ' 24' ' ' VAL . 24.5 t-20 -121.09 144.65 48.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.751 -0.659 . . . . 74.31 110.275 -175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 164' ' ' PRO . 32.1 m -135.32 150.88 29.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.431 . . . . 71.51 111.05 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 28.3 m-85 -103.28 119.71 39.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.832 -0.622 . . . . 74.43 111.018 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.67 105.03 14.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.063 0.459 . . . . 65.42 110.797 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG2' HG12 ' A' ' 22' ' ' ILE . 37.3 mt-10 -90.0 118.23 29.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.965 -0.754 . . . . 73.25 108.965 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -108.34 178.15 4.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 73.01 111.106 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 160' ' ' ILE . 33.2 t -79.55 6.67 9.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.98 -0.554 . . . . 75.42 110.431 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.606 ' HG3' HG21 ' A' ' 142' ' ' VAL . 6.8 mmt -113.56 -38.28 4.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.918 -0.583 . . . . 74.15 110.171 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -178.01 -132.69 1.74 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.268 -0.733 . . . . 74.54 111.268 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -139.64 131.34 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.17 -0.678 . . . . 70.24 109.17 177.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.533 ' N ' HD11 ' A' ' 22' ' ' ILE . 4.1 mp -123.47 124.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.584 -0.735 . . . . 74.32 110.095 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.548 HG12 HD22 ' A' ' 13' ' ' ASN . 20.7 t -99.42 133.6 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.171 -0.677 . . . . 74.42 109.171 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 3.9 pp -142.04 161.86 36.94 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.502 -0.479 . . . . 74.14 110.859 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.51 166.07 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.903 -0.59 . . . . 73.15 109.57 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -107.49 161.28 14.98 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.094 -0.706 . . . . 74.35 109.094 178.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 131' ' ' ARG . 7.0 m-85 -84.62 97.04 9.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.668 0.747 . . . . 74.22 111.216 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 15.0 m95 -88.78 9.88 22.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.45 -1.315 . . . . 73.32 107.45 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 28' ' ' TYR . 28.6 mmmt -79.17 -55.0 5.42 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 113.413 -1.721 . . . . 74.13 110.603 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.85 1.75 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.177 0.436 . . . . 74.55 112.177 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.68 77.97 29.35 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.049 -0.26 . . . . 75.02 110.339 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 7.3 Cg_exo -73.8 -9.7 22.66 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.237 2.624 . . . . 63.32 113.164 -173.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -100.37 -51.99 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.31 0.576 . . . . 65.1 109.957 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.459 HG21 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -61.2 -39.77 91.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.95 -1.023 . . . . 74.55 111.574 -175.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 29' ' ' TRP . 26.0 p -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.325 -0.398 . . . . 75.24 110.767 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 10.4 mmmm -63.47 -41.07 98.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.626 -0.261 . . . . 73.55 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.447 ' O ' HD21 ' A' ' 42' ' ' LEU . 65.5 t30 -60.25 -47.84 84.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.358 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.418 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 11.3 t80 -65.24 -52.21 55.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.205 0.526 . . . . 74.33 110.131 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.17 81.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.294 -0.866 . . . . 73.54 112.181 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.645 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 44.3 mt-10 -77.53 -24.11 50.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.926 -0.309 . . . . 73.53 111.723 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 38' ' ' ASN . 2.9 mm? -74.4 -27.54 60.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.168 0.508 . . . . 74.22 109.878 171.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.94 -41.27 71.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 72.14 110.573 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.645 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 8.4 ppt_? -79.7 -15.36 57.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 73.34 110.768 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HD3' ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -74.92 -32.93 61.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.045 -0.724 . . . . 72.53 109.045 172.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.19 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.817 -0.706 . . . . 75.04 111.791 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HE1' ' HA3' ' A' ' 74' ' ' GLY . 6.2 t80 -76.63 -39.39 52.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.602 -0.299 . . . . 74.23 111.268 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -74.84 -15.51 60.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 75.31 112.162 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -76.3 90.65 3.19 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.725 0.774 . . . . 74.23 109.151 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.39 8.55 4.41 Favored Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.351 -1.295 . . . . 73.15 112.138 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -97.31 158.72 15.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.01 -0.367 . . . . 73.41 110.01 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -136.51 167.11 22.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.432 -0.507 . . . . 73.3 110.479 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 86.0 m-85 -83.35 118.87 23.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.943 -0.571 . . . . 74.23 109.548 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -92.3 -32.66 14.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.3 110.11 -172.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -121.72 120.86 35.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.961 -0.385 . . . . 72.11 109.961 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.484 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -131.82 95.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.083 -0.71 . . . . 72.42 109.083 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.625 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.6 mt -102.38 125.13 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.167 -0.469 . . . . 74.2 109.878 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -55.15 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.61 0.569 . . . . 74.33 110.945 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 41.15 44.16 2.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.4 1.062 . . . . 74.32 112.254 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -138.3 -81.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 72.15 110.056 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 ptp -160.96 156.9 25.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.688 -0.687 . . . . 74.53 110.307 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.484 HG23 HG13 ' A' ' 56' ' ' ILE . 37.4 mt -134.77 105.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 63.44 109.857 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.494 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.1 tm0? -84.48 128.71 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 74.52 110.181 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -124.97 147.88 16.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.13 -0.557 . . . . 72.12 112.61 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.27 -125.32 3.02 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.618 -0.593 . . . . 75.21 111.618 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.8 t0 42.15 84.08 0.19 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.947 0.899 . . . . 73.42 113.125 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 85.1 Cg_endo -79.17 -26.98 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.635 2.223 . . . . 72.34 111.729 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.479 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 20.1 p -84.11 -39.35 19.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.179 -0.919 . . . . 74.13 111.664 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.23 21.61 14.86 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.774 -0.931 . . . . 74.43 110.774 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.8 p -113.43 -24.88 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.534 . . . . 73.4 110.576 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.21 -13.46 65.78 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.659 -0.7 . . . . 75.45 111.832 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.31 15.51 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.18 0.514 . . . . 73.14 110.208 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.479 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -77.02 170.16 55.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.52 -0.763 . . . . 71.54 112.199 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.614 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . 69.43 -175.76 32.59 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.945 -0.645 . . . . 64.35 112.547 -175.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 56.3 19.75 4.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.236 0.614 . . . . 72.43 112.354 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m -84.26 -1.36 55.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.64 -0.709 . . . . 71.12 110.746 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.605 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.6 tt -61.75 -37.84 79.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.743 -0.662 . . . . 73.23 111.358 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.605 ' HD1' HG23 ' A' ' 77' ' ' ILE . 21.6 p90 -103.22 4.16 36.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.217 0.532 . . . . 73.45 110.957 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.82 -108.99 2.84 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.342 -0.845 . . . . 72.15 112.467 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -89.97 -166.15 1.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.752 0.31 . . . . 73.53 110.233 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -60.62 161.06 8.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.616 . . . . 75.33 109.772 171.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -100.5 -71.53 0.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 74.21 111.179 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.576 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 14.0 tp10 -151.19 -168.31 3.06 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.802 -1.555 . . . . 65.24 106.802 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.827 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 0.9 OUTLIER -136.55 119.54 16.42 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.606 -0.887 . . . . 72.12 108.606 162.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -100.37 29.65 4.27 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.378 -1.283 . . . . 74.52 110.486 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 31.3 mt -48.89 99.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.376 -0.829 . . . . 75.53 111.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -170.69 83.63 0.54 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.61 -1.177 . . . . 75.44 108.839 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.9 84.13 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.284 1.99 . . . . 73.54 111.337 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.94 -18.15 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.329 1.061 . . . . 62.03 108.873 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -104.16 165.61 10.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.332 -1.304 . . . . 74.54 108.79 172.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -119.3 144.37 46.85 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.426 -0.352 . . . . 75.1 110.143 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 120' ' ' GLN . 51.4 p90 -71.33 115.31 10.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 74.14 108.197 174.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.574 ' HG1' ' HB1' ' A' ' 187' ' ' ALA . 77.2 p -99.82 -30.83 11.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.832 -0.622 . . . . 71.33 110.104 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.42 -148.8 5.87 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.063 -0.971 . . . . 64.54 110.94 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.56 144.61 30.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.74 0.305 . . . . 62.55 111.02 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 111.58 22.93 5.87 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.812 -0.709 . . . . 75.23 111.993 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.9 mm -91.39 115.06 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.785 -0.366 . . . . 61.4 110.048 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.691 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 6.8 mt -83.1 124.78 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.233 -0.44 . . . . 74.4 111.115 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.82 171.73 13.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.103 0.478 . . . . 53.14 111.367 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.634 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 24.1 tpp -86.11 137.81 32.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.618 -0.719 . . . . 74.05 111.033 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 111' ' ' GLN . . . -92.75 113.46 25.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.451 0.644 . . . . 75.0 110.346 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.6 -169.58 3.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.002 -0.999 . . . . 73.2 109.03 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.54 -41.58 4.78 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.846 -0.342 . . . . 70.31 111.026 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.3 -55.23 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.504 -0.855 . . . . 75.44 112.474 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 77.51 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.022 1.814 . . . . 74.33 112.099 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.827 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 3.5 p-10 44.93 48.26 9.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.685 0.615 . . . . 74.42 112.13 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.44 29.82 7.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 75.24 111.082 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.634 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 23.6 p30 -93.67 161.78 14.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.965 0.412 . . . . 75.32 110.915 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.541 ' O ' ' HE3' ' A' ' 100' ' ' MET . . . -165.08 -118.21 0.43 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 52.12 112.284 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -105.4 16.92 24.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.377 0.608 . . . . 73.5 109.944 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 72.2 mm-40 -93.87 145.28 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 65.33 109.375 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -145.44 170.88 15.51 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.102 -0.373 . . . . 73.23 110.394 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 28.6 p90 -157.05 152.76 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.955 0.407 . . . . 74.44 111.042 173.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.473 HG23 ' CD2' ' A' ' 98' ' ' LEU . 15.4 t -107.14 146.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 75.05 109.757 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.6 p -100.14 124.26 45.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.875 -0.417 . . . . 72.55 109.875 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.481 HD11 ' HA3' ' A' ' 143' ' ' GLY . 73.9 mt -85.58 -8.14 58.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.709 -0.678 . . . . 74.43 111.117 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.631 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . . . -147.21 167.0 14.56 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.044 -0.526 . . . . 74.25 110.556 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' A' ' 117' ' ' ALA . 17.8 Cg_endo -60.35 113.08 1.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.804 2.336 . . . . 74.21 111.945 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.429 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 31.0 p -107.12 102.36 11.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 63.2 111.67 -175.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -108.43 18.04 21.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.695 0.76 . . . . 75.42 109.921 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -113.86 -3.5 13.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.049 -0.978 . . . . 74.13 111.515 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.7 pp -125.98 9.57 7.51 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.514 -0.474 . . . . 75.02 112.111 -175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.51 -32.61 51.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.456 0.646 . . . . 71.15 111.225 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.79 22.75 8.56 Favored Glycine 0 CA--C 1.509 -0.339 0 CA-C-N 115.423 -0.808 . . . . 60.1 111.68 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.8 mmtm -114.7 -38.71 3.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.306 0.574 . . . . 72.13 109.496 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -137.1 129.45 29.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.39 -0.823 . . . . 73.35 108.956 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -75.25 144.97 42.3 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.047 -0.661 . . . . 74.12 109.568 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.42 ' O ' HD22 ' A' ' 90' ' ' LEU . 44.2 mt -115.35 125.42 72.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.945 -171.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.631 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.3 p90 -154.18 72.83 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.964 0.888 . . . . 73.43 110.895 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -165.58 160.15 33.49 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.923 -1.608 . . . . 71.44 114.326 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.412 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.1 mtm180 -141.87 126.35 17.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.498 . . . . 74.02 109.748 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 96' ' ' GLY . 11.0 p -91.42 136.13 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.274 0.559 . . . . 71.53 110.907 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 38.4 t -141.16 147.73 38.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.045 -0.525 . . . . 74.55 109.992 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.412 ' HA ' ' N ' ' A' ' 184' ' ' ASP . 12.5 tt0 52.42 35.41 17.41 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.124 0.488 . . . . 73.21 112.158 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.48 27.83 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.28 -0.962 . . . . 53.35 112.734 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.465 HG23 ' CG ' ' A' ' 184' ' ' ASP . 9.7 tp -75.13 -38.71 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.721 -0.282 . . . . 75.12 110.299 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.66 -32.08 82.23 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.015 -0.612 . . . . 71.32 111.94 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.547 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 70.0 mmm -69.53 -52.0 30.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.962 -0.384 . . . . 74.13 109.962 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 23' ' ' ILE . 93.0 t -58.07 -29.69 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.143 0.497 . . . . 72.03 110.409 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.646 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -68.0 -55.61 11.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.882 -0.599 . . . . 73.12 109.975 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -14.92 61.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.176 -0.466 . . . . 72.12 111.288 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.705 HG11 HG22 ' A' ' 157' ' ' VAL . 30.4 t -78.61 -39.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.325 0.583 . . . . 75.35 109.544 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -80.49 -21.07 65.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.564 -0.827 . . . . 55.44 112.642 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 85.3 mtp -72.8 -17.03 61.61 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.945 0.35 . . . . 75.32 111.945 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 142' ' ' VAL . 34.4 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.63 . . . . 72.44 111.372 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 HG11 ' A' ' 142' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.559 -0.534 . . . . 73.13 109.559 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -125.96 158.88 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.278 0.561 . . . . 72.32 111.924 -176.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.403 HG21 ' HB1' ' A' ' 162' ' ' ALA . 4.1 mp -88.27 106.2 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.578 -1.192 . . . . 75.53 109.133 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 19' ' ' SER . 26.0 mm -71.67 -53.81 19.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.846 -0.616 . . . . 74.45 110.41 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.435 ' CD ' HG23 ' A' ' 160' ' ' ILE . 2.8 mptm? -129.9 137.98 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.726 -0.67 . . . . 72.41 109.843 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -146.06 110.23 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.019 0.437 . . . . 72.02 110.911 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.34 140.85 31.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.533 -0.758 . . . . 74.23 110.738 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.66 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 39.2 Cg_endo -67.8 135.24 34.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.604 2.203 . . . . 72.21 111.855 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.469 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 9.1 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 110.206 -0.294 . . . . 72.14 110.206 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.465 ' CG ' HG23 ' A' ' 136' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.73 -0.471 . . . . 72.03 109.73 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.55 140.95 3.0 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.859 -0.686 . . . . 53.41 112.518 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -83.5 -163.0 34.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.424 -0.893 . . . . 71.22 112.049 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.668 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -78.07 160.67 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.801 0.334 . . . . 73.5 110.474 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.469 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.9 m-85 -106.82 100.04 29.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.47 . . . . 74.11 110.144 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.672 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.8 Cg_exo -76.81 -6.37 16.76 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.155 2.57 . . . . 75.02 113.0 -173.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -81.87 -29.92 32.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.511 -0.313 . . . . 73.33 111.057 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.0 pt -76.52 -19.01 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.991 0.367 . . . . 73.43 111.991 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 56.4 m170 67.63 48.43 1.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 74.05 111.916 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.45 HG13 HG13 ' A' ' 191' ' ' ILE . 7.3 p -152.34 141.33 14.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.494 -0.321 . . . . 74.1 110.267 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.64 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 74.11 111.704 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.429 ' NE2' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -163.37 136.5 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.737 -0.665 . . . . 74.24 109.339 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -109.1 146.84 34.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 75.33 111.292 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 36.0 Cg_endo -65.6 -62.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.806 2.337 . . . . 72.25 112.418 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.57 26.49 3.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.565 -0.289 . . . . 74.15 111.013 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 202' ' ' ARG . 71.5 m-20 68.31 12.58 8.8 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.266 -0.425 . . . . 71.53 111.708 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.6 ptm -60.5 -24.0 64.96 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.229 0.455 . . . . 72.14 112.229 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -114.45 18.15 18.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.593 -0.813 . . . . 72.43 112.327 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 29.0 mmt180 -66.56 -34.44 77.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 74.24 110.62 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.09 -0.957 . . . . 75.51 109.875 -177.197 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 79.1 Cg_exo . . . . . 0 CA--C 1.53 0.282 0 CA-C-O 121.076 0.365 . . . . 75.53 113.019 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 58.8 Cg_endo -70.99 -7.55 21.68 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.125 2.55 . . . . 63.13 113.289 -175.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.34 147.62 48.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.396 -0.594 . . . . 73.11 109.396 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 164' ' ' PRO . 27.9 m -129.09 146.82 33.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.056 -0.35 . . . . 75.02 110.056 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 46.2 p90 -107.29 128.23 54.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 74.35 110.374 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.13 99.43 8.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 75.42 109.993 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -87.75 115.12 24.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.725 -0.843 . . . . 73.1 108.725 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 177.01 4.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.433 0.635 . . . . 75.44 112.036 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -71.68 -10.34 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.227 -0.897 . . . . 71.12 110.456 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -98.84 -41.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.922 -0.581 . . . . 65.34 110.535 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.521 ' HA3' ' HE3' ' A' ' 138' ' ' MET . . . -176.48 -129.03 1.18 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.026 -0.83 . . . . 52.51 111.026 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -144.06 136.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.099 0.476 . . . . 75.44 110.188 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.474 HG12 HG23 ' A' ' 139' ' ' VAL . 5.2 mp -134.83 122.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.454 -0.794 . . . . 74.3 109.032 176.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 133' ' ' CYS . 3.6 m -102.87 150.99 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.933 -0.707 . . . . 74.05 110.152 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 HD23 ' HG ' ' A' ' 98' ' ' LEU . 4.3 pp -143.99 161.07 39.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.782 -0.645 . . . . 74.14 109.757 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB2' ' HZ2' ' A' ' 29' ' ' TRP . 6.8 pt-20 -138.07 161.24 37.26 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.532 -0.758 . . . . 73.52 108.963 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 172.12 7.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.942 0.401 . . . . 74.34 110.489 -172.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.486 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 5.8 m-85 -91.61 96.2 10.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.407 0.622 . . . . 75.15 111.376 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -82.48 -5.25 58.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.056 -0.974 . . . . 74.12 110.439 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -68.31 -53.9 21.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.598 -0.728 . . . . 73.23 111.284 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -127.76 5.26 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 73.42 110.875 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.46 74.48 79.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.974 0.416 . . . . 74.4 110.699 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.19 -26.08 9.43 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.0 2.466 . . . . 75.31 112.737 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.51 -43.62 10.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.289 0.566 . . . . 74.41 109.908 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.461 HG21 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -59.79 -42.02 92.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 73.2 111.663 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.5 p -64.94 -33.34 75.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 72.34 111.538 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -31.07 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.83 -0.348 . . . . 75.13 111.499 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.44 -44.29 94.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.799 -0.445 . . . . 74.23 109.799 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.45 ' HE1' HG22 ' A' ' 14' ' ' VAL . 18.0 t80 -63.97 -47.17 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.956 -0.565 . . . . 72.52 109.803 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.19 71.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 53.41 112.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 50.4 mm-40 -67.88 -29.3 68.38 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.696 0.284 . . . . 74.54 111.362 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 75' ' ' ALA . 1.2 mm? -69.53 -37.41 77.08 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.185 0.517 . . . . 75.23 110.27 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.66 76.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 74.02 111.016 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 8.7 ptm180 -67.95 -30.07 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.372 -0.376 . . . . 74.31 111.375 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HD2' ' HE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -67.18 -35.17 79.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.392 -0.596 . . . . 75.15 109.392 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.56 27.02 6.23 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.527 -0.844 . . . . 74.01 112.775 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.442 ' HE1' ' HD2' ' A' ' 45' ' ' ARG . 14.9 m-85 -82.09 -29.82 31.59 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.794 -0.239 . . . . 53.51 111.518 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.0 -17.13 60.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.99 0.424 . . . . 73.42 110.574 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 40.3 m-80 -69.47 -11.32 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.471 . . . . 75.32 110.403 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -119.52 16.25 10.53 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.84 -0.695 . . . . 73.11 112.059 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.656 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.4 p -97.32 159.95 14.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 75.15 110.992 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -142.56 155.83 45.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.152 -0.477 . . . . 74.32 109.953 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.4 m-85 -84.29 126.41 33.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.597 . . . . 71.2 109.387 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.83 -13.99 6.26 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.776 -0.369 . . . . 74.01 111.892 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.877 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 25.7 mmt85 -121.71 101.06 7.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.57 -0.53 . . . . 71.44 109.57 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HG13 HG21 ' A' ' 62' ' ' ILE . 4.8 mp -122.43 92.17 2.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.84 -0.8 . . . . 75.41 108.84 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.5 mt -100.11 121.52 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.868 -0.605 . . . . 74.42 109.422 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -49.95 132.03 22.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.941 0.776 . . . . 74.01 110.726 177.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 44.41 40.05 3.56 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.171 0.919 . . . . 74.42 112.328 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.7 t80 -134.64 -81.98 0.44 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 71.33 110.382 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.585 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 27.1 ptt? -161.19 155.09 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 71.43 110.679 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' A' ' 116' ' ' LEU . 35.7 mt -125.16 101.66 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.916 -0.584 . . . . 74.44 109.973 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.877 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 21.1 mt-30 -86.05 123.04 30.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.014 -0.539 . . . . 71.45 111.296 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -129.97 137.61 9.65 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 65.51 112.111 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.656 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 157.63 -155.8 26.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.133 -1.032 . . . . 75.24 112.933 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.475 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 46.2 t0 56.4 89.81 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 124.082 0.953 . . . . 73.23 112.234 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 41.8 Cg_endo -69.73 -17.6 37.61 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.01 2.473 . . . . 74.12 112.14 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -97.64 -39.51 9.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.012 -0.54 . . . . 74.32 112.25 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.71 25.03 33.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.582 -0.818 . . . . 72.31 111.605 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 60.9 p -101.11 -16.88 16.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 71.31 110.943 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 -17.93 42.63 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.068 -0.969 . . . . 75.42 112.126 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.492 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 1.5 ptp180 -106.55 -33.96 7.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 71.52 110.784 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.475 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 87.48 -159.05 30.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.673 -0.775 . . . . 75.5 112.346 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 -114.04 1.01 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.479 -0.649 . . . . 74.4 111.479 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . 57.59 39.31 27.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.015 0.436 . . . . 73.45 112.162 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.2 t -109.41 21.69 16.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 64.02 109.575 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.0 pt -72.11 -21.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.042 -0.526 . . . . 74.35 111.043 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 82' ' ' PHE . 5.2 p90 -106.77 5.45 28.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.512 0.672 . . . . 70.5 110.783 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.65 -117.51 4.66 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.272 -0.876 . . . . 52.23 111.738 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -161.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.653 -0.869 . . . . 73.31 108.653 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -63.36 159.24 18.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 74.33 110.103 175.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.441 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 77.7 t80 -95.36 -67.67 0.84 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.061 -0.518 . . . . 74.31 111.253 -170.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -169.98 152.47 4.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 72.44 108.994 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.76 105.31 8.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.488 0.661 . . . . 73.35 109.245 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -101.68 21.96 13.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.808 -0.633 . . . . 71.52 109.586 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.68 97.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.987 . . . . 71.3 110.629 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -168.34 81.97 0.77 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.018 0.437 . . . . 74.14 109.836 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 51.5 Cg_endo -68.22 106.97 1.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.29 1.994 . . . . 73.24 111.74 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.53 -28.1 65.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.152 -1.055 . . . . 74.51 108.152 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.7 pp -84.21 178.5 7.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.88 -1.509 . . . . 74.54 109.337 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -141.1 167.2 22.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.586 -0.446 . . . . 72.55 109.925 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -63.51 123.16 18.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.163 0.506 . . . . 75.52 109.65 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.0 p -122.62 -40.78 2.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 74.53 110.573 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.42 -148.05 5.92 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.418 -0.81 . . . . 51.45 111.363 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.01 136.8 33.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.732 0.301 . . . . 72.52 110.73 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 116.98 20.07 5.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.85 -0.69 . . . . 61.12 112.208 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 189' ' ' PRO . 10.3 mm -86.64 111.66 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 74.43 109.37 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.686 HD23 HG21 ' A' ' 114' ' ' VAL . 3.2 tm? -87.85 122.89 32.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.148 0.499 . . . . 62.31 110.275 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 128' ' ' ILE . . . -132.07 167.06 20.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.729 -0.669 . . . . 75.12 110.178 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.486 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 34.6 ttp -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.563 -0.532 . . . . 72.2 109.563 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.29 162.36 13.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.99 0.424 . . . . 63.22 110.664 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.757 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.5 p-10 -158.71 162.91 37.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.02 -0.536 . . . . 75.14 110.61 -171.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.08 -19.45 18.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.787 0.803 . . . . 61.11 109.601 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.76 172.37 33.79 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.208 -1.557 . . . . 64.14 109.208 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.98 -44.66 36.27 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.003 2.469 . . . . 62.34 112.421 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.44 -17.6 20.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 64.52 111.108 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -84.12 47.34 1.31 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.519 0.676 . . . . 74.25 110.056 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.757 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 36.6 m-80 -64.33 129.87 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.727 -1.124 . . . . 74.1 108.944 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.24 -146.39 6.43 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.823 -1.18 . . . . 71.42 114.244 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 35.6 t -99.06 27.65 4.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.231 0.539 . . . . 72.21 110.095 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 70.9 mt-30 -118.73 152.09 36.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.789 -0.641 . . . . 72.22 109.888 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.1 p90 -140.46 170.31 16.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.225 -0.657 . . . . 73.42 109.225 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 p90 -156.95 150.1 23.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.239 0.542 . . . . 74.01 111.173 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.686 HG21 HD23 ' A' ' 98' ' ' LEU . 16.1 t -113.34 141.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 75.24 109.338 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.8 p -94.83 125.93 39.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.896 0.379 . . . . 71.0 110.301 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.525 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 34.0 mt -85.56 -7.53 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 71.44 110.228 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.64 159.75 40.36 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.183 -0.917 . . . . 75.34 109.65 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.32 114.62 3.69 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.389 2.06 . . . . 65.15 112.594 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -106.59 118.31 36.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 75.33 110.469 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.51 19.51 19.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 75.42 110.769 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.603 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -128.15 5.2 5.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.825 . . . . 74.45 111.015 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.2 mt -111.3 -1.81 15.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 75.53 111.461 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 10.2 p-10 -70.08 -10.13 57.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.113 0.482 . . . . 74.55 111.358 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.15 17.68 6.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 74.24 111.757 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -121.73 -28.0 4.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.032 0.444 . . . . 64.3 110.205 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.14 134.68 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 74.34 110.327 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -69.04 112.03 5.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.98 0.419 . . . . 63.33 110.272 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 99' ' ' ALA . 39.2 mt -98.79 119.46 46.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.5 110.368 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 35' ' ' THR . 5.6 p90 -156.88 74.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.503 0.668 . . . . 75.33 110.672 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.685 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.6 157.84 29.88 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 118.98 -1.581 . . . . 55.43 114.257 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 190' ' ' GLU . 4.5 mtt180 -125.82 125.53 43.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.583 -0.895 . . . . 74.15 108.583 173.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.426 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.1 p -88.04 132.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.196 -0.602 . . . . 71.1 110.159 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.515 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 47.8 t -139.94 152.03 46.03 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.287 -0.258 . . . . 73.24 111.095 -176.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.74 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.0 pt20 41.67 35.23 0.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.545 1.138 . . . . 75.01 113.11 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.36 15.75 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.559 -0.829 . . . . 71.54 112.343 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.1 tp -72.28 -33.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.619 0.247 . . . . 61.22 110.626 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.49 -37.38 93.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.724 -0.751 . . . . 64.52 111.256 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.521 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 77.9 mmm -71.43 -49.46 41.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.285 -0.265 . . . . 73.41 110.285 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 23' ' ' ILE . 86.5 t -55.81 -30.59 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.998 0.428 . . . . 54.41 110.815 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.95 -51.14 27.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.014 -0.539 . . . . 74.04 110.566 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -76.29 -13.83 60.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.948 -0.569 . . . . 73.42 111.391 -177.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 145' ' ' VAL . 79.0 t -91.76 -27.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 71.14 109.895 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -93.35 -8.01 61.58 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.541 -0.838 . . . . 73.3 113.001 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.4 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 27.3 ptm -85.14 -11.14 55.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.798 0.333 . . . . 73.13 110.369 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 142' ' ' VAL . 28.9 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 73.5 110.77 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 22.2 t . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 108.019 -1.104 . . . . 74.32 108.019 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 2.6 mppt? -127.51 152.84 47.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.334 -0.546 . . . . 63.45 111.407 -167.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.438 HG23 ' HB1' ' A' ' 162' ' ' ALA . 4.0 mp -89.78 109.85 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.45 -0.944 . . . . 74.44 108.45 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.448 HG22 ' CD ' ' A' ' 161' ' ' LYS . 28.5 mm -76.65 -51.87 18.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.102 -0.499 . . . . 71.34 110.679 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.498 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -131.73 129.84 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.739 . . . . 71.14 110.084 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' A' ' 159' ' ' ILE . . . -140.99 110.8 6.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.939 0.4 . . . . 60.11 110.792 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.59 155.14 53.09 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.543 -0.753 . . . . 71.32 109.708 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.667 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.77 137.68 39.12 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.295 1.997 . . . . 75.44 111.332 175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.774 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 5.8 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 120.961 0.41 . . . . 73.53 110.884 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.74 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.3 m-20 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.349 0.595 . . . . 64.22 110.41 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 155.38 144.18 3.85 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.072 -0.967 . . . . 64.12 110.963 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -80.36 -166.55 34.59 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.242 -0.98 . . . . 73.24 112.395 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.611 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.34 175.51 9.68 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.586 -0.524 . . . . 63.14 109.586 177.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.37 102.45 53.13 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.856 0.36 . . . . 72.24 110.511 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' A' ' 97' ' ' ILE . 2.5 Cg_endo -79.69 -13.38 13.23 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.05 2.5 . . . . 74.14 111.065 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.486 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 26.1 tt0 -70.85 -35.16 72.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.016 -0.993 . . . . 74.04 109.773 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.8 pt -92.15 156.45 3.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.144 -1.058 . . . . 71.15 108.144 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -106.39 74.77 1.04 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.996 -0.682 . . . . 74.41 110.921 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.7 149.1 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.393 -0.821 . . . . 71.32 108.977 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.33 118.49 24.9 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.811 -0.356 . . . . 61.22 110.863 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.552 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -152.08 153.23 33.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.543 -0.54 . . . . 74.51 109.543 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 202' ' ' ARG . 62.6 m-85 -120.65 137.74 26.7 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.453 -0.34 . . . . 75.22 111.126 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.85 -55.87 0.95 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.967 2.445 . . . . 73.21 112.289 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 15.12 2.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.641 -0.254 . . . . 75.33 111.458 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 t70 61.91 80.84 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.472 1.13 . . . . 63.42 109.661 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 13.1 ptm -129.96 -10.13 4.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.271 -1.331 . . . . 70.51 110.541 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -142.19 14.97 2.55 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.375 -0.917 . . . . 71.44 112.801 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.433 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 3.1 ptt180 -98.15 -34.81 10.6 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 119.373 -0.931 . . . . 75.43 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.7 mmpt? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.517 -0.754 . . . . 74.24 110.084 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.462 -0.374 0 N-CA-C 111.531 -0.219 . . . . 73.25 111.531 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 38.5 Cg_endo -67.57 -7.5 19.48 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.885 2.39 . . . . 75.41 113.268 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.652 HD22 HG12 ' A' ' 24' ' ' VAL . 18.0 t-20 -133.16 141.41 48.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 73.21 110.731 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.4 m -131.08 157.01 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.116 -0.493 . . . . 54.13 109.973 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.53 ' HB2' HD11 ' A' ' 22' ' ' ILE . 23.7 p90 -121.03 138.82 53.99 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 74.03 110.638 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -114.77 103.68 11.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.627 -0.715 . . . . 65.34 109.754 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' HG12 ' A' ' 22' ' ' ILE . 37.8 tt0 -88.13 114.65 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.304 -0.628 . . . . 74.13 109.304 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 HG13 ' A' ' 159' ' ' ILE . 59.3 p -104.04 177.06 4.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.312 -0.404 . . . . 73.05 110.696 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.42 ' HB2' HD13 ' A' ' 160' ' ' ILE . 27.7 t -71.23 -20.41 62.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.994 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 142' ' ' VAL . 79.8 mtp -95.01 -33.94 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.26 . . . . 70.52 110.937 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -171.17 -138.6 2.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.454 -0.879 . . . . 61.54 112.153 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.98 129.99 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.068 -0.716 . . . . 75.31 109.068 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -124.14 123.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.487 -0.778 . . . . 74.54 110.316 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 13' ' ' ASN . 23.2 t -103.26 138.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.721 -0.474 . . . . 75.21 109.721 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD21 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.72 165.06 33.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 71.02 110.599 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 9.6 pt-20 -136.56 165.21 26.39 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.919 -0.582 . . . . 73.12 110.115 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.01 162.08 13.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.96 0.409 . . . . 74.4 110.504 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 4.0 m-85 -81.53 98.12 8.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.205 -0.452 . . . . 75.45 111.695 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.488 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 42.7 m95 -83.4 -3.72 57.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.117 -0.492 . . . . 75.44 110.594 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -78.84 -62.15 1.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 74.21 111.075 -175.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -125.5 18.76 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.571 -0.286 . . . . 74.54 111.76 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.7 ' HB1' ' HG1' ' A' ' 35' ' ' THR . . . -142.0 71.69 23.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 65.01 111.14 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.35 -44.3 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.992 2.461 . . . . 73.35 113.052 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 1.9 tpmt? -73.66 -36.1 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 65.11 110.543 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.7 ' HG1' ' HB1' ' A' ' 32' ' ' ALA . 14.5 p -68.95 -43.34 75.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.16 -0.473 . . . . 71.21 110.616 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' CE2' ' A' ' 29' ' ' TRP . 25.0 t -53.88 -50.83 65.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.457 -0.792 . . . . 73.44 110.78 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 10.3 mmpt? -60.37 -37.01 79.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 74.23 111.114 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.508 HD21 ' HD1' ' A' ' 39' ' ' PHE . 9.7 t30 -62.17 -56.17 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 74.32 110.323 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HD1' HD21 ' A' ' 38' ' ' ASN . 3.2 m-30 -66.12 -40.05 90.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 73.52 111.565 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.35 94.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.61 -0.268 . . . . 73.3 111.0 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.81 -48.91 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 75.45 111.773 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -65.25 -25.79 67.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.395 -0.522 . . . . 74.32 111.008 -179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.79 -55.72 7.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.017 0.437 . . . . 74.24 110.778 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 44' ' ' ARG . 6.4 ppt_? -79.3 -28.3 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 74.12 112.24 -172.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -74.54 -52.9 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.875 0.369 . . . . 75.11 110.404 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.94 50.02 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.31 -0.948 . . . . 74.51 112.616 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.511 ' HB2' HD12 ' A' ' 42' ' ' LEU . 56.0 t80 -103.48 -51.44 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.793 -0.239 . . . . 75.02 111.091 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' HA ' ' CG2' ' A' ' 51' ' ' THR . 76.0 m-85 -68.49 -18.99 64.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 121.146 -0.222 . . . . 74.0 111.316 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -74.34 84.48 1.93 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.63 -0.878 . . . . 75.4 108.63 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.53 24.41 1.13 Allowed Glycine 0 C--N 1.301 -1.384 0 CA-C-N 113.979 -1.464 . . . . 73.23 111.77 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 48' ' ' TYR . 34.3 p -108.91 158.67 17.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.928 -0.397 . . . . 74.1 109.928 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 12.2 ptpt -138.39 158.12 44.89 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.783 0.325 . . . . 70.23 111.168 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 78.9 m-85 -84.04 121.66 27.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.412 -0.588 . . . . 72.54 109.412 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -96.52 -40.62 8.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.111 -0.495 . . . . 72.34 110.467 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -123.71 114.65 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.343 -0.243 . . . . 74.43 110.343 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.64 89.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.698 -0.853 . . . . 75.33 108.698 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.0 mt -96.56 120.8 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.911 -0.586 . . . . 73.12 110.164 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -53.65 129.12 31.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.723 -0.671 . . . . 70.44 111.003 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 58.28 26.76 14.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.262 -0.881 . . . . 72.01 111.852 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.616 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 1.1 t80 -128.92 -83.45 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.201 0.524 . . . . 74.23 110.469 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 27.3 ptt? -161.26 153.45 19.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.349 -0.841 . . . . 75.12 110.033 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.487 ' CD1' HD21 ' A' ' 116' ' ' LEU . 23.4 mt -119.42 99.76 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.12 -0.696 . . . . 72.53 109.12 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.899 -0.591 . . . . 72.24 110.247 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.06 151.2 20.65 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.941 -0.647 . . . . 74.2 112.191 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 51' ' ' THR . . . 156.25 -77.93 0.2 Allowed Glycine 0 C--O 1.219 -0.797 0 C-N-CA 119.642 -1.266 . . . . 75.31 114.027 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -45.91 108.65 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 122.155 0.979 . . . . 72.53 113.205 -165.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 59.7 Cg_endo -74.46 -14.6 22.48 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.539 2.826 . . . . 75.54 111.891 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.5 p -84.63 -28.76 26.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.952 -1.022 . . . . 63.54 111.381 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 2.98 90.7 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.401 -0.68 . . . . 55.32 111.401 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.6 p -88.34 -24.61 23.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.319 0.581 . . . . 75.54 110.574 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.5 -16.35 48.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.287 -0.87 . . . . 73.24 112.096 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -82.0 -48.12 11.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 75.34 110.245 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.575 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 98.09 -174.57 28.9 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.592 -0.731 . . . . 65.43 112.525 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.29 -93.49 0.86 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.393 -0.683 . . . . 74.3 111.393 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.59 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 61.36 43.31 10.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.652 0.739 . . . . 62.22 111.97 172.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -86.35 24.65 1.33 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.528 -0.76 . . . . 74.22 111.157 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 pt -100.26 -17.7 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.809 -0.356 . . . . 72.33 111.487 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.637 ' HH ' ' HA2' ' A' ' 109' ' ' GLY . 30.2 p90 -121.3 -22.6 5.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.483 -0.487 . . . . 74.4 111.999 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.79 -99.65 1.15 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.563 -0.827 . . . . 64.24 111.467 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 23.6 mtpt -78.88 161.9 26.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.968 -0.382 . . . . 75.11 109.968 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HG2' ' HA ' ' A' ' 107' ' ' THR . 1.2 mp0 -66.08 172.07 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.248 0.547 . . . . 74.53 111.281 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -95.92 -71.96 0.65 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.52 -0.764 . . . . 74.41 109.067 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 5.8 tp10 -169.27 172.01 7.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.494 -1.299 . . . . 73.34 107.494 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.473 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 13.1 p-10 -77.87 107.86 10.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 64.22 109.263 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.42 18.35 5.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 74.3 109.483 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.5 mt -57.04 102.07 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.815 -1.084 . . . . 73.41 110.269 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -157.18 75.38 4.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.552 -0.536 . . . . 65.44 109.552 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HG3' ' O ' ' A' ' 123' ' ' ASP . 37.0 Cg_endo -66.15 91.12 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.621 2.214 . . . . 75.52 112.221 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.28 -16.69 51.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.329 1.061 . . . . 74.44 108.917 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 189' ' ' PRO . 1.5 pp -93.8 175.61 6.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.417 -1.265 . . . . 74.21 110.217 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -131.01 146.31 52.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.212 -0.449 . . . . 75.4 109.886 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.604 ' HE2' ' HB3' ' A' ' 123' ' ' ASP . 96.2 m-85 -69.77 94.15 0.79 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.276 -0.638 . . . . 73.32 109.276 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 195' ' ' GLN . 39.1 p -81.99 -41.71 20.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.945 -1.025 . . . . 61.4 110.434 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.564 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.5 -131.94 1.36 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 31.54 111.645 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.21 143.28 28.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.764 0.316 . . . . 71.43 110.782 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 25.0 5.57 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.741 -0.742 . . . . 71.13 112.128 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 189' ' ' PRO . 7.1 mm -86.45 110.0 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.237 -0.653 . . . . 74.45 109.237 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.745 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.8 tm? -87.19 113.01 22.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.202 -0.453 . . . . 71.31 110.058 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -127.12 171.23 11.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.923 -0.58 . . . . 75.42 110.589 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.491 ' SD ' ' HB ' ' A' ' 127' ' ' THR . 15.2 ptm -95.14 148.34 22.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.821 0.343 . . . . 71.21 110.146 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -94.92 124.82 39.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.028 0.442 . . . . 73.52 110.46 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.646 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -144.28 164.15 31.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 70.42 110.234 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -71.98 -44.87 62.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.99 -0.55 . . . . 62.52 110.53 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.28 -97.48 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.741 -0.742 . . . . 45.01 112.089 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.98 88.64 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.885 2.39 . . . . 75.1 112.145 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 53.51 12.54 0.38 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.688 1.195 . . . . 71.33 113.707 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.2 m -88.16 61.55 6.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.989 -0.745 . . . . 74.14 108.989 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.6 p30 -81.62 143.49 31.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.011 -0.995 . . . . 74.2 111.34 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.637 ' HA2' ' HH ' ' A' ' 78' ' ' TYR . . . -124.89 -172.27 13.47 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.519 -0.764 . . . . 61.43 112.033 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 75' ' ' ALA . 15.9 p -88.44 3.85 48.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 70.34 110.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 77.4 mt-30 -80.75 159.09 25.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 73.43 110.236 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -139.77 169.36 17.87 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.896 -0.409 . . . . 74.33 109.896 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.71 146.82 25.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.116 0.484 . . . . 74.24 110.127 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.653 HG22 HD22 ' A' ' 98' ' ' LEU . 13.1 t -110.44 134.24 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.508 -0.769 . . . . 74.13 109.36 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 p -91.69 125.58 36.46 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.024 0.44 . . . . 75.43 110.323 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 62' ' ' ILE . 47.1 mt -81.54 -9.7 59.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 73.34 110.683 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.24 159.54 32.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.585 -0.734 . . . . 74.13 110.201 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.564 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 34.9 Cg_exo -60.56 122.85 11.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.732 2.288 . . . . 62.52 111.939 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.409 HG23 ' CZ2' ' A' ' 121' ' ' TRP . 3.5 p -127.76 89.15 2.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.227 0.537 . . . . 63.42 110.158 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.52 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.9 OUTLIER -93.22 24.19 3.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.875 0.845 . . . . 75.33 110.144 -166.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.665 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.3 p90 -116.56 -0.18 12.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.315 -1.311 . . . . 75.24 109.504 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.665 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 90.5 mt -108.19 1.05 21.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.368 -0.833 . . . . 72.01 110.796 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.604 ' HB3' ' HE2' ' A' ' 92' ' ' PHE . 16.9 p-10 -68.59 -15.87 63.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.374 -0.83 . . . . 75.24 111.276 -174.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 14.62 10.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.478 -0.868 . . . . 74.13 111.646 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -116.89 -37.24 3.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 73.33 110.546 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -133.27 130.28 38.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 65.45 110.088 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.491 ' HB ' ' SD ' ' A' ' 100' ' ' MET . 19.0 m -65.59 126.5 28.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 74.14 110.21 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.51 ' HB ' HD22 ' A' ' 90' ' ' LEU . 22.6 mt -107.27 127.96 62.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.47 -0.332 . . . . 75.35 110.347 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.616 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 22.7 p90 -159.47 70.83 0.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.521 0.677 . . . . 74.03 110.816 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.745 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.66 155.16 26.39 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.903 -1.141 . . . . 73.12 113.296 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -136.2 120.57 18.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.688 -0.486 . . . . 75.12 109.688 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.34 137.28 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.149 0.5 . . . . 75.4 110.892 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.59 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 35.4 t -144.83 149.33 35.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.052 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.8 tt0 47.64 52.48 12.52 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.403 0.62 . . . . 74.44 111.585 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.83 25.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.379 -0.915 . . . . 74.15 112.05 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.404 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -79.49 -30.94 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.822 -0.436 . . . . 75.33 109.822 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.22 88.89 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.799 -0.715 . . . . 73.53 111.439 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.561 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 54.3 mmm -71.96 -52.44 17.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.936 -0.394 . . . . 63.35 109.936 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.86 -32.04 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.175 0.512 . . . . 75.24 110.926 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.412 ' HB2' ' SD ' ' A' ' 200' ' ' MET . 1.8 t30 -71.4 -50.86 27.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.794 -0.639 . . . . 74.24 110.878 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.466 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.1 OUTLIER -77.87 -12.36 59.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 73.32 111.29 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.563 ' O ' HG22 ' A' ' 145' ' ' VAL . 70.2 t -91.32 -32.32 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.096 0.474 . . . . 63.43 110.434 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.29 -17.37 60.85 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.554 -0.832 . . . . 74.22 113.11 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.466 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.2 ptp -88.36 -13.16 41.34 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.594 -0.442 . . . . 65.2 111.347 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 142' ' ' VAL . 27.5 m . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.307 0.575 . . . . 75.12 110.814 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 109.295 -0.632 . . . . 75.44 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -144.52 166.77 24.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.91 -0.586 . . . . 74.32 111.677 -168.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 162' ' ' ALA . 3.7 mp -88.5 113.18 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.153 -0.93 . . . . 71.54 109.476 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.478 HG21 ' CD ' ' A' ' 161' ' ' LYS . 26.7 mm -75.56 -61.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.626 -0.716 . . . . 75.42 110.389 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.478 ' CD ' HG21 ' A' ' 160' ' ' ILE . 2.1 mptm? -124.95 131.18 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 73.33 110.103 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 159' ' ' ILE . . . -137.68 113.8 9.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.355 -0.384 . . . . 72.34 110.694 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -148.61 156.03 41.78 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 73.21 110.012 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 56.7 Cg_endo -70.33 134.62 27.18 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.19 1.927 . . . . 75.01 111.513 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.208 0.527 . . . . 74.43 110.731 -175.148 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.51 -0.571 0 CA-C-O 121.757 0.789 . . . . 63.23 110.842 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 141.31 148.05 5.0 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.3 -1.318 . . . . 61.41 111.458 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -84.67 -167.35 42.79 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.337 -0.935 . . . . 64.25 111.346 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.535 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -76.04 165.28 25.18 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.202 -0.666 . . . . 71.2 109.202 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -106.84 93.4 8.81 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.637 0.256 . . . . 72.21 110.562 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.689 ' HB2' HD11 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -71.94 -11.85 27.83 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.522 2.148 . . . . 74.4 112.685 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.424 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 41.4 tt0 -71.37 -38.36 71.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.399 0.618 . . . . 74.15 109.632 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.6 155.0 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.972 -1.121 . . . . 74.01 107.972 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.4 m170 -104.76 92.75 4.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.116 -0.634 . . . . 73.15 110.599 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.01 146.92 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.565 -0.743 . . . . 71.53 109.778 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.8 108.0 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.792 0.329 . . . . 53.22 111.171 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.582 ' HG2' ' HB ' ' A' ' 93' ' ' THR . 19.4 pt20 -139.34 141.53 37.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 74.4 110.745 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.469 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 27.6 m-85 -112.6 135.53 21.52 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 120.715 0.293 . . . . 74.43 110.83 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.9 Cg_endo -62.26 -65.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.97 2.447 . . . . 74.43 112.253 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -125.44 19.5 8.09 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.158 0.504 . . . . 75.1 110.078 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 71.18 8.88 6.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.057 -0.974 . . . . 65.13 113.198 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 140' ' ' ASN . 25.1 ptt? -63.89 -29.09 70.3 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.808 -0.357 . . . . 75.4 111.463 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.21 -2.47 90.49 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.822 -0.704 . . . . 64.13 112.35 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.469 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 14.3 mtp180 -87.24 -61.17 1.78 Allowed 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 110.132 -0.321 . . . . 74.44 110.132 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt . . . . . 0 C--O 1.249 1.043 0 O-C-N 125.123 1.514 . . . . 75.3 112.78 -172.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.796 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 19.2 Cg_endo . . . . . 0 CA--C 1.531 0.363 0 CA-C-O 121.0 0.333 . . . . 75.53 112.848 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.39 -11.75 9.38 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.194 2.596 . . . . 52.24 114.108 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.495 HD22 HG11 ' A' ' 24' ' ' VAL . 27.3 t-20 -131.22 148.49 52.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.639 0.257 . . . . 72.42 110.847 -171.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 28.5 m -132.75 147.37 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.138 0.494 . . . . 64.01 111.021 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 39.1 m-85 -105.09 118.96 37.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.68 -0.691 . . . . 73.4 110.528 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 mt -106.02 98.24 7.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.447 -0.342 . . . . 74.01 110.118 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.762 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 6.0 tt0 -89.79 113.06 24.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.457 -0.571 . . . . 72.4 109.457 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -105.47 178.11 4.65 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.068 -0.515 . . . . 63.51 111.09 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -73.75 -15.06 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 73.42 111.049 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.7 mmm -99.23 -32.73 11.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.923 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -178.43 -134.16 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.015 -0.612 . . . . 70.42 111.741 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.496 HD11 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.29 130.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.184 -0.672 . . . . 72.14 109.184 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.496 ' N ' HD11 ' A' ' 22' ' ' ILE . 3.9 mp -122.81 128.42 75.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.556 -0.747 . . . . 74.41 110.203 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 13' ' ' ASN . 46.2 t -110.74 141.77 25.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.232 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 HD23 ' HG ' ' A' ' 98' ' ' LEU . 4.4 pp -155.49 166.6 33.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.878 0.37 . . . . 75.21 111.035 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.37 173.49 10.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.589 -0.732 . . . . 75.32 109.575 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.425 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -111.95 161.18 16.7 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.41 -0.589 . . . . 73.34 109.41 176.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.747 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 5.2 m-85 -80.23 102.16 9.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.548 0.689 . . . . 73.25 112.482 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -82.73 -3.5 56.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.931 -1.031 . . . . 75.33 109.68 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 5.3 mptt -71.64 -57.37 4.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.329 -0.85 . . . . 73.4 111.176 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -136.9 21.49 3.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.055 0.391 . . . . 74.34 112.055 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 35' ' ' THR . . . -135.26 66.72 67.02 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 74.22 110.597 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.71 -51.27 4.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.883 2.389 . . . . 73.21 112.862 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -84.26 -25.63 29.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.741 -0.384 . . . . 75.21 110.243 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.7 -50.29 69.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.194 -0.669 . . . . 71.23 109.194 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 4.4 t -57.25 -43.99 83.46 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.427 -0.806 . . . . 62.41 110.28 172.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -59.95 -39.19 84.73 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.569 -0.741 . . . . 75.1 110.53 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -55.69 -50.49 70.15 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.899 0.381 . . . . 73.15 110.222 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.48 -42.75 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 74.54 111.164 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.44 86.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.011 0.434 . . . . 73.23 111.35 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -46.92 86.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 75.05 110.638 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 42' ' ' LEU . 34.4 mt -69.63 -30.48 68.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 64.31 111.764 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.64 67.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.95 -0.568 . . . . 74.33 111.084 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -74.95 -15.63 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.415 . . . . 74.12 110.346 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.51 ' HB2' HD12 ' A' ' 77' ' ' ILE . 23.5 tpt180 -77.67 -51.68 10.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.795 -0.639 . . . . 73.23 109.676 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.24 27.02 5.74 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.63 -0.714 . . . . 72.42 112.192 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.19 11.36 12.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 72.04 111.485 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.51 -14.75 18.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.751 0.31 . . . . 75.45 110.461 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 32.2 m-80 -80.64 99.28 8.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.94 0.876 . . . . 71.4 109.48 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.31 7.31 9.24 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 114.033 -1.439 . . . . 53.04 111.697 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.454 ' HB ' ' C ' ' A' ' 65' ' ' GLY . 81.9 p -88.84 165.4 14.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.555 0.217 . . . . 61.35 110.489 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.0 158.61 43.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 74.24 110.564 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.588 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 73.3 m-85 -80.6 133.65 35.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.4 0.619 . . . . 61.11 111.388 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.672 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 60.8 m80 -93.64 -56.75 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.966 -1.016 . . . . 74.24 110.507 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.3 mmm180 -114.88 112.72 23.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.852 -1.067 . . . . 74.24 109.805 -170.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 62' ' ' ILE . 4.4 mp -123.11 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.756 -0.831 . . . . 74.13 108.756 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 25.6 mt -103.58 127.32 57.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.022 -0.536 . . . . 73.14 109.714 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -59.83 130.75 48.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.413 0.446 . . . . 75.14 111.096 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 54.1 31.65 14.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.282 -0.872 . . . . 71.42 111.417 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -130.71 -82.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.222 0.534 . . . . 74.43 110.301 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.669 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.7 ptm -160.5 155.83 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.54 -0.754 . . . . 75.31 110.603 -176.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 23.2 mt -132.97 101.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.765 -0.652 . . . . 72.41 109.742 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 50.4 tt0 -89.54 128.22 35.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.474 . . . . 75.0 110.986 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -131.14 160.16 23.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.87 -0.681 . . . . 70.1 112.613 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.454 ' C ' ' HB ' ' A' ' 51' ' ' THR . . . 137.77 -150.8 21.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 73.42 112.309 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.672 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 0.2 OUTLIER 68.08 96.02 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 112.954 0.724 . . . . 73.21 112.954 178.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.59 -17.56 11.17 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.244 1.962 . . . . 65.25 109.819 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.463 ' OG1' HG23 ' A' ' 70' ' ' THR . 3.0 p -92.25 -48.32 6.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.131 -1.395 . . . . 72.32 112.154 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.1 13.42 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.526 -0.63 . . . . 73.44 111.526 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 HG23 ' OG1' ' A' ' 68' ' ' THR . 4.0 t -112.39 -29.1 7.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 74.13 111.85 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.34 -21.86 9.82 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.372 -0.918 . . . . 74.1 112.839 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.33 -29.45 11.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 74.42 110.571 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.72 -169.04 15.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.55 -0.833 . . . . 53.41 113.361 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.33 36.9 2.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.332 -0.461 . . . . 71.12 112.725 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -76.26 59.5 1.39 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.545 0.688 . . . . 72.14 111.124 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -85.85 9.93 15.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.512 -0.767 . . . . 75.04 109.876 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 45' ' ' ARG . 3.0 tt -62.0 -38.6 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 75.11 110.117 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 13.04 22.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.723 0.773 . . . . 75.31 110.409 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -80.87 1.63 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.705 -1.134 . . . . 44.12 112.028 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -133.42 -179.85 5.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.968 0.413 . . . . 73.41 110.43 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.692 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -72.17 174.82 6.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.564 -0.744 . . . . 72.15 110.231 177.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.01 -64.4 1.31 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.391 0.615 . . . . 74.02 110.225 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -161.64 176.5 10.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.495 -1.298 . . . . 74.33 107.495 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.54 ' OD1' ' HG ' ' A' ' 86' ' ' LEU . 2.5 t0 -81.07 138.22 35.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.78 -0.768 . . . . 63.42 110.045 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -100.08 13.81 32.83 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.521 -0.763 . . . . 74.21 110.58 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.54 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 47.5 mt -51.54 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.694 0.621 . . . . 72.32 111.104 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -166.58 79.77 1.04 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.479 -0.782 . . . . 73.31 109.533 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.44 102.56 0.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.598 2.199 . . . . 64.34 112.078 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.94 -14.9 59.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.473 1.13 . . . . 71.3 108.917 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.3 pp -113.24 -174.92 2.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.251 -1.34 . . . . 75.52 109.545 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -141.28 166.38 24.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.963 -0.754 . . . . 72.2 108.963 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -63.9 123.37 18.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.441 0.639 . . . . 73.11 110.511 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.469 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 35.4 p -122.78 -44.81 2.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.528 -0.76 . . . . 74.02 110.005 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.75 -145.27 4.31 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.482 -0.781 . . . . 72.31 111.787 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.61 143.2 26.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.632 0.253 . . . . 71.04 110.923 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.77 22.0 6.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.589 -0.815 . . . . 74.44 111.894 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 189' ' ' PRO . 12.4 mm -84.37 111.33 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.642 . . . . 74.31 109.268 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.703 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.6 124.44 32.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.668 -0.493 . . . . 74.55 109.668 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -133.42 171.32 14.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.048 -0.524 . . . . 74.0 111.383 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.436 ' HE3' ' HB2' ' A' ' 108' ' ' ASN . 25.4 ttt -107.54 132.36 53.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.693 -0.685 . . . . 72.21 109.805 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -96.29 163.19 13.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.411 . . . . 74.31 110.147 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -158.76 164.75 35.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 72.22 109.723 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.53 58.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.118 0.485 . . . . 75.33 111.187 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 147.45 -136.54 6.13 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 120.858 -0.686 . . . . 73.34 111.875 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 18.2 Cg_endo -54.12 97.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 123.305 2.67 . . . . 63.13 111.811 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 3.2 p30 58.53 13.15 2.39 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.211 -1.359 . . . . 73.21 112.645 173.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.4 m -89.31 60.48 5.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.386 0.613 . . . . 74.54 109.369 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.436 ' HB2' ' HE3' ' A' ' 100' ' ' MET . 2.3 p30 -85.1 151.95 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.598 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.94 -110.07 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.976 -0.556 . . . . 63.45 112.124 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 79.8 p -123.48 61.33 1.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.75 0.786 . . . . 64.34 110.568 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 69.8 mm-40 -126.91 146.0 50.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.586 -1.188 . . . . 72.34 109.716 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -148.93 164.91 33.13 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.581 -0.525 . . . . 73.24 109.581 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 48.6 p90 -158.36 152.12 23.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 74.24 111.302 175.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.686 HG22 HD22 ' A' ' 98' ' ' LEU . 15.9 t -113.27 143.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.33 109.115 175.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.7 p -98.79 130.55 45.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.966 0.412 . . . . 75.12 110.28 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.462 HD13 ' HA3' ' A' ' 143' ' ' GLY . 55.3 mt -86.85 -5.5 59.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.721 -0.672 . . . . 74.33 110.651 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.95 163.52 25.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.697 -0.683 . . . . 73.15 110.135 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 21.5 Cg_exo -66.46 120.18 7.28 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.629 2.219 . . . . 74.41 112.074 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -104.68 156.56 17.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 73.42 111.617 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.95 12.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.256 0.551 . . . . 74.04 110.487 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -110.59 -11.03 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 74.13 112.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -129.85 -1.28 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.315 0.578 . . . . 75.04 111.149 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 -13.5 60.67 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.904 -1.044 . . . . 71.14 110.933 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.47 8.49 28.41 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.155 -0.778 . . . . 70.44 111.155 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -114.83 -23.4 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 74.21 109.159 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 100' ' ' MET . 86.0 m-70 -134.64 133.95 40.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.655 -1.157 . . . . 71.0 108.405 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -73.22 147.89 44.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.412 . . . . 71.23 110.52 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 99' ' ' ALA . 29.4 mt -125.16 122.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 73.33 110.62 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 35' ' ' THR . 6.7 p90 -159.58 74.25 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.59 0.71 . . . . 75.01 110.925 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.703 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.45 157.16 29.25 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.574 -1.298 . . . . 71.42 113.177 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -132.58 120.07 21.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.902 -0.406 . . . . 75.55 109.902 173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.6 p -82.73 137.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 73.0 110.582 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.528 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 43.7 t -141.25 153.09 45.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.366 -0.379 . . . . 73.13 110.508 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 2.8 pt20 40.4 39.42 0.7 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.508 1.123 . . . . 71.13 113.221 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.24 31.96 0.12 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.825 -0.702 . . . . 71.5 112.124 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.476 HG23 ' CG ' ' A' ' 184' ' ' ASP . 10.4 tp -83.79 -31.03 7.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 74.12 109.486 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.56 93.0 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.673 -0.694 . . . . 72.25 111.867 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.536 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 60.0 mmm -67.74 -50.63 56.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.641 -0.503 . . . . 75.11 109.641 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 62' ' ' ILE . 85.0 t -53.78 -32.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 75.33 110.833 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -72.82 -53.13 12.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.005 -0.543 . . . . 75.33 110.982 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.18 -14.1 60.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.113 -0.494 . . . . 73.42 111.186 -177.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 157' ' ' VAL . 51.4 t -88.73 -38.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.971 0.415 . . . . 74.25 110.294 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.53 -24.76 64.56 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.592 -0.813 . . . . 70.33 112.775 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.6 ptp -78.24 -16.91 57.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.824 -0.35 . . . . 70.44 111.539 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.643 0.735 . . . . 73.12 110.782 -179.68 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.481 HG22 HG13 ' A' ' 142' ' ' VAL . 2.7 t . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 114.068 1.136 . . . . 74.52 114.068 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.52 149.04 41.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.461 -1.245 . . . . 75.32 109.482 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.412 HD13 ' OG1' ' A' ' 51' ' ' THR . 3.9 mp -84.02 100.58 7.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.435 -0.95 . . . . 72.33 108.435 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.458 HG21 ' HD3' ' A' ' 161' ' ' LYS . 26.0 mm -70.9 -57.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.497 -0.774 . . . . 74.41 110.875 -174.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -136.24 126.65 26.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.358 0.599 . . . . 75.13 111.067 176.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -126.7 120.9 30.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.344 -0.844 . . . . 64.44 110.169 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -139.22 135.99 17.71 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.088 -0.506 . . . . 74.02 110.288 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.796 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 64.7 Cg_endo -75.83 131.93 13.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.503 2.136 . . . . 72.53 111.729 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.451 -0.341 . . . . 73.12 110.622 -177.498 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.476 ' CG ' HG23 ' A' ' 136' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 109.7 -0.481 . . . . 74.11 109.7 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 139.56 151.76 5.74 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.86 -0.686 . . . . 72.23 112.089 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.22 -166.54 42.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.618 -0.801 . . . . 71.14 111.814 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.84 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -79.83 168.1 19.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.881 0.372 . . . . 74.31 110.216 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.38 98.49 46.66 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.111 0.482 . . . . 74.42 110.457 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.648 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 72.8 Cg_endo -78.84 -9.55 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.736 2.291 . . . . 60.44 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.747 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 32.2 tt0 -75.08 -34.58 61.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.049 -0.978 . . . . 72.44 111.355 -174.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.5 pt -74.04 -19.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.106 -0.497 . . . . 73.51 111.273 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.8 m170 72.45 32.18 1.65 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.455 -0.793 . . . . 74.43 111.62 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.72 147.02 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.887 -0.597 . . . . 74.33 109.679 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.94 131.18 41.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.614 0.598 . . . . 52.31 112.614 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.66 157.52 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.933 -1.136 . . . . 74.15 107.933 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -121.18 150.01 52.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.766 -0.373 . . . . 72.33 111.404 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.84 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 40.7 Cg_endo -69.41 -76.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.597 2.198 . . . . 73.41 111.639 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.419 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -114.3 19.45 16.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 71.22 110.263 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 72.83 0.72 3.76 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.679 0.992 . . . . 75.34 113.679 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -61.41 -28.95 69.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.936 0.335 . . . . 73.3 111.402 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.85 -4.36 85.43 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.726 -0.75 . . . . 73.34 112.994 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -79.44 -35.29 40.69 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.902 0.382 . . . . 72.55 109.972 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-N 114.573 -1.194 . . . . 75.12 110.906 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HG3' ' HB3' ' A' ' 164' ' ' PRO . 32.4 Cg_endo . . . . . 0 C--O 1.233 0.24 0 CA-C-O 120.827 0.261 . . . . 74.51 112.536 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.12 -20.31 19.23 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.44 112.557 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.445 HD22 HG13 ' A' ' 24' ' ' VAL . 26.9 t-20 -139.12 146.13 40.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 74.42 109.578 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 164' ' ' PRO . 26.8 m -139.9 163.53 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 74.14 111.716 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 165' ' ' SER . 34.9 m-85 -104.93 124.65 49.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.555 -0.748 . . . . 73.35 110.785 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.89 95.99 5.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.668 -0.493 . . . . 72.21 109.668 170.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -90.1 112.39 23.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.225 -0.657 . . . . 62.45 109.225 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -97.46 -179.72 4.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.011 0.434 . . . . 72.4 111.083 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.669 ' HG ' HD11 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -67.65 -29.74 69.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.775 -0.648 . . . . 72.13 110.545 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 142' ' ' VAL . 93.9 mtp -88.12 -34.69 17.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.591 . . . . 71.12 111.358 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -173.82 -133.28 1.66 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.689 -0.767 . . . . 71.22 111.915 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.0 tt -140.75 137.43 35.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.116 0.484 . . . . 73.25 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 126.78 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.826 -0.625 . . . . 65.21 109.821 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 13.3 t -105.91 142.04 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 71.43 109.723 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.65 164.08 36.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 73.31 110.933 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 10.2 pt-20 -130.95 165.21 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.568 -0.742 . . . . 73.34 109.765 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.01 157.74 16.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.234 -0.439 . . . . 75.33 109.923 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -79.82 103.44 9.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 72.42 111.969 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -81.81 0.84 37.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 75.32 110.891 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -70.31 -66.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.033 -0.531 . . . . 72.43 111.274 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 t-160 -126.51 9.91 7.21 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.729 -0.388 . . . . 73.3 111.034 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.73 65.38 72.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 121.078 -0.249 . . . . 72.21 111.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 31' ' ' HIS . 13.2 Cg_exo -69.85 -45.56 1.5 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.647 2.231 . . . . 74.23 112.196 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.39 -35.1 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 75.4 109.972 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.414 HG21 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -65.52 -46.19 80.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.673 -0.694 . . . . 72.45 110.199 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -55.08 -48.93 72.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.952 -0.567 . . . . 74.43 110.496 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -36.0 78.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.806 -0.634 . . . . 73.14 110.935 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.35 -40.17 85.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 73.05 110.228 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.81 -47.56 58.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 74.52 109.792 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.51 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 63.31 111.78 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 51.2 mm-40 -60.35 -38.89 85.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.22 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 42' ' ' LEU . 30.7 mt -68.56 -30.46 69.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.889 0.376 . . . . 73.22 110.882 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.76 64.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 71.4 111.212 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -74.24 -29.1 61.54 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.775 -0.37 . . . . 75.53 111.244 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.4 -46.11 42.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.625 -0.509 . . . . 74.24 109.625 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.17 42.62 1.61 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.675 -0.774 . . . . 72.53 111.781 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -76.04 -27.91 57.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.249 0.547 . . . . 75.43 110.422 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.4 m-85 -78.2 -3.27 41.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.022 -0.535 . . . . 72.3 111.043 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -73.78 -0.64 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.098 0.475 . . . . 61.01 110.539 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.88 7.55 5.79 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.95 -0.568 . . . . 55.45 112.131 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 65' ' ' GLY . 35.3 p -88.02 149.45 23.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.353 . . . . 72.32 111.247 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 11.7 ptpt -139.39 157.41 45.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.59 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.548 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 80.9 m-85 -86.13 131.09 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.786 0.327 . . . . 72.33 110.356 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -109.93 -38.91 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 72.33 110.992 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 26.4 mmm180 -115.37 117.37 30.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.076 -0.342 . . . . 74.12 110.076 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 HG13 HG21 ' A' ' 62' ' ' ILE . 4.6 mp -131.23 94.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.94 -0.763 . . . . 75.03 108.94 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.748 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 36.9 mt -105.23 128.34 59.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.841 -0.618 . . . . 74.34 109.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.42 128.72 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.075 0.464 . . . . 74.3 111.13 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 203' ' ' LYS . 60.6 m-20 54.12 35.43 22.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.848 -1.069 . . . . 64.02 111.512 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.748 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 4.2 t80 -132.44 -82.39 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.989 0.424 . . . . 75.55 110.279 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 22.7 ptp -159.74 158.63 31.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 74.32 110.573 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.464 ' CD1' HD22 ' A' ' 116' ' ' LEU . 35.1 mt -130.22 100.28 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.622 -0.717 . . . . 70.3 109.419 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.57 127.71 34.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.333 -0.394 . . . . 73.34 110.494 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -139.18 149.58 20.77 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.616 -0.802 . . . . 73.31 112.335 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 51' ' ' THR . . . 151.14 -71.76 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.926 -1.13 . . . . 71.43 113.524 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.425 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 32.0 t0 -42.86 105.91 0.45 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.899 0.703 . . . . 74.21 112.899 -168.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 97.6 Cg_endo -86.2 -18.52 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.315 2.676 . . . . 74.44 111.54 176.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.403 ' HB ' HG23 ' A' ' 70' ' ' THR . 77.6 p -89.62 -32.7 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.309 -0.86 . . . . 74.34 111.371 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 31.64 59.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.832 -0.907 . . . . 74.33 110.832 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.507 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 64.3 p -102.88 -30.55 10.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 71.21 111.056 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.34 -3.31 23.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.299 -0.864 . . . . 74.14 112.085 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.507 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -119.12 -31.34 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.647 0.26 . . . . 74.52 111.277 178.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 95.39 -169.65 27.81 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.809 -0.71 . . . . 74.13 112.797 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.88 -105.52 2.29 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.26 -0.495 . . . . 52.33 112.246 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 44.77 48.96 8.98 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 74.3 112.645 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.44 12.71 2.83 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.021 -0.536 . . . . 75.52 110.919 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.6 -20.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.737 0.303 . . . . 75.54 110.611 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.42 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 16.0 p90 -101.2 -2.01 32.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.167 0.508 . . . . 74.33 111.143 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.42 1.4 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 55.42 113.125 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.32 -168.05 1.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.841 0.353 . . . . 75.14 111.251 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.2 173.87 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 73.53 111.886 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 89.7 m-85 -139.67 -162.02 1.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.897 -1.047 . . . . 75.23 108.965 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.82 159.29 34.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.606 -0.516 . . . . 73.23 109.606 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -61.35 136.28 57.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.609 -0.515 . . . . 73.32 109.609 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.07 16.53 25.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 73.13 110.714 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.4 mt -71.8 96.81 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.147 0.499 . . . . 74.31 111.958 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.48 78.48 6.96 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.715 -0.675 . . . . 73.21 111.031 173.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 89.33 0.55 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.593 2.195 . . . . 74.55 112.428 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.22 10.76 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 71.3 110.544 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -122.98 -175.72 3.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.232 -0.895 . . . . 71.54 109.846 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -124.77 144.26 50.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.627 0.251 . . . . 65.15 110.827 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 68.34 0.63 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.637 0.732 . . . . 75.44 109.888 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.1 p -65.53 -39.39 91.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.159 -0.928 . . . . 74.32 112.066 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.608 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -170.42 -137.03 2.19 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.372 -0.918 . . . . 44.43 112.538 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.71 140.61 30.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.617 0.246 . . . . 60.52 110.741 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.25 24.32 5.73 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.774 -0.727 . . . . 61.11 111.775 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.8 mm -88.39 109.79 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.441 -0.577 . . . . 74.45 109.441 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.48 119.69 26.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.562 -0.532 . . . . 75.42 109.562 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 128' ' ' ILE . . . -131.7 174.24 10.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 74.51 111.478 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.816 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 28.2 ttt -106.93 142.32 36.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.729 -0.669 . . . . 75.43 109.907 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -103.79 118.16 36.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.527 0.68 . . . . 70.12 111.095 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.8 p-10 -115.47 165.74 12.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.998 -1.001 . . . . 71.31 109.964 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.5 -37.38 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.862 0.839 . . . . 64.12 109.19 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -138.83 174.49 22.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 108.644 -1.782 . . . . 74.3 108.644 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.57 -49.61 11.73 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.073 2.515 . . . . 75.04 112.811 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.57 -11.1 19.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.521 -0.308 . . . . 72.53 111.275 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 m -86.14 55.46 3.55 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.667 -0.864 . . . . 75.11 108.667 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 38.6 m-80 -62.15 117.22 5.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.356 -1.293 . . . . 72.43 109.505 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.462 ' H ' ' HA ' ' A' ' 102' ' ' ASN . . . -90.95 -168.16 41.82 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 73.01 112.672 -172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -99.46 20.27 14.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.42 0.628 . . . . 64.45 110.094 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 17.4 mt-30 -109.89 159.04 17.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.478 -0.783 . . . . 75.35 110.77 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -139.89 174.17 10.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.665 . . . . 74.0 109.203 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.08 154.69 24.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 73.23 111.692 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.665 HG23 HD22 ' A' ' 98' ' ' LEU . 16.0 t -113.22 145.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.274 -0.876 . . . . 74.21 109.23 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 p -100.94 131.1 46.97 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.062 0.458 . . . . 55.1 110.459 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.495 ' CD1' ' HA3' ' A' ' 143' ' ' GLY . 59.8 mt -89.2 -5.39 57.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 62.33 110.994 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.39 164.22 21.9 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.756 -0.656 . . . . 74.11 109.849 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.608 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 38.9 Cg_exo -61.06 107.04 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.464 2.109 . . . . 61.21 111.887 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.533 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 23.4 p -96.37 96.89 9.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.81 -0.632 . . . . 63.24 111.02 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.02 9.9 42.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.57 0.7 . . . . 75.43 110.471 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.441 ' CZ2' HG21 ' A' ' 119' ' ' THR . 2.2 p90 -108.57 -12.42 14.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.77 -1.105 . . . . 75.3 111.591 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.533 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 3.3 pp -114.91 9.8 16.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 75.05 111.342 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.85 -34.37 65.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.465 -0.789 . . . . 73.14 110.885 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.39 15.36 30.03 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.524 -0.762 . . . . 73.31 112.033 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.59 -35.93 5.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.075 0.464 . . . . 72.32 110.078 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -140.82 139.4 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.796 -0.638 . . . . 73.51 109.671 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -77.68 148.71 34.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.156 0.503 . . . . 72.11 110.446 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.499 HG22 ' HB3' ' A' ' 99' ' ' ALA . 45.1 mt -126.88 122.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.59 . . . . 75.43 110.555 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.816 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.4 p90 -153.93 72.94 0.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.685 0.755 . . . . 71.34 111.212 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.08 152.24 22.27 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.557 -1.306 . . . . 73.42 113.676 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.412 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 74.0 mtp180 -130.14 117.22 19.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.218 -0.66 . . . . 55.2 109.218 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.44 135.34 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.051 0.453 . . . . 74.53 110.385 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.631 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 51.3 t -143.65 145.01 32.14 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.26 -0.427 . . . . 73.53 110.096 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.66 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.7 tt0 50.92 40.69 25.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.354 0.597 . . . . 73.22 111.85 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.62 24.82 0.1 OUTLIER Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.143 -1.027 . . . . 62.04 112.152 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.41 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.5 tp -78.61 -32.32 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.088 -0.245 . . . . 75.23 110.478 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.35 94.4 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.155 -0.778 . . . . 72.42 111.155 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.584 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 72.1 mmm -68.09 -55.64 11.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.145 -0.317 . . . . 74.41 110.145 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.1 t -51.57 -31.25 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.218 0.532 . . . . 72.32 110.644 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.6 t30 -70.11 -56.79 5.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.713 -0.676 . . . . 72.31 110.538 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.474 ' HD2' ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -72.62 -15.64 61.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.767 0.318 . . . . 72.41 111.261 -177.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.658 HG22 ' SD ' ' A' ' 20' ' ' MET . 75.3 t -79.73 -43.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.369 -0.604 . . . . 70.43 109.369 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -76.48 -25.86 64.64 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.417 -0.897 . . . . 73.0 112.549 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 77.7 mtp -73.53 -11.27 60.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.76 0.282 . . . . 74.43 111.76 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.561 0.696 . . . . 75.35 111.243 178.21 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.78 0.8 . . . . 74.22 111.697 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.67 172.97 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.165 -0.925 . . . . 71.34 109.276 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 159' ' ' ILE . 3.3 mp -89.52 105.01 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.728 -0.841 . . . . 75.05 108.728 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.669 HD11 ' HG ' ' A' ' 19' ' ' SER . 22.7 mm -73.92 -48.22 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.364 -0.835 . . . . 55.43 110.989 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.554 ' HD3' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -131.86 126.08 33.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.944 -0.571 . . . . 74.54 110.828 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.16 122.82 30.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.0 0.429 . . . . 70.2 110.566 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -155.91 150.87 20.75 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.842 -0.617 . . . . 75.42 110.268 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 14' ' ' VAL . 54.7 Cg_endo -70.86 134.25 25.26 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.638 2.226 . . . . 74.53 112.887 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.6 p . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 74.13 109.934 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.6 m-20 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.275 0.559 . . . . 71.13 110.443 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.54 146.93 4.47 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.228 -0.896 . . . . 71.32 111.306 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -84.59 -166.61 41.55 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.373 -0.918 . . . . 62.11 111.929 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.653 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -74.9 170.86 15.1 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.741 0.305 . . . . 64.14 110.271 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.14 93.17 17.21 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-O 121.153 0.501 . . . . 72.21 110.449 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 6.0 Cg_exo -76.36 -13.56 18.62 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.888 2.392 . . . . 74.13 111.715 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.24 -34.79 42.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.902 -1.045 . . . . 74.32 111.072 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.444 HG13 HG11 ' A' ' 193' ' ' VAL . 31.3 pt -80.31 -11.7 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 75.12 111.428 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 32.5 m170 61.04 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.416 -0.811 . . . . 72.02 111.321 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 191' ' ' ILE . 6.4 p -164.21 152.95 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.059 -0.349 . . . . 72.21 110.059 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.14 113.97 14.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 75.32 111.911 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -161.94 157.32 23.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 73.25 109.625 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -124.02 156.35 66.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.503 -0.317 . . . . 72.33 110.726 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.653 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 49.0 Cg_endo -69.34 -69.7 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.478 2.119 . . . . 72.52 112.272 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.429 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.6 pt? -120.25 23.57 10.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 72.4 109.95 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 68.56 13.92 9.0 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.226 -0.897 . . . . 72.34 111.846 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.6 ptm -52.24 -46.04 65.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 70.23 112.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 -2.15 90.11 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.745 -0.74 . . . . 72.11 113.141 -175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -80.02 -26.5 39.77 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.374 0.607 . . . . 73.41 110.206 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.69 ' HB3' ' HZ2' ' A' ' 203' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-N 114.9 -1.045 . . . . 74.5 109.927 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.905 ' HB3' ' HB3' ' A' ' 164' ' ' PRO . 4.7 Cg_endo . . . . . 0 CA--C 1.529 0.24 0 N-CA-C 113.146 0.402 . . . . 73.02 113.146 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.82 -31.51 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.894 2.396 . . . . 74.42 111.304 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.23 139.84 30.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.144 -0.935 . . . . 63.34 109.329 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 164' ' ' PRO . 24.6 m -135.89 165.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.539 -0.3 . . . . 71.24 110.617 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.569 ' HB2' HD11 ' A' ' 22' ' ' ILE . 38.5 p90 -124.13 134.11 53.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.167 0.508 . . . . 73.22 110.61 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.16 111.12 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 74.45 110.451 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 7.1 tp10 -85.67 112.09 20.69 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.383 -0.969 . . . . 71.03 108.383 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -105.0 -179.8 4.05 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.066 0.46 . . . . 62.3 111.263 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.536 ' HG ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -80.53 -1.48 42.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 70.14 111.035 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.596 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.0 mmt -108.32 -44.89 4.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 73.54 109.95 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -171.6 -140.9 3.19 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.592 -1.003 . . . . 65.42 110.592 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -133.08 131.47 58.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.529 -0.545 . . . . 75.41 109.529 -178.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 139' ' ' VAL . 4.1 mp -125.96 128.37 71.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.759 -0.655 . . . . 74.41 110.947 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 85.1 t -111.52 143.71 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.82 -0.437 . . . . 74.52 109.82 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.12 161.24 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.215 0.531 . . . . 73.25 110.852 176.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -125.72 168.81 13.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.366 -0.834 . . . . 74.23 109.823 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 27' ' ' LEU . 1.1 mm? -108.54 163.05 13.57 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.198 -0.667 . . . . 75.31 109.198 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.742 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 2.9 m-85 -83.35 89.82 7.07 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.253 -0.579 . . . . 74.4 111.993 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -7.19 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.453 -1.314 . . . . 75.33 107.453 170.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -66.79 -43.06 84.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.426 -1.715 . . . . 64.53 110.746 -176.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -140.06 -1.61 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 75.44 111.584 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.6 88.97 18.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.742 -0.383 . . . . 73.43 111.435 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.23 -6.11 17.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.895 2.396 . . . . 75.01 112.626 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 15.4 mtpt -100.1 -53.8 3.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.399 -0.364 . . . . 74.11 111.101 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.407 HG21 ' SD ' ' A' ' 100' ' ' MET . 8.8 m -53.93 -35.86 62.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 70.31 111.977 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.615 ' SG ' ' HE2' ' A' ' 37' ' ' LYS . 6.1 p -66.89 -28.43 68.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 73.12 111.517 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.615 ' HE2' ' SG ' ' A' ' 36' ' ' CYS . 36.8 mmtt -79.93 -34.83 38.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.347 -0.388 . . . . 74.43 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -57.04 -53.2 60.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.557 -0.747 . . . . 74.4 110.531 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 14' ' ' VAL . 23.4 t80 -61.55 -50.68 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 74.31 109.838 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -42.19 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.961 -1.018 . . . . 73.24 111.49 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.07 -48.92 70.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 61.43 110.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 47' ' ' TYR . 2.6 mm? -74.78 -29.12 61.02 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.582 -0.447 . . . . 74.22 111.695 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.1 65.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.691 -0.231 . . . . 71.14 111.521 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.14 -21.54 53.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 72.44 110.423 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.434 ' C ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.65 -45.69 24.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.018 -0.734 . . . . 74.51 109.018 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.09 2.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.697 -0.763 . . . . 71.44 111.62 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.53 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -71.15 -30.77 66.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.139 0.495 . . . . 72.22 110.265 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -78.18 -7.72 57.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.598 -0.728 . . . . 70.33 111.502 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.78 -8.1 53.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 74.22 111.168 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.49 31.69 2.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.71 . . . . 73.51 112.252 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.719 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 20.3 p -107.46 150.63 26.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.041 0.448 . . . . 74.45 111.863 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -120.17 169.93 9.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 74.1 109.169 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -88.08 118.49 27.68 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 74.23 109.329 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -93.31 -28.77 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 73.01 110.413 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 41.1 mmt180 -137.67 109.74 7.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 73.44 110.134 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 56' ' ' ILE . 4.1 mp -115.07 79.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.395 -0.595 . . . . 72.42 109.395 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.09 134.47 27.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.051 -0.522 . . . . 73.33 109.639 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 2.4 mptp? -74.62 128.76 36.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.443 -0.344 . . . . 72.22 110.388 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.8 32.28 21.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.005 0.815 . . . . 71.14 110.923 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.86 -83.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 74.2 111.144 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptm -160.63 155.15 23.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.822 -0.626 . . . . 70.41 110.718 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.491 ' CD1' HD21 ' A' ' 116' ' ' LEU . 36.1 mt -130.58 103.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.629 -0.714 . . . . 74.3 109.723 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.8 tt0 -80.14 126.6 31.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.9 -0.591 . . . . 72.22 110.447 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.28 129.38 7.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.836 -0.697 . . . . 73.32 111.646 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.719 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 134.81 -148.12 19.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.458 -0.877 . . . . 72.24 112.859 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.8 t0 53.21 81.75 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 123.892 0.877 . . . . 75.3 111.534 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HD3' ' CE1' ' A' ' 47' ' ' TYR . 54.7 Cg_endo -72.32 -24.02 20.05 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.792 2.328 . . . . 72.24 111.159 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 5.6 p -81.9 -46.32 14.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.256 -0.884 . . . . 71.24 111.751 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.32 26.55 10.0 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.578 -0.82 . . . . 74.24 111.412 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 t -128.81 -19.31 3.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.775 0.321 . . . . 73.02 111.121 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.88 -18.57 55.69 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.524 -0.846 . . . . 72.22 113.313 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.467 ' C ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -110.9 5.22 20.33 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.429 -0.453 . . . . 73.54 111.152 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.482 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -86.85 176.85 47.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 70.54 112.647 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.53 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 85.18 -45.26 3.48 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.034 -0.603 . . . . 62.44 112.533 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 110' ' ' SER . . . -76.32 25.25 0.13 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.834 0.454 . . . . 62.03 111.702 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 74' ' ' GLY . 7.4 m -59.5 -24.35 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 64.42 111.06 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.568 HG22 ' HD1' ' A' ' 78' ' ' TYR . 3.4 tt -56.22 -48.36 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.717 -0.674 . . . . 74.22 111.284 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.568 ' HD1' HG22 ' A' ' 77' ' ' ILE . 30.2 p90 -108.97 -6.09 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.657 0.265 . . . . 70.21 111.593 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.58 -95.95 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.622 -0.799 . . . . 63.03 113.524 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -112.06 -174.33 2.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.744 0.783 . . . . 75.31 112.16 -173.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.539 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -85.91 175.18 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.388 -1.278 . . . . 74.13 108.751 170.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -132.98 -60.47 0.86 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.293 -0.563 . . . . 73.15 111.717 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.72 177.87 8.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.437 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.651 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -103.95 149.49 25.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.789 -0.449 . . . . 72.45 109.789 174.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -121.79 23.87 9.93 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.8 mt -59.53 102.86 0.16 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.425 -0.807 . . . . 73.13 111.062 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -161.84 82.09 1.84 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.923 0.392 . . . . 71.13 110.377 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.78 81.25 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.44 2.093 . . . . 72.54 111.296 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.76 -4.41 59.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.054 0.93 . . . . 73.24 109.403 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.72 -153.29 0.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.37 -1.286 . . . . 72.53 108.611 173.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -152.43 142.04 21.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.588 -0.445 . . . . 74.42 110.946 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.666 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 34.8 p90 -59.83 123.63 17.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.529 -0.76 . . . . 75.02 109.398 170.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.0 p -116.2 -40.13 3.31 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.253 -0.43 . . . . 75.32 110.995 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.36 -143.54 3.73 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.034 -0.603 . . . . 64.33 112.274 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 151.3 19.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.686 0.279 . . . . 71.25 110.626 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.35 23.73 8.28 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.52 -0.848 . . . . 63.54 111.319 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.411 HD11 ' HG3' ' A' ' 189' ' ' PRO . 8.1 mm -89.04 111.36 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.643 -0.502 . . . . 74.43 109.643 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.69 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -86.72 120.16 27.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.749 -0.66 . . . . 75.04 109.719 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.422 ' CB ' HG12 ' A' ' 128' ' ' ILE . . . -134.42 172.86 12.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.151 -0.477 . . . . 73.5 111.319 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.563 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 64.7 mtp -90.52 141.78 28.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 72.15 110.411 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.22 156.66 18.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.136 -0.484 . . . . 64.21 109.754 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.579 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.7 p-10 -159.75 163.25 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.386 -0.37 . . . . 74.31 110.712 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.1 -38.7 15.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.68 . . . . 72.4 110.303 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.16 -80.67 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.522 -0.847 . . . . 72.01 112.65 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.13 85.3 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.976 2.451 . . . . 70.13 112.934 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 52.32 33.08 12.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.392 -0.822 . . . . 71.52 112.136 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -76.26 39.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.212 0.449 . . . . 75.23 112.212 -174.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.651 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 14.7 m-80 -84.66 139.58 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.377 -0.601 . . . . 73.23 109.377 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.15 -68.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.85 -1.167 . . . . 45.43 113.533 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.526 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 33.8 t -109.13 -24.24 11.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.573 0.582 . . . . 73.44 112.573 -169.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -91.37 137.47 32.34 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.487 -0.485 . . . . 54.32 110.051 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 87.9 m-85 -141.12 167.5 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.653 0.263 . . . . 72.43 110.679 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 34.1 p90 -159.4 158.27 31.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.753 0.311 . . . . 73.41 110.719 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.69 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -112.14 146.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 71.41 109.686 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -98.55 131.84 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 70.43 110.232 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.9 mt -85.76 -7.71 58.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.896 -0.593 . . . . 74.25 111.024 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.96 158.41 33.89 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.106 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.666 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 56.2 Cg_endo -71.76 123.91 9.77 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.362 2.042 . . . . 72.5 112.04 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.0 p -108.81 158.57 17.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 74.43 110.937 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 21.67 2.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.105 0.479 . . . . 74.5 111.005 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.32 -3.98 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.064 -0.516 . . . . 75.04 112.113 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 4.3 pp -130.4 3.94 4.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.497 -0.481 . . . . 74.23 111.617 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.64 -28.36 69.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 73.22 110.493 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.28 13.07 55.18 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.29 -0.724 . . . . 62.2 111.29 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 25.1 mmmt -116.22 -22.94 8.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.119 -0.697 . . . . 75.14 109.119 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.474 ' HB3' ' O ' ' A' ' 100' ' ' MET . 85.4 m-70 -134.67 134.68 41.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.37 -0.832 . . . . 75.13 110.042 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.9 m -72.81 121.4 19.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.06 -0.348 . . . . 72.45 110.06 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 99' ' ' ALA . 45.1 mt -108.71 114.65 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.92 -0.312 . . . . 64.32 111.768 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.5 m-85 -156.59 76.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 72.44 110.399 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.86 157.11 29.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.582 -0.818 . . . . 72.34 112.871 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.642 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 55.9 mtm180 -134.98 125.89 27.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.976 -0.379 . . . . 72.31 109.976 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.49 139.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.037 0.446 . . . . 64.42 110.41 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 41.3 t -139.24 143.58 38.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.551 -174.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.6 pt20 41.21 40.14 1.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.246 1.018 . . . . 73.54 113.239 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.47 41.41 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 71.2 111.901 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.82 -36.35 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.672 0.272 . . . . 73.23 110.636 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -36.36 92.05 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.903 -0.665 . . . . 74.24 111.681 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.567 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 72.0 mmm -67.83 -51.66 45.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.26 -0.274 . . . . 64.42 110.26 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 23' ' ' ILE . 91.9 t -54.31 -32.66 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.131 0.491 . . . . 71.32 110.668 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -70.39 -51.87 26.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 74.02 110.45 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.588 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -76.81 -10.14 59.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.966 -0.561 . . . . 75.23 111.355 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.596 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.8 t -87.11 -38.9 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.277 0.561 . . . . 72.45 109.792 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -78.31 -33.96 38.08 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.574 -0.822 . . . . 50.03 112.87 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 22.1 ptm -78.93 -18.91 53.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.08 0.4 . . . . 74.15 112.08 -173.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.234 0.239 0 C-N-CA 119.962 -0.695 . . . . 61.3 110.095 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 158' ' ' LYS . 3.6 t . . . . . 0 CA--C 1.518 -0.274 0 CA-C-O 121.847 0.832 . . . . 74.02 112.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 158' ' ' LYS . 2.0 mppt? -139.65 170.95 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.691 -1.14 . . . . 70.42 109.301 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 159' ' ' ILE . 3.7 mp -90.52 106.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.734 -0.839 . . . . 64.04 108.734 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.536 HD13 ' HG ' ' A' ' 19' ' ' SER . 26.0 mm -73.62 -52.3 21.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.607 -0.724 . . . . 73.42 110.251 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.518 ' HD2' HG21 ' A' ' 160' ' ' ILE . 4.9 mptp? -130.73 143.42 50.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.542 -0.754 . . . . 72.51 109.298 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.94 127.22 13.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.944 -0.391 . . . . 63.32 109.944 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -148.23 155.23 43.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.569 -0.53 . . . . 74.11 109.569 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.905 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 7.8 Cg_endo -85.07 131.62 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.431 2.087 . . . . 75.34 112.117 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 116.047 -0.524 . . . . 73.43 110.688 -179.098 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.504 0.669 . . . . 74.22 111.172 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.3 137.6 2.6 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 114.742 -1.117 . . . . 60.13 110.922 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.66 -160.89 14.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.395 -0.907 . . . . 74.01 112.564 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.818 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -83.2 172.5 12.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.667 0.27 . . . . 53.03 110.395 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.2 98.48 22.7 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.868 -0.419 . . . . 75.53 109.868 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 1.4 Cg_endo -82.54 -8.52 11.46 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.766 2.31 . . . . 72.13 111.773 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.423 ' N ' ' HH ' ' A' ' 28' ' ' TYR . 7.3 pt-20 -80.83 -26.76 36.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.974 -0.557 . . . . 75.11 110.301 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.3 pt -94.23 152.12 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.181 -1.044 . . . . 74.32 108.181 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -102.88 64.2 0.85 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.215 -0.594 . . . . 64.24 111.091 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.61 135.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.478 . . . . 74.34 110.477 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.61 110.33 3.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 75.54 111.027 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.37 149.25 29.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.911 -0.774 . . . . 73.34 108.911 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 70.6 m-85 -119.03 144.59 36.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.91 0.337 . . . . 72.21 111.91 -170.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.818 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 31.6 Cg_endo -64.35 -59.6 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.728 2.285 . . . . 75.32 112.093 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.0 OUTLIER -143.79 37.51 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.462 -0.335 . . . . 72.52 111.402 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.3 m-20 74.37 -14.61 0.69 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.817 0.673 . . . . 64.33 112.817 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptm -49.18 -33.35 12.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.291 0.849 . . . . 74.21 113.291 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.73 -1.56 63.58 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.371 -0.918 . . . . 75.21 113.315 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.415 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 36.4 ptt180 -120.32 -6.77 9.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.214 0.507 . . . . 71.12 110.95 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.247 0.929 0 CA-C-N 114.89 -1.05 . . . . 74.34 110.519 178.686 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 CA--C 1.529 0.255 0 N-CA-C 112.984 0.34 . . . . 75.15 112.984 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 -22.42 7.36 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.916 2.411 . . . . 71.21 112.521 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.32 147.48 36.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.996 -0.742 . . . . 74.32 108.996 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.4 m -137.67 152.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.215 0.531 . . . . 72.55 111.782 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.73 122.53 42.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.155 -0.93 . . . . 74.12 110.566 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 mt -114.98 98.02 6.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.774 0.321 . . . . 73.33 110.41 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.35 124.98 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.021 -0.733 . . . . 74.34 109.021 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.462 HG23 HG13 ' A' ' 159' ' ' ILE . 74.8 p -111.84 178.74 4.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.173 0.511 . . . . 75.44 111.274 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB3' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -76.4 -6.19 50.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.676 -0.693 . . . . 74.32 111.027 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.813 ' HG3' HG21 ' A' ' 142' ' ' VAL . 6.9 mmt -102.52 -43.38 5.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.926 -0.579 . . . . 71.04 109.867 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.53 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -171.56 -130.75 1.27 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.494 -0.642 . . . . 73.42 111.494 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 23' ' ' ILE . 19.4 tt -132.7 137.99 52.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.029 0.443 . . . . 74.42 110.0 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 139' ' ' VAL . 20.1 mm -129.13 117.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.174 -0.676 . . . . 74.42 109.174 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 133' ' ' CYS . 2.9 m -113.56 147.04 17.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 119.147 -1.021 . . . . 73.11 110.152 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.34 163.94 36.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.941 -0.572 . . . . 74.54 110.611 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.448 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.7 pt-20 -129.65 166.73 19.19 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.043 -0.98 . . . . 75.42 109.662 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -104.16 163.89 12.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.623 -0.51 . . . . 73.52 109.623 179.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.763 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 4.5 m-85 -82.58 98.95 9.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.177 0.513 . . . . 73.01 111.385 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.54 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -83.47 -0.56 50.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.551 -0.75 . . . . 65.14 110.014 -179.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -79.38 -53.88 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 75.32 111.466 -176.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.0 15.43 4.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.925 0.342 . . . . 74.24 111.925 -175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.66 67.15 77.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.896 0.379 . . . . 74.51 110.108 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 16.8 Cg_exo -66.98 -43.98 5.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.798 2.332 . . . . 64.2 112.401 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -76.03 -45.42 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 75.04 110.034 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.5 m -63.02 -32.84 74.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 73.23 111.221 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.54 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 33.4 t -59.74 -43.09 94.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.593 -0.276 . . . . 70.43 110.758 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 45.6 mmtt -70.04 -32.44 70.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.974 -0.38 . . . . 73.22 109.974 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.61 -58.47 7.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 75.23 109.746 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 27' ' ' LEU . 1.8 t80 -67.45 -37.05 82.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.75 . . . . 74.15 110.349 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.65 -43.06 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 72.05 111.457 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.693 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 10.5 tp10 -61.53 -42.94 99.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.932 0.396 . . . . 74.4 111.29 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 110' ' ' SER . 4.3 mm? -66.37 -24.14 66.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 74.13 110.54 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 14' ' ' VAL . . . -80.85 -31.07 35.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.099 -0.5 . . . . 73.22 110.129 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.693 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 38.6 mtp85 -61.95 -46.24 90.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.205 -0.907 . . . . 72.23 110.841 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -74.73 -49.35 21.4 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.831 -0.347 . . . . 75.34 110.83 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.65 49.76 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 72.51 111.941 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.614 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 23.6 t80 -70.99 -29.93 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.116 0.484 . . . . 73.45 111.235 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 32.2 m-85 -81.15 -5.88 58.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.642 . . . . 74.25 112.121 -169.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -75.57 -6.1 48.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 74.54 110.547 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.22 14.66 6.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 71.1 111.829 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 45.2 p -93.17 143.22 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.477 . . . . 71.51 111.015 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -140.2 147.09 39.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.794 -0.639 . . . . 74.42 110.054 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 63.9 m-85 -80.97 124.4 29.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.533 -0.543 . . . . 73.24 109.533 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -118.57 -19.83 8.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.563 -0.289 . . . . 64.32 111.366 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.89 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 34.5 mmt180 -122.82 105.5 10.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.805 -0.443 . . . . 75.13 109.805 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.02 81.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.297 0.57 . . . . 73.15 110.033 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.8 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 17.5 mt -89.91 132.82 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 2.3 mptp? -70.88 133.41 46.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.413 . . . . 75.45 110.008 -173.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 42.33 42.47 2.61 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.459 1.1 . . . . 63.53 111.716 -172.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.8 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.0 t80 -131.52 -84.34 0.51 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.628 -0.715 . . . . 72.34 109.705 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.669 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptt? -161.19 157.16 25.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.328 -0.851 . . . . 74.31 110.165 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.486 ' CD1' HD22 ' A' ' 116' ' ' LEU . 44.6 mt -124.5 100.07 7.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.727 -0.67 . . . . 73.31 109.469 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.89 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 46.5 mt-30 -84.83 119.81 25.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.656 -0.702 . . . . 73.42 110.866 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -138.48 140.56 11.18 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.715 -0.675 . . . . 75.33 111.775 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 164.04 -91.81 0.11 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.409 -1.376 . . . . 64.41 114.081 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -28.44 104.58 0.19 Allowed Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.003 1.112 . . . . 74.45 114.003 -163.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 91.1 Cg_endo -81.96 -12.5 10.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.852 3.035 . . . . 72.33 112.47 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 70' ' ' THR . 64.3 p -103.36 -32.33 9.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 71.22 111.882 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 27.95 62.1 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.293 -0.723 . . . . 62.12 111.293 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.582 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 72.2 p -103.81 -34.85 8.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.213 0.53 . . . . 74.31 111.222 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.98 -30.59 4.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.49 -0.777 . . . . 64.53 111.663 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 4.7 ptm180 -81.21 -37.42 28.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.043 0.449 . . . . 74.42 110.045 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.527 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 65.38 79.36 0.19 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.945 -0.57 . . . . 61.11 113.029 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.614 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 66.9 -130.97 30.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.022 -0.609 . . . . 55.11 112.745 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 55.55 22.19 4.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.105 0.562 . . . . 73.55 111.521 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -72.79 -12.6 61.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.712 -0.676 . . . . 54.25 110.868 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -51.96 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.389 -0.369 . . . . 72.4 110.424 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.417 ' HB3' ' HZ ' ' A' ' 82' ' ' PHE . 97.7 m-85 -77.64 -34.16 53.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.795 0.807 . . . . 74.11 109.105 175.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.12 -78.84 0.24 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.606 -1.179 . . . . 71.11 112.104 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -135.99 -168.57 2.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.786 0.327 . . . . 71.33 110.977 -175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.476 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -76.41 166.43 23.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 74.32 111.532 -177.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' HZ ' ' HB3' ' A' ' 78' ' ' TYR . 73.9 m-85 -132.38 -44.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.814 -0.63 . . . . 74.43 110.398 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -163.47 156.33 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.679 -0.859 . . . . 74.02 108.679 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' ASP . 2.4 p-10 -74.81 125.11 28.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.352 -0.61 . . . . 74.33 109.352 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -98.36 20.79 12.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.048 0.451 . . . . 73.2 110.31 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -68.75 100.93 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.696 . . . . 74.11 110.952 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -156.45 77.04 4.36 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.981 -0.554 . . . . 74.31 109.926 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.39 93.59 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.552 2.168 . . . . 73.33 112.077 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.41 -10.19 58.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.248 1.023 . . . . 71.35 109.195 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.6 OUTLIER -108.16 174.17 5.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.597 -1.183 . . . . 73.02 109.306 178.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -131.28 145.1 51.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.067 -0.346 . . . . 74.51 110.067 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -55.59 126.44 25.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.36 0.6 . . . . 74.35 109.571 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.508 ' HG1' ' HA ' ' A' ' 189' ' ' PRO . 20.7 p -127.04 -45.46 1.56 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.539 -0.755 . . . . 74.44 110.262 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.32 -144.75 4.07 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.344 -0.844 . . . . 42.04 111.304 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.92 145.47 25.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.734 0.302 . . . . 64.22 110.77 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.63 21.83 6.64 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.732 -0.747 . . . . 64.44 111.906 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 189' ' ' PRO . 9.3 mm -86.8 111.21 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.487 -0.561 . . . . 74.44 109.487 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.773 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.92 122.03 30.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 72.35 109.824 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.23 170.65 14.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.84 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.817 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 39.5 ttp -103.64 144.15 31.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.916 0.389 . . . . 73.21 110.063 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.684 ' HA ' ' HD1' ' A' ' 126' ' ' HIS . . . -98.74 151.74 20.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.127 0.489 . . . . 75.24 110.547 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -161.0 169.79 21.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 74.32 109.61 -172.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.13 -27.48 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.418 0.627 . . . . 55.52 110.545 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.85 174.82 32.33 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 109.594 -1.402 . . . . 75.44 109.594 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.48 -46.85 19.29 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.303 2.669 . . . . 71.11 112.692 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 8.4 p-10 -100.88 -12.95 18.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.385 -0.37 . . . . 71.01 111.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -83.17 50.31 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.499 0.666 . . . . 75.22 109.411 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.663 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 47.1 m-80 -70.94 141.29 51.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.893 -1.049 . . . . 74.24 110.9 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.17 -169.78 12.69 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.127 -0.789 . . . . 62.3 111.127 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.57 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . 24.4 p -94.53 6.69 48.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.367 0.584 . . . . 75.03 111.469 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 73.2 mt-30 -72.79 161.59 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 64.43 109.68 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -141.75 171.35 14.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.666 -0.414 . . . . 74.23 111.268 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.17 150.87 18.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.04 -0.527 . . . . 73.52 110.195 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.641 HG22 HD21 ' A' ' 98' ' ' LEU . 16.0 t -113.73 141.78 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.462 -0.57 . . . . 72.22 109.462 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -95.37 129.08 42.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.166 0.508 . . . . 75.33 110.318 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD22 ' CD1' ' A' ' 62' ' ' ILE . 61.6 mt -87.14 -3.2 59.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 72.44 110.662 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.33 163.37 24.37 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.763 -0.653 . . . . 75.15 110.062 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.31 125.42 15.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.595 2.197 . . . . 73.5 111.845 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.3 p -114.5 140.87 48.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.394 -0.367 . . . . 74.21 111.247 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -137.01 24.47 3.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 75.43 111.003 174.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -120.72 -8.87 9.42 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.374 0.509 . . . . 74.31 112.374 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.5 pp -127.72 4.42 6.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.745 -0.382 . . . . 73.4 111.745 -173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 1.4 m-20 -71.51 -22.45 61.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.823 -0.626 . . . . 63.33 110.334 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.81 7.87 55.7 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.928 -0.869 . . . . 74.1 110.928 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.7 mmtm -112.16 -33.2 6.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 72.32 109.426 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.684 ' HD1' ' HA ' ' A' ' 101' ' ' ALA . 58.4 m-70 -135.57 137.54 42.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.29 -0.868 . . . . 73.23 109.418 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.3 t -78.54 146.54 34.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.39 -0.524 . . . . 75.35 110.255 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 99' ' ' ALA . 51.8 mt -122.28 124.86 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.9 -0.591 . . . . 72.24 110.279 -175.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.817 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.9 p90 -159.23 73.2 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.633 0.73 . . . . 74.35 110.725 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.773 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.37 157.27 29.56 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.177 -1.487 . . . . 72.01 113.732 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.428 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 24.4 mtm180 -137.06 123.69 21.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.34 . . . . 75.34 110.132 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.66 140.95 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 53.33 110.906 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.515 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 45.1 t -137.34 152.24 49.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.44 . . . . 74.32 110.026 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.5 pt20 41.13 31.09 0.13 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.534 1.134 . . . . 74.55 113.506 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.72 12.71 0.48 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.478 -0.867 . . . . 44.03 112.426 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.53 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -71.5 -34.25 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.799 -0.236 . . . . 74.24 110.92 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.57 91.76 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.484 -0.865 . . . . 61.54 111.387 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.53 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 75.5 mmm -71.2 -46.36 61.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.095 -0.335 . . . . 72.44 110.095 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 23' ' ' ILE . 79.9 t -57.07 -31.82 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.236 0.541 . . . . 74.52 110.4 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -68.39 -52.72 29.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.72 -0.673 . . . . 74.43 109.901 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.594 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.97 -8.57 56.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 74.35 111.023 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.813 HG21 ' HG3' ' A' ' 20' ' ' MET . 56.0 t -87.99 -43.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.265 0.555 . . . . 75.43 109.808 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.415 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -77.9 -37.54 29.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.608 -0.806 . . . . 75.35 112.78 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 24.0 ptm -73.86 -27.52 61.12 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.597 0.221 . . . . 71.41 111.597 -173.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.516 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.34 111.077 -175.504 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.1 p . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 122.123 0.963 . . . . 64.25 109.876 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.76 168.46 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.859 -1.064 . . . . 64.33 110.524 -172.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.462 HG13 HG23 ' A' ' 18' ' ' THR . 3.4 mp -87.14 115.59 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.983 -0.747 . . . . 72.31 108.983 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.552 HG23 ' HD3' ' A' ' 161' ' ' LYS . 31.0 mm -75.56 -62.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.368 -0.833 . . . . 73.42 110.973 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HD3' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -129.68 135.64 48.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.811 0.339 . . . . 74.44 110.266 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -131.92 133.87 45.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.023 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 21.8 p90 -152.93 147.49 19.13 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 74.32 110.673 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.529 ' HA ' HG12 ' A' ' 14' ' ' VAL . 15.0 Cg_exo -70.16 152.27 67.16 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.128 2.552 . . . . 73.24 113.119 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 64.32 109.89 175.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.2 m-20 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.304 0.573 . . . . 73.33 111.237 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 165.92 143.65 3.81 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.311 -0.859 . . . . 63.03 111.205 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.2 -171.53 41.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.579 -0.82 . . . . 74.55 111.954 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.814 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -78.26 167.02 22.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.033 -0.358 . . . . 63.43 110.033 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.502 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.2 m-85 -110.81 97.15 32.26 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 74.12 111.218 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.521 ' HB2' HD13 ' A' ' 90' ' ' LEU . 57.7 Cg_endo -75.03 -4.78 15.91 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.61 2.207 . . . . 71.14 112.791 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.763 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 26.4 tt0 -76.18 -31.61 58.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.782 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 188' ' ' PHE . 13.3 pt -79.89 -17.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 74.43 111.929 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 17.2 m170 67.99 33.22 4.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.129 -0.487 . . . . 74.14 111.892 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 191' ' ' ILE . 4.9 p -136.57 149.85 27.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.658 0.266 . . . . 75.14 110.797 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 115.82 9.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.272 0.558 . . . . 72.22 112.155 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 93' ' ' THR . 2.3 pp0? -156.57 159.34 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.504 -0.924 . . . . 72.0 108.504 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -132.23 145.24 56.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 120.547 -0.461 . . . . 74.22 111.585 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.814 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -67.4 -68.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.402 2.068 . . . . 73.24 111.693 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.403 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 2.4 pt? -126.24 24.88 6.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.032 0.444 . . . . 75.22 110.621 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 75.39 -10.0 1.31 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.914 1.079 . . . . 74.32 113.914 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -55.42 -27.74 49.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.322 0.49 . . . . 71.52 112.322 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.81 -0.23 89.72 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.843 -0.694 . . . . 63.41 112.879 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.46 -33.47 48.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.962 0.411 . . . . 73.14 111.135 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.683 ' HZ3' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.3 -0.857 . . . . 74.34 110.183 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.63 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 18.0 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 CA-C-O 120.851 0.271 . . . . 71.31 112.012 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -4.87 16.17 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.999 2.466 . . . . 62.42 113.744 -175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.499 HD22 HG12 ' A' ' 24' ' ' VAL . 21.9 t-20 -128.98 144.2 51.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.885 0.374 . . . . 74.44 110.577 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 34.4 m -137.48 147.38 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.092 0.472 . . . . 74.43 110.854 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.531 ' CD1' ' HB3' ' A' ' 165' ' ' SER . 13.3 m-85 -103.45 132.18 49.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.777 -0.647 . . . . 74.41 110.831 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 159' ' ' ILE . 3.4 mm? -114.58 104.81 12.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.041 -0.527 . . . . 74.33 109.749 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.28 115.46 28.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.278 -0.638 . . . . 74.33 109.278 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -107.12 178.92 4.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 75.11 111.738 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.4 p -75.25 -10.08 59.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.724 -0.671 . . . . 73.12 110.798 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.444 ' HE2' HG22 ' A' ' 142' ' ' VAL . 6.5 mmt -94.46 -42.11 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.654 . . . . 62.51 109.932 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -179.83 -116.51 0.51 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.474 -0.785 . . . . 73.03 111.336 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -150.54 138.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.063 0.459 . . . . 74.32 110.477 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.28 127.52 57.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.686 -0.688 . . . . 75.14 109.571 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 8.5 t -113.62 147.45 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.855 -0.424 . . . . 62.34 109.855 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.37 163.5 39.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.984 0.421 . . . . 65.31 110.652 174.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' CD ' ' HG ' ' A' ' 133' ' ' CYS . 1.8 pt-20 -129.76 163.0 27.16 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.653 -0.703 . . . . 73.45 110.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.23 161.92 13.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 71.44 110.509 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.484 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 2.7 m-85 -88.32 100.26 12.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 74.51 111.635 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -85.89 7.06 25.58 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.002 -0.74 . . . . 73.23 109.002 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 4.4 mptp? -78.01 -57.34 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.753 -1.112 . . . . 74.2 111.54 -176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -132.31 14.96 4.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.423 -0.353 . . . . 72.42 111.81 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.53 80.42 71.95 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.787 -0.449 . . . . 62.11 109.787 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.614 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 59.4 Cg_endo -73.19 -25.18 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.445 2.096 . . . . 73.32 113.729 -171.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HZ2' ' HG3' ' A' ' 83' ' ' GLU . 54.7 mtmt -100.66 -33.69 10.18 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.126 -0.63 . . . . 74.44 111.637 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.65 95.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 75.32 111.177 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -57.62 -51.62 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 63.14 111.017 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 67.6 mttt -66.73 -41.71 87.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.829 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.03 -47.86 74.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.819 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE1' HG22 ' A' ' 14' ' ' VAL . 32.7 t80 -67.64 -50.96 55.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.448 . . . . 73.41 110.246 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.36 80.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.32 -0.855 . . . . 75.22 111.663 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.63 -47.66 82.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.891 -0.595 . . . . 72.32 110.32 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 75' ' ' ALA . 3.5 mm? -66.33 -27.55 67.99 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.113 -0.494 . . . . 73.03 111.07 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.55 52.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.84 -0.618 . . . . 62.13 110.91 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -73.74 -26.09 60.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.903 -0.406 . . . . 75.43 109.903 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -60.46 -47.6 85.43 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.83 -0.623 . . . . 75.43 109.587 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.51 20.51 6.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.486 -0.864 . . . . 62.23 113.575 170.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -79.58 -11.2 59.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.201 0.501 . . . . 75.14 111.359 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.486 ' HA ' HG22 ' A' ' 51' ' ' THR . 95.6 m-85 -85.11 -4.84 59.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.893 0.378 . . . . 64.53 110.967 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 38.6 m-80 -77.9 4.95 10.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.269 0.557 . . . . 71.44 110.046 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.77 21.22 2.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.707 -0.679 . . . . 60.25 111.698 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.949 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 28.8 p -96.0 152.61 18.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.555 0.217 . . . . 74.33 110.702 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 3.7 mtmt -134.94 155.94 49.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.522 -0.308 . . . . 74.42 110.512 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB2' HG12 ' A' ' 157' ' ' VAL . 97.5 m-85 -92.43 113.79 26.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 75.23 109.0 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -112.83 -24.01 9.81 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.519 -0.473 . . . . 75.55 112.257 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 27.2 mmm180 -114.49 106.21 14.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.248 -0.581 . . . . 74.21 110.148 177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -124.57 92.86 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.102 -0.703 . . . . 65.45 109.102 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.4 mt -98.32 122.18 49.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.231 -0.655 . . . . 75.21 109.231 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 42.1 mtpt -56.94 127.71 33.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.297 0.373 . . . . 72.2 111.635 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 56.17 32.89 21.03 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.123 -0.944 . . . . 73.24 111.373 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.761 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.3 t80 -130.97 -82.67 0.53 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.449 . . . . 74.41 110.267 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.649 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.9 ptt? -161.64 157.61 24.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.702 -0.681 . . . . 74.13 110.205 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.616 HG23 HG13 ' A' ' 56' ' ' ILE . 29.0 mt -131.99 108.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 74.14 109.79 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.2 tt0 -79.5 124.16 28.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.314 -0.403 . . . . 61.02 110.074 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -133.96 127.78 4.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.437 -0.665 . . . . 71.41 111.437 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.949 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 139.17 -155.45 23.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.07 -1.062 . . . . 64.33 112.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.501 ' HB2' ' CG ' ' A' ' 111' ' ' GLN . 22.3 t0 53.74 96.15 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.741 0.817 . . . . 73.41 112.324 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.11 -16.49 44.75 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.334 2.023 . . . . 72.21 112.606 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 70' ' ' THR . 48.5 p -93.6 -36.07 12.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 71.22 110.683 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 18.8 75.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.095 -0.574 . . . . 73.35 112.696 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.445 HG22 ' OG1' ' A' ' 68' ' ' THR . 9.9 t -111.64 -10.32 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 75.23 111.563 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.73 35.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.2 -1.0 . . . . 71.35 112.986 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -86.46 -47.63 9.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 74.41 111.02 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.51 173.41 32.32 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.42 -0.809 . . . . 75.4 111.421 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.0 -10.68 58.44 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 120.719 -0.753 . . . . 63.13 112.181 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.506 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -55.92 -77.36 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.971 -0.615 . . . . 73.52 112.074 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 m 59.27 15.39 4.24 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.186 -0.461 . . . . 64.01 111.497 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 pt -68.4 -17.21 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.592 0.71 . . . . 74.14 110.445 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.2 -12.33 26.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.727 -1.124 . . . . 73.51 111.147 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.58 -76.77 1.3 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.241 -0.505 . . . . 63.42 112.464 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -87.47 -156.17 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.576 -0.527 . . . . 74.2 109.576 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.78 174.38 1.44 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 73.04 110.559 172.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 106' ' ' ASP . 26.2 t80 -118.17 -175.09 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.271 -0.422 . . . . 74.3 110.218 -172.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 15.3 mm-40 -76.48 121.36 23.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.645 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 7.8 p-10 -76.77 86.44 3.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.869 0.842 . . . . 74.35 109.066 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.48 39.53 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.313 -0.858 . . . . 74.23 109.555 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD22 ' HB ' ' A' ' 127' ' ' THR . 15.5 mt -69.26 98.98 1.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.381 -1.281 . . . . 74.24 110.63 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -162.07 83.47 1.69 Allowed Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.725 -0.67 . . . . 73.13 109.867 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.889 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 28.6 Cg_endo -62.28 82.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 123.154 2.57 . . . . 74.24 112.209 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.45 -25.83 54.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.409 -0.814 . . . . 72.35 109.682 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.6 pp -85.17 -179.96 7.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 73.33 109.796 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -124.42 141.23 52.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.46 -0.496 . . . . 72.12 110.672 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.66 72.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.664 0.745 . . . . 74.14 110.006 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -66.4 -37.86 86.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.773 -1.103 . . . . 73.33 112.575 -171.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.42 -140.93 3.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.361 -0.923 . . . . 52.21 112.758 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' SD ' ' A' ' 200' ' ' MET . . . -91.1 137.49 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.751 0.31 . . . . 74.41 110.686 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.48 23.35 5.74 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.669 -0.777 . . . . 41.43 111.852 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.0 mm -85.41 109.6 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.346 -0.612 . . . . 73.21 109.346 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.695 HD22 HG21 ' A' ' 114' ' ' VAL . 3.2 tm? -86.3 118.41 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.212 0.529 . . . . 74.25 109.774 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' A' ' 128' ' ' ILE . . . -125.04 168.12 13.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.053 -0.521 . . . . 71.41 110.847 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.6 ttt -91.71 132.77 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.191 -0.459 . . . . 75.45 109.805 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 111' ' ' GLN . . . -96.26 141.08 30.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.01 -0.367 . . . . 63.12 110.01 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -150.38 165.35 33.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.147 -0.479 . . . . 72.45 110.792 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 107' ' ' THR . . . -69.55 -46.66 65.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.845 -0.616 . . . . 73.3 110.296 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.94 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.472 -0.87 . . . . 71.4 112.715 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.28 89.43 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.918 2.412 . . . . 73.21 112.193 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 p30 50.13 29.37 3.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.317 -0.856 . . . . 74.2 111.571 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.499 ' HB ' ' HB1' ' A' ' 103' ' ' ALA . 1.7 m -96.58 55.51 1.43 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.113 -1.069 . . . . 72.4 108.113 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -92.85 137.15 32.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.995 -1.457 . . . . 71.03 110.096 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.21 -107.8 0.76 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.231 -0.985 . . . . 73.31 113.616 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.8 p -127.28 56.43 1.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.546 0.688 . . . . 64.32 110.601 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 66' ' ' ASP . 18.8 mp0 -130.32 147.3 52.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.18 -0.918 . . . . 64.21 110.136 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -139.78 169.3 17.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -155.79 147.87 23.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.87 0.367 . . . . 74.21 110.296 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.695 HG21 HD22 ' A' ' 98' ' ' LEU . 17.8 t -111.54 140.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.885 -0.598 . . . . 70.03 109.391 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -94.86 128.81 41.89 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.853 0.359 . . . . 75.03 110.14 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.46 HD12 ' HA3' ' A' ' 143' ' ' GLY . 67.6 mt -83.62 -8.71 59.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.764 -0.653 . . . . 73.15 110.168 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.42 156.58 34.91 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.164 -0.926 . . . . 75.44 109.679 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.35 124.58 14.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.503 2.135 . . . . 55.2 112.236 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 p -123.99 122.12 37.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.405 . . . . 65.51 110.234 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 5.18 31.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.716 0.293 . . . . 75.24 111.373 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.607 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -108.39 -3.1 18.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.607 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.9 mt -102.04 3.74 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.188 -0.46 . . . . 73.32 111.371 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.889 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 p-10 -70.67 -15.2 62.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.68 -0.691 . . . . 73.41 111.155 -172.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.86 15.96 9.53 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.329 -0.709 . . . . 65.42 111.329 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.66 -41.31 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.271 0.558 . . . . 75.55 110.109 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -142.31 126.1 17.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.005 -1.109 . . . . 75.03 108.005 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 86' ' ' LEU . 11.3 t -72.22 143.11 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.669 -0.812 . . . . 74.04 110.459 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 99' ' ' ALA . 40.4 mt -114.87 119.94 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.57 -0.741 . . . . 73.35 110.54 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.3 m-85 -157.23 75.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.318 0.387 . . . . 75.3 110.138 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.66 158.24 30.38 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.585 -0.817 . . . . 75.12 112.611 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.484 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 11.4 mtp180 -135.12 114.98 12.91 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.719 -0.475 . . . . 75.21 109.719 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' GLY . 14.3 p -79.86 130.6 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.37 0.605 . . . . 75.31 110.068 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.656 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 87.7 m -140.5 140.12 35.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.765 -0.652 . . . . 64.3 110.576 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 54.67 42.33 31.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.124 0.488 . . . . 73.32 111.764 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 41.58 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.43 -0.89 . . . . 54.13 111.99 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.0 tp -90.77 -34.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.59 0.233 . . . . 75.23 111.011 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.92 -35.87 91.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.807 -0.711 . . . . 64.52 111.624 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.431 ' O ' HG21 ' A' ' 142' ' ' VAL . 75.6 mmm -68.34 -51.2 47.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 72.14 110.337 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 62' ' ' ILE . 98.5 t -55.03 -31.12 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.296 0.57 . . . . 75.44 110.789 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.93 -55.01 10.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.819 -0.628 . . . . 62.42 110.681 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -17.66 62.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.367 -0.379 . . . . 75.12 111.213 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.444 HG22 ' HE2' ' A' ' 20' ' ' MET . 55.0 t -84.3 -37.75 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.1 0.476 . . . . 74.32 109.934 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -83.38 -7.5 86.44 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.775 -0.726 . . . . 75.5 113.002 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.33 -1.06 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.755 -0.378 . . . . 74.44 111.294 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 142' ' ' VAL . 33.0 m . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.971 0.415 . . . . 72.42 111.242 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.139 0.495 . . . . 62.14 111.374 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -121.94 162.88 20.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 72.43 109.533 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 16' ' ' LEU . 3.5 mp -88.9 103.27 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.458 ' C ' ' HD2' ' A' ' 161' ' ' LYS . 32.1 mm -66.81 -56.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.479 -0.782 . . . . 74.52 110.636 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.482 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 3.5 mptp? -128.92 137.25 51.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 73.55 110.374 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.19 27.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.209 -0.451 . . . . 62.14 110.242 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -148.22 135.36 10.46 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.767 -0.651 . . . . 73.15 110.723 -173.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.63 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 59.8 Cg_endo -72.78 139.38 30.5 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.706 2.271 . . . . 72.32 112.044 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 16.9 t . . . . . 0 C--N 1.326 -0.456 0 N-CA-C 109.6 -0.518 . . . . 74.21 109.6 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.381 0 CA-C-O 121.732 0.777 . . . . 74.0 110.913 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.05 4.11 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.574 -1.194 . . . . 72.31 110.863 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.59 -167.9 44.2 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.27 -0.967 . . . . 62.32 111.659 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 189' ' ' PRO . . . -75.43 163.54 27.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.228 -0.656 . . . . 73.23 109.228 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -102.24 103.29 29.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.806 0.336 . . . . 74.55 110.19 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.609 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 6.0 Cg_exo -77.43 -18.46 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.776 2.318 . . . . 73.43 111.298 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.87 -33.59 62.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 75.03 110.238 -172.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -89.22 157.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -106.82 89.68 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.057 -0.657 . . . . 74.15 110.638 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 194' ' ' ALA . 6.1 p -158.08 -171.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.626 -0.879 . . . . 71.12 108.626 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.746 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -123.45 117.61 25.54 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 122.188 -0.32 . . . . 72.31 110.669 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -156.45 155.27 31.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.864 -0.421 . . . . 71.45 109.864 177.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -117.31 149.24 44.23 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.458 -0.337 . . . . 74.34 110.546 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.501 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.8 Cg_endo -67.31 -65.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.408 2.072 . . . . 63.12 112.108 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.9 27.54 4.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.942 0.401 . . . . 70.32 110.635 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 72.59 5.02 5.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.52 -0.764 . . . . 65.44 112.687 173.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 201' ' ' GLY . 2.0 ppp? -63.58 -50.4 69.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.102 0.408 . . . . 71.24 112.102 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.487 ' N ' ' SD ' ' A' ' 200' ' ' MET . . . -75.75 15.34 4.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.263 -0.494 . . . . 71.41 114.148 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -81.78 -17.05 48.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 73.01 110.464 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.252 1.204 0 CA-C-N 114.872 -1.058 . . . . 73.13 110.945 178.524 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 34.4 Cg_exo . . . . . 0 C--O 1.233 0.252 0 CA-C-O 120.809 0.254 . . . . 60.5 112.023 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.665 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 56.6 Cg_endo -71.55 -16.98 30.4 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.84 2.36 . . . . 74.53 113.534 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.477 HD22 HG12 ' A' ' 24' ' ' VAL . 22.2 t-20 -132.51 147.8 52.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.092 -174.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 164' ' ' PRO . 26.9 m -139.04 152.02 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.257 0.551 . . . . 72.24 111.438 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.524 ' HD1' HG23 ' A' ' 24' ' ' VAL . 97.4 m-85 -102.94 121.31 42.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.079 -0.964 . . . . 72.25 110.743 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -108.09 103.07 12.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.805 0.336 . . . . 73.42 110.307 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -85.15 122.45 29.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.228 -0.656 . . . . 64.32 109.228 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -114.97 176.61 4.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.212 0.529 . . . . 75.13 112.041 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.509 ' HB2' HD13 ' A' ' 160' ' ' ILE . 32.7 t -75.51 -1.6 25.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.606 -0.725 . . . . 71.43 110.565 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mmt -107.2 -39.7 5.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.814 -0.63 . . . . 74.54 110.274 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.64 -126.41 0.98 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.232 -0.747 . . . . 63.22 111.232 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -139.84 137.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.035 0.445 . . . . 75.21 109.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -120.93 118.03 54.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.77 -0.65 . . . . 75.3 109.677 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG23 ' HD1' ' A' ' 15' ' ' TYR . 46.5 t -106.16 131.18 56.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.82 -0.437 . . . . 75.01 109.82 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.66 164.57 33.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.997 0.427 . . . . 73.35 110.414 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 12.2 pt-20 -135.5 166.56 22.91 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.774 -0.648 . . . . 73.33 109.876 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -103.52 160.03 15.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.495 -0.557 . . . . 74.11 109.495 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.802 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 12.1 m-85 -83.89 91.58 7.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 72.32 111.962 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.665 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 78.9 m95 -84.22 6.48 22.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.607 -0.724 . . . . 74.14 110.314 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -73.6 -63.03 1.29 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.609 -0.723 . . . . 73.45 110.495 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.406 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 37.6 m80 -131.07 16.2 5.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.083 0.401 . . . . 75.02 112.083 -176.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -133.83 56.95 21.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.024 -0.27 . . . . 75.21 110.983 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 14.0 Cg_exo -68.82 -25.9 32.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.442 2.094 . . . . 73.3 112.023 -175.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -66.44 -54.23 26.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 74.45 110.176 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.639 ' HB ' ' CE2' ' A' ' 129' ' ' PHE . 1.6 p -64.16 -40.23 95.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.182 -0.917 . . . . 71.04 110.988 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 86.3 m -58.31 -46.78 85.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.079 -0.964 . . . . 65.33 111.02 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -59.49 -41.39 89.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.422 -0.354 . . . . 75.32 110.189 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.72 -56.54 20.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 52.13 110.326 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HE2' ' HB3' ' A' ' 112' ' ' PHE . 3.4 m-85 -66.74 -42.29 86.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.759 -0.655 . . . . 73.41 111.492 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.81 97.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.455 -0.339 . . . . 73.03 111.571 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.39 -43.67 98.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.024 0.44 . . . . 75.22 110.198 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 110' ' ' SER . 35.3 mt -70.59 -24.46 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.873 -0.603 . . . . 73.32 111.97 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.75 86.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.005 -0.543 . . . . 75.25 110.313 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -75.56 -34.28 60.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 74.52 109.927 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.563 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 14.3 tpp180 -64.83 -46.75 80.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 75.44 110.273 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.38 28.87 5.0 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.926 -0.654 . . . . 64.01 113.075 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.748 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 5.2 m-85 -87.15 -2.92 58.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 75.01 111.674 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -76.42 -12.69 60.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 75.35 110.303 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 49' ' ' ASN . 0.8 OUTLIER -79.45 3.16 19.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.22 0.533 . . . . 75.02 109.91 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -131.69 15.4 5.18 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.694 -0.684 . . . . 74.03 112.253 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.556 HG22 ' HD3' ' A' ' 67' ' ' PRO . 13.6 p -98.63 138.03 36.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.837 0.318 . . . . 65.21 110.497 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' CG ' ' HG3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -128.71 124.5 35.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.418 -0.355 . . . . 75.11 110.427 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 96.2 m-85 -70.06 103.34 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.412 -0.588 . . . . 74.25 109.412 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -114.25 -15.43 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.031 -0.668 . . . . 75.12 112.06 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 11.3 mmt180 -105.42 101.61 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.982 -0.687 . . . . 74.41 109.597 175.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 62' ' ' ILE . 4.2 mp -125.87 95.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.018 -0.734 . . . . 71.43 109.018 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.816 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 44.0 mt -91.88 127.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 109.184 -0.673 . . . . 74.53 109.184 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -48.72 111.41 0.46 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.99 0.806 . . . . 72.3 112.133 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 203' ' ' LYS . 43.2 m-20 56.4 39.66 29.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.112 -0.949 . . . . 70.14 111.307 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 9.7 t80 -128.59 -76.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.813 -0.631 . . . . 74.12 109.987 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.411 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.4 ptt? -160.59 155.59 24.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 72.55 110.673 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 56' ' ' ILE . 49.0 mt -128.41 105.28 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 73.23 109.48 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 39.6 tt0 -85.49 127.2 34.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.739 -0.664 . . . . 74.04 111.893 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.39 117.38 4.62 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.454 -1.058 . . . . 51.41 110.454 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.24 146.59 33.43 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 114.423 0.529 . . . . 53.43 114.423 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.477 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 64.9 t0 -46.0 126.73 7.07 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 124.792 1.237 . . . . 74.34 111.837 174.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD3' HG22 ' A' ' 51' ' ' THR . 29.3 Cg_endo -64.46 -30.77 62.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.177 2.584 . . . . 72.25 112.763 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.468 ' OG1' HG21 ' A' ' 70' ' ' THR . 62.7 p -84.1 -32.86 24.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 74.1 110.061 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.83 70.84 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.51 -0.768 . . . . 71.41 113.01 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 72' ' ' ARG . 8.8 t -105.52 -26.02 12.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.121 0.46 . . . . 64.2 111.536 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.97 -5.34 10.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.476 -0.869 . . . . 74.3 113.223 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 70' ' ' THR . 8.5 ptm180 -100.85 -23.75 14.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.076 0.438 . . . . 72.43 111.101 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 85.47 175.11 50.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.827 -0.702 . . . . 73.51 112.098 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA3' ' HD2' ' A' ' 47' ' ' TYR . . . -86.93 28.79 5.33 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.525 0.514 . . . . 70.42 112.28 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . -93.1 25.13 3.4 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.74 0.781 . . . . 71.12 110.883 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 55.4 m -75.65 -5.69 46.77 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.089 -0.96 . . . . 62.32 110.583 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.1 tt -55.62 -40.17 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.562 -0.745 . . . . 74.35 110.96 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.487 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 34.8 p90 -102.12 -9.14 20.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 63.43 111.276 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 76' ' ' SER . . . 126.74 -119.27 3.28 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.24 -0.744 . . . . 74.01 111.24 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -137.91 146.45 43.33 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.049 0.452 . . . . 72.45 111.726 176.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.431 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 1.7 mp0 38.1 -166.55 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 O-C-N 125.692 1.87 . . . . 64.25 115.294 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB2' ' OD1' ' A' ' 108' ' ' ASN . 20.8 m-85 -154.41 -165.74 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.531 -1.213 . . . . 74.01 108.446 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.78 160.05 26.31 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.172 -1.048 . . . . 73.13 108.172 171.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.27 123.54 23.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 75.11 109.993 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.06 31.31 6.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.421 -0.585 . . . . 74.3 109.421 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD21 ' OG1' ' A' ' 127' ' ' THR . 47.9 mt -66.11 98.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.716 . . . . 75.44 110.319 -176.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -166.06 89.96 0.86 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.898 -0.592 . . . . 71.13 109.85 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.98 95.36 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.779 2.319 . . . . 72.23 111.61 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.42 -17.58 61.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.403 1.096 . . . . 74.41 108.7 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -106.5 170.83 7.7 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.875 -1.511 . . . . 72.44 108.797 175.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -128.16 142.88 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.843 -0.343 . . . . 71.45 110.165 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -56.16 122.69 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.433 0.635 . . . . 65.24 109.369 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.2 p -119.48 -45.9 2.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.556 -0.747 . . . . 70.41 109.771 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.597 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -155.96 -139.27 2.72 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.054 -0.975 . . . . 71.11 111.389 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.67 144.65 25.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 73.4 110.844 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.18 24.32 5.47 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.786 -0.721 . . . . 73.04 112.13 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.87 110.79 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.355 -0.609 . . . . 74.5 109.355 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.874 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -86.52 117.4 25.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.731 -0.668 . . . . 74.31 109.889 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 128' ' ' ILE . . . -132.2 173.32 11.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 74.24 111.056 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.533 ' HE3' ' HB2' ' A' ' 108' ' ' ASN . 28.1 ttm -94.36 148.19 22.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 70.21 111.281 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 100' ' ' MET . . . -99.52 122.09 42.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.699 -0.682 . . . . 72.31 109.222 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.58 165.88 24.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.221 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.12 -28.67 14.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.32 0.581 . . . . 53.24 110.422 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.23 180.0 29.17 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.651 -1.38 . . . . 61.11 109.651 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.408 ' HA ' HD12 ' A' ' 86' ' ' LEU . 7.1 Cg_endo -49.7 -50.54 12.88 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 74.32 112.786 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -102.77 -1.83 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.57 -0.286 . . . . 61.42 111.092 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.431 ' HA ' ' CG ' ' A' ' 81' ' ' GLN . 7.9 m -88.34 53.85 2.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.865 0.84 . . . . 74.25 109.114 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' A' ' 82' ' ' PHE . 3.7 p30 -82.88 158.46 22.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.289 -1.323 . . . . 71.02 109.8 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.89 -129.51 1.04 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.445 -0.883 . . . . 75.51 112.965 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.515 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 3.3 p -114.07 -1.09 13.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.002 0.371 . . . . 75.13 112.002 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 71.9 mt-30 -79.32 150.31 31.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.729 -0.471 . . . . 63.54 109.729 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.507 ' HB3' ' HE2' ' A' ' 39' ' ' PHE . 29.8 p90 -148.11 164.98 32.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.857 -0.337 . . . . 74.14 110.468 -176.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.2 151.49 29.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.889 0.376 . . . . 75.44 110.321 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.704 HG21 HD23 ' A' ' 98' ' ' LEU . 15.1 t -110.15 141.42 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.814 -0.63 . . . . 74.32 109.352 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.3 p -95.14 124.92 39.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.115 0.483 . . . . 74.41 110.318 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.497 HD22 ' CD1' ' A' ' 62' ' ' ILE . 54.2 mt -81.83 -8.98 59.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.631 -0.713 . . . . 74.41 110.569 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.23 42.3 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.386 -0.825 . . . . 71.3 109.801 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 18.8 Cg_exo -65.98 120.24 7.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.714 2.276 . . . . 70.22 111.934 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -108.43 116.23 31.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.206 -0.452 . . . . 55.21 110.476 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -104.44 11.41 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.106 0.479 . . . . 74.31 110.903 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.523 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -118.42 0.27 11.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.679 -0.691 . . . . 73.21 111.138 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 91.2 mt -104.01 10.24 36.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.107 -0.497 . . . . 73.03 110.511 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -62.73 -22.18 66.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.196 -0.911 . . . . 75.12 111.496 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.91 21.51 4.66 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.713 -0.756 . . . . 62.34 111.727 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -117.08 -32.1 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 73.22 110.23 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.65 131.31 27.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.863 -0.608 . . . . 75.22 110.319 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.416 ' OG1' HD21 ' A' ' 86' ' ' LEU . 46.1 m -68.31 119.42 12.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.982 0.42 . . . . 74.44 109.932 171.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' ALA . 46.2 mt -102.47 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 74.44 110.029 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.639 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 15.0 p90 -160.3 71.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 75.42 111.264 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.874 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.83 154.02 24.7 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.611 -1.281 . . . . 65.22 114.053 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -131.75 118.64 20.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.461 -0.57 . . . . 75.01 109.461 170.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.06 139.03 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 72.43 110.459 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.515 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 46.0 t -141.51 150.02 41.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.453 -0.339 . . . . 72.52 110.956 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.9 pt20 39.02 40.02 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.807 1.243 . . . . 73.14 113.474 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.57 23.07 0.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.874 -0.679 . . . . 44.02 111.834 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 tp -76.63 -32.88 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.717 0.294 . . . . 74.51 110.233 -175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.09 87.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.818 -0.706 . . . . 74.42 111.672 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 78.6 mmm -72.23 -50.07 30.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.414 -0.217 . . . . 74.23 110.414 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.415 HG11 HD13 ' A' ' 62' ' ' ILE . 86.6 t -57.77 -28.71 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 71.25 110.565 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.622 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -72.14 -55.29 7.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 72.11 110.572 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -70.69 -17.3 62.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.128 -0.487 . . . . 74.24 111.015 -176.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 145' ' ' VAL . 53.1 t -87.48 -33.32 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.258 0.552 . . . . 74.44 109.666 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.77 -13.36 82.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.787 -0.721 . . . . 61.41 112.687 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.622 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 67.9 mtp -85.17 -2.2 57.75 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.871 -0.194 . . . . 75.22 111.382 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 142' ' ' VAL . 6.1 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.294 0.568 . . . . 73.42 110.489 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 53' ' ' PHE . 3.6 p . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 121.292 0.567 . . . . 74.13 110.308 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.411 ' HG3' ' CG ' ' A' ' 52' ' ' LYS . 10.2 mptt -111.36 151.34 28.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.634 . . . . 70.45 110.86 -172.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.44 HD11 ' HG1' ' A' ' 51' ' ' THR . 3.7 mp -82.53 99.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.287 -1.005 . . . . 74.41 108.287 169.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 19' ' ' SER . 36.4 mm -62.9 -50.78 78.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 73.55 110.218 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -143.16 152.44 41.79 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.555 -0.748 . . . . 73.55 109.992 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.95 132.95 37.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.472 . . . . 72.13 109.875 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 43.4 m-85 -134.31 125.65 17.94 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.582 . . . . 65.33 109.957 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.53 ' HA ' HG11 ' A' ' 14' ' ' VAL . 19.5 Cg_endo -62.21 136.15 58.52 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.81 1.673 . . . . 72.34 111.139 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.494 ' HA ' ' HE2' ' A' ' 15' ' ' TYR . 8.6 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.999 0.428 . . . . 74.42 110.679 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.681 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.511 -0.539 0 CA-C-O 121.571 0.7 . . . . 65.2 110.26 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 156.17 146.39 4.45 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.926 -1.034 . . . . 63.52 110.998 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.9 -178.18 52.15 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.282 -0.961 . . . . 55.13 111.397 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.873 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.5 141.69 53.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.43 -0.582 . . . . 75.25 109.43 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 61.4 m-85 -88.96 104.44 7.6 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 75.11 110.277 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.614 ' HB2' HD13 ' A' ' 90' ' ' LEU . 1.1 Cg_endo -82.47 -5.55 11.77 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.804 2.336 . . . . 72.44 111.301 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.802 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 31.4 tt0 -78.66 -34.34 46.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 64.34 110.438 -175.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.534 HG13 HG12 ' A' ' 193' ' ' VAL . 17.7 pt -79.59 -13.6 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.497 -0.774 . . . . 70.22 111.555 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 58.9 m170 64.92 40.29 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.501 -0.772 . . . . 75.0 111.971 172.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.534 HG12 HG13 ' A' ' 191' ' ' ILE . 9.8 p -144.19 145.47 21.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.296 -0.411 . . . . 74.31 110.758 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.32 122.11 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.853 -0.612 . . . . 55.03 112.339 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -166.93 158.46 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.031 -0.986 . . . . 74.52 108.967 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 25.6 m-85 -126.11 148.45 63.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.939 -0.305 . . . . 74.14 110.587 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.873 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -66.38 -59.37 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.52 2.147 . . . . 72.01 111.786 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.7 33.15 1.81 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.882 0.372 . . . . 72.53 110.647 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.42 3.55 3.82 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.811 -0.632 . . . . 72.42 112.683 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.2 ptm -56.73 -30.54 63.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.936 0.347 . . . . 75.14 111.936 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.3 -1.78 89.34 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.675 -0.774 . . . . 74.33 112.514 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 85.3 mtt180 -101.19 -12.19 18.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.578 . . . . 63.3 110.234 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 21.1 ttmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.616 -1.175 . . . . 74.01 111.433 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.866 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 27.1 Cg_exo . . . . . 0 N--CA 1.464 -0.25 0 N-CA-C 110.564 -0.591 . . . . 73.34 110.564 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 72.7 Cg_endo -75.28 -18.22 18.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 73.45 113.395 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.505 HD22 HG11 ' A' ' 24' ' ' VAL . 23.1 t-20 -140.42 152.22 45.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.503 -0.555 . . . . 74.14 109.503 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.712 HG23 ' HE1' ' A' ' 39' ' ' PHE . 33.2 m -136.8 144.87 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.382 0.61 . . . . 75.11 111.29 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.84 123.53 43.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.207 -0.906 . . . . 73.21 111.004 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 16' ' ' LEU . 3.0 mm? -108.0 102.78 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.435 -0.348 . . . . 71.21 110.571 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -91.05 108.19 19.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.232 -0.655 . . . . 73.35 109.232 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -101.55 -179.95 4.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.228 0.537 . . . . 60.33 112.09 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB2' HD11 ' A' ' 160' ' ' ILE . 22.9 t -72.48 -11.01 60.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 75.32 110.948 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.437 ' HE2' HG22 ' A' ' 142' ' ' VAL . 4.7 mmt -102.89 -41.05 6.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.623 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.517 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -175.45 -129.39 1.2 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.419 -0.672 . . . . 71.02 111.419 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -139.69 138.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.923 -0.399 . . . . 75.42 109.923 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.63 129.99 64.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.843 -0.617 . . . . 72.42 109.647 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 21.6 t -105.59 134.34 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.361 -0.607 . . . . 75.24 109.361 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.745 ' HB2' HD12 ' A' ' 98' ' ' LEU . 3.8 pp -144.17 160.76 40.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.406 -0.517 . . . . 75.12 111.127 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -146.26 170.04 17.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 73.03 110.631 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.66 169.76 8.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.932 -0.576 . . . . 74.23 110.624 -173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -87.72 105.18 17.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.04 0.447 . . . . 71.41 110.851 176.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.493 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 1.4 m0 -85.88 0.06 54.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.005 -0.543 . . . . 71.44 109.854 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -72.62 -68.82 0.45 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.744 -0.662 . . . . 72.14 111.024 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -124.15 11.65 8.85 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.695 -0.402 . . . . 72.41 110.992 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' CG ' ' A' ' 129' ' ' PHE . . . -129.6 69.19 81.31 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.275 -0.57 . . . . 64.02 112.278 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.551 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 18.8 Cg_exo -65.73 -33.36 44.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.493 1.462 . . . . 70.01 109.706 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -57.0 -56.78 17.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.299 -0.864 . . . . 74.22 110.725 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 m -61.59 -36.22 80.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 70.34 110.823 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.63 -48.64 76.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.22 111.022 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.36 -37.25 77.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.659 0.266 . . . . 74.01 110.405 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HA ' ' HH ' ' A' ' 78' ' ' TYR . 55.4 t-20 -55.58 -62.05 1.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.926 -0.579 . . . . 63.51 110.476 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.712 ' HE1' HG23 ' A' ' 14' ' ' VAL . 5.0 t80 -65.01 -44.7 88.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.696 -0.684 . . . . 71.0 110.767 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.866 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -57.59 -48.77 78.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.451 -0.795 . . . . 63.31 112.198 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.28 -39.27 92.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.927 0.394 . . . . 73.11 111.159 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 3.6 mm? -69.15 -24.32 64.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.548 -0.296 . . . . 74.11 111.056 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.14 36.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.178 -0.464 . . . . 73.43 111.244 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.5 -29.03 70.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.178 0.513 . . . . 75.52 110.184 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 49.1 mtt180 -79.07 -50.55 10.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 75.31 109.86 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.03 52.82 0.68 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.809 . . . . 74.31 113.036 171.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.65 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 3.9 p90 -76.09 -25.97 56.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.343 0.592 . . . . 74.52 110.481 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.676 ' CD1' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.5 -7.95 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.479 -0.782 . . . . 74.25 112.844 -173.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -71.75 -5.73 36.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.499 . . . . 75.53 110.47 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.29 33.87 2.71 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.756 -0.656 . . . . 73.34 111.508 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.831 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.1 p -114.61 153.8 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.858 0.361 . . . . 72.4 111.119 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.565 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -146.13 161.61 39.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.249 -0.432 . . . . 74.33 109.889 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 97.9 m-85 -87.22 124.06 32.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.616 -0.513 . . . . 74.55 109.616 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -105.49 -32.77 8.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.996 -0.282 . . . . 73.12 111.13 -172.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -118.44 107.58 13.99 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.841 -0.343 . . . . 74.01 110.383 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.591 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -120.22 91.43 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.691 -0.855 . . . . 72.34 108.691 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.85 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.3 mt -93.24 128.91 44.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.98 -0.554 . . . . 73.24 110.116 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -52.2 109.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.341 1.026 . . . . 75.32 111.539 -176.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.557 ' OD2' ' HA2' ' A' ' 201' ' ' GLY . 6.6 t70 53.1 50.35 18.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.765 0.793 . . . . 72.14 110.703 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.85 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 7.1 t80 -137.55 -77.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.332 -0.849 . . . . 75.21 109.117 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.647 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.4 ptt? -162.29 154.9 19.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.939 -1.028 . . . . 73.53 109.739 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.591 HG23 HG13 ' A' ' 56' ' ' ILE . 36.1 mt -128.54 101.59 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.124 -0.489 . . . . 73.5 109.817 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.4 tm0? -82.26 126.38 32.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.394 -0.821 . . . . 74.1 109.833 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -142.69 145.68 15.93 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.176 -1.011 . . . . 71.43 113.569 -176.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.831 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 130.33 -138.58 10.3 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.735 -0.745 . . . . 62.15 112.37 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.882 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 23.1 t0 44.85 89.09 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 124.49 1.116 . . . . 74.43 113.249 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 72.6 Cg_endo -75.21 -13.5 20.97 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.863 2.375 . . . . 72.54 111.878 172.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -95.94 -34.9 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 65.14 112.058 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.47 21.92 71.41 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.127 -0.558 . . . . 53.3 112.37 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -120.09 2.24 10.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 73.2 111.159 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.59 -5.08 66.94 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.559 -0.829 . . . . 63.5 112.755 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -88.52 -46.75 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.335 0.588 . . . . 75.32 109.97 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.882 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 72.87 67.98 1.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.468 -0.787 . . . . 73.32 112.451 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.66 -105.05 1.57 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.859 -0.686 . . . . 73.23 111.59 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 53.62 35.85 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.962 0.448 . . . . 73.55 111.353 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 m -56.16 -32.24 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 74.11 111.779 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -70.53 -56.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.367 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' HH ' ' HA ' ' A' ' 38' ' ' ASN . 90.9 m-85 -69.86 -40.13 75.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.324 0.583 . . . . 75.32 110.465 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 -67.7 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.264 -0.88 . . . . 75.13 112.556 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -113.14 -178.65 3.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.156 0.503 . . . . 74.14 112.001 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.414 ' OE1' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -104.01 162.1 13.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.451 -0.795 . . . . 75.45 109.092 177.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -130.3 -67.86 0.72 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.41 -0.516 . . . . 70.24 111.108 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.8 -179.46 5.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.949 0.404 . . . . 74.15 110.466 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.436 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 6.1 p-10 -91.53 136.44 33.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.607 -0.724 . . . . 74.55 109.612 174.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -100.24 15.66 26.84 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 73.53 109.147 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.93 104.58 2.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.438 -0.801 . . . . 75.32 111.697 -173.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -173.37 81.69 0.4 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 75.35 109.906 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.11 93.0 0.46 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.562 2.175 . . . . 74.43 112.342 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.39 -38.56 84.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.365 0.602 . . . . 73.45 110.123 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' CD1' ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -81.16 -176.54 6.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.263 -0.881 . . . . 75.11 110.769 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -122.99 144.11 49.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.758 -0.46 . . . . 75.34 109.758 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.45 76.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.021 0.915 . . . . 73.14 109.677 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.7 p -61.52 -46.7 88.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.474 -1.239 . . . . 73.11 111.768 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.2 -140.21 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.62 -0.8 . . . . 53.24 112.27 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 137.7 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.661 0.267 . . . . 61.04 110.743 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.475 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 113.01 20.74 6.23 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.737 -0.744 . . . . 73.43 111.788 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.521 HD13 ' HB3' ' A' ' 189' ' ' PRO . 10.5 mm -87.41 114.7 26.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.238 -0.653 . . . . 74.24 109.238 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD12 ' HB2' ' A' ' 25' ' ' LEU . 8.5 mt -85.47 127.07 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.264 0.554 . . . . 72.02 111.467 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 163.81 26.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.316 -0.856 . . . . 71.41 110.105 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 108' ' ' ASN . 40.7 ttp -97.24 140.26 31.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.637 -0.505 . . . . 73.33 109.637 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.521 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -90.96 137.73 32.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 61.43 110.587 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -137.42 159.1 42.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.569 -0.741 . . . . 61.02 110.304 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.48 -2.11 36.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.605 0.717 . . . . 73.04 110.021 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.5 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -174.21 172.69 45.54 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.884 -1.686 . . . . 75.41 108.884 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 -44.91 34.68 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.659 2.24 . . . . 73.44 112.321 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.29 -3.7 18.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 73.03 110.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.5 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.6 m -85.8 52.44 2.47 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.735 0.779 . . . . 64.02 109.099 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 44.9 m-80 -79.68 130.58 35.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.773 -1.103 . . . . 74.44 110.332 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.27 -138.95 6.46 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.708 -0.758 . . . . 75.15 112.46 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -119.53 14.13 12.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.777 0.322 . . . . 72.42 111.349 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.521 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 pt20 -92.81 168.02 11.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.703 -0.226 . . . . 73.31 110.446 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -145.88 177.49 8.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.802 0.335 . . . . 75.32 111.127 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 45.6 p90 -160.29 151.87 19.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.319 173.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.0 t -106.61 146.84 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 73.53 109.56 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.421 HG21 ' HG1' ' A' ' 119' ' ' THR . 30.2 p -102.01 126.95 49.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.058 -0.349 . . . . 64.24 110.058 177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.456 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 68.2 mt -87.62 -7.71 57.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.317 0.58 . . . . 74.24 110.55 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.542 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . . . -150.89 165.14 18.01 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.397 -0.82 . . . . 72.11 109.809 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 117' ' ' ALA . 18.3 Cg_endo -58.59 113.85 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.631 2.221 . . . . 73.32 111.652 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.421 ' HG1' HG21 ' A' ' 115' ' ' THR . 16.6 p -100.06 88.44 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.231 0.538 . . . . 75.21 111.492 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.667 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -96.9 19.64 12.37 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.916 0.865 . . . . 75.52 108.845 -178.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.952 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -121.19 1.39 10.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.308 -1.314 . . . . 73.3 109.891 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.952 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 63.6 mt -121.71 6.37 9.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.485 -0.779 . . . . 72.13 110.41 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.01 -17.29 64.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 71.1 111.448 -172.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.11 18.58 5.01 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.507 -0.854 . . . . 72.31 111.298 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -120.91 -30.13 4.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.119 0.485 . . . . 73.33 110.249 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -139.67 141.2 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.165 -0.68 . . . . 62.42 109.165 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -78.16 144.55 36.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.978 0.418 . . . . 75.22 110.129 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.432 ' O ' HD23 ' A' ' 90' ' ' LEU . 49.3 mt -122.72 112.96 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.14 -0.482 . . . . 71.22 110.928 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.598 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.0 m-85 -155.82 77.31 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.608 0.568 . . . . 75.22 110.763 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -163.27 164.49 36.12 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.623 -0.799 . . . . 72.53 112.553 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -141.76 126.04 17.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.067 -0.346 . . . . 71.22 110.067 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.9 p -92.56 138.06 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.149 0.499 . . . . 75.13 110.911 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.544 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 47.9 t -144.23 146.0 32.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.1 -0.5 . . . . 73.42 110.204 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 7.9 tt0 50.25 40.49 22.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.254 0.55 . . . . 72.41 111.991 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.66 17.47 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.151 -1.023 . . . . 75.33 112.512 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 184' ' ' ASP . 11.2 tp -74.27 -33.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.061 -0.256 . . . . 74.41 110.617 -174.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.47 -38.31 96.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.543 -0.837 . . . . 73.54 111.243 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.517 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 76.1 mmm -69.33 -51.82 33.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.0 -0.37 . . . . 73.42 110.0 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.436 HG12 HD11 ' A' ' 62' ' ' ILE . 89.7 t -54.89 -31.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.054 0.454 . . . . 74.52 110.922 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.75 -53.73 12.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 74.23 110.587 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -73.48 -13.92 61.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.556 -0.747 . . . . 74.14 111.078 -176.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 20' ' ' MET . 53.4 t -88.51 -40.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 64.14 110.104 174.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.6 -9.41 86.89 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.708 -0.678 . . . . 74.05 112.735 -177.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.541 ' HG3' HG13 ' A' ' 145' ' ' VAL . 14.6 ptp -96.18 -13.62 23.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.669 0.271 . . . . 74.22 111.21 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 144' ' ' MET . 32.2 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.272 0.558 . . . . 62.41 111.635 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 53' ' ' PHE . 5.7 p . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 122.629 1.204 . . . . 73.35 111.187 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -133.49 159.63 39.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.085 -1.416 . . . . 75.33 109.784 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 159' ' ' ILE . 3.8 mp -81.37 103.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.815 -0.809 . . . . 75.24 108.815 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.3 mm -67.59 -65.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 74.11 109.951 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.525 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 mptm? -133.08 135.84 45.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.394 -0.821 . . . . 74.35 109.098 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.676 ' HB1' ' CD1' ' A' ' 48' ' ' TYR . . . -130.96 143.21 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.938 0.399 . . . . 74.13 110.089 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 17.0 m-85 -133.7 128.94 20.16 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.781 -0.645 . . . . 73.42 109.74 -171.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.433 ' HA ' HG12 ' A' ' 14' ' ' VAL . 74.2 Cg_endo -80.16 129.11 7.62 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.816 1.677 . . . . 64.54 111.529 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 74.22 109.956 -179.531 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.676 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.8 m-20 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.424 0.63 . . . . 72.53 110.715 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.46 144.01 3.87 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.15 -0.932 . . . . 63.14 111.164 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.88 -174.24 48.34 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.275 -0.964 . . . . 54.2 112.135 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.942 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.42 149.43 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.532 -0.544 . . . . 75.31 109.532 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -89.92 103.47 6.42 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 75.41 110.309 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 90.3 Cg_endo -80.61 -6.69 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.218 1.945 . . . . 71.33 111.066 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.73 -27.48 55.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.666 -1.152 . . . . 73.34 110.764 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 193' ' ' VAL . 15.8 pt -89.0 -12.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.976 -0.556 . . . . 73.22 111.703 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 90' ' ' LEU . 12.0 m170 58.27 45.31 17.38 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.801 -0.636 . . . . 74.13 111.588 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 191' ' ' ILE . 7.0 p -141.91 147.99 21.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.342 -0.39 . . . . 75.32 110.31 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.21 107.81 2.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.162 0.506 . . . . 73.34 112.202 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -158.38 157.48 32.42 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.873 -0.788 . . . . 73.23 108.873 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 202' ' ' ARG . 46.8 m-85 -128.01 151.65 76.22 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.895 -0.322 . . . . 71.44 110.949 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.942 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.6 Cg_endo -67.57 -57.55 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.408 2.072 . . . . 74.43 111.711 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.449 HD22 ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -126.52 15.85 7.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.13 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 1.2 m-20 64.18 22.98 13.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.583 0.957 . . . . 60.13 113.583 171.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.77 -46.87 51.09 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.886 -0.325 . . . . 71.52 111.494 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.557 ' HA2' ' OD2' ' A' ' 59' ' ' ASP . . . -79.09 0.5 79.01 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.053 -0.594 . . . . 70.44 113.593 -172.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 15.9 ptm180 -96.33 -18.01 20.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.157 0.503 . . . . 74.41 111.168 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.493 -0.776 . . . . 64.53 109.904 -175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 40' ' ' ALA . 50.9 Cg_exo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.876 0.282 . . . . 73.21 112.701 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 29' ' ' TRP . 71.8 Cg_endo -78.98 -13.51 14.11 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.813 2.342 . . . . 72.41 112.575 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.631 HD22 HG13 ' A' ' 24' ' ' VAL . 4.0 t-20 -151.72 142.01 22.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 75.45 109.666 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.6 149.33 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.823 0.344 . . . . 71.54 110.952 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.686 ' CD1' ' HB2' ' A' ' 165' ' ' SER . 7.0 m-85 -107.89 132.57 53.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.02 -0.536 . . . . 73.41 110.789 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 16' ' ' LEU . 2.4 mm? -118.88 102.5 8.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.498 -0.774 . . . . 74.52 109.917 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.36 109.58 17.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.088 -0.708 . . . . 71.42 109.088 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -98.28 178.2 5.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.939 0.4 . . . . 74.41 110.769 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 160' ' ' ILE . 6.9 p -70.96 -28.14 64.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.961 -0.563 . . . . 65.12 111.365 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.537 ' SD ' HG22 ' A' ' 142' ' ' VAL . 83.3 mtp -91.05 -41.58 10.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.55 -0.296 . . . . 73.44 111.118 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.501 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -163.8 -143.08 3.59 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.858 -0.687 . . . . 54.23 111.396 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' HD12 ' A' ' 23' ' ' ILE . 20.4 tt -128.11 138.92 53.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 117.026 0.413 . . . . 71.43 109.895 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 22' ' ' ILE . 10.8 mm -125.53 132.27 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.617 -0.512 . . . . 75.41 109.617 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 18.3 t -120.0 139.86 45.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 110.14 -0.319 . . . . 75.41 110.14 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.413 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 161.37 42.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 73.32 110.449 174.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 14.6 pt-20 -130.87 167.68 18.53 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.015 -0.539 . . . . 74.02 110.167 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.28 157.9 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.416 -0.356 . . . . 74.23 110.688 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HH ' ' HG2' ' A' ' 189' ' ' PRO . 4.9 m-85 -80.07 102.49 9.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 72.22 111.499 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 12' ' ' PRO . 11.5 m0 -80.58 -6.27 58.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.887 -0.597 . . . . 73.21 110.453 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -73.83 -53.35 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 74.55 111.732 -172.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.62 6.09 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.925 0.342 . . . . 73.42 111.925 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 35' ' ' THR . . . -132.19 79.01 67.46 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.996 0.426 . . . . 72.33 111.52 -176.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.8 Cg_exo -71.84 -41.03 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.371 2.047 . . . . 74.12 111.573 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -77.33 -43.31 33.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.933 -0.576 . . . . 74.43 110.143 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 2.1 m -57.23 -42.38 81.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 72.33 110.334 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.7 t -60.77 -47.96 83.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 75.12 110.651 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -62.95 -35.53 80.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.153 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.22 -53.31 59.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 73.14 110.76 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.481 ' HZ ' ' HG3' ' A' ' 100' ' ' MET . 76.9 m-85 -67.96 -44.42 76.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 64.55 111.164 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.649 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . -61.84 -35.96 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 63.42 112.13 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -66.35 -44.71 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.422 0.63 . . . . 72.32 109.948 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . 30.4 mt -67.64 -22.12 65.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.144 -0.48 . . . . 74.11 111.128 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.0 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 72.31 110.362 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 32.4 mmt180 -63.84 -49.6 72.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.311 0.576 . . . . 65.44 110.073 174.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -74.9 -51.97 12.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.378 -0.828 . . . . 71.12 110.802 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.9 44.86 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 74.42 112.129 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -70.6 -26.53 63.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.042 0.449 . . . . 74.14 110.714 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.3 m-85 -76.67 -16.49 59.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.41 111.572 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -74.52 2.33 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 73.3 110.942 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.32 11.7 5.26 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.921 -0.657 . . . . 53.42 111.907 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.573 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.4 p -90.45 137.93 31.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 74.22 110.951 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 2.0 mtmt -129.49 150.75 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.388 -0.597 . . . . 75.14 109.388 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 72.4 m-85 -78.05 122.37 25.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.851 -0.425 . . . . 72.34 109.851 177.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -107.36 -30.46 8.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.55 -0.295 . . . . 64.51 111.064 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 25.5 mmt180 -119.04 110.58 17.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.907 -0.405 . . . . 73.41 109.907 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.4 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -127.15 93.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 74.15 109.082 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 35.2 mt -104.1 125.48 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.028 -0.533 . . . . 75.24 109.94 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -50.42 129.39 21.84 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.65 0.594 . . . . 75.32 111.62 177.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' HE3' ' A' ' 58' ' ' LYS . 3.4 p30 42.22 43.74 3.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.231 0.957 . . . . 75.5 112.418 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.709 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -135.67 -77.54 0.43 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 74.35 110.291 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.7 ptp -160.05 156.05 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 64.34 110.634 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.498 ' CD1' HD22 ' A' ' 116' ' ' LEU . 40.6 mt -131.58 101.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.736 -0.666 . . . . 72.22 109.417 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -88.42 128.92 35.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.647 -0.706 . . . . 73.2 109.802 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -137.17 144.24 15.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.708 -0.758 . . . . 71.33 112.369 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 147.14 -143.3 11.17 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.658 -0.782 . . . . 60.11 112.578 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' HE22 ' A' ' 111' ' ' GLN . 44.5 t0 46.86 77.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 124.16 0.984 . . . . 70.43 112.71 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.72 -12.08 22.09 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.495 2.13 . . . . 73.32 111.587 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.423 ' HB ' HG21 ' A' ' 70' ' ' THR . 20.0 p -91.81 -42.83 9.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.458 -0.792 . . . . 74.25 111.961 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.22 32.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.602 -0.809 . . . . 70.53 112.001 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.55 HG23 ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.45 -2.65 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 72.15 111.038 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.69 -35.7 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.381 -0.914 . . . . 73.42 113.316 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HG2' HG23 ' A' ' 70' ' ' THR . 14.3 ptm180 -78.67 -28.88 45.38 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.219 0.509 . . . . 74.05 110.888 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.04 -162.65 54.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.023 -0.608 . . . . 75.41 113.179 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.97 6.79 61.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.294 -0.479 . . . . 72.55 112.386 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 110' ' ' SER . . . -87.35 22.59 2.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.34 1.067 . . . . 71.41 110.723 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -85.51 5.8 29.76 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.318 -1.31 . . . . 74.2 109.805 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.49 -28.51 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.342 -0.845 . . . . 70.4 111.213 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.436 ' OH ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 p90 -100.18 10.86 40.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.512 0.672 . . . . 75.21 110.788 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.41 -110.26 3.96 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.11 -0.95 . . . . 74.22 112.417 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -95.88 -169.02 1.86 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.426 0.291 . . . . 74.33 110.275 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 159.26 26.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 71.24 109.826 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -102.47 -85.18 0.44 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.836 0.35 . . . . 74.53 110.944 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -162.02 157.19 23.19 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.459 -0.941 . . . . 75.55 108.459 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.31 110.95 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.533 0.682 . . . . 64.45 110.438 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.43 28.83 3.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.841 -0.618 . . . . 72.11 109.377 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.38 100.31 0.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 72.05 110.502 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -159.92 72.74 3.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.798 -0.637 . . . . 75.14 109.827 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.21 98.21 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.206 1.938 . . . . 73.3 112.642 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.56 24.39 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.489 0.662 . . . . 73.34 110.318 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.66 HD12 ' HB2' ' A' ' 189' ' ' PRO . 1.8 pp -137.24 -169.06 2.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.501 -0.772 . . . . 75.13 110.278 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -140.6 151.06 44.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.033 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -72.43 69.5 0.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.713 0.768 . . . . 75.23 110.668 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.9 p -68.7 -39.94 80.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.174 -0.921 . . . . 72.11 111.824 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 -142.43 3.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.504 -0.855 . . . . 73.14 112.913 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 141.62 28.43 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.302 0.241 . . . . 60.32 111.018 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 111.41 22.2 6.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.793 -0.718 . . . . 52.14 111.917 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.1 mm -87.52 111.25 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.684 -0.487 . . . . 74.42 109.684 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -88.44 118.9 28.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.139 0.495 . . . . 73.41 109.715 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -129.3 173.4 10.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.063 -0.517 . . . . 52.42 110.817 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.521 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 12.3 ttp -104.02 137.04 42.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.141 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -89.21 144.46 26.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 63.35 110.73 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.511 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.2 p-10 -153.12 158.77 42.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 71.15 110.593 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.19 -16.56 20.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.74 0.781 . . . . 75.31 109.794 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.404 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -157.05 174.07 34.65 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.698 -1.761 . . . . 71.11 108.698 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.03 -47.73 22.52 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.844 2.363 . . . . 74.42 112.082 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -104.31 -5.07 22.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 64.22 110.986 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -87.61 49.33 1.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.767 0.794 . . . . 63.01 108.865 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.521 ' HB2' ' HE1' ' A' ' 100' ' ' MET . 5.7 p30 -94.37 145.08 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 74.22 111.386 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -129.79 -167.26 12.04 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.013 -1.235 . . . . 71.31 110.013 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 19.5 t -87.47 14.88 7.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.94 0.87 . . . . 65.41 110.016 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 10.1 mm-40 -67.53 145.99 54.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.056 -1.09 . . . . 72.41 108.056 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.72 166.32 24.25 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.191 -0.603 . . . . 71.24 111.433 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.51 151.38 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.777 -0.647 . . . . 73.33 110.128 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.692 HG22 HD22 ' A' ' 98' ' ' LEU . 17.5 t -110.39 143.65 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.221 -0.659 . . . . 75.11 109.221 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.765 HG21 ' HG1' ' A' ' 119' ' ' THR . 29.3 p -98.99 126.38 44.67 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.048 0.451 . . . . 72.23 110.159 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.498 HD22 ' CD1' ' A' ' 62' ' ' ILE . 69.3 mt -83.99 -5.87 59.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.721 -0.672 . . . . 71.05 110.629 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . . . -146.5 162.01 36.01 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.706 -0.679 . . . . 61.15 109.829 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 117' ' ' ALA . 21.6 Cg_endo -61.8 112.91 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.653 2.235 . . . . 72.14 112.018 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.765 ' HG1' HG21 ' A' ' 115' ' ' THR . 16.2 p -97.51 102.72 14.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.397 0.618 . . . . 73.53 111.163 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.52 17.71 23.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.424 0.631 . . . . 72.54 110.355 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.29 -3.38 9.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 72.11 111.673 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.1 pp -133.07 8.17 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 74.43 112.443 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -62.74 -27.48 69.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.007 0.432 . . . . 74.44 111.021 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.34 11.35 36.53 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.751 . . . . 74.0 112.05 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -117.18 -27.46 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.489 0.661 . . . . 75.42 109.56 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.38 130.46 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 74.53 108.68 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.0 t -75.37 143.95 42.55 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.198 -0.601 . . . . 72.21 110.109 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 99' ' ' ALA . 42.4 mt -122.95 116.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 73.44 110.501 -173.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.6 m-85 -151.96 74.13 1.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.998 0.427 . . . . 74.25 110.459 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.74 155.81 27.27 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.719 -0.753 . . . . 71.14 112.179 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.417 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 14.3 mtp180 -135.07 118.91 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.426 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.0 p -79.96 136.94 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.405 0.622 . . . . 71.4 110.55 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.667 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 44.1 t -141.8 145.76 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.674 -0.694 . . . . 74.52 109.693 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.5 tt0 42.75 48.75 4.92 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.483 0.658 . . . . 73.51 112.363 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -172.12 13.58 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.833 -1.175 . . . . 65.35 112.988 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.542 HG21 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -73.54 -31.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.874 0.337 . . . . 74.34 110.238 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -37.38 94.75 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.701 -0.762 . . . . 53.14 111.203 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.566 ' O ' HG21 ' A' ' 142' ' ' VAL . 69.8 mmm -72.47 -50.66 24.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.85 -0.426 . . . . 72.42 109.85 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.426 HG11 HD12 ' A' ' 62' ' ' ILE . 90.1 t -53.91 -30.65 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 71.42 110.83 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -69.91 -52.47 24.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.962 -0.563 . . . . 74.43 110.612 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.23 -17.07 60.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.447 -0.342 . . . . 75.55 111.402 -179.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 138' ' ' MET . 83.9 t -83.47 -34.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 73.42 109.957 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -91.01 -3.74 69.87 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.864 -0.684 . . . . 72.52 112.619 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.6 ptm -95.89 -12.2 25.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.728 0.299 . . . . 73.11 110.954 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 142' ' ' VAL . 21.4 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.668 . . . . 75.45 110.397 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.739 0.781 . . . . 74.44 109.326 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -155.88 176.42 12.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.251 -0.886 . . . . 74.33 110.486 -171.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 159' ' ' ILE . 3.3 mp -90.17 109.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.456 -0.572 . . . . 74.11 109.456 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.626 HG21 ' HD3' ' A' ' 161' ' ' LYS . 27.6 mm -75.48 -49.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.628 -0.715 . . . . 75.04 110.871 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.626 ' HD3' HG21 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.78 140.55 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.774 -0.648 . . . . 74.33 109.92 178.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -144.01 134.91 25.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.846 0.355 . . . . 74.4 111.574 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -160.64 151.77 15.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 74.12 110.375 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 10.3 Cg_exo -70.73 142.23 43.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.832 2.355 . . . . 75.14 112.483 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.686 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 46.7 m . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.383 -0.599 . . . . 74.21 109.383 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.542 ' HB3' HG21 ' A' ' 136' ' ' ILE . 4.2 m-20 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.933 0.397 . . . . 73.12 110.123 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.08 142.95 3.74 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.719 -0.753 . . . . 62.43 111.515 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -82.44 -164.62 35.09 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.261 -0.971 . . . . 75.22 111.992 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.822 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.32 166.95 22.5 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.112 -0.329 . . . . 71.51 110.112 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.31 95.19 41.92 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-O 121.153 0.502 . . . . 73.23 110.336 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.66 ' HB2' HD12 ' A' ' 90' ' ' LEU . 55.6 Cg_endo -70.77 -19.37 31.41 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.914 2.409 . . . . 74.12 111.651 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.517 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 32.0 tt0 -73.09 -37.53 66.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.903 -1.044 . . . . 74.03 111.522 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.513 HG13 HG11 ' A' ' 193' ' ' VAL . 30.4 pt -75.14 -13.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.175 -0.466 . . . . 73.21 111.75 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 59.8 m170 63.02 70.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 73.54 111.231 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 191' ' ' ILE . 9.3 p -170.8 140.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 74.23 110.003 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.31 117.18 7.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 73.21 111.517 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.35 149.31 11.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.097 -0.705 . . . . 74.13 109.097 175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 29.0 m-85 -120.2 147.41 44.77 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.744 -0.207 . . . . 75.43 110.852 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.822 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.4 Cg_endo -63.67 -64.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.527 2.151 . . . . 72.31 112.025 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.73 26.55 4.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.215 0.531 . . . . 71.52 109.985 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' HD3' ' A' ' 202' ' ' ARG . 78.3 m-20 70.08 6.55 5.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.225 -0.898 . . . . 74.11 112.05 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.9 ptm -54.24 -34.28 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 71.44 112.198 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.96 10.91 71.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.358 -0.925 . . . . 72.32 113.222 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.49 ' HD3' ' OD1' ' A' ' 199' ' ' ASP . 4.7 ptm180 -127.21 -39.59 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.138 0.469 . . . . 75.54 110.501 176.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 203' ' ' LYS . 1.2 ptmm? . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.853 -0.594 . . . . 64.54 110.124 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' CB ' ' HB2' ' A' ' 164' ' ' PRO . 82.2 Cg_exo . . . . . 0 CA--C 1.529 0.244 0 CA-C-O 121.125 0.385 . . . . 65.4 113.061 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.75 -24.72 15.35 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.972 2.448 . . . . 74.24 113.279 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.688 HD22 HG13 ' A' ' 24' ' ' VAL . 11.1 t-20 -131.87 146.66 52.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.574 -0.528 . . . . 71.44 109.574 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.675 HG22 ' HE1' ' A' ' 39' ' ' PHE . 22.0 m -131.72 144.17 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.311 0.577 . . . . 73.14 111.157 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 77.0 m-85 -97.71 120.41 38.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.632 -0.713 . . . . 73.23 110.701 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -107.57 103.81 13.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.043 -0.354 . . . . 71.34 110.043 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HG2' HG12 ' A' ' 22' ' ' ILE . 29.6 mt-10 -92.18 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.491 -0.559 . . . . 75.43 109.491 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -103.5 179.26 4.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.162 0.506 . . . . 72.11 111.534 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' ' 160' ' ' ILE . 11.5 p -73.62 -18.35 61.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 73.01 111.176 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.7 mmm -98.65 -35.86 10.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 73.32 111.201 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -172.4 -133.94 1.72 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.691 . . . . 63.21 111.817 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.495 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -141.4 133.83 29.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.075 -0.713 . . . . 75.22 109.075 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -127.76 126.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.757 -0.656 . . . . 64.41 109.777 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.688 HG13 HD22 ' A' ' 13' ' ' ASN . 10.9 t -108.44 135.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.553 -0.536 . . . . 72.15 109.553 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.24 162.21 39.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.346 0.593 . . . . 75.41 110.621 175.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' A' ' 131' ' ' ARG . 2.7 pt-20 -140.42 164.6 29.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.91 -1.041 . . . . 74.25 109.398 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HG ' ' A' ' 36' ' ' CYS . 1.1 mm? -100.28 175.37 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.891 0.377 . . . . 74.13 110.826 -171.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.3 m-85 -88.92 101.49 14.12 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.31 0.576 . . . . 73.23 111.052 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.401 ' HZ2' ' HB2' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -82.21 -2.13 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.261 -0.881 . . . . 74.03 110.486 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -75.07 -67.5 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 74.52 111.24 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -117.51 13.08 14.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 73.41 110.782 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 35' ' ' THR . . . -136.91 62.2 39.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.824 0.345 . . . . 62.13 110.945 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.594 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 18.5 Cg_exo -65.99 -50.96 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.591 2.194 . . . . 75.04 112.091 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -74.02 -35.08 64.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.401 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.533 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.4 m -62.96 -37.6 87.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.714 -0.675 . . . . 72.22 110.08 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.59 ' HG ' HD21 ' A' ' 27' ' ' LEU . 25.2 t -63.85 -39.58 94.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.79 -0.641 . . . . 75.21 110.925 175.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mmpt? -63.73 -39.66 94.83 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.831 -0.433 . . . . 73.41 109.831 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -53.7 -57.51 10.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.698 -0.683 . . . . 72.25 110.133 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.675 ' HE1' HG22 ' A' ' 14' ' ' VAL . 17.3 t80 -59.29 -49.71 76.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 72.22 110.754 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.99 75.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.391 -0.822 . . . . 62.31 112.357 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.641 ' OE2' ' HD3' ' A' ' 44' ' ' ARG . 25.9 mm-40 -63.27 -41.93 99.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.638 -0.255 . . . . 74.35 111.602 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 47' ' ' TYR . 3.6 mm? -69.29 -27.36 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.254 -0.578 . . . . 75.53 110.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.0 65.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 74.11 110.802 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.641 ' HD3' ' OE2' ' A' ' 41' ' ' GLU . 2.9 ptm180 -75.05 -29.39 60.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 74.31 111.39 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 1.3 tmt_? -65.23 -37.31 86.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.35 0.595 . . . . 74.23 109.854 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.5 32.14 2.2 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.587 -0.816 . . . . 72.11 111.987 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.488 ' HB2' HD11 ' A' ' 42' ' ' LEU . 85.0 t80 -85.91 -44.31 12.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.015 0.436 . . . . 74.13 110.259 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -78.71 -9.27 59.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.057 -0.52 . . . . 75.12 111.041 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -77.62 8.01 4.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.402 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.83 16.27 1.98 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.871 -0.604 . . . . 73.13 111.891 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.68 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -97.95 159.45 14.92 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.707 -0.29 . . . . 64.54 110.832 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -140.63 146.82 38.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.81 0.338 . . . . 72.52 111.544 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.554 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 65.4 m-85 -78.48 100.91 7.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -109.98 -14.56 14.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.471 -0.492 . . . . 74.34 111.671 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.936 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 12.7 mmm180 -110.03 112.92 25.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.092 -0.707 . . . . 71.0 109.092 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 62' ' ' ILE . 19.7 mm -124.84 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.348 -0.612 . . . . 65.42 109.348 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 10.8 mt -102.0 115.49 43.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.652 -0.499 . . . . 65.34 109.652 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 38.7 mtpt -57.13 129.27 41.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.127 0.267 . . . . 73.34 111.269 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.99 26.69 16.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.545 -0.752 . . . . 71.41 110.979 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -128.93 -81.71 0.57 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 74.32 109.976 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -161.04 159.71 29.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 75.23 110.325 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD12 ' HA3' ' A' ' 143' ' ' GLY . 62.4 mt -128.78 103.48 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 74.45 109.382 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.936 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 50.9 mt-30 -85.6 124.53 32.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.606 -0.725 . . . . 73.41 111.526 -176.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.02 139.16 10.74 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.754 -0.657 . . . . 71.22 112.487 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.68 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 142.96 -154.77 25.58 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.466 -0.873 . . . . 71.25 112.85 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.1 t0 55.78 102.6 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.355 1.062 . . . . 72.22 112.714 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.77 -17.16 11.17 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.102 2.535 . . . . 75.43 111.515 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.9 p -90.3 -38.27 13.5 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.787 -0.642 . . . . 64.32 110.305 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.28 25.85 60.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 71.2 111.359 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.422 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 76.1 p -97.96 -35.24 10.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 72.34 111.078 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.87 -20.85 6.71 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.668 -0.696 . . . . 71.51 112.274 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 7.2 ptm180 -93.57 -28.0 16.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 75.24 110.934 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.76 -179.52 53.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.7 -0.762 . . . . 72.32 111.831 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.477 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . -79.74 -87.52 0.54 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.861 -0.685 . . . . 63.31 112.371 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.44 27.07 4.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.845 0.831 . . . . 63.54 111.228 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -85.99 16.39 4.23 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.041 -0.981 . . . . 62.03 111.754 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG13 ' HD1' ' A' ' 78' ' ' TYR . 46.4 pt -81.85 -29.53 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.715 -0.394 . . . . 73.45 110.143 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.571 ' HD1' HG13 ' A' ' 77' ' ' ILE . 2.9 p90 -117.95 14.05 14.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.924 0.868 . . . . 74.51 110.521 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -77.06 1.81 Allowed Glycine 0 C--N 1.318 -0.441 0 CA-C-N 114.59 -1.186 . . . . 72.43 113.425 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -111.98 -163.85 0.88 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.272 -0.27 . . . . 74.15 110.272 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 168.0 14.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.647 . . . . 73.13 109.252 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -98.88 -80.1 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.77 -0.372 . . . . 75.01 111.308 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.51 163.57 27.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.964 -0.754 . . . . 71.51 108.964 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.34 143.66 34.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 74.43 109.756 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 23.8 7.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.75 -0.659 . . . . 74.13 109.604 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -54.51 100.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.52 -0.764 . . . . 71.2 111.648 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.61 91.33 0.43 Allowed Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.39 -0.823 . . . . 72.35 109.412 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 90' ' ' LEU . 19.2 Cg_endo -57.6 92.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.611 2.207 . . . . 74.42 111.071 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.28 23.3 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.145 0.974 . . . . 75.51 109.146 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -145.3 -176.88 5.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.361 -1.29 . . . . 74.34 108.625 -178.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HD3' HG22 ' A' ' 93' ' ' THR . 54.2 tttm -113.61 147.88 37.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.324 0.583 . . . . 72.53 110.938 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.24 79.99 4.67 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.091 0.948 . . . . 74.33 108.481 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.417 HG22 ' HD3' ' A' ' 91' ' ' LYS . 26.8 p -75.65 -41.95 52.69 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.612 -1.176 . . . . 74.32 111.838 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.791 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.83 -137.79 2.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.658 -0.782 . . . . 74.05 112.293 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.77 147.29 24.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.815 0.341 . . . . 40.21 110.891 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 106.41 21.95 8.08 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.446 -0.662 . . . . 75.11 111.446 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 mm -90.03 110.9 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.479 -0.563 . . . . 73.42 109.479 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.967 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -85.89 117.77 24.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.76 -0.654 . . . . 73.21 109.538 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.0 169.81 12.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.125 0.488 . . . . 74.42 111.854 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.846 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 14.0 tpt -90.45 135.4 33.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.412 -0.813 . . . . 75.24 109.983 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -97.86 149.33 22.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.522 -0.548 . . . . 74.2 109.522 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.656 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -163.11 159.26 22.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 73.11 110.7 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.39 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.627 0.727 . . . . 74.0 109.814 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.423 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -137.31 177.76 19.56 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.988 -1.645 . . . . 64.43 108.988 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 -51.84 9.72 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.021 2.481 . . . . 74.02 112.86 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.7 -4.83 29.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 71.14 111.59 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 2.2 m -88.81 49.68 1.83 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.327 0.584 . . . . 72.55 109.469 -175.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.656 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -74.27 -66.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.806 -1.088 . . . . 51.54 110.944 178.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 -100.77 2.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.625 -0.797 . . . . 71.25 112.343 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -152.87 35.94 0.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.012 0.434 . . . . 72.52 110.81 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 19.9 mt-30 -102.54 146.56 27.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 74.51 110.186 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -142.44 166.9 23.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.711 0.291 . . . . 73.43 110.795 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -158.59 153.23 24.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.926 0.393 . . . . 74.41 111.004 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.694 HG23 HD21 ' A' ' 98' ' ' LEU . 17.7 t -108.62 145.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 74.44 109.265 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.651 HG23 ' HG1' ' A' ' 119' ' ' THR . 27.6 p -99.88 129.67 45.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.897 0.379 . . . . 61.14 110.452 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD23 ' CD1' ' A' ' 62' ' ' ILE . 64.7 mt -84.79 -9.63 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.644 -0.707 . . . . 74.15 110.984 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.32 164.18 28.03 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.9 -0.591 . . . . 62.4 110.054 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.791 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 35.5 Cg_exo -60.98 114.52 2.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.454 2.103 . . . . 75.12 111.493 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.651 ' HG1' HG23 ' A' ' 115' ' ' THR . 8.7 p -100.12 94.56 6.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.277 0.561 . . . . 74.55 111.189 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -98.11 14.56 27.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 72.11 110.104 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.586 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.6 p90 -118.29 -3.36 11.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.026 -0.988 . . . . 74.51 110.495 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.591 HD23 ' HD2' ' A' ' 126' ' ' HIS . 83.5 mt -105.06 8.82 34.44 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.792 -0.64 . . . . 74.21 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.1 -23.58 55.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.064 -1.425 . . . . 75.14 111.315 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.29 23.22 3.49 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 120.874 -0.679 . . . . 72.4 111.983 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.45 -32.95 3.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.936 0.398 . . . . 72.21 110.279 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.591 ' HD2' HD23 ' A' ' 122' ' ' LEU . 96.9 m-70 -141.24 139.53 33.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.322 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.7 m -75.46 135.98 40.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.777 -0.453 . . . . 64.1 109.777 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -115.46 124.75 72.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 121.058 -0.257 . . . . 74.25 110.828 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.846 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 3.8 p90 -157.4 74.07 0.75 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.949 0.88 . . . . 75.05 110.932 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.967 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.83 152.39 22.55 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.01 -1.567 . . . . 74.12 113.841 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -138.62 110.2 7.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 74.55 109.726 174.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.9 p -79.93 139.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 72.43 111.264 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.625 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.1 t -142.47 151.71 42.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.096 -0.502 . . . . 71.5 109.892 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 42.42 60.07 2.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.258 0.623 . . . . 73.21 112.15 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.54 24.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.035 -1.079 . . . . 71.23 112.883 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tp -78.02 -32.51 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.109 -0.33 . . . . 73.55 110.109 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.46 -37.35 94.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.949 -0.644 . . . . 64.25 111.934 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.564 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 74.9 mmm -67.02 -51.1 59.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.511 -0.551 . . . . 73.15 109.511 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 62' ' ' ILE . 74.8 t -54.21 -32.92 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 74.13 110.586 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.8 t30 -71.29 -56.08 6.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 73.53 110.656 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.8 -13.8 61.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.463 -0.335 . . . . 70.35 111.307 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 145' ' ' VAL . 44.6 t -88.82 -36.62 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 65.41 110.505 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.537 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -83.52 -18.98 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 72.12 113.2 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 60.5 mtp -89.87 -8.76 51.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.2 0.444 . . . . 73.25 112.2 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 142' ' ' VAL . 30.1 m . . . . . 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.468 . . . . 63.04 110.737 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 120.534 0.207 . . . . 75.55 110.644 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.95 159.37 19.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.265 0.555 . . . . 70.54 111.443 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 162' ' ' ALA . 4.3 mp -87.74 102.4 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.644 -1.162 . . . . 75.41 108.494 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 19' ' ' SER . 30.7 mm -68.21 -56.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.537 -0.756 . . . . 74.41 110.009 -176.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 14.5 mptt -127.4 136.97 52.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 72.35 109.998 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 159' ' ' ILE . . . -133.81 115.96 15.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.939 0.399 . . . . 70.23 110.385 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.62 116.3 26.59 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.64 . . . . 72.0 110.918 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.59 ' HB3' HG13 ' A' ' 14' ' ' VAL . 56.8 Cg_endo -73.02 126.91 11.62 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.172 1.915 . . . . 75.11 111.413 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.7 m . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 70.33 111.339 -176.346 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.324 0.583 . . . . 74.32 111.454 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.24 145.53 4.36 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.118 -0.947 . . . . 62.34 111.188 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.49 -161.77 15.64 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.549 -0.834 . . . . 72.51 112.065 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.726 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.92 -177.12 6.58 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 110.326 -0.25 . . . . 75.34 110.326 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.86 91.96 28.27 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 109.648 -0.501 . . . . 73.4 109.648 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 3.6 Cg_exo -78.67 -12.18 15.18 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.899 2.4 . . . . 73.43 112.148 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.88 -36.51 70.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.95 -0.568 . . . . 74.4 109.997 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.2 pt -88.07 156.15 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.98 -0.748 . . . . 73.15 108.98 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -105.32 89.06 3.01 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.374 -0.53 . . . . 75.53 110.291 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 194' ' ' ALA . 9.7 p -163.92 170.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.83 -0.804 . . . . 71.31 108.83 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -94.9 115.72 27.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.865 0.364 . . . . 71.42 111.05 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -144.18 153.27 41.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.449 -0.945 . . . . 75.22 108.449 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.98 139.03 34.5 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.79 0.329 . . . . 75.35 111.034 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.8 Cg_endo -63.26 -54.13 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.713 2.275 . . . . 74.21 112.06 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.48 35.31 0.96 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.455 -0.339 . . . . 74.15 111.457 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.522 ' OD2' ' HD3' ' A' ' 202' ' ' ARG . 7.4 t70 75.77 -14.05 0.82 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.074 0.55 . . . . 75.42 111.66 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.5 ptm -46.1 -29.93 1.71 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.877 1.066 . . . . 72.2 113.877 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -111.09 10.72 29.23 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 72.34 113.254 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.522 ' HD3' ' OD2' ' A' ' 199' ' ' ASP . 44.0 mtp180 -72.43 -38.42 68.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 117.62 0.71 . . . . 70.24 111.91 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 203' ' ' LYS . 3.7 mppt? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.747 -0.645 . . . . 75.44 110.633 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 4.2 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 N-CA-C 113.068 0.372 . . . . 75.21 113.068 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.15 -44.85 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.811 2.341 . . . . 74.45 112.263 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.513 HD22 HG12 ' A' ' 24' ' ' VAL . 11.6 t-20 -124.88 144.39 50.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.458 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG23 ' HE1' ' A' ' 39' ' ' PHE . 22.4 m -133.23 162.91 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 64.11 110.394 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -122.33 134.86 54.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.064 0.459 . . . . 74.31 110.376 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.4 mt -111.87 107.98 17.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 71.11 109.391 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -92.24 119.46 31.87 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.428 -0.582 . . . . 63.35 109.428 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -109.07 178.3 4.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.141 0.496 . . . . 75.21 110.986 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 t -67.27 -15.89 63.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 73.34 110.442 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 142' ' ' VAL . 5.7 mmt -95.55 -34.62 11.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.034 -0.53 . . . . 74.34 111.007 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . 174.18 -130.79 1.87 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.086 -0.806 . . . . 71.4 111.086 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.236 0.541 . . . . 74.55 110.486 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.96 114.13 37.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.429 -0.805 . . . . 72.13 109.767 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.593 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 41.3 t -96.4 141.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.839 -0.619 . . . . 75.23 109.374 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.1 163.79 36.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.137 0.494 . . . . 71.54 111.015 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.17 162.92 30.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.505 -0.77 . . . . 72.44 109.892 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 166.04 10.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.764 -0.653 . . . . 72.1 109.394 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 5.3 m-85 -85.75 93.5 8.88 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 74.01 111.702 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.616 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -79.47 -8.75 59.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.743 0.782 . . . . 70.21 109.343 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -70.34 -45.01 67.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.384 -1.28 . . . . 73.23 111.658 -173.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -137.86 8.61 2.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.807 0.299 . . . . 72.02 111.807 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.22 67.27 10.69 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.835 0.679 . . . . 72.24 112.835 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.488 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 21.3 Cg_exo -65.54 -27.4 53.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.025 1.817 . . . . 70.35 110.996 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -62.87 -59.48 4.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 72.23 110.892 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -62.67 -36.34 82.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.597 . . . . 75.32 110.208 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.616 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 39.5 t -53.73 -53.47 51.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.238 -0.892 . . . . 70.21 111.278 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 3.0 mtmp? -69.88 -27.28 64.68 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.789 -0.364 . . . . 74.42 111.666 -173.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.526 ' O ' HD22 ' A' ' 42' ' ' LEU . 59.8 t30 -59.48 -49.83 76.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.489 -0.56 . . . . 71.22 109.489 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.78 ' HE1' HG23 ' A' ' 14' ' ' VAL . 12.3 t80 -68.81 -51.33 41.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 75.23 109.852 176.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -55.54 -44.86 77.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 63.44 112.985 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 43.4 mt-10 -77.77 -26.59 49.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 121.126 -0.229 . . . . 72.11 111.572 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 38' ' ' ASN . 3.2 mm? -78.99 -20.88 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.788 -0.765 . . . . 73.02 110.428 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.38 -44.31 36.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.075 -0.511 . . . . 73.33 110.951 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.688 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -62.98 -36.76 84.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.629 -0.26 . . . . 74.43 111.314 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -72.77 -46.93 50.76 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.203 -0.599 . . . . 74.31 109.423 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.33 42.83 1.03 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.522 -0.847 . . . . 72.21 113.46 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.678 ' HD1' ' HG3' ' A' ' 67' ' ' PRO . 1.2 m-85 -77.45 -15.95 59.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 73.32 110.405 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.82 0.27 51.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.761 -0.654 . . . . 71.25 111.001 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 48.7 m-80 -81.81 2.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.052 0.453 . . . . 74.43 109.868 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -134.71 14.05 4.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.002 -0.618 . . . . 71.42 112.176 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.6 p -88.83 149.22 23.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.661 0.267 . . . . 75.43 110.46 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -138.65 128.42 25.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.553 -0.294 . . . . 71.55 110.556 -176.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 61.0 m-85 -67.07 110.74 3.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.97 -0.752 . . . . 75.4 108.97 175.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -111.86 -18.48 12.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.835 -0.346 . . . . 74.32 111.133 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 26.5 mmt85 -110.34 105.27 14.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.523 -0.547 . . . . 74.55 109.523 173.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.16 91.2 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.907 -0.775 . . . . 75.3 108.907 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.1 mt -102.8 119.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.739 -0.664 . . . . 74.35 109.262 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.928 ' HB2' ' HZ2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -52.02 139.25 23.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.446 0.466 . . . . 75.43 110.219 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 44.21 33.79 0.89 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.384 1.052 . . . . 75.34 112.6 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.714 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -131.54 -82.92 0.51 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.385 0.612 . . . . 75.42 110.213 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.547 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptm -159.76 156.59 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.804 . . . . 74.24 110.812 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 116' ' ' LEU . 43.1 mt -129.37 103.26 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.519 -0.764 . . . . 73.4 108.943 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 42.7 tt0 -87.93 124.61 33.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.764 -0.653 . . . . 74.22 111.835 -173.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.79 113.57 4.03 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.061 -0.815 . . . . 72.14 111.061 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.8 157.61 43.83 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.706 -0.283 . . . . 74.11 112.667 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' HG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -68.66 156.56 90.61 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 123.804 0.355 . . . . 74.25 111.492 -175.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.678 ' HG3' ' HD1' ' A' ' 47' ' ' TYR . 23.7 Cg_endo -58.71 -21.86 58.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.723 2.949 . . . . 70.12 113.521 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.427 ' HG1' ' CG ' ' A' ' 66' ' ' ASP . 41.3 p -86.66 -30.43 21.73 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.644 -0.502 . . . . 74.34 109.644 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.94 71.08 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.725 -0.75 . . . . 75.01 111.642 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.3 p -88.56 -32.14 18.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.56 0.695 . . . . 71.41 109.401 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.1 46.65 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.881 -1.054 . . . . 52.51 111.674 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -119.83 -2.97 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.761 0.282 . . . . 72.12 111.761 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.75 -155.3 11.68 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.607 -0.806 . . . . 74.1 112.557 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.4 167.65 42.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.337 -0.935 . . . . 74.44 111.639 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 55.2 -96.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.785 0.434 . . . . 71.15 110.925 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m 69.07 -31.79 0.21 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.86 0.864 . . . . 75.43 113.126 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 75' ' ' ALA . 5.9 tt -55.84 -42.76 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.575 0.583 . . . . 71.33 112.575 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.542 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 13.8 p90 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.421 0.629 . . . . 75.14 110.774 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 112.3 -104.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.224 -0.898 . . . . 73.02 112.336 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 39.5 mtmt -125.68 -162.05 1.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.317 -0.623 . . . . 75.21 109.317 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.481 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -66.57 157.13 33.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.901 -0.778 . . . . 74.41 108.901 174.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -117.57 -54.24 2.37 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.646 -0.421 . . . . 74.45 111.417 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -166.61 -175.87 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.437 -0.579 . . . . 74.1 109.437 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -83.93 132.31 34.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 71.14 110.037 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.93 8.76 43.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.787 -0.642 . . . . 71.02 109.671 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.21 105.63 0.52 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.84 -0.618 . . . . 74.43 111.893 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -163.2 80.97 1.58 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 71.11 109.571 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.05 88.32 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.012 1.808 . . . . 63.51 111.578 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.7 -18.69 37.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.112 0.958 . . . . 74.43 109.377 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.7 pp -101.18 -178.84 3.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.52 -1.218 . . . . 74.52 108.75 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -138.35 147.78 43.86 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.121 -0.632 . . . . 73.41 110.416 171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 120' ' ' GLN . 1.2 p90 -62.8 109.38 1.42 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.801 0.81 . . . . 73.44 110.726 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -99.26 -44.99 6.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.228 -0.896 . . . . 75.44 110.428 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.66 -139.25 2.77 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.725 -0.75 . . . . 72.34 112.389 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.12 145.6 26.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.63 0.253 . . . . 73.45 110.687 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 107.66 22.26 7.45 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.648 -0.787 . . . . 71.34 111.618 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.481 HD12 ' HG3' ' A' ' 189' ' ' PRO . 9.9 mm -84.76 109.68 18.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.214 -0.662 . . . . 74.3 109.214 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.746 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -84.87 115.18 22.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.006 -0.543 . . . . 73.11 109.569 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB3' HG23 ' A' ' 128' ' ' ILE . . . -128.79 176.84 7.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 74.22 110.855 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.7 ttt -104.19 142.07 35.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 72.41 111.145 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -97.97 141.89 30.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.471 . . . . 71.01 110.174 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -157.78 160.6 37.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.738 -0.665 . . . . 74.4 110.132 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.73 -9.02 25.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.613 0.721 . . . . 63.41 110.333 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.99 169.38 40.23 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.107 -1.597 . . . . 72.12 109.107 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.18 -42.49 46.59 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.098 2.532 . . . . 72.01 112.794 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -103.03 -5.45 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 71.01 111.806 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -84.94 48.4 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.432 0.634 . . . . 75.13 110.061 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -89.73 121.54 31.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.892 . . . . 74.43 109.712 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.01 -94.79 2.21 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.659 -0.781 . . . . 73.43 112.452 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' ' 75' ' ' ALA . 18.0 t -140.87 6.92 2.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.377 0.608 . . . . 74.41 109.999 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 19.4 mp0 -81.02 143.91 32.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.696 -0.684 . . . . 75.11 110.363 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -144.24 162.32 36.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.369 -0.234 . . . . 74.24 110.369 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.492 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 41.9 p90 -154.02 157.21 38.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 74.0 111.148 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.673 HG23 HD22 ' A' ' 98' ' ' LEU . 18.2 t -112.11 145.88 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.928 -0.578 . . . . 72.14 109.444 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -99.52 130.38 45.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.952 0.406 . . . . 71.24 110.141 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 62' ' ' ILE . 59.5 mt -84.46 -7.1 59.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 73.53 110.775 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.39 163.35 24.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 73.31 109.929 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.25 113.12 2.75 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.602 2.201 . . . . 73.41 112.203 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.1 p -103.08 110.66 22.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 72.52 110.393 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.486 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 1.1 pp0? -99.59 15.82 25.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.332 0.587 . . . . 75.43 110.82 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.585 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.4 p90 -121.32 -2.65 9.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.467 -0.788 . . . . 74.13 110.89 -175.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.585 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.8 mt -102.97 7.93 39.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 75.51 110.475 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.89 -15.38 62.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.045 -0.98 . . . . 73.25 111.74 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.39 19.69 3.8 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.805 -0.712 . . . . 75.51 111.695 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -121.04 -28.8 4.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.266 0.555 . . . . 62.31 109.958 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.493 ' HD2' HD23 ' A' ' 122' ' ' LEU . 93.5 m-70 -138.64 144.55 39.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.489 -0.778 . . . . 73.41 109.376 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.5 t -85.37 145.19 27.61 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.398 -0.593 . . . . 75.14 109.398 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.507 HG23 ' HB3' ' A' ' 99' ' ' ALA . 31.4 mt -126.06 116.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.349 -0.387 . . . . 71.24 110.751 -176.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -154.41 74.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.456 0.472 . . . . 74.42 110.863 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.746 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.35 157.35 29.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.24 -0.981 . . . . 52.1 112.882 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 30.5 mtp180 -137.89 118.88 14.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.979 -0.378 . . . . 74.45 109.979 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 96' ' ' GLY . 7.5 p -81.76 138.36 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 62.43 110.411 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.593 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.3 t -143.23 142.85 31.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.034 -0.53 . . . . 72.22 110.132 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.653 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.6 tt0 54.23 35.99 23.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.345 0.593 . . . . 70.41 112.035 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.12 29.41 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.236 -0.983 . . . . 75.11 112.565 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 tp -83.39 -30.33 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 73.34 110.121 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.03 -31.65 81.59 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.659 . . . . 60.01 111.586 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.537 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 53.1 mmm -72.18 -49.35 36.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.486 -0.561 . . . . 72.32 109.486 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.453 HG11 HD13 ' A' ' 62' ' ' ILE . 61.8 t -55.0 -31.82 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.196 0.522 . . . . 75.31 110.508 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.04 -52.41 24.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.867 -0.606 . . . . 62.52 110.638 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -15.23 61.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.397 -0.365 . . . . 74.43 111.394 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.611 ' O ' HG21 ' A' ' 145' ' ' VAL . 53.7 t -86.58 -38.82 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.31 -0.405 . . . . 74.53 110.555 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.83 -12.68 68.31 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.641 -0.79 . . . . 73.24 112.831 -176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.2 ptm -82.0 -17.17 47.79 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.622 -0.34 . . . . 73.41 110.806 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 142' ' ' VAL . 19.2 m . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.675 -0.41 . . . . 74.01 110.798 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 C--O 1.221 -0.447 0 N-CA-C 107.99 -1.115 . . . . 70.12 107.99 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.41 155.91 28.82 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.363 -0.535 . . . . 72.55 111.427 -168.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.544 HG21 ' HB1' ' A' ' 162' ' ' ALA . 3.4 mp -85.13 109.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.801 -1.091 . . . . 73.21 109.391 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.521 HG23 ' HD3' ' A' ' 161' ' ' LYS . 26.4 mm -71.49 -49.98 43.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.478 -0.783 . . . . 71.31 110.497 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.521 ' HD3' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.93 130.34 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.824 -0.625 . . . . 75.0 110.758 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.544 ' HB1' HG21 ' A' ' 159' ' ' ILE . . . -133.31 112.71 11.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.84 0.352 . . . . 74.53 110.537 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -142.15 152.35 61.14 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.64 -0.709 . . . . 64.25 110.032 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.542 ' HA ' HG11 ' A' ' 14' ' ' VAL . 30.9 Cg_endo -67.24 131.7 25.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.374 2.049 . . . . 71.22 111.984 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 120.973 0.416 . . . . 74.15 110.692 -176.276 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.329 0.585 . . . . 55.14 110.991 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 142.3 135.74 3.13 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.968 -1.014 . . . . 74.02 110.879 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.16 -176.7 51.42 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.265 -0.969 . . . . 70.3 111.775 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.803 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -72.44 145.52 47.55 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.691 -0.485 . . . . 72.53 109.691 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 98.3 m-85 -97.81 105.06 24.58 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-O 121.182 0.515 . . . . 70.22 110.368 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.668 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.6 Cg_endo -83.58 -7.44 10.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.215 2.61 . . . . 71.42 111.313 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 39.0 tt0 -86.06 -35.05 20.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.105 -0.952 . . . . 71.33 110.789 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.565 HG13 HG12 ' A' ' 193' ' ' VAL . 21.4 pt -74.63 -13.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 71.15 110.483 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 47.3 m170 61.59 54.96 2.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.835 -1.075 . . . . 71.45 111.236 173.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.565 HG12 HG13 ' A' ' 191' ' ' ILE . 9.9 p -150.16 141.15 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.512 . . . . 73.51 109.875 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.28 110.14 5.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 74.03 111.425 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.64 155.89 30.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.312 -0.625 . . . . 75.51 109.312 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.452 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 24.5 m-85 -118.44 154.11 52.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.651 -0.249 . . . . 73.23 111.266 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.803 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 44.4 Cg_endo -68.4 -75.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.413 2.075 . . . . 71.34 112.138 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 199' ' ' ASP . 1.4 pt? -127.66 32.07 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.726 -0.215 . . . . 74.3 110.982 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 198' ' ' LEU . 11.5 t70 77.01 -6.21 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.174 0.435 . . . . 74.03 112.174 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.8 ptm -49.5 -28.39 5.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.214 0.82 . . . . 74.41 113.214 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.04 2.82 35.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.186 -1.007 . . . . 60.52 113.331 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 44.5 mtp-105 -84.85 -63.34 1.35 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.759 0.79 . . . . 75.54 109.798 176.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . 18.1 mmmt . . . . . 0 C--O 1.246 0.891 0 CA-C-N 112.779 -2.01 . . . . 74.21 111.754 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 11.9 Cg_exo . . . . . 0 CA--C 1.53 0.304 0 N-CA-C 114.26 0.831 . . . . 74.35 114.26 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.71 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 86.3 Cg_endo -78.43 13.49 1.83 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.827 3.018 . . . . 71.35 113.608 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 26' ' ' GLU . 20.4 t-20 -133.36 138.94 46.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.741 -0.663 . . . . 74.01 109.899 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 164' ' ' PRO . 33.3 m -138.92 156.73 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.708 0.29 . . . . 74.43 110.681 -177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HD1' ' HB2' ' A' ' 165' ' ' SER . 27.8 p90 -123.99 141.13 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.074 0.464 . . . . 73.14 111.041 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.51 110.08 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.674 -0.694 . . . . 75.12 109.407 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.831 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 32.0 tt0 -88.83 113.25 24.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.492 -0.929 . . . . 72.02 108.492 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -103.13 -179.95 4.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.963 -0.562 . . . . 72.44 110.939 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -75.3 -15.74 60.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 74.34 110.649 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 92.5 mmm -97.1 -38.81 9.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.626 . . . . 73.25 110.664 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.571 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -175.49 -139.87 3.22 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.231 -0.748 . . . . 62.34 111.231 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -136.7 130.62 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.507 -0.553 . . . . 75.11 109.507 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.422 HG12 ' CG2' ' A' ' 139' ' ' VAL . 4.2 mp -124.85 130.49 73.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 71.54 110.467 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 15' ' ' TYR . 59.1 t -113.85 145.05 20.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.904 -0.406 . . . . 74.43 109.904 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.77 36.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.345 0.593 . . . . 70.43 110.725 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.443 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 9.4 pt-20 -134.1 162.15 32.91 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.211 -0.904 . . . . 70.14 108.999 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -97.44 175.5 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.6 -0.519 . . . . 75.31 109.6 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 3.9 m-30 -79.21 100.41 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 72.44 110.878 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.71 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 15.3 m0 -79.82 -7.06 58.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.956 -0.565 . . . . 73.12 110.45 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.52 -65.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.848 -0.614 . . . . 74.51 111.247 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.95 -16.06 20.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.813 -171.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -130.71 72.3 81.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.745 0.646 . . . . 73.4 112.745 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 14.0 Cg_exo -69.45 -20.88 35.72 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.392 2.061 . . . . 72.14 110.826 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -82.01 -45.55 15.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.057 -0.974 . . . . 74.43 110.836 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 12.1 m -65.92 -39.24 90.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.051 -0.522 . . . . 74.54 111.586 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 4.7 p -64.31 -39.78 94.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 70.4 111.699 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' A' ' 37' ' ' LYS . 9.5 mtmp? -91.14 -8.8 47.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.295 -0.562 . . . . 73.22 110.8 -178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 48.9 t30 -72.44 -55.54 6.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.657 -0.701 . . . . 71.05 109.349 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.28 -40.88 98.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.284 -0.416 . . . . 74.11 110.888 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.29 -42.8 61.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 62.52 111.312 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 10.0 mm-40 -56.84 -50.88 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.274 -0.421 . . . . 73.15 111.422 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.578 HD13 ' CG ' ' A' ' 47' ' ' TYR . 2.7 mm? -62.77 -28.15 69.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.501 -0.318 . . . . 75.21 111.466 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -51.84 25.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 74.53 110.942 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -72.47 -29.65 63.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.31 111.472 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -68.02 -52.42 35.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.997 0.427 . . . . 65.34 109.954 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.13 43.45 0.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.057 -1.068 . . . . 54.02 113.233 171.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.578 ' CG ' HD13 ' A' ' 42' ' ' LEU . 18.7 m-85 -92.24 -33.49 14.64 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.465 -0.432 . . . . 74.11 111.395 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -82.06 -16.4 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 75.31 110.874 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -70.78 -0.96 10.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.478 . . . . 74.22 111.028 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.05 34.52 2.07 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.518 -0.633 . . . . 75.4 111.518 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.548 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -104.21 149.62 25.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.979 0.418 . . . . 74.23 111.014 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -128.2 148.67 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 72.22 109.394 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.56 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 87.3 m-85 -80.08 122.5 26.86 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.499 -0.556 . . . . 74.5 109.499 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -106.61 -39.61 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.871 0.323 . . . . 72.23 111.871 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 39.3 mmt180 -108.91 105.42 14.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.923 -0.311 . . . . 74.45 110.23 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.56 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -123.58 91.28 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.895 -0.779 . . . . 74.12 108.895 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.889 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.2 mt -96.28 130.48 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.71 -0.677 . . . . 74.13 109.237 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 43.8 mttt -54.97 108.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.928 0.767 . . . . 73.31 111.831 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 55.99 44.9 24.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.285 -0.87 . . . . 75.53 110.828 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.889 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 12.8 t80 -129.93 -75.99 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.269 -0.878 . . . . 73.24 109.12 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.521 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.75 154.63 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.215 -0.902 . . . . 74.3 109.884 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.56 HG23 HG13 ' A' ' 56' ' ' ILE . 46.8 mt -129.41 102.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.044 -0.525 . . . . 72.42 109.996 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 49.3 tt0 -86.02 122.51 30.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 74.41 110.526 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -125.17 142.7 14.02 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.886 -0.597 . . . . 72.35 112.011 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 149.66 -141.86 9.24 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.504 -0.855 . . . . 60.41 112.332 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.18 78.54 0.39 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.814 0.672 . . . . 74.2 112.814 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.78 -12.94 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 121.98 1.786 . . . . 71.44 110.442 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.8 p -103.23 -47.55 4.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.156 -0.929 . . . . 65.1 110.777 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.68 15.39 54.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.438 -0.665 . . . . 53.43 111.438 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -80.95 -41.54 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.29 0.567 . . . . 74.31 111.499 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -16.29 4.97 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.492 -0.776 . . . . 72.04 111.374 -174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -109.8 -30.33 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 74.43 110.903 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.6 -155.82 28.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.6 -0.809 . . . . 75.21 111.409 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.48 -105.48 0.24 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.624 -0.798 . . . . 60.03 112.282 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.98 36.4 21.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.609 0.719 . . . . 74.31 111.455 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -91.19 12.85 18.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.615 -0.72 . . . . 70.43 111.047 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG13 ' HD1' ' A' ' 78' ' ' TYR . 47.6 pt -74.23 -22.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.348 -0.387 . . . . 71.23 111.181 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.579 ' HE2' ' HA ' ' A' ' 81' ' ' GLN . 6.8 p90 -110.81 3.38 18.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.498 0.666 . . . . 71.43 110.495 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 -115.55 4.83 Favored Glycine 0 C--O 1.237 0.295 0 CA-C-N 115.182 -0.917 . . . . 64.25 111.856 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -76.31 179.19 5.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.25 -1.018 . . . . 74.52 108.25 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.592 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -78.61 149.73 32.87 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.47 -0.937 . . . . 75.21 108.47 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -102.11 -85.66 0.43 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.329 0.862 . . . . 74.12 113.329 -156.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.65 157.65 43.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.841 0.353 . . . . 72.41 111.205 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.7 126.2 30.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.31 0.576 . . . . 74.43 110.2 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -105.99 18.7 21.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.793 -0.639 . . . . 74.34 109.496 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 127' ' ' THR . 59.3 mt -62.01 104.63 0.48 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.952 -0.567 . . . . 70.22 110.891 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -169.88 80.45 0.63 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.413 -0.588 . . . . 73.32 109.413 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.21 100.39 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.464 2.109 . . . . 73.31 112.076 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.23 -3.59 52.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.228 1.013 . . . . 62.31 109.532 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.477 HD23 ' CE2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -109.94 -171.39 1.83 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.239 -1.346 . . . . 74.44 111.315 -172.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -147.07 145.99 29.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.198 -1.038 . . . . 75.1 108.198 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 26.8 p90 -58.48 124.79 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.24 0.543 . . . . 75.01 110.066 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.4 p -121.98 -45.59 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.665 -0.698 . . . . 65.55 110.084 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -151.31 6.11 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.483 -0.78 . . . . 63.24 111.891 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.14 22.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.337 0.255 . . . . 72.45 110.704 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.69 22.7 7.21 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.476 -0.868 . . . . 74.22 111.835 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 189' ' ' PRO . 10.4 mm -84.88 109.63 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.521 -0.548 . . . . 75.11 109.521 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 114' ' ' VAL . 3.2 tm? -85.59 120.72 27.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.611 -0.514 . . . . 75.12 109.611 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB1' HG21 ' A' ' 128' ' ' ILE . . . -129.22 174.88 9.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.116 -0.493 . . . . 70.5 111.136 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.502 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 24.9 ttt -105.53 137.68 42.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.908 -0.587 . . . . 75.54 109.502 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB1' ' CB ' ' A' ' 111' ' ' GLN . . . -96.65 142.68 28.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.036 0.445 . . . . 63.13 110.171 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.81 161.34 42.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.528 -0.76 . . . . 74.35 110.348 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.31 -26.59 15.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.691 0.757 . . . . 74.31 109.559 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.03 178.16 27.68 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 109.2 -1.56 . . . . 74.32 109.2 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HA ' HD12 ' A' ' 86' ' ' LEU . 6.7 Cg_endo -48.45 -52.53 8.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.959 2.439 . . . . 63.33 112.479 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -101.42 -3.41 28.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.034 -0.53 . . . . 73.2 110.419 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.592 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -88.56 47.11 1.46 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.391 0.615 . . . . 63.22 109.608 -177.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.48 ' HB2' ' HE2' ' A' ' 100' ' ' MET . 5.4 p30 -94.75 130.08 41.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.056 -0.975 . . . . 74.22 109.989 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.79 -121.86 2.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.245 -0.978 . . . . 74.22 113.563 -173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 t -105.31 12.16 32.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.959 0.409 . . . . 72.45 110.909 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 26.5 mt-30 -94.38 147.85 22.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 72.52 111.243 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.31 167.92 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.675 -0.861 . . . . 74.43 108.675 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 46.9 p90 -155.16 150.59 27.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 73.33 111.118 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.722 HG23 HD21 ' A' ' 98' ' ' LEU . 14.2 t -112.97 140.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.012 -0.736 . . . . 74.43 109.012 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -94.44 127.08 40.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.094 0.473 . . . . 63.34 109.936 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 62.5 mt -83.51 -7.9 59.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.555 -0.748 . . . . 71.11 110.492 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . . . -144.82 159.79 49.25 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 72.22 110.071 175.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 36.3 Cg_endo -66.14 112.06 2.19 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.51 2.14 . . . . 72.24 112.368 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.1 p -106.13 141.65 37.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.825 -0.625 . . . . 55.13 111.331 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.535 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -131.9 -0.25 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 73.42 110.646 175.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 2.52 55.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.47 -0.786 . . . . 75.41 112.489 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.15 6.65 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.23 0.826 . . . . 74.54 113.23 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 4.5 m-20 -64.65 -28.69 69.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.119 0.485 . . . . 74.54 111.042 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -102.57 13.11 56.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 63.13 111.448 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -116.61 -40.74 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 75.31 109.387 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -135.92 124.68 23.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.131 -0.941 . . . . 73.52 108.506 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.528 ' HB ' HD21 ' A' ' 86' ' ' LEU . 15.1 t -71.05 147.91 48.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.171 0.51 . . . . 73.11 110.768 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.454 HG21 ' HB1' ' A' ' 99' ' ' ALA . 44.8 mt -121.58 123.32 69.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.853 -0.612 . . . . 74.41 110.523 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -159.31 75.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.32 0.581 . . . . 74.41 111.587 175.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.653 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.3 158.45 30.83 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.768 -0.729 . . . . 74.44 112.734 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.443 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -132.11 125.02 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.964 -0.754 . . . . 74.11 108.964 173.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.405 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 10.3 p -84.98 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.052 0.453 . . . . 74.31 110.291 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 34.5 t -141.2 147.69 38.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.43 -0.35 . . . . 74.24 111.016 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 42.62 35.27 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.379 1.072 . . . . 70.23 113.216 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.16 42.49 0.19 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.637 -0.792 . . . . 70.51 111.972 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 tp -91.86 -33.83 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.796 0.332 . . . . 74.45 110.413 -176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -34.9 90.05 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.03 -0.605 . . . . 55.2 112.016 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.571 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 70.3 mmm -67.12 -51.25 56.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.797 -0.446 . . . . 74.51 109.797 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 62' ' ' ILE . 63.9 t -54.29 -30.68 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 74.12 110.954 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.78 -54.65 10.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 60.45 110.914 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.594 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.72 -16.38 60.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.187 -0.46 . . . . 64.35 111.418 -177.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 145' ' ' VAL . 64.5 t -86.21 -29.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 73.35 109.942 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.45 -7.56 79.08 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.691 -0.766 . . . . 71.31 112.607 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 16.6 ptp -96.58 -11.98 24.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.857 -0.337 . . . . 75.22 111.869 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 142' ' ' VAL . 23.9 m . . . . . 0 C--N 1.332 -0.193 0 C-N-CA 120.207 -0.597 . . . . 72.45 110.637 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.52 -0.548 . . . . 71.42 109.52 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -123.55 155.14 38.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.922 0.391 . . . . 75.24 110.634 -172.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.416 HG21 ' HB1' ' A' ' 162' ' ' ALA . 3.8 mp -91.52 101.59 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.208 -1.034 . . . . 74.51 108.208 168.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 161' ' ' LYS . 32.2 mm -65.35 -48.63 82.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 75.53 110.918 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.831 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -143.9 138.52 28.62 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.488 -0.778 . . . . 61.43 110.071 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 159' ' ' ILE . . . -141.5 118.89 11.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.414 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.83 158.37 62.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.839 -0.618 . . . . 63.34 109.803 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.539 ' HA ' HG11 ' A' ' 14' ' ' VAL . 28.7 Cg_endo -64.35 137.99 58.47 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.175 1.917 . . . . 74.11 111.119 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.667 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 25.4 t . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.163 0.506 . . . . 72.13 111.283 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.85 -0.426 . . . . 73.31 109.85 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.78 144.52 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.914 -0.585 . . . . 71.35 111.868 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.57 -168.64 45.06 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.542 -0.837 . . . . 74.45 111.828 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.807 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -84.27 152.09 24.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.856 0.36 . . . . 75.22 110.238 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 191' ' ' ILE . 94.7 m-85 -98.67 112.29 62.26 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.406 -0.59 . . . . 75.45 109.406 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.565 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 54.2 Cg_endo -85.91 -5.44 8.78 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.511 2.141 . . . . 72.54 112.719 -177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.57 -19.83 32.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.801 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.8 pt -77.42 -16.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 71.33 111.266 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.38 31.09 10.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.85 -0.614 . . . . 72.21 111.69 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.32 149.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.968 -0.293 . . . . 74.14 110.971 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.48 124.07 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.214 0.531 . . . . 72.43 111.725 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.97 130.05 0.77 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.374 -0.83 . . . . 65.04 109.76 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 87.7 m-85 -115.86 146.71 37.54 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.452 -0.34 . . . . 75.41 110.426 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 38.0 Cg_endo -67.22 -62.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.383 2.055 . . . . 74.43 111.706 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.42 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 0.8 OUTLIER -131.79 23.63 4.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 74.35 109.832 175.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 29.7 m-20 70.59 6.35 5.78 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.372 -0.831 . . . . 63.12 112.166 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 17.7 ptm -55.47 -32.14 62.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 74.31 112.292 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.69 4.6 85.04 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.534 -0.841 . . . . 73.1 113.503 -174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 11.1 ptm180 -116.51 -3.72 11.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.897 0.856 . . . . 73.34 110.089 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 203' ' ' LYS . 26.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-N 114.13 -1.396 . . . . 73.05 110.714 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 CA--C 1.529 0.251 0 CA-C-O 120.948 0.312 . . . . 75.34 112.149 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.713 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 91.3 Cg_endo -88.22 7.97 4.27 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.457 2.772 . . . . 72.32 113.18 -173.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 165' ' ' SER . 21.2 t-20 -127.09 145.5 50.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.084 -0.962 . . . . 73.22 108.433 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 164' ' ' PRO . 29.1 m -136.15 157.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.853 0.358 . . . . 73.43 111.071 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.842 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 50.0 p90 -121.74 130.52 53.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.218 0.533 . . . . 70.02 110.382 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -109.44 102.68 11.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.559 -0.746 . . . . 72.21 109.567 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -82.4 111.18 18.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.499 -0.926 . . . . 65.2 108.499 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -103.07 -179.74 4.04 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.116 0.484 . . . . 72.24 111.376 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 t -67.86 -24.57 65.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 75.23 109.929 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.516 ' HE2' HG23 ' A' ' 142' ' ' VAL . 6.1 mmt -86.63 -44.85 11.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 73.41 110.636 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -175.46 -126.92 0.98 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.804 -0.712 . . . . 65.01 111.554 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.26 137.09 46.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.924 0.362 . . . . 75.33 110.098 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -124.93 115.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.02 -0.536 . . . . 65.42 109.7 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.658 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 46.7 t -102.77 137.33 31.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.521 -0.472 . . . . 74.43 109.744 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.19 163.34 37.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.112 0.482 . . . . 74.4 110.809 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB3' HD21 ' A' ' 13' ' ' ASN . 10.6 pt-20 -128.59 166.27 19.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.537 -0.756 . . . . 75.32 109.402 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -102.33 165.62 11.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.423 -0.955 . . . . 72.52 108.423 176.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.593 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.3 m-85 -89.64 90.38 8.22 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.612 -0.835 . . . . 75.11 111.345 177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.713 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -74.75 -11.89 60.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.266 1.032 . . . . 75.15 108.281 175.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.7 -35.57 77.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.2 -1.818 . . . . 75.54 110.95 -177.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -124.77 -20.89 4.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.792 -0.64 . . . . 72.02 110.721 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.09 85.13 50.99 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.129 0.418 . . . . 54.12 112.129 -169.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.57 -41.75 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.322 2.015 . . . . 74.41 111.491 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.85 -43.23 36.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.661 -0.7 . . . . 73.41 111.053 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.2 -39.83 95.76 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.662 -0.699 . . . . 75.03 110.282 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.612 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 15.0 t -60.41 -46.08 91.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.844 -0.616 . . . . 74.12 110.101 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -59.59 -34.84 73.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 75.34 110.815 -178.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 35' ' ' THR . 38.2 t-20 -50.56 -61.36 2.24 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.584 -0.524 . . . . 75.42 109.584 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 112' ' ' PHE . 23.4 m-85 -67.97 -41.34 82.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.05 -0.523 . . . . 74.21 111.67 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' ARG . . . -56.54 -45.77 81.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 73.5 111.787 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' HG2' ' HE2' ' A' ' 37' ' ' LYS . 19.4 mm-40 -67.46 -42.27 83.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.096 -0.242 . . . . 74.33 111.198 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 47' ' ' TYR . 3.5 mm? -66.11 -26.44 67.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.997 -0.281 . . . . 75.41 110.554 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.21 73.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.726 0.298 . . . . 71.25 110.628 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 29.9 mtm180 -66.31 -43.47 86.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.532 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.56 -43.61 98.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 73.43 110.853 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.14 64.12 0.53 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.834 -0.698 . . . . 74.33 111.502 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 42' ' ' LEU . 73.1 t80 -86.0 -50.77 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.104 0.478 . . . . 70.13 110.154 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.578 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 7.0 m-85 -76.42 -10.82 59.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.368 -0.833 . . . . 75.32 111.796 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.73 -19.29 63.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 74.33 111.318 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.01 40.03 1.61 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.713 . . . . 75.0 111.996 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.635 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.6 p -118.28 156.62 28.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 75.33 111.153 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 15.1 ptpt -141.98 163.05 33.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.735 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.54 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.9 m-85 -86.86 133.64 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.101 -0.499 . . . . 74.05 109.663 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -120.21 -28.96 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.254 -0.578 . . . . 64.42 111.457 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.2 mmt180 -112.6 109.59 19.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.121 -0.326 . . . . 75.54 110.121 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 53' ' ' PHE . 14.8 mm -121.51 88.6 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.04 -0.726 . . . . 74.54 109.04 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 18.3 mt -103.31 119.59 52.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.231 -0.587 . . . . 73.32 110.099 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -54.33 138.02 40.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.707 0.629 . . . . 64.32 110.759 178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p30 44.24 33.19 0.79 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.383 1.052 . . . . 74.32 112.68 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.35 -83.74 0.54 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.158 -0.473 . . . . 74.44 110.11 179.218 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -161.47 158.11 26.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.593 . . . . 72.21 110.389 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CD1' HD23 ' A' ' 116' ' ' LEU . 59.8 mt -128.81 103.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.594 -0.73 . . . . 74.41 109.656 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -86.51 121.52 29.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.11 -0.495 . . . . 74.41 110.252 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.18 140.81 11.86 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.658 -0.782 . . . . 61.44 112.603 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 138.86 -151.77 21.86 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.653 -0.784 . . . . 63.14 112.302 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t0 58.3 95.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 123.756 0.823 . . . . 71.2 111.98 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 49.1 Cg_endo -71.31 -18.32 30.18 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.718 2.278 . . . . 75.41 112.359 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.592 ' OG1' HG23 ' A' ' 70' ' ' THR . 81.8 p -91.65 -32.86 15.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.469 . . . . 65.3 110.887 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.77 22.88 71.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.817 -0.629 . . . . 64.43 112.284 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.592 HG23 ' OG1' ' A' ' 68' ' ' THR . 14.2 t -107.51 -20.94 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.649 0.24 . . . . 70.01 111.649 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.44 -13.96 6.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.316 -0.945 . . . . 74.0 113.506 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -0.82 7.08 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.107 0.78 . . . . 75.21 113.107 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 66.11 -164.9 39.58 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.882 -0.675 . . . . 51.33 113.337 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.18 -81.0 0.8 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 73.5 111.598 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.588 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . 59.31 34.47 22.94 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.696 0.76 . . . . 63.43 111.153 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.4 m -66.25 -25.93 67.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 71.32 112.718 -170.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.578 HG23 ' CD1' ' A' ' 78' ' ' TYR . 3.6 tt -65.78 -40.13 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.928 0.344 . . . . 71.1 111.928 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.588 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 13.3 p90 -107.01 -17.25 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.791 0.329 . . . . 75.23 111.333 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.94 -62.99 4.51 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.047 -0.597 . . . . 64.04 113.811 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 91.7 mttt -118.47 177.66 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.669 -0.312 . . . . 71.35 111.666 -175.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 164.68 25.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.93 -0.577 . . . . 73.54 110.441 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -110.53 -68.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.373 -0.376 . . . . 73.45 111.127 -172.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -168.02 156.69 9.15 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.129 -0.693 . . . . 73.13 109.129 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 9.4 p-10 -89.93 131.59 35.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 71.13 109.764 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 25.8 tt0 -105.53 8.01 33.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 75.43 110.262 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 mt -46.87 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.353 -0.84 . . . . 74.32 112.543 -170.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -179.56 87.0 0.2 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.404 -0.817 . . . . 75.51 109.23 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 30.9 Cg_endo -63.49 96.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.444 2.096 . . . . 75.21 111.828 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -11.38 59.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 74.43 109.46 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -105.02 170.56 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.598 -1.26 . . . . 73.01 107.598 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -126.0 150.83 47.77 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.926 -0.71 . . . . 75.25 110.79 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 35.7 p90 -65.5 121.83 15.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.169 -0.678 . . . . 74.44 109.169 173.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.5 p -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.963 -0.562 . . . . 71.55 110.61 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.26 -145.2 4.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.484 -0.78 . . . . 75.13 111.633 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.12 146.2 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.806 0.336 . . . . 74.12 111.048 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.67 26.18 5.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.754 -0.736 . . . . 74.54 111.98 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 189' ' ' PRO . 8.8 mm -90.07 111.51 23.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.583 -0.525 . . . . 75.33 109.583 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.88 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.91 117.73 24.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.866 -0.606 . . . . 74.42 109.673 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.78 176.92 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.404 . . . . 71.34 111.774 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.985 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 17.4 tpt -93.77 138.96 31.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 75.53 111.885 -173.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.21 132.89 43.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.198 -0.455 . . . . 75.0 110.315 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.4 162.07 36.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.209 -0.451 . . . . 71.32 110.596 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' A' ' 107' ' ' THR . . . -82.54 -26.32 32.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.117 -0.492 . . . . 75.51 110.846 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 169.24 -134.38 3.18 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 121.0 -0.619 . . . . 74.44 112.16 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 25.8 Cg_endo -59.64 92.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.192 2.594 . . . . 71.31 111.713 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 2.2 p30 62.29 10.08 3.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.975 1.31 . . . . 72.02 112.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 103' ' ' ALA . 1.4 m -82.17 57.85 3.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.475 0.655 . . . . 74.42 109.307 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.99 143.12 26.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.593 -0.731 . . . . 70.43 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.26 -98.96 2.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.746 -0.74 . . . . 72.13 111.966 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.407 ' OG ' ' HG ' ' A' ' 42' ' ' LEU . 9.2 t -147.68 10.55 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.421 . . . . 74.32 110.536 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.54 159.04 17.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.688 0.28 . . . . 70.5 111.166 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 41.4 p90 -140.25 175.43 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.682 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -154.69 151.47 28.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 72.05 110.521 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.744 HG22 HD23 ' A' ' 98' ' ' LEU . 16.5 t -109.23 143.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.31 -0.626 . . . . 72.31 109.31 177.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -96.98 129.5 44.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.035 0.445 . . . . 74.21 110.402 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.513 HD23 ' CD1' ' A' ' 62' ' ' ILE . 71.0 mt -85.5 -7.27 58.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.779 -0.646 . . . . 74.24 110.886 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.94 160.21 47.41 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.643 -0.708 . . . . 71.51 109.972 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 29.6 Cg_endo -64.06 111.79 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.492 2.128 . . . . 62.52 111.555 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.1 p -100.68 122.07 42.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 74.13 111.93 -172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 1.1 pm0 -120.89 24.38 10.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.655 0.741 . . . . 75.2 109.815 174.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -115.45 -3.11 12.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.282 -0.872 . . . . 72.45 111.457 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.39 12.05 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 63.41 111.058 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.438 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 8.7 p-10 -63.14 -28.57 70.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 74.01 111.049 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.97 17.84 19.58 Favored Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.652 -0.785 . . . . 63.14 111.205 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -116.45 -34.6 4.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.254 0.549 . . . . 75.13 109.889 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.78 123.39 24.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.434 -0.95 . . . . 72.42 108.434 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 t -70.87 144.13 50.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.33 -0.548 . . . . 71.32 109.833 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.2 mt -113.49 124.38 70.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.832 -0.622 . . . . 73.22 111.28 -173.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.985 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 5.7 p90 -156.37 72.68 0.76 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.849 0.833 . . . . 74.12 110.468 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.88 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.59 157.47 29.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.616 -1.278 . . . . 70.44 113.53 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.593 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 38.5 mtp180 -139.63 121.88 15.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 74.12 110.002 173.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.37 137.11 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 75.0 110.306 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.658 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 48.5 t -149.56 147.82 28.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.268 -0.424 . . . . 70.44 109.954 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER 48.04 67.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 75.25 110.05 -175.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 139' ' ' VAL . . . 158.89 19.68 0.03 OUTLIER Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.269 -0.878 . . . . 70.22 113.267 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.631 HG21 ' CG ' ' A' ' 184' ' ' ASP . 11.1 tp -80.73 -32.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.319 -0.623 . . . . 72.43 109.319 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.11 93.62 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.043 -0.823 . . . . 72.51 111.043 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.482 ' O ' HG22 ' A' ' 142' ' ' VAL . 79.2 mmm -70.56 -48.94 52.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.768 -0.456 . . . . 75.44 109.768 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 135' ' ' GLY . 69.4 t -56.28 -29.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.925 0.393 . . . . 74.53 110.8 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -70.59 -56.53 6.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.422 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.487 ' HE ' ' HB2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.87 -15.42 62.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.379 . . . . 75.45 111.085 -177.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.516 HG23 ' HE2' ' A' ' 20' ' ' MET . 75.3 t -84.41 -39.6 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 74.13 110.154 174.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -78.15 -27.15 58.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.535 -0.84 . . . . 74.3 112.843 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.2 mmm -75.11 -13.27 60.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.859 0.318 . . . . 74.05 111.859 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.233 0.539 . . . . 72.03 110.834 178.82 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.79 0.805 . . . . 71.22 111.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -154.16 173.03 16.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.998 -1.001 . . . . 62.54 109.42 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 159' ' ' ILE . 3.6 mp -89.74 114.43 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.27 -0.641 . . . . 72.22 109.27 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.547 HG21 ' HD3' ' A' ' 161' ' ' LYS . 26.8 mm -79.89 -58.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.686 -0.688 . . . . 62.4 110.53 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.547 ' HD3' HG21 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -125.07 137.01 54.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.108 -0.496 . . . . 72.25 109.786 176.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -141.39 122.71 14.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.63 -0.259 . . . . 62.12 110.857 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -145.04 154.12 54.21 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.99 -0.55 . . . . 71.23 109.867 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.545 ' HA ' HG13 ' A' ' 14' ' ' VAL . 9.2 Cg_endo -57.13 138.96 88.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.181 1.921 . . . . 73.52 111.68 171.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.842 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 38.3 t . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.81 -0.632 . . . . 62.14 111.148 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.631 ' CG ' HG21 ' A' ' 136' ' ' ILE . 12.6 t0 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 108.972 -0.751 . . . . 61.54 108.972 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 148.33 159.47 8.49 Favored Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.541 -0.838 . . . . 53.53 112.782 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.6 -166.63 39.11 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.887 -0.673 . . . . 73.21 112.321 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.786 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -79.7 173.31 12.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.804 0.335 . . . . 64.51 110.4 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.58 100.81 40.31 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.616 -0.265 . . . . 72.42 110.58 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.722 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.3 Cg_endo -80.34 -5.05 13.38 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.518 2.145 . . . . 74.43 111.734 176.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.562 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 20.7 tt0 -77.15 -39.24 49.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.217 -0.902 . . . . 63.23 109.56 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.14 152.68 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.385 -0.969 . . . . 73.03 108.385 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -104.75 81.45 1.77 Allowed 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.223 -0.591 . . . . 73.31 110.808 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -156.93 146.87 11.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.998 -1.001 . . . . 75.45 109.111 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.888 0.375 . . . . 73.21 110.847 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.446 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -153.52 150.24 28.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.878 -0.786 . . . . 64.2 108.878 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 199' ' ' ASP . 40.6 m-85 -122.7 142.27 37.22 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.688 -0.233 . . . . 74.24 110.479 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.786 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.9 -63.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.4 2.067 . . . . 73.41 111.488 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -122.44 16.71 10.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 74.22 109.844 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 13.4 m-20 70.24 8.0 6.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.198 -0.91 . . . . 74.55 113.367 171.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -61.91 -21.42 64.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.766 0.284 . . . . 73.3 111.766 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.89 -5.39 83.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.831 -0.7 . . . . 73.23 112.958 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -82.68 -20.72 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.392 0.615 . . . . 70.05 110.462 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm . . . . . 0 C--O 1.245 0.849 0 CA-C-N 114.733 -1.121 . . . . 74.55 111.368 -175.237 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 9.6 Cg_endo . . . . . 0 N--CA 1.45 -1.074 0 N-CA-C 111.112 -0.38 . . . . 71.23 111.112 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 40.4 Cg_endo -67.73 -19.78 46.99 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.368 2.045 . . . . 73.31 112.45 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.66 HD22 HG13 ' A' ' 24' ' ' VAL . 22.5 t-20 -139.42 145.96 39.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.605 -0.725 . . . . 74.52 110.149 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 164' ' ' PRO . 29.6 m -133.85 145.16 33.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.399 0.618 . . . . 64.12 111.156 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' HE1' ' HB3' ' A' ' 165' ' ' SER . 84.3 m-85 -99.75 123.51 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.3 -0.864 . . . . 72.34 111.145 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.36 103.69 11.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 73.14 109.911 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.16 117.15 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.245 -0.65 . . . . 74.34 109.245 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 179.96 4.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.124 0.488 . . . . 74.15 111.739 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -64.33 -26.46 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.339 -0.846 . . . . 70.05 110.673 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.707 ' HG3' HG23 ' A' ' 142' ' ' VAL . 7.1 mmt -91.54 -37.19 13.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.885 -0.598 . . . . 74.2 111.429 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.539 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -179.68 -128.9 1.26 Allowed Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.64 -0.791 . . . . 75.2 111.395 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.46 136.36 43.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.073 0.463 . . . . 75.44 110.039 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.4 120.79 57.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.603 -0.726 . . . . 75.52 109.14 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.66 HG13 HD22 ' A' ' 13' ' ' ASN . 6.9 t -101.4 141.59 17.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.688 -0.687 . . . . 74.22 109.179 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -147.76 161.59 40.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.272 -0.571 . . . . 74.32 111.16 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -132.27 163.76 27.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.144 -0.935 . . . . 72.35 110.429 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.71 168.09 10.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 73.25 109.901 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.662 ' HH ' ' HG2' ' A' ' 189' ' ' PRO . 6.3 m-85 -89.99 97.77 11.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.875 0.369 . . . . 74.21 110.991 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.483 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 76.5 m95 -88.82 14.74 9.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.966 0.889 . . . . 74.42 109.003 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.52 -54.1 4.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.109 -1.405 . . . . 72.51 110.545 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.64 9.36 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 74.44 111.914 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.09 71.41 73.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.287 . . . . 70.22 110.887 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.15 -42.1 11.49 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.748 2.298 . . . . 70.41 112.987 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.45 -46.89 52.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 72.33 110.321 -177.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -41.23 86.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.21 -0.905 . . . . 75.42 110.93 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 129' ' ' PHE . 89.1 m -52.18 -51.0 60.74 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.921 -0.581 . . . . 75.22 111.425 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.565 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 4.5 mtmp? -73.14 -23.86 60.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 74.44 111.532 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -56.46 -47.86 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 74.44 109.411 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 112' ' ' PHE . 3.8 m-85 -77.76 -42.31 34.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.478 -0.783 . . . . 72.24 111.069 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -55.89 -48.8 74.97 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.113 0.412 . . . . 74.4 112.113 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.636 ' HB3' HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -59.72 -43.83 94.01 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.11 0.481 . . . . 72.44 110.769 178.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 75' ' ' ALA . 28.1 mt -67.36 -30.45 70.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.907 -0.588 . . . . 74.31 111.319 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.53 76.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.691 -0.686 . . . . 71.52 111.41 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -81.16 -7.26 59.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.538 -0.465 . . . . 74.43 111.384 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -89.43 -49.38 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.792 -0.448 . . . . 75.22 109.792 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 41.03 0.54 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 115.819 -0.628 . . . . 55.51 112.005 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.465 ' HB2' HD22 ' A' ' 42' ' ' LEU . 50.5 t80 -71.4 -37.34 71.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.672 0.389 . . . . 75.35 111.672 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 45.2 m-85 -75.97 -16.41 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.46 . . . . 75.4 112.016 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -68.74 -7.7 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 74.14 111.585 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -127.36 16.09 6.34 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.578 -0.82 . . . . 71.22 112.472 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -101.53 150.06 23.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.322 . . . . 73.01 111.433 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 2.1 mptt -130.96 153.37 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 75.43 110.107 -177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 75.1 m-85 -90.04 108.41 19.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.475 -0.935 . . . . 74.24 108.475 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -110.63 -8.88 14.56 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.341 -0.544 . . . . 70.42 111.262 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 26.6 mmt180 -121.11 106.06 11.19 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.914 0.388 . . . . 73.3 110.278 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.17 89.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.86 -0.793 . . . . 73.2 108.86 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.723 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 39.1 mt -91.2 120.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.557 -0.905 . . . . 74.33 108.557 176.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 4.2 ptmm? -58.6 118.38 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.724 0.64 . . . . 74.04 111.438 -175.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 203' ' ' LYS . 41.9 m-20 61.72 40.49 13.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.868 -1.06 . . . . 71.12 111.182 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.723 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -136.69 -78.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 74.4 110.271 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.66 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 25.4 ptm -160.32 155.87 25.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 72.23 110.6 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 46.8 mt -128.17 102.92 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 74.54 109.454 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.53 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -81.07 127.2 32.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.01 -0.541 . . . . 72.42 110.486 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.84 139.72 11.18 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.811 -0.709 . . . . 54.34 112.145 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.27 -149.14 20.45 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.061 -1.066 . . . . 72.21 113.26 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 1.4 t70 48.14 86.42 0.15 Allowed Pre-proline 0 N--CA 1.461 0.117 0 C-N-CA 124.689 1.196 . . . . 65.23 112.617 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 82.3 Cg_endo -75.71 -18.13 17.49 Favored 'Trans proline' 0 CA--C 1.521 -0.165 0 C-N-CA 122.889 2.392 . . . . 72.54 110.679 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.521 ' OG1' HG21 ' A' ' 70' ' ' THR . 3.6 p -84.3 -42.36 15.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.129 -1.396 . . . . 74.41 112.072 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 86.0 29.66 25.2 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 73.03 111.396 -174.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.521 HG21 ' OG1' ' A' ' 68' ' ' THR . 5.2 t -112.39 -33.68 6.11 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.974 0.361 . . . . 74.23 111.974 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.85 -0.66 11.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.127 -1.035 . . . . 72.31 113.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -126.26 -24.06 3.75 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.607 -0.349 . . . . 72.25 111.351 178.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 97.47 -171.09 26.2 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.563 -0.827 . . . . 53.51 112.818 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.58 -98.06 1.98 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.281 -0.485 . . . . 73.53 112.185 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.63 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 59.31 33.77 22.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.698 0.761 . . . . 74.23 111.096 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -76.44 15.12 0.65 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.63 -1.168 . . . . 74.42 110.922 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 41' ' ' GLU . 6.8 tt -94.27 -38.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.871 -0.604 . . . . 72.44 111.091 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.63 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 34.7 p90 -106.11 -18.45 14.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.026 -0.67 . . . . 63.55 111.6 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.4 -103.62 2.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.316 -0.945 . . . . 74.14 113.449 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -125.61 174.94 7.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.984 0.421 . . . . 75.24 111.72 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -87.0 -96.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.375 -0.829 . . . . 75.15 111.535 -171.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 13.2 m-30 78.17 14.88 1.45 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.086 0.555 . . . . 74.55 112.325 172.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.47 126.5 5.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.57 -0.741 . . . . 74.41 110.224 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.599 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 5.4 p-10 -82.68 122.09 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.953 -0.758 . . . . 75.33 108.953 170.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -99.67 19.05 16.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.998 -0.742 . . . . 71.51 108.998 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 84' ' ' ASP . 28.1 mt -58.8 99.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.385 -1.28 . . . . 74.41 110.094 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -154.62 74.81 5.79 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 109.986 -0.376 . . . . 74.25 109.986 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.36 92.59 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.78 2.32 . . . . 73.52 112.238 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.0 -33.26 67.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 74.32 108.695 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -93.99 178.08 5.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.513 -1.221 . . . . 71.21 109.124 174.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -144.38 160.73 40.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.07 -0.344 . . . . 75.35 110.07 178.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.582 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 26.2 p90 -56.65 119.68 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.874 0.845 . . . . 72.33 111.053 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.459 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 33.8 p -116.62 -43.66 2.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.728 -0.669 . . . . 74.41 110.537 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.9 -155.18 7.82 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.363 -0.835 . . . . 74.33 111.339 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.37 141.15 31.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.776 0.322 . . . . 64.32 110.791 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.77 23.73 4.56 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.816 -0.706 . . . . 54.41 111.949 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -90.18 116.69 32.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 74.24 109.701 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.866 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -91.97 123.31 35.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.626 -0.715 . . . . 75.33 110.099 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 128' ' ' ILE . . . -140.8 169.02 18.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 75.04 111.144 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.509 ' CG ' ' HE1' ' A' ' 129' ' ' PHE . 26.3 mtm -92.32 156.32 17.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.038 0.447 . . . . 73.12 110.495 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 166.86 10.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.821 -0.627 . . . . 63.13 109.709 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -120.42 179.06 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.742 0.306 . . . . 74.53 110.403 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.06 18.82 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.84 -0.618 . . . . 75.14 110.611 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.51 -142.92 14.17 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.748 -0.739 . . . . 71.15 112.846 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -58.77 92.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.645 2.897 . . . . 74.34 112.216 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.77 32.56 7.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.478 -1.237 . . . . 53.12 111.003 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.5 m -80.27 56.29 2.45 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.517 -1.219 . . . . 75.32 110.058 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 m-80 -72.57 100.62 2.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.027 -0.988 . . . . 73.34 109.633 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -116.32 -135.87 5.71 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.254 -0.974 . . . . 74.02 113.315 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 47.8 p -96.88 -4.78 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.898 0.38 . . . . 75.11 111.404 -176.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -71.17 142.77 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.027 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.513 ' HB3' ' HZ ' ' A' ' 39' ' ' PHE . 52.3 p90 -143.5 169.38 17.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.828 0.347 . . . . 71.22 110.812 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.51 155.21 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 74.11 110.665 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.702 HG22 HD21 ' A' ' 98' ' ' LEU . 18.4 t -110.61 144.05 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.899 -0.591 . . . . 74.31 109.482 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.5 p -97.01 124.58 41.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.101 0.477 . . . . 74.41 110.538 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD23 ' CD1' ' A' ' 62' ' ' ILE . 71.9 mt -83.66 -9.53 58.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.592 -0.731 . . . . 73.25 110.243 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.4 156.84 42.54 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.172 -0.922 . . . . 75.11 109.611 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.561 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 57.5 Cg_endo -72.28 113.34 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.262 1.975 . . . . 73.35 112.33 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.2 p -100.49 145.47 28.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 65.44 109.863 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -123.31 17.99 9.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 72.41 110.722 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.793 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 1.1 p90 -124.08 -1.72 8.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 72.14 111.33 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.793 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 86.9 mt -114.36 -6.1 12.92 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.975 0.417 . . . . 73.15 110.839 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.42 -19.19 64.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 72.25 111.249 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.53 12.52 10.24 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.52 -0.848 . . . . 61.12 111.841 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -120.14 -24.33 6.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 74.35 109.775 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.477 ' HB3' ' O ' ' A' ' 100' ' ' MET . 38.9 m80 -130.24 125.56 35.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.703 -0.681 . . . . 64.05 110.189 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.0 m -65.9 110.67 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.427 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.413 HG21 ' HB1' ' A' ' 99' ' ' ALA . 32.5 mt -96.84 120.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.167 -0.469 . . . . 74.33 110.539 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 1.3 p90 -153.76 72.26 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.548 1.166 . . . . 73.23 109.742 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.866 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.63 153.1 23.58 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 118.269 -1.92 . . . . 63.33 113.857 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.4 mtp-105 -133.32 123.63 25.8 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.923 -0.769 . . . . 75.51 108.923 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.78 131.61 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.442 0.639 . . . . 74.41 109.901 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.637 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.6 m -134.36 139.1 45.39 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.507 -0.769 . . . . 50.13 110.263 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 47.09 46.38 16.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.325 0.491 . . . . 62.15 112.325 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.88 29.46 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.952 -1.118 . . . . 71.24 112.587 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tp -76.73 -33.52 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 73.43 110.435 -176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.32 -35.32 91.46 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.015 -0.612 . . . . 73.44 111.682 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.539 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 68.4 mmm -69.37 -52.73 24.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.019 -0.363 . . . . 73.44 110.019 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.83 -30.97 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.135 0.493 . . . . 71.33 110.822 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.72 -53.62 14.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.762 -0.654 . . . . 75.53 110.612 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.547 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.38 -14.96 60.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.04 -0.527 . . . . 74.44 111.097 -177.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.707 HG23 ' HG3' ' A' ' 20' ' ' MET . 54.4 t -85.66 -38.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.18 0.514 . . . . 62.22 110.049 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -82.01 -15.01 75.99 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.574 -0.822 . . . . 74.21 112.94 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.547 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.9 ptm -96.39 0.89 51.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.683 0.241 . . . . 73.44 111.155 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 121.6 0.714 . . . . 73.22 112.084 -177.14 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.517 HG21 HG12 ' A' ' 142' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.828 0.823 . . . . 75.04 110.561 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -120.43 165.95 14.24 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.719 -1.128 . . . . 71.52 108.824 176.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 48' ' ' TYR . 3.5 mp -88.92 103.3 13.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.451 -0.944 . . . . 74.34 108.451 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.418 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.8 mm -66.87 -59.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.368 -0.833 . . . . 74.43 110.233 -176.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 6.0 mptp? -128.63 132.93 48.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.659 . . . . 74.34 109.977 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.13 135.54 49.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.335 -0.393 . . . . 70.1 110.663 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -154.47 128.1 4.42 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.641 -0.709 . . . . 74.34 110.617 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.443 ' HB3' HG12 ' A' ' 14' ' ' VAL . 91.7 Cg_endo -80.73 149.7 18.42 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.852 2.368 . . . . 75.42 112.817 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.529 ' HB3' ' HE1' ' A' ' 15' ' ' TYR . 21.4 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 70.21 110.128 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.3 0.572 . . . . 53.43 111.014 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.95 145.98 4.35 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.021 -0.99 . . . . 70.21 111.117 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.62 -167.33 25.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.281 -0.961 . . . . 63.4 112.291 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.757 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.55 171.14 12.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.783 0.325 . . . . 75.31 110.485 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.71 94.38 8.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.988 0.423 . . . . 72.2 110.022 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.662 ' HG2' ' HH ' ' A' ' 28' ' ' TYR . 58.2 Cg_endo -77.83 -7.99 16.67 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.12 1.88 . . . . 72.44 112.802 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.511 ' OE2' ' HD2' ' A' ' 189' ' ' PRO . 1.3 mp0 -75.31 -35.01 61.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.104 0.478 . . . . 73.14 110.445 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.468 HG13 HG12 ' A' ' 193' ' ' VAL . 14.7 pt -79.05 -13.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.929 -0.578 . . . . 70.2 111.509 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.0 m170 65.85 30.68 9.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.704 -0.68 . . . . 71.41 112.204 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.468 HG12 HG13 ' A' ' 191' ' ' ILE . 4.6 p -123.49 149.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.142 -0.318 . . . . 74.21 110.142 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.52 119.0 18.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.162 -0.472 . . . . 71.54 111.601 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -164.97 156.7 15.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.477 -0.783 . . . . 75.23 109.589 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.46 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 10.8 m-85 -120.7 146.22 42.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.799 -0.36 . . . . 73.54 111.122 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.757 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.5 Cg_endo -62.15 -59.89 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.946 2.43 . . . . 70.3 111.968 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.7 21.17 5.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.901 0.381 . . . . 74.33 110.006 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 62.65 19.42 11.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.54 -0.755 . . . . 75.41 111.646 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 ptm -53.28 -53.51 49.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.524 -0.762 . . . . 75.34 112.289 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.78 -8.08 71.63 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.32 -0.467 . . . . 74.21 113.442 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.46 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 78.7 mtp180 -80.9 -42.78 20.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.888 0.375 . . . . 70.42 110.177 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.7 ' HZ3' ' HB2' ' A' ' 203' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-N 114.383 -1.28 . . . . 75.24 112.067 -174.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.617 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 51.6 Cg_exo . . . . . 0 N--CA 1.457 -0.675 0 N-CA-C 110.268 -0.705 . . . . 61.14 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.9 0.15 5.41 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.241 2.627 . . . . 74.33 113.276 -172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.55 HD22 HG12 ' A' ' 24' ' ' VAL . 3.1 t-20 -135.7 129.13 32.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.35 -0.841 . . . . 75.14 108.799 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 164' ' ' PRO . 18.7 m -130.85 162.58 38.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.563 0.221 . . . . 72.52 110.493 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.608 ' HB3' HG21 ' A' ' 24' ' ' VAL . 39.5 p90 -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.287 0.565 . . . . 72.43 112.096 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.23 116.39 28.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.005 -0.998 . . . . 73.5 109.423 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.36 112.64 20.51 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.903 -0.777 . . . . 75.54 108.903 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -105.31 177.98 4.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.926 0.393 . . . . 73.0 111.428 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.5 ' HB2' HD12 ' A' ' 160' ' ' ILE . 23.2 t -72.79 -11.44 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 71.22 110.557 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.638 ' HG3' HG22 ' A' ' 142' ' ' VAL . 8.7 mmt -100.39 -39.96 7.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 73.04 110.498 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -175.86 -127.0 0.99 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.789 -0.719 . . . . 74.42 111.505 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -145.82 130.79 12.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.28 -0.637 . . . . 75.05 109.28 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 ' N ' HD11 ' A' ' 22' ' ' ILE . 4.1 mp -126.43 129.19 71.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 75.41 110.399 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 15' ' ' TYR . 42.5 t -110.18 142.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.864 -0.421 . . . . 71.33 109.864 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.65 159.35 44.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.459 0.647 . . . . 73.11 111.002 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -132.74 163.5 28.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.484 -0.78 . . . . 72.14 110.005 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD12 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -98.4 166.99 11.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.445 -0.343 . . . . 75.22 110.158 -175.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.772 ' HE2' ' HB3' ' A' ' 190' ' ' GLU . 11.1 m-85 -87.73 99.34 12.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.374 0.607 . . . . 64.41 111.316 175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.467 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -81.45 0.1 39.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.283 -0.871 . . . . 73.44 109.37 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.58 -69.55 0.31 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.133 -0.94 . . . . 73.02 111.035 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.423 ' HD1' ' CG ' ' A' ' 89' ' ' ASP . 46.4 m80 -129.26 17.83 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.413 -0.358 . . . . 75.23 111.195 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.6 63.82 71.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.575 -0.284 . . . . 74.24 111.296 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.21 -44.0 2.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.643 2.229 . . . . 74.02 111.815 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -60.99 -47.15 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.757 0.789 . . . . 75.23 110.051 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.419 HG21 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -65.97 -41.28 91.37 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.56 -1.2 . . . . 73.3 110.965 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 41.8 t -57.43 -41.62 80.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 75.54 110.387 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 7.4 mmpt? -58.84 -45.45 90.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.925 -0.579 . . . . 74.31 110.897 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -53.49 -52.98 57.81 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.592 0.558 . . . . 63.31 110.511 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.491 ' CD2' HD12 ' A' ' 27' ' ' LEU . 37.4 t80 -69.02 -44.06 73.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.284 -0.417 . . . . 74.25 110.692 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 44' ' ' ARG . . . -55.26 -53.01 61.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 65.31 112.004 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 41.8 mm-40 -66.35 -31.12 71.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 71.1 110.354 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -66.79 -36.87 83.4 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.292 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . . . -67.44 -35.73 79.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.579 -0.737 . . . . 75.33 110.085 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 15.2 mmm180 -61.57 -44.54 96.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.934 -0.575 . . . . 65.3 110.991 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -48.18 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 75.53 110.245 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.42 43.42 1.86 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.127 -1.035 . . . . 74.42 112.412 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.59 -18.92 56.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.077 0.465 . . . . 70.15 111.041 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.674 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.8 -6.01 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 74.0 111.738 -177.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.9 -8.82 47.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.182 -0.463 . . . . 75.55 111.242 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -136.9 26.32 3.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.828 -0.701 . . . . 71.22 112.153 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.527 ' HG1' ' HB ' ' A' ' 159' ' ' ILE . 32.2 p -98.76 148.05 24.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 64.14 111.437 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -135.72 161.65 34.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.332 -0.618 . . . . 55.43 109.332 177.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 74.2 m-85 -80.77 116.41 20.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 61.43 109.915 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -97.56 -22.16 16.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 65.14 110.451 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.786 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 33.5 mmt180 -125.27 116.31 21.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.54 110.151 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 62' ' ' ILE . 20.3 mm -124.42 88.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.108 -0.701 . . . . 75.12 109.108 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 13.7 mt -98.16 126.01 51.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.198 -0.667 . . . . 74.34 109.198 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.28 118.84 8.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.655 0.597 . . . . 73.31 110.656 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 57.81 40.63 25.95 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.894 0.747 . . . . 74.55 110.946 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.842 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.1 t80 -133.24 -81.02 0.48 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.221 0.534 . . . . 73.34 109.916 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.49 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.94 156.62 25.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.96 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.497 ' CD1' HD21 ' A' ' 116' ' ' LEU . 48.5 mt -126.92 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.405 -0.591 . . . . 74.45 109.405 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.786 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 18.3 mt-30 -85.6 124.65 32.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.31 -0.404 . . . . 74.1 110.93 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -119.57 141.24 15.46 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 60.51 111.93 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.8 -137.25 5.34 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.046 -0.597 . . . . 72.03 111.918 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 49.44 78.58 0.39 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.419 0.896 . . . . 61.52 113.419 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HG3' ' HA2' ' A' ' 74' ' ' GLY . 68.4 Cg_endo -76.56 -17.26 16.38 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.789 1.659 . . . . 73.42 110.395 168.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.772 ' HG1' HG23 ' A' ' 70' ' ' THR . 33.9 p -96.61 -44.39 7.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.909 -1.041 . . . . 75.12 111.12 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.63 53.82 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.773 -0.727 . . . . 74.52 111.981 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.772 HG23 ' HG1' ' A' ' 68' ' ' THR . 10.3 t -98.95 -10.61 22.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 64.14 110.95 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.97 -15.4 58.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.863 -0.684 . . . . 64.32 112.939 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.35 18.4 1.71 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.956 0.354 . . . . 71.13 111.956 -175.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.421 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -84.74 -167.92 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.27 -0.967 . . . . 71.35 111.994 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.539 ' HA2' ' HG3' ' A' ' 67' ' ' PRO . . . 113.7 -117.97 4.34 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.249 -0.977 . . . . 65.54 113.272 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.869 ' H ' ' HB2' ' A' ' 110' ' ' SER . . . -60.8 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.242 0.617 . . . . 75.01 112.497 -173.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -99.69 7.63 44.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.845 -0.798 . . . . 74.4 108.845 174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.04 -38.65 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.869 -1.059 . . . . 72.31 111.132 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.858 ' HB2' ' HE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -98.89 -3.47 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.271 -0.422 . . . . 65.22 111.654 -178.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.86 -73.71 2.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.04 -0.6 . . . . 64.03 112.735 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -113.68 171.51 7.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.791 0.329 . . . . 74.24 110.703 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 161.32 28.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 63.45 110.467 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.858 ' HE2' ' HB2' ' A' ' 78' ' ' TYR . 71.1 m-85 -131.74 -169.15 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 73.25 110.351 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -46.47 139.21 5.14 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.836 0.71 . . . . 63.32 112.166 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.16 135.45 42.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.143 -0.688 . . . . 70.01 109.143 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG3' HG21 ' A' ' 35' ' ' THR . 25.9 mm-40 -102.68 19.42 19.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.831 -0.622 . . . . 73.23 110.116 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.06 98.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.622 -0.717 . . . . 71.21 110.655 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -167.75 82.13 0.83 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.962 -0.563 . . . . 74.24 109.876 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.56 92.54 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.846 2.364 . . . . 72.02 112.372 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.423 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 15.3 t70 -71.31 -37.14 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.13 0.967 . . . . 75.21 109.079 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -84.3 179.04 7.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.543 -1.208 . . . . 74.53 108.985 172.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -139.59 169.1 18.36 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.479 -0.488 . . . . 71.31 109.881 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -63.49 123.12 17.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 74.3 109.539 171.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p -125.32 -40.99 2.08 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.567 0.699 . . . . 73.13 109.843 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.549 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.42 -143.4 3.69 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 114.934 -1.03 . . . . 64.52 111.179 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.6 150.83 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.704 0.287 . . . . 64.14 110.519 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.71 23.59 7.79 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.704 -0.76 . . . . 75.34 111.426 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HG3' ' A' ' 189' ' ' PRO . 8.6 mm -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.33 -0.619 . . . . 73.42 109.33 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.872 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -83.38 122.88 29.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.263 -0.426 . . . . 75.12 109.883 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.79 171.94 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.154 0.502 . . . . 70.13 111.654 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.735 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 26.4 ttt -107.25 143.14 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.616 -0.72 . . . . 73.41 110.13 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -104.61 136.68 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.2 0.524 . . . . 74.41 110.64 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -139.43 166.23 25.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.583 -0.735 . . . . 73.52 109.766 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -85.88 -34.81 20.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.527 -0.306 . . . . 63.21 111.103 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.32 -123.05 1.07 Allowed Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.534 -0.841 . . . . 74.11 112.337 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.55 90.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.99 2.46 . . . . 75.14 112.201 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' PHE . 2.2 p30 59.87 11.08 2.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 74.25 112.373 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 m -81.48 61.18 4.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.69 0.757 . . . . 75.12 109.095 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -73.5 150.88 41.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.394 -1.276 . . . . 72.43 109.886 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.41 -139.82 3.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.632 -0.794 . . . . 71.33 111.958 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.869 ' HB2' ' H ' ' A' ' 75' ' ' ALA . 33.7 t -113.73 8.48 17.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.975 0.417 . . . . 73.42 110.359 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 9.2 mm-40 -82.47 138.81 34.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.14 -0.482 . . . . 72.44 110.386 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.88 167.29 21.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.111 -0.7 . . . . 74.12 109.111 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.742 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 51.5 p90 -157.12 153.87 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 74.32 112.059 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.794 HG21 HD22 ' A' ' 98' ' ' LEU . 17.4 t -113.64 142.52 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.237 -0.892 . . . . 73.05 108.752 174.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.443 HG23 ' HG1' ' A' ' 119' ' ' THR . 30.9 p -96.04 129.38 43.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.123 0.487 . . . . 74.13 110.621 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 62' ' ' ILE . 74.3 mt -82.49 -10.5 58.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.432 -0.804 . . . . 74.52 110.78 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.56 164.12 24.32 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.414 -0.812 . . . . 71.41 110.022 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 23.9 Cg_exo -64.19 113.96 2.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.707 2.271 . . . . 64.31 112.134 177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.443 ' HG1' HG23 ' A' ' 115' ' ' THR . 13.8 p -100.35 112.95 25.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.207 -0.451 . . . . 75.12 111.106 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.666 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -114.16 27.4 9.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.612 0.72 . . . . 73.34 109.756 -177.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.735 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -129.83 3.52 4.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.153 -0.931 . . . . 75.33 110.983 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.735 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 94.4 mt -113.13 7.84 18.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 73.35 110.931 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 -27.28 56.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.913 -1.04 . . . . 71.24 111.917 -176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.3 25.43 4.85 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.088 -0.805 . . . . 65.12 111.088 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -116.86 -40.38 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.952 0.406 . . . . 71.13 110.067 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -142.3 137.12 30.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 72.5 111.11 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.1 m -68.75 121.77 17.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.658 -0.701 . . . . 71.55 110.796 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.507 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.9 mt -108.4 120.88 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.457 -0.201 . . . . 73.25 110.457 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.735 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.2 p90 -157.71 73.62 0.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.865 0.841 . . . . 72.31 110.81 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.872 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.96 150.94 20.43 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.274 -1.441 . . . . 64.1 113.433 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -127.54 119.63 26.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.862 -0.792 . . . . 73.33 108.862 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.66 132.08 32.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.338 0.589 . . . . 65.22 109.864 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . 0.566 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.1 m -133.55 141.21 47.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 71.03 110.916 -171.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.3 pt20 41.68 35.3 0.47 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.478 1.111 . . . . 75.33 113.842 176.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.32 37.6 0.23 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.585 -0.817 . . . . 70.14 112.211 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.475 HG12 ' HB2' ' A' ' 197' ' ' PRO . 9.3 tp -85.33 -34.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.78 0.324 . . . . 73.41 110.542 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.59 -35.59 81.34 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.038 -0.601 . . . . 61.03 112.413 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.479 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 81.2 mmm -70.54 -51.32 29.45 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.336 -0.246 . . . . 71.34 110.336 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 62' ' ' ILE . 91.7 t -52.55 -32.12 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.001 0.429 . . . . 75.34 110.933 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.454 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.6 t30 -69.5 -53.8 17.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.84 -0.618 . . . . 73.51 110.559 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -15.43 61.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.055 -0.52 . . . . 73.2 110.975 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.638 HG22 ' HG3' ' A' ' 20' ' ' MET . 45.1 t -84.0 -37.59 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.442 . . . . 73.2 110.315 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -74.78 -18.62 80.09 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.42 -0.895 . . . . 70.23 112.613 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.454 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 42.8 mtm -99.66 1.34 43.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.947 0.351 . . . . 74.11 111.947 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.428 HG13 ' HA ' ' A' ' 142' ' ' VAL . 30.7 m . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.578 . . . . 75.31 111.903 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 142' ' ' VAL . 12.8 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 108.896 -0.779 . . . . 71.14 108.896 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.1 mttm -124.09 169.57 11.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.981 0.419 . . . . 74.3 111.207 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.527 ' HB ' ' HG1' ' A' ' 51' ' ' THR . 3.9 mp -93.45 99.81 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.838 -1.171 . . . . 75.15 107.838 170.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.557 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.4 mm -63.26 -61.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.62 -0.511 . . . . 65.11 109.62 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.557 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.2 mptp? -138.32 154.7 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.016 -0.735 . . . . 73.42 109.016 172.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -142.51 150.72 40.84 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.661 -0.496 . . . . 74.15 109.661 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 98.6 m-85 -156.05 145.62 15.37 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.339 -0.615 . . . . 74.12 109.339 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.617 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 5.4 Cg_exo -74.94 142.55 28.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.403 2.069 . . . . 73.41 111.954 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 72.2 110.074 178.687 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.4 m-20 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.445 0.641 . . . . 54.44 110.836 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.51 145.87 4.29 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.173 -0.922 . . . . 73.12 110.811 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -79.3 -161.12 20.94 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.083 -1.055 . . . . 75.3 112.153 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.624 ' HB2' ' OE1' ' A' ' 195' ' ' GLN . . . -80.95 176.73 9.57 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.153 -0.314 . . . . 71.33 110.153 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.446 ' O ' HG12 ' A' ' 191' ' ' ILE . 76.7 m-85 -116.19 92.54 36.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.646 -0.502 . . . . 70.14 109.646 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 10.3 Cg_exo -70.48 -18.07 33.85 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.21 2.607 . . . . 74.25 113.279 -173.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.772 ' HB3' ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -78.14 -35.1 49.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.262 0.468 . . . . 71.55 112.262 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.453 HG13 HG11 ' A' ' 193' ' ' VAL . 22.3 pt -73.03 -13.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 71.45 111.773 -171.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 63.8 m170 68.91 29.45 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.774 . . . . 72.13 111.926 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.453 HG11 HG13 ' A' ' 191' ' ' ILE . 3.9 p -127.28 165.66 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.979 -0.748 . . . . 74.34 108.979 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.24 129.77 34.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 63.22 111.59 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.624 ' OE1' ' HB2' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -158.54 153.45 25.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.019 -0.734 . . . . 73.11 109.019 174.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 83.9 m-85 -122.07 138.19 28.5 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.726 -0.39 . . . . 73.01 111.038 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.551 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 33.0 Cg_endo -64.23 -51.5 2.06 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.622 2.215 . . . . 74.24 111.967 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -154.83 41.15 0.45 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.387 -0.37 . . . . 73.42 111.166 178.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 2.0 m-20 75.32 -12.82 0.92 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.038 0.535 . . . . 73.13 112.257 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.559 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 23.0 ptm -50.64 -31.88 17.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.622 0.971 . . . . 72.32 113.622 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.86 2.7 55.65 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 119.803 -1.189 . . . . 75.54 113.677 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.49 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 31.8 ptt180 -118.98 1.89 11.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 117.565 0.682 . . . . 74.44 111.951 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 200' ' ' MET . 41.4 mtmt . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.116 -0.947 . . . . 74.42 110.831 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 121.005 0.431 . . . . 65.12 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.92 117.59 26.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.362 -0.381 . . . . 72.11 111.39 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.66 -38.67 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.26 0.552 . . . . 74.14 110.26 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 78' ' ' TYR . 78.4 mt -129.01 112.65 18.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.443 -0.798 . . . . 71.42 110.107 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.26 113.79 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.882 2.388 . . . . 71.13 111.911 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.07 -48.38 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.711 2.274 . . . . 64.41 111.51 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.64 67.94 0.59 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.34 -0.845 . . . . 75.11 112.038 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p 176.49 -173.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.641 -1.163 . . . . 73.41 108.469 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -104.19 119.96 40.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.275 -0.269 . . . . 75.52 110.275 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 1.3 mp0 -109.45 99.42 36.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.117 -0.327 . . . . 75.01 110.117 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 24.5 Cg_exo -63.68 145.87 91.72 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.021 1.814 . . . . 62.51 110.789 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 53.1 Cg_endo -69.55 -5.37 15.92 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.499 2.133 . . . . 72.42 112.116 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.643 HD22 HG13 ' A' ' 24' ' ' VAL . 4.7 t-20 -130.99 142.17 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.081 -0.963 . . . . 73.24 109.449 -175.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 164' ' ' PRO . 21.8 m -135.54 157.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.981 -0.377 . . . . 75.15 109.981 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HB2' HD12 ' A' ' 22' ' ' ILE . 50.8 p90 -121.06 130.46 53.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.267 0.556 . . . . 74.52 110.754 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -111.15 102.17 10.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.501 -0.772 . . . . 74.11 109.806 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.86 110.65 17.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.22 -0.659 . . . . 74.53 109.22 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.498 HG21 ' HE2' ' A' ' 53' ' ' PHE . 72.1 p -99.81 -179.7 4.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.149 -0.478 . . . . 74.34 110.719 -175.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 p -69.27 -16.88 63.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.091 -0.504 . . . . 62.21 110.878 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.412 ' HE2' HG23 ' A' ' 142' ' ' VAL . 4.4 mmt -94.83 -41.05 9.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 70.13 111.019 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -176.78 -127.49 1.05 Allowed Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.639 -0.791 . . . . 74.42 111.717 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 15' ' ' TYR . 19.6 tt -135.7 137.94 48.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.888 0.375 . . . . 73.23 110.188 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -122.41 108.75 22.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.191 -0.67 . . . . 75.11 109.191 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG13 HD22 ' A' ' 13' ' ' ASN . 39.5 t -98.03 131.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.334 -0.617 . . . . 74.53 109.334 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 25' ' ' LEU . 4.6 pp -146.99 159.26 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.119 0.485 . . . . 73.34 110.793 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -125.61 164.12 21.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.698 -0.683 . . . . 72.33 110.604 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 27' ' ' LEU . 0.9 OUTLIER -110.34 159.29 17.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.275 -0.875 . . . . 70.44 109.128 -178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.679 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.2 m-85 -86.46 88.79 7.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.398 0.618 . . . . 75.3 111.536 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.543 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 34.0 m95 -79.91 -3.59 48.76 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.416 -0.957 . . . . 72.11 108.416 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.82 -41.2 26.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 74.31 111.135 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.415 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 12.0 t60 -132.2 -17.33 2.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.658 -0.417 . . . . 73.52 111.774 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.91 88.62 31.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.779 -0.368 . . . . 75.42 111.024 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 31' ' ' HIS . 11.1 Cg_exo -71.15 -17.17 31.62 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.83 2.353 . . . . 65.42 112.694 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 7.5 mptt -90.31 -54.75 3.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.084 0.469 . . . . 74.42 110.475 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.7 m -55.38 -44.11 75.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 74.53 111.646 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -64.48 -37.6 88.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.371 . . . . 71.11 110.844 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.933 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -73.77 -38.92 64.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 74.53 110.53 -178.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.91 -58.71 7.38 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.386 0.429 . . . . 75.32 110.902 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.599 ' HD1' ' HH ' ' A' ' 48' ' ' TYR . 65.6 m-85 -61.83 -43.79 98.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.33 111.076 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 10' ' ' GLN . . . -59.57 -44.08 93.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 74.23 111.393 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -59.44 -45.19 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.31 111.429 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 47' ' ' TYR . 3.9 mm? -73.45 -23.34 60.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.736 0.303 . . . . 74.32 111.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.9 -48.71 52.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.386 . . . . 75.23 110.874 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -12.74 60.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.922 0.392 . . . . 74.11 111.022 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -52.35 9.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.839 -0.8 . . . . 75.23 108.839 172.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.92 45.84 0.93 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.675 -0.97 . . . . 64.44 110.675 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -88.86 -33.65 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.881 0.372 . . . . 70.42 111.368 -176.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.599 ' HH ' ' HD1' ' A' ' 39' ' ' PHE . 85.2 m-85 -71.94 -14.69 61.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.329 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -74.95 10.64 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 65.13 111.123 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.16 24.95 1.9 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.865 -0.607 . . . . 72.32 111.63 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.729 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 43.1 p -115.33 160.43 19.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.683 0.278 . . . . 72.32 111.082 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.9 ptpt -139.64 164.05 30.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.372 -0.377 . . . . 74.45 110.006 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.2 m-85 -82.24 117.68 22.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.831 -0.803 . . . . 74.44 108.831 173.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.83 -27.06 14.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.413 -0.358 . . . . 72.24 110.76 -169.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 30.5 mmt180 -132.02 116.68 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.517 -0.31 . . . . 73.31 110.564 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.52 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -127.28 94.25 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.007 -0.738 . . . . 62.23 109.007 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.758 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.8 mt -106.35 125.2 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.245 -0.434 . . . . 72.54 110.07 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.5 mtpt -60.27 130.79 48.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.223 0.327 . . . . 75.53 111.41 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 58.38 28.07 16.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.462 -0.79 . . . . 65.11 111.424 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.758 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -128.64 -87.52 0.55 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 72.12 109.86 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.727 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.7 ptt? -161.28 157.82 26.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 55.41 110.031 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.529 HD12 ' HA3' ' A' ' 143' ' ' GLY . 50.6 mt -128.62 102.07 7.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.613 -0.721 . . . . 73.42 109.682 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 23.5 tm0? -80.56 126.35 31.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 75.5 110.007 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.58 137.04 9.58 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.978 -0.63 . . . . 71.03 112.402 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.729 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 131.04 -137.47 9.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.071 -0.585 . . . . 70.41 112.12 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 4.5 t0 48.07 83.33 0.22 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 123.901 0.881 . . . . 73.13 112.241 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.26 -19.56 33.59 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.73 2.287 . . . . 73.14 111.498 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.57 ' OG1' HG21 ' A' ' 70' ' ' THR . 34.5 p -82.58 -34.55 27.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.144 -0.935 . . . . 71.11 111.534 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 76.22 28.0 60.92 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.102 -0.571 . . . . 74.22 111.835 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.57 HG21 ' OG1' ' A' ' 68' ' ' THR . 11.5 t -117.66 -17.48 9.91 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.101 0.408 . . . . 71.34 112.101 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.94 25.59 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 119.87 -1.157 . . . . 74.4 113.631 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.549 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.97 -7.36 6.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.336 0.568 . . . . 73.52 111.877 178.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 70.9 -163.87 53.64 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.182 -0.532 . . . . 72.21 113.342 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.12 -88.05 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.683 -0.567 . . . . 64.44 111.683 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB2' ' CE1' ' A' ' 78' ' ' TYR . . . 59.87 33.08 21.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.278 0.561 . . . . 74.03 111.934 173.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 t -78.83 0.66 26.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 70.51 111.686 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.8 pt -74.01 -29.76 26.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.722 -0.391 . . . . 70.35 111.254 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 4' ' ' ILE . 23.1 p90 -108.05 1.73 22.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.3 0.572 . . . . 75.01 111.107 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -77.58 2.09 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.341 -0.845 . . . . 72.23 113.39 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -92.37 -170.39 2.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.851 0.358 . . . . 72.14 110.505 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.44 163.65 13.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.621 -0.511 . . . . 74.41 109.621 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 57.6 t80 -110.33 156.02 21.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.103 -0.239 . . . . 73.55 111.091 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.13 158.14 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.161 0.913 . . . . 73.22 112.16 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -75.22 106.76 6.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.299 -0.864 . . . . 73.04 110.838 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.5 21.37 9.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 74.24 109.354 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 HD23 ' OG1' ' A' ' 127' ' ' THR . 38.2 mt -59.32 97.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -0.999 . . . . 75.51 111.551 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -168.22 85.45 0.72 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 73.34 109.961 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.41 93.7 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.59 2.193 . . . . 72.03 111.947 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.61 -26.4 66.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.698 0.761 . . . . 64.45 109.65 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.659 HD12 ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -83.12 177.75 8.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.899 -1.046 . . . . 70.33 108.808 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -133.8 159.86 39.34 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.907 -0.717 . . . . 73.43 110.541 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 118' ' ' PRO . 1.2 p90 -70.46 77.18 0.57 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.315 -0.857 . . . . 72.3 110.829 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -68.49 -40.59 80.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.945 -1.025 . . . . 75.3 111.421 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.66 -146.92 4.85 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.0 -0.619 . . . . 73.52 111.949 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.89 145.78 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.783 0.325 . . . . 53.34 110.751 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.09 24.3 6.34 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.67 -0.776 . . . . 74.23 111.535 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.2 mm -88.18 112.42 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.565 -0.532 . . . . 74.32 109.565 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.691 HD21 HG21 ' A' ' 114' ' ' VAL . 3.3 tm? -85.45 121.76 28.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.987 -0.551 . . . . 74.21 109.594 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 113' ' ' PHE . . . -126.69 163.52 23.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.125 0.488 . . . . 75.34 111.186 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.533 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 28.1 ttt -91.62 134.16 34.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.483 -0.781 . . . . 73.45 109.939 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -96.5 151.24 19.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.132 0.492 . . . . 72.54 110.979 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.4 p-10 -155.84 159.38 39.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 74.3 110.581 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.62 -13.45 22.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.244 0.545 . . . . 73.32 110.808 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.462 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -162.58 -179.99 37.51 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.224 -1.55 . . . . 75.32 109.224 176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.63 -50.69 12.94 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.737 2.292 . . . . 72.0 112.063 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.89 19.56 15.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 75.02 110.367 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.3 m -101.08 51.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.317 -0.994 . . . . 73.02 108.317 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.533 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 42.3 m-80 -77.37 134.84 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.421 -1.263 . . . . 74.25 110.375 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.57 -157.21 10.09 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.745 -0.74 . . . . 71.01 112.506 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -95.7 8.99 41.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.162 0.506 . . . . 70.42 111.166 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 6.3 pt20 -90.8 158.6 16.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.871 -0.604 . . . . 72.3 111.328 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . 50.9 p90 -142.17 176.45 8.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.02 -0.536 . . . . 73.13 109.971 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 51.1 p90 -159.54 152.04 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 72.24 110.608 173.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.691 HG21 HD21 ' A' ' 98' ' ' LEU . 19.3 t -110.93 142.78 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.288 -0.634 . . . . 64.52 109.288 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.7 p -97.39 130.09 44.56 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.771 0.319 . . . . 74.32 110.154 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 62' ' ' ILE . 57.0 mt -86.22 -6.69 58.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.06 0.457 . . . . 72.45 110.957 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.19 166.88 14.33 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.805 -0.634 . . . . 72.24 109.794 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 92' ' ' PHE . 32.2 Cg_exo -59.41 106.63 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.591 2.194 . . . . 74.41 112.043 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.483 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.1 p -94.02 103.42 15.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.62 -0.718 . . . . 72.22 111.793 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.19 3.6 30.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.651 0.739 . . . . 73.3 110.255 176.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.483 ' CZ2' HG22 ' A' ' 119' ' ' THR . 1.2 p90 -93.71 -3.7 51.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.995 -1.002 . . . . 74.41 111.295 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.19 16.53 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.549 -0.296 . . . . 73.3 111.207 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.75 -38.9 57.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.281 -0.872 . . . . 75.3 111.552 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.12 22.48 10.39 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.608 -0.806 . . . . 64.02 112.083 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -118.4 -26.49 6.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.061 0.458 . . . . 74.22 110.135 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -137.34 128.09 27.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 73.23 110.486 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.405 ' OG1' HD23 ' A' ' 86' ' ' LEU . 21.5 m -68.73 120.71 15.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.433 . . . . 75.53 110.669 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.21 117.58 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.547 0.203 . . . . 75.25 111.547 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 47.9 m-85 -158.77 77.04 0.75 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.511 0.507 . . . . 73.03 110.698 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.34 163.24 35.45 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.116 -0.564 . . . . 52.2 112.285 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.679 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 78.3 mtm180 -142.31 127.14 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.028 -0.36 . . . . 72.35 110.028 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -87.06 142.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 75.34 110.686 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 43.6 t -145.77 147.72 32.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 64.35 110.773 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.705 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.3 tt0 48.41 34.04 4.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.568 0.747 . . . . 75.34 112.567 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 139' ' ' VAL . . . -163.45 16.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.061 -1.066 . . . . 74.23 112.407 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 tp -73.18 -31.74 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.159 -0.311 . . . . 62.53 110.159 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.93 95.49 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.982 -0.847 . . . . 71.11 110.982 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.445 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 81.8 mmm -68.61 -48.85 63.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.098 -0.334 . . . . 75.31 110.098 176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.472 HG12 HD11 ' A' ' 62' ' ' ILE . 85.7 t -56.33 -30.23 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 73.22 110.532 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.72 -52.83 11.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.815 -0.63 . . . . 72.31 110.97 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -14.43 60.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.051 -0.522 . . . . 75.1 111.305 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.412 HG23 ' HE2' ' A' ' 20' ' ' MET . 46.4 t -93.52 -33.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.077 0.465 . . . . 73.2 110.382 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.529 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -82.8 -22.03 58.6 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.595 -0.812 . . . . 61.11 113.0 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ptp -84.33 -13.26 52.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.853 -0.339 . . . . 74.45 111.659 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 154' ' ' VAL . 31.4 m -93.31 137.74 21.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 74.42 111.256 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -116.71 -46.91 2.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.453 . . . . 65.12 110.642 175.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 1.9 p -119.91 146.34 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.074 0.464 . . . . 74.2 111.418 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.614 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 46.9 t30 -93.44 -33.6 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 72.45 109.362 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.7 t -168.2 176.0 6.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.287 -0.869 . . . . 62.23 108.986 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 18.67 -97.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.197 1.184 . . . . 75.3 114.197 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -129.43 26.47 5.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.122 0.963 . . . . 75.21 109.624 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -103.63 116.49 61.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.297 -0.865 . . . . 70.25 109.661 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 46.3 Cg_exo -56.58 154.9 28.43 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.576 2.184 . . . . 74.1 111.098 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.614 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 76.7 t -55.99 118.11 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 71.34 109.318 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -45.89 133.95 8.22 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 124.224 0.952 . . . . 74.44 111.715 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -45.36 126.71 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.616 -1.175 . . . . 73.1 112.785 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p -97.17 128.73 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.609 -1.178 . . . . 75.43 109.439 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -127.21 165.4 19.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.141 -0.481 . . . . 73.11 110.721 -175.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 162' ' ' ALA . 4.0 mp -86.76 105.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.617 -0.72 . . . . 74.41 109.102 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.539 HG21 ' HD2' ' A' ' 161' ' ' LYS . 25.1 mm -70.46 -56.37 11.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.562 -0.744 . . . . 73.14 110.673 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.539 ' HD2' HG21 ' A' ' 160' ' ' ILE . 2.5 mptm? -133.34 128.04 34.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 70.13 110.147 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . . . -131.27 123.99 29.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.864 0.364 . . . . 72.42 110.672 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.22 143.24 32.84 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.89 -0.596 . . . . 63.53 109.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.837 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 74.4 Cg_endo -78.47 124.58 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.198 1.932 . . . . 64.02 112.241 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.5 m -163.57 137.92 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.522 -0.763 . . . . 73.33 109.234 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 13' ' ' ASN . . . -86.76 110.27 3.51 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.759 -0.734 . . . . 62.34 112.879 -174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.27 105.93 3.19 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.979 -0.848 . . . . 71.54 110.979 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.15 -64.01 2.08 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.875 -0.679 . . . . 63.32 112.653 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.29 150.06 26.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.676 -0.773 . . . . 61.42 111.978 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.1 t -153.09 140.35 19.51 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.833 -0.432 . . . . 74.33 109.833 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.73 -160.08 11.32 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.873 -0.679 . . . . 74.14 111.869 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 169.94 153.35 8.54 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.672 -0.775 . . . . 70.12 112.388 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -172.88 56.47 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.159 -0.776 . . . . 73.23 111.159 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -77.05 105.59 8.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.026 0.441 . . . . 73.3 110.863 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 113.71 -25.56 10.87 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.89 -0.671 . . . . 73.44 111.61 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -174.47 79.12 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.681 -0.771 . . . . 54.52 112.412 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -89.46 53.67 3.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.899 -0.667 . . . . 71.45 111.777 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 m -64.68 -33.29 75.59 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.662 0.385 . . . . 71.13 111.211 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.09 -94.0 0.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.966 -0.635 . . . . 72.52 112.121 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.68 132.89 7.48 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.7 -0.762 . . . . 72.11 111.884 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.33 61.37 1.19 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.259 -0.736 . . . . 73.03 111.259 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.4 m -74.43 100.82 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 71.24 110.694 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.58 -150.01 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.292 -0.723 . . . . 63.24 111.292 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.1 m-20 -121.13 169.29 10.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.32 0.581 . . . . 71.43 110.189 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.16 146.08 4.48 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.256 -0.884 . . . . 73.23 111.638 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.25 -167.38 39.86 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.359 -0.924 . . . . 73.33 111.864 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -79.38 167.21 21.18 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.605 -0.516 . . . . 74.43 109.605 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.407 ' O ' HG12 ' A' ' 191' ' ' ILE . 92.4 m-85 -114.06 103.62 55.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.142 0.496 . . . . 75.43 110.32 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.659 ' HB2' HD12 ' A' ' 90' ' ' LEU . 73.0 Cg_endo -79.87 -11.68 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.707 2.271 . . . . 74.32 112.069 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.69 -20.0 40.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.41 -0.814 . . . . 63.2 111.336 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.423 HG13 HG12 ' A' ' 193' ' ' VAL . 18.4 pt -87.9 -13.6 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.0 0.428 . . . . 71.31 110.969 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.1 m170 68.85 29.83 4.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.34 -0.846 . . . . 74.43 112.456 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.423 HG12 HG13 ' A' ' 191' ' ' ILE . 4.2 p -130.81 148.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.803 -0.443 . . . . 71.34 109.803 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.48 124.53 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.953 0.406 . . . . 63.21 111.831 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.588 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -163.29 152.31 14.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 71.11 109.174 175.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.408 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 52.8 m-85 -117.67 146.01 37.75 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.624 0.25 . . . . 64.41 111.217 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 36.2 Cg_endo -66.0 -59.63 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.643 2.229 . . . . 75.12 112.191 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.2 pt? -143.98 38.87 1.33 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.769 0.285 . . . . 74.33 111.769 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.2 m-20 76.43 -19.23 0.43 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.75 1.019 . . . . 73.22 113.75 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -60.37 -23.09 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.728 0.64 . . . . 72.22 112.728 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 -13.37 60.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.241 -0.981 . . . . 63.13 112.955 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.408 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 24.8 ptt180 -110.71 -24.16 10.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.081 0.441 . . . . 75.44 111.261 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.362 -0.828 . . . . 71.34 110.394 176.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.923 0.392 . . . . 64.35 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.64 -174.52 4.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.992 -0.549 . . . . 75.2 109.528 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -66.43 132.63 48.72 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.191 -0.204 . . . . 75.51 110.526 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.682 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 86.3 mt 74.88 98.06 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.849 0.718 . . . . 71.3 111.709 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.415 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 17.0 Cg_endo -92.06 106.14 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.245 2.63 . . . . 72.33 110.796 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 17.5 Cg_endo -57.95 138.59 86.76 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.953 2.436 . . . . 75.32 111.858 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.89 144.85 37.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.13 -0.486 . . . . 70.25 110.024 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -88.24 -8.61 55.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.516 -0.311 . . . . 72.14 111.546 -173.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -105.5 119.14 38.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.486 -0.561 . . . . 75.3 109.486 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -97.24 109.98 52.2 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.734 -0.666 . . . . 74.22 110.869 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 31.0 Cg_endo -66.91 113.46 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.311 2.007 . . . . 72.23 110.787 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -63.27 -39.94 35.2 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.592 2.195 . . . . 75.23 112.67 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.414 HD22 HG22 ' A' ' 24' ' ' VAL . 26.2 t-20 -134.0 150.88 51.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 71.33 110.031 -173.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.538 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.0 m -129.23 141.65 46.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 75.14 110.498 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' HA ' HG11 ' A' ' 24' ' ' VAL . 24.1 m-85 -96.93 124.86 41.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 73.01 110.67 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 162' ' ' ALA . 27.7 mt -112.22 100.56 8.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.564 -0.289 . . . . 74.11 110.23 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.838 ' HB2' ' HG2' ' A' ' 161' ' ' LYS . 35.8 mt-10 -82.48 110.76 17.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.233 -0.654 . . . . 72.33 109.233 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -105.57 177.76 4.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.185 0.516 . . . . 72.1 111.899 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 9.9 p -71.97 -19.26 61.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 74.22 110.611 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.1 mmt -92.4 -38.78 11.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.823 -0.626 . . . . 63.23 110.833 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -178.66 -126.51 1.01 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.909 -0.663 . . . . 71.51 111.448 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.03 137.2 38.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.796 -0.446 . . . . 74.13 109.796 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.621 HG12 HG22 ' A' ' 139' ' ' VAL . 3.9 mp -139.02 130.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.721 -0.672 . . . . 74.33 109.227 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 133' ' ' CYS . 2.2 m -118.94 151.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.019 -0.672 . . . . 74.13 110.664 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -145.96 161.45 40.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 75.32 110.22 176.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -129.77 164.19 24.59 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.149 -0.932 . . . . 74.41 109.439 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.03 162.97 12.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.025 -0.361 . . . . 71.3 110.025 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.43 ' HH ' ' HB2' ' A' ' 189' ' ' PRO . 10.1 m-85 -86.39 101.75 13.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.325 0.583 . . . . 74.25 111.72 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.517 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -82.82 -1.68 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.223 -0.898 . . . . 74.45 110.184 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -68.87 -67.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 65.1 111.362 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -124.2 11.08 8.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 64.4 111.521 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.88 59.78 47.03 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.477 -0.329 . . . . 72.33 111.465 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 16.6 Cg_exo -67.53 -46.46 2.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.476 2.117 . . . . 55.13 111.975 -177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -63.91 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 74.31 110.307 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.535 ' HG1' ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -67.13 -41.04 86.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.391 -0.822 . . . . 75.25 110.495 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.517 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 18.5 t -58.52 -48.19 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 72.54 110.533 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.38 -34.61 78.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 72.24 111.275 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.442 ' O ' HD21 ' A' ' 42' ' ' LEU . 6.7 t30 -54.69 -52.36 62.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 73.54 110.407 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.538 ' HE1' HG21 ' A' ' 14' ' ' VAL . 27.4 t80 -67.71 -44.84 76.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.201 0.524 . . . . 70.44 109.911 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -55.52 -44.58 76.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.306 -0.861 . . . . 74.24 112.087 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.5 mt-10 -69.77 -38.78 76.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.11 -0.236 . . . . 75.11 111.19 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD21 ' O ' ' A' ' 38' ' ' ASN . 4.0 mm? -65.14 -26.92 68.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 73.31 110.395 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.93 -45.2 64.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.973 -0.558 . . . . 72.23 109.873 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.6 mtp180 -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 75.45 111.063 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 9.1 mpt_? -73.01 -40.46 65.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.012 -0.366 . . . . 74.04 110.012 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 30.03 6.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.655 -0.784 . . . . 61.24 112.479 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -76.88 -17.01 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 74.41 111.385 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -74.3 -17.22 60.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.132 0.419 . . . . 73.22 112.132 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -71.19 -8.52 54.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.058 0.456 . . . . 73.21 110.606 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -122.69 31.21 4.87 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.942 -0.647 . . . . 64.43 111.951 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.811 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 73.4 p -112.11 154.3 25.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 71.02 111.155 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.82 157.46 43.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 74.4 109.948 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' CD1' ' HA3' ' A' ' 64' ' ' GLY . 97.9 m-85 -89.59 121.58 31.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 72.43 109.642 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -104.89 -35.6 7.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.53 -0.304 . . . . 72.34 111.803 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -113.41 112.96 24.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.686 -0.405 . . . . 73.03 110.356 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.623 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -125.99 94.33 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.179 -0.674 . . . . 75.43 109.179 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.818 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 24.2 mt -96.47 122.05 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.742 -0.663 . . . . 64.34 109.408 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 1.029 ' HD2' ' HB3' ' A' ' 146' ' ' GLU . 39.4 mtpt -53.49 120.93 6.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.525 0.516 . . . . 74.34 111.554 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 54.9 41.14 32.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.385 -0.825 . . . . 65.05 111.329 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.818 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 8.5 t80 -133.23 -80.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.775 -0.648 . . . . 74.41 109.46 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.684 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.6 ptt? -161.23 157.49 25.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.395 -0.82 . . . . 74.03 110.085 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.623 HG23 HG13 ' A' ' 56' ' ' ILE . 49.8 mt -127.11 101.39 7.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.409 -0.589 . . . . 75.31 109.409 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 37.7 tt0 -83.84 121.38 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.839 -0.619 . . . . 65.15 110.139 -177.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.56 ' HA3' ' CD1' ' A' ' 53' ' ' PHE . . . -142.93 151.35 23.09 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.519 -0.848 . . . . 21.43 112.719 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 135.14 -148.93 19.78 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.548 -0.834 . . . . 75.45 112.051 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 t70 59.67 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 O-C-N 124.376 0.692 . . . . 72.03 111.145 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.9 Cg_endo -64.53 -20.59 65.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.042 2.495 . . . . 71.34 112.445 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.522 ' OG1' HG23 ' A' ' 70' ' ' THR . 9.9 p -82.52 -27.56 31.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 75.34 111.422 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.17 26.59 68.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.91 -0.662 . . . . 72.04 111.685 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.522 HG23 ' OG1' ' A' ' 68' ' ' THR . 14.7 t -118.54 -24.09 6.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.487 0.185 . . . . 62.02 111.215 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.79 9.35 43.38 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 72.24 113.253 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HG3' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -150.38 21.77 0.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 75.04 110.718 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.5 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -103.7 -176.15 25.91 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.748 -0.739 . . . . 74.13 112.234 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 110' ' ' SER . . . 83.37 161.27 31.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.578 -0.82 . . . . 62.01 111.645 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 58.98 16.3 4.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.094 0.473 . . . . 75.15 111.567 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -68.65 -12.55 61.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.552 . . . . 74.15 110.941 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.599 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.2 pt -64.55 -39.44 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.367 -0.378 . . . . 72.13 110.369 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.682 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 95.5 m-85 -75.02 -32.93 61.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.662 -0.496 . . . . 75.03 109.662 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.37 8.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.548 -0.834 . . . . 73.42 112.93 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -171.2 2.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.982 -0.377 . . . . 71.1 109.982 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -70.93 164.27 25.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 64.32 110.577 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -99.22 143.0 29.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 72.34 109.642 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 106' ' ' ASP . 35.1 tt0 -58.87 147.26 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.634 0.584 . . . . 71.35 110.726 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -67.33 125.3 25.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.741 0.781 . . . . 55.24 110.611 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.535 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 14.8 tp10 -117.77 29.36 7.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.644 -1.162 . . . . 74.14 108.361 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -49.61 100.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.72 -1.127 . . . . 75.24 111.175 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.64 78.69 9.83 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.066 -0.516 . . . . 73.42 111.128 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.66 66.4 2.3 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.56 2.173 . . . . 74.01 111.638 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.99 -23.55 59.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.053 0.93 . . . . 63.34 109.436 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -89.13 166.42 13.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.462 -1.244 . . . . 74.53 108.879 174.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -113.71 141.58 47.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.278 -0.569 . . . . 74.41 110.836 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.96 70.42 0.76 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.968 . . . . 71.12 109.801 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 193' ' ' VAL . 37.1 p -62.7 -40.89 98.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.091 . . . . 63.13 111.765 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.81 -144.73 4.09 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.761 -0.733 . . . . 75.53 111.911 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.05 144.02 27.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.798 0.332 . . . . 70.04 110.523 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.65 22.08 6.19 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.829 -0.7 . . . . 73.2 111.706 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 mm -88.39 114.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.442 -0.577 . . . . 73.43 109.442 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.74 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -89.86 120.28 30.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.956 -0.565 . . . . 75.55 109.746 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -128.33 160.92 30.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.948 -0.569 . . . . 64.54 110.257 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.648 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 39.0 ttp -91.06 143.16 26.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.601 -0.518 . . . . 71.35 109.601 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.3 114.4 26.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.274 0.559 . . . . 43.32 110.975 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 2.9 p-10 -115.7 149.93 37.63 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.283 -0.871 . . . . 74.41 109.897 175.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -83.84 -28.01 28.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.258 -0.883 . . . . 64.45 111.285 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.37 -108.89 0.32 Allowed Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 120.912 -0.661 . . . . 43.45 112.147 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.06 89.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.892 2.395 . . . . 65.35 112.009 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 3.3 p30 48.1 31.11 2.35 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.878 -1.055 . . . . 64.25 111.898 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.438 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 1.3 m -85.38 52.25 2.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.292 0.567 . . . . 71.2 109.996 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.5 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 19.0 m-80 -91.26 173.82 7.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.303 -0.862 . . . . 75.02 109.032 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.39 -96.71 0.13 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.353 -1.403 . . . . 75.54 114.234 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.508 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 46.9 t -126.87 12.19 7.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.391 0.615 . . . . 73.44 110.448 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.648 ' O ' ' HG3' ' A' ' 100' ' ' MET . 18.9 mp0 -101.14 147.04 26.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 74.4 109.474 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -147.21 176.09 10.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.809 0.338 . . . . 73.2 110.906 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.444 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.4 p90 -160.46 152.52 20.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.98 0.419 . . . . 74.11 110.202 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.662 HG21 HD21 ' A' ' 98' ' ' LEU . 18.5 t -112.91 138.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.786 -0.643 . . . . 71.23 109.268 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.9 p -93.3 125.47 37.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.058 0.456 . . . . 73.22 109.999 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD22 ' CD1' ' A' ' 62' ' ' ILE . 54.4 mt -85.29 -6.46 59.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.59 -0.732 . . . . 75.03 110.357 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.41 161.14 34.78 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.338 -0.846 . . . . 74.3 109.997 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.43 113.7 2.38 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.644 2.229 . . . . 75.12 112.224 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.2 p -105.31 103.57 13.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.102 -0.499 . . . . 74.54 110.938 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -99.78 13.84 32.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.862 0.839 . . . . 64.14 109.479 -177.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.735 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -111.05 3.85 18.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.673 -1.149 . . . . 74.04 110.748 -178.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -113.29 6.4 17.34 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.272 -0.422 . . . . 72.01 111.642 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.05 -31.72 43.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.536 -0.757 . . . . 70.04 112.132 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -125.51 20.49 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.496 -0.859 . . . . 73.1 111.691 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.71 -31.25 5.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 74.13 110.656 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.405 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 35.1 m80 -142.27 141.14 32.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 72.41 111.04 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.1 m -78.32 111.08 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 74.4 110.277 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 99' ' ' ALA . 38.6 mt -98.99 122.82 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.42 110.71 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 35' ' ' THR . 5.5 p90 -159.71 73.31 0.55 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.689 0.757 . . . . 73.4 110.898 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.74 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.49 156.66 28.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.292 -1.432 . . . . 72.01 113.802 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.419 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.9 mtm180 -134.77 122.32 21.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.504 0.321 . . . . 75.13 110.282 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -83.64 138.69 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.036 0.446 . . . . 65.23 110.66 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.534 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 41.1 t -139.86 157.66 45.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.253 -0.43 . . . . 71.14 109.907 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.4 pt20 36.86 42.77 0.24 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.252 1.021 . . . . 73.3 113.18 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.76 17.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.455 -0.879 . . . . 74.42 112.509 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.497 ' H ' ' HB3' ' A' ' 184' ' ' ASP . 11.3 tp -74.34 -34.51 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.387 -0.227 . . . . 74.04 110.387 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.28 95.33 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.736 -0.745 . . . . 63.11 111.367 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 142' ' ' VAL . 75.6 mmm -70.31 -50.79 35.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 110.114 -0.328 . . . . 75.14 110.114 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.621 HG22 HG12 ' A' ' 23' ' ' ILE . 86.3 t -55.96 -30.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.043 0.449 . . . . 74.21 110.699 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.531 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.8 t30 -70.48 -53.32 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.991 -0.55 . . . . 74.21 110.521 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.39 61.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.35 -0.386 . . . . 72.11 111.225 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 138' ' ' MET . 50.6 t -83.47 -34.85 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.225 0.536 . . . . 63.23 109.733 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -79.53 -21.51 66.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.622 -0.799 . . . . 71.03 112.624 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.531 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 56.4 mtm -82.52 -23.96 34.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.944 0.35 . . . . 73.4 111.944 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.3 m -78.47 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.488 0.661 . . . . 71.24 110.196 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 1.029 ' HB3' ' HD2' ' A' ' 58' ' ' LYS . 8.4 pt-20 -90.42 -165.4 1.34 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 72.44 111.493 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 28.3 p -84.07 150.09 25.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.881 -0.6 . . . . 72.51 111.36 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' HA ' HG22 ' A' ' 154' ' ' VAL . 45.6 t30 -65.72 -30.9 71.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.674 0.749 . . . . 75.15 109.501 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 37.6 t -142.64 -80.67 0.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.98 -1.009 . . . . 74.13 108.91 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.434 ' C ' ' H ' ' A' ' 152' ' ' ARG . 9.4 pt20 -147.15 125.11 11.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.789 -0.642 . . . . 72.3 109.974 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 69.87 -13.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.326 0.65 . . . . 71.21 112.715 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 150' ' ' GLN . 2.7 ptm180 -107.76 108.07 61.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.461 -0.57 . . . . 75.04 109.461 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 23.4 Cg_endo -61.37 145.39 98.28 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.659 2.239 . . . . 74.24 112.284 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 146' ' ' GLU . 65.2 t -59.17 -54.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.189 0.518 . . . . 73.44 109.928 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -119.52 117.76 29.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.986 -0.746 . . . . 75.44 108.986 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.57 136.58 34.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.836 0.351 . . . . 74.34 110.298 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 53' ' ' PHE . 3.3 p -122.82 126.51 73.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.688 0.756 . . . . 74.23 111.725 -175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -122.93 163.77 19.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.069 -0.969 . . . . 73.03 109.67 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 159' ' ' ILE . 3.6 mp -90.25 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.815 -1.18 . . . . 72.44 107.815 170.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.403 HD11 ' HB3' ' A' ' 19' ' ' SER . 32.2 mm -67.07 -53.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.693 -0.685 . . . . 75.12 110.618 -173.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.838 ' HG2' ' HB2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -142.06 132.56 25.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.606 -0.724 . . . . 64.44 110.018 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' A' ' 48' ' ' TYR . . . -133.46 146.15 50.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.787 0.327 . . . . 74.35 110.625 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.413 ' HE1' ' HB2' ' A' ' 161' ' ' LYS . 85.0 m-85 -148.37 140.7 14.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 75.01 109.822 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.447 ' HD3' ' OH ' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -78.15 132.49 11.54 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.186 1.924 . . . . 65.34 111.579 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.452 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 49.5 m -151.52 -163.9 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 61.02 111.249 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.46 137.13 4.41 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 70.23 111.682 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.6 141.76 17.14 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.898 -0.668 . . . . 61.1 111.751 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.27 123.25 4.91 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.618 -0.801 . . . . 72.02 111.948 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -85.03 111.48 3.52 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.536 -0.84 . . . . 64.51 111.472 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -59.72 101.36 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 64.22 110.862 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.02 -40.18 2.1 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.98 -0.555 . . . . 75.13 112.772 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.31 34.72 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.253 -0.739 . . . . 72.13 111.253 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.21 -131.63 2.89 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.179 -0.768 . . . . 61.24 111.179 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.2 t -158.14 -68.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.765 -0.457 . . . . 72.34 109.765 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 166.83 -176.43 41.89 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.439 -0.664 . . . . 61.23 111.439 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.19 -55.02 4.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.884 -0.674 . . . . 53.43 112.485 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -128.97 -169.49 12.59 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.124 -0.56 . . . . 52.03 111.953 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 m -80.81 -27.64 36.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 72.13 111.016 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 111.41 163.3 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.835 -0.698 . . . . 72.33 111.877 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.53 7.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.788 . . . . 71.43 112.412 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.4 52.78 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.045 -0.598 . . . . 74.12 112.385 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 m -150.13 93.03 1.95 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.37 . . . . 63.11 110.247 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.63 -63.07 3.0 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.726 -0.749 . . . . 74.45 112.156 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 19.2 m-20 -125.07 167.51 14.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.523 0.678 . . . . 74.22 111.445 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 158.67 140.86 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.654 -1.157 . . . . 65.52 110.463 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.31 -169.81 40.57 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.233 -0.984 . . . . 74.22 111.97 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.76 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -75.34 166.67 23.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 110.153 -0.314 . . . . 71.24 110.153 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.97 100.03 11.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.482 -0.562 . . . . 70.31 109.482 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 5.5 Cg_exo -79.55 -9.75 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.666 2.244 . . . . 64.42 112.188 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.4 ' HB2' HH11 ' A' ' 131' ' ' ARG . 37.0 tt0 -74.17 -32.43 63.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.407 0.622 . . . . 75.21 109.63 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 pt -85.69 162.33 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.445 -0.946 . . . . 74.13 108.445 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -114.97 41.39 2.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.89 0.376 . . . . 74.32 111.25 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.713 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.6 p -109.57 -174.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.318 -0.623 . . . . 65.14 109.318 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.713 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -115.84 114.38 24.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.646 0.26 . . . . 75.14 111.064 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.577 HE21 ' HB2' ' A' ' 187' ' ' ALA . 3.7 pm0 -155.12 152.97 30.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.46 -0.571 . . . . 70.41 109.46 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -121.39 139.82 30.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.545 -0.298 . . . . 74.34 110.402 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.76 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 19.7 Cg_endo -58.31 -57.9 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.937 2.424 . . . . 74.54 111.99 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.12 23.85 4.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 75.11 109.873 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.474 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 30.2 m-20 69.55 9.5 7.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.36 -0.836 . . . . 75.1 112.169 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.9 ptm -53.0 -40.33 63.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 72.44 112.002 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.38 61.95 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.855 -0.688 . . . . 72.3 113.318 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.474 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 19.6 mtp180 -94.84 -3.68 48.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.827 0.346 . . . . 75.41 110.685 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 4.2 tppp? . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.604 -1.18 . . . . 75.32 112.142 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ppp? . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.845 0.355 . . . . 75.53 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.91 179.9 7.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.939 -0.573 . . . . 61.32 109.839 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -82.44 146.91 29.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.124 -0.324 . . . . 75.45 110.124 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 77' ' ' ILE . 51.8 mm 76.58 107.19 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 O-C-N 123.845 0.716 . . . . 73.34 110.368 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 2.8 Cg_endo -79.93 109.92 2.47 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.361 2.707 . . . . 71.13 112.936 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.02 87.87 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.134 2.556 . . . . 74.25 112.025 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -74.45 -44.19 52.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 74.44 110.582 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -125.27 -179.36 4.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.856 -0.611 . . . . 73.51 110.012 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -88.18 -23.76 23.51 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.23 -0.285 . . . . 71.15 110.23 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 2.1 mp0 72.25 130.12 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.1 0.875 . . . . 72.0 112.059 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 10' ' ' GLN . 31.0 Cg_exo -63.1 136.85 58.5 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.92 2.413 . . . . 72.13 111.931 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.441 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 32.1 Cg_endo -65.15 -22.48 61.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.928 2.419 . . . . 71.32 113.052 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -124.21 138.97 54.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.055 0.455 . . . . 75.03 110.936 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 164' ' ' PRO . 20.9 m -128.99 157.35 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.778 -0.646 . . . . 74.22 109.418 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.622 ' CB ' HG12 ' A' ' 24' ' ' VAL . 55.4 p90 -115.14 132.12 56.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.367 0.603 . . . . 75.12 111.551 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -110.32 109.13 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.086 -0.961 . . . . 75.23 110.25 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.13 112.39 23.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.19 -0.671 . . . . 74.02 109.19 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -104.68 178.89 4.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.97 0.414 . . . . 74.43 110.682 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 160' ' ' ILE . 12.9 p -80.44 -6.13 57.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.292 0.568 . . . . 75.24 110.463 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mmm -98.83 -41.58 7.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 74.25 109.565 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.552 ' HA3' ' HE3' ' A' ' 138' ' ' MET . . . -174.01 -134.13 1.8 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.1 -0.8 . . . . 62.12 111.1 177.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.73 130.72 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.958 -0.756 . . . . 65.34 108.958 177.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 139' ' ' VAL . 4.8 mp -132.15 124.9 53.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 74.33 110.122 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.622 HG12 ' CB ' ' A' ' 15' ' ' TYR . 3.2 m -106.48 146.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.272 -0.571 . . . . 70.4 109.767 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.47 162.01 37.62 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.982 0.42 . . . . 74.21 110.14 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -135.14 165.14 26.09 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.709 -0.678 . . . . 73.12 110.767 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.65 166.86 10.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.806 -0.634 . . . . 74.55 110.237 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -87.0 96.23 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.327 0.584 . . . . 71.44 111.635 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.441 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 42.0 m95 -88.82 1.9 54.49 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.256 -0.884 . . . . 73.32 109.511 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -74.11 -50.2 20.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 72.44 111.324 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -137.97 8.63 2.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 75.41 111.426 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.84 85.54 57.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 74.12 110.503 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.07 -11.58 21.35 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.184 2.59 . . . . 71.14 113.002 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.66 -48.88 3.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 73.4 111.55 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -35.93 73.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 65.2 111.194 -175.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -54.81 -53.22 58.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.816 -0.629 . . . . 75.24 111.609 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 6.0 mtmp? -81.81 -23.63 36.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.993 -0.549 . . . . 74.3 111.188 -172.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.494 ' O ' HD22 ' A' ' 42' ' ' LEU . 4.3 m-20 -52.06 -47.02 65.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.551 0.691 . . . . 70.25 109.221 171.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HZ ' ' HB2' ' A' ' 100' ' ' MET . 19.2 m-85 -77.08 -49.57 15.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.378 -0.828 . . . . 74.32 110.834 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -57.25 -35.64 69.99 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.694 0.628 . . . . 63.5 112.694 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 49.0 mt-10 -88.0 -15.32 36.78 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.062 -0.399 . . . . 73.21 111.314 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 38' ' ' ASN . 2.4 mm? -75.03 -20.87 59.4 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.031 -0.667 . . . . 73.31 109.299 164.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' HE1' ' A' ' 48' ' ' TYR . . . -74.52 -41.83 59.97 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.708 -0.678 . . . . 75.35 110.949 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.799 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 1.3 ptp180 -67.79 -27.36 66.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.754 0.311 . . . . 75.01 110.552 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.52 -39.17 77.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.687 -0.857 . . . . 73.02 108.687 172.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.89 15.42 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.633 -0.712 . . . . 74.24 111.477 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.584 ' HD2' ' HG3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -72.79 -20.08 61.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 53.32 110.512 -173.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.528 ' HE1' ' HA ' ' A' ' 43' ' ' ALA . 78.0 m-85 -62.53 -28.54 69.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.811 -0.632 . . . . 74.14 111.177 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 29.1 m-80 -72.73 91.0 1.44 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.963 0.887 . . . . 75.53 109.47 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.56 11.68 3.61 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 113.896 -1.502 . . . . 64.12 112.009 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 70.2 p -99.83 154.42 18.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 72.01 110.569 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -130.69 155.86 45.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.471 -0.331 . . . . 74.33 110.722 -176.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.8 m-85 -81.75 109.51 16.22 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.944 -0.762 . . . . 75.02 108.944 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 -37.96 12.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.106 -0.497 . . . . 73.44 111.676 -171.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 17.0 mmt180 -112.12 114.14 26.81 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 75.14 109.239 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.19 89.21 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.06 -0.718 . . . . 64.31 109.06 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -93.9 125.17 46.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.989 -0.745 . . . . 72.4 108.989 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 12.4 ptmm? -53.41 135.56 39.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.507 0.505 . . . . 75.34 110.946 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 42.68 37.01 0.91 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.213 0.946 . . . . 64.43 112.412 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' N ' ' HB2' ' A' ' 116' ' ' LEU . 2.7 m-85 -134.4 -80.44 0.45 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.066 -0.515 . . . . 73.54 111.398 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.46 155.83 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 75.12 111.065 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 20.8 mt -132.3 106.36 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 75.43 110.004 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' OE1' ' HG2' ' A' ' 55' ' ' ARG . 44.4 tt0 -83.81 128.77 34.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.06 -0.348 . . . . 73.14 110.06 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.67 132.84 7.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.64 -0.79 . . . . 62.53 112.592 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 152.81 -112.79 0.55 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.55 -0.833 . . . . 75.41 113.452 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 31.09 73.14 0.5 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 74.43 113.364 -170.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HG3' ' HD2' ' A' ' 47' ' ' TYR . 72.9 Cg_endo -78.84 -16.29 12.9 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.049 1.833 . . . . 71.13 111.543 174.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 p -105.18 -57.34 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.715 -0.675 . . . . 74.51 111.177 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.13 0.02 41.18 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.826 -0.702 . . . . 65.23 112.06 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.9 t -80.95 -6.78 59.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.293 0.568 . . . . 75.31 110.687 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.41 -25.51 26.72 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.624 -0.798 . . . . 65.33 112.55 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.21 -32.24 13.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 72.24 111.414 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -161.45 15.34 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.625 -0.797 . . . . 73.23 111.58 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.61 -84.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.02 -0.61 . . . . 73.33 112.101 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 60.73 39.37 17.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.225 0.536 . . . . 52.24 111.272 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m -55.78 -29.27 59.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.159 -0.928 . . . . 74.21 112.439 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 4' ' ' ILE . 7.9 tt -73.95 -41.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.207 0.447 . . . . 74.24 112.207 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' HD1' HG22 ' A' ' 77' ' ' ILE . 43.8 p90 -108.02 -8.69 15.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.338 -0.545 . . . . 75.52 112.215 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.12 -101.14 1.43 Allowed Glycine 0 C--N 1.329 0.169 0 C-N-CA 121.138 -0.553 . . . . 74.11 113.254 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -69.12 163.78 24.04 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.518 -0.549 . . . . 72.3 109.518 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.577 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 1.6 mp0 -58.75 174.06 0.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.683 0.754 . . . . 74.1 112.257 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -116.88 155.73 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.088 -0.96 . . . . 73.12 109.424 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.55 159.42 8.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.522 0.514 . . . . 75.0 110.555 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.528 0.68 . . . . 72.43 111.688 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -91.48 13.41 17.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.078 -0.965 . . . . 74.41 109.788 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.12 106.32 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.644 -0.707 . . . . 75.31 110.738 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -164.92 71.01 1.45 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 73.2 109.882 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -76.29 81.44 2.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.395 2.063 . . . . 75.01 113.094 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.96 -18.13 41.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.686 0.755 . . . . 75.24 109.793 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 2.9 pp -87.55 177.27 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.105 -0.952 . . . . 74.44 108.819 173.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.65 ' HD2' ' HA ' ' A' ' 192' ' ' HIS . 2.9 tmtm? -137.23 135.37 37.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.838 0.351 . . . . 75.12 110.425 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER -63.98 89.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.916 0.865 . . . . 73.12 109.977 173.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 193' ' ' VAL . 16.4 p -71.72 -51.01 25.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.602 -1.181 . . . . 74.15 111.083 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -147.85 -132.9 2.27 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.615 -0.802 . . . . 75.44 111.998 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.16 147.06 24.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.824 0.345 . . . . 45.35 110.852 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.446 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.2 20.98 8.3 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.751 -0.738 . . . . 53.22 111.582 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -87.05 111.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.387 -0.597 . . . . 71.25 109.387 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.715 HD22 HG21 ' A' ' 114' ' ' VAL . 3.1 tm? -88.15 118.74 27.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.721 -0.672 . . . . 71.44 109.809 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.63 173.83 9.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.005 -0.543 . . . . 54.34 111.512 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.514 ' HB2' ' HZ ' ' A' ' 39' ' ' PHE . 25.2 ttt -101.25 128.59 47.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.335 -0.848 . . . . 65.23 109.982 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -90.76 114.55 26.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.612 0.72 . . . . 71.33 110.991 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.462 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 3.9 p-10 -121.1 160.39 23.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.953 -1.021 . . . . 75.42 110.244 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.61 -25.31 16.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.152 -0.476 . . . . 62.21 110.832 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -152.75 -176.98 25.9 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.889 -1.285 . . . . 75.32 109.889 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.16 -53.72 5.98 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.338 2.692 . . . . 62.14 112.475 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.415 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 3.8 p30 -116.83 16.97 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.164 0.507 . . . . 73.33 110.671 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -92.73 53.55 2.06 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 75.32 108.261 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 106' ' ' ASP . 36.2 m-80 -87.04 107.81 18.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.641 -1.163 . . . . 74.22 110.281 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.88 -166.01 34.41 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.195 -0.762 . . . . 73.23 111.195 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m -100.22 67.12 1.35 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.908 -0.775 . . . . 72.23 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 69.2 mt-30 -124.83 147.76 48.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.111 -0.95 . . . . 72.44 110.174 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -120.4 155.81 32.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.427 -0.351 . . . . 71.24 110.919 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -153.76 141.74 20.26 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.111 -0.495 . . . . 75.23 110.37 168.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.715 HG21 HD22 ' A' ' 98' ' ' LEU . 15.9 t -110.94 142.43 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.602 -0.726 . . . . 74.54 109.424 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.58 127.04 41.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.382 . . . . 72.44 110.131 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 62' ' ' ILE . 65.3 mt -84.54 -9.03 58.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.773 -0.649 . . . . 71.53 109.859 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.0 157.7 31.96 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.107 -0.952 . . . . 71.51 109.556 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.412 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 27.5 Cg_exo -62.56 115.66 3.04 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.536 2.157 . . . . 52.53 112.264 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 p -105.77 106.92 17.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.006 0.431 . . . . 74.41 110.33 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp0? -97.34 20.71 11.13 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.381 0.61 . . . . 72.02 111.089 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.669 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -123.81 -1.77 8.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.314 -0.857 . . . . 75.31 110.337 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.669 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 97.9 mt -105.8 3.86 29.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.914 -0.584 . . . . 75.22 111.14 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.44 -23.68 67.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.455 -0.793 . . . . 74.42 111.134 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.29 18.4 7.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.686 -0.768 . . . . 70.21 111.504 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -115.49 -35.84 4.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.112 0.482 . . . . 73.35 109.708 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.462 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 54.0 m80 -141.59 132.66 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 74.53 109.093 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.7 t -74.78 147.14 41.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 64.31 110.302 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 99' ' ' ALA . 43.3 mt -123.97 119.57 57.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.004 -0.544 . . . . 75.4 110.388 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -156.32 72.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.447 . . . . 71.3 110.198 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -166.17 165.6 38.27 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.249 -0.74 . . . . 63.43 111.249 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -152.97 132.01 12.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 74.31 111.084 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 96' ' ' GLY . 5.2 p -79.94 144.6 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.856 . . . . 74.31 110.716 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.55 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 42.7 t -139.23 151.99 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.175 -0.466 . . . . 62.12 109.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.473 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.4 tt0 45.42 42.15 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.59 0.556 . . . . 73.41 111.893 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 27.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.206 -0.997 . . . . 62.22 112.397 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.407 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.3 tp -81.92 -31.19 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.898 -0.408 . . . . 75.41 109.898 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.85 91.72 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.786 -0.721 . . . . 74.2 111.39 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.552 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 69.8 mmm -68.28 -49.58 59.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.233 -0.284 . . . . 64.15 110.233 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.408 HG21 HG12 ' A' ' 23' ' ' ILE . 95.0 t -55.84 -30.53 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.251 0.548 . . . . 74.52 110.502 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.12 -52.62 22.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.717 -0.674 . . . . 74.42 110.709 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.3 OUTLIER -72.92 -14.73 61.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 74.45 111.481 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 138' ' ' MET . 63.6 t -89.95 -35.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.98 0.419 . . . . 74.11 110.492 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -81.33 -11.83 82.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 63.3 112.867 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 ptp -95.67 0.65 52.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.573 0.225 . . . . 75.25 111.235 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 142' ' ' VAL . 32.5 m -65.24 144.27 14.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.478 0.656 . . . . 74.24 111.958 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.79 -169.84 1.69 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.525 -0.761 . . . . 73.25 109.439 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.1 p -60.29 143.27 53.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.691 0.281 . . . . 71.44 110.97 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.94 -59.47 3.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.17 0.509 . . . . 73.41 110.512 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 24.5 m -157.39 158.94 36.84 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.691 -0.855 . . . . 64.45 108.691 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 52.05 25.6 3.29 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.235 0.457 . . . . 75.34 112.235 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.47 29.91 19.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.062 0.545 . . . . 75.54 111.891 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 149' ' ' SER . 5.5 ptm180 -98.79 130.66 27.23 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.073 -1.084 . . . . 75.34 108.073 171.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.83 144.96 75.07 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.397 2.065 . . . . 74.11 111.325 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 156' ' ' ASP . 79.8 t -52.36 -61.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 110.279 -0.267 . . . . 74.33 110.279 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.47 -43.08 0.52 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.007 0.817 . . . . 74.11 112.523 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 154' ' ' VAL . 28.4 t70 -78.88 64.45 3.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.601 0.715 . . . . 64.31 111.305 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -121.9 115.5 46.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.618 -1.253 . . . . 71.52 107.618 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 2.3 mppt? -128.48 156.01 43.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.027 -0.669 . . . . 73.14 111.877 -166.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.33 104.23 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.694 -1.139 . . . . 75.51 108.199 168.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.567 HG23 ' HD3' ' A' ' 161' ' ' LYS . 32.2 mm -69.37 -58.36 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 73.51 110.6 -174.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.592 ' HB3' ' HE1' ' A' ' 163' ' ' TYR . 3.9 mppt? -132.13 139.4 48.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.73 -0.668 . . . . 71.24 110.131 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 48' ' ' TYR . . . -138.92 127.3 22.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 75.24 110.69 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.592 ' HE1' ' HB3' ' A' ' 161' ' ' LYS . 42.6 m-85 -140.22 155.06 70.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.877 -0.786 . . . . 72.1 108.877 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.7 Cg_exo -71.86 138.28 31.18 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.709 1.606 . . . . 72.32 110.364 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.2 t -76.48 -40.42 50.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 73.02 111.152 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.73 -106.26 2.69 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.59 -0.814 . . . . 71.12 111.5 -177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.47 -55.8 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.663 -0.779 . . . . 73.41 111.771 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 102.92 2.48 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.943 -0.646 . . . . 70.23 111.773 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.0 72.27 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.852 -0.69 . . . . 62.1 111.876 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.9 t -111.45 -170.89 1.73 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.685 0.278 . . . . 73.13 110.259 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 115.68 98.38 2.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.013 -0.613 . . . . 74.24 112.021 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -94.06 73.87 1.12 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.815 -0.707 . . . . 51.55 111.784 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -85.47 47.65 3.86 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.132 -0.556 . . . . 71.34 112.663 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.9 m -107.0 103.4 12.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.816 -0.438 . . . . 74.52 109.816 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 136.08 -172.63 22.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.484 -0.647 . . . . 74.53 111.484 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.16 -72.25 1.4 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.288 -0.482 . . . . 62.41 112.667 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 166.93 -89.37 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.608 -0.597 . . . . 75.52 111.608 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.3 m -96.41 -36.19 10.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.213 0.53 . . . . 61.31 109.741 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.98 -170.51 41.96 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.058 -0.817 . . . . 72.53 111.058 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.82 47.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.267 -0.968 . . . . 65.0 112.712 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -162.35 178.05 38.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.753 -0.737 . . . . 72.31 111.823 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.5 m -117.12 -5.16 11.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 71.2 110.426 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.74 97.7 0.21 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.306 -1.118 . . . . 64.4 110.306 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -77.17 169.88 17.53 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.008 0.908 . . . . 74.44 111.857 -171.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 140.17 142.41 4.19 Favored Glycine 0 N--CA 1.426 -2.026 0 CA-C-N 113.82 -1.536 . . . . 73.22 111.263 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 172.06 54.1 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.691 -0.766 . . . . 63.41 111.656 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.777 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -66.36 148.59 51.64 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.848 -0.427 . . . . 62.03 109.848 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -80.1 107.18 6.29 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.372 -0.377 . . . . 73.32 110.185 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 5.3 Cg_exo -79.97 -5.84 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.762 2.308 . . . . 74.12 111.594 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.65 -22.29 60.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 74.22 110.446 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.0 pt -97.16 172.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.268 -0.641 . . . . 75.31 109.268 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.65 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 63.9 m170 -121.24 27.4 8.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 72.54 111.111 -175.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.0 p -111.87 167.22 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.936 -0.574 . . . . 74.22 110.144 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -89.22 108.68 19.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.924 0.392 . . . . 61.32 111.375 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -152.2 150.11 29.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.241 -0.651 . . . . 74.54 109.241 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -127.08 151.68 74.65 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.678 -0.237 . . . . 73.31 110.955 -173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.777 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 38.2 Cg_endo -66.38 -70.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.59 2.193 . . . . 75.14 111.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.428 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.9 pt? -114.99 16.41 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.033 0.444 . . . . 73.44 110.236 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.582 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 11.2 m-20 70.17 7.57 6.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.35 -0.841 . . . . 74.31 113.127 171.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.8 -31.18 71.38 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.884 0.327 . . . . 74.31 111.884 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.14 -1.14 87.6 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.808 -0.711 . . . . 50.12 112.907 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.582 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 69.8 mtp180 -80.98 -21.52 40.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 74.41 111.145 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.522 -0.763 . . . . 75.41 111.583 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.744 0.307 . . . . 73.24 110.707 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.91 137.61 54.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.677 -0.49 . . . . 71.41 109.677 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.57 84.26 6.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.686 -0.234 . . . . 61.35 111.528 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt 66.3 102.66 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 123.907 0.754 . . . . 74.42 112.364 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.02 116.48 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.223 1.949 . . . . 73.23 111.422 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.11 31.41 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.037 2.491 . . . . 73.22 112.125 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -77.67 108.03 10.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.724 . . . . 74.33 109.641 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.5 p -142.75 128.96 19.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 71.34 111.441 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -95.65 -1.61 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.539 . . . . 74.42 110.265 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' HG2' ' HB3' ' A' ' 44' ' ' ARG . 2.6 mp0 -59.26 147.62 74.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.43 -0.804 . . . . 72.45 111.343 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 13.3 Cg_exo -70.52 155.21 63.91 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.072 2.514 . . . . 73.4 112.161 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.5 -2.16 11.36 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.083 2.522 . . . . 74.34 112.886 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.548 HD22 HG12 ' A' ' 24' ' ' VAL . 24.5 t-20 -121.09 144.65 48.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.751 -0.659 . . . . 74.31 110.275 -175.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 164' ' ' PRO . 32.1 m -135.32 150.88 29.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.431 . . . . 71.51 111.05 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 28.3 m-85 -103.28 119.71 39.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.832 -0.622 . . . . 74.43 111.018 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.67 105.03 14.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.063 0.459 . . . . 65.42 110.797 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG2' HG12 ' A' ' 22' ' ' ILE . 37.3 mt-10 -90.0 118.23 29.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.965 -0.754 . . . . 73.25 108.965 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -108.34 178.15 4.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 73.01 111.106 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 160' ' ' ILE . 33.2 t -79.55 6.67 9.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.98 -0.554 . . . . 75.42 110.431 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.606 ' HG3' HG21 ' A' ' 142' ' ' VAL . 6.8 mmt -113.56 -38.28 4.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.918 -0.583 . . . . 74.15 110.171 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -178.01 -132.69 1.74 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.268 -0.733 . . . . 74.54 111.268 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -139.64 131.34 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.17 -0.678 . . . . 70.24 109.17 177.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.533 ' N ' HD11 ' A' ' 22' ' ' ILE . 4.1 mp -123.47 124.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.584 -0.735 . . . . 74.32 110.095 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.548 HG12 HD22 ' A' ' 13' ' ' ASN . 20.7 t -99.42 133.6 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.171 -0.677 . . . . 74.42 109.171 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 3.9 pp -142.04 161.86 36.94 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.502 -0.479 . . . . 74.14 110.859 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.51 166.07 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.903 -0.59 . . . . 73.15 109.57 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -107.49 161.28 14.98 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.094 -0.706 . . . . 74.35 109.094 178.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 131' ' ' ARG . 7.0 m-85 -84.62 97.04 9.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.668 0.747 . . . . 74.22 111.216 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 15.0 m95 -88.78 9.88 22.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.45 -1.315 . . . . 73.32 107.45 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 28' ' ' TYR . 28.6 mmmt -79.17 -55.0 5.42 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 113.413 -1.721 . . . . 74.13 110.603 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.85 1.75 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.177 0.436 . . . . 74.55 112.177 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.68 77.97 29.35 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.049 -0.26 . . . . 75.02 110.339 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 7.3 Cg_exo -73.8 -9.7 22.66 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.237 2.624 . . . . 63.32 113.164 -173.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -100.37 -51.99 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.31 0.576 . . . . 65.1 109.957 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.459 HG21 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -61.2 -39.77 91.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.95 -1.023 . . . . 74.55 111.574 -175.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 29' ' ' TRP . 26.0 p -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.325 -0.398 . . . . 75.24 110.767 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 10.4 mmmm -63.47 -41.07 98.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.626 -0.261 . . . . 73.55 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' O ' HD21 ' A' ' 42' ' ' LEU . 65.5 t30 -60.25 -47.84 84.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.358 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 11.3 t80 -65.24 -52.21 55.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.205 0.526 . . . . 74.33 110.131 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.17 81.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.294 -0.866 . . . . 73.54 112.181 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.645 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 44.3 mt-10 -77.53 -24.11 50.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.926 -0.309 . . . . 73.53 111.723 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 38' ' ' ASN . 2.9 mm? -74.4 -27.54 60.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.168 0.508 . . . . 74.22 109.878 171.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.94 -41.27 71.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 72.14 110.573 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.645 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 8.4 ppt_? -79.7 -15.36 57.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 73.34 110.768 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HD3' ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -74.92 -32.93 61.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.045 -0.724 . . . . 72.53 109.045 172.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.19 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.817 -0.706 . . . . 75.04 111.791 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HE1' ' HA3' ' A' ' 74' ' ' GLY . 6.2 t80 -76.63 -39.39 52.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.602 -0.299 . . . . 74.23 111.268 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -74.84 -15.51 60.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 75.31 112.162 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -76.3 90.65 3.19 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.725 0.774 . . . . 74.23 109.151 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.39 8.55 4.41 Favored Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.351 -1.295 . . . . 73.15 112.138 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -97.31 158.72 15.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.01 -0.367 . . . . 73.41 110.01 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -136.51 167.11 22.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.432 -0.507 . . . . 73.3 110.479 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 86.0 m-85 -83.35 118.87 23.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.943 -0.571 . . . . 74.23 109.548 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -92.3 -32.66 14.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.3 110.11 -172.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -121.72 120.86 35.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.961 -0.385 . . . . 72.11 109.961 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.484 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -131.82 95.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.083 -0.71 . . . . 72.42 109.083 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.625 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.6 mt -102.38 125.13 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.167 -0.469 . . . . 74.2 109.878 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -55.15 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.61 0.569 . . . . 74.33 110.945 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 41.15 44.16 2.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.4 1.062 . . . . 74.32 112.254 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -138.3 -81.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 72.15 110.056 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 ptp -160.96 156.9 25.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.688 -0.687 . . . . 74.53 110.307 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.484 HG23 HG13 ' A' ' 56' ' ' ILE . 37.4 mt -134.77 105.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 63.44 109.857 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.494 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.1 tm0? -84.48 128.71 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 74.52 110.181 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -124.97 147.88 16.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.13 -0.557 . . . . 72.12 112.61 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.27 -125.32 3.02 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.618 -0.593 . . . . 75.21 111.618 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.8 t0 42.15 84.08 0.19 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.947 0.899 . . . . 73.42 113.125 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 85.1 Cg_endo -79.17 -26.98 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.635 2.223 . . . . 72.34 111.729 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.479 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 20.1 p -84.11 -39.35 19.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.179 -0.919 . . . . 74.13 111.664 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.23 21.61 14.86 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.774 -0.931 . . . . 74.43 110.774 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.8 p -113.43 -24.88 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.534 . . . . 73.4 110.576 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.21 -13.46 65.78 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.659 -0.7 . . . . 75.45 111.832 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.31 15.51 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.18 0.514 . . . . 73.14 110.208 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.479 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -77.02 170.16 55.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.52 -0.763 . . . . 71.54 112.199 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.614 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . 69.43 -175.76 32.59 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.945 -0.645 . . . . 64.35 112.547 -175.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 56.3 19.75 4.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.236 0.614 . . . . 72.43 112.354 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m -84.26 -1.36 55.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.64 -0.709 . . . . 71.12 110.746 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.605 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.6 tt -61.75 -37.84 79.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.743 -0.662 . . . . 73.23 111.358 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.605 ' HD1' HG23 ' A' ' 77' ' ' ILE . 21.6 p90 -103.22 4.16 36.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.217 0.532 . . . . 73.45 110.957 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.82 -108.99 2.84 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.342 -0.845 . . . . 72.15 112.467 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -89.97 -166.15 1.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.752 0.31 . . . . 73.53 110.233 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.483 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -60.62 161.06 8.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.616 . . . . 75.33 109.772 171.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -100.5 -71.53 0.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 74.21 111.179 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.576 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 14.0 tp10 -151.19 -168.31 3.06 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.802 -1.555 . . . . 65.24 106.802 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.827 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 0.9 OUTLIER -136.55 119.54 16.42 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.606 -0.887 . . . . 72.12 108.606 162.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -100.37 29.65 4.27 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.378 -1.283 . . . . 74.52 110.486 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 31.3 mt -48.89 99.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.376 -0.829 . . . . 75.53 111.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -170.69 83.63 0.54 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.61 -1.177 . . . . 75.44 108.839 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.9 84.13 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.284 1.99 . . . . 73.54 111.337 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.94 -18.15 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.329 1.061 . . . . 62.03 108.873 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.672 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -104.16 165.61 10.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.332 -1.304 . . . . 74.54 108.79 172.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -119.3 144.37 46.85 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.426 -0.352 . . . . 75.1 110.143 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 120' ' ' GLN . 51.4 p90 -71.33 115.31 10.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 74.14 108.197 174.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.574 ' HG1' ' HB1' ' A' ' 187' ' ' ALA . 77.2 p -99.82 -30.83 11.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.832 -0.622 . . . . 71.33 110.104 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.42 -148.8 5.87 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.063 -0.971 . . . . 64.54 110.94 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.56 144.61 30.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.74 0.305 . . . . 62.55 111.02 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 111.58 22.93 5.87 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.812 -0.709 . . . . 75.23 111.993 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.9 mm -91.39 115.06 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.785 -0.366 . . . . 61.4 110.048 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.691 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 6.8 mt -83.1 124.78 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.233 -0.44 . . . . 74.4 111.115 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.82 171.73 13.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.103 0.478 . . . . 53.14 111.367 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.634 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 24.1 tpp -86.11 137.81 32.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.618 -0.719 . . . . 74.05 111.033 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 111' ' ' GLN . . . -92.75 113.46 25.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.451 0.644 . . . . 75.0 110.346 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.6 -169.58 3.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.002 -0.999 . . . . 73.2 109.03 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.54 -41.58 4.78 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.846 -0.342 . . . . 70.31 111.026 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.3 -55.23 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.504 -0.855 . . . . 75.44 112.474 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 77.51 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.022 1.814 . . . . 74.33 112.099 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.827 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 3.5 p-10 44.93 48.26 9.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.685 0.615 . . . . 74.42 112.13 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.44 29.82 7.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 75.24 111.082 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.634 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 23.6 p30 -93.67 161.78 14.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.965 0.412 . . . . 75.32 110.915 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.541 ' O ' ' HE3' ' A' ' 100' ' ' MET . . . -165.08 -118.21 0.43 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 52.12 112.284 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -105.4 16.92 24.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.377 0.608 . . . . 73.5 109.944 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 72.2 mm-40 -93.87 145.28 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 65.33 109.375 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -145.44 170.88 15.51 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.102 -0.373 . . . . 73.23 110.394 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 28.6 p90 -157.05 152.76 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.955 0.407 . . . . 74.44 111.042 173.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.473 HG23 ' CD2' ' A' ' 98' ' ' LEU . 15.4 t -107.14 146.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 75.05 109.757 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.6 p -100.14 124.26 45.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.875 -0.417 . . . . 72.55 109.875 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.481 HD11 ' HA3' ' A' ' 143' ' ' GLY . 73.9 mt -85.58 -8.14 58.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.709 -0.678 . . . . 74.43 111.117 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.631 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . . . -147.21 167.0 14.56 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.044 -0.526 . . . . 74.25 110.556 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' A' ' 117' ' ' ALA . 17.8 Cg_endo -60.35 113.08 1.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.804 2.336 . . . . 74.21 111.945 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.429 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 31.0 p -107.12 102.36 11.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 63.2 111.67 -175.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.8 OUTLIER -108.43 18.04 21.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.695 0.76 . . . . 75.42 109.921 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -113.86 -3.5 13.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.049 -0.978 . . . . 74.13 111.515 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.7 pp -125.98 9.57 7.51 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.514 -0.474 . . . . 75.02 112.111 -175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.51 -32.61 51.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.456 0.646 . . . . 71.15 111.225 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.79 22.75 8.56 Favored Glycine 0 CA--C 1.509 -0.339 0 CA-C-N 115.423 -0.808 . . . . 60.1 111.68 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.8 mmtm -114.7 -38.71 3.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.306 0.574 . . . . 72.13 109.496 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -137.1 129.45 29.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.39 -0.823 . . . . 73.35 108.956 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -75.25 144.97 42.3 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.047 -0.661 . . . . 74.12 109.568 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.42 ' O ' HD22 ' A' ' 90' ' ' LEU . 44.2 mt -115.35 125.42 72.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.945 -171.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.631 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.3 p90 -154.18 72.83 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.964 0.888 . . . . 73.43 110.895 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.691 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -165.58 160.15 33.49 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.923 -1.608 . . . . 71.44 114.326 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.1 mtm180 -141.87 126.35 17.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.498 . . . . 74.02 109.748 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 96' ' ' GLY . 11.0 p -91.42 136.13 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.274 0.559 . . . . 71.53 110.907 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 38.4 t -141.16 147.73 38.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.045 -0.525 . . . . 74.55 109.992 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.587 ' HG3' ' HA3' ' A' ' 183' ' ' GLY . 12.5 tt0 52.42 35.41 17.41 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.124 0.488 . . . . 73.21 112.158 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.48 27.83 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.28 -0.962 . . . . 53.35 112.734 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.465 HG23 ' CG ' ' A' ' 184' ' ' ASP . 9.7 tp -75.13 -38.71 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.721 -0.282 . . . . 75.12 110.299 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.66 -32.08 82.23 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.015 -0.612 . . . . 71.32 111.94 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.547 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 70.0 mmm -69.53 -52.0 30.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.962 -0.384 . . . . 74.13 109.962 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 23' ' ' ILE . 93.0 t -58.07 -29.69 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.143 0.497 . . . . 72.03 110.409 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.646 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -68.0 -55.61 11.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.882 -0.599 . . . . 73.12 109.975 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -14.92 61.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.176 -0.466 . . . . 72.12 111.288 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.705 HG11 HG22 ' A' ' 157' ' ' VAL . 30.4 t -78.61 -39.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.325 0.583 . . . . 75.35 109.544 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -80.49 -21.07 65.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.564 -0.827 . . . . 55.44 112.642 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 85.3 mtp -72.8 -17.03 61.61 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.945 0.35 . . . . 75.32 111.945 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 142' ' ' VAL . 34.4 m -92.96 128.36 44.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.63 . . . . 72.44 111.372 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 4.1 pt-20 -111.46 -60.07 1.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.529 -0.76 . . . . 74.51 110.873 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 2.9 p -122.78 153.83 39.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 75.52 111.536 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.941 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 54.8 t30 -75.66 -48.32 22.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.552 -0.749 . . . . 75.21 110.449 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 t -166.9 -57.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.183 -0.917 . . . . 72.22 109.14 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -90.85 -155.61 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.621 -0.718 . . . . 75.43 110.234 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -76.7 29.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.159 0.584 . . . . 75.33 112.482 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.1 ptp180 -135.55 142.61 41.74 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.733 0.301 . . . . 74.31 110.867 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 46.1 Cg_exo -57.44 152.24 48.33 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.753 2.302 . . . . 73.44 111.677 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.941 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 45.5 t -50.23 -69.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 123.577 0.548 . . . . 75.21 111.687 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -169.25 150.68 4.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.368 -0.975 . . . . 62.03 108.368 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.59 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 11.3 p-10 -77.12 114.38 15.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.922 -0.77 . . . . 74.24 108.922 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.705 HG22 HG11 ' A' ' 142' ' ' VAL . 40.9 t -74.13 126.26 34.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.559 -0.534 . . . . 73.13 109.559 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -125.96 158.88 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.278 0.561 . . . . 72.32 111.924 -176.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.403 HG21 ' HB1' ' A' ' 162' ' ' ALA . 4.1 mp -88.27 106.2 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.578 -1.192 . . . . 75.53 109.133 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 19' ' ' SER . 26.0 mm -71.67 -53.81 19.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.846 -0.616 . . . . 74.45 110.41 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.435 ' CD ' HG23 ' A' ' 160' ' ' ILE . 2.8 mptm? -129.9 137.98 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.726 -0.67 . . . . 72.41 109.843 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -146.06 110.23 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.019 0.437 . . . . 72.02 110.911 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.34 140.85 31.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.533 -0.758 . . . . 74.23 110.738 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.66 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 39.2 Cg_endo -67.8 135.24 34.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.604 2.203 . . . . 72.21 111.855 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.469 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 9.1 t -164.34 -173.1 2.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.206 -0.294 . . . . 72.14 110.206 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -92.62 98.73 2.44 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.918 -0.658 . . . . 71.35 112.489 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.5 ' HA2' ' OH ' ' A' ' 15' ' ' TYR . . . -97.59 109.29 3.8 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 62.34 112.154 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.63 166.09 31.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.95 -0.643 . . . . 70.32 112.224 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.75 142.08 14.03 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.847 -0.692 . . . . 62.02 111.978 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.8 m -87.49 110.06 20.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.954 0.406 . . . . 71.13 110.57 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.94 -144.99 18.17 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.869 -0.682 . . . . 41.03 111.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 163.58 -134.74 3.5 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.595 -0.812 . . . . 71.13 112.082 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -71.28 105.15 1.57 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.957 -0.639 . . . . 72.23 112.595 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.0 t -54.3 -49.64 69.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.739 0.304 . . . . 75.03 110.775 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.21 -88.41 0.14 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.575 -0.821 . . . . 54.25 112.559 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -116.15 28.13 7.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.04 -0.6 . . . . 74.34 111.849 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -165.75 166.98 38.86 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.44 -0.664 . . . . 65.52 111.44 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.5 p -78.16 129.31 35.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.96 0.41 . . . . 74.2 110.45 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.08 147.52 5.07 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.406 -0.677 . . . . 55.42 111.406 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.67 165.27 39.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.781 -0.723 . . . . 54.11 112.359 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 96.11 -165.43 24.09 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.613 -0.803 . . . . 72.43 111.711 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 m -154.47 121.5 5.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.92 0.39 . . . . 62.25 110.635 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.587 ' HA3' ' HG3' ' A' ' 134' ' ' GLN . . . 78.6 -91.79 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.915 -0.659 . . . . 64.42 113.4 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.465 ' CG ' HG23 ' A' ' 136' ' ' ILE . 0.6 OUTLIER -166.29 -163.43 0.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.73 -0.471 . . . . 72.03 109.73 -171.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.55 140.95 3.0 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.859 -0.686 . . . . 53.41 112.518 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -83.5 -163.0 34.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.424 -0.893 . . . . 71.22 112.049 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.668 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -78.07 160.67 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.801 0.334 . . . . 73.5 110.474 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.469 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.9 m-85 -106.82 100.04 29.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.47 . . . . 74.11 110.144 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.672 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.8 Cg_exo -76.81 -6.37 16.76 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.155 2.57 . . . . 75.02 113.0 -173.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -81.87 -29.92 32.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.511 -0.313 . . . . 73.33 111.057 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.0 pt -76.52 -19.01 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.991 0.367 . . . . 73.43 111.991 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 56.4 m170 67.63 48.43 1.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 74.05 111.916 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.45 HG13 HG13 ' A' ' 191' ' ' ILE . 7.3 p -152.34 141.33 14.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.494 -0.321 . . . . 74.1 110.267 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.64 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 74.11 111.704 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.429 ' NE2' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -163.37 136.5 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.737 -0.665 . . . . 74.24 109.339 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -109.1 146.84 34.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 75.33 111.292 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 36.0 Cg_endo -65.6 -62.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.806 2.337 . . . . 72.25 112.418 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.57 26.49 3.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.565 -0.289 . . . . 74.15 111.013 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 202' ' ' ARG . 71.5 m-20 68.31 12.58 8.8 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.266 -0.425 . . . . 71.53 111.708 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.6 ptm -60.5 -24.0 64.96 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.229 0.455 . . . . 72.14 112.229 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -114.45 18.15 18.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.593 -0.813 . . . . 72.43 112.327 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 29.0 mmt180 -66.56 -34.44 77.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 74.24 110.62 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.09 -0.957 . . . . 75.51 109.875 -177.197 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HE3' ' HG3' ' A' ' 6' ' ' PRO . 26.4 mmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.978 -0.378 . . . . 74.54 109.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.01 -59.24 2.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 74.42 110.649 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.57 155.56 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 72.42 109.648 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 58.0 mt 67.16 101.76 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 123.774 0.671 . . . . 74.12 110.683 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.07 131.02 12.69 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.73 2.286 . . . . 72.2 113.378 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.598 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 53.0 Cg_endo -70.89 168.5 22.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.621 2.214 . . . . 75.23 111.145 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.69 35.1 22.25 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.669 -0.493 . . . . 72.01 109.669 -173.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.797 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 1.4 m -54.83 115.37 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.374 -0.83 . . . . 74.14 110.805 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -82.55 9.23 9.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.454 -0.794 . . . . 75.12 112.76 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' CD ' ' HD2' ' A' ' 44' ' ' ARG . 2.2 mp0 -64.78 124.77 87.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.096 -0.502 . . . . 74.24 110.561 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 79.1 Cg_exo -50.0 149.29 11.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.418 2.745 . . . . 75.53 113.019 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 58.8 Cg_endo -70.99 -7.55 21.68 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.125 2.55 . . . . 63.13 113.289 -175.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -124.34 147.62 48.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.396 -0.594 . . . . 73.11 109.396 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 164' ' ' PRO . 27.9 m -129.09 146.82 33.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.056 -0.35 . . . . 75.02 110.056 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 46.2 p90 -107.29 128.23 54.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 74.35 110.374 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.13 99.43 8.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 75.42 109.993 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -87.75 115.12 24.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.725 -0.843 . . . . 73.1 108.725 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 177.01 4.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.433 0.635 . . . . 75.44 112.036 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -71.68 -10.34 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.227 -0.897 . . . . 71.12 110.456 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -98.84 -41.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.922 -0.581 . . . . 65.34 110.535 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.521 ' HA3' ' HE3' ' A' ' 138' ' ' MET . . . -176.48 -129.03 1.18 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.026 -0.83 . . . . 52.51 111.026 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -144.06 136.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.099 0.476 . . . . 75.44 110.188 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.474 HG12 HG23 ' A' ' 139' ' ' VAL . 5.2 mp -134.83 122.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.454 -0.794 . . . . 74.3 109.032 176.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 133' ' ' CYS . 3.6 m -102.87 150.99 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.933 -0.707 . . . . 74.05 110.152 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 HD23 ' HG ' ' A' ' 98' ' ' LEU . 4.3 pp -143.99 161.07 39.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.782 -0.645 . . . . 74.14 109.757 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HB2' ' HZ2' ' A' ' 29' ' ' TRP . 6.8 pt-20 -138.07 161.24 37.26 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.532 -0.758 . . . . 73.52 108.963 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 172.12 7.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.942 0.401 . . . . 74.34 110.489 -172.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.486 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 5.8 m-85 -91.61 96.2 10.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.407 0.622 . . . . 75.15 111.376 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.526 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -82.48 -5.25 58.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.056 -0.974 . . . . 74.12 110.439 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -68.31 -53.9 21.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.598 -0.728 . . . . 73.23 111.284 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -127.76 5.26 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 73.42 110.875 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.46 74.48 79.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.974 0.416 . . . . 74.4 110.699 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.19 -26.08 9.43 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.0 2.466 . . . . 75.31 112.737 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.51 -43.62 10.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.289 0.566 . . . . 74.41 109.908 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.461 HG21 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -59.79 -42.02 92.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 73.2 111.663 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.5 p -64.94 -33.34 75.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 72.34 111.538 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.797 ' HD2' ' HB2' ' A' ' 8' ' ' SER . 0.2 OUTLIER -78.14 -31.07 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.83 -0.348 . . . . 75.13 111.499 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.44 -44.29 94.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.799 -0.445 . . . . 74.23 109.799 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.45 ' HE1' HG22 ' A' ' 14' ' ' VAL . 18.0 t80 -63.97 -47.17 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.956 -0.565 . . . . 72.52 109.803 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.19 71.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 53.41 112.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.695 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 50.4 mm-40 -67.88 -29.3 68.38 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.696 0.284 . . . . 74.54 111.362 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 75' ' ' ALA . 1.2 mm? -69.53 -37.41 77.08 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.185 0.517 . . . . 75.23 110.27 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.66 76.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 74.02 111.016 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 8.7 ptm180 -67.95 -30.07 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.372 -0.376 . . . . 74.31 111.375 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HD2' ' HE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -67.18 -35.17 79.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.392 -0.596 . . . . 75.15 109.392 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.56 27.02 6.23 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.527 -0.844 . . . . 74.01 112.775 171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.442 ' HE1' ' HD2' ' A' ' 45' ' ' ARG . 14.9 m-85 -82.09 -29.82 31.59 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.794 -0.239 . . . . 53.51 111.518 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.0 -17.13 60.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.99 0.424 . . . . 73.42 110.574 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 40.3 m-80 -69.47 -11.32 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.471 . . . . 75.32 110.403 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -119.52 16.25 10.53 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.84 -0.695 . . . . 73.11 112.059 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.656 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.4 p -97.32 159.95 14.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 75.15 110.992 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.484 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -142.56 155.83 45.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.152 -0.477 . . . . 74.32 109.953 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.4 m-85 -84.29 126.41 33.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.597 . . . . 71.2 109.387 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.83 -13.99 6.26 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.776 -0.369 . . . . 74.01 111.892 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.877 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 25.7 mmt85 -121.71 101.06 7.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.57 -0.53 . . . . 71.44 109.57 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HG13 HG21 ' A' ' 62' ' ' ILE . 4.8 mp -122.43 92.17 2.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.84 -0.8 . . . . 75.41 108.84 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.5 mt -100.11 121.52 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.868 -0.605 . . . . 74.42 109.422 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -49.95 132.03 22.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.941 0.776 . . . . 74.01 110.726 177.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 44.41 40.05 3.56 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.171 0.919 . . . . 74.42 112.328 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.7 t80 -134.64 -81.98 0.44 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 71.33 110.382 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.585 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 27.1 ptt? -161.19 155.09 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 71.43 110.679 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' A' ' 116' ' ' LEU . 35.7 mt -125.16 101.66 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.916 -0.584 . . . . 74.44 109.973 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.877 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 21.1 mt-30 -86.05 123.04 30.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.014 -0.539 . . . . 71.45 111.296 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -129.97 137.61 9.65 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 65.51 112.111 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.656 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 157.63 -155.8 26.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.133 -1.032 . . . . 75.24 112.933 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.475 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 46.2 t0 56.4 89.81 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 124.082 0.953 . . . . 73.23 112.234 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 41.8 Cg_endo -69.73 -17.6 37.61 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.01 2.473 . . . . 74.12 112.14 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -97.64 -39.51 9.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.012 -0.54 . . . . 74.32 112.25 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.71 25.03 33.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.582 -0.818 . . . . 72.31 111.605 -174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 60.9 p -101.11 -16.88 16.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 71.31 110.943 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 -17.93 42.63 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.068 -0.969 . . . . 75.42 112.126 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 1.5 ptp180 -106.55 -33.96 7.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 71.52 110.784 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.475 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 87.48 -159.05 30.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.673 -0.775 . . . . 75.5 112.346 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 -114.04 1.01 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.479 -0.649 . . . . 74.4 111.479 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . 57.59 39.31 27.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.015 0.436 . . . . 73.45 112.162 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.2 t -109.41 21.69 16.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 64.02 109.575 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.0 pt -72.11 -21.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.042 -0.526 . . . . 74.35 111.043 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.476 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 5.2 p90 -106.77 5.45 28.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.512 0.672 . . . . 70.5 110.783 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.65 -117.51 4.66 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.272 -0.876 . . . . 52.23 111.738 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.56 -161.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.653 -0.869 . . . . 73.31 108.653 172.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -63.36 159.24 18.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 74.33 110.103 175.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.441 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 77.7 t80 -95.36 -67.67 0.84 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.061 -0.518 . . . . 74.31 111.253 -170.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -169.98 152.47 4.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 72.44 108.994 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.76 105.31 8.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.488 0.661 . . . . 73.35 109.245 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -101.68 21.96 13.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.808 -0.633 . . . . 71.52 109.586 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.68 97.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.987 . . . . 71.3 110.629 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -168.34 81.97 0.77 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.018 0.437 . . . . 74.14 109.836 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 51.5 Cg_endo -68.22 106.97 1.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.29 1.994 . . . . 73.24 111.74 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.53 -28.1 65.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.152 -1.055 . . . . 74.51 108.152 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.7 pp -84.21 178.5 7.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.88 -1.509 . . . . 74.54 109.337 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -141.1 167.2 22.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.586 -0.446 . . . . 72.55 109.925 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -63.51 123.16 18.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.163 0.506 . . . . 75.52 109.65 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.0 p -122.62 -40.78 2.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 74.53 110.573 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.42 -148.05 5.92 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.418 -0.81 . . . . 51.45 111.363 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.01 136.8 33.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.732 0.301 . . . . 72.52 110.73 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 116.98 20.07 5.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.85 -0.69 . . . . 61.12 112.208 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 189' ' ' PRO . 10.3 mm -86.64 111.66 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 74.43 109.37 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.686 HD23 HG21 ' A' ' 114' ' ' VAL . 3.2 tm? -87.85 122.89 32.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.148 0.499 . . . . 62.31 110.275 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 128' ' ' ILE . . . -132.07 167.06 20.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.729 -0.669 . . . . 75.12 110.178 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.486 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 34.6 ttp -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.563 -0.532 . . . . 72.2 109.563 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.29 162.36 13.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.99 0.424 . . . . 63.22 110.664 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.757 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.5 p-10 -158.71 162.91 37.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.02 -0.536 . . . . 75.14 110.61 -171.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.08 -19.45 18.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.787 0.803 . . . . 61.11 109.601 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.76 172.37 33.79 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.208 -1.557 . . . . 64.14 109.208 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.98 -44.66 36.27 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.003 2.469 . . . . 62.34 112.421 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.44 -17.6 20.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 64.52 111.108 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -84.12 47.34 1.31 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.519 0.676 . . . . 74.25 110.056 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.757 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 36.6 m-80 -64.33 129.87 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.727 -1.124 . . . . 74.1 108.944 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.24 -146.39 6.43 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.823 -1.18 . . . . 71.42 114.244 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 35.6 t -99.06 27.65 4.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.231 0.539 . . . . 72.21 110.095 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 70.9 mt-30 -118.73 152.09 36.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.789 -0.641 . . . . 72.22 109.888 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.1 p90 -140.46 170.31 16.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.225 -0.657 . . . . 73.42 109.225 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.484 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 p90 -156.95 150.1 23.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.239 0.542 . . . . 74.01 111.173 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.686 HG21 HD23 ' A' ' 98' ' ' LEU . 16.1 t -113.34 141.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 75.24 109.338 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.8 p -94.83 125.93 39.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.896 0.379 . . . . 71.0 110.301 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 34.0 mt -85.56 -7.53 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 71.44 110.228 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.64 159.75 40.36 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.183 -0.917 . . . . 75.34 109.65 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.32 114.62 3.69 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.389 2.06 . . . . 65.15 112.594 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -106.59 118.31 36.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 75.33 110.469 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.51 19.51 19.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 75.42 110.769 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.603 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -128.15 5.2 5.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.825 . . . . 74.45 111.015 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.2 mt -111.3 -1.81 15.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 75.53 111.461 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 10.2 p-10 -70.08 -10.13 57.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.113 0.482 . . . . 74.55 111.358 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.15 17.68 6.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 74.24 111.757 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -121.73 -28.0 4.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.032 0.444 . . . . 64.3 110.205 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.14 134.68 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 74.34 110.327 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -69.04 112.03 5.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.98 0.419 . . . . 63.33 110.272 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.499 HG23 ' HB3' ' A' ' 99' ' ' ALA . 39.2 mt -98.79 119.46 46.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.5 110.368 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 35' ' ' THR . 5.6 p90 -156.88 74.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.503 0.668 . . . . 75.33 110.672 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.685 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.6 157.84 29.88 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 118.98 -1.581 . . . . 55.43 114.257 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 190' ' ' GLU . 4.5 mtt180 -125.82 125.53 43.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.583 -0.895 . . . . 74.15 108.583 173.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.426 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.1 p -88.04 132.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.196 -0.602 . . . . 71.1 110.159 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.515 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 47.8 t -139.94 152.03 46.03 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.287 -0.258 . . . . 73.24 111.095 -176.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.74 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.0 pt20 41.67 35.23 0.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.545 1.138 . . . . 75.01 113.11 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.36 15.75 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.559 -0.829 . . . . 71.54 112.343 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.1 tp -72.28 -33.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.619 0.247 . . . . 61.22 110.626 -174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.49 -37.38 93.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.724 -0.751 . . . . 64.52 111.256 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.521 ' HE3' ' HA3' ' A' ' 21' ' ' GLY . 77.9 mmm -71.43 -49.46 41.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.285 -0.265 . . . . 73.41 110.285 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 23' ' ' ILE . 86.5 t -55.81 -30.59 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.998 0.428 . . . . 54.41 110.815 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.95 -51.14 27.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.014 -0.539 . . . . 74.04 110.566 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -76.29 -13.83 60.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.948 -0.569 . . . . 73.42 111.391 -177.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 145' ' ' VAL . 79.0 t -91.76 -27.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 71.14 109.895 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -93.35 -8.01 61.58 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.541 -0.838 . . . . 73.3 113.001 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.4 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 27.3 ptm -85.14 -11.14 55.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.798 0.333 . . . . 73.13 110.369 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 142' ' ' VAL . 28.9 m -80.17 162.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 73.5 110.77 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 14.2 pt-20 -142.63 -40.38 0.33 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.669 -0.696 . . . . 74.5 110.032 175.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 p -123.03 138.78 54.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.074 -0.512 . . . . 75.21 111.024 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 154' ' ' VAL . 25.9 p-10 -99.38 4.42 46.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.669 . . . . 73.13 109.549 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.577 ' HB3' ' CG ' ' A' ' 152' ' ' ARG . 35.4 t -163.68 -156.92 0.38 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.751 -1.113 . . . . 74.55 108.278 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -45.26 -62.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.428 0.899 . . . . 63.14 113.428 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.8 11.78 1.84 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.922 0.391 . . . . 74.52 111.182 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.577 ' CG ' ' HB3' ' A' ' 149' ' ' SER . 12.6 ptm180 -97.9 133.76 22.96 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.282 -0.417 . . . . 74.23 110.418 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 20.4 Cg_endo -60.46 146.94 95.86 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.998 2.465 . . . . 70.13 112.539 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.514 ' HA ' ' HB3' ' A' ' 148' ' ' ASN . 66.5 t -61.25 109.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 73.22 110.67 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.9 -22.8 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.643 -0.708 . . . . 73.33 110.804 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.12 84.36 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.3 0.572 . . . . 72.35 112.361 -172.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 22.2 t -139.15 122.91 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.019 -1.104 . . . . 74.32 108.019 169.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 2.6 mppt? -127.51 152.84 47.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.334 -0.546 . . . . 63.45 111.407 -167.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.438 HG23 ' HB1' ' A' ' 162' ' ' ALA . 4.0 mp -89.78 109.85 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.45 -0.944 . . . . 74.44 108.45 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.448 HG22 ' CD ' ' A' ' 161' ' ' LYS . 28.5 mm -76.65 -51.87 18.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.102 -0.499 . . . . 71.34 110.679 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.498 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -131.73 129.84 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.739 . . . . 71.14 110.084 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' A' ' 159' ' ' ILE . . . -140.99 110.8 6.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.939 0.4 . . . . 60.11 110.792 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.59 155.14 53.09 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.543 -0.753 . . . . 71.32 109.708 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.667 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.77 137.68 39.12 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.295 1.997 . . . . 75.44 111.332 175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.774 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 5.8 t -136.42 149.96 48.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.961 0.41 . . . . 73.53 110.884 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.41 154.52 20.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.872 -0.68 . . . . 73.02 111.711 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -146.02 95.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.804 -0.713 . . . . 53.31 112.012 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.3 137.25 14.85 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.728 -0.749 . . . . 71.13 112.142 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -101.51 150.99 18.58 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.776 -0.726 . . . . 64.23 112.005 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.4 t -149.86 129.72 13.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.826 -0.435 . . . . 72.1 109.826 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 143.32 141.21 3.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.874 -0.679 . . . . 72.54 112.091 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -137.26 88.09 0.22 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 64.55 112.309 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.44 144.19 13.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.888 -0.672 . . . . 71.44 112.292 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.2 t -74.97 -31.34 61.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.09 0.472 . . . . 71.45 109.764 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.41 -105.63 3.17 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.066 -0.588 . . . . 73.4 112.212 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.25 61.55 4.44 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.825 -0.703 . . . . 75.44 111.907 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.45 -176.4 29.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.187 -0.53 . . . . 74.11 111.983 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 22.5 m -139.34 155.92 47.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.696 0.284 . . . . 72.12 110.415 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.01 -121.73 7.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.333 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 102.49 -66.7 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.948 -0.644 . . . . 72.45 111.794 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.15 163.11 19.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.832 -0.699 . . . . 75.0 112.358 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.2 m -120.45 17.95 12.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.006 0.432 . . . . 74.25 110.361 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.77 -92.72 1.34 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.89 -0.672 . . . . 74.55 111.819 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.74 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.3 m-20 -126.93 172.57 10.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.349 0.595 . . . . 64.22 110.41 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 155.38 144.18 3.85 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.072 -0.967 . . . . 64.12 110.963 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -80.36 -166.55 34.59 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.242 -0.98 . . . . 73.24 112.395 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.611 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.34 175.51 9.68 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.586 -0.524 . . . . 63.14 109.586 177.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.37 102.45 53.13 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.856 0.36 . . . . 72.24 110.511 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' A' ' 97' ' ' ILE . 2.5 Cg_endo -79.69 -13.38 13.23 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.05 2.5 . . . . 74.14 111.065 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.486 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 26.1 tt0 -70.85 -35.16 72.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.016 -0.993 . . . . 74.04 109.773 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.8 pt -92.15 156.45 3.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.144 -1.058 . . . . 71.15 108.144 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -106.39 74.77 1.04 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.996 -0.682 . . . . 74.41 110.921 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.7 149.1 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.393 -0.821 . . . . 71.32 108.977 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.33 118.49 24.9 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.811 -0.356 . . . . 61.22 110.863 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.552 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -152.08 153.23 33.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.543 -0.54 . . . . 74.51 109.543 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 202' ' ' ARG . 62.6 m-85 -120.65 137.74 26.7 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.453 -0.34 . . . . 75.22 111.126 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.85 -55.87 0.95 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.967 2.445 . . . . 73.21 112.289 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 15.12 2.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.641 -0.254 . . . . 75.33 111.458 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 1.7 t70 61.91 80.84 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.472 1.13 . . . . 63.42 109.661 -170.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 13.1 ptm -129.96 -10.13 4.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.271 -1.331 . . . . 70.51 110.541 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -142.19 14.97 2.55 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.375 -0.917 . . . . 71.44 112.801 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.433 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 3.1 ptt180 -98.15 -34.81 10.6 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 119.373 -0.931 . . . . 75.43 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.7 mmpt? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.517 -0.754 . . . . 74.24 110.084 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.869 0.366 . . . . 72.3 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.52 105.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 73.41 109.715 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.9 153.66 22.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.424 -0.353 . . . . 73.13 110.736 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 16.3 mm 63.79 85.89 0.15 Allowed Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 124.043 0.839 . . . . 74.05 111.777 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -96.09 93.96 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.72 2.946 . . . . 75.23 110.944 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.589 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 14.1 Cg_exo -69.71 -46.06 1.39 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.957 2.438 . . . . 63.11 112.874 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.0 t70 63.47 20.42 12.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.034 0.921 . . . . 74.34 110.081 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.8 m -144.67 124.0 13.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.094 -0.957 . . . . 54.41 109.812 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -72.01 -59.26 2.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.144 -0.48 . . . . 75.33 110.262 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 73.03 151.58 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 124.023 0.827 . . . . 65.14 111.995 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.3 145.34 98.14 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.564 2.176 . . . . 73.25 111.531 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 38.5 Cg_endo -67.57 -7.5 19.48 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.885 2.39 . . . . 75.41 113.268 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.652 HD22 HG12 ' A' ' 24' ' ' VAL . 18.0 t-20 -133.16 141.41 48.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 73.21 110.731 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.4 m -131.08 157.01 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.116 -0.493 . . . . 54.13 109.973 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' HB2' HD11 ' A' ' 22' ' ' ILE . 23.7 p90 -121.03 138.82 53.99 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 74.03 110.638 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -114.77 103.68 11.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.627 -0.715 . . . . 65.34 109.754 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HA ' HG12 ' A' ' 22' ' ' ILE . 37.8 tt0 -88.13 114.65 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.304 -0.628 . . . . 74.13 109.304 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 HG13 ' A' ' 159' ' ' ILE . 59.3 p -104.04 177.06 4.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.312 -0.404 . . . . 73.05 110.696 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.42 ' HB2' HD13 ' A' ' 160' ' ' ILE . 27.7 t -71.23 -20.41 62.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.994 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 142' ' ' VAL . 79.8 mtp -95.01 -33.94 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.26 . . . . 70.52 110.937 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -171.17 -138.6 2.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.454 -0.879 . . . . 61.54 112.153 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.98 129.99 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.068 -0.716 . . . . 75.31 109.068 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -124.14 123.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.487 -0.778 . . . . 74.54 110.316 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.652 HG12 HD22 ' A' ' 13' ' ' ASN . 23.2 t -103.26 138.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.721 -0.474 . . . . 75.21 109.721 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD21 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.72 165.06 33.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 71.02 110.599 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 9.6 pt-20 -136.56 165.21 26.39 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.919 -0.582 . . . . 73.12 110.115 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.01 162.08 13.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.96 0.409 . . . . 74.4 110.504 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 4.0 m-85 -81.53 98.12 8.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.205 -0.452 . . . . 75.45 111.695 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.488 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 42.7 m95 -83.4 -3.72 57.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.117 -0.492 . . . . 75.44 110.594 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -78.84 -62.15 1.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 74.21 111.075 -175.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -125.5 18.76 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.571 -0.286 . . . . 74.54 111.76 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.7 ' HB1' ' HG1' ' A' ' 35' ' ' THR . . . -142.0 71.69 23.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 65.01 111.14 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.35 -44.3 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.992 2.461 . . . . 73.35 113.052 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 1.9 tpmt? -73.66 -36.1 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 65.11 110.543 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.7 ' HG1' ' HB1' ' A' ' 32' ' ' ALA . 14.5 p -68.95 -43.34 75.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.16 -0.473 . . . . 71.21 110.616 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' CE2' ' A' ' 29' ' ' TRP . 25.0 t -53.88 -50.83 65.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.457 -0.792 . . . . 73.44 110.78 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 10.3 mmpt? -60.37 -37.01 79.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 74.23 111.114 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.508 HD21 ' HD1' ' A' ' 39' ' ' PHE . 9.7 t30 -62.17 -56.17 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 74.32 110.323 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HD1' HD21 ' A' ' 38' ' ' ASN . 3.2 m-30 -66.12 -40.05 90.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 73.52 111.565 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.35 94.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.61 -0.268 . . . . 73.3 111.0 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.81 -48.91 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 75.45 111.773 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -65.25 -25.79 67.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.395 -0.522 . . . . 74.32 111.008 -179.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.79 -55.72 7.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.017 0.437 . . . . 74.24 110.778 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 44' ' ' ARG . 6.4 ppt_? -79.3 -28.3 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 74.12 112.24 -172.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -74.54 -52.9 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.875 0.369 . . . . 75.11 110.404 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.94 50.02 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.31 -0.948 . . . . 74.51 112.616 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' HB2' HD12 ' A' ' 42' ' ' LEU . 56.0 t80 -103.48 -51.44 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.793 -0.239 . . . . 75.02 111.091 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' HA ' ' CG2' ' A' ' 51' ' ' THR . 76.0 m-85 -68.49 -18.99 64.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 121.146 -0.222 . . . . 74.0 111.316 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -74.34 84.48 1.93 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.63 -0.878 . . . . 75.4 108.63 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.53 24.41 1.13 Allowed Glycine 0 C--N 1.301 -1.384 0 CA-C-N 113.979 -1.464 . . . . 73.23 111.77 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 48' ' ' TYR . 34.3 p -108.91 158.67 17.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.928 -0.397 . . . . 74.1 109.928 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 12.2 ptpt -138.39 158.12 44.89 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.783 0.325 . . . . 70.23 111.168 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 78.9 m-85 -84.04 121.66 27.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.412 -0.588 . . . . 72.54 109.412 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -96.52 -40.62 8.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.111 -0.495 . . . . 72.34 110.467 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -123.71 114.65 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.343 -0.243 . . . . 74.43 110.343 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -119.64 89.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.698 -0.853 . . . . 75.33 108.698 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.0 mt -96.56 120.8 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.911 -0.586 . . . . 73.12 110.164 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -53.65 129.12 31.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.723 -0.671 . . . . 70.44 111.003 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 58.28 26.76 14.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.262 -0.881 . . . . 72.01 111.852 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.616 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 1.1 t80 -128.92 -83.45 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.201 0.524 . . . . 74.23 110.469 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 27.3 ptt? -161.26 153.45 19.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.349 -0.841 . . . . 75.12 110.033 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.487 ' CD1' HD21 ' A' ' 116' ' ' LEU . 23.4 mt -119.42 99.76 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.12 -0.696 . . . . 72.53 109.12 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.899 -0.591 . . . . 72.24 110.247 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.06 151.2 20.65 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.941 -0.647 . . . . 74.2 112.191 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 51' ' ' THR . . . 156.25 -77.93 0.2 Allowed Glycine 0 C--O 1.219 -0.797 0 C-N-CA 119.642 -1.266 . . . . 75.31 114.027 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -45.91 108.65 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 122.155 0.979 . . . . 72.53 113.205 -165.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 59.7 Cg_endo -74.46 -14.6 22.48 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.539 2.826 . . . . 75.54 111.891 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.5 p -84.63 -28.76 26.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.952 -1.022 . . . . 63.54 111.381 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 2.98 90.7 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.401 -0.68 . . . . 55.32 111.401 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.6 p -88.34 -24.61 23.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.319 0.581 . . . . 75.54 110.574 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.5 -16.35 48.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.287 -0.87 . . . . 73.24 112.096 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -82.0 -48.12 11.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 75.34 110.245 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.575 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 98.09 -174.57 28.9 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.592 -0.731 . . . . 65.43 112.525 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.29 -93.49 0.86 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.393 -0.683 . . . . 74.3 111.393 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.59 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 61.36 43.31 10.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.652 0.739 . . . . 62.22 111.97 172.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -86.35 24.65 1.33 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.528 -0.76 . . . . 74.22 111.157 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 pt -100.26 -17.7 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.809 -0.356 . . . . 72.33 111.487 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.637 ' HH ' ' HA2' ' A' ' 109' ' ' GLY . 30.2 p90 -121.3 -22.6 5.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.483 -0.487 . . . . 74.4 111.999 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.79 -99.65 1.15 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.563 -0.827 . . . . 64.24 111.467 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 23.6 mtpt -78.88 161.9 26.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.968 -0.382 . . . . 75.11 109.968 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HG2' ' HA ' ' A' ' 107' ' ' THR . 1.2 mp0 -66.08 172.07 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.248 0.547 . . . . 74.53 111.281 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -95.92 -71.96 0.65 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.52 -0.764 . . . . 74.41 109.067 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 5.8 tp10 -169.27 172.01 7.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.494 -1.299 . . . . 73.34 107.494 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.473 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 13.1 p-10 -77.87 107.86 10.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 64.22 109.263 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.42 18.35 5.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 74.3 109.483 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.5 mt -57.04 102.07 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.815 -1.084 . . . . 73.41 110.269 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -157.18 75.38 4.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.552 -0.536 . . . . 65.44 109.552 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HG3' ' O ' ' A' ' 123' ' ' ASP . 37.0 Cg_endo -66.15 91.12 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.621 2.214 . . . . 75.52 112.221 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.28 -16.69 51.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.329 1.061 . . . . 74.44 108.917 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 189' ' ' PRO . 1.5 pp -93.8 175.61 6.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.417 -1.265 . . . . 74.21 110.217 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -131.01 146.31 52.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.212 -0.449 . . . . 75.4 109.886 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.604 ' HE2' ' HB3' ' A' ' 123' ' ' ASP . 96.2 m-85 -69.77 94.15 0.79 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.276 -0.638 . . . . 73.32 109.276 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 195' ' ' GLN . 39.1 p -81.99 -41.71 20.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.945 -1.025 . . . . 61.4 110.434 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.564 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.5 -131.94 1.36 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 31.54 111.645 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.21 143.28 28.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.764 0.316 . . . . 71.43 110.782 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 25.0 5.57 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.741 -0.742 . . . . 71.13 112.128 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.569 HD12 ' HB3' ' A' ' 189' ' ' PRO . 7.1 mm -86.45 110.0 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.237 -0.653 . . . . 74.45 109.237 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.745 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.8 tm? -87.19 113.01 22.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.202 -0.453 . . . . 71.31 110.058 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -127.12 171.23 11.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.923 -0.58 . . . . 75.42 110.589 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.491 ' SD ' ' HB ' ' A' ' 127' ' ' THR . 15.2 ptm -95.14 148.34 22.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.821 0.343 . . . . 71.21 110.146 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -94.92 124.82 39.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.028 0.442 . . . . 73.52 110.46 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.646 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -144.28 164.15 31.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 70.42 110.234 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.526 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -71.98 -44.87 62.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.99 -0.55 . . . . 62.52 110.53 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.28 -97.48 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.741 -0.742 . . . . 45.01 112.089 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.98 88.64 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.885 2.39 . . . . 75.1 112.145 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 53.51 12.54 0.38 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.688 1.195 . . . . 71.33 113.707 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.2 m -88.16 61.55 6.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.989 -0.745 . . . . 74.14 108.989 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.646 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.6 p30 -81.62 143.49 31.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.011 -0.995 . . . . 74.2 111.34 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.637 ' HA2' ' HH ' ' A' ' 78' ' ' TYR . . . -124.89 -172.27 13.47 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.519 -0.764 . . . . 61.43 112.033 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.562 ' OG ' ' HB3' ' A' ' 75' ' ' ALA . 15.9 p -88.44 3.85 48.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 70.34 110.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 77.4 mt-30 -80.75 159.09 25.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 73.43 110.236 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -139.77 169.36 17.87 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.896 -0.409 . . . . 74.33 109.896 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.71 146.82 25.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.116 0.484 . . . . 74.24 110.127 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.653 HG22 HD22 ' A' ' 98' ' ' LEU . 13.1 t -110.44 134.24 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.508 -0.769 . . . . 74.13 109.36 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 p -91.69 125.58 36.46 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.024 0.44 . . . . 75.43 110.323 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 62' ' ' ILE . 47.1 mt -81.54 -9.7 59.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 73.34 110.683 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.24 159.54 32.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.585 -0.734 . . . . 74.13 110.201 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.564 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 34.9 Cg_exo -60.56 122.85 11.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.732 2.288 . . . . 62.52 111.939 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.409 HG23 ' CZ2' ' A' ' 121' ' ' TRP . 3.5 p -127.76 89.15 2.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.227 0.537 . . . . 63.42 110.158 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.52 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.9 OUTLIER -93.22 24.19 3.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.875 0.845 . . . . 75.33 110.144 -166.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.665 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.3 p90 -116.56 -0.18 12.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.315 -1.311 . . . . 75.24 109.504 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.665 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 90.5 mt -108.19 1.05 21.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.368 -0.833 . . . . 72.01 110.796 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.604 ' HB3' ' HE2' ' A' ' 92' ' ' PHE . 16.9 p-10 -68.59 -15.87 63.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.374 -0.83 . . . . 75.24 111.276 -174.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 14.62 10.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.478 -0.868 . . . . 74.13 111.646 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -116.89 -37.24 3.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 73.33 110.546 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -133.27 130.28 38.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 65.45 110.088 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.491 ' HB ' ' SD ' ' A' ' 100' ' ' MET . 19.0 m -65.59 126.5 28.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 74.14 110.21 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.51 ' HB ' HD22 ' A' ' 90' ' ' LEU . 22.6 mt -107.27 127.96 62.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.47 -0.332 . . . . 75.35 110.347 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.616 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 22.7 p90 -159.47 70.83 0.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.521 0.677 . . . . 74.03 110.816 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.745 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.66 155.16 26.39 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.903 -1.141 . . . . 73.12 113.296 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -136.2 120.57 18.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.688 -0.486 . . . . 75.12 109.688 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.34 137.28 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.149 0.5 . . . . 75.4 110.892 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.59 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 35.4 t -144.83 149.33 35.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.052 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.8 tt0 47.64 52.48 12.52 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.403 0.62 . . . . 74.44 111.585 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.83 25.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.379 -0.915 . . . . 74.15 112.05 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.404 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -79.49 -30.94 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.822 -0.436 . . . . 75.33 109.822 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.22 88.89 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.799 -0.715 . . . . 73.53 111.439 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.561 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 54.3 mmm -71.96 -52.44 17.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.936 -0.394 . . . . 63.35 109.936 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.86 -32.04 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.175 0.512 . . . . 75.24 110.926 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.412 ' HB2' ' SD ' ' A' ' 200' ' ' MET . 1.8 t30 -71.4 -50.86 27.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.794 -0.639 . . . . 74.24 110.878 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.466 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.1 OUTLIER -77.87 -12.36 59.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 73.32 111.29 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.563 ' O ' HG22 ' A' ' 145' ' ' VAL . 70.2 t -91.32 -32.32 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.096 0.474 . . . . 63.43 110.434 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.29 -17.37 60.85 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.554 -0.832 . . . . 74.22 113.11 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.466 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.2 ptp -88.36 -13.16 41.34 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.594 -0.442 . . . . 65.2 111.347 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 142' ' ' VAL . 27.5 m -73.84 140.24 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.307 0.575 . . . . 75.12 110.814 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 7.6 pt-20 -128.45 -40.25 1.62 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.37 -0.832 . . . . 74.12 109.894 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 15.6 p -137.89 152.1 48.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.758 -0.655 . . . . 73.14 110.636 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.75 -67.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.883 0.327 . . . . 61.43 111.883 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.9 t -141.04 -8.32 1.03 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.064 0.459 . . . . 74.34 110.309 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' A' ' 147' ' ' THR . 23.0 mm-40 -130.07 -166.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.994 -0.743 . . . . 70.42 108.994 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 19.61 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.672 0.749 . . . . 74.32 110.272 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 5.8 ptm180 -106.13 131.97 21.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 74.14 109.767 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 43.5 Cg_exo -57.02 154.02 35.32 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.134 2.556 . . . . 75.34 112.985 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.3 t -64.02 157.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 73.15 110.358 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 156' ' ' ASP . 7.7 t70 -76.64 -166.27 0.64 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.759 0.314 . . . . 73.51 110.862 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.492 ' H ' ' CG ' ' A' ' 155' ' ' ASP . 31.2 t70 -73.43 113.28 10.35 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.949 0.499 . . . . 74.3 111.953 -173.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.85 133.36 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.295 -0.632 . . . . 75.44 109.295 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -144.52 166.77 24.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.91 -0.586 . . . . 74.32 111.677 -168.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 162' ' ' ALA . 3.7 mp -88.5 113.18 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.153 -0.93 . . . . 71.54 109.476 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.478 HG21 ' CD ' ' A' ' 161' ' ' LYS . 26.7 mm -75.56 -61.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.626 -0.716 . . . . 75.42 110.389 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.478 ' CD ' HG21 ' A' ' 160' ' ' ILE . 2.1 mptm? -124.95 131.18 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 73.33 110.103 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 159' ' ' ILE . . . -137.68 113.8 9.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.355 -0.384 . . . . 72.34 110.694 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -148.61 156.03 41.78 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 73.21 110.012 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 56.7 Cg_endo -70.33 134.62 27.18 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.19 1.927 . . . . 75.01 111.513 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 29.0 t -87.33 129.13 35.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.208 0.527 . . . . 74.43 110.731 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.07 11.68 29.17 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.439 -0.8 . . . . 65.42 112.151 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -142.02 -172.76 13.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.871 -0.681 . . . . 64.22 111.902 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -163.4 -109.14 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 75.43 112.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -169.37 137.76 4.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.872 -0.68 . . . . 72.11 112.191 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 m -75.19 -35.43 61.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.091 0.472 . . . . 70.05 110.639 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.49 157.45 28.61 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.118 -0.793 . . . . 74.55 111.118 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -167.51 175.39 42.53 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.476 -0.869 . . . . 70.51 112.309 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 86.12 -138.24 15.82 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.925 -0.655 . . . . 74.52 111.8 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 t -106.59 -32.33 8.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.683 -0.488 . . . . 64.52 109.683 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.97 -148.2 22.3 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.783 -0.723 . . . . 63.04 112.526 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.91 -34.55 5.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.01 -0.614 . . . . 63.01 111.864 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 177.54 -128.09 1.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.481 -0.648 . . . . 70.21 111.481 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 38.1 m -87.39 120.85 29.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.812 0.339 . . . . 63.14 110.109 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 128.63 61.75 0.11 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.709 -0.758 . . . . 73.34 112.051 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.6 145.43 11.88 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.885 -0.674 . . . . 64.14 112.041 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.72 -15.87 26.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.817 -0.706 . . . . 73.34 111.939 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 p -111.9 108.19 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.808 0.337 . . . . 74.13 110.647 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.44 -58.42 0.32 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.049 -0.596 . . . . 64.45 111.615 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -102.14 173.08 6.54 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.757 0.789 . . . . 63.23 110.842 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 141.31 148.05 5.0 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.3 -1.318 . . . . 61.41 111.458 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -84.67 -167.35 42.79 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.337 -0.935 . . . . 64.25 111.346 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.535 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -76.04 165.28 25.18 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.202 -0.666 . . . . 71.2 109.202 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -106.84 93.4 8.81 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.637 0.256 . . . . 72.21 110.562 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.689 ' HB2' HD11 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -71.94 -11.85 27.83 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.522 2.148 . . . . 74.4 112.685 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.424 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 41.4 tt0 -71.37 -38.36 71.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.399 0.618 . . . . 74.15 109.632 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.6 155.0 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.972 -1.121 . . . . 74.01 107.972 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.4 m170 -104.76 92.75 4.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.116 -0.634 . . . . 73.15 110.599 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.01 146.92 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.565 -0.743 . . . . 71.53 109.778 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.8 108.0 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.792 0.329 . . . . 53.22 111.171 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.582 ' HG2' ' HB ' ' A' ' 93' ' ' THR . 19.4 pt20 -139.34 141.53 37.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 74.4 110.745 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.469 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 27.6 m-85 -112.6 135.53 21.52 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 120.715 0.293 . . . . 74.43 110.83 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.9 Cg_endo -62.26 -65.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.97 2.447 . . . . 74.43 112.253 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -125.44 19.5 8.09 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.158 0.504 . . . . 75.1 110.078 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 71.18 8.88 6.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.057 -0.974 . . . . 65.13 113.198 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.412 ' SD ' ' HB2' ' A' ' 140' ' ' ASN . 25.1 ptt? -63.89 -29.09 70.3 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.808 -0.357 . . . . 75.4 111.463 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.21 -2.47 90.49 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.822 -0.704 . . . . 64.13 112.35 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.469 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 14.3 mtp180 -87.24 -61.17 1.78 Allowed 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 110.132 -0.321 . . . . 74.44 110.132 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt . . . . . 0 C--O 1.249 1.043 0 O-C-N 125.123 1.514 . . . . 75.3 112.78 -172.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.105 -0.331 . . . . 61.12 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.05 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.341 0.591 . . . . 73.33 110.231 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.91 147.66 35.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.247 -0.888 . . . . 73.22 109.617 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.1 mm 68.57 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.482 0.658 . . . . 64.51 110.736 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.59 140.11 46.48 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.647 2.231 . . . . 74.13 112.37 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.65 58.32 2.55 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.148 2.565 . . . . 65.43 112.2 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.59 -49.01 79.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 75.44 111.646 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.8 m -142.3 179.85 6.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.181 -0.463 . . . . 62.2 109.902 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 43.3 p90 -87.68 -22.87 24.41 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.155 -0.218 . . . . 74.14 110.475 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mp0 72.69 132.7 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 73.42 111.585 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.796 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 19.2 Cg_endo -59.64 151.61 68.59 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.236 2.624 . . . . 75.53 112.848 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.39 -11.75 9.38 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.194 2.596 . . . . 52.24 114.108 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.495 HD22 HG11 ' A' ' 24' ' ' VAL . 27.3 t-20 -131.22 148.49 52.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.639 0.257 . . . . 72.42 110.847 -171.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 28.5 m -132.75 147.37 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.138 0.494 . . . . 64.01 111.021 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 39.1 m-85 -105.09 118.96 37.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.68 -0.691 . . . . 73.4 110.528 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 mt -106.02 98.24 7.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.447 -0.342 . . . . 74.01 110.118 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.762 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 6.0 tt0 -89.79 113.06 24.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.457 -0.571 . . . . 72.4 109.457 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -105.47 178.11 4.65 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.068 -0.515 . . . . 63.51 111.09 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -73.75 -15.06 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 73.42 111.049 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.7 mmm -99.23 -32.73 11.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 72.53 110.923 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -178.43 -134.16 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.015 -0.612 . . . . 70.42 111.741 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.496 HD11 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.29 130.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.184 -0.672 . . . . 72.14 109.184 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.496 ' N ' HD11 ' A' ' 22' ' ' ILE . 3.9 mp -122.81 128.42 75.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.556 -0.747 . . . . 74.41 110.203 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 13' ' ' ASN . 46.2 t -110.74 141.77 25.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.226 -0.443 . . . . 64.24 110.232 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 HD23 ' HG ' ' A' ' 98' ' ' LEU . 4.4 pp -155.49 166.6 33.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.878 0.37 . . . . 75.21 111.035 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.37 173.49 10.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.589 -0.732 . . . . 75.32 109.575 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.425 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -111.95 161.18 16.7 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.41 -0.589 . . . . 73.34 109.41 176.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.747 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 5.2 m-85 -80.23 102.16 9.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.548 0.689 . . . . 73.25 112.482 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -82.73 -3.5 56.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.931 -1.031 . . . . 75.33 109.68 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 5.3 mptt -71.64 -57.37 4.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.329 -0.85 . . . . 73.4 111.176 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -136.9 21.49 3.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.055 0.391 . . . . 74.34 112.055 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 35' ' ' THR . . . -135.26 66.72 67.02 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 74.22 110.597 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.71 -51.27 4.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.883 2.389 . . . . 73.21 112.862 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -84.26 -25.63 29.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.741 -0.384 . . . . 75.21 110.243 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.7 -50.29 69.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.194 -0.669 . . . . 71.23 109.194 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 4.4 t -57.25 -43.99 83.46 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.427 -0.806 . . . . 62.41 110.28 172.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.609 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -59.95 -39.19 84.73 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.569 -0.741 . . . . 75.1 110.53 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -55.69 -50.49 70.15 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.899 0.381 . . . . 73.15 110.222 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.48 -42.75 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 74.54 111.164 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 10' ' ' GLN . . . -58.02 -43.44 86.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.011 0.434 . . . . 73.23 111.35 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -46.92 86.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 75.05 110.638 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 42' ' ' LEU . 34.4 mt -69.63 -30.48 68.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 64.31 111.764 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.64 67.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.95 -0.568 . . . . 74.33 111.084 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -74.95 -15.63 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.415 . . . . 74.12 110.346 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.51 ' HB2' HD12 ' A' ' 77' ' ' ILE . 23.5 tpt180 -77.67 -51.68 10.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.795 -0.639 . . . . 73.23 109.676 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.24 27.02 5.74 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.63 -0.714 . . . . 72.42 112.192 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.19 11.36 12.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 72.04 111.485 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.51 -14.75 18.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.751 0.31 . . . . 75.45 110.461 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 32.2 m-80 -80.64 99.28 8.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.94 0.876 . . . . 71.4 109.48 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.31 7.31 9.24 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 114.033 -1.439 . . . . 53.04 111.697 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.454 ' HB ' ' C ' ' A' ' 65' ' ' GLY . 81.9 p -88.84 165.4 14.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.555 0.217 . . . . 61.35 110.489 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.0 158.61 43.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 74.24 110.564 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.588 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 73.3 m-85 -80.6 133.65 35.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.4 0.619 . . . . 61.11 111.388 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.672 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 60.8 m80 -93.64 -56.75 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.966 -1.016 . . . . 74.24 110.507 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.3 mmm180 -114.88 112.72 23.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.852 -1.067 . . . . 74.24 109.805 -170.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.513 HG13 HG23 ' A' ' 62' ' ' ILE . 4.4 mp -123.11 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.756 -0.831 . . . . 74.13 108.756 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 25.6 mt -103.58 127.32 57.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.022 -0.536 . . . . 73.14 109.714 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -59.83 130.75 48.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.413 0.446 . . . . 75.14 111.096 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 54.1 31.65 14.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.282 -0.872 . . . . 71.42 111.417 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -130.71 -82.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.222 0.534 . . . . 74.43 110.301 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.669 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.7 ptm -160.5 155.83 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.54 -0.754 . . . . 75.31 110.603 -176.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 23.2 mt -132.97 101.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.765 -0.652 . . . . 72.41 109.742 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 50.4 tt0 -89.54 128.22 35.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.474 . . . . 75.0 110.986 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -131.14 160.16 23.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.87 -0.681 . . . . 70.1 112.613 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' C ' ' HB ' ' A' ' 51' ' ' THR . . . 137.77 -150.8 21.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 73.42 112.309 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.672 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 0.2 OUTLIER 68.08 96.02 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 112.954 0.724 . . . . 73.21 112.954 178.087 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.59 -17.56 11.17 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.244 1.962 . . . . 65.25 109.819 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.463 ' OG1' HG23 ' A' ' 70' ' ' THR . 3.0 p -92.25 -48.32 6.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.131 -1.395 . . . . 72.32 112.154 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.1 13.42 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.526 -0.63 . . . . 73.44 111.526 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 HG23 ' OG1' ' A' ' 68' ' ' THR . 4.0 t -112.39 -29.1 7.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 74.13 111.85 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.34 -21.86 9.82 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.372 -0.918 . . . . 74.1 112.839 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.33 -29.45 11.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 74.42 110.571 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.72 -169.04 15.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.55 -0.833 . . . . 53.41 113.361 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.33 36.9 2.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.332 -0.461 . . . . 71.12 112.725 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -76.26 59.5 1.39 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.545 0.688 . . . . 72.14 111.124 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -85.85 9.93 15.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.512 -0.767 . . . . 75.04 109.876 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 45' ' ' ARG . 3.0 tt -62.0 -38.6 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 75.11 110.117 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 13.04 22.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.723 0.773 . . . . 75.31 110.409 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -80.87 1.63 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.705 -1.134 . . . . 44.12 112.028 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -133.42 -179.85 5.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.968 0.413 . . . . 73.41 110.43 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.692 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -72.17 174.82 6.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.564 -0.744 . . . . 72.15 110.231 177.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.01 -64.4 1.31 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.391 0.615 . . . . 74.02 110.225 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -161.64 176.5 10.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.495 -1.298 . . . . 74.33 107.495 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.54 ' OD1' ' HG ' ' A' ' 86' ' ' LEU . 2.5 t0 -81.07 138.22 35.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.78 -0.768 . . . . 63.42 110.045 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -100.08 13.81 32.83 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.521 -0.763 . . . . 74.21 110.58 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.54 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 47.5 mt -51.54 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.694 0.621 . . . . 72.32 111.104 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -166.58 79.77 1.04 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.479 -0.782 . . . . 73.31 109.533 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.44 102.56 0.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.598 2.199 . . . . 64.34 112.078 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.94 -14.9 59.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.473 1.13 . . . . 71.3 108.917 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.3 pp -113.24 -174.92 2.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.251 -1.34 . . . . 75.52 109.545 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -141.28 166.38 24.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.963 -0.754 . . . . 72.2 108.963 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -63.9 123.37 18.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.441 0.639 . . . . 73.11 110.511 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.469 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 35.4 p -122.78 -44.81 2.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.528 -0.76 . . . . 74.02 110.005 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.5 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.75 -145.27 4.31 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.482 -0.781 . . . . 72.31 111.787 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.61 143.2 26.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.632 0.253 . . . . 71.04 110.923 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.77 22.0 6.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.589 -0.815 . . . . 74.44 111.894 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 189' ' ' PRO . 12.4 mm -84.37 111.33 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.642 . . . . 74.31 109.268 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.703 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.6 124.44 32.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.668 -0.493 . . . . 74.55 109.668 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.517 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -133.42 171.32 14.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.048 -0.524 . . . . 74.0 111.383 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.436 ' HE3' ' HB2' ' A' ' 108' ' ' ASN . 25.4 ttt -107.54 132.36 53.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.693 -0.685 . . . . 72.21 109.805 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -96.29 163.19 13.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.411 . . . . 74.31 110.147 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -158.76 164.75 35.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 72.22 109.723 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.53 58.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.118 0.485 . . . . 75.33 111.187 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 147.45 -136.54 6.13 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 120.858 -0.686 . . . . 73.34 111.875 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 18.2 Cg_endo -54.12 97.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 123.305 2.67 . . . . 63.13 111.811 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 3.2 p30 58.53 13.15 2.39 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.211 -1.359 . . . . 73.21 112.645 173.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.4 m -89.31 60.48 5.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.386 0.613 . . . . 74.54 109.369 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.436 ' HB2' ' HE3' ' A' ' 100' ' ' MET . 2.3 p30 -85.1 151.95 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.598 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.94 -110.07 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.976 -0.556 . . . . 63.45 112.124 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 79.8 p -123.48 61.33 1.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.75 0.786 . . . . 64.34 110.568 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 69.8 mm-40 -126.91 146.0 50.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.586 -1.188 . . . . 72.34 109.716 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -148.93 164.91 33.13 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.581 -0.525 . . . . 73.24 109.581 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.483 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 48.6 p90 -158.36 152.12 23.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 74.24 111.302 175.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.686 HG22 HD22 ' A' ' 98' ' ' LEU . 15.9 t -113.27 143.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.33 109.115 175.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.7 p -98.79 130.55 45.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.966 0.412 . . . . 75.12 110.28 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.462 HD13 ' HA3' ' A' ' 143' ' ' GLY . 55.3 mt -86.85 -5.5 59.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.721 -0.672 . . . . 74.33 110.651 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.95 163.52 25.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.697 -0.683 . . . . 73.15 110.135 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 21.5 Cg_exo -66.46 120.18 7.28 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.629 2.219 . . . . 74.41 112.074 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -104.68 156.56 17.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 73.42 111.617 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.95 12.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.256 0.551 . . . . 74.04 110.487 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -110.59 -11.03 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 74.13 112.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -129.85 -1.28 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.315 0.578 . . . . 75.04 111.149 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 -13.5 60.67 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.904 -1.044 . . . . 71.14 110.933 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.47 8.49 28.41 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.155 -0.778 . . . . 70.44 111.155 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -114.83 -23.4 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 74.21 109.159 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 100' ' ' MET . 86.0 m-70 -134.64 133.95 40.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.655 -1.157 . . . . 71.0 108.405 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -73.22 147.89 44.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.412 . . . . 71.23 110.52 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 99' ' ' ALA . 29.4 mt -125.16 122.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 73.33 110.62 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 35' ' ' THR . 6.7 p90 -159.58 74.25 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.59 0.71 . . . . 75.01 110.925 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.703 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.45 157.16 29.25 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.574 -1.298 . . . . 71.42 113.177 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -132.58 120.07 21.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.902 -0.406 . . . . 75.55 109.902 173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.6 p -82.73 137.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 73.0 110.582 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.528 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 43.7 t -141.25 153.09 45.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.366 -0.379 . . . . 73.13 110.508 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 2.8 pt20 40.4 39.42 0.7 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.508 1.123 . . . . 71.13 113.221 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.24 31.96 0.12 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.825 -0.702 . . . . 71.5 112.124 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.476 HG23 ' CG ' ' A' ' 184' ' ' ASP . 10.4 tp -83.79 -31.03 7.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 74.12 109.486 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.56 93.0 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.673 -0.694 . . . . 72.25 111.867 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.536 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 60.0 mmm -67.74 -50.63 56.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.641 -0.503 . . . . 75.11 109.641 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 62' ' ' ILE . 85.0 t -53.78 -32.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 75.33 110.833 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -72.82 -53.13 12.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.005 -0.543 . . . . 75.33 110.982 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.508 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.18 -14.1 60.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.113 -0.494 . . . . 73.42 111.186 -177.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 157' ' ' VAL . 51.4 t -88.73 -38.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.971 0.415 . . . . 74.25 110.294 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.53 -24.76 64.56 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.592 -0.813 . . . . 70.33 112.775 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.6 ptp -78.24 -16.91 57.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.824 -0.35 . . . . 70.44 111.539 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.1 m -95.28 114.71 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.643 0.735 . . . . 73.12 110.782 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -112.19 -53.74 2.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.37 -0.832 . . . . 73.35 110.063 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 6.6 p -130.83 145.41 51.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.642 -0.708 . . . . 52.11 109.996 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.524 ' OD1' ' HG3' ' A' ' 152' ' ' ARG . 25.2 p-10 -89.77 -12.32 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.592 -0.521 . . . . 73.41 109.592 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.736 ' HB3' ' HD2' ' A' ' 152' ' ' ARG . 9.8 t -170.01 -163.76 0.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.451 -0.795 . . . . 72.42 108.991 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.7 110.37 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.389 0.514 . . . . 74.35 112.389 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 48.92 49.19 19.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.287 -0.87 . . . . 75.41 112.69 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HD2' ' HB3' ' A' ' 149' ' ' SER . 9.9 ptp180 -148.13 112.7 3.84 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.476 -0.784 . . . . 74.41 109.141 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 71.8 Cg_endo -78.76 160.83 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.886 2.391 . . . . 73.52 113.74 -170.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.2 31.29 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.32 -0.855 . . . . 75.25 108.924 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.29 137.27 56.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.519 -0.764 . . . . 75.03 110.705 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 158' ' ' LYS . 18.9 t70 -174.87 -63.41 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.358 -0.837 . . . . 73.34 110.646 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.481 HG22 HG13 ' A' ' 142' ' ' VAL . 2.7 t -21.46 112.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 O-C-N 126.136 2.148 . . . . 74.52 114.068 -166.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -117.52 149.04 41.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.461 -1.245 . . . . 75.32 109.482 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.412 HD13 ' OG1' ' A' ' 51' ' ' THR . 3.9 mp -84.02 100.58 7.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.435 -0.95 . . . . 72.33 108.435 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.458 HG21 ' HD3' ' A' ' 161' ' ' LYS . 26.0 mm -70.9 -57.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.497 -0.774 . . . . 74.41 110.875 -174.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.762 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -136.24 126.65 26.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.358 0.599 . . . . 75.13 111.067 176.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -126.7 120.9 30.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.344 -0.844 . . . . 64.44 110.169 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -139.22 135.99 17.71 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.088 -0.506 . . . . 74.02 110.288 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.796 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 64.7 Cg_endo -75.83 131.93 13.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.503 2.136 . . . . 72.53 111.729 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.3 m -150.75 -174.75 4.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.451 -0.341 . . . . 73.12 110.622 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.76 130.3 10.11 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.789 -0.719 . . . . 64.01 112.039 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -167.88 -164.25 23.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.781 -0.723 . . . . 74.22 111.782 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.96 -143.78 15.9 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.878 -0.677 . . . . 60.42 111.736 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.32 42.36 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.557 -0.617 . . . . 73.31 111.557 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.3 m -144.78 151.4 38.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.836 0.318 . . . . 54.14 110.518 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.94 -119.54 0.73 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.713 -0.555 . . . . 74.44 111.713 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 132.47 -132.6 6.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.805 -0.712 . . . . 74.2 112.048 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.29 83.18 1.63 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.788 -0.72 . . . . 73.02 111.808 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.0 m -149.85 129.98 13.58 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.782 0.325 . . . . 75.42 110.24 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.97 -106.05 3.25 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.901 -0.666 . . . . 71.05 112.144 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -164.04 -84.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.848 -0.691 . . . . 71.41 112.085 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -89.53 -57.42 1.75 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.846 -0.692 . . . . 62.43 112.221 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.3 t -107.56 109.6 21.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 73.33 110.053 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.69 127.79 2.92 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.033 -0.603 . . . . 74.41 111.724 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.56 154.04 7.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 65.23 112.085 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.76 63.15 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.084 -0.579 . . . . 44.41 112.812 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.5 t -140.82 151.23 44.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.519 . . . . 65.53 109.6 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -91.26 -68.13 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.692 -0.766 . . . . 74.23 111.607 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.476 ' CG ' HG23 ' A' ' 136' ' ' ILE . 0.4 OUTLIER -101.32 -171.23 1.95 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 74.11 109.7 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 139.56 151.76 5.74 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.86 -0.686 . . . . 72.23 112.089 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.22 -166.54 42.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.618 -0.801 . . . . 71.14 111.814 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.84 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -79.83 168.1 19.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.881 0.372 . . . . 74.31 110.216 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.38 98.49 46.66 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.111 0.482 . . . . 74.42 110.457 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.648 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 72.8 Cg_endo -78.84 -9.55 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.736 2.291 . . . . 60.44 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.747 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 32.2 tt0 -75.08 -34.58 61.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.049 -0.978 . . . . 72.44 111.355 -174.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.5 pt -74.04 -19.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.106 -0.497 . . . . 73.51 111.273 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.8 m170 72.45 32.18 1.65 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.455 -0.793 . . . . 74.43 111.62 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.72 147.02 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.887 -0.597 . . . . 74.33 109.679 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.94 131.18 41.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.614 0.598 . . . . 52.31 112.614 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.66 157.52 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.933 -1.136 . . . . 74.15 107.933 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -121.18 150.01 52.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.766 -0.373 . . . . 72.33 111.404 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.84 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 40.7 Cg_endo -69.41 -76.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.597 2.198 . . . . 73.41 111.639 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.419 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -114.3 19.45 16.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 71.22 110.263 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 72.83 0.72 3.76 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.679 0.992 . . . . 75.34 113.679 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -61.41 -28.95 69.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.936 0.335 . . . . 73.3 111.402 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.85 -4.36 85.43 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.726 -0.75 . . . . 73.34 112.994 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -79.44 -35.29 40.69 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.902 0.382 . . . . 72.55 109.972 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-N 114.573 -1.194 . . . . 75.12 110.906 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.035 0.445 . . . . 62.52 110.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . . . -100.84 94.92 6.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.01 0.433 . . . . 73.43 111.504 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.57 -46.73 45.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 70.25 109.905 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.9 mt -131.01 88.23 46.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.395 -0.82 . . . . 74.24 109.667 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 90.0 Cg_endo -90.23 159.8 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.131 2.554 . . . . 75.34 112.643 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.45 96.02 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.238 1.959 . . . . 75.55 112.436 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.17 -74.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.859 -0.61 . . . . 71.21 110.174 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 m -99.03 -152.75 0.42 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.794 -0.817 . . . . 74.51 108.794 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.5 p90 -84.56 -20.91 30.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.019 -0.272 . . . . 75.34 110.643 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.61 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 2.8 mp0 65.49 143.55 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 115.583 -0.735 . . . . 72.4 111.824 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HG3' ' HB3' ' A' ' 164' ' ' PRO . 32.4 Cg_endo -63.29 127.19 19.43 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.816 2.344 . . . . 74.51 112.536 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.12 -20.31 19.23 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.44 112.557 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.445 HD22 HG13 ' A' ' 24' ' ' VAL . 26.9 t-20 -139.12 146.13 40.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 74.42 109.578 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 164' ' ' PRO . 26.8 m -139.9 163.53 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 74.14 111.716 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 165' ' ' SER . 34.9 m-85 -104.93 124.65 49.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.555 -0.748 . . . . 73.35 110.785 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.89 95.99 5.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.668 -0.493 . . . . 72.21 109.668 170.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -90.1 112.39 23.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.225 -0.657 . . . . 62.45 109.225 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -97.46 -179.72 4.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.011 0.434 . . . . 72.4 111.083 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.669 ' HG ' HD11 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -67.65 -29.74 69.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.775 -0.648 . . . . 72.13 110.545 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 142' ' ' VAL . 93.9 mtp -88.12 -34.69 17.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.591 . . . . 71.12 111.358 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -173.82 -133.28 1.66 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.689 -0.767 . . . . 71.22 111.915 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.0 tt -140.75 137.43 35.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.116 0.484 . . . . 73.25 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 126.78 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.826 -0.625 . . . . 65.21 109.821 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 13.3 t -105.91 142.04 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 71.43 109.723 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.65 164.08 36.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 73.31 110.933 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 10.2 pt-20 -130.95 165.21 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.568 -0.742 . . . . 73.34 109.765 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.01 157.74 16.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.234 -0.439 . . . . 75.33 109.923 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -79.82 103.44 9.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 72.42 111.969 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -81.81 0.84 37.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 75.32 110.891 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -70.31 -66.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.033 -0.531 . . . . 72.43 111.274 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 t-160 -126.51 9.91 7.21 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.729 -0.388 . . . . 73.3 111.034 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.73 65.38 72.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 121.078 -0.249 . . . . 72.21 111.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' C ' ' A' ' 31' ' ' HIS . 13.2 Cg_exo -69.85 -45.56 1.5 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.647 2.231 . . . . 74.23 112.196 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.39 -35.1 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 75.4 109.972 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.414 HG21 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -65.52 -46.19 80.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.673 -0.694 . . . . 72.45 110.199 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -55.08 -48.93 72.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.952 -0.567 . . . . 74.43 110.496 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -61.11 -36.0 78.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.806 -0.634 . . . . 73.14 110.935 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.35 -40.17 85.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 73.05 110.228 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.81 -47.56 58.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 74.52 109.792 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.51 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 63.31 111.78 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 51.2 mm-40 -60.35 -38.89 85.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.22 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 42' ' ' LEU . 30.7 mt -68.56 -30.46 69.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.889 0.376 . . . . 73.22 110.882 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.76 64.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 71.4 111.212 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -74.24 -29.1 61.54 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.775 -0.37 . . . . 75.53 111.244 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.4 -46.11 42.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.625 -0.509 . . . . 74.24 109.625 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.17 42.62 1.61 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.675 -0.774 . . . . 72.53 111.781 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -76.04 -27.91 57.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.249 0.547 . . . . 75.43 110.422 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.4 m-85 -78.2 -3.27 41.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.022 -0.535 . . . . 72.3 111.043 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -73.78 -0.64 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.098 0.475 . . . . 61.01 110.539 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.88 7.55 5.79 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.95 -0.568 . . . . 55.45 112.131 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 65' ' ' GLY . 35.3 p -88.02 149.45 23.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.353 . . . . 72.32 111.247 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 11.7 ptpt -139.39 157.41 45.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.197 -0.456 . . . . 72.25 110.59 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.548 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 80.9 m-85 -86.13 131.09 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.786 0.327 . . . . 72.33 110.356 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -109.93 -38.91 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 72.33 110.992 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 26.4 mmm180 -115.37 117.37 30.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.076 -0.342 . . . . 74.12 110.076 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 HG13 HG21 ' A' ' 62' ' ' ILE . 4.6 mp -131.23 94.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.94 -0.763 . . . . 75.03 108.94 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.748 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 36.9 mt -105.23 128.34 59.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.841 -0.618 . . . . 74.34 109.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.42 128.72 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.075 0.464 . . . . 74.3 111.13 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 203' ' ' LYS . 60.6 m-20 54.12 35.43 22.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.848 -1.069 . . . . 64.02 111.512 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.748 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 4.2 t80 -132.44 -82.39 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.989 0.424 . . . . 75.55 110.279 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 22.7 ptp -159.74 158.63 31.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 74.32 110.573 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.464 ' CD1' HD22 ' A' ' 116' ' ' LEU . 35.1 mt -130.22 100.28 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.622 -0.717 . . . . 70.3 109.419 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.57 127.71 34.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.333 -0.394 . . . . 73.34 110.494 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -139.18 149.58 20.77 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.616 -0.802 . . . . 73.31 112.335 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 51' ' ' THR . . . 151.14 -71.76 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.926 -1.13 . . . . 71.43 113.524 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.425 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 32.0 t0 -42.86 105.91 0.45 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.899 0.703 . . . . 74.21 112.899 -168.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 97.6 Cg_endo -86.2 -18.52 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.315 2.676 . . . . 74.44 111.54 176.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.403 ' HB ' HG23 ' A' ' 70' ' ' THR . 77.6 p -89.62 -32.7 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.309 -0.86 . . . . 74.34 111.371 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 31.64 59.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.832 -0.907 . . . . 74.33 110.832 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.507 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 64.3 p -102.88 -30.55 10.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 71.21 111.056 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.34 -3.31 23.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.299 -0.864 . . . . 74.14 112.085 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.507 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -119.12 -31.34 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.647 0.26 . . . . 74.52 111.277 178.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 95.39 -169.65 27.81 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.809 -0.71 . . . . 74.13 112.797 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.88 -105.52 2.29 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.26 -0.495 . . . . 52.33 112.246 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 44.77 48.96 8.98 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 74.3 112.645 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.44 12.71 2.83 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.021 -0.536 . . . . 75.52 110.919 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.6 -20.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.737 0.303 . . . . 75.54 110.611 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.42 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 16.0 p90 -101.2 -2.01 32.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.167 0.508 . . . . 74.33 111.143 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.42 1.4 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 55.42 113.125 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.32 -168.05 1.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.841 0.353 . . . . 75.14 111.251 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.2 173.87 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 73.53 111.886 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 89.7 m-85 -139.67 -162.02 1.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.897 -1.047 . . . . 75.23 108.965 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.82 159.29 34.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.606 -0.516 . . . . 73.23 109.606 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -61.35 136.28 57.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.609 -0.515 . . . . 73.32 109.609 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.07 16.53 25.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 73.13 110.714 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.4 mt -71.8 96.81 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.147 0.499 . . . . 74.31 111.958 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.48 78.48 6.96 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.715 -0.675 . . . . 73.21 111.031 173.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 89.33 0.55 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.593 2.195 . . . . 74.55 112.428 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.22 10.76 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 71.3 110.544 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -122.98 -175.72 3.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.232 -0.895 . . . . 71.54 109.846 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -124.77 144.26 50.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.627 0.251 . . . . 65.15 110.827 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 68.34 0.63 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.637 0.732 . . . . 75.44 109.888 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.1 p -65.53 -39.39 91.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.159 -0.928 . . . . 74.32 112.066 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.608 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -170.42 -137.03 2.19 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.372 -0.918 . . . . 44.43 112.538 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.71 140.61 30.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.617 0.246 . . . . 60.52 110.741 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.25 24.32 5.73 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.774 -0.727 . . . . 61.11 111.775 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.8 mm -88.39 109.79 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.441 -0.577 . . . . 74.45 109.441 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.48 119.69 26.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.562 -0.532 . . . . 75.42 109.562 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 128' ' ' ILE . . . -131.7 174.24 10.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 74.51 111.478 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.816 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 28.2 ttt -106.93 142.32 36.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.729 -0.669 . . . . 75.43 109.907 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -103.79 118.16 36.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.527 0.68 . . . . 70.12 111.095 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.639 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.8 p-10 -115.47 165.74 12.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.998 -1.001 . . . . 71.31 109.964 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.5 -37.38 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.862 0.839 . . . . 64.12 109.19 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -138.83 174.49 22.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 108.644 -1.782 . . . . 74.3 108.644 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.57 -49.61 11.73 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.073 2.515 . . . . 75.04 112.811 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.57 -11.1 19.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.521 -0.308 . . . . 72.53 111.275 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.1 m -86.14 55.46 3.55 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.667 -0.864 . . . . 75.11 108.667 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 38.6 m-80 -62.15 117.22 5.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.356 -1.293 . . . . 72.43 109.505 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.462 ' H ' ' HA ' ' A' ' 102' ' ' ASN . . . -90.95 -168.16 41.82 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 73.01 112.672 -172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -99.46 20.27 14.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.42 0.628 . . . . 64.45 110.094 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 17.4 mt-30 -109.89 159.04 17.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.478 -0.783 . . . . 75.35 110.77 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -139.89 174.17 10.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.665 . . . . 74.0 109.203 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.08 154.69 24.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 73.23 111.692 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.665 HG23 HD22 ' A' ' 98' ' ' LEU . 16.0 t -113.22 145.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.274 -0.876 . . . . 74.21 109.23 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 p -100.94 131.1 46.97 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.062 0.458 . . . . 55.1 110.459 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.495 ' CD1' ' HA3' ' A' ' 143' ' ' GLY . 59.8 mt -89.2 -5.39 57.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 62.33 110.994 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.39 164.22 21.9 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.756 -0.656 . . . . 74.11 109.849 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.608 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 38.9 Cg_exo -61.06 107.04 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.464 2.109 . . . . 61.21 111.887 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.533 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 23.4 p -96.37 96.89 9.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.81 -0.632 . . . . 63.24 111.02 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.02 9.9 42.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.57 0.7 . . . . 75.43 110.471 -176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.441 ' CZ2' HG21 ' A' ' 119' ' ' THR . 2.2 p90 -108.57 -12.42 14.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.77 -1.105 . . . . 75.3 111.591 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.533 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 3.3 pp -114.91 9.8 16.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 75.05 111.342 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.85 -34.37 65.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.465 -0.789 . . . . 73.14 110.885 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.39 15.36 30.03 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.524 -0.762 . . . . 73.31 112.033 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.59 -35.93 5.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.075 0.464 . . . . 72.32 110.078 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -140.82 139.4 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.796 -0.638 . . . . 73.51 109.671 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -77.68 148.71 34.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.156 0.503 . . . . 72.11 110.446 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.499 HG22 ' HB3' ' A' ' 99' ' ' ALA . 45.1 mt -126.88 122.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.59 . . . . 75.43 110.555 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.816 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.4 p90 -153.93 72.94 0.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.685 0.755 . . . . 71.34 111.212 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.08 152.24 22.27 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.557 -1.306 . . . . 73.42 113.676 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 74.0 mtp180 -130.14 117.22 19.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.218 -0.66 . . . . 55.2 109.218 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.44 135.34 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.051 0.453 . . . . 74.53 110.385 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.631 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 51.3 t -143.65 145.01 32.14 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.26 -0.427 . . . . 73.53 110.096 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.66 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.7 tt0 50.92 40.69 25.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.354 0.597 . . . . 73.22 111.85 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.62 24.82 0.1 OUTLIER Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.143 -1.027 . . . . 62.04 112.152 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.41 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.5 tp -78.61 -32.32 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.088 -0.245 . . . . 75.23 110.478 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.35 94.4 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.155 -0.778 . . . . 72.42 111.155 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.584 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 72.1 mmm -68.09 -55.64 11.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.145 -0.317 . . . . 74.41 110.145 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.1 t -51.57 -31.25 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.218 0.532 . . . . 72.32 110.644 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.6 t30 -70.11 -56.79 5.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.713 -0.676 . . . . 72.31 110.538 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.474 ' HD2' ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -72.62 -15.64 61.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.767 0.318 . . . . 72.41 111.261 -177.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.658 HG22 ' SD ' ' A' ' 20' ' ' MET . 75.3 t -79.73 -43.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.369 -0.604 . . . . 70.43 109.369 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -76.48 -25.86 64.64 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.417 -0.897 . . . . 73.0 112.549 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 77.7 mtp -73.53 -11.27 60.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.76 0.282 . . . . 74.43 111.76 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.66 117.02 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.561 0.696 . . . . 75.35 111.243 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.51 -92.3 0.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.605 -0.725 . . . . 71.34 110.282 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.0 p -117.01 149.37 40.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.93 -0.577 . . . . 73.52 109.691 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -83.75 -147.04 0.09 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.261 -0.274 . . . . 64.31 110.261 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.5 t -60.67 -32.97 72.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 63.32 110.234 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -97.14 171.93 8.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.311 -0.626 . . . . 74.14 109.311 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.36 63.59 7.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.053 0.93 . . . . 72.45 109.718 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -137.91 143.51 40.2 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.528 -1.215 . . . . 64.34 109.05 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.39 129.56 33.31 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.289 1.993 . . . . 75.4 111.497 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.3 t -53.85 -45.01 62.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.06 -0.518 . . . . 74.43 110.599 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.65 128.7 23.68 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.485 -0.561 . . . . 75.41 109.485 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.17 88.15 6.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.46 . . . . 75.14 109.941 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.52 126.97 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.78 0.8 . . . . 74.22 111.697 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.67 172.97 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.165 -0.925 . . . . 71.34 109.276 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 159' ' ' ILE . 3.3 mp -89.52 105.01 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.728 -0.841 . . . . 75.05 108.728 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.669 HD11 ' HG ' ' A' ' 19' ' ' SER . 22.7 mm -73.92 -48.22 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.364 -0.835 . . . . 55.43 110.989 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.554 ' HD3' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -131.86 126.08 33.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.944 -0.571 . . . . 74.54 110.828 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.16 122.82 30.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.0 0.429 . . . . 70.2 110.566 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -155.91 150.87 20.75 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.842 -0.617 . . . . 75.42 110.268 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 14' ' ' VAL . 54.7 Cg_endo -70.86 134.25 25.26 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.638 2.226 . . . . 74.53 112.887 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.6 p -81.93 -46.47 13.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 74.13 109.934 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.16 -76.92 1.0 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.544 -0.753 . . . . 73.02 111.774 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.32 57.56 1.02 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.76 -0.733 . . . . 74.15 112.634 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.2 24.11 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.099 -0.801 . . . . 71.42 111.099 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.51 157.72 25.45 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.024 -1.084 . . . . 72.44 112.891 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.5 t -155.81 140.43 16.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.294 -0.632 . . . . 63.33 109.294 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.62 135.7 2.59 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.647 -0.787 . . . . 73.22 112.001 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 118.59 -146.2 18.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.91 -0.662 . . . . 75.32 111.909 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 181' ' ' GLY . . . 82.33 47.05 6.23 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.977 -0.63 . . . . 74.51 112.651 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 m -82.34 90.93 6.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.976 -0.379 . . . . 72.24 109.976 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -137.83 103.09 0.4 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.651 -0.785 . . . . 72.21 112.722 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.13 -156.36 48.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.079 -0.581 . . . . 73.42 112.915 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -106.18 1.8 37.81 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.011 -0.614 . . . . 65.44 112.197 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.2 t -158.15 154.84 28.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.827 -0.434 . . . . 72.34 109.827 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.16 -71.14 0.2 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.931 -0.652 . . . . 63.54 111.594 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.56 -161.16 46.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.672 . . . . 75.34 112.528 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -144.86 51.24 0.62 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.862 -0.685 . . . . 62.24 111.855 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 33.8 t -131.95 111.74 11.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.931 -0.396 . . . . 70.42 109.931 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.67 -80.78 0.29 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.82 -0.705 . . . . 71.14 111.663 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.6 m-20 -126.18 170.65 11.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.275 0.559 . . . . 71.13 110.443 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.54 146.93 4.47 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.228 -0.896 . . . . 71.32 111.306 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -84.59 -166.61 41.55 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.373 -0.918 . . . . 62.11 111.929 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.653 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -74.9 170.86 15.1 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.741 0.305 . . . . 64.14 110.271 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -111.14 93.17 17.21 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-O 121.153 0.501 . . . . 72.21 110.449 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 6.0 Cg_exo -76.36 -13.56 18.62 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.888 2.392 . . . . 74.13 111.715 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.24 -34.79 42.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.902 -1.045 . . . . 74.32 111.072 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.444 HG13 HG11 ' A' ' 193' ' ' VAL . 31.3 pt -80.31 -11.7 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 75.12 111.428 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 32.5 m170 61.04 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.416 -0.811 . . . . 72.02 111.321 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 191' ' ' ILE . 6.4 p -164.21 152.95 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.059 -0.349 . . . . 72.21 110.059 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.14 113.97 14.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 75.32 111.911 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -161.94 157.32 23.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 73.25 109.625 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -124.02 156.35 66.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.503 -0.317 . . . . 72.33 110.726 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.653 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 49.0 Cg_endo -69.34 -69.7 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.478 2.119 . . . . 72.52 112.272 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.429 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.6 pt? -120.25 23.57 10.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 72.4 109.95 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 68.56 13.92 9.0 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.226 -0.897 . . . . 72.34 111.846 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.6 ptm -52.24 -46.04 65.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 70.23 112.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 -2.15 90.11 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.745 -0.74 . . . . 72.11 113.141 -175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -80.02 -26.5 39.77 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.374 0.607 . . . . 73.41 110.206 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.69 ' HB3' ' HZ2' ' A' ' 203' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-N 114.9 -1.045 . . . . 74.5 109.927 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.556 0.217 . . . . 74.15 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.17 129.71 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.637 0.256 . . . . 74.42 111.062 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.88 -59.09 2.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.007 0.432 . . . . 53.31 110.353 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 78' ' ' TYR . 74.6 mt -134.65 102.34 11.49 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.702 -0.681 . . . . 73.42 110.556 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -87.04 113.91 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.03 2.487 . . . . 75.13 111.366 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.92 142.26 46.75 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.501 2.134 . . . . 74.24 112.255 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -87.62 10.99 16.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 64.54 111.283 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.0 p 61.61 -68.75 0.05 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.82 1.248 . . . . 65.0 112.417 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -65.69 119.81 11.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.832 0.348 . . . . 74.04 110.377 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.92 109.0 56.81 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 109.173 -0.677 . . . . 71.44 109.173 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.905 ' HB3' ' HB3' ' A' ' 164' ' ' PRO . 4.7 Cg_endo -49.24 112.04 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.442 2.762 . . . . 73.02 113.146 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.82 -31.51 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.894 2.396 . . . . 74.42 111.304 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.23 139.84 30.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.144 -0.935 . . . . 63.34 109.329 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 164' ' ' PRO . 24.6 m -135.89 165.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.539 -0.3 . . . . 71.24 110.617 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.569 ' HB2' HD11 ' A' ' 22' ' ' ILE . 38.5 p90 -124.13 134.11 53.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.167 0.508 . . . . 73.22 110.61 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.16 111.12 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 74.45 110.451 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 7.1 tp10 -85.67 112.09 20.69 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.383 -0.969 . . . . 71.03 108.383 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -105.0 -179.8 4.05 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.066 0.46 . . . . 62.3 111.263 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.536 ' HG ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -80.53 -1.48 42.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 70.14 111.035 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.596 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.0 mmt -108.32 -44.89 4.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 73.54 109.95 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -171.6 -140.9 3.19 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.592 -1.003 . . . . 65.42 110.592 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -133.08 131.47 58.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.529 -0.545 . . . . 75.41 109.529 -178.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 139' ' ' VAL . 4.1 mp -125.96 128.37 71.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.759 -0.655 . . . . 74.41 110.947 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 85.1 t -111.52 143.71 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.82 -0.437 . . . . 74.52 109.82 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.12 161.24 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.215 0.531 . . . . 73.25 110.852 176.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -125.72 168.81 13.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.366 -0.834 . . . . 74.23 109.823 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 27' ' ' LEU . 1.1 mm? -108.54 163.05 13.57 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.198 -0.667 . . . . 75.31 109.198 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.742 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 2.9 m-85 -83.35 89.82 7.07 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.253 -0.579 . . . . 74.4 111.993 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -7.19 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.453 -1.314 . . . . 75.33 107.453 170.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -66.79 -43.06 84.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.426 -1.715 . . . . 64.53 110.746 -176.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -140.06 -1.61 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 75.44 111.584 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.6 88.97 18.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.742 -0.383 . . . . 73.43 111.435 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.23 -6.11 17.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.895 2.396 . . . . 75.01 112.626 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 15.4 mtpt -100.1 -53.8 3.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.399 -0.364 . . . . 74.11 111.101 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.407 HG21 ' SD ' ' A' ' 100' ' ' MET . 8.8 m -53.93 -35.86 62.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 70.31 111.977 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.615 ' SG ' ' HE2' ' A' ' 37' ' ' LYS . 6.1 p -66.89 -28.43 68.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 73.12 111.517 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.615 ' HE2' ' SG ' ' A' ' 36' ' ' CYS . 36.8 mmtt -79.93 -34.83 38.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.347 -0.388 . . . . 74.43 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -57.04 -53.2 60.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.557 -0.747 . . . . 74.4 110.531 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 14' ' ' VAL . 23.4 t80 -61.55 -50.68 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 74.31 109.838 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -42.19 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.961 -1.018 . . . . 73.24 111.49 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.07 -48.92 70.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 61.43 110.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 47' ' ' TYR . 2.6 mm? -74.78 -29.12 61.02 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.582 -0.447 . . . . 74.22 111.695 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.1 65.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.691 -0.231 . . . . 71.14 111.521 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.507 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 3.7 ppt_? -77.14 -21.54 53.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 72.44 110.423 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.434 ' C ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.65 -45.69 24.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.018 -0.734 . . . . 74.51 109.018 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.09 2.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.697 -0.763 . . . . 71.44 111.62 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -71.15 -30.77 66.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.139 0.495 . . . . 72.22 110.265 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -78.18 -7.72 57.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.598 -0.728 . . . . 70.33 111.502 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.78 -8.1 53.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 74.22 111.168 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.49 31.69 2.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.71 . . . . 73.51 112.252 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.719 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 20.3 p -107.46 150.63 26.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.041 0.448 . . . . 74.45 111.863 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -120.17 169.93 9.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 74.1 109.169 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -88.08 118.49 27.68 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 74.23 109.329 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -93.31 -28.77 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 73.01 110.413 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 41.1 mmt180 -137.67 109.74 7.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 73.44 110.134 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 56' ' ' ILE . 4.1 mp -115.07 79.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.395 -0.595 . . . . 72.42 109.395 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.09 134.47 27.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.051 -0.522 . . . . 73.33 109.639 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.968 ' HE3' ' HA ' ' A' ' 146' ' ' GLU . 2.4 mptp? -74.62 128.76 36.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.443 -0.344 . . . . 72.22 110.388 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.8 32.28 21.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.005 0.815 . . . . 71.14 110.923 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.86 -83.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 74.2 111.144 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptm -160.63 155.15 23.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.822 -0.626 . . . . 70.41 110.718 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.491 ' CD1' HD21 ' A' ' 116' ' ' LEU . 36.1 mt -130.58 103.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.629 -0.714 . . . . 74.3 109.723 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.8 tt0 -80.14 126.6 31.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.9 -0.591 . . . . 72.22 110.447 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.28 129.38 7.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.836 -0.697 . . . . 73.32 111.646 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.719 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 134.81 -148.12 19.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.458 -0.877 . . . . 72.24 112.859 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.8 t0 53.21 81.75 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 123.892 0.877 . . . . 75.3 111.534 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HD3' ' CE1' ' A' ' 47' ' ' TYR . 54.7 Cg_endo -72.32 -24.02 20.05 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.792 2.328 . . . . 72.24 111.159 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.482 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 5.6 p -81.9 -46.32 14.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.256 -0.884 . . . . 71.24 111.751 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.32 26.55 10.0 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.578 -0.82 . . . . 74.24 111.412 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 t -128.81 -19.31 3.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.775 0.321 . . . . 73.02 111.121 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.88 -18.57 55.69 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.524 -0.846 . . . . 72.22 113.313 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.467 ' C ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -110.9 5.22 20.33 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.429 -0.453 . . . . 73.54 111.152 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.482 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -86.85 176.85 47.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 70.54 112.647 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.53 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 85.18 -45.26 3.48 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.034 -0.603 . . . . 62.44 112.533 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 110' ' ' SER . . . -76.32 25.25 0.13 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.834 0.454 . . . . 62.03 111.702 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 74' ' ' GLY . 7.4 m -59.5 -24.35 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 64.42 111.06 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.568 HG22 ' HD1' ' A' ' 78' ' ' TYR . 3.4 tt -56.22 -48.36 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.717 -0.674 . . . . 74.22 111.284 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.568 ' HD1' HG22 ' A' ' 77' ' ' ILE . 30.2 p90 -108.97 -6.09 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.657 0.265 . . . . 70.21 111.593 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.58 -95.95 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.622 -0.799 . . . . 63.03 113.524 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -112.06 -174.33 2.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.744 0.783 . . . . 75.31 112.16 -173.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.539 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -85.91 175.18 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.388 -1.278 . . . . 74.13 108.751 170.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -132.98 -60.47 0.86 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.293 -0.563 . . . . 73.15 111.717 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.72 177.87 8.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.437 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.651 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -103.95 149.49 25.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.789 -0.449 . . . . 72.45 109.789 174.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -121.79 23.87 9.93 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.8 mt -59.53 102.86 0.16 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.425 -0.807 . . . . 73.13 111.062 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -161.84 82.09 1.84 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.923 0.392 . . . . 71.13 110.377 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.78 81.25 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.44 2.093 . . . . 72.54 111.296 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.76 -4.41 59.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.054 0.93 . . . . 73.24 109.403 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.72 -153.29 0.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.37 -1.286 . . . . 72.53 108.611 173.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -152.43 142.04 21.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.588 -0.445 . . . . 74.42 110.946 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.666 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 34.8 p90 -59.83 123.63 17.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.529 -0.76 . . . . 75.02 109.398 170.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.0 p -116.2 -40.13 3.31 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.253 -0.43 . . . . 75.32 110.995 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.36 -143.54 3.73 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.034 -0.603 . . . . 64.33 112.274 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 151.3 19.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.686 0.279 . . . . 71.25 110.626 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.35 23.73 8.28 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.52 -0.848 . . . . 63.54 111.319 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.411 HD11 ' HG3' ' A' ' 189' ' ' PRO . 8.1 mm -89.04 111.36 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.643 -0.502 . . . . 74.43 109.643 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.69 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -86.72 120.16 27.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.749 -0.66 . . . . 75.04 109.719 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.422 ' CB ' HG12 ' A' ' 128' ' ' ILE . . . -134.42 172.86 12.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.151 -0.477 . . . . 73.5 111.319 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.563 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 64.7 mtp -90.52 141.78 28.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 72.15 110.411 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.22 156.66 18.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.136 -0.484 . . . . 64.21 109.754 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.579 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.7 p-10 -159.75 163.25 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.386 -0.37 . . . . 74.31 110.712 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.1 -38.7 15.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.68 . . . . 72.4 110.303 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.16 -80.67 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.522 -0.847 . . . . 72.01 112.65 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.13 85.3 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.976 2.451 . . . . 70.13 112.934 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 52.32 33.08 12.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.392 -0.822 . . . . 71.52 112.136 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -76.26 39.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.212 0.449 . . . . 75.23 112.212 -174.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.651 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 14.7 m-80 -84.66 139.58 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.377 -0.601 . . . . 73.23 109.377 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.15 -68.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.85 -1.167 . . . . 45.43 113.533 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.526 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . 33.8 t -109.13 -24.24 11.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.573 0.582 . . . . 73.44 112.573 -169.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -91.37 137.47 32.34 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.487 -0.485 . . . . 54.32 110.051 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 87.9 m-85 -141.12 167.5 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.653 0.263 . . . . 72.43 110.679 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 34.1 p90 -159.4 158.27 31.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.753 0.311 . . . . 73.41 110.719 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.69 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -112.14 146.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 71.41 109.686 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -98.55 131.84 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 70.43 110.232 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.9 mt -85.76 -7.71 58.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.896 -0.593 . . . . 74.25 111.024 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.96 158.41 33.89 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.106 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.666 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 56.2 Cg_endo -71.76 123.91 9.77 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.362 2.042 . . . . 72.5 112.04 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.0 p -108.81 158.57 17.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 74.43 110.937 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 21.67 2.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.105 0.479 . . . . 74.5 111.005 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.32 -3.98 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.064 -0.516 . . . . 75.04 112.113 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 4.3 pp -130.4 3.94 4.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.497 -0.481 . . . . 74.23 111.617 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.64 -28.36 69.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 73.22 110.493 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.28 13.07 55.18 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.29 -0.724 . . . . 62.2 111.29 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 25.1 mmmt -116.22 -22.94 8.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.119 -0.697 . . . . 75.14 109.119 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.474 ' HB3' ' O ' ' A' ' 100' ' ' MET . 85.4 m-70 -134.67 134.68 41.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.37 -0.832 . . . . 75.13 110.042 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.9 m -72.81 121.4 19.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.06 -0.348 . . . . 72.45 110.06 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 99' ' ' ALA . 45.1 mt -108.71 114.65 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.92 -0.312 . . . . 64.32 111.768 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.5 m-85 -156.59 76.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 72.44 110.399 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.86 157.11 29.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.582 -0.818 . . . . 72.34 112.871 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.642 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 55.9 mtm180 -134.98 125.89 27.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.976 -0.379 . . . . 72.31 109.976 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.49 139.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.037 0.446 . . . . 64.42 110.41 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.498 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 41.3 t -139.24 143.58 38.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.551 -174.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.6 pt20 41.21 40.14 1.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.246 1.018 . . . . 73.54 113.239 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.47 41.41 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 71.2 111.901 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.82 -36.35 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.672 0.272 . . . . 73.23 110.636 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -36.36 92.05 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.903 -0.665 . . . . 74.24 111.681 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.567 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 72.0 mmm -67.83 -51.66 45.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.26 -0.274 . . . . 64.42 110.26 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 23' ' ' ILE . 91.9 t -54.31 -32.66 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.131 0.491 . . . . 71.32 110.668 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -70.39 -51.87 26.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 74.02 110.45 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.588 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -76.81 -10.14 59.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.966 -0.561 . . . . 75.23 111.355 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.596 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.8 t -87.11 -38.9 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.277 0.561 . . . . 72.45 109.792 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -78.31 -33.96 38.08 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.574 -0.822 . . . . 50.03 112.87 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.588 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 22.1 ptm -78.93 -18.91 53.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.08 0.4 . . . . 74.15 112.08 -173.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.37 126.32 37.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 119.962 -0.695 . . . . 61.3 110.095 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.968 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 11.0 pt-20 -78.82 -174.36 3.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.864 -0.607 . . . . 70.44 111.5 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.8 p -84.89 161.21 19.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.713 -0.676 . . . . 73.35 110.654 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -73.86 -38.87 64.31 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.103 -1.073 . . . . 73.13 108.103 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.83 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 30.6 t -158.26 139.94 13.72 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.093 -1.412 . . . . 71.14 108.361 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 42.48 -94.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.076 0.86 . . . . 71.44 113.155 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.52 10.52 9.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.02 0.378 . . . . 73.32 112.02 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.83 ' HD3' ' HB3' ' A' ' 149' ' ' SER . 3.1 ptm180 -95.43 111.37 55.07 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.33 -0.618 . . . . 74.23 109.33 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.16 146.39 90.52 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.713 2.275 . . . . 75.02 112.939 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 146' ' ' GLU . 61.0 t -62.47 -54.47 33.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.351 0.596 . . . . 71.33 109.586 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -102.47 133.22 47.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.684 -0.689 . . . . 74.02 109.794 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 158' ' ' LYS . 32.0 t70 -86.62 100.22 12.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.926 -0.579 . . . . 71.31 109.609 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 158' ' ' LYS . 3.6 t -104.47 123.08 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.847 0.832 . . . . 74.02 112.478 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 158' ' ' LYS . 2.0 mppt? -139.65 170.95 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.691 -1.14 . . . . 70.42 109.301 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 159' ' ' ILE . 3.7 mp -90.52 106.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.734 -0.839 . . . . 64.04 108.734 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.536 HD13 ' HG ' ' A' ' 19' ' ' SER . 26.0 mm -73.62 -52.3 21.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.607 -0.724 . . . . 73.42 110.251 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.518 ' HD2' HG21 ' A' ' 160' ' ' ILE . 4.9 mptp? -130.73 143.42 50.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.542 -0.754 . . . . 72.51 109.298 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.94 127.22 13.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.944 -0.391 . . . . 63.32 109.944 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -148.23 155.23 43.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.569 -0.53 . . . . 74.11 109.569 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.905 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 7.8 Cg_endo -85.07 131.62 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.431 2.087 . . . . 75.34 112.117 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.3 p -109.18 -27.79 9.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.047 -0.524 . . . . 73.43 110.688 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.04 -37.39 3.78 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.834 -0.698 . . . . 44.11 112.092 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -179.81 70.37 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.65 -0.786 . . . . 73.2 112.404 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.5 118.16 4.81 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.853 -0.689 . . . . 45.22 111.736 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.466 ' HA3' ' SG ' ' A' ' 133' ' ' CYS . . . 106.24 162.42 22.71 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.702 -0.761 . . . . 52.43 111.967 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.1 p -141.37 154.73 45.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.524 0.202 . . . . 75.23 110.523 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.1 53.29 0.64 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.504 -0.855 . . . . 63.24 112.32 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.17 93.1 0.78 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.802 -0.713 . . . . 62.43 111.971 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.17 165.35 24.41 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.992 -0.623 . . . . 64.15 112.237 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -159.47 103.46 1.59 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.105 -0.332 . . . . 73.41 110.105 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 153.74 -154.77 25.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.932 -0.651 . . . . 61.52 111.597 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.49 -56.41 4.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.941 -0.647 . . . . 61.13 112.484 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.87 -67.82 3.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.08 -0.581 . . . . 75.5 111.852 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 26.9 m -137.11 19.13 2.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.297 0.57 . . . . 75.23 110.139 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.36 -176.42 35.33 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.506 -0.77 . . . . 73.2 111.444 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 124.34 0.22 8.74 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.943 -0.646 . . . . 74.14 111.987 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.68 37.91 4.34 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.884 -0.674 . . . . 73.05 111.427 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.9 m -88.48 120.77 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.692 0.282 . . . . 65.52 110.932 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.55 -102.97 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.675 -0.774 . . . . 74.43 111.547 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -130.37 171.6 12.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.504 0.669 . . . . 74.22 111.172 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.3 137.6 2.6 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 114.742 -1.117 . . . . 60.13 110.922 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.66 -160.89 14.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.395 -0.907 . . . . 74.01 112.564 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.818 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -83.2 172.5 12.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.667 0.27 . . . . 53.03 110.395 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.2 98.48 22.7 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.868 -0.419 . . . . 75.53 109.868 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 1.4 Cg_endo -82.54 -8.52 11.46 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.766 2.31 . . . . 72.13 111.773 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.423 ' N ' ' HH ' ' A' ' 28' ' ' TYR . 7.3 pt-20 -80.83 -26.76 36.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.974 -0.557 . . . . 75.11 110.301 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.3 pt -94.23 152.12 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.181 -1.044 . . . . 74.32 108.181 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -102.88 64.2 0.85 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.215 -0.594 . . . . 64.24 111.091 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.61 135.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.478 . . . . 74.34 110.477 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.61 110.33 3.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 75.54 111.027 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.37 149.25 29.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.911 -0.774 . . . . 73.34 108.911 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 70.6 m-85 -119.03 144.59 36.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.91 0.337 . . . . 72.21 111.91 -170.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.818 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 31.6 Cg_endo -64.35 -59.6 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.728 2.285 . . . . 75.32 112.093 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.0 OUTLIER -143.79 37.51 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.462 -0.335 . . . . 72.52 111.402 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.3 m-20 74.37 -14.61 0.69 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.817 0.673 . . . . 64.33 112.817 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptm -49.18 -33.35 12.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.291 0.849 . . . . 74.21 113.291 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.73 -1.56 63.58 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.371 -0.918 . . . . 75.21 113.315 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.415 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 36.4 ptt180 -120.32 -6.77 9.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.214 0.507 . . . . 71.12 110.95 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.247 0.929 0 CA-C-N 114.89 -1.05 . . . . 74.34 110.519 178.686 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.35 -0.611 . . . . 71.22 109.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.56 -11.29 19.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.358 0.503 . . . . 63.3 112.358 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.92 154.74 24.43 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.29 -0.164 . . . . 74.45 111.216 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 41.1 mm 74.37 123.88 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 O-C-N 124.026 0.829 . . . . 73.12 111.522 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 10.1 Cg_endo -89.81 104.64 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.338 2.692 . . . . 75.52 112.512 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 4' ' ' ILE . 1.3 Cg_endo -83.01 106.42 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.065 2.51 . . . . 74.31 111.726 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -80.29 178.95 7.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.397 -0.594 . . . . 75.54 109.397 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -105.46 -17.87 14.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.526 0.203 . . . . 71.04 111.158 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -118.46 102.05 8.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.591 0.71 . . . . 74.5 111.091 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -106.07 120.2 49.68 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.864 -1.062 . . . . 63.2 110.095 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.78 124.65 16.76 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.385 2.724 . . . . 75.15 112.984 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 -22.42 7.36 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.916 2.411 . . . . 71.21 112.521 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -142.32 147.48 36.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.996 -0.742 . . . . 74.32 108.996 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.4 m -137.67 152.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.215 0.531 . . . . 72.55 111.782 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.73 122.53 42.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.155 -0.93 . . . . 74.12 110.566 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 mt -114.98 98.02 6.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.774 0.321 . . . . 73.33 110.41 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.35 124.98 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.021 -0.733 . . . . 74.34 109.021 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.462 HG23 HG13 ' A' ' 159' ' ' ILE . 74.8 p -111.84 178.74 4.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.173 0.511 . . . . 75.44 111.274 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB3' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -76.4 -6.19 50.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.676 -0.693 . . . . 74.32 111.027 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.813 ' HG3' HG21 ' A' ' 142' ' ' VAL . 6.9 mmt -102.52 -43.38 5.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.926 -0.579 . . . . 71.04 109.867 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.53 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -171.56 -130.75 1.27 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.494 -0.642 . . . . 73.42 111.494 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 23' ' ' ILE . 19.4 tt -132.7 137.99 52.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.029 0.443 . . . . 74.42 110.0 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 139' ' ' VAL . 20.1 mm -129.13 117.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.174 -0.676 . . . . 74.42 109.174 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 133' ' ' CYS . 2.9 m -113.56 147.04 17.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 119.147 -1.021 . . . . 73.11 110.152 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.34 163.94 36.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.941 -0.572 . . . . 74.54 110.611 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.7 pt-20 -129.65 166.73 19.19 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.043 -0.98 . . . . 75.42 109.662 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.514 HD13 ' CD2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -104.16 163.89 12.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.623 -0.51 . . . . 73.52 109.623 179.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.763 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 4.5 m-85 -82.58 98.95 9.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.177 0.513 . . . . 73.01 111.385 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.54 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -83.47 -0.56 50.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.551 -0.75 . . . . 65.14 110.014 -179.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -79.38 -53.88 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 75.32 111.466 -176.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.0 15.43 4.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.925 0.342 . . . . 74.24 111.925 -175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.66 67.15 77.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.896 0.379 . . . . 74.51 110.108 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 16.8 Cg_exo -66.98 -43.98 5.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.798 2.332 . . . . 64.2 112.401 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -76.03 -45.42 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 75.04 110.034 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.5 m -63.02 -32.84 74.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 73.23 111.221 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.54 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 33.4 t -59.74 -43.09 94.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.593 -0.276 . . . . 70.43 110.758 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 45.6 mmtt -70.04 -32.44 70.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.974 -0.38 . . . . 73.22 109.974 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.61 -58.47 7.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 75.23 109.746 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 27' ' ' LEU . 1.8 t80 -67.45 -37.05 82.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.75 . . . . 74.15 110.349 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.65 -43.06 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 72.05 111.457 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.693 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 10.5 tp10 -61.53 -42.94 99.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.932 0.396 . . . . 74.4 111.29 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 110' ' ' SER . 4.3 mm? -66.37 -24.14 66.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 74.13 110.54 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 14' ' ' VAL . . . -80.85 -31.07 35.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.099 -0.5 . . . . 73.22 110.129 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.693 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 38.6 mtp85 -61.95 -46.24 90.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.205 -0.907 . . . . 72.23 110.841 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -74.73 -49.35 21.4 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.831 -0.347 . . . . 75.34 110.83 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.65 49.76 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 72.51 111.941 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.614 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 23.6 t80 -70.99 -29.93 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.116 0.484 . . . . 73.45 111.235 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 32.2 m-85 -81.15 -5.88 58.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.642 . . . . 74.25 112.121 -169.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -75.57 -6.1 48.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 74.54 110.547 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.22 14.66 6.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 71.1 111.829 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 45.2 p -93.17 143.22 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.477 . . . . 71.51 111.015 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -140.2 147.09 39.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.794 -0.639 . . . . 74.42 110.054 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 63.9 m-85 -80.97 124.4 29.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.533 -0.543 . . . . 73.24 109.533 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -118.57 -19.83 8.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.563 -0.289 . . . . 64.32 111.366 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.89 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 34.5 mmt180 -122.82 105.5 10.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.805 -0.443 . . . . 75.13 109.805 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -122.02 81.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.297 0.57 . . . . 73.15 110.033 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.8 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 17.5 mt -89.91 132.82 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.226 -0.657 . . . . 74.22 109.226 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.762 ' HE3' ' HA ' ' A' ' 146' ' ' GLU . 2.3 mptp? -70.88 133.41 46.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.413 . . . . 75.45 110.008 -173.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 42.33 42.47 2.61 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.459 1.1 . . . . 63.53 111.716 -172.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.8 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.0 t80 -131.52 -84.34 0.51 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.628 -0.715 . . . . 72.34 109.705 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.669 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptt? -161.19 157.16 25.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.328 -0.851 . . . . 74.31 110.165 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.486 ' CD1' HD22 ' A' ' 116' ' ' LEU . 44.6 mt -124.5 100.07 7.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.727 -0.67 . . . . 73.31 109.469 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.89 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 46.5 mt-30 -84.83 119.81 25.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.656 -0.702 . . . . 73.42 110.866 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -138.48 140.56 11.18 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.715 -0.675 . . . . 75.33 111.775 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 164.04 -91.81 0.11 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.409 -1.376 . . . . 64.41 114.081 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -28.44 104.58 0.19 Allowed Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.003 1.112 . . . . 74.45 114.003 -163.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 91.1 Cg_endo -81.96 -12.5 10.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.852 3.035 . . . . 72.33 112.47 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 70' ' ' THR . 64.3 p -103.36 -32.33 9.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 71.22 111.882 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 27.95 62.1 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.293 -0.723 . . . . 62.12 111.293 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.582 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 72.2 p -103.81 -34.85 8.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.213 0.53 . . . . 74.31 111.222 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.98 -30.59 4.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.49 -0.777 . . . . 64.53 111.663 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 4.7 ptm180 -81.21 -37.42 28.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.043 0.449 . . . . 74.42 110.045 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.527 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 65.38 79.36 0.19 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.945 -0.57 . . . . 61.11 113.029 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.614 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 66.9 -130.97 30.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.022 -0.609 . . . . 55.11 112.745 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 55.55 22.19 4.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.105 0.562 . . . . 73.55 111.521 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -72.79 -12.6 61.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.712 -0.676 . . . . 54.25 110.868 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -51.96 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.389 -0.369 . . . . 72.4 110.424 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.513 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 97.7 m-85 -77.64 -34.16 53.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.795 0.807 . . . . 74.11 109.105 175.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.12 -78.84 0.24 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.606 -1.179 . . . . 71.11 112.104 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -135.99 -168.57 2.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.786 0.327 . . . . 71.33 110.977 -175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.476 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -76.41 166.43 23.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 74.32 111.532 -177.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' HZ ' ' HB3' ' A' ' 78' ' ' TYR . 73.9 m-85 -132.38 -44.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.814 -0.63 . . . . 74.43 110.398 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -163.47 156.33 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.679 -0.859 . . . . 74.02 108.679 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' ASP . 2.4 p-10 -74.81 125.11 28.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.352 -0.61 . . . . 74.33 109.352 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -98.36 20.79 12.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.048 0.451 . . . . 73.2 110.31 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -68.75 100.93 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.696 . . . . 74.11 110.952 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -156.45 77.04 4.36 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.981 -0.554 . . . . 74.31 109.926 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.39 93.59 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.552 2.168 . . . . 73.33 112.077 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.41 -10.19 58.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.248 1.023 . . . . 71.35 109.195 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.6 OUTLIER -108.16 174.17 5.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.597 -1.183 . . . . 73.02 109.306 178.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -131.28 145.1 51.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.067 -0.346 . . . . 74.51 110.067 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -55.59 126.44 25.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.36 0.6 . . . . 74.35 109.571 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.508 ' HG1' ' HA ' ' A' ' 189' ' ' PRO . 20.7 p -127.04 -45.46 1.56 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.539 -0.755 . . . . 74.44 110.262 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.32 -144.75 4.07 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.344 -0.844 . . . . 42.04 111.304 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.92 145.47 25.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.734 0.302 . . . . 64.22 110.77 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.63 21.83 6.64 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.732 -0.747 . . . . 64.44 111.906 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 189' ' ' PRO . 9.3 mm -86.8 111.21 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.487 -0.561 . . . . 74.44 109.487 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.773 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.92 122.03 30.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 72.35 109.824 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.23 170.65 14.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.84 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.817 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 39.5 ttp -103.64 144.15 31.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.916 0.389 . . . . 73.21 110.063 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.684 ' HA ' ' HD1' ' A' ' 126' ' ' HIS . . . -98.74 151.74 20.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.127 0.489 . . . . 75.24 110.547 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -161.0 169.79 21.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 74.32 109.61 -172.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.13 -27.48 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.418 0.627 . . . . 55.52 110.545 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.85 174.82 32.33 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 109.594 -1.402 . . . . 75.44 109.594 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.48 -46.85 19.29 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.303 2.669 . . . . 71.11 112.692 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 8.4 p-10 -100.88 -12.95 18.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.385 -0.37 . . . . 71.01 111.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -83.17 50.31 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.499 0.666 . . . . 75.22 109.411 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.663 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 47.1 m-80 -70.94 141.29 51.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.893 -1.049 . . . . 74.24 110.9 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.17 -169.78 12.69 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.127 -0.789 . . . . 62.3 111.127 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.57 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . 24.4 p -94.53 6.69 48.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.367 0.584 . . . . 75.03 111.469 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 73.2 mt-30 -72.79 161.59 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 64.43 109.68 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -141.75 171.35 14.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.666 -0.414 . . . . 74.23 111.268 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.17 150.87 18.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.04 -0.527 . . . . 73.52 110.195 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.641 HG22 HD21 ' A' ' 98' ' ' LEU . 16.0 t -113.73 141.78 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.462 -0.57 . . . . 72.22 109.462 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -95.37 129.08 42.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.166 0.508 . . . . 75.33 110.318 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD22 ' CD1' ' A' ' 62' ' ' ILE . 61.6 mt -87.14 -3.2 59.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 72.44 110.662 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.33 163.37 24.37 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.763 -0.653 . . . . 75.15 110.062 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.31 125.42 15.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.595 2.197 . . . . 73.5 111.845 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.3 p -114.5 140.87 48.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.394 -0.367 . . . . 74.21 111.247 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -137.01 24.47 3.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 75.43 111.003 174.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -120.72 -8.87 9.42 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.374 0.509 . . . . 74.31 112.374 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.5 pp -127.72 4.42 6.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.745 -0.382 . . . . 73.4 111.745 -173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 1.4 m-20 -71.51 -22.45 61.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.823 -0.626 . . . . 63.33 110.334 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.81 7.87 55.7 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.928 -0.869 . . . . 74.1 110.928 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.7 mmtm -112.16 -33.2 6.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 72.32 109.426 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.684 ' HD1' ' HA ' ' A' ' 101' ' ' ALA . 58.4 m-70 -135.57 137.54 42.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.29 -0.868 . . . . 73.23 109.418 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.3 t -78.54 146.54 34.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.39 -0.524 . . . . 75.35 110.255 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 99' ' ' ALA . 51.8 mt -122.28 124.86 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.9 -0.591 . . . . 72.24 110.279 -175.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.817 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.9 p90 -159.23 73.2 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.633 0.73 . . . . 74.35 110.725 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.773 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.37 157.27 29.56 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.177 -1.487 . . . . 72.01 113.732 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.428 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 24.4 mtm180 -137.06 123.69 21.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.34 . . . . 75.34 110.132 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.66 140.95 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 53.33 110.906 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.515 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 45.1 t -137.34 152.24 49.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.44 . . . . 74.32 110.026 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.5 pt20 41.13 31.09 0.13 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.534 1.134 . . . . 74.55 113.506 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.72 12.71 0.48 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.478 -0.867 . . . . 44.03 112.426 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.53 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -71.5 -34.25 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.799 -0.236 . . . . 74.24 110.92 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.57 91.76 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.484 -0.865 . . . . 61.54 111.387 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.53 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 75.5 mmm -71.2 -46.36 61.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.095 -0.335 . . . . 72.44 110.095 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 23' ' ' ILE . 79.9 t -57.07 -31.82 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.236 0.541 . . . . 74.52 110.4 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -68.39 -52.72 29.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.72 -0.673 . . . . 74.43 109.901 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.594 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.97 -8.57 56.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 74.35 111.023 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.813 HG21 ' HG3' ' A' ' 20' ' ' MET . 56.0 t -87.99 -43.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.265 0.555 . . . . 75.43 109.808 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.415 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -77.9 -37.54 29.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.608 -0.806 . . . . 75.35 112.78 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 24.0 ptm -73.86 -27.52 61.12 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.597 0.221 . . . . 71.41 111.597 -173.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.01 117.41 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.34 111.077 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.762 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 mp0 -87.39 -72.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.011 -0.995 . . . . 74.12 109.933 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 11.0 p -122.38 151.04 41.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.121 -0.945 . . . . 71.31 110.602 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -74.25 -43.6 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.919 -0.312 . . . . 72.33 111.204 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.8 m -158.63 -52.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.38 0.61 . . . . 75.42 110.0 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -92.65 -173.44 3.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 74.35 109.945 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.39 56.38 1.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.03 0.919 . . . . 72.3 109.875 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -141.95 118.51 7.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.87 -1.059 . . . . 74.34 109.143 175.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 32.7 Cg_exo -62.33 153.71 68.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.655 2.237 . . . . 70.12 112.389 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.83 90.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.639 -0.875 . . . . 75.11 108.639 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.52 21.48 4.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.594 -0.73 . . . . 71.24 112.827 -166.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -137.09 109.4 7.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.792 0.806 . . . . 73.52 111.497 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.1 p -159.62 117.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.123 0.963 . . . . 64.25 109.876 171.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.76 168.46 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.859 -1.064 . . . . 64.33 110.524 -172.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.462 HG13 HG23 ' A' ' 18' ' ' THR . 3.4 mp -87.14 115.59 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.983 -0.747 . . . . 72.31 108.983 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.552 HG23 ' HD3' ' A' ' 161' ' ' LYS . 31.0 mm -75.56 -62.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.368 -0.833 . . . . 73.42 110.973 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HD3' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -129.68 135.64 48.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.811 0.339 . . . . 74.44 110.266 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -131.92 133.87 45.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 74.31 111.023 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 21.8 p90 -152.93 147.49 19.13 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 74.32 110.673 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.529 ' HA ' HG12 ' A' ' 14' ' ' VAL . 15.0 Cg_exo -70.16 152.27 67.16 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.128 2.552 . . . . 73.24 113.119 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.5 t -87.89 151.78 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 64.32 109.89 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -93.1 53.52 2.52 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.843 -0.694 . . . . 53.21 112.934 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.41 -116.68 3.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.713 -0.755 . . . . 72.22 112.355 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -158.44 -178.64 32.66 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.956 -0.64 . . . . 55.23 111.963 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.11 102.98 2.99 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.697 . . . . 74.1 112.239 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.3 t -93.98 92.31 7.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 73.13 110.156 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.07 -83.99 1.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.707 -0.758 . . . . 73.31 111.753 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.93 -146.89 20.73 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.695 -0.764 . . . . 72.43 112.273 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 76.76 -154.18 43.21 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.867 -0.682 . . . . 71.51 111.856 -177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.0 t -130.69 121.82 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.389 . . . . 51.44 110.345 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -119.48 18.68 10.04 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.05 -0.595 . . . . 73.15 111.62 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.5 -92.24 0.42 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.89 -0.672 . . . . 74.1 112.007 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.0 27.34 0.63 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.131 -0.557 . . . . 73.32 111.881 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 62.9 m -158.13 154.6 27.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.118 -0.327 . . . . 75.24 110.118 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 132.47 133.91 3.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.716 -0.754 . . . . 72.55 112.174 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.69 56.44 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 65.51 111.711 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 61.1 4.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.095 -0.574 . . . . 51.24 112.945 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.3 p -95.28 -15.88 22.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.135 0.493 . . . . 74.55 110.255 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.03 -104.0 2.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.658 -0.701 . . . . 63.4 111.943 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.2 m-20 -99.86 178.13 4.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.304 0.573 . . . . 73.33 111.237 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 165.92 143.65 3.81 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.311 -0.859 . . . . 63.03 111.205 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.2 -171.53 41.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.579 -0.82 . . . . 74.55 111.954 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.814 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -78.26 167.02 22.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.033 -0.358 . . . . 63.43 110.033 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.502 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.2 m-85 -110.81 97.15 32.26 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 74.12 111.218 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.521 ' HB2' HD13 ' A' ' 90' ' ' LEU . 57.7 Cg_endo -75.03 -4.78 15.91 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.61 2.207 . . . . 71.14 112.791 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.763 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 26.4 tt0 -76.18 -31.61 58.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.782 -176.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 188' ' ' PHE . 13.3 pt -79.89 -17.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 74.43 111.929 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 17.2 m170 67.99 33.22 4.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.129 -0.487 . . . . 74.14 111.892 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.425 HG13 HG13 ' A' ' 191' ' ' ILE . 4.9 p -136.57 149.85 27.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.658 0.266 . . . . 75.14 110.797 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 115.82 9.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.272 0.558 . . . . 72.22 112.155 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 93' ' ' THR . 2.3 pp0? -156.57 159.34 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.504 -0.924 . . . . 72.0 108.504 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -132.23 145.24 56.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 120.547 -0.461 . . . . 74.22 111.585 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.814 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -67.4 -68.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.402 2.068 . . . . 73.24 111.693 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.403 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 2.4 pt? -126.24 24.88 6.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.032 0.444 . . . . 75.22 110.621 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 75.39 -10.0 1.31 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.914 1.079 . . . . 74.32 113.914 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -55.42 -27.74 49.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.322 0.49 . . . . 71.52 112.322 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.81 -0.23 89.72 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.843 -0.694 . . . . 63.41 112.879 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.46 -33.47 48.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.962 0.411 . . . . 73.14 111.135 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.683 ' HZ3' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.3 -0.857 . . . . 74.34 110.183 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.304 0.097 . . . . 74.23 111.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 78.13 0.3 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.21 0.529 . . . . 75.2 110.903 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.22 -57.14 2.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.593 -0.731 . . . . 51.51 110.451 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 78' ' ' TYR . 54.0 mt -113.3 116.17 46.79 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.831 . . . . 73.1 109.313 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 40.2 Cg_exo -57.13 119.73 7.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.494 2.796 . . . . 74.2 113.823 -170.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.7 -24.99 5.68 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.913 2.408 . . . . 74.13 111.41 171.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.91 35.84 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 74.54 110.95 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -55.32 111.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.008 0.432 . . . . 74.02 110.833 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -90.36 9.33 29.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.891 -0.595 . . . . 72.4 111.117 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 2.3 mp0 -60.84 141.84 92.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.938 -1.028 . . . . 74.23 111.092 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.63 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 18.0 Cg_endo -61.97 150.75 85.09 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.554 2.17 . . . . 71.31 112.012 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -4.87 16.17 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.999 2.466 . . . . 62.42 113.744 -175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.499 HD22 HG12 ' A' ' 24' ' ' VAL . 21.9 t-20 -128.98 144.2 51.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.885 0.374 . . . . 74.44 110.577 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 34.4 m -137.48 147.38 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.092 0.472 . . . . 74.43 110.854 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.531 ' CD1' ' HB3' ' A' ' 165' ' ' SER . 13.3 m-85 -103.45 132.18 49.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.777 -0.647 . . . . 74.41 110.831 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.556 HD11 HG21 ' A' ' 159' ' ' ILE . 3.4 mm? -114.58 104.81 12.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.041 -0.527 . . . . 74.33 109.749 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.28 115.46 28.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.278 -0.638 . . . . 74.33 109.278 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -107.12 178.92 4.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 75.11 111.738 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.4 p -75.25 -10.08 59.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.724 -0.671 . . . . 73.12 110.798 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.444 ' HE2' HG22 ' A' ' 142' ' ' VAL . 6.5 mmt -94.46 -42.11 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.654 . . . . 62.51 109.932 177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -179.83 -116.51 0.51 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.474 -0.785 . . . . 73.03 111.336 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -150.54 138.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.063 0.459 . . . . 74.32 110.477 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -132.28 127.52 57.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.686 -0.688 . . . . 75.14 109.571 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 8.5 t -113.62 147.45 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.855 -0.424 . . . . 62.34 109.855 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.37 163.5 39.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.984 0.421 . . . . 65.31 110.652 174.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' CD ' ' HG ' ' A' ' 133' ' ' CYS . 1.8 pt-20 -129.76 163.0 27.16 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.653 -0.703 . . . . 73.45 110.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.23 161.92 13.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 71.44 110.509 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.484 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 2.7 m-85 -88.32 100.26 12.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 74.51 111.635 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -85.89 7.06 25.58 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.002 -0.74 . . . . 73.23 109.002 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 4.4 mptp? -78.01 -57.34 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.753 -1.112 . . . . 74.2 111.54 -176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -132.31 14.96 4.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.423 -0.353 . . . . 72.42 111.81 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.53 80.42 71.95 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.787 -0.449 . . . . 62.11 109.787 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.614 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 59.4 Cg_endo -73.19 -25.18 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.445 2.096 . . . . 73.32 113.729 -171.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HZ2' ' HG3' ' A' ' 83' ' ' GLU . 54.7 mtmt -100.66 -33.69 10.18 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.126 -0.63 . . . . 74.44 111.637 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.65 95.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 75.32 111.177 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -57.62 -51.62 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 63.14 111.017 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.614 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 67.6 mttt -66.73 -41.71 87.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.829 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.03 -47.86 74.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.819 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE1' HG22 ' A' ' 14' ' ' VAL . 32.7 t80 -67.64 -50.96 55.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.448 . . . . 73.41 110.246 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.36 80.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.32 -0.855 . . . . 75.22 111.663 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.63 -47.66 82.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.891 -0.595 . . . . 72.32 110.32 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 75' ' ' ALA . 3.5 mm? -66.33 -27.55 67.99 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.113 -0.494 . . . . 73.03 111.07 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.55 52.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.84 -0.618 . . . . 62.13 110.91 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.503 ' HG2' ' HG3' ' A' ' 10' ' ' GLN . 6.6 ppt_? -73.74 -26.09 60.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.903 -0.406 . . . . 75.43 109.903 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -60.46 -47.6 85.43 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.83 -0.623 . . . . 75.43 109.587 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.51 20.51 6.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.486 -0.864 . . . . 62.23 113.575 170.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -79.58 -11.2 59.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.201 0.501 . . . . 75.14 111.359 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' HA ' HG22 ' A' ' 51' ' ' THR . 95.6 m-85 -85.11 -4.84 59.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.893 0.378 . . . . 64.53 110.967 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 38.6 m-80 -77.9 4.95 10.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.269 0.557 . . . . 71.44 110.046 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.77 21.22 2.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.707 -0.679 . . . . 60.25 111.698 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.949 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 28.8 p -96.0 152.61 18.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.555 0.217 . . . . 74.33 110.702 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 3.7 mtmt -134.94 155.94 49.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.522 -0.308 . . . . 74.42 110.512 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HB2' HG12 ' A' ' 157' ' ' VAL . 97.5 m-85 -92.43 113.79 26.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 75.23 109.0 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -112.83 -24.01 9.81 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.519 -0.473 . . . . 75.55 112.257 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 27.2 mmm180 -114.49 106.21 14.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.248 -0.581 . . . . 74.21 110.148 177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -124.57 92.86 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.102 -0.703 . . . . 65.45 109.102 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.4 mt -98.32 122.18 49.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.231 -0.655 . . . . 75.21 109.231 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 42.1 mtpt -56.94 127.71 33.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.297 0.373 . . . . 72.2 111.635 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 56.17 32.89 21.03 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.123 -0.944 . . . . 73.24 111.373 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.761 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.3 t80 -130.97 -82.67 0.53 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.449 . . . . 74.41 110.267 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.649 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.9 ptt? -161.64 157.61 24.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.702 -0.681 . . . . 74.13 110.205 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.616 HG23 HG13 ' A' ' 56' ' ' ILE . 29.0 mt -131.99 108.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 74.14 109.79 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.2 tt0 -79.5 124.16 28.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.314 -0.403 . . . . 61.02 110.074 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -133.96 127.78 4.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.437 -0.665 . . . . 71.41 111.437 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.949 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 139.17 -155.45 23.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.07 -1.062 . . . . 64.33 112.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.501 ' HB2' ' CG ' ' A' ' 111' ' ' GLN . 22.3 t0 53.74 96.15 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.741 0.817 . . . . 73.41 112.324 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.11 -16.49 44.75 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.334 2.023 . . . . 72.21 112.606 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.445 ' OG1' HG22 ' A' ' 70' ' ' THR . 48.5 p -93.6 -36.07 12.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 71.22 110.683 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 18.8 75.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.095 -0.574 . . . . 73.35 112.696 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.445 HG22 ' OG1' ' A' ' 68' ' ' THR . 9.9 t -111.64 -10.32 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 75.23 111.563 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.73 35.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.2 -1.0 . . . . 71.35 112.986 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -86.46 -47.63 9.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 74.41 111.02 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.51 173.41 32.32 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.42 -0.809 . . . . 75.4 111.421 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.0 -10.68 58.44 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 120.719 -0.753 . . . . 63.13 112.181 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.506 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -55.92 -77.36 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.971 -0.615 . . . . 73.52 112.074 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 m 59.27 15.39 4.24 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.186 -0.461 . . . . 64.01 111.497 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 pt -68.4 -17.21 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.592 0.71 . . . . 74.14 110.445 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.534 ' HA ' HD12 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -95.2 -12.33 26.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.727 -1.124 . . . . 73.51 111.147 -177.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.58 -76.77 1.3 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.241 -0.505 . . . . 63.42 112.464 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -87.47 -156.17 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.576 -0.527 . . . . 74.2 109.576 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.78 174.38 1.44 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 73.04 110.559 172.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 106' ' ' ASP . 26.2 t80 -118.17 -175.09 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.271 -0.422 . . . . 74.3 110.218 -172.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 15.3 mm-40 -76.48 121.36 23.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.645 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 7.8 p-10 -76.77 86.44 3.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.869 0.842 . . . . 74.35 109.066 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.48 39.53 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.313 -0.858 . . . . 74.23 109.555 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD22 ' HB ' ' A' ' 127' ' ' THR . 15.5 mt -69.26 98.98 1.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.381 -1.281 . . . . 74.24 110.63 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -162.07 83.47 1.69 Allowed Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.725 -0.67 . . . . 73.13 109.867 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.889 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 28.6 Cg_endo -62.28 82.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 123.154 2.57 . . . . 74.24 112.209 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.45 -25.83 54.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.409 -0.814 . . . . 72.35 109.682 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.6 pp -85.17 -179.96 7.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 73.33 109.796 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -124.42 141.23 52.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.46 -0.496 . . . . 72.12 110.672 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.66 72.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.664 0.745 . . . . 74.14 110.006 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -66.4 -37.86 86.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.773 -1.103 . . . . 73.33 112.575 -171.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.42 -140.93 3.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.361 -0.923 . . . . 52.21 112.758 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' SD ' ' A' ' 200' ' ' MET . . . -91.1 137.49 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.751 0.31 . . . . 74.41 110.686 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.48 23.35 5.74 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.669 -0.777 . . . . 41.43 111.852 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.0 mm -85.41 109.6 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.346 -0.612 . . . . 73.21 109.346 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.695 HD22 HG21 ' A' ' 114' ' ' VAL . 3.2 tm? -86.3 118.41 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.212 0.529 . . . . 74.25 109.774 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' HB3' HG22 ' A' ' 128' ' ' ILE . . . -125.04 168.12 13.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.053 -0.521 . . . . 71.41 110.847 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.6 ttt -91.71 132.77 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.191 -0.459 . . . . 75.45 109.805 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 111' ' ' GLN . . . -96.26 141.08 30.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.01 -0.367 . . . . 63.12 110.01 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -150.38 165.35 33.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.147 -0.479 . . . . 72.45 110.792 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 107' ' ' THR . . . -69.55 -46.66 65.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.845 -0.616 . . . . 73.3 110.296 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.94 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.472 -0.87 . . . . 71.4 112.715 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.28 89.43 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.918 2.412 . . . . 73.21 112.193 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 p30 50.13 29.37 3.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.317 -0.856 . . . . 74.2 111.571 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.499 ' HB ' ' HB1' ' A' ' 103' ' ' ALA . 1.7 m -96.58 55.51 1.43 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.113 -1.069 . . . . 72.4 108.113 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -92.85 137.15 32.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.995 -1.457 . . . . 71.03 110.096 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.21 -107.8 0.76 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.231 -0.985 . . . . 73.31 113.616 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.8 p -127.28 56.43 1.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.546 0.688 . . . . 64.32 110.601 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' A' ' 66' ' ' ASP . 18.8 mp0 -130.32 147.3 52.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.18 -0.918 . . . . 64.21 110.136 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -139.78 169.3 17.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -155.79 147.87 23.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.87 0.367 . . . . 74.21 110.296 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.695 HG21 HD22 ' A' ' 98' ' ' LEU . 17.8 t -111.54 140.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.885 -0.598 . . . . 70.03 109.391 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -94.86 128.81 41.89 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.853 0.359 . . . . 75.03 110.14 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.46 HD12 ' HA3' ' A' ' 143' ' ' GLY . 67.6 mt -83.62 -8.71 59.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.764 -0.653 . . . . 73.15 110.168 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.42 156.58 34.91 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.164 -0.926 . . . . 75.44 109.679 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.35 124.58 14.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.503 2.135 . . . . 55.2 112.236 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 p -123.99 122.12 37.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.405 . . . . 65.51 110.234 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 5.18 31.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.716 0.293 . . . . 75.24 111.373 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.607 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -108.39 -3.1 18.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.607 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.9 mt -102.04 3.74 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.188 -0.46 . . . . 73.32 111.371 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.889 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 p-10 -70.67 -15.2 62.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.68 -0.691 . . . . 73.41 111.155 -172.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.86 15.96 9.53 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.329 -0.709 . . . . 65.42 111.329 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.66 -41.31 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.271 0.558 . . . . 75.55 110.109 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -142.31 126.1 17.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.005 -1.109 . . . . 75.03 108.005 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 86' ' ' LEU . 11.3 t -72.22 143.11 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.669 -0.812 . . . . 74.04 110.459 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.489 HG22 ' HB3' ' A' ' 99' ' ' ALA . 40.4 mt -114.87 119.94 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.57 -0.741 . . . . 73.35 110.54 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.3 m-85 -157.23 75.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.318 0.387 . . . . 75.3 110.138 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.66 158.24 30.38 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.585 -0.817 . . . . 75.12 112.611 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.484 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 11.4 mtp180 -135.12 114.98 12.91 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.719 -0.475 . . . . 75.21 109.719 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' GLY . 14.3 p -79.86 130.6 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.37 0.605 . . . . 75.31 110.068 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.656 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 87.7 m -140.5 140.12 35.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.765 -0.652 . . . . 64.3 110.576 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 54.67 42.33 31.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.124 0.488 . . . . 73.32 111.764 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 41.58 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.43 -0.89 . . . . 54.13 111.99 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.0 tp -90.77 -34.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.59 0.233 . . . . 75.23 111.011 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.92 -35.87 91.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.807 -0.711 . . . . 64.52 111.624 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.431 ' O ' HG21 ' A' ' 142' ' ' VAL . 75.6 mmm -68.34 -51.2 47.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 72.14 110.337 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 62' ' ' ILE . 98.5 t -55.03 -31.12 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.296 0.57 . . . . 75.44 110.789 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.93 -55.01 10.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.819 -0.628 . . . . 62.42 110.681 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -17.66 62.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.367 -0.379 . . . . 75.12 111.213 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.444 HG22 ' HE2' ' A' ' 20' ' ' MET . 55.0 t -84.3 -37.75 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.1 0.476 . . . . 74.32 109.934 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -83.38 -7.5 86.44 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.775 -0.726 . . . . 75.5 113.002 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.33 -1.06 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.755 -0.378 . . . . 74.44 111.294 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 142' ' ' VAL . 33.0 m -63.39 154.72 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.971 0.415 . . . . 72.42 111.242 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -90.43 -159.66 0.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.503 0.668 . . . . 71.34 110.34 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 p -107.57 131.87 53.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.189 -0.914 . . . . 71.14 110.783 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 1.083 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 46.2 t30 -69.23 -73.6 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.492 -0.776 . . . . 75.24 110.851 -173.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -87.72 -75.4 0.41 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 74.51 110.668 -177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.03 -81.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.114 0.483 . . . . 72.25 110.978 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -111.67 7.65 20.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.44 109.785 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -105.02 139.79 20.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.436 -0.802 . . . . 75.44 110.19 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.7 149.56 82.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.926 2.417 . . . . 73.1 112.023 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 1.083 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 70.4 t -57.35 -61.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.226 -0.443 . . . . 73.42 111.919 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -106.87 113.37 26.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.947 0.403 . . . . 54.1 111.504 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.47 103.31 9.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.805 -0.634 . . . . 74.31 109.38 174.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.496 HG12 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p -96.16 139.95 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.139 0.495 . . . . 62.14 111.374 -176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -121.94 162.88 20.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 72.43 109.533 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 16' ' ' LEU . 3.5 mp -88.9 103.27 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.445 -0.946 . . . . 73.11 108.445 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.458 ' C ' ' HD2' ' A' ' 161' ' ' LYS . 32.1 mm -66.81 -56.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.479 -0.782 . . . . 74.52 110.636 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.482 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 3.5 mptp? -128.92 137.25 51.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 73.55 110.374 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.19 27.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.209 -0.451 . . . . 62.14 110.242 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -148.22 135.36 10.46 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.767 -0.651 . . . . 73.15 110.723 -173.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.63 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 59.8 Cg_endo -72.78 139.38 30.5 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.706 2.271 . . . . 72.32 112.044 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 16.9 t -169.7 -157.31 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.6 -0.518 . . . . 74.21 109.6 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.51 71.46 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.992 -0.623 . . . . 64.31 112.049 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -131.61 29.77 3.37 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 61.3 112.515 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.75 122.42 5.71 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 65.24 112.316 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.24 151.39 17.93 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.907 -0.663 . . . . 74.3 111.823 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.737 ' HB3' ' HA ' ' A' ' 182' ' ' SER . 64.2 m -139.46 31.97 2.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.842 0.321 . . . . 73.13 110.86 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -78.2 63.95 3.52 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.825 -0.702 . . . . 73.22 112.695 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.34 156.35 15.66 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.448 -0.661 . . . . 74.13 111.448 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.96 110.0 1.23 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.306 -0.95 . . . . 43.02 113.114 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.5 p -117.59 98.58 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.144 0.497 . . . . 64.34 110.123 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.12 -158.09 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.984 -0.627 . . . . 72.21 112.477 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.5 -66.35 3.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.25 -0.5 . . . . 74.55 112.024 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.31 -92.09 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.174 -0.536 . . . . 45.34 111.83 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.4 m -98.6 152.42 19.62 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.942 0.401 . . . . 73.13 110.983 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.86 -121.81 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.082 -0.58 . . . . 55.25 111.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.73 -69.72 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.805 -0.712 . . . . 61.14 112.107 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.26 8.53 85.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.917 -0.659 . . . . 74.41 112.078 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.737 ' HA ' ' HB3' ' A' ' 170' ' ' SER . 56.3 m -155.86 167.31 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.838 -0.43 . . . . 61.12 109.838 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.46 -124.53 5.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.734 -0.745 . . . . 65.53 111.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.29 174.27 6.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.732 0.777 . . . . 74.0 110.913 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.05 4.11 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.574 -1.194 . . . . 72.31 110.863 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.59 -167.9 44.2 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.27 -0.967 . . . . 62.32 111.659 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 189' ' ' PRO . . . -75.43 163.54 27.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.228 -0.656 . . . . 73.23 109.228 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -102.24 103.29 29.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.806 0.336 . . . . 74.55 110.19 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.609 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 6.0 Cg_exo -77.43 -18.46 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.776 2.318 . . . . 73.43 111.298 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.87 -33.59 62.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 75.03 110.238 -172.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -89.22 157.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -106.82 89.68 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.057 -0.657 . . . . 74.15 110.638 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 194' ' ' ALA . 6.1 p -158.08 -171.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.626 -0.879 . . . . 71.12 108.626 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.746 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -123.45 117.61 25.54 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 122.188 -0.32 . . . . 72.31 110.669 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -156.45 155.27 31.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.864 -0.421 . . . . 71.45 109.864 177.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -117.31 149.24 44.23 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.458 -0.337 . . . . 74.34 110.546 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.501 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.8 Cg_endo -67.31 -65.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.408 2.072 . . . . 63.12 112.108 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.9 27.54 4.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.942 0.401 . . . . 70.32 110.635 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 72.59 5.02 5.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.52 -0.764 . . . . 65.44 112.687 173.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 201' ' ' GLY . 2.0 ppp? -63.58 -50.4 69.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.102 0.408 . . . . 71.24 112.102 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.487 ' N ' ' SD ' ' A' ' 200' ' ' MET . . . -75.75 15.34 4.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.263 -0.494 . . . . 71.41 114.148 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -81.78 -17.05 48.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 73.01 110.464 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.252 1.204 0 CA-C-N 114.872 -1.058 . . . . 73.13 110.945 178.524 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.931 -0.396 . . . . 74.44 109.931 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.76 168.59 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.834 -0.432 . . . . 72.53 109.834 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.31 -57.16 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 65.43 110.758 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 78' ' ' TYR . 60.1 mt -122.76 131.63 24.35 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.833 -0.621 . . . . 73.25 110.643 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.65 127.25 17.58 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.733 2.289 . . . . 64.4 112.023 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 -36.5 85.56 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.31 . . . . 74.21 112.063 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.96 136.64 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.929 -0.578 . . . . 73.45 109.957 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 t -179.84 159.41 0.83 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 74.24 109.488 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -97.32 -29.51 13.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.306 -0.406 . . . . 72.1 110.552 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.2 mp0 67.72 135.88 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 O-C-N 123.653 0.596 . . . . 74.54 112.151 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 34.4 Cg_exo -60.17 132.43 44.19 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.718 2.279 . . . . 60.5 112.023 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.665 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 56.6 Cg_endo -71.55 -16.98 30.4 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.84 2.36 . . . . 74.53 113.534 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.477 HD22 HG12 ' A' ' 24' ' ' VAL . 22.2 t-20 -132.51 147.8 52.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.252 -0.431 . . . . 75.44 110.092 -174.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 164' ' ' PRO . 26.9 m -139.04 152.02 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.257 0.551 . . . . 72.24 111.438 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.524 ' HD1' HG23 ' A' ' 24' ' ' VAL . 97.4 m-85 -102.94 121.31 42.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.079 -0.964 . . . . 72.25 110.743 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -108.09 103.07 12.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.805 0.336 . . . . 73.42 110.307 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -85.15 122.45 29.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.228 -0.656 . . . . 64.32 109.228 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -114.97 176.61 4.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.212 0.529 . . . . 75.13 112.041 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.509 ' HB2' HD13 ' A' ' 160' ' ' ILE . 32.7 t -75.51 -1.6 25.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.606 -0.725 . . . . 71.43 110.565 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mmt -107.2 -39.7 5.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.814 -0.63 . . . . 74.54 110.274 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.64 -126.41 0.98 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.232 -0.747 . . . . 63.22 111.232 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -139.84 137.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.035 0.445 . . . . 75.21 109.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -120.93 118.03 54.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.77 -0.65 . . . . 75.3 109.677 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG23 ' HD1' ' A' ' 15' ' ' TYR . 46.5 t -106.16 131.18 56.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.82 -0.437 . . . . 75.01 109.82 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.66 164.57 33.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.997 0.427 . . . . 73.35 110.414 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 12.2 pt-20 -135.5 166.56 22.91 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.774 -0.648 . . . . 73.33 109.876 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -103.52 160.03 15.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.495 -0.557 . . . . 74.11 109.495 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.802 ' HH ' ' HB2' ' A' ' 190' ' ' GLU . 12.1 m-85 -83.89 91.58 7.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 72.32 111.962 178.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.665 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 78.9 m95 -84.22 6.48 22.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.607 -0.724 . . . . 74.14 110.314 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -73.6 -63.03 1.29 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.609 -0.723 . . . . 73.45 110.495 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.406 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 37.6 m80 -131.07 16.2 5.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.083 0.401 . . . . 75.02 112.083 -176.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -133.83 56.95 21.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.024 -0.27 . . . . 75.21 110.983 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 14.0 Cg_exo -68.82 -25.9 32.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.442 2.094 . . . . 73.3 112.023 -175.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -66.44 -54.23 26.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 74.45 110.176 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.639 ' HB ' ' CE2' ' A' ' 129' ' ' PHE . 1.6 p -64.16 -40.23 95.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.182 -0.917 . . . . 71.04 110.988 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 86.3 m -58.31 -46.78 85.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.079 -0.964 . . . . 65.33 111.02 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -59.49 -41.39 89.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.422 -0.354 . . . . 75.32 110.189 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.72 -56.54 20.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 52.13 110.326 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HE2' ' HB3' ' A' ' 112' ' ' PHE . 3.4 m-85 -66.74 -42.29 86.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.759 -0.655 . . . . 73.41 111.492 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 10' ' ' GLN . . . -63.93 -41.81 97.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.455 -0.339 . . . . 73.03 111.571 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' HG21 ' A' ' 4' ' ' ILE . 33.5 tt0 -61.39 -43.67 98.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.024 0.44 . . . . 75.22 110.198 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' ' HB3' ' A' ' 110' ' ' SER . 35.3 mt -70.59 -24.46 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.873 -0.603 . . . . 73.32 111.97 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.75 86.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.005 -0.543 . . . . 75.25 110.313 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' HD2' ' HG3' ' A' ' 10' ' ' GLN . 74.5 mtp180 -75.56 -34.28 60.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 74.52 109.927 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.563 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 14.3 tpp180 -64.83 -46.75 80.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 75.44 110.273 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.38 28.87 5.0 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.926 -0.654 . . . . 64.01 113.075 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.748 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 5.2 m-85 -87.15 -2.92 58.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 75.01 111.674 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -76.42 -12.69 60.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 75.35 110.303 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 49' ' ' ASN . 0.8 OUTLIER -79.45 3.16 19.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.22 0.533 . . . . 75.02 109.91 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -131.69 15.4 5.18 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.694 -0.684 . . . . 74.03 112.253 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.556 HG22 ' HD3' ' A' ' 67' ' ' PRO . 13.6 p -98.63 138.03 36.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.837 0.318 . . . . 65.21 110.497 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' CG ' ' HG3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -128.71 124.5 35.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.418 -0.355 . . . . 75.11 110.427 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 96.2 m-85 -70.06 103.34 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.412 -0.588 . . . . 74.25 109.412 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -114.25 -15.43 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.031 -0.668 . . . . 75.12 112.06 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 11.3 mmt180 -105.42 101.61 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.982 -0.687 . . . . 74.41 109.597 175.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 62' ' ' ILE . 4.2 mp -125.87 95.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.018 -0.734 . . . . 71.43 109.018 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.816 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 44.0 mt -91.88 127.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 109.184 -0.673 . . . . 74.53 109.184 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -48.72 111.41 0.46 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.99 0.806 . . . . 72.3 112.133 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 203' ' ' LYS . 43.2 m-20 56.4 39.66 29.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.112 -0.949 . . . . 70.14 111.307 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 9.7 t80 -128.59 -76.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.813 -0.631 . . . . 74.12 109.987 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.411 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.4 ptt? -160.59 155.59 24.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 72.55 110.673 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 56' ' ' ILE . 49.0 mt -128.41 105.28 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 73.23 109.48 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 39.6 tt0 -85.49 127.2 34.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.739 -0.664 . . . . 74.04 111.893 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.39 117.38 4.62 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.454 -1.058 . . . . 51.41 110.454 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.24 146.59 33.43 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 114.423 0.529 . . . . 53.43 114.423 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.477 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 64.9 t0 -46.0 126.73 7.07 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 124.792 1.237 . . . . 74.34 111.837 174.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD3' HG22 ' A' ' 51' ' ' THR . 29.3 Cg_endo -64.46 -30.77 62.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.177 2.584 . . . . 72.25 112.763 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.468 ' OG1' HG21 ' A' ' 70' ' ' THR . 62.7 p -84.1 -32.86 24.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 74.1 110.061 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.83 70.84 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.51 -0.768 . . . . 71.41 113.01 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 72' ' ' ARG . 8.8 t -105.52 -26.02 12.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.121 0.46 . . . . 64.2 111.536 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.97 -5.34 10.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.476 -0.869 . . . . 74.3 113.223 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.497 ' HG2' HG23 ' A' ' 70' ' ' THR . 8.5 ptm180 -100.85 -23.75 14.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.076 0.438 . . . . 72.43 111.101 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 85.47 175.11 50.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.827 -0.702 . . . . 73.51 112.098 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.748 ' HA3' ' HD2' ' A' ' 47' ' ' TYR . . . -86.93 28.79 5.33 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.525 0.514 . . . . 70.42 112.28 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . -93.1 25.13 3.4 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.74 0.781 . . . . 71.12 110.883 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 55.4 m -75.65 -5.69 46.77 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.089 -0.96 . . . . 62.32 110.583 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.1 tt -55.62 -40.17 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.562 -0.745 . . . . 74.35 110.96 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.504 ' HA ' HD11 ' A' ' 4' ' ' ILE . 34.8 p90 -102.12 -9.14 20.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 63.43 111.276 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 76' ' ' SER . . . 126.74 -119.27 3.28 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.24 -0.744 . . . . 74.01 111.24 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -137.91 146.45 43.33 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.049 0.452 . . . . 72.45 111.726 176.34 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.431 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 1.7 mp0 38.1 -166.55 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 O-C-N 125.692 1.87 . . . . 64.25 115.294 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' HB2' ' OD1' ' A' ' 108' ' ' ASN . 20.8 m-85 -154.41 -165.74 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.531 -1.213 . . . . 74.01 108.446 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.78 160.05 26.31 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.172 -1.048 . . . . 73.13 108.172 171.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.27 123.54 23.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 75.11 109.993 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.06 31.31 6.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.421 -0.585 . . . . 74.3 109.421 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD21 ' OG1' ' A' ' 127' ' ' THR . 47.9 mt -66.11 98.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.716 . . . . 75.44 110.319 -176.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -166.06 89.96 0.86 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.898 -0.592 . . . . 71.13 109.85 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.98 95.36 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.779 2.319 . . . . 72.23 111.61 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.42 -17.58 61.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.403 1.096 . . . . 74.41 108.7 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -106.5 170.83 7.7 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.875 -1.511 . . . . 72.44 108.797 175.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -128.16 142.88 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.843 -0.343 . . . . 71.45 110.165 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -56.16 122.69 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.433 0.635 . . . . 65.24 109.369 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.2 p -119.48 -45.9 2.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.556 -0.747 . . . . 70.41 109.771 -177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.597 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -155.96 -139.27 2.72 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.054 -0.975 . . . . 71.11 111.389 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.67 144.65 25.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 73.4 110.844 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.18 24.32 5.47 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.786 -0.721 . . . . 73.04 112.13 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.87 110.79 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.355 -0.609 . . . . 74.5 109.355 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.874 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -86.52 117.4 25.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.731 -0.668 . . . . 74.31 109.889 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 128' ' ' ILE . . . -132.2 173.32 11.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 74.24 111.056 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.533 ' HE3' ' HB2' ' A' ' 108' ' ' ASN . 28.1 ttm -94.36 148.19 22.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 70.21 111.281 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' N ' ' HG2' ' A' ' 100' ' ' MET . . . -99.52 122.09 42.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.699 -0.682 . . . . 72.31 109.222 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.58 165.88 24.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.221 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.12 -28.67 14.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.32 0.581 . . . . 53.24 110.422 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.23 180.0 29.17 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.651 -1.38 . . . . 61.11 109.651 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.408 ' HA ' HD12 ' A' ' 86' ' ' LEU . 7.1 Cg_endo -49.7 -50.54 12.88 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 74.32 112.786 -178.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -102.77 -1.83 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.57 -0.286 . . . . 61.42 111.092 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.431 ' HA ' ' CG ' ' A' ' 81' ' ' GLN . 7.9 m -88.34 53.85 2.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.865 0.84 . . . . 74.25 109.114 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' A' ' 82' ' ' PHE . 3.7 p30 -82.88 158.46 22.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.289 -1.323 . . . . 71.02 109.8 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.89 -129.51 1.04 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.445 -0.883 . . . . 75.51 112.965 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.515 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 3.3 p -114.07 -1.09 13.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.002 0.371 . . . . 75.13 112.002 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 71.9 mt-30 -79.32 150.31 31.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.729 -0.471 . . . . 63.54 109.729 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.507 ' HB3' ' HE2' ' A' ' 39' ' ' PHE . 29.8 p90 -148.11 164.98 32.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.857 -0.337 . . . . 74.14 110.468 -176.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.2 151.49 29.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.889 0.376 . . . . 75.44 110.321 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.704 HG21 HD23 ' A' ' 98' ' ' LEU . 15.1 t -110.15 141.42 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.814 -0.63 . . . . 74.32 109.352 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.3 p -95.14 124.92 39.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.115 0.483 . . . . 74.41 110.318 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.497 HD22 ' CD1' ' A' ' 62' ' ' ILE . 54.2 mt -81.83 -8.98 59.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.631 -0.713 . . . . 74.41 110.569 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.23 42.3 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.386 -0.825 . . . . 71.3 109.801 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 18.8 Cg_exo -65.98 120.24 7.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.714 2.276 . . . . 70.22 111.934 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -108.43 116.23 31.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.206 -0.452 . . . . 55.21 110.476 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -104.44 11.41 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.106 0.479 . . . . 74.31 110.903 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.523 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -118.42 0.27 11.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.679 -0.691 . . . . 73.21 111.138 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 91.2 mt -104.01 10.24 36.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.107 -0.497 . . . . 73.03 110.511 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -62.73 -22.18 66.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.196 -0.911 . . . . 75.12 111.496 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.91 21.51 4.66 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.713 -0.756 . . . . 62.34 111.727 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -117.08 -32.1 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 73.22 110.23 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.65 131.31 27.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.863 -0.608 . . . . 75.22 110.319 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.416 ' OG1' HD21 ' A' ' 86' ' ' LEU . 46.1 m -68.31 119.42 12.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.982 0.42 . . . . 74.44 109.932 171.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' ALA . 46.2 mt -102.47 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 74.44 110.029 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.639 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 15.0 p90 -160.3 71.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 75.42 111.264 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.874 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.83 154.02 24.7 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.611 -1.281 . . . . 65.22 114.053 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -131.75 118.64 20.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.461 -0.57 . . . . 75.01 109.461 170.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.06 139.03 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 72.43 110.459 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.515 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 46.0 t -141.51 150.02 41.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.453 -0.339 . . . . 72.52 110.956 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.9 pt20 39.02 40.02 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.807 1.243 . . . . 73.14 113.474 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.57 23.07 0.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.874 -0.679 . . . . 44.02 111.834 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 tp -76.63 -32.88 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.717 0.294 . . . . 74.51 110.233 -175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.09 87.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.818 -0.706 . . . . 74.42 111.672 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 78.6 mmm -72.23 -50.07 30.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.414 -0.217 . . . . 74.23 110.414 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.415 HG11 HD13 ' A' ' 62' ' ' ILE . 86.6 t -57.77 -28.71 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 71.25 110.565 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.622 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -72.14 -55.29 7.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 72.11 110.572 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -70.69 -17.3 62.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.128 -0.487 . . . . 74.24 111.015 -176.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 145' ' ' VAL . 53.1 t -87.48 -33.32 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.258 0.552 . . . . 74.44 109.666 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.77 -13.36 82.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.787 -0.721 . . . . 61.41 112.687 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.622 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 67.9 mtp -85.17 -2.2 57.75 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.871 -0.194 . . . . 75.22 111.382 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 142' ' ' VAL . 6.1 m -80.81 135.67 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.294 0.568 . . . . 73.42 110.489 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 147' ' ' THR . 13.0 pt-20 -129.75 -56.53 1.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.576 . . . . 74.25 109.956 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.404 ' H ' ' HG3' ' A' ' 146' ' ' GLU . 2.9 p -128.78 141.52 51.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.045 0.45 . . . . 72.04 110.432 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.629 ' HB3' ' HG3' ' A' ' 152' ' ' ARG . 11.7 t-20 -52.32 -60.94 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.888 -1.051 . . . . 71.33 112.168 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 75.1 m -163.45 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.344 -0.984 . . . . 61.42 108.344 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -93.78 -167.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.758 -1.11 . . . . 63.24 108.441 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.88 59.42 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.855 0.836 . . . . 75.35 109.571 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.629 ' HG3' ' HB3' ' A' ' 148' ' ' ASN . 6.4 ptp180 -134.31 133.18 21.47 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.993 -1.003 . . . . 72.11 109.489 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.59 139.37 69.59 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.347 2.031 . . . . 73.04 111.469 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.57 HG23 ' HB ' ' A' ' 145' ' ' VAL . 14.9 t -62.49 152.03 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.936 -0.574 . . . . 73.13 111.368 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.89 138.7 57.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 74.01 110.115 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 158' ' ' LYS . 8.9 p-10 -68.43 153.56 43.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 65.53 111.673 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 53' ' ' PHE . 3.6 p -103.54 135.96 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.57 . . . . 74.13 110.308 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 156' ' ' ASP . 10.2 mptt -111.36 151.34 28.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.634 . . . . 70.45 110.86 -172.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.44 HD11 ' HG1' ' A' ' 51' ' ' THR . 3.7 mp -82.53 99.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.287 -1.005 . . . . 74.41 108.287 169.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 19' ' ' SER . 36.4 mm -62.9 -50.78 78.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 73.55 110.218 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -143.16 152.44 41.79 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.555 -0.748 . . . . 73.55 109.992 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.95 132.95 37.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.472 . . . . 72.13 109.875 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.578 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 43.4 m-85 -134.31 125.65 17.94 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.582 . . . . 65.33 109.957 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.53 ' HA ' HG11 ' A' ' 14' ' ' VAL . 19.5 Cg_endo -62.21 136.15 58.52 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.81 1.673 . . . . 72.34 111.139 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.494 ' HA ' ' HE2' ' A' ' 15' ' ' TYR . 8.6 t -62.11 142.7 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.999 0.428 . . . . 74.42 110.679 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 110.66 5.33 27.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.768 -0.729 . . . . 60.21 111.723 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -171.03 38.65 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 61.51 111.857 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.07 10.5 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.78 -0.724 . . . . 72.1 112.206 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 164.82 172.79 32.72 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.463 -0.655 . . . . 74.31 111.463 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.3 m -124.03 -31.01 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.698 0.285 . . . . 74.31 111.137 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.2 -161.26 24.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.729 -0.748 . . . . 75.15 111.742 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.33 59.2 0.5 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.675 -0.774 . . . . 62.35 112.184 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 127.35 137.1 4.43 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.791 -0.718 . . . . 72.24 111.908 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.3 m -106.7 103.43 12.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.701 0.286 . . . . 70.31 110.383 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -121.58 -153.27 8.92 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.776 -0.726 . . . . 62.5 112.256 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -102.05 22.13 39.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.902 -0.666 . . . . 64.32 111.76 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -91.24 98.77 2.48 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.038 -0.601 . . . . 60.24 111.936 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 19.0 m -107.75 85.85 2.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.159 0.504 . . . . 73.13 110.096 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -100.94 126.59 8.97 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.725 -0.67 . . . . 73.14 111.923 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.19 102.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.88 -0.676 . . . . 73.43 111.625 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.67 -164.5 26.38 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.809 -0.71 . . . . 74.13 111.999 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.0 m -71.15 141.94 50.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.346 -0.242 . . . . 74.24 110.346 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.8 111.14 3.2 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.516 -0.85 . . . . 61.12 111.894 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.681 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -77.29 174.01 11.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.571 0.7 . . . . 65.2 110.26 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 156.17 146.39 4.45 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.926 -1.034 . . . . 63.52 110.998 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.9 -178.18 52.15 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.282 -0.961 . . . . 55.13 111.397 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.873 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.5 141.69 53.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.43 -0.582 . . . . 75.25 109.43 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 61.4 m-85 -88.96 104.44 7.6 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 75.11 110.277 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.614 ' HB2' HD13 ' A' ' 90' ' ' LEU . 1.1 Cg_endo -82.47 -5.55 11.77 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.804 2.336 . . . . 72.44 111.301 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.802 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 31.4 tt0 -78.66 -34.34 46.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 64.34 110.438 -175.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.534 HG13 HG12 ' A' ' 193' ' ' VAL . 17.7 pt -79.59 -13.6 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.497 -0.774 . . . . 70.22 111.555 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 58.9 m170 64.92 40.29 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.501 -0.772 . . . . 75.0 111.971 172.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.534 HG12 HG13 ' A' ' 191' ' ' ILE . 9.8 p -144.19 145.47 21.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.296 -0.411 . . . . 74.31 110.758 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.32 122.11 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.853 -0.612 . . . . 55.03 112.339 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -166.93 158.46 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.031 -0.986 . . . . 74.52 108.967 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.422 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 25.6 m-85 -126.11 148.45 63.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.939 -0.305 . . . . 74.14 110.587 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.873 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -66.38 -59.37 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.52 2.147 . . . . 72.01 111.786 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.7 33.15 1.81 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.882 0.372 . . . . 72.53 110.647 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.42 3.55 3.82 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.811 -0.632 . . . . 72.42 112.683 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.2 ptm -56.73 -30.54 63.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.936 0.347 . . . . 75.14 111.936 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.3 -1.78 89.34 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.675 -0.774 . . . . 74.33 112.514 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.422 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 85.3 mtt180 -101.19 -12.19 18.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.578 . . . . 63.3 110.234 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.524 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 21.1 ttmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.616 -1.175 . . . . 74.01 111.433 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.716 0.293 . . . . 71.53 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.67 85.36 6.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.29 0.567 . . . . 72.34 110.394 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.59 -67.73 0.83 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 61.53 111.004 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.471 HD12 ' HA ' ' A' ' 78' ' ' TYR . 48.6 mm -121.03 97.31 48.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 75.33 111.137 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -97.53 121.95 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.446 2.764 . . . . 74.25 112.603 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.36 142.93 87.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.447 2.098 . . . . 74.14 111.09 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.58 -64.24 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.234 0.54 . . . . 74.03 111.143 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -135.02 -147.09 0.26 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.6 -0.727 . . . . 74.33 109.075 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -76.85 165.8 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.191 -0.67 . . . . 74.52 109.191 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HG3' ' A' ' 37' ' ' LYS . 3.0 mp0 -104.18 133.38 20.26 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.658 -0.246 . . . . 75.44 111.521 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.866 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 27.1 Cg_exo -63.36 116.23 3.49 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.552 2.168 . . . . 73.34 110.564 168.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 72.7 Cg_endo -75.28 -18.22 18.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 73.45 113.395 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.505 HD22 HG11 ' A' ' 24' ' ' VAL . 23.1 t-20 -140.42 152.22 45.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.503 -0.555 . . . . 74.14 109.503 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.712 HG23 ' HE1' ' A' ' 39' ' ' PHE . 33.2 m -136.8 144.87 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.382 0.61 . . . . 75.11 111.29 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.84 123.53 43.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.207 -0.906 . . . . 73.21 111.004 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 16' ' ' LEU . 3.0 mm? -108.0 102.78 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.435 -0.348 . . . . 71.21 110.571 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -91.05 108.19 19.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.232 -0.655 . . . . 73.35 109.232 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -101.55 -179.95 4.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.228 0.537 . . . . 60.33 112.09 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB2' HD11 ' A' ' 160' ' ' ILE . 22.9 t -72.48 -11.01 60.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 75.32 110.948 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.437 ' HE2' HG22 ' A' ' 142' ' ' VAL . 4.7 mmt -102.89 -41.05 6.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.623 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.517 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -175.45 -129.39 1.2 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.419 -0.672 . . . . 71.02 111.419 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -139.69 138.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.923 -0.399 . . . . 75.42 109.923 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.63 129.99 64.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.843 -0.617 . . . . 72.42 109.647 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 21.6 t -105.59 134.34 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.361 -0.607 . . . . 75.24 109.361 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.745 ' HB2' HD12 ' A' ' 98' ' ' LEU . 3.8 pp -144.17 160.76 40.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.406 -0.517 . . . . 75.12 111.127 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -146.26 170.04 17.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 73.03 110.631 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.66 169.76 8.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.932 -0.576 . . . . 74.23 110.624 -173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -87.72 105.18 17.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.04 0.447 . . . . 71.41 110.851 176.123 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.493 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 1.4 m0 -85.88 0.06 54.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.005 -0.543 . . . . 71.44 109.854 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -72.62 -68.82 0.45 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.744 -0.662 . . . . 72.14 111.024 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -124.15 11.65 8.85 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.695 -0.402 . . . . 72.41 110.992 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB3' ' CG ' ' A' ' 129' ' ' PHE . . . -129.6 69.19 81.31 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.275 -0.57 . . . . 64.02 112.278 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.551 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 18.8 Cg_exo -65.73 -33.36 44.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.493 1.462 . . . . 70.01 109.706 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -57.0 -56.78 17.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.299 -0.864 . . . . 74.22 110.725 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 m -61.59 -36.22 80.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 70.34 110.823 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.0 t -63.63 -48.64 76.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.22 111.022 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.36 -37.25 77.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.659 0.266 . . . . 74.01 110.405 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HA ' ' HH ' ' A' ' 78' ' ' TYR . 55.4 t-20 -55.58 -62.05 1.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.926 -0.579 . . . . 63.51 110.476 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.712 ' HE1' HG23 ' A' ' 14' ' ' VAL . 5.0 t80 -65.01 -44.7 88.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.696 -0.684 . . . . 71.0 110.767 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.866 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -57.59 -48.77 78.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.451 -0.795 . . . . 63.31 112.198 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.28 -39.27 92.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.927 0.394 . . . . 73.11 111.159 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 3.6 mm? -69.15 -24.32 64.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.548 -0.296 . . . . 74.11 111.056 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.14 36.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.178 -0.464 . . . . 73.43 111.244 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.5 -29.03 70.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.178 0.513 . . . . 75.52 110.184 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 49.1 mtt180 -79.07 -50.55 10.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 75.31 109.86 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.03 52.82 0.68 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.809 . . . . 74.31 113.036 171.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.65 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 3.9 p90 -76.09 -25.97 56.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.343 0.592 . . . . 74.52 110.481 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.676 ' CD1' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.5 -7.95 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.479 -0.782 . . . . 74.25 112.844 -173.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -71.75 -5.73 36.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.499 . . . . 75.53 110.47 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.29 33.87 2.71 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.756 -0.656 . . . . 73.34 111.508 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.831 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.1 p -114.61 153.8 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.858 0.361 . . . . 72.4 111.119 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.565 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -146.13 161.61 39.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.249 -0.432 . . . . 74.33 109.889 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 97.9 m-85 -87.22 124.06 32.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.616 -0.513 . . . . 74.55 109.616 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -105.49 -32.77 8.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.996 -0.282 . . . . 73.12 111.13 -172.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -118.44 107.58 13.99 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.841 -0.343 . . . . 74.01 110.383 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.591 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -120.22 91.43 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.691 -0.855 . . . . 72.34 108.691 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.85 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.3 mt -93.24 128.91 44.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.98 -0.554 . . . . 73.24 110.116 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -52.2 109.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.341 1.026 . . . . 75.32 111.539 -176.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.557 ' OD2' ' HA2' ' A' ' 201' ' ' GLY . 6.6 t70 53.1 50.35 18.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.765 0.793 . . . . 72.14 110.703 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.85 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 7.1 t80 -137.55 -77.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.332 -0.849 . . . . 75.21 109.117 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.647 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.4 ptt? -162.29 154.9 19.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.939 -1.028 . . . . 73.53 109.739 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.591 HG23 HG13 ' A' ' 56' ' ' ILE . 36.1 mt -128.54 101.59 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.124 -0.489 . . . . 73.5 109.817 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.4 tm0? -82.26 126.38 32.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.394 -0.821 . . . . 74.1 109.833 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -142.69 145.68 15.93 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.176 -1.011 . . . . 71.43 113.569 -176.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.831 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 130.33 -138.58 10.3 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.735 -0.745 . . . . 62.15 112.37 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.882 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 23.1 t0 44.85 89.09 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 124.49 1.116 . . . . 74.43 113.249 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 72.6 Cg_endo -75.21 -13.5 20.97 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.863 2.375 . . . . 72.54 111.878 172.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -95.94 -34.9 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 65.14 112.058 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.47 21.92 71.41 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.127 -0.558 . . . . 53.3 112.37 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -120.09 2.24 10.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 73.2 111.159 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.59 -5.08 66.94 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.559 -0.829 . . . . 63.5 112.755 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -88.52 -46.75 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.335 0.588 . . . . 75.32 109.97 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.882 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 72.87 67.98 1.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.468 -0.787 . . . . 73.32 112.451 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.66 -105.05 1.57 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.859 -0.686 . . . . 73.23 111.59 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 53.62 35.85 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.962 0.448 . . . . 73.55 111.353 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 m -56.16 -32.24 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 74.11 111.779 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -70.53 -56.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.367 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' HH ' ' HA ' ' A' ' 38' ' ' ASN . 90.9 m-85 -69.86 -40.13 75.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.324 0.583 . . . . 75.32 110.465 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 -67.7 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.264 -0.88 . . . . 75.13 112.556 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -113.14 -178.65 3.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.156 0.503 . . . . 74.14 112.001 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.414 ' OE1' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -104.01 162.1 13.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.451 -0.795 . . . . 75.45 109.092 177.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -130.3 -67.86 0.72 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.41 -0.516 . . . . 70.24 111.108 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.8 -179.46 5.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.949 0.404 . . . . 74.15 110.466 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.436 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 6.1 p-10 -91.53 136.44 33.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.607 -0.724 . . . . 74.55 109.612 174.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -100.24 15.66 26.84 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 73.53 109.147 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.93 104.58 2.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.438 -0.801 . . . . 75.32 111.697 -173.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -173.37 81.69 0.4 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 75.35 109.906 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.11 93.0 0.46 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.562 2.175 . . . . 74.43 112.342 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.39 -38.56 84.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.365 0.602 . . . . 73.45 110.123 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' CD1' ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -81.16 -176.54 6.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.263 -0.881 . . . . 75.11 110.769 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -122.99 144.11 49.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.758 -0.46 . . . . 75.34 109.758 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.45 76.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.021 0.915 . . . . 73.14 109.677 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.7 p -61.52 -46.7 88.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.474 -1.239 . . . . 73.11 111.768 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.2 -140.21 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.62 -0.8 . . . . 53.24 112.27 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 137.7 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.661 0.267 . . . . 61.04 110.743 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 113.01 20.74 6.23 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.737 -0.744 . . . . 73.43 111.788 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.521 HD13 ' HB3' ' A' ' 189' ' ' PRO . 10.5 mm -87.41 114.7 26.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.238 -0.653 . . . . 74.24 109.238 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD12 ' HB2' ' A' ' 25' ' ' LEU . 8.5 mt -85.47 127.07 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.264 0.554 . . . . 72.02 111.467 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 163.81 26.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.316 -0.856 . . . . 71.41 110.105 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 108' ' ' ASN . 40.7 ttp -97.24 140.26 31.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.637 -0.505 . . . . 73.33 109.637 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.521 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -90.96 137.73 32.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 61.43 110.587 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -137.42 159.1 42.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.569 -0.741 . . . . 61.02 110.304 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.48 -2.11 36.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.605 0.717 . . . . 73.04 110.021 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.5 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -174.21 172.69 45.54 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.884 -1.686 . . . . 75.41 108.884 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 -44.91 34.68 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.659 2.24 . . . . 73.44 112.321 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.29 -3.7 18.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 73.03 110.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.5 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.6 m -85.8 52.44 2.47 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.735 0.779 . . . . 64.02 109.099 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 44.9 m-80 -79.68 130.58 35.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.773 -1.103 . . . . 74.44 110.332 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.27 -138.95 6.46 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.708 -0.758 . . . . 75.15 112.46 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -119.53 14.13 12.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.777 0.322 . . . . 72.42 111.349 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.521 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 pt20 -92.81 168.02 11.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.703 -0.226 . . . . 73.31 110.446 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -145.88 177.49 8.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.802 0.335 . . . . 75.32 111.127 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 45.6 p90 -160.29 151.87 19.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.319 173.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.0 t -106.61 146.84 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 73.53 109.56 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.421 HG21 ' HG1' ' A' ' 119' ' ' THR . 30.2 p -102.01 126.95 49.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.058 -0.349 . . . . 64.24 110.058 177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.456 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 68.2 mt -87.62 -7.71 57.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.317 0.58 . . . . 74.24 110.55 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.542 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . . . -150.89 165.14 18.01 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.397 -0.82 . . . . 72.11 109.809 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 117' ' ' ALA . 18.3 Cg_endo -58.59 113.85 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.631 2.221 . . . . 73.32 111.652 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.421 ' HG1' HG21 ' A' ' 115' ' ' THR . 16.6 p -100.06 88.44 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.231 0.538 . . . . 75.21 111.492 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.667 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -96.9 19.64 12.37 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.916 0.865 . . . . 75.52 108.845 -178.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.952 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -121.19 1.39 10.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.308 -1.314 . . . . 73.3 109.891 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.952 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 63.6 mt -121.71 6.37 9.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.485 -0.779 . . . . 72.13 110.41 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.01 -17.29 64.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 71.1 111.448 -172.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.11 18.58 5.01 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.507 -0.854 . . . . 72.31 111.298 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -120.91 -30.13 4.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.119 0.485 . . . . 73.33 110.249 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -139.67 141.2 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.165 -0.68 . . . . 62.42 109.165 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -78.16 144.55 36.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.978 0.418 . . . . 75.22 110.129 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.432 ' O ' HD23 ' A' ' 90' ' ' LEU . 49.3 mt -122.72 112.96 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.14 -0.482 . . . . 71.22 110.928 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.598 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.0 m-85 -155.82 77.31 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.608 0.568 . . . . 75.22 110.763 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -163.27 164.49 36.12 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.623 -0.799 . . . . 72.53 112.553 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -141.76 126.04 17.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.067 -0.346 . . . . 71.22 110.067 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.9 p -92.56 138.06 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.149 0.499 . . . . 75.13 110.911 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.544 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 47.9 t -144.23 146.0 32.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.1 -0.5 . . . . 73.42 110.204 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.676 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 7.9 tt0 50.25 40.49 22.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.254 0.55 . . . . 72.41 111.991 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.66 17.47 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.151 -1.023 . . . . 75.33 112.512 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 184' ' ' ASP . 11.2 tp -74.27 -33.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.061 -0.256 . . . . 74.41 110.617 -174.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.47 -38.31 96.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.543 -0.837 . . . . 73.54 111.243 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.517 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 76.1 mmm -69.33 -51.82 33.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.0 -0.37 . . . . 73.42 110.0 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.436 HG12 HD11 ' A' ' 62' ' ' ILE . 89.7 t -54.89 -31.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.054 0.454 . . . . 74.52 110.922 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.75 -53.73 12.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 74.23 110.587 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -73.48 -13.92 61.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.556 -0.747 . . . . 74.14 111.078 -176.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 20' ' ' MET . 53.4 t -88.51 -40.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 64.14 110.104 174.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.6 -9.41 86.89 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.708 -0.678 . . . . 74.05 112.735 -177.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.541 ' HG3' HG13 ' A' ' 145' ' ' VAL . 14.6 ptp -96.18 -13.62 23.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.669 0.271 . . . . 74.22 111.21 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 144' ' ' MET . 32.2 m -109.94 126.82 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.272 0.558 . . . . 62.41 111.635 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 1.3 pt-20 -124.46 -45.1 1.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 74.23 109.752 168.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 12.5 p -140.57 152.52 45.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.746 -0.661 . . . . 72.22 110.121 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' HB2' ' H ' ' A' ' 149' ' ' SER . 11.8 p30 -94.06 -144.33 0.24 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.715 -0.22 . . . . 62.45 110.7 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 148' ' ' ASN . 6.5 m -62.7 -25.72 68.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.195 0.521 . . . . 71.24 109.961 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.65 ' HB2' ' HG2' ' A' ' 152' ' ' ARG . 35.0 mt-30 -97.46 169.9 9.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 74.11 108.863 175.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.5 22.8 1.48 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.726 0.774 . . . . 73.34 109.859 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 1.4 ptm180 -102.31 147.95 34.72 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.437 -0.801 . . . . 74.2 110.09 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 31.6 Cg_exo -59.21 134.62 60.43 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.702 2.268 . . . . 73.1 112.33 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 148' ' ' ASN . 34.0 t -64.34 -69.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.398 0.618 . . . . 72.22 110.001 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.4 147.6 47.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.191 -0.913 . . . . 73.23 109.148 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.85 179.85 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.547 -0.538 . . . . 72.24 109.547 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 53' ' ' PHE . 5.7 p -156.13 108.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 122.629 1.204 . . . . 73.35 111.187 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -133.49 159.63 39.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.085 -1.416 . . . . 75.33 109.784 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 159' ' ' ILE . 3.8 mp -81.37 103.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.815 -0.809 . . . . 75.24 108.815 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.3 mm -67.59 -65.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 74.11 109.951 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.525 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 mptm? -133.08 135.84 45.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.394 -0.821 . . . . 74.35 109.098 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.676 ' HB1' ' CD1' ' A' ' 48' ' ' TYR . . . -130.96 143.21 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.938 0.399 . . . . 74.13 110.089 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 17.0 m-85 -133.7 128.94 20.16 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.781 -0.645 . . . . 73.42 109.74 -171.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.433 ' HA ' HG12 ' A' ' 14' ' ' VAL . 74.2 Cg_endo -80.16 129.11 7.62 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.816 1.677 . . . . 64.54 111.529 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p -75.17 113.22 12.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 74.22 109.956 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -139.94 -80.48 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.83 -0.7 . . . . 71.02 112.317 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.63 -2.39 90.63 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 73.14 113.41 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.03 -27.89 9.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.676 -0.773 . . . . 73.3 112.323 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 138.91 -94.13 0.2 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.6 -0.6 . . . . 72.12 111.6 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m -154.44 132.4 11.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.079 -0.341 . . . . 71.02 110.079 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -86.01 54.74 4.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.869 -0.681 . . . . 74.01 112.236 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.84 -170.61 25.68 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.112 -0.566 . . . . 75.11 111.826 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 75.52 -78.0 1.19 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.156 -0.545 . . . . 73.5 112.205 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.7 m -152.24 121.19 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.904 -0.406 . . . . 74.22 109.904 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -74.19 75.36 1.15 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.834 -0.698 . . . . 45.31 112.18 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -110.19 119.7 5.43 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.698 -0.561 . . . . 53.14 111.698 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 174.62 82.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.865 -0.683 . . . . 71.53 111.567 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 50.2 m -133.66 31.92 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.234 0.54 . . . . 74.15 110.223 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -80.41 162.8 46.05 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.663 -0.699 . . . . 73.4 112.031 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -156.53 86.0 0.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.667 -0.777 . . . . 65.04 112.311 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 156.01 158.82 9.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.937 -0.649 . . . . 75.13 112.02 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.0 p -104.65 -52.54 2.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 73.23 110.632 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 95.59 -69.06 1.05 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.979 -0.629 . . . . 72.12 112.114 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.676 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.8 m-20 -100.04 171.68 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 72.53 110.715 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.46 144.01 3.87 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.15 -0.932 . . . . 63.14 111.164 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.88 -174.24 48.34 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.275 -0.964 . . . . 54.2 112.135 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.942 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.42 149.43 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.532 -0.544 . . . . 75.31 109.532 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -89.92 103.47 6.42 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 75.41 110.309 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 90.3 Cg_endo -80.61 -6.69 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.218 1.945 . . . . 71.33 111.066 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.73 -27.48 55.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.666 -1.152 . . . . 73.34 110.764 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 193' ' ' VAL . 15.8 pt -89.0 -12.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.976 -0.556 . . . . 73.22 111.703 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 90' ' ' LEU . 12.0 m170 58.27 45.31 17.38 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.801 -0.636 . . . . 74.13 111.588 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 191' ' ' ILE . 7.0 p -141.91 147.99 21.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.342 -0.39 . . . . 75.32 110.31 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.21 107.81 2.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.162 0.506 . . . . 73.34 112.202 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -158.38 157.48 32.42 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.873 -0.788 . . . . 73.23 108.873 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 202' ' ' ARG . 46.8 m-85 -128.01 151.65 76.22 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.895 -0.322 . . . . 71.44 110.949 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.942 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.6 Cg_endo -67.57 -57.55 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.408 2.072 . . . . 74.43 111.711 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.449 HD22 ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -126.52 15.85 7.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.13 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 1.2 m-20 64.18 22.98 13.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.583 0.957 . . . . 60.13 113.583 171.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.77 -46.87 51.09 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.886 -0.325 . . . . 71.52 111.494 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.557 ' HA2' ' OD2' ' A' ' 59' ' ' ASP . . . -79.09 0.5 79.01 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.053 -0.594 . . . . 70.44 113.593 -172.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 15.9 ptm180 -96.33 -18.01 20.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.157 0.503 . . . . 74.41 111.168 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.493 -0.776 . . . . 64.53 109.904 -175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.973 -0.38 . . . . 74.01 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.89 99.47 3.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.378 0.609 . . . . 73.54 111.16 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.31 -61.08 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.322 -0.854 . . . . 71.43 108.772 173.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 mm -128.57 123.34 22.17 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.053 -0.976 . . . . 74.32 109.109 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.54 147.88 21.98 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.802 2.334 . . . . 75.41 112.445 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.23 150.45 32.6 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.91 2.407 . . . . 75.14 112.421 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.54 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 2.0 m-20 -75.91 55.12 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 72.34 110.747 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.603 ' HB2' HE22 ' A' ' 10' ' ' GLN . 6.7 m -78.64 -162.48 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.685 -0.689 . . . . 74.13 109.868 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 9.4 p-90 -57.3 -65.92 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.849 0.314 . . . . 75.41 111.849 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.618 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 2.3 mp0 69.34 159.39 0.15 Allowed Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 122.892 0.477 . . . . 73.04 111.564 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 40' ' ' ALA . 50.9 Cg_exo -55.29 119.33 6.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.742 2.295 . . . . 73.21 112.701 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 29' ' ' TRP . 71.8 Cg_endo -78.98 -13.51 14.11 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.813 2.342 . . . . 72.41 112.575 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.631 HD22 HG13 ' A' ' 24' ' ' VAL . 4.0 t-20 -151.72 142.01 22.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 75.45 109.666 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.6 149.33 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.823 0.344 . . . . 71.54 110.952 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.686 ' CD1' ' HB2' ' A' ' 165' ' ' SER . 7.0 m-85 -107.89 132.57 53.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.02 -0.536 . . . . 73.41 110.789 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 16' ' ' LEU . 2.4 mm? -118.88 102.5 8.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.498 -0.774 . . . . 74.52 109.917 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.36 109.58 17.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.088 -0.708 . . . . 71.42 109.088 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -98.28 178.2 5.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.939 0.4 . . . . 74.41 110.769 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.496 ' HB3' HD11 ' A' ' 160' ' ' ILE . 6.9 p -70.96 -28.14 64.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.961 -0.563 . . . . 65.12 111.365 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.537 ' SD ' HG22 ' A' ' 142' ' ' VAL . 83.3 mtp -91.05 -41.58 10.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.55 -0.296 . . . . 73.44 111.118 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.501 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -163.8 -143.08 3.59 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.858 -0.687 . . . . 54.23 111.396 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' O ' HD12 ' A' ' 23' ' ' ILE . 20.4 tt -128.11 138.92 53.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 117.026 0.413 . . . . 71.43 109.895 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 22' ' ' ILE . 10.8 mm -125.53 132.27 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.617 -0.512 . . . . 75.41 109.617 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 18.3 t -120.0 139.86 45.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 110.14 -0.319 . . . . 75.41 110.14 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 161.37 42.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 73.32 110.449 174.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 14.6 pt-20 -130.87 167.68 18.53 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.015 -0.539 . . . . 74.02 110.167 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.28 157.9 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.416 -0.356 . . . . 74.23 110.688 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.611 ' HH ' ' HG2' ' A' ' 189' ' ' PRO . 4.9 m-85 -80.07 102.49 9.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 72.22 111.499 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 12' ' ' PRO . 11.5 m0 -80.58 -6.27 58.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.887 -0.597 . . . . 73.21 110.453 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.541 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -73.83 -53.35 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 74.55 111.732 -172.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.62 6.09 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.925 0.342 . . . . 73.42 111.925 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 35' ' ' THR . . . -132.19 79.01 67.46 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.996 0.426 . . . . 72.33 111.52 -176.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.8 Cg_exo -71.84 -41.03 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.371 2.047 . . . . 74.12 111.573 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -77.33 -43.31 33.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.933 -0.576 . . . . 74.43 110.143 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 32' ' ' ALA . 2.1 m -57.23 -42.38 81.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 72.33 110.334 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.7 t -60.77 -47.96 83.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 75.12 110.651 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.618 ' HE2' ' HB2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -62.95 -35.53 80.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.202 -0.453 . . . . 74.41 111.153 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.22 -53.31 59.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 73.14 110.76 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.481 ' HZ ' ' HG3' ' A' ' 100' ' ' MET . 76.9 m-85 -67.96 -44.42 76.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 64.55 111.164 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.649 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . -61.84 -35.96 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 63.42 112.13 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -66.35 -44.71 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.422 0.63 . . . . 72.32 109.948 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.745 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . 30.4 mt -67.64 -22.12 65.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.144 -0.48 . . . . 74.11 111.128 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.0 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 72.31 110.362 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 32.4 mmt180 -63.84 -49.6 72.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.311 0.576 . . . . 65.44 110.073 174.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -74.9 -51.97 12.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.378 -0.828 . . . . 71.12 110.802 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.9 44.86 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 74.42 112.129 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.745 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -70.6 -26.53 63.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.042 0.449 . . . . 74.14 110.714 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.3 m-85 -76.67 -16.49 59.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 75.41 111.572 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -74.52 2.33 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 73.3 110.942 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.32 11.7 5.26 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.921 -0.657 . . . . 53.42 111.907 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.573 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.4 p -90.45 137.93 31.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 74.22 110.951 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 2.0 mtmt -129.49 150.75 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.388 -0.597 . . . . 75.14 109.388 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 72.4 m-85 -78.05 122.37 25.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.851 -0.425 . . . . 72.34 109.851 177.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -107.36 -30.46 8.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.55 -0.295 . . . . 64.51 111.064 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 25.5 mmt180 -119.04 110.58 17.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.907 -0.405 . . . . 73.41 109.907 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.4 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -127.15 93.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 74.15 109.082 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 35.2 mt -104.1 125.48 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.028 -0.533 . . . . 75.24 109.94 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -50.42 129.39 21.84 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.65 0.594 . . . . 75.32 111.62 177.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' HE3' ' A' ' 58' ' ' LYS . 3.4 p30 42.22 43.74 3.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.231 0.957 . . . . 75.5 112.418 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.709 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -135.67 -77.54 0.43 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 74.35 110.291 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.7 ptp -160.05 156.05 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 64.34 110.634 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.498 ' CD1' HD22 ' A' ' 116' ' ' LEU . 40.6 mt -131.58 101.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.736 -0.666 . . . . 72.22 109.417 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -88.42 128.92 35.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.647 -0.706 . . . . 73.2 109.802 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -137.17 144.24 15.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.708 -0.758 . . . . 71.33 112.369 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 147.14 -143.3 11.17 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.658 -0.782 . . . . 60.11 112.578 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' HE22 ' A' ' 111' ' ' GLN . 44.5 t0 46.86 77.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 124.16 0.984 . . . . 70.43 112.71 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.72 -12.08 22.09 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.495 2.13 . . . . 73.32 111.587 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.423 ' HB ' HG21 ' A' ' 70' ' ' THR . 20.0 p -91.81 -42.83 9.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.458 -0.792 . . . . 74.25 111.961 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.22 32.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.602 -0.809 . . . . 70.53 112.001 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.55 HG23 ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.45 -2.65 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 72.15 111.038 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.69 -35.7 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.381 -0.914 . . . . 73.42 113.316 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HG2' HG23 ' A' ' 70' ' ' THR . 14.3 ptm180 -78.67 -28.88 45.38 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.219 0.509 . . . . 74.05 110.888 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.04 -162.65 54.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.023 -0.608 . . . . 75.41 113.179 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.97 6.79 61.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.294 -0.479 . . . . 72.55 112.386 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 110' ' ' SER . . . -87.35 22.59 2.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.34 1.067 . . . . 71.41 110.723 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -85.51 5.8 29.76 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.318 -1.31 . . . . 74.2 109.805 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.49 -28.51 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.342 -0.845 . . . . 70.4 111.213 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.436 ' OH ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 p90 -100.18 10.86 40.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.512 0.672 . . . . 75.21 110.788 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.41 -110.26 3.96 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.11 -0.95 . . . . 74.22 112.417 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -95.88 -169.02 1.86 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.426 0.291 . . . . 74.33 110.275 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 159.26 26.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 71.24 109.826 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -102.47 -85.18 0.44 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.836 0.35 . . . . 74.53 110.944 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -162.02 157.19 23.19 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.459 -0.941 . . . . 75.55 108.459 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.31 110.95 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.533 0.682 . . . . 64.45 110.438 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.43 28.83 3.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.841 -0.618 . . . . 72.11 109.377 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.38 100.31 0.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 72.05 110.502 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -159.92 72.74 3.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.798 -0.637 . . . . 75.14 109.827 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.21 98.21 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.206 1.938 . . . . 73.3 112.642 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.56 24.39 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.489 0.662 . . . . 73.34 110.318 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.66 HD12 ' HB2' ' A' ' 189' ' ' PRO . 1.8 pp -137.24 -169.06 2.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.501 -0.772 . . . . 75.13 110.278 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -140.6 151.06 44.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.033 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -72.43 69.5 0.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.713 0.768 . . . . 75.23 110.668 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.9 p -68.7 -39.94 80.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.174 -0.921 . . . . 72.11 111.824 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 -142.43 3.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.504 -0.855 . . . . 73.14 112.913 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 141.62 28.43 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.302 0.241 . . . . 60.32 111.018 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 111.41 22.2 6.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.793 -0.718 . . . . 52.14 111.917 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.1 mm -87.52 111.25 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.684 -0.487 . . . . 74.42 109.684 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -88.44 118.9 28.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.139 0.495 . . . . 73.41 109.715 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 128' ' ' ILE . . . -129.3 173.4 10.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.063 -0.517 . . . . 52.42 110.817 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.521 ' HE1' ' HB2' ' A' ' 108' ' ' ASN . 12.3 ttp -104.02 137.04 42.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.141 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -89.21 144.46 26.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 63.35 110.73 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.511 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.2 p-10 -153.12 158.77 42.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 71.15 110.593 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.19 -16.56 20.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.74 0.781 . . . . 75.31 109.794 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.404 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -157.05 174.07 34.65 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.698 -1.761 . . . . 71.11 108.698 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.03 -47.73 22.52 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.844 2.363 . . . . 74.42 112.082 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -104.31 -5.07 22.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 64.22 110.986 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -87.61 49.33 1.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.767 0.794 . . . . 63.01 108.865 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.521 ' HB2' ' HE1' ' A' ' 100' ' ' MET . 5.7 p30 -94.37 145.08 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 74.22 111.386 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -129.79 -167.26 12.04 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.013 -1.235 . . . . 71.31 110.013 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 19.5 t -87.47 14.88 7.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.94 0.87 . . . . 65.41 110.016 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 10.1 mm-40 -67.53 145.99 54.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.056 -1.09 . . . . 72.41 108.056 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.72 166.32 24.25 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.191 -0.603 . . . . 71.24 111.433 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.51 151.38 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.777 -0.647 . . . . 73.33 110.128 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.692 HG22 HD22 ' A' ' 98' ' ' LEU . 17.5 t -110.39 143.65 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.221 -0.659 . . . . 75.11 109.221 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.765 HG21 ' HG1' ' A' ' 119' ' ' THR . 29.3 p -98.99 126.38 44.67 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.048 0.451 . . . . 72.23 110.159 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.498 HD22 ' CD1' ' A' ' 62' ' ' ILE . 69.3 mt -83.99 -5.87 59.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.721 -0.672 . . . . 71.05 110.629 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . . . -146.5 162.01 36.01 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.706 -0.679 . . . . 61.15 109.829 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 117' ' ' ALA . 21.6 Cg_endo -61.8 112.91 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.653 2.235 . . . . 72.14 112.018 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.765 ' HG1' HG21 ' A' ' 115' ' ' THR . 16.2 p -97.51 102.72 14.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.397 0.618 . . . . 73.53 111.163 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.52 17.71 23.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.424 0.631 . . . . 72.54 110.355 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.29 -3.38 9.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 72.11 111.673 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.1 pp -133.07 8.17 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 74.43 112.443 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -62.74 -27.48 69.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.007 0.432 . . . . 74.44 111.021 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.34 11.35 36.53 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.751 . . . . 74.0 112.05 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -117.18 -27.46 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.489 0.661 . . . . 75.42 109.56 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.38 130.46 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 74.53 108.68 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.0 t -75.37 143.95 42.55 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.198 -0.601 . . . . 72.21 110.109 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 99' ' ' ALA . 42.4 mt -122.95 116.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 73.44 110.501 -173.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.6 m-85 -151.96 74.13 1.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.998 0.427 . . . . 74.25 110.459 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.74 155.81 27.27 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.719 -0.753 . . . . 71.14 112.179 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.417 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 14.3 mtp180 -135.07 118.91 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.426 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.0 p -79.96 136.94 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.405 0.622 . . . . 71.4 110.55 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.667 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 44.1 t -141.8 145.76 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.674 -0.694 . . . . 74.52 109.693 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.5 tt0 42.75 48.75 4.92 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.483 0.658 . . . . 73.51 112.363 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -172.12 13.58 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.833 -1.175 . . . . 65.35 112.988 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.542 HG21 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -73.54 -31.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.874 0.337 . . . . 74.34 110.238 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -37.38 94.75 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.701 -0.762 . . . . 53.14 111.203 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.566 ' O ' HG21 ' A' ' 142' ' ' VAL . 69.8 mmm -72.47 -50.66 24.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.85 -0.426 . . . . 72.42 109.85 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.426 HG11 HD12 ' A' ' 62' ' ' ILE . 90.1 t -53.91 -30.65 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 71.42 110.83 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -69.91 -52.47 24.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.962 -0.563 . . . . 74.43 110.612 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.23 -17.07 60.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.447 -0.342 . . . . 75.55 111.402 -179.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 138' ' ' MET . 83.9 t -83.47 -34.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 73.42 109.957 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -91.01 -3.74 69.87 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.864 -0.684 . . . . 72.52 112.619 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.6 ptm -95.89 -12.2 25.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.728 0.299 . . . . 73.11 110.954 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 142' ' ' VAL . 21.4 m -83.28 116.39 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.668 . . . . 75.45 110.397 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.06 -61.76 1.65 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.543 -0.753 . . . . 73.25 111.397 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.1 p -143.68 163.45 33.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.232 0.539 . . . . 62.42 111.736 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -89.42 168.92 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.433 -0.951 . . . . 71.03 108.433 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.2 m -57.88 -19.11 27.01 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.201 0.815 . . . . 73.2 113.201 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -84.77 13.55 5.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.956 0.354 . . . . 73.3 111.956 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 63.52 36.94 10.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.56 0.695 . . . . 75.03 110.748 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 152.7 75.46 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 74.14 108.833 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.36 145.3 21.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.351 2.034 . . . . 72.0 111.528 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.16 -25.41 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.828 0.347 . . . . 75.32 110.84 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 81.24 -80.95 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.195 0.813 . . . . 74.54 113.195 163.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.54 91.38 5.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.013 0.911 . . . . 74.41 112.652 -170.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.73 120.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.105 -0.952 . . . . 74.44 109.326 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -155.88 176.42 12.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.251 -0.886 . . . . 74.33 110.486 -171.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 159' ' ' ILE . 3.3 mp -90.17 109.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.456 -0.572 . . . . 74.11 109.456 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.626 HG21 ' HD3' ' A' ' 161' ' ' LYS . 27.6 mm -75.48 -49.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.628 -0.715 . . . . 75.04 110.871 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.626 ' HD3' HG21 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.78 140.55 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.774 -0.648 . . . . 74.33 109.92 178.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -144.01 134.91 25.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.846 0.355 . . . . 74.4 111.574 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -160.64 151.77 15.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 74.12 110.375 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 10.3 Cg_exo -70.73 142.23 43.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.832 2.355 . . . . 75.14 112.483 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.686 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 46.7 m -160.58 -162.4 0.95 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.383 -0.599 . . . . 74.21 109.383 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.02 38.96 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.565 -0.826 . . . . 74.22 112.412 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.37 103.93 2.1 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.676 -0.773 . . . . 75.13 111.791 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.9 129.34 48.03 Favored Glycine 0 C--O 1.236 0.262 0 C-N-CA 121.329 -0.462 . . . . 71.42 112.473 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -159.41 162.84 33.12 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.922 -0.656 . . . . 71.02 112.045 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.4 m -90.57 -48.44 7.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.922 0.391 . . . . 73.23 110.204 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.3 -64.87 3.43 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.898 -0.592 . . . . 72.51 112.408 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 105.78 -90.01 0.65 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.171 -0.772 . . . . 74.43 111.171 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 95.37 163.35 34.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.887 -0.673 . . . . 54.14 112.608 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 p -73.46 -36.72 65.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.922 0.391 . . . . 73.55 111.209 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -135.66 71.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 52.24 111.897 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.73 -158.77 12.95 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.643 -0.789 . . . . 60.41 112.413 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.09 -7.95 67.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.122 -0.561 . . . . 74.11 112.046 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.4 p -80.67 169.06 18.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.62 0.247 . . . . 75.54 110.982 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.98 135.8 21.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.048 -0.596 . . . . 72.55 112.483 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.77 60.41 0.26 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.228 -0.51 . . . . 44.05 111.889 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.03 24.63 9.93 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.362 -0.695 . . . . 53.22 111.362 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.9 m -84.93 139.22 31.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.808 0.337 . . . . 65.12 110.547 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.12 6.53 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.865 -0.684 . . . . 61.51 112.0 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.542 ' HB3' HG21 ' A' ' 136' ' ' ILE . 4.2 m-20 -85.38 -175.25 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.933 0.397 . . . . 73.12 110.123 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 170.08 142.95 3.74 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.719 -0.753 . . . . 62.43 111.515 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -82.44 -164.62 35.09 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.261 -0.971 . . . . 75.22 111.992 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.822 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.32 166.95 22.5 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.112 -0.329 . . . . 71.51 110.112 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.31 95.19 41.92 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-O 121.153 0.502 . . . . 73.23 110.336 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.66 ' HB2' HD12 ' A' ' 90' ' ' LEU . 55.6 Cg_endo -70.77 -19.37 31.41 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.914 2.409 . . . . 74.12 111.651 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.517 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 32.0 tt0 -73.09 -37.53 66.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.903 -1.044 . . . . 74.03 111.522 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.513 HG13 HG11 ' A' ' 193' ' ' VAL . 30.4 pt -75.14 -13.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.175 -0.466 . . . . 73.21 111.75 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 59.8 m170 63.02 70.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 73.54 111.231 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 191' ' ' ILE . 9.3 p -170.8 140.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 74.23 110.003 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.31 117.18 7.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 73.21 111.517 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.35 149.31 11.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.097 -0.705 . . . . 74.13 109.097 175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 29.0 m-85 -120.2 147.41 44.77 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.744 -0.207 . . . . 75.43 110.852 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.822 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.4 Cg_endo -63.67 -64.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.527 2.151 . . . . 72.31 112.025 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.73 26.55 4.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.215 0.531 . . . . 71.52 109.985 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.49 ' OD1' ' HD3' ' A' ' 202' ' ' ARG . 78.3 m-20 70.08 6.55 5.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.225 -0.898 . . . . 74.11 112.05 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.9 ptm -54.24 -34.28 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 71.44 112.198 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.96 10.91 71.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.358 -0.925 . . . . 72.32 113.222 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.49 ' HD3' ' OD1' ' A' ' 199' ' ' ASP . 4.7 ptm180 -127.21 -39.59 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.138 0.469 . . . . 75.54 110.501 176.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 203' ' ' LYS . 1.2 ptmm? . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.853 -0.594 . . . . 64.54 110.124 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.859 0.361 . . . . 74.41 110.265 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.15 91.8 7.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.103 0.478 . . . . 74.31 110.444 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.18 -36.24 14.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.656 -0.702 . . . . 72.43 110.273 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.3 mm -129.7 126.76 22.77 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.171 -0.922 . . . . 71.33 109.805 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 32.5 Cg_endo -64.41 140.09 68.16 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.565 2.176 . . . . 73.34 112.303 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 19.0 Cg_exo -66.73 166.23 22.99 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.62 2.213 . . . . 75.3 111.774 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -53.22 104.43 0.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.11 0.481 . . . . 71.03 110.91 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -129.61 -156.55 0.76 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.572 -0.74 . . . . 63.3 109.525 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -83.6 90.82 7.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.078 0.942 . . . . 63.25 110.629 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HB2' ' HZ2' ' A' ' 37' ' ' LYS . 2.4 mp0 -100.6 135.47 20.13 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 114.138 -1.392 . . . . 73.2 109.031 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' CB ' ' HB2' ' A' ' 164' ' ' PRO . 82.2 Cg_exo -46.92 123.03 6.8 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.253 2.635 . . . . 65.4 113.061 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.75 -24.72 15.35 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.972 2.448 . . . . 74.24 113.279 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.782 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 11.1 t-20 -131.87 146.66 52.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.574 -0.528 . . . . 71.44 109.574 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.675 HG22 ' HE1' ' A' ' 39' ' ' PHE . 22.0 m -131.72 144.17 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.311 0.577 . . . . 73.14 111.157 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 77.0 m-85 -97.71 120.41 38.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.632 -0.713 . . . . 73.23 110.701 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -107.57 103.81 13.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.043 -0.354 . . . . 71.34 110.043 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HG2' HG12 ' A' ' 22' ' ' ILE . 29.6 mt-10 -92.18 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.491 -0.559 . . . . 75.43 109.491 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -103.5 179.26 4.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.162 0.506 . . . . 72.11 111.534 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' ' 160' ' ' ILE . 11.5 p -73.62 -18.35 61.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 73.01 111.176 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.7 mmm -98.65 -35.86 10.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 73.32 111.201 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.564 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -172.4 -133.94 1.72 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.691 . . . . 63.21 111.817 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.495 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -141.4 133.83 29.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.075 -0.713 . . . . 75.22 109.075 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -127.76 126.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.757 -0.656 . . . . 64.41 109.777 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.688 HG13 HD22 ' A' ' 13' ' ' ASN . 10.9 t -108.44 135.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.553 -0.536 . . . . 72.15 109.553 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' C ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.24 162.21 39.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.346 0.593 . . . . 75.41 110.621 175.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' A' ' 131' ' ' ARG . 2.7 pt-20 -140.42 164.6 29.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.91 -1.041 . . . . 74.25 109.398 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HG ' ' A' ' 36' ' ' CYS . 1.1 mm? -100.28 175.37 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.891 0.377 . . . . 74.13 110.826 -171.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.3 m-85 -88.92 101.49 14.12 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.31 0.576 . . . . 73.23 111.052 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.401 ' HZ2' ' HB2' ' A' ' 26' ' ' GLU . 0.8 OUTLIER -82.21 -2.13 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.261 -0.881 . . . . 74.03 110.486 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -75.07 -67.5 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 74.52 111.24 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -117.51 13.08 14.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 73.41 110.782 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' A' ' 35' ' ' THR . . . -136.91 62.2 39.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.824 0.345 . . . . 62.13 110.945 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.594 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 18.5 Cg_exo -65.99 -50.96 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.591 2.194 . . . . 75.04 112.091 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -74.02 -35.08 64.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.401 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.533 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.4 m -62.96 -37.6 87.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.714 -0.675 . . . . 72.22 110.08 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.59 ' HG ' HD21 ' A' ' 27' ' ' LEU . 25.2 t -63.85 -39.58 94.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.79 -0.641 . . . . 75.21 110.925 175.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mmpt? -63.73 -39.66 94.83 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.831 -0.433 . . . . 73.41 109.831 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -53.7 -57.51 10.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.698 -0.683 . . . . 72.25 110.133 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.675 ' HE1' HG22 ' A' ' 14' ' ' VAL . 17.3 t80 -59.29 -49.71 76.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 72.22 110.754 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.99 75.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.391 -0.822 . . . . 62.31 112.357 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.641 ' OE2' ' HD3' ' A' ' 44' ' ' ARG . 25.9 mm-40 -63.27 -41.93 99.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.638 -0.255 . . . . 74.35 111.602 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 47' ' ' TYR . 3.6 mm? -69.29 -27.36 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.254 -0.578 . . . . 75.53 110.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.0 65.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 74.11 110.802 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.641 ' HD3' ' OE2' ' A' ' 41' ' ' GLU . 2.9 ptm180 -75.05 -29.39 60.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 74.31 111.39 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 1.3 tmt_? -65.23 -37.31 86.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.35 0.595 . . . . 74.23 109.854 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.5 32.14 2.2 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.587 -0.816 . . . . 72.11 111.987 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.488 ' HB2' HD11 ' A' ' 42' ' ' LEU . 85.0 t80 -85.91 -44.31 12.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.015 0.436 . . . . 74.13 110.259 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -78.71 -9.27 59.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.057 -0.52 . . . . 75.12 111.041 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -77.62 8.01 4.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.402 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.83 16.27 1.98 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.871 -0.604 . . . . 73.13 111.891 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.68 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -97.95 159.45 14.92 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.707 -0.29 . . . . 64.54 110.832 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -140.63 146.82 38.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.81 0.338 . . . . 72.52 111.544 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 65.4 m-85 -78.48 100.91 7.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.407 -0.961 . . . . 75.2 108.407 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -109.98 -14.56 14.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.471 -0.492 . . . . 74.34 111.671 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.936 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 12.7 mmm180 -110.03 112.92 25.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.092 -0.707 . . . . 71.0 109.092 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 62' ' ' ILE . 19.7 mm -124.84 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.348 -0.612 . . . . 65.42 109.348 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 10.8 mt -102.0 115.49 43.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.652 -0.499 . . . . 65.34 109.652 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.646 ' HD2' ' HB3' ' A' ' 146' ' ' GLU . 38.7 mtpt -57.13 129.27 41.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.127 0.267 . . . . 73.34 111.269 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.99 26.69 16.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.545 -0.752 . . . . 71.41 110.979 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -128.93 -81.71 0.57 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 74.32 109.976 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -161.04 159.71 29.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 75.23 110.325 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD12 ' HA3' ' A' ' 143' ' ' GLY . 62.4 mt -128.78 103.48 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 74.45 109.382 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.936 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 50.9 mt-30 -85.6 124.53 32.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.606 -0.725 . . . . 73.41 111.526 -176.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.02 139.16 10.74 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.754 -0.657 . . . . 71.22 112.487 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.68 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 142.96 -154.77 25.58 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.466 -0.873 . . . . 71.25 112.85 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.1 t0 55.78 102.6 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.355 1.062 . . . . 72.22 112.714 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.77 -17.16 11.17 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.102 2.535 . . . . 75.43 111.515 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.9 p -90.3 -38.27 13.5 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.787 -0.642 . . . . 64.32 110.305 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.28 25.85 60.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 71.2 111.359 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.422 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 76.1 p -97.96 -35.24 10.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 72.34 111.078 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.87 -20.85 6.71 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.668 -0.696 . . . . 71.51 112.274 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 7.2 ptm180 -93.57 -28.0 16.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 75.24 110.934 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.76 -179.52 53.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.7 -0.762 . . . . 72.32 111.831 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.477 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . -79.74 -87.52 0.54 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.861 -0.685 . . . . 63.31 112.371 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.44 27.07 4.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.845 0.831 . . . . 63.54 111.228 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -85.99 16.39 4.23 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.041 -0.981 . . . . 62.03 111.754 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG13 ' HD1' ' A' ' 78' ' ' TYR . 46.4 pt -81.85 -29.53 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.715 -0.394 . . . . 73.45 110.143 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.571 ' HD1' HG13 ' A' ' 77' ' ' ILE . 2.9 p90 -117.95 14.05 14.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.924 0.868 . . . . 74.51 110.521 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -77.06 1.81 Allowed Glycine 0 C--N 1.318 -0.441 0 CA-C-N 114.59 -1.186 . . . . 72.43 113.425 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -111.98 -163.85 0.88 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.272 -0.27 . . . . 74.15 110.272 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.61 168.0 14.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.647 . . . . 73.13 109.252 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -98.88 -80.1 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.77 -0.372 . . . . 75.01 111.308 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.51 163.57 27.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.964 -0.754 . . . . 71.51 108.964 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.34 143.66 34.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 74.43 109.756 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 23.8 7.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.75 -0.659 . . . . 74.13 109.604 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 78.2 mt -54.51 100.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.52 -0.764 . . . . 71.2 111.648 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.61 91.33 0.43 Allowed Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.39 -0.823 . . . . 72.35 109.412 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 90' ' ' LEU . 19.2 Cg_endo -57.6 92.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.611 2.207 . . . . 74.42 111.071 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.28 23.3 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.145 0.974 . . . . 75.51 109.146 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -145.3 -176.88 5.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.361 -1.29 . . . . 74.34 108.625 -178.322 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HD3' HG22 ' A' ' 93' ' ' THR . 54.2 tttm -113.61 147.88 37.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.324 0.583 . . . . 72.53 110.938 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.24 79.99 4.67 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.091 0.948 . . . . 74.33 108.481 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.417 HG22 ' HD3' ' A' ' 91' ' ' LYS . 26.8 p -75.65 -41.95 52.69 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.612 -1.176 . . . . 74.32 111.838 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.791 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.83 -137.79 2.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.658 -0.782 . . . . 74.05 112.293 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.77 147.29 24.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.815 0.341 . . . . 40.21 110.891 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 106.41 21.95 8.08 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.446 -0.662 . . . . 75.11 111.446 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 mm -90.03 110.9 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.479 -0.563 . . . . 73.42 109.479 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.967 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -85.89 117.77 24.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.76 -0.654 . . . . 73.21 109.538 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.0 169.81 12.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.125 0.488 . . . . 74.42 111.854 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.846 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 14.0 tpt -90.45 135.4 33.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.412 -0.813 . . . . 75.24 109.983 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -97.86 149.33 22.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.522 -0.548 . . . . 74.2 109.522 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.656 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -163.11 159.26 22.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 73.11 110.7 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.39 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.627 0.727 . . . . 74.0 109.814 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.423 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -137.31 177.76 19.56 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.988 -1.645 . . . . 64.43 108.988 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 -51.84 9.72 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.021 2.481 . . . . 74.02 112.86 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.7 -4.83 29.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 71.14 111.59 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 2.2 m -88.81 49.68 1.83 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.327 0.584 . . . . 72.55 109.469 -175.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.656 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -74.27 -66.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.806 -1.088 . . . . 51.54 110.944 178.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 -100.77 2.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.625 -0.797 . . . . 71.25 112.343 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -152.87 35.94 0.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.012 0.434 . . . . 72.52 110.81 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 19.9 mt-30 -102.54 146.56 27.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 74.51 110.186 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -142.44 166.9 23.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.711 0.291 . . . . 73.43 110.795 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -158.59 153.23 24.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.926 0.393 . . . . 74.41 111.004 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.694 HG23 HD21 ' A' ' 98' ' ' LEU . 17.7 t -108.62 145.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 74.44 109.265 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.651 HG23 ' HG1' ' A' ' 119' ' ' THR . 27.6 p -99.88 129.67 45.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.897 0.379 . . . . 61.14 110.452 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD23 ' CD1' ' A' ' 62' ' ' ILE . 64.7 mt -84.79 -9.63 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.644 -0.707 . . . . 74.15 110.984 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.32 164.18 28.03 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.9 -0.591 . . . . 62.4 110.054 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.791 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 35.5 Cg_exo -60.98 114.52 2.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.454 2.103 . . . . 75.12 111.493 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.651 ' HG1' HG23 ' A' ' 115' ' ' THR . 8.7 p -100.12 94.56 6.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.277 0.561 . . . . 74.55 111.189 -174.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -98.11 14.56 27.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 72.11 110.104 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.586 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.6 p90 -118.29 -3.36 11.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.026 -0.988 . . . . 74.51 110.495 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.591 HD23 ' HD2' ' A' ' 126' ' ' HIS . 83.5 mt -105.06 8.82 34.44 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.792 -0.64 . . . . 74.21 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.1 -23.58 55.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.064 -1.425 . . . . 75.14 111.315 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.29 23.22 3.49 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 120.874 -0.679 . . . . 72.4 111.983 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.45 -32.95 3.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.936 0.398 . . . . 72.21 110.279 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.591 ' HD2' HD23 ' A' ' 122' ' ' LEU . 96.9 m-70 -141.24 139.53 33.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 74.32 110.322 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.7 m -75.46 135.98 40.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.777 -0.453 . . . . 64.1 109.777 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -115.46 124.75 72.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 121.058 -0.257 . . . . 74.25 110.828 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.846 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 3.8 p90 -157.4 74.07 0.75 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.949 0.88 . . . . 75.05 110.932 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.967 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.83 152.39 22.55 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.01 -1.567 . . . . 74.12 113.841 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.593 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -138.62 110.2 7.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 74.55 109.726 174.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.9 p -79.93 139.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 72.43 111.264 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.625 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.1 t -142.47 151.71 42.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.096 -0.502 . . . . 71.5 109.892 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 42.42 60.07 2.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.258 0.623 . . . . 73.21 112.15 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.54 24.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.035 -1.079 . . . . 71.23 112.883 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tp -78.02 -32.51 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.109 -0.33 . . . . 73.55 110.109 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.46 -37.35 94.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.949 -0.644 . . . . 64.25 111.934 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.564 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 74.9 mmm -67.02 -51.1 59.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.511 -0.551 . . . . 73.15 109.511 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 62' ' ' ILE . 74.8 t -54.21 -32.92 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 74.13 110.586 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.476 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.8 t30 -71.29 -56.08 6.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 73.53 110.656 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.8 -13.8 61.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.463 -0.335 . . . . 70.35 111.307 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 145' ' ' VAL . 44.6 t -88.82 -36.62 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 65.41 110.505 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.537 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -83.52 -18.98 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 72.12 113.2 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 60.5 mtp -89.87 -8.76 51.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.2 0.444 . . . . 73.25 112.2 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 142' ' ' VAL . 30.1 m -87.09 160.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.468 . . . . 63.04 110.737 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.646 ' HB3' ' HD2' ' A' ' 58' ' ' LYS . 15.2 pt-20 -141.93 -49.82 0.39 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.141 -0.481 . . . . 63.15 110.583 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 16.8 p -119.04 146.02 45.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.751 0.31 . . . . 64.13 111.156 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 154' ' ' VAL . 32.1 p-10 -92.56 -32.52 14.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.329 0.492 . . . . 72.44 112.329 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.6 m -147.06 -67.37 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.984 0.421 . . . . 72.45 110.226 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' A' ' 147' ' ' THR . 28.9 mm-40 -101.8 -157.01 0.58 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.892 -0.781 . . . . 64.12 108.892 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.6 59.7 2.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.077 0.942 . . . . 74.43 109.72 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.538 ' HG3' ' OD1' ' A' ' 148' ' ' ASN . 12.2 ptp180 -138.72 135.51 17.9 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.302 -1.317 . . . . 64.31 108.735 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 16.8 Cg_exo -65.4 149.03 88.53 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.643 2.229 . . . . 74.2 113.671 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.539 ' HA ' ' HB3' ' A' ' 148' ' ' ASN . 40.7 t -65.63 151.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.433 -0.803 . . . . 75.33 110.191 175.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.64 137.59 48.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.302 -0.408 . . . . 70.13 110.014 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -71.74 145.85 48.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.54 -0.541 . . . . 63.54 109.54 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.99 125.93 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.057 -0.52 . . . . 75.55 110.644 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.95 159.37 19.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.265 0.555 . . . . 70.54 111.443 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.443 HG23 ' HB3' ' A' ' 162' ' ' ALA . 4.3 mp -87.74 102.4 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.644 -1.162 . . . . 75.41 108.494 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 19' ' ' SER . 30.7 mm -68.21 -56.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.537 -0.756 . . . . 74.41 110.009 -176.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 14.5 mptt -127.4 136.97 52.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 72.35 109.998 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 159' ' ' ILE . . . -133.81 115.96 15.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.939 0.399 . . . . 70.23 110.385 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.62 116.3 26.59 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.64 . . . . 72.0 110.918 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.59 ' HB3' HG13 ' A' ' 14' ' ' VAL . 56.8 Cg_endo -73.02 126.91 11.62 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.172 1.915 . . . . 75.11 111.413 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.7 m -158.86 -80.78 0.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 70.33 111.339 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.782 ' HA2' ' HB3' ' A' ' 13' ' ' ASN . . . 132.8 161.44 9.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.914 -0.66 . . . . 75.33 111.477 -175.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -149.09 -69.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.57 -0.824 . . . . 32.21 112.506 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.87 -83.03 0.94 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 60.12 112.388 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.85 152.86 8.7 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.698 . . . . 64.33 112.098 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -106.95 -35.16 6.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 55.35 110.166 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 103.78 -124.96 8.26 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.865 -0.607 . . . . 75.03 112.339 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 65.6 -131.51 34.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.019 -0.61 . . . . 74.12 112.032 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 174' ' ' SER . . . 92.56 -63.86 2.23 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.756 -0.735 . . . . 74.53 112.601 175.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 173' ' ' GLY . 30.0 p 50.31 91.41 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.607 0.763 . . . . 74.31 112.058 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -149.32 134.01 4.72 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.852 -0.689 . . . . 74.01 112.006 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.32 123.87 6.32 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.796 -0.716 . . . . 74.32 111.678 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.46 -113.38 4.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 73.53 111.987 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 12.1 t -84.93 132.59 34.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.797 0.332 . . . . 74.34 110.168 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.08 145.78 38.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.67 -0.776 . . . . 70.01 111.996 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.73 153.88 22.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.837 -0.697 . . . . 74.12 111.898 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.82 -44.44 3.63 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.716 -0.754 . . . . 61.11 111.841 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.5 m 64.4 12.16 7.08 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.971 0.509 . . . . 64.13 111.871 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -165.04 171.91 40.55 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.111 -0.566 . . . . 53.0 112.082 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.93 -173.8 2.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.324 0.583 . . . . 74.32 111.454 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.24 145.53 4.36 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.118 -0.947 . . . . 62.34 111.188 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.49 -161.77 15.64 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.549 -0.834 . . . . 72.51 112.065 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.726 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.92 -177.12 6.58 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 110.326 -0.25 . . . . 75.34 110.326 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.86 91.96 28.27 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 109.648 -0.501 . . . . 73.4 109.648 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 3.6 Cg_exo -78.67 -12.18 15.18 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.899 2.4 . . . . 73.43 112.148 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.88 -36.51 70.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.95 -0.568 . . . . 74.4 109.997 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.2 pt -88.07 156.15 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.98 -0.748 . . . . 73.15 108.98 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -105.32 89.06 3.01 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.374 -0.53 . . . . 75.53 110.291 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 194' ' ' ALA . 9.7 p -163.92 170.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.83 -0.804 . . . . 71.31 108.83 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -94.9 115.72 27.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.865 0.364 . . . . 71.42 111.05 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -144.18 153.27 41.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.449 -0.945 . . . . 75.22 108.449 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.98 139.03 34.5 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.79 0.329 . . . . 75.35 111.034 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.726 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.8 Cg_endo -63.26 -54.13 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.713 2.275 . . . . 74.21 112.06 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.48 35.31 0.96 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.455 -0.339 . . . . 74.15 111.457 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.522 ' OD2' ' HD3' ' A' ' 202' ' ' ARG . 7.4 t70 75.77 -14.05 0.82 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.074 0.55 . . . . 75.42 111.66 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.5 ptm -46.1 -29.93 1.71 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.877 1.066 . . . . 72.2 113.877 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -111.09 10.72 29.23 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 72.34 113.254 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.522 ' HD3' ' OD2' ' A' ' 199' ' ' ASP . 44.0 mtp180 -72.43 -38.42 68.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 117.62 0.71 . . . . 70.24 111.91 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 203' ' ' LYS . 3.7 mppt? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.747 -0.645 . . . . 75.44 110.633 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.078 0.466 . . . . 72.23 110.022 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.14 160.77 14.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.976 -0.556 . . . . 50.3 110.354 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.81 55.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.17 -0.468 . . . . 74.15 110.672 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.453 HD13 HG12 ' A' ' 77' ' ' ILE . 71.7 mt 70.0 99.27 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 O-C-N 123.911 0.757 . . . . 71.41 111.296 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -89.34 132.03 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.041 2.494 . . . . 74.54 113.034 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.602 ' HG3' ' HD2' ' A' ' 37' ' ' LYS . 62.8 Cg_endo -78.38 -41.69 0.26 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.628 2.219 . . . . 74.14 112.528 176.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.09 -95.57 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.312 0.645 . . . . 73.42 112.653 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.1 m -76.89 -26.66 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.689 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.459 ' O ' ' HB2' ' A' ' 6' ' ' PRO . 1.8 t-105 -105.31 113.8 27.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.054 0.454 . . . . 75.13 110.506 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.8 93.64 4.81 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.658 -0.701 . . . . 64.05 110.743 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 4.2 Cg_endo -86.64 113.33 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.696 2.93 . . . . 75.21 113.068 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.15 -44.85 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.811 2.341 . . . . 74.45 112.263 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.513 HD22 HG12 ' A' ' 24' ' ' VAL . 11.6 t-20 -124.88 144.39 50.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.458 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG23 ' HE1' ' A' ' 39' ' ' PHE . 22.4 m -133.23 162.91 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 64.11 110.394 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -122.33 134.86 54.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.064 0.459 . . . . 74.31 110.376 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.4 mt -111.87 107.98 17.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 71.11 109.391 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -92.24 119.46 31.87 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.428 -0.582 . . . . 63.35 109.428 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -109.07 178.3 4.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.141 0.496 . . . . 75.21 110.986 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 t -67.27 -15.89 63.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 73.34 110.442 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 142' ' ' VAL . 5.7 mmt -95.55 -34.62 11.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.034 -0.53 . . . . 74.34 111.007 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . 174.18 -130.79 1.87 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.086 -0.806 . . . . 71.4 111.086 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.236 0.541 . . . . 74.55 110.486 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.96 114.13 37.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.429 -0.805 . . . . 72.13 109.767 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.593 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 41.3 t -96.4 141.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.839 -0.619 . . . . 75.23 109.374 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.1 163.79 36.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.137 0.494 . . . . 71.54 111.015 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.17 162.92 30.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.505 -0.77 . . . . 72.44 109.892 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 166.04 10.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.764 -0.653 . . . . 72.1 109.394 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 5.3 m-85 -85.75 93.5 8.88 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 74.01 111.702 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.616 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -79.47 -8.75 59.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.743 0.782 . . . . 70.21 109.343 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' HZ3' ' CD ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -70.34 -45.01 67.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.384 -1.28 . . . . 73.23 111.658 -173.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -137.86 8.61 2.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.807 0.299 . . . . 72.02 111.807 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.22 67.27 10.69 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.835 0.679 . . . . 72.24 112.835 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.488 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 21.3 Cg_exo -65.54 -27.4 53.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.025 1.817 . . . . 70.35 110.996 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -62.87 -59.48 4.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 72.23 110.892 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -62.67 -36.34 82.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.597 . . . . 75.32 110.208 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.616 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 39.5 t -53.73 -53.47 51.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.238 -0.892 . . . . 70.21 111.278 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HD2' ' HG3' ' A' ' 6' ' ' PRO . 3.0 mtmp? -69.88 -27.28 64.68 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.789 -0.364 . . . . 74.42 111.666 -173.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.526 ' O ' HD22 ' A' ' 42' ' ' LEU . 59.8 t30 -59.48 -49.83 76.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.489 -0.56 . . . . 71.22 109.489 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.78 ' HE1' HG23 ' A' ' 14' ' ' VAL . 12.3 t80 -68.81 -51.33 41.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 75.23 109.852 176.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -55.54 -44.86 77.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 63.44 112.985 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 43.4 mt-10 -77.77 -26.59 49.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 121.126 -0.229 . . . . 72.11 111.572 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 38' ' ' ASN . 3.2 mm? -78.99 -20.88 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.788 -0.765 . . . . 73.02 110.428 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.38 -44.31 36.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.075 -0.511 . . . . 73.33 110.951 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.688 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -62.98 -36.76 84.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.629 -0.26 . . . . 74.43 111.314 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -72.77 -46.93 50.76 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.203 -0.599 . . . . 74.31 109.423 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.33 42.83 1.03 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.522 -0.847 . . . . 72.21 113.46 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.678 ' HD1' ' HG3' ' A' ' 67' ' ' PRO . 1.2 m-85 -77.45 -15.95 59.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 73.32 110.405 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.82 0.27 51.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.761 -0.654 . . . . 71.25 111.001 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 48.7 m-80 -81.81 2.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.052 0.453 . . . . 74.43 109.868 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -134.71 14.05 4.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.002 -0.618 . . . . 71.42 112.176 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.6 p -88.83 149.22 23.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.661 0.267 . . . . 75.43 110.46 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -138.65 128.42 25.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.553 -0.294 . . . . 71.55 110.556 -176.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 61.0 m-85 -67.07 110.74 3.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.97 -0.752 . . . . 75.4 108.97 175.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -111.86 -18.48 12.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.835 -0.346 . . . . 74.32 111.133 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 26.5 mmt85 -110.34 105.27 14.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.523 -0.547 . . . . 74.55 109.523 173.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.16 91.2 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.907 -0.775 . . . . 75.3 108.907 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.1 mt -102.8 119.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.739 -0.664 . . . . 74.35 109.262 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.928 ' HB2' ' HZ2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -52.02 139.25 23.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.446 0.466 . . . . 75.43 110.219 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 44.21 33.79 0.89 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.384 1.052 . . . . 75.34 112.6 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.714 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -131.54 -82.92 0.51 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.385 0.612 . . . . 75.42 110.213 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.547 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptm -159.76 156.59 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.804 . . . . 74.24 110.812 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' CD1' HD23 ' A' ' 116' ' ' LEU . 43.1 mt -129.37 103.26 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.519 -0.764 . . . . 73.4 108.943 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 42.7 tt0 -87.93 124.61 33.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.764 -0.653 . . . . 74.22 111.835 -173.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.79 113.57 4.03 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.061 -0.815 . . . . 72.14 111.061 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.8 157.61 43.83 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.706 -0.283 . . . . 74.11 112.667 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' CG ' ' HG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -68.66 156.56 90.61 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 123.804 0.355 . . . . 74.25 111.492 -175.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.678 ' HG3' ' HD1' ' A' ' 47' ' ' TYR . 23.7 Cg_endo -58.71 -21.86 58.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.723 2.949 . . . . 70.12 113.521 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.427 ' HG1' ' CG ' ' A' ' 66' ' ' ASP . 41.3 p -86.66 -30.43 21.73 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.644 -0.502 . . . . 74.34 109.644 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.94 71.08 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.725 -0.75 . . . . 75.01 111.642 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.3 p -88.56 -32.14 18.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.56 0.695 . . . . 71.41 109.401 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.1 46.65 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.881 -1.054 . . . . 52.51 111.674 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -119.83 -2.97 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.761 0.282 . . . . 72.12 111.761 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.75 -155.3 11.68 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.607 -0.806 . . . . 74.1 112.557 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.4 167.65 42.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.337 -0.935 . . . . 74.44 111.639 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.542 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 55.2 -96.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.785 0.434 . . . . 71.15 110.925 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m 69.07 -31.79 0.21 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.86 0.864 . . . . 75.43 113.126 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 75' ' ' ALA . 5.9 tt -55.84 -42.76 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.575 0.583 . . . . 71.33 112.575 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.542 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 13.8 p90 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.421 0.629 . . . . 75.14 110.774 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 112.3 -104.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.224 -0.898 . . . . 73.02 112.336 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 39.5 mtmt -125.68 -162.05 1.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.317 -0.623 . . . . 75.21 109.317 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.481 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -66.57 157.13 33.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.901 -0.778 . . . . 74.41 108.901 174.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -117.57 -54.24 2.37 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.646 -0.421 . . . . 74.45 111.417 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -166.61 -175.87 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.437 -0.579 . . . . 74.1 109.437 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -83.93 132.31 34.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 71.14 110.037 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.93 8.76 43.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.787 -0.642 . . . . 71.02 109.671 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.21 105.63 0.52 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.84 -0.618 . . . . 74.43 111.893 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -163.2 80.97 1.58 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 71.11 109.571 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.05 88.32 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.012 1.808 . . . . 63.51 111.578 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.7 -18.69 37.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.112 0.958 . . . . 74.43 109.377 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.7 pp -101.18 -178.84 3.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.52 -1.218 . . . . 74.52 108.75 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -138.35 147.78 43.86 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.121 -0.632 . . . . 73.41 110.416 171.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.486 ' CE2' ' HA ' ' A' ' 120' ' ' GLN . 1.2 p90 -62.8 109.38 1.42 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.801 0.81 . . . . 73.44 110.726 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -99.26 -44.99 6.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.228 -0.896 . . . . 75.44 110.428 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.66 -139.25 2.77 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.725 -0.75 . . . . 72.34 112.389 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.12 145.6 26.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.63 0.253 . . . . 73.45 110.687 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 132' ' ' VAL . . . 107.66 22.26 7.45 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.648 -0.787 . . . . 71.34 111.618 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.481 HD12 ' HG3' ' A' ' 189' ' ' PRO . 9.9 mm -84.76 109.68 18.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.214 -0.662 . . . . 74.3 109.214 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.746 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -84.87 115.18 22.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.006 -0.543 . . . . 73.11 109.569 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB3' HG23 ' A' ' 128' ' ' ILE . . . -128.79 176.84 7.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 74.22 110.855 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.7 ttt -104.19 142.07 35.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 72.41 111.145 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -97.97 141.89 30.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.471 . . . . 71.01 110.174 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -157.78 160.6 37.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.738 -0.665 . . . . 74.4 110.132 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.73 -9.02 25.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.613 0.721 . . . . 63.41 110.333 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.99 169.38 40.23 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.107 -1.597 . . . . 72.12 109.107 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.18 -42.49 46.59 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.098 2.532 . . . . 72.01 112.794 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -103.03 -5.45 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 71.01 111.806 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -84.94 48.4 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.432 0.634 . . . . 75.13 110.061 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -89.73 121.54 31.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.892 . . . . 74.43 109.712 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.01 -94.79 2.21 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.659 -0.781 . . . . 73.43 112.452 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB3' ' A' ' 75' ' ' ALA . 18.0 t -140.87 6.92 2.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.377 0.608 . . . . 74.41 109.999 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 19.4 mp0 -81.02 143.91 32.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.696 -0.684 . . . . 75.11 110.363 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -144.24 162.32 36.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.369 -0.234 . . . . 74.24 110.369 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.492 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 41.9 p90 -154.02 157.21 38.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 74.0 111.148 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.673 HG23 HD22 ' A' ' 98' ' ' LEU . 18.2 t -112.11 145.88 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.928 -0.578 . . . . 72.14 109.444 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -99.52 130.38 45.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.952 0.406 . . . . 71.24 110.141 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.523 HD23 ' CD1' ' A' ' 62' ' ' ILE . 59.5 mt -84.46 -7.1 59.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 73.53 110.775 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.39 163.35 24.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 73.31 109.929 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.25 113.12 2.75 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.602 2.201 . . . . 73.41 112.203 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.1 p -103.08 110.66 22.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 72.52 110.393 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.486 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 1.1 pp0? -99.59 15.82 25.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.332 0.587 . . . . 75.43 110.82 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.585 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.4 p90 -121.32 -2.65 9.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.467 -0.788 . . . . 74.13 110.89 -175.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.585 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.8 mt -102.97 7.93 39.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 75.51 110.475 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.89 -15.38 62.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.045 -0.98 . . . . 73.25 111.74 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.39 19.69 3.8 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.805 -0.712 . . . . 75.51 111.695 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -121.04 -28.8 4.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.266 0.555 . . . . 62.31 109.958 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.493 ' HD2' HD23 ' A' ' 122' ' ' LEU . 93.5 m-70 -138.64 144.55 39.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.489 -0.778 . . . . 73.41 109.376 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.5 t -85.37 145.19 27.61 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.398 -0.593 . . . . 75.14 109.398 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.507 HG23 ' HB3' ' A' ' 99' ' ' ALA . 31.4 mt -126.06 116.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.349 -0.387 . . . . 71.24 110.751 -176.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -154.41 74.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.456 0.472 . . . . 74.42 110.863 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.746 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.35 157.35 29.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.24 -0.981 . . . . 52.1 112.882 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.477 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 30.5 mtp180 -137.89 118.88 14.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.979 -0.378 . . . . 74.45 109.979 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 96' ' ' GLY . 7.5 p -81.76 138.36 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 62.43 110.411 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.593 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.3 t -143.23 142.85 31.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.034 -0.53 . . . . 72.22 110.132 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.653 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.6 tt0 54.23 35.99 23.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.345 0.593 . . . . 70.41 112.035 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.12 29.41 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.236 -0.983 . . . . 75.11 112.565 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 tp -83.39 -30.33 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 73.34 110.121 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.03 -31.65 81.59 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.659 . . . . 60.01 111.586 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.537 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 53.1 mmm -72.18 -49.35 36.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.486 -0.561 . . . . 72.32 109.486 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.453 HG11 HD13 ' A' ' 62' ' ' ILE . 61.8 t -55.0 -31.82 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.196 0.522 . . . . 75.31 110.508 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.04 -52.41 24.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.867 -0.606 . . . . 62.52 110.638 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -15.23 61.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.397 -0.365 . . . . 74.43 111.394 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.611 ' O ' HG21 ' A' ' 145' ' ' VAL . 53.7 t -86.58 -38.82 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.31 -0.405 . . . . 74.53 110.555 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.83 -12.68 68.31 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.641 -0.79 . . . . 73.24 112.831 -176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.2 ptm -82.0 -17.17 47.79 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.622 -0.34 . . . . 73.41 110.806 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 142' ' ' VAL . 19.2 m -77.88 162.63 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.675 -0.41 . . . . 74.01 110.798 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.93 -61.73 0.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 72.21 111.041 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 17.2 p -130.68 147.35 52.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.11 0.481 . . . . 71.3 111.663 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -97.81 100.49 11.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.666 . . . . 74.3 110.869 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.3 t 69.36 -67.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.771 0.669 . . . . 72.11 111.41 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.518 ' O ' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -90.94 -177.13 4.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.932 -0.766 . . . . 74.21 108.932 176.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.14 53.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 75.34 110.516 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 152' ' ' ARG . 12.4 ptm85 -122.21 130.9 24.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.915 -1.039 . . . . 73.32 108.766 176.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.81 141.72 92.53 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.653 2.235 . . . . 74.31 112.219 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.0 t -61.39 150.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 72.53 109.671 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.24 173.99 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.33 0.586 . . . . 62.34 111.652 -174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.8 130.87 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 71.23 112.589 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.44 110.96 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.99 -1.115 . . . . 70.12 107.99 170.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.41 155.91 28.82 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.363 -0.535 . . . . 72.55 111.427 -168.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.544 HG21 ' HB1' ' A' ' 162' ' ' ALA . 3.4 mp -85.13 109.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.801 -1.091 . . . . 73.21 109.391 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.521 HG23 ' HD3' ' A' ' 161' ' ' LYS . 26.4 mm -71.49 -49.98 43.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.478 -0.783 . . . . 71.31 110.497 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.521 ' HD3' HG23 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.93 130.34 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.824 -0.625 . . . . 75.0 110.758 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.544 ' HB1' HG21 ' A' ' 159' ' ' ILE . . . -133.31 112.71 11.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.84 0.352 . . . . 74.53 110.537 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -142.15 152.35 61.14 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.64 -0.709 . . . . 64.25 110.032 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.542 ' HA ' HG11 ' A' ' 14' ' ' VAL . 30.9 Cg_endo -67.24 131.7 25.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.374 2.049 . . . . 71.22 111.984 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.4 t -107.59 1.62 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.973 0.416 . . . . 74.15 110.692 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.42 -78.35 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.747 -0.739 . . . . 64.32 111.829 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.76 -155.08 16.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.748 -0.739 . . . . 63.43 112.442 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.08 -106.92 3.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.012 -0.613 . . . . 64.2 111.885 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.31 176.49 15.17 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.892 -0.67 . . . . 72.24 112.091 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.0 t -156.21 104.44 2.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.868 -0.419 . . . . 74.4 109.868 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 145.64 -134.86 5.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.073 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.21 159.74 32.31 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.916 -0.659 . . . . 74.02 111.906 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.53 167.61 13.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.787 -0.721 . . . . 73.11 111.998 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.3 m -128.08 111.92 14.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.892 -0.41 . . . . 55.42 109.892 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.35 169.01 22.25 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.952 -0.642 . . . . 65.44 112.643 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.48 49.53 0.84 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.156 -0.545 . . . . 64.24 111.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -161.11 169.77 36.77 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 121.078 -0.582 . . . . 62.24 111.674 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -75.52 138.77 41.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.58 0.229 . . . . 75.22 110.679 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.78 -105.31 2.91 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.757 -0.735 . . . . 75.41 111.909 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.91 -86.75 1.35 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.038 -0.601 . . . . 74.42 111.872 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 179.38 69.21 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.772 -0.728 . . . . 72.03 112.269 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.9 t -107.99 107.75 18.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.853 -0.795 . . . . 73.54 108.853 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.95 6.39 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.746 -0.74 . . . . 61.21 112.309 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.653 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -100.19 178.0 4.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.329 0.585 . . . . 55.14 110.991 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 142.3 135.74 3.13 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.968 -1.014 . . . . 74.02 110.879 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.16 -176.7 51.42 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.265 -0.969 . . . . 70.3 111.775 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.803 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -72.44 145.52 47.55 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.691 -0.485 . . . . 72.53 109.691 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 98.3 m-85 -97.81 105.06 24.58 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-O 121.182 0.515 . . . . 70.22 110.368 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.668 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.6 Cg_endo -83.58 -7.44 10.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.215 2.61 . . . . 71.42 111.313 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.495 ' CD ' ' HZ3' ' A' ' 30' ' ' LYS . 39.0 tt0 -86.06 -35.05 20.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.105 -0.952 . . . . 71.33 110.789 -173.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.565 HG13 HG12 ' A' ' 193' ' ' VAL . 21.4 pt -74.63 -13.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 71.15 110.483 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 47.3 m170 61.59 54.96 2.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.835 -1.075 . . . . 71.45 111.236 173.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.565 HG12 HG13 ' A' ' 191' ' ' ILE . 9.9 p -150.16 141.15 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.512 . . . . 73.51 109.875 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.28 110.14 5.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 74.03 111.425 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.64 155.89 30.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.312 -0.625 . . . . 75.51 109.312 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.452 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 24.5 m-85 -118.44 154.11 52.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.651 -0.249 . . . . 73.23 111.266 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.803 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 44.4 Cg_endo -68.4 -75.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.413 2.075 . . . . 71.34 112.138 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 199' ' ' ASP . 1.4 pt? -127.66 32.07 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.726 -0.215 . . . . 74.3 110.982 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 198' ' ' LEU . 11.5 t70 77.01 -6.21 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.174 0.435 . . . . 74.03 112.174 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.8 ptm -49.5 -28.39 5.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.214 0.82 . . . . 74.41 113.214 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.04 2.82 35.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.186 -1.007 . . . . 60.52 113.331 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 44.5 mtp-105 -84.85 -63.34 1.35 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.759 0.79 . . . . 75.54 109.798 176.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . 18.1 mmmt . . . . . 0 C--O 1.246 0.891 0 CA-C-N 112.779 -2.01 . . . . 74.21 111.754 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.607 0.241 . . . . 64.5 110.755 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.418 ' HA ' ' HZ ' ' A' ' 82' ' ' PHE . . . -97.87 167.3 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 72.22 109.982 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.71 162.52 27.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.933 -0.121 . . . . 54.34 111.034 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 77' ' ' ILE . 53.3 mt 73.03 115.11 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 O-C-N 124.127 0.892 . . . . 75.24 111.692 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 22.3 Cg_exo -65.98 149.12 86.36 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.84 2.36 . . . . 72.23 112.325 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 7.6 Cg_exo -74.81 38.13 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.582 2.855 . . . . 75.1 113.225 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' O ' ' HD1' ' A' ' 9' ' ' TRP . 35.3 m-20 -92.49 -9.27 42.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 75.44 110.6 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.0 p -69.3 99.04 1.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 73.44 111.061 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.461 ' HD1' ' O ' ' A' ' 7' ' ' ASP . 15.8 p-90 -117.7 4.24 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 75.44 110.199 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -51.93 142.76 25.02 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 114.995 -1.002 . . . . 70.52 112.25 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 11.9 Cg_exo -35.76 123.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.987 3.791 . . . . 74.35 114.26 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.71 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 86.3 Cg_endo -78.43 13.49 1.83 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.827 3.018 . . . . 71.35 113.608 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 26' ' ' GLU . 20.4 t-20 -133.36 138.94 46.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.741 -0.663 . . . . 74.01 109.899 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 164' ' ' PRO . 33.3 m -138.92 156.73 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.708 0.29 . . . . 74.43 110.681 -177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HD1' ' HB2' ' A' ' 165' ' ' SER . 27.8 p90 -123.99 141.13 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.074 0.464 . . . . 73.14 111.041 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.51 110.08 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.674 -0.694 . . . . 75.12 109.407 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.831 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 32.0 tt0 -88.83 113.25 24.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.492 -0.929 . . . . 72.02 108.492 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -103.13 -179.95 4.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.963 -0.562 . . . . 72.44 110.939 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -75.3 -15.74 60.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 74.34 110.649 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 92.5 mmm -97.1 -38.81 9.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.626 . . . . 73.25 110.664 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -175.49 -139.87 3.22 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.231 -0.748 . . . . 62.34 111.231 177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -136.7 130.62 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.507 -0.553 . . . . 75.11 109.507 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.422 HG12 ' CG2' ' A' ' 139' ' ' VAL . 4.2 mp -124.85 130.49 73.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 71.54 110.467 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 15' ' ' TYR . 59.1 t -113.85 145.05 20.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.904 -0.406 . . . . 74.43 109.904 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.77 36.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.345 0.593 . . . . 70.43 110.725 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.443 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 9.4 pt-20 -134.1 162.15 32.91 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.211 -0.904 . . . . 70.14 108.999 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.617 ' HB2' ' HB3' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -97.44 175.5 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.6 -0.519 . . . . 75.31 109.6 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 3.9 m-30 -79.21 100.41 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 72.44 110.878 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.71 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 15.3 m0 -79.82 -7.06 58.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.956 -0.565 . . . . 73.12 110.45 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.52 -65.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.848 -0.614 . . . . 74.51 111.247 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.95 -16.06 20.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.813 -171.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -130.71 72.3 81.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.745 0.646 . . . . 73.4 112.745 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 14.0 Cg_exo -69.45 -20.88 35.72 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.392 2.061 . . . . 72.14 110.826 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -82.01 -45.55 15.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.057 -0.974 . . . . 74.43 110.836 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 12.1 m -65.92 -39.24 90.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.051 -0.522 . . . . 74.54 111.586 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 4.7 p -64.31 -39.78 94.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 70.4 111.699 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' A' ' 37' ' ' LYS . 9.5 mtmp? -91.14 -8.8 47.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.295 -0.562 . . . . 73.22 110.8 -178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 48.9 t30 -72.44 -55.54 6.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.657 -0.701 . . . . 71.05 109.349 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.28 -40.88 98.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.284 -0.416 . . . . 74.11 110.888 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.29 -42.8 61.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 62.52 111.312 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 10.0 mm-40 -56.84 -50.88 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.274 -0.421 . . . . 73.15 111.422 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.578 HD13 ' CG ' ' A' ' 47' ' ' TYR . 2.7 mm? -62.77 -28.15 69.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.501 -0.318 . . . . 75.21 111.466 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -51.84 25.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 74.53 110.942 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -72.47 -29.65 63.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.31 111.472 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -68.02 -52.42 35.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.997 0.427 . . . . 65.34 109.954 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.13 43.45 0.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.057 -1.068 . . . . 54.02 113.233 171.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.578 ' CG ' HD13 ' A' ' 42' ' ' LEU . 18.7 m-85 -92.24 -33.49 14.64 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.465 -0.432 . . . . 74.11 111.395 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -82.06 -16.4 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 75.31 110.874 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -70.78 -0.96 10.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.478 . . . . 74.22 111.028 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.05 34.52 2.07 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.518 -0.633 . . . . 75.4 111.518 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.548 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -104.21 149.62 25.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.979 0.418 . . . . 74.23 111.014 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -128.2 148.67 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 72.22 109.394 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 87.3 m-85 -80.08 122.5 26.86 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.499 -0.556 . . . . 74.5 109.499 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -106.61 -39.61 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.871 0.323 . . . . 72.23 111.871 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 39.3 mmt180 -108.91 105.42 14.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.923 -0.311 . . . . 74.45 110.23 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.689 HD13 ' HB2' ' A' ' 155' ' ' ASP . 4.8 mp -123.58 91.28 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.895 -0.779 . . . . 74.12 108.895 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.889 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.2 mt -96.28 130.48 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.71 -0.677 . . . . 74.13 109.237 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.978 ' HE2' ' HB3' ' A' ' 146' ' ' GLU . 43.8 mttt -54.97 108.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.928 0.767 . . . . 73.31 111.831 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 55.99 44.9 24.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.285 -0.87 . . . . 75.53 110.828 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.889 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 12.8 t80 -129.93 -75.99 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.269 -0.878 . . . . 73.24 109.12 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.521 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.75 154.63 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.215 -0.902 . . . . 74.3 109.884 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.56 HG23 HG13 ' A' ' 56' ' ' ILE . 46.8 mt -129.41 102.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.044 -0.525 . . . . 72.42 109.996 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 49.3 tt0 -86.02 122.51 30.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 74.41 110.526 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -125.17 142.7 14.02 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.886 -0.597 . . . . 72.35 112.011 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.548 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 149.66 -141.86 9.24 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.504 -0.855 . . . . 60.41 112.332 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.18 78.54 0.39 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.814 0.672 . . . . 74.2 112.814 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.78 -12.94 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 121.98 1.786 . . . . 71.44 110.442 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.8 p -103.23 -47.55 4.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.156 -0.929 . . . . 65.1 110.777 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.68 15.39 54.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.438 -0.665 . . . . 53.43 111.438 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -80.95 -41.54 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.29 0.567 . . . . 74.31 111.499 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -16.29 4.97 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.492 -0.776 . . . . 72.04 111.374 -174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -109.8 -30.33 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 74.43 110.903 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.6 -155.82 28.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.6 -0.809 . . . . 75.21 111.409 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.48 -105.48 0.24 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.624 -0.798 . . . . 60.03 112.282 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.98 36.4 21.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.609 0.719 . . . . 74.31 111.455 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -91.19 12.85 18.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.615 -0.72 . . . . 70.43 111.047 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.514 HG13 HD12 ' A' ' 4' ' ' ILE . 47.6 pt -74.23 -22.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.348 -0.387 . . . . 71.23 111.181 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.579 ' HE2' ' HA ' ' A' ' 81' ' ' GLN . 6.8 p90 -110.81 3.38 18.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.498 0.666 . . . . 71.43 110.495 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 -115.55 4.83 Favored Glycine 0 C--O 1.237 0.295 0 CA-C-N 115.182 -0.917 . . . . 64.25 111.856 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -76.31 179.19 5.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.25 -1.018 . . . . 74.52 108.25 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.592 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -78.61 149.73 32.87 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.47 -0.937 . . . . 75.21 108.47 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' A' ' 2' ' ' ALA . 9.7 t80 -102.11 -85.66 0.43 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.329 0.862 . . . . 74.12 113.329 -156.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.65 157.65 43.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.841 0.353 . . . . 72.41 111.205 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.7 126.2 30.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.31 0.576 . . . . 74.43 110.2 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -105.99 18.7 21.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.793 -0.639 . . . . 74.34 109.496 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 127' ' ' THR . 59.3 mt -62.01 104.63 0.48 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.952 -0.567 . . . . 70.22 110.891 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -169.88 80.45 0.63 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.413 -0.588 . . . . 73.32 109.413 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.21 100.39 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.464 2.109 . . . . 73.31 112.076 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.23 -3.59 52.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.228 1.013 . . . . 62.31 109.532 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.477 HD23 ' CE2' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -109.94 -171.39 1.83 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.239 -1.346 . . . . 74.44 111.315 -172.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -147.07 145.99 29.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.198 -1.038 . . . . 75.1 108.198 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 26.8 p90 -58.48 124.79 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.24 0.543 . . . . 75.01 110.066 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.4 p -121.98 -45.59 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.665 -0.698 . . . . 65.55 110.084 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -151.31 6.11 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.483 -0.78 . . . . 63.24 111.891 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.14 22.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.337 0.255 . . . . 72.45 110.704 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.69 22.7 7.21 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.476 -0.868 . . . . 74.22 111.835 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 189' ' ' PRO . 10.4 mm -84.88 109.63 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.521 -0.548 . . . . 75.11 109.521 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.722 HD21 HG23 ' A' ' 114' ' ' VAL . 3.2 tm? -85.59 120.72 27.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.611 -0.514 . . . . 75.12 109.611 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB1' HG21 ' A' ' 128' ' ' ILE . . . -129.22 174.88 9.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.116 -0.493 . . . . 70.5 111.136 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.502 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 24.9 ttt -105.53 137.68 42.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.908 -0.587 . . . . 75.54 109.502 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.491 ' HB1' ' CB ' ' A' ' 111' ' ' GLN . . . -96.65 142.68 28.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.036 0.445 . . . . 63.13 110.171 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.81 161.34 42.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.528 -0.76 . . . . 74.35 110.348 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.31 -26.59 15.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.691 0.757 . . . . 74.31 109.559 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.03 178.16 27.68 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 109.2 -1.56 . . . . 74.32 109.2 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HA ' HD12 ' A' ' 86' ' ' LEU . 6.7 Cg_endo -48.45 -52.53 8.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.959 2.439 . . . . 63.33 112.479 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -101.42 -3.41 28.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.034 -0.53 . . . . 73.2 110.419 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.592 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -88.56 47.11 1.46 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.391 0.615 . . . . 63.22 109.608 -177.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.48 ' HB2' ' HE2' ' A' ' 100' ' ' MET . 5.4 p30 -94.75 130.08 41.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.056 -0.975 . . . . 74.22 109.989 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.79 -121.86 2.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.245 -0.978 . . . . 74.22 113.563 -173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 t -105.31 12.16 32.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.959 0.409 . . . . 72.45 110.909 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 26.5 mt-30 -94.38 147.85 22.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 72.52 111.243 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.31 167.92 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.675 -0.861 . . . . 74.43 108.675 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 46.9 p90 -155.16 150.59 27.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 73.33 111.118 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.722 HG23 HD21 ' A' ' 98' ' ' LEU . 14.2 t -112.97 140.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.012 -0.736 . . . . 74.43 109.012 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -94.44 127.08 40.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.094 0.473 . . . . 63.34 109.936 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.476 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 62.5 mt -83.51 -7.9 59.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.555 -0.748 . . . . 71.11 110.492 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . . . -144.82 159.79 49.25 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 72.22 110.071 175.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 36.3 Cg_endo -66.14 112.06 2.19 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.51 2.14 . . . . 72.24 112.368 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.1 p -106.13 141.65 37.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.825 -0.625 . . . . 55.13 111.331 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.535 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -131.9 -0.25 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 73.42 110.646 175.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 2.52 55.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.47 -0.786 . . . . 75.41 112.489 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.15 6.65 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.23 0.826 . . . . 74.54 113.23 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 4.5 m-20 -64.65 -28.69 69.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.119 0.485 . . . . 74.54 111.042 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -102.57 13.11 56.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 63.13 111.448 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -116.61 -40.74 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 75.31 109.387 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -135.92 124.68 23.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.131 -0.941 . . . . 73.52 108.506 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.528 ' HB ' HD21 ' A' ' 86' ' ' LEU . 15.1 t -71.05 147.91 48.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.171 0.51 . . . . 73.11 110.768 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.454 HG21 ' HB1' ' A' ' 99' ' ' ALA . 44.8 mt -121.58 123.32 69.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.853 -0.612 . . . . 74.41 110.523 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -159.31 75.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.32 0.581 . . . . 74.41 111.587 175.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.653 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.3 158.45 30.83 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.768 -0.729 . . . . 74.44 112.734 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.443 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -132.11 125.02 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.964 -0.754 . . . . 74.11 108.964 173.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.405 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 10.3 p -84.98 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.052 0.453 . . . . 74.31 110.291 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.481 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 34.5 t -141.2 147.69 38.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.43 -0.35 . . . . 74.24 111.016 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 42.62 35.27 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.379 1.072 . . . . 70.23 113.216 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.16 42.49 0.19 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.637 -0.792 . . . . 70.51 111.972 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 tp -91.86 -33.83 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.796 0.332 . . . . 74.45 110.413 -176.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -34.9 90.05 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.03 -0.605 . . . . 55.2 112.016 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.571 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 70.3 mmm -67.12 -51.25 56.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.797 -0.446 . . . . 74.51 109.797 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 62' ' ' ILE . 63.9 t -54.29 -30.68 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 74.12 110.954 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.78 -54.65 10.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 60.45 110.914 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.594 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.72 -16.38 60.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.187 -0.46 . . . . 64.35 111.418 -177.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 145' ' ' VAL . 64.5 t -86.21 -29.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 73.35 109.942 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.45 -7.56 79.08 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.691 -0.766 . . . . 71.31 112.607 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.594 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 16.6 ptp -96.58 -11.98 24.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.857 -0.337 . . . . 75.22 111.869 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 142' ' ' VAL . 23.9 m -74.93 136.67 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.207 -0.597 . . . . 72.45 110.637 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.978 ' HB3' ' HE2' ' A' ' 58' ' ' LYS . 4.6 pt-20 -117.51 -53.0 2.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.008 -0.542 . . . . 72.11 111.023 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' A' ' 146' ' ' GLU . 4.6 p -132.42 162.21 31.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.083 -0.508 . . . . 63.42 110.253 -175.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -93.91 -157.06 0.52 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.917 -0.771 . . . . 64.32 108.917 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.1 t -56.37 -35.75 68.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.282 0.492 . . . . 61.15 110.803 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.66 171.98 8.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 75.24 110.279 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.08 61.48 6.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.953 0.882 . . . . 64.22 109.995 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 18.3 ptp180 -146.72 145.42 22.92 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.779 -1.101 . . . . 74.5 108.999 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 24.4 Cg_exo -62.69 144.6 94.28 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.519 2.146 . . . . 74.23 112.982 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 145' ' ' VAL . 10.4 p -102.3 28.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 122.615 1.198 . . . . 72.21 108.468 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.689 ' HB2' HD13 ' A' ' 56' ' ' ILE . 7.1 p-10 -71.41 -13.59 61.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.01 -1.45 . . . . 75.03 112.332 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.473 ' OD1' ' HE2' ' A' ' 158' ' ' LYS . 8.1 t0 -72.82 78.68 1.13 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.165 0.507 . . . . 64.34 110.721 -176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.87 137.56 44.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 71.42 109.52 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -123.55 155.14 38.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.922 0.391 . . . . 75.24 110.634 -172.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.416 HG21 ' HB1' ' A' ' 162' ' ' ALA . 3.8 mp -91.52 101.59 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.208 -1.034 . . . . 74.51 108.208 168.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 161' ' ' LYS . 32.2 mm -65.35 -48.63 82.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 75.53 110.918 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.831 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -143.9 138.52 28.62 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.488 -0.778 . . . . 61.43 110.071 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.416 ' HB1' HG21 ' A' ' 159' ' ' ILE . . . -141.5 118.89 11.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.414 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.83 158.37 62.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.839 -0.618 . . . . 63.34 109.803 -175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.539 ' HA ' HG11 ' A' ' 14' ' ' VAL . 28.7 Cg_endo -64.35 137.99 58.47 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.175 1.917 . . . . 74.11 111.119 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.667 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 25.4 t -120.27 150.52 40.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.163 0.506 . . . . 72.13 111.283 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.69 -174.73 45.77 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.173 -0.771 . . . . 62.23 111.173 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -125.49 110.79 1.38 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.648 -0.787 . . . . 52.41 112.346 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -92.21 71.88 1.61 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.81 -0.71 . . . . 75.11 111.913 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -91.42 24.38 19.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.987 -0.625 . . . . 72.44 113.069 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -100.05 63.35 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.96 0.41 . . . . 74.24 110.286 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -99.5 -57.68 0.93 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.918 -0.658 . . . . 75.01 112.166 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.95 2.24 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.884 -0.674 . . . . 73.3 112.245 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -132.04 -17.43 1.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.881 -0.676 . . . . 74.02 112.508 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.1 t 54.16 61.44 3.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.343 0.592 . . . . 73.23 110.675 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.43 -50.14 3.53 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.734 -0.746 . . . . 75.34 112.08 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.47 55.1 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.856 -0.688 . . . . 63.41 112.406 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -82.62 124.53 6.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.693 -0.765 . . . . 51.1 112.02 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 m -85.86 71.03 10.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 65.14 110.831 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.13 176.42 33.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.768 -0.729 . . . . 71.51 112.012 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.79 64.79 4.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.95 -0.643 . . . . 50.02 112.156 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.6 90.23 1.22 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.987 -0.625 . . . . 72.31 112.16 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.7 t -97.7 -14.82 20.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 72.04 109.521 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 162.63 -80.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.404 -0.817 . . . . 64.23 111.608 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.52 -172.31 2.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.85 -0.426 . . . . 73.31 109.85 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.78 144.52 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.914 -0.585 . . . . 71.35 111.868 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.57 -168.64 45.06 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.542 -0.837 . . . . 74.45 111.828 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.807 ' HB3' ' HD3' ' A' ' 197' ' ' PRO . . . -84.27 152.09 24.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.856 0.36 . . . . 75.22 110.238 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 191' ' ' ILE . 94.7 m-85 -98.67 112.29 62.26 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.406 -0.59 . . . . 75.45 109.406 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.565 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 54.2 Cg_endo -85.91 -5.44 8.78 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.511 2.141 . . . . 72.54 112.719 -177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.57 -19.83 32.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.801 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.8 pt -77.42 -16.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 71.33 111.266 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.38 31.09 10.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.85 -0.614 . . . . 72.21 111.69 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.32 149.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.968 -0.293 . . . . 74.14 110.971 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.48 124.07 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.214 0.531 . . . . 72.43 111.725 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.97 130.05 0.77 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.374 -0.83 . . . . 65.04 109.76 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 87.7 m-85 -115.86 146.71 37.54 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.452 -0.34 . . . . 75.41 110.426 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' A' ' 187' ' ' ALA . 38.0 Cg_endo -67.22 -62.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.383 2.055 . . . . 74.43 111.706 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.42 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 0.8 OUTLIER -131.79 23.63 4.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 74.35 109.832 175.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 29.7 m-20 70.59 6.35 5.78 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.372 -0.831 . . . . 63.12 112.166 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 17.7 ptm -55.47 -32.14 62.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 74.31 112.292 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.69 4.6 85.04 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.534 -0.841 . . . . 73.1 113.503 -174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 11.1 ptm180 -116.51 -3.72 11.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.897 0.856 . . . . 73.34 110.089 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 203' ' ' LYS . 26.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-N 114.13 -1.396 . . . . 73.05 110.714 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.931 0.396 . . . . 64.31 110.186 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.62 -167.53 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.391 -0.368 . . . . 62.31 110.343 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.04 132.17 37.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.161 -0.311 . . . . 73.24 110.161 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm 67.63 109.19 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.922 0.764 . . . . 72.33 111.333 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.76 161.0 30.39 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.847 2.365 . . . . 74.43 112.485 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.91 138.95 78.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.728 2.285 . . . . 74.22 111.686 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -55.54 109.29 0.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.704 0.764 . . . . 74.32 112.223 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.466 ' HB3' HE22 ' A' ' 10' ' ' GLN . 6.2 m -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.615 -1.175 . . . . 74.31 107.901 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 46.6 p90 -79.3 -54.5 5.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.204 0.816 . . . . 74.25 113.204 -169.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.606 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mp0 66.27 175.95 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 110.153 -0.314 . . . . 75.11 110.153 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 10' ' ' GLN . 73.1 Cg_exo -50.73 112.49 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.119 1.879 . . . . 75.34 112.149 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.713 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 91.3 Cg_endo -88.22 7.97 4.27 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.457 2.772 . . . . 72.32 113.18 -173.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 165' ' ' SER . 21.2 t-20 -127.09 145.5 50.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.084 -0.962 . . . . 73.22 108.433 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG13 ' HA ' ' A' ' 164' ' ' PRO . 29.1 m -136.15 157.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.853 0.358 . . . . 73.43 111.071 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.842 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 50.0 p90 -121.74 130.52 53.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.218 0.533 . . . . 70.02 110.382 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -109.44 102.68 11.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.559 -0.746 . . . . 72.21 109.567 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -82.4 111.18 18.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.499 -0.926 . . . . 65.2 108.499 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -103.07 -179.74 4.04 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.116 0.484 . . . . 72.24 111.376 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 t -67.86 -24.57 65.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 75.23 109.929 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.516 ' HE2' HG23 ' A' ' 142' ' ' VAL . 6.1 mmt -86.63 -44.85 11.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 73.41 110.636 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -175.46 -126.92 0.98 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.804 -0.712 . . . . 65.01 111.554 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.26 137.09 46.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.924 0.362 . . . . 75.33 110.098 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -124.93 115.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.02 -0.536 . . . . 65.42 109.7 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.658 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 46.7 t -102.77 137.33 31.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.521 -0.472 . . . . 74.43 109.744 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.19 163.34 37.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.112 0.482 . . . . 74.4 110.809 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.405 ' HB3' HD21 ' A' ' 13' ' ' ASN . 10.6 pt-20 -128.59 166.27 19.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.537 -0.756 . . . . 75.32 109.402 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -102.33 165.62 11.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.423 -0.955 . . . . 72.52 108.423 176.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.593 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.3 m-85 -89.64 90.38 8.22 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.612 -0.835 . . . . 75.11 111.345 177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.713 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -74.75 -11.89 60.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.266 1.032 . . . . 75.15 108.281 175.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.7 -35.57 77.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.2 -1.818 . . . . 75.54 110.95 -177.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -124.77 -20.89 4.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.792 -0.64 . . . . 72.02 110.721 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.09 85.13 50.99 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.129 0.418 . . . . 54.12 112.129 -169.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.57 -41.75 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.322 2.015 . . . . 74.41 111.491 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.85 -43.23 36.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.661 -0.7 . . . . 73.41 111.053 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.529 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.2 -39.83 95.76 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.662 -0.699 . . . . 75.03 110.282 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.612 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 15.0 t -60.41 -46.08 91.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.844 -0.616 . . . . 74.12 110.101 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -59.59 -34.84 73.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 75.34 110.815 -178.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 35' ' ' THR . 38.2 t-20 -50.56 -61.36 2.24 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.584 -0.524 . . . . 75.42 109.584 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 112' ' ' PHE . 23.4 m-85 -67.97 -41.34 82.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.05 -0.523 . . . . 74.21 111.67 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 44' ' ' ARG . . . -56.54 -45.77 81.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 73.5 111.787 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' HG2' ' HE2' ' A' ' 37' ' ' LYS . 19.4 mm-40 -67.46 -42.27 83.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.096 -0.242 . . . . 74.33 111.198 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 47' ' ' TYR . 3.5 mm? -66.11 -26.44 67.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.997 -0.281 . . . . 75.41 110.554 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.21 73.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.726 0.298 . . . . 71.25 110.628 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.579 ' HD3' ' HG2' ' A' ' 10' ' ' GLN . 29.9 mtm180 -66.31 -43.47 86.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.532 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.56 -43.61 98.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 73.43 110.853 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.14 64.12 0.53 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.834 -0.698 . . . . 74.33 111.502 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' HB2' HD11 ' A' ' 42' ' ' LEU . 73.1 t80 -86.0 -50.77 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.104 0.478 . . . . 70.13 110.154 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.578 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 7.0 m-85 -76.42 -10.82 59.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.368 -0.833 . . . . 75.32 111.796 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.73 -19.29 63.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 74.33 111.318 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.01 40.03 1.61 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.713 . . . . 75.0 111.996 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.635 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.6 p -118.28 156.62 28.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 75.33 111.153 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 15.1 ptpt -141.98 163.05 33.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.735 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.54 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.9 m-85 -86.86 133.64 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.101 -0.499 . . . . 74.05 109.663 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -120.21 -28.96 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.254 -0.578 . . . . 64.42 111.457 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.2 mmt180 -112.6 109.59 19.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.121 -0.326 . . . . 75.54 110.121 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.438 HD12 ' HB3' ' A' ' 53' ' ' PHE . 14.8 mm -121.51 88.6 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.04 -0.726 . . . . 74.54 109.04 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 18.3 mt -103.31 119.59 52.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.231 -0.587 . . . . 73.32 110.099 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -54.33 138.02 40.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.707 0.629 . . . . 64.32 110.759 178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p30 44.24 33.19 0.79 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.383 1.052 . . . . 74.32 112.68 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.506 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.35 -83.74 0.54 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.158 -0.473 . . . . 74.44 110.11 179.218 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -161.47 158.11 26.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.593 . . . . 72.21 110.389 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CD1' HD23 ' A' ' 116' ' ' LEU . 59.8 mt -128.81 103.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.594 -0.73 . . . . 74.41 109.656 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -86.51 121.52 29.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.11 -0.495 . . . . 74.41 110.252 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.18 140.81 11.86 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.658 -0.782 . . . . 61.44 112.603 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 138.86 -151.77 21.86 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.653 -0.784 . . . . 63.14 112.302 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t0 58.3 95.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 123.756 0.823 . . . . 71.2 111.98 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 49.1 Cg_endo -71.31 -18.32 30.18 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.718 2.278 . . . . 75.41 112.359 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.592 ' OG1' HG23 ' A' ' 70' ' ' THR . 81.8 p -91.65 -32.86 15.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.469 . . . . 65.3 110.887 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.77 22.88 71.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.817 -0.629 . . . . 64.43 112.284 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.592 HG23 ' OG1' ' A' ' 68' ' ' THR . 14.2 t -107.51 -20.94 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.649 0.24 . . . . 70.01 111.649 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.44 -13.96 6.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.316 -0.945 . . . . 74.0 113.506 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -0.82 7.08 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.107 0.78 . . . . 75.21 113.107 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 66.11 -164.9 39.58 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.882 -0.675 . . . . 51.33 113.337 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.18 -81.0 0.8 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 73.5 111.598 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.588 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . 59.31 34.47 22.94 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.696 0.76 . . . . 63.43 111.153 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.4 m -66.25 -25.93 67.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 71.32 112.718 -170.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.578 HG23 ' CD1' ' A' ' 78' ' ' TYR . 3.6 tt -65.78 -40.13 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.928 0.344 . . . . 71.1 111.928 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.588 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 13.3 p90 -107.01 -17.25 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.791 0.329 . . . . 75.23 111.333 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.94 -62.99 4.51 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.047 -0.597 . . . . 64.04 113.811 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 91.7 mttt -118.47 177.66 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.669 -0.312 . . . . 71.35 111.666 -175.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 164.68 25.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.93 -0.577 . . . . 73.54 110.441 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -110.53 -68.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.373 -0.376 . . . . 73.45 111.127 -172.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -168.02 156.69 9.15 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.129 -0.693 . . . . 73.13 109.129 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 9.4 p-10 -89.93 131.59 35.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 71.13 109.764 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 25.8 tt0 -105.53 8.01 33.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 75.43 110.262 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 mt -46.87 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.353 -0.84 . . . . 74.32 112.543 -170.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -179.56 87.0 0.2 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.404 -0.817 . . . . 75.51 109.23 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 30.9 Cg_endo -63.49 96.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.444 2.096 . . . . 75.21 111.828 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -11.38 59.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 74.43 109.46 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -105.02 170.56 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.598 -1.26 . . . . 73.01 107.598 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -126.0 150.83 47.77 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.926 -0.71 . . . . 75.25 110.79 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 35.7 p90 -65.5 121.83 15.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.169 -0.678 . . . . 74.44 109.169 173.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.5 p -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.963 -0.562 . . . . 71.55 110.61 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.26 -145.2 4.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.484 -0.78 . . . . 75.13 111.633 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.12 146.2 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.806 0.336 . . . . 74.12 111.048 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.67 26.18 5.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.754 -0.736 . . . . 74.54 111.98 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 189' ' ' PRO . 8.8 mm -90.07 111.51 23.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.583 -0.525 . . . . 75.33 109.583 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.88 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.91 117.73 24.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.866 -0.606 . . . . 74.42 109.673 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.78 176.92 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.404 . . . . 71.34 111.774 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.985 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 17.4 tpt -93.77 138.96 31.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 75.53 111.885 -173.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.21 132.89 43.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.198 -0.455 . . . . 75.0 110.315 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.4 162.07 36.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.209 -0.451 . . . . 71.32 110.596 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' A' ' 107' ' ' THR . . . -82.54 -26.32 32.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.117 -0.492 . . . . 75.51 110.846 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 169.24 -134.38 3.18 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 121.0 -0.619 . . . . 74.44 112.16 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 25.8 Cg_endo -59.64 92.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.192 2.594 . . . . 71.31 111.713 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 2.2 p30 62.29 10.08 3.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.975 1.31 . . . . 72.02 112.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 103' ' ' ALA . 1.4 m -82.17 57.85 3.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.475 0.655 . . . . 74.42 109.307 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.99 143.12 26.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.593 -0.731 . . . . 70.43 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.26 -98.96 2.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.746 -0.74 . . . . 72.13 111.966 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.407 ' OG ' ' HG ' ' A' ' 42' ' ' LEU . 9.2 t -147.68 10.55 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.421 . . . . 74.32 110.536 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.54 159.04 17.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.688 0.28 . . . . 70.5 111.166 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 41.4 p90 -140.25 175.43 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 73.53 110.682 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -154.69 151.47 28.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 72.05 110.521 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.744 HG22 HD23 ' A' ' 98' ' ' LEU . 16.5 t -109.23 143.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.31 -0.626 . . . . 72.31 109.31 177.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -96.98 129.5 44.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.035 0.445 . . . . 74.21 110.402 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.513 HD23 ' CD1' ' A' ' 62' ' ' ILE . 71.0 mt -85.5 -7.27 58.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.779 -0.646 . . . . 74.24 110.886 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.94 160.21 47.41 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.643 -0.708 . . . . 71.51 109.972 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.453 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 29.6 Cg_endo -64.06 111.79 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.492 2.128 . . . . 62.52 111.555 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.1 p -100.68 122.07 42.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 74.13 111.93 -172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 1.1 pm0 -120.89 24.38 10.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.655 0.741 . . . . 75.2 109.815 174.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -115.45 -3.11 12.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.282 -0.872 . . . . 72.45 111.457 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.39 12.05 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 63.41 111.058 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.438 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 8.7 p-10 -63.14 -28.57 70.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 74.01 111.049 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.97 17.84 19.58 Favored Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.652 -0.785 . . . . 63.14 111.205 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -116.45 -34.6 4.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.254 0.549 . . . . 75.13 109.889 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.78 123.39 24.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.434 -0.95 . . . . 72.42 108.434 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 t -70.87 144.13 50.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.33 -0.548 . . . . 71.32 109.833 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.2 mt -113.49 124.38 70.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.832 -0.622 . . . . 73.22 111.28 -173.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.985 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 5.7 p90 -156.37 72.68 0.76 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.849 0.833 . . . . 74.12 110.468 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.88 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.59 157.47 29.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.616 -1.278 . . . . 70.44 113.53 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.593 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 38.5 mtp180 -139.63 121.88 15.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 74.12 110.002 173.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.37 137.11 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 75.0 110.306 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.658 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 48.5 t -149.56 147.82 28.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.268 -0.424 . . . . 70.44 109.954 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER 48.04 67.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 75.25 110.05 -175.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 139' ' ' VAL . . . 158.89 19.68 0.03 OUTLIER Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.269 -0.878 . . . . 70.22 113.267 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.631 HG21 ' CG ' ' A' ' 184' ' ' ASP . 11.1 tp -80.73 -32.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.319 -0.623 . . . . 72.43 109.319 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.11 93.62 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.043 -0.823 . . . . 72.51 111.043 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.482 ' O ' HG22 ' A' ' 142' ' ' VAL . 79.2 mmm -70.56 -48.94 52.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.768 -0.456 . . . . 75.44 109.768 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 135' ' ' GLY . 69.4 t -56.28 -29.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.925 0.393 . . . . 74.53 110.8 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -70.59 -56.53 6.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.422 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.487 ' HE ' ' HB2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.87 -15.42 62.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.379 . . . . 75.45 111.085 -177.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.516 HG23 ' HE2' ' A' ' 20' ' ' MET . 75.3 t -84.41 -39.6 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 74.13 110.154 174.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -78.15 -27.15 58.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.535 -0.84 . . . . 74.3 112.843 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.2 mmm -75.11 -13.27 60.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.859 0.318 . . . . 74.05 111.859 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.9 m -106.48 118.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.233 0.539 . . . . 72.03 110.834 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.804 ' HG3' ' HG1' ' A' ' 147' ' ' THR . 16.5 pt-20 -106.28 -38.22 6.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.432 -0.507 . . . . 63.43 109.703 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.804 ' HG1' ' HG3' ' A' ' 146' ' ' GLU . 0.6 OUTLIER -152.7 164.86 36.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.65 0.738 . . . . 75.24 112.169 178.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -76.71 -175.0 3.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.317 -1.31 . . . . 75.14 109.077 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 t -61.58 -27.6 68.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.862 -0.792 . . . . 74.33 108.862 171.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 152' ' ' ARG . 43.9 mt-30 -90.78 167.41 12.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.136 -0.938 . . . . 71.43 109.014 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.44 67.23 8.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.289 1.043 . . . . 74.41 109.104 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 14.8 ptp180 -148.4 144.29 18.44 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 113.664 -1.607 . . . . 74.51 108.63 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.32 130.35 37.22 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.419 1.412 . . . . 75.03 109.71 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -45.31 -53.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.529 0.518 . . . . 73.55 111.165 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -146.75 147.53 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.224 -0.658 . . . . 70.43 109.224 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -72.1 118.14 14.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.84 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.9 129.77 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.79 0.805 . . . . 71.22 111.478 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -154.16 173.03 16.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.998 -1.001 . . . . 62.54 109.42 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 159' ' ' ILE . 3.6 mp -89.74 114.43 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.27 -0.641 . . . . 72.22 109.27 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.547 HG21 ' HD3' ' A' ' 161' ' ' LYS . 26.8 mm -79.89 -58.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.686 -0.688 . . . . 62.4 110.53 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.547 ' HD3' HG21 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -125.07 137.01 54.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.108 -0.496 . . . . 72.25 109.786 176.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -141.39 122.71 14.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.63 -0.259 . . . . 62.12 110.857 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -145.04 154.12 54.21 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.99 -0.55 . . . . 71.23 109.867 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.545 ' HA ' HG13 ' A' ' 14' ' ' VAL . 9.2 Cg_endo -57.13 138.96 88.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.181 1.921 . . . . 73.52 111.68 171.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.842 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 38.3 t -118.53 152.19 36.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.81 -0.632 . . . . 62.14 111.148 -172.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -125.42 57.83 0.68 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.006 -0.837 . . . . 72.21 111.006 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.42 162.7 47.91 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.954 -0.641 . . . . 70.51 112.595 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.95 -65.9 0.51 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.063 -0.589 . . . . 71.42 111.727 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.08 -132.95 21.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.793 -0.718 . . . . 73.53 112.058 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.0 p -86.17 -5.37 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.033 0.444 . . . . 72.13 110.665 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.37 -49.37 4.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.98 -0.628 . . . . 64.04 112.654 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.44 -119.97 5.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.896 -0.669 . . . . 70.42 111.812 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 111.59 149.16 11.27 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.624 -0.798 . . . . 71.32 112.306 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -153.75 109.92 3.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.85 0.357 . . . . 73.0 110.209 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -141.27 -141.4 3.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.842 -0.695 . . . . 65.11 112.191 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.76 -66.62 3.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.141 -0.552 . . . . 63.52 111.86 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -118.01 -70.38 0.38 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.367 -0.693 . . . . 52.33 111.367 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.8 m -130.89 158.73 39.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.303 -0.258 . . . . 73.34 110.303 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.29 -141.65 7.71 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.796 -0.716 . . . . 73.01 111.813 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.59 -173.49 25.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.919 -0.658 . . . . 72.22 112.138 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -96.19 112.01 4.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.862 -0.685 . . . . 55.44 112.01 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.9 t -82.22 146.58 29.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.898 0.38 . . . . 62.32 110.097 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 123.89 -135.28 9.66 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.341 -0.704 . . . . 42.32 111.341 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.631 ' CG ' HG21 ' A' ' 136' ' ' ILE . 12.6 t0 -155.35 174.94 14.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.972 -0.751 . . . . 61.54 108.972 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 148.33 159.47 8.49 Favored Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.541 -0.838 . . . . 53.53 112.782 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.6 -166.63 39.11 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.887 -0.673 . . . . 73.21 112.321 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.786 ' HB1' ' HD3' ' A' ' 197' ' ' PRO . . . -79.7 173.31 12.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.804 0.335 . . . . 64.51 110.4 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.58 100.81 40.31 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.616 -0.265 . . . . 72.42 110.58 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.722 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.3 Cg_endo -80.34 -5.05 13.38 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.518 2.145 . . . . 74.43 111.734 176.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.562 ' HB2' ' HH ' ' A' ' 28' ' ' TYR . 20.7 tt0 -77.15 -39.24 49.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.217 -0.902 . . . . 63.23 109.56 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.14 152.68 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.385 -0.969 . . . . 73.03 108.385 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -104.75 81.45 1.77 Allowed 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.223 -0.591 . . . . 73.31 110.808 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -156.93 146.87 11.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.998 -1.001 . . . . 75.45 109.111 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.888 0.375 . . . . 73.21 110.847 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.446 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -153.52 150.24 28.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.878 -0.786 . . . . 64.2 108.878 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' ' 199' ' ' ASP . 40.6 m-85 -122.7 142.27 37.22 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.688 -0.233 . . . . 74.24 110.479 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.786 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.9 -63.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.4 2.067 . . . . 73.41 111.488 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -122.44 16.71 10.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 74.22 109.844 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 13.4 m-20 70.24 8.0 6.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.198 -0.91 . . . . 74.55 113.367 171.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -61.91 -21.42 64.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.766 0.284 . . . . 73.3 111.766 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.89 -5.39 83.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.831 -0.7 . . . . 73.23 112.958 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -82.68 -20.72 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.392 0.615 . . . . 70.05 110.462 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm . . . . . 0 C--O 1.245 0.849 0 CA-C-N 114.733 -1.121 . . . . 74.55 111.368 -175.237 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.236 -0.283 . . . . 74.31 110.236 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.22 18.54 18.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 62.14 110.773 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.15 -44.53 68.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.435 -0.802 . . . . 71.45 110.016 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.611 HG12 HG12 ' A' ' 77' ' ' ILE . 58.7 mt -129.76 103.7 17.4 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.894 -1.048 . . . . 75.43 109.115 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.87 139.23 67.23 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.914 2.409 . . . . 64.54 112.791 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.38 -39.09 92.9 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.922 2.414 . . . . 74.13 111.354 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.42 102.5 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.784 0.802 . . . . 70.2 109.047 174.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.734 ' HB3' HE22 ' A' ' 10' ' ' GLN . 31.9 m -121.34 122.02 38.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.537 -0.756 . . . . 73.2 111.602 -171.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.539 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 25.8 t90 -92.68 107.83 19.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.326 -0.62 . . . . 74.15 109.326 172.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.734 HE22 ' HB3' ' A' ' 8' ' ' SER . 1.5 mp0 -93.91 107.23 26.41 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.753 -0.658 . . . . 71.44 111.341 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' A' ' 40' ' ' ALA . 9.6 Cg_endo -90.31 116.86 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.556 2.838 . . . . 71.23 111.112 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 40.4 Cg_endo -67.73 -19.78 46.99 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.368 2.045 . . . . 73.31 112.45 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.66 HD22 HG13 ' A' ' 24' ' ' VAL . 22.5 t-20 -139.42 145.96 39.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.605 -0.725 . . . . 74.52 110.149 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 164' ' ' PRO . 29.6 m -133.85 145.16 33.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.399 0.618 . . . . 64.12 111.156 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' HE1' ' HB3' ' A' ' 165' ' ' SER . 84.3 m-85 -99.75 123.51 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.3 -0.864 . . . . 72.34 111.145 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.36 103.69 11.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 73.14 109.911 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.16 117.15 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.245 -0.65 . . . . 74.34 109.245 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 179.96 4.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.124 0.488 . . . . 74.15 111.739 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -64.33 -26.46 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.339 -0.846 . . . . 70.05 110.673 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.707 ' HG3' HG23 ' A' ' 142' ' ' VAL . 7.1 mmt -91.54 -37.19 13.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.885 -0.598 . . . . 74.2 111.429 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.539 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -179.68 -128.9 1.26 Allowed Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.64 -0.791 . . . . 75.2 111.395 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.46 136.36 43.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.073 0.463 . . . . 75.44 110.039 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.4 120.79 57.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.603 -0.726 . . . . 75.52 109.14 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.66 HG13 HD22 ' A' ' 13' ' ' ASN . 6.9 t -101.4 141.59 17.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.688 -0.687 . . . . 74.22 109.179 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -147.76 161.59 40.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.272 -0.571 . . . . 74.32 111.16 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -132.27 163.76 27.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.144 -0.935 . . . . 72.35 110.429 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.71 168.09 10.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 73.25 109.901 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.662 ' HH ' ' HG2' ' A' ' 189' ' ' PRO . 6.3 m-85 -89.99 97.77 11.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.875 0.369 . . . . 74.21 110.991 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.483 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 76.5 m95 -88.82 14.74 9.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.966 0.889 . . . . 74.42 109.003 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.52 -54.1 4.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.109 -1.405 . . . . 72.51 110.545 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.64 9.36 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 74.44 111.914 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.09 71.41 73.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.287 . . . . 70.22 110.887 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.15 -42.1 11.49 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.748 2.298 . . . . 70.41 112.987 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.484 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.45 -46.89 52.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 72.33 110.321 -177.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -41.23 86.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.21 -0.905 . . . . 75.42 110.93 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 129' ' ' PHE . 89.1 m -52.18 -51.0 60.74 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.921 -0.581 . . . . 75.22 111.425 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.565 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 4.5 mtmp? -73.14 -23.86 60.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 74.44 111.532 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -56.46 -47.86 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 74.44 109.411 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 112' ' ' PHE . 3.8 m-85 -77.76 -42.31 34.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.478 -0.783 . . . . 72.24 111.069 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . -55.89 -48.8 74.97 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.113 0.412 . . . . 74.4 112.113 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.636 ' HB3' HD11 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -59.72 -43.83 94.01 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.11 0.481 . . . . 72.44 110.769 178.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 75' ' ' ALA . 28.1 mt -67.36 -30.45 70.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.907 -0.588 . . . . 74.31 111.319 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.53 76.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.691 -0.686 . . . . 71.52 111.41 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 8' ' ' SER . 17.7 ptt180 -81.16 -7.26 59.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.538 -0.465 . . . . 74.43 111.384 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -89.43 -49.38 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.792 -0.448 . . . . 75.22 109.792 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 41.03 0.54 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 115.819 -0.628 . . . . 55.51 112.005 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.465 ' HB2' HD22 ' A' ' 42' ' ' LEU . 50.5 t80 -71.4 -37.34 71.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.672 0.389 . . . . 75.35 111.672 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 45.2 m-85 -75.97 -16.41 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.46 . . . . 75.4 112.016 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -68.74 -7.7 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 74.14 111.585 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -127.36 16.09 6.34 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.578 -0.82 . . . . 71.22 112.472 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -101.53 150.06 23.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.322 . . . . 73.01 111.433 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 2.1 mptt -130.96 153.37 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 75.43 110.107 -177.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 75.1 m-85 -90.04 108.41 19.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.475 -0.935 . . . . 74.24 108.475 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -110.63 -8.88 14.56 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.341 -0.544 . . . . 70.42 111.262 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 26.6 mmt180 -121.11 106.06 11.19 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.914 0.388 . . . . 73.3 110.278 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.17 89.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.86 -0.793 . . . . 73.2 108.86 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.723 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 39.1 mt -91.2 120.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.557 -0.905 . . . . 74.33 108.557 176.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 4.2 ptmm? -58.6 118.38 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.724 0.64 . . . . 74.04 111.438 -175.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 203' ' ' LYS . 41.9 m-20 61.72 40.49 13.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.868 -1.06 . . . . 71.12 111.182 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.723 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -136.69 -78.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 74.4 110.271 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.66 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 25.4 ptm -160.32 155.87 25.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 72.23 110.6 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 46.8 mt -128.17 102.92 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 74.54 109.454 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.53 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -81.07 127.2 32.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.01 -0.541 . . . . 72.42 110.486 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.84 139.72 11.18 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.811 -0.709 . . . . 54.34 112.145 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.27 -149.14 20.45 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.061 -1.066 . . . . 72.21 113.26 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.488 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 1.4 t70 48.14 86.42 0.15 Allowed Pre-proline 0 N--CA 1.461 0.117 0 C-N-CA 124.689 1.196 . . . . 65.23 112.617 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 82.3 Cg_endo -75.71 -18.13 17.49 Favored 'Trans proline' 0 CA--C 1.521 -0.165 0 C-N-CA 122.889 2.392 . . . . 72.54 110.679 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.521 ' OG1' HG21 ' A' ' 70' ' ' THR . 3.6 p -84.3 -42.36 15.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.129 -1.396 . . . . 74.41 112.072 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 86.0 29.66 25.2 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 73.03 111.396 -174.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.521 HG21 ' OG1' ' A' ' 68' ' ' THR . 5.2 t -112.39 -33.68 6.11 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.974 0.361 . . . . 74.23 111.974 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.85 -0.66 11.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.127 -1.035 . . . . 72.31 113.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -126.26 -24.06 3.75 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.607 -0.349 . . . . 72.25 111.351 178.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 97.47 -171.09 26.2 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.563 -0.827 . . . . 53.51 112.818 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.58 -98.06 1.98 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.281 -0.485 . . . . 73.53 112.185 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.63 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 59.31 33.77 22.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.698 0.761 . . . . 74.23 111.096 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -76.44 15.12 0.65 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.63 -1.168 . . . . 74.42 110.922 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 41' ' ' GLU . 6.8 tt -94.27 -38.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.871 -0.604 . . . . 72.44 111.091 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.63 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 34.7 p90 -106.11 -18.45 14.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.026 -0.67 . . . . 63.55 111.6 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.4 -103.62 2.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.316 -0.945 . . . . 74.14 113.449 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -125.61 174.94 7.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.984 0.421 . . . . 75.24 111.72 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -87.0 -96.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.375 -0.829 . . . . 75.15 111.535 -171.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 13.2 m-30 78.17 14.88 1.45 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.086 0.555 . . . . 74.55 112.325 172.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.47 126.5 5.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.57 -0.741 . . . . 74.41 110.224 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.599 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 5.4 p-10 -82.68 122.09 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.953 -0.758 . . . . 75.33 108.953 170.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -99.67 19.05 16.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.998 -0.742 . . . . 71.51 108.998 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 84' ' ' ASP . 28.1 mt -58.8 99.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.385 -1.28 . . . . 74.41 110.094 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -154.62 74.81 5.79 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 109.986 -0.376 . . . . 74.25 109.986 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.36 92.59 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.78 2.32 . . . . 73.52 112.238 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.0 -33.26 67.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 74.32 108.695 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -93.99 178.08 5.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.513 -1.221 . . . . 71.21 109.124 174.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -144.38 160.73 40.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.07 -0.344 . . . . 75.35 110.07 178.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 26.2 p90 -56.65 119.68 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.874 0.845 . . . . 72.33 111.053 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.459 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 33.8 p -116.62 -43.66 2.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.728 -0.669 . . . . 74.41 110.537 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.9 -155.18 7.82 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.363 -0.835 . . . . 74.33 111.339 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.37 141.15 31.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.776 0.322 . . . . 64.32 110.791 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.77 23.73 4.56 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.816 -0.706 . . . . 54.41 111.949 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -90.18 116.69 32.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 74.24 109.701 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.866 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -91.97 123.31 35.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.626 -0.715 . . . . 75.33 110.099 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 128' ' ' ILE . . . -140.8 169.02 18.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 75.04 111.144 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.509 ' CG ' ' HE1' ' A' ' 129' ' ' PHE . 26.3 mtm -92.32 156.32 17.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.038 0.447 . . . . 73.12 110.495 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 166.86 10.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.821 -0.627 . . . . 63.13 109.709 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -120.42 179.06 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.742 0.306 . . . . 74.53 110.403 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.06 18.82 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.84 -0.618 . . . . 75.14 110.611 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.51 -142.92 14.17 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.748 -0.739 . . . . 71.15 112.846 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -58.77 92.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.645 2.897 . . . . 74.34 112.216 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.77 32.56 7.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.478 -1.237 . . . . 53.12 111.003 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.5 m -80.27 56.29 2.45 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.517 -1.219 . . . . 75.32 110.058 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.599 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 m-80 -72.57 100.62 2.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.027 -0.988 . . . . 73.34 109.633 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.465 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -116.32 -135.87 5.71 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.254 -0.974 . . . . 74.02 113.315 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 47.8 p -96.88 -4.78 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.898 0.38 . . . . 75.11 111.404 -176.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -71.17 142.77 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.027 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.513 ' HB3' ' HZ ' ' A' ' 39' ' ' PHE . 52.3 p90 -143.5 169.38 17.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.828 0.347 . . . . 71.22 110.812 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.51 155.21 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 74.11 110.665 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.702 HG22 HD21 ' A' ' 98' ' ' LEU . 18.4 t -110.61 144.05 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.899 -0.591 . . . . 74.31 109.482 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.5 p -97.01 124.58 41.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.101 0.477 . . . . 74.41 110.538 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD23 ' CD1' ' A' ' 62' ' ' ILE . 71.9 mt -83.66 -9.53 58.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.592 -0.731 . . . . 73.25 110.243 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.4 156.84 42.54 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.172 -0.922 . . . . 75.11 109.611 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.561 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 57.5 Cg_endo -72.28 113.34 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.262 1.975 . . . . 73.35 112.33 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.2 p -100.49 145.47 28.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 65.44 109.863 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -123.31 17.99 9.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 72.41 110.722 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.793 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 1.1 p90 -124.08 -1.72 8.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 72.14 111.33 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.793 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 86.9 mt -114.36 -6.1 12.92 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.975 0.417 . . . . 73.15 110.839 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.42 -19.19 64.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 72.25 111.249 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.53 12.52 10.24 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.52 -0.848 . . . . 61.12 111.841 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -120.14 -24.33 6.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 74.35 109.775 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.477 ' HB3' ' O ' ' A' ' 100' ' ' MET . 38.9 m80 -130.24 125.56 35.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.703 -0.681 . . . . 64.05 110.189 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.0 m -65.9 110.67 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.427 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.413 HG21 ' HB1' ' A' ' 99' ' ' ALA . 32.5 mt -96.84 120.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.167 -0.469 . . . . 74.33 110.539 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 1.3 p90 -153.76 72.26 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.548 1.166 . . . . 73.23 109.742 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.866 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.63 153.1 23.58 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 118.269 -1.92 . . . . 63.33 113.857 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.4 mtp-105 -133.32 123.63 25.8 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.923 -0.769 . . . . 75.51 108.923 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.78 131.61 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.442 0.639 . . . . 74.41 109.901 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.637 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.6 m -134.36 139.1 45.39 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.507 -0.769 . . . . 50.13 110.263 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 47.09 46.38 16.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.325 0.491 . . . . 62.15 112.325 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.88 29.46 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.952 -1.118 . . . . 71.24 112.587 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.4 tp -76.73 -33.52 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 73.43 110.435 -176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.32 -35.32 91.46 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.015 -0.612 . . . . 73.44 111.682 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.539 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 68.4 mmm -69.37 -52.73 24.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.019 -0.363 . . . . 73.44 110.019 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.83 -30.97 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.135 0.493 . . . . 71.33 110.822 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.72 -53.62 14.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.762 -0.654 . . . . 75.53 110.612 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.547 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.38 -14.96 60.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.04 -0.527 . . . . 74.44 111.097 -177.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.707 HG23 ' HG3' ' A' ' 20' ' ' MET . 54.4 t -85.66 -38.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.18 0.514 . . . . 62.22 110.049 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -82.01 -15.01 75.99 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.574 -0.822 . . . . 74.21 112.94 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.547 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.9 ptm -96.39 0.89 51.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.683 0.241 . . . . 73.44 111.155 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.2 m -57.84 152.71 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.6 0.714 . . . . 73.22 112.084 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.501 ' O ' HG21 ' A' ' 154' ' ' VAL . 7.3 pt-20 -97.81 -170.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.14 -0.936 . . . . 74.41 109.91 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 17.8 p -85.05 148.42 26.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.002 0.429 . . . . 72.4 111.737 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -73.49 -54.63 7.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.894 -0.593 . . . . 75.54 111.059 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.2 m -150.62 -52.66 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.712 -0.477 . . . . 73.3 109.712 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 152' ' ' ARG . 40.0 mt-30 -81.9 -164.96 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.402 -0.592 . . . . 75.31 109.402 173.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.62 13.18 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.462 . . . . 70.14 110.752 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 150' ' ' GLN . 2.0 ptm180 -94.11 121.37 64.1 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 74.12 109.751 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 40.1 Cg_exo -56.45 150.13 52.89 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.382 2.055 . . . . 75.44 110.308 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 146' ' ' GLU . 57.9 t -49.94 102.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.393 0.616 . . . . 73.33 110.564 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.57 93.96 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.194 -0.912 . . . . 63.3 110.56 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -152.07 14.01 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.627 -0.715 . . . . 74.22 110.217 175.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.517 HG21 HG12 ' A' ' 142' ' ' VAL . 2.9 t -92.85 97.36 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.828 0.823 . . . . 75.04 110.561 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -120.43 165.95 14.24 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.719 -1.128 . . . . 71.52 108.824 176.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 48' ' ' TYR . 3.5 mp -88.92 103.3 13.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.451 -0.944 . . . . 74.34 108.451 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.418 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.8 mm -66.87 -59.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.368 -0.833 . . . . 74.43 110.233 -176.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 6.0 mptp? -128.63 132.93 48.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.659 . . . . 74.34 109.977 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.13 135.54 49.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.335 -0.393 . . . . 70.1 110.663 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -154.47 128.1 4.42 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.641 -0.709 . . . . 74.34 110.617 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.471 ' HG2' ' HZ3' ' A' ' 9' ' ' TRP . 91.7 Cg_endo -80.73 149.7 18.42 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.852 2.368 . . . . 75.42 112.817 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.529 ' HB3' ' HE1' ' A' ' 15' ' ' TYR . 21.4 t -152.44 -152.76 0.44 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 70.21 110.128 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.28 -45.57 0.11 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.003 -0.617 . . . . 72.03 111.996 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 128.94 -146.85 17.34 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.03 -0.605 . . . . 72.33 111.692 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.09 116.07 3.36 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.978 -0.629 . . . . 70.03 112.487 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 147.5 113.53 0.75 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.664 -0.779 . . . . 51.53 112.704 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.4 t -165.37 -169.5 1.62 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.668 -0.493 . . . . 72.12 109.668 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.86 -124.22 1.41 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 70.51 112.088 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.61 172.63 37.01 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.944 -0.646 . . . . 60.34 112.079 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.36 136.21 4.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.839 -0.696 . . . . 74.25 111.815 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 38.9 m 57.64 82.44 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 73.15 111.14 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -77.27 81.37 1.2 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.617 . . . . 33.41 112.176 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 143.42 -39.73 1.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.097 -0.573 . . . . 64.1 111.707 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -92.74 -149.02 24.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.865 -0.683 . . . . 73.53 112.212 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.4 m -95.88 109.0 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.843 0.354 . . . . 70.35 110.494 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 175.01 178.44 44.87 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.97 -0.633 . . . . 74.14 111.929 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.53 -45.87 0.38 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.86 -0.686 . . . . 72.2 111.804 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.52 80.93 1.22 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.782 -0.723 . . . . 63.13 111.803 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.0 m -94.95 -166.9 1.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 65.1 110.798 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.64 -172.2 39.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.884 -0.674 . . . . 72.43 111.579 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.85 -179.74 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.572 . . . . 53.43 111.014 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.95 145.98 4.35 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.021 -0.99 . . . . 70.21 111.117 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.62 -167.33 25.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.281 -0.961 . . . . 63.4 112.291 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.757 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.55 171.14 12.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.783 0.325 . . . . 75.31 110.485 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.71 94.38 8.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.988 0.423 . . . . 72.2 110.022 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.662 ' HG2' ' HH ' ' A' ' 28' ' ' TYR . 58.2 Cg_endo -77.83 -7.99 16.67 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.12 1.88 . . . . 72.44 112.802 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.511 ' OE2' ' HD2' ' A' ' 189' ' ' PRO . 1.3 mp0 -75.31 -35.01 61.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.104 0.478 . . . . 73.14 110.445 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.468 HG13 HG12 ' A' ' 193' ' ' VAL . 14.7 pt -79.05 -13.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.929 -0.578 . . . . 70.2 111.509 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.0 m170 65.85 30.68 9.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.704 -0.68 . . . . 71.41 112.204 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.468 HG12 HG13 ' A' ' 191' ' ' ILE . 4.6 p -123.49 149.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.142 -0.318 . . . . 74.21 110.142 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.52 119.0 18.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.162 -0.472 . . . . 71.54 111.601 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -164.97 156.7 15.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.477 -0.783 . . . . 75.23 109.589 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.46 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 10.8 m-85 -120.7 146.22 42.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.799 -0.36 . . . . 73.54 111.122 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.757 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.5 Cg_endo -62.15 -59.89 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.946 2.43 . . . . 70.3 111.968 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.7 21.17 5.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.901 0.381 . . . . 74.33 110.006 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 62.65 19.42 11.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.54 -0.755 . . . . 75.41 111.646 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 ptm -53.28 -53.51 49.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.524 -0.762 . . . . 75.34 112.289 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.78 -8.08 71.63 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.32 -0.467 . . . . 74.21 113.442 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.46 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 78.7 mtp180 -80.9 -42.78 20.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.888 0.375 . . . . 70.42 110.177 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.7 ' HZ3' ' HB2' ' A' ' 203' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-N 114.383 -1.28 . . . . 75.24 112.067 -174.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.76 0.314 . . . . 74.25 110.542 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.2 151.46 38.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 72.2 110.625 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -101.94 116.41 32.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.33 -0.395 . . . . 73.02 110.57 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 78' ' ' TYR . 79.1 mt 73.01 125.54 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.229 0 O-C-N 123.809 0.693 . . . . 71.12 111.09 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.04 109.01 2.07 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.382 2.055 . . . . 73.04 111.751 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.04 2.84 8.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.885 2.39 . . . . 52.32 112.055 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.0 89.4 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.41 0.624 . . . . 71.24 110.643 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 t -157.96 154.81 28.37 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.854 -1.165 . . . . 75.44 107.854 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -104.55 117.92 35.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.521 . . . . 73.13 110.898 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -111.04 142.12 25.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.771 . . . . 74.41 109.076 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.617 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 51.6 Cg_exo -57.91 116.95 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.77 1.647 . . . . 61.14 110.268 167.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.9 0.15 5.41 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.241 2.627 . . . . 74.33 113.276 -172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.55 HD22 HG12 ' A' ' 24' ' ' VAL . 3.1 t-20 -135.7 129.13 32.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.35 -0.841 . . . . 75.14 108.799 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 164' ' ' PRO . 18.7 m -130.85 162.58 38.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.563 0.221 . . . . 72.52 110.493 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.608 ' HB3' HG21 ' A' ' 24' ' ' VAL . 39.5 p90 -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.287 0.565 . . . . 72.43 112.096 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.23 116.39 28.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.005 -0.998 . . . . 73.5 109.423 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.36 112.64 20.51 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.903 -0.777 . . . . 75.54 108.903 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -105.31 177.98 4.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.926 0.393 . . . . 73.0 111.428 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.5 ' HB2' HD12 ' A' ' 160' ' ' ILE . 23.2 t -72.79 -11.44 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 71.22 110.557 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.638 ' HG3' HG22 ' A' ' 142' ' ' VAL . 8.7 mmt -100.39 -39.96 7.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 73.04 110.498 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' HA3' ' HE1' ' A' ' 138' ' ' MET . . . -175.86 -127.0 0.99 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.789 -0.719 . . . . 74.42 111.505 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -145.82 130.79 12.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.28 -0.637 . . . . 75.05 109.28 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 ' N ' HD11 ' A' ' 22' ' ' ILE . 4.1 mp -126.43 129.19 71.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 75.41 110.399 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' A' ' 15' ' ' TYR . 42.5 t -110.18 142.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.864 -0.421 . . . . 71.33 109.864 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' C ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.65 159.35 44.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.459 0.647 . . . . 73.11 111.002 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -132.74 163.5 28.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.484 -0.78 . . . . 72.14 110.005 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD12 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -98.4 166.99 11.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.445 -0.343 . . . . 75.22 110.158 -175.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.772 ' HE2' ' HB3' ' A' ' 190' ' ' GLU . 11.1 m-85 -87.73 99.34 12.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.374 0.607 . . . . 64.41 111.316 175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.467 ' HD1' ' SG ' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -81.45 0.1 39.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.283 -0.871 . . . . 73.44 109.37 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.58 -69.55 0.31 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.133 -0.94 . . . . 73.02 111.035 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.423 ' HD1' ' CG ' ' A' ' 89' ' ' ASP . 46.4 m80 -129.26 17.83 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.413 -0.358 . . . . 75.23 111.195 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.6 63.82 71.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.575 -0.284 . . . . 74.24 111.296 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.21 -44.0 2.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.643 2.229 . . . . 74.02 111.815 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -60.99 -47.15 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.757 0.789 . . . . 75.23 110.051 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.419 HG21 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -65.97 -41.28 91.37 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.56 -1.2 . . . . 73.3 110.965 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 29' ' ' TRP . 41.8 t -57.43 -41.62 80.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 75.54 110.387 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 37' ' ' LYS . 7.4 mmpt? -58.84 -45.45 90.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.925 -0.579 . . . . 74.31 110.897 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -53.49 -52.98 57.81 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.592 0.558 . . . . 63.31 110.511 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.491 ' CD2' HD12 ' A' ' 27' ' ' LEU . 37.4 t80 -69.02 -44.06 73.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.284 -0.417 . . . . 74.25 110.692 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 44' ' ' ARG . . . -55.26 -53.01 61.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 65.31 112.004 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 41.8 mm-40 -66.35 -31.12 71.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 71.1 110.354 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -66.79 -36.87 83.4 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.292 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . . . -67.44 -35.73 79.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.579 -0.737 . . . . 75.33 110.085 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 15.2 mmm180 -61.57 -44.54 96.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.934 -0.575 . . . . 65.3 110.991 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -48.18 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 75.53 110.245 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.42 43.42 1.86 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.127 -1.035 . . . . 74.42 112.412 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.59 -18.92 56.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.077 0.465 . . . . 70.15 111.041 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.674 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.8 -6.01 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 74.0 111.738 -177.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.9 -8.82 47.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.182 -0.463 . . . . 75.55 111.242 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -136.9 26.32 3.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.828 -0.701 . . . . 71.22 112.153 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.527 ' HG1' ' HB ' ' A' ' 159' ' ' ILE . 32.2 p -98.76 148.05 24.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 64.14 111.437 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -135.72 161.65 34.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.332 -0.618 . . . . 55.43 109.332 177.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 74.2 m-85 -80.77 116.41 20.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 61.43 109.915 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -97.56 -22.16 16.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 65.14 110.451 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.786 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 33.5 mmt180 -125.27 116.31 21.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.54 110.151 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 62' ' ' ILE . 20.3 mm -124.42 88.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.108 -0.701 . . . . 75.12 109.108 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 13.7 mt -98.16 126.01 51.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.198 -0.667 . . . . 74.34 109.198 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.28 118.84 8.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.655 0.597 . . . . 73.31 110.656 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 57.81 40.63 25.95 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.894 0.747 . . . . 74.55 110.946 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.842 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.1 t80 -133.24 -81.02 0.48 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.221 0.534 . . . . 73.34 109.916 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.49 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.94 156.62 25.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.96 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.497 ' CD1' HD21 ' A' ' 116' ' ' LEU . 48.5 mt -126.92 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.405 -0.591 . . . . 74.45 109.405 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.786 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 18.3 mt-30 -85.6 124.65 32.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.31 -0.404 . . . . 74.1 110.93 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -119.57 141.24 15.46 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 60.51 111.93 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.8 -137.25 5.34 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.046 -0.597 . . . . 72.03 111.918 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 49.44 78.58 0.39 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.419 0.896 . . . . 61.52 113.419 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HG3' ' HA2' ' A' ' 74' ' ' GLY . 68.4 Cg_endo -76.56 -17.26 16.38 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.789 1.659 . . . . 73.42 110.395 168.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.772 ' HG1' HG23 ' A' ' 70' ' ' THR . 33.9 p -96.61 -44.39 7.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.909 -1.041 . . . . 75.12 111.12 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.63 53.82 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.773 -0.727 . . . . 74.52 111.981 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.772 HG23 ' HG1' ' A' ' 68' ' ' THR . 10.3 t -98.95 -10.61 22.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 64.14 110.95 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.97 -15.4 58.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.863 -0.684 . . . . 64.32 112.939 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.35 18.4 1.71 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.956 0.354 . . . . 71.13 111.956 -175.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.421 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -84.74 -167.92 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.27 -0.967 . . . . 71.35 111.994 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.539 ' HA2' ' HG3' ' A' ' 67' ' ' PRO . . . 113.7 -117.97 4.34 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.249 -0.977 . . . . 65.54 113.272 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.869 ' H ' ' HB2' ' A' ' 110' ' ' SER . . . -60.8 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.242 0.617 . . . . 75.01 112.497 -173.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -99.69 7.63 44.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.845 -0.798 . . . . 74.4 108.845 174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.04 -38.65 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.869 -1.059 . . . . 72.31 111.132 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.858 ' HB2' ' HE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -98.89 -3.47 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.271 -0.422 . . . . 65.22 111.654 -178.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.86 -73.71 2.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.04 -0.6 . . . . 64.03 112.735 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -113.68 171.51 7.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.791 0.329 . . . . 74.24 110.703 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 161.32 28.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 63.45 110.467 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.858 ' HE2' ' HB2' ' A' ' 78' ' ' TYR . 71.1 m-85 -131.74 -169.15 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 73.25 110.351 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -46.47 139.21 5.14 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.836 0.71 . . . . 63.32 112.166 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.16 135.45 42.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.143 -0.688 . . . . 70.01 109.143 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG3' HG21 ' A' ' 35' ' ' THR . 25.9 mm-40 -102.68 19.42 19.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.831 -0.622 . . . . 73.23 110.116 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.06 98.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.622 -0.717 . . . . 71.21 110.655 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -167.75 82.13 0.83 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.962 -0.563 . . . . 74.24 109.876 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.56 92.54 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.846 2.364 . . . . 72.02 112.372 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.423 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 15.3 t70 -71.31 -37.14 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.13 0.967 . . . . 75.21 109.079 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -84.3 179.04 7.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.543 -1.208 . . . . 74.53 108.985 172.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -139.59 169.1 18.36 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.479 -0.488 . . . . 71.31 109.881 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -63.49 123.12 17.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 74.3 109.539 171.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p -125.32 -40.99 2.08 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.567 0.699 . . . . 73.13 109.843 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.549 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.42 -143.4 3.69 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 114.934 -1.03 . . . . 64.52 111.179 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.6 150.83 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.704 0.287 . . . . 64.14 110.519 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.71 23.59 7.79 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.704 -0.76 . . . . 75.34 111.426 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.405 HD13 ' HG3' ' A' ' 189' ' ' PRO . 8.6 mm -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.33 -0.619 . . . . 73.42 109.33 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.872 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -83.38 122.88 29.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.263 -0.426 . . . . 75.12 109.883 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.507 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.79 171.94 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.154 0.502 . . . . 70.13 111.654 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.735 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 26.4 ttt -107.25 143.14 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.616 -0.72 . . . . 73.41 110.13 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 111' ' ' GLN . . . -104.61 136.68 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.2 0.524 . . . . 74.41 110.64 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -139.43 166.23 25.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.583 -0.735 . . . . 73.52 109.766 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -85.88 -34.81 20.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.527 -0.306 . . . . 63.21 111.103 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.32 -123.05 1.07 Allowed Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.534 -0.841 . . . . 74.11 112.337 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.55 90.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.99 2.46 . . . . 75.14 112.201 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' PHE . 2.2 p30 59.87 11.08 2.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 74.25 112.373 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 m -81.48 61.18 4.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.69 0.757 . . . . 75.12 109.095 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -73.5 150.88 41.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.394 -1.276 . . . . 72.43 109.886 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.41 -139.82 3.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.632 -0.794 . . . . 71.33 111.958 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.869 ' HB2' ' H ' ' A' ' 75' ' ' ALA . 33.7 t -113.73 8.48 17.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.975 0.417 . . . . 73.42 110.359 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 9.2 mm-40 -82.47 138.81 34.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.14 -0.482 . . . . 72.44 110.386 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.88 167.29 21.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.111 -0.7 . . . . 74.12 109.111 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.742 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 51.5 p90 -157.12 153.87 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 74.32 112.059 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.794 HG21 HD22 ' A' ' 98' ' ' LEU . 17.4 t -113.64 142.52 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.237 -0.892 . . . . 73.05 108.752 174.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.443 HG23 ' HG1' ' A' ' 119' ' ' THR . 30.9 p -96.04 129.38 43.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.123 0.487 . . . . 74.13 110.621 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 62' ' ' ILE . 74.3 mt -82.49 -10.5 58.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.432 -0.804 . . . . 74.52 110.78 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.56 164.12 24.32 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.414 -0.812 . . . . 71.41 110.022 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 23.9 Cg_exo -64.19 113.96 2.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.707 2.271 . . . . 64.31 112.134 177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.443 ' HG1' HG23 ' A' ' 115' ' ' THR . 13.8 p -100.35 112.95 25.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.207 -0.451 . . . . 75.12 111.106 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.666 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -114.16 27.4 9.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.612 0.72 . . . . 73.34 109.756 -177.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.735 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -129.83 3.52 4.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.153 -0.931 . . . . 75.33 110.983 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.735 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 94.4 mt -113.13 7.84 18.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 73.35 110.931 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 -27.28 56.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.913 -1.04 . . . . 71.24 111.917 -176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.3 25.43 4.85 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.088 -0.805 . . . . 65.12 111.088 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -116.86 -40.38 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.952 0.406 . . . . 71.13 110.067 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -142.3 137.12 30.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 72.5 111.11 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.1 m -68.75 121.77 17.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.658 -0.701 . . . . 71.55 110.796 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.507 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.9 mt -108.4 120.88 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.457 -0.201 . . . . 73.25 110.457 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.735 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.2 p90 -157.71 73.62 0.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.865 0.841 . . . . 72.31 110.81 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.872 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.96 150.94 20.43 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.274 -1.441 . . . . 64.1 113.433 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -127.54 119.63 26.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.862 -0.792 . . . . 73.33 108.862 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.66 132.08 32.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.338 0.589 . . . . 65.22 109.864 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . 0.566 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.1 m -133.55 141.21 47.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 71.03 110.916 -171.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.3 pt20 41.68 35.3 0.47 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.478 1.111 . . . . 75.33 113.842 176.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.32 37.6 0.23 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.585 -0.817 . . . . 70.14 112.211 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.475 HG12 ' HB2' ' A' ' 197' ' ' PRO . 9.3 tp -85.33 -34.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.78 0.324 . . . . 73.41 110.542 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.59 -35.59 81.34 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.038 -0.601 . . . . 61.03 112.413 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.479 ' HE1' ' HA3' ' A' ' 21' ' ' GLY . 81.2 mmm -70.54 -51.32 29.45 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.336 -0.246 . . . . 71.34 110.336 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 62' ' ' ILE . 91.7 t -52.55 -32.12 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.001 0.429 . . . . 75.34 110.933 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.454 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.6 t30 -69.5 -53.8 17.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.84 -0.618 . . . . 73.51 110.559 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -15.43 61.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.055 -0.52 . . . . 73.2 110.975 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.638 HG22 ' HG3' ' A' ' 20' ' ' MET . 45.1 t -84.0 -37.59 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.442 . . . . 73.2 110.315 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . -74.78 -18.62 80.09 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.42 -0.895 . . . . 70.23 112.613 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.454 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 42.8 mtm -99.66 1.34 43.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.947 0.351 . . . . 74.11 111.947 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.428 HG13 ' HA ' ' A' ' 142' ' ' VAL . 30.7 m -52.71 137.04 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.578 . . . . 75.31 111.903 -176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -117.98 -61.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.758 -0.656 . . . . 75.32 110.335 176.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 27.6 p -131.91 150.67 52.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.8 0.333 . . . . 65.42 111.365 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.625 ' OD1' ' HG3' ' A' ' 152' ' ' ARG . 35.0 p-10 -87.31 -12.6 46.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.201 0.524 . . . . 73.3 110.431 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.9 m -150.96 -72.25 0.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 73.4 109.707 174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.34 129.31 0.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 74.34 109.817 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.1 t70 64.13 13.28 7.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.59 0.71 . . . . 74.11 111.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.625 ' HG3' ' OD1' ' A' ' 148' ' ' ASN . 9.3 ptp180 -142.46 120.57 7.39 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.288 -0.634 . . . . 71.15 109.288 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 84.3 Cg_endo -81.24 163.77 19.69 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.239 2.626 . . . . 72.03 115.243 -165.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 148' ' ' ASN . 46.6 t -101.61 125.07 55.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.885 -1.052 . . . . 71.35 110.149 171.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -149.05 11.52 0.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.634 -0.506 . . . . 71.52 109.634 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.525 ' O ' ' HG3' ' A' ' 158' ' ' LYS . 6.6 p-10 -109.7 27.57 9.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.761 -0.654 . . . . 74.1 112.184 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 142' ' ' VAL . 12.8 t -73.27 116.6 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.896 -0.779 . . . . 71.14 108.896 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.1 mttm -124.09 169.57 11.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.981 0.419 . . . . 74.3 111.207 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.527 ' HB ' ' HG1' ' A' ' 51' ' ' THR . 3.9 mp -93.45 99.81 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.838 -1.171 . . . . 75.15 107.838 170.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.557 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.4 mm -63.26 -61.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.62 -0.511 . . . . 65.11 109.62 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.557 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.2 mptp? -138.32 154.7 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.016 -0.735 . . . . 73.42 109.016 172.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -142.51 150.72 40.84 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.661 -0.496 . . . . 74.15 109.661 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 98.6 m-85 -156.05 145.62 15.37 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.339 -0.615 . . . . 74.12 109.339 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.617 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 5.4 Cg_exo -74.94 142.55 28.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.403 2.069 . . . . 73.41 111.954 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.5 t -105.73 136.75 44.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 72.2 110.074 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.19 -38.44 72.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.885 -0.674 . . . . 71.43 112.835 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -127.22 168.99 19.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.721 -0.752 . . . . 74.15 112.423 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.78 156.69 19.45 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.467 -0.653 . . . . 72.02 111.467 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.68 143.94 6.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.698 -0.763 . . . . 73.42 112.004 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.2 p -81.51 -18.64 44.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 63.32 111.242 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 82.38 -69.8 3.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.747 -0.74 . . . . 74.31 112.603 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -150.73 -143.03 3.64 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.914 -0.66 . . . . 74.11 112.37 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.49 62.14 0.32 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.026 -0.606 . . . . 71.23 112.008 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 m -91.9 127.64 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 74.32 110.701 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 172.33 -88.32 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 71.11 111.602 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.45 46.44 1.09 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.031 -0.604 . . . . 73.41 112.114 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.4 -81.58 0.95 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.027 -0.606 . . . . 72.43 112.438 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.7 p -89.71 -11.74 41.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.148 0.499 . . . . 72.42 110.444 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.62 89.23 0.47 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.896 -0.669 . . . . 61.14 111.546 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.87 28.38 7.74 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.689 -0.767 . . . . 73.21 112.552 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.4 64.28 4.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.761 -0.733 . . . . 73.51 111.577 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -100.19 135.15 42.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.695 0.283 . . . . 73.12 110.401 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.71 167.26 22.56 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.928 -0.653 . . . . 55.51 112.292 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.524 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.4 m-20 -97.74 174.77 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.445 0.641 . . . . 54.44 110.836 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.51 145.87 4.29 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.173 -0.922 . . . . 73.12 110.811 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -79.3 -161.12 20.94 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.083 -1.055 . . . . 75.3 112.153 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.624 ' HB2' ' OE1' ' A' ' 195' ' ' GLN . . . -80.95 176.73 9.57 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.153 -0.314 . . . . 71.33 110.153 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.446 ' O ' HG12 ' A' ' 191' ' ' ILE . 76.7 m-85 -116.19 92.54 36.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.646 -0.502 . . . . 70.14 109.646 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.521 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 10.3 Cg_exo -70.48 -18.07 33.85 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.21 2.607 . . . . 74.25 113.279 -173.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.772 ' HB3' ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -78.14 -35.1 49.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.262 0.468 . . . . 71.55 112.262 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.453 HG13 HG11 ' A' ' 193' ' ' VAL . 22.3 pt -73.03 -13.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 71.45 111.773 -171.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 63.8 m170 68.91 29.45 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.774 . . . . 72.13 111.926 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.453 HG11 HG13 ' A' ' 191' ' ' ILE . 3.9 p -127.28 165.66 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.979 -0.748 . . . . 74.34 108.979 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.24 129.77 34.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 63.22 111.59 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.624 ' OE1' ' HB2' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -158.54 153.45 25.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.019 -0.734 . . . . 73.11 109.019 174.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 83.9 m-85 -122.07 138.19 28.5 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.726 -0.39 . . . . 73.01 111.038 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.551 ' HD3' ' HB1' ' A' ' 187' ' ' ALA . 33.0 Cg_endo -64.23 -51.5 2.06 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.622 2.215 . . . . 74.24 111.967 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -154.83 41.15 0.45 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.387 -0.37 . . . . 73.42 111.166 178.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 2.0 m-20 75.32 -12.82 0.92 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.038 0.535 . . . . 73.13 112.257 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.559 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 23.0 ptm -50.64 -31.88 17.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.622 0.971 . . . . 72.32 113.622 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.86 2.7 55.65 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 119.803 -1.189 . . . . 75.54 113.677 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.49 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 31.8 ptt180 -118.98 1.89 11.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 117.565 0.682 . . . . 74.44 111.951 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 200' ' ' MET . 41.4 mtmt . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.116 -0.947 . . . . 74.42 110.831 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.864 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 24.5 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 N-CA-C 110.789 -0.504 . . . . 62.509999999999998 110.789 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 53.1 Cg_endo -69.55 -5.37 15.92 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.499 2.133 . . . . 72.109999999999999 112.116 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -130.99 142.17 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.081 -0.963 . . . . 73.239999999999995 109.449 -175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 164' ' ' PRO . 21.8 m -135.54 157.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.981 -0.377 . . . . 75.150000000000006 109.981 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.555 ' HB2' HD11 ' A' ' 22' ' ' ILE . 50.8 p90 -121.06 130.46 53.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.267 0.556 . . . . 74.519999999999996 110.754 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -111.15 102.17 10.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.501 -0.772 . . . . 64.129999999999995 109.806 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.86 110.65 17.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.22 -0.659 . . . . 74.530000000000001 109.22 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.499 HG21 ' HE2' ' A' ' 53' ' ' PHE . 72.1 p -99.81 -179.7 4.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.719 -175.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 p -69.27 -16.88 63.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.091 -0.504 . . . . 62.210000000000001 110.878 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.4 mmt -94.83 -41.05 9.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 70.129999999999995 111.019 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.78 -127.49 1.05 Allowed Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.639 -0.791 . . . . 43.439999999999998 111.717 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 15' ' ' TYR . 19.6 tt -135.7 137.94 48.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.888 0.375 . . . . 73.230000000000004 110.188 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -122.41 108.75 22.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.191 -0.67 . . . . 75.109999999999999 109.191 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 39.5 t -98.03 131.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.334 -0.617 . . . . 74.450000000000003 109.334 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 25' ' ' LEU . 4.6 pp -146.99 159.26 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.119 0.485 . . . . 73.340000000000003 110.793 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -125.61 164.12 21.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.698 -0.683 . . . . 71.230000000000004 110.604 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.34 159.29 17.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.275 -0.875 . . . . 70.439999999999998 109.128 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.2 m-85 -86.46 88.79 7.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.398 0.618 . . . . 75.299999999999997 111.536 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 34.0 m95 -79.91 -3.59 48.76 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.416 -0.957 . . . . 72.109999999999999 108.416 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.82 -41.2 26.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 74.310000000000002 111.135 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 12.0 t60 -132.2 -17.33 2.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.658 -0.417 . . . . 73.519999999999996 111.774 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.91 88.62 31.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.779 -0.368 . . . . 75.420000000000002 111.024 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' HIS . 11.1 Cg_exo -71.15 -17.17 31.62 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.83 2.353 . . . . 60.25 112.694 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 7.5 mptt -90.31 -54.75 3.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.084 0.469 . . . . 72.230000000000004 110.475 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.7 m -55.38 -44.11 75.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 74.530000000000001 111.646 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -64.48 -37.6 88.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.844 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.937 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -73.77 -38.92 64.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 74.530000000000001 110.53 -178.288 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.91 -58.71 7.38 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.386 0.429 . . . . 73.109999999999999 110.902 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 112' ' ' PHE . 65.6 m-85 -61.83 -43.79 98.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.076 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.08 93.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 73.209999999999994 111.393 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -59.44 -45.19 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.310000000000002 111.429 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.9 mm? -73.45 -23.34 60.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.736 0.303 . . . . 74.319999999999993 111.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.9 -48.71 52.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.386 . . . . 74.420000000000002 110.874 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -12.74 60.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.922 0.392 . . . . 64.310000000000002 111.022 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -52.35 9.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.839 -0.8 . . . . 74.209999999999994 108.839 172.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.92 45.84 0.93 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.675 -0.97 . . . . 64.439999999999998 110.675 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' HD12 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -88.86 -33.65 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.881 0.372 . . . . 62.509999999999998 111.368 -176.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 85.2 m-85 -71.94 -14.69 61.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.329 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -74.95 10.64 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 65.129999999999995 111.123 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.16 24.95 1.9 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.865 -0.607 . . . . 70.420000000000002 111.63 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.719 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 43.1 p -115.33 160.43 19.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.683 0.278 . . . . 72.319999999999993 111.082 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.9 ptpt -139.64 164.05 30.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.372 -0.377 . . . . 61.25 110.006 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.531 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.2 m-85 -82.24 117.68 22.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.831 -0.803 . . . . 72.209999999999994 108.831 173.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.83 -27.06 14.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.413 -0.358 . . . . 72.239999999999995 110.76 -169.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 30.5 mmt180 -132.02 116.68 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.517 -0.31 . . . . 73.310000000000002 110.564 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -127.28 94.25 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.007 -0.738 . . . . 62.229999999999997 109.007 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.8 mt -106.35 125.2 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.245 -0.434 . . . . 72.540000000000006 110.07 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.5 mtpt -60.27 130.79 48.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.223 0.327 . . . . 72.349999999999994 111.41 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 58.38 28.07 16.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.462 -0.79 . . . . 64.099999999999994 111.424 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -128.64 -87.52 0.55 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 65.25 109.86 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.731 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.7 ptt? -161.28 157.82 26.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 55.409999999999997 110.031 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 ' HA3' ' A' ' 143' ' ' GLY . 50.6 mt -128.62 102.07 7.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.613 -0.721 . . . . 73.420000000000002 109.682 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 23.5 tm0? -80.56 126.35 31.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 75.5 110.007 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.58 137.04 9.58 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.978 -0.63 . . . . 71.030000000000001 112.402 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.719 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 131.04 -137.47 9.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.071 -0.585 . . . . 53.119999999999997 112.12 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 4.5 t0 48.07 83.33 0.22 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 123.901 0.881 . . . . 73.129999999999995 112.241 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.26 -19.56 33.59 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.73 2.287 . . . . 71.030000000000001 111.498 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.571 ' OG1' HG22 ' A' ' 70' ' ' THR . 34.5 p -82.58 -34.55 27.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.144 -0.935 . . . . 71.109999999999999 111.534 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.0 60.92 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.102 -0.571 . . . . 74.219999999999999 111.835 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 72' ' ' ARG . 11.5 t -117.66 -17.48 9.91 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.101 0.408 . . . . 71.340000000000003 112.101 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.94 25.59 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 119.87 -1.157 . . . . 52.130000000000003 113.631 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.62 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.97 -7.36 6.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.336 0.568 . . . . 73.519999999999996 111.877 178.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 70.9 -163.87 53.64 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.182 -0.532 . . . . 72.209999999999994 113.342 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.12 -88.05 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.683 -0.567 . . . . 64.439999999999998 111.683 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 59.87 33.08 21.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.278 0.561 . . . . 74.030000000000001 111.934 173.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 t -78.83 0.66 26.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 70.510000000000005 111.686 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.8 pt -74.01 -29.76 26.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.722 -0.391 . . . . 65.420000000000002 111.254 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 23.1 p90 -108.05 1.73 22.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.3 0.572 . . . . 75.010000000000005 111.107 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -77.58 2.09 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.341 -0.845 . . . . 72.230000000000004 113.39 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -92.37 -170.39 2.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.851 0.358 . . . . 64.200000000000003 110.505 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 4.5 pm0 -95.44 163.65 13.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.621 -0.511 . . . . 74.340000000000003 109.621 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 57.6 t80 -110.33 156.02 21.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.103 -0.239 . . . . 73.549999999999997 111.091 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.13 158.14 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.161 0.913 . . . . 73.219999999999999 112.16 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -75.22 106.76 6.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.299 -0.864 . . . . 73.040000000000006 110.838 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.5 21.37 9.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 62.149999999999999 109.354 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.413 HD23 ' OG1' ' A' ' 127' ' ' THR . 38.2 mt -59.32 97.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -0.999 . . . . 74.25 111.551 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -168.22 85.45 0.72 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 73.340000000000003 109.961 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.41 93.7 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.59 2.193 . . . . 61.130000000000003 111.947 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.61 -26.4 66.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.698 0.761 . . . . 63.539999999999999 109.65 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -83.12 177.75 8.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.899 -1.046 . . . . 70.239999999999995 108.808 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -133.8 159.86 39.34 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.907 -0.717 . . . . 72.230000000000004 110.541 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 118' ' ' PRO . 1.2 p90 -70.46 77.18 0.57 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.315 -0.857 . . . . 63.25 110.829 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -68.49 -40.59 80.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.945 -1.025 . . . . 75.299999999999997 111.421 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.66 -146.92 4.85 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.0 -0.619 . . . . 64.310000000000002 111.949 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.89 145.78 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.783 0.325 . . . . 43.009999999999998 110.751 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.09 24.3 6.34 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.67 -0.776 . . . . 74.230000000000004 111.535 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.2 mm -88.18 112.42 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.565 -0.532 . . . . 64.040000000000006 109.565 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.717 HD23 HG22 ' A' ' 114' ' ' VAL . 3.3 tm? -85.45 121.76 28.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.987 -0.551 . . . . 61.009999999999998 109.594 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -126.69 163.52 23.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.125 0.488 . . . . 75.340000000000003 111.186 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 28.1 ttt -91.62 134.16 34.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.483 -0.781 . . . . 73.450000000000003 109.939 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -96.5 151.24 19.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.132 0.492 . . . . 52.420000000000002 110.979 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.4 p-10 -155.84 159.38 39.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 73.400000000000006 110.581 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.62 -13.45 22.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.244 0.545 . . . . 73.319999999999993 110.808 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -162.58 -179.99 37.51 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.224 -1.55 . . . . 61.149999999999999 109.224 176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.63 -50.69 12.94 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.737 2.292 . . . . 72.0 112.063 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.89 19.56 15.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 72.140000000000001 110.367 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.3 m -101.08 51.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.317 -0.994 . . . . 71.239999999999995 108.317 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 42.3 m-80 -77.37 134.84 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.421 -1.263 . . . . 74.25 110.375 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.57 -157.21 10.09 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.745 -0.74 . . . . 71.010000000000005 112.506 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -95.7 8.99 41.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.162 0.506 . . . . 61.439999999999998 111.166 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 6.3 pt20 -90.8 158.6 16.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.871 -0.604 . . . . 72.299999999999997 111.328 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.477 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . 50.9 p90 -142.17 176.45 8.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.02 -0.536 . . . . 73.129999999999995 109.971 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 51.1 p90 -159.54 152.04 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 110.608 173.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.717 HG22 HD23 ' A' ' 98' ' ' LEU . 19.3 t -110.93 142.78 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.288 -0.634 . . . . 62.140000000000001 109.288 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.7 p -97.39 130.09 44.56 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.771 0.319 . . . . 72.450000000000003 110.154 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 62' ' ' ILE . 57.0 mt -86.22 -6.69 58.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.06 0.457 . . . . 72.450000000000003 110.957 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.19 166.88 14.33 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.805 -0.634 . . . . 52.100000000000001 109.794 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 92' ' ' PHE . 32.2 Cg_exo -59.41 106.63 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.591 2.194 . . . . 63.310000000000002 112.043 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.495 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.1 p -94.02 103.42 15.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.62 -0.718 . . . . 72.219999999999999 111.793 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.19 3.6 30.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.651 0.739 . . . . 73.299999999999997 110.255 176.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.495 ' CZ2' HG22 ' A' ' 119' ' ' THR . 1.2 p90 -93.71 -3.7 51.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.995 -1.002 . . . . 74.409999999999997 111.295 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.19 16.53 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.549 -0.296 . . . . 61.439999999999998 111.207 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.75 -38.9 57.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.281 -0.872 . . . . 75.299999999999997 111.552 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.12 22.48 10.39 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.608 -0.806 . . . . 64.019999999999996 112.083 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -118.4 -26.49 6.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.061 0.458 . . . . 73.010000000000005 110.135 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -137.34 128.09 27.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 51.030000000000001 110.486 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.413 ' OG1' HD23 ' A' ' 86' ' ' LEU . 21.5 m -68.73 120.71 15.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.433 . . . . 75.530000000000001 110.669 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 99' ' ' ALA . 47.8 mt -104.21 117.58 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.547 0.203 . . . . 73.430000000000007 111.547 -176.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 47.9 m-85 -158.77 77.04 0.75 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.511 0.507 . . . . 73.030000000000001 110.698 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.34 163.24 35.45 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.116 -0.564 . . . . 52.200000000000003 112.285 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 78.3 mtm180 -142.31 127.14 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.028 -0.36 . . . . 72.349999999999994 110.028 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -87.06 142.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 75.340000000000003 110.686 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 43.6 t -145.77 147.72 32.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 64.099999999999994 110.773 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 20.6 tt0 48.41 34.04 4.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.568 0.747 . . . . 75.340000000000003 112.567 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -163.45 16.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.061 -1.066 . . . . 72.099999999999994 112.407 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.0 tp -73.18 -31.74 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.159 -0.311 . . . . 62.530000000000001 110.159 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.93 95.49 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.982 -0.847 . . . . 71.109999999999999 110.982 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 81.8 mmm -68.61 -48.85 63.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.098 -0.334 . . . . 74.519999999999996 110.098 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.523 HG13 HD12 ' A' ' 62' ' ' ILE . 85.7 t -56.33 -30.23 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 71.340000000000003 110.532 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.72 -52.83 11.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.815 -0.63 . . . . 72.310000000000002 110.97 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -14.43 60.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.051 -0.522 . . . . 75.099999999999994 111.305 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.52 -33.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.077 0.465 . . . . 73.200000000000003 110.382 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.567 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -82.8 -22.03 58.6 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.595 -0.812 . . . . 61.109999999999999 113.0 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ptp -84.33 -13.26 52.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.853 -0.339 . . . . 72.129999999999995 111.659 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 54.310000000000002 111.256 -177.695 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.439 -0.578 . . . . 75.430000000000007 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -127.21 165.4 19.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.141 -0.481 . . . . 73.109999999999999 110.721 -175.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -86.76 105.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.617 -0.72 . . . . 73.230000000000004 109.102 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.1 mm -70.46 -56.37 11.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.562 -0.744 . . . . 73.140000000000001 110.673 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.5 mptm? -133.34 128.04 34.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 54.539999999999999 110.147 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -131.27 123.99 29.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.864 0.364 . . . . 71.239999999999995 110.672 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.22 143.24 32.84 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.89 -0.596 . . . . 63.530000000000001 109.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.864 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 74.4 Cg_endo -78.47 124.58 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.198 1.932 . . . . 62.119999999999997 112.241 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 115.522 -0.763 . . . . 73.329999999999998 109.234 -178.79 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.1 m-20 . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 121.32 0.581 . . . . 71.430000000000007 110.189 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.16 146.08 4.48 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.256 -0.884 . . . . 50.039999999999999 111.638 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.25 -167.38 39.86 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.359 -0.924 . . . . 55.039999999999999 111.864 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.702 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.38 167.21 21.18 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.605 -0.516 . . . . 74.430000000000007 109.605 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 191' ' ' ILE . 92.4 m-85 -114.06 103.62 55.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.142 0.496 . . . . 75.430000000000007 110.32 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.697 ' HB2' HD13 ' A' ' 90' ' ' LEU . 73.0 Cg_endo -79.87 -11.68 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.707 2.271 . . . . 74.319999999999993 112.069 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.69 -20.0 40.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.41 -0.814 . . . . 53.25 111.336 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 188' ' ' PHE . 18.4 pt -87.9 -13.6 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.969 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.1 m170 68.85 29.83 4.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.34 -0.846 . . . . 74.430000000000007 112.456 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 191' ' ' ILE . 4.2 p -130.81 148.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.803 -0.443 . . . . 71.340000000000003 109.803 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.48 124.53 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.953 0.406 . . . . 63.210000000000001 111.831 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -163.29 152.31 14.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 64.010000000000005 109.174 175.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 52.8 m-85 -117.67 146.01 37.75 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.624 0.25 . . . . 62.409999999999997 111.217 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.702 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.2 Cg_endo -66.0 -59.63 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.643 2.229 . . . . 75.120000000000005 112.191 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.2 pt? -143.98 38.87 1.33 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.769 0.285 . . . . 74.329999999999998 111.769 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.2 m-20 76.43 -19.23 0.43 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.75 1.019 . . . . 73.219999999999999 113.75 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -60.37 -23.09 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.728 0.64 . . . . 72.219999999999999 112.728 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 -13.37 60.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.241 -0.981 . . . . 63.130000000000003 112.955 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.419 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 24.8 ptt180 -110.71 -24.16 10.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.081 0.441 . . . . 75.439999999999998 111.261 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.362 -0.828 . . . . 52.310000000000002 110.394 176.785 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 31.0 Cg_endo . . . . . 0 N--CA 1.459 -0.554 0 N-CA-C 110.787 -0.505 . . . . 72.230000000000004 110.787 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 26.7 Cg_endo -63.27 -39.94 35.2 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.592 2.195 . . . . 74.329999999999998 112.67 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.452 HD21 HG23 ' A' ' 24' ' ' VAL . 26.2 t-20 -134.0 150.88 51.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 71.329999999999998 110.031 -173.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.55 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.0 m -129.23 141.65 46.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 75.140000000000001 110.498 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.511 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.1 m-85 -96.93 124.86 41.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 73.010000000000005 110.67 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD23 ' HB1' ' A' ' 162' ' ' ALA . 27.7 mt -112.22 100.56 8.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.564 -0.289 . . . . 73.510000000000005 110.23 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.848 ' HB2' ' HG2' ' A' ' 161' ' ' LYS . 35.8 mt-10 -82.48 110.76 17.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.233 -0.654 . . . . 72.329999999999998 109.233 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -105.57 177.76 4.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.185 0.516 . . . . 72.099999999999994 111.899 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 9.9 p -71.97 -19.26 61.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 74.219999999999999 110.611 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.43 ' HG3' HG22 ' A' ' 142' ' ' VAL . 5.1 mmt -92.4 -38.78 11.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.823 -0.626 . . . . 63.229999999999997 110.833 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.66 -126.51 1.01 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.909 -0.663 . . . . 63.130000000000003 111.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.03 137.2 38.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.796 -0.446 . . . . 50.210000000000001 109.796 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 139' ' ' VAL . 3.9 mp -139.02 130.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.721 -0.672 . . . . 72.519999999999996 109.227 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.2 m -118.94 151.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.019 -0.672 . . . . 74.129999999999995 110.664 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -145.96 161.45 40.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 74.099999999999994 110.22 176.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.0 pt-20 -129.77 164.19 24.59 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.149 -0.932 . . . . 62.520000000000003 109.439 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.03 162.97 12.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.025 -0.361 . . . . 71.299999999999997 110.025 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 131' ' ' ARG . 10.1 m-85 -86.39 101.75 13.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.325 0.583 . . . . 74.25 111.72 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.634 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -82.82 -1.68 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.223 -0.898 . . . . 72.540000000000006 110.184 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -68.87 -67.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.362 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.413 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 m170 -124.2 11.08 8.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 64.400000000000006 111.521 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.438 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.88 59.78 47.03 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.465 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 16.6 Cg_exo -67.53 -46.46 2.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.476 2.117 . . . . 55.130000000000003 111.975 -177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -63.91 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 65.439999999999998 110.307 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -67.13 -41.04 86.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.391 -0.822 . . . . 75.25 110.495 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 18.5 t -58.52 -48.19 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 72.540000000000006 110.533 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.38 -34.61 78.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 72.239999999999995 111.275 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.45 ' O ' HD23 ' A' ' 42' ' ' LEU . 6.7 t30 -54.69 -52.36 62.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 63.530000000000001 110.407 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HE1' HG21 ' A' ' 14' ' ' VAL . 27.4 t80 -67.71 -44.84 76.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.201 0.524 . . . . 70.239999999999995 109.911 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.52 -44.58 76.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.306 -0.861 . . . . 74.239999999999995 112.087 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.5 mt-10 -69.77 -38.78 76.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.11 -0.236 . . . . 75.109999999999999 111.19 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 38' ' ' ASN . 4.0 mm? -65.14 -26.92 68.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 73.310000000000002 110.395 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.93 -45.2 64.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.973 -0.558 . . . . 72.230000000000004 109.873 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.6 mtp180 -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 75.450000000000003 111.063 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 9.1 mpt_? -73.01 -40.46 65.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.012 -0.366 . . . . 53.210000000000001 110.012 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 30.03 6.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.655 -0.784 . . . . 61.240000000000002 112.479 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -76.88 -17.01 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 72.420000000000002 111.385 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -74.3 -17.22 60.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -71.19 -8.52 54.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.058 0.456 . . . . 73.209999999999994 110.606 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -122.69 31.21 4.87 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.942 -0.647 . . . . 64.430000000000007 111.951 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.811 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 73.4 p -112.11 154.3 25.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 61.0 111.155 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.82 157.46 43.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 109.948 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CD1' ' HA3' ' A' ' 64' ' ' GLY . 97.9 m-85 -89.59 121.58 31.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 71.099999999999994 109.642 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -104.89 -35.6 7.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.53 -0.304 . . . . 72.340000000000003 111.803 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -113.41 112.96 24.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.686 -0.405 . . . . 72.239999999999995 110.356 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -125.99 94.33 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.179 -0.674 . . . . 74.430000000000007 109.179 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.851 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 24.2 mt -96.47 122.05 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.742 -0.663 . . . . 41.240000000000002 109.408 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.4 mtpt -53.49 120.93 6.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.525 0.516 . . . . 74.340000000000003 111.554 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 54.9 41.14 32.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.385 -0.825 . . . . 65.049999999999997 111.329 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.851 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 8.5 t80 -133.23 -80.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.775 -0.648 . . . . 74.409999999999997 109.46 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.678 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.6 ptt? -161.23 157.49 25.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.395 -0.82 . . . . 70.25 110.085 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 HG13 ' A' ' 56' ' ' ILE . 49.8 mt -127.11 101.39 7.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.409 -0.589 . . . . 73.099999999999994 109.409 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 37.7 tt0 -83.84 121.38 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.839 -0.619 . . . . 65.150000000000006 110.139 -177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA3' ' CD1' ' A' ' 53' ' ' PHE . . . -142.93 151.35 23.09 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.519 -0.848 . . . . 15.050000000000001 112.719 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 135.14 -148.93 19.78 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.548 -0.834 . . . . 75.450000000000003 112.051 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 t70 59.67 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 O-C-N 124.376 0.692 . . . . 72.030000000000001 111.145 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.9 Cg_endo -64.53 -20.59 65.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.042 2.495 . . . . 54.240000000000002 112.445 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 70' ' ' THR . 9.9 p -82.52 -27.56 31.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 71.349999999999994 111.422 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.17 26.59 68.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.91 -0.662 . . . . 72.040000000000006 111.685 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 72' ' ' ARG . 14.7 t -118.54 -24.09 6.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.487 0.185 . . . . 62.009999999999998 111.215 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.79 9.35 43.38 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 64.239999999999995 113.253 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -150.38 21.77 0.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 62.350000000000001 110.718 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.503 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -103.7 -176.15 25.91 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.748 -0.739 . . . . 74.129999999999995 112.234 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 110' ' ' SER . . . 83.37 161.27 31.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.578 -0.82 . . . . 62.009999999999998 111.645 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' H ' HD11 ' A' ' 42' ' ' LEU . . . 58.98 16.3 4.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.094 0.473 . . . . 61.329999999999998 111.567 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -68.65 -12.55 61.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.552 . . . . 74.150000000000006 110.941 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.2 pt -64.55 -39.44 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.367 -0.378 . . . . 60.43 110.369 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.61 ' N ' HG13 ' A' ' 77' ' ' ILE . 95.5 m-85 -75.02 -32.93 61.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.662 -0.496 . . . . 73.239999999999995 109.662 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.37 8.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.548 -0.834 . . . . 73.420000000000002 112.93 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -171.2 2.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.982 -0.377 . . . . 60.109999999999999 109.982 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 4.0 pm0 -70.93 164.27 25.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 64.319999999999993 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -99.22 143.0 29.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 72.340000000000003 109.642 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 106' ' ' ASP . 35.1 tt0 -58.87 147.26 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.634 0.584 . . . . 70.409999999999997 110.726 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.443 ' HA ' HD21 ' A' ' 108' ' ' ASN . 11.2 p-10 -67.33 125.3 25.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.741 0.781 . . . . 55.039999999999999 110.611 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.77 29.36 7.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.644 -1.162 . . . . 74.140000000000001 108.361 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -49.61 100.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.72 -1.127 . . . . 54.049999999999997 111.175 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.64 78.69 9.83 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.066 -0.516 . . . . 72.25 111.128 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.66 66.4 2.3 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.56 2.173 . . . . 74.010000000000005 111.638 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.99 -23.55 59.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.053 0.93 . . . . 63.340000000000003 109.436 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -89.13 166.42 13.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.462 -1.244 . . . . 74.530000000000001 108.879 174.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -113.71 141.58 47.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.278 -0.569 . . . . 63.329999999999998 110.836 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.96 70.42 0.76 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.968 . . . . 71.120000000000005 109.801 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 193' ' ' VAL . 37.1 p -62.7 -40.89 98.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.091 . . . . 62.43 111.765 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.81 -144.73 4.09 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.761 -0.733 . . . . 75.530000000000001 111.911 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.05 144.02 27.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.798 0.332 . . . . 44.32 110.523 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.65 22.08 6.19 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 111.706 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 mm -88.39 114.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -89.86 120.28 30.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 109.746 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.33 160.92 30.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.948 -0.569 . . . . 64.540000000000006 110.257 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 39.0 ttp -91.06 143.16 26.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.601 -0.518 . . . . 55.539999999999999 109.601 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.3 114.4 26.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.274 0.559 . . . . 33.229999999999997 110.975 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.463 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 2.9 p-10 -115.7 149.93 37.63 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.283 -0.871 . . . . 73.030000000000001 109.897 175.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.506 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -83.84 -28.01 28.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.258 -0.883 . . . . 64.450000000000003 111.285 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.37 -108.89 0.32 Allowed Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 120.912 -0.661 . . . . 43.450000000000003 112.147 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.06 89.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.892 2.395 . . . . 63.219999999999999 112.009 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 3.3 p30 48.1 31.11 2.35 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.878 -1.055 . . . . 64.25 111.898 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 103' ' ' ALA . 1.3 m -85.38 52.25 2.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.292 0.567 . . . . 41.340000000000003 109.996 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 19.0 m-80 -91.26 173.82 7.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.303 -0.862 . . . . 75.019999999999996 109.032 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.39 -96.71 0.13 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.353 -1.403 . . . . 75.540000000000006 114.234 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.536 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 46.9 t -126.87 12.19 7.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.391 0.615 . . . . 73.439999999999998 110.448 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 100' ' ' MET . 18.9 mp0 -101.14 147.04 26.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 74.400000000000006 109.474 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -147.21 176.09 10.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.809 0.338 . . . . 73.200000000000003 110.906 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.4 p90 -160.46 152.52 20.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.98 0.419 . . . . 63.530000000000001 110.202 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 98' ' ' LEU . 18.5 t -112.91 138.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.786 -0.643 . . . . 71.230000000000004 109.268 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.9 p -93.3 125.47 37.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.058 0.456 . . . . 54.329999999999998 109.999 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.4 mt -85.29 -6.46 59.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.357 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.41 161.14 34.78 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.338 -0.846 . . . . 71.349999999999994 109.997 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.43 113.7 2.38 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.644 2.229 . . . . 74.129999999999995 112.224 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.2 p -105.31 103.57 13.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.102 -0.499 . . . . 54.409999999999997 110.938 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 120' ' ' GLN . 0.6 OUTLIER -99.78 13.84 32.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.862 0.839 . . . . 64.140000000000001 109.479 -177.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.742 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -111.05 3.85 18.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.673 -1.149 . . . . 74.040000000000006 110.748 -178.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.742 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -113.29 6.4 17.34 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.272 -0.422 . . . . 71.519999999999996 111.642 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.05 -31.72 43.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.536 -0.757 . . . . 62.43 112.132 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -125.51 20.49 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.496 -0.859 . . . . 73.099999999999994 111.691 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.71 -31.25 5.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 74.129999999999995 110.656 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.463 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 35.1 m80 -142.27 141.14 32.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 64.099999999999994 111.04 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.1 m -78.32 111.08 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 55.0 110.277 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 90' ' ' LEU . 38.6 mt -98.99 122.82 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.299999999999997 110.71 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.5 p90 -159.71 73.31 0.55 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.689 0.757 . . . . 71.329999999999998 110.898 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.748 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.49 156.66 28.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.292 -1.432 . . . . 61.420000000000002 113.802 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.9 mtm180 -134.77 122.32 21.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.504 0.321 . . . . 75.129999999999995 110.282 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -83.64 138.69 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.036 0.446 . . . . 63.240000000000002 110.66 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 41.1 t -139.86 157.66 45.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 109.907 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.4 pt20 36.86 42.77 0.24 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.252 1.021 . . . . 64.430000000000007 113.18 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.76 17.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.455 -0.879 . . . . 74.420000000000002 112.509 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.536 ' H ' ' HB3' ' A' ' 184' ' ' ASP . 11.3 tp -74.34 -34.51 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.387 -0.227 . . . . 72.299999999999997 110.387 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.28 95.33 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.736 -0.745 . . . . 63.109999999999999 111.367 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -70.31 -50.79 35.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 110.114 -0.328 . . . . 75.140000000000001 110.114 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 23' ' ' ILE . 86.3 t -55.96 -30.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.043 0.449 . . . . 73.5 110.699 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.533 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.8 t30 -70.48 -53.32 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 110.521 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.39 61.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.35 -0.386 . . . . 71.319999999999993 111.225 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 20' ' ' MET . 50.6 t -83.47 -34.85 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.225 0.536 . . . . 55.340000000000003 109.733 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -79.53 -21.51 66.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.622 -0.799 . . . . 71.030000000000001 112.624 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 56.4 mtm -82.52 -23.96 34.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.944 0.35 . . . . 73.400000000000006 111.944 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.488 0.661 . . . . 61.420000000000002 110.196 178.647 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.688 0.756 . . . . 55.340000000000003 111.725 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -122.93 163.77 19.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.069 -0.969 . . . . 73.030000000000001 109.67 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -90.25 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.815 -1.18 . . . . 64.319999999999993 107.815 170.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 19' ' ' SER . 32.2 mm -67.07 -53.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.693 -0.685 . . . . 75.120000000000005 110.618 -173.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.848 ' HG2' ' HB2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -142.06 132.56 25.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.606 -0.724 . . . . 54.049999999999997 110.018 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -133.46 146.15 50.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.787 0.327 . . . . 74.349999999999994 110.625 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 161' ' ' LYS . 85.0 m-85 -148.37 140.7 14.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 75.010000000000005 109.822 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.452 ' HD3' ' OH ' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -78.15 132.49 11.54 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.186 1.924 . . . . 65.219999999999999 111.579 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 49.5 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 61.020000000000003 111.249 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.573 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 19.2 m-20 . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.523 0.678 . . . . 74.219999999999999 111.445 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 158.67 140.86 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.654 -1.157 . . . . 62.140000000000001 110.463 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.31 -169.81 40.57 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.233 -0.984 . . . . 71.519999999999996 111.97 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -75.34 166.67 23.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 110.153 -0.314 . . . . 71.239999999999995 110.153 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.97 100.03 11.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.482 -0.562 . . . . 70.310000000000002 109.482 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 5.5 Cg_exo -79.55 -9.75 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.666 2.244 . . . . 64.420000000000002 112.188 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.424 ' HB2' HH11 ' A' ' 131' ' ' ARG . 37.0 tt0 -74.17 -32.43 63.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.407 0.622 . . . . 75.209999999999994 109.63 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 pt -85.69 162.33 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.445 -0.946 . . . . 74.129999999999995 108.445 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -114.97 41.39 2.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 111.25 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.6 p -109.57 -174.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.318 -0.623 . . . . 53.439999999999998 109.318 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.738 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -115.84 114.38 24.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.646 0.26 . . . . 64.549999999999997 111.064 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.463 HE21 HG13 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -155.12 152.97 30.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.46 -0.571 . . . . 70.409999999999997 109.46 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -121.39 139.82 30.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.545 -0.298 . . . . 72.010000000000005 110.402 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 19.7 Cg_endo -58.31 -57.9 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.937 2.424 . . . . 64.400000000000006 111.99 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.12 23.85 4.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 73.409999999999997 109.873 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 30.2 m-20 69.55 9.5 7.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.36 -0.836 . . . . 70.510000000000005 112.169 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.9 ptm -53.0 -40.33 63.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 72.439999999999998 112.002 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.38 61.95 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.855 -0.688 . . . . 72.099999999999994 113.318 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 19.6 mtp180 -94.84 -3.68 48.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 110.685 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 4.2 tppp? . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.604 -1.18 . . . . 62.100000000000001 112.142 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo . . . . . 0 N--CA 1.465 -0.199 0 CA-C-O 120.631 0.179 . . . . 72.129999999999995 111.931 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 32.1 Cg_endo -65.15 -22.48 61.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.928 2.419 . . . . 71.319999999999993 113.052 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -124.21 138.97 54.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.055 0.455 . . . . 75.030000000000001 110.936 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 164' ' ' PRO . 20.9 m -128.99 157.35 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.778 -0.646 . . . . 74.219999999999999 109.418 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' CB ' HG12 ' A' ' 24' ' ' VAL . 55.4 p90 -115.14 132.12 56.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.367 0.603 . . . . 75.120000000000005 111.551 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -110.32 109.13 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.086 -0.961 . . . . 62.420000000000002 110.25 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.13 112.39 23.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.19 -0.671 . . . . 74.019999999999996 109.19 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -104.68 178.89 4.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 110.682 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.482 ' HB3' HD11 ' A' ' 160' ' ' ILE . 12.9 p -80.44 -6.13 57.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.292 0.568 . . . . 75.239999999999995 110.463 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mmm -98.83 -41.58 7.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 60.240000000000002 109.565 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.01 -134.13 1.8 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.1 -0.8 . . . . 62.119999999999997 111.1 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.73 130.72 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.958 -0.756 . . . . 61.340000000000003 108.958 177.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 139' ' ' VAL . 4.8 mp -132.15 124.9 53.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.122 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CB ' ' A' ' 15' ' ' TYR . 3.2 m -106.48 146.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.272 -0.571 . . . . 65.109999999999999 109.767 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.47 162.01 37.62 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.982 0.42 . . . . 74.200000000000003 110.14 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -135.14 165.14 26.09 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.709 -0.678 . . . . 71.120000000000005 110.767 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.65 166.86 10.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.806 -0.634 . . . . 74.549999999999997 110.237 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -87.0 96.23 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.327 0.584 . . . . 71.439999999999998 111.635 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.402 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 42.0 m95 -88.82 1.9 54.49 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.256 -0.884 . . . . 72.209999999999994 109.511 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -74.11 -50.2 20.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 60.329999999999998 111.324 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -137.97 8.63 2.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 75.319999999999993 111.426 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.84 85.54 57.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 74.120000000000005 110.503 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.07 -11.58 21.35 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.184 2.59 . . . . 71.140000000000001 113.002 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.66 -48.88 3.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 73.230000000000004 111.55 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -35.93 73.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 65.200000000000003 111.194 -175.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -54.81 -53.22 58.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.816 -0.629 . . . . 75.239999999999995 111.609 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 6.0 mtmp? -81.81 -23.63 36.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.993 -0.549 . . . . 74.299999999999997 111.188 -172.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.499 ' O ' HD23 ' A' ' 42' ' ' LEU . 4.3 m-20 -52.06 -47.02 65.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.551 0.691 . . . . 70.25 109.221 171.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.513 ' HZ ' ' HB2' ' A' ' 100' ' ' MET . 19.2 m-85 -77.08 -49.57 15.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.378 -0.828 . . . . 74.319999999999993 110.834 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -57.25 -35.64 69.99 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.694 0.628 . . . . 63.5 112.694 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 49.0 mt-10 -88.0 -15.32 36.78 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.062 -0.399 . . . . 73.209999999999994 111.314 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.4 mm? -75.03 -20.87 59.4 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.031 -0.667 . . . . 73.310000000000002 109.299 164.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.521 ' HA ' ' HE1' ' A' ' 48' ' ' TYR . . . -74.52 -41.83 59.97 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.708 -0.678 . . . . 75.349999999999994 110.949 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 1.3 ptp180 -67.79 -27.36 66.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.754 0.311 . . . . 75.010000000000005 110.552 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.52 -39.17 77.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.687 -0.857 . . . . 73.019999999999996 108.687 172.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.89 15.42 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.633 -0.712 . . . . 74.239999999999995 111.477 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.6 ' HD2' ' HG3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -72.79 -20.08 61.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 53.32 110.512 -173.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 78.0 m-85 -62.53 -28.54 69.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.811 -0.632 . . . . 74.140000000000001 111.177 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 29.1 m-80 -72.73 91.0 1.44 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.963 0.887 . . . . 72.140000000000001 109.47 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.56 11.68 3.61 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 113.896 -1.502 . . . . 64.120000000000005 112.009 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.561 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 70.2 p -99.83 154.42 18.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 63.549999999999997 110.569 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -130.69 155.86 45.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.471 -0.331 . . . . 74.319999999999993 110.722 -176.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.8 m-85 -81.75 109.51 16.22 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.944 -0.762 . . . . 70.299999999999997 108.944 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 -37.96 12.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.106 -0.497 . . . . 73.439999999999998 111.676 -171.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 17.0 mmt180 -112.12 114.14 26.81 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 75.140000000000001 109.239 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 53' ' ' PHE . 4.0 mp -124.19 89.21 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.06 -0.718 . . . . 64.310000000000002 109.06 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -93.9 125.17 46.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.989 -0.745 . . . . 72.230000000000004 108.989 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 12.4 ptmm? -53.41 135.56 39.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.507 0.505 . . . . 75.340000000000003 110.946 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 42.68 37.01 0.91 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.213 0.946 . . . . 64.430000000000007 112.412 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.432 ' N ' ' HB2' ' A' ' 116' ' ' LEU . 2.7 m-85 -134.4 -80.44 0.45 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.066 -0.515 . . . . 31.309999999999999 111.398 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.46 155.83 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 65.129999999999995 111.065 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 116' ' ' LEU . 20.8 mt -132.3 106.36 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 75.430000000000007 110.004 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' OE1' ' HG2' ' A' ' 55' ' ' ARG . 44.4 tt0 -83.81 128.77 34.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.06 -0.348 . . . . 42.439999999999998 110.06 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.67 132.84 7.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.64 -0.79 . . . . 62.130000000000003 112.592 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 152.81 -112.79 0.55 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.55 -0.833 . . . . 21.329999999999998 113.452 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 31.09 73.14 0.5 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 74.430000000000007 113.364 -170.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.6 ' HG3' ' HD2' ' A' ' 47' ' ' TYR . 72.9 Cg_endo -78.84 -16.29 12.9 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.049 1.833 . . . . 71.129999999999995 111.543 174.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 p -105.18 -57.34 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.715 -0.675 . . . . 72.400000000000006 111.177 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.13 0.02 41.18 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.826 -0.702 . . . . 65.230000000000004 112.06 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 72' ' ' ARG . 1.9 t -80.95 -6.78 59.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 110.687 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.41 -25.51 26.72 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.624 -0.798 . . . . 65.329999999999998 112.55 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' CG ' HG23 ' A' ' 70' ' ' THR . 0.4 OUTLIER -94.21 -32.24 13.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 62.039999999999999 111.414 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -161.45 15.34 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.625 -0.797 . . . . 73.230000000000004 111.58 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.61 -84.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.02 -0.61 . . . . 44.509999999999998 112.101 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 60.73 39.37 17.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.225 0.536 . . . . 35.409999999999997 111.272 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m -55.78 -29.27 59.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.159 -0.928 . . . . 74.209999999999994 112.439 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG23 ' HD1' ' A' ' 78' ' ' TYR . 7.9 tt -73.95 -41.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.207 0.447 . . . . 63.340000000000003 112.207 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' HD1' HG23 ' A' ' 77' ' ' ILE . 43.8 p90 -108.02 -8.69 15.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.338 -0.545 . . . . 74.230000000000004 112.215 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.12 -101.14 1.43 Allowed Glycine 0 C--N 1.329 0.169 0 C-N-CA 121.138 -0.553 . . . . 74.109999999999999 113.254 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -69.12 163.78 24.04 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.518 -0.549 . . . . 55.43 109.518 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -58.75 174.06 0.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.683 0.754 . . . . 74.099999999999994 112.257 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -116.88 155.73 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.088 -0.96 . . . . 73.120000000000005 109.424 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.55 159.42 8.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.522 0.514 . . . . 75.0 110.555 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.688 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -91.48 13.41 17.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.078 -0.965 . . . . 73.400000000000006 109.788 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.12 106.32 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.738 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -164.92 71.01 1.45 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 73.200000000000003 109.882 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -76.29 81.44 2.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.395 2.063 . . . . 64.129999999999995 113.094 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.96 -18.13 41.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.686 0.755 . . . . 75.239999999999995 109.793 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 189' ' ' PRO . 2.9 pp -87.55 177.27 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.105 -0.952 . . . . 74.439999999999998 108.819 173.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.663 ' HD2' ' HA ' ' A' ' 192' ' ' HIS . 2.9 tmtm? -137.23 135.37 37.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.838 0.351 . . . . 74.030000000000001 110.425 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER -63.98 89.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.916 0.865 . . . . 72.409999999999997 109.977 173.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 193' ' ' VAL . 16.4 p -71.72 -51.01 25.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.602 -1.181 . . . . 74.150000000000006 111.083 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -147.85 -132.9 2.27 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.615 -0.802 . . . . 72.409999999999997 111.998 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.16 147.06 24.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.824 0.345 . . . . 41.340000000000003 110.852 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.2 20.98 8.3 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.751 -0.738 . . . . 34.520000000000003 111.582 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -87.05 111.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.387 -0.597 . . . . 63.5 109.387 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -88.15 118.74 27.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.721 -0.672 . . . . 64.230000000000004 109.809 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.515 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.63 173.83 9.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.005 -0.543 . . . . 54.340000000000003 111.512 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 39' ' ' PHE . 25.2 ttt -101.25 128.59 47.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.335 -0.848 . . . . 65.230000000000004 109.982 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -90.76 114.55 26.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.612 0.72 . . . . 71.329999999999998 110.991 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 3.9 p-10 -121.1 160.39 23.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.953 -1.021 . . . . 75.420000000000002 110.244 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.61 -25.31 16.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.152 -0.476 . . . . 31.210000000000001 110.832 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -152.75 -176.98 25.9 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.889 -1.285 . . . . 33.350000000000001 109.889 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.16 -53.72 5.98 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.338 2.692 . . . . 54.229999999999997 112.475 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.83 16.97 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.164 0.507 . . . . 73.329999999999998 110.671 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.468 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -92.73 53.55 2.06 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 71.230000000000004 108.261 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -87.04 107.81 18.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.641 -1.163 . . . . 74.219999999999999 110.281 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.88 -166.01 34.41 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.195 -0.762 . . . . 73.230000000000004 111.195 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m -100.22 67.12 1.35 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.908 -0.775 . . . . 70.049999999999997 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 69.2 mt-30 -124.83 147.76 48.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.111 -0.95 . . . . 53.329999999999998 110.174 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -120.4 155.81 32.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.427 -0.351 . . . . 71.239999999999995 110.919 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -153.76 141.74 20.26 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.111 -0.495 . . . . 75.230000000000004 110.37 168.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.732 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -110.94 142.43 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.602 -0.726 . . . . 72.230000000000004 109.424 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.58 127.04 41.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.382 . . . . 72.430000000000007 110.131 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 62' ' ' ILE . 65.3 mt -84.54 -9.03 58.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.773 -0.649 . . . . 55.43 109.859 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.0 157.7 31.96 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.107 -0.952 . . . . 71.510000000000005 109.556 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.421 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 27.5 Cg_exo -62.56 115.66 3.04 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.536 2.157 . . . . 52.530000000000001 112.264 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 p -105.77 106.92 17.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.006 0.431 . . . . 74.409999999999997 110.33 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp0? -97.34 20.71 11.13 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.381 0.61 . . . . 72.019999999999996 111.089 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.674 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -123.81 -1.77 8.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.314 -0.857 . . . . 75.310000000000002 110.337 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.674 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 97.9 mt -105.8 3.86 29.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.914 -0.584 . . . . 75.219999999999999 111.14 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.44 -23.68 67.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.455 -0.793 . . . . 74.420000000000002 111.134 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.29 18.4 7.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.686 -0.768 . . . . 63.450000000000003 111.504 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -115.49 -35.84 4.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.112 0.482 . . . . 71.109999999999999 109.708 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 98.1 m-70 -141.59 132.66 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 72.109999999999999 109.093 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.7 t -74.78 147.14 41.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 110.302 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.515 HG23 ' HB2' ' A' ' 99' ' ' ALA . 43.3 mt -123.97 119.57 57.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.004 -0.544 . . . . 75.400000000000006 110.388 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -156.32 72.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.447 . . . . 71.299999999999997 110.198 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -166.17 165.6 38.27 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.249 -0.74 . . . . 54.140000000000001 111.249 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -152.97 132.01 12.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 74.030000000000001 111.084 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' GLY . 5.2 p -79.94 144.6 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.856 . . . . 45.219999999999999 110.716 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.594 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 42.7 t -139.23 151.99 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.175 -0.466 . . . . 42.399999999999999 109.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.4 tt0 45.42 42.15 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.59 0.556 . . . . 73.150000000000006 111.893 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 27.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.206 -0.997 . . . . 62.119999999999997 112.397 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.3 tp -81.92 -31.19 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.898 -0.408 . . . . 75.409999999999997 109.898 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.85 91.72 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.786 -0.721 . . . . 12.32 111.39 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 69.8 mmm -68.28 -49.58 59.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.233 -0.284 . . . . 63.229999999999997 110.233 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 23' ' ' ILE . 95.0 t -55.84 -30.53 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.251 0.548 . . . . 72.109999999999999 110.502 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -70.12 -52.62 22.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.717 -0.674 . . . . 72.019999999999996 110.709 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.3 OUTLIER -72.92 -14.73 61.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 74.450000000000003 111.481 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 145' ' ' VAL . 63.6 t -89.95 -35.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.98 0.419 . . . . 74.109999999999999 110.492 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -81.33 -11.83 82.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 63.299999999999997 112.867 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 ptp -95.67 0.65 52.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.573 0.225 . . . . 72.400000000000006 111.235 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.5 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.958 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 107.618 -1.253 . . . . 64.319999999999993 107.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 2.3 mppt? -128.48 156.01 43.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.027 -0.669 . . . . 73.140000000000001 111.877 -166.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -86.33 104.23 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.694 -1.139 . . . . 75.510000000000005 108.199 168.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.684 HG22 ' HD3' ' A' ' 161' ' ' LYS . 32.2 mm -69.37 -58.36 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 73.510000000000005 110.6 -174.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.684 ' HD3' HG22 ' A' ' 160' ' ' ILE . 3.9 mppt? -132.13 139.4 48.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.73 -0.668 . . . . 71.239999999999995 110.131 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -138.92 127.3 22.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.69 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 161' ' ' LYS . 42.6 m-85 -140.22 155.06 70.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.7 Cg_exo -71.86 138.28 31.18 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.709 1.606 . . . . 72.319999999999993 110.364 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 73.019999999999996 111.152 -171.763 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER . . . . . 0 CA--C 1.503 -0.851 0 CA-C-O 122.008 0.908 . . . . 62.329999999999998 111.857 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 140.17 142.41 4.19 Favored Glycine 0 N--CA 1.426 -2.026 0 CA-C-N 113.82 -1.536 . . . . 61.100000000000001 111.263 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 172.06 54.1 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.691 -0.766 . . . . 63.409999999999997 111.656 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -66.36 148.59 51.64 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.848 -0.427 . . . . 62.030000000000001 109.848 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -80.1 107.18 6.29 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.372 -0.377 . . . . 73.319999999999993 110.185 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.632 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.3 Cg_exo -79.97 -5.84 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.762 2.308 . . . . 53.240000000000002 111.594 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.65 -22.29 60.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 71.400000000000006 110.446 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.426 HD12 HG12 ' A' ' 193' ' ' VAL . 8.0 pt -97.16 172.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.268 -0.641 . . . . 65.430000000000007 109.268 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' HIS . . . . . 0.663 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 63.9 m170 -121.24 27.4 8.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 72.540000000000006 111.111 -175.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.0 p -111.87 167.22 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.144 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.429 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -89.22 108.68 19.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.924 0.392 . . . . 61.32 111.375 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 150.11 29.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.241 -0.651 . . . . 71.019999999999996 109.241 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -127.08 151.68 74.65 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.678 -0.237 . . . . 73.310000000000002 110.955 -173.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.2 Cg_endo -66.38 -70.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.59 2.193 . . . . 75.140000000000001 111.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -114.99 16.41 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.033 0.444 . . . . 73.439999999999998 110.236 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 11.2 m-20 70.17 7.57 6.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.35 -0.841 . . . . 74.310000000000002 113.127 171.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.8 -31.18 71.38 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.884 0.327 . . . . 72.030000000000001 111.884 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.14 -1.14 87.6 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.808 -0.711 . . . . 50.119999999999997 112.907 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 69.8 mtp180 -80.98 -21.52 40.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 53.119999999999997 111.145 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.612 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.522 -0.763 . . . . 63.409999999999997 111.583 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 13.3 Cg_exo . . . . . 0 CA--C 1.531 0.348 0 CA-C-O 120.747 0.228 . . . . 73.329999999999998 112.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.5 -2.16 11.36 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.083 2.522 . . . . 45.329999999999998 112.886 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.437 HD22 ' CG1' ' A' ' 24' ' ' VAL . 4.7 t30 -121.09 144.65 48.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 110.275 -175.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 32.1 m -135.32 150.88 29.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.431 . . . . 65.25 111.05 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 28.3 m-85 -103.28 119.71 39.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.832 -0.622 . . . . 74.430000000000007 111.018 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.67 105.03 14.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.063 0.459 . . . . 65.420000000000002 110.797 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' HG12 ' A' ' 22' ' ' ILE . 37.3 mt-10 -90.0 118.23 29.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.965 -0.754 . . . . 73.25 108.965 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -108.34 178.15 4.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 73.010000000000005 111.106 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 160' ' ' ILE . 33.2 t -79.55 6.67 9.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.98 -0.554 . . . . 73.349999999999994 110.431 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.602 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.8 mmt -113.56 -38.28 4.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.918 -0.583 . . . . 70.150000000000006 110.171 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.01 -132.69 1.74 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.268 -0.733 . . . . 74.540000000000006 111.268 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -139.64 131.34 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.17 -0.678 . . . . 64.120000000000005 109.17 177.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -123.47 124.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.584 -0.735 . . . . 71.310000000000002 110.095 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 20.7 t -99.42 133.6 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.171 -0.677 . . . . 62.240000000000002 109.171 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 3.9 pp -142.04 161.86 36.94 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.502 -0.479 . . . . 65.209999999999994 110.859 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.51 166.07 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.903 -0.59 . . . . 73.150000000000006 109.57 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -107.49 161.28 14.98 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.094 -0.706 . . . . 61.340000000000003 109.094 178.205 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 7.0 m-85 -84.62 97.04 9.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.668 0.747 . . . . 74.219999999999999 111.216 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 15.0 m95 -88.78 9.88 22.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.45 -1.315 . . . . 73.319999999999993 107.45 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.17 -55.0 5.42 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 113.413 -1.721 . . . . 74.129999999999995 110.603 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.85 1.75 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.177 0.436 . . . . 74.150000000000006 112.177 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.68 77.97 29.35 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.049 -0.26 . . . . 61.200000000000003 110.339 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 7.3 Cg_exo -73.8 -9.7 22.66 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.237 2.624 . . . . 51.149999999999999 113.164 -173.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -100.37 -51.99 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.31 0.576 . . . . 65.099999999999994 109.957 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.49 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -61.2 -39.77 91.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.95 -1.023 . . . . 74.549999999999997 111.574 -175.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 29' ' ' TRP . 26.0 p -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.325 -0.398 . . . . 75.239999999999995 110.767 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.4 mmmm -63.47 -41.07 98.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.626 -0.261 . . . . 72.239999999999995 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' HD23 ' A' ' 42' ' ' LEU . 65.5 t30 -60.25 -47.84 84.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.358 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 11.3 t80 -65.24 -52.21 55.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.131 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.17 81.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.294 -0.866 . . . . 65.450000000000003 112.181 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 44.3 mt-10 -77.53 -24.11 50.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.926 -0.309 . . . . 73.530000000000001 111.723 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.9 mm? -74.4 -27.54 60.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.168 0.508 . . . . 64.129999999999995 109.878 171.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.94 -41.27 71.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 72.140000000000001 110.573 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.678 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 8.4 ppt_? -79.7 -15.36 57.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 72.200000000000003 110.768 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -74.92 -32.93 61.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.045 -0.724 . . . . 71.140000000000001 109.045 172.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.19 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.817 -0.706 . . . . 74.010000000000005 111.791 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.627 ' HE1' ' HA3' ' A' ' 74' ' ' GLY . 6.2 t80 -76.63 -39.39 52.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.602 -0.299 . . . . 74.230000000000004 111.268 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -74.84 -15.51 60.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 112.162 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -76.3 90.65 3.19 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.725 0.774 . . . . 74.230000000000004 109.151 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.39 8.55 4.41 Favored Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.351 -1.295 . . . . 73.150000000000006 112.138 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -97.31 158.72 15.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.01 -0.367 . . . . 71.5 110.01 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -136.51 167.11 22.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.432 -0.507 . . . . 73.150000000000006 110.479 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 86.0 m-85 -83.35 118.87 23.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.943 -0.571 . . . . 71.209999999999994 109.548 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -92.3 -32.66 14.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.299999999999997 110.11 -172.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -121.72 120.86 35.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.961 -0.385 . . . . 72.109999999999999 109.961 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.512 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -131.82 95.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.083 -0.71 . . . . 61.119999999999997 109.083 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.6 mt -102.38 125.13 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 109.878 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -55.15 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.61 0.569 . . . . 61.329999999999998 110.945 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 41.15 44.16 2.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.4 1.062 . . . . 74.319999999999993 112.254 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -138.3 -81.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 72.150000000000006 110.056 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 ptp -160.96 156.9 25.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.688 -0.687 . . . . 61.409999999999997 110.307 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.512 HG23 HG13 ' A' ' 56' ' ' ILE . 37.4 mt -134.77 105.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 63.439999999999998 109.857 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.1 tm0? -84.48 128.71 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 74.519999999999996 110.181 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -124.97 147.88 16.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.13 -0.557 . . . . 63.039999999999999 112.61 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.27 -125.32 3.02 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.618 -0.593 . . . . 75.209999999999994 111.618 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.8 t0 42.15 84.08 0.19 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.947 0.899 . . . . 72.239999999999995 113.125 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 85.1 Cg_endo -79.17 -26.98 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.635 2.223 . . . . 72.340000000000003 111.729 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 20.1 p -84.11 -39.35 19.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.179 -0.919 . . . . 74.129999999999995 111.664 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.23 21.61 14.86 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.774 -0.931 . . . . 74.430000000000007 110.774 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.8 p -113.43 -24.88 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.534 . . . . 73.400000000000006 110.576 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.21 -13.46 65.78 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.659 -0.7 . . . . 75.450000000000003 111.832 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.31 15.51 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.18 0.514 . . . . 73.140000000000001 110.208 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.491 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -77.02 170.16 55.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.52 -0.763 . . . . 62.140000000000001 112.199 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.627 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . 69.43 -175.76 32.59 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.945 -0.645 . . . . 64.349999999999994 112.547 -175.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . 56.3 19.75 4.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.236 0.614 . . . . 70.329999999999998 112.354 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m -84.26 -1.36 55.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.64 -0.709 . . . . 71.120000000000005 110.746 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.6 tt -61.75 -37.84 79.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.743 -0.662 . . . . 73.230000000000004 111.358 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.617 ' HD1' HG23 ' A' ' 77' ' ' ILE . 21.6 p90 -103.22 4.16 36.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.217 0.532 . . . . 73.450000000000003 110.957 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.82 -108.99 2.84 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.342 -0.845 . . . . 72.150000000000006 112.467 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -89.97 -166.15 1.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.752 0.31 . . . . 71.140000000000001 110.233 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.487 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 4.5 pm0 -60.62 161.06 8.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.616 . . . . 75.329999999999998 109.772 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -100.5 -71.53 0.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 73.209999999999994 111.179 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 14.0 tp10 -151.19 -168.31 3.06 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.802 -1.555 . . . . 65.239999999999995 106.802 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.827 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 0.9 OUTLIER -136.55 119.54 16.42 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.606 -0.887 . . . . 72.120000000000005 108.606 162.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -100.37 29.65 4.27 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.378 -1.283 . . . . 74.519999999999996 110.486 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 31.3 mt -48.89 99.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.376 -0.829 . . . . 33.350000000000001 111.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -170.69 83.63 0.54 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.61 -1.177 . . . . 75.439999999999998 108.839 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.9 84.13 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.284 1.99 . . . . 72.530000000000001 111.337 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.94 -18.15 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.329 1.061 . . . . 62.030000000000001 108.873 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -104.16 165.61 10.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.332 -1.304 . . . . 62.409999999999997 108.79 172.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -119.3 144.37 46.85 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.426 -0.352 . . . . 74.030000000000001 110.143 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.681 ' CZ ' ' HB3' ' A' ' 120' ' ' GLN . 51.4 p90 -71.33 115.31 10.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 72.019999999999996 108.197 174.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 189' ' ' PRO . 77.2 p -99.82 -30.83 11.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.832 -0.622 . . . . 71.329999999999998 110.104 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.42 -148.8 5.87 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.063 -0.971 . . . . 64.540000000000006 110.94 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.56 144.61 30.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.74 0.305 . . . . 61.420000000000002 111.02 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.58 22.93 5.87 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.812 -0.709 . . . . 71.430000000000007 111.993 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 7.9 mm -91.39 115.06 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.785 -0.366 . . . . 51.140000000000001 110.048 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.697 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 6.8 mt -83.1 124.78 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.233 -0.44 . . . . 74.400000000000006 111.115 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.82 171.73 13.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.103 0.478 . . . . 52.109999999999999 111.367 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.652 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 24.1 tpp -86.11 137.81 32.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.618 -0.719 . . . . 74.049999999999997 111.033 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -92.75 113.46 25.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.451 0.644 . . . . 75.0 110.346 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.6 -169.58 3.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.002 -0.999 . . . . 70.109999999999999 109.03 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.54 -41.58 4.78 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.846 -0.342 . . . . 70.310000000000002 111.026 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.3 -55.23 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.504 -0.855 . . . . 75.439999999999998 112.474 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 77.51 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.022 1.814 . . . . 45.109999999999999 112.099 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.827 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 3.5 p-10 44.93 48.26 9.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.685 0.615 . . . . 74.420000000000002 112.13 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.44 29.82 7.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 72.349999999999994 111.082 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.652 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 23.6 p30 -93.67 161.78 14.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.965 0.412 . . . . 64.129999999999995 110.915 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -165.08 -118.21 0.43 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 52.119999999999997 112.284 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 5.5 t -105.4 16.92 24.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.377 0.608 . . . . 64.519999999999996 109.944 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 72.2 mm-40 -93.87 145.28 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 61.210000000000001 109.375 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -145.44 170.88 15.51 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.102 -0.373 . . . . 71.409999999999997 110.394 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 28.6 p90 -157.05 152.76 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.955 0.407 . . . . 74.439999999999998 111.042 173.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.48 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.4 t -107.14 146.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 72.120000000000005 109.757 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.6 p -100.14 124.26 45.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.875 -0.417 . . . . 72.549999999999997 109.875 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.521 HD11 ' HA3' ' A' ' 143' ' ' GLY . 73.9 mt -85.58 -8.14 58.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.709 -0.678 . . . . 74.319999999999993 111.117 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.21 167.0 14.56 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.044 -0.526 . . . . 55.340000000000003 110.556 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.621 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 17.8 Cg_endo -60.35 113.08 1.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.804 2.336 . . . . 72.329999999999998 111.945 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.413 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 31.0 p -107.12 102.36 11.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 42.329999999999998 111.67 -175.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.681 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -108.43 18.04 21.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 109.921 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -113.86 -3.5 13.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.049 -0.978 . . . . 72.540000000000006 111.515 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.7 pp -125.98 9.57 7.51 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.514 -0.474 . . . . 75.019999999999996 112.111 -175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.51 -32.61 51.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.456 0.646 . . . . 71.150000000000006 111.225 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.79 22.75 8.56 Favored Glycine 0 CA--C 1.509 -0.339 0 CA-C-N 115.423 -0.808 . . . . 60.100000000000001 111.68 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.8 mmtm -114.7 -38.71 3.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.306 0.574 . . . . 62.119999999999997 109.496 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -137.1 129.45 29.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.39 -0.823 . . . . 73.349999999999994 108.956 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -75.25 144.97 42.3 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.047 -0.661 . . . . 63.119999999999997 109.568 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.422 ' O ' HD21 ' A' ' 90' ' ' LEU . 44.2 mt -115.35 125.42 72.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.945 -171.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.3 p90 -154.18 72.83 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.964 0.888 . . . . 71.310000000000002 110.895 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.697 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -165.58 160.15 33.49 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.923 -1.608 . . . . 71.439999999999998 114.326 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.1 mtm180 -141.87 126.35 17.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.498 . . . . 72.200000000000003 109.748 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.0 p -91.42 136.13 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.274 0.559 . . . . 71.120000000000005 110.907 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.581 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 38.4 t -141.16 147.73 38.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.045 -0.525 . . . . 62.439999999999998 109.992 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.424 ' HA ' ' N ' ' A' ' 184' ' ' ASP . 12.5 tt0 52.42 35.41 17.41 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.124 0.488 . . . . 73.209999999999994 112.158 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.48 27.83 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.28 -0.962 . . . . 53.350000000000001 112.734 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -75.13 -38.71 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.721 -0.282 . . . . 75.120000000000005 110.299 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.66 -32.08 82.23 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.015 -0.612 . . . . 71.319999999999993 111.94 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.475 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.0 mmm -69.53 -52.0 30.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.962 -0.384 . . . . 73.010000000000005 109.962 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 23' ' ' ILE . 93.0 t -58.07 -29.69 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.143 0.497 . . . . 65.120000000000005 110.409 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.651 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -68.0 -55.61 11.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.882 -0.599 . . . . 73.120000000000005 109.975 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -14.92 61.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.176 -0.466 . . . . 65.209999999999994 111.288 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.725 HG13 HG21 ' A' ' 157' ' ' VAL . 30.4 t -78.61 -39.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.325 0.583 . . . . 75.349999999999994 109.544 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -80.49 -21.07 65.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.564 -0.827 . . . . 33.43 112.642 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 85.3 mtp -72.8 -17.03 61.61 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.945 0.35 . . . . 75.319999999999993 111.945 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 142' ' ' VAL . 34.4 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.63 . . . . 72.439999999999998 111.372 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.725 HG21 HG13 ' A' ' 142' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.559 -0.534 . . . . 65.310000000000002 109.559 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -125.96 158.88 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 111.924 -176.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.1 mp -88.27 106.2 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.578 -1.192 . . . . 71.430000000000007 109.133 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 19' ' ' SER . 26.0 mm -71.67 -53.81 19.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.846 -0.616 . . . . 74.25 110.41 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.8 mptm? -129.9 137.98 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.726 -0.67 . . . . 71.219999999999999 109.843 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -146.06 110.23 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.019 0.437 . . . . 60.409999999999997 110.911 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.34 140.85 31.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.533 -0.758 . . . . 71.519999999999996 110.738 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.687 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 39.2 Cg_endo -67.8 135.24 34.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.604 2.203 . . . . 72.209999999999994 111.855 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.482 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 9.1 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 110.206 -0.294 . . . . 65.319999999999993 110.206 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.445 ' CG ' HG22 ' A' ' 136' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.73 -0.471 . . . . 70.549999999999997 109.73 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.55 140.95 3.0 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.859 -0.686 . . . . 50.340000000000003 112.518 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -83.5 -163.0 34.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.424 -0.893 . . . . 53.119999999999997 112.049 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.689 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.07 160.67 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.801 0.334 . . . . 55.030000000000001 110.474 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.482 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.9 m-85 -106.82 100.04 29.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.47 . . . . 74.109999999999999 110.144 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.673 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.8 Cg_exo -76.81 -6.37 16.76 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.155 2.57 . . . . 72.299999999999997 113.0 -173.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -81.87 -29.92 32.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.511 -0.313 . . . . 72.299999999999997 111.057 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.0 pt -76.52 -19.01 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.991 0.367 . . . . 64.129999999999995 111.991 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.4 m170 67.63 48.43 1.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 72.140000000000001 111.916 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 191' ' ' ILE . 7.3 p -152.34 141.33 14.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.494 -0.321 . . . . 74.099999999999994 110.267 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.64 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 44.409999999999997 111.704 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -163.37 136.5 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.737 -0.665 . . . . 74.239999999999995 109.339 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -109.1 146.84 34.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 75.329999999999998 111.292 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.0 Cg_endo -65.6 -62.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.806 2.337 . . . . 72.25 112.418 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.57 26.49 3.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.565 -0.289 . . . . 74.150000000000006 111.013 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 202' ' ' ARG . 71.5 m-20 68.31 12.58 8.8 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.266 -0.425 . . . . 71.530000000000001 111.708 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.6 ptm -60.5 -24.0 64.96 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.229 0.455 . . . . 72.140000000000001 112.229 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -114.45 18.15 18.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.593 -0.813 . . . . 72.430000000000007 112.327 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 29.0 mmt180 -66.56 -34.44 77.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 70.120000000000005 110.62 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.09 -0.957 . . . . 71.329999999999998 109.875 -177.197 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 79.1 Cg_exo . . . . . 0 CA--C 1.53 0.282 0 CA-C-O 121.076 0.365 . . . . 75.530000000000001 113.019 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 58.8 Cg_endo -70.99 -7.55 21.68 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.125 2.55 . . . . 63.130000000000003 113.289 -175.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -124.34 147.62 48.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.396 -0.594 . . . . 73.109999999999999 109.396 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 27.9 m -129.09 146.82 33.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.056 -0.35 . . . . 75.019999999999996 110.056 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.79 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 46.2 p90 -107.29 128.23 54.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 74.349999999999994 110.374 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.13 99.43 8.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 73.310000000000002 109.993 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 36.8 tt0 -87.75 115.12 24.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.725 -0.843 . . . . 73.099999999999994 108.725 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 177.01 4.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.433 0.635 . . . . 74.120000000000005 112.036 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -71.68 -10.34 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.227 -0.897 . . . . 71.120000000000005 110.456 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -98.84 -41.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.922 -0.581 . . . . 65.340000000000003 110.535 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.48 -129.03 1.18 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.026 -0.83 . . . . 52.509999999999998 111.026 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -144.06 136.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.099 0.476 . . . . 75.439999999999998 110.188 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 139' ' ' VAL . 5.2 mp -134.83 122.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.454 -0.794 . . . . 74.299999999999997 109.032 176.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 133' ' ' CYS . 3.6 m -102.87 150.99 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.933 -0.707 . . . . 72.519999999999996 110.152 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.3 pp -143.99 161.07 39.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.782 -0.645 . . . . 73.420000000000002 109.757 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 29' ' ' TRP . 6.8 pt-20 -138.07 161.24 37.26 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.532 -0.758 . . . . 73.519999999999996 108.963 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 172.12 7.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 110.489 -172.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -91.61 96.2 10.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.407 0.622 . . . . 75.150000000000006 111.376 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -82.48 -5.25 58.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.056 -0.974 . . . . 73.329999999999998 110.439 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -68.31 -53.9 21.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.598 -0.728 . . . . 64.049999999999997 111.284 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -127.76 5.26 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 73.420000000000002 110.875 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.46 74.48 79.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.974 0.416 . . . . 52.439999999999998 110.699 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.19 -26.08 9.43 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.0 2.466 . . . . 75.310000000000002 112.737 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -89.51 -43.62 10.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.289 0.566 . . . . 74.409999999999997 109.908 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.502 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -59.79 -42.02 92.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 65.099999999999994 111.663 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.5 p -64.94 -33.34 75.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 72.150000000000006 111.538 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -31.07 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.83 -0.348 . . . . 75.129999999999995 111.499 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.44 -44.29 94.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 14' ' ' VAL . 18.0 t80 -63.97 -47.17 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.956 -0.565 . . . . 71.5 109.803 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.19 71.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 53.409999999999997 112.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.715 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 50.4 mm-40 -67.88 -29.3 68.38 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.696 0.284 . . . . 61.210000000000001 111.362 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 1.2 mm? -69.53 -37.41 77.08 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.185 0.517 . . . . 73.400000000000006 110.27 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.66 76.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 54.009999999999998 111.016 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 8.7 ptm180 -67.95 -30.07 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.372 -0.376 . . . . 73.010000000000005 111.375 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' HE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -67.18 -35.17 79.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.392 -0.596 . . . . 74.299999999999997 109.392 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 104.56 27.02 6.23 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.527 -0.844 . . . . 74.010000000000005 112.775 171.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 51' ' ' THR . 14.9 m-85 -82.09 -29.82 31.59 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.794 -0.239 . . . . 53.009999999999998 111.518 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.0 -17.13 60.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.99 0.424 . . . . 73.420000000000002 110.574 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 40.3 m-80 -69.47 -11.32 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.471 . . . . 72.510000000000005 110.403 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -119.52 16.25 10.53 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.84 -0.695 . . . . 73.109999999999999 112.059 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.639 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.4 p -97.32 159.95 14.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 44.119999999999997 110.992 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -142.56 155.83 45.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.152 -0.477 . . . . 74.319999999999993 109.953 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.4 m-85 -84.29 126.41 33.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.597 . . . . 61.450000000000003 109.387 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.83 -13.99 6.26 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.776 -0.369 . . . . 52.450000000000003 111.892 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 25.7 mmt85 -121.71 101.06 7.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.57 -0.53 . . . . 71.099999999999994 109.57 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -122.43 92.17 2.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.84 -0.8 . . . . 43.310000000000002 108.84 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.772 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.5 mt -100.11 121.52 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.868 -0.605 . . . . 73.540000000000006 109.422 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -49.95 132.03 22.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.941 0.776 . . . . 74.010000000000005 110.726 177.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 44.41 40.05 3.56 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.171 0.919 . . . . 72.439999999999998 112.328 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.772 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.7 t80 -134.64 -81.98 0.44 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 64.340000000000003 110.382 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.584 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 27.1 ptt? -161.19 155.09 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 71.430000000000007 110.679 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 116' ' ' LEU . 35.7 mt -125.16 101.66 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.916 -0.584 . . . . 71.439999999999998 109.973 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 70.0 mt-30 -86.05 123.04 30.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.014 -0.539 . . . . 71.450000000000003 111.296 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -129.97 137.61 9.65 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 65.510000000000005 112.111 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 157.63 -155.8 26.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.133 -1.032 . . . . 73.120000000000005 112.933 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 46.2 t0 56.4 89.81 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 112.234 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 41.8 Cg_endo -69.73 -17.6 37.61 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.01 2.473 . . . . 73.540000000000006 112.14 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -97.64 -39.51 9.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.012 -0.54 . . . . 74.319999999999993 112.25 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.71 25.03 33.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.582 -0.818 . . . . 72.310000000000002 111.605 -174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 60.9 p -101.11 -16.88 16.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 62.310000000000002 110.943 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 -17.93 42.63 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.068 -0.969 . . . . 75.420000000000002 112.126 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 1.5 ptp180 -106.55 -33.96 7.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 65.430000000000007 110.784 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.483 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 87.48 -159.05 30.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.673 -0.775 . . . . 61.210000000000001 112.346 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 -114.04 1.01 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.479 -0.649 . . . . 73.010000000000005 111.479 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . 57.59 39.31 27.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.015 0.436 . . . . 61.009999999999998 112.162 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.2 t -109.41 21.69 16.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 54.240000000000002 109.575 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.0 pt -72.11 -21.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.043 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 82' ' ' PHE . 5.2 p90 -106.77 5.45 28.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.512 0.672 . . . . 70.310000000000002 110.783 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.65 -117.51 4.66 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.272 -0.876 . . . . 42.030000000000001 111.738 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -88.56 -161.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.653 -0.869 . . . . 73.310000000000002 108.653 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.45 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 5.1 pm0 -63.36 159.24 18.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 71.129999999999995 110.103 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 77.7 t80 -95.36 -67.67 0.84 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.061 -0.518 . . . . 74.310000000000002 111.253 -170.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -169.98 152.47 4.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 71.549999999999997 108.994 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.76 105.31 8.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.488 0.661 . . . . 73.349999999999994 109.245 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -101.68 21.96 13.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.808 -0.633 . . . . 64.140000000000001 109.586 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.68 97.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.987 . . . . 65.439999999999998 110.629 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -168.34 81.97 0.77 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 109.836 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 51.5 Cg_endo -68.22 106.97 1.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.29 1.994 . . . . 73.239999999999995 111.74 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.53 -28.1 65.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.152 -1.055 . . . . 74.510000000000005 108.152 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.7 pp -84.21 178.5 7.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.88 -1.509 . . . . 73.239999999999995 109.337 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -141.1 167.2 22.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.586 -0.446 . . . . 65.030000000000001 109.925 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -63.51 123.16 18.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.163 0.506 . . . . 61.350000000000001 109.65 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.0 p -122.62 -40.78 2.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 74.530000000000001 110.573 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.42 -148.05 5.92 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.418 -0.81 . . . . 51.450000000000003 111.363 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.01 136.8 33.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.732 0.301 . . . . 54.229999999999997 110.73 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 116.98 20.07 5.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.85 -0.69 . . . . 61.119999999999997 112.208 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.3 mm -86.64 111.66 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 51.409999999999997 109.37 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.704 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -87.85 122.89 32.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.148 0.499 . . . . 62.310000000000002 110.275 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.07 167.06 20.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.729 -0.669 . . . . 75.120000000000005 110.178 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 34.6 ttp -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.563 -0.532 . . . . 72.200000000000003 109.563 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.29 162.36 13.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.99 0.424 . . . . 63.219999999999999 110.664 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.789 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.5 p-10 -158.71 162.91 37.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.02 -0.536 . . . . 75.140000000000001 110.61 -171.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.08 -19.45 18.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.787 0.803 . . . . 51.399999999999999 109.601 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.76 172.37 33.79 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.208 -1.557 . . . . 64.140000000000001 109.208 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.98 -44.66 36.27 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.003 2.469 . . . . 52.340000000000003 112.421 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.44 -17.6 20.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 64.519999999999996 111.108 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -84.12 47.34 1.31 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.519 0.676 . . . . 62.310000000000002 110.056 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.789 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 36.6 m-80 -64.33 129.87 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.727 -1.124 . . . . 72.319999999999993 108.944 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.24 -146.39 6.43 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.823 -1.18 . . . . 71.420000000000002 114.244 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 35.6 t -99.06 27.65 4.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.231 0.539 . . . . 62.219999999999999 110.095 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 70.9 mt-30 -118.73 152.09 36.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.789 -0.641 . . . . 72.219999999999999 109.888 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.1 p90 -140.46 170.31 16.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.225 -0.657 . . . . 72.120000000000005 109.225 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 p90 -156.95 150.1 23.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.239 0.542 . . . . 74.010000000000005 111.173 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 HD23 ' A' ' 98' ' ' LEU . 16.1 t -113.34 141.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 40.210000000000001 109.338 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.8 p -94.83 125.93 39.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.896 0.379 . . . . 71.0 110.301 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 34.0 mt -85.56 -7.53 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 71.439999999999998 110.228 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.64 159.75 40.36 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.183 -0.917 . . . . 75.340000000000003 109.65 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 42.9 Cg_endo -69.32 114.62 3.69 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.389 2.06 . . . . 64.200000000000003 112.594 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -106.59 118.31 36.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.469 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.51 19.51 19.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 62.140000000000001 110.769 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.61 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -128.15 5.2 5.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.825 . . . . 72.329999999999998 111.015 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.61 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.2 mt -111.3 -1.81 15.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 75.140000000000001 111.461 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 10.2 p-10 -70.08 -10.13 57.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.113 0.482 . . . . 74.549999999999997 111.358 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.15 17.68 6.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 74.239999999999995 111.757 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -121.73 -28.0 4.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.032 0.444 . . . . 55.219999999999999 110.205 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.14 134.68 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 110.327 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -69.04 112.03 5.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.98 0.419 . . . . 63.329999999999998 110.272 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 99' ' ' ALA . 39.2 mt -98.79 119.46 46.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.5 110.368 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.6 p90 -156.88 74.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.503 0.668 . . . . 72.340000000000003 110.672 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.6 157.84 29.88 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 118.98 -1.581 . . . . 55.43 114.257 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 190' ' ' GLU . 4.5 mtt180 -125.82 125.53 43.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.583 -0.895 . . . . 64.319999999999993 108.583 173.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.433 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.1 p -88.04 132.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.196 -0.602 . . . . 71.099999999999994 110.159 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 47.8 t -139.94 152.03 46.03 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.287 -0.258 . . . . 43.32 111.095 -176.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.0 pt20 41.67 35.23 0.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.545 1.138 . . . . 74.430000000000007 113.11 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.36 15.75 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.559 -0.829 . . . . 71.540000000000006 112.343 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.1 tp -72.28 -33.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.619 0.247 . . . . 61.219999999999999 110.626 -174.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.49 -37.38 93.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.724 -0.751 . . . . 44.210000000000001 111.256 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 77.9 mmm -71.43 -49.46 41.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.285 -0.265 . . . . 72.049999999999997 110.285 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 23' ' ' ILE . 86.5 t -55.81 -30.59 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.998 0.428 . . . . 31.239999999999998 110.815 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.95 -51.14 27.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.014 -0.539 . . . . 72.340000000000003 110.566 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -76.29 -13.83 60.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.948 -0.569 . . . . 64.129999999999995 111.391 -177.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 145' ' ' VAL . 79.0 t -91.76 -27.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 71.140000000000001 109.895 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -93.35 -8.01 61.58 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.541 -0.838 . . . . 73.299999999999997 113.001 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 27.3 ptm -85.14 -11.14 55.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.798 0.333 . . . . 65.219999999999999 110.369 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 142' ' ' VAL . 28.9 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 64.349999999999994 110.77 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 22.2 t . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 108.019 -1.104 . . . . 73.140000000000001 108.019 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 2.6 mppt? -127.51 152.84 47.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.334 -0.546 . . . . 63.450000000000003 111.407 -167.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -89.78 109.85 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.45 -0.944 . . . . 62.140000000000001 108.45 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.431 HG22 ' CD ' ' A' ' 161' ' ' LYS . 28.5 mm -76.65 -51.87 18.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.102 -0.499 . . . . 71.340000000000003 110.679 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -131.73 129.84 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.739 . . . . 71.140000000000001 110.084 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -140.99 110.8 6.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.939 0.4 . . . . 60.109999999999999 110.792 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.59 155.14 53.09 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.543 -0.753 . . . . 71.319999999999993 109.708 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.673 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.77 137.68 39.12 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.295 1.997 . . . . 75.439999999999998 111.332 175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.79 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 5.8 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 120.961 0.41 . . . . 73.530000000000001 110.884 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.3 m-20 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.349 0.595 . . . . 64.219999999999999 110.41 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 155.38 144.18 3.85 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.072 -0.967 . . . . 64.120000000000005 110.963 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.433 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -80.36 -166.55 34.59 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.242 -0.98 . . . . 64.310000000000002 112.395 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.34 175.51 9.68 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.586 -0.524 . . . . 63.140000000000001 109.586 177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.37 102.45 53.13 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 110.511 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 97' ' ' ILE . 2.5 Cg_endo -79.69 -13.38 13.23 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.05 2.5 . . . . 74.140000000000001 111.065 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 131' ' ' ARG . 26.1 tt0 -70.85 -35.16 72.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.016 -0.993 . . . . 74.040000000000006 109.773 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.8 pt -92.15 156.45 3.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.144 -1.058 . . . . 64.109999999999999 108.144 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -106.39 74.77 1.04 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.996 -0.682 . . . . 74.109999999999999 110.921 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.7 149.1 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.393 -0.821 . . . . 63.109999999999999 108.977 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.33 118.49 24.9 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.811 -0.356 . . . . 61.219999999999999 110.863 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.591 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -152.08 153.23 33.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.543 -0.54 . . . . 72.439999999999998 109.543 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 202' ' ' ARG . 62.6 m-85 -120.65 137.74 26.7 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.453 -0.34 . . . . 53.049999999999997 111.126 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.85 -55.87 0.95 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.967 2.445 . . . . 63.409999999999997 112.289 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 15.12 2.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.641 -0.254 . . . . 75.329999999999998 111.458 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 202' ' ' ARG . 1.7 t70 61.91 80.84 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.472 1.13 . . . . 62.340000000000003 109.661 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 13.1 ptm -129.96 -10.13 4.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.271 -1.331 . . . . 70.129999999999995 110.541 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -142.19 14.97 2.55 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.375 -0.917 . . . . 64.0 112.801 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 3.1 ptt180 -98.15 -34.81 10.6 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 119.373 -0.931 . . . . 75.430000000000007 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.7 mmpt? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.517 -0.754 . . . . 73.430000000000007 110.084 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.462 -0.374 0 N-CA-C 111.531 -0.219 . . . . 73.129999999999995 111.531 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 38.5 Cg_endo -67.57 -7.5 19.48 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.885 2.39 . . . . 75.409999999999997 113.268 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.504 HD22 ' CG1' ' A' ' 24' ' ' VAL . 4.3 t30 -133.16 141.41 48.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 71.420000000000002 110.731 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.4 m -131.08 157.01 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.116 -0.493 . . . . 54.130000000000003 109.973 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 22' ' ' ILE . 23.7 p90 -121.03 138.82 53.99 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 74.030000000000001 110.638 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -114.77 103.68 11.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.627 -0.715 . . . . 61.409999999999997 109.754 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 22' ' ' ILE . 37.8 tt0 -88.13 114.65 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 159' ' ' ILE . 59.3 p -104.04 177.06 4.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.312 -0.404 . . . . 71.329999999999998 110.696 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.433 ' HB2' HD11 ' A' ' 160' ' ' ILE . 27.7 t -71.23 -20.41 62.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 73.030000000000001 110.994 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 142' ' ' VAL . 79.8 mtp -95.01 -33.94 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.26 . . . . 52.539999999999999 110.937 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.487 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -171.17 -138.6 2.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.454 -0.879 . . . . 61.539999999999999 112.153 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.98 129.99 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.068 -0.716 . . . . 63.140000000000001 109.068 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -124.14 123.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.487 -0.778 . . . . 74.540000000000006 110.316 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 23.2 t -103.26 138.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.721 -0.474 . . . . 54.140000000000001 109.721 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.72 165.06 33.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 71.019999999999996 110.599 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 9.6 pt-20 -136.56 165.21 26.39 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.919 -0.582 . . . . 73.120000000000005 110.115 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.01 162.08 13.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.96 0.409 . . . . 61.340000000000003 110.504 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 4.0 m-85 -81.53 98.12 8.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 111.695 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 42.7 m95 -83.4 -3.72 57.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.117 -0.492 . . . . 65.129999999999995 110.594 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -78.84 -62.15 1.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 71.239999999999995 111.075 -175.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -125.5 18.76 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.571 -0.286 . . . . 73.329999999999998 111.76 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -142.0 71.69 23.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 45.399999999999999 111.14 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.35 -44.3 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.992 2.461 . . . . 73.349999999999994 113.052 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.9 tpmt? -73.66 -36.1 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 65.109999999999999 110.543 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.628 ' OG1' ' HB1' ' A' ' 32' ' ' ALA . 14.5 p -68.95 -43.34 75.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.16 -0.473 . . . . 71.209999999999994 110.616 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' CE2' ' A' ' 29' ' ' TRP . 25.0 t -53.88 -50.83 65.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.457 -0.792 . . . . 72.25 110.78 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.816 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.3 mmpt? -60.37 -37.01 79.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 72.519999999999996 111.114 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -62.17 -56.17 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 74.319999999999993 110.323 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -66.12 -40.05 90.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 71.420000000000002 111.565 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.35 94.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.61 -0.268 . . . . 73.299999999999997 111.0 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.81 -48.91 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 75.450000000000003 111.773 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -65.25 -25.79 67.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.395 -0.522 . . . . 74.319999999999993 111.008 -179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.79 -55.72 7.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.017 0.437 . . . . 74.120000000000005 110.778 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 44' ' ' ARG . 6.4 ppt_? -79.3 -28.3 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 74.120000000000005 112.24 -172.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -74.54 -52.9 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.875 0.369 . . . . 75.109999999999999 110.404 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.94 50.02 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.31 -0.948 . . . . 74.510000000000005 112.616 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB2' HD12 ' A' ' 42' ' ' LEU . 56.0 t80 -103.48 -51.44 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.793 -0.239 . . . . 75.019999999999996 111.091 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 51' ' ' THR . 76.0 m-85 -68.49 -18.99 64.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 121.146 -0.222 . . . . 74.0 111.316 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -74.34 84.48 1.93 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.63 -0.878 . . . . 75.400000000000006 108.63 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.53 24.41 1.13 Allowed Glycine 0 C--N 1.301 -1.384 0 CA-C-N 113.979 -1.464 . . . . 73.230000000000004 111.77 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 48' ' ' TYR . 34.3 p -108.91 158.67 17.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.928 -0.397 . . . . 54.030000000000001 109.928 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 12.2 ptpt -138.39 158.12 44.89 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.783 0.325 . . . . 63.140000000000001 111.168 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 78.9 m-85 -84.04 121.66 27.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.412 -0.588 . . . . 72.540000000000006 109.412 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -96.52 -40.62 8.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.467 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -123.71 114.65 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.343 -0.243 . . . . 61.310000000000002 110.343 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -119.64 89.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.698 -0.853 . . . . 75.329999999999998 108.698 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.0 mt -96.56 120.8 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.164 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -53.65 129.12 31.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.723 -0.671 . . . . 70.439999999999998 111.003 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 58.28 26.76 14.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.262 -0.881 . . . . 72.010000000000005 111.852 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.652 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 1.1 t80 -128.92 -83.45 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.201 0.524 . . . . 74.230000000000004 110.469 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.448 ' H ' ' HB3' ' A' ' 60' ' ' PHE . 27.3 ptt? -161.26 153.45 19.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.349 -0.841 . . . . 74.230000000000004 110.033 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 116' ' ' LEU . 23.4 mt -119.42 99.76 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.12 -0.696 . . . . 63.119999999999997 109.12 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.899 -0.591 . . . . 64.310000000000002 110.247 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.06 151.2 20.65 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.941 -0.647 . . . . 74.200000000000003 112.191 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.25 -77.93 0.2 Allowed Glycine 0 C--O 1.219 -0.797 0 C-N-CA 119.642 -1.266 . . . . 74.329999999999998 114.027 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -45.91 108.65 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 122.155 0.979 . . . . 72.530000000000001 113.205 -165.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 59.7 Cg_endo -74.46 -14.6 22.48 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.539 2.826 . . . . 44.25 111.891 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.5 p -84.63 -28.76 26.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.952 -1.022 . . . . 44.149999999999999 111.381 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 2.98 90.7 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.401 -0.68 . . . . 55.32 111.401 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.6 p -88.34 -24.61 23.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.319 0.581 . . . . 74.109999999999999 110.574 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.5 -16.35 48.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.287 -0.87 . . . . 63.310000000000002 112.096 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -82.0 -48.12 11.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 75.340000000000003 110.245 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.594 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 98.09 -174.57 28.9 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.592 -0.731 . . . . 65.430000000000007 112.525 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.29 -93.49 0.86 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.393 -0.683 . . . . 74.299999999999997 111.393 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 61.36 43.31 10.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.652 0.739 . . . . 62.219999999999999 111.97 172.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -86.35 24.65 1.33 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.528 -0.76 . . . . 71.5 111.157 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 pt -100.26 -17.7 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.809 -0.356 . . . . 63.219999999999999 111.487 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 30.2 p90 -121.3 -22.6 5.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.483 -0.487 . . . . 74.400000000000006 111.999 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.79 -99.65 1.15 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.563 -0.827 . . . . 44.310000000000002 111.467 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 23.6 mtpt -78.88 161.9 26.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.968 -0.382 . . . . 73.340000000000003 109.968 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 107' ' ' THR . 1.2 mp0 -66.08 172.07 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.248 0.547 . . . . 70.010000000000005 111.281 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -95.92 -71.96 0.65 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.52 -0.764 . . . . 74.409999999999997 109.067 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 5.8 tp10 -169.27 172.01 7.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.494 -1.299 . . . . 72.310000000000002 107.494 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 13.1 p-10 -77.87 107.86 10.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 54.310000000000002 109.263 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.42 18.35 5.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 71.040000000000006 109.483 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.5 mt -57.04 102.07 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.815 -1.084 . . . . 73.409999999999997 110.269 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -157.18 75.38 4.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.552 -0.536 . . . . 65.439999999999998 109.552 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 123' ' ' ASP . 37.0 Cg_endo -66.15 91.12 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.621 2.214 . . . . 61.200000000000003 112.221 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.28 -16.69 51.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.329 1.061 . . . . 74.439999999999998 108.917 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.5 pp -93.8 175.61 6.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.417 -1.265 . . . . 74.209999999999994 110.217 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -131.01 146.31 52.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 109.886 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.616 ' HE2' ' HB3' ' A' ' 123' ' ' ASP . 96.2 m-85 -69.77 94.15 0.79 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.276 -0.638 . . . . 72.239999999999995 109.276 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 195' ' ' GLN . 39.1 p -81.99 -41.71 20.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.945 -1.025 . . . . 61.299999999999997 110.434 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.5 -131.94 1.36 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 31.539999999999999 111.645 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.21 143.28 28.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.764 0.316 . . . . 71.430000000000007 110.782 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 25.0 5.57 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.741 -0.742 . . . . 70.400000000000006 112.128 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 189' ' ' PRO . 7.1 mm -86.45 110.0 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.237 -0.653 . . . . 74.450000000000003 109.237 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.738 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.8 tm? -87.19 113.01 22.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.202 -0.453 . . . . 61.43 110.058 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -127.12 171.23 11.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.923 -0.58 . . . . 75.420000000000002 110.589 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.503 ' SD ' ' HB ' ' A' ' 127' ' ' THR . 15.2 ptm -95.14 148.34 22.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.821 0.343 . . . . 65.040000000000006 110.146 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -94.92 124.82 39.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.028 0.442 . . . . 73.519999999999996 110.46 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.674 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -144.28 164.15 31.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 70.420000000000002 110.234 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -71.98 -44.87 62.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.99 -0.55 . . . . 55.329999999999998 110.53 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.28 -97.48 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.741 -0.742 . . . . 45.009999999999998 112.089 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.98 88.64 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.885 2.39 . . . . 72.129999999999995 112.145 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 53.51 12.54 0.38 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.688 1.195 . . . . 60.32 113.707 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.2 m -88.16 61.55 6.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.989 -0.745 . . . . 63.229999999999997 108.989 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.6 p30 -81.62 143.49 31.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.011 -0.995 . . . . 74.200000000000003 111.34 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -124.89 -172.27 13.47 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.519 -0.764 . . . . 61.43 112.033 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 75' ' ' ALA . 15.9 p -88.44 3.85 48.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 70.340000000000003 110.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 77.4 mt-30 -80.75 159.09 25.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 71.319999999999993 110.236 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -139.77 169.36 17.87 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.896 -0.409 . . . . 74.329999999999998 109.896 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.71 146.82 25.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.116 0.484 . . . . 72.120000000000005 110.127 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.668 HG22 HD23 ' A' ' 98' ' ' LEU . 13.1 t -110.44 134.24 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.508 -0.769 . . . . 64.239999999999995 109.36 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 p -91.69 125.58 36.46 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.024 0.44 . . . . 75.430000000000007 110.323 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 62' ' ' ILE . 47.1 mt -81.54 -9.7 59.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 73.340000000000003 110.683 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.24 159.54 32.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.585 -0.734 . . . . 74.129999999999995 110.201 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 34.9 Cg_exo -60.56 122.85 11.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.732 2.288 . . . . 62.520000000000003 111.939 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 3.5 p -127.76 89.15 2.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.227 0.537 . . . . 34.409999999999997 110.158 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -93.22 24.19 3.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.875 0.845 . . . . 64.099999999999994 110.144 -166.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.671 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.3 p90 -116.56 -0.18 12.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.315 -1.311 . . . . 75.239999999999995 109.504 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.671 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 90.5 mt -108.19 1.05 21.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.368 -0.833 . . . . 72.010000000000005 110.796 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.616 ' HB3' ' HE2' ' A' ' 92' ' ' PHE . 16.9 p-10 -68.59 -15.87 63.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.374 -0.83 . . . . 75.239999999999995 111.276 -174.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 14.62 10.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.478 -0.868 . . . . 74.129999999999995 111.646 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -116.89 -37.24 3.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 65.129999999999995 110.546 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -133.27 130.28 38.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 65.450000000000003 110.088 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.503 ' HB ' ' SD ' ' A' ' 100' ' ' MET . 19.0 m -65.59 126.5 28.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 71.209999999999994 110.21 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 99' ' ' ALA . 22.6 mt -107.27 127.96 62.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.47 -0.332 . . . . 72.420000000000002 110.347 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.623 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 22.7 p90 -159.47 70.83 0.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.521 0.677 . . . . 73.0 110.816 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.66 155.16 26.39 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.903 -1.141 . . . . 73.120000000000005 113.296 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -136.2 120.57 18.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.34 137.28 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.149 0.5 . . . . 74.230000000000004 110.892 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.605 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 35.4 t -144.83 149.33 35.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.052 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.8 tt0 47.64 52.48 12.52 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.403 0.62 . . . . 74.439999999999998 111.585 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.83 25.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.379 -0.915 . . . . 74.150000000000006 112.05 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -79.49 -30.94 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.822 -0.436 . . . . 64.299999999999997 109.822 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.22 88.89 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.799 -0.715 . . . . 71.120000000000005 111.439 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.552 ' HE1' HH11 ' A' ' 141' ' ' ARG . 54.3 mmm -71.96 -52.44 17.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.936 -0.394 . . . . 63.350000000000001 109.936 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.86 -32.04 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.175 0.512 . . . . 53.32 110.926 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.418 ' HA ' ' SD ' ' A' ' 200' ' ' MET . 1.8 t30 -71.4 -50.86 27.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.794 -0.639 . . . . 74.239999999999995 110.878 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.552 HH11 ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -77.87 -12.36 59.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 64.120000000000005 111.29 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 145' ' ' VAL . 70.2 t -91.32 -32.32 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.096 0.474 . . . . 54.43 110.434 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.29 -17.37 60.85 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.554 -0.832 . . . . 60.109999999999999 113.11 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.2 ptp -88.36 -13.16 41.34 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.594 -0.442 . . . . 61.020000000000003 111.347 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 142' ' ' VAL . 27.5 m . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.307 0.575 . . . . 53.530000000000001 110.814 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 109.295 -0.632 . . . . 72.150000000000006 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -144.52 166.77 24.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.91 -0.586 . . . . 73.049999999999997 111.677 -168.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.7 mp -88.5 113.18 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.153 -0.93 . . . . 65.530000000000001 109.476 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.49 HG22 ' CD ' ' A' ' 161' ' ' LYS . 26.7 mm -75.56 -61.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.626 -0.716 . . . . 53.240000000000002 110.389 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 160' ' ' ILE . 2.1 mptm? -124.95 131.18 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 110.103 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -137.68 113.8 9.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.355 -0.384 . . . . 53.030000000000001 110.694 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -148.61 156.03 41.78 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 72.510000000000005 110.012 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 56.7 Cg_endo -70.33 134.62 27.18 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.19 1.927 . . . . 64.430000000000007 111.513 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.411 ' HB3' HD21 ' A' ' 13' ' ' ASN . 29.0 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.208 0.527 . . . . 74.430000000000007 110.731 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.51 -0.571 0 CA-C-O 121.757 0.789 . . . . 63.229999999999997 110.842 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 141.31 148.05 5.0 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.3 -1.318 . . . . 61.409999999999997 111.458 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -84.67 -167.35 42.79 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.337 -0.935 . . . . 33.530000000000001 111.346 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.519 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -76.04 165.28 25.18 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.202 -0.666 . . . . 60.25 109.202 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.403 ' O ' HG21 ' A' ' 93' ' ' THR . 98.0 m-85 -106.84 93.4 8.81 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.637 0.256 . . . . 72.209999999999994 110.562 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.744 ' HB2' HD13 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -71.94 -11.85 27.83 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.522 2.148 . . . . 73.400000000000006 112.685 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.37 -38.36 71.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.399 0.618 . . . . 74.150000000000006 109.632 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.6 155.0 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.972 -1.121 . . . . 74.010000000000005 107.972 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.4 m170 -104.76 92.75 4.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.116 -0.634 . . . . 73.150000000000006 110.599 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.01 146.92 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.565 -0.743 . . . . 61.109999999999999 109.778 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.8 108.0 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.792 0.329 . . . . 24.210000000000001 111.171 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 93' ' ' THR . 4.7 pt20 -139.34 141.53 37.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 110.745 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.476 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 27.6 m-85 -112.6 135.53 21.52 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 120.715 0.293 . . . . 73.519999999999996 110.83 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.9 Cg_endo -62.26 -65.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.97 2.447 . . . . 74.430000000000007 112.253 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.3 pt? -125.44 19.5 8.09 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.158 0.504 . . . . 75.099999999999994 110.078 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 41.8 m-20 71.18 8.88 6.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.057 -0.974 . . . . 65.129999999999995 113.198 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' A' ' 140' ' ' ASN . 25.1 ptt? -63.89 -29.09 70.3 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.808 -0.357 . . . . 75.400000000000006 111.463 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.21 -2.47 90.49 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.822 -0.704 . . . . 50.240000000000002 112.35 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.476 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 14.3 mtp180 -87.24 -61.17 1.78 Allowed 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 110.132 -0.321 . . . . 74.439999999999998 110.132 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt . . . . . 0 C--O 1.249 1.043 0 O-C-N 125.123 1.514 . . . . 75.299999999999997 112.78 -172.638 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.851 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 19.2 Cg_endo . . . . . 0 CA--C 1.531 0.363 0 CA-C-O 121.0 0.333 . . . . 72.319999999999993 112.848 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.39 -11.75 9.38 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.194 2.596 . . . . 52.240000000000002 114.108 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.528 HD21 HG12 ' A' ' 24' ' ' VAL . 27.3 t-20 -131.22 148.49 52.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.639 0.257 . . . . 72.420000000000002 110.847 -171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 28.5 m -132.75 147.37 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.138 0.494 . . . . 64.010000000000005 111.021 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 39.1 m-85 -105.09 118.96 37.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.68 -0.691 . . . . 71.019999999999996 110.528 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 mt -106.02 98.24 7.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.447 -0.342 . . . . 60.119999999999997 110.118 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 6.0 tt0 -89.79 113.06 24.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.457 -0.571 . . . . 61.439999999999998 109.457 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -105.47 178.11 4.65 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.068 -0.515 . . . . 63.509999999999998 111.09 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -73.75 -15.06 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 73.420000000000002 111.049 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.408 ' HG3' HG22 ' A' ' 157' ' ' VAL . 89.7 mmm -99.23 -32.73 11.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 63.009999999999998 110.923 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.43 -134.16 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.015 -0.612 . . . . 62.299999999999997 111.741 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.29 130.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.184 -0.672 . . . . 72.140000000000001 109.184 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.9 mp -122.81 128.42 75.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.556 -0.747 . . . . 72.25 110.203 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.528 HG12 HD21 ' A' ' 13' ' ' ASN . 46.2 t -110.74 141.77 25.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.226 -0.443 . . . . 64.019999999999996 110.232 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.4 pp -155.49 166.6 33.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.878 0.37 . . . . 73.519999999999996 111.035 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.37 173.49 10.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.589 -0.732 . . . . 75.319999999999993 109.575 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -111.95 161.18 16.7 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.41 -0.589 . . . . 61.100000000000001 109.41 176.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.2 m-85 -80.23 102.16 9.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.548 0.689 . . . . 71.310000000000002 112.482 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -82.73 -3.5 56.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.931 -1.031 . . . . 75.329999999999998 109.68 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 30' ' ' LYS . 5.3 mptt -71.64 -57.37 4.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.329 -0.85 . . . . 73.400000000000006 111.176 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -136.9 21.49 3.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.055 0.391 . . . . 73.329999999999998 112.055 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -135.26 66.72 67.02 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 74.219999999999999 110.597 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.71 -51.27 4.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.883 2.389 . . . . 63.520000000000003 112.862 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -84.26 -25.63 29.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.741 -0.384 . . . . 75.209999999999994 110.243 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.7 -50.29 69.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.194 -0.669 . . . . 71.230000000000004 109.194 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 4.4 t -57.25 -43.99 83.46 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.427 -0.806 . . . . 61.399999999999999 110.28 172.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.628 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -59.95 -39.19 84.73 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.569 -0.741 . . . . 75.099999999999994 110.53 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -55.69 -50.49 70.15 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.899 0.381 . . . . 73.150000000000006 110.222 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.48 -42.75 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 74.540000000000006 111.164 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.44 86.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.011 0.434 . . . . 71.010000000000005 111.35 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -46.92 86.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 75.049999999999997 110.638 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.63 -30.48 68.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 61.439999999999998 111.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.64 67.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.95 -0.568 . . . . 74.329999999999998 111.084 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -74.95 -15.63 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.415 . . . . 72.349999999999994 110.346 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' HD12 ' A' ' 77' ' ' ILE . 23.5 tpt180 -77.67 -51.68 10.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.795 -0.639 . . . . 62.219999999999999 109.676 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.24 27.02 5.74 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.63 -0.714 . . . . 72.420000000000002 112.192 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.19 11.36 12.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 72.040000000000006 111.485 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.51 -14.75 18.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.751 0.31 . . . . 75.450000000000003 110.461 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 32.2 m-80 -80.64 99.28 8.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.94 0.876 . . . . 71.400000000000006 109.48 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.31 7.31 9.24 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 114.033 -1.439 . . . . 53.039999999999999 111.697 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.458 ' HB ' ' C ' ' A' ' 65' ' ' GLY . 81.9 p -88.84 165.4 14.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.555 0.217 . . . . 61.350000000000001 110.489 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -139.0 158.61 43.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 74.239999999999995 110.564 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 73.3 m-85 -80.6 133.65 35.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.4 0.619 . . . . 53.420000000000002 111.388 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.678 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 60.8 m80 -93.64 -56.75 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.966 -1.016 . . . . 74.040000000000006 110.507 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.3 mmm180 -114.88 112.72 23.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.852 -1.067 . . . . 73.329999999999998 109.805 -170.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 62' ' ' ILE . 4.4 mp -123.11 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.816 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 25.6 mt -103.58 127.32 57.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.022 -0.536 . . . . 73.140000000000001 109.714 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -59.83 130.75 48.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.413 0.446 . . . . 72.319999999999993 111.096 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 54.1 31.65 14.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 111.417 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -130.71 -82.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 110.301 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.658 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.7 ptm -160.5 155.83 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.54 -0.754 . . . . 75.310000000000002 110.603 -176.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 23.2 mt -132.97 101.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.765 -0.652 . . . . 54.109999999999999 109.742 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 50.4 tt0 -89.54 128.22 35.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.474 . . . . 75.0 110.986 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -131.14 160.16 23.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.87 -0.681 . . . . 64.329999999999998 112.613 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.458 ' C ' ' HB ' ' A' ' 51' ' ' THR . . . 137.77 -150.8 21.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 34.100000000000001 112.309 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.678 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 0.2 OUTLIER 68.08 96.02 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 112.954 0.724 . . . . 73.209999999999994 112.954 178.087 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.59 -17.56 11.17 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.244 1.962 . . . . 62.210000000000001 109.819 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.0 p -92.25 -48.32 6.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.131 -1.395 . . . . 52.539999999999999 112.154 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.1 13.42 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.526 -0.63 . . . . 71.409999999999997 111.526 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 68' ' ' THR . 4.0 t -112.39 -29.1 7.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 74.129999999999995 111.85 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.34 -21.86 9.82 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.372 -0.918 . . . . 70.319999999999993 112.839 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.435 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -103.33 -29.45 11.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 73.510000000000005 110.571 177.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.72 -169.04 15.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.55 -0.833 . . . . 53.409999999999997 113.361 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.33 36.9 2.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.332 -0.461 . . . . 70.140000000000001 112.725 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -76.26 59.5 1.39 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.545 0.688 . . . . 72.140000000000001 111.124 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -85.85 9.93 15.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.512 -0.767 . . . . 72.239999999999995 109.876 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 45' ' ' ARG . 3.0 tt -62.0 -38.6 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 70.310000000000002 110.117 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 13.04 22.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.723 0.773 . . . . 72.019999999999996 110.409 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -80.87 1.63 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.705 -1.134 . . . . 42.119999999999997 112.028 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HE3' ' NE2' ' A' ' 81' ' ' GLN . 20.7 ptmt -133.42 -179.85 5.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.968 0.413 . . . . 73.409999999999997 110.43 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.483 ' NE2' ' HE3' ' A' ' 80' ' ' LYS . 5.0 pm0 -72.17 174.82 6.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.564 -0.744 . . . . 72.150000000000006 110.231 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.01 -64.4 1.31 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.391 0.615 . . . . 74.019999999999996 110.225 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -161.64 176.5 10.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.495 -1.298 . . . . 74.329999999999998 107.495 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.539 ' OD1' ' HG ' ' A' ' 86' ' ' LEU . 2.5 t0 -81.07 138.22 35.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.78 -0.768 . . . . 63.420000000000002 110.045 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -100.08 13.81 32.83 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.521 -0.763 . . . . 74.209999999999994 110.58 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 47.5 mt -51.54 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.694 0.621 . . . . 72.319999999999993 111.104 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -166.58 79.77 1.04 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.479 -0.782 . . . . 54.229999999999997 109.533 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.44 102.56 0.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.598 2.199 . . . . 61.229999999999997 112.078 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.94 -14.9 59.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.473 1.13 . . . . 71.299999999999997 108.917 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.3 pp -113.24 -174.92 2.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.251 -1.34 . . . . 64.140000000000001 109.545 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -141.28 166.38 24.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.963 -0.754 . . . . 54.420000000000002 108.963 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -63.9 123.37 18.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.441 0.639 . . . . 73.109999999999999 110.511 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 35.4 p -122.78 -44.81 2.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.528 -0.76 . . . . 74.019999999999996 110.005 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.75 -145.27 4.31 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.482 -0.781 . . . . 64.219999999999999 111.787 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.61 143.2 26.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.632 0.253 . . . . 71.040000000000006 110.923 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.77 22.0 6.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.589 -0.815 . . . . 74.439999999999998 111.894 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.4 mm -84.37 111.33 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.642 . . . . 74.310000000000002 109.268 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.6 124.44 32.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.668 -0.493 . . . . 61.140000000000001 109.668 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.42 171.32 14.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.048 -0.524 . . . . 41.340000000000003 111.383 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 25.4 ttt -107.54 132.36 53.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.693 -0.685 . . . . 72.209999999999994 109.805 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -96.29 163.19 13.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.411 . . . . 24.23 110.147 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -158.76 164.75 35.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 72.219999999999999 109.723 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.53 58.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 111.187 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 147.45 -136.54 6.13 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 120.858 -0.686 . . . . 71.099999999999994 111.875 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 18.2 Cg_endo -54.12 97.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 123.305 2.67 . . . . 55.219999999999999 111.811 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 3.2 p30 58.53 13.15 2.39 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.211 -1.359 . . . . 73.129999999999995 112.645 173.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.4 m -89.31 60.48 5.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.386 0.613 . . . . 74.540000000000006 109.369 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -85.1 151.95 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.598 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.94 -110.07 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.976 -0.556 . . . . 63.350000000000001 112.124 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 79.8 p -123.48 61.33 1.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.75 0.786 . . . . 64.340000000000003 110.568 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.609 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 69.8 mm-40 -126.91 146.0 50.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.586 -1.188 . . . . 61.340000000000003 109.716 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -148.93 164.91 33.13 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.581 -0.525 . . . . 73.239999999999995 109.581 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 48.6 p90 -158.36 152.12 23.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 74.239999999999995 111.302 175.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.688 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -113.27 143.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.329999999999998 109.115 175.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.7 p -98.79 130.55 45.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.28 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.3 mt -86.85 -5.5 59.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.721 -0.672 . . . . 70.299999999999997 110.651 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.95 163.52 25.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.697 -0.683 . . . . 51.219999999999999 110.135 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.503 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 21.5 Cg_exo -66.46 120.18 7.28 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.629 2.219 . . . . 74.409999999999997 112.074 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -104.68 156.56 17.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.617 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.95 12.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.256 0.551 . . . . 74.040000000000006 110.487 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -110.59 -11.03 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 74.129999999999995 112.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -129.85 -1.28 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.315 0.578 . . . . 75.040000000000006 111.149 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 -13.5 60.67 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.904 -1.044 . . . . 71.140000000000001 110.933 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.47 8.49 28.41 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.155 -0.778 . . . . 61.409999999999997 111.155 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -114.83 -23.4 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 71.299999999999997 109.159 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 100' ' ' MET . 86.0 m-70 -134.64 133.95 40.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.655 -1.157 . . . . 71.0 108.405 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -73.22 147.89 44.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.412 . . . . 63.100000000000001 110.52 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 99' ' ' ALA . 29.4 mt -125.16 122.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 73.329999999999998 110.62 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' A' ' 35' ' ' THR . 6.7 p90 -159.58 74.25 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.59 0.71 . . . . 75.010000000000005 110.925 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.7 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.45 157.16 29.25 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.574 -1.298 . . . . 71.420000000000002 113.177 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -132.58 120.07 21.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.902 -0.406 . . . . 75.549999999999997 109.902 173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.6 p -82.73 137.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 73.0 110.582 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 43.7 t -141.25 153.09 45.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.366 -0.379 . . . . 73.129999999999995 110.508 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 2.8 pt20 40.4 39.42 0.7 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.508 1.123 . . . . 54.5 113.221 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.24 31.96 0.12 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.825 -0.702 . . . . 45.549999999999997 112.124 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -83.79 -31.03 7.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 74.120000000000005 109.486 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.56 93.0 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.673 -0.694 . . . . 72.25 111.867 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.42 ' HE1' HH11 ' A' ' 141' ' ' ARG . 60.0 mmm -67.74 -50.63 56.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.641 -0.503 . . . . 73.129999999999995 109.641 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 62' ' ' ILE . 85.0 t -53.78 -32.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 63.009999999999998 110.833 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -72.82 -53.13 12.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.005 -0.543 . . . . 75.329999999999998 110.982 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.18 -14.1 60.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.113 -0.494 . . . . 73.420000000000002 111.186 -177.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 157' ' ' VAL . 51.4 t -88.73 -38.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.971 0.415 . . . . 63.009999999999998 110.294 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.53 -24.76 64.56 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.592 -0.813 . . . . 64.219999999999999 112.775 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.521 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.6 ptp -78.24 -16.91 57.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.824 -0.35 . . . . 70.109999999999999 111.539 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.643 0.735 . . . . 73.099999999999994 110.782 -179.68 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.474 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 t . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 114.068 1.136 . . . . 52.119999999999997 114.068 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.52 149.04 41.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.461 -1.245 . . . . 63.43 109.482 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.405 HD13 ' OG1' ' A' ' 51' ' ' THR . 3.9 mp -84.02 100.58 7.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.435 -0.95 . . . . 63.25 108.435 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.452 ' CG2' ' HD3' ' A' ' 161' ' ' LYS . 26.0 mm -70.9 -57.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.497 -0.774 . . . . 74.409999999999997 110.875 -174.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.793 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -136.24 126.65 26.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.358 0.599 . . . . 54.210000000000001 111.067 176.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -126.7 120.9 30.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.344 -0.844 . . . . 64.439999999999998 110.169 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -139.22 135.99 17.71 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.088 -0.506 . . . . 74.019999999999996 110.288 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.851 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 64.7 Cg_endo -75.83 131.93 13.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.503 2.136 . . . . 72.530000000000001 111.729 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.451 -0.341 . . . . 73.120000000000005 110.622 -177.498 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 134' ' ' GLN . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 109.7 -0.481 . . . . 72.530000000000001 109.7 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 139.56 151.76 5.74 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.86 -0.686 . . . . 72.230000000000004 112.089 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.22 -166.54 42.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.618 -0.801 . . . . 71.140000000000001 111.814 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.854 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.83 168.1 19.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.881 0.372 . . . . 62.520000000000003 110.216 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.38 98.49 46.66 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.111 0.482 . . . . 74.150000000000006 110.457 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.654 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 72.8 Cg_endo -78.84 -9.55 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.736 2.291 . . . . 60.020000000000003 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.08 -34.58 61.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.049 -0.978 . . . . 72.439999999999998 111.355 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 191' ' ' ILE . 10.5 pt -74.04 -19.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.106 -0.497 . . . . 64.329999999999998 111.273 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.8 m170 72.45 32.18 1.65 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.455 -0.793 . . . . 62.25 111.62 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.72 147.02 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.887 -0.597 . . . . 64.109999999999999 109.679 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.94 131.18 41.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.614 0.598 . . . . 52.310000000000002 112.614 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.66 157.52 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.933 -1.136 . . . . 74.150000000000006 107.933 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -121.18 150.01 52.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.766 -0.373 . . . . 72.329999999999998 111.404 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.854 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.7 Cg_endo -69.41 -76.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.597 2.198 . . . . 72.109999999999999 111.639 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.7 pt? -114.3 19.45 16.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 70.200000000000003 110.263 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 72.83 0.72 3.76 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.679 0.992 . . . . 74.129999999999995 113.679 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -61.41 -28.95 69.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.936 0.335 . . . . 71.129999999999995 111.402 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.85 -4.36 85.43 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.726 -0.75 . . . . 73.340000000000003 112.994 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -79.44 -35.29 40.69 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.902 0.382 . . . . 72.549999999999997 109.972 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-N 114.573 -1.194 . . . . 74.120000000000005 110.906 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HG3' ' HB3' ' A' ' 164' ' ' PRO . 32.4 Cg_endo . . . . . 0 C--O 1.233 0.24 0 CA-C-O 120.827 0.261 . . . . 70.239999999999995 112.536 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.12 -20.31 19.23 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 55.140000000000001 112.557 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.457 HD21 HG12 ' A' ' 24' ' ' VAL . 26.9 t-20 -139.12 146.13 40.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 74.420000000000002 109.578 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.8 m -139.9 163.53 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 74.140000000000001 111.716 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 165' ' ' SER . 34.9 m-85 -104.93 124.65 49.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.555 -0.748 . . . . 73.230000000000004 110.785 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.89 95.99 5.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.668 -0.493 . . . . 65.319999999999993 109.668 170.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -90.1 112.39 23.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.225 -0.657 . . . . 55.130000000000003 109.225 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -97.46 -179.72 4.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.011 0.434 . . . . 71.129999999999995 111.083 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -67.65 -29.74 69.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.775 -0.648 . . . . 62.399999999999999 110.545 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.662 ' SD ' HG22 ' A' ' 142' ' ' VAL . 93.9 mtp -88.12 -34.69 17.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.591 . . . . 71.120000000000005 111.358 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -173.82 -133.28 1.66 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.689 -0.767 . . . . 71.219999999999999 111.915 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.0 tt -140.75 137.43 35.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.116 0.484 . . . . 73.25 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 126.78 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.826 -0.625 . . . . 63.130000000000003 109.821 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 13.3 t -105.91 142.04 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 64.340000000000003 109.723 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.65 164.08 36.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 73.310000000000002 110.933 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 10.2 pt-20 -130.95 165.21 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.568 -0.742 . . . . 73.340000000000003 109.765 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.01 157.74 16.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 109.923 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -79.82 103.44 9.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 72.420000000000002 111.969 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -81.81 0.84 37.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 75.319999999999993 110.891 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -70.31 -66.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.033 -0.531 . . . . 72.430000000000007 111.274 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.421 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 t-160 -126.51 9.91 7.21 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.729 -0.388 . . . . 73.299999999999997 111.034 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.73 65.38 72.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 121.078 -0.249 . . . . 22.510000000000002 111.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 31' ' ' HIS . 13.2 Cg_exo -69.85 -45.56 1.5 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.647 2.231 . . . . 74.230000000000004 112.196 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.39 -35.1 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 109.972 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -65.52 -46.19 80.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.199 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -55.08 -48.93 72.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.952 -0.567 . . . . 74.430000000000007 110.496 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -36.0 78.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.806 -0.634 . . . . 70.5 110.935 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.35 -40.17 85.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 73.049999999999997 110.228 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.81 -47.56 58.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 74.420000000000002 109.792 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.51 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 63.310000000000002 111.78 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 51.2 mm-40 -60.35 -38.89 85.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 55.409999999999997 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 42' ' ' LEU . 30.7 mt -68.56 -30.46 69.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.889 0.376 . . . . 73.219999999999999 110.882 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.76 64.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 71.400000000000006 111.212 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -74.24 -29.1 61.54 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.775 -0.37 . . . . 75.530000000000001 111.244 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.4 -46.11 42.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.17 42.62 1.61 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.675 -0.774 . . . . 72.530000000000001 111.781 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -76.04 -27.91 57.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.249 0.547 . . . . 74.340000000000003 110.422 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.554 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.4 m-85 -78.2 -3.27 41.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.022 -0.535 . . . . 72.299999999999997 111.043 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -73.78 -0.64 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.098 0.475 . . . . 61.009999999999998 110.539 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.88 7.55 5.79 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.95 -0.568 . . . . 54.32 112.131 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 65' ' ' GLY . 35.3 p -88.02 149.45 23.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.353 . . . . 63.420000000000002 111.247 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 11.7 ptpt -139.39 157.41 45.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.197 -0.456 . . . . 64.010000000000005 110.59 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 80.9 m-85 -86.13 131.09 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.356 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -109.93 -38.91 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 72.140000000000001 110.992 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 26.4 mmm180 -115.37 117.37 30.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.076 -0.342 . . . . 70.310000000000002 110.076 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -131.23 94.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.94 -0.763 . . . . 72.239999999999995 108.94 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 36.9 mt -105.23 128.34 59.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.841 -0.618 . . . . 72.420000000000002 109.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.42 128.72 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.075 0.464 . . . . 73.540000000000006 111.13 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 54.12 35.43 22.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.848 -1.069 . . . . 64.019999999999996 111.512 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.786 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 4.2 t80 -132.44 -82.39 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.989 0.424 . . . . 73.310000000000002 110.279 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.478 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 22.7 ptp -159.74 158.63 31.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 110.573 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 116' ' ' LEU . 35.1 mt -130.22 100.28 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.622 -0.717 . . . . 70.299999999999997 109.419 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 50.1 tt0 -85.57 127.71 34.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.333 -0.394 . . . . 73.120000000000005 110.494 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -139.18 149.58 20.77 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.616 -0.802 . . . . 65.140000000000001 112.335 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 51' ' ' THR . . . 151.14 -71.76 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.926 -1.13 . . . . 61.509999999999998 113.524 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 32.0 t0 -42.86 105.91 0.45 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.899 0.703 . . . . 74.209999999999994 112.899 -168.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 97.6 Cg_endo -86.2 -18.52 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.315 2.676 . . . . 74.439999999999998 111.54 176.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 70' ' ' THR . 77.6 p -89.62 -32.7 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.309 -0.86 . . . . 74.340000000000003 111.371 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 31.64 59.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.832 -0.907 . . . . 74.329999999999998 110.832 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 64.3 p -102.88 -30.55 10.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 71.209999999999994 111.056 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.34 -3.31 23.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.299 -0.864 . . . . 63.210000000000001 112.085 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -119.12 -31.34 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.647 0.26 . . . . 61.420000000000002 111.277 178.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 95.39 -169.65 27.81 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.809 -0.71 . . . . 74.129999999999995 112.797 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.88 -105.52 2.29 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.26 -0.495 . . . . 32.420000000000002 112.246 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 44.77 48.96 8.98 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 65.109999999999999 112.645 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.44 12.71 2.83 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.021 -0.536 . . . . 54.219999999999999 110.919 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.6 -20.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.737 0.303 . . . . 53.420000000000002 110.611 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 16.0 p90 -101.2 -2.01 32.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.143 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.42 1.4 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 55.420000000000002 113.125 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.32 -168.05 1.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.841 0.353 . . . . 75.140000000000001 111.251 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.2 173.87 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 73.530000000000001 111.886 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 89.7 m-85 -139.67 -162.02 1.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.897 -1.047 . . . . 75.230000000000004 108.965 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.82 159.29 34.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.606 -0.516 . . . . 61.509999999999998 109.606 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -61.35 136.28 57.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.609 -0.515 . . . . 72.010000000000005 109.609 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.07 16.53 25.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 73.129999999999995 110.714 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.4 mt -71.8 96.81 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.147 0.499 . . . . 74.310000000000002 111.958 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.48 78.48 6.96 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.715 -0.675 . . . . 62.109999999999999 111.031 173.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 89.33 0.55 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.593 2.195 . . . . 74.019999999999996 112.428 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.22 10.76 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 71.299999999999997 110.544 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -122.98 -175.72 3.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.232 -0.895 . . . . 70.239999999999995 109.846 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -124.77 144.26 50.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.627 0.251 . . . . 53.530000000000001 110.827 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 68.34 0.63 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.637 0.732 . . . . 75.439999999999998 109.888 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.1 p -65.53 -39.39 91.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.159 -0.928 . . . . 74.319999999999993 112.066 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.609 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -170.42 -137.03 2.19 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.372 -0.918 . . . . 44.43 112.538 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.71 140.61 30.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.617 0.246 . . . . 60.520000000000003 110.741 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.25 24.32 5.73 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.774 -0.727 . . . . 61.109999999999999 111.775 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.434 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.8 mm -88.39 109.79 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.441 -0.577 . . . . 71.349999999999994 109.441 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.48 119.69 26.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.562 -0.532 . . . . 71.420000000000002 109.562 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.7 174.24 10.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 74.510000000000005 111.478 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.828 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 28.2 ttt -106.93 142.32 36.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.729 -0.669 . . . . 65.319999999999993 109.907 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -103.79 118.16 36.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.527 0.68 . . . . 70.120000000000005 111.095 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.667 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.8 p-10 -115.47 165.74 12.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.998 -1.001 . . . . 71.310000000000002 109.964 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.5 -37.38 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.862 0.839 . . . . 64.120000000000005 109.19 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -138.83 174.49 22.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 108.644 -1.782 . . . . 61.420000000000002 108.644 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.57 -49.61 11.73 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.073 2.515 . . . . 73.010000000000005 112.811 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.57 -11.1 19.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.521 -0.308 . . . . 72.530000000000001 111.275 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 3.1 m -86.14 55.46 3.55 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.667 -0.864 . . . . 54.32 108.667 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.667 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 18.7 m120 -62.15 117.22 5.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.356 -1.293 . . . . 72.430000000000007 109.505 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' A' ' 102' ' ' ASN . . . -90.95 -168.16 41.82 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 63.0 112.672 -172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -99.46 20.27 14.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.42 0.628 . . . . 62.039999999999999 110.094 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 17.4 mt-30 -109.89 159.04 17.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.478 -0.783 . . . . 63.310000000000002 110.77 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -139.89 174.17 10.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.665 . . . . 74.0 109.203 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.2 p90 -160.08 154.69 24.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 54.329999999999998 111.692 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.22 145.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.274 -0.876 . . . . 74.209999999999994 109.23 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 p -100.94 131.1 46.97 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.062 0.458 . . . . 43.210000000000001 110.459 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 62' ' ' ILE . 59.8 mt -89.2 -5.39 57.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 62.329999999999998 110.994 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.39 164.22 21.9 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.849 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.609 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 38.9 Cg_exo -61.06 107.04 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.464 2.109 . . . . 61.210000000000001 111.887 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 23.4 p -96.37 96.89 9.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.81 -0.632 . . . . 63.219999999999999 111.02 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 120' ' ' GLN . 1.0 OUTLIER -100.02 9.9 42.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.57 0.7 . . . . 75.430000000000007 110.471 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.451 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -108.57 -12.42 14.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.77 -1.105 . . . . 74.420000000000002 111.591 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 3.3 pp -114.91 9.8 16.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 75.030000000000001 111.342 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.85 -34.37 65.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.465 -0.789 . . . . 62.149999999999999 110.885 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.39 15.36 30.03 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.524 -0.762 . . . . 73.310000000000002 112.033 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.59 -35.93 5.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.075 0.464 . . . . 72.319999999999993 110.078 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -140.82 139.4 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.796 -0.638 . . . . 73.400000000000006 109.671 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -77.68 148.71 34.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.156 0.503 . . . . 55.219999999999999 110.446 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 99' ' ' ALA . 45.1 mt -126.88 122.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.59 . . . . 75.430000000000007 110.555 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.828 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.4 p90 -153.93 72.94 0.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.685 0.755 . . . . 71.340000000000003 111.212 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.08 152.24 22.27 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.557 -1.306 . . . . 73.420000000000002 113.676 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.42 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 74.0 mtp180 -130.14 117.22 19.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.218 -0.66 . . . . 55.200000000000003 109.218 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.44 135.34 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.051 0.453 . . . . 64.0 110.385 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.64 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 51.3 t -143.65 145.01 32.14 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.26 -0.427 . . . . 73.530000000000001 110.096 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.692 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.7 tt0 50.92 40.69 25.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.354 0.597 . . . . 73.219999999999999 111.85 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -170.62 24.82 0.1 OUTLIER Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.143 -1.027 . . . . 62.039999999999999 112.152 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.5 tp -78.61 -32.32 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.088 -0.245 . . . . 75.230000000000004 110.478 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 141' ' ' ARG . . . -62.23 -37.35 94.4 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.155 -0.778 . . . . 72.420000000000002 111.155 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.58 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 72.1 mmm -68.09 -55.64 11.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.145 -0.317 . . . . 74.409999999999997 110.145 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 90.1 t -51.57 -31.25 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.218 0.532 . . . . 64.409999999999997 110.644 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.552 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.6 t30 -70.11 -56.79 5.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.713 -0.676 . . . . 72.310000000000002 110.538 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.532 ' HD2' ' HE3' ' A' ' 138' ' ' MET . 0.1 OUTLIER -72.62 -15.64 61.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.767 0.318 . . . . 71.140000000000001 111.261 -177.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG22 ' SD ' ' A' ' 20' ' ' MET . 75.3 t -79.73 -43.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.369 -0.604 . . . . 54.32 109.369 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -76.48 -25.86 64.64 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.417 -0.897 . . . . 63.43 112.549 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.552 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 77.7 mtp -73.53 -11.27 60.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.76 0.282 . . . . 65.400000000000006 111.76 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.561 0.696 . . . . 75.349999999999994 111.243 178.21 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.78 0.8 . . . . 72.519999999999996 111.697 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.67 172.97 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.165 -0.925 . . . . 65.219999999999999 109.276 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -89.52 105.01 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.728 -0.841 . . . . 75.049999999999997 108.728 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 22.7 mm -73.92 -48.22 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.364 -0.835 . . . . 55.43 110.989 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -131.86 126.08 33.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.944 -0.571 . . . . 62.530000000000001 110.828 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.16 122.82 30.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.0 0.429 . . . . 70.200000000000003 110.566 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -155.91 150.87 20.75 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.842 -0.617 . . . . 75.420000000000002 110.268 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 14' ' ' VAL . 54.7 Cg_endo -70.86 134.25 25.26 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.638 2.226 . . . . 74.530000000000001 112.887 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.53 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.6 p . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 61.310000000000002 109.934 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.6 m-20 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.275 0.559 . . . . 71.129999999999995 110.443 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.54 146.93 4.47 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.228 -0.896 . . . . 71.319999999999993 111.306 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -84.59 -166.61 41.55 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.373 -0.918 . . . . 51.43 111.929 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.641 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -74.9 170.86 15.1 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.741 0.305 . . . . 64.140000000000001 110.271 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.411 ' HD1' HH21 ' A' ' 131' ' ' ARG . 91.8 m-85 -111.14 93.17 17.21 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-O 121.153 0.501 . . . . 71.310000000000002 110.449 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 6.0 Cg_exo -76.36 -13.56 18.62 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.888 2.392 . . . . 73.129999999999995 111.715 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.24 -34.79 42.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.902 -1.045 . . . . 74.319999999999993 111.072 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 193' ' ' VAL . 31.3 pt -80.31 -11.7 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 71.239999999999995 111.428 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.04 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.416 -0.811 . . . . 72.019999999999996 111.321 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 191' ' ' ILE . 6.4 p -164.21 152.95 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.059 -0.349 . . . . 62.310000000000002 110.059 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.14 113.97 14.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.911 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -161.94 157.32 23.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 70.219999999999999 109.625 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -124.02 156.35 66.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.503 -0.317 . . . . 72.150000000000006 110.726 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 49.0 Cg_endo -69.34 -69.7 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.478 2.119 . . . . 50.409999999999997 112.272 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.6 pt? -120.25 23.57 10.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 72.400000000000006 109.95 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 68.56 13.92 9.0 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.226 -0.897 . . . . 72.340000000000003 111.846 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.6 ptm -52.24 -46.04 65.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 70.230000000000004 112.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 -2.15 90.11 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.745 -0.74 . . . . 72.109999999999999 113.141 -175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -80.02 -26.5 39.77 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.374 0.607 . . . . 60.409999999999997 110.206 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.632 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-N 114.9 -1.045 . . . . 72.439999999999998 109.927 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 164' ' ' PRO . 4.7 Cg_endo . . . . . 0 CA--C 1.529 0.24 0 N-CA-C 113.146 0.402 . . . . 73.019999999999996 113.146 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.1 Cg_exo -78.82 -31.51 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.894 2.396 . . . . 74.420000000000002 111.304 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -143.23 139.84 30.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.144 -0.935 . . . . 63.340000000000003 109.329 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG21 ' HE1' ' A' ' 39' ' ' PHE . 24.6 m -135.89 165.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.539 -0.3 . . . . 53.439999999999998 110.617 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD11 ' A' ' 22' ' ' ILE . 38.5 p90 -124.13 134.11 53.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.167 0.508 . . . . 73.219999999999999 110.61 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.16 111.12 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 72.230000000000004 110.451 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 7.1 tp10 -85.67 112.09 20.69 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.383 -0.969 . . . . 71.030000000000001 108.383 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -105.0 -179.8 4.05 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.066 0.46 . . . . 55.340000000000003 111.263 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -1.48 42.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 62.32 111.035 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.608 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.0 mmt -108.32 -44.89 4.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 73.439999999999998 109.95 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.6 -140.9 3.19 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.592 -1.003 . . . . 60.310000000000002 110.592 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -133.08 131.47 58.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.529 -0.545 . . . . 74.230000000000004 109.529 -178.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.478 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -125.96 128.37 71.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.759 -0.655 . . . . 63.32 110.947 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 85.1 t -111.52 143.71 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.82 -0.437 . . . . 74.519999999999996 109.82 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.12 161.24 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.215 0.531 . . . . 73.25 110.852 176.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -125.72 168.81 13.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.366 -0.834 . . . . 72.219999999999999 109.823 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 ' CG ' ' A' ' 39' ' ' PHE . 1.1 mm? -108.54 163.05 13.57 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.198 -0.667 . . . . 64.409999999999997 109.198 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 2.9 m-85 -83.35 89.82 7.07 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.253 -0.579 . . . . 74.400000000000006 111.993 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -7.19 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.453 -1.314 . . . . 62.420000000000002 107.453 170.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -66.79 -43.06 84.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.426 -1.715 . . . . 53.329999999999998 110.746 -176.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -140.06 -1.61 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 75.439999999999998 111.584 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.6 88.97 18.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.742 -0.383 . . . . 21.100000000000001 111.435 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.23 -6.11 17.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.895 2.396 . . . . 75.010000000000005 112.626 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 15.4 mtpt -100.1 -53.8 3.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.399 -0.364 . . . . 74.109999999999999 111.101 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.416 HG23 ' SD ' ' A' ' 100' ' ' MET . 8.8 m -53.93 -35.86 62.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 70.310000000000002 111.977 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.629 ' SG ' ' HE2' ' A' ' 37' ' ' LYS . 6.1 p -66.89 -28.43 68.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 70.120000000000005 111.517 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HE2' ' SG ' ' A' ' 36' ' ' CYS . 36.8 mmtt -79.93 -34.83 38.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.347 -0.388 . . . . 73.129999999999995 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -57.04 -53.2 60.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.557 -0.747 . . . . 73.430000000000007 110.531 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HE1' HG21 ' A' ' 14' ' ' VAL . 23.4 t80 -61.55 -50.68 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 64.239999999999995 109.838 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -42.19 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.961 -1.018 . . . . 72.230000000000004 111.49 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.07 -48.92 70.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 61.43 110.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD12 ' CB ' ' A' ' 47' ' ' TYR . 2.6 mm? -74.78 -29.12 61.02 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.582 -0.447 . . . . 72.340000000000003 111.695 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.1 65.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.691 -0.231 . . . . 63.229999999999997 111.521 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.14 -21.54 53.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 65.099999999999994 110.423 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' C ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.65 -45.69 24.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.018 -0.734 . . . . 64.219999999999999 109.018 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.09 2.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.697 -0.763 . . . . 44.25 111.62 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -71.15 -30.77 66.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.139 0.495 . . . . 72.219999999999999 110.265 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -78.18 -7.72 57.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.598 -0.728 . . . . 70.329999999999998 111.502 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.78 -8.1 53.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 72.319999999999993 111.168 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.49 31.69 2.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.71 . . . . 72.349999999999994 112.252 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.715 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 20.3 p -107.46 150.63 26.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.041 0.448 . . . . 73.439999999999998 111.863 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 1.4 mmtp -120.17 169.93 9.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 63.100000000000001 109.169 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -88.08 118.49 27.68 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 63.210000000000001 109.329 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -93.31 -28.77 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 110.413 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 41.1 mmt180 -137.67 109.74 7.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 44.439999999999998 110.134 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 56' ' ' ILE . 4.1 mp -115.07 79.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.395 -0.595 . . . . 71.299999999999997 109.395 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.09 134.47 27.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.051 -0.522 . . . . 73.329999999999998 109.639 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 2.4 mptp? -74.62 128.76 36.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.443 -0.344 . . . . 72.219999999999999 110.388 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.8 32.28 21.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.005 0.815 . . . . 54.409999999999997 110.923 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.86 -83.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 74.200000000000003 111.144 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptm -160.63 155.15 23.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.822 -0.626 . . . . 64.219999999999999 110.718 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.508 HD12 HG13 ' A' ' 139' ' ' VAL . 36.1 mt -130.58 103.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.629 -0.714 . . . . 73.200000000000003 109.723 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.433 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.8 tt0 -80.14 126.6 31.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.9 -0.591 . . . . 72.219999999999999 110.447 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.28 129.38 7.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.836 -0.697 . . . . 70.310000000000002 111.646 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.715 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 134.81 -148.12 19.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.458 -0.877 . . . . 72.239999999999995 112.859 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.8 t0 53.21 81.75 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 123.892 0.877 . . . . 75.299999999999997 111.534 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD3' ' CE1' ' A' ' 47' ' ' TYR . 54.7 Cg_endo -72.32 -24.02 20.05 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.792 2.328 . . . . 42.109999999999999 111.159 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 5.6 p -81.9 -46.32 14.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.256 -0.884 . . . . 71.239999999999995 111.751 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.32 26.55 10.0 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.578 -0.82 . . . . 74.239999999999995 111.412 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 72' ' ' ARG . 6.6 t -128.81 -19.31 3.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.775 0.321 . . . . 73.019999999999996 111.121 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.88 -18.57 55.69 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.524 -0.846 . . . . 64.230000000000004 113.313 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -110.9 5.22 20.33 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.429 -0.453 . . . . 73.540000000000006 111.152 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -86.85 176.85 47.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 64.230000000000004 112.647 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 85.18 -45.26 3.48 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.034 -0.603 . . . . 62.439999999999998 112.533 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . -76.32 25.25 0.13 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.834 0.454 . . . . 60.299999999999997 111.702 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 74' ' ' GLY . 7.4 m -59.5 -24.35 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 62.530000000000001 111.06 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.591 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.4 tt -56.22 -48.36 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.717 -0.674 . . . . 74.219999999999999 111.284 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG23 ' A' ' 77' ' ' ILE . 30.2 p90 -108.97 -6.09 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.657 0.265 . . . . 62.450000000000003 111.593 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.58 -95.95 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.622 -0.799 . . . . 63.030000000000001 113.524 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -112.06 -174.33 2.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.744 0.783 . . . . 72.299999999999997 112.16 -173.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.551 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 4.5 pm0 -85.91 175.18 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.388 -1.278 . . . . 74.129999999999995 108.751 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -132.98 -60.47 0.86 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.293 -0.563 . . . . 72.299999999999997 111.717 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.72 177.87 8.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.437 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -103.95 149.49 25.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.789 -0.449 . . . . 72.450000000000003 109.789 174.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -121.79 23.87 9.93 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' A' ' 127' ' ' THR . 55.8 mt -59.53 102.86 0.16 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.425 -0.807 . . . . 73.129999999999995 111.062 -174.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -161.84 82.09 1.84 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.923 0.392 . . . . 60.539999999999999 110.377 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.78 81.25 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.44 2.093 . . . . 72.540000000000006 111.296 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.76 -4.41 59.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.054 0.93 . . . . 64.510000000000005 109.403 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -94.72 -153.29 0.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.37 -1.286 . . . . 72.530000000000001 108.611 173.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -152.43 142.04 21.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.588 -0.445 . . . . 74.420000000000002 110.946 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 34.8 p90 -59.83 123.63 17.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.529 -0.76 . . . . 74.129999999999995 109.398 170.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.0 p -116.2 -40.13 3.31 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.253 -0.43 . . . . 63.340000000000003 110.995 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.36 -143.54 3.73 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.034 -0.603 . . . . 64.329999999999998 112.274 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 151.3 19.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.686 0.279 . . . . 62.420000000000002 110.626 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 103.35 23.73 8.28 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.52 -0.848 . . . . 51.350000000000001 111.319 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.1 mm -89.04 111.36 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.643 -0.502 . . . . 73.519999999999996 109.643 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -86.72 120.16 27.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 109.719 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 128' ' ' ILE . . . -134.42 172.86 12.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.151 -0.477 . . . . 73.5 111.319 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.57 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 64.7 mtp -90.52 141.78 28.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 72.150000000000006 110.411 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.22 156.66 18.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.136 -0.484 . . . . 64.209999999999994 109.754 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.7 p-10 -159.75 163.25 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.386 -0.37 . . . . 74.310000000000002 110.712 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.1 -38.7 15.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.68 . . . . 72.400000000000006 110.303 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.16 -80.67 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.522 -0.847 . . . . 32.0 112.65 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.13 85.3 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.976 2.451 . . . . 61.399999999999999 112.934 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 52.32 33.08 12.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.392 -0.822 . . . . 71.519999999999996 112.136 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -76.26 39.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.212 0.449 . . . . 75.109999999999999 112.212 -174.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 84' ' ' ASP . 10.2 m120 -84.66 139.58 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.377 -0.601 . . . . 73.140000000000001 109.377 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.15 -68.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.85 -1.167 . . . . 40.340000000000003 113.533 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 33.8 t -109.13 -24.24 11.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.573 0.582 . . . . 70.120000000000005 112.573 -169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -91.37 137.47 32.34 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.487 -0.485 . . . . 54.32 110.051 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 87.9 m-85 -141.12 167.5 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.653 0.263 . . . . 72.219999999999999 110.679 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 34.1 p90 -159.4 158.27 31.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.753 0.311 . . . . 72.450000000000003 110.719 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -112.14 146.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 61.439999999999998 109.686 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -98.55 131.84 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 70.430000000000007 110.232 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.9 mt -85.76 -7.71 58.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 111.024 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.96 158.41 33.89 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.797 -0.638 . . . . 61.140000000000001 110.106 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.684 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 56.2 Cg_endo -71.76 123.91 9.77 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.362 2.042 . . . . 72.5 112.04 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.4 HG21 HD21 ' A' ' 122' ' ' LEU . 41.0 p -108.81 158.57 17.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 110.937 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 21.67 2.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.105 0.479 . . . . 62.530000000000001 111.005 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.32 -3.98 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.064 -0.516 . . . . 75.040000000000006 112.113 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 4.3 pp -130.4 3.94 4.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.497 -0.481 . . . . 74.230000000000004 111.617 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.64 -28.36 69.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 73.219999999999999 110.493 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.28 13.07 55.18 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.29 -0.724 . . . . 62.100000000000001 111.29 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 25.1 mmmt -116.22 -22.94 8.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.119 -0.697 . . . . 71.219999999999999 109.119 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 100' ' ' MET . 85.4 m-70 -134.67 134.68 41.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.37 -0.832 . . . . 70.340000000000003 110.042 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 86' ' ' LEU . 18.9 m -72.81 121.4 19.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.06 -0.348 . . . . 72.450000000000003 110.06 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 99' ' ' ALA . 45.1 mt -108.71 114.65 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.92 -0.312 . . . . 64.319999999999993 111.768 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.5 m-85 -156.59 76.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 72.439999999999998 110.399 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.86 157.11 29.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.582 -0.818 . . . . 72.340000000000003 112.871 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.67 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 55.9 mtm180 -134.98 125.89 27.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.976 -0.379 . . . . 72.310000000000002 109.976 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.1 p -80.49 139.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.037 0.446 . . . . 64.420000000000002 110.41 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 41.3 t -139.24 143.58 38.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.551 -174.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.6 pt20 41.21 40.14 1.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.246 1.018 . . . . 73.540000000000006 113.239 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.47 41.41 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 44.310000000000002 111.901 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.2 tp -88.82 -36.35 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.672 0.272 . . . . 73.230000000000004 110.636 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -36.36 92.05 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.903 -0.665 . . . . 51.109999999999999 111.681 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.0 mmm -67.83 -51.66 45.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.26 -0.274 . . . . 64.420000000000002 110.26 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 62' ' ' ILE . 91.9 t -54.31 -32.66 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.131 0.491 . . . . 53.43 110.668 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -70.39 -51.87 26.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 74.019999999999996 110.45 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -76.81 -10.14 59.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.966 -0.561 . . . . 74.450000000000003 111.355 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.8 t -87.11 -38.9 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.277 0.561 . . . . 72.450000000000003 109.792 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.467 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.31 -33.96 38.08 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.574 -0.822 . . . . 50.030000000000001 112.87 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 22.1 ptm -78.93 -18.91 53.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.08 0.4 . . . . 72.540000000000006 112.08 -173.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.234 0.239 0 C-N-CA 119.962 -0.695 . . . . 61.299999999999997 110.095 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 158' ' ' LYS . 3.6 t . . . . . 0 CA--C 1.518 -0.274 0 CA-C-O 121.847 0.832 . . . . 65.239999999999995 112.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 158' ' ' LYS . 2.0 mppt? -139.65 170.95 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.691 -1.14 . . . . 64.420000000000002 109.301 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.7 mp -90.52 106.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.734 -0.839 . . . . 64.040000000000006 108.734 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.552 HG22 ' HD2' ' A' ' 161' ' ' LYS . 26.0 mm -73.62 -52.3 21.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 110.251 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HD2' HG22 ' A' ' 160' ' ' ILE . 4.9 mptp? -130.73 143.42 50.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.542 -0.754 . . . . 71.319999999999993 109.298 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.94 127.22 13.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.944 -0.391 . . . . 63.32 109.944 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 95.3 m-85 -148.23 155.23 43.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.569 -0.53 . . . . 74.010000000000005 109.569 -174.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 7.8 Cg_endo -85.07 131.62 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.431 2.087 . . . . 73.109999999999999 112.117 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 116.047 -0.524 . . . . 73.430000000000007 110.688 -179.098 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.504 0.669 . . . . 73.310000000000002 111.172 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.525 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 152.3 137.6 2.6 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 114.742 -1.117 . . . . 23.239999999999998 110.922 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.66 -160.89 14.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.395 -0.907 . . . . 74.010000000000005 112.564 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.833 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.2 172.5 12.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.667 0.27 . . . . 53.030000000000001 110.395 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.2 98.48 22.7 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.868 -0.419 . . . . 75.530000000000001 109.868 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 1.4 Cg_endo -82.54 -8.52 11.46 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.766 2.31 . . . . 61.420000000000002 111.773 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.83 -26.76 36.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.974 -0.557 . . . . 73.420000000000002 110.301 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.3 pt -94.23 152.12 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.181 -1.044 . . . . 63.210000000000001 108.181 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -102.88 64.2 0.85 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.215 -0.594 . . . . 64.239999999999995 111.091 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.61 135.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.478 . . . . 74.340000000000003 110.477 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.61 110.33 3.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 75.540000000000006 111.027 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.37 149.25 29.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.911 -0.774 . . . . 70.140000000000001 108.911 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 70.6 m-85 -119.03 144.59 36.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.91 0.337 . . . . 60.329999999999998 111.91 -170.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.833 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.6 Cg_endo -64.35 -59.6 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.728 2.285 . . . . 64.129999999999995 112.093 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.0 OUTLIER -143.79 37.51 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.462 -0.335 . . . . 64.019999999999996 111.402 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.3 m-20 74.37 -14.61 0.69 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.817 0.673 . . . . 64.120000000000005 112.817 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptm -49.18 -33.35 12.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.291 0.849 . . . . 72.239999999999995 113.291 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.73 -1.56 63.58 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.371 -0.918 . . . . 75.209999999999994 113.315 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 36.4 ptt180 -120.32 -6.77 9.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.214 0.507 . . . . 71.120000000000005 110.95 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.247 0.929 0 CA-C-N 114.89 -1.05 . . . . 74.340000000000003 110.519 178.686 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 CA--C 1.529 0.255 0 N-CA-C 112.984 0.34 . . . . 74.329999999999998 112.984 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 -22.42 7.36 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.916 2.411 . . . . 71.030000000000001 112.521 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 24.8 t-20 -142.32 147.48 36.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.996 -0.742 . . . . 74.319999999999993 108.996 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.4 m -137.67 152.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.215 0.531 . . . . 72.549999999999997 111.782 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.73 122.53 42.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.155 -0.93 . . . . 72.420000000000002 110.566 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 mt -114.98 98.02 6.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.774 0.321 . . . . 73.209999999999994 110.41 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.35 124.98 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.021 -0.733 . . . . 70.540000000000006 109.021 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 159' ' ' ILE . 74.8 p -111.84 178.74 4.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.173 0.511 . . . . 50.43 111.274 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -76.4 -6.19 50.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 111.027 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.9 mmt -102.52 -43.38 5.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.926 -0.579 . . . . 25.510000000000002 109.867 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.56 -130.75 1.27 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.494 -0.642 . . . . 73.420000000000002 111.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 23' ' ' ILE . 19.4 tt -132.7 137.99 52.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.029 0.443 . . . . 74.420000000000002 110.0 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.493 HD12 HG23 ' A' ' 139' ' ' VAL . 20.1 mm -129.13 117.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.174 -0.676 . . . . 74.420000000000002 109.174 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.9 m -113.56 147.04 17.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 119.147 -1.021 . . . . 73.109999999999999 110.152 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.34 163.94 36.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.941 -0.572 . . . . 74.439999999999998 110.611 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.7 pt-20 -129.65 166.73 19.19 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.043 -0.98 . . . . 75.420000000000002 109.662 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -104.16 163.89 12.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.623 -0.51 . . . . 73.519999999999996 109.623 179.226 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 4.5 m-85 -82.58 98.95 9.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.177 0.513 . . . . 64.109999999999999 111.385 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.92 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -83.47 -0.56 50.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.551 -0.75 . . . . 65.140000000000001 110.014 -179.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -79.38 -53.88 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 75.319999999999993 111.466 -176.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.0 15.43 4.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.925 0.342 . . . . 74.239999999999995 111.925 -175.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.66 67.15 77.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.896 0.379 . . . . 71.040000000000006 110.108 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 16.8 Cg_exo -66.98 -43.98 5.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.798 2.332 . . . . 60.43 112.401 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -76.03 -45.42 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 75.040000000000006 110.034 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.5 m -63.02 -32.84 74.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 64.400000000000006 111.221 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.92 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 33.4 t -59.74 -43.09 94.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.593 -0.276 . . . . 52.32 110.758 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 45.6 mmtt -70.04 -32.44 70.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.974 -0.38 . . . . 73.219999999999999 109.974 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.61 -58.47 7.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 75.230000000000004 109.746 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD2' HD11 ' A' ' 27' ' ' LEU . 1.8 t80 -67.45 -37.05 82.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.75 . . . . 64.219999999999999 110.349 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.65 -43.06 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 70.219999999999999 111.457 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.689 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 10.5 tp10 -61.53 -42.94 99.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.932 0.396 . . . . 72.120000000000005 111.29 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.597 ' HG ' ' HB2' ' A' ' 110' ' ' SER . 4.3 mm? -66.37 -24.14 66.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 54.399999999999999 110.54 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.472 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -80.85 -31.07 35.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.099 -0.5 . . . . 73.219999999999999 110.129 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 38.6 mtp85 -61.95 -46.24 90.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.205 -0.907 . . . . 72.230000000000004 110.841 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -74.73 -49.35 21.4 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.831 -0.347 . . . . 75.340000000000003 110.83 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.65 49.76 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 61.130000000000003 111.941 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.62 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 23.6 t80 -70.99 -29.93 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.116 0.484 . . . . 73.450000000000003 111.235 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 32.2 m-85 -81.15 -5.88 58.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.642 . . . . 74.25 112.121 -169.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -75.57 -6.1 48.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 71.219999999999999 110.547 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.22 14.66 6.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 54.520000000000003 111.829 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 45.2 p -93.17 143.22 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.477 . . . . 71.510000000000005 111.015 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -140.2 147.09 39.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.794 -0.639 . . . . 72.200000000000003 110.054 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 63.9 m-85 -80.97 124.4 29.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.533 -0.543 . . . . 73.239999999999995 109.533 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -118.57 -19.83 8.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.563 -0.289 . . . . 64.319999999999993 111.366 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 34.5 mmt180 -122.82 105.5 10.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.805 -0.443 . . . . 74.450000000000003 109.805 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.401 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -122.02 81.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.297 0.57 . . . . 73.150000000000006 110.033 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.831 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 17.5 mt -89.91 132.82 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.226 -0.657 . . . . 74.219999999999999 109.226 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 2.3 mptp? -70.88 133.41 46.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.413 . . . . 72.430000000000007 110.008 -173.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 42.33 42.47 2.61 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.459 1.1 . . . . 63.530000000000001 111.716 -172.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.831 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.0 t80 -131.52 -84.34 0.51 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.628 -0.715 . . . . 72.340000000000003 109.705 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.674 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptt? -161.19 157.16 25.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.328 -0.851 . . . . 74.310000000000002 110.165 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 116' ' ' LEU . 44.6 mt -124.5 100.07 7.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.727 -0.67 . . . . 54.509999999999998 109.469 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 46.5 mt-30 -84.83 119.81 25.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.656 -0.702 . . . . 73.420000000000002 110.866 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -138.48 140.56 11.18 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.715 -0.675 . . . . 54.509999999999998 111.775 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 164.04 -91.81 0.11 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.409 -1.376 . . . . 64.409999999999997 114.081 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -28.44 104.58 0.19 Allowed Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.003 1.112 . . . . 74.450000000000003 114.003 -163.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 91.1 Cg_endo -81.96 -12.5 10.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.852 3.035 . . . . 72.329999999999998 112.47 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 70' ' ' THR . 64.3 p -103.36 -32.33 9.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 71.219999999999999 111.882 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 27.95 62.1 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.293 -0.723 . . . . 62.119999999999997 111.293 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.595 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 72.2 p -103.81 -34.85 8.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 111.222 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.98 -30.59 4.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 111.663 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 4.7 ptm180 -81.21 -37.42 28.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.043 0.449 . . . . 73.299999999999997 110.045 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 65.38 79.36 0.19 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.945 -0.57 . . . . 61.109999999999999 113.029 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.62 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 66.9 -130.97 30.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.022 -0.609 . . . . 55.109999999999999 112.745 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 55.55 22.19 4.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.105 0.562 . . . . 62.350000000000001 111.521 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -72.79 -12.6 61.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.712 -0.676 . . . . 53.049999999999997 110.868 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.418 HD12 ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -71.18 -51.96 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.389 -0.369 . . . . 72.319999999999993 110.424 178.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.426 ' HB3' ' HZ ' ' A' ' 82' ' ' PHE . 97.7 m-85 -77.64 -34.16 53.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.795 0.807 . . . . 74.109999999999999 109.105 175.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.12 -78.84 0.24 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.606 -1.179 . . . . 71.109999999999999 112.104 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -135.99 -168.57 2.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.786 0.327 . . . . 64.230000000000004 110.977 -175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 5.1 pm0 -76.41 166.43 23.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 71.239999999999995 111.532 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' HZ ' ' HB3' ' A' ' 78' ' ' TYR . 73.9 m-85 -132.38 -44.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.814 -0.63 . . . . 74.319999999999993 110.398 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -163.47 156.33 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.679 -0.859 . . . . 63.310000000000002 108.679 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ASP . 2.4 p-10 -74.81 125.11 28.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.352 -0.61 . . . . 74.329999999999998 109.352 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -98.36 20.79 12.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.048 0.451 . . . . 73.200000000000003 110.31 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -68.75 100.93 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.696 . . . . 74.109999999999999 110.952 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -156.45 77.04 4.36 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.981 -0.554 . . . . 74.310000000000002 109.926 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.39 93.59 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.552 2.168 . . . . 42.240000000000002 112.077 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.41 -10.19 58.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.248 1.023 . . . . 65.439999999999998 109.195 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.6 OUTLIER -108.16 174.17 5.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.597 -1.183 . . . . 73.019999999999996 109.306 178.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 93' ' ' THR . 32.6 ttpt -131.28 145.1 51.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.067 -0.346 . . . . 74.510000000000005 110.067 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -55.59 126.44 25.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.36 0.6 . . . . 74.349999999999994 109.571 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LYS . 20.7 p -127.04 -45.46 1.56 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.539 -0.755 . . . . 64.329999999999998 110.262 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.32 -144.75 4.07 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.344 -0.844 . . . . 42.039999999999999 111.304 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.92 145.47 25.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 110.77 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.63 21.83 6.64 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.732 -0.747 . . . . 64.439999999999998 111.906 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.3 mm -86.8 111.21 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.487 -0.561 . . . . 70.349999999999994 109.487 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.777 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.92 122.03 30.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 72.349999999999994 109.824 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.23 170.65 14.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.84 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.829 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 39.5 ttp -103.64 144.15 31.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.916 0.389 . . . . 73.209999999999994 110.063 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -98.74 151.74 20.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.127 0.489 . . . . 75.239999999999995 110.547 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -161.0 169.79 21.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 74.319999999999993 109.61 -172.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.13 -27.48 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.418 0.627 . . . . 51.310000000000002 110.545 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.85 174.82 32.33 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 109.594 -1.402 . . . . 42.439999999999998 109.594 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.48 -46.85 19.29 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.303 2.669 . . . . 71.109999999999999 112.692 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 8.4 p-10 -100.88 -12.95 18.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.385 -0.37 . . . . 64.420000000000002 111.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 1.3 m -83.17 50.31 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.499 0.666 . . . . 73.319999999999993 109.411 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.693 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 22.5 m120 -70.94 141.29 51.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.893 -1.049 . . . . 74.239999999999995 110.9 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.17 -169.78 12.69 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.127 -0.789 . . . . 41.130000000000003 111.127 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.597 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . 24.4 p -94.53 6.69 48.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.367 0.584 . . . . 75.030000000000001 111.469 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 23.3 mt-30 -72.79 161.59 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 64.430000000000007 109.68 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -141.75 171.35 14.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.666 -0.414 . . . . 74.230000000000004 111.268 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.17 150.87 18.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.04 -0.527 . . . . 65.140000000000001 110.195 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.661 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.73 141.78 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.462 -0.57 . . . . 61.130000000000003 109.462 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -95.37 129.08 42.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.166 0.508 . . . . 72.439999999999998 110.318 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 62' ' ' ILE . 61.6 mt -87.14 -3.2 59.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 72.439999999999998 110.662 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.33 163.37 24.37 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.763 -0.653 . . . . 75.150000000000006 110.062 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.31 125.42 15.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.595 2.197 . . . . 73.219999999999999 111.845 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.3 p -114.5 140.87 48.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.394 -0.367 . . . . 74.209999999999994 111.247 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -137.01 24.47 3.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 111.003 174.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -120.72 -8.87 9.42 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.374 0.509 . . . . 63.439999999999998 112.374 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.5 pp -127.72 4.42 6.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.745 -0.382 . . . . 73.400000000000006 111.745 -173.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 1.4 m-20 -71.51 -22.45 61.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.823 -0.626 . . . . 60.43 110.334 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.81 7.87 55.7 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.928 -0.869 . . . . 73.540000000000006 110.928 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.7 mmtm -112.16 -33.2 6.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 72.319999999999993 109.426 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.462 ' ND1' ' HA ' ' A' ' 101' ' ' ALA . 58.4 m-70 -135.57 137.54 42.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.29 -0.868 . . . . 73.230000000000004 109.418 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.3 t -78.54 146.54 34.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.39 -0.524 . . . . 75.349999999999994 110.255 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 99' ' ' ALA . 51.8 mt -122.28 124.86 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.9 -0.591 . . . . 72.239999999999995 110.279 -175.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.829 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.9 p90 -159.23 73.2 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.633 0.73 . . . . 74.349999999999994 110.725 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.777 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.37 157.27 29.56 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.177 -1.487 . . . . 72.010000000000005 113.732 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.45 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 24.4 mtm180 -137.06 123.69 21.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.34 . . . . 75.340000000000003 110.132 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.66 140.95 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 53.329999999999998 110.906 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 45.1 t -137.34 152.24 49.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.026 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.5 pt20 41.13 31.09 0.13 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.534 1.134 . . . . 74.340000000000003 113.506 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.72 12.71 0.48 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.478 -0.867 . . . . 34.329999999999998 112.426 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -71.5 -34.25 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.799 -0.236 . . . . 54.530000000000001 110.92 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.57 91.76 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.484 -0.865 . . . . 41.350000000000001 111.387 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.5 mmm -71.2 -46.36 61.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.095 -0.335 . . . . 72.439999999999998 110.095 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.493 HG23 HD12 ' A' ' 23' ' ' ILE . 79.9 t -57.07 -31.82 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.236 0.541 . . . . 72.129999999999995 110.4 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -68.39 -52.72 29.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.72 -0.673 . . . . 74.430000000000007 109.901 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.605 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.97 -8.57 56.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 72.510000000000005 111.023 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 20' ' ' MET . 56.0 t -87.99 -43.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.265 0.555 . . . . 71.010000000000005 109.808 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -77.9 -37.54 29.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.608 -0.806 . . . . 75.349999999999994 112.78 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 24.0 ptm -73.86 -27.52 61.12 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.597 0.221 . . . . 62.240000000000002 111.597 -173.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.516 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.140000000000001 111.077 -175.504 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 53' ' ' PHE . 6.1 p . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 122.123 0.963 . . . . 63.229999999999997 109.876 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.76 168.46 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.859 -1.064 . . . . 64.329999999999998 110.524 -172.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.473 HG13 HG22 ' A' ' 18' ' ' THR . 3.4 mp -87.14 115.59 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.983 -0.747 . . . . 71.25 108.983 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 161' ' ' LYS . 31.0 mm -75.56 -62.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.368 -0.833 . . . . 73.420000000000002 110.973 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.655 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -129.68 135.64 48.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.811 0.339 . . . . 71.319999999999993 110.266 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -131.92 133.87 45.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 62.240000000000002 111.023 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 21.8 p90 -152.93 147.49 19.13 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 72.140000000000001 110.673 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 15.0 Cg_exo -70.16 152.27 67.16 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.128 2.552 . . . . 72.040000000000006 113.119 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 64.319999999999993 109.89 175.812 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.2 m-20 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.304 0.573 . . . . 45.409999999999997 111.237 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 165.92 143.65 3.81 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.311 -0.859 . . . . 45.229999999999997 111.205 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.2 -171.53 41.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.579 -0.82 . . . . 60.030000000000001 111.954 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.815 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.26 167.02 22.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.033 -0.358 . . . . 51.439999999999998 110.033 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.515 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.2 m-85 -110.81 97.15 32.26 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 71.549999999999997 111.218 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 90' ' ' LEU . 57.7 Cg_endo -75.03 -4.78 15.91 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.61 2.207 . . . . 62.43 112.791 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.18 -31.61 58.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 64.310000000000002 110.782 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 188' ' ' PHE . 13.3 pt -79.89 -17.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.040000000000006 111.929 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 17.2 m170 67.99 33.22 4.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 111.892 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 191' ' ' ILE . 4.9 p -136.57 149.85 27.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.658 0.266 . . . . 75.140000000000001 110.797 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 115.82 9.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.272 0.558 . . . . 65.25 112.155 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -156.57 159.34 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.504 -0.924 . . . . 72.0 108.504 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -132.23 145.24 56.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 120.547 -0.461 . . . . 74.219999999999999 111.585 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -67.4 -68.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.402 2.068 . . . . 73.239999999999995 111.693 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -126.24 24.88 6.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 110.621 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 75.39 -10.0 1.31 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.914 1.079 . . . . 74.319999999999993 113.914 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -55.42 -27.74 49.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.322 0.49 . . . . 71.519999999999996 112.322 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.81 -0.23 89.72 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.843 -0.694 . . . . 62.43 112.879 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.46 -33.47 48.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 111.135 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.3 -0.857 . . . . 74.340000000000003 110.183 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 18.0 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 CA-C-O 120.851 0.271 . . . . 71.310000000000002 112.012 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -4.87 16.17 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.999 2.466 . . . . 62.039999999999999 113.744 -175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -128.98 144.2 51.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.885 0.374 . . . . 74.439999999999998 110.577 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 34.4 m -137.48 147.38 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.092 0.472 . . . . 74.430000000000007 110.854 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CD1' ' HB3' ' A' ' 165' ' ' SER . 13.3 m-85 -103.45 132.18 49.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.777 -0.647 . . . . 74.409999999999997 110.831 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD12 HG21 ' A' ' 159' ' ' ILE . 3.4 mm? -114.58 104.81 12.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.041 -0.527 . . . . 54.549999999999997 109.749 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.28 115.46 28.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.278 -0.638 . . . . 74.329999999999998 109.278 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -107.12 178.92 4.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 75.109999999999999 111.738 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.4 p -75.25 -10.08 59.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.724 -0.671 . . . . 44.109999999999999 110.798 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.5 mmt -94.46 -42.11 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.654 . . . . 53.119999999999997 109.932 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.83 -116.51 0.51 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.474 -0.785 . . . . 73.030000000000001 111.336 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -150.54 138.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.063 0.459 . . . . 63.130000000000003 110.477 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -132.28 127.52 57.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.686 -0.688 . . . . 74.099999999999994 109.571 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 8.5 t -113.62 147.45 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.855 -0.424 . . . . 62.219999999999999 109.855 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.37 163.5 39.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.984 0.421 . . . . 62.219999999999999 110.652 174.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 131' ' ' ARG . 1.8 pt-20 -129.76 163.0 27.16 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.653 -0.703 . . . . 73.450000000000003 110.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.23 161.92 13.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 71.439999999999998 110.509 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.478 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 2.7 m-85 -88.32 100.26 12.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 74.510000000000005 111.635 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -85.89 7.06 25.58 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.002 -0.74 . . . . 73.230000000000004 109.002 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 4.4 mptp? -78.01 -57.34 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.753 -1.112 . . . . 73.530000000000001 111.54 -176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -132.31 14.96 4.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.423 -0.353 . . . . 72.420000000000002 111.81 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.53 80.42 71.95 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.787 -0.449 . . . . 55.439999999999998 109.787 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.606 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 59.4 Cg_endo -73.19 -25.18 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.445 2.096 . . . . 71.109999999999999 113.729 -171.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -100.66 -33.69 10.18 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.126 -0.63 . . . . 74.439999999999998 111.637 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.65 95.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.177 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -57.62 -51.62 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 63.140000000000001 111.017 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 67.6 mttt -66.73 -41.71 87.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.829 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.03 -47.86 74.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.819 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.417 ' HE1' HG21 ' A' ' 14' ' ' VAL . 32.7 t80 -67.64 -50.96 55.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.246 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.36 80.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.32 -0.855 . . . . 52.539999999999999 111.663 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.63 -47.66 82.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.891 -0.595 . . . . 72.319999999999993 110.32 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 3.5 mm? -66.33 -27.55 67.99 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.113 -0.494 . . . . 73.030000000000001 111.07 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.55 52.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.84 -0.618 . . . . 60.130000000000003 110.91 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -73.74 -26.09 60.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.903 -0.406 . . . . 75.430000000000007 109.903 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -60.46 -47.6 85.43 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.83 -0.623 . . . . 75.430000000000007 109.587 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.51 20.51 6.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.486 -0.864 . . . . 62.229999999999997 113.575 170.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -79.58 -11.2 59.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.201 0.501 . . . . 75.140000000000001 111.359 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HA ' HG23 ' A' ' 51' ' ' THR . 95.6 m-85 -85.11 -4.84 59.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.893 0.378 . . . . 64.530000000000001 110.967 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 38.6 m-80 -77.9 4.95 10.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.269 0.557 . . . . 71.439999999999998 110.046 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.77 21.22 2.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.707 -0.679 . . . . 53.420000000000002 111.698 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.945 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 28.8 p -96.0 152.61 18.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.555 0.217 . . . . 64.239999999999995 110.702 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 3.7 mtmt -134.94 155.94 49.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.522 -0.308 . . . . 74.420000000000002 110.512 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' A' ' 157' ' ' VAL . 97.5 m-85 -92.43 113.79 26.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 72.049999999999997 109.0 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -112.83 -24.01 9.81 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.519 -0.473 . . . . 75.549999999999997 112.257 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 27.2 mmm180 -114.49 106.21 14.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.248 -0.581 . . . . 52.140000000000001 110.148 177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -124.57 92.86 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.102 -0.703 . . . . 34.32 109.102 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.4 mt -98.32 122.18 49.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 42.1 mtpt -56.94 127.71 33.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.297 0.373 . . . . 72.140000000000001 111.635 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 56.17 32.89 21.03 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.123 -0.944 . . . . 73.109999999999999 111.373 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.3 t80 -130.97 -82.67 0.53 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.267 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.9 ptt? -161.64 157.61 24.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.702 -0.681 . . . . 74.129999999999995 110.205 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.637 HG23 HG13 ' A' ' 56' ' ' ILE . 29.0 mt -131.99 108.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 60.030000000000001 109.79 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.2 tt0 -79.5 124.16 28.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.314 -0.403 . . . . 54.439999999999998 110.074 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -133.96 127.78 4.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.437 -0.665 . . . . 63.399999999999999 111.437 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.945 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 139.17 -155.45 23.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.07 -1.062 . . . . 64.329999999999998 112.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 111' ' ' GLN . 22.3 t0 53.74 96.15 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.741 0.817 . . . . 73.409999999999997 112.324 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.11 -16.49 44.75 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.334 2.023 . . . . 72.209999999999994 112.606 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 70' ' ' THR . 48.5 p -93.6 -36.07 12.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 64.329999999999998 110.683 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 18.8 75.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.095 -0.574 . . . . 72.140000000000001 112.696 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 68' ' ' THR . 9.9 t -111.64 -10.32 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 75.230000000000004 111.563 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.73 35.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.2 -1.0 . . . . 41.030000000000001 112.986 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -86.46 -47.63 9.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 61.130000000000003 111.02 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.51 173.41 32.32 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.42 -0.809 . . . . 63.43 111.421 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.0 -10.68 58.44 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 120.719 -0.753 . . . . 52.020000000000003 112.181 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -55.92 -77.36 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.971 -0.615 . . . . 73.519999999999996 112.074 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 m 59.27 15.39 4.24 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.186 -0.461 . . . . 64.010000000000005 111.497 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 pt -68.4 -17.21 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.592 0.71 . . . . 74.140000000000001 110.445 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.2 -12.33 26.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.727 -1.124 . . . . 73.510000000000005 111.147 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.58 -76.77 1.3 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.241 -0.505 . . . . 50.240000000000002 112.464 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -87.47 -156.17 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.576 -0.527 . . . . 74.200000000000003 109.576 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.78 174.38 1.44 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 73.040000000000006 110.559 172.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 106' ' ' ASP . 26.2 t80 -118.17 -175.09 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.271 -0.422 . . . . 74.299999999999997 110.218 -172.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -76.48 121.36 23.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 74.329999999999998 110.645 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 7.8 p-10 -76.77 86.44 3.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.869 0.842 . . . . 74.349999999999994 109.066 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.48 39.53 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.313 -0.858 . . . . 74.230000000000004 109.555 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.484 HD23 ' HB ' ' A' ' 127' ' ' THR . 15.5 mt -69.26 98.98 1.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.381 -1.281 . . . . 71.439999999999998 110.63 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -162.07 83.47 1.69 Allowed Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.725 -0.67 . . . . 73.129999999999995 109.867 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.891 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 28.6 Cg_endo -62.28 82.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 123.154 2.57 . . . . 73.209999999999994 112.209 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.45 -25.83 54.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.409 -0.814 . . . . 72.349999999999994 109.682 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.6 pp -85.17 -179.96 7.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 72.150000000000006 109.796 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -124.42 141.23 52.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.46 -0.496 . . . . 65.209999999999994 110.672 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.66 72.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.664 0.745 . . . . 71.019999999999996 110.006 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -66.4 -37.86 86.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.773 -1.103 . . . . 73.329999999999998 112.575 -171.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' H ' HD11 ' A' ' 97' ' ' ILE . . . -166.42 -140.93 3.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.361 -0.923 . . . . 51.450000000000003 112.758 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' SD ' ' A' ' 200' ' ' MET . . . -91.1 137.49 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.751 0.31 . . . . 74.409999999999997 110.686 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.48 23.35 5.74 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.669 -0.777 . . . . 41.43 111.852 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 94' ' ' GLY . 11.0 mm -85.41 109.6 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.346 -0.612 . . . . 72.319999999999993 109.346 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -86.3 118.41 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.212 0.529 . . . . 62.340000000000003 109.774 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -125.04 168.12 13.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.053 -0.521 . . . . 62.200000000000003 110.847 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.6 ttt -91.71 132.77 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.191 -0.459 . . . . 75.450000000000003 109.805 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 111' ' ' GLN . . . -96.26 141.08 30.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.01 -0.367 . . . . 63.119999999999997 110.01 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -150.38 165.35 33.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.147 -0.479 . . . . 72.450000000000003 110.792 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -69.55 -46.66 65.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.845 -0.616 . . . . 73.299999999999997 110.296 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.94 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.472 -0.87 . . . . 71.400000000000006 112.715 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.28 89.43 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.918 2.412 . . . . 54.210000000000001 112.193 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 p30 50.13 29.37 3.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.317 -0.856 . . . . 74.200000000000003 111.571 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 m -96.58 55.51 1.43 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.113 -1.069 . . . . 65.030000000000001 108.113 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -92.85 137.15 32.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.995 -1.457 . . . . 71.030000000000001 110.096 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.21 -107.8 0.76 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.231 -0.985 . . . . 73.310000000000002 113.616 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.8 p -127.28 56.43 1.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.546 0.688 . . . . 64.319999999999993 110.601 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 66' ' ' ASP . 18.8 mp0 -130.32 147.3 52.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.18 -0.918 . . . . 64.209999999999994 110.136 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -139.78 169.3 17.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.769 -0.456 . . . . 73.409999999999997 109.769 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -155.79 147.87 23.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.87 0.367 . . . . 63.549999999999997 110.296 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.8 t -111.54 140.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.885 -0.598 . . . . 50.439999999999998 109.391 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -94.86 128.81 41.89 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.853 0.359 . . . . 62.329999999999998 110.14 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD11 ' HA3' ' A' ' 143' ' ' GLY . 67.6 mt -83.62 -8.71 59.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.764 -0.653 . . . . 70.010000000000005 110.168 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.42 156.58 34.91 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.164 -0.926 . . . . 61.399999999999999 109.679 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.35 124.58 14.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.503 2.135 . . . . 52.32 112.236 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 p -123.99 122.12 37.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.405 . . . . 61.340000000000003 110.234 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 5.18 31.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.716 0.293 . . . . 73.319999999999993 111.373 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.611 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -108.39 -3.1 18.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.611 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.9 mt -102.04 3.74 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 111.371 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.891 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 p-10 -70.67 -15.2 62.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.68 -0.691 . . . . 73.409999999999997 111.155 -172.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.86 15.96 9.53 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.329 -0.709 . . . . 65.420000000000002 111.329 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.66 -41.31 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.271 0.558 . . . . 72.209999999999994 110.109 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -142.31 126.1 17.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.005 -1.109 . . . . 75.030000000000001 108.005 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.484 ' HB ' HD23 ' A' ' 86' ' ' LEU . 11.3 t -72.22 143.11 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.669 -0.812 . . . . 72.340000000000003 110.459 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' ALA . 40.4 mt -114.87 119.94 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.57 -0.741 . . . . 71.450000000000003 110.54 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.3 m-85 -157.23 75.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.318 0.387 . . . . 75.299999999999997 110.138 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.66 158.24 30.38 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.585 -0.817 . . . . 75.120000000000005 112.611 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 11.4 mtp180 -135.12 114.98 12.91 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.719 -0.475 . . . . 75.209999999999994 109.719 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 96' ' ' GLY . 14.3 p -79.86 130.6 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.37 0.605 . . . . 73.420000000000002 110.068 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.662 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 87.7 m -140.5 140.12 35.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.765 -0.652 . . . . 62.450000000000003 110.576 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 54.67 42.33 31.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.124 0.488 . . . . 64.5 111.764 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 41.58 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.43 -0.89 . . . . 54.130000000000003 111.99 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.0 tp -90.77 -34.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.59 0.233 . . . . 65.120000000000005 111.011 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.92 -35.87 91.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.807 -0.711 . . . . 64.519999999999996 111.624 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -68.34 -51.2 47.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 54.32 110.337 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.505 HG13 HD12 ' A' ' 62' ' ' ILE . 98.5 t -55.03 -31.12 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.296 0.57 . . . . 75.439999999999998 110.789 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.93 -55.01 10.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.819 -0.628 . . . . 61.219999999999999 110.681 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -17.66 62.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.367 -0.379 . . . . 72.439999999999998 111.213 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 145' ' ' VAL . 55.0 t -84.3 -37.75 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.1 0.476 . . . . 74.319999999999993 109.934 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -83.38 -7.5 86.44 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.775 -0.726 . . . . 74.0 113.002 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.33 -1.06 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.755 -0.378 . . . . 71.209999999999994 111.294 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 142' ' ' VAL . 33.0 m . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.971 0.415 . . . . 72.340000000000003 111.242 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.139 0.495 . . . . 62.140000000000001 111.374 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -121.94 162.88 20.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 60.439999999999998 109.533 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.626 HG21 HD12 ' A' ' 16' ' ' LEU . 3.5 mp -88.9 103.27 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.445 -0.946 . . . . 73.109999999999999 108.445 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 161' ' ' LYS . 32.1 mm -66.81 -56.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.479 -0.782 . . . . 74.519999999999996 110.636 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 3.5 mptp? -128.92 137.25 51.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 64.019999999999996 110.374 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.19 27.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.209 -0.451 . . . . 62.140000000000001 110.242 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -148.22 135.36 10.46 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.767 -0.651 . . . . 72.200000000000003 110.723 -173.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.68 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 59.8 Cg_endo -72.78 139.38 30.5 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.706 2.271 . . . . 71.519999999999996 112.044 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.544 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 16.9 t . . . . . 0 C--N 1.326 -0.456 0 N-CA-C 109.6 -0.518 . . . . 70.430000000000007 109.6 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.381 0 CA-C-O 121.732 0.777 . . . . 74.0 110.913 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 144.67 144.05 4.11 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.574 -1.194 . . . . 72.310000000000002 110.863 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.59 -167.9 44.2 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.27 -0.967 . . . . 62.32 111.659 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 189' ' ' PRO . . . -75.43 163.54 27.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.228 -0.656 . . . . 65.409999999999997 109.228 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -102.24 103.29 29.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.19 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 6.0 Cg_exo -77.43 -18.46 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.776 2.318 . . . . 64.239999999999995 111.298 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.87 -33.59 62.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 75.030000000000001 110.238 -172.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -89.22 157.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -106.82 89.68 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.057 -0.657 . . . . 74.150000000000006 110.638 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 194' ' ' ALA . 6.1 p -158.08 -171.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.626 -0.879 . . . . 71.120000000000005 108.626 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.745 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -123.45 117.61 25.54 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 122.188 -0.32 . . . . 72.310000000000002 110.669 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -156.45 155.27 31.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.864 -0.421 . . . . 62.109999999999999 109.864 177.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -117.31 149.24 44.23 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.458 -0.337 . . . . 73.519999999999996 110.546 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.533 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.8 Cg_endo -67.31 -65.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.408 2.072 . . . . 63.119999999999997 112.108 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.9 27.54 4.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.635 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 72.59 5.02 5.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.52 -0.764 . . . . 65.439999999999998 112.687 173.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 201' ' ' GLY . 2.0 ppp? -63.58 -50.4 69.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.102 0.408 . . . . 60.25 112.102 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.487 ' N ' ' SD ' ' A' ' 200' ' ' MET . . . -75.75 15.34 4.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.263 -0.494 . . . . 71.409999999999997 114.148 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -81.78 -17.05 48.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 72.140000000000001 110.464 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.252 1.204 0 CA-C-N 114.872 -1.058 . . . . 73.129999999999995 110.945 178.524 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 34.4 Cg_exo . . . . . 0 C--O 1.233 0.252 0 CA-C-O 120.809 0.254 . . . . 52.399999999999999 112.023 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 56.6 Cg_endo -71.55 -16.98 30.4 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.84 2.36 . . . . 73.310000000000002 113.534 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.505 HD21 HG12 ' A' ' 24' ' ' VAL . 22.2 t-20 -132.51 147.8 52.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.252 -0.431 . . . . 63.240000000000002 110.092 -174.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.9 m -139.04 152.02 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.257 0.551 . . . . 65.420000000000002 111.438 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HD1' HG22 ' A' ' 24' ' ' VAL . 97.4 m-85 -102.94 121.31 42.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.079 -0.964 . . . . 72.25 110.743 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -108.09 103.07 12.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.805 0.336 . . . . 73.420000000000002 110.307 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -85.15 122.45 29.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.228 -0.656 . . . . 64.319999999999993 109.228 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -114.97 176.61 4.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.212 0.529 . . . . 71.439999999999998 112.041 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 160' ' ' ILE . 32.7 t -75.51 -1.6 25.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.606 -0.725 . . . . 71.430000000000007 110.565 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mmt -107.2 -39.7 5.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.814 -0.63 . . . . 74.329999999999998 110.274 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.64 -126.41 0.98 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.232 -0.747 . . . . 63.219999999999999 111.232 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -139.84 137.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.035 0.445 . . . . 74.140000000000001 109.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -120.93 118.03 54.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.77 -0.65 . . . . 73.400000000000006 109.677 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 15' ' ' TYR . 46.5 t -106.16 131.18 56.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.82 -0.437 . . . . 75.010000000000005 109.82 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.66 164.57 33.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.997 0.427 . . . . 73.349999999999994 110.414 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 12.2 pt-20 -135.5 166.56 22.91 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.774 -0.648 . . . . 72.219999999999999 109.876 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -103.52 160.03 15.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.495 -0.557 . . . . 64.5 109.495 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -83.89 91.58 7.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 72.319999999999993 111.962 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.653 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 78.9 m95 -84.22 6.48 22.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.607 -0.724 . . . . 72.430000000000007 110.314 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -73.6 -63.03 1.29 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.609 -0.723 . . . . 71.219999999999999 110.495 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.419 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 37.6 m80 -131.07 16.2 5.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.083 0.401 . . . . 73.310000000000002 112.083 -176.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -133.83 56.95 21.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.024 -0.27 . . . . 74.219999999999999 110.983 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 14.0 Cg_exo -68.82 -25.9 32.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.442 2.094 . . . . 73.299999999999997 112.023 -175.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -66.44 -54.23 26.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 53.350000000000001 110.176 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.651 ' HB ' ' CE2' ' A' ' 129' ' ' PHE . 1.6 p -64.16 -40.23 95.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.182 -0.917 . . . . 63.399999999999999 110.988 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 86.3 m -58.31 -46.78 85.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.079 -0.964 . . . . 62.539999999999999 111.02 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -59.49 -41.39 89.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.422 -0.354 . . . . 63.439999999999998 110.189 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.72 -56.54 20.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 52.130000000000003 110.326 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HE2' ' HB3' ' A' ' 112' ' ' PHE . 3.4 m-85 -66.74 -42.29 86.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.759 -0.655 . . . . 63.149999999999999 111.492 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.81 97.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.455 -0.339 . . . . 54.25 111.571 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.39 -43.67 98.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.024 0.44 . . . . 75.219999999999999 110.198 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.541 ' CD1' ' HB3' ' A' ' 110' ' ' SER . 35.3 mt -70.59 -24.46 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.873 -0.603 . . . . 71.209999999999994 111.97 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.75 86.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.005 -0.543 . . . . 73.329999999999998 110.313 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -75.56 -34.28 60.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 74.519999999999996 109.927 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 14.3 tpp180 -64.83 -46.75 80.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 75.439999999999998 110.273 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.38 28.87 5.0 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.926 -0.654 . . . . 50.329999999999998 113.075 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.76 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 5.2 m-85 -87.15 -2.92 58.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 111.674 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -76.42 -12.69 60.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 75.349999999999994 110.303 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.45 3.16 19.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.22 0.533 . . . . 75.019999999999996 109.91 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -131.69 15.4 5.18 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.694 -0.684 . . . . 74.030000000000001 112.253 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.559 HG22 ' HD3' ' A' ' 67' ' ' PRO . 13.6 p -98.63 138.03 36.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.837 0.318 . . . . 61.149999999999999 110.497 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' CG ' ' HG3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -128.71 124.5 35.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.418 -0.355 . . . . 75.109999999999999 110.427 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 96.2 m-85 -70.06 103.34 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.412 -0.588 . . . . 74.25 109.412 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -114.25 -15.43 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.031 -0.668 . . . . 64.25 112.06 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 11.3 mmt180 -105.42 101.61 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.982 -0.687 . . . . 74.329999999999998 109.597 175.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG13 HG23 ' A' ' 62' ' ' ILE . 4.2 mp -125.87 95.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.018 -0.734 . . . . 63.049999999999997 109.018 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 44.0 mt -91.88 127.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 109.184 -0.673 . . . . 62.030000000000001 109.184 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -48.72 111.41 0.46 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.99 0.806 . . . . 72.299999999999997 112.133 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' HD2' ' A' ' 203' ' ' LYS . 43.2 m-20 56.4 39.66 29.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.112 -0.949 . . . . 65.450000000000003 111.307 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.84 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 9.7 t80 -128.59 -76.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.813 -0.631 . . . . 73.219999999999999 109.987 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.401 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.4 ptt? -160.59 155.59 24.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 72.519999999999996 110.673 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 56' ' ' ILE . 49.0 mt -128.41 105.28 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 73.230000000000004 109.48 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 39.6 tt0 -85.49 127.2 34.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.739 -0.664 . . . . 74.040000000000006 111.893 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.39 117.38 4.62 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.454 -1.058 . . . . 31.440000000000001 110.454 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.24 146.59 33.43 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 114.423 0.529 . . . . 53.43 114.423 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 64.9 t0 -46.0 126.73 7.07 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 124.792 1.237 . . . . 74.340000000000003 111.837 174.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD3' HG22 ' A' ' 51' ' ' THR . 29.3 Cg_endo -64.46 -30.77 62.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.177 2.584 . . . . 72.25 112.763 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 70' ' ' THR . 62.7 p -84.1 -32.86 24.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 74.099999999999994 110.061 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.83 70.84 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.51 -0.768 . . . . 71.409999999999997 113.01 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 72' ' ' ARG . 8.8 t -105.52 -26.02 12.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.121 0.46 . . . . 43.420000000000002 111.536 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.97 -5.34 10.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.476 -0.869 . . . . 30.039999999999999 113.223 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.512 ' HG2' HG23 ' A' ' 70' ' ' THR . 8.5 ptm180 -100.85 -23.75 14.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.076 0.438 . . . . 71.5 111.101 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 85.47 175.11 50.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.827 -0.702 . . . . 73.510000000000005 112.098 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.76 ' HA3' ' HD2' ' A' ' 47' ' ' TYR . . . -86.93 28.79 5.33 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.525 0.514 . . . . 70.420000000000002 112.28 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . -93.1 25.13 3.4 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.74 0.781 . . . . 35.200000000000003 110.883 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 55.4 m -75.65 -5.69 46.77 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.089 -0.96 . . . . 62.240000000000002 110.583 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.1 tt -55.62 -40.17 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.562 -0.745 . . . . 74.349999999999994 110.96 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 34.8 p90 -102.12 -9.14 20.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 63.43 111.276 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 76' ' ' SER . . . 126.74 -119.27 3.28 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.24 -0.744 . . . . 74.010000000000005 111.24 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -137.91 146.45 43.33 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.049 0.452 . . . . 64.209999999999994 111.726 176.34 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.437 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 1.7 mp0 38.1 -166.55 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 O-C-N 125.692 1.87 . . . . 64.25 115.294 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB2' ' OD1' ' A' ' 108' ' ' ASN . 20.8 m-85 -154.41 -165.74 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.531 -1.213 . . . . 74.010000000000005 108.446 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.78 160.05 26.31 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.172 -1.048 . . . . 51.5 108.172 171.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.27 123.54 23.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 75.109999999999999 109.993 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.06 31.31 6.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.421 -0.585 . . . . 53.450000000000003 109.421 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' A' ' 127' ' ' THR . 47.9 mt -66.11 98.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.716 . . . . 75.439999999999998 110.319 -176.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -166.06 89.96 0.86 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.898 -0.592 . . . . 71.109999999999999 109.85 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.98 95.36 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.779 2.319 . . . . 54.130000000000003 111.61 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.42 -17.58 61.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.403 1.096 . . . . 74.409999999999997 108.7 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.653 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -106.5 170.83 7.7 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.875 -1.511 . . . . 51.32 108.797 175.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 93' ' ' THR . 38.6 ttpt -128.16 142.88 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.843 -0.343 . . . . 71.450000000000003 110.165 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -56.16 122.69 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.433 0.635 . . . . 65.239999999999995 109.369 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -119.48 -45.9 2.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.556 -0.747 . . . . 70.409999999999997 109.771 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.607 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -155.96 -139.27 2.72 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.054 -0.975 . . . . 44.049999999999997 111.389 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.67 144.65 25.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 73.400000000000006 110.844 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.18 24.32 5.47 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.786 -0.721 . . . . 73.040000000000006 112.13 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.403 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.0 mm -86.87 110.79 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.355 -0.609 . . . . 70.040000000000006 109.355 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -86.52 117.4 25.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.731 -0.668 . . . . 74.310000000000002 109.889 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.2 173.32 11.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 54.140000000000001 111.056 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.541 ' HG2' ' N ' ' A' ' 101' ' ' ALA . 28.1 ttm -94.36 148.19 22.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 70.209999999999994 111.281 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' N ' ' HG2' ' A' ' 100' ' ' MET . . . -99.52 122.09 42.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.699 -0.682 . . . . 71.040000000000006 109.222 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.58 165.88 24.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 110.221 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.12 -28.67 14.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.32 0.581 . . . . 53.240000000000002 110.422 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.412 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.23 180.0 29.17 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.651 -1.38 . . . . 61.109999999999999 109.651 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.7 -50.54 12.88 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 64.239999999999995 112.786 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -102.77 -1.83 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.57 -0.286 . . . . 52.420000000000002 111.092 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 81' ' ' GLN . 7.9 m -88.34 53.85 2.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.865 0.84 . . . . 74.25 109.114 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 82' ' ' PHE . 3.7 p30 -82.88 158.46 22.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.289 -1.323 . . . . 63.020000000000003 109.8 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.89 -129.51 1.04 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.445 -0.883 . . . . 24.129999999999999 112.965 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 3.3 p -114.07 -1.09 13.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.002 0.371 . . . . 53.439999999999998 112.002 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 71.9 mt-30 -79.32 150.31 31.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.729 -0.471 . . . . 63.539999999999999 109.729 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' HB3' ' HE2' ' A' ' 39' ' ' PHE . 29.8 p90 -148.11 164.98 32.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.857 -0.337 . . . . 70.209999999999994 110.468 -176.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.2 151.49 29.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.889 0.376 . . . . 75.209999999999994 110.321 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.73 HG22 HD23 ' A' ' 98' ' ' LEU . 15.1 t -110.15 141.42 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.814 -0.63 . . . . 72.510000000000005 109.352 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.3 p -95.14 124.92 39.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.115 0.483 . . . . 63.530000000000001 110.318 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.2 mt -81.83 -8.98 59.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.631 -0.713 . . . . 70.430000000000007 110.569 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.23 42.3 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.386 -0.825 . . . . 35.43 109.801 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.607 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 18.8 Cg_exo -65.98 120.24 7.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.714 2.276 . . . . 53.0 111.934 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -108.43 116.23 31.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 110.476 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.44 11.41 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.106 0.479 . . . . 74.120000000000005 110.903 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.527 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -118.42 0.27 11.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.679 -0.691 . . . . 62.210000000000001 111.138 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 91.2 mt -104.01 10.24 36.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.107 -0.497 . . . . 73.030000000000001 110.511 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -62.73 -22.18 66.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.196 -0.911 . . . . 73.409999999999997 111.496 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.91 21.51 4.66 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.713 -0.756 . . . . 62.340000000000003 111.727 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -117.08 -32.1 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 62.399999999999999 110.23 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.65 131.31 27.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.863 -0.608 . . . . 75.219999999999999 110.319 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.433 ' OG1' HD23 ' A' ' 86' ' ' LEU . 46.1 m -68.31 119.42 12.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.982 0.42 . . . . 71.310000000000002 109.932 171.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 99' ' ' ALA . 46.2 mt -102.47 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.029 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.651 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 15.0 p90 -160.3 71.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 75.420000000000002 111.264 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.83 154.02 24.7 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.611 -1.281 . . . . 42.130000000000003 114.053 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -131.75 118.64 20.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.461 -0.57 . . . . 74.120000000000005 109.461 170.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.06 139.03 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 72.319999999999993 110.459 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 46.0 t -141.51 150.02 41.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.453 -0.339 . . . . 64.519999999999996 110.956 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.9 pt20 39.02 40.02 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.807 1.243 . . . . 73.140000000000001 113.474 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.57 23.07 0.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.874 -0.679 . . . . 44.020000000000003 111.834 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 tp -76.63 -32.88 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.717 0.294 . . . . 73.239999999999995 110.233 -175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.09 87.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.818 -0.706 . . . . 44.140000000000001 111.672 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 78.6 mmm -72.23 -50.07 30.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.414 -0.217 . . . . 74.230000000000004 110.414 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 62' ' ' ILE . 86.6 t -57.77 -28.71 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 71.25 110.565 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.627 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -72.14 -55.29 7.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 51.240000000000002 110.572 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -70.69 -17.3 62.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.128 -0.487 . . . . 70.430000000000007 111.015 -176.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.1 t -87.48 -33.32 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.258 0.552 . . . . 74.439999999999998 109.666 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.77 -13.36 82.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.787 -0.721 . . . . 51.229999999999997 112.687 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.627 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 67.9 mtp -85.17 -2.2 57.75 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.871 -0.194 . . . . 75.140000000000001 111.382 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 142' ' ' VAL . 6.1 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.294 0.568 . . . . 73.420000000000002 110.489 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.6 p . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 121.292 0.567 . . . . 73.010000000000005 110.308 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.435 ' HG3' ' CG ' ' A' ' 52' ' ' LYS . 10.2 mptt -111.36 151.34 28.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.634 . . . . 70.450000000000003 110.86 -172.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.53 99.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.287 -1.005 . . . . 74.409999999999997 108.287 169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.534 HG22 ' HD3' ' A' ' 161' ' ' LYS . 36.4 mm -62.9 -50.78 78.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 73.549999999999997 110.218 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.596 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -143.16 152.44 41.79 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.555 -0.748 . . . . 72.329999999999998 109.992 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.95 132.95 37.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.472 . . . . 62.049999999999997 109.875 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 43.4 m-85 -134.31 125.65 17.94 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.582 . . . . 64.400000000000006 109.957 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . 19.5 Cg_endo -62.21 136.15 58.52 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.81 1.673 . . . . 62.210000000000001 111.139 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.504 ' HA ' ' HE2' ' A' ' 15' ' ' TYR . 8.6 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.999 0.428 . . . . 74.420000000000002 110.679 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.511 -0.539 0 CA-C-O 121.571 0.7 . . . . 65.200000000000003 110.26 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 156.17 146.39 4.45 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.926 -1.034 . . . . 63.520000000000003 110.998 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.9 -178.18 52.15 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.282 -0.961 . . . . 55.130000000000003 111.397 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.893 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.5 141.69 53.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.43 -0.582 . . . . 75.25 109.43 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 61.4 m-85 -88.96 104.44 7.6 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 53.520000000000003 110.277 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.653 ' HB2' HD12 ' A' ' 90' ' ' LEU . 1.1 Cg_endo -82.47 -5.55 11.77 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.804 2.336 . . . . 72.439999999999998 111.301 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.66 -34.34 46.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 64.129999999999995 110.438 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 193' ' ' VAL . 17.7 pt -79.59 -13.6 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.497 -0.774 . . . . 70.219999999999999 111.555 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 58.9 m170 64.92 40.29 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.501 -0.772 . . . . 71.420000000000002 111.971 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 HG13 ' A' ' 191' ' ' ILE . 9.8 p -144.19 145.47 21.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 110.758 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.32 122.11 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.853 -0.612 . . . . 55.030000000000001 112.339 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.488 HE22 ' HA ' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -166.93 158.46 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.031 -0.986 . . . . 71.200000000000003 108.967 175.014 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 25.6 m-85 -126.11 148.45 63.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.939 -0.305 . . . . 65.140000000000001 110.587 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.893 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -66.38 -59.37 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.52 2.147 . . . . 63.119999999999997 111.786 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.7 33.15 1.81 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.882 0.372 . . . . 72.530000000000001 110.647 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.42 3.55 3.82 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.811 -0.632 . . . . 61.229999999999997 112.683 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.2 ptm -56.73 -30.54 63.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.936 0.347 . . . . 75.140000000000001 111.936 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.3 -1.78 89.34 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.675 -0.774 . . . . 74.329999999999998 112.514 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 85.3 mtt180 -101.19 -12.19 18.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.578 . . . . 61.210000000000001 110.234 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . 21.1 ttmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.616 -1.175 . . . . 74.010000000000005 111.433 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.862 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 27.1 Cg_exo . . . . . 0 N--CA 1.464 -0.25 0 N-CA-C 110.564 -0.591 . . . . 73.340000000000003 110.564 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 72.7 Cg_endo -75.28 -18.22 18.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 62.039999999999999 113.395 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -140.42 152.22 45.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.503 -0.555 . . . . 74.140000000000001 109.503 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.734 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.2 m -136.8 144.87 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.382 0.61 . . . . 64.299999999999997 111.29 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.84 123.53 43.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.207 -0.906 . . . . 63.32 111.004 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 16' ' ' LEU . 3.0 mm? -108.0 102.78 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.435 -0.348 . . . . 71.209999999999994 110.571 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -91.05 108.19 19.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.232 -0.655 . . . . 73.349999999999994 109.232 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -101.55 -179.95 4.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.228 0.537 . . . . 45.530000000000001 112.09 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB2' HD11 ' A' ' 160' ' ' ILE . 22.9 t -72.48 -11.01 60.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 75.319999999999993 110.948 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.4 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.7 mmt -102.89 -41.05 6.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.197 -0.456 . . . . 72.219999999999999 110.623 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.45 -129.39 1.2 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.419 -0.672 . . . . 71.019999999999996 111.419 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -139.69 138.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.923 -0.399 . . . . 74.219999999999999 109.923 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.63 129.99 64.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.843 -0.617 . . . . 72.420000000000002 109.647 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 21.6 t -105.59 134.34 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.361 -0.607 . . . . 75.239999999999995 109.361 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.774 ' HB2' HD11 ' A' ' 98' ' ' LEU . 3.8 pp -144.17 160.76 40.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.406 -0.517 . . . . 63.329999999999998 111.127 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -146.26 170.04 17.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 73.030000000000001 110.631 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.66 169.76 8.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.932 -0.576 . . . . 72.299999999999997 110.624 -173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.606 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -87.72 105.18 17.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.04 0.447 . . . . 71.409999999999997 110.851 176.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 1.4 m0 -85.88 0.06 54.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.005 -0.543 . . . . 53.409999999999997 109.854 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -72.62 -68.82 0.45 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.744 -0.662 . . . . 72.140000000000001 111.024 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -124.15 11.65 8.85 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.695 -0.402 . . . . 72.340000000000003 110.992 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB2' ' CG ' ' A' ' 129' ' ' PHE . . . -129.6 69.19 81.31 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.275 -0.57 . . . . 33.409999999999997 112.278 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.553 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 18.8 Cg_exo -65.73 -33.36 44.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.493 1.462 . . . . 70.010000000000005 109.706 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -57.0 -56.78 17.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.299 -0.864 . . . . 54.030000000000001 110.725 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 m -61.59 -36.22 80.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 70.340000000000003 110.823 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 54.0 t -63.63 -48.64 76.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 70.510000000000005 111.022 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.36 -37.25 77.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.659 0.266 . . . . 73.129999999999995 110.405 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 55.4 t-20 -55.58 -62.05 1.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.926 -0.579 . . . . 63.509999999999998 110.476 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HE1' HG21 ' A' ' 14' ' ' VAL . 5.0 t80 -65.01 -44.7 88.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.696 -0.684 . . . . 71.0 110.767 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -57.59 -48.77 78.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.451 -0.795 . . . . 52.43 112.198 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.28 -39.27 92.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.927 0.394 . . . . 63.509999999999998 111.159 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 3.6 mm? -69.15 -24.32 64.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.548 -0.296 . . . . 61.020000000000003 111.056 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.14 36.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.244 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.5 -29.03 70.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.178 0.513 . . . . 75.519999999999996 110.184 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 49.1 mtt180 -79.07 -50.55 10.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 74.519999999999996 109.86 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.03 52.82 0.68 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.809 . . . . 74.310000000000002 113.036 171.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.66 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 3.9 p90 -76.09 -25.97 56.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.343 0.592 . . . . 74.019999999999996 110.481 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.679 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.5 -7.95 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.479 -0.782 . . . . 64.109999999999999 112.844 -173.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -71.75 -5.73 36.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.499 . . . . 74.439999999999998 110.47 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.29 33.87 2.71 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.756 -0.656 . . . . 52.240000000000002 111.508 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.833 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.1 p -114.61 153.8 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.858 0.361 . . . . 53.310000000000002 111.119 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -146.13 161.61 39.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 109.889 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.638 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 97.9 m-85 -87.22 124.06 32.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.616 -0.513 . . . . 64.019999999999996 109.616 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -105.49 -32.77 8.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.996 -0.282 . . . . 73.120000000000005 111.13 -172.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -118.44 107.58 13.99 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.841 -0.343 . . . . 74.010000000000005 110.383 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.622 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -120.22 91.43 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.691 -0.855 . . . . 72.340000000000003 108.691 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.3 mt -93.24 128.91 44.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.98 -0.554 . . . . 73.109999999999999 110.116 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -52.2 109.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.341 1.026 . . . . 75.319999999999993 111.539 -176.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.564 ' OD2' ' HA2' ' A' ' 201' ' ' GLY . 6.6 t70 53.1 50.35 18.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.765 0.793 . . . . 71.310000000000002 110.703 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 7.1 t80 -137.55 -77.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.332 -0.849 . . . . 71.319999999999993 109.117 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.637 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.4 ptt? -162.29 154.9 19.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.939 -1.028 . . . . 73.530000000000001 109.739 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.622 HG23 HG13 ' A' ' 56' ' ' ILE . 36.1 mt -128.54 101.59 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.124 -0.489 . . . . 73.5 109.817 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.4 tm0? -82.26 126.38 32.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.394 -0.821 . . . . 74.099999999999994 109.833 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -142.69 145.68 15.93 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.176 -1.011 . . . . 71.430000000000007 113.569 -176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.833 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 130.33 -138.58 10.3 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.735 -0.745 . . . . 31.109999999999999 112.37 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.896 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 23.1 t0 44.85 89.09 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 124.49 1.116 . . . . 74.430000000000007 113.249 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 72.6 Cg_endo -75.21 -13.5 20.97 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.863 2.375 . . . . 63.25 111.878 172.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -95.94 -34.9 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 65.140000000000001 112.058 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.47 21.92 71.41 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.127 -0.558 . . . . 53.299999999999997 112.37 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -120.09 2.24 10.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 72.019999999999996 111.159 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.59 -5.08 66.94 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.559 -0.829 . . . . 63.5 112.755 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -88.52 -46.75 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.335 0.588 . . . . 75.319999999999993 109.97 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.896 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 72.87 67.98 1.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.468 -0.787 . . . . 63.229999999999997 112.451 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.66 -105.05 1.57 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.859 -0.686 . . . . 73.230000000000004 111.59 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 53.62 35.85 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.962 0.448 . . . . 73.329999999999998 111.353 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 m -56.16 -32.24 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 73.120000000000005 111.779 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -70.53 -56.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.367 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.462 ' CD1' HG23 ' A' ' 77' ' ' ILE . 90.9 m-85 -69.86 -40.13 75.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.324 0.583 . . . . 53.119999999999997 110.465 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 -67.7 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.264 -0.88 . . . . 75.129999999999995 112.556 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -113.14 -178.65 3.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.156 0.503 . . . . 64.120000000000005 112.001 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.573 ' NE2' HG23 ' A' ' 107' ' ' THR . 13.8 pm0 -104.01 162.1 13.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.451 -0.795 . . . . 74.549999999999997 109.092 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -130.3 -67.86 0.72 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.41 -0.516 . . . . 70.239999999999995 111.108 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.8 -179.46 5.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.466 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -91.53 136.44 33.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.607 -0.724 . . . . 74.549999999999997 109.612 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -100.24 15.66 26.84 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 54.32 109.147 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.93 104.58 2.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.438 -0.801 . . . . 73.329999999999998 111.697 -173.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -173.37 81.69 0.4 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 75.349999999999994 109.906 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.11 93.0 0.46 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.562 2.175 . . . . 74.430000000000007 112.342 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.39 -38.56 84.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.365 0.602 . . . . 73.450000000000003 110.123 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -81.16 -176.54 6.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.263 -0.881 . . . . 75.109999999999999 110.769 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -122.99 144.11 49.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.758 -0.46 . . . . 64.099999999999994 109.758 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.45 76.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.021 0.915 . . . . 53.420000000000002 109.677 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.7 p -61.52 -46.7 88.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.474 -1.239 . . . . 64.120000000000005 111.768 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.2 -140.21 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.62 -0.8 . . . . 53.240000000000002 112.27 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 137.7 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.661 0.267 . . . . 55.229999999999997 110.743 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 113.01 20.74 6.23 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.737 -0.744 . . . . 73.430000000000007 111.788 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.5 mm -87.41 114.7 26.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.238 -0.653 . . . . 72.049999999999997 109.238 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 25' ' ' LEU . 8.5 mt -85.47 127.07 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.264 0.554 . . . . 72.019999999999996 111.467 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 163.81 26.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 110.105 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.421 ' CE ' ' HB3' ' A' ' 108' ' ' ASN . 40.7 ttp -97.24 140.26 31.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.637 -0.505 . . . . 50.329999999999998 109.637 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -90.96 137.73 32.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 61.43 110.587 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -137.42 159.1 42.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.569 -0.741 . . . . 61.020000000000003 110.304 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.48 -2.11 36.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.605 0.717 . . . . 73.040000000000006 110.021 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.504 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -174.21 172.69 45.54 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.884 -1.686 . . . . 72.420000000000002 108.884 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 -44.91 34.68 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.659 2.24 . . . . 63.549999999999997 112.321 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.29 -3.7 18.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 54.119999999999997 110.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.573 HG23 ' NE2' ' A' ' 81' ' ' GLN . 4.6 m -85.8 52.44 2.47 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.735 0.779 . . . . 64.019999999999996 109.099 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 m120 -79.68 130.58 35.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.773 -1.103 . . . . 63.329999999999998 110.332 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.27 -138.95 6.46 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.708 -0.758 . . . . 43.340000000000003 112.46 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -119.53 14.13 12.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.777 0.322 . . . . 72.420000000000002 111.349 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 pt20 -92.81 168.02 11.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.703 -0.226 . . . . 71.510000000000005 110.446 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -145.88 177.49 8.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.802 0.335 . . . . 74.150000000000006 111.127 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 45.6 p90 -160.29 151.87 19.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.319 173.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.0 t -106.61 146.84 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 71.209999999999994 109.56 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.2 p -102.01 126.95 49.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.058 -0.349 . . . . 64.239999999999995 110.058 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 68.2 mt -87.62 -7.71 57.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.317 0.58 . . . . 73.430000000000007 110.55 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -150.89 165.14 18.01 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.397 -0.82 . . . . 64.409999999999997 109.809 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.3 Cg_endo -58.59 113.85 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.631 2.221 . . . . 73.319999999999993 111.652 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.404 HG22 ' HE1' ' A' ' 121' ' ' TRP . 16.6 p -100.06 88.44 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.231 0.538 . . . . 74.239999999999995 111.492 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.9 19.64 12.37 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.916 0.865 . . . . 64.219999999999999 108.845 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.963 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -121.19 1.39 10.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.308 -1.314 . . . . 73.299999999999997 109.891 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.963 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 63.6 mt -121.71 6.37 9.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.485 -0.779 . . . . 72.129999999999995 110.41 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.01 -17.29 64.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 71.099999999999994 111.448 -172.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.11 18.58 5.01 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.507 -0.854 . . . . 72.310000000000002 111.298 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -120.91 -30.13 4.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.119 0.485 . . . . 73.329999999999998 110.249 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -139.67 141.2 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.165 -0.68 . . . . 62.420000000000002 109.165 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -78.16 144.55 36.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.978 0.418 . . . . 75.219999999999999 110.129 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.434 ' O ' HD21 ' A' ' 90' ' ' LEU . 49.3 mt -122.72 112.96 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.14 -0.482 . . . . 63.420000000000002 110.928 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.0 m-85 -155.82 77.31 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.608 0.568 . . . . 75.219999999999999 110.763 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.478 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -163.27 164.49 36.12 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.623 -0.799 . . . . 72.530000000000001 112.553 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -141.76 126.04 17.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.067 -0.346 . . . . 62.409999999999997 110.067 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.9 p -92.56 138.06 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.149 0.499 . . . . 74.040000000000006 110.911 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 47.9 t -144.23 146.0 32.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.1 -0.5 . . . . 71.329999999999998 110.204 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.712 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 7.9 tt0 50.25 40.49 22.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.254 0.55 . . . . 72.409999999999997 111.991 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.66 17.47 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.151 -1.023 . . . . 75.329999999999998 112.512 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.2 tp -74.27 -33.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.061 -0.256 . . . . 73.319999999999993 110.617 -174.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.47 -38.31 96.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.543 -0.837 . . . . 73.540000000000006 111.243 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 142' ' ' VAL . 76.1 mmm -69.33 -51.82 33.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.0 -0.37 . . . . 73.310000000000002 110.0 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.462 HG13 HD12 ' A' ' 62' ' ' ILE . 89.7 t -54.89 -31.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.054 0.454 . . . . 74.519999999999996 110.922 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.455 ' ND2' HD11 ' A' ' 198' ' ' LEU . 1.9 t-20 -71.75 -53.73 12.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 74.230000000000004 110.587 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -73.48 -13.92 61.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.556 -0.747 . . . . 74.140000000000001 111.078 -176.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 138' ' ' MET . 53.4 t -88.51 -40.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 64.140000000000001 110.104 174.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.6 -9.41 86.89 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.708 -0.678 . . . . 74.049999999999997 112.735 -177.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.541 ' HG3' HG13 ' A' ' 145' ' ' VAL . 14.6 ptp -96.18 -13.62 23.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.669 0.271 . . . . 74.219999999999999 111.21 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 144' ' ' MET . 32.2 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.272 0.558 . . . . 62.409999999999997 111.635 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 53' ' ' PHE . 5.7 p . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 122.629 1.204 . . . . 73.349999999999994 111.187 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -133.49 159.63 39.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.085 -1.416 . . . . 72.319999999999993 109.784 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.8 mp -81.37 103.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.815 -0.809 . . . . 75.129999999999995 108.815 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.3 mm -67.59 -65.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 71.219999999999999 109.951 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 mptm? -133.08 135.84 45.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.394 -0.821 . . . . 72.430000000000007 109.098 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.679 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -130.96 143.21 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.938 0.399 . . . . 61.219999999999999 110.089 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 17.0 m-85 -133.7 128.94 20.16 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.781 -0.645 . . . . 61.229999999999997 109.74 -171.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.16 129.11 7.62 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.816 1.677 . . . . 64.540000000000006 111.529 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 74.219999999999999 109.956 -179.531 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.8 m-20 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.424 0.63 . . . . 72.530000000000001 110.715 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.46 144.01 3.87 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.15 -0.932 . . . . 63.140000000000001 111.164 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.88 -174.24 48.34 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.275 -0.964 . . . . 54.200000000000003 112.135 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.95 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.42 149.43 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.532 -0.544 . . . . 75.310000000000002 109.532 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -89.92 103.47 6.42 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.309 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 90.3 Cg_endo -80.61 -6.69 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.218 1.945 . . . . 71.329999999999998 111.066 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.73 -27.48 55.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.666 -1.152 . . . . 73.340000000000003 110.764 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 193' ' ' VAL . 15.8 pt -89.0 -12.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.976 -0.556 . . . . 62.140000000000001 111.703 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 90' ' ' LEU . 12.0 m170 58.27 45.31 17.38 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.801 -0.636 . . . . 71.540000000000006 111.588 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 191' ' ' ILE . 7.0 p -141.91 147.99 21.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.342 -0.39 . . . . 52.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.21 107.81 2.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 112.202 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.38 157.48 32.42 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.873 -0.788 . . . . 71.25 108.873 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 202' ' ' ARG . 46.8 m-85 -128.01 151.65 76.22 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.895 -0.322 . . . . 71.439999999999998 110.949 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.95 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.6 Cg_endo -67.57 -57.55 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 111.711 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -126.52 15.85 7.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.122 -0.49 . . . . 65.450000000000003 110.13 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 1.2 m-20 64.18 22.98 13.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.583 0.957 . . . . 60.130000000000003 113.583 171.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.77 -46.87 51.09 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.886 -0.325 . . . . 60.310000000000002 111.494 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.564 ' HA2' ' OD2' ' A' ' 59' ' ' ASP . . . -79.09 0.5 79.01 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.053 -0.594 . . . . 63.340000000000003 113.593 -172.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 15.9 ptm180 -96.33 -18.01 20.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.157 0.503 . . . . 45.420000000000002 111.168 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.493 -0.776 . . . . 64.530000000000001 109.904 -175.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 50.9 Cg_exo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.876 0.282 . . . . 55.450000000000003 112.701 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 29' ' ' TRP . 71.8 Cg_endo -78.98 -13.51 14.11 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.813 2.342 . . . . 72.409999999999997 112.575 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -151.72 142.01 22.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 72.299999999999997 109.666 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.6 149.33 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.823 0.344 . . . . 71.540000000000006 110.952 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.698 ' CD1' ' HB2' ' A' ' 165' ' ' SER . 7.0 m-85 -107.89 132.57 53.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.02 -0.536 . . . . 63.420000000000002 110.789 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' HD22 ' A' ' 16' ' ' LEU . 2.4 mm? -118.88 102.5 8.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.498 -0.774 . . . . 60.439999999999998 109.917 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.36 109.58 17.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.088 -0.708 . . . . 71.420000000000002 109.088 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -98.28 178.2 5.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.939 0.4 . . . . 74.409999999999997 110.769 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 160' ' ' ILE . 6.9 p -70.96 -28.14 64.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.961 -0.563 . . . . 63.200000000000003 111.365 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.541 ' SD ' HG22 ' A' ' 142' ' ' VAL . 83.3 mtp -91.05 -41.58 10.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.55 -0.296 . . . . 73.439999999999998 111.118 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 -143.08 3.59 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.858 -0.687 . . . . 33.340000000000003 111.396 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 23' ' ' ILE . 20.4 tt -128.11 138.92 53.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 117.026 0.413 . . . . 71.430000000000007 109.895 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 22' ' ' ILE . 10.8 mm -125.53 132.27 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.617 -0.512 . . . . 51.299999999999997 109.617 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 18.3 t -120.0 139.86 45.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 110.14 -0.319 . . . . 75.349999999999994 110.14 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 161.37 42.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 73.319999999999993 110.449 174.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 14.6 pt-20 -130.87 167.68 18.53 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.015 -0.539 . . . . 71.299999999999997 110.167 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.28 157.9 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.416 -0.356 . . . . 64.219999999999999 110.688 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 4.9 m-85 -80.07 102.49 9.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 72.219999999999999 111.499 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 12' ' ' PRO . 11.5 m0 -80.58 -6.27 58.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.887 -0.597 . . . . 73.209999999999994 110.453 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -73.83 -53.35 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 74.549999999999997 111.732 -172.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.62 6.09 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.925 0.342 . . . . 73.420000000000002 111.925 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.19 79.01 67.46 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.996 0.426 . . . . 54.340000000000003 111.52 -176.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.8 Cg_exo -71.84 -41.03 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.371 2.047 . . . . 73.530000000000001 111.573 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -77.33 -43.31 33.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.933 -0.576 . . . . 73.5 110.143 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 2.1 m -57.23 -42.38 81.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.349999999999994 110.334 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.7 t -60.77 -47.96 83.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 110.651 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -62.95 -35.53 80.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.202 -0.453 . . . . 60.439999999999998 111.153 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.22 -53.31 59.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 71.219999999999999 110.76 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HZ ' ' HG3' ' A' ' 100' ' ' MET . 76.9 m-85 -67.96 -44.42 76.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 111.164 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -61.84 -35.96 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 60.32 112.13 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -66.35 -44.71 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.422 0.63 . . . . 61.140000000000001 109.948 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.744 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . 30.4 mt -67.64 -22.12 65.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 111.128 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.0 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 72.310000000000002 110.362 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 32.4 mmt180 -63.84 -49.6 72.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.311 0.576 . . . . 64.340000000000003 110.073 174.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -74.9 -51.97 12.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.378 -0.828 . . . . 71.120000000000005 110.802 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.9 44.86 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 74.420000000000002 112.129 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.744 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -70.6 -26.53 63.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.042 0.449 . . . . 74.140000000000001 110.714 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.503 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.3 m-85 -76.67 -16.49 59.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 62.32 111.572 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -74.52 2.33 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 73.299999999999997 110.942 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.32 11.7 5.26 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.921 -0.657 . . . . 53.420000000000002 111.907 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.4 p -90.45 137.93 31.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 74.219999999999999 110.951 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 2.0 mtmt -129.49 150.75 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.388 -0.597 . . . . 73.010000000000005 109.388 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 72.4 m-85 -78.05 122.37 25.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.851 -0.425 . . . . 70.409999999999997 109.851 177.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -107.36 -30.46 8.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.55 -0.295 . . . . 60.340000000000003 111.064 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 25.5 mmt180 -119.04 110.58 17.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.907 -0.405 . . . . 73.099999999999994 109.907 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.426 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -127.15 93.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 71.540000000000006 109.082 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 35.2 mt -104.1 125.48 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 109.94 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -50.42 129.39 21.84 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.65 0.594 . . . . 75.319999999999993 111.62 177.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' HE3' ' A' ' 58' ' ' LYS . 3.4 p30 42.22 43.74 3.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.231 0.957 . . . . 75.5 112.418 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.743 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -135.67 -77.54 0.43 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 72.310000000000002 110.291 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.7 ptp -160.05 156.05 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 64.140000000000001 110.634 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' A' ' 116' ' ' LEU . 40.6 mt -131.58 101.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.736 -0.666 . . . . 61.520000000000003 109.417 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 24.6 tm0? -88.42 128.92 35.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.647 -0.706 . . . . 73.200000000000003 109.802 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -137.17 144.24 15.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.708 -0.758 . . . . 71.329999999999998 112.369 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 147.14 -143.3 11.17 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.658 -0.782 . . . . 60.109999999999999 112.578 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HA ' HE22 ' A' ' 111' ' ' GLN . 44.5 t0 46.86 77.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 124.16 0.984 . . . . 70.430000000000007 112.71 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.72 -12.08 22.09 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.495 2.13 . . . . 73.010000000000005 111.587 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.0 p -91.81 -42.83 9.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.458 -0.792 . . . . 74.25 111.961 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.22 32.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.602 -0.809 . . . . 70.530000000000001 112.001 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.45 -2.65 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 52.140000000000001 111.038 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.69 -35.7 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.381 -0.914 . . . . 73.409999999999997 113.316 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.711 ' HG2' HG23 ' A' ' 70' ' ' THR . 14.3 ptm180 -78.67 -28.88 45.38 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.219 0.509 . . . . 72.519999999999996 110.888 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.04 -162.65 54.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.023 -0.608 . . . . 15.529999999999999 113.179 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.97 6.79 61.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.294 -0.479 . . . . 72.549999999999997 112.386 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -87.35 22.59 2.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.34 1.067 . . . . 71.409999999999997 110.723 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -85.51 5.8 29.76 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.318 -1.31 . . . . 51.109999999999999 109.805 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.49 -28.51 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.342 -0.845 . . . . 70.400000000000006 111.213 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 p90 -100.18 10.86 40.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.512 0.672 . . . . 75.209999999999994 110.788 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.41 -110.26 3.96 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.11 -0.95 . . . . 61.340000000000003 112.417 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -95.88 -169.02 1.86 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.426 0.291 . . . . 54.530000000000001 110.275 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -65.97 159.26 26.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 63.509999999999998 109.826 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -102.47 -85.18 0.44 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.836 0.35 . . . . 74.530000000000001 110.944 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -162.02 157.19 23.19 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.459 -0.941 . . . . 74.319999999999993 108.459 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.31 110.95 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.533 0.682 . . . . 64.450000000000003 110.438 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.43 28.83 3.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.841 -0.618 . . . . 72.109999999999999 109.377 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.38 100.31 0.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 71.319999999999993 110.502 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -159.92 72.74 3.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.798 -0.637 . . . . 75.140000000000001 109.827 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.21 98.21 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.206 1.938 . . . . 73.299999999999997 112.642 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.56 24.39 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.489 0.662 . . . . 73.340000000000003 110.318 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.8 pp -137.24 -169.06 2.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.501 -0.772 . . . . 73.209999999999994 110.278 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -140.6 151.06 44.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.033 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -72.43 69.5 0.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.713 0.768 . . . . 70.099999999999994 110.668 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.9 p -68.7 -39.94 80.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.174 -0.921 . . . . 63.25 111.824 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 -142.43 3.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.504 -0.855 . . . . 73.140000000000001 112.913 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 141.62 28.43 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.302 0.241 . . . . 60.32 111.018 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.41 22.2 6.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.793 -0.718 . . . . 52.140000000000001 111.917 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.1 mm -87.52 111.25 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.684 -0.487 . . . . 55.100000000000001 109.684 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -88.44 118.9 28.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.139 0.495 . . . . 73.409999999999997 109.715 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.3 173.4 10.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.063 -0.517 . . . . 52.420000000000002 110.817 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.479 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 12.3 ttp -104.02 137.04 42.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.139 -0.482 . . . . 65.430000000000007 110.141 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -89.21 144.46 26.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 63.350000000000001 110.73 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.2 p-10 -153.12 158.77 42.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 71.150000000000006 110.593 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.19 -16.56 20.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.74 0.781 . . . . 64.540000000000006 109.794 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -157.05 174.07 34.65 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.698 -1.761 . . . . 71.109999999999999 108.698 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.03 -47.73 22.52 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.844 2.363 . . . . 41.350000000000001 112.082 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -104.31 -5.07 22.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 64.209999999999994 110.986 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.409 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -87.61 49.33 1.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.767 0.794 . . . . 63.009999999999998 108.865 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 5.7 p30 -94.37 145.08 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 65.140000000000001 111.386 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -129.79 -167.26 12.04 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.013 -1.235 . . . . 64.540000000000006 110.013 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 19.5 t -87.47 14.88 7.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.94 0.87 . . . . 65.409999999999997 110.016 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 10.1 mm-40 -67.53 145.99 54.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.056 -1.09 . . . . 72.409999999999997 108.056 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.72 166.32 24.25 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.191 -0.603 . . . . 71.239999999999995 111.433 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.51 151.38 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.777 -0.647 . . . . 73.329999999999998 110.128 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -110.39 143.65 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.221 -0.659 . . . . 75.109999999999999 109.221 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -98.99 126.38 44.67 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.048 0.451 . . . . 63.509999999999998 110.159 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 62' ' ' ILE . 69.3 mt -83.99 -5.87 59.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.721 -0.672 . . . . 65.430000000000007 110.629 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -146.5 162.01 36.01 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.706 -0.679 . . . . 43.109999999999999 109.829 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 21.6 Cg_endo -61.8 112.91 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.018 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.418 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.2 p -97.51 102.72 14.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.397 0.618 . . . . 73.530000000000001 111.163 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.52 17.71 23.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.424 0.631 . . . . 72.349999999999994 110.355 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.29 -3.38 9.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 64.010000000000005 111.673 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.1 pp -133.07 8.17 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 74.430000000000007 112.443 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -62.74 -27.48 69.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.007 0.432 . . . . 65.099999999999994 111.021 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.34 11.35 36.53 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.751 . . . . 44.310000000000002 112.05 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -117.18 -27.46 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.489 0.661 . . . . 71.310000000000002 109.56 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.38 130.46 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 74.530000000000001 108.68 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.0 t -75.37 143.95 42.55 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.198 -0.601 . . . . 71.239999999999995 110.109 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.4 mt -122.95 116.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 73.439999999999998 110.501 -173.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.6 m-85 -151.96 74.13 1.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.998 0.427 . . . . 72.0 110.459 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.664 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.74 155.81 27.27 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.719 -0.753 . . . . 71.140000000000001 112.179 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.432 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 14.3 mtp180 -135.07 118.91 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.621 -0.511 . . . . 73.400000000000006 109.621 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.432 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.0 p -79.96 136.94 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.405 0.622 . . . . 63.210000000000001 110.55 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.676 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 44.1 t -141.8 145.76 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.674 -0.694 . . . . 72.219999999999999 109.693 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 23.0 tt0 42.75 48.75 4.92 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.483 0.658 . . . . 73.049999999999997 112.363 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 184' ' ' ASP . . . -172.12 13.58 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.833 -1.175 . . . . 54.43 112.988 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -73.54 -31.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.874 0.337 . . . . 53.530000000000001 110.238 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -37.38 94.75 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.701 -0.762 . . . . 53.140000000000001 111.203 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 142' ' ' VAL . 69.8 mmm -72.47 -50.66 24.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.85 -0.426 . . . . 72.420000000000002 109.85 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 62' ' ' ILE . 90.1 t -53.91 -30.65 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 64.209999999999994 110.83 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -69.91 -52.47 24.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.962 -0.563 . . . . 74.430000000000007 110.612 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.523 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.23 -17.07 60.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.447 -0.342 . . . . 74.230000000000004 111.402 -179.202 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 138' ' ' MET . 83.9 t -83.47 -34.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 109.957 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -91.01 -3.74 69.87 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.864 -0.684 . . . . 72.519999999999996 112.619 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.523 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.6 ptm -95.89 -12.2 25.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.728 0.299 . . . . 51.219999999999999 110.954 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 142' ' ' VAL . 21.4 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.668 . . . . 75.450000000000003 110.397 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 53' ' ' PHE . 3.6 p . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.739 0.781 . . . . 71.400000000000006 109.326 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -155.88 176.42 12.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.251 -0.886 . . . . 55.039999999999999 110.486 -171.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -90.17 109.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.456 -0.572 . . . . 74.109999999999999 109.456 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.709 HG22 ' HD3' ' A' ' 161' ' ' LYS . 27.6 mm -75.48 -49.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.628 -0.715 . . . . 74.430000000000007 110.871 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.709 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.78 140.55 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 109.92 178.201 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.503 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -144.01 134.91 25.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.846 0.355 . . . . 74.400000000000006 111.574 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -160.64 151.77 15.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 74.120000000000005 110.375 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 10.3 Cg_exo -70.73 142.23 43.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.832 2.355 . . . . 70.209999999999994 112.483 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.698 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 46.7 m . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.383 -0.599 . . . . 62.100000000000001 109.383 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 136' ' ' ILE . 4.2 m-20 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.123 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 170.08 142.95 3.74 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.719 -0.753 . . . . 61.229999999999997 111.515 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -82.44 -164.62 35.09 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.261 -0.971 . . . . 75.219999999999999 111.992 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.835 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.32 166.95 22.5 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.112 -0.329 . . . . 32.130000000000003 110.112 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.31 95.19 41.92 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-O 121.153 0.502 . . . . 73.0 110.336 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.683 ' HB2' HD13 ' A' ' 90' ' ' LEU . 55.6 Cg_endo -70.77 -19.37 31.41 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.914 2.409 . . . . 71.319999999999993 111.651 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.09 -37.53 66.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.903 -1.044 . . . . 72.099999999999994 111.522 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.518 HG13 HG12 ' A' ' 193' ' ' VAL . 30.4 pt -75.14 -13.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.175 -0.466 . . . . 63.130000000000003 111.75 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' HIS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 59.8 m170 63.02 70.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 73.540000000000006 111.231 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 191' ' ' ILE . 9.3 p -170.8 140.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 110.003 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.31 117.18 7.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 63.009999999999998 111.517 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.35 149.31 11.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.097 -0.705 . . . . 74.129999999999995 109.097 175.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 202' ' ' ARG . 29.0 m-85 -120.2 147.41 44.77 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.744 -0.207 . . . . 75.430000000000007 110.852 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.835 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.4 Cg_endo -63.67 -64.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.527 2.151 . . . . 72.310000000000002 112.025 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.73 26.55 4.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.215 0.531 . . . . 60.119999999999997 109.985 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.51 ' OD1' ' HD3' ' A' ' 202' ' ' ARG . 78.3 m-20 70.08 6.55 5.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.225 -0.898 . . . . 74.109999999999999 112.05 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.9 ptm -54.24 -34.28 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 64.040000000000006 112.198 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.96 10.91 71.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.358 -0.925 . . . . 72.319999999999993 113.222 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.51 ' HD3' ' OD1' ' A' ' 199' ' ' ASP . 4.7 ptm180 -127.21 -39.59 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.138 0.469 . . . . 75.540000000000006 110.501 176.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 203' ' ' LYS . 1.2 ptmm? . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.853 -0.594 . . . . 64.109999999999999 110.124 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' CB ' ' HB2' ' A' ' 164' ' ' PRO . 82.2 Cg_exo . . . . . 0 CA--C 1.529 0.244 0 CA-C-O 121.125 0.385 . . . . 61.219999999999999 113.061 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.75 -24.72 15.35 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.972 2.448 . . . . 74.239999999999995 113.279 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -131.87 146.66 52.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.574 -0.528 . . . . 64.109999999999999 109.574 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.688 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.0 m -131.72 144.17 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.311 0.577 . . . . 73.140000000000001 111.157 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 77.0 m-85 -97.71 120.41 38.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.632 -0.713 . . . . 73.230000000000004 110.701 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -107.57 103.81 13.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.043 -0.354 . . . . 63.210000000000001 110.043 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 22' ' ' ILE . 29.6 mt-10 -92.18 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.491 -0.559 . . . . 73.420000000000002 109.491 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -103.5 179.26 4.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.162 0.506 . . . . 72.109999999999999 111.534 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.436 ' HB3' HD11 ' A' ' 160' ' ' ILE . 11.5 p -73.62 -18.35 61.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 62.450000000000003 111.176 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.7 mmm -98.65 -35.86 10.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 73.319999999999993 111.201 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -172.4 -133.94 1.72 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.691 . . . . 63.210000000000001 111.817 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -141.4 133.83 29.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.075 -0.713 . . . . 54.299999999999997 109.075 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -127.76 126.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.757 -0.656 . . . . 51.520000000000003 109.777 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 10.9 t -108.44 135.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.553 -0.536 . . . . 71.430000000000007 109.553 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.24 162.21 39.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.346 0.593 . . . . 75.409999999999997 110.621 175.68 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 131' ' ' ARG . 2.7 pt-20 -140.42 164.6 29.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.91 -1.041 . . . . 65.530000000000001 109.398 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.28 175.37 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.891 0.377 . . . . 74.129999999999995 110.826 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.3 m-85 -88.92 101.49 14.12 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.31 0.576 . . . . 62.310000000000002 111.052 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.563 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -82.21 -2.13 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.261 -0.881 . . . . 74.030000000000001 110.486 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -75.07 -67.5 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 74.519999999999996 111.24 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -117.51 13.08 14.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 73.409999999999997 110.782 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -136.91 62.2 39.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.824 0.345 . . . . 62.130000000000003 110.945 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 18.5 Cg_exo -65.99 -50.96 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.591 2.194 . . . . 75.040000000000006 112.091 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -74.02 -35.08 64.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.401 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.4 m -62.96 -37.6 87.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.714 -0.675 . . . . 72.209999999999994 110.08 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.563 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 25.2 t -63.85 -39.58 94.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.79 -0.641 . . . . 75.209999999999994 110.925 175.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mmpt? -63.73 -39.66 94.83 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.831 -0.433 . . . . 73.230000000000004 109.831 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -53.7 -57.51 10.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.698 -0.683 . . . . 72.25 110.133 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 14' ' ' VAL . 17.3 t80 -59.29 -49.71 76.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 72.219999999999999 110.754 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.99 75.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.391 -0.822 . . . . 62.310000000000002 112.357 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.658 ' OE2' ' HD3' ' A' ' 44' ' ' ARG . 25.9 mm-40 -63.27 -41.93 99.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.638 -0.255 . . . . 74.349999999999994 111.602 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.6 mm? -69.29 -27.36 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.254 -0.578 . . . . 75.530000000000001 110.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.0 65.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 72.450000000000003 110.802 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.658 ' HD3' ' OE2' ' A' ' 41' ' ' GLU . 2.9 ptm180 -75.05 -29.39 60.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 74.310000000000002 111.39 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 1.3 tmt_? -65.23 -37.31 86.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.35 0.595 . . . . 73.319999999999993 109.854 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.5 32.14 2.2 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.587 -0.816 . . . . 65.109999999999999 111.987 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 42' ' ' LEU . 85.0 t80 -85.91 -44.31 12.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.015 0.436 . . . . 64.340000000000003 110.259 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -78.71 -9.27 59.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 111.041 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -77.62 8.01 4.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 51.039999999999999 110.402 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.83 16.27 1.98 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.871 -0.604 . . . . 50.409999999999997 111.891 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.68 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -97.95 159.45 14.92 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.707 -0.29 . . . . 64.540000000000006 110.832 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -140.63 146.82 38.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.81 0.338 . . . . 34.32 111.544 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 65.4 m-85 -78.48 100.91 7.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.407 -0.961 . . . . 75.200000000000003 108.407 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -109.98 -14.56 14.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.471 -0.492 . . . . 74.340000000000003 111.671 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.948 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 12.7 mmm180 -110.03 112.92 25.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.092 -0.707 . . . . 53.229999999999997 109.092 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD13 HG23 ' A' ' 62' ' ' ILE . 19.7 mm -124.84 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.348 -0.612 . . . . 65.420000000000002 109.348 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 10.8 mt -102.0 115.49 43.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.652 -0.499 . . . . 65.340000000000003 109.652 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 38.7 mtpt -57.13 129.27 41.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.127 0.267 . . . . 63.149999999999999 111.269 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.99 26.69 16.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.545 -0.752 . . . . 71.409999999999997 110.979 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -128.93 -81.71 0.57 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 74.319999999999993 109.976 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -161.04 159.71 29.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 73.310000000000002 110.325 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.581 HD11 ' HA3' ' A' ' 143' ' ' GLY . 62.4 mt -128.78 103.48 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 73.439999999999998 109.382 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.948 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 50.9 mt-30 -85.6 124.53 32.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.606 -0.725 . . . . 60.140000000000001 111.526 -176.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.02 139.16 10.74 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.754 -0.657 . . . . 43.119999999999997 112.487 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.68 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 142.96 -154.77 25.58 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.466 -0.873 . . . . 71.25 112.85 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 69' ' ' GLY . 34.1 t0 55.78 102.6 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.355 1.062 . . . . 72.219999999999999 112.714 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' CZ ' ' A' ' 47' ' ' TYR . 88.6 Cg_endo -79.77 -17.16 11.17 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.102 2.535 . . . . 75.120000000000005 111.515 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.9 p -90.3 -38.27 13.5 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.787 -0.642 . . . . 54.299999999999997 110.305 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 78.28 25.85 60.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 71.200000000000003 111.359 -176.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 76.1 p -97.96 -35.24 10.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 72.340000000000003 111.078 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.87 -20.85 6.71 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.668 -0.696 . . . . 41.25 112.274 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.444 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 7.2 ptm180 -93.57 -28.0 16.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 75.219999999999999 110.934 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.76 -179.52 53.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.7 -0.762 . . . . 51.240000000000002 111.831 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . -79.74 -87.52 0.54 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.861 -0.685 . . . . 63.310000000000002 112.371 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.44 27.07 4.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.845 0.831 . . . . 63.539999999999999 111.228 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -85.99 16.39 4.23 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.041 -0.981 . . . . 52.200000000000003 111.754 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.591 HG13 ' HD1' ' A' ' 78' ' ' TYR . 46.4 pt -81.85 -29.53 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.715 -0.394 . . . . 71.310000000000002 110.143 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG13 ' A' ' 77' ' ' ILE . 2.9 p90 -117.95 14.05 14.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.924 0.868 . . . . 74.510000000000005 110.521 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -77.06 1.81 Allowed Glycine 0 C--N 1.318 -0.441 0 CA-C-N 114.59 -1.186 . . . . 72.430000000000007 113.425 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -111.98 -163.85 0.88 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.272 -0.27 . . . . 70.530000000000001 110.272 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 5.0 pm0 -86.61 168.0 14.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.647 . . . . 73.129999999999995 109.252 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -98.88 -80.1 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.77 -0.372 . . . . 75.010000000000005 111.308 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.51 163.57 27.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.964 -0.754 . . . . 71.0 108.964 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.34 143.66 34.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 74.430000000000007 109.756 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 23.8 7.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.75 -0.659 . . . . 74.129999999999995 109.604 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 127' ' ' THR . 78.2 mt -54.51 100.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.52 -0.764 . . . . 71.200000000000003 111.648 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.61 91.33 0.43 Allowed Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.39 -0.823 . . . . 71.400000000000006 109.412 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' LEU . 19.2 Cg_endo -57.6 92.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.611 2.207 . . . . 44.420000000000002 111.071 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.28 23.3 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.145 0.974 . . . . 75.510000000000005 109.146 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -145.3 -176.88 5.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.361 -1.29 . . . . 73.439999999999998 108.625 -178.322 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HD3' HG22 ' A' ' 93' ' ' THR . 54.2 tttm -113.61 147.88 37.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.324 0.583 . . . . 62.439999999999998 110.938 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.24 79.99 4.67 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.091 0.948 . . . . 74.329999999999998 108.481 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.426 HG22 ' HD3' ' A' ' 91' ' ' LYS . 26.8 p -75.65 -41.95 52.69 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.612 -1.176 . . . . 74.319999999999993 111.838 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.795 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.83 -137.79 2.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.658 -0.782 . . . . 74.049999999999997 112.293 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.77 147.29 24.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.815 0.341 . . . . 40.210000000000001 110.891 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 106.41 21.95 8.08 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.446 -0.662 . . . . 75.109999999999999 111.446 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 mm -90.03 110.9 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.479 -0.563 . . . . 72.140000000000001 109.479 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -85.89 117.77 24.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.76 -0.654 . . . . 73.209999999999994 109.538 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.0 169.81 12.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.125 0.488 . . . . 52.030000000000001 111.854 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.845 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 14.0 tpt -90.45 135.4 33.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.412 -0.813 . . . . 75.239999999999995 109.983 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -97.86 149.33 22.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.522 -0.548 . . . . 74.200000000000003 109.522 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -163.11 159.26 22.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 73.109999999999999 110.7 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.39 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.627 0.727 . . . . 73.439999999999998 109.814 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -137.31 177.76 19.56 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.988 -1.645 . . . . 64.430000000000007 108.988 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 -51.84 9.72 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.021 2.481 . . . . 55.310000000000002 112.86 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.7 -4.83 29.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 71.140000000000001 111.59 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 2.2 m -88.81 49.68 1.83 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.327 0.584 . . . . 72.549999999999997 109.469 -175.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -74.27 -66.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.806 -1.088 . . . . 51.509999999999998 110.944 178.357 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 -100.77 2.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.625 -0.797 . . . . 71.25 112.343 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -152.87 35.94 0.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.012 0.434 . . . . 61.409999999999997 110.81 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 19.9 mt-30 -102.54 146.56 27.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 74.510000000000005 110.186 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -142.44 166.9 23.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.711 0.291 . . . . 61.229999999999997 110.795 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -158.59 153.23 24.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.926 0.393 . . . . 74.409999999999997 111.004 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 HD23 ' A' ' 98' ' ' LEU . 17.7 t -108.62 145.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 72.219999999999999 109.265 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -99.88 129.67 45.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.897 0.379 . . . . 54.439999999999998 110.452 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 62' ' ' ILE . 64.7 mt -84.79 -9.63 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 110.984 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.32 164.18 28.03 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.9 -0.591 . . . . 62.399999999999999 110.054 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 35.5 Cg_exo -60.98 114.52 2.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.454 2.103 . . . . 62.140000000000001 111.493 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.7 p -100.12 94.56 6.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.277 0.561 . . . . 74.549999999999997 111.189 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.11 14.56 27.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 72.109999999999999 110.104 -177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.59 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.6 p90 -118.29 -3.36 11.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.026 -0.988 . . . . 73.450000000000003 110.495 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.601 HD22 ' HD2' ' A' ' 126' ' ' HIS . 83.5 mt -105.06 8.82 34.44 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.792 -0.64 . . . . 74.209999999999994 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.1 -23.58 55.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.064 -1.425 . . . . 75.140000000000001 111.315 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.29 23.22 3.49 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 120.874 -0.679 . . . . 72.400000000000006 111.983 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.45 -32.95 3.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.936 0.398 . . . . 72.209999999999994 110.279 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.601 ' HD2' HD22 ' A' ' 122' ' ' LEU . 96.9 m-70 -141.24 139.53 33.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.322 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 86' ' ' LEU . 23.7 m -75.46 135.98 40.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.777 -0.453 . . . . 61.329999999999998 109.777 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -115.46 124.75 72.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 121.058 -0.257 . . . . 74.25 110.828 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.845 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 3.8 p90 -157.4 74.07 0.75 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.949 0.88 . . . . 65.209999999999994 110.932 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.83 152.39 22.55 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.01 -1.567 . . . . 74.120000000000005 113.841 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.631 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -138.62 110.2 7.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 74.549999999999997 109.726 174.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.9 p -79.93 139.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 44.439999999999998 111.264 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.633 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.1 t -142.47 151.71 42.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.096 -0.502 . . . . 51.219999999999999 109.892 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 42.42 60.07 2.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.258 0.623 . . . . 73.209999999999994 112.15 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.54 24.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.035 -1.079 . . . . 71.230000000000004 112.883 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -78.02 -32.51 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.109 -0.33 . . . . 73.549999999999997 110.109 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.46 -37.35 94.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.949 -0.644 . . . . 64.25 111.934 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.502 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 74.9 mmm -67.02 -51.1 59.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.511 -0.551 . . . . 53.420000000000002 109.511 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 62' ' ' ILE . 74.8 t -54.21 -32.92 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 64.099999999999994 110.586 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.8 t30 -71.29 -56.08 6.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 60.020000000000003 110.656 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.8 -13.8 61.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.463 -0.335 . . . . 70.349999999999994 111.307 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 145' ' ' VAL . 44.6 t -88.82 -36.62 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 63.25 110.505 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.581 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -83.52 -18.98 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 72.120000000000005 113.2 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 60.5 mtp -89.87 -8.76 51.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.2 0.444 . . . . 73.25 112.2 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.1 m . . . . . 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.468 . . . . 52.240000000000002 110.737 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 120.534 0.207 . . . . 61.299999999999997 110.644 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.95 159.37 19.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.265 0.555 . . . . 64.519999999999996 111.443 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.3 mp -87.74 102.4 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.644 -1.162 . . . . 50.439999999999998 108.494 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 19' ' ' SER . 30.7 mm -68.21 -56.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.537 -0.756 . . . . 74.409999999999997 110.009 -176.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 14.5 mptt -127.4 136.97 52.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 72.299999999999997 109.998 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.81 115.96 15.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.939 0.399 . . . . 70.230000000000004 110.385 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.62 116.3 26.59 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.64 . . . . 72.0 110.918 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 14' ' ' VAL . 56.8 Cg_endo -73.02 126.91 11.62 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.172 1.915 . . . . 73.409999999999997 111.413 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.7 m . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 64.439999999999998 111.339 -176.346 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.324 0.583 . . . . 74.319999999999993 111.454 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.24 145.53 4.36 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.118 -0.947 . . . . 62.340000000000003 111.188 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.49 -161.77 15.64 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.549 -0.834 . . . . 72.510000000000005 112.065 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.721 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.92 -177.12 6.58 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 110.326 -0.25 . . . . 40.399999999999999 110.326 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.86 91.96 28.27 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 109.648 -0.501 . . . . 64.230000000000004 109.648 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.6 Cg_exo -78.67 -12.18 15.18 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.899 2.4 . . . . 73.200000000000003 112.148 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.88 -36.51 70.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.95 -0.568 . . . . 71.349999999999994 109.997 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.2 pt -88.07 156.15 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.98 -0.748 . . . . 73.030000000000001 108.98 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -105.32 89.06 3.01 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.374 -0.53 . . . . 73.340000000000003 110.291 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 194' ' ' ALA . 9.7 p -163.92 170.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.83 -0.804 . . . . 71.310000000000002 108.83 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -94.9 115.72 27.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.865 0.364 . . . . 71.420000000000002 111.05 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.655 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -144.18 153.27 41.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.449 -0.945 . . . . 75.219999999999999 108.449 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.98 139.03 34.5 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.79 0.329 . . . . 75.349999999999994 111.034 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.8 Cg_endo -63.26 -54.13 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.713 2.275 . . . . 74.209999999999994 112.06 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.48 35.31 0.96 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.455 -0.339 . . . . 62.329999999999998 111.457 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.546 ' OD2' ' HD3' ' A' ' 202' ' ' ARG . 7.4 t70 75.77 -14.05 0.82 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.074 0.55 . . . . 64.400000000000006 111.66 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.5 ptm -46.1 -29.93 1.71 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.877 1.066 . . . . 72.200000000000003 113.877 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -111.09 10.72 29.23 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 72.340000000000003 113.254 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.546 ' HD3' ' OD2' ' A' ' 199' ' ' ASP . 44.0 mtp180 -72.43 -38.42 68.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 117.62 0.71 . . . . 70.239999999999995 111.91 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 203' ' ' LYS . 3.7 mppt? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.747 -0.645 . . . . 75.439999999999998 110.633 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 4.2 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 N-CA-C 113.068 0.372 . . . . 53.210000000000001 113.068 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 6.2 Cg_exo -75.15 -44.85 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.811 2.341 . . . . 62.439999999999998 112.263 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -124.88 144.39 50.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 72.329999999999998 110.458 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.79 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.4 m -133.23 162.91 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 64.109999999999999 110.394 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -122.33 134.86 54.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.064 0.459 . . . . 74.310000000000002 110.376 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.4 mt -111.87 107.98 17.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 71.109999999999999 109.391 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -92.24 119.46 31.87 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.428 -0.582 . . . . 63.210000000000001 109.428 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.402 HG22 HG13 ' A' ' 159' ' ' ILE . 69.1 p -109.07 178.3 4.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.141 0.496 . . . . 71.25 110.986 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 t -67.27 -15.89 63.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 110.442 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.587 ' HG3' HG22 ' A' ' 142' ' ' VAL . 5.7 mmt -95.55 -34.62 11.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.007 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.18 -130.79 1.87 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.086 -0.806 . . . . 63.240000000000002 111.086 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.236 0.541 . . . . 64.230000000000004 110.486 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.96 114.13 37.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.429 -0.805 . . . . 65.230000000000004 109.767 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 41.3 t -96.4 141.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.839 -0.619 . . . . 75.230000000000004 109.374 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.1 163.79 36.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.137 0.494 . . . . 65.200000000000003 111.015 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.17 162.92 30.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.505 -0.77 . . . . 71.239999999999995 109.892 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 166.04 10.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.764 -0.653 . . . . 72.099999999999994 109.394 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 5.3 m-85 -85.75 93.5 8.88 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 74.010000000000005 111.702 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.845 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -79.47 -8.75 59.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.743 0.782 . . . . 70.209999999999994 109.343 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HE2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -70.34 -45.01 67.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.384 -1.28 . . . . 73.230000000000004 111.658 -173.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -137.86 8.61 2.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.807 0.299 . . . . 71.310000000000002 111.807 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.22 67.27 10.69 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.835 0.679 . . . . 60.399999999999999 112.835 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.49 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 21.3 Cg_exo -65.54 -27.4 53.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.025 1.817 . . . . 43.310000000000002 110.996 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -62.87 -59.48 4.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 64.310000000000002 110.892 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -62.67 -36.34 82.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.597 . . . . 75.319999999999993 110.208 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.845 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 39.5 t -53.73 -53.47 51.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.238 -0.892 . . . . 70.209999999999994 111.278 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 3.0 mtmp? -69.88 -27.28 64.68 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.789 -0.364 . . . . 74.420000000000002 111.666 -173.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' O ' HD23 ' A' ' 42' ' ' LEU . 59.8 t30 -59.48 -49.83 76.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.489 -0.56 . . . . 64.299999999999997 109.489 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.79 ' HE1' HG21 ' A' ' 14' ' ' VAL . 12.3 t80 -68.81 -51.33 41.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.852 176.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.54 -44.86 77.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 63.439999999999998 112.985 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 43.4 mt-10 -77.77 -26.59 49.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 121.126 -0.229 . . . . 72.109999999999999 111.572 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 38' ' ' ASN . 3.2 mm? -78.99 -20.88 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.788 -0.765 . . . . 72.030000000000001 110.428 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.38 -44.31 36.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 110.951 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.711 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -62.98 -36.76 84.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.629 -0.26 . . . . 71.349999999999994 111.314 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -72.77 -46.93 50.76 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.203 -0.599 . . . . 74.310000000000002 109.423 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.33 42.83 1.03 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.522 -0.847 . . . . 72.209999999999994 113.46 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HD1' ' HG3' ' A' ' 67' ' ' PRO . 1.2 m-85 -77.45 -15.95 59.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 73.319999999999993 110.405 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.82 0.27 51.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.761 -0.654 . . . . 62.439999999999998 111.001 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 48.7 m-80 -81.81 2.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 109.868 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -134.71 14.05 4.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.002 -0.618 . . . . 64.329999999999998 112.176 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.6 p -88.83 149.22 23.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.661 0.267 . . . . 54.210000000000001 110.46 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -138.65 128.42 25.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.553 -0.294 . . . . 71.239999999999995 110.556 -176.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 61.0 m-85 -67.07 110.74 3.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.97 -0.752 . . . . 75.400000000000006 108.97 175.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -111.86 -18.48 12.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.835 -0.346 . . . . 74.319999999999993 111.133 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.5 mmt85 -110.34 105.27 14.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.523 -0.547 . . . . 74.120000000000005 109.523 173.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.16 91.2 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.907 -0.775 . . . . 71.319999999999993 108.907 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.1 mt -102.8 119.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.739 -0.664 . . . . 73.439999999999998 109.262 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -52.02 139.25 23.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.446 0.466 . . . . 55.509999999999998 110.219 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 44.21 33.79 0.89 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.384 1.052 . . . . 75.340000000000003 112.6 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -131.54 -82.92 0.51 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.385 0.612 . . . . 71.0 110.213 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.539 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptm -159.76 156.59 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.804 . . . . 62.43 110.812 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 116' ' ' LEU . 43.1 mt -129.37 103.26 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.519 -0.764 . . . . 73.400000000000006 108.943 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 42.7 tt0 -87.93 124.61 33.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.764 -0.653 . . . . 74.219999999999999 111.835 -173.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.79 113.57 4.03 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.061 -0.815 . . . . 44.439999999999998 111.061 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.8 157.61 43.83 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.706 -0.283 . . . . 74.109999999999999 112.667 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.66 156.56 90.61 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 123.804 0.355 . . . . 72.209999999999994 111.492 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HG3' ' HD1' ' A' ' 47' ' ' TYR . 23.7 Cg_endo -58.71 -21.86 58.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.723 2.949 . . . . 70.120000000000005 113.521 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -86.66 -30.43 21.73 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.644 -0.502 . . . . 73.209999999999994 109.644 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.94 71.08 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.725 -0.75 . . . . 75.010000000000005 111.642 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.3 p -88.56 -32.14 18.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.56 0.695 . . . . 71.120000000000005 109.401 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.1 46.65 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.881 -1.054 . . . . 52.509999999999998 111.674 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -119.83 -2.97 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.761 0.282 . . . . 63.130000000000003 111.761 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.75 -155.3 11.68 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.607 -0.806 . . . . 74.099999999999994 112.557 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.4 167.65 42.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.337 -0.935 . . . . 74.439999999999998 111.639 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 55.2 -96.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.785 0.434 . . . . 71.150000000000006 110.925 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m 69.07 -31.79 0.21 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.86 0.864 . . . . 75.430000000000007 113.126 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.426 ' H ' ' C ' ' A' ' 75' ' ' ALA . 5.9 tt -55.84 -42.76 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.575 0.583 . . . . 64.120000000000005 112.575 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.571 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 13.8 p90 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.421 0.629 . . . . 75.140000000000001 110.774 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 112.3 -104.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 112.336 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 39.5 mtmt -125.68 -162.05 1.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.317 -0.623 . . . . 74.420000000000002 109.317 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -66.57 157.13 33.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.901 -0.778 . . . . 74.409999999999997 108.901 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -117.57 -54.24 2.37 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.646 -0.421 . . . . 73.310000000000002 111.417 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -166.61 -175.87 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.437 -0.579 . . . . 74.099999999999994 109.437 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -83.93 132.31 34.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 71.140000000000001 110.037 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB2' HG21 ' A' ' 127' ' ' THR . 35.2 mm-40 -96.93 8.76 43.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.787 -0.642 . . . . 63.009999999999998 109.671 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.21 105.63 0.52 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.84 -0.618 . . . . 72.319999999999993 111.893 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -163.2 80.97 1.58 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 71.109999999999999 109.571 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.05 88.32 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.012 1.808 . . . . 63.509999999999998 111.578 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.7 -18.69 37.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.112 0.958 . . . . 74.430000000000007 109.377 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.7 pp -101.18 -178.84 3.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.52 -1.218 . . . . 63.32 108.75 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -138.35 147.78 43.86 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.121 -0.632 . . . . 73.409999999999997 110.416 171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 120' ' ' GLN . 1.2 p90 -62.8 109.38 1.42 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.801 0.81 . . . . 71.010000000000005 110.726 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -99.26 -44.99 6.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.228 -0.896 . . . . 52.43 110.428 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.66 -139.25 2.77 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.725 -0.75 . . . . 72.340000000000003 112.389 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.12 145.6 26.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.63 0.253 . . . . 63.200000000000003 110.687 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.66 22.26 7.45 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.648 -0.787 . . . . 71.340000000000003 111.618 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HG3' ' A' ' 189' ' ' PRO . 9.9 mm -84.76 109.68 18.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.214 -0.662 . . . . 74.299999999999997 109.214 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -84.87 115.18 22.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.006 -0.543 . . . . 73.109999999999999 109.569 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.79 176.84 7.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 70.310000000000002 110.855 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 26.7 ttt -104.19 142.07 35.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 72.409999999999997 111.145 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -97.97 141.89 30.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.471 . . . . 71.010000000000005 110.174 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -157.78 160.6 37.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.738 -0.665 . . . . 74.400000000000006 110.132 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.73 -9.02 25.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.613 0.721 . . . . 54.329999999999998 110.333 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.99 169.38 40.23 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.107 -1.597 . . . . 70.230000000000004 109.107 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.18 -42.49 46.59 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.098 2.532 . . . . 72.010000000000005 112.794 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -103.03 -5.45 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 64.409999999999997 111.806 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -84.94 48.4 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.432 0.634 . . . . 63.140000000000001 110.061 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -89.73 121.54 31.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.892 . . . . 73.109999999999999 109.712 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.01 -94.79 2.21 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.659 -0.781 . . . . 43.329999999999998 112.452 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 18.0 t -140.87 6.92 2.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.377 0.608 . . . . 74.409999999999997 109.999 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.412 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 19.4 mp0 -81.02 143.91 32.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.696 -0.684 . . . . 74.099999999999994 110.363 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 m-85 -144.24 162.32 36.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.369 -0.234 . . . . 74.239999999999995 110.369 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 41.9 p90 -154.02 157.21 38.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 70.099999999999994 111.148 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.693 HG22 HD23 ' A' ' 98' ' ' LEU . 18.2 t -112.11 145.88 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.928 -0.578 . . . . 71.310000000000002 109.444 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -99.52 130.38 45.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.952 0.406 . . . . 64.019999999999996 110.141 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 62' ' ' ILE . 59.5 mt -84.46 -7.1 59.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 51.229999999999997 110.775 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.39 163.35 24.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 34.32 109.929 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.25 113.12 2.75 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.602 2.201 . . . . 73.409999999999997 112.203 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.1 p -103.08 110.66 22.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 72.519999999999996 110.393 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -99.59 15.82 25.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.332 0.587 . . . . 75.430000000000007 110.82 -170.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.591 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.4 p90 -121.32 -2.65 9.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.467 -0.788 . . . . 74.129999999999995 110.89 -175.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.8 mt -102.97 7.93 39.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 43.539999999999999 110.475 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.89 -15.38 62.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.045 -0.98 . . . . 52.200000000000003 111.74 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.39 19.69 3.8 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.805 -0.712 . . . . 22.210000000000001 111.695 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -121.04 -28.8 4.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.266 0.555 . . . . 52.350000000000001 109.958 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.499 ' HD2' HD22 ' A' ' 122' ' ' LEU . 93.5 m-70 -138.64 144.55 39.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.489 -0.778 . . . . 73.409999999999997 109.376 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.407 HG21 ' HB2' ' A' ' 85' ' ' GLU . 14.5 t -85.37 145.19 27.61 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.398 -0.593 . . . . 75.140000000000001 109.398 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' A' ' 99' ' ' ALA . 31.4 mt -126.06 116.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.349 -0.387 . . . . 71.239999999999995 110.751 -176.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -154.41 74.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.456 0.472 . . . . 74.109999999999999 110.863 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.739 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.35 157.35 29.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.24 -0.981 . . . . 52.100000000000001 112.882 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 30.5 mtp180 -137.89 118.88 14.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.979 -0.378 . . . . 74.450000000000003 109.979 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.5 p -81.76 138.36 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 54.119999999999997 110.411 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.3 t -143.23 142.85 31.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.034 -0.53 . . . . 52.439999999999998 110.132 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.6 tt0 54.23 35.99 23.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.345 0.593 . . . . 61.140000000000001 112.035 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.12 29.41 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.236 -0.983 . . . . 75.109999999999999 112.565 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -83.39 -30.33 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 73.340000000000003 110.121 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.03 -31.65 81.59 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.659 . . . . 60.009999999999998 111.586 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.1 mmm -72.18 -49.35 36.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.486 -0.561 . . . . 72.319999999999993 109.486 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.476 HG13 HD12 ' A' ' 62' ' ' ILE . 61.8 t -55.0 -31.82 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.196 0.522 . . . . 75.310000000000002 110.508 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.04 -52.41 24.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.867 -0.606 . . . . 54.049999999999997 110.638 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -15.23 61.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.397 -0.365 . . . . 74.430000000000007 111.394 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.7 t -86.58 -38.82 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.31 -0.405 . . . . 74.530000000000001 110.555 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.83 -12.68 68.31 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.641 -0.79 . . . . 73.239999999999995 112.831 -176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.2 ptm -82.0 -17.17 47.79 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.622 -0.34 . . . . 73.409999999999997 110.806 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 142' ' ' VAL . 19.2 m . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.675 -0.41 . . . . 74.010000000000005 110.798 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 C--O 1.221 -0.447 0 N-CA-C 107.99 -1.115 . . . . 70.120000000000005 107.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.41 155.91 28.82 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.363 -0.535 . . . . 72.209999999999994 111.427 -168.573 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.4 mp -85.13 109.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.801 -1.091 . . . . 64.450000000000003 109.391 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.4 mm -71.49 -49.98 43.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.478 -0.783 . . . . 62.229999999999997 110.497 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.93 130.34 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.824 -0.625 . . . . 74.340000000000003 110.758 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.31 112.71 11.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.84 0.352 . . . . 21.510000000000002 110.537 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -142.15 152.35 61.14 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.64 -0.709 . . . . 64.25 110.032 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 30.9 Cg_endo -67.24 131.7 25.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.374 2.049 . . . . 64.219999999999999 111.984 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.4 ' H ' ' HA ' ' A' ' 14' ' ' VAL . 32.4 t . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.692 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.7 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.329 0.585 . . . . 55.140000000000001 110.991 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 142.3 135.74 3.13 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.968 -1.014 . . . . 61.32 110.879 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.16 -176.7 51.42 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.265 -0.969 . . . . 70.299999999999997 111.775 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.809 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.44 145.52 47.55 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.691 -0.485 . . . . 64.230000000000004 109.691 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 98.3 m-85 -97.81 105.06 24.58 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-O 121.182 0.515 . . . . 61.350000000000001 110.368 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.71 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.6 Cg_endo -83.58 -7.44 10.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.215 2.61 . . . . 71.420000000000002 111.313 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.06 -35.05 20.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.105 -0.952 . . . . 71.329999999999998 110.789 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 193' ' ' VAL . 21.4 pt -74.63 -13.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 64.310000000000002 110.483 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 47.3 m170 61.59 54.96 2.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.835 -1.075 . . . . 54.43 111.236 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.561 HG12 HG13 ' A' ' 191' ' ' ILE . 9.9 p -150.16 141.15 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.512 . . . . 63.109999999999999 109.875 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.28 110.14 5.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 74.030000000000001 111.425 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.64 155.89 30.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.312 -0.625 . . . . 73.409999999999997 109.312 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.478 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 24.5 m-85 -118.44 154.11 52.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.651 -0.249 . . . . 71.120000000000005 111.266 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 44.4 Cg_endo -68.4 -75.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.413 2.075 . . . . 62.109999999999999 112.138 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 199' ' ' ASP . 1.4 pt? -127.66 32.07 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.726 -0.215 . . . . 74.299999999999997 110.982 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 198' ' ' LEU . 11.5 t70 77.01 -6.21 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.174 0.435 . . . . 44.130000000000003 112.174 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.8 ptm -49.5 -28.39 5.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.214 0.82 . . . . 50.140000000000001 113.214 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.04 2.82 35.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.186 -1.007 . . . . 60.520000000000003 113.331 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.478 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 44.5 mtp-105 -84.85 -63.34 1.35 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.759 0.79 . . . . 75.540000000000006 109.798 176.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 203' ' ' LYS . 18.1 mmmt . . . . . 0 C--O 1.246 0.891 0 CA-C-N 112.779 -2.01 . . . . 74.209999999999994 111.754 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 11.9 Cg_exo . . . . . 0 CA--C 1.53 0.304 0 N-CA-C 114.26 0.831 . . . . 74.349999999999994 114.26 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 86.3 Cg_endo -78.43 13.49 1.83 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.827 3.018 . . . . 71.349999999999994 113.608 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 165' ' ' SER . 4.9 t30 -133.36 138.94 46.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.741 -0.663 . . . . 74.010000000000005 109.899 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.3 m -138.92 156.73 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.708 0.29 . . . . 72.200000000000003 110.681 -177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.679 ' HD1' ' HB2' ' A' ' 165' ' ' SER . 27.8 p90 -123.99 141.13 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.074 0.464 . . . . 73.140000000000001 111.041 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.51 110.08 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.674 -0.694 . . . . 75.120000000000005 109.407 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.858 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 32.0 tt0 -88.83 113.25 24.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.492 -0.929 . . . . 71.310000000000002 108.492 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -103.13 -179.95 4.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.963 -0.562 . . . . 53.310000000000002 110.939 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -75.3 -15.74 60.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 74.340000000000003 110.649 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 92.5 mmm -97.1 -38.81 9.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.626 . . . . 73.25 110.664 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.49 -139.87 3.22 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.231 -0.748 . . . . 51.329999999999998 111.231 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -136.7 130.62 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.507 -0.553 . . . . 72.099999999999994 109.507 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG12 ' CG2' ' A' ' 139' ' ' VAL . 4.2 mp -124.85 130.49 73.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 71.540000000000006 110.467 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 15' ' ' TYR . 59.1 t -113.85 145.05 20.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.904 -0.406 . . . . 74.430000000000007 109.904 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.77 36.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.345 0.593 . . . . 63.43 110.725 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.466 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 9.4 pt-20 -134.1 162.15 32.91 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.211 -0.904 . . . . 54.210000000000001 108.999 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -97.44 175.5 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.6 -0.519 . . . . 75.310000000000002 109.6 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.576 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 3.9 m-30 -79.21 100.41 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 72.439999999999998 110.878 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.728 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 15.3 m0 -79.82 -7.06 58.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.956 -0.565 . . . . 73.120000000000005 110.45 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.52 -65.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.848 -0.614 . . . . 74.510000000000005 111.247 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.95 -16.06 20.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 73.230000000000004 110.813 -171.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -130.71 72.3 81.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.745 0.646 . . . . 73.400000000000006 112.745 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 14.0 Cg_exo -69.45 -20.88 35.72 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.392 2.061 . . . . 64.219999999999999 110.826 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -82.01 -45.55 15.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.057 -0.974 . . . . 74.430000000000007 110.836 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 12.1 m -65.92 -39.24 90.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.051 -0.522 . . . . 74.540000000000006 111.586 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 4.7 p -64.31 -39.78 94.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 70.400000000000006 111.699 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 9.5 mtmp? -91.14 -8.8 47.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.295 -0.562 . . . . 55.43 110.8 -178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 48.9 t30 -72.44 -55.54 6.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.657 -0.701 . . . . 71.049999999999997 109.349 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.28 -40.88 98.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.284 -0.416 . . . . 71.5 110.888 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.29 -42.8 61.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 62.520000000000003 111.312 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 10.0 mm-40 -56.84 -50.88 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.274 -0.421 . . . . 72.209999999999994 111.422 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 47' ' ' TYR . 2.7 mm? -62.77 -28.15 69.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.501 -0.318 . . . . 75.209999999999994 111.466 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -51.84 25.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 65.510000000000005 110.942 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -72.47 -29.65 63.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.310000000000002 111.472 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -68.02 -52.42 35.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.997 0.427 . . . . 65.340000000000003 109.954 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 131.13 43.45 0.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.057 -1.068 . . . . 54.020000000000003 113.233 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.576 ' CG ' HD12 ' A' ' 42' ' ' LEU . 18.7 m-85 -92.24 -33.49 14.64 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.465 -0.432 . . . . 74.109999999999999 111.395 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -82.06 -16.4 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 75.310000000000002 110.874 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.437 HD22 ' HA2' ' A' ' 46' ' ' GLY . 38.3 m-80 -70.78 -0.96 10.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.478 . . . . 74.219999999999999 111.028 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.05 34.52 2.07 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.518 -0.633 . . . . 75.400000000000006 111.518 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.531 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -104.21 149.62 25.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.979 0.418 . . . . 72.209999999999994 111.014 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -128.2 148.67 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 51.509999999999998 109.394 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 87.3 m-85 -80.08 122.5 26.86 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.499 -0.556 . . . . 74.5 109.499 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -106.61 -39.61 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.871 0.323 . . . . 72.230000000000004 111.871 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 39.3 mmt180 -108.91 105.42 14.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.923 -0.311 . . . . 63.509999999999998 110.23 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.601 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -123.58 91.28 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.895 -0.779 . . . . 72.109999999999999 108.895 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.2 mt -96.28 130.48 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 109.237 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 43.8 mttt -54.97 108.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.928 0.767 . . . . 70.409999999999997 111.831 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 55.99 44.9 24.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.285 -0.87 . . . . 75.530000000000001 110.828 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 12.8 t80 -129.93 -75.99 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.269 -0.878 . . . . 63.439999999999998 109.12 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.516 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.75 154.63 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.215 -0.902 . . . . 61.149999999999999 109.884 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.601 HG23 HG13 ' A' ' 56' ' ' ILE . 46.8 mt -129.41 102.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.044 -0.525 . . . . 72.340000000000003 109.996 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 49.3 tt0 -86.02 122.51 30.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 74.409999999999997 110.526 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -125.17 142.7 14.02 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.886 -0.597 . . . . 72.349999999999994 112.011 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 149.66 -141.86 9.24 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.504 -0.855 . . . . 60.409999999999997 112.332 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.18 78.54 0.39 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.814 0.672 . . . . 74.200000000000003 112.814 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.78 -12.94 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 121.98 1.786 . . . . 62.200000000000003 110.442 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.8 p -103.23 -47.55 4.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.156 -0.929 . . . . 64.230000000000004 110.777 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.68 15.39 54.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.438 -0.665 . . . . 31.210000000000001 111.438 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -80.95 -41.54 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.29 0.567 . . . . 74.310000000000002 111.499 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -16.29 4.97 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.492 -0.776 . . . . 44.119999999999997 111.374 -174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -109.8 -30.33 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 65.219999999999999 110.903 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.6 -155.82 28.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.6 -0.809 . . . . 75.209999999999994 111.409 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.48 -105.48 0.24 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.624 -0.798 . . . . 60.030000000000001 112.282 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.98 36.4 21.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.609 0.719 . . . . 74.310000000000002 111.455 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -91.19 12.85 18.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.615 -0.72 . . . . 62.310000000000002 111.047 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.461 HG13 ' HD1' ' A' ' 78' ' ' TYR . 47.6 pt -74.23 -22.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.348 -0.387 . . . . 52.009999999999998 111.181 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 81' ' ' GLN . 6.8 p90 -110.81 3.38 18.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.498 0.666 . . . . 71.430000000000007 110.495 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 -115.55 4.83 Favored Glycine 0 C--O 1.237 0.295 0 CA-C-N 115.182 -0.917 . . . . 63.310000000000002 111.856 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -76.31 179.19 5.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.25 -1.018 . . . . 74.519999999999996 108.25 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.646 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -78.61 149.73 32.87 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.47 -0.937 . . . . 75.209999999999994 108.47 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -102.11 -85.66 0.43 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.329 0.862 . . . . 71.319999999999993 113.329 -156.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.65 157.65 43.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.841 0.353 . . . . 63.32 111.205 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.7 126.2 30.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.31 0.576 . . . . 74.430000000000007 110.2 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -105.99 18.7 21.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 109.496 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' A' ' 127' ' ' THR . 59.3 mt -62.01 104.63 0.48 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.952 -0.567 . . . . 70.219999999999999 110.891 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -169.88 80.45 0.63 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.413 -0.588 . . . . 73.319999999999993 109.413 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.21 100.39 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.464 2.109 . . . . 73.310000000000002 112.076 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.23 -3.59 52.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.228 1.013 . . . . 61.140000000000001 109.532 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -109.94 -171.39 1.83 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.315 -172.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -147.07 145.99 29.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.198 -1.038 . . . . 75.099999999999994 108.198 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 26.8 p90 -58.48 124.79 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.24 0.543 . . . . 75.010000000000005 110.066 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.4 p -121.98 -45.59 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.665 -0.698 . . . . 65.200000000000003 110.084 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -151.31 6.11 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.483 -0.78 . . . . 63.240000000000002 111.891 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.14 22.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.337 0.255 . . . . 71.230000000000004 110.704 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.69 22.7 7.21 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.476 -0.868 . . . . 74.219999999999999 111.835 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.4 mm -84.88 109.63 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.521 -0.548 . . . . 51.450000000000003 109.521 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -85.59 120.72 27.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.611 -0.514 . . . . 75.120000000000005 109.611 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.22 174.88 9.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.116 -0.493 . . . . 62.450000000000003 111.136 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.516 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 24.9 ttt -105.53 137.68 42.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 109.502 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.65 142.68 28.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.036 0.445 . . . . 54.210000000000001 110.171 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.81 161.34 42.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.528 -0.76 . . . . 73.230000000000004 110.348 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.31 -26.59 15.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.691 0.757 . . . . 74.230000000000004 109.559 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -150.03 178.16 27.68 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 109.2 -1.56 . . . . 74.319999999999993 109.2 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HA ' HD11 ' A' ' 86' ' ' LEU . 6.7 Cg_endo -48.45 -52.53 8.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.959 2.439 . . . . 63.329999999999998 112.479 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -101.42 -3.41 28.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 110.419 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.646 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -88.56 47.11 1.46 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.391 0.615 . . . . 63.219999999999999 109.608 -177.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' GLN . 5.4 p30 -94.75 130.08 41.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.056 -0.975 . . . . 74.219999999999999 109.989 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.79 -121.86 2.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.245 -0.978 . . . . 74.219999999999999 113.563 -173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 t -105.31 12.16 32.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 110.909 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 26.5 mt-30 -94.38 147.85 22.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 55.229999999999997 111.243 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.31 167.92 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.675 -0.861 . . . . 74.430000000000007 108.675 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 46.9 p90 -155.16 150.59 27.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 73.329999999999998 111.118 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 98' ' ' LEU . 14.2 t -112.97 140.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.012 -0.736 . . . . 70.439999999999998 109.012 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -94.44 127.08 40.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.094 0.473 . . . . 63.039999999999999 109.936 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 62.5 mt -83.51 -7.9 59.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.555 -0.748 . . . . 71.109999999999999 110.492 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -144.82 159.79 49.25 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 72.219999999999999 110.071 175.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 36.3 Cg_endo -66.14 112.06 2.19 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.51 2.14 . . . . 54.100000000000001 112.368 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.1 p -106.13 141.65 37.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.825 -0.625 . . . . 54.109999999999999 111.331 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.551 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -131.9 -0.25 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 73.420000000000002 110.646 175.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 2.52 55.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.47 -0.786 . . . . 75.409999999999997 112.489 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.15 6.65 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.23 0.826 . . . . 70.219999999999999 113.23 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.551 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 4.5 m-20 -64.65 -28.69 69.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.119 0.485 . . . . 74.540000000000006 111.042 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -102.57 13.11 56.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 63.130000000000003 111.448 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -116.61 -40.74 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 73.109999999999999 109.387 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.92 124.68 23.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.131 -0.941 . . . . 73.519999999999996 108.506 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.553 ' HB ' HD23 ' A' ' 86' ' ' LEU . 15.1 t -71.05 147.91 48.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.171 0.51 . . . . 72.430000000000007 110.768 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 99' ' ' ALA . 44.8 mt -121.58 123.32 69.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.853 -0.612 . . . . 74.409999999999997 110.523 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -159.31 75.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.32 0.581 . . . . 74.409999999999997 111.587 175.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.654 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.3 158.45 30.83 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.768 -0.729 . . . . 74.439999999999998 112.734 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.466 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -132.11 125.02 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.964 -0.754 . . . . 65.510000000000005 108.964 173.158 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.3 p -84.98 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.052 0.453 . . . . 74.310000000000002 110.291 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.514 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 34.5 t -141.2 147.69 38.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.43 -0.35 . . . . 74.239999999999995 111.016 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 42.62 35.27 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.379 1.072 . . . . 62.039999999999999 113.216 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.16 42.49 0.19 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.637 -0.792 . . . . 70.510000000000005 111.972 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -91.86 -33.83 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.796 0.332 . . . . 74.450000000000003 110.413 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -34.9 90.05 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.03 -0.605 . . . . 55.200000000000003 112.016 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.3 mmm -67.12 -51.25 56.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.797 -0.446 . . . . 74.510000000000005 109.797 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 62' ' ' ILE . 63.9 t -54.29 -30.68 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 74.120000000000005 110.954 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.78 -54.65 10.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 35.229999999999997 110.914 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.72 -16.38 60.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.187 -0.46 . . . . 52.130000000000003 111.418 -177.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 145' ' ' VAL . 64.5 t -86.21 -29.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 71.310000000000002 109.942 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.45 -7.56 79.08 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.691 -0.766 . . . . 71.310000000000002 112.607 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 16.6 ptp -96.58 -11.98 24.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.857 -0.337 . . . . 74.450000000000003 111.869 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 142' ' ' VAL . 23.9 m . . . . . 0 C--N 1.332 -0.193 0 C-N-CA 120.207 -0.597 . . . . 72.450000000000003 110.637 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.52 -0.548 . . . . 71.319999999999993 109.52 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -123.55 155.14 38.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.922 0.391 . . . . 73.099999999999994 110.634 -172.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.8 mp -91.52 101.59 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.208 -1.034 . . . . 74.510000000000005 108.208 168.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 161' ' ' LYS . 32.2 mm -65.35 -48.63 82.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 64.219999999999999 110.918 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.858 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -143.9 138.52 28.62 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.488 -0.778 . . . . 61.43 110.071 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -141.5 118.89 11.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.142 -0.481 . . . . 73.420000000000002 110.414 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 161' ' ' LYS . 84.9 m-85 -141.83 158.37 62.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 109.803 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 14' ' ' VAL . 28.7 Cg_endo -64.35 137.99 58.47 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.175 1.917 . . . . 74.109999999999999 111.119 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.679 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 25.4 t . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.163 0.506 . . . . 61.130000000000003 111.283 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.85 -0.426 . . . . 70.239999999999995 109.85 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.78 144.52 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.914 -0.585 . . . . 65.099999999999994 111.868 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.57 -168.64 45.06 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.542 -0.837 . . . . 44.310000000000002 111.828 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.834 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -84.27 152.09 24.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.238 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 191' ' ' ILE . 94.7 m-85 -98.67 112.29 62.26 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.406 -0.59 . . . . 75.450000000000003 109.406 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.601 ' HB3' HD12 ' A' ' 97' ' ' ILE . 54.2 Cg_endo -85.91 -5.44 8.78 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.511 2.141 . . . . 72.540000000000006 112.719 -177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.57 -19.83 32.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 110.801 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.8 pt -77.42 -16.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 62.130000000000003 111.266 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.38 31.09 10.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.85 -0.614 . . . . 72.209999999999994 111.69 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.32 149.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.968 -0.293 . . . . 54.030000000000001 110.971 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.48 124.07 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.214 0.531 . . . . 72.430000000000007 111.725 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.97 130.05 0.77 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.374 -0.83 . . . . 60.130000000000003 109.76 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 87.7 m-85 -115.86 146.71 37.54 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.452 -0.34 . . . . 72.030000000000001 110.426 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.0 Cg_endo -67.22 -62.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.383 2.055 . . . . 64.150000000000006 111.706 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 23.63 4.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 74.349999999999994 109.832 175.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 29.7 m-20 70.59 6.35 5.78 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.372 -0.831 . . . . 63.119999999999997 112.166 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 17.7 ptm -55.47 -32.14 62.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 74.310000000000002 112.292 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.69 4.6 85.04 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.534 -0.841 . . . . 73.099999999999994 113.503 -174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 11.1 ptm180 -116.51 -3.72 11.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.897 0.856 . . . . 71.340000000000003 110.089 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 203' ' ' LYS . 26.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-N 114.13 -1.396 . . . . 73.049999999999997 110.714 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 CA--C 1.529 0.251 0 CA-C-O 120.948 0.312 . . . . 75.340000000000003 112.149 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.724 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 91.3 Cg_endo -88.22 7.97 4.27 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.457 2.772 . . . . 72.319999999999993 113.18 -173.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.469 HD22 ' HB3' ' A' ' 26' ' ' GLU . 21.2 t-20 -127.09 145.5 50.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.084 -0.962 . . . . 73.219999999999999 108.433 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 164' ' ' PRO . 29.1 m -136.15 157.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.853 0.358 . . . . 54.530000000000001 111.071 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.825 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 50.0 p90 -121.74 130.52 53.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.218 0.533 . . . . 70.019999999999996 110.382 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 16' ' ' LEU . 1.7 mm? -109.44 102.68 11.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.559 -0.746 . . . . 72.209999999999994 109.567 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -82.4 111.18 18.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.499 -0.926 . . . . 60.299999999999997 108.499 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -103.07 -179.74 4.04 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.116 0.484 . . . . 43.409999999999997 111.376 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 t -67.86 -24.57 65.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 75.230000000000004 109.929 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.486 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.1 mmt -86.63 -44.85 11.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 72.540000000000006 110.636 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.46 -126.92 0.98 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.804 -0.712 . . . . 65.010000000000005 111.554 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.26 137.09 46.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.924 0.362 . . . . 74.349999999999994 110.098 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -124.93 115.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.02 -0.536 . . . . 64.349999999999994 109.7 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 46.7 t -102.77 137.33 31.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.521 -0.472 . . . . 74.430000000000007 109.744 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.19 163.34 37.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.112 0.482 . . . . 52.43 110.809 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 13' ' ' ASN . 10.6 pt-20 -128.59 166.27 19.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.537 -0.756 . . . . 62.350000000000001 109.402 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -102.33 165.62 11.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.423 -0.955 . . . . 72.519999999999996 108.423 176.389 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 3.3 m-85 -89.64 90.38 8.22 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.612 -0.835 . . . . 74.310000000000002 111.345 177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.8 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -74.75 -11.89 60.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.266 1.032 . . . . 71.239999999999995 108.281 175.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.7 -35.57 77.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.2 -1.818 . . . . 75.540000000000006 110.95 -177.201 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -124.77 -20.89 4.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.792 -0.64 . . . . 72.019999999999996 110.721 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.539 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.09 85.13 50.99 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.129 0.418 . . . . 54.119999999999997 112.129 -169.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.57 -41.75 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 111.491 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.85 -43.23 36.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.661 -0.7 . . . . 73.409999999999997 111.053 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.557 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -63.2 -39.83 95.76 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.662 -0.699 . . . . 75.030000000000001 110.282 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.8 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 15.0 t -60.41 -46.08 91.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.844 -0.616 . . . . 53.25 110.101 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -59.59 -34.84 73.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 75.340000000000003 110.815 -178.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 35' ' ' THR . 38.2 t-20 -50.56 -61.36 2.24 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.584 -0.524 . . . . 75.420000000000002 109.584 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 112' ' ' PHE . 23.4 m-85 -67.97 -41.34 82.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.05 -0.523 . . . . 74.209999999999994 111.67 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 44' ' ' ARG . . . -56.54 -45.77 81.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 73.5 111.787 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG2' ' HE2' ' A' ' 37' ' ' LYS . 19.4 mm-40 -67.46 -42.27 83.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.096 -0.242 . . . . 52.109999999999999 111.198 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.5 mm? -66.11 -26.44 67.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.997 -0.281 . . . . 75.409999999999997 110.554 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.21 73.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.726 0.298 . . . . 71.25 110.628 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 29.9 mtm180 -66.31 -43.47 86.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.532 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.56 -43.61 98.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 72.420000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.14 64.12 0.53 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.834 -0.698 . . . . 41.520000000000003 111.502 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' HB2' HD12 ' A' ' 42' ' ' LEU . 73.1 t80 -86.0 -50.77 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.104 0.478 . . . . 70.129999999999995 110.154 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 7.0 m-85 -76.42 -10.82 59.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.368 -0.833 . . . . 71.409999999999997 111.796 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.73 -19.29 63.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 61.32 111.318 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.01 40.03 1.61 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.713 . . . . 41.350000000000001 111.996 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.626 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.6 p -118.28 156.62 28.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 70.319999999999993 111.153 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -141.98 163.05 33.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.103 -0.499 . . . . 55.049999999999997 110.735 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.9 m-85 -86.86 133.64 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.101 -0.499 . . . . 74.049999999999997 109.663 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -120.21 -28.96 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.254 -0.578 . . . . 63.43 111.457 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.2 mmt180 -112.6 109.59 19.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.121 -0.326 . . . . 74.109999999999999 110.121 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 53' ' ' PHE . 14.8 mm -121.51 88.6 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.04 -0.726 . . . . 74.540000000000006 109.04 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 18.3 mt -103.31 119.59 52.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.231 -0.587 . . . . 62.25 110.099 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -54.33 138.02 40.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.707 0.629 . . . . 64.319999999999993 110.759 178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p30 44.24 33.19 0.79 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.383 1.052 . . . . 71.019999999999996 112.68 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.35 -83.74 0.54 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.158 -0.473 . . . . 74.439999999999998 110.11 179.218 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -161.47 158.11 26.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.593 . . . . 65.510000000000005 110.389 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' HD21 ' A' ' 116' ' ' LEU . 59.8 mt -128.81 103.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.594 -0.73 . . . . 72.430000000000007 109.656 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -86.51 121.52 29.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.11 -0.495 . . . . 74.409999999999997 110.252 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.18 140.81 11.86 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.658 -0.782 . . . . 52.530000000000001 112.603 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.626 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 138.86 -151.77 21.86 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.653 -0.784 . . . . 44.25 112.302 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t0 58.3 95.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 123.756 0.823 . . . . 71.200000000000003 111.98 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 49.1 Cg_endo -71.31 -18.32 30.18 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.718 2.278 . . . . 75.409999999999997 112.359 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 70' ' ' THR . 81.8 p -91.65 -32.86 15.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.469 . . . . 63.329999999999998 110.887 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.77 22.88 71.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.817 -0.629 . . . . 64.430000000000007 112.284 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.581 HG22 ' OG1' ' A' ' 68' ' ' THR . 14.2 t -107.51 -20.94 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.649 0.24 . . . . 70.010000000000005 111.649 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.44 -13.96 6.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.316 -0.945 . . . . 74.0 113.506 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -0.82 7.08 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.107 0.78 . . . . 72.319999999999993 113.107 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.415 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 66.11 -164.9 39.58 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.882 -0.675 . . . . 42.409999999999997 113.337 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.18 -81.0 0.8 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 73.5 111.598 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . 59.31 34.47 22.94 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.696 0.76 . . . . 63.43 111.153 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.4 m -66.25 -25.93 67.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 40.219999999999999 112.718 -170.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.587 HG23 ' CD1' ' A' ' 78' ' ' TYR . 3.6 tt -65.78 -40.13 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.928 0.344 . . . . 71.099999999999994 111.928 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 13.3 p90 -107.01 -17.25 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.791 0.329 . . . . 72.040000000000006 111.333 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.94 -62.99 4.51 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.047 -0.597 . . . . 64.040000000000006 113.811 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 91.7 mttt -118.47 177.66 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.669 -0.312 . . . . 63.039999999999999 111.666 -175.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' NE2' HG23 ' A' ' 107' ' ' THR . 5.9 pm0 -71.46 164.68 25.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.93 -0.577 . . . . 73.540000000000006 110.441 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -110.53 -68.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.373 -0.376 . . . . 71.329999999999998 111.127 -172.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -168.02 156.69 9.15 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.129 -0.693 . . . . 73.129999999999995 109.129 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 9.4 p-10 -89.93 131.59 35.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 53.399999999999999 109.764 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 25.8 tt0 -105.53 8.01 33.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 75.430000000000007 110.262 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 mt -46.87 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.353 -0.84 . . . . 55.299999999999997 112.543 -170.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -179.56 87.0 0.2 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.404 -0.817 . . . . 73.230000000000004 109.23 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 30.9 Cg_endo -63.49 96.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.444 2.096 . . . . 71.230000000000004 111.828 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -11.38 59.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 64.430000000000007 109.46 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -105.02 170.56 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.598 -1.26 . . . . 73.010000000000005 107.598 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -126.0 150.83 47.77 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.926 -0.71 . . . . 75.25 110.79 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 35.7 p90 -65.5 121.83 15.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.169 -0.678 . . . . 74.439999999999998 109.169 173.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.5 p -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.963 -0.562 . . . . 71.549999999999997 110.61 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.26 -145.2 4.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.484 -0.78 . . . . 75.129999999999995 111.633 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.12 146.2 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.806 0.336 . . . . 74.120000000000005 111.048 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.67 26.18 5.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.754 -0.736 . . . . 74.540000000000006 111.98 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 189' ' ' PRO . 8.8 mm -90.07 111.51 23.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.583 -0.525 . . . . 75.329999999999998 109.583 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.91 117.73 24.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.866 -0.606 . . . . 74.420000000000002 109.673 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.78 176.92 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.404 . . . . 23.34 111.774 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.983 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 17.4 tpt -93.77 138.96 31.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 74.519999999999996 111.885 -173.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.21 132.89 43.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.198 -0.455 . . . . 65.329999999999998 110.315 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.4 162.07 36.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 110.596 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -82.54 -26.32 32.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.117 -0.492 . . . . 45.119999999999997 110.846 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 169.24 -134.38 3.18 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 121.0 -0.619 . . . . 74.439999999999998 112.16 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 25.8 Cg_endo -59.64 92.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.192 2.594 . . . . 71.310000000000002 111.713 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 2.2 p30 62.29 10.08 3.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.975 1.31 . . . . 72.019999999999996 112.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.4 m -82.17 57.85 3.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.475 0.655 . . . . 74.420000000000002 109.307 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.99 143.12 26.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.593 -0.731 . . . . 70.430000000000007 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.26 -98.96 2.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.746 -0.74 . . . . 72.129999999999995 111.966 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 42' ' ' LEU . 9.2 t -147.68 10.55 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.421 . . . . 55.119999999999997 110.536 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.54 159.04 17.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.688 0.28 . . . . 70.5 111.166 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 41.4 p90 -140.25 175.43 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 110.682 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -154.69 151.47 28.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 71.010000000000005 110.521 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 HD23 ' A' ' 98' ' ' LEU . 16.5 t -109.23 143.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.31 -0.626 . . . . 72.310000000000002 109.31 177.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -96.98 129.5 44.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.035 0.445 . . . . 73.519999999999996 110.402 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 62' ' ' ILE . 71.0 mt -85.5 -7.27 58.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.886 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.94 160.21 47.41 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.643 -0.708 . . . . 52.140000000000001 109.972 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 29.6 Cg_endo -64.06 111.79 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.492 2.128 . . . . 53.439999999999998 111.555 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.1 p -100.68 122.07 42.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 55.420000000000002 111.93 -172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.89 24.38 10.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.655 0.741 . . . . 75.200000000000003 109.815 174.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -115.45 -3.11 12.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.282 -0.872 . . . . 72.450000000000003 111.457 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.39 12.05 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 63.409999999999997 111.058 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.466 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 8.7 p-10 -63.14 -28.57 70.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 74.010000000000005 111.049 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.97 17.84 19.58 Favored Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.652 -0.785 . . . . 54.43 111.205 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -116.45 -34.6 4.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.254 0.549 . . . . 75.129999999999995 109.889 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.78 123.39 24.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.434 -0.95 . . . . 64.430000000000007 108.434 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 t -70.87 144.13 50.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.33 -0.548 . . . . 71.129999999999995 109.833 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.2 mt -113.49 124.38 70.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.832 -0.622 . . . . 73.219999999999999 111.28 -173.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.983 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 5.7 p90 -156.37 72.68 0.76 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.849 0.833 . . . . 74.120000000000005 110.468 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.59 157.47 29.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.616 -1.278 . . . . 41.409999999999997 113.53 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.614 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 38.5 mtp180 -139.63 121.88 15.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 70.219999999999999 110.002 173.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -86.37 137.11 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 75.0 110.306 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 48.5 t -149.56 147.82 28.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 109.954 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 8.9 tm0? 48.04 67.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 74.239999999999995 110.05 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 158.89 19.68 0.03 OUTLIER Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.269 -0.878 . . . . 70.219999999999999 113.267 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 184' ' ' ASP . 11.1 tp -80.73 -32.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.319 -0.623 . . . . 61.240000000000002 109.319 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.11 93.62 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.043 -0.823 . . . . 72.510000000000005 111.043 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.2 mmm -70.56 -48.94 52.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.768 -0.456 . . . . 50.030000000000001 109.768 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.4 t -56.28 -29.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.925 0.393 . . . . 73.099999999999994 110.8 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -70.59 -56.53 6.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.422 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.49 ' HE ' ' HB2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.87 -15.42 62.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.379 . . . . 75.450000000000003 111.085 -177.204 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 138' ' ' MET . 75.3 t -84.41 -39.6 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 53.109999999999999 110.154 174.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.15 -27.15 58.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.535 -0.84 . . . . 52.130000000000003 112.843 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.2 mmm -75.11 -13.27 60.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.859 0.318 . . . . 53.020000000000003 111.859 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.233 0.539 . . . . 64.010000000000005 110.834 178.82 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.79 0.805 . . . . 64.129999999999995 111.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -154.16 173.03 16.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.998 -1.001 . . . . 62.539999999999999 109.42 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -89.74 114.43 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.27 -0.641 . . . . 72.219999999999999 109.27 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.8 mm -79.89 -58.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.686 -0.688 . . . . 51.109999999999999 110.53 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -125.07 137.01 54.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.108 -0.496 . . . . 72.25 109.786 176.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -141.39 122.71 14.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.63 -0.259 . . . . 62.119999999999997 110.857 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -145.04 154.12 54.21 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.99 -0.55 . . . . 71.230000000000004 109.867 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 14' ' ' VAL . 9.2 Cg_endo -57.13 138.96 88.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.181 1.921 . . . . 73.519999999999996 111.68 171.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.825 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 38.3 t . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.81 -0.632 . . . . 61.229999999999997 111.148 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 136' ' ' ILE . 12.6 t0 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 108.972 -0.751 . . . . 61.539999999999999 108.972 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 148.33 159.47 8.49 Favored Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.541 -0.838 . . . . 53.530000000000001 112.782 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.6 -166.63 39.11 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.887 -0.673 . . . . 64.200000000000003 112.321 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.7 173.31 12.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.804 0.335 . . . . 64.510000000000005 110.4 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.58 100.81 40.31 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.616 -0.265 . . . . 63.030000000000001 110.58 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.747 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.3 Cg_endo -80.34 -5.05 13.38 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.518 2.145 . . . . 74.430000000000007 111.734 176.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -77.15 -39.24 49.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.217 -0.902 . . . . 63.229999999999997 109.56 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.14 152.68 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.385 -0.969 . . . . 73.030000000000001 108.385 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -104.75 81.45 1.77 Allowed 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.223 -0.591 . . . . 73.310000000000002 110.808 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -156.93 146.87 11.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.998 -1.001 . . . . 75.450000000000003 109.111 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 110.847 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.479 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -153.52 150.24 28.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.878 -0.786 . . . . 64.200000000000003 108.878 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 199' ' ' ASP . 40.6 m-85 -122.7 142.27 37.22 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.688 -0.233 . . . . 64.230000000000004 110.479 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.764 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.9 -63.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.4 2.067 . . . . 73.409999999999997 111.488 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.1 pt? -122.44 16.71 10.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 55.149999999999999 109.844 174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 13.4 m-20 70.24 8.0 6.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.198 -0.91 . . . . 74.549999999999997 113.367 171.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -61.91 -21.42 64.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.766 0.284 . . . . 71.310000000000002 111.766 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.89 -5.39 83.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.831 -0.7 . . . . 54.219999999999999 112.958 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -82.68 -20.72 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.392 0.615 . . . . 70.049999999999997 110.462 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm . . . . . 0 C--O 1.245 0.849 0 CA-C-N 114.733 -1.121 . . . . 73.549999999999997 111.368 -175.237 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 9.6 Cg_endo . . . . . 0 N--CA 1.45 -1.074 0 N-CA-C 111.112 -0.38 . . . . 71.230000000000004 111.112 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.496 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 40.4 Cg_endo -67.73 -19.78 46.99 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.368 2.045 . . . . 73.310000000000002 112.45 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.516 HD22 ' CG1' ' A' ' 24' ' ' VAL . 5.0 t30 -139.42 145.96 39.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.605 -0.725 . . . . 74.019999999999996 110.149 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.6 m -133.85 145.16 33.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.399 0.618 . . . . 53.539999999999999 111.156 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.537 ' HE1' ' HB3' ' A' ' 165' ' ' SER . 84.3 m-85 -99.75 123.51 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.3 -0.864 . . . . 72.340000000000003 111.145 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.36 103.69 11.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 64.540000000000006 109.911 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.16 117.15 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.245 -0.65 . . . . 74.340000000000003 109.245 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 179.96 4.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.124 0.488 . . . . 74.150000000000006 111.739 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -64.33 -26.46 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.339 -0.846 . . . . 70.049999999999997 110.673 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 142' ' ' VAL . 7.1 mmt -91.54 -37.19 13.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.885 -0.598 . . . . 65.430000000000007 111.429 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.68 -128.9 1.26 Allowed Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.64 -0.791 . . . . 73.439999999999998 111.395 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.46 136.36 43.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.073 0.463 . . . . 75.439999999999998 110.039 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.4 120.79 57.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.603 -0.726 . . . . 73.129999999999995 109.14 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 6.9 t -101.4 141.59 17.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.688 -0.687 . . . . 74.219999999999999 109.179 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -147.76 161.59 40.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.272 -0.571 . . . . 64.409999999999997 111.16 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -132.27 163.76 27.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.144 -0.935 . . . . 72.349999999999994 110.429 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.71 168.09 10.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 73.25 109.901 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 m-85 -89.99 97.77 11.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 110.991 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.496 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 76.5 m95 -88.82 14.74 9.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.966 0.889 . . . . 72.340000000000003 109.003 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.52 -54.1 4.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.109 -1.405 . . . . 72.510000000000005 110.545 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.64 9.36 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 74.439999999999998 111.914 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.09 71.41 73.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.287 . . . . 62.229999999999997 110.887 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.15 -42.1 11.49 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.748 2.298 . . . . 70.409999999999997 112.987 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.45 -46.89 52.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 72.329999999999998 110.321 -177.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -41.23 86.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.21 -0.905 . . . . 75.420000000000002 110.93 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 129' ' ' PHE . 89.1 m -52.18 -51.0 60.74 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 111.425 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 4.5 mtmp? -73.14 -23.86 60.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.532 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -56.46 -47.86 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 74.439999999999998 109.411 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HZ ' ' HB3' ' A' ' 112' ' ' PHE . 3.8 m-85 -77.76 -42.31 34.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.478 -0.783 . . . . 55.329999999999998 111.069 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -55.89 -48.8 74.97 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.113 0.412 . . . . 74.400000000000006 112.113 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.669 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -59.72 -43.83 94.01 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.11 0.481 . . . . 62.039999999999999 110.769 178.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 75' ' ' ALA . 28.1 mt -67.36 -30.45 70.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.907 -0.588 . . . . 74.310000000000002 111.319 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.53 76.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.691 -0.686 . . . . 71.519999999999996 111.41 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 41' ' ' GLU . 17.7 ptt180 -81.16 -7.26 59.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.538 -0.465 . . . . 72.129999999999995 111.384 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -89.43 -49.38 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.792 -0.448 . . . . 53.020000000000003 109.792 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 41.03 0.54 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 115.819 -0.628 . . . . 51.109999999999999 112.005 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' HD22 ' A' ' 42' ' ' LEU . 50.5 t80 -71.4 -37.34 71.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.672 0.389 . . . . 65.540000000000006 111.672 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 45.2 m-85 -75.97 -16.41 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.46 . . . . 72.430000000000007 112.016 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -68.74 -7.7 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 74.140000000000001 111.585 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -127.36 16.09 6.34 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.578 -0.82 . . . . 54.119999999999997 112.472 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -101.53 150.06 23.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.322 . . . . 73.010000000000005 111.433 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 2.1 mptt -130.96 153.37 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.107 -177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 75.1 m-85 -90.04 108.41 19.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.475 -0.935 . . . . 74.239999999999995 108.475 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -110.63 -8.88 14.56 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.341 -0.544 . . . . 70.420000000000002 111.262 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.6 mmt180 -121.11 106.06 11.19 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.914 0.388 . . . . 73.299999999999997 110.278 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -122.17 89.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.86 -0.793 . . . . 61.310000000000002 108.86 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 39.1 mt -91.2 120.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.557 -0.905 . . . . 54.409999999999997 108.557 176.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 4.2 ptmm? -58.6 118.38 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.724 0.64 . . . . 60.409999999999997 111.438 -175.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' CG ' ' HZ3' ' A' ' 203' ' ' LYS . 41.9 m-20 61.72 40.49 13.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.868 -1.06 . . . . 61.25 111.182 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -136.69 -78.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 70.040000000000006 110.271 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.653 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 25.4 ptm -160.32 155.87 25.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.6 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.545 HD11 HD21 ' A' ' 116' ' ' LEU . 46.8 mt -128.17 102.92 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 73.430000000000007 109.454 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -81.07 127.2 32.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.01 -0.541 . . . . 64.510000000000005 110.486 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.84 139.72 11.18 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.811 -0.709 . . . . 40.219999999999999 112.145 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.27 -149.14 20.45 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.061 -1.066 . . . . 64.510000000000005 113.26 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 1.4 t70 48.14 86.42 0.15 Allowed Pre-proline 0 N--CA 1.461 0.117 0 C-N-CA 124.689 1.196 . . . . 65.230000000000004 112.617 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 82.3 Cg_endo -75.71 -18.13 17.49 Favored 'Trans proline' 0 CA--C 1.521 -0.165 0 C-N-CA 122.889 2.392 . . . . 71.439999999999998 110.679 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.6 p -84.3 -42.36 15.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.129 -1.396 . . . . 71.030000000000001 112.072 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 86.0 29.66 25.2 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 73.030000000000001 111.396 -174.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' OG1' ' A' ' 68' ' ' THR . 5.2 t -112.39 -33.68 6.11 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.974 0.361 . . . . 45.32 111.974 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.85 -0.66 11.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.127 -1.035 . . . . 50.420000000000002 113.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.26 -24.06 3.75 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.607 -0.349 . . . . 63.009999999999998 111.351 178.257 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 97.47 -171.09 26.2 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.563 -0.827 . . . . 45.539999999999999 112.818 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.58 -98.06 1.98 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.281 -0.485 . . . . 64.239999999999995 112.185 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . 59.31 33.77 22.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.698 0.761 . . . . 74.230000000000004 111.096 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -76.44 15.12 0.65 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.63 -1.168 . . . . 74.310000000000002 110.922 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 41' ' ' GLU . 6.8 tt -94.27 -38.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.871 -0.604 . . . . 63.43 111.091 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.66 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 34.7 p90 -106.11 -18.45 14.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.026 -0.67 . . . . 63.43 111.6 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.4 -103.62 2.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.316 -0.945 . . . . 74.140000000000001 113.449 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -125.61 174.94 7.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.984 0.421 . . . . 74.129999999999995 111.72 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 17.0 mp0 -87.0 -96.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.375 -0.829 . . . . 75.150000000000006 111.535 -171.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 13.2 m-30 78.17 14.88 1.45 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.086 0.555 . . . . 73.129999999999995 112.325 172.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.47 126.5 5.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.57 -0.741 . . . . 71.140000000000001 110.224 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.468 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.4 p-10 -82.68 122.09 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.953 -0.758 . . . . 75.329999999999998 108.953 170.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -99.67 19.05 16.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.998 -0.742 . . . . 71.510000000000005 108.998 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 84' ' ' ASP . 28.1 mt -58.8 99.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.385 -1.28 . . . . 60.32 110.094 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -154.62 74.81 5.79 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 109.986 -0.376 . . . . 74.25 109.986 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.36 92.59 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.78 2.32 . . . . 65.25 112.238 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.0 -33.26 67.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 74.319999999999993 108.695 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -93.99 178.08 5.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.513 -1.221 . . . . 70.140000000000001 109.124 174.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -144.38 160.73 40.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.07 -0.344 . . . . 74.349999999999994 110.07 178.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.59 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 26.2 p90 -56.65 119.68 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.874 0.845 . . . . 53.020000000000003 111.053 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 33.8 p -116.62 -43.66 2.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.728 -0.669 . . . . 74.409999999999997 110.537 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.9 -155.18 7.82 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.363 -0.835 . . . . 74.329999999999998 111.339 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.37 141.15 31.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.776 0.322 . . . . 61.549999999999997 110.791 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.77 23.73 4.56 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.816 -0.706 . . . . 54.409999999999997 111.949 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -90.18 116.69 32.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 74.239999999999995 109.701 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.876 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -91.97 123.31 35.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.626 -0.715 . . . . 75.329999999999998 110.099 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.44 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -140.8 169.02 18.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 75.040000000000006 111.144 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.513 ' CG ' ' HE1' ' A' ' 129' ' ' PHE . 26.3 mtm -92.32 156.32 17.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.038 0.447 . . . . 73.120000000000005 110.495 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 166.86 10.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.821 -0.627 . . . . 51.25 109.709 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -120.42 179.06 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.742 0.306 . . . . 63.329999999999998 110.403 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.06 18.82 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.84 -0.618 . . . . 75.140000000000001 110.611 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.51 -142.92 14.17 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.748 -0.739 . . . . 71.150000000000006 112.846 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -58.77 92.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.645 2.897 . . . . 74.340000000000003 112.216 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.77 32.56 7.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.478 -1.237 . . . . 52.520000000000003 111.003 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.5 m -80.27 56.29 2.45 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.517 -1.219 . . . . 75.319999999999993 110.058 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 84' ' ' ASP . 15.8 m120 -72.57 100.62 2.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.027 -0.988 . . . . 73.230000000000004 109.633 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -116.32 -135.87 5.71 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.254 -0.974 . . . . 74.019999999999996 113.315 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 47.8 p -96.88 -4.78 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.404 -176.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -71.17 142.77 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.027 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.53 ' HB3' ' HZ ' ' A' ' 39' ' ' PHE . 52.3 p90 -143.5 169.38 17.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.828 0.347 . . . . 71.209999999999994 110.812 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.51 155.21 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 74.109999999999999 110.665 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.711 HG22 HD23 ' A' ' 98' ' ' LEU . 18.4 t -110.61 144.05 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.899 -0.591 . . . . 55.020000000000003 109.482 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.5 p -97.01 124.58 41.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.101 0.477 . . . . 62.530000000000001 110.538 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 62' ' ' ILE . 71.9 mt -83.66 -9.53 58.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.592 -0.731 . . . . 72.040000000000006 110.243 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.4 156.84 42.54 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.172 -0.922 . . . . 61.299999999999997 109.611 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 57.5 Cg_endo -72.28 113.34 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.262 1.975 . . . . 73.349999999999994 112.33 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.2 p -100.49 145.47 28.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 64.420000000000002 109.863 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 17.99 9.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 63.32 110.722 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.797 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 1.1 p90 -124.08 -1.72 8.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 72.140000000000001 111.33 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 86.9 mt -114.36 -6.1 12.92 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.975 0.417 . . . . 73.150000000000006 110.839 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.42 -19.19 64.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 72.25 111.249 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.53 12.52 10.24 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.52 -0.848 . . . . 34.539999999999999 111.841 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -120.14 -24.33 6.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 109.775 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 100' ' ' MET . 38.9 m80 -130.24 125.56 35.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.703 -0.681 . . . . 63.539999999999999 110.189 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.0 m -65.9 110.67 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 33.210000000000001 110.427 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 99' ' ' ALA . 32.5 mt -96.84 120.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.539 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 1.3 p90 -153.76 72.26 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.548 1.166 . . . . 73.230000000000004 109.742 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.876 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.63 153.1 23.58 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 118.269 -1.92 . . . . 33.039999999999999 113.857 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.4 mtp-105 -133.32 123.63 25.8 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.923 -0.769 . . . . 75.510000000000005 108.923 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.78 131.61 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.442 0.639 . . . . 54.509999999999998 109.901 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.644 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.6 m -134.36 139.1 45.39 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.507 -0.769 . . . . 50.130000000000003 110.263 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 47.09 46.38 16.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.325 0.491 . . . . 62.149999999999999 112.325 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.88 29.46 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.952 -1.118 . . . . 41.439999999999998 112.587 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -76.73 -33.52 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 70.25 110.435 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.32 -35.32 91.46 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.015 -0.612 . . . . 73.439999999999998 111.682 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 142' ' ' VAL . 68.4 mmm -69.37 -52.73 24.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.019 -0.363 . . . . 73.030000000000001 110.019 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.83 -30.97 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.135 0.493 . . . . 71.329999999999998 110.822 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.72 -53.62 14.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.762 -0.654 . . . . 75.340000000000003 110.612 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.38 -14.96 60.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 111.097 -177.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.4 t -85.66 -38.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.18 0.514 . . . . 62.219999999999999 110.049 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -82.01 -15.01 75.99 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.574 -0.822 . . . . 74.209999999999994 112.94 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.558 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.9 ptm -96.39 0.89 51.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.683 0.241 . . . . 73.140000000000001 111.155 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 121.6 0.714 . . . . 73.219999999999999 112.084 -177.14 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 142' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.828 0.823 . . . . 75.040000000000006 110.561 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -120.43 165.95 14.24 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.719 -1.128 . . . . 70.420000000000002 108.824 176.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 48' ' ' TYR . 3.5 mp -88.92 103.3 13.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.451 -0.944 . . . . 74.340000000000003 108.451 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.429 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.8 mm -66.87 -59.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.368 -0.833 . . . . 64.019999999999996 110.233 -176.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 6.0 mptp? -128.63 132.93 48.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.659 . . . . 74.340000000000003 109.977 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.13 135.54 49.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.335 -0.393 . . . . 64.340000000000003 110.663 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -154.47 128.1 4.42 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.641 -0.709 . . . . 72.150000000000006 110.617 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 91.7 Cg_endo -80.73 149.7 18.42 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.852 2.368 . . . . 75.420000000000002 112.817 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.537 ' HB3' ' HE1' ' A' ' 15' ' ' TYR . 21.4 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 64.340000000000003 110.128 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.3 0.572 . . . . 45.140000000000001 111.014 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 156.95 145.98 4.35 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.021 -0.99 . . . . 70.209999999999994 111.117 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.62 -167.33 25.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.281 -0.961 . . . . 54.329999999999998 112.291 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.774 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.55 171.14 12.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.783 0.325 . . . . 62.049999999999997 110.485 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.71 94.38 8.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 110.022 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 90' ' ' LEU . 58.2 Cg_endo -77.83 -7.99 16.67 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.12 1.88 . . . . 72.439999999999998 112.802 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.508 ' OE2' ' HD2' ' A' ' 189' ' ' PRO . 1.3 mp0 -75.31 -35.01 61.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.104 0.478 . . . . 72.019999999999996 110.445 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 193' ' ' VAL . 14.7 pt -79.05 -13.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.929 -0.578 . . . . 70.200000000000003 111.509 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.0 m170 65.85 30.68 9.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.704 -0.68 . . . . 64.349999999999994 112.204 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 191' ' ' ILE . 4.6 p -123.49 149.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.142 -0.318 . . . . 71.340000000000003 110.142 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.52 119.0 18.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.162 -0.472 . . . . 71.540000000000006 111.601 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.41 HE21 ' HB ' ' A' ' 93' ' ' THR . 2.3 pp0? -164.97 156.7 15.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.477 -0.783 . . . . 75.230000000000004 109.589 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 10.8 m-85 -120.7 146.22 42.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.799 -0.36 . . . . 71.319999999999993 111.122 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.5 Cg_endo -62.15 -59.89 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.946 2.43 . . . . 63.130000000000003 111.968 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.7 21.17 5.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.901 0.381 . . . . 74.329999999999998 110.006 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 62.65 19.42 11.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.54 -0.755 . . . . 75.409999999999997 111.646 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 ptm -53.28 -53.51 49.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.524 -0.762 . . . . 75.340000000000003 112.289 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.78 -8.08 71.63 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.32 -0.467 . . . . 74.209999999999994 113.442 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.482 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 78.7 mtp180 -80.9 -42.78 20.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.888 0.375 . . . . 70.420000000000002 110.177 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 203' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-N 114.383 -1.28 . . . . 73.140000000000001 112.067 -174.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 51.6 Cg_exo . . . . . 0 N--CA 1.457 -0.675 0 N-CA-C 110.268 -0.705 . . . . 54.299999999999997 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.9 0.15 5.41 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.241 2.627 . . . . 62.210000000000001 113.276 -172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.7 129.13 32.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.35 -0.841 . . . . 75.140000000000001 108.799 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 39' ' ' PHE . 18.7 m -130.85 162.58 38.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.563 0.221 . . . . 63.030000000000001 110.493 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HB3' HG22 ' A' ' 24' ' ' VAL . 39.5 p90 -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.287 0.565 . . . . 72.430000000000007 112.096 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.23 116.39 28.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.005 -0.998 . . . . 73.5 109.423 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.36 112.64 20.51 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.903 -0.777 . . . . 75.540000000000006 108.903 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -105.31 177.98 4.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.926 0.393 . . . . 73.0 111.428 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' HD11 ' A' ' 160' ' ' ILE . 23.2 t -72.79 -11.44 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 61.43 110.557 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.647 ' HG3' HG22 ' A' ' 142' ' ' VAL . 8.7 mmt -100.39 -39.96 7.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 53.549999999999997 110.498 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.86 -127.0 0.99 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.789 -0.719 . . . . 62.530000000000001 111.505 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -145.82 130.79 12.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.28 -0.637 . . . . 75.049999999999997 109.28 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -126.43 129.19 71.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 75.409999999999997 110.399 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 15' ' ' TYR . 42.5 t -110.18 142.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.864 -0.421 . . . . 71.329999999999998 109.864 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.65 159.35 44.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.459 0.647 . . . . 72.450000000000003 111.002 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -132.74 163.5 28.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.484 -0.78 . . . . 71.099999999999994 110.005 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -98.4 166.99 11.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.445 -0.343 . . . . 75.219999999999999 110.158 -175.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.79 ' HE2' ' HB3' ' A' ' 190' ' ' GLU . 11.1 m-85 -87.73 99.34 12.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.374 0.607 . . . . 64.409999999999997 111.316 175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.715 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -81.45 0.1 39.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.283 -0.871 . . . . 73.439999999999998 109.37 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.58 -69.55 0.31 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.133 -0.94 . . . . 73.019999999999996 111.035 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.433 ' HD1' ' CG ' ' A' ' 89' ' ' ASP . 46.4 m80 -129.26 17.83 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.413 -0.358 . . . . 75.230000000000004 111.195 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.6 63.82 71.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.575 -0.284 . . . . 74.239999999999995 111.296 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.21 -44.0 2.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.643 2.229 . . . . 72.030000000000001 111.815 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -60.99 -47.15 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.757 0.789 . . . . 75.230000000000004 110.051 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -65.97 -41.28 91.37 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.56 -1.2 . . . . 73.299999999999997 110.965 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.715 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 41.8 t -57.43 -41.62 80.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 75.530000000000001 110.387 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 7.4 mmpt? -58.84 -45.45 90.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.925 -0.579 . . . . 62.520000000000003 110.897 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -53.49 -52.98 57.81 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.592 0.558 . . . . 53.409999999999997 110.511 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 27' ' ' LEU . 37.4 t80 -69.02 -44.06 73.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.284 -0.417 . . . . 74.25 110.692 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 44' ' ' ARG . . . -55.26 -53.01 61.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 43.43 112.004 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 41.8 mm-40 -66.35 -31.12 71.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 71.099999999999994 110.354 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -66.79 -36.87 83.4 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.056 -0.52 . . . . 72.120000000000005 110.292 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . . . -67.44 -35.73 79.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.579 -0.737 . . . . 75.329999999999998 110.085 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 15.2 mmm180 -61.57 -44.54 96.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.934 -0.575 . . . . 65.299999999999997 110.991 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -48.18 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 110.245 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.42 43.42 1.86 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.127 -1.035 . . . . 74.420000000000002 112.412 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.59 -18.92 56.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.077 0.465 . . . . 70.150000000000006 111.041 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.683 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.8 -6.01 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 74.0 111.738 -177.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.9 -8.82 47.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.182 -0.463 . . . . 75.549999999999997 111.242 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -136.9 26.32 3.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 112.153 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.2 p -98.76 148.05 24.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 64.140000000000001 111.437 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -135.72 161.65 34.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.332 -0.618 . . . . 50.130000000000003 109.332 177.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.6 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 74.2 m-85 -80.77 116.41 20.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 61.43 109.915 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -97.56 -22.16 16.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 65.140000000000001 110.451 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.774 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 33.5 mmt180 -125.27 116.31 21.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.540000000000006 110.151 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 62' ' ' ILE . 20.3 mm -124.42 88.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.108 -0.701 . . . . 71.150000000000006 109.108 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 13.7 mt -98.16 126.01 51.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.198 -0.667 . . . . 71.530000000000001 109.198 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.28 118.84 8.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.655 0.597 . . . . 73.310000000000002 110.656 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 57.81 40.63 25.95 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.894 0.747 . . . . 71.439999999999998 110.946 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.1 t80 -133.24 -81.02 0.48 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.221 0.534 . . . . 73.340000000000003 109.916 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.48 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.94 156.62 25.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.475 -0.784 . . . . 73.120000000000005 109.96 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.566 HD11 HD21 ' A' ' 116' ' ' LEU . 48.5 mt -126.92 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.405 -0.591 . . . . 72.510000000000005 109.405 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.774 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 18.3 mt-30 -85.6 124.65 32.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.31 -0.404 . . . . 72.409999999999997 110.93 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -119.57 141.24 15.46 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 52.119999999999997 111.93 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.8 -137.25 5.34 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.046 -0.597 . . . . 72.030000000000001 111.918 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 49.44 78.58 0.39 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.419 0.896 . . . . 61.520000000000003 113.419 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HG3' ' HA2' ' A' ' 74' ' ' GLY . 68.4 Cg_endo -76.56 -17.26 16.38 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.789 1.659 . . . . 71.409999999999997 110.395 168.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 70' ' ' THR . 33.9 p -96.61 -44.39 7.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.909 -1.041 . . . . 75.120000000000005 111.12 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.63 53.82 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 111.981 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' OG1' ' A' ' 68' ' ' THR . 10.3 t -98.95 -10.61 22.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.95 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.97 -15.4 58.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.863 -0.684 . . . . 64.319999999999993 112.939 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -144.35 18.4 1.71 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.956 0.354 . . . . 71.129999999999995 111.956 -175.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -84.74 -167.92 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.27 -0.967 . . . . 44.219999999999999 111.994 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 67' ' ' PRO . . . 113.7 -117.97 4.34 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.249 -0.977 . . . . 64.450000000000003 113.272 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.946 ' H ' ' HB2' ' A' ' 110' ' ' SER . . . -60.8 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.242 0.617 . . . . 75.010000000000005 112.497 -173.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -99.69 7.63 44.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.845 -0.798 . . . . 74.400000000000006 108.845 174.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.04 -38.65 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.869 -1.059 . . . . 64.129999999999995 111.132 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.87 ' HB2' ' HE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -98.89 -3.47 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 111.654 -178.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.86 -73.71 2.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.04 -0.6 . . . . 41.229999999999997 112.735 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -113.68 171.51 7.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.791 0.329 . . . . 71.109999999999999 110.703 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -76.24 161.32 28.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 61.039999999999999 110.467 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.87 ' HE2' ' HB2' ' A' ' 78' ' ' TYR . 71.1 m-85 -131.74 -169.15 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 73.25 110.351 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -46.47 139.21 5.14 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.836 0.71 . . . . 62.32 112.166 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.16 135.45 42.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.143 -0.688 . . . . 70.010000000000005 109.143 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 35' ' ' THR . 25.9 mm-40 -102.68 19.42 19.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.831 -0.622 . . . . 73.230000000000004 110.116 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.06 98.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.622 -0.717 . . . . 65.540000000000006 110.655 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -167.75 82.13 0.83 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.962 -0.563 . . . . 74.239999999999995 109.876 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.56 92.54 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.846 2.364 . . . . 62.130000000000003 112.372 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 15.3 t70 -71.31 -37.14 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.13 0.967 . . . . 75.209999999999994 109.079 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -84.3 179.04 7.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.543 -1.208 . . . . 53.420000000000002 108.985 172.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -139.59 169.1 18.36 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.479 -0.488 . . . . 64.319999999999993 109.881 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -63.49 123.12 17.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 60.409999999999997 109.539 171.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p -125.32 -40.99 2.08 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.567 0.699 . . . . 54.119999999999997 109.843 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.42 -143.4 3.69 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 114.934 -1.03 . . . . 64.519999999999996 111.179 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.6 150.83 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.704 0.287 . . . . 62.549999999999997 110.519 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.71 23.59 7.79 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.704 -0.76 . . . . 75.340000000000003 111.426 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.6 mm -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.33 -0.619 . . . . 52.299999999999997 109.33 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -83.38 122.88 29.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 109.883 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.79 171.94 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.154 0.502 . . . . 70.129999999999995 111.654 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.748 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 26.4 ttt -107.25 143.14 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.616 -0.72 . . . . 63.32 110.13 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -104.61 136.68 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.2 0.524 . . . . 45.340000000000003 110.64 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -139.43 166.23 25.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.583 -0.735 . . . . 62.039999999999999 109.766 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -85.88 -34.81 20.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.527 -0.306 . . . . 63.210000000000001 111.103 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.32 -123.05 1.07 Allowed Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.534 -0.841 . . . . 74.109999999999999 112.337 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.55 90.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.99 2.46 . . . . 71.219999999999999 112.201 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' PHE . 2.2 p30 59.87 11.08 2.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 74.25 112.373 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 m -81.48 61.18 4.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.69 0.757 . . . . 75.120000000000005 109.095 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.5 150.88 41.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.394 -1.276 . . . . 63.439999999999998 109.886 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.41 -139.82 3.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.632 -0.794 . . . . 53.130000000000003 111.958 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.946 ' HB2' ' H ' ' A' ' 75' ' ' ALA . 33.7 t -113.73 8.48 17.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.975 0.417 . . . . 71.129999999999995 110.359 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 9.2 mm-40 -82.47 138.81 34.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.386 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.88 167.29 21.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.111 -0.7 . . . . 72.219999999999999 109.111 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.768 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 51.5 p90 -157.12 153.87 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 72.530000000000001 112.059 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 98' ' ' LEU . 17.4 t -113.64 142.52 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.237 -0.892 . . . . 60.219999999999999 108.752 174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.9 p -96.04 129.38 43.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.123 0.487 . . . . 74.129999999999995 110.621 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 62' ' ' ILE . 74.3 mt -82.49 -10.5 58.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.432 -0.804 . . . . 44.549999999999997 110.78 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.56 164.12 24.32 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.414 -0.812 . . . . 61.310000000000002 110.022 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.554 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 23.9 Cg_exo -64.19 113.96 2.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.707 2.271 . . . . 64.209999999999994 112.134 177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.8 p -100.35 112.95 25.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.207 -0.451 . . . . 75.120000000000005 111.106 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.16 27.4 9.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.612 0.72 . . . . 54.420000000000002 109.756 -177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.74 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -129.83 3.52 4.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.153 -0.931 . . . . 73.310000000000002 110.983 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.74 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 94.4 mt -113.13 7.84 18.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.931 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 -27.28 56.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.913 -1.04 . . . . 62.399999999999999 111.917 -176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.3 25.43 4.85 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.088 -0.805 . . . . 65.120000000000005 111.088 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -116.86 -40.38 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.952 0.406 . . . . 60.420000000000002 110.067 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -142.3 137.12 30.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 63.020000000000003 111.11 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.1 m -68.75 121.77 17.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.658 -0.701 . . . . 54.149999999999999 110.796 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.9 mt -108.4 120.88 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.457 -0.201 . . . . 34.509999999999998 110.457 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.748 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.2 p90 -157.71 73.62 0.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.865 0.841 . . . . 72.310000000000002 110.81 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.868 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.96 150.94 20.43 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.274 -1.441 . . . . 63.219999999999999 113.433 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -127.54 119.63 26.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.862 -0.792 . . . . 73.329999999999998 108.862 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.403 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 9.2 p -79.66 132.08 32.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.338 0.589 . . . . 65.219999999999999 109.864 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' CYS . . . . . 0.578 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.1 m -133.55 141.21 47.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 61.219999999999999 110.916 -171.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.3 pt20 41.68 35.3 0.47 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.478 1.111 . . . . 71.109999999999999 113.842 176.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.32 37.6 0.23 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.585 -0.817 . . . . 64.430000000000007 112.211 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 197' ' ' PRO . 9.3 tp -85.33 -34.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.78 0.324 . . . . 73.409999999999997 110.542 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.59 -35.59 81.34 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.038 -0.601 . . . . 61.0 112.413 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 81.2 mmm -70.54 -51.32 29.45 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.336 -0.246 . . . . 71.340000000000003 110.336 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 62' ' ' ILE . 91.7 t -52.55 -32.12 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.001 0.429 . . . . 75.340000000000003 110.933 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.6 t30 -69.5 -53.8 17.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.84 -0.618 . . . . 73.510000000000005 110.559 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -15.43 61.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.055 -0.52 . . . . 73.200000000000003 110.975 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 20' ' ' MET . 45.1 t -84.0 -37.59 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.442 . . . . 73.200000000000003 110.315 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -74.78 -18.62 80.09 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.42 -0.895 . . . . 70.230000000000004 112.613 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 42.8 mtm -99.66 1.34 43.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.947 0.351 . . . . 42.509999999999998 111.947 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 142' ' ' VAL . 30.7 m . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.578 . . . . 75.310000000000002 111.903 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.485 HG21 HG13 ' A' ' 142' ' ' VAL . 12.8 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 108.896 -0.779 . . . . 61.130000000000003 108.896 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.1 mttm -124.09 169.57 11.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.981 0.419 . . . . 73.219999999999999 111.207 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -93.45 99.81 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.838 -1.171 . . . . 71.439999999999998 107.838 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.592 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.4 mm -63.26 -61.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.62 -0.511 . . . . 34.109999999999999 109.62 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.592 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.2 mptp? -138.32 154.7 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.016 -0.735 . . . . 72.120000000000005 109.016 172.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -142.51 150.72 40.84 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.661 -0.496 . . . . 65.140000000000001 109.661 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 98.6 m-85 -156.05 145.62 15.37 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.339 -0.615 . . . . 74.120000000000005 109.339 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 5.4 Cg_exo -74.94 142.55 28.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.403 2.069 . . . . 73.409999999999997 111.954 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 11' ' ' PRO . 25.5 t . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 72.200000000000003 110.074 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.4 m-20 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.445 0.641 . . . . 54.439999999999998 110.836 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.51 145.87 4.29 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.173 -0.922 . . . . 73.120000000000005 110.811 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -79.3 -161.12 20.94 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.083 -1.055 . . . . 75.299999999999997 112.153 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.649 ' HB1' ' OE1' ' A' ' 195' ' ' GLN . . . -80.95 176.73 9.57 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.153 -0.314 . . . . 71.329999999999998 110.153 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' ILE . 76.7 m-85 -116.19 92.54 36.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.646 -0.502 . . . . 70.140000000000001 109.646 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 10.3 Cg_exo -70.48 -18.07 33.85 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.21 2.607 . . . . 72.329999999999998 113.279 -173.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.79 ' HB3' ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -78.14 -35.1 49.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.262 0.468 . . . . 62.520000000000003 112.262 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 188' ' ' PHE . 22.3 pt -73.03 -13.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 71.340000000000003 111.773 -171.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 63.8 m170 68.91 29.45 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.774 . . . . 72.129999999999995 111.926 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 191' ' ' ILE . 3.9 p -127.28 165.66 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.979 -0.748 . . . . 74.340000000000003 108.979 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.24 129.77 34.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 43.219999999999999 111.59 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.649 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -158.54 153.45 25.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.019 -0.734 . . . . 71.109999999999999 109.019 174.389 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 83.9 m-85 -122.07 138.19 28.5 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.726 -0.39 . . . . 72.109999999999999 111.038 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.0 Cg_endo -64.23 -51.5 2.06 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.622 2.215 . . . . 74.239999999999995 111.967 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -154.83 41.15 0.45 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.387 -0.37 . . . . 71.519999999999996 111.166 178.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 2.0 m-20 75.32 -12.82 0.92 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 112.257 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.573 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 23.0 ptm -50.64 -31.88 17.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.622 0.971 . . . . 72.319999999999993 113.622 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.86 2.7 55.65 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 119.803 -1.189 . . . . 72.120000000000005 113.677 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.498 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 31.8 ptt180 -118.98 1.89 11.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 117.565 0.682 . . . . 65.340000000000003 111.951 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 200' ' ' MET . 41.4 mtmt . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.116 -0.947 . . . . 70.310000000000002 110.831 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 121.005 0.431 . . . . 65.120000000000005 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.92 117.59 26.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.362 -0.381 . . . . 72.109999999999999 111.39 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.66 -38.67 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.26 0.552 . . . . 30.210000000000001 110.26 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 78' ' ' TYR . 78.4 mt -129.01 112.65 18.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.443 -0.798 . . . . 71.329999999999998 110.107 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 2.9 Cg_exo -76.26 113.79 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.882 2.388 . . . . 71.129999999999995 111.911 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.07 -48.38 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.711 2.274 . . . . 62.549999999999997 111.51 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.64 67.94 0.59 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.34 -0.845 . . . . 75.109999999999999 112.038 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p 176.49 -173.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.641 -1.163 . . . . 70.049999999999997 108.469 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -104.19 119.96 40.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.275 -0.269 . . . . 61.420000000000002 110.275 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.444 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.3 mp0 -109.45 99.42 36.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.117 -0.327 . . . . 75.010000000000005 110.117 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.864 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 24.5 Cg_exo -63.68 145.87 91.72 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.021 1.814 . . . . 62.509999999999998 110.789 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 53.1 Cg_endo -69.55 -5.37 15.92 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.499 2.133 . . . . 72.109999999999999 112.116 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.69 HD21 HG12 ' A' ' 24' ' ' VAL . 4.7 t-20 -130.99 142.17 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.081 -0.963 . . . . 73.239999999999995 109.449 -175.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 164' ' ' PRO . 21.8 m -135.54 157.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.981 -0.377 . . . . 75.150000000000006 109.981 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.555 ' HB2' HD11 ' A' ' 22' ' ' ILE . 50.8 p90 -121.06 130.46 53.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.267 0.556 . . . . 74.519999999999996 110.754 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -111.15 102.17 10.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.501 -0.772 . . . . 64.129999999999995 109.806 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.86 110.65 17.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.22 -0.659 . . . . 74.530000000000001 109.22 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.499 HG21 ' HE2' ' A' ' 53' ' ' PHE . 72.1 p -99.81 -179.7 4.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.719 -175.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 p -69.27 -16.88 63.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.091 -0.504 . . . . 62.210000000000001 110.878 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.4 mmt -94.83 -41.05 9.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 70.129999999999995 111.019 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.78 -127.49 1.05 Allowed Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.639 -0.791 . . . . 43.439999999999998 111.717 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 15' ' ' TYR . 19.6 tt -135.7 137.94 48.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.888 0.375 . . . . 73.230000000000004 110.188 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -122.41 108.75 22.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.191 -0.67 . . . . 75.109999999999999 109.191 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG12 HD21 ' A' ' 13' ' ' ASN . 39.5 t -98.03 131.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.334 -0.617 . . . . 74.450000000000003 109.334 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 25' ' ' LEU . 4.6 pp -146.99 159.26 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.119 0.485 . . . . 73.340000000000003 110.793 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -125.61 164.12 21.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.698 -0.683 . . . . 71.230000000000004 110.604 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.34 159.29 17.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.275 -0.875 . . . . 70.439999999999998 109.128 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.2 m-85 -86.46 88.79 7.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.398 0.618 . . . . 75.299999999999997 111.536 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 34.0 m95 -79.91 -3.59 48.76 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.416 -0.957 . . . . 72.109999999999999 108.416 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.82 -41.2 26.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 74.310000000000002 111.135 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 12.0 t60 -132.2 -17.33 2.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.658 -0.417 . . . . 73.519999999999996 111.774 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.91 88.62 31.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.779 -0.368 . . . . 75.420000000000002 111.024 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' HIS . 11.1 Cg_exo -71.15 -17.17 31.62 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.83 2.353 . . . . 60.25 112.694 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 7.5 mptt -90.31 -54.75 3.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.084 0.469 . . . . 72.230000000000004 110.475 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.7 m -55.38 -44.11 75.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 74.530000000000001 111.646 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -64.48 -37.6 88.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.844 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.937 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -73.77 -38.92 64.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 74.530000000000001 110.53 -178.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.91 -58.71 7.38 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.386 0.429 . . . . 73.109999999999999 110.902 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 112' ' ' PHE . 65.6 m-85 -61.83 -43.79 98.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.076 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 10' ' ' GLN . . . -59.57 -44.08 93.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 73.209999999999994 111.393 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -59.44 -45.19 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.310000000000002 111.429 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.9 mm? -73.45 -23.34 60.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.736 0.303 . . . . 74.319999999999993 111.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.9 -48.71 52.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.386 . . . . 74.420000000000002 110.874 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -12.74 60.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.922 0.392 . . . . 64.310000000000002 111.022 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -52.35 9.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.839 -0.8 . . . . 74.209999999999994 108.839 172.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.92 45.84 0.93 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.675 -0.97 . . . . 64.439999999999998 110.675 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' HD12 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -88.86 -33.65 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.881 0.372 . . . . 62.509999999999998 111.368 -176.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 85.2 m-85 -71.94 -14.69 61.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.329 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -74.95 10.64 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 65.129999999999995 111.123 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.16 24.95 1.9 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.865 -0.607 . . . . 70.420000000000002 111.63 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.719 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 43.1 p -115.33 160.43 19.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.683 0.278 . . . . 72.319999999999993 111.082 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.9 ptpt -139.64 164.05 30.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.372 -0.377 . . . . 61.25 110.006 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.531 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.2 m-85 -82.24 117.68 22.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.831 -0.803 . . . . 72.209999999999994 108.831 173.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.83 -27.06 14.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.413 -0.358 . . . . 72.239999999999995 110.76 -169.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 30.5 mmt180 -132.02 116.68 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.517 -0.31 . . . . 73.310000000000002 110.564 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -127.28 94.25 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.007 -0.738 . . . . 62.229999999999997 109.007 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.8 mt -106.35 125.2 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.245 -0.434 . . . . 72.540000000000006 110.07 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.5 mtpt -60.27 130.79 48.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.223 0.327 . . . . 72.349999999999994 111.41 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 58.38 28.07 16.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.462 -0.79 . . . . 64.099999999999994 111.424 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -128.64 -87.52 0.55 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 65.25 109.86 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.731 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.7 ptt? -161.28 157.82 26.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 55.409999999999997 110.031 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 ' HA3' ' A' ' 143' ' ' GLY . 50.6 mt -128.62 102.07 7.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.613 -0.721 . . . . 73.420000000000002 109.682 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 23.5 tm0? -80.56 126.35 31.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 75.5 110.007 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.58 137.04 9.58 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.978 -0.63 . . . . 71.030000000000001 112.402 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.719 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 131.04 -137.47 9.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.071 -0.585 . . . . 53.119999999999997 112.12 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 4.5 t0 48.07 83.33 0.22 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 123.901 0.881 . . . . 73.129999999999995 112.241 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.26 -19.56 33.59 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.73 2.287 . . . . 71.030000000000001 111.498 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.571 ' OG1' HG22 ' A' ' 70' ' ' THR . 34.5 p -82.58 -34.55 27.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.144 -0.935 . . . . 71.109999999999999 111.534 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.0 60.92 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.102 -0.571 . . . . 74.219999999999999 111.835 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 72' ' ' ARG . 11.5 t -117.66 -17.48 9.91 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.101 0.408 . . . . 71.340000000000003 112.101 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.94 25.59 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 119.87 -1.157 . . . . 52.130000000000003 113.631 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.62 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.97 -7.36 6.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.336 0.568 . . . . 73.519999999999996 111.877 178.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 70.9 -163.87 53.64 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.182 -0.532 . . . . 72.209999999999994 113.342 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.12 -88.05 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.683 -0.567 . . . . 64.439999999999998 111.683 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 59.87 33.08 21.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.278 0.561 . . . . 74.030000000000001 111.934 173.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 t -78.83 0.66 26.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 70.510000000000005 111.686 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.8 pt -74.01 -29.76 26.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.722 -0.391 . . . . 65.420000000000002 111.254 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' HB3' HD11 ' A' ' 4' ' ' ILE . 23.1 p90 -108.05 1.73 22.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.3 0.572 . . . . 75.010000000000005 111.107 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -77.58 2.09 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.341 -0.845 . . . . 72.230000000000004 113.39 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -92.37 -170.39 2.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.851 0.358 . . . . 64.200000000000003 110.505 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 4.5 pm0 -95.44 163.65 13.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.621 -0.511 . . . . 74.340000000000003 109.621 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 57.6 t80 -110.33 156.02 21.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.103 -0.239 . . . . 73.549999999999997 111.091 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.13 158.14 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.161 0.913 . . . . 73.219999999999999 112.16 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -75.22 106.76 6.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.299 -0.864 . . . . 73.040000000000006 110.838 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.5 21.37 9.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 62.149999999999999 109.354 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.413 HD23 ' OG1' ' A' ' 127' ' ' THR . 38.2 mt -59.32 97.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -0.999 . . . . 74.25 111.551 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -168.22 85.45 0.72 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 73.340000000000003 109.961 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.41 93.7 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.59 2.193 . . . . 61.130000000000003 111.947 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.61 -26.4 66.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.698 0.761 . . . . 63.539999999999999 109.65 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -83.12 177.75 8.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.899 -1.046 . . . . 70.239999999999995 108.808 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -133.8 159.86 39.34 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.907 -0.717 . . . . 72.230000000000004 110.541 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 118' ' ' PRO . 1.2 p90 -70.46 77.18 0.57 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.315 -0.857 . . . . 63.25 110.829 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -68.49 -40.59 80.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.945 -1.025 . . . . 75.299999999999997 111.421 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.66 -146.92 4.85 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.0 -0.619 . . . . 64.310000000000002 111.949 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.89 145.78 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.783 0.325 . . . . 43.009999999999998 110.751 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.09 24.3 6.34 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.67 -0.776 . . . . 74.230000000000004 111.535 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.2 mm -88.18 112.42 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.565 -0.532 . . . . 64.040000000000006 109.565 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.717 HD23 HG22 ' A' ' 114' ' ' VAL . 3.3 tm? -85.45 121.76 28.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.987 -0.551 . . . . 61.009999999999998 109.594 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -126.69 163.52 23.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.125 0.488 . . . . 75.340000000000003 111.186 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 28.1 ttt -91.62 134.16 34.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.483 -0.781 . . . . 73.450000000000003 109.939 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -96.5 151.24 19.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.132 0.492 . . . . 52.420000000000002 110.979 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.4 p-10 -155.84 159.38 39.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 73.400000000000006 110.581 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.62 -13.45 22.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.244 0.545 . . . . 73.319999999999993 110.808 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -162.58 -179.99 37.51 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.224 -1.55 . . . . 61.149999999999999 109.224 176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.63 -50.69 12.94 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.737 2.292 . . . . 72.0 112.063 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.89 19.56 15.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 72.140000000000001 110.367 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.3 m -101.08 51.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.317 -0.994 . . . . 71.239999999999995 108.317 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 42.3 m-80 -77.37 134.84 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.421 -1.263 . . . . 74.25 110.375 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.57 -157.21 10.09 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.745 -0.74 . . . . 71.010000000000005 112.506 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -95.7 8.99 41.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.162 0.506 . . . . 61.439999999999998 111.166 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 6.3 pt20 -90.8 158.6 16.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.871 -0.604 . . . . 72.299999999999997 111.328 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.477 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . 50.9 p90 -142.17 176.45 8.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.02 -0.536 . . . . 73.129999999999995 109.971 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 51.1 p90 -159.54 152.04 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 110.608 173.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.717 HG22 HD23 ' A' ' 98' ' ' LEU . 19.3 t -110.93 142.78 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.288 -0.634 . . . . 62.140000000000001 109.288 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.7 p -97.39 130.09 44.56 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.771 0.319 . . . . 72.450000000000003 110.154 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 62' ' ' ILE . 57.0 mt -86.22 -6.69 58.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.06 0.457 . . . . 72.450000000000003 110.957 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.19 166.88 14.33 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.805 -0.634 . . . . 52.100000000000001 109.794 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 92' ' ' PHE . 32.2 Cg_exo -59.41 106.63 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.591 2.194 . . . . 63.310000000000002 112.043 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.495 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.1 p -94.02 103.42 15.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.62 -0.718 . . . . 72.219999999999999 111.793 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.19 3.6 30.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.651 0.739 . . . . 73.299999999999997 110.255 176.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.495 ' CZ2' HG22 ' A' ' 119' ' ' THR . 1.2 p90 -93.71 -3.7 51.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.995 -1.002 . . . . 74.409999999999997 111.295 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.19 16.53 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.549 -0.296 . . . . 61.439999999999998 111.207 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.75 -38.9 57.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.281 -0.872 . . . . 75.299999999999997 111.552 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.12 22.48 10.39 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.608 -0.806 . . . . 64.019999999999996 112.083 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -118.4 -26.49 6.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.061 0.458 . . . . 73.010000000000005 110.135 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -137.34 128.09 27.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 51.030000000000001 110.486 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.413 ' OG1' HD23 ' A' ' 86' ' ' LEU . 21.5 m -68.73 120.71 15.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.433 . . . . 75.530000000000001 110.669 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 99' ' ' ALA . 47.8 mt -104.21 117.58 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.547 0.203 . . . . 73.430000000000007 111.547 -176.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 47.9 m-85 -158.77 77.04 0.75 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.511 0.507 . . . . 73.030000000000001 110.698 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.34 163.24 35.45 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.116 -0.564 . . . . 52.200000000000003 112.285 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 78.3 mtm180 -142.31 127.14 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.028 -0.36 . . . . 72.349999999999994 110.028 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -87.06 142.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 75.340000000000003 110.686 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 43.6 t -145.77 147.72 32.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 64.099999999999994 110.773 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 20.6 tt0 48.41 34.04 4.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.568 0.747 . . . . 75.340000000000003 112.567 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -163.45 16.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.061 -1.066 . . . . 72.099999999999994 112.407 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.0 tp -73.18 -31.74 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.159 -0.311 . . . . 62.530000000000001 110.159 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.93 95.49 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.982 -0.847 . . . . 71.109999999999999 110.982 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 81.8 mmm -68.61 -48.85 63.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.098 -0.334 . . . . 74.519999999999996 110.098 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.523 HG13 HD12 ' A' ' 62' ' ' ILE . 85.7 t -56.33 -30.23 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 71.340000000000003 110.532 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -73.72 -52.83 11.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.815 -0.63 . . . . 72.310000000000002 110.97 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -14.43 60.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.051 -0.522 . . . . 75.099999999999994 111.305 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.52 -33.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.077 0.465 . . . . 73.200000000000003 110.382 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.567 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -82.8 -22.03 58.6 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.595 -0.812 . . . . 61.109999999999999 113.0 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ptp -84.33 -13.26 52.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.853 -0.339 . . . . 72.129999999999995 111.659 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 154' ' ' VAL . 31.4 m -93.31 137.74 21.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 54.310000000000002 111.256 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -116.71 -46.91 2.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.453 . . . . 65.120000000000005 110.642 175.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 1.9 p -119.91 146.34 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.074 0.464 . . . . 73.329999999999998 111.418 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.65 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 46.9 t30 -93.44 -33.6 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 72.030000000000001 109.362 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.7 t -168.2 176.0 6.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.287 -0.869 . . . . 62.229999999999997 108.986 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 18.67 -97.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.197 1.184 . . . . 75.299999999999997 114.197 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -129.43 26.47 5.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.122 0.963 . . . . 75.209999999999994 109.624 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -103.63 116.49 61.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.297 -0.865 . . . . 62.009999999999998 109.661 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 46.3 Cg_exo -56.58 154.9 28.43 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.576 2.184 . . . . 74.099999999999994 111.098 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.65 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 76.7 t -55.99 118.11 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 71.340000000000003 109.318 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -45.89 133.95 8.22 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 124.224 0.952 . . . . 74.439999999999998 111.715 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -45.36 126.71 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.616 -1.175 . . . . 62.009999999999998 112.785 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p -97.17 128.73 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.609 -1.178 . . . . 75.430000000000007 109.439 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -127.21 165.4 19.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.141 -0.481 . . . . 73.109999999999999 110.721 -175.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -86.76 105.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.617 -0.72 . . . . 73.230000000000004 109.102 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.1 mm -70.46 -56.37 11.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.562 -0.744 . . . . 73.140000000000001 110.673 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.5 mptm? -133.34 128.04 34.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 54.539999999999999 110.147 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -131.27 123.99 29.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.864 0.364 . . . . 71.239999999999995 110.672 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.22 143.24 32.84 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.89 -0.596 . . . . 63.530000000000001 109.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.864 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 74.4 Cg_endo -78.47 124.58 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.198 1.932 . . . . 62.119999999999997 112.241 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.5 m -163.57 137.92 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.522 -0.763 . . . . 73.329999999999998 109.234 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 13' ' ' ASN . . . -86.76 110.27 3.51 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.759 -0.734 . . . . 62.340000000000003 112.879 -174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.27 105.93 3.19 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.979 -0.848 . . . . 71.540000000000006 110.979 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.15 -64.01 2.08 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.875 -0.679 . . . . 63.32 112.653 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.29 150.06 26.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.676 -0.773 . . . . 61.420000000000002 111.978 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.1 t -153.09 140.35 19.51 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.833 -0.432 . . . . 73.25 109.833 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.73 -160.08 11.32 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.873 -0.679 . . . . 71.230000000000004 111.869 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 169.94 153.35 8.54 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.672 -0.775 . . . . 70.120000000000005 112.388 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -172.88 56.47 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.159 -0.776 . . . . 64.519999999999996 111.159 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -77.05 105.59 8.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.026 0.441 . . . . 64.150000000000006 110.863 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 113.71 -25.56 10.87 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.89 -0.671 . . . . 73.439999999999998 111.61 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -174.47 79.12 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.681 -0.771 . . . . 33.030000000000001 112.412 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -89.46 53.67 3.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.899 -0.667 . . . . 71.450000000000003 111.777 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 m -64.68 -33.29 75.59 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.662 0.385 . . . . 71.129999999999995 111.211 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.09 -94.0 0.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.966 -0.635 . . . . 53.420000000000002 112.121 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.68 132.89 7.48 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.7 -0.762 . . . . 72.109999999999999 111.884 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.33 61.37 1.19 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.259 -0.736 . . . . 65.340000000000003 111.259 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.4 m -74.43 100.82 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 71.239999999999995 110.694 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.58 -150.01 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.292 -0.723 . . . . 63.240000000000002 111.292 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.1 m-20 -121.13 169.29 10.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.32 0.581 . . . . 71.430000000000007 110.189 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.16 146.08 4.48 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.256 -0.884 . . . . 50.039999999999999 111.638 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.25 -167.38 39.86 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.359 -0.924 . . . . 55.039999999999999 111.864 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.702 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.38 167.21 21.18 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.605 -0.516 . . . . 74.430000000000007 109.605 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 191' ' ' ILE . 92.4 m-85 -114.06 103.62 55.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.142 0.496 . . . . 75.430000000000007 110.32 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.697 ' HB2' HD13 ' A' ' 90' ' ' LEU . 73.0 Cg_endo -79.87 -11.68 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.707 2.271 . . . . 74.319999999999993 112.069 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.69 -20.0 40.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.41 -0.814 . . . . 53.25 111.336 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 188' ' ' PHE . 18.4 pt -87.9 -13.6 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.969 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.1 m170 68.85 29.83 4.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.34 -0.846 . . . . 74.430000000000007 112.456 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 191' ' ' ILE . 4.2 p -130.81 148.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.803 -0.443 . . . . 71.340000000000003 109.803 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.48 124.53 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.953 0.406 . . . . 63.210000000000001 111.831 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -163.29 152.31 14.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 64.010000000000005 109.174 175.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 52.8 m-85 -117.67 146.01 37.75 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.624 0.25 . . . . 62.409999999999997 111.217 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.702 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.2 Cg_endo -66.0 -59.63 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.643 2.229 . . . . 75.120000000000005 112.191 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.2 pt? -143.98 38.87 1.33 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.769 0.285 . . . . 74.329999999999998 111.769 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.2 m-20 76.43 -19.23 0.43 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.75 1.019 . . . . 73.219999999999999 113.75 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -60.37 -23.09 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.728 0.64 . . . . 72.219999999999999 112.728 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 -13.37 60.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.241 -0.981 . . . . 63.130000000000003 112.955 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.419 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 24.8 ptt180 -110.71 -24.16 10.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.081 0.441 . . . . 75.439999999999998 111.261 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.362 -0.828 . . . . 52.310000000000002 110.394 176.785 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.923 0.392 . . . . 63.229999999999997 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.64 -174.52 4.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.992 -0.549 . . . . 75.200000000000003 109.528 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -66.43 132.63 48.72 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.191 -0.204 . . . . 75.510000000000005 110.526 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.689 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 86.3 mt 74.88 98.06 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.849 0.718 . . . . 52.149999999999999 111.709 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 17.0 Cg_endo -92.06 106.14 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.245 2.63 . . . . 72.329999999999998 110.796 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 17.5 Cg_endo -57.95 138.59 86.76 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.953 2.436 . . . . 73.030000000000001 111.858 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.89 144.85 37.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.13 -0.486 . . . . 70.25 110.024 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -88.24 -8.61 55.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.516 -0.311 . . . . 72.140000000000001 111.546 -173.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -105.5 119.14 38.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.486 -0.561 . . . . 75.299999999999997 109.486 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -97.24 109.98 52.2 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.734 -0.666 . . . . 73.439999999999998 110.869 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 31.0 Cg_endo -66.91 113.46 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.311 2.007 . . . . 72.230000000000004 110.787 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 26.7 Cg_endo -63.27 -39.94 35.2 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.592 2.195 . . . . 74.329999999999998 112.67 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.452 HD21 HG23 ' A' ' 24' ' ' VAL . 26.2 t-20 -134.0 150.88 51.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 71.329999999999998 110.031 -173.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.55 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.0 m -129.23 141.65 46.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 75.140000000000001 110.498 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.511 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.1 m-85 -96.93 124.86 41.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 73.010000000000005 110.67 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD23 ' HB1' ' A' ' 162' ' ' ALA . 27.7 mt -112.22 100.56 8.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.564 -0.289 . . . . 73.510000000000005 110.23 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.848 ' HB2' ' HG2' ' A' ' 161' ' ' LYS . 35.8 mt-10 -82.48 110.76 17.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.233 -0.654 . . . . 72.329999999999998 109.233 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -105.57 177.76 4.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.185 0.516 . . . . 72.099999999999994 111.899 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 9.9 p -71.97 -19.26 61.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 74.219999999999999 110.611 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.441 ' HE3' HG22 ' A' ' 142' ' ' VAL . 5.1 mmt -92.4 -38.78 11.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.823 -0.626 . . . . 63.229999999999997 110.833 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.66 -126.51 1.01 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.909 -0.663 . . . . 63.130000000000003 111.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.03 137.2 38.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.796 -0.446 . . . . 50.210000000000001 109.796 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 139' ' ' VAL . 3.9 mp -139.02 130.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.721 -0.672 . . . . 72.519999999999996 109.227 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.2 m -118.94 151.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.019 -0.672 . . . . 74.129999999999995 110.664 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -145.96 161.45 40.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 74.099999999999994 110.22 176.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.0 pt-20 -129.77 164.19 24.59 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.149 -0.932 . . . . 62.520000000000003 109.439 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.03 162.97 12.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.025 -0.361 . . . . 71.299999999999997 110.025 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 131' ' ' ARG . 10.1 m-85 -86.39 101.75 13.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.325 0.583 . . . . 74.25 111.72 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.634 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -82.82 -1.68 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.223 -0.898 . . . . 72.540000000000006 110.184 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -68.87 -67.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.362 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.413 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 m170 -124.2 11.08 8.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 64.400000000000006 111.521 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.438 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.88 59.78 47.03 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.465 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 16.6 Cg_exo -67.53 -46.46 2.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.476 2.117 . . . . 55.130000000000003 111.975 -177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -63.91 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 65.439999999999998 110.307 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -67.13 -41.04 86.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.391 -0.822 . . . . 75.25 110.495 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 18.5 t -58.52 -48.19 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 72.540000000000006 110.533 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.38 -34.61 78.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 72.239999999999995 111.275 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.45 ' O ' HD23 ' A' ' 42' ' ' LEU . 6.7 t30 -54.69 -52.36 62.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 63.530000000000001 110.407 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HE1' HG21 ' A' ' 14' ' ' VAL . 27.4 t80 -67.71 -44.84 76.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.201 0.524 . . . . 70.239999999999995 109.911 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.52 -44.58 76.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.306 -0.861 . . . . 74.239999999999995 112.087 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.5 mt-10 -69.77 -38.78 76.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.11 -0.236 . . . . 75.109999999999999 111.19 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 38' ' ' ASN . 4.0 mm? -65.14 -26.92 68.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 73.310000000000002 110.395 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.93 -45.2 64.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.973 -0.558 . . . . 72.230000000000004 109.873 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.6 mtp180 -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 75.450000000000003 111.063 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 9.1 mpt_? -73.01 -40.46 65.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.012 -0.366 . . . . 53.210000000000001 110.012 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 30.03 6.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.655 -0.784 . . . . 61.240000000000002 112.479 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -76.88 -17.01 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 72.420000000000002 111.385 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -74.3 -17.22 60.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -71.19 -8.52 54.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.058 0.456 . . . . 73.209999999999994 110.606 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -122.69 31.21 4.87 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.942 -0.647 . . . . 64.430000000000007 111.951 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.811 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 73.4 p -112.11 154.3 25.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 61.0 111.155 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.82 157.46 43.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 109.948 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CD1' ' HA3' ' A' ' 64' ' ' GLY . 97.9 m-85 -89.59 121.58 31.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 71.099999999999994 109.642 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -104.89 -35.6 7.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.53 -0.304 . . . . 72.340000000000003 111.803 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -113.41 112.96 24.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.686 -0.405 . . . . 72.239999999999995 110.356 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -125.99 94.33 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.179 -0.674 . . . . 74.430000000000007 109.179 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.851 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 24.2 mt -96.47 122.05 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.742 -0.663 . . . . 41.240000000000002 109.408 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 1.038 ' HD2' ' HB3' ' A' ' 146' ' ' GLU . 39.4 mtpt -53.49 120.93 6.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.525 0.516 . . . . 74.340000000000003 111.554 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 54.9 41.14 32.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.385 -0.825 . . . . 65.049999999999997 111.329 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.851 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 8.5 t80 -133.23 -80.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.775 -0.648 . . . . 74.409999999999997 109.46 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.678 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.6 ptt? -161.23 157.49 25.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.395 -0.82 . . . . 70.25 110.085 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 HG13 ' A' ' 56' ' ' ILE . 49.8 mt -127.11 101.39 7.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.409 -0.589 . . . . 73.099999999999994 109.409 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 37.7 tt0 -83.84 121.38 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.839 -0.619 . . . . 65.150000000000006 110.139 -177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA3' ' CD1' ' A' ' 53' ' ' PHE . . . -142.93 151.35 23.09 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.519 -0.848 . . . . 15.050000000000001 112.719 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 135.14 -148.93 19.78 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.548 -0.834 . . . . 75.450000000000003 112.051 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 t70 59.67 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 O-C-N 124.376 0.692 . . . . 72.030000000000001 111.145 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.9 Cg_endo -64.53 -20.59 65.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.042 2.495 . . . . 54.240000000000002 112.445 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 70' ' ' THR . 9.9 p -82.52 -27.56 31.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 71.349999999999994 111.422 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.17 26.59 68.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.91 -0.662 . . . . 72.040000000000006 111.685 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 72' ' ' ARG . 14.7 t -118.54 -24.09 6.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.487 0.185 . . . . 62.009999999999998 111.215 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.79 9.35 43.38 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 64.239999999999995 113.253 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -150.38 21.77 0.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 62.350000000000001 110.718 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.503 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -103.7 -176.15 25.91 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.748 -0.739 . . . . 74.129999999999995 112.234 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 110' ' ' SER . . . 83.37 161.27 31.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.578 -0.82 . . . . 62.009999999999998 111.645 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' H ' HD11 ' A' ' 42' ' ' LEU . . . 58.98 16.3 4.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.094 0.473 . . . . 61.329999999999998 111.567 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -68.65 -12.55 61.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.552 . . . . 74.150000000000006 110.941 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.2 pt -64.55 -39.44 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.367 -0.378 . . . . 60.43 110.369 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.689 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 95.5 m-85 -75.02 -32.93 61.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.662 -0.496 . . . . 73.239999999999995 109.662 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.37 8.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.548 -0.834 . . . . 73.420000000000002 112.93 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -171.2 2.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.982 -0.377 . . . . 60.109999999999999 109.982 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 4.0 pm0 -70.93 164.27 25.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 64.319999999999993 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -99.22 143.0 29.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 72.340000000000003 109.642 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 106' ' ' ASP . 35.1 tt0 -58.87 147.26 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.634 0.584 . . . . 70.409999999999997 110.726 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.443 ' HA ' HD21 ' A' ' 108' ' ' ASN . 11.2 p-10 -67.33 125.3 25.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.741 0.781 . . . . 55.039999999999999 110.611 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.77 29.36 7.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.644 -1.162 . . . . 74.140000000000001 108.361 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -49.61 100.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.72 -1.127 . . . . 54.049999999999997 111.175 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.64 78.69 9.83 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.066 -0.516 . . . . 72.25 111.128 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.66 66.4 2.3 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.56 2.173 . . . . 74.010000000000005 111.638 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.99 -23.55 59.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.053 0.93 . . . . 63.340000000000003 109.436 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -89.13 166.42 13.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.462 -1.244 . . . . 74.530000000000001 108.879 174.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -113.71 141.58 47.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.278 -0.569 . . . . 63.329999999999998 110.836 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.96 70.42 0.76 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.968 . . . . 71.120000000000005 109.801 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 193' ' ' VAL . 37.1 p -62.7 -40.89 98.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.091 . . . . 62.43 111.765 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.81 -144.73 4.09 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.761 -0.733 . . . . 75.530000000000001 111.911 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.05 144.02 27.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.798 0.332 . . . . 44.32 110.523 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.65 22.08 6.19 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 111.706 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 mm -88.39 114.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -89.86 120.28 30.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 109.746 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.33 160.92 30.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.948 -0.569 . . . . 64.540000000000006 110.257 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 39.0 ttp -91.06 143.16 26.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.601 -0.518 . . . . 55.539999999999999 109.601 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.3 114.4 26.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.274 0.559 . . . . 33.229999999999997 110.975 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.463 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 2.9 p-10 -115.7 149.93 37.63 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.283 -0.871 . . . . 73.030000000000001 109.897 175.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.506 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -83.84 -28.01 28.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.258 -0.883 . . . . 64.450000000000003 111.285 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.37 -108.89 0.32 Allowed Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 120.912 -0.661 . . . . 43.450000000000003 112.147 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.06 89.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.892 2.395 . . . . 63.219999999999999 112.009 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 3.3 p30 48.1 31.11 2.35 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.878 -1.055 . . . . 64.25 111.898 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 103' ' ' ALA . 1.3 m -85.38 52.25 2.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.292 0.567 . . . . 41.340000000000003 109.996 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 19.0 m-80 -91.26 173.82 7.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.303 -0.862 . . . . 75.019999999999996 109.032 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.39 -96.71 0.13 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.353 -1.403 . . . . 75.540000000000006 114.234 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.536 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 46.9 t -126.87 12.19 7.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.391 0.615 . . . . 73.439999999999998 110.448 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 100' ' ' MET . 18.9 mp0 -101.14 147.04 26.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 74.400000000000006 109.474 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -147.21 176.09 10.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.809 0.338 . . . . 73.200000000000003 110.906 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.4 p90 -160.46 152.52 20.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.98 0.419 . . . . 63.530000000000001 110.202 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 98' ' ' LEU . 18.5 t -112.91 138.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.786 -0.643 . . . . 71.230000000000004 109.268 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.9 p -93.3 125.47 37.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.058 0.456 . . . . 54.329999999999998 109.999 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.4 mt -85.29 -6.46 59.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.357 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.41 161.14 34.78 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.338 -0.846 . . . . 71.349999999999994 109.997 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.43 113.7 2.38 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.644 2.229 . . . . 74.129999999999995 112.224 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.2 p -105.31 103.57 13.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.102 -0.499 . . . . 54.409999999999997 110.938 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 120' ' ' GLN . 0.6 OUTLIER -99.78 13.84 32.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.862 0.839 . . . . 64.140000000000001 109.479 -177.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.742 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -111.05 3.85 18.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.673 -1.149 . . . . 74.040000000000006 110.748 -178.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.742 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -113.29 6.4 17.34 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.272 -0.422 . . . . 71.519999999999996 111.642 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.05 -31.72 43.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.536 -0.757 . . . . 62.43 112.132 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -125.51 20.49 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.496 -0.859 . . . . 73.099999999999994 111.691 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.71 -31.25 5.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 74.129999999999995 110.656 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.463 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 35.1 m80 -142.27 141.14 32.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 64.099999999999994 111.04 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.1 m -78.32 111.08 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 55.0 110.277 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 90' ' ' LEU . 38.6 mt -98.99 122.82 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.299999999999997 110.71 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.5 p90 -159.71 73.31 0.55 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.689 0.757 . . . . 71.329999999999998 110.898 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.748 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.49 156.66 28.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.292 -1.432 . . . . 61.420000000000002 113.802 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.9 mtm180 -134.77 122.32 21.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.504 0.321 . . . . 75.129999999999995 110.282 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -83.64 138.69 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.036 0.446 . . . . 63.240000000000002 110.66 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 41.1 t -139.86 157.66 45.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 109.907 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.4 pt20 36.86 42.77 0.24 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.252 1.021 . . . . 64.430000000000007 113.18 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.76 17.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.455 -0.879 . . . . 74.420000000000002 112.509 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.536 ' H ' ' HB3' ' A' ' 184' ' ' ASP . 11.3 tp -74.34 -34.51 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.387 -0.227 . . . . 72.299999999999997 110.387 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.28 95.33 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.736 -0.745 . . . . 63.109999999999999 111.367 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -70.31 -50.79 35.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 110.114 -0.328 . . . . 75.140000000000001 110.114 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 23' ' ' ILE . 86.3 t -55.96 -30.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.043 0.449 . . . . 73.5 110.699 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.533 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.8 t30 -70.48 -53.32 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 110.521 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.39 61.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.35 -0.386 . . . . 71.319999999999993 111.225 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.441 HG22 ' HE3' ' A' ' 20' ' ' MET . 50.6 t -83.47 -34.85 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.225 0.536 . . . . 55.340000000000003 109.733 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -79.53 -21.51 66.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.622 -0.799 . . . . 71.030000000000001 112.624 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 56.4 mtm -82.52 -23.96 34.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.944 0.35 . . . . 73.400000000000006 111.944 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.3 m -78.47 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.488 0.661 . . . . 61.420000000000002 110.196 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.038 ' HB3' ' HD2' ' A' ' 58' ' ' LYS . 8.4 pt-20 -90.42 -165.4 1.34 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 72.439999999999998 111.493 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 28.3 p -84.07 150.09 25.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.881 -0.6 . . . . 63.340000000000003 111.36 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 45.6 t30 -65.72 -30.9 71.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.674 0.749 . . . . 75.150000000000006 109.501 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 37.6 t -142.64 -80.67 0.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.98 -1.009 . . . . 74.129999999999995 108.91 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 152' ' ' ARG . 9.4 pt20 -147.15 125.11 11.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.789 -0.642 . . . . 72.299999999999997 109.974 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 69.87 -13.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.326 0.65 . . . . 63.219999999999999 112.715 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 150' ' ' GLN . 2.7 ptm180 -107.76 108.07 61.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.461 -0.57 . . . . 71.540000000000006 109.461 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 23.4 Cg_endo -61.37 145.39 98.28 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.659 2.239 . . . . 74.239999999999995 112.284 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 146' ' ' GLU . 65.2 t -59.17 -54.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.189 0.518 . . . . 71.140000000000001 109.928 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -119.52 117.76 29.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.986 -0.746 . . . . 75.439999999999998 108.986 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.57 136.58 34.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.836 0.351 . . . . 74.340000000000003 110.298 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.3 p -122.82 126.51 73.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.688 0.756 . . . . 55.340000000000003 111.725 -175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -122.93 163.77 19.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.069 -0.969 . . . . 73.030000000000001 109.67 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -90.25 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.815 -1.18 . . . . 64.319999999999993 107.815 170.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 19' ' ' SER . 32.2 mm -67.07 -53.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.693 -0.685 . . . . 75.120000000000005 110.618 -173.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.848 ' HG2' ' HB2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -142.06 132.56 25.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.606 -0.724 . . . . 54.049999999999997 110.018 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -133.46 146.15 50.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.787 0.327 . . . . 74.349999999999994 110.625 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 161' ' ' LYS . 85.0 m-85 -148.37 140.7 14.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 75.010000000000005 109.822 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.452 ' HD3' ' OH ' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -78.15 132.49 11.54 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.186 1.924 . . . . 65.219999999999999 111.579 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 49.5 m -151.52 -163.9 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 61.020000000000003 111.249 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.46 137.13 4.41 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 70.230000000000004 111.682 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.6 141.76 17.14 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.898 -0.668 . . . . 54.420000000000002 111.751 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.27 123.25 4.91 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.618 -0.801 . . . . 72.019999999999996 111.948 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -85.03 111.48 3.52 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.536 -0.84 . . . . 62.420000000000002 111.472 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -59.72 101.36 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 64.219999999999999 110.862 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.02 -40.18 2.1 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.98 -0.555 . . . . 75.129999999999995 112.772 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.31 34.72 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.253 -0.739 . . . . 72.129999999999995 111.253 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.21 -131.63 2.89 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.179 -0.768 . . . . 21.140000000000001 111.179 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.2 t -158.14 -68.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.765 -0.457 . . . . 43.450000000000003 109.765 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 166.83 -176.43 41.89 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.439 -0.664 . . . . 53.020000000000003 111.439 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.19 -55.02 4.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.884 -0.674 . . . . 34.43 112.485 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -128.97 -169.49 12.59 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.124 -0.56 . . . . 52.030000000000001 111.953 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 m -80.81 -27.64 36.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 71.120000000000005 111.016 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 111.41 163.3 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.835 -0.698 . . . . 44.240000000000002 111.877 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.53 7.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.788 . . . . 71.430000000000007 112.412 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.4 52.78 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.045 -0.598 . . . . 60.130000000000003 112.385 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 m -150.13 93.03 1.95 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.37 . . . . 63.109999999999999 110.247 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.63 -63.07 3.0 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.726 -0.749 . . . . 74.450000000000003 112.156 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.573 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 19.2 m-20 -125.07 167.51 14.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.523 0.678 . . . . 74.219999999999999 111.445 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 158.67 140.86 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.654 -1.157 . . . . 62.140000000000001 110.463 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.31 -169.81 40.57 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.233 -0.984 . . . . 71.519999999999996 111.97 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -75.34 166.67 23.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 110.153 -0.314 . . . . 71.239999999999995 110.153 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.97 100.03 11.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.482 -0.562 . . . . 70.310000000000002 109.482 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 5.5 Cg_exo -79.55 -9.75 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.666 2.244 . . . . 64.420000000000002 112.188 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.424 ' HB2' HH11 ' A' ' 131' ' ' ARG . 37.0 tt0 -74.17 -32.43 63.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.407 0.622 . . . . 75.209999999999994 109.63 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 pt -85.69 162.33 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.445 -0.946 . . . . 74.129999999999995 108.445 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -114.97 41.39 2.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 111.25 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.6 p -109.57 -174.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.318 -0.623 . . . . 53.439999999999998 109.318 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.738 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -115.84 114.38 24.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.646 0.26 . . . . 64.549999999999997 111.064 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.463 HE21 HG13 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -155.12 152.97 30.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.46 -0.571 . . . . 70.409999999999997 109.46 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -121.39 139.82 30.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.545 -0.298 . . . . 72.010000000000005 110.402 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 19.7 Cg_endo -58.31 -57.9 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.937 2.424 . . . . 64.400000000000006 111.99 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.12 23.85 4.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 73.409999999999997 109.873 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 30.2 m-20 69.55 9.5 7.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.36 -0.836 . . . . 70.510000000000005 112.169 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.9 ptm -53.0 -40.33 63.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 72.439999999999998 112.002 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.38 61.95 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.855 -0.688 . . . . 72.099999999999994 113.318 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 19.6 mtp180 -94.84 -3.68 48.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 110.685 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 4.2 tppp? . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.604 -1.18 . . . . 62.100000000000001 112.142 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ppp? . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.845 0.355 . . . . 75.530000000000001 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.91 179.9 7.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.939 -0.573 . . . . 55.039999999999999 109.839 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -82.44 146.91 29.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.124 -0.324 . . . . 64.200000000000003 110.124 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 78' ' ' TYR . 51.8 mm 76.58 107.19 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 O-C-N 123.845 0.716 . . . . 73.340000000000003 110.368 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 2.8 Cg_endo -79.93 109.92 2.47 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.361 2.707 . . . . 71.120000000000005 112.936 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.02 87.87 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.134 2.556 . . . . 74.239999999999995 112.025 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -74.45 -44.19 52.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 110.582 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -125.27 -179.36 4.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.856 -0.611 . . . . 73.140000000000001 110.012 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -88.18 -23.76 23.51 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.23 -0.285 . . . . 71.150000000000006 110.23 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 2.1 mp0 72.25 130.12 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.1 0.875 . . . . 71.319999999999993 112.059 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 10' ' ' GLN . 31.0 Cg_exo -63.1 136.85 58.5 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.92 2.413 . . . . 72.129999999999995 111.931 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 32.1 Cg_endo -65.15 -22.48 61.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.928 2.419 . . . . 71.319999999999993 113.052 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -124.21 138.97 54.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.055 0.455 . . . . 75.030000000000001 110.936 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 164' ' ' PRO . 20.9 m -128.99 157.35 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.778 -0.646 . . . . 74.219999999999999 109.418 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' CB ' HG12 ' A' ' 24' ' ' VAL . 55.4 p90 -115.14 132.12 56.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.367 0.603 . . . . 75.120000000000005 111.551 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -110.32 109.13 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.086 -0.961 . . . . 62.420000000000002 110.25 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.13 112.39 23.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.19 -0.671 . . . . 74.019999999999996 109.19 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -104.68 178.89 4.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 110.682 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.482 ' HB3' HD11 ' A' ' 160' ' ' ILE . 12.9 p -80.44 -6.13 57.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.292 0.568 . . . . 75.239999999999995 110.463 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mmm -98.83 -41.58 7.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 60.240000000000002 109.565 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.01 -134.13 1.8 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.1 -0.8 . . . . 62.119999999999997 111.1 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.73 130.72 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.958 -0.756 . . . . 61.340000000000003 108.958 177.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 139' ' ' VAL . 4.8 mp -132.15 124.9 53.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.122 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CB ' ' A' ' 15' ' ' TYR . 3.2 m -106.48 146.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.272 -0.571 . . . . 65.109999999999999 109.767 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.47 162.01 37.62 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.982 0.42 . . . . 74.200000000000003 110.14 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -135.14 165.14 26.09 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.709 -0.678 . . . . 71.120000000000005 110.767 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.65 166.86 10.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.806 -0.634 . . . . 74.549999999999997 110.237 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -87.0 96.23 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.327 0.584 . . . . 71.439999999999998 111.635 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.402 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 42.0 m95 -88.82 1.9 54.49 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.256 -0.884 . . . . 72.209999999999994 109.511 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -74.11 -50.2 20.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 60.329999999999998 111.324 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -137.97 8.63 2.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 75.319999999999993 111.426 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.84 85.54 57.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 74.120000000000005 110.503 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.07 -11.58 21.35 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.184 2.59 . . . . 71.140000000000001 113.002 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.66 -48.88 3.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 73.230000000000004 111.55 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -35.93 73.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 65.200000000000003 111.194 -175.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -54.81 -53.22 58.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.816 -0.629 . . . . 75.239999999999995 111.609 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 6.0 mtmp? -81.81 -23.63 36.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.993 -0.549 . . . . 74.299999999999997 111.188 -172.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.499 ' O ' HD23 ' A' ' 42' ' ' LEU . 4.3 m-20 -52.06 -47.02 65.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.551 0.691 . . . . 70.25 109.221 171.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.513 ' HZ ' ' HB2' ' A' ' 100' ' ' MET . 19.2 m-85 -77.08 -49.57 15.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.378 -0.828 . . . . 74.319999999999993 110.834 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -57.25 -35.64 69.99 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.694 0.628 . . . . 63.5 112.694 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 49.0 mt-10 -88.0 -15.32 36.78 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.062 -0.399 . . . . 73.209999999999994 111.314 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.4 mm? -75.03 -20.87 59.4 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.031 -0.667 . . . . 73.310000000000002 109.299 164.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.521 ' HA ' ' HE1' ' A' ' 48' ' ' TYR . . . -74.52 -41.83 59.97 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.708 -0.678 . . . . 75.349999999999994 110.949 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 1.3 ptp180 -67.79 -27.36 66.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.754 0.311 . . . . 75.010000000000005 110.552 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.52 -39.17 77.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.687 -0.857 . . . . 73.019999999999996 108.687 172.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.89 15.42 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.633 -0.712 . . . . 74.239999999999995 111.477 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.6 ' HD2' ' HG3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -72.79 -20.08 61.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 53.32 110.512 -173.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 78.0 m-85 -62.53 -28.54 69.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.811 -0.632 . . . . 74.140000000000001 111.177 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 29.1 m-80 -72.73 91.0 1.44 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.963 0.887 . . . . 72.140000000000001 109.47 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.56 11.68 3.61 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 113.896 -1.502 . . . . 64.120000000000005 112.009 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.561 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 70.2 p -99.83 154.42 18.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 63.549999999999997 110.569 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -130.69 155.86 45.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.471 -0.331 . . . . 74.319999999999993 110.722 -176.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.8 m-85 -81.75 109.51 16.22 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.944 -0.762 . . . . 70.299999999999997 108.944 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 -37.96 12.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.106 -0.497 . . . . 73.439999999999998 111.676 -171.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 17.0 mmt180 -112.12 114.14 26.81 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 75.140000000000001 109.239 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 53' ' ' PHE . 4.0 mp -124.19 89.21 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.06 -0.718 . . . . 64.310000000000002 109.06 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -93.9 125.17 46.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.989 -0.745 . . . . 72.230000000000004 108.989 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 12.4 ptmm? -53.41 135.56 39.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.507 0.505 . . . . 75.340000000000003 110.946 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 42.68 37.01 0.91 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.213 0.946 . . . . 64.430000000000007 112.412 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.432 ' N ' ' HB2' ' A' ' 116' ' ' LEU . 2.7 m-85 -134.4 -80.44 0.45 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.066 -0.515 . . . . 31.309999999999999 111.398 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.46 155.83 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 65.129999999999995 111.065 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 116' ' ' LEU . 20.8 mt -132.3 106.36 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 75.430000000000007 110.004 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' OE1' ' HG2' ' A' ' 55' ' ' ARG . 44.4 tt0 -83.81 128.77 34.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.06 -0.348 . . . . 42.439999999999998 110.06 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.67 132.84 7.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.64 -0.79 . . . . 62.130000000000003 112.592 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 152.81 -112.79 0.55 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.55 -0.833 . . . . 21.329999999999998 113.452 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 31.09 73.14 0.5 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 74.430000000000007 113.364 -170.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.6 ' HG3' ' HD2' ' A' ' 47' ' ' TYR . 72.9 Cg_endo -78.84 -16.29 12.9 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.049 1.833 . . . . 71.129999999999995 111.543 174.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 p -105.18 -57.34 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.715 -0.675 . . . . 72.400000000000006 111.177 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.13 0.02 41.18 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.826 -0.702 . . . . 65.230000000000004 112.06 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 72' ' ' ARG . 1.9 t -80.95 -6.78 59.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 110.687 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.41 -25.51 26.72 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.624 -0.798 . . . . 65.329999999999998 112.55 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' CG ' HG23 ' A' ' 70' ' ' THR . 0.4 OUTLIER -94.21 -32.24 13.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 62.039999999999999 111.414 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -161.45 15.34 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.625 -0.797 . . . . 73.230000000000004 111.58 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.61 -84.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.02 -0.61 . . . . 44.509999999999998 112.101 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 60.73 39.37 17.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.225 0.536 . . . . 35.409999999999997 111.272 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m -55.78 -29.27 59.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.159 -0.928 . . . . 74.209999999999994 112.439 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.514 HG12 HD12 ' A' ' 4' ' ' ILE . 7.9 tt -73.95 -41.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.207 0.447 . . . . 63.340000000000003 112.207 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.533 ' HB3' HD11 ' A' ' 4' ' ' ILE . 43.8 p90 -108.02 -8.69 15.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.338 -0.545 . . . . 74.230000000000004 112.215 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.12 -101.14 1.43 Allowed Glycine 0 C--N 1.329 0.169 0 C-N-CA 121.138 -0.553 . . . . 74.109999999999999 113.254 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -69.12 163.78 24.04 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.518 -0.549 . . . . 55.43 109.518 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -58.75 174.06 0.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.683 0.754 . . . . 74.099999999999994 112.257 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -116.88 155.73 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.088 -0.96 . . . . 73.120000000000005 109.424 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.55 159.42 8.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.522 0.514 . . . . 75.0 110.555 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.688 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -91.48 13.41 17.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.078 -0.965 . . . . 73.400000000000006 109.788 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.12 106.32 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.738 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -164.92 71.01 1.45 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 73.200000000000003 109.882 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -76.29 81.44 2.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.395 2.063 . . . . 64.129999999999995 113.094 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.96 -18.13 41.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.686 0.755 . . . . 75.239999999999995 109.793 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 189' ' ' PRO . 2.9 pp -87.55 177.27 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.105 -0.952 . . . . 74.439999999999998 108.819 173.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.663 ' HD2' ' HA ' ' A' ' 192' ' ' HIS . 2.9 tmtm? -137.23 135.37 37.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.838 0.351 . . . . 74.030000000000001 110.425 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER -63.98 89.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.916 0.865 . . . . 72.409999999999997 109.977 173.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 193' ' ' VAL . 16.4 p -71.72 -51.01 25.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.602 -1.181 . . . . 74.150000000000006 111.083 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -147.85 -132.9 2.27 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.615 -0.802 . . . . 72.409999999999997 111.998 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.16 147.06 24.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.824 0.345 . . . . 41.340000000000003 110.852 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.2 20.98 8.3 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.751 -0.738 . . . . 34.520000000000003 111.582 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -87.05 111.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.387 -0.597 . . . . 63.5 109.387 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -88.15 118.74 27.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.721 -0.672 . . . . 64.230000000000004 109.809 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.515 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.63 173.83 9.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.005 -0.543 . . . . 54.340000000000003 111.512 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 39' ' ' PHE . 25.2 ttt -101.25 128.59 47.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.335 -0.848 . . . . 65.230000000000004 109.982 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -90.76 114.55 26.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.612 0.72 . . . . 71.329999999999998 110.991 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 3.9 p-10 -121.1 160.39 23.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.953 -1.021 . . . . 75.420000000000002 110.244 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.61 -25.31 16.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.152 -0.476 . . . . 31.210000000000001 110.832 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -152.75 -176.98 25.9 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.889 -1.285 . . . . 33.350000000000001 109.889 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.16 -53.72 5.98 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.338 2.692 . . . . 54.229999999999997 112.475 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.83 16.97 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.164 0.507 . . . . 73.329999999999998 110.671 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.468 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -92.73 53.55 2.06 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 71.230000000000004 108.261 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -87.04 107.81 18.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.641 -1.163 . . . . 74.219999999999999 110.281 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.88 -166.01 34.41 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.195 -0.762 . . . . 73.230000000000004 111.195 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m -100.22 67.12 1.35 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.908 -0.775 . . . . 70.049999999999997 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 69.2 mt-30 -124.83 147.76 48.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.111 -0.95 . . . . 53.329999999999998 110.174 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -120.4 155.81 32.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.427 -0.351 . . . . 71.239999999999995 110.919 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -153.76 141.74 20.26 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.111 -0.495 . . . . 75.230000000000004 110.37 168.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.732 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -110.94 142.43 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.602 -0.726 . . . . 72.230000000000004 109.424 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.58 127.04 41.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.382 . . . . 72.430000000000007 110.131 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 62' ' ' ILE . 65.3 mt -84.54 -9.03 58.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.773 -0.649 . . . . 55.43 109.859 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.0 157.7 31.96 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.107 -0.952 . . . . 71.510000000000005 109.556 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.421 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 27.5 Cg_exo -62.56 115.66 3.04 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.536 2.157 . . . . 52.530000000000001 112.264 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 p -105.77 106.92 17.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.006 0.431 . . . . 74.409999999999997 110.33 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp0? -97.34 20.71 11.13 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.381 0.61 . . . . 72.019999999999996 111.089 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.674 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -123.81 -1.77 8.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.314 -0.857 . . . . 75.310000000000002 110.337 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.674 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 97.9 mt -105.8 3.86 29.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.914 -0.584 . . . . 75.219999999999999 111.14 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.44 -23.68 67.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.455 -0.793 . . . . 74.420000000000002 111.134 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.29 18.4 7.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.686 -0.768 . . . . 63.450000000000003 111.504 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -115.49 -35.84 4.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.112 0.482 . . . . 71.109999999999999 109.708 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 98.1 m-70 -141.59 132.66 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 72.109999999999999 109.093 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.7 t -74.78 147.14 41.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 110.302 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.515 HG23 ' HB2' ' A' ' 99' ' ' ALA . 43.3 mt -123.97 119.57 57.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.004 -0.544 . . . . 75.400000000000006 110.388 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -156.32 72.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.447 . . . . 71.299999999999997 110.198 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -166.17 165.6 38.27 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.249 -0.74 . . . . 54.140000000000001 111.249 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -152.97 132.01 12.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 74.030000000000001 111.084 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' GLY . 5.2 p -79.94 144.6 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.856 . . . . 45.219999999999999 110.716 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.594 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 42.7 t -139.23 151.99 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.175 -0.466 . . . . 42.399999999999999 109.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.4 tt0 45.42 42.15 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.59 0.556 . . . . 73.150000000000006 111.893 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 27.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.206 -0.997 . . . . 62.119999999999997 112.397 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.3 tp -81.92 -31.19 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.898 -0.408 . . . . 75.409999999999997 109.898 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.85 91.72 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.786 -0.721 . . . . 12.32 111.39 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 69.8 mmm -68.28 -49.58 59.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.233 -0.284 . . . . 63.229999999999997 110.233 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 23' ' ' ILE . 95.0 t -55.84 -30.53 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.251 0.548 . . . . 72.109999999999999 110.502 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -70.12 -52.62 22.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.717 -0.674 . . . . 72.019999999999996 110.709 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.3 OUTLIER -72.92 -14.73 61.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 74.450000000000003 111.481 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 145' ' ' VAL . 63.6 t -89.95 -35.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.98 0.419 . . . . 74.109999999999999 110.492 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -81.33 -11.83 82.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 63.299999999999997 112.867 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 ptp -95.67 0.65 52.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.573 0.225 . . . . 72.400000000000006 111.235 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.5 m -65.24 144.27 14.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.958 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.79 -169.84 1.69 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.525 -0.761 . . . . 73.25 109.439 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.1 p -60.29 143.27 53.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.691 0.281 . . . . 70.319999999999993 110.97 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.94 -59.47 3.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.17 0.509 . . . . 61.350000000000001 110.512 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 24.5 m -157.39 158.94 36.84 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.691 -0.855 . . . . 62.340000000000003 108.691 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 52.05 25.6 3.29 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.235 0.457 . . . . 75.340000000000003 112.235 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.47 29.91 19.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.062 0.545 . . . . 70.439999999999998 111.891 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 149' ' ' SER . 5.5 ptm180 -98.79 130.66 27.23 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.073 -1.084 . . . . 73.209999999999994 108.073 171.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.83 144.96 75.07 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.397 2.065 . . . . 65.230000000000004 111.325 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.36 -61.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 110.279 -0.267 . . . . 73.319999999999993 110.279 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.47 -43.08 0.52 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.007 0.817 . . . . 74.109999999999999 112.523 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -78.88 64.45 3.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.601 0.715 . . . . 64.310000000000002 111.305 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -121.9 115.5 46.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.618 -1.253 . . . . 64.319999999999993 107.618 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 2.3 mppt? -128.48 156.01 43.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.027 -0.669 . . . . 73.140000000000001 111.877 -166.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -86.33 104.23 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.694 -1.139 . . . . 75.510000000000005 108.199 168.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.684 HG22 ' HD3' ' A' ' 161' ' ' LYS . 32.2 mm -69.37 -58.36 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 73.510000000000005 110.6 -174.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.684 ' HD3' HG22 ' A' ' 160' ' ' ILE . 3.9 mppt? -132.13 139.4 48.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.73 -0.668 . . . . 71.239999999999995 110.131 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -138.92 127.3 22.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.69 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 161' ' ' LYS . 42.6 m-85 -140.22 155.06 70.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.7 Cg_exo -71.86 138.28 31.18 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.709 1.606 . . . . 72.319999999999993 110.364 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.2 t -76.48 -40.42 50.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 73.019999999999996 111.152 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.73 -106.26 2.69 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.59 -0.814 . . . . 63.149999999999999 111.5 -177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.47 -55.8 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.663 -0.779 . . . . 73.409999999999997 111.771 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 102.92 2.48 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.943 -0.646 . . . . 70.230000000000004 111.773 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.0 72.27 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.852 -0.69 . . . . 62.100000000000001 111.876 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.9 t -111.45 -170.89 1.73 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.685 0.278 . . . . 73.129999999999995 110.259 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 115.68 98.38 2.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.013 -0.613 . . . . 74.239999999999995 112.021 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -94.06 73.87 1.12 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.815 -0.707 . . . . 43.450000000000003 111.784 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -85.47 47.65 3.86 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.132 -0.556 . . . . 71.340000000000003 112.663 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.9 m -107.0 103.4 12.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.816 -0.438 . . . . 74.519999999999996 109.816 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 136.08 -172.63 22.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.484 -0.647 . . . . 74.530000000000001 111.484 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.16 -72.25 1.4 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.288 -0.482 . . . . 44.32 112.667 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 166.93 -89.37 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.608 -0.597 . . . . 75.519999999999996 111.608 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.3 m -96.41 -36.19 10.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.213 0.53 . . . . 61.020000000000003 109.741 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.98 -170.51 41.96 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.058 -0.817 . . . . 64.219999999999999 111.058 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.82 47.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.267 -0.968 . . . . 53.109999999999999 112.712 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -162.35 178.05 38.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.753 -0.737 . . . . 72.310000000000002 111.823 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.5 m -117.12 -5.16 11.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 71.200000000000003 110.426 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.74 97.7 0.21 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.306 -1.118 . . . . 64.400000000000006 110.306 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -77.17 169.88 17.53 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.008 0.908 . . . . 62.329999999999998 111.857 -171.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 140.17 142.41 4.19 Favored Glycine 0 N--CA 1.426 -2.026 0 CA-C-N 113.82 -1.536 . . . . 61.100000000000001 111.263 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 172.06 54.1 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.691 -0.766 . . . . 63.409999999999997 111.656 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -66.36 148.59 51.64 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.848 -0.427 . . . . 62.030000000000001 109.848 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -80.1 107.18 6.29 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.372 -0.377 . . . . 73.319999999999993 110.185 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.632 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.3 Cg_exo -79.97 -5.84 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.762 2.308 . . . . 53.240000000000002 111.594 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.65 -22.29 60.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 71.400000000000006 110.446 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.426 HD12 HG12 ' A' ' 193' ' ' VAL . 8.0 pt -97.16 172.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.268 -0.641 . . . . 65.430000000000007 109.268 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' HIS . . . . . 0.663 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 63.9 m170 -121.24 27.4 8.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 72.540000000000006 111.111 -175.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.0 p -111.87 167.22 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.144 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.429 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -89.22 108.68 19.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.924 0.392 . . . . 61.32 111.375 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 150.11 29.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.241 -0.651 . . . . 71.019999999999996 109.241 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -127.08 151.68 74.65 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.678 -0.237 . . . . 73.310000000000002 110.955 -173.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.2 Cg_endo -66.38 -70.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.59 2.193 . . . . 75.140000000000001 111.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -114.99 16.41 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.033 0.444 . . . . 73.439999999999998 110.236 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 11.2 m-20 70.17 7.57 6.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.35 -0.841 . . . . 74.310000000000002 113.127 171.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.8 -31.18 71.38 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.884 0.327 . . . . 72.030000000000001 111.884 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.14 -1.14 87.6 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.808 -0.711 . . . . 50.119999999999997 112.907 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 69.8 mtp180 -80.98 -21.52 40.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 53.119999999999997 111.145 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.612 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.522 -0.763 . . . . 63.409999999999997 111.583 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.744 0.307 . . . . 73.239999999999995 110.707 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.91 137.61 54.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.677 -0.49 . . . . 54.030000000000001 109.677 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.57 84.26 6.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.686 -0.234 . . . . 61.350000000000001 111.528 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt 66.3 102.66 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 123.907 0.754 . . . . 61.030000000000001 112.364 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.02 116.48 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.223 1.949 . . . . 73.230000000000004 111.422 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.11 31.41 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.037 2.491 . . . . 73.219999999999999 112.125 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -77.67 108.03 10.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.724 . . . . 74.329999999999998 109.641 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.5 p -142.75 128.96 19.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 71.340000000000003 111.441 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -95.65 -1.61 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.539 . . . . 74.420000000000002 110.265 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG2' ' HB3' ' A' ' 44' ' ' ARG . 2.6 mp0 -59.26 147.62 74.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.43 -0.804 . . . . 72.450000000000003 111.343 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 13.3 Cg_exo -70.52 155.21 63.91 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.072 2.514 . . . . 73.329999999999998 112.161 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.5 -2.16 11.36 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.083 2.522 . . . . 45.329999999999998 112.886 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.437 HD22 ' CG1' ' A' ' 24' ' ' VAL . 4.7 t30 -121.09 144.65 48.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 110.275 -175.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 32.1 m -135.32 150.88 29.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.431 . . . . 65.25 111.05 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 28.3 m-85 -103.28 119.71 39.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.832 -0.622 . . . . 74.430000000000007 111.018 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.67 105.03 14.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.063 0.459 . . . . 65.420000000000002 110.797 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' HG12 ' A' ' 22' ' ' ILE . 37.3 mt-10 -90.0 118.23 29.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.965 -0.754 . . . . 73.25 108.965 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -108.34 178.15 4.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 73.010000000000005 111.106 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 160' ' ' ILE . 33.2 t -79.55 6.67 9.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.98 -0.554 . . . . 73.349999999999994 110.431 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.602 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.8 mmt -113.56 -38.28 4.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.918 -0.583 . . . . 70.150000000000006 110.171 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.01 -132.69 1.74 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.268 -0.733 . . . . 74.540000000000006 111.268 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -139.64 131.34 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.17 -0.678 . . . . 64.120000000000005 109.17 177.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -123.47 124.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.584 -0.735 . . . . 71.310000000000002 110.095 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 20.7 t -99.42 133.6 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.171 -0.677 . . . . 62.240000000000002 109.171 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 3.9 pp -142.04 161.86 36.94 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.502 -0.479 . . . . 65.209999999999994 110.859 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.51 166.07 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.903 -0.59 . . . . 73.150000000000006 109.57 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -107.49 161.28 14.98 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.094 -0.706 . . . . 61.340000000000003 109.094 178.205 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 7.0 m-85 -84.62 97.04 9.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.668 0.747 . . . . 74.219999999999999 111.216 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 15.0 m95 -88.78 9.88 22.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.45 -1.315 . . . . 73.319999999999993 107.45 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.17 -55.0 5.42 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 113.413 -1.721 . . . . 74.129999999999995 110.603 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.85 1.75 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.177 0.436 . . . . 74.150000000000006 112.177 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.68 77.97 29.35 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.049 -0.26 . . . . 61.200000000000003 110.339 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 7.3 Cg_exo -73.8 -9.7 22.66 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.237 2.624 . . . . 51.149999999999999 113.164 -173.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -100.37 -51.99 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.31 0.576 . . . . 65.099999999999994 109.957 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.49 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -61.2 -39.77 91.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.95 -1.023 . . . . 74.549999999999997 111.574 -175.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 29' ' ' TRP . 26.0 p -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.325 -0.398 . . . . 75.239999999999995 110.767 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.4 mmmm -63.47 -41.07 98.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.626 -0.261 . . . . 72.239999999999995 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' HD23 ' A' ' 42' ' ' LEU . 65.5 t30 -60.25 -47.84 84.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.358 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 11.3 t80 -65.24 -52.21 55.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.131 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.17 81.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.294 -0.866 . . . . 65.450000000000003 112.181 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 44.3 mt-10 -77.53 -24.11 50.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.926 -0.309 . . . . 73.530000000000001 111.723 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.9 mm? -74.4 -27.54 60.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.168 0.508 . . . . 64.129999999999995 109.878 171.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.94 -41.27 71.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 72.140000000000001 110.573 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.678 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 8.4 ppt_? -79.7 -15.36 57.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 72.200000000000003 110.768 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -74.92 -32.93 61.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.045 -0.724 . . . . 71.140000000000001 109.045 172.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.19 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.817 -0.706 . . . . 74.010000000000005 111.791 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.627 ' HE1' ' HA3' ' A' ' 74' ' ' GLY . 6.2 t80 -76.63 -39.39 52.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.602 -0.299 . . . . 74.230000000000004 111.268 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -74.84 -15.51 60.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 112.162 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -76.3 90.65 3.19 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.725 0.774 . . . . 74.230000000000004 109.151 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.39 8.55 4.41 Favored Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.351 -1.295 . . . . 73.150000000000006 112.138 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -97.31 158.72 15.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.01 -0.367 . . . . 71.5 110.01 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -136.51 167.11 22.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.432 -0.507 . . . . 73.150000000000006 110.479 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 86.0 m-85 -83.35 118.87 23.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.943 -0.571 . . . . 71.209999999999994 109.548 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -92.3 -32.66 14.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.299999999999997 110.11 -172.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -121.72 120.86 35.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.961 -0.385 . . . . 72.109999999999999 109.961 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -131.82 95.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.083 -0.71 . . . . 61.119999999999997 109.083 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.6 mt -102.38 125.13 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 109.878 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -55.15 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.61 0.569 . . . . 61.329999999999998 110.945 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 41.15 44.16 2.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.4 1.062 . . . . 74.319999999999993 112.254 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -138.3 -81.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 72.150000000000006 110.056 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 ptp -160.96 156.9 25.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.688 -0.687 . . . . 61.409999999999997 110.307 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.512 HG23 HG13 ' A' ' 56' ' ' ILE . 37.4 mt -134.77 105.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 63.439999999999998 109.857 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.1 tm0? -84.48 128.71 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 74.519999999999996 110.181 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -124.97 147.88 16.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.13 -0.557 . . . . 63.039999999999999 112.61 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.27 -125.32 3.02 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.618 -0.593 . . . . 75.209999999999994 111.618 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.8 t0 42.15 84.08 0.19 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.947 0.899 . . . . 72.239999999999995 113.125 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 85.1 Cg_endo -79.17 -26.98 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.635 2.223 . . . . 72.340000000000003 111.729 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 20.1 p -84.11 -39.35 19.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.179 -0.919 . . . . 74.129999999999995 111.664 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.23 21.61 14.86 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.774 -0.931 . . . . 74.430000000000007 110.774 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.8 p -113.43 -24.88 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.534 . . . . 73.400000000000006 110.576 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.21 -13.46 65.78 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.659 -0.7 . . . . 75.450000000000003 111.832 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.31 15.51 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.18 0.514 . . . . 73.140000000000001 110.208 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.491 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -77.02 170.16 55.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.52 -0.763 . . . . 62.140000000000001 112.199 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.627 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . 69.43 -175.76 32.59 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.945 -0.645 . . . . 64.349999999999994 112.547 -175.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . 56.3 19.75 4.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.236 0.614 . . . . 70.329999999999998 112.354 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m -84.26 -1.36 55.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.64 -0.709 . . . . 71.120000000000005 110.746 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.6 tt -61.75 -37.84 79.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.743 -0.662 . . . . 73.230000000000004 111.358 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.617 ' HD1' HG23 ' A' ' 77' ' ' ILE . 21.6 p90 -103.22 4.16 36.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.217 0.532 . . . . 73.450000000000003 110.957 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.82 -108.99 2.84 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.342 -0.845 . . . . 72.150000000000006 112.467 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -89.97 -166.15 1.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.752 0.31 . . . . 71.140000000000001 110.233 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.487 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 4.5 pm0 -60.62 161.06 8.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.616 . . . . 75.329999999999998 109.772 171.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -100.5 -71.53 0.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 73.209999999999994 111.179 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 14.0 tp10 -151.19 -168.31 3.06 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.802 -1.555 . . . . 65.239999999999995 106.802 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.827 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 0.9 OUTLIER -136.55 119.54 16.42 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.606 -0.887 . . . . 72.120000000000005 108.606 162.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -100.37 29.65 4.27 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.378 -1.283 . . . . 74.519999999999996 110.486 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 31.3 mt -48.89 99.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.376 -0.829 . . . . 33.350000000000001 111.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -170.69 83.63 0.54 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.61 -1.177 . . . . 75.439999999999998 108.839 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.9 84.13 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.284 1.99 . . . . 72.530000000000001 111.337 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.94 -18.15 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.329 1.061 . . . . 62.030000000000001 108.873 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -104.16 165.61 10.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.332 -1.304 . . . . 62.409999999999997 108.79 172.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -119.3 144.37 46.85 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.426 -0.352 . . . . 74.030000000000001 110.143 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.681 ' CZ ' ' HB3' ' A' ' 120' ' ' GLN . 51.4 p90 -71.33 115.31 10.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 72.019999999999996 108.197 174.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 189' ' ' PRO . 77.2 p -99.82 -30.83 11.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.832 -0.622 . . . . 71.329999999999998 110.104 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.42 -148.8 5.87 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.063 -0.971 . . . . 64.540000000000006 110.94 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.56 144.61 30.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.74 0.305 . . . . 61.420000000000002 111.02 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.58 22.93 5.87 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.812 -0.709 . . . . 71.430000000000007 111.993 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 7.9 mm -91.39 115.06 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.785 -0.366 . . . . 51.140000000000001 110.048 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.697 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 6.8 mt -83.1 124.78 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.233 -0.44 . . . . 74.400000000000006 111.115 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.82 171.73 13.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.103 0.478 . . . . 52.109999999999999 111.367 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.652 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 24.1 tpp -86.11 137.81 32.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.618 -0.719 . . . . 74.049999999999997 111.033 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -92.75 113.46 25.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.451 0.644 . . . . 75.0 110.346 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.6 -169.58 3.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.002 -0.999 . . . . 70.109999999999999 109.03 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.54 -41.58 4.78 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.846 -0.342 . . . . 70.310000000000002 111.026 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.3 -55.23 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.504 -0.855 . . . . 75.439999999999998 112.474 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 77.51 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.022 1.814 . . . . 45.109999999999999 112.099 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.827 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 3.5 p-10 44.93 48.26 9.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.685 0.615 . . . . 74.420000000000002 112.13 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.44 29.82 7.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 72.349999999999994 111.082 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.652 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 23.6 p30 -93.67 161.78 14.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.965 0.412 . . . . 64.129999999999995 110.915 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -165.08 -118.21 0.43 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 52.119999999999997 112.284 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 5.5 t -105.4 16.92 24.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.377 0.608 . . . . 64.519999999999996 109.944 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 72.2 mm-40 -93.87 145.28 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 61.210000000000001 109.375 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -145.44 170.88 15.51 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.102 -0.373 . . . . 71.409999999999997 110.394 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 28.6 p90 -157.05 152.76 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.955 0.407 . . . . 74.439999999999998 111.042 173.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.48 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.4 t -107.14 146.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 72.120000000000005 109.757 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.6 p -100.14 124.26 45.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.875 -0.417 . . . . 72.549999999999997 109.875 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.521 HD11 ' HA3' ' A' ' 143' ' ' GLY . 73.9 mt -85.58 -8.14 58.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.709 -0.678 . . . . 74.319999999999993 111.117 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.21 167.0 14.56 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.044 -0.526 . . . . 55.340000000000003 110.556 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.621 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 17.8 Cg_endo -60.35 113.08 1.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.804 2.336 . . . . 72.329999999999998 111.945 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.413 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 31.0 p -107.12 102.36 11.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 42.329999999999998 111.67 -175.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.681 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.2 OUTLIER -108.43 18.04 21.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 109.921 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -113.86 -3.5 13.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.049 -0.978 . . . . 72.540000000000006 111.515 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.7 pp -125.98 9.57 7.51 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.514 -0.474 . . . . 75.019999999999996 112.111 -175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.51 -32.61 51.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.456 0.646 . . . . 71.150000000000006 111.225 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.79 22.75 8.56 Favored Glycine 0 CA--C 1.509 -0.339 0 CA-C-N 115.423 -0.808 . . . . 60.100000000000001 111.68 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.8 mmtm -114.7 -38.71 3.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.306 0.574 . . . . 62.119999999999997 109.496 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -137.1 129.45 29.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.39 -0.823 . . . . 73.349999999999994 108.956 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -75.25 144.97 42.3 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.047 -0.661 . . . . 63.119999999999997 109.568 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.422 ' O ' HD21 ' A' ' 90' ' ' LEU . 44.2 mt -115.35 125.42 72.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.945 -171.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.3 p90 -154.18 72.83 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.964 0.888 . . . . 71.310000000000002 110.895 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.697 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -165.58 160.15 33.49 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.923 -1.608 . . . . 71.439999999999998 114.326 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.1 mtm180 -141.87 126.35 17.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.498 . . . . 72.200000000000003 109.748 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.0 p -91.42 136.13 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.274 0.559 . . . . 71.120000000000005 110.907 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.581 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 38.4 t -141.16 147.73 38.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.045 -0.525 . . . . 62.439999999999998 109.992 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.618 ' HG3' ' HA3' ' A' ' 183' ' ' GLY . 12.5 tt0 52.42 35.41 17.41 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.124 0.488 . . . . 73.209999999999994 112.158 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.48 27.83 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.28 -0.962 . . . . 53.350000000000001 112.734 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -75.13 -38.71 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.721 -0.282 . . . . 75.120000000000005 110.299 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.66 -32.08 82.23 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.015 -0.612 . . . . 71.319999999999993 111.94 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.475 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.0 mmm -69.53 -52.0 30.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.962 -0.384 . . . . 73.010000000000005 109.962 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 23' ' ' ILE . 93.0 t -58.07 -29.69 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.143 0.497 . . . . 65.120000000000005 110.409 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.651 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -68.0 -55.61 11.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.882 -0.599 . . . . 73.120000000000005 109.975 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -14.92 61.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.176 -0.466 . . . . 65.209999999999994 111.288 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.725 HG13 HG21 ' A' ' 157' ' ' VAL . 30.4 t -78.61 -39.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.325 0.583 . . . . 75.349999999999994 109.544 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -80.49 -21.07 65.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.564 -0.827 . . . . 33.43 112.642 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 85.3 mtp -72.8 -17.03 61.61 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.945 0.35 . . . . 75.319999999999993 111.945 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.562 ' HB ' HG21 ' A' ' 154' ' ' VAL . 34.4 m -92.96 128.36 44.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.63 . . . . 72.439999999999998 111.372 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 4.1 pt-20 -111.46 -60.07 1.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.529 -0.76 . . . . 74.510000000000005 110.873 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 2.9 p -122.78 153.83 39.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 75.140000000000001 111.536 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.955 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 54.8 t30 -75.66 -48.32 22.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.552 -0.749 . . . . 75.209999999999994 110.449 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 t -166.9 -57.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.183 -0.917 . . . . 64.209999999999994 109.14 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -90.85 -155.61 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.621 -0.718 . . . . 75.019999999999996 110.234 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -76.7 29.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.159 0.584 . . . . 75.329999999999998 112.482 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.1 ptp180 -135.55 142.61 41.74 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.733 0.301 . . . . 74.310000000000002 110.867 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 46.1 Cg_exo -57.44 152.24 48.33 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.753 2.302 . . . . 73.439999999999998 111.677 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.955 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 45.5 t -50.23 -69.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 123.577 0.548 . . . . 75.209999999999994 111.687 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -169.25 150.68 4.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.368 -0.975 . . . . 62.030000000000001 108.368 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 11.3 p-10 -77.12 114.38 15.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.922 -0.77 . . . . 74.239999999999995 108.922 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.725 HG21 HG13 ' A' ' 142' ' ' VAL . 40.9 t -74.13 126.26 34.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.559 -0.534 . . . . 65.310000000000002 109.559 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -125.96 158.88 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 111.924 -176.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.1 mp -88.27 106.2 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.578 -1.192 . . . . 71.430000000000007 109.133 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 19' ' ' SER . 26.0 mm -71.67 -53.81 19.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.846 -0.616 . . . . 74.25 110.41 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.8 mptm? -129.9 137.98 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.726 -0.67 . . . . 71.219999999999999 109.843 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -146.06 110.23 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.019 0.437 . . . . 60.409999999999997 110.911 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.34 140.85 31.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.533 -0.758 . . . . 71.519999999999996 110.738 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.687 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 39.2 Cg_endo -67.8 135.24 34.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.604 2.203 . . . . 72.209999999999994 111.855 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.482 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 9.1 t -164.34 -173.1 2.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.206 -0.294 . . . . 65.319999999999993 110.206 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -92.62 98.73 2.44 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.918 -0.658 . . . . 71.349999999999994 112.489 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 15' ' ' TYR . . . -97.59 109.29 3.8 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 62.340000000000003 112.154 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.63 166.09 31.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.95 -0.643 . . . . 70.319999999999993 112.224 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 182' ' ' SER . . . -123.75 142.08 14.03 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.847 -0.692 . . . . 62.020000000000003 111.978 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.8 m -87.49 110.06 20.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.954 0.406 . . . . 64.120000000000005 110.57 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.94 -144.99 18.17 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.869 -0.682 . . . . 31.34 111.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 163.58 -134.74 3.5 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.595 -0.812 . . . . 63.350000000000001 112.082 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -71.28 105.15 1.57 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.957 -0.639 . . . . 64.120000000000005 112.595 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.0 t -54.3 -49.64 69.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.739 0.304 . . . . 75.030000000000001 110.775 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.21 -88.41 0.14 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.575 -0.821 . . . . 41.229999999999997 112.559 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -116.15 28.13 7.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.04 -0.6 . . . . 74.340000000000003 111.849 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -165.75 166.98 38.86 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.44 -0.664 . . . . 32.100000000000001 111.44 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.5 p -78.16 129.31 35.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.96 0.41 . . . . 74.200000000000003 110.45 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.08 147.52 5.07 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.406 -0.677 . . . . 55.420000000000002 111.406 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.67 165.27 39.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.781 -0.723 . . . . 54.109999999999999 112.359 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 96.11 -165.43 24.09 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.613 -0.803 . . . . 72.430000000000007 111.711 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.404 ' HB2' ' HA2' ' A' ' 169' ' ' GLY . 36.9 m -154.47 121.5 5.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.92 0.39 . . . . 23.539999999999999 110.635 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.618 ' HA3' ' HG3' ' A' ' 134' ' ' GLN . . . 78.6 -91.79 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.915 -0.659 . . . . 64.420000000000002 113.4 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.445 ' CG ' HG22 ' A' ' 136' ' ' ILE . 0.6 OUTLIER -166.29 -163.43 0.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.73 -0.471 . . . . 70.549999999999997 109.73 -171.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.55 140.95 3.0 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.859 -0.686 . . . . 50.340000000000003 112.518 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -83.5 -163.0 34.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.424 -0.893 . . . . 53.119999999999997 112.049 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.689 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.07 160.67 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.801 0.334 . . . . 55.030000000000001 110.474 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.482 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.9 m-85 -106.82 100.04 29.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.47 . . . . 74.109999999999999 110.144 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.673 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.8 Cg_exo -76.81 -6.37 16.76 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.155 2.57 . . . . 72.299999999999997 113.0 -173.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -81.87 -29.92 32.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.511 -0.313 . . . . 72.299999999999997 111.057 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.0 pt -76.52 -19.01 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.991 0.367 . . . . 64.129999999999995 111.991 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.4 m170 67.63 48.43 1.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 72.140000000000001 111.916 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 191' ' ' ILE . 7.3 p -152.34 141.33 14.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.494 -0.321 . . . . 74.099999999999994 110.267 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.64 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 44.409999999999997 111.704 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -163.37 136.5 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.737 -0.665 . . . . 74.239999999999995 109.339 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -109.1 146.84 34.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 75.329999999999998 111.292 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.0 Cg_endo -65.6 -62.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.806 2.337 . . . . 72.25 112.418 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.57 26.49 3.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.565 -0.289 . . . . 74.150000000000006 111.013 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 202' ' ' ARG . 71.5 m-20 68.31 12.58 8.8 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.266 -0.425 . . . . 71.530000000000001 111.708 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.6 ptm -60.5 -24.0 64.96 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.229 0.455 . . . . 72.140000000000001 112.229 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -114.45 18.15 18.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.593 -0.813 . . . . 72.430000000000007 112.327 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 29.0 mmt180 -66.56 -34.44 77.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 70.120000000000005 110.62 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.09 -0.957 . . . . 71.329999999999998 109.875 -177.197 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.978 -0.378 . . . . 74.540000000000006 109.978 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.01 -59.24 2.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 110.649 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.57 155.56 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 42.310000000000002 109.648 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 58.0 mt 67.16 101.76 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 123.774 0.671 . . . . 74.120000000000005 110.683 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.07 131.02 12.69 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.73 2.286 . . . . 70.120000000000005 113.378 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.89 168.5 22.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.621 2.214 . . . . 75.230000000000004 111.145 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.69 35.1 22.25 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.669 -0.493 . . . . 72.010000000000005 109.669 -173.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.826 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 1.4 m -54.83 115.37 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.374 -0.83 . . . . 72.219999999999999 110.805 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -82.55 9.23 9.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.454 -0.794 . . . . 75.120000000000005 112.76 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.476 ' CD ' ' HD2' ' A' ' 44' ' ' ARG . 2.2 mp0 -64.78 124.77 87.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.096 -0.502 . . . . 74.239999999999995 110.561 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 79.1 Cg_exo -50.0 149.29 11.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.418 2.745 . . . . 75.530000000000001 113.019 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 58.8 Cg_endo -70.99 -7.55 21.68 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.125 2.55 . . . . 63.130000000000003 113.289 -175.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -124.34 147.62 48.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.396 -0.594 . . . . 73.109999999999999 109.396 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 27.9 m -129.09 146.82 33.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.056 -0.35 . . . . 75.019999999999996 110.056 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.79 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 46.2 p90 -107.29 128.23 54.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 74.349999999999994 110.374 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.13 99.43 8.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 73.310000000000002 109.993 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 36.8 tt0 -87.75 115.12 24.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.725 -0.843 . . . . 73.099999999999994 108.725 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 177.01 4.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.433 0.635 . . . . 74.120000000000005 112.036 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -71.68 -10.34 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.227 -0.897 . . . . 71.120000000000005 110.456 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -98.84 -41.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.922 -0.581 . . . . 65.340000000000003 110.535 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.48 -129.03 1.18 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.026 -0.83 . . . . 52.509999999999998 111.026 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -144.06 136.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.099 0.476 . . . . 75.439999999999998 110.188 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 139' ' ' VAL . 5.2 mp -134.83 122.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.454 -0.794 . . . . 74.299999999999997 109.032 176.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 133' ' ' CYS . 3.6 m -102.87 150.99 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.933 -0.707 . . . . 72.519999999999996 110.152 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.3 pp -143.99 161.07 39.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.782 -0.645 . . . . 73.420000000000002 109.757 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 29' ' ' TRP . 6.8 pt-20 -138.07 161.24 37.26 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.532 -0.758 . . . . 73.519999999999996 108.963 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 172.12 7.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 110.489 -172.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -91.61 96.2 10.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.407 0.622 . . . . 75.150000000000006 111.376 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -82.48 -5.25 58.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.056 -0.974 . . . . 73.329999999999998 110.439 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -68.31 -53.9 21.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.598 -0.728 . . . . 64.049999999999997 111.284 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -127.76 5.26 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 73.420000000000002 110.875 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.46 74.48 79.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.974 0.416 . . . . 52.439999999999998 110.699 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.19 -26.08 9.43 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.0 2.466 . . . . 75.310000000000002 112.737 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -89.51 -43.62 10.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.289 0.566 . . . . 74.409999999999997 109.908 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.502 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -59.79 -42.02 92.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 65.099999999999994 111.663 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.5 p -64.94 -33.34 75.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 72.150000000000006 111.538 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.826 ' HD2' ' HB2' ' A' ' 8' ' ' SER . 0.2 OUTLIER -78.14 -31.07 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.83 -0.348 . . . . 75.129999999999995 111.499 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.44 -44.29 94.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 14' ' ' VAL . 18.0 t80 -63.97 -47.17 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.956 -0.565 . . . . 71.5 109.803 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.19 71.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 53.409999999999997 112.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.715 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 50.4 mm-40 -67.88 -29.3 68.38 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.696 0.284 . . . . 61.210000000000001 111.362 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 1.2 mm? -69.53 -37.41 77.08 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.185 0.517 . . . . 73.400000000000006 110.27 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.66 76.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 54.009999999999998 111.016 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 8.7 ptm180 -67.95 -30.07 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.372 -0.376 . . . . 73.010000000000005 111.375 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' HE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -67.18 -35.17 79.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.392 -0.596 . . . . 74.299999999999997 109.392 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 104.56 27.02 6.23 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.527 -0.844 . . . . 74.010000000000005 112.775 171.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 51' ' ' THR . 14.9 m-85 -82.09 -29.82 31.59 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.794 -0.239 . . . . 53.009999999999998 111.518 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.0 -17.13 60.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.99 0.424 . . . . 73.420000000000002 110.574 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 40.3 m-80 -69.47 -11.32 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.471 . . . . 72.510000000000005 110.403 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -119.52 16.25 10.53 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.84 -0.695 . . . . 73.109999999999999 112.059 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.639 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.4 p -97.32 159.95 14.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 44.119999999999997 110.992 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -142.56 155.83 45.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.152 -0.477 . . . . 74.319999999999993 109.953 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.4 m-85 -84.29 126.41 33.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.597 . . . . 61.450000000000003 109.387 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.83 -13.99 6.26 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.776 -0.369 . . . . 52.450000000000003 111.892 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 25.7 mmt85 -121.71 101.06 7.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.57 -0.53 . . . . 71.099999999999994 109.57 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -122.43 92.17 2.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.84 -0.8 . . . . 43.310000000000002 108.84 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.772 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.5 mt -100.11 121.52 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.868 -0.605 . . . . 73.540000000000006 109.422 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -49.95 132.03 22.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.941 0.776 . . . . 74.010000000000005 110.726 177.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 44.41 40.05 3.56 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.171 0.919 . . . . 72.439999999999998 112.328 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.772 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.7 t80 -134.64 -81.98 0.44 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 64.340000000000003 110.382 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.584 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 27.1 ptt? -161.19 155.09 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 71.430000000000007 110.679 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 116' ' ' LEU . 35.7 mt -125.16 101.66 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.916 -0.584 . . . . 71.439999999999998 109.973 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 70.0 mt-30 -86.05 123.04 30.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.014 -0.539 . . . . 71.450000000000003 111.296 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -129.97 137.61 9.65 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 65.510000000000005 112.111 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 157.63 -155.8 26.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.133 -1.032 . . . . 73.120000000000005 112.933 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 46.2 t0 56.4 89.81 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 112.234 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 41.8 Cg_endo -69.73 -17.6 37.61 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.01 2.473 . . . . 73.540000000000006 112.14 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -97.64 -39.51 9.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.012 -0.54 . . . . 74.319999999999993 112.25 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.71 25.03 33.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.582 -0.818 . . . . 72.310000000000002 111.605 -174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 60.9 p -101.11 -16.88 16.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 62.310000000000002 110.943 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 -17.93 42.63 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.068 -0.969 . . . . 75.420000000000002 112.126 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 1.5 ptp180 -106.55 -33.96 7.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 65.430000000000007 110.784 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.483 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 87.48 -159.05 30.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.673 -0.775 . . . . 61.210000000000001 112.346 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 -114.04 1.01 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.479 -0.649 . . . . 73.010000000000005 111.479 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . 57.59 39.31 27.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.015 0.436 . . . . 61.009999999999998 112.162 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.2 t -109.41 21.69 16.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 54.240000000000002 109.575 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.0 pt -72.11 -21.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.043 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 5.2 p90 -106.77 5.45 28.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.512 0.672 . . . . 70.310000000000002 110.783 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.65 -117.51 4.66 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.272 -0.876 . . . . 42.030000000000001 111.738 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -88.56 -161.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.653 -0.869 . . . . 73.310000000000002 108.653 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.45 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 5.1 pm0 -63.36 159.24 18.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 71.129999999999995 110.103 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 77.7 t80 -95.36 -67.67 0.84 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.061 -0.518 . . . . 74.310000000000002 111.253 -170.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -169.98 152.47 4.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 71.549999999999997 108.994 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.76 105.31 8.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.488 0.661 . . . . 73.349999999999994 109.245 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -101.68 21.96 13.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.808 -0.633 . . . . 64.140000000000001 109.586 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.68 97.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.987 . . . . 65.439999999999998 110.629 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -168.34 81.97 0.77 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 109.836 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 51.5 Cg_endo -68.22 106.97 1.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.29 1.994 . . . . 73.239999999999995 111.74 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.53 -28.1 65.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.152 -1.055 . . . . 74.510000000000005 108.152 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.7 pp -84.21 178.5 7.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.88 -1.509 . . . . 73.239999999999995 109.337 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -141.1 167.2 22.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.586 -0.446 . . . . 65.030000000000001 109.925 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -63.51 123.16 18.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.163 0.506 . . . . 61.350000000000001 109.65 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.0 p -122.62 -40.78 2.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 74.530000000000001 110.573 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.42 -148.05 5.92 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.418 -0.81 . . . . 51.450000000000003 111.363 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.01 136.8 33.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.732 0.301 . . . . 54.229999999999997 110.73 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 116.98 20.07 5.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.85 -0.69 . . . . 61.119999999999997 112.208 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.3 mm -86.64 111.66 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 51.409999999999997 109.37 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.704 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -87.85 122.89 32.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.148 0.499 . . . . 62.310000000000002 110.275 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.07 167.06 20.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.729 -0.669 . . . . 75.120000000000005 110.178 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 34.6 ttp -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.563 -0.532 . . . . 72.200000000000003 109.563 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.29 162.36 13.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.99 0.424 . . . . 63.219999999999999 110.664 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.789 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.5 p-10 -158.71 162.91 37.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.02 -0.536 . . . . 75.140000000000001 110.61 -171.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.08 -19.45 18.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.787 0.803 . . . . 51.399999999999999 109.601 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.76 172.37 33.79 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.208 -1.557 . . . . 64.140000000000001 109.208 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.98 -44.66 36.27 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.003 2.469 . . . . 52.340000000000003 112.421 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.44 -17.6 20.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 64.519999999999996 111.108 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -84.12 47.34 1.31 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.519 0.676 . . . . 62.310000000000002 110.056 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.789 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 36.6 m-80 -64.33 129.87 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.727 -1.124 . . . . 72.319999999999993 108.944 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.24 -146.39 6.43 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.823 -1.18 . . . . 71.420000000000002 114.244 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 35.6 t -99.06 27.65 4.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.231 0.539 . . . . 62.219999999999999 110.095 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 70.9 mt-30 -118.73 152.09 36.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.789 -0.641 . . . . 72.219999999999999 109.888 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.1 p90 -140.46 170.31 16.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.225 -0.657 . . . . 72.120000000000005 109.225 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 p90 -156.95 150.1 23.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.239 0.542 . . . . 74.010000000000005 111.173 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 HD23 ' A' ' 98' ' ' LEU . 16.1 t -113.34 141.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 40.210000000000001 109.338 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.8 p -94.83 125.93 39.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.896 0.379 . . . . 71.0 110.301 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 34.0 mt -85.56 -7.53 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 71.439999999999998 110.228 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.64 159.75 40.36 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.183 -0.917 . . . . 75.340000000000003 109.65 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 42.9 Cg_endo -69.32 114.62 3.69 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.389 2.06 . . . . 64.200000000000003 112.594 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -106.59 118.31 36.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.469 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.51 19.51 19.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 62.140000000000001 110.769 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.61 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -128.15 5.2 5.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.825 . . . . 72.329999999999998 111.015 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.61 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.2 mt -111.3 -1.81 15.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 75.140000000000001 111.461 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 10.2 p-10 -70.08 -10.13 57.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.113 0.482 . . . . 74.549999999999997 111.358 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.15 17.68 6.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 74.239999999999995 111.757 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -121.73 -28.0 4.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.032 0.444 . . . . 55.219999999999999 110.205 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.14 134.68 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 110.327 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -69.04 112.03 5.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.98 0.419 . . . . 63.329999999999998 110.272 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 99' ' ' ALA . 39.2 mt -98.79 119.46 46.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.5 110.368 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.6 p90 -156.88 74.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.503 0.668 . . . . 72.340000000000003 110.672 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.6 157.84 29.88 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 118.98 -1.581 . . . . 55.43 114.257 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 190' ' ' GLU . 4.5 mtt180 -125.82 125.53 43.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.583 -0.895 . . . . 64.319999999999993 108.583 173.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.433 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.1 p -88.04 132.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.196 -0.602 . . . . 71.099999999999994 110.159 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 47.8 t -139.94 152.03 46.03 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.287 -0.258 . . . . 43.32 111.095 -176.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.0 pt20 41.67 35.23 0.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.545 1.138 . . . . 74.430000000000007 113.11 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.36 15.75 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.559 -0.829 . . . . 71.540000000000006 112.343 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.1 tp -72.28 -33.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.619 0.247 . . . . 61.219999999999999 110.626 -174.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.49 -37.38 93.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.724 -0.751 . . . . 44.210000000000001 111.256 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 77.9 mmm -71.43 -49.46 41.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.285 -0.265 . . . . 72.049999999999997 110.285 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 23' ' ' ILE . 86.5 t -55.81 -30.59 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.998 0.428 . . . . 31.239999999999998 110.815 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.95 -51.14 27.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.014 -0.539 . . . . 72.340000000000003 110.566 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -76.29 -13.83 60.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.948 -0.569 . . . . 64.129999999999995 111.391 -177.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 145' ' ' VAL . 79.0 t -91.76 -27.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 71.140000000000001 109.895 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -93.35 -8.01 61.58 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.541 -0.838 . . . . 73.299999999999997 113.001 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 27.3 ptm -85.14 -11.14 55.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.798 0.333 . . . . 65.219999999999999 110.369 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 142' ' ' VAL . 28.9 m -80.17 162.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 64.349999999999994 110.77 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 14.2 pt-20 -142.63 -40.38 0.33 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.669 -0.696 . . . . 74.5 110.032 175.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 p -123.03 138.78 54.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 111.024 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 154' ' ' VAL . 25.9 p-10 -99.38 4.42 46.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.669 . . . . 73.129999999999995 109.549 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.591 ' HB3' ' CG ' ' A' ' 152' ' ' ARG . 35.4 t -163.68 -156.92 0.38 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.751 -1.113 . . . . 74.549999999999997 108.278 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 151' ' ' ASP . 7.6 pt20 -45.26 -62.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.428 0.899 . . . . 63.140000000000001 113.428 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 150' ' ' GLN . 2.9 p30 -142.8 11.78 1.84 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.922 0.391 . . . . 74.519999999999996 111.182 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.591 ' CG ' ' HB3' ' A' ' 149' ' ' SER . 12.6 ptm180 -97.9 133.76 22.96 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.282 -0.417 . . . . 74.230000000000004 110.418 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 20.4 Cg_endo -60.46 146.94 95.86 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.998 2.465 . . . . 50.329999999999998 112.539 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 148' ' ' ASN . 66.5 t -61.25 109.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 73.209999999999994 110.67 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.9 -22.8 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.643 -0.708 . . . . 62.009999999999998 110.804 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.12 84.36 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.3 0.572 . . . . 72.349999999999994 112.361 -172.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 22.2 t -139.15 122.91 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.019 -1.104 . . . . 73.140000000000001 108.019 169.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 2.6 mppt? -127.51 152.84 47.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.334 -0.546 . . . . 63.450000000000003 111.407 -167.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -89.78 109.85 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.45 -0.944 . . . . 62.140000000000001 108.45 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.431 HG22 ' CD ' ' A' ' 161' ' ' LYS . 28.5 mm -76.65 -51.87 18.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.102 -0.499 . . . . 71.340000000000003 110.679 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -131.73 129.84 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.739 . . . . 71.140000000000001 110.084 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -140.99 110.8 6.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.939 0.4 . . . . 60.109999999999999 110.792 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.59 155.14 53.09 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.543 -0.753 . . . . 71.319999999999993 109.708 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.673 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.77 137.68 39.12 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.295 1.997 . . . . 75.439999999999998 111.332 175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.79 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 5.8 t -136.42 149.96 48.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.961 0.41 . . . . 73.530000000000001 110.884 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.41 154.52 20.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.872 -0.68 . . . . 44.219999999999999 111.711 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -146.02 95.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.804 -0.713 . . . . 53.310000000000002 112.012 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.3 137.25 14.85 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.728 -0.749 . . . . 71.129999999999995 112.142 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -101.51 150.99 18.58 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.776 -0.726 . . . . 42.030000000000001 112.005 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.4 t -149.86 129.72 13.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.826 -0.435 . . . . 72.099999999999994 109.826 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 143.32 141.21 3.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.874 -0.679 . . . . 72.540000000000006 112.091 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -137.26 88.09 0.22 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 64.549999999999997 112.309 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.44 144.19 13.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.888 -0.672 . . . . 11.25 112.292 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.2 t -74.97 -31.34 61.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.09 0.472 . . . . 63.329999999999998 109.764 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.41 -105.63 3.17 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.066 -0.588 . . . . 61.409999999999997 112.212 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.25 61.55 4.44 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.825 -0.703 . . . . 75.439999999999998 111.907 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.45 -176.4 29.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.187 -0.53 . . . . 74.109999999999999 111.983 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 22.5 m -139.34 155.92 47.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.696 0.284 . . . . 71.420000000000002 110.415 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.01 -121.73 7.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.748 -0.739 . . . . 72.019999999999996 112.333 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 102.49 -66.7 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.948 -0.644 . . . . 72.450000000000003 111.794 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.15 163.11 19.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.832 -0.699 . . . . 75.0 112.358 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.2 m -120.45 17.95 12.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.006 0.432 . . . . 52.329999999999998 110.361 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.77 -92.72 1.34 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.89 -0.672 . . . . 51.43 111.819 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.3 m-20 -126.93 172.57 10.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.349 0.595 . . . . 64.219999999999999 110.41 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 155.38 144.18 3.85 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.072 -0.967 . . . . 64.120000000000005 110.963 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.433 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -80.36 -166.55 34.59 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.242 -0.98 . . . . 64.310000000000002 112.395 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.34 175.51 9.68 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.586 -0.524 . . . . 63.140000000000001 109.586 177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.37 102.45 53.13 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 110.511 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 97' ' ' ILE . 2.5 Cg_endo -79.69 -13.38 13.23 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.05 2.5 . . . . 74.140000000000001 111.065 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 131' ' ' ARG . 26.1 tt0 -70.85 -35.16 72.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.016 -0.993 . . . . 74.040000000000006 109.773 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.8 pt -92.15 156.45 3.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.144 -1.058 . . . . 64.109999999999999 108.144 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -106.39 74.77 1.04 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.996 -0.682 . . . . 74.109999999999999 110.921 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.7 149.1 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.393 -0.821 . . . . 63.109999999999999 108.977 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.33 118.49 24.9 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.811 -0.356 . . . . 61.219999999999999 110.863 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.591 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -152.08 153.23 33.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.543 -0.54 . . . . 72.439999999999998 109.543 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 202' ' ' ARG . 62.6 m-85 -120.65 137.74 26.7 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.453 -0.34 . . . . 53.049999999999997 111.126 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.85 -55.87 0.95 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.967 2.445 . . . . 63.409999999999997 112.289 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 15.12 2.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.641 -0.254 . . . . 75.329999999999998 111.458 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 202' ' ' ARG . 1.7 t70 61.91 80.84 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.472 1.13 . . . . 62.340000000000003 109.661 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 13.1 ptm -129.96 -10.13 4.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.271 -1.331 . . . . 70.129999999999995 110.541 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -142.19 14.97 2.55 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.375 -0.917 . . . . 64.0 112.801 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 3.1 ptt180 -98.15 -34.81 10.6 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 119.373 -0.931 . . . . 75.430000000000007 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.7 mmpt? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.517 -0.754 . . . . 73.430000000000007 110.084 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.869 0.366 . . . . 72.129999999999995 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.52 105.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 73.120000000000005 109.715 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.9 153.66 22.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.424 -0.353 . . . . 73.129999999999995 110.736 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.825 HD11 ' HB3' ' A' ' 78' ' ' TYR . 16.3 mm 63.79 85.89 0.15 Allowed Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 124.043 0.839 . . . . 74.030000000000001 111.777 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -96.09 93.96 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.72 2.946 . . . . 74.510000000000005 110.944 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 14.1 Cg_exo -69.71 -46.06 1.39 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.957 2.438 . . . . 52.149999999999999 112.874 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.0 t70 63.47 20.42 12.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.034 0.921 . . . . 74.340000000000003 110.081 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.8 m -144.67 124.0 13.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.094 -0.957 . . . . 54.130000000000003 109.812 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -72.01 -59.26 2.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.144 -0.48 . . . . 72.230000000000004 110.262 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 73.03 151.58 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 124.023 0.827 . . . . 65.140000000000001 111.995 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.3 145.34 98.14 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.564 2.176 . . . . 73.129999999999995 111.531 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 38.5 Cg_endo -67.57 -7.5 19.48 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.885 2.39 . . . . 75.409999999999997 113.268 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.504 HD22 ' CG1' ' A' ' 24' ' ' VAL . 4.3 t30 -133.16 141.41 48.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 71.420000000000002 110.731 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.4 m -131.08 157.01 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.116 -0.493 . . . . 54.130000000000003 109.973 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 22' ' ' ILE . 23.7 p90 -121.03 138.82 53.99 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 74.030000000000001 110.638 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -114.77 103.68 11.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.627 -0.715 . . . . 61.409999999999997 109.754 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 22' ' ' ILE . 37.8 tt0 -88.13 114.65 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 159' ' ' ILE . 59.3 p -104.04 177.06 4.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.312 -0.404 . . . . 71.329999999999998 110.696 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.433 ' HB2' HD11 ' A' ' 160' ' ' ILE . 27.7 t -71.23 -20.41 62.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 73.030000000000001 110.994 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 142' ' ' VAL . 79.8 mtp -95.01 -33.94 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.26 . . . . 52.539999999999999 110.937 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.487 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -171.17 -138.6 2.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.454 -0.879 . . . . 61.539999999999999 112.153 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.98 129.99 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.068 -0.716 . . . . 63.140000000000001 109.068 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -124.14 123.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.487 -0.778 . . . . 74.540000000000006 110.316 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 23.2 t -103.26 138.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.721 -0.474 . . . . 54.140000000000001 109.721 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.72 165.06 33.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 71.019999999999996 110.599 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 9.6 pt-20 -136.56 165.21 26.39 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.919 -0.582 . . . . 73.120000000000005 110.115 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.01 162.08 13.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.96 0.409 . . . . 61.340000000000003 110.504 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 4.0 m-85 -81.53 98.12 8.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 111.695 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 42.7 m95 -83.4 -3.72 57.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.117 -0.492 . . . . 65.129999999999995 110.594 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -78.84 -62.15 1.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 71.239999999999995 111.075 -175.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -125.5 18.76 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.571 -0.286 . . . . 73.329999999999998 111.76 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -142.0 71.69 23.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 45.399999999999999 111.14 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.35 -44.3 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.992 2.461 . . . . 73.349999999999994 113.052 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.9 tpmt? -73.66 -36.1 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 65.109999999999999 110.543 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.628 ' OG1' ' HB1' ' A' ' 32' ' ' ALA . 14.5 p -68.95 -43.34 75.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.16 -0.473 . . . . 71.209999999999994 110.616 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' CE2' ' A' ' 29' ' ' TRP . 25.0 t -53.88 -50.83 65.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.457 -0.792 . . . . 72.25 110.78 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.816 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.3 mmpt? -60.37 -37.01 79.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 72.519999999999996 111.114 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -62.17 -56.17 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 74.319999999999993 110.323 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -66.12 -40.05 90.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 71.420000000000002 111.565 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.35 94.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.61 -0.268 . . . . 73.299999999999997 111.0 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.81 -48.91 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 75.450000000000003 111.773 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -65.25 -25.79 67.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.395 -0.522 . . . . 74.319999999999993 111.008 -179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.79 -55.72 7.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.017 0.437 . . . . 74.120000000000005 110.778 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 44' ' ' ARG . 6.4 ppt_? -79.3 -28.3 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 74.120000000000005 112.24 -172.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -74.54 -52.9 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.875 0.369 . . . . 75.109999999999999 110.404 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.94 50.02 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.31 -0.948 . . . . 74.510000000000005 112.616 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB2' HD12 ' A' ' 42' ' ' LEU . 56.0 t80 -103.48 -51.44 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.793 -0.239 . . . . 75.019999999999996 111.091 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 51' ' ' THR . 76.0 m-85 -68.49 -18.99 64.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 121.146 -0.222 . . . . 74.0 111.316 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -74.34 84.48 1.93 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.63 -0.878 . . . . 75.400000000000006 108.63 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.53 24.41 1.13 Allowed Glycine 0 C--N 1.301 -1.384 0 CA-C-N 113.979 -1.464 . . . . 73.230000000000004 111.77 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 48' ' ' TYR . 34.3 p -108.91 158.67 17.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.928 -0.397 . . . . 54.030000000000001 109.928 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 12.2 ptpt -138.39 158.12 44.89 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.783 0.325 . . . . 63.140000000000001 111.168 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 78.9 m-85 -84.04 121.66 27.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.412 -0.588 . . . . 72.540000000000006 109.412 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -96.52 -40.62 8.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.467 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -123.71 114.65 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.343 -0.243 . . . . 61.310000000000002 110.343 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -119.64 89.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.698 -0.853 . . . . 75.329999999999998 108.698 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.0 mt -96.56 120.8 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.164 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -53.65 129.12 31.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.723 -0.671 . . . . 70.439999999999998 111.003 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 58.28 26.76 14.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.262 -0.881 . . . . 72.010000000000005 111.852 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.652 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 1.1 t80 -128.92 -83.45 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.201 0.524 . . . . 74.230000000000004 110.469 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.448 ' H ' ' HB3' ' A' ' 60' ' ' PHE . 27.3 ptt? -161.26 153.45 19.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.349 -0.841 . . . . 74.230000000000004 110.033 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 116' ' ' LEU . 23.4 mt -119.42 99.76 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.12 -0.696 . . . . 63.119999999999997 109.12 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.899 -0.591 . . . . 64.310000000000002 110.247 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.06 151.2 20.65 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.941 -0.647 . . . . 74.200000000000003 112.191 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.25 -77.93 0.2 Allowed Glycine 0 C--O 1.219 -0.797 0 C-N-CA 119.642 -1.266 . . . . 74.329999999999998 114.027 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -45.91 108.65 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 122.155 0.979 . . . . 72.530000000000001 113.205 -165.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 59.7 Cg_endo -74.46 -14.6 22.48 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.539 2.826 . . . . 44.25 111.891 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.5 p -84.63 -28.76 26.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.952 -1.022 . . . . 44.149999999999999 111.381 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 2.98 90.7 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.401 -0.68 . . . . 55.32 111.401 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.6 p -88.34 -24.61 23.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.319 0.581 . . . . 74.109999999999999 110.574 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.5 -16.35 48.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.287 -0.87 . . . . 63.310000000000002 112.096 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -82.0 -48.12 11.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 75.340000000000003 110.245 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.594 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 98.09 -174.57 28.9 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.592 -0.731 . . . . 65.430000000000007 112.525 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.29 -93.49 0.86 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.393 -0.683 . . . . 74.299999999999997 111.393 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 61.36 43.31 10.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.652 0.739 . . . . 62.219999999999999 111.97 172.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -86.35 24.65 1.33 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.528 -0.76 . . . . 71.5 111.157 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 pt -100.26 -17.7 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.809 -0.356 . . . . 63.219999999999999 111.487 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.825 ' HB3' HD11 ' A' ' 4' ' ' ILE . 30.2 p90 -121.3 -22.6 5.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.483 -0.487 . . . . 74.400000000000006 111.999 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.79 -99.65 1.15 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.563 -0.827 . . . . 44.310000000000002 111.467 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 23.6 mtpt -78.88 161.9 26.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.968 -0.382 . . . . 73.340000000000003 109.968 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 107' ' ' THR . 1.2 mp0 -66.08 172.07 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.248 0.547 . . . . 70.010000000000005 111.281 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -95.92 -71.96 0.65 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.52 -0.764 . . . . 74.409999999999997 109.067 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 5.8 tp10 -169.27 172.01 7.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.494 -1.299 . . . . 72.310000000000002 107.494 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 13.1 p-10 -77.87 107.86 10.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 54.310000000000002 109.263 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.42 18.35 5.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 71.040000000000006 109.483 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.5 mt -57.04 102.07 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.815 -1.084 . . . . 73.409999999999997 110.269 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -157.18 75.38 4.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.552 -0.536 . . . . 65.439999999999998 109.552 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 123' ' ' ASP . 37.0 Cg_endo -66.15 91.12 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.621 2.214 . . . . 61.200000000000003 112.221 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.28 -16.69 51.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.329 1.061 . . . . 74.439999999999998 108.917 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.5 pp -93.8 175.61 6.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.417 -1.265 . . . . 74.209999999999994 110.217 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -131.01 146.31 52.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 109.886 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.616 ' HE2' ' HB3' ' A' ' 123' ' ' ASP . 96.2 m-85 -69.77 94.15 0.79 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.276 -0.638 . . . . 72.239999999999995 109.276 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 195' ' ' GLN . 39.1 p -81.99 -41.71 20.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.945 -1.025 . . . . 61.299999999999997 110.434 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.5 -131.94 1.36 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 31.539999999999999 111.645 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.21 143.28 28.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.764 0.316 . . . . 71.430000000000007 110.782 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 25.0 5.57 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.741 -0.742 . . . . 70.400000000000006 112.128 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 189' ' ' PRO . 7.1 mm -86.45 110.0 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.237 -0.653 . . . . 74.450000000000003 109.237 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.738 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.8 tm? -87.19 113.01 22.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.202 -0.453 . . . . 61.43 110.058 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -127.12 171.23 11.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.923 -0.58 . . . . 75.420000000000002 110.589 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.503 ' SD ' ' HB ' ' A' ' 127' ' ' THR . 15.2 ptm -95.14 148.34 22.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.821 0.343 . . . . 65.040000000000006 110.146 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -94.92 124.82 39.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.028 0.442 . . . . 73.519999999999996 110.46 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.674 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -144.28 164.15 31.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 70.420000000000002 110.234 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -71.98 -44.87 62.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.99 -0.55 . . . . 55.329999999999998 110.53 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.28 -97.48 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.741 -0.742 . . . . 45.009999999999998 112.089 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.98 88.64 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.885 2.39 . . . . 72.129999999999995 112.145 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 53.51 12.54 0.38 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.688 1.195 . . . . 60.32 113.707 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.2 m -88.16 61.55 6.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.989 -0.745 . . . . 63.229999999999997 108.989 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.6 p30 -81.62 143.49 31.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.011 -0.995 . . . . 74.200000000000003 111.34 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -124.89 -172.27 13.47 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.519 -0.764 . . . . 61.43 112.033 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 75' ' ' ALA . 15.9 p -88.44 3.85 48.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 70.340000000000003 110.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 77.4 mt-30 -80.75 159.09 25.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 71.319999999999993 110.236 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -139.77 169.36 17.87 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.896 -0.409 . . . . 74.329999999999998 109.896 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.71 146.82 25.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.116 0.484 . . . . 72.120000000000005 110.127 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.668 HG22 HD23 ' A' ' 98' ' ' LEU . 13.1 t -110.44 134.24 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.508 -0.769 . . . . 64.239999999999995 109.36 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 p -91.69 125.58 36.46 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.024 0.44 . . . . 75.430000000000007 110.323 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 62' ' ' ILE . 47.1 mt -81.54 -9.7 59.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 73.340000000000003 110.683 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.24 159.54 32.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.585 -0.734 . . . . 74.129999999999995 110.201 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 34.9 Cg_exo -60.56 122.85 11.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.732 2.288 . . . . 62.520000000000003 111.939 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 3.5 p -127.76 89.15 2.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.227 0.537 . . . . 34.409999999999997 110.158 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.413 ' CD ' ' H ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -93.22 24.19 3.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.875 0.845 . . . . 64.099999999999994 110.144 -166.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.671 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.3 p90 -116.56 -0.18 12.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.315 -1.311 . . . . 75.239999999999995 109.504 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.671 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 90.5 mt -108.19 1.05 21.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.368 -0.833 . . . . 72.010000000000005 110.796 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.616 ' HB3' ' HE2' ' A' ' 92' ' ' PHE . 16.9 p-10 -68.59 -15.87 63.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.374 -0.83 . . . . 75.239999999999995 111.276 -174.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 14.62 10.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.478 -0.868 . . . . 74.129999999999995 111.646 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -116.89 -37.24 3.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 65.129999999999995 110.546 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -133.27 130.28 38.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 65.450000000000003 110.088 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.503 ' HB ' ' SD ' ' A' ' 100' ' ' MET . 19.0 m -65.59 126.5 28.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 71.209999999999994 110.21 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 99' ' ' ALA . 22.6 mt -107.27 127.96 62.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.47 -0.332 . . . . 72.420000000000002 110.347 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.623 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 22.7 p90 -159.47 70.83 0.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.521 0.677 . . . . 73.0 110.816 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.66 155.16 26.39 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.903 -1.141 . . . . 73.120000000000005 113.296 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -136.2 120.57 18.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.34 137.28 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.149 0.5 . . . . 74.230000000000004 110.892 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.605 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 35.4 t -144.83 149.33 35.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.052 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.8 tt0 47.64 52.48 12.52 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.403 0.62 . . . . 74.439999999999998 111.585 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.83 25.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.379 -0.915 . . . . 74.150000000000006 112.05 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -79.49 -30.94 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.822 -0.436 . . . . 64.299999999999997 109.822 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.22 88.89 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.799 -0.715 . . . . 71.120000000000005 111.439 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.552 ' HE1' HH11 ' A' ' 141' ' ' ARG . 54.3 mmm -71.96 -52.44 17.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.936 -0.394 . . . . 63.350000000000001 109.936 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.86 -32.04 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.175 0.512 . . . . 53.32 110.926 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.418 ' HA ' ' SD ' ' A' ' 200' ' ' MET . 1.8 t30 -71.4 -50.86 27.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.794 -0.639 . . . . 74.239999999999995 110.878 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.552 HH11 ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -77.87 -12.36 59.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 64.120000000000005 111.29 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 145' ' ' VAL . 70.2 t -91.32 -32.32 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.096 0.474 . . . . 54.43 110.434 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.29 -17.37 60.85 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.554 -0.832 . . . . 60.109999999999999 113.11 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.2 ptp -88.36 -13.16 41.34 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.594 -0.442 . . . . 61.020000000000003 111.347 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 142' ' ' VAL . 27.5 m -73.84 140.24 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.307 0.575 . . . . 53.530000000000001 110.814 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 7.6 pt-20 -128.45 -40.25 1.62 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.37 -0.832 . . . . 63.310000000000002 109.894 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 15.6 p -137.89 152.1 48.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.758 -0.655 . . . . 62.229999999999997 110.636 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.75 -67.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.883 0.327 . . . . 61.43 111.883 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.9 t -141.04 -8.32 1.03 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.064 0.459 . . . . 74.340000000000003 110.309 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.603 ' O ' ' HB ' ' A' ' 147' ' ' THR . 23.0 mm-40 -130.07 -166.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.994 -0.743 . . . . 70.420000000000002 108.994 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 19.61 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.672 0.749 . . . . 63.530000000000001 110.272 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 5.8 ptm180 -106.13 131.97 21.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 74.140000000000001 109.767 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 43.5 Cg_exo -57.02 154.02 35.32 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.134 2.556 . . . . 63.219999999999999 112.985 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.3 t -64.02 157.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 72.219999999999999 110.358 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 156' ' ' ASP . 7.7 t70 -76.64 -166.27 0.64 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.759 0.314 . . . . 73.510000000000005 110.862 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.459 ' H ' ' CG ' ' A' ' 155' ' ' ASP . 31.2 t70 -73.43 113.28 10.35 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.949 0.499 . . . . 74.299999999999997 111.953 -173.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.85 133.36 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.295 -0.632 . . . . 72.150000000000006 109.295 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -144.52 166.77 24.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.91 -0.586 . . . . 73.049999999999997 111.677 -168.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.7 mp -88.5 113.18 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.153 -0.93 . . . . 65.530000000000001 109.476 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.49 HG22 ' CD ' ' A' ' 161' ' ' LYS . 26.7 mm -75.56 -61.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.626 -0.716 . . . . 53.240000000000002 110.389 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 160' ' ' ILE . 2.1 mptm? -124.95 131.18 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 110.103 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -137.68 113.8 9.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.355 -0.384 . . . . 53.030000000000001 110.694 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -148.61 156.03 41.78 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 72.510000000000005 110.012 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 56.7 Cg_endo -70.33 134.62 27.18 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.19 1.927 . . . . 64.430000000000007 111.513 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.411 ' HB3' HD21 ' A' ' 13' ' ' ASN . 29.0 t -87.33 129.13 35.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.208 0.527 . . . . 74.430000000000007 110.731 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.07 11.68 29.17 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.439 -0.8 . . . . 65.420000000000002 112.151 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -142.02 -172.76 13.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.871 -0.681 . . . . 52.439999999999998 111.902 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -163.4 -109.14 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 75.430000000000007 112.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -169.37 137.76 4.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.872 -0.68 . . . . 50.109999999999999 112.191 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 m -75.19 -35.43 61.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.091 0.472 . . . . 70.049999999999997 110.639 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.49 157.45 28.61 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.118 -0.793 . . . . 74.549999999999997 111.118 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -167.51 175.39 42.53 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.476 -0.869 . . . . 70.510000000000005 112.309 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 86.12 -138.24 15.82 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.925 -0.655 . . . . 72.040000000000006 111.8 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 t -106.59 -32.33 8.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.683 -0.488 . . . . 64.519999999999996 109.683 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.97 -148.2 22.3 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.783 -0.723 . . . . 63.039999999999999 112.526 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.91 -34.55 5.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.01 -0.614 . . . . 53.240000000000002 111.864 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 177.54 -128.09 1.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.481 -0.648 . . . . 70.209999999999994 111.481 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 38.1 m -87.39 120.85 29.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.812 0.339 . . . . 63.140000000000001 110.109 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 128.63 61.75 0.11 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.709 -0.758 . . . . 73.340000000000003 112.051 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.6 145.43 11.88 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.885 -0.674 . . . . 61.009999999999998 112.041 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.72 -15.87 26.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.817 -0.706 . . . . 52.43 111.939 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 p -111.9 108.19 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.808 0.337 . . . . 74.129999999999995 110.647 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.44 -58.42 0.32 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.049 -0.596 . . . . 64.450000000000003 111.615 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -102.14 173.08 6.54 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.757 0.789 . . . . 63.229999999999997 110.842 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 141.31 148.05 5.0 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.3 -1.318 . . . . 61.409999999999997 111.458 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -84.67 -167.35 42.79 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.337 -0.935 . . . . 33.530000000000001 111.346 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.519 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -76.04 165.28 25.18 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.202 -0.666 . . . . 60.25 109.202 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.403 ' O ' HG21 ' A' ' 93' ' ' THR . 98.0 m-85 -106.84 93.4 8.81 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.637 0.256 . . . . 72.209999999999994 110.562 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.744 ' HB2' HD13 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -71.94 -11.85 27.83 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.522 2.148 . . . . 73.400000000000006 112.685 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.37 -38.36 71.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.399 0.618 . . . . 74.150000000000006 109.632 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.6 155.0 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.972 -1.121 . . . . 74.010000000000005 107.972 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.4 m170 -104.76 92.75 4.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.116 -0.634 . . . . 73.150000000000006 110.599 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.01 146.92 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.565 -0.743 . . . . 61.109999999999999 109.778 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.8 108.0 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.792 0.329 . . . . 24.210000000000001 111.171 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 93' ' ' THR . 4.7 pt20 -139.34 141.53 37.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 110.745 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.476 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 27.6 m-85 -112.6 135.53 21.52 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 120.715 0.293 . . . . 73.519999999999996 110.83 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.9 Cg_endo -62.26 -65.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.97 2.447 . . . . 74.430000000000007 112.253 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.3 pt? -125.44 19.5 8.09 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.158 0.504 . . . . 75.099999999999994 110.078 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 41.8 m-20 71.18 8.88 6.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.057 -0.974 . . . . 65.129999999999995 113.198 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' A' ' 140' ' ' ASN . 25.1 ptt? -63.89 -29.09 70.3 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.808 -0.357 . . . . 75.400000000000006 111.463 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.21 -2.47 90.49 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.822 -0.704 . . . . 50.240000000000002 112.35 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.476 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 14.3 mtp180 -87.24 -61.17 1.78 Allowed 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 110.132 -0.321 . . . . 74.439999999999998 110.132 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt . . . . . 0 C--O 1.249 1.043 0 O-C-N 125.123 1.514 . . . . 75.299999999999997 112.78 -172.638 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.105 -0.331 . . . . 61.030000000000001 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.05 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.341 0.591 . . . . 41.43 110.231 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.91 147.66 35.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.247 -0.888 . . . . 71.319999999999993 109.617 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 51.1 mm 68.57 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.482 0.658 . . . . 55.350000000000001 110.736 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 4' ' ' ILE . 43.8 Cg_endo -68.59 140.11 46.48 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.647 2.231 . . . . 74.129999999999995 112.37 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.65 58.32 2.55 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.148 2.565 . . . . 34.409999999999997 112.2 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.59 -49.01 79.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 75.439999999999998 111.646 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.8 m -142.3 179.85 6.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.181 -0.463 . . . . 62.200000000000003 109.902 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 43.3 p90 -87.68 -22.87 24.41 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.155 -0.218 . . . . 74.140000000000001 110.475 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.619 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.9 mp0 72.69 132.7 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 62.210000000000001 111.585 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.851 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 19.2 Cg_endo -59.64 151.61 68.59 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.236 2.624 . . . . 72.319999999999993 112.848 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.39 -11.75 9.38 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.194 2.596 . . . . 52.240000000000002 114.108 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.528 HD21 HG12 ' A' ' 24' ' ' VAL . 27.3 t-20 -131.22 148.49 52.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.639 0.257 . . . . 72.420000000000002 110.847 -171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 28.5 m -132.75 147.37 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.138 0.494 . . . . 64.010000000000005 111.021 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 39.1 m-85 -105.09 118.96 37.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.68 -0.691 . . . . 71.019999999999996 110.528 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 mt -106.02 98.24 7.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.447 -0.342 . . . . 60.119999999999997 110.118 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 6.0 tt0 -89.79 113.06 24.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.457 -0.571 . . . . 61.439999999999998 109.457 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -105.47 178.11 4.65 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.068 -0.515 . . . . 63.509999999999998 111.09 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -73.75 -15.06 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 73.420000000000002 111.049 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.408 ' HG3' HG22 ' A' ' 157' ' ' VAL . 89.7 mmm -99.23 -32.73 11.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 63.009999999999998 110.923 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.43 -134.16 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.015 -0.612 . . . . 62.299999999999997 111.741 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.29 130.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.184 -0.672 . . . . 72.140000000000001 109.184 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.9 mp -122.81 128.42 75.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.556 -0.747 . . . . 72.25 110.203 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.528 HG12 HD21 ' A' ' 13' ' ' ASN . 46.2 t -110.74 141.77 25.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.226 -0.443 . . . . 64.019999999999996 110.232 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.4 pp -155.49 166.6 33.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.878 0.37 . . . . 73.519999999999996 111.035 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.37 173.49 10.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.589 -0.732 . . . . 75.319999999999993 109.575 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -111.95 161.18 16.7 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.41 -0.589 . . . . 61.100000000000001 109.41 176.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.2 m-85 -80.23 102.16 9.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.548 0.689 . . . . 71.310000000000002 112.482 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -82.73 -3.5 56.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.931 -1.031 . . . . 75.329999999999998 109.68 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 30' ' ' LYS . 5.3 mptt -71.64 -57.37 4.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.329 -0.85 . . . . 73.400000000000006 111.176 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -136.9 21.49 3.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.055 0.391 . . . . 73.329999999999998 112.055 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -135.26 66.72 67.02 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 74.219999999999999 110.597 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.71 -51.27 4.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.883 2.389 . . . . 63.520000000000003 112.862 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -84.26 -25.63 29.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.741 -0.384 . . . . 75.209999999999994 110.243 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.7 -50.29 69.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.194 -0.669 . . . . 71.230000000000004 109.194 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 4.4 t -57.25 -43.99 83.46 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.427 -0.806 . . . . 61.399999999999999 110.28 172.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.628 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -59.95 -39.19 84.73 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.569 -0.741 . . . . 75.099999999999994 110.53 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -55.69 -50.49 70.15 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.899 0.381 . . . . 73.150000000000006 110.222 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.48 -42.75 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 74.540000000000006 111.164 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 10' ' ' GLN . . . -58.02 -43.44 86.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.011 0.434 . . . . 71.010000000000005 111.35 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -46.92 86.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 75.049999999999997 110.638 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.63 -30.48 68.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 61.439999999999998 111.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.64 67.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.95 -0.568 . . . . 74.329999999999998 111.084 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -74.95 -15.63 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.415 . . . . 72.349999999999994 110.346 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' HD12 ' A' ' 77' ' ' ILE . 23.5 tpt180 -77.67 -51.68 10.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.795 -0.639 . . . . 62.219999999999999 109.676 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.24 27.02 5.74 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.63 -0.714 . . . . 72.420000000000002 112.192 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.19 11.36 12.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 72.040000000000006 111.485 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.51 -14.75 18.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.751 0.31 . . . . 75.450000000000003 110.461 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 32.2 m-80 -80.64 99.28 8.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.94 0.876 . . . . 71.400000000000006 109.48 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.31 7.31 9.24 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 114.033 -1.439 . . . . 53.039999999999999 111.697 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.458 ' HB ' ' C ' ' A' ' 65' ' ' GLY . 81.9 p -88.84 165.4 14.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.555 0.217 . . . . 61.350000000000001 110.489 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -139.0 158.61 43.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 74.239999999999995 110.564 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 73.3 m-85 -80.6 133.65 35.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.4 0.619 . . . . 53.420000000000002 111.388 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.678 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 60.8 m80 -93.64 -56.75 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.966 -1.016 . . . . 74.040000000000006 110.507 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.3 mmm180 -114.88 112.72 23.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.852 -1.067 . . . . 73.329999999999998 109.805 -170.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 62' ' ' ILE . 4.4 mp -123.11 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.816 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 25.6 mt -103.58 127.32 57.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.022 -0.536 . . . . 73.140000000000001 109.714 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -59.83 130.75 48.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.413 0.446 . . . . 72.319999999999993 111.096 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 54.1 31.65 14.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 111.417 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -130.71 -82.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 110.301 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.658 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.7 ptm -160.5 155.83 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.54 -0.754 . . . . 75.310000000000002 110.603 -176.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 23.2 mt -132.97 101.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.765 -0.652 . . . . 54.109999999999999 109.742 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 50.4 tt0 -89.54 128.22 35.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.474 . . . . 75.0 110.986 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -131.14 160.16 23.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.87 -0.681 . . . . 64.329999999999998 112.613 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.458 ' C ' ' HB ' ' A' ' 51' ' ' THR . . . 137.77 -150.8 21.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 34.100000000000001 112.309 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.678 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 0.2 OUTLIER 68.08 96.02 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 112.954 0.724 . . . . 73.209999999999994 112.954 178.087 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.59 -17.56 11.17 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.244 1.962 . . . . 62.210000000000001 109.819 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.0 p -92.25 -48.32 6.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.131 -1.395 . . . . 52.539999999999999 112.154 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.1 13.42 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.526 -0.63 . . . . 71.409999999999997 111.526 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 68' ' ' THR . 4.0 t -112.39 -29.1 7.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 74.129999999999995 111.85 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.34 -21.86 9.82 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.372 -0.918 . . . . 70.319999999999993 112.839 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.435 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -103.33 -29.45 11.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 73.510000000000005 110.571 177.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.72 -169.04 15.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.55 -0.833 . . . . 53.409999999999997 113.361 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.33 36.9 2.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.332 -0.461 . . . . 70.140000000000001 112.725 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -76.26 59.5 1.39 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.545 0.688 . . . . 72.140000000000001 111.124 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -85.85 9.93 15.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.512 -0.767 . . . . 72.239999999999995 109.876 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 45' ' ' ARG . 3.0 tt -62.0 -38.6 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 70.310000000000002 110.117 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 13.04 22.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.723 0.773 . . . . 72.019999999999996 110.409 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -80.87 1.63 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.705 -1.134 . . . . 42.119999999999997 112.028 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.483 ' HE3' ' NE2' ' A' ' 81' ' ' GLN . 20.7 ptmt -133.42 -179.85 5.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.968 0.413 . . . . 73.409999999999997 110.43 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.483 ' NE2' ' HE3' ' A' ' 80' ' ' LYS . 5.0 pm0 -72.17 174.82 6.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.564 -0.744 . . . . 72.150000000000006 110.231 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.01 -64.4 1.31 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.391 0.615 . . . . 74.019999999999996 110.225 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -161.64 176.5 10.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.495 -1.298 . . . . 74.329999999999998 107.495 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.539 ' OD1' ' HG ' ' A' ' 86' ' ' LEU . 2.5 t0 -81.07 138.22 35.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.78 -0.768 . . . . 63.420000000000002 110.045 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -100.08 13.81 32.83 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.521 -0.763 . . . . 74.209999999999994 110.58 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 47.5 mt -51.54 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.694 0.621 . . . . 72.319999999999993 111.104 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -166.58 79.77 1.04 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.479 -0.782 . . . . 54.229999999999997 109.533 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.44 102.56 0.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.598 2.199 . . . . 61.229999999999997 112.078 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.94 -14.9 59.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.473 1.13 . . . . 71.299999999999997 108.917 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.3 pp -113.24 -174.92 2.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.251 -1.34 . . . . 64.140000000000001 109.545 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -141.28 166.38 24.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.963 -0.754 . . . . 54.420000000000002 108.963 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -63.9 123.37 18.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.441 0.639 . . . . 73.109999999999999 110.511 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 35.4 p -122.78 -44.81 2.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.528 -0.76 . . . . 74.019999999999996 110.005 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.75 -145.27 4.31 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.482 -0.781 . . . . 64.219999999999999 111.787 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.61 143.2 26.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.632 0.253 . . . . 71.040000000000006 110.923 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.77 22.0 6.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.589 -0.815 . . . . 74.439999999999998 111.894 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.4 mm -84.37 111.33 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.642 . . . . 74.310000000000002 109.268 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.6 124.44 32.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.668 -0.493 . . . . 61.140000000000001 109.668 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.42 171.32 14.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.048 -0.524 . . . . 41.340000000000003 111.383 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 25.4 ttt -107.54 132.36 53.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.693 -0.685 . . . . 72.209999999999994 109.805 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -96.29 163.19 13.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.411 . . . . 24.23 110.147 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -158.76 164.75 35.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 72.219999999999999 109.723 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.53 58.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 111.187 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 147.45 -136.54 6.13 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 120.858 -0.686 . . . . 71.099999999999994 111.875 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 18.2 Cg_endo -54.12 97.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 123.305 2.67 . . . . 55.219999999999999 111.811 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 3.2 p30 58.53 13.15 2.39 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.211 -1.359 . . . . 73.129999999999995 112.645 173.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.4 m -89.31 60.48 5.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.386 0.613 . . . . 74.540000000000006 109.369 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -85.1 151.95 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.598 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.94 -110.07 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.976 -0.556 . . . . 63.350000000000001 112.124 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 79.8 p -123.48 61.33 1.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.75 0.786 . . . . 64.340000000000003 110.568 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.609 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 69.8 mm-40 -126.91 146.0 50.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.586 -1.188 . . . . 61.340000000000003 109.716 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -148.93 164.91 33.13 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.581 -0.525 . . . . 73.239999999999995 109.581 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 48.6 p90 -158.36 152.12 23.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 74.239999999999995 111.302 175.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.688 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -113.27 143.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.329999999999998 109.115 175.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.7 p -98.79 130.55 45.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.28 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.3 mt -86.85 -5.5 59.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.721 -0.672 . . . . 70.299999999999997 110.651 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.95 163.52 25.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.697 -0.683 . . . . 51.219999999999999 110.135 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.503 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 21.5 Cg_exo -66.46 120.18 7.28 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.629 2.219 . . . . 74.409999999999997 112.074 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -104.68 156.56 17.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.617 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.95 12.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.256 0.551 . . . . 74.040000000000006 110.487 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -110.59 -11.03 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 74.129999999999995 112.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -129.85 -1.28 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.315 0.578 . . . . 75.040000000000006 111.149 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 -13.5 60.67 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.904 -1.044 . . . . 71.140000000000001 110.933 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.47 8.49 28.41 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.155 -0.778 . . . . 61.409999999999997 111.155 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -114.83 -23.4 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 71.299999999999997 109.159 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 100' ' ' MET . 86.0 m-70 -134.64 133.95 40.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.655 -1.157 . . . . 71.0 108.405 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -73.22 147.89 44.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.412 . . . . 63.100000000000001 110.52 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 99' ' ' ALA . 29.4 mt -125.16 122.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 73.329999999999998 110.62 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' A' ' 35' ' ' THR . 6.7 p90 -159.58 74.25 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.59 0.71 . . . . 75.010000000000005 110.925 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.7 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.45 157.16 29.25 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.574 -1.298 . . . . 71.420000000000002 113.177 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -132.58 120.07 21.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.902 -0.406 . . . . 75.549999999999997 109.902 173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.6 p -82.73 137.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 73.0 110.582 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 43.7 t -141.25 153.09 45.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.366 -0.379 . . . . 73.129999999999995 110.508 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 2.8 pt20 40.4 39.42 0.7 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.508 1.123 . . . . 54.5 113.221 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.24 31.96 0.12 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.825 -0.702 . . . . 45.549999999999997 112.124 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -83.79 -31.03 7.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 74.120000000000005 109.486 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.56 93.0 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.673 -0.694 . . . . 72.25 111.867 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.42 ' HE1' HH11 ' A' ' 141' ' ' ARG . 60.0 mmm -67.74 -50.63 56.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.641 -0.503 . . . . 73.129999999999995 109.641 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 62' ' ' ILE . 85.0 t -53.78 -32.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 63.009999999999998 110.833 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -72.82 -53.13 12.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.005 -0.543 . . . . 75.329999999999998 110.982 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.18 -14.1 60.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.113 -0.494 . . . . 73.420000000000002 111.186 -177.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 157' ' ' VAL . 51.4 t -88.73 -38.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.971 0.415 . . . . 63.009999999999998 110.294 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.53 -24.76 64.56 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.592 -0.813 . . . . 64.219999999999999 112.775 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.521 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.6 ptp -78.24 -16.91 57.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.824 -0.35 . . . . 70.109999999999999 111.539 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.1 m -95.28 114.71 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.643 0.735 . . . . 73.099999999999994 110.782 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -112.19 -53.74 2.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.37 -0.832 . . . . 73.349999999999994 110.063 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 6.6 p -130.83 145.41 51.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.642 -0.708 . . . . 24.210000000000001 109.996 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 152' ' ' ARG . 25.2 p-10 -89.77 -12.32 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.592 -0.521 . . . . 73.409999999999997 109.592 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.747 ' HB3' ' HD2' ' A' ' 152' ' ' ARG . 9.8 t -170.01 -163.76 0.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.451 -0.795 . . . . 71.540000000000006 108.991 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.7 110.37 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.389 0.514 . . . . 74.349999999999994 112.389 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 48.92 49.19 19.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.287 -0.87 . . . . 73.099999999999994 112.69 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.747 ' HD2' ' HB3' ' A' ' 149' ' ' SER . 9.9 ptp180 -148.13 112.7 3.84 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.476 -0.784 . . . . 72.530000000000001 109.141 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 71.8 Cg_endo -78.76 160.83 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.886 2.391 . . . . 73.519999999999996 113.74 -170.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.2 31.29 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.32 -0.855 . . . . 74.25 108.924 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.29 137.27 56.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.519 -0.764 . . . . 75.030000000000001 110.705 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 158' ' ' LYS . 18.9 t70 -174.87 -63.41 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.358 -0.837 . . . . 73.340000000000003 110.646 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.474 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 t -21.46 112.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 O-C-N 126.136 2.148 . . . . 52.119999999999997 114.068 -166.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.52 149.04 41.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.461 -1.245 . . . . 63.43 109.482 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.405 HD13 ' OG1' ' A' ' 51' ' ' THR . 3.9 mp -84.02 100.58 7.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.435 -0.95 . . . . 63.25 108.435 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.452 ' CG2' ' HD3' ' A' ' 161' ' ' LYS . 26.0 mm -70.9 -57.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.497 -0.774 . . . . 74.409999999999997 110.875 -174.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.793 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -136.24 126.65 26.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.358 0.599 . . . . 54.210000000000001 111.067 176.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -126.7 120.9 30.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.344 -0.844 . . . . 64.439999999999998 110.169 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -139.22 135.99 17.71 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.088 -0.506 . . . . 74.019999999999996 110.288 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.851 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 64.7 Cg_endo -75.83 131.93 13.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.503 2.136 . . . . 72.530000000000001 111.729 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.3 m -150.75 -174.75 4.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.451 -0.341 . . . . 73.120000000000005 110.622 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.76 130.3 10.11 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.789 -0.719 . . . . 64.010000000000005 112.039 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -167.88 -164.25 23.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.781 -0.723 . . . . 74.219999999999999 111.782 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.96 -143.78 15.9 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.878 -0.677 . . . . 60.420000000000002 111.736 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.32 42.36 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.557 -0.617 . . . . 73.310000000000002 111.557 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.3 m -144.78 151.4 38.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.836 0.318 . . . . 51.219999999999999 110.518 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.94 -119.54 0.73 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.713 -0.555 . . . . 74.439999999999998 111.713 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 132.47 -132.6 6.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.805 -0.712 . . . . 74.200000000000003 112.048 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.29 83.18 1.63 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.788 -0.72 . . . . 73.019999999999996 111.808 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.0 m -149.85 129.98 13.58 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.782 0.325 . . . . 75.420000000000002 110.24 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.97 -106.05 3.25 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.901 -0.666 . . . . 53.409999999999997 112.144 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -164.04 -84.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.848 -0.691 . . . . 71.409999999999997 112.085 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -89.53 -57.42 1.75 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.846 -0.692 . . . . 62.43 112.221 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.3 t -107.56 109.6 21.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 72.030000000000001 110.053 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.69 127.79 2.92 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.033 -0.603 . . . . 62.420000000000002 111.724 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.56 154.04 7.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 63.149999999999999 112.085 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.76 63.15 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.084 -0.579 . . . . 35.5 112.812 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.5 t -140.82 151.23 44.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.519 . . . . 53.509999999999998 109.6 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -91.26 -68.13 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.692 -0.766 . . . . 74.230000000000004 111.607 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -101.32 -171.23 1.95 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 72.530000000000001 109.7 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 139.56 151.76 5.74 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.86 -0.686 . . . . 72.230000000000004 112.089 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.22 -166.54 42.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.618 -0.801 . . . . 71.140000000000001 111.814 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.854 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.83 168.1 19.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.881 0.372 . . . . 62.520000000000003 110.216 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.38 98.49 46.66 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.111 0.482 . . . . 74.150000000000006 110.457 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.654 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 72.8 Cg_endo -78.84 -9.55 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.736 2.291 . . . . 60.020000000000003 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.08 -34.58 61.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.049 -0.978 . . . . 72.439999999999998 111.355 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 191' ' ' ILE . 10.5 pt -74.04 -19.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.106 -0.497 . . . . 64.329999999999998 111.273 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.8 m170 72.45 32.18 1.65 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.455 -0.793 . . . . 62.25 111.62 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.72 147.02 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.887 -0.597 . . . . 64.109999999999999 109.679 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.94 131.18 41.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.614 0.598 . . . . 52.310000000000002 112.614 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.66 157.52 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.933 -1.136 . . . . 74.150000000000006 107.933 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -121.18 150.01 52.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.766 -0.373 . . . . 72.329999999999998 111.404 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.854 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.7 Cg_endo -69.41 -76.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.597 2.198 . . . . 72.109999999999999 111.639 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.7 pt? -114.3 19.45 16.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 70.200000000000003 110.263 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 72.83 0.72 3.76 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.679 0.992 . . . . 74.129999999999995 113.679 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -61.41 -28.95 69.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.936 0.335 . . . . 71.129999999999995 111.402 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.85 -4.36 85.43 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.726 -0.75 . . . . 73.340000000000003 112.994 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -79.44 -35.29 40.69 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.902 0.382 . . . . 72.549999999999997 109.972 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-N 114.573 -1.194 . . . . 74.120000000000005 110.906 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.035 0.445 . . . . 62.32 110.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.84 94.92 6.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.01 0.433 . . . . 73.430000000000007 111.504 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.57 -46.73 45.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 70.25 109.905 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.9 mt -131.01 88.23 46.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.395 -0.82 . . . . 53.350000000000001 109.667 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -90.23 159.8 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.131 2.554 . . . . 65.340000000000003 112.643 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.45 96.02 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.238 1.959 . . . . 72.310000000000002 112.436 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.17 -74.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.859 -0.61 . . . . 63.100000000000001 110.174 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 m -99.03 -152.75 0.42 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.794 -0.817 . . . . 60.439999999999998 108.794 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.5 p90 -84.56 -20.91 30.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.019 -0.272 . . . . 75.340000000000003 110.643 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.617 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 2.8 mp0 65.49 143.55 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 115.583 -0.735 . . . . 63.549999999999997 111.824 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HG3' ' HB3' ' A' ' 164' ' ' PRO . 32.4 Cg_endo -63.29 127.19 19.43 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.816 2.344 . . . . 70.239999999999995 112.536 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.12 -20.31 19.23 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 55.140000000000001 112.557 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.457 HD21 HG12 ' A' ' 24' ' ' VAL . 26.9 t-20 -139.12 146.13 40.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 74.420000000000002 109.578 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.8 m -139.9 163.53 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 74.140000000000001 111.716 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 165' ' ' SER . 34.9 m-85 -104.93 124.65 49.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.555 -0.748 . . . . 73.230000000000004 110.785 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.89 95.99 5.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.668 -0.493 . . . . 65.319999999999993 109.668 170.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -90.1 112.39 23.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.225 -0.657 . . . . 55.130000000000003 109.225 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -97.46 -179.72 4.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.011 0.434 . . . . 71.129999999999995 111.083 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -67.65 -29.74 69.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.775 -0.648 . . . . 62.399999999999999 110.545 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.662 ' SD ' HG22 ' A' ' 142' ' ' VAL . 93.9 mtp -88.12 -34.69 17.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.591 . . . . 71.120000000000005 111.358 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -173.82 -133.28 1.66 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.689 -0.767 . . . . 71.219999999999999 111.915 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.0 tt -140.75 137.43 35.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.116 0.484 . . . . 73.25 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 126.78 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.826 -0.625 . . . . 63.130000000000003 109.821 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 13.3 t -105.91 142.04 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 64.340000000000003 109.723 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.65 164.08 36.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 73.310000000000002 110.933 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 10.2 pt-20 -130.95 165.21 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.568 -0.742 . . . . 73.340000000000003 109.765 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.01 157.74 16.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 109.923 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -79.82 103.44 9.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 72.420000000000002 111.969 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -81.81 0.84 37.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 75.319999999999993 110.891 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -70.31 -66.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.033 -0.531 . . . . 72.430000000000007 111.274 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.421 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 t-160 -126.51 9.91 7.21 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.729 -0.388 . . . . 73.299999999999997 111.034 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.73 65.38 72.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 121.078 -0.249 . . . . 22.510000000000002 111.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 31' ' ' HIS . 13.2 Cg_exo -69.85 -45.56 1.5 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.647 2.231 . . . . 74.230000000000004 112.196 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.39 -35.1 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 109.972 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -65.52 -46.19 80.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.199 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -55.08 -48.93 72.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.952 -0.567 . . . . 74.430000000000007 110.496 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HE2' ' HB2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -61.11 -36.0 78.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.806 -0.634 . . . . 70.5 110.935 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.35 -40.17 85.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 73.049999999999997 110.228 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.81 -47.56 58.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 74.420000000000002 109.792 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.51 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 63.310000000000002 111.78 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 51.2 mm-40 -60.35 -38.89 85.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 55.409999999999997 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 42' ' ' LEU . 30.7 mt -68.56 -30.46 69.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.889 0.376 . . . . 73.219999999999999 110.882 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.76 64.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 71.400000000000006 111.212 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -74.24 -29.1 61.54 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.775 -0.37 . . . . 75.530000000000001 111.244 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.4 -46.11 42.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.17 42.62 1.61 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.675 -0.774 . . . . 72.530000000000001 111.781 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -76.04 -27.91 57.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.249 0.547 . . . . 74.340000000000003 110.422 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.554 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.4 m-85 -78.2 -3.27 41.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.022 -0.535 . . . . 72.299999999999997 111.043 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -73.78 -0.64 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.098 0.475 . . . . 61.009999999999998 110.539 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.88 7.55 5.79 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.95 -0.568 . . . . 54.32 112.131 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 65' ' ' GLY . 35.3 p -88.02 149.45 23.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.353 . . . . 63.420000000000002 111.247 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 11.7 ptpt -139.39 157.41 45.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.197 -0.456 . . . . 64.010000000000005 110.59 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 80.9 m-85 -86.13 131.09 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.356 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -109.93 -38.91 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 72.140000000000001 110.992 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 26.4 mmm180 -115.37 117.37 30.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.076 -0.342 . . . . 70.310000000000002 110.076 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -131.23 94.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.94 -0.763 . . . . 72.239999999999995 108.94 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 36.9 mt -105.23 128.34 59.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.841 -0.618 . . . . 72.420000000000002 109.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.42 128.72 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.075 0.464 . . . . 73.540000000000006 111.13 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 54.12 35.43 22.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.848 -1.069 . . . . 64.019999999999996 111.512 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.786 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 4.2 t80 -132.44 -82.39 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.989 0.424 . . . . 73.310000000000002 110.279 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.478 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 22.7 ptp -159.74 158.63 31.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 110.573 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 116' ' ' LEU . 35.1 mt -130.22 100.28 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.622 -0.717 . . . . 70.299999999999997 109.419 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 50.1 tt0 -85.57 127.71 34.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.333 -0.394 . . . . 73.120000000000005 110.494 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -139.18 149.58 20.77 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.616 -0.802 . . . . 65.140000000000001 112.335 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 51' ' ' THR . . . 151.14 -71.76 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.926 -1.13 . . . . 61.509999999999998 113.524 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 32.0 t0 -42.86 105.91 0.45 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.899 0.703 . . . . 74.209999999999994 112.899 -168.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 97.6 Cg_endo -86.2 -18.52 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.315 2.676 . . . . 74.439999999999998 111.54 176.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 70' ' ' THR . 77.6 p -89.62 -32.7 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.309 -0.86 . . . . 74.340000000000003 111.371 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 31.64 59.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.832 -0.907 . . . . 74.329999999999998 110.832 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 64.3 p -102.88 -30.55 10.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 71.209999999999994 111.056 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.34 -3.31 23.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.299 -0.864 . . . . 63.210000000000001 112.085 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -119.12 -31.34 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.647 0.26 . . . . 61.420000000000002 111.277 178.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 95.39 -169.65 27.81 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.809 -0.71 . . . . 74.129999999999995 112.797 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.88 -105.52 2.29 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.26 -0.495 . . . . 32.420000000000002 112.246 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 44.77 48.96 8.98 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 65.109999999999999 112.645 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.44 12.71 2.83 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.021 -0.536 . . . . 54.219999999999999 110.919 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.6 -20.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.737 0.303 . . . . 53.420000000000002 110.611 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 16.0 p90 -101.2 -2.01 32.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.143 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.42 1.4 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 55.420000000000002 113.125 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.32 -168.05 1.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.841 0.353 . . . . 75.140000000000001 111.251 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.2 173.87 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 73.530000000000001 111.886 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 89.7 m-85 -139.67 -162.02 1.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.897 -1.047 . . . . 75.230000000000004 108.965 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.82 159.29 34.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.606 -0.516 . . . . 61.509999999999998 109.606 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -61.35 136.28 57.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.609 -0.515 . . . . 72.010000000000005 109.609 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.07 16.53 25.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 73.129999999999995 110.714 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.4 mt -71.8 96.81 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.147 0.499 . . . . 74.310000000000002 111.958 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.48 78.48 6.96 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.715 -0.675 . . . . 62.109999999999999 111.031 173.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 89.33 0.55 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.593 2.195 . . . . 74.019999999999996 112.428 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.22 10.76 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 71.299999999999997 110.544 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -122.98 -175.72 3.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.232 -0.895 . . . . 70.239999999999995 109.846 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -124.77 144.26 50.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.627 0.251 . . . . 53.530000000000001 110.827 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 68.34 0.63 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.637 0.732 . . . . 75.439999999999998 109.888 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.1 p -65.53 -39.39 91.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.159 -0.928 . . . . 74.319999999999993 112.066 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.609 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -170.42 -137.03 2.19 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.372 -0.918 . . . . 44.43 112.538 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.71 140.61 30.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.617 0.246 . . . . 60.520000000000003 110.741 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.25 24.32 5.73 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.774 -0.727 . . . . 61.109999999999999 111.775 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.434 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.8 mm -88.39 109.79 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.441 -0.577 . . . . 71.349999999999994 109.441 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.48 119.69 26.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.562 -0.532 . . . . 71.420000000000002 109.562 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.7 174.24 10.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 74.510000000000005 111.478 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.828 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 28.2 ttt -106.93 142.32 36.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.729 -0.669 . . . . 65.319999999999993 109.907 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -103.79 118.16 36.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.527 0.68 . . . . 70.120000000000005 111.095 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.667 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.8 p-10 -115.47 165.74 12.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.998 -1.001 . . . . 71.310000000000002 109.964 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.5 -37.38 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.862 0.839 . . . . 64.120000000000005 109.19 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -138.83 174.49 22.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 108.644 -1.782 . . . . 61.420000000000002 108.644 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.57 -49.61 11.73 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.073 2.515 . . . . 73.010000000000005 112.811 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.57 -11.1 19.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.521 -0.308 . . . . 72.530000000000001 111.275 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 3.1 m -86.14 55.46 3.55 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.667 -0.864 . . . . 54.32 108.667 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.667 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 18.7 m120 -62.15 117.22 5.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.356 -1.293 . . . . 72.430000000000007 109.505 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' A' ' 102' ' ' ASN . . . -90.95 -168.16 41.82 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 63.0 112.672 -172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -99.46 20.27 14.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.42 0.628 . . . . 62.039999999999999 110.094 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 17.4 mt-30 -109.89 159.04 17.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.478 -0.783 . . . . 63.310000000000002 110.77 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -139.89 174.17 10.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.665 . . . . 74.0 109.203 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.2 p90 -160.08 154.69 24.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 54.329999999999998 111.692 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.22 145.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.274 -0.876 . . . . 74.209999999999994 109.23 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 p -100.94 131.1 46.97 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.062 0.458 . . . . 43.210000000000001 110.459 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 62' ' ' ILE . 59.8 mt -89.2 -5.39 57.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 62.329999999999998 110.994 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.39 164.22 21.9 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.849 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.609 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 38.9 Cg_exo -61.06 107.04 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.464 2.109 . . . . 61.210000000000001 111.887 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 23.4 p -96.37 96.89 9.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.81 -0.632 . . . . 63.219999999999999 111.02 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 120' ' ' GLN . 1.0 OUTLIER -100.02 9.9 42.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.57 0.7 . . . . 75.430000000000007 110.471 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.451 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -108.57 -12.42 14.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.77 -1.105 . . . . 74.420000000000002 111.591 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 3.3 pp -114.91 9.8 16.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 75.030000000000001 111.342 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.85 -34.37 65.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.465 -0.789 . . . . 62.149999999999999 110.885 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.39 15.36 30.03 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.524 -0.762 . . . . 73.310000000000002 112.033 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.59 -35.93 5.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.075 0.464 . . . . 72.319999999999993 110.078 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -140.82 139.4 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.796 -0.638 . . . . 73.400000000000006 109.671 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -77.68 148.71 34.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.156 0.503 . . . . 55.219999999999999 110.446 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 99' ' ' ALA . 45.1 mt -126.88 122.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.59 . . . . 75.430000000000007 110.555 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.828 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.4 p90 -153.93 72.94 0.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.685 0.755 . . . . 71.340000000000003 111.212 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.08 152.24 22.27 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.557 -1.306 . . . . 73.420000000000002 113.676 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.42 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 74.0 mtp180 -130.14 117.22 19.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.218 -0.66 . . . . 55.200000000000003 109.218 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.44 135.34 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.051 0.453 . . . . 64.0 110.385 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.64 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 51.3 t -143.65 145.01 32.14 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.26 -0.427 . . . . 73.530000000000001 110.096 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.692 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.7 tt0 50.92 40.69 25.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.354 0.597 . . . . 73.219999999999999 111.85 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -170.62 24.82 0.1 OUTLIER Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.143 -1.027 . . . . 62.039999999999999 112.152 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.5 tp -78.61 -32.32 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.088 -0.245 . . . . 75.230000000000004 110.478 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 141' ' ' ARG . . . -62.23 -37.35 94.4 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.155 -0.778 . . . . 72.420000000000002 111.155 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.58 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 72.1 mmm -68.09 -55.64 11.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.145 -0.317 . . . . 74.409999999999997 110.145 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 90.1 t -51.57 -31.25 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.218 0.532 . . . . 64.409999999999997 110.644 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.552 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.6 t30 -70.11 -56.79 5.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.713 -0.676 . . . . 72.310000000000002 110.538 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.532 ' HD2' ' HE3' ' A' ' 138' ' ' MET . 0.1 OUTLIER -72.62 -15.64 61.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.767 0.318 . . . . 71.140000000000001 111.261 -177.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG22 ' SD ' ' A' ' 20' ' ' MET . 75.3 t -79.73 -43.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.369 -0.604 . . . . 54.32 109.369 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -76.48 -25.86 64.64 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.417 -0.897 . . . . 63.43 112.549 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.552 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 77.7 mtp -73.53 -11.27 60.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.76 0.282 . . . . 65.400000000000006 111.76 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.66 117.02 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.561 0.696 . . . . 75.349999999999994 111.243 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.51 -92.3 0.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.605 -0.725 . . . . 71.340000000000003 110.282 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.0 p -117.01 149.37 40.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.93 -0.577 . . . . 73.340000000000003 109.691 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -83.75 -147.04 0.09 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.261 -0.274 . . . . 53.43 110.261 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.5 t -60.67 -32.97 72.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 51.219999999999999 110.234 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -97.14 171.93 8.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.311 -0.626 . . . . 74.140000000000001 109.311 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.36 63.59 7.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.053 0.93 . . . . 72.450000000000003 109.718 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -137.91 143.51 40.2 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.528 -1.215 . . . . 64.340000000000003 109.05 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.39 129.56 33.31 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.289 1.993 . . . . 72.540000000000006 111.497 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.3 t -53.85 -45.01 62.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.06 -0.518 . . . . 73.420000000000002 110.599 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.65 128.7 23.68 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.485 -0.561 . . . . 75.409999999999997 109.485 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.17 88.15 6.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.46 . . . . 72.5 109.941 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.52 126.97 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.78 0.8 . . . . 72.519999999999996 111.697 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.67 172.97 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.165 -0.925 . . . . 65.219999999999999 109.276 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -89.52 105.01 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.728 -0.841 . . . . 75.049999999999997 108.728 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 22.7 mm -73.92 -48.22 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.364 -0.835 . . . . 55.43 110.989 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -131.86 126.08 33.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.944 -0.571 . . . . 62.530000000000001 110.828 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.16 122.82 30.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.0 0.429 . . . . 70.200000000000003 110.566 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -155.91 150.87 20.75 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.842 -0.617 . . . . 75.420000000000002 110.268 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 14' ' ' VAL . 54.7 Cg_endo -70.86 134.25 25.26 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.638 2.226 . . . . 74.530000000000001 112.887 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.53 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.6 p -81.93 -46.47 13.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 61.310000000000002 109.934 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.16 -76.92 1.0 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.544 -0.753 . . . . 73.019999999999996 111.774 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.32 57.56 1.02 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.76 -0.733 . . . . 70.040000000000006 112.634 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.2 24.11 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.099 -0.801 . . . . 65.319999999999993 111.099 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.51 157.72 25.45 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.024 -1.084 . . . . 72.439999999999998 112.891 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.5 t -155.81 140.43 16.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.294 -0.632 . . . . 63.329999999999998 109.294 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.62 135.7 2.59 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.647 -0.787 . . . . 65.019999999999996 112.001 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 118.59 -146.2 18.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.91 -0.662 . . . . 75.319999999999993 111.909 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.749 ' HA3' ' HA3' ' A' ' 181' ' ' GLY . . . 82.33 47.05 6.23 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.977 -0.63 . . . . 53.32 112.651 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 m -82.34 90.93 6.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.976 -0.379 . . . . 72.239999999999995 109.976 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -137.83 103.09 0.4 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.651 -0.785 . . . . 72.209999999999994 112.722 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.13 -156.36 48.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.079 -0.581 . . . . 54.450000000000003 112.915 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -106.18 1.8 37.81 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.011 -0.614 . . . . 52.219999999999999 112.197 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.2 t -158.15 154.84 28.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.827 -0.434 . . . . 61.329999999999998 109.827 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.16 -71.14 0.2 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.931 -0.652 . . . . 54.109999999999999 111.594 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.56 -161.16 46.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.672 . . . . 44.340000000000003 112.528 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.749 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -144.86 51.24 0.62 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.862 -0.685 . . . . 62.149999999999999 111.855 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 33.8 t -131.95 111.74 11.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.931 -0.396 . . . . 70.420000000000002 109.931 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.67 -80.78 0.29 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.82 -0.705 . . . . 35.310000000000002 111.663 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.6 m-20 -126.18 170.65 11.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.275 0.559 . . . . 71.129999999999995 110.443 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.54 146.93 4.47 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.228 -0.896 . . . . 71.319999999999993 111.306 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -84.59 -166.61 41.55 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.373 -0.918 . . . . 51.43 111.929 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.641 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -74.9 170.86 15.1 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.741 0.305 . . . . 64.140000000000001 110.271 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.411 ' HD1' HH21 ' A' ' 131' ' ' ARG . 91.8 m-85 -111.14 93.17 17.21 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-O 121.153 0.501 . . . . 71.310000000000002 110.449 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 6.0 Cg_exo -76.36 -13.56 18.62 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.888 2.392 . . . . 73.129999999999995 111.715 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.24 -34.79 42.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.902 -1.045 . . . . 74.319999999999993 111.072 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 193' ' ' VAL . 31.3 pt -80.31 -11.7 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 71.239999999999995 111.428 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.04 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.416 -0.811 . . . . 72.019999999999996 111.321 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 191' ' ' ILE . 6.4 p -164.21 152.95 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.059 -0.349 . . . . 62.310000000000002 110.059 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.14 113.97 14.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.911 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -161.94 157.32 23.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 70.219999999999999 109.625 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -124.02 156.35 66.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.503 -0.317 . . . . 72.150000000000006 110.726 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 49.0 Cg_endo -69.34 -69.7 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.478 2.119 . . . . 50.409999999999997 112.272 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.6 pt? -120.25 23.57 10.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 72.400000000000006 109.95 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 68.56 13.92 9.0 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.226 -0.897 . . . . 72.340000000000003 111.846 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.6 ptm -52.24 -46.04 65.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 70.230000000000004 112.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 -2.15 90.11 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.745 -0.74 . . . . 72.109999999999999 113.141 -175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -80.02 -26.5 39.77 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.374 0.607 . . . . 60.409999999999997 110.206 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.632 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-N 114.9 -1.045 . . . . 72.439999999999998 109.927 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.556 0.217 . . . . 70.219999999999999 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.17 129.71 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.637 0.256 . . . . 74.420000000000002 111.062 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.88 -59.09 2.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.007 0.432 . . . . 44.520000000000003 110.353 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 78' ' ' TYR . 74.6 mt -134.65 102.34 11.49 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.702 -0.681 . . . . 73.420000000000002 110.556 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -87.04 113.91 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.03 2.487 . . . . 75.129999999999995 111.366 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.92 142.26 46.75 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.501 2.134 . . . . 74.239999999999995 112.255 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -87.62 10.99 16.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 64.540000000000006 111.283 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.0 p 61.61 -68.75 0.05 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.82 1.248 . . . . 65.0 112.417 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -65.69 119.81 11.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.832 0.348 . . . . 74.040000000000006 110.377 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.92 109.0 56.81 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 109.173 -0.677 . . . . 71.439999999999998 109.173 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 164' ' ' PRO . 4.7 Cg_endo -49.24 112.04 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.442 2.762 . . . . 73.019999999999996 113.146 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.1 Cg_exo -78.82 -31.51 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.894 2.396 . . . . 74.420000000000002 111.304 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 14.8 t-20 -143.23 139.84 30.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.144 -0.935 . . . . 63.340000000000003 109.329 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.483 HG21 ' HE1' ' A' ' 39' ' ' PHE . 24.6 m -135.89 165.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.539 -0.3 . . . . 53.439999999999998 110.617 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD11 ' A' ' 22' ' ' ILE . 38.5 p90 -124.13 134.11 53.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.167 0.508 . . . . 73.219999999999999 110.61 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.16 111.12 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 72.230000000000004 110.451 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 7.1 tp10 -85.67 112.09 20.69 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.383 -0.969 . . . . 71.030000000000001 108.383 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -105.0 -179.8 4.05 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.066 0.46 . . . . 55.340000000000003 111.263 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -1.48 42.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 62.32 111.035 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.608 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.0 mmt -108.32 -44.89 4.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 73.439999999999998 109.95 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.6 -140.9 3.19 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.592 -1.003 . . . . 60.310000000000002 110.592 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -133.08 131.47 58.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.529 -0.545 . . . . 74.230000000000004 109.529 -178.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -125.96 128.37 71.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.759 -0.655 . . . . 63.32 110.947 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 85.1 t -111.52 143.71 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.82 -0.437 . . . . 74.519999999999996 109.82 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.12 161.24 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.215 0.531 . . . . 73.25 110.852 176.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' HD22 ' A' ' 13' ' ' ASN . 5.8 pt-20 -125.72 168.81 13.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.366 -0.834 . . . . 72.219999999999999 109.823 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 ' CG ' ' A' ' 39' ' ' PHE . 1.1 mm? -108.54 163.05 13.57 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.198 -0.667 . . . . 64.409999999999997 109.198 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 2.9 m-85 -83.35 89.82 7.07 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.253 -0.579 . . . . 74.400000000000006 111.993 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -7.19 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.453 -1.314 . . . . 62.420000000000002 107.453 170.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -66.79 -43.06 84.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.426 -1.715 . . . . 53.329999999999998 110.746 -176.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -140.06 -1.61 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 75.439999999999998 111.584 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.6 88.97 18.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.742 -0.383 . . . . 21.100000000000001 111.435 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.23 -6.11 17.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.895 2.396 . . . . 75.010000000000005 112.626 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 15.4 mtpt -100.1 -53.8 3.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.399 -0.364 . . . . 74.109999999999999 111.101 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.416 HG23 ' SD ' ' A' ' 100' ' ' MET . 8.8 m -53.93 -35.86 62.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 70.310000000000002 111.977 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.629 ' SG ' ' HE2' ' A' ' 37' ' ' LYS . 6.1 p -66.89 -28.43 68.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 70.120000000000005 111.517 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HE2' ' SG ' ' A' ' 36' ' ' CYS . 36.8 mmtt -79.93 -34.83 38.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.347 -0.388 . . . . 73.129999999999995 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -57.04 -53.2 60.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.557 -0.747 . . . . 73.430000000000007 110.531 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HE1' HG21 ' A' ' 14' ' ' VAL . 23.4 t80 -61.55 -50.68 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 64.239999999999995 109.838 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -42.19 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.961 -1.018 . . . . 72.230000000000004 111.49 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.07 -48.92 70.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 61.43 110.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD12 ' CB ' ' A' ' 47' ' ' TYR . 2.6 mm? -74.78 -29.12 61.02 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.582 -0.447 . . . . 72.340000000000003 111.695 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.1 65.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.691 -0.231 . . . . 63.229999999999997 111.521 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 3.7 ppt_? -77.14 -21.54 53.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 65.099999999999994 110.423 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' C ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.65 -45.69 24.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.018 -0.734 . . . . 64.219999999999999 109.018 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.09 2.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.697 -0.763 . . . . 44.25 111.62 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -71.15 -30.77 66.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.139 0.495 . . . . 72.219999999999999 110.265 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -78.18 -7.72 57.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.598 -0.728 . . . . 70.329999999999998 111.502 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.78 -8.1 53.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 72.319999999999993 111.168 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.49 31.69 2.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.71 . . . . 72.349999999999994 112.252 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.715 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 20.3 p -107.46 150.63 26.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.041 0.448 . . . . 73.439999999999998 111.863 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 1.4 mmtp -120.17 169.93 9.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 63.100000000000001 109.169 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -88.08 118.49 27.68 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 63.210000000000001 109.329 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -93.31 -28.77 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 110.413 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 41.1 mmt180 -137.67 109.74 7.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 44.439999999999998 110.134 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 56' ' ' ILE . 4.1 mp -115.07 79.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.395 -0.595 . . . . 71.299999999999997 109.395 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.09 134.47 27.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.051 -0.522 . . . . 73.329999999999998 109.639 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.988 ' HE3' ' HA ' ' A' ' 146' ' ' GLU . 2.4 mptp? -74.62 128.76 36.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.443 -0.344 . . . . 72.219999999999999 110.388 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.8 32.28 21.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.005 0.815 . . . . 54.409999999999997 110.923 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.86 -83.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 74.200000000000003 111.144 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptm -160.63 155.15 23.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.822 -0.626 . . . . 64.219999999999999 110.718 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.508 HD12 HG13 ' A' ' 139' ' ' VAL . 36.1 mt -130.58 103.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.629 -0.714 . . . . 73.200000000000003 109.723 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.8 tt0 -80.14 126.6 31.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.9 -0.591 . . . . 72.219999999999999 110.447 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.28 129.38 7.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.836 -0.697 . . . . 70.310000000000002 111.646 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.715 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 134.81 -148.12 19.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.458 -0.877 . . . . 72.239999999999995 112.859 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.8 t0 53.21 81.75 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 123.892 0.877 . . . . 75.299999999999997 111.534 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD3' ' CE1' ' A' ' 47' ' ' TYR . 54.7 Cg_endo -72.32 -24.02 20.05 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.792 2.328 . . . . 42.109999999999999 111.159 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 5.6 p -81.9 -46.32 14.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.256 -0.884 . . . . 71.239999999999995 111.751 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.32 26.55 10.0 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.578 -0.82 . . . . 74.239999999999995 111.412 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 72' ' ' ARG . 6.6 t -128.81 -19.31 3.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.775 0.321 . . . . 73.019999999999996 111.121 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.88 -18.57 55.69 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.524 -0.846 . . . . 64.230000000000004 113.313 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -110.9 5.22 20.33 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.429 -0.453 . . . . 73.540000000000006 111.152 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -86.85 176.85 47.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 64.230000000000004 112.647 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 85.18 -45.26 3.48 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.034 -0.603 . . . . 62.439999999999998 112.533 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . -76.32 25.25 0.13 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.834 0.454 . . . . 60.299999999999997 111.702 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 74' ' ' GLY . 7.4 m -59.5 -24.35 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 62.530000000000001 111.06 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.591 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.4 tt -56.22 -48.36 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.717 -0.674 . . . . 74.219999999999999 111.284 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG23 ' A' ' 77' ' ' ILE . 30.2 p90 -108.97 -6.09 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.657 0.265 . . . . 62.450000000000003 111.593 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.58 -95.95 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.622 -0.799 . . . . 63.030000000000001 113.524 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -112.06 -174.33 2.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.744 0.783 . . . . 72.299999999999997 112.16 -173.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.551 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 4.5 pm0 -85.91 175.18 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.388 -1.278 . . . . 74.129999999999995 108.751 170.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -132.98 -60.47 0.86 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.293 -0.563 . . . . 72.299999999999997 111.717 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.72 177.87 8.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.437 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -103.95 149.49 25.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.789 -0.449 . . . . 72.450000000000003 109.789 174.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -121.79 23.87 9.93 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' A' ' 127' ' ' THR . 55.8 mt -59.53 102.86 0.16 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.425 -0.807 . . . . 73.129999999999995 111.062 -174.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -161.84 82.09 1.84 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.923 0.392 . . . . 60.539999999999999 110.377 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.78 81.25 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.44 2.093 . . . . 72.540000000000006 111.296 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.76 -4.41 59.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.054 0.93 . . . . 64.510000000000005 109.403 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -94.72 -153.29 0.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.37 -1.286 . . . . 72.530000000000001 108.611 173.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -152.43 142.04 21.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.588 -0.445 . . . . 74.420000000000002 110.946 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 34.8 p90 -59.83 123.63 17.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.529 -0.76 . . . . 74.129999999999995 109.398 170.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.0 p -116.2 -40.13 3.31 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.253 -0.43 . . . . 63.340000000000003 110.995 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.36 -143.54 3.73 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.034 -0.603 . . . . 64.329999999999998 112.274 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 151.3 19.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.686 0.279 . . . . 62.420000000000002 110.626 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 103.35 23.73 8.28 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.52 -0.848 . . . . 51.350000000000001 111.319 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.1 mm -89.04 111.36 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.643 -0.502 . . . . 73.519999999999996 109.643 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -86.72 120.16 27.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 109.719 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 128' ' ' ILE . . . -134.42 172.86 12.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.151 -0.477 . . . . 73.5 111.319 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.57 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 64.7 mtp -90.52 141.78 28.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 72.150000000000006 110.411 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.22 156.66 18.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.136 -0.484 . . . . 64.209999999999994 109.754 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.7 p-10 -159.75 163.25 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.386 -0.37 . . . . 74.310000000000002 110.712 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.1 -38.7 15.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.68 . . . . 72.400000000000006 110.303 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.16 -80.67 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.522 -0.847 . . . . 32.0 112.65 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.13 85.3 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.976 2.451 . . . . 61.399999999999999 112.934 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 52.32 33.08 12.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.392 -0.822 . . . . 71.519999999999996 112.136 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -76.26 39.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.212 0.449 . . . . 75.109999999999999 112.212 -174.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 84' ' ' ASP . 10.2 m120 -84.66 139.58 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.377 -0.601 . . . . 73.140000000000001 109.377 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.15 -68.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.85 -1.167 . . . . 40.340000000000003 113.533 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 33.8 t -109.13 -24.24 11.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.573 0.582 . . . . 70.120000000000005 112.573 -169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -91.37 137.47 32.34 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.487 -0.485 . . . . 54.32 110.051 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 87.9 m-85 -141.12 167.5 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.653 0.263 . . . . 72.219999999999999 110.679 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 34.1 p90 -159.4 158.27 31.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.753 0.311 . . . . 72.450000000000003 110.719 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -112.14 146.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 61.439999999999998 109.686 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -98.55 131.84 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 70.430000000000007 110.232 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.9 mt -85.76 -7.71 58.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 111.024 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.96 158.41 33.89 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.797 -0.638 . . . . 61.140000000000001 110.106 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.684 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 56.2 Cg_endo -71.76 123.91 9.77 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.362 2.042 . . . . 72.5 112.04 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.4 HG21 HD21 ' A' ' 122' ' ' LEU . 41.0 p -108.81 158.57 17.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 110.937 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 21.67 2.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.105 0.479 . . . . 62.530000000000001 111.005 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.32 -3.98 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.064 -0.516 . . . . 75.040000000000006 112.113 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 4.3 pp -130.4 3.94 4.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.497 -0.481 . . . . 74.230000000000004 111.617 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.64 -28.36 69.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 73.219999999999999 110.493 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.28 13.07 55.18 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.29 -0.724 . . . . 62.100000000000001 111.29 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 25.1 mmmt -116.22 -22.94 8.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.119 -0.697 . . . . 71.219999999999999 109.119 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 100' ' ' MET . 85.4 m-70 -134.67 134.68 41.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.37 -0.832 . . . . 70.340000000000003 110.042 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 86' ' ' LEU . 18.9 m -72.81 121.4 19.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.06 -0.348 . . . . 72.450000000000003 110.06 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 99' ' ' ALA . 45.1 mt -108.71 114.65 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.92 -0.312 . . . . 64.319999999999993 111.768 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.5 m-85 -156.59 76.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 72.439999999999998 110.399 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.86 157.11 29.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.582 -0.818 . . . . 72.340000000000003 112.871 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.67 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 55.9 mtm180 -134.98 125.89 27.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.976 -0.379 . . . . 72.310000000000002 109.976 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.1 p -80.49 139.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.037 0.446 . . . . 64.420000000000002 110.41 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 41.3 t -139.24 143.58 38.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.551 -174.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.6 pt20 41.21 40.14 1.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.246 1.018 . . . . 73.540000000000006 113.239 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.47 41.41 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 44.310000000000002 111.901 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.2 tp -88.82 -36.35 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.672 0.272 . . . . 73.230000000000004 110.636 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -36.36 92.05 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.903 -0.665 . . . . 51.109999999999999 111.681 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.0 mmm -67.83 -51.66 45.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.26 -0.274 . . . . 64.420000000000002 110.26 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 62' ' ' ILE . 91.9 t -54.31 -32.66 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.131 0.491 . . . . 53.43 110.668 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -70.39 -51.87 26.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 74.019999999999996 110.45 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -76.81 -10.14 59.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.966 -0.561 . . . . 74.450000000000003 111.355 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.8 t -87.11 -38.9 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.277 0.561 . . . . 72.450000000000003 109.792 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.467 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.31 -33.96 38.08 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.574 -0.822 . . . . 50.030000000000001 112.87 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 22.1 ptm -78.93 -18.91 53.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.08 0.4 . . . . 72.540000000000006 112.08 -173.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.37 126.32 37.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 119.962 -0.695 . . . . 61.299999999999997 110.095 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.988 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 11.0 pt-20 -78.82 -174.36 3.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.864 -0.607 . . . . 70.439999999999998 111.5 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.8 p -84.89 161.21 19.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.713 -0.676 . . . . 73.310000000000002 110.654 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -73.86 -38.87 64.31 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.103 -1.073 . . . . 65.230000000000004 108.103 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.834 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 30.6 t -158.26 139.94 13.72 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.093 -1.412 . . . . 71.129999999999995 108.361 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 42.48 -94.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.076 0.86 . . . . 54.310000000000002 113.155 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.52 10.52 9.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.02 0.378 . . . . 73.319999999999993 112.02 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.834 ' HD3' ' HB3' ' A' ' 149' ' ' SER . 3.1 ptm180 -95.43 111.37 55.07 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.33 -0.618 . . . . 73.340000000000003 109.33 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.16 146.39 90.52 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.713 2.275 . . . . 75.019999999999996 112.939 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 146' ' ' GLU . 61.0 t -62.47 -54.47 33.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.351 0.596 . . . . 71.329999999999998 109.586 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -102.47 133.22 47.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.684 -0.689 . . . . 72.019999999999996 109.794 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' OD2' ' HD2' ' A' ' 158' ' ' LYS . 32.0 t70 -86.62 100.22 12.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.926 -0.579 . . . . 71.230000000000004 109.609 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 158' ' ' LYS . 3.6 t -104.47 123.08 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.847 0.832 . . . . 65.239999999999995 112.478 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 158' ' ' LYS . 2.0 mppt? -139.65 170.95 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.691 -1.14 . . . . 64.420000000000002 109.301 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.7 mp -90.52 106.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.734 -0.839 . . . . 64.040000000000006 108.734 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.552 HG22 ' HD2' ' A' ' 161' ' ' LYS . 26.0 mm -73.62 -52.3 21.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 110.251 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HD2' HG22 ' A' ' 160' ' ' ILE . 4.9 mptp? -130.73 143.42 50.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.542 -0.754 . . . . 71.319999999999993 109.298 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.94 127.22 13.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.944 -0.391 . . . . 63.32 109.944 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 95.3 m-85 -148.23 155.23 43.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.569 -0.53 . . . . 74.010000000000005 109.569 -174.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 7.8 Cg_endo -85.07 131.62 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.431 2.087 . . . . 73.109999999999999 112.117 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.3 p -109.18 -27.79 9.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.047 -0.524 . . . . 73.430000000000007 110.688 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.04 -37.39 3.78 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.834 -0.698 . . . . 33.219999999999999 112.092 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -179.81 70.37 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.65 -0.786 . . . . 72.530000000000001 112.404 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.5 118.16 4.81 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.853 -0.689 . . . . 45.219999999999999 111.736 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.47 ' HA3' ' SG ' ' A' ' 133' ' ' CYS . . . 106.24 162.42 22.71 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.702 -0.761 . . . . 50.439999999999998 111.967 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.1 p -141.37 154.73 45.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.524 0.202 . . . . 72.530000000000001 110.523 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.1 53.29 0.64 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.504 -0.855 . . . . 63.240000000000002 112.32 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.17 93.1 0.78 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.802 -0.713 . . . . 62.43 111.971 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.17 165.35 24.41 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.992 -0.623 . . . . 60.310000000000002 112.237 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -159.47 103.46 1.59 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.105 -0.332 . . . . 72.030000000000001 110.105 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 153.74 -154.77 25.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.932 -0.651 . . . . 61.520000000000003 111.597 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.49 -56.41 4.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.941 -0.647 . . . . 61.130000000000003 112.484 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.87 -67.82 3.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.08 -0.581 . . . . 63.130000000000003 111.852 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 26.9 m -137.11 19.13 2.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.297 0.57 . . . . 75.230000000000004 110.139 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.36 -176.42 35.33 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.506 -0.77 . . . . 73.200000000000003 111.444 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 124.34 0.22 8.74 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.943 -0.646 . . . . 74.140000000000001 111.987 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.68 37.91 4.34 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.884 -0.674 . . . . 73.049999999999997 111.427 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.9 m -88.48 120.77 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.692 0.282 . . . . 64.340000000000003 110.932 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.55 -102.97 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.675 -0.774 . . . . 74.430000000000007 111.547 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -130.37 171.6 12.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.504 0.669 . . . . 73.310000000000002 111.172 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.525 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 152.3 137.6 2.6 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 114.742 -1.117 . . . . 23.239999999999998 110.922 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.66 -160.89 14.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.395 -0.907 . . . . 74.010000000000005 112.564 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.833 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.2 172.5 12.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.667 0.27 . . . . 53.030000000000001 110.395 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.2 98.48 22.7 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.868 -0.419 . . . . 75.530000000000001 109.868 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 1.4 Cg_endo -82.54 -8.52 11.46 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.766 2.31 . . . . 61.420000000000002 111.773 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.83 -26.76 36.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.974 -0.557 . . . . 73.420000000000002 110.301 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.3 pt -94.23 152.12 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.181 -1.044 . . . . 63.210000000000001 108.181 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -102.88 64.2 0.85 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.215 -0.594 . . . . 64.239999999999995 111.091 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.61 135.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.478 . . . . 74.340000000000003 110.477 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.61 110.33 3.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 75.540000000000006 111.027 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.37 149.25 29.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.911 -0.774 . . . . 70.140000000000001 108.911 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 70.6 m-85 -119.03 144.59 36.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.91 0.337 . . . . 60.329999999999998 111.91 -170.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.833 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.6 Cg_endo -64.35 -59.6 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.728 2.285 . . . . 64.129999999999995 112.093 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.0 OUTLIER -143.79 37.51 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.462 -0.335 . . . . 64.019999999999996 111.402 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.3 m-20 74.37 -14.61 0.69 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.817 0.673 . . . . 64.120000000000005 112.817 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptm -49.18 -33.35 12.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.291 0.849 . . . . 72.239999999999995 113.291 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.73 -1.56 63.58 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.371 -0.918 . . . . 75.209999999999994 113.315 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 36.4 ptt180 -120.32 -6.77 9.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.214 0.507 . . . . 71.120000000000005 110.95 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.247 0.929 0 CA-C-N 114.89 -1.05 . . . . 74.340000000000003 110.519 178.686 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.35 -0.611 . . . . 71.219999999999999 109.35 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.56 -11.29 19.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.358 0.503 . . . . 55.409999999999997 112.358 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.92 154.74 24.43 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.29 -0.164 . . . . 74.450000000000003 111.216 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.521 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 41.1 mm 74.37 123.88 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 O-C-N 124.026 0.829 . . . . 73.120000000000005 111.522 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 10.1 Cg_endo -89.81 104.64 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.338 2.692 . . . . 75.519999999999996 112.512 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 4' ' ' ILE . 1.3 Cg_endo -83.01 106.42 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.065 2.51 . . . . 74.310000000000002 111.726 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -80.29 178.95 7.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.397 -0.594 . . . . 75.540000000000006 109.397 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -105.46 -17.87 14.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.526 0.203 . . . . 50.140000000000001 111.158 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -118.46 102.05 8.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.591 0.71 . . . . 61.039999999999999 111.091 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -106.07 120.2 49.68 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.864 -1.062 . . . . 63.200000000000003 110.095 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.78 124.65 16.76 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.385 2.724 . . . . 74.329999999999998 112.984 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 -22.42 7.36 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.916 2.411 . . . . 71.030000000000001 112.521 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 24.8 t-20 -142.32 147.48 36.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.996 -0.742 . . . . 74.319999999999993 108.996 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.4 m -137.67 152.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.215 0.531 . . . . 72.549999999999997 111.782 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.73 122.53 42.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.155 -0.93 . . . . 72.420000000000002 110.566 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 mt -114.98 98.02 6.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.774 0.321 . . . . 73.209999999999994 110.41 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.35 124.98 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.021 -0.733 . . . . 70.540000000000006 109.021 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 159' ' ' ILE . 74.8 p -111.84 178.74 4.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.173 0.511 . . . . 50.43 111.274 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -76.4 -6.19 50.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 111.027 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.9 mmt -102.52 -43.38 5.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.926 -0.579 . . . . 25.510000000000002 109.867 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.56 -130.75 1.27 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.494 -0.642 . . . . 73.420000000000002 111.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 23' ' ' ILE . 19.4 tt -132.7 137.99 52.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.029 0.443 . . . . 74.420000000000002 110.0 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.493 HD12 HG23 ' A' ' 139' ' ' VAL . 20.1 mm -129.13 117.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.174 -0.676 . . . . 74.420000000000002 109.174 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.9 m -113.56 147.04 17.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 119.147 -1.021 . . . . 73.109999999999999 110.152 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.34 163.94 36.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.941 -0.572 . . . . 74.439999999999998 110.611 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.7 pt-20 -129.65 166.73 19.19 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.043 -0.98 . . . . 75.420000000000002 109.662 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -104.16 163.89 12.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.623 -0.51 . . . . 73.519999999999996 109.623 179.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 4.5 m-85 -82.58 98.95 9.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.177 0.513 . . . . 64.109999999999999 111.385 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.92 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -83.47 -0.56 50.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.551 -0.75 . . . . 65.140000000000001 110.014 -179.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -79.38 -53.88 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 75.319999999999993 111.466 -176.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.0 15.43 4.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.925 0.342 . . . . 74.239999999999995 111.925 -175.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.66 67.15 77.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.896 0.379 . . . . 71.040000000000006 110.108 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 16.8 Cg_exo -66.98 -43.98 5.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.798 2.332 . . . . 60.43 112.401 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -76.03 -45.42 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 75.040000000000006 110.034 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.5 m -63.02 -32.84 74.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 64.400000000000006 111.221 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.92 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 33.4 t -59.74 -43.09 94.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.593 -0.276 . . . . 52.32 110.758 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 45.6 mmtt -70.04 -32.44 70.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.974 -0.38 . . . . 73.219999999999999 109.974 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.61 -58.47 7.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 75.230000000000004 109.746 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD2' HD11 ' A' ' 27' ' ' LEU . 1.8 t80 -67.45 -37.05 82.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.75 . . . . 64.219999999999999 110.349 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.65 -43.06 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 70.219999999999999 111.457 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.689 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 10.5 tp10 -61.53 -42.94 99.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.932 0.396 . . . . 72.120000000000005 111.29 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.597 ' HG ' ' HB2' ' A' ' 110' ' ' SER . 4.3 mm? -66.37 -24.14 66.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 54.399999999999999 110.54 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.472 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -80.85 -31.07 35.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.099 -0.5 . . . . 73.219999999999999 110.129 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 38.6 mtp85 -61.95 -46.24 90.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.205 -0.907 . . . . 72.230000000000004 110.841 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -74.73 -49.35 21.4 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.831 -0.347 . . . . 75.340000000000003 110.83 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.65 49.76 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 61.130000000000003 111.941 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.62 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 23.6 t80 -70.99 -29.93 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.116 0.484 . . . . 73.450000000000003 111.235 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 32.2 m-85 -81.15 -5.88 58.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.642 . . . . 74.25 112.121 -169.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -75.57 -6.1 48.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 71.219999999999999 110.547 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.22 14.66 6.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 54.520000000000003 111.829 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 45.2 p -93.17 143.22 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.477 . . . . 71.510000000000005 111.015 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -140.2 147.09 39.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.794 -0.639 . . . . 72.200000000000003 110.054 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 63.9 m-85 -80.97 124.4 29.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.533 -0.543 . . . . 73.239999999999995 109.533 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -118.57 -19.83 8.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.563 -0.289 . . . . 64.319999999999993 111.366 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 34.5 mmt180 -122.82 105.5 10.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.805 -0.443 . . . . 74.450000000000003 109.805 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.401 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -122.02 81.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.297 0.57 . . . . 73.150000000000006 110.033 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.831 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 17.5 mt -89.91 132.82 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.226 -0.657 . . . . 74.219999999999999 109.226 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.788 ' HE3' ' HA ' ' A' ' 146' ' ' GLU . 2.3 mptp? -70.88 133.41 46.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.413 . . . . 72.430000000000007 110.008 -173.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 42.33 42.47 2.61 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.459 1.1 . . . . 63.530000000000001 111.716 -172.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.831 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.0 t80 -131.52 -84.34 0.51 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.628 -0.715 . . . . 72.340000000000003 109.705 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.674 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptt? -161.19 157.16 25.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.328 -0.851 . . . . 74.310000000000002 110.165 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 116' ' ' LEU . 44.6 mt -124.5 100.07 7.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.727 -0.67 . . . . 54.509999999999998 109.469 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 46.5 mt-30 -84.83 119.81 25.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.656 -0.702 . . . . 73.420000000000002 110.866 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -138.48 140.56 11.18 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.715 -0.675 . . . . 54.509999999999998 111.775 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 164.04 -91.81 0.11 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.409 -1.376 . . . . 64.409999999999997 114.081 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -28.44 104.58 0.19 Allowed Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.003 1.112 . . . . 74.450000000000003 114.003 -163.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 91.1 Cg_endo -81.96 -12.5 10.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.852 3.035 . . . . 72.329999999999998 112.47 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 70' ' ' THR . 64.3 p -103.36 -32.33 9.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 71.219999999999999 111.882 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 27.95 62.1 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.293 -0.723 . . . . 62.119999999999997 111.293 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.595 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 72.2 p -103.81 -34.85 8.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 111.222 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.98 -30.59 4.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 111.663 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 4.7 ptm180 -81.21 -37.42 28.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.043 0.449 . . . . 73.299999999999997 110.045 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 65.38 79.36 0.19 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.945 -0.57 . . . . 61.109999999999999 113.029 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.62 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 66.9 -130.97 30.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.022 -0.609 . . . . 55.109999999999999 112.745 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 55.55 22.19 4.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.105 0.562 . . . . 62.350000000000001 111.521 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -72.79 -12.6 61.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.712 -0.676 . . . . 53.049999999999997 110.868 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.418 HD12 ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -71.18 -51.96 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.389 -0.369 . . . . 72.319999999999993 110.424 178.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.521 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 97.7 m-85 -77.64 -34.16 53.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.795 0.807 . . . . 74.109999999999999 109.105 175.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.12 -78.84 0.24 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.606 -1.179 . . . . 71.109999999999999 112.104 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -135.99 -168.57 2.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.786 0.327 . . . . 64.230000000000004 110.977 -175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 5.1 pm0 -76.41 166.43 23.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 71.239999999999995 111.532 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' HZ ' ' HB3' ' A' ' 78' ' ' TYR . 73.9 m-85 -132.38 -44.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.814 -0.63 . . . . 74.319999999999993 110.398 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -163.47 156.33 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.679 -0.859 . . . . 63.310000000000002 108.679 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ASP . 2.4 p-10 -74.81 125.11 28.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.352 -0.61 . . . . 74.329999999999998 109.352 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -98.36 20.79 12.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.048 0.451 . . . . 73.200000000000003 110.31 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -68.75 100.93 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.696 . . . . 74.109999999999999 110.952 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -156.45 77.04 4.36 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.981 -0.554 . . . . 74.310000000000002 109.926 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.39 93.59 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.552 2.168 . . . . 42.240000000000002 112.077 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.41 -10.19 58.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.248 1.023 . . . . 65.439999999999998 109.195 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.6 OUTLIER -108.16 174.17 5.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.597 -1.183 . . . . 73.019999999999996 109.306 178.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 93' ' ' THR . 32.6 ttpt -131.28 145.1 51.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.067 -0.346 . . . . 74.510000000000005 110.067 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -55.59 126.44 25.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.36 0.6 . . . . 74.349999999999994 109.571 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LYS . 20.7 p -127.04 -45.46 1.56 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.539 -0.755 . . . . 64.329999999999998 110.262 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.32 -144.75 4.07 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.344 -0.844 . . . . 42.039999999999999 111.304 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.92 145.47 25.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 110.77 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.63 21.83 6.64 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.732 -0.747 . . . . 64.439999999999998 111.906 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.3 mm -86.8 111.21 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.487 -0.561 . . . . 70.349999999999994 109.487 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.777 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.92 122.03 30.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 72.349999999999994 109.824 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.23 170.65 14.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.84 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.829 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 39.5 ttp -103.64 144.15 31.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.916 0.389 . . . . 73.209999999999994 110.063 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -98.74 151.74 20.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.127 0.489 . . . . 75.239999999999995 110.547 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -161.0 169.79 21.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 74.319999999999993 109.61 -172.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.13 -27.48 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.418 0.627 . . . . 51.310000000000002 110.545 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.85 174.82 32.33 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 109.594 -1.402 . . . . 42.439999999999998 109.594 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.48 -46.85 19.29 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.303 2.669 . . . . 71.109999999999999 112.692 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 8.4 p-10 -100.88 -12.95 18.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.385 -0.37 . . . . 64.420000000000002 111.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 1.3 m -83.17 50.31 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.499 0.666 . . . . 73.319999999999993 109.411 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.693 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 22.5 m120 -70.94 141.29 51.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.893 -1.049 . . . . 74.239999999999995 110.9 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.17 -169.78 12.69 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.127 -0.789 . . . . 41.130000000000003 111.127 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.597 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . 24.4 p -94.53 6.69 48.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.367 0.584 . . . . 75.030000000000001 111.469 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 23.3 mt-30 -72.79 161.59 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 64.430000000000007 109.68 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -141.75 171.35 14.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.666 -0.414 . . . . 74.230000000000004 111.268 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.17 150.87 18.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.04 -0.527 . . . . 65.140000000000001 110.195 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.661 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.73 141.78 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.462 -0.57 . . . . 61.130000000000003 109.462 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -95.37 129.08 42.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.166 0.508 . . . . 72.439999999999998 110.318 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 62' ' ' ILE . 61.6 mt -87.14 -3.2 59.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 72.439999999999998 110.662 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.33 163.37 24.37 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.763 -0.653 . . . . 75.150000000000006 110.062 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.31 125.42 15.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.595 2.197 . . . . 73.219999999999999 111.845 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.3 p -114.5 140.87 48.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.394 -0.367 . . . . 74.209999999999994 111.247 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -137.01 24.47 3.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 111.003 174.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -120.72 -8.87 9.42 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.374 0.509 . . . . 63.439999999999998 112.374 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.5 pp -127.72 4.42 6.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.745 -0.382 . . . . 73.400000000000006 111.745 -173.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 1.4 m-20 -71.51 -22.45 61.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.823 -0.626 . . . . 60.43 110.334 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.81 7.87 55.7 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.928 -0.869 . . . . 73.540000000000006 110.928 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.7 mmtm -112.16 -33.2 6.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 72.319999999999993 109.426 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.462 ' ND1' ' HA ' ' A' ' 101' ' ' ALA . 58.4 m-70 -135.57 137.54 42.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.29 -0.868 . . . . 73.230000000000004 109.418 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.3 t -78.54 146.54 34.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.39 -0.524 . . . . 75.349999999999994 110.255 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 99' ' ' ALA . 51.8 mt -122.28 124.86 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.9 -0.591 . . . . 72.239999999999995 110.279 -175.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.829 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.9 p90 -159.23 73.2 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.633 0.73 . . . . 74.349999999999994 110.725 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.777 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.37 157.27 29.56 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.177 -1.487 . . . . 72.010000000000005 113.732 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.45 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 24.4 mtm180 -137.06 123.69 21.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.34 . . . . 75.340000000000003 110.132 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.66 140.95 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 53.329999999999998 110.906 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 45.1 t -137.34 152.24 49.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.026 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.5 pt20 41.13 31.09 0.13 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.534 1.134 . . . . 74.340000000000003 113.506 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.72 12.71 0.48 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.478 -0.867 . . . . 34.329999999999998 112.426 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -71.5 -34.25 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.799 -0.236 . . . . 54.530000000000001 110.92 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.57 91.76 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.484 -0.865 . . . . 41.350000000000001 111.387 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.5 mmm -71.2 -46.36 61.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.095 -0.335 . . . . 72.439999999999998 110.095 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.493 HG23 HD12 ' A' ' 23' ' ' ILE . 79.9 t -57.07 -31.82 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.236 0.541 . . . . 72.129999999999995 110.4 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -68.39 -52.72 29.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.72 -0.673 . . . . 74.430000000000007 109.901 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.605 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.97 -8.57 56.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 72.510000000000005 111.023 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 20' ' ' MET . 56.0 t -87.99 -43.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.265 0.555 . . . . 71.010000000000005 109.808 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -77.9 -37.54 29.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.608 -0.806 . . . . 75.349999999999994 112.78 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 24.0 ptm -73.86 -27.52 61.12 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.597 0.221 . . . . 62.240000000000002 111.597 -173.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.01 117.41 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.140000000000001 111.077 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.788 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 mp0 -87.39 -72.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.011 -0.995 . . . . 71.409999999999997 109.933 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 11.0 p -122.38 151.04 41.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.121 -0.945 . . . . 71.129999999999995 110.602 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -74.25 -43.6 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.919 -0.312 . . . . 72.329999999999998 111.204 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.8 m -158.63 -52.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.38 0.61 . . . . 73.340000000000003 110.0 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -92.65 -173.44 3.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 74.349999999999994 109.945 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.39 56.38 1.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.03 0.919 . . . . 72.299999999999997 109.875 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 0.9 OUTLIER -141.95 118.51 7.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.87 -1.059 . . . . 74.340000000000003 109.143 175.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 32.7 Cg_exo -62.33 153.71 68.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.655 2.237 . . . . 70.120000000000005 112.389 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.83 90.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.639 -0.875 . . . . 65.239999999999995 108.639 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.52 21.48 4.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.594 -0.73 . . . . 71.239999999999995 112.827 -166.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -137.09 109.4 7.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.792 0.806 . . . . 43.140000000000001 111.497 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 53' ' ' PHE . 6.1 p -159.62 117.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.123 0.963 . . . . 63.229999999999997 109.876 171.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.76 168.46 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.859 -1.064 . . . . 64.329999999999998 110.524 -172.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.473 HG13 HG22 ' A' ' 18' ' ' THR . 3.4 mp -87.14 115.59 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.983 -0.747 . . . . 71.25 108.983 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 161' ' ' LYS . 31.0 mm -75.56 -62.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.368 -0.833 . . . . 73.420000000000002 110.973 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.655 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -129.68 135.64 48.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.811 0.339 . . . . 71.319999999999993 110.266 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -131.92 133.87 45.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 62.240000000000002 111.023 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 21.8 p90 -152.93 147.49 19.13 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 72.140000000000001 110.673 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 15.0 Cg_exo -70.16 152.27 67.16 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.128 2.552 . . . . 72.040000000000006 113.119 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.5 t -87.89 151.78 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 64.319999999999993 109.89 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -93.1 53.52 2.52 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.843 -0.694 . . . . 53.210000000000001 112.934 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.41 -116.68 3.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.713 -0.755 . . . . 63.210000000000001 112.355 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -158.44 -178.64 32.66 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.956 -0.64 . . . . 33.509999999999998 111.963 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.11 102.98 2.99 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.697 . . . . 74.099999999999994 112.239 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.3 t -93.98 92.31 7.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 71.329999999999998 110.156 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.07 -83.99 1.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.707 -0.758 . . . . 73.310000000000002 111.753 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.93 -146.89 20.73 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.695 -0.764 . . . . 64.120000000000005 112.273 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 76.76 -154.18 43.21 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.867 -0.682 . . . . 71.510000000000005 111.856 -177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.0 t -130.69 121.82 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.389 . . . . 51.329999999999998 110.345 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -119.48 18.68 10.04 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.05 -0.595 . . . . 72.109999999999999 111.62 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.5 -92.24 0.42 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.89 -0.672 . . . . 42.140000000000001 112.007 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.0 27.34 0.63 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.131 -0.557 . . . . 62.409999999999997 111.881 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 62.9 m -158.13 154.6 27.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.118 -0.327 . . . . 53.140000000000001 110.118 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 132.47 133.91 3.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.716 -0.754 . . . . 72.129999999999995 112.174 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.69 56.44 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 65.510000000000005 111.711 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 61.1 4.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.095 -0.574 . . . . 33.509999999999998 112.945 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.3 p -95.28 -15.88 22.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.135 0.493 . . . . 74.549999999999997 110.255 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.03 -104.0 2.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.658 -0.701 . . . . 63.399999999999999 111.943 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.2 m-20 -99.86 178.13 4.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.304 0.573 . . . . 45.409999999999997 111.237 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 165.92 143.65 3.81 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.311 -0.859 . . . . 45.229999999999997 111.205 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.2 -171.53 41.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.579 -0.82 . . . . 60.030000000000001 111.954 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.815 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.26 167.02 22.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.033 -0.358 . . . . 51.439999999999998 110.033 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.515 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.2 m-85 -110.81 97.15 32.26 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 71.549999999999997 111.218 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 90' ' ' LEU . 57.7 Cg_endo -75.03 -4.78 15.91 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.61 2.207 . . . . 62.43 112.791 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.18 -31.61 58.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 64.310000000000002 110.782 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 188' ' ' PHE . 13.3 pt -79.89 -17.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.040000000000006 111.929 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 17.2 m170 67.99 33.22 4.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 111.892 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 191' ' ' ILE . 4.9 p -136.57 149.85 27.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.658 0.266 . . . . 75.140000000000001 110.797 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 115.82 9.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.272 0.558 . . . . 65.25 112.155 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -156.57 159.34 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.504 -0.924 . . . . 72.0 108.504 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -132.23 145.24 56.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 120.547 -0.461 . . . . 74.219999999999999 111.585 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -67.4 -68.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.402 2.068 . . . . 73.239999999999995 111.693 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -126.24 24.88 6.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 110.621 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 75.39 -10.0 1.31 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.914 1.079 . . . . 74.319999999999993 113.914 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -55.42 -27.74 49.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.322 0.49 . . . . 71.519999999999996 112.322 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.81 -0.23 89.72 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.843 -0.694 . . . . 62.43 112.879 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.46 -33.47 48.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 111.135 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.3 -0.857 . . . . 74.340000000000003 110.183 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.304 0.097 . . . . 74.230000000000004 111.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 78.13 0.3 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.21 0.529 . . . . 62.020000000000003 110.903 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.22 -57.14 2.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.593 -0.731 . . . . 51.509999999999998 110.451 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 78' ' ' TYR . 54.0 mt -113.3 116.17 46.79 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.831 . . . . 73.099999999999994 109.313 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 40.2 Cg_exo -57.13 119.73 7.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.494 2.796 . . . . 74.200000000000003 113.823 -170.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.1 Cg_exo -79.7 -24.99 5.68 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.913 2.408 . . . . 74.129999999999995 111.41 171.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.91 35.84 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 74.540000000000006 110.95 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -55.32 111.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.008 0.432 . . . . 74.019999999999996 110.833 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -90.36 9.33 29.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.891 -0.595 . . . . 72.400000000000006 111.117 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 1.3 mp0 -60.84 141.84 92.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.938 -1.028 . . . . 74.230000000000004 111.092 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 18.0 Cg_endo -61.97 150.75 85.09 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.554 2.17 . . . . 71.310000000000002 112.012 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -4.87 16.17 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.999 2.466 . . . . 62.039999999999999 113.744 -175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -128.98 144.2 51.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.885 0.374 . . . . 74.439999999999998 110.577 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 34.4 m -137.48 147.38 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.092 0.472 . . . . 74.430000000000007 110.854 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CD1' ' HB3' ' A' ' 165' ' ' SER . 13.3 m-85 -103.45 132.18 49.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.777 -0.647 . . . . 74.409999999999997 110.831 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD12 HG21 ' A' ' 159' ' ' ILE . 3.4 mm? -114.58 104.81 12.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.041 -0.527 . . . . 54.549999999999997 109.749 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.28 115.46 28.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.278 -0.638 . . . . 74.329999999999998 109.278 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -107.12 178.92 4.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 75.109999999999999 111.738 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.4 p -75.25 -10.08 59.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.724 -0.671 . . . . 44.109999999999999 110.798 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.5 mmt -94.46 -42.11 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.654 . . . . 53.119999999999997 109.932 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.83 -116.51 0.51 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.474 -0.785 . . . . 73.030000000000001 111.336 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -150.54 138.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.063 0.459 . . . . 63.130000000000003 110.477 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -132.28 127.52 57.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.686 -0.688 . . . . 74.099999999999994 109.571 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 8.5 t -113.62 147.45 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.855 -0.424 . . . . 62.219999999999999 109.855 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.37 163.5 39.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.984 0.421 . . . . 62.219999999999999 110.652 174.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 131' ' ' ARG . 1.8 pt-20 -129.76 163.0 27.16 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.653 -0.703 . . . . 73.450000000000003 110.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.23 161.92 13.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 71.439999999999998 110.509 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.478 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 2.7 m-85 -88.32 100.26 12.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 74.510000000000005 111.635 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -85.89 7.06 25.58 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.002 -0.74 . . . . 73.230000000000004 109.002 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 4.4 mptp? -78.01 -57.34 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.753 -1.112 . . . . 73.530000000000001 111.54 -176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -132.31 14.96 4.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.423 -0.353 . . . . 72.420000000000002 111.81 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.53 80.42 71.95 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.787 -0.449 . . . . 55.439999999999998 109.787 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.606 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 59.4 Cg_endo -73.19 -25.18 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.445 2.096 . . . . 71.109999999999999 113.729 -171.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -100.66 -33.69 10.18 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.126 -0.63 . . . . 74.439999999999998 111.637 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.65 95.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.177 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -57.62 -51.62 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 63.140000000000001 111.017 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 67.6 mttt -66.73 -41.71 87.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.829 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.03 -47.86 74.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.819 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.417 ' HE1' HG21 ' A' ' 14' ' ' VAL . 32.7 t80 -67.64 -50.96 55.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.246 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.36 80.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.32 -0.855 . . . . 52.539999999999999 111.663 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.63 -47.66 82.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.891 -0.595 . . . . 72.319999999999993 110.32 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 3.5 mm? -66.33 -27.55 67.99 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.113 -0.494 . . . . 73.030000000000001 111.07 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.55 52.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.84 -0.618 . . . . 60.130000000000003 110.91 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HG2' ' HG3' ' A' ' 10' ' ' GLN . 6.6 ppt_? -73.74 -26.09 60.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.903 -0.406 . . . . 75.430000000000007 109.903 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -60.46 -47.6 85.43 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.83 -0.623 . . . . 75.430000000000007 109.587 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.51 20.51 6.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.486 -0.864 . . . . 62.229999999999997 113.575 170.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -79.58 -11.2 59.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.201 0.501 . . . . 75.140000000000001 111.359 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HA ' HG23 ' A' ' 51' ' ' THR . 95.6 m-85 -85.11 -4.84 59.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.893 0.378 . . . . 64.530000000000001 110.967 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 38.6 m-80 -77.9 4.95 10.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.269 0.557 . . . . 71.439999999999998 110.046 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.77 21.22 2.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.707 -0.679 . . . . 53.420000000000002 111.698 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.945 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 28.8 p -96.0 152.61 18.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.555 0.217 . . . . 64.239999999999995 110.702 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 3.7 mtmt -134.94 155.94 49.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.522 -0.308 . . . . 74.420000000000002 110.512 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' A' ' 157' ' ' VAL . 97.5 m-85 -92.43 113.79 26.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 72.049999999999997 109.0 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -112.83 -24.01 9.81 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.519 -0.473 . . . . 75.549999999999997 112.257 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 27.2 mmm180 -114.49 106.21 14.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.248 -0.581 . . . . 52.140000000000001 110.148 177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -124.57 92.86 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.102 -0.703 . . . . 34.32 109.102 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.4 mt -98.32 122.18 49.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 42.1 mtpt -56.94 127.71 33.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.297 0.373 . . . . 72.140000000000001 111.635 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 56.17 32.89 21.03 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.123 -0.944 . . . . 73.109999999999999 111.373 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.3 t80 -130.97 -82.67 0.53 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.267 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.9 ptt? -161.64 157.61 24.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.702 -0.681 . . . . 74.129999999999995 110.205 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.637 HG23 HG13 ' A' ' 56' ' ' ILE . 29.0 mt -131.99 108.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 60.030000000000001 109.79 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.2 tt0 -79.5 124.16 28.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.314 -0.403 . . . . 54.439999999999998 110.074 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -133.96 127.78 4.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.437 -0.665 . . . . 63.399999999999999 111.437 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.945 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 139.17 -155.45 23.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.07 -1.062 . . . . 64.329999999999998 112.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 111' ' ' GLN . 22.3 t0 53.74 96.15 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.741 0.817 . . . . 73.409999999999997 112.324 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.11 -16.49 44.75 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.334 2.023 . . . . 72.209999999999994 112.606 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 70' ' ' THR . 48.5 p -93.6 -36.07 12.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 64.329999999999998 110.683 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 18.8 75.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.095 -0.574 . . . . 72.140000000000001 112.696 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 68' ' ' THR . 9.9 t -111.64 -10.32 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 75.230000000000004 111.563 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.73 35.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.2 -1.0 . . . . 41.030000000000001 112.986 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -86.46 -47.63 9.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 61.130000000000003 111.02 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.51 173.41 32.32 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.42 -0.809 . . . . 63.43 111.421 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.0 -10.68 58.44 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 120.719 -0.753 . . . . 52.020000000000003 112.181 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -55.92 -77.36 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.971 -0.615 . . . . 73.519999999999996 112.074 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 m 59.27 15.39 4.24 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.186 -0.461 . . . . 64.010000000000005 111.497 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 pt -68.4 -17.21 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.592 0.71 . . . . 74.140000000000001 110.445 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HA ' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -95.2 -12.33 26.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.727 -1.124 . . . . 73.510000000000005 111.147 -177.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.58 -76.77 1.3 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.241 -0.505 . . . . 50.240000000000002 112.464 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -87.47 -156.17 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.576 -0.527 . . . . 74.200000000000003 109.576 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.78 174.38 1.44 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 73.040000000000006 110.559 172.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 106' ' ' ASP . 26.2 t80 -118.17 -175.09 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.271 -0.422 . . . . 74.299999999999997 110.218 -172.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -76.48 121.36 23.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 74.329999999999998 110.645 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 7.8 p-10 -76.77 86.44 3.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.869 0.842 . . . . 74.349999999999994 109.066 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.48 39.53 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.313 -0.858 . . . . 74.230000000000004 109.555 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.484 HD23 ' HB ' ' A' ' 127' ' ' THR . 15.5 mt -69.26 98.98 1.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.381 -1.281 . . . . 71.439999999999998 110.63 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -162.07 83.47 1.69 Allowed Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.725 -0.67 . . . . 73.129999999999995 109.867 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.891 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 28.6 Cg_endo -62.28 82.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 123.154 2.57 . . . . 73.209999999999994 112.209 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.45 -25.83 54.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.409 -0.814 . . . . 72.349999999999994 109.682 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.6 pp -85.17 -179.96 7.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 72.150000000000006 109.796 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -124.42 141.23 52.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.46 -0.496 . . . . 65.209999999999994 110.672 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.66 72.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.664 0.745 . . . . 71.019999999999996 110.006 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -66.4 -37.86 86.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.773 -1.103 . . . . 73.329999999999998 112.575 -171.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' H ' HD11 ' A' ' 97' ' ' ILE . . . -166.42 -140.93 3.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.361 -0.923 . . . . 51.450000000000003 112.758 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' SD ' ' A' ' 200' ' ' MET . . . -91.1 137.49 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.751 0.31 . . . . 74.409999999999997 110.686 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.48 23.35 5.74 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.669 -0.777 . . . . 41.43 111.852 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 94' ' ' GLY . 11.0 mm -85.41 109.6 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.346 -0.612 . . . . 72.319999999999993 109.346 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -86.3 118.41 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.212 0.529 . . . . 62.340000000000003 109.774 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -125.04 168.12 13.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.053 -0.521 . . . . 62.200000000000003 110.847 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.6 ttt -91.71 132.77 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.191 -0.459 . . . . 75.450000000000003 109.805 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 111' ' ' GLN . . . -96.26 141.08 30.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.01 -0.367 . . . . 63.119999999999997 110.01 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -150.38 165.35 33.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.147 -0.479 . . . . 72.450000000000003 110.792 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -69.55 -46.66 65.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.845 -0.616 . . . . 73.299999999999997 110.296 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.94 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.472 -0.87 . . . . 71.400000000000006 112.715 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.28 89.43 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.918 2.412 . . . . 54.210000000000001 112.193 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 p30 50.13 29.37 3.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.317 -0.856 . . . . 74.200000000000003 111.571 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 m -96.58 55.51 1.43 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.113 -1.069 . . . . 65.030000000000001 108.113 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -92.85 137.15 32.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.995 -1.457 . . . . 71.030000000000001 110.096 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.21 -107.8 0.76 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.231 -0.985 . . . . 73.310000000000002 113.616 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.8 p -127.28 56.43 1.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.546 0.688 . . . . 64.319999999999993 110.601 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 66' ' ' ASP . 18.8 mp0 -130.32 147.3 52.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.18 -0.918 . . . . 64.209999999999994 110.136 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -139.78 169.3 17.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.769 -0.456 . . . . 73.409999999999997 109.769 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -155.79 147.87 23.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.87 0.367 . . . . 63.549999999999997 110.296 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.8 t -111.54 140.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.885 -0.598 . . . . 50.439999999999998 109.391 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -94.86 128.81 41.89 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.853 0.359 . . . . 62.329999999999998 110.14 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD11 ' HA3' ' A' ' 143' ' ' GLY . 67.6 mt -83.62 -8.71 59.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.764 -0.653 . . . . 70.010000000000005 110.168 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.42 156.58 34.91 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.164 -0.926 . . . . 61.399999999999999 109.679 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.35 124.58 14.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.503 2.135 . . . . 52.32 112.236 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 p -123.99 122.12 37.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.405 . . . . 61.340000000000003 110.234 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 5.18 31.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.716 0.293 . . . . 73.319999999999993 111.373 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.611 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -108.39 -3.1 18.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.611 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.9 mt -102.04 3.74 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 111.371 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.891 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 p-10 -70.67 -15.2 62.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.68 -0.691 . . . . 73.409999999999997 111.155 -172.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.86 15.96 9.53 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.329 -0.709 . . . . 65.420000000000002 111.329 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.66 -41.31 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.271 0.558 . . . . 72.209999999999994 110.109 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -142.31 126.1 17.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.005 -1.109 . . . . 75.030000000000001 108.005 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.484 ' HB ' HD23 ' A' ' 86' ' ' LEU . 11.3 t -72.22 143.11 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.669 -0.812 . . . . 72.340000000000003 110.459 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' ALA . 40.4 mt -114.87 119.94 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.57 -0.741 . . . . 71.450000000000003 110.54 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.3 m-85 -157.23 75.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.318 0.387 . . . . 75.299999999999997 110.138 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.66 158.24 30.38 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.585 -0.817 . . . . 75.120000000000005 112.611 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 11.4 mtp180 -135.12 114.98 12.91 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.719 -0.475 . . . . 75.209999999999994 109.719 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 96' ' ' GLY . 14.3 p -79.86 130.6 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.37 0.605 . . . . 73.420000000000002 110.068 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.662 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 87.7 m -140.5 140.12 35.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.765 -0.652 . . . . 62.450000000000003 110.576 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 54.67 42.33 31.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.124 0.488 . . . . 64.5 111.764 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 41.58 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.43 -0.89 . . . . 54.130000000000003 111.99 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.0 tp -90.77 -34.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.59 0.233 . . . . 65.120000000000005 111.011 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.92 -35.87 91.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.807 -0.711 . . . . 64.519999999999996 111.624 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -68.34 -51.2 47.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 54.32 110.337 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.505 HG13 HD12 ' A' ' 62' ' ' ILE . 98.5 t -55.03 -31.12 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.296 0.57 . . . . 75.439999999999998 110.789 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.93 -55.01 10.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.819 -0.628 . . . . 61.219999999999999 110.681 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -17.66 62.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.367 -0.379 . . . . 72.439999999999998 111.213 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 145' ' ' VAL . 55.0 t -84.3 -37.75 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.1 0.476 . . . . 74.319999999999993 109.934 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -83.38 -7.5 86.44 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.775 -0.726 . . . . 74.0 113.002 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.33 -1.06 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.755 -0.378 . . . . 71.209999999999994 111.294 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 142' ' ' VAL . 33.0 m -63.39 154.72 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.971 0.415 . . . . 72.340000000000003 111.242 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -90.43 -159.66 0.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.503 0.668 . . . . 71.140000000000001 110.34 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 p -107.57 131.87 53.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.189 -0.914 . . . . 64.540000000000006 110.783 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 1.078 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 46.2 t30 -69.23 -73.6 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.492 -0.776 . . . . 75.239999999999995 110.851 -173.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -87.72 -75.4 0.41 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 74.510000000000005 110.668 -177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.03 -81.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.114 0.483 . . . . 71.0 110.978 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -111.67 7.65 20.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.439999999999998 109.785 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -105.02 139.79 20.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.436 -0.802 . . . . 65.129999999999995 110.19 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.7 149.56 82.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.926 2.417 . . . . 73.099999999999994 112.023 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.078 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 70.4 t -57.35 -61.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.226 -0.443 . . . . 63.200000000000003 111.919 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -106.87 113.37 26.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.947 0.403 . . . . 54.100000000000001 111.504 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.47 103.31 9.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 109.38 174.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p -96.16 139.95 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.139 0.495 . . . . 62.140000000000001 111.374 -176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -121.94 162.88 20.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 60.439999999999998 109.533 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.626 HG21 HD12 ' A' ' 16' ' ' LEU . 3.5 mp -88.9 103.27 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.445 -0.946 . . . . 73.109999999999999 108.445 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 161' ' ' LYS . 32.1 mm -66.81 -56.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.479 -0.782 . . . . 74.519999999999996 110.636 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 3.5 mptp? -128.92 137.25 51.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 64.019999999999996 110.374 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.19 27.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.209 -0.451 . . . . 62.140000000000001 110.242 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -148.22 135.36 10.46 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.767 -0.651 . . . . 72.200000000000003 110.723 -173.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.68 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 59.8 Cg_endo -72.78 139.38 30.5 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.706 2.271 . . . . 71.519999999999996 112.044 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.544 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 16.9 t -169.7 -157.31 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.6 -0.518 . . . . 70.430000000000007 109.6 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.51 71.46 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.992 -0.623 . . . . 64.310000000000002 112.049 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -131.61 29.77 3.37 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 61.299999999999997 112.515 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.75 122.42 5.71 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 64.239999999999995 112.316 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.24 151.39 17.93 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.907 -0.663 . . . . 74.299999999999997 111.823 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.766 ' HB3' ' HA ' ' A' ' 182' ' ' SER . 64.2 m -139.46 31.97 2.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.842 0.321 . . . . 62.039999999999999 110.86 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -78.2 63.95 3.52 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.825 -0.702 . . . . 60.130000000000003 112.695 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.34 156.35 15.66 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.448 -0.661 . . . . 52.200000000000003 111.448 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.96 110.0 1.23 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.306 -0.95 . . . . 43.020000000000003 113.114 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.5 p -117.59 98.58 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.144 0.497 . . . . 64.340000000000003 110.123 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.12 -158.09 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.984 -0.627 . . . . 72.209999999999994 112.477 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.5 -66.35 3.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.25 -0.5 . . . . 74.549999999999997 112.024 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.31 -92.09 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.174 -0.536 . . . . 43.049999999999997 111.83 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.4 m -98.6 152.42 19.62 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.983 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.86 -121.81 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.082 -0.58 . . . . 55.25 111.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.73 -69.72 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.805 -0.712 . . . . 44.43 112.107 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.26 8.53 85.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.917 -0.659 . . . . 74.409999999999997 112.078 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.766 ' HA ' ' HB3' ' A' ' 170' ' ' SER . 56.3 m -155.86 167.31 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.838 -0.43 . . . . 51.240000000000002 109.838 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.46 -124.53 5.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.734 -0.745 . . . . 65.530000000000001 111.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.29 174.27 6.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.732 0.777 . . . . 74.0 110.913 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 144.67 144.05 4.11 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.574 -1.194 . . . . 72.310000000000002 110.863 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.59 -167.9 44.2 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.27 -0.967 . . . . 62.32 111.659 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 189' ' ' PRO . . . -75.43 163.54 27.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.228 -0.656 . . . . 65.409999999999997 109.228 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -102.24 103.29 29.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.19 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 6.0 Cg_exo -77.43 -18.46 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.776 2.318 . . . . 64.239999999999995 111.298 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.87 -33.59 62.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 75.030000000000001 110.238 -172.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -89.22 157.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -106.82 89.68 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.057 -0.657 . . . . 74.150000000000006 110.638 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 194' ' ' ALA . 6.1 p -158.08 -171.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.626 -0.879 . . . . 71.120000000000005 108.626 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.745 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -123.45 117.61 25.54 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 122.188 -0.32 . . . . 72.310000000000002 110.669 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -156.45 155.27 31.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.864 -0.421 . . . . 62.109999999999999 109.864 177.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -117.31 149.24 44.23 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.458 -0.337 . . . . 73.519999999999996 110.546 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.533 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.8 Cg_endo -67.31 -65.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.408 2.072 . . . . 63.119999999999997 112.108 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.9 27.54 4.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.635 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 72.59 5.02 5.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.52 -0.764 . . . . 65.439999999999998 112.687 173.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 201' ' ' GLY . 2.0 ppp? -63.58 -50.4 69.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.102 0.408 . . . . 60.25 112.102 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.487 ' N ' ' SD ' ' A' ' 200' ' ' MET . . . -75.75 15.34 4.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.263 -0.494 . . . . 71.409999999999997 114.148 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -81.78 -17.05 48.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 72.140000000000001 110.464 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.252 1.204 0 CA-C-N 114.872 -1.058 . . . . 73.129999999999995 110.945 178.524 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.931 -0.396 . . . . 74.439999999999998 109.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.76 168.59 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.834 -0.432 . . . . 72.530000000000001 109.834 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.31 -57.16 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 65.430000000000007 110.758 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 78' ' ' TYR . 60.1 mt -122.76 131.63 24.35 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.833 -0.621 . . . . 61.219999999999999 110.643 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.65 127.25 17.58 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.733 2.289 . . . . 64.400000000000006 112.023 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 -36.5 85.56 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.31 . . . . 73.030000000000001 112.063 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.96 136.64 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.929 -0.578 . . . . 73.450000000000003 109.957 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 t -179.84 159.41 0.83 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 74.239999999999995 109.488 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -97.32 -29.51 13.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.306 -0.406 . . . . 71.140000000000001 110.552 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.488 ' HG3' ' HD2' ' A' ' 44' ' ' ARG . 1.2 mp0 67.72 135.88 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 O-C-N 123.653 0.596 . . . . 74.540000000000006 112.151 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 34.4 Cg_exo -60.17 132.43 44.19 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.718 2.279 . . . . 52.399999999999999 112.023 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 56.6 Cg_endo -71.55 -16.98 30.4 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.84 2.36 . . . . 73.310000000000002 113.534 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.505 HD21 HG12 ' A' ' 24' ' ' VAL . 22.2 t-20 -132.51 147.8 52.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.252 -0.431 . . . . 63.240000000000002 110.092 -174.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.9 m -139.04 152.02 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.257 0.551 . . . . 65.420000000000002 111.438 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HD1' HG22 ' A' ' 24' ' ' VAL . 97.4 m-85 -102.94 121.31 42.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.079 -0.964 . . . . 72.25 110.743 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -108.09 103.07 12.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.805 0.336 . . . . 73.420000000000002 110.307 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -85.15 122.45 29.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.228 -0.656 . . . . 64.319999999999993 109.228 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -114.97 176.61 4.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.212 0.529 . . . . 71.439999999999998 112.041 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 160' ' ' ILE . 32.7 t -75.51 -1.6 25.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.606 -0.725 . . . . 71.430000000000007 110.565 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mmt -107.2 -39.7 5.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.814 -0.63 . . . . 74.329999999999998 110.274 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.64 -126.41 0.98 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.232 -0.747 . . . . 63.219999999999999 111.232 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -139.84 137.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.035 0.445 . . . . 74.140000000000001 109.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -120.93 118.03 54.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.77 -0.65 . . . . 73.400000000000006 109.677 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 15' ' ' TYR . 46.5 t -106.16 131.18 56.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.82 -0.437 . . . . 75.010000000000005 109.82 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.66 164.57 33.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.997 0.427 . . . . 73.349999999999994 110.414 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 12.2 pt-20 -135.5 166.56 22.91 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.774 -0.648 . . . . 72.219999999999999 109.876 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -103.52 160.03 15.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.495 -0.557 . . . . 64.5 109.495 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -83.89 91.58 7.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 72.319999999999993 111.962 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.653 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 78.9 m95 -84.22 6.48 22.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.607 -0.724 . . . . 72.430000000000007 110.314 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -73.6 -63.03 1.29 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.609 -0.723 . . . . 71.219999999999999 110.495 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.419 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 37.6 m80 -131.07 16.2 5.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.083 0.401 . . . . 73.310000000000002 112.083 -176.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -133.83 56.95 21.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.024 -0.27 . . . . 74.219999999999999 110.983 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 14.0 Cg_exo -68.82 -25.9 32.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.442 2.094 . . . . 73.299999999999997 112.023 -175.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -66.44 -54.23 26.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 53.350000000000001 110.176 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.651 ' HB ' ' CE2' ' A' ' 129' ' ' PHE . 1.6 p -64.16 -40.23 95.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.182 -0.917 . . . . 63.399999999999999 110.988 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 86.3 m -58.31 -46.78 85.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.079 -0.964 . . . . 62.539999999999999 111.02 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -59.49 -41.39 89.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.422 -0.354 . . . . 63.439999999999998 110.189 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.72 -56.54 20.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 52.130000000000003 110.326 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HE2' ' HB3' ' A' ' 112' ' ' PHE . 3.4 m-85 -66.74 -42.29 86.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.759 -0.655 . . . . 63.149999999999999 111.492 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 10' ' ' GLN . . . -63.93 -41.81 97.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.455 -0.339 . . . . 54.25 111.571 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' OE1' HG23 ' A' ' 4' ' ' ILE . 33.5 tt0 -61.39 -43.67 98.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.024 0.44 . . . . 75.219999999999999 110.198 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.541 ' CD1' ' HB3' ' A' ' 110' ' ' SER . 35.3 mt -70.59 -24.46 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.873 -0.603 . . . . 71.209999999999994 111.97 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.75 86.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.005 -0.543 . . . . 73.329999999999998 110.313 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.488 ' HD2' ' HG3' ' A' ' 10' ' ' GLN . 74.5 mtp180 -75.56 -34.28 60.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 74.519999999999996 109.927 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 14.3 tpp180 -64.83 -46.75 80.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 75.439999999999998 110.273 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.38 28.87 5.0 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.926 -0.654 . . . . 50.329999999999998 113.075 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.76 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 5.2 m-85 -87.15 -2.92 58.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 111.674 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -76.42 -12.69 60.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 75.349999999999994 110.303 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.45 3.16 19.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.22 0.533 . . . . 75.019999999999996 109.91 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -131.69 15.4 5.18 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.694 -0.684 . . . . 74.030000000000001 112.253 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.559 HG22 ' HD3' ' A' ' 67' ' ' PRO . 13.6 p -98.63 138.03 36.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.837 0.318 . . . . 61.149999999999999 110.497 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' CG ' ' HG3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -128.71 124.5 35.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.418 -0.355 . . . . 75.109999999999999 110.427 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 96.2 m-85 -70.06 103.34 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.412 -0.588 . . . . 74.25 109.412 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -114.25 -15.43 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.031 -0.668 . . . . 64.25 112.06 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 11.3 mmt180 -105.42 101.61 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.982 -0.687 . . . . 74.329999999999998 109.597 175.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG13 HG23 ' A' ' 62' ' ' ILE . 4.2 mp -125.87 95.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.018 -0.734 . . . . 63.049999999999997 109.018 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 44.0 mt -91.88 127.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 109.184 -0.673 . . . . 62.030000000000001 109.184 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -48.72 111.41 0.46 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.99 0.806 . . . . 72.299999999999997 112.133 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' HD2' ' A' ' 203' ' ' LYS . 43.2 m-20 56.4 39.66 29.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.112 -0.949 . . . . 65.450000000000003 111.307 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.84 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 9.7 t80 -128.59 -76.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.813 -0.631 . . . . 73.219999999999999 109.987 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.401 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.4 ptt? -160.59 155.59 24.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 72.519999999999996 110.673 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 56' ' ' ILE . 49.0 mt -128.41 105.28 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 73.230000000000004 109.48 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 39.6 tt0 -85.49 127.2 34.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.739 -0.664 . . . . 74.040000000000006 111.893 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.39 117.38 4.62 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.454 -1.058 . . . . 31.440000000000001 110.454 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.24 146.59 33.43 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 114.423 0.529 . . . . 53.43 114.423 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 64.9 t0 -46.0 126.73 7.07 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 124.792 1.237 . . . . 74.340000000000003 111.837 174.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD3' HG22 ' A' ' 51' ' ' THR . 29.3 Cg_endo -64.46 -30.77 62.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.177 2.584 . . . . 72.25 112.763 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 70' ' ' THR . 62.7 p -84.1 -32.86 24.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 74.099999999999994 110.061 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.83 70.84 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.51 -0.768 . . . . 71.409999999999997 113.01 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 72' ' ' ARG . 8.8 t -105.52 -26.02 12.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.121 0.46 . . . . 43.420000000000002 111.536 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.97 -5.34 10.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.476 -0.869 . . . . 30.039999999999999 113.223 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.512 ' HG2' HG23 ' A' ' 70' ' ' THR . 8.5 ptm180 -100.85 -23.75 14.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.076 0.438 . . . . 71.5 111.101 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 85.47 175.11 50.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.827 -0.702 . . . . 73.510000000000005 112.098 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.76 ' HA3' ' HD2' ' A' ' 47' ' ' TYR . . . -86.93 28.79 5.33 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.525 0.514 . . . . 70.420000000000002 112.28 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . -93.1 25.13 3.4 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.74 0.781 . . . . 35.200000000000003 110.883 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 55.4 m -75.65 -5.69 46.77 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.089 -0.96 . . . . 62.240000000000002 110.583 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.1 tt -55.62 -40.17 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.562 -0.745 . . . . 74.349999999999994 110.96 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.534 ' HA ' HD11 ' A' ' 4' ' ' ILE . 34.8 p90 -102.12 -9.14 20.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 63.43 111.276 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 76' ' ' SER . . . 126.74 -119.27 3.28 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.24 -0.744 . . . . 74.010000000000005 111.24 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -137.91 146.45 43.33 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.049 0.452 . . . . 64.209999999999994 111.726 176.34 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.437 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 1.7 mp0 38.1 -166.55 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 O-C-N 125.692 1.87 . . . . 64.25 115.294 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB2' ' OD1' ' A' ' 108' ' ' ASN . 20.8 m-85 -154.41 -165.74 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.531 -1.213 . . . . 74.010000000000005 108.446 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.78 160.05 26.31 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.172 -1.048 . . . . 51.5 108.172 171.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.27 123.54 23.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 75.109999999999999 109.993 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.06 31.31 6.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.421 -0.585 . . . . 53.450000000000003 109.421 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' A' ' 127' ' ' THR . 47.9 mt -66.11 98.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.716 . . . . 75.439999999999998 110.319 -176.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -166.06 89.96 0.86 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.898 -0.592 . . . . 71.109999999999999 109.85 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.98 95.36 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.779 2.319 . . . . 54.130000000000003 111.61 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.42 -17.58 61.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.403 1.096 . . . . 74.409999999999997 108.7 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -106.5 170.83 7.7 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.875 -1.511 . . . . 51.32 108.797 175.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 93' ' ' THR . 38.6 ttpt -128.16 142.88 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.843 -0.343 . . . . 71.450000000000003 110.165 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -56.16 122.69 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.433 0.635 . . . . 65.239999999999995 109.369 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -119.48 -45.9 2.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.556 -0.747 . . . . 70.409999999999997 109.771 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.607 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -155.96 -139.27 2.72 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.054 -0.975 . . . . 44.049999999999997 111.389 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.67 144.65 25.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 73.400000000000006 110.844 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.18 24.32 5.47 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.786 -0.721 . . . . 73.040000000000006 112.13 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.403 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.0 mm -86.87 110.79 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.355 -0.609 . . . . 70.040000000000006 109.355 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -86.52 117.4 25.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.731 -0.668 . . . . 74.310000000000002 109.889 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.2 173.32 11.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 54.140000000000001 111.056 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.541 ' HG2' ' N ' ' A' ' 101' ' ' ALA . 28.1 ttm -94.36 148.19 22.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 70.209999999999994 111.281 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' N ' ' HG2' ' A' ' 100' ' ' MET . . . -99.52 122.09 42.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.699 -0.682 . . . . 71.040000000000006 109.222 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.58 165.88 24.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 110.221 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.12 -28.67 14.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.32 0.581 . . . . 53.240000000000002 110.422 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.412 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.23 180.0 29.17 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.651 -1.38 . . . . 61.109999999999999 109.651 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.7 -50.54 12.88 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 64.239999999999995 112.786 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -102.77 -1.83 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.57 -0.286 . . . . 52.420000000000002 111.092 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 81' ' ' GLN . 7.9 m -88.34 53.85 2.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.865 0.84 . . . . 74.25 109.114 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 82' ' ' PHE . 3.7 p30 -82.88 158.46 22.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.289 -1.323 . . . . 63.020000000000003 109.8 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.89 -129.51 1.04 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.445 -0.883 . . . . 24.129999999999999 112.965 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 3.3 p -114.07 -1.09 13.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.002 0.371 . . . . 53.439999999999998 112.002 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 71.9 mt-30 -79.32 150.31 31.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.729 -0.471 . . . . 63.539999999999999 109.729 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' HB3' ' HE2' ' A' ' 39' ' ' PHE . 29.8 p90 -148.11 164.98 32.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.857 -0.337 . . . . 70.209999999999994 110.468 -176.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.2 151.49 29.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.889 0.376 . . . . 75.209999999999994 110.321 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.73 HG22 HD23 ' A' ' 98' ' ' LEU . 15.1 t -110.15 141.42 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.814 -0.63 . . . . 72.510000000000005 109.352 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.3 p -95.14 124.92 39.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.115 0.483 . . . . 63.530000000000001 110.318 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.2 mt -81.83 -8.98 59.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.631 -0.713 . . . . 70.430000000000007 110.569 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.23 42.3 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.386 -0.825 . . . . 35.43 109.801 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.607 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 18.8 Cg_exo -65.98 120.24 7.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.714 2.276 . . . . 53.0 111.934 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -108.43 116.23 31.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 110.476 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.44 11.41 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.106 0.479 . . . . 74.120000000000005 110.903 -174.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.527 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -118.42 0.27 11.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.679 -0.691 . . . . 62.210000000000001 111.138 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 91.2 mt -104.01 10.24 36.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.107 -0.497 . . . . 73.030000000000001 110.511 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -62.73 -22.18 66.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.196 -0.911 . . . . 73.409999999999997 111.496 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.91 21.51 4.66 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.713 -0.756 . . . . 62.340000000000003 111.727 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -117.08 -32.1 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 62.399999999999999 110.23 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.65 131.31 27.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.863 -0.608 . . . . 75.219999999999999 110.319 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.433 ' OG1' HD23 ' A' ' 86' ' ' LEU . 46.1 m -68.31 119.42 12.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.982 0.42 . . . . 71.310000000000002 109.932 171.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 99' ' ' ALA . 46.2 mt -102.47 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.029 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.651 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 15.0 p90 -160.3 71.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 75.420000000000002 111.264 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.83 154.02 24.7 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.611 -1.281 . . . . 42.130000000000003 114.053 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -131.75 118.64 20.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.461 -0.57 . . . . 74.120000000000005 109.461 170.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.06 139.03 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 72.319999999999993 110.459 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 46.0 t -141.51 150.02 41.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.453 -0.339 . . . . 64.519999999999996 110.956 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.9 pt20 39.02 40.02 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.807 1.243 . . . . 73.140000000000001 113.474 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.57 23.07 0.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.874 -0.679 . . . . 44.020000000000003 111.834 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 tp -76.63 -32.88 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.717 0.294 . . . . 73.239999999999995 110.233 -175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.09 87.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.818 -0.706 . . . . 44.140000000000001 111.672 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 78.6 mmm -72.23 -50.07 30.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.414 -0.217 . . . . 74.230000000000004 110.414 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 62' ' ' ILE . 86.6 t -57.77 -28.71 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 71.25 110.565 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.627 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -72.14 -55.29 7.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 51.240000000000002 110.572 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -70.69 -17.3 62.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.128 -0.487 . . . . 70.430000000000007 111.015 -176.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.1 t -87.48 -33.32 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.258 0.552 . . . . 74.439999999999998 109.666 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.77 -13.36 82.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.787 -0.721 . . . . 51.229999999999997 112.687 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.627 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 67.9 mtp -85.17 -2.2 57.75 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.871 -0.194 . . . . 75.140000000000001 111.382 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' A' ' 154' ' ' VAL . 6.1 m -80.81 135.67 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.294 0.568 . . . . 73.420000000000002 110.489 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 147' ' ' THR . 13.0 pt-20 -129.75 -56.53 1.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.576 . . . . 74.25 109.956 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 146' ' ' GLU . 2.9 p -128.78 141.52 51.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.045 0.45 . . . . 70.340000000000003 110.432 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.659 ' HB3' ' HG3' ' A' ' 152' ' ' ARG . 11.7 t-20 -52.32 -60.94 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.888 -1.051 . . . . 62.43 112.168 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 75.1 m -163.45 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.344 -0.984 . . . . 50.539999999999999 108.344 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -93.78 -167.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.758 -1.11 . . . . 61.520000000000003 108.441 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.88 59.42 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.855 0.836 . . . . 74.420000000000002 109.571 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.659 ' HG3' ' HB3' ' A' ' 148' ' ' ASN . 6.4 ptp180 -134.31 133.18 21.47 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.993 -1.003 . . . . 72.109999999999999 109.489 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.59 139.37 69.59 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.347 2.031 . . . . 70.409999999999997 111.469 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 ' HB ' ' A' ' 145' ' ' VAL . 14.9 t -62.49 152.03 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.936 -0.574 . . . . 71.299999999999997 111.368 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.89 138.7 57.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 74.010000000000005 110.115 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' A' ' 158' ' ' LYS . 8.9 p-10 -68.43 153.56 43.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 65.530000000000001 111.673 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.6 p -103.54 135.96 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.57 . . . . 73.010000000000005 110.308 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' A' ' 156' ' ' ASP . 10.2 mptt -111.36 151.34 28.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.634 . . . . 70.450000000000003 110.86 -172.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.53 99.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.287 -1.005 . . . . 74.409999999999997 108.287 169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.534 HG22 ' HD3' ' A' ' 161' ' ' LYS . 36.4 mm -62.9 -50.78 78.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 73.549999999999997 110.218 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.596 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -143.16 152.44 41.79 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.555 -0.748 . . . . 72.329999999999998 109.992 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.95 132.95 37.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.472 . . . . 62.049999999999997 109.875 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 43.4 m-85 -134.31 125.65 17.94 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.582 . . . . 64.400000000000006 109.957 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . 19.5 Cg_endo -62.21 136.15 58.52 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.81 1.673 . . . . 62.210000000000001 111.139 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.504 ' HA ' ' HE2' ' A' ' 15' ' ' TYR . 8.6 t -62.11 142.7 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.999 0.428 . . . . 74.420000000000002 110.679 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 110.66 5.33 27.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.768 -0.729 . . . . 60.210000000000001 111.723 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -171.03 38.65 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 52.509999999999998 111.857 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.07 10.5 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.78 -0.724 . . . . 72.099999999999994 112.206 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 164.82 172.79 32.72 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.463 -0.655 . . . . 63.420000000000002 111.463 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.3 m -124.03 -31.01 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.698 0.285 . . . . 42.119999999999997 111.137 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.2 -161.26 24.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.729 -0.748 . . . . 75.150000000000006 111.742 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.33 59.2 0.5 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.675 -0.774 . . . . 62.350000000000001 112.184 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 127.35 137.1 4.43 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.791 -0.718 . . . . 34.549999999999997 111.908 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.3 m -106.7 103.43 12.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.701 0.286 . . . . 51.340000000000003 110.383 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -121.58 -153.27 8.92 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.776 -0.726 . . . . 54.119999999999997 112.256 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -102.05 22.13 39.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.902 -0.666 . . . . 64.319999999999993 111.76 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -91.24 98.77 2.48 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.038 -0.601 . . . . 42.210000000000001 111.936 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 19.0 m -107.75 85.85 2.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.159 0.504 . . . . 73.129999999999995 110.096 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -100.94 126.59 8.97 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.725 -0.67 . . . . 42.43 111.923 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.19 102.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.88 -0.676 . . . . 73.430000000000007 111.625 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.67 -164.5 26.38 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.809 -0.71 . . . . 74.129999999999995 111.999 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.0 m -71.15 141.94 50.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.346 -0.242 . . . . 72.420000000000002 110.346 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.8 111.14 3.2 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.516 -0.85 . . . . 61.119999999999997 111.894 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -77.29 174.01 11.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.571 0.7 . . . . 65.200000000000003 110.26 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 156.17 146.39 4.45 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.926 -1.034 . . . . 63.520000000000003 110.998 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.9 -178.18 52.15 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.282 -0.961 . . . . 55.130000000000003 111.397 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.893 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.5 141.69 53.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.43 -0.582 . . . . 75.25 109.43 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 61.4 m-85 -88.96 104.44 7.6 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 53.520000000000003 110.277 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.653 ' HB2' HD12 ' A' ' 90' ' ' LEU . 1.1 Cg_endo -82.47 -5.55 11.77 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.804 2.336 . . . . 72.439999999999998 111.301 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.66 -34.34 46.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 64.129999999999995 110.438 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 193' ' ' VAL . 17.7 pt -79.59 -13.6 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.497 -0.774 . . . . 70.219999999999999 111.555 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 58.9 m170 64.92 40.29 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.501 -0.772 . . . . 71.420000000000002 111.971 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 HG13 ' A' ' 191' ' ' ILE . 9.8 p -144.19 145.47 21.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 110.758 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.32 122.11 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.853 -0.612 . . . . 55.030000000000001 112.339 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.488 HE22 ' HA ' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -166.93 158.46 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.031 -0.986 . . . . 71.200000000000003 108.967 175.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 25.6 m-85 -126.11 148.45 63.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.939 -0.305 . . . . 65.140000000000001 110.587 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.893 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -66.38 -59.37 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.52 2.147 . . . . 63.119999999999997 111.786 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.7 33.15 1.81 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.882 0.372 . . . . 72.530000000000001 110.647 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.42 3.55 3.82 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.811 -0.632 . . . . 61.229999999999997 112.683 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.2 ptm -56.73 -30.54 63.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.936 0.347 . . . . 75.140000000000001 111.936 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.3 -1.78 89.34 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.675 -0.774 . . . . 74.329999999999998 112.514 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 85.3 mtt180 -101.19 -12.19 18.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.578 . . . . 61.210000000000001 110.234 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . 21.1 ttmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.616 -1.175 . . . . 74.010000000000005 111.433 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.716 0.293 . . . . 71.530000000000001 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.67 85.36 6.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.29 0.567 . . . . 72.340000000000003 110.394 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.59 -67.73 0.83 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 61.530000000000001 111.004 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 48.6 mm -121.03 97.31 48.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 40.450000000000003 111.137 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -97.53 121.95 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.446 2.764 . . . . 74.25 112.603 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.36 142.93 87.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.447 2.098 . . . . 53.439999999999998 111.09 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.58 -64.24 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.234 0.54 . . . . 74.030000000000001 111.143 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.419 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 2.5 p -135.02 -147.09 0.26 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.6 -0.727 . . . . 74.329999999999998 109.075 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.419 ' H ' ' HB2' ' A' ' 8' ' ' SER . 36.5 p90 -76.85 165.8 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.191 -0.67 . . . . 74.519999999999996 109.191 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' A' ' 37' ' ' LYS . 3.0 mp0 -104.18 133.38 20.26 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.658 -0.246 . . . . 74.340000000000003 111.521 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.862 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 27.1 Cg_exo -63.36 116.23 3.49 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.552 2.168 . . . . 73.340000000000003 110.564 168.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 72.7 Cg_endo -75.28 -18.22 18.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 62.039999999999999 113.395 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -140.42 152.22 45.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.503 -0.555 . . . . 74.140000000000001 109.503 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.734 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.2 m -136.8 144.87 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.382 0.61 . . . . 64.299999999999997 111.29 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.84 123.53 43.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.207 -0.906 . . . . 63.32 111.004 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 16' ' ' LEU . 3.0 mm? -108.0 102.78 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.435 -0.348 . . . . 71.209999999999994 110.571 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -91.05 108.19 19.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.232 -0.655 . . . . 73.349999999999994 109.232 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -101.55 -179.95 4.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.228 0.537 . . . . 45.530000000000001 112.09 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB2' HD11 ' A' ' 160' ' ' ILE . 22.9 t -72.48 -11.01 60.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 75.319999999999993 110.948 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.4 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.7 mmt -102.89 -41.05 6.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.197 -0.456 . . . . 72.219999999999999 110.623 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.45 -129.39 1.2 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.419 -0.672 . . . . 71.019999999999996 111.419 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -139.69 138.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.923 -0.399 . . . . 74.219999999999999 109.923 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.63 129.99 64.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.843 -0.617 . . . . 72.420000000000002 109.647 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 21.6 t -105.59 134.34 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.361 -0.607 . . . . 75.239999999999995 109.361 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.774 ' HB2' HD11 ' A' ' 98' ' ' LEU . 3.8 pp -144.17 160.76 40.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.406 -0.517 . . . . 63.329999999999998 111.127 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -146.26 170.04 17.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 73.030000000000001 110.631 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.66 169.76 8.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.932 -0.576 . . . . 72.299999999999997 110.624 -173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.606 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -87.72 105.18 17.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.04 0.447 . . . . 71.409999999999997 110.851 176.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 1.4 m0 -85.88 0.06 54.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.005 -0.543 . . . . 53.409999999999997 109.854 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -72.62 -68.82 0.45 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.744 -0.662 . . . . 72.140000000000001 111.024 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -124.15 11.65 8.85 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.695 -0.402 . . . . 72.340000000000003 110.992 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB2' ' CG ' ' A' ' 129' ' ' PHE . . . -129.6 69.19 81.31 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.275 -0.57 . . . . 33.409999999999997 112.278 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.553 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 18.8 Cg_exo -65.73 -33.36 44.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.493 1.462 . . . . 70.010000000000005 109.706 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -57.0 -56.78 17.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.299 -0.864 . . . . 54.030000000000001 110.725 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 m -61.59 -36.22 80.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 70.340000000000003 110.823 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 54.0 t -63.63 -48.64 76.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 70.510000000000005 111.022 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.36 -37.25 77.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.659 0.266 . . . . 73.129999999999995 110.405 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 55.4 t-20 -55.58 -62.05 1.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.926 -0.579 . . . . 63.509999999999998 110.476 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HE1' HG21 ' A' ' 14' ' ' VAL . 5.0 t80 -65.01 -44.7 88.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.696 -0.684 . . . . 71.0 110.767 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -57.59 -48.77 78.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.451 -0.795 . . . . 52.43 112.198 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.28 -39.27 92.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.927 0.394 . . . . 63.509999999999998 111.159 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 3.6 mm? -69.15 -24.32 64.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.548 -0.296 . . . . 61.020000000000003 111.056 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.14 36.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.244 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.5 -29.03 70.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.178 0.513 . . . . 75.519999999999996 110.184 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 49.1 mtt180 -79.07 -50.55 10.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 74.519999999999996 109.86 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.03 52.82 0.68 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.809 . . . . 74.310000000000002 113.036 171.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.66 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 3.9 p90 -76.09 -25.97 56.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.343 0.592 . . . . 74.019999999999996 110.481 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.679 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.5 -7.95 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.479 -0.782 . . . . 64.109999999999999 112.844 -173.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -71.75 -5.73 36.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.499 . . . . 74.439999999999998 110.47 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.29 33.87 2.71 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.756 -0.656 . . . . 52.240000000000002 111.508 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.833 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.1 p -114.61 153.8 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.858 0.361 . . . . 53.310000000000002 111.119 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -146.13 161.61 39.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 109.889 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.638 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 97.9 m-85 -87.22 124.06 32.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.616 -0.513 . . . . 64.019999999999996 109.616 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -105.49 -32.77 8.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.996 -0.282 . . . . 73.120000000000005 111.13 -172.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -118.44 107.58 13.99 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.841 -0.343 . . . . 74.010000000000005 110.383 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.622 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -120.22 91.43 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.691 -0.855 . . . . 72.340000000000003 108.691 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.3 mt -93.24 128.91 44.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.98 -0.554 . . . . 73.109999999999999 110.116 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -52.2 109.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.341 1.026 . . . . 75.319999999999993 111.539 -176.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.564 ' OD2' ' HA2' ' A' ' 201' ' ' GLY . 6.6 t70 53.1 50.35 18.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.765 0.793 . . . . 71.310000000000002 110.703 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 7.1 t80 -137.55 -77.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.332 -0.849 . . . . 71.319999999999993 109.117 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.637 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.4 ptt? -162.29 154.9 19.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.939 -1.028 . . . . 73.530000000000001 109.739 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.622 HG23 HG13 ' A' ' 56' ' ' ILE . 36.1 mt -128.54 101.59 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.124 -0.489 . . . . 73.5 109.817 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.4 tm0? -82.26 126.38 32.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.394 -0.821 . . . . 74.099999999999994 109.833 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -142.69 145.68 15.93 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.176 -1.011 . . . . 71.430000000000007 113.569 -176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.833 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 130.33 -138.58 10.3 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.735 -0.745 . . . . 31.109999999999999 112.37 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.896 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 23.1 t0 44.85 89.09 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 124.49 1.116 . . . . 74.430000000000007 113.249 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 72.6 Cg_endo -75.21 -13.5 20.97 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.863 2.375 . . . . 63.25 111.878 172.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -95.94 -34.9 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 65.140000000000001 112.058 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.47 21.92 71.41 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.127 -0.558 . . . . 53.299999999999997 112.37 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -120.09 2.24 10.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 72.019999999999996 111.159 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.59 -5.08 66.94 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.559 -0.829 . . . . 63.5 112.755 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -88.52 -46.75 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.335 0.588 . . . . 75.319999999999993 109.97 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.896 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 72.87 67.98 1.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.468 -0.787 . . . . 63.229999999999997 112.451 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.66 -105.05 1.57 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.859 -0.686 . . . . 73.230000000000004 111.59 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 53.62 35.85 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.962 0.448 . . . . 73.329999999999998 111.353 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 m -56.16 -32.24 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 73.120000000000005 111.779 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -70.53 -56.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.367 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 90.9 m-85 -69.86 -40.13 75.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.324 0.583 . . . . 53.119999999999997 110.465 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 -67.7 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.264 -0.88 . . . . 75.129999999999995 112.556 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -113.14 -178.65 3.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.156 0.503 . . . . 64.120000000000005 112.001 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.573 ' NE2' HG23 ' A' ' 107' ' ' THR . 13.8 pm0 -104.01 162.1 13.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.451 -0.795 . . . . 74.549999999999997 109.092 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -130.3 -67.86 0.72 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.41 -0.516 . . . . 70.239999999999995 111.108 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.8 -179.46 5.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.466 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -91.53 136.44 33.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.607 -0.724 . . . . 74.549999999999997 109.612 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -100.24 15.66 26.84 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 54.32 109.147 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.93 104.58 2.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.438 -0.801 . . . . 73.329999999999998 111.697 -173.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -173.37 81.69 0.4 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 75.349999999999994 109.906 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.11 93.0 0.46 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.562 2.175 . . . . 74.430000000000007 112.342 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.39 -38.56 84.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.365 0.602 . . . . 73.450000000000003 110.123 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -81.16 -176.54 6.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.263 -0.881 . . . . 75.109999999999999 110.769 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -122.99 144.11 49.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.758 -0.46 . . . . 64.099999999999994 109.758 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.45 76.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.021 0.915 . . . . 53.420000000000002 109.677 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.7 p -61.52 -46.7 88.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.474 -1.239 . . . . 64.120000000000005 111.768 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.2 -140.21 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.62 -0.8 . . . . 53.240000000000002 112.27 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 137.7 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.661 0.267 . . . . 55.229999999999997 110.743 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 113.01 20.74 6.23 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.737 -0.744 . . . . 73.430000000000007 111.788 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.5 mm -87.41 114.7 26.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.238 -0.653 . . . . 72.049999999999997 109.238 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 25' ' ' LEU . 8.5 mt -85.47 127.07 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.264 0.554 . . . . 72.019999999999996 111.467 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 163.81 26.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 110.105 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.421 ' CE ' ' HB3' ' A' ' 108' ' ' ASN . 40.7 ttp -97.24 140.26 31.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.637 -0.505 . . . . 50.329999999999998 109.637 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -90.96 137.73 32.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 61.43 110.587 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -137.42 159.1 42.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.569 -0.741 . . . . 61.020000000000003 110.304 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.48 -2.11 36.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.605 0.717 . . . . 73.040000000000006 110.021 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.504 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -174.21 172.69 45.54 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.884 -1.686 . . . . 72.420000000000002 108.884 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 -44.91 34.68 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.659 2.24 . . . . 63.549999999999997 112.321 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.29 -3.7 18.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 54.119999999999997 110.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.573 HG23 ' NE2' ' A' ' 81' ' ' GLN . 4.6 m -85.8 52.44 2.47 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.735 0.779 . . . . 64.019999999999996 109.099 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 m120 -79.68 130.58 35.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.773 -1.103 . . . . 63.329999999999998 110.332 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.27 -138.95 6.46 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.708 -0.758 . . . . 43.340000000000003 112.46 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -119.53 14.13 12.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.777 0.322 . . . . 72.420000000000002 111.349 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 pt20 -92.81 168.02 11.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.703 -0.226 . . . . 71.510000000000005 110.446 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -145.88 177.49 8.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.802 0.335 . . . . 74.150000000000006 111.127 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 45.6 p90 -160.29 151.87 19.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.319 173.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.0 t -106.61 146.84 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 71.209999999999994 109.56 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.2 p -102.01 126.95 49.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.058 -0.349 . . . . 64.239999999999995 110.058 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 68.2 mt -87.62 -7.71 57.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.317 0.58 . . . . 73.430000000000007 110.55 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -150.89 165.14 18.01 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.397 -0.82 . . . . 64.409999999999997 109.809 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.3 Cg_endo -58.59 113.85 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.631 2.221 . . . . 73.319999999999993 111.652 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.404 HG22 ' HE1' ' A' ' 121' ' ' TRP . 16.6 p -100.06 88.44 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.231 0.538 . . . . 74.239999999999995 111.492 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.9 19.64 12.37 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.916 0.865 . . . . 64.219999999999999 108.845 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.963 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -121.19 1.39 10.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.308 -1.314 . . . . 73.299999999999997 109.891 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.963 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 63.6 mt -121.71 6.37 9.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.485 -0.779 . . . . 72.129999999999995 110.41 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.01 -17.29 64.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 71.099999999999994 111.448 -172.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.11 18.58 5.01 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.507 -0.854 . . . . 72.310000000000002 111.298 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -120.91 -30.13 4.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.119 0.485 . . . . 73.329999999999998 110.249 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -139.67 141.2 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.165 -0.68 . . . . 62.420000000000002 109.165 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -78.16 144.55 36.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.978 0.418 . . . . 75.219999999999999 110.129 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.434 ' O ' HD21 ' A' ' 90' ' ' LEU . 49.3 mt -122.72 112.96 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.14 -0.482 . . . . 63.420000000000002 110.928 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.0 m-85 -155.82 77.31 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.608 0.568 . . . . 75.219999999999999 110.763 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.478 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -163.27 164.49 36.12 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.623 -0.799 . . . . 72.530000000000001 112.553 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -141.76 126.04 17.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.067 -0.346 . . . . 62.409999999999997 110.067 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.9 p -92.56 138.06 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.149 0.499 . . . . 74.040000000000006 110.911 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 47.9 t -144.23 146.0 32.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.1 -0.5 . . . . 71.329999999999998 110.204 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.712 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 7.9 tt0 50.25 40.49 22.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.254 0.55 . . . . 72.409999999999997 111.991 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.66 17.47 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.151 -1.023 . . . . 75.329999999999998 112.512 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.2 tp -74.27 -33.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.061 -0.256 . . . . 73.319999999999993 110.617 -174.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.47 -38.31 96.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.543 -0.837 . . . . 73.540000000000006 111.243 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 142' ' ' VAL . 76.1 mmm -69.33 -51.82 33.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.0 -0.37 . . . . 73.310000000000002 110.0 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.462 HG13 HD12 ' A' ' 62' ' ' ILE . 89.7 t -54.89 -31.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.054 0.454 . . . . 74.519999999999996 110.922 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.455 ' ND2' HD11 ' A' ' 198' ' ' LEU . 1.9 t-20 -71.75 -53.73 12.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 74.230000000000004 110.587 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -73.48 -13.92 61.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.556 -0.747 . . . . 74.140000000000001 111.078 -176.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 138' ' ' MET . 53.4 t -88.51 -40.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 64.140000000000001 110.104 174.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.6 -9.41 86.89 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.708 -0.678 . . . . 74.049999999999997 112.735 -177.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.541 ' HG3' HG13 ' A' ' 145' ' ' VAL . 14.6 ptp -96.18 -13.62 23.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.669 0.271 . . . . 74.219999999999999 111.21 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 144' ' ' MET . 32.2 m -109.94 126.82 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.272 0.558 . . . . 62.409999999999997 111.635 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 1.3 pt-20 -124.46 -45.1 1.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 74.230000000000004 109.752 168.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 12.5 p -140.57 152.52 45.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.746 -0.661 . . . . 72.150000000000006 110.121 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' HB3' HG22 ' A' ' 154' ' ' VAL . 11.8 p30 -94.06 -144.33 0.24 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.715 -0.22 . . . . 62.450000000000003 110.7 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.5 m -62.7 -25.72 68.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.195 0.521 . . . . 64.409999999999997 109.961 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.692 ' HB2' ' HG2' ' A' ' 152' ' ' ARG . 35.0 mt-30 -97.46 169.9 9.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 74.109999999999999 108.863 175.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.5 22.8 1.48 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.726 0.774 . . . . 73.340000000000003 109.859 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 1.4 ptm180 -102.31 147.95 34.72 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.437 -0.801 . . . . 63.340000000000003 110.09 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 31.6 Cg_exo -59.21 134.62 60.43 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.702 2.268 . . . . 62.049999999999997 112.33 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 148' ' ' ASN . 34.0 t -64.34 -69.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.398 0.618 . . . . 72.219999999999999 110.001 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.4 147.6 47.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.191 -0.913 . . . . 72.400000000000006 109.148 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.85 179.85 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.547 -0.538 . . . . 65.109999999999999 109.547 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 53' ' ' PHE . 5.7 p -156.13 108.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 122.629 1.204 . . . . 73.349999999999994 111.187 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -133.49 159.63 39.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.085 -1.416 . . . . 72.319999999999993 109.784 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.8 mp -81.37 103.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.815 -0.809 . . . . 75.129999999999995 108.815 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.3 mm -67.59 -65.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 71.219999999999999 109.951 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 mptm? -133.08 135.84 45.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.394 -0.821 . . . . 72.430000000000007 109.098 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.679 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -130.96 143.21 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.938 0.399 . . . . 61.219999999999999 110.089 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 17.0 m-85 -133.7 128.94 20.16 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.781 -0.645 . . . . 61.229999999999997 109.74 -171.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.16 129.11 7.62 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.816 1.677 . . . . 64.540000000000006 111.529 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p -75.17 113.22 12.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 74.219999999999999 109.956 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -139.94 -80.48 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.83 -0.7 . . . . 71.019999999999996 112.317 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.63 -2.39 90.63 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 73.140000000000001 113.41 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.03 -27.89 9.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.676 -0.773 . . . . 65.129999999999995 112.323 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 138.91 -94.13 0.2 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.6 -0.6 . . . . 72.120000000000005 111.6 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m -154.44 132.4 11.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.079 -0.341 . . . . 65.430000000000007 110.079 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -86.01 54.74 4.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.869 -0.681 . . . . 74.010000000000005 112.236 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.84 -170.61 25.68 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.112 -0.566 . . . . 71.400000000000006 111.826 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 75.52 -78.0 1.19 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.156 -0.545 . . . . 61.420000000000002 112.205 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.7 m -152.24 121.19 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.904 -0.406 . . . . 74.219999999999999 109.904 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -74.19 75.36 1.15 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.834 -0.698 . . . . 24.219999999999999 112.18 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -110.19 119.7 5.43 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.698 -0.561 . . . . 53.140000000000001 111.698 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 174.62 82.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.865 -0.683 . . . . 62.219999999999999 111.567 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 50.2 m -133.66 31.92 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.234 0.54 . . . . 74.150000000000006 110.223 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -80.41 162.8 46.05 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.663 -0.699 . . . . 73.400000000000006 112.031 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -156.53 86.0 0.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.667 -0.777 . . . . 44.549999999999997 112.311 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 156.01 158.82 9.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.937 -0.649 . . . . 74.219999999999999 112.02 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.0 p -104.65 -52.54 2.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 72.209999999999994 110.632 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 95.59 -69.06 1.05 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.979 -0.629 . . . . 72.120000000000005 112.114 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.8 m-20 -100.04 171.68 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 72.530000000000001 110.715 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.46 144.01 3.87 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.15 -0.932 . . . . 63.140000000000001 111.164 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.88 -174.24 48.34 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.275 -0.964 . . . . 54.200000000000003 112.135 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.95 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.42 149.43 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.532 -0.544 . . . . 75.310000000000002 109.532 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -89.92 103.47 6.42 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.309 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 90.3 Cg_endo -80.61 -6.69 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.218 1.945 . . . . 71.329999999999998 111.066 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.73 -27.48 55.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.666 -1.152 . . . . 73.340000000000003 110.764 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 193' ' ' VAL . 15.8 pt -89.0 -12.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.976 -0.556 . . . . 62.140000000000001 111.703 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 90' ' ' LEU . 12.0 m170 58.27 45.31 17.38 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.801 -0.636 . . . . 71.540000000000006 111.588 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 191' ' ' ILE . 7.0 p -141.91 147.99 21.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.342 -0.39 . . . . 52.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.21 107.81 2.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 112.202 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.38 157.48 32.42 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.873 -0.788 . . . . 71.25 108.873 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 202' ' ' ARG . 46.8 m-85 -128.01 151.65 76.22 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.895 -0.322 . . . . 71.439999999999998 110.949 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.95 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.6 Cg_endo -67.57 -57.55 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 111.711 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -126.52 15.85 7.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.122 -0.49 . . . . 65.450000000000003 110.13 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 1.2 m-20 64.18 22.98 13.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.583 0.957 . . . . 60.130000000000003 113.583 171.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.77 -46.87 51.09 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.886 -0.325 . . . . 60.310000000000002 111.494 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.564 ' HA2' ' OD2' ' A' ' 59' ' ' ASP . . . -79.09 0.5 79.01 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.053 -0.594 . . . . 63.340000000000003 113.593 -172.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 15.9 ptm180 -96.33 -18.01 20.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.157 0.503 . . . . 45.420000000000002 111.168 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.493 -0.776 . . . . 64.530000000000001 109.904 -175.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.973 -0.38 . . . . 74.010000000000005 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.89 99.47 3.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.378 0.609 . . . . 73.540000000000006 111.16 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.31 -61.08 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.322 -0.854 . . . . 62.32 108.772 173.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 mm -128.57 123.34 22.17 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.053 -0.976 . . . . 72.200000000000003 109.109 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 73.4 Cg_exo -51.54 147.88 21.98 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.802 2.334 . . . . 75.409999999999997 112.445 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 50.8 Cg_exo -54.23 150.45 32.6 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.91 2.407 . . . . 75.140000000000001 112.421 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 2.0 m-20 -75.91 55.12 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 72.340000000000003 110.747 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.663 ' HB2' HE22 ' A' ' 10' ' ' GLN . 6.7 m -78.64 -162.48 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.685 -0.689 . . . . 74.129999999999995 109.868 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.427 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 9.4 p-90 -57.3 -65.92 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.849 0.314 . . . . 75.409999999999997 111.849 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 8' ' ' SER . 2.3 mp0 69.34 159.39 0.15 Allowed Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 122.892 0.477 . . . . 54.450000000000003 111.564 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 50.9 Cg_exo -55.29 119.33 6.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.742 2.295 . . . . 55.450000000000003 112.701 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 29' ' ' TRP . 71.8 Cg_endo -78.98 -13.51 14.11 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.813 2.342 . . . . 72.409999999999997 112.575 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -151.72 142.01 22.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 72.299999999999997 109.666 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.6 149.33 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.823 0.344 . . . . 71.540000000000006 110.952 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.698 ' CD1' ' HB2' ' A' ' 165' ' ' SER . 7.0 m-85 -107.89 132.57 53.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.02 -0.536 . . . . 63.420000000000002 110.789 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' HD22 ' A' ' 16' ' ' LEU . 2.4 mm? -118.88 102.5 8.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.498 -0.774 . . . . 60.439999999999998 109.917 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.36 109.58 17.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.088 -0.708 . . . . 71.420000000000002 109.088 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -98.28 178.2 5.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.939 0.4 . . . . 74.409999999999997 110.769 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 160' ' ' ILE . 6.9 p -70.96 -28.14 64.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.961 -0.563 . . . . 63.200000000000003 111.365 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.541 ' SD ' HG22 ' A' ' 142' ' ' VAL . 83.3 mtp -91.05 -41.58 10.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.55 -0.296 . . . . 73.439999999999998 111.118 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 -143.08 3.59 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.858 -0.687 . . . . 33.340000000000003 111.396 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 23' ' ' ILE . 20.4 tt -128.11 138.92 53.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 117.026 0.413 . . . . 71.430000000000007 109.895 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 22' ' ' ILE . 10.8 mm -125.53 132.27 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.617 -0.512 . . . . 51.299999999999997 109.617 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 18.3 t -120.0 139.86 45.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 110.14 -0.319 . . . . 75.349999999999994 110.14 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 161.37 42.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 73.319999999999993 110.449 174.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 14.6 pt-20 -130.87 167.68 18.53 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.015 -0.539 . . . . 71.299999999999997 110.167 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.28 157.9 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.416 -0.356 . . . . 64.219999999999999 110.688 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 4.9 m-85 -80.07 102.49 9.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 72.219999999999999 111.499 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 12' ' ' PRO . 11.5 m0 -80.58 -6.27 58.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.887 -0.597 . . . . 73.209999999999994 110.453 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -73.83 -53.35 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 74.549999999999997 111.732 -172.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.62 6.09 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.925 0.342 . . . . 73.420000000000002 111.925 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.19 79.01 67.46 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.996 0.426 . . . . 54.340000000000003 111.52 -176.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.8 Cg_exo -71.84 -41.03 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.371 2.047 . . . . 73.530000000000001 111.573 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -77.33 -43.31 33.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.933 -0.576 . . . . 73.5 110.143 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 2.1 m -57.23 -42.38 81.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.349999999999994 110.334 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.7 t -60.77 -47.96 83.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 110.651 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HE2' ' HB2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -62.95 -35.53 80.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.202 -0.453 . . . . 60.439999999999998 111.153 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.22 -53.31 59.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 71.219999999999999 110.76 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HZ ' ' HG3' ' A' ' 100' ' ' MET . 76.9 m-85 -67.96 -44.42 76.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 111.164 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -61.84 -35.96 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 60.32 112.13 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -66.35 -44.71 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.422 0.63 . . . . 61.140000000000001 109.948 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.744 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . 30.4 mt -67.64 -22.12 65.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 111.128 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.0 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 72.310000000000002 110.362 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 32.4 mmt180 -63.84 -49.6 72.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.311 0.576 . . . . 64.340000000000003 110.073 174.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -74.9 -51.97 12.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.378 -0.828 . . . . 71.120000000000005 110.802 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.9 44.86 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 74.420000000000002 112.129 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.744 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -70.6 -26.53 63.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.042 0.449 . . . . 74.140000000000001 110.714 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.3 m-85 -76.67 -16.49 59.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 62.32 111.572 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -74.52 2.33 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 73.299999999999997 110.942 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.32 11.7 5.26 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.921 -0.657 . . . . 53.420000000000002 111.907 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.4 p -90.45 137.93 31.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 74.219999999999999 110.951 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 2.0 mtmt -129.49 150.75 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.388 -0.597 . . . . 73.010000000000005 109.388 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 72.4 m-85 -78.05 122.37 25.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.851 -0.425 . . . . 70.409999999999997 109.851 177.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -107.36 -30.46 8.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.55 -0.295 . . . . 60.340000000000003 111.064 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 25.5 mmt180 -119.04 110.58 17.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.907 -0.405 . . . . 73.099999999999994 109.907 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.426 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -127.15 93.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 71.540000000000006 109.082 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 35.2 mt -104.1 125.48 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 109.94 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -50.42 129.39 21.84 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.65 0.594 . . . . 75.319999999999993 111.62 177.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' HE3' ' A' ' 58' ' ' LYS . 3.4 p30 42.22 43.74 3.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.231 0.957 . . . . 75.5 112.418 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.743 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -135.67 -77.54 0.43 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 72.310000000000002 110.291 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.7 ptp -160.05 156.05 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 64.140000000000001 110.634 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' A' ' 116' ' ' LEU . 40.6 mt -131.58 101.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.736 -0.666 . . . . 61.520000000000003 109.417 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 24.6 tm0? -88.42 128.92 35.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.647 -0.706 . . . . 73.200000000000003 109.802 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -137.17 144.24 15.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.708 -0.758 . . . . 71.329999999999998 112.369 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 147.14 -143.3 11.17 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.658 -0.782 . . . . 60.109999999999999 112.578 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HA ' HE22 ' A' ' 111' ' ' GLN . 44.5 t0 46.86 77.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 124.16 0.984 . . . . 70.430000000000007 112.71 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.72 -12.08 22.09 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.495 2.13 . . . . 73.010000000000005 111.587 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.0 p -91.81 -42.83 9.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.458 -0.792 . . . . 74.25 111.961 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.22 32.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.602 -0.809 . . . . 70.530000000000001 112.001 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.45 -2.65 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 52.140000000000001 111.038 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.69 -35.7 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.381 -0.914 . . . . 73.409999999999997 113.316 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.711 ' HG2' HG23 ' A' ' 70' ' ' THR . 14.3 ptm180 -78.67 -28.88 45.38 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.219 0.509 . . . . 72.519999999999996 110.888 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.04 -162.65 54.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.023 -0.608 . . . . 15.529999999999999 113.179 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.97 6.79 61.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.294 -0.479 . . . . 72.549999999999997 112.386 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -87.35 22.59 2.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.34 1.067 . . . . 71.409999999999997 110.723 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -85.51 5.8 29.76 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.318 -1.31 . . . . 51.109999999999999 109.805 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.49 -28.51 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.342 -0.845 . . . . 70.400000000000006 111.213 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 p90 -100.18 10.86 40.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.512 0.672 . . . . 75.209999999999994 110.788 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.41 -110.26 3.96 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.11 -0.95 . . . . 61.340000000000003 112.417 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -95.88 -169.02 1.86 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.426 0.291 . . . . 54.530000000000001 110.275 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -65.97 159.26 26.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 63.509999999999998 109.826 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -102.47 -85.18 0.44 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.836 0.35 . . . . 74.530000000000001 110.944 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -162.02 157.19 23.19 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.459 -0.941 . . . . 74.319999999999993 108.459 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.31 110.95 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.533 0.682 . . . . 64.450000000000003 110.438 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.43 28.83 3.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.841 -0.618 . . . . 72.109999999999999 109.377 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.38 100.31 0.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 71.319999999999993 110.502 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -159.92 72.74 3.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.798 -0.637 . . . . 75.140000000000001 109.827 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.21 98.21 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.206 1.938 . . . . 73.299999999999997 112.642 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.56 24.39 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.489 0.662 . . . . 73.340000000000003 110.318 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.8 pp -137.24 -169.06 2.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.501 -0.772 . . . . 73.209999999999994 110.278 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -140.6 151.06 44.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.033 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -72.43 69.5 0.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.713 0.768 . . . . 70.099999999999994 110.668 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.9 p -68.7 -39.94 80.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.174 -0.921 . . . . 63.25 111.824 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 -142.43 3.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.504 -0.855 . . . . 73.140000000000001 112.913 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 141.62 28.43 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.302 0.241 . . . . 60.32 111.018 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.41 22.2 6.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.793 -0.718 . . . . 52.140000000000001 111.917 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.1 mm -87.52 111.25 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.684 -0.487 . . . . 55.100000000000001 109.684 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -88.44 118.9 28.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.139 0.495 . . . . 73.409999999999997 109.715 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.3 173.4 10.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.063 -0.517 . . . . 52.420000000000002 110.817 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.479 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 12.3 ttp -104.02 137.04 42.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.139 -0.482 . . . . 65.430000000000007 110.141 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -89.21 144.46 26.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 63.350000000000001 110.73 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.2 p-10 -153.12 158.77 42.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 71.150000000000006 110.593 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.19 -16.56 20.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.74 0.781 . . . . 64.540000000000006 109.794 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -157.05 174.07 34.65 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.698 -1.761 . . . . 71.109999999999999 108.698 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.03 -47.73 22.52 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.844 2.363 . . . . 41.350000000000001 112.082 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -104.31 -5.07 22.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 64.209999999999994 110.986 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.409 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -87.61 49.33 1.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.767 0.794 . . . . 63.009999999999998 108.865 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 5.7 p30 -94.37 145.08 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 65.140000000000001 111.386 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -129.79 -167.26 12.04 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.013 -1.235 . . . . 64.540000000000006 110.013 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 19.5 t -87.47 14.88 7.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.94 0.87 . . . . 65.409999999999997 110.016 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 10.1 mm-40 -67.53 145.99 54.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.056 -1.09 . . . . 72.409999999999997 108.056 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.72 166.32 24.25 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.191 -0.603 . . . . 71.239999999999995 111.433 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.51 151.38 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.777 -0.647 . . . . 73.329999999999998 110.128 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -110.39 143.65 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.221 -0.659 . . . . 75.109999999999999 109.221 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -98.99 126.38 44.67 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.048 0.451 . . . . 63.509999999999998 110.159 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 62' ' ' ILE . 69.3 mt -83.99 -5.87 59.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.721 -0.672 . . . . 65.430000000000007 110.629 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -146.5 162.01 36.01 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.706 -0.679 . . . . 43.109999999999999 109.829 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 21.6 Cg_endo -61.8 112.91 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.018 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.418 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.2 p -97.51 102.72 14.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.397 0.618 . . . . 73.530000000000001 111.163 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.52 17.71 23.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.424 0.631 . . . . 72.349999999999994 110.355 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.29 -3.38 9.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 64.010000000000005 111.673 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.1 pp -133.07 8.17 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 74.430000000000007 112.443 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -62.74 -27.48 69.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.007 0.432 . . . . 65.099999999999994 111.021 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.34 11.35 36.53 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.751 . . . . 44.310000000000002 112.05 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -117.18 -27.46 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.489 0.661 . . . . 71.310000000000002 109.56 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.38 130.46 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 74.530000000000001 108.68 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.0 t -75.37 143.95 42.55 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.198 -0.601 . . . . 71.239999999999995 110.109 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.4 mt -122.95 116.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 73.439999999999998 110.501 -173.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.6 m-85 -151.96 74.13 1.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.998 0.427 . . . . 72.0 110.459 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.664 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.74 155.81 27.27 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.719 -0.753 . . . . 71.140000000000001 112.179 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.432 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 14.3 mtp180 -135.07 118.91 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.621 -0.511 . . . . 73.400000000000006 109.621 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.432 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.0 p -79.96 136.94 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.405 0.622 . . . . 63.210000000000001 110.55 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.676 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 44.1 t -141.8 145.76 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.674 -0.694 . . . . 72.219999999999999 109.693 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 23.0 tt0 42.75 48.75 4.92 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.483 0.658 . . . . 73.049999999999997 112.363 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 184' ' ' ASP . . . -172.12 13.58 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.833 -1.175 . . . . 54.43 112.988 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -73.54 -31.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.874 0.337 . . . . 53.530000000000001 110.238 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -37.38 94.75 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.701 -0.762 . . . . 53.140000000000001 111.203 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 142' ' ' VAL . 69.8 mmm -72.47 -50.66 24.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.85 -0.426 . . . . 72.420000000000002 109.85 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 62' ' ' ILE . 90.1 t -53.91 -30.65 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 64.209999999999994 110.83 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -69.91 -52.47 24.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.962 -0.563 . . . . 74.430000000000007 110.612 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.523 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.23 -17.07 60.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.447 -0.342 . . . . 74.230000000000004 111.402 -179.202 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 138' ' ' MET . 83.9 t -83.47 -34.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 109.957 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -91.01 -3.74 69.87 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.864 -0.684 . . . . 72.519999999999996 112.619 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.523 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.6 ptm -95.89 -12.2 25.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.728 0.299 . . . . 51.219999999999999 110.954 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 142' ' ' VAL . 21.4 m -83.28 116.39 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.668 . . . . 75.450000000000003 110.397 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.06 -61.76 1.65 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.543 -0.753 . . . . 73.25 111.397 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.1 p -143.68 163.45 33.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.232 0.539 . . . . 53.420000000000002 111.736 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -89.42 168.92 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.433 -0.951 . . . . 54.240000000000002 108.433 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.2 m -57.88 -19.11 27.01 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.201 0.815 . . . . 73.200000000000003 113.201 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -84.77 13.55 5.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.956 0.354 . . . . 73.219999999999999 111.956 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 63.52 36.94 10.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.56 0.695 . . . . 75.030000000000001 110.748 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 152.7 75.46 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 72.299999999999997 108.833 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.36 145.3 21.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.351 2.034 . . . . 72.0 111.528 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.16 -25.41 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.828 0.347 . . . . 75.319999999999993 110.84 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 81.24 -80.95 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.195 0.813 . . . . 74.540000000000006 113.195 163.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.54 91.38 5.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.013 0.911 . . . . 74.409999999999997 112.652 -170.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 53' ' ' PHE . 3.6 p -145.73 120.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.105 -0.952 . . . . 71.400000000000006 109.326 167.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -155.88 176.42 12.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.251 -0.886 . . . . 55.039999999999999 110.486 -171.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -90.17 109.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.456 -0.572 . . . . 74.109999999999999 109.456 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.709 HG22 ' HD3' ' A' ' 161' ' ' LYS . 27.6 mm -75.48 -49.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.628 -0.715 . . . . 74.430000000000007 110.871 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.709 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.78 140.55 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 109.92 178.201 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.503 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -144.01 134.91 25.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.846 0.355 . . . . 74.400000000000006 111.574 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -160.64 151.77 15.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 74.120000000000005 110.375 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 10.3 Cg_exo -70.73 142.23 43.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.832 2.355 . . . . 70.209999999999994 112.483 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.698 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 46.7 m -160.58 -162.4 0.95 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.383 -0.599 . . . . 62.100000000000001 109.383 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.02 38.96 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.565 -0.826 . . . . 72.349999999999994 112.412 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.37 103.93 2.1 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.676 -0.773 . . . . 75.129999999999995 111.791 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.9 129.34 48.03 Favored Glycine 0 C--O 1.236 0.262 0 C-N-CA 121.329 -0.462 . . . . 71.420000000000002 112.473 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -159.41 162.84 33.12 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.922 -0.656 . . . . 61.32 112.045 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.4 m -90.57 -48.44 7.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.922 0.391 . . . . 73.230000000000004 110.204 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.3 -64.87 3.43 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.898 -0.592 . . . . 72.510000000000005 112.408 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 105.78 -90.01 0.65 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.171 -0.772 . . . . 74.430000000000007 111.171 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 95.37 163.35 34.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.887 -0.673 . . . . 54.140000000000001 112.608 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 p -73.46 -36.72 65.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.922 0.391 . . . . 73.549999999999997 111.209 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -135.66 71.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 52.240000000000002 111.897 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.73 -158.77 12.95 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.643 -0.789 . . . . 42.439999999999998 112.413 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.09 -7.95 67.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.122 -0.561 . . . . 50.140000000000001 112.046 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.4 p -80.67 169.06 18.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.62 0.247 . . . . 75.540000000000006 110.982 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.98 135.8 21.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.048 -0.596 . . . . 72.549999999999997 112.483 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.77 60.41 0.26 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.228 -0.51 . . . . 44.049999999999997 111.889 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.03 24.63 9.93 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.362 -0.695 . . . . 53.219999999999999 111.362 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.9 m -84.93 139.22 31.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.808 0.337 . . . . 52.219999999999999 110.547 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.12 6.53 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.865 -0.684 . . . . 61.509999999999998 112.0 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 136' ' ' ILE . 4.2 m-20 -85.38 -175.25 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.123 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 170.08 142.95 3.74 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.719 -0.753 . . . . 61.229999999999997 111.515 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -82.44 -164.62 35.09 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.261 -0.971 . . . . 75.219999999999999 111.992 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.835 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.32 166.95 22.5 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.112 -0.329 . . . . 32.130000000000003 110.112 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.31 95.19 41.92 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-O 121.153 0.502 . . . . 73.0 110.336 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.683 ' HB2' HD13 ' A' ' 90' ' ' LEU . 55.6 Cg_endo -70.77 -19.37 31.41 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.914 2.409 . . . . 71.319999999999993 111.651 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.09 -37.53 66.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.903 -1.044 . . . . 72.099999999999994 111.522 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.518 HG13 HG12 ' A' ' 193' ' ' VAL . 30.4 pt -75.14 -13.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.175 -0.466 . . . . 63.130000000000003 111.75 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' HIS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 59.8 m170 63.02 70.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 73.540000000000006 111.231 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 191' ' ' ILE . 9.3 p -170.8 140.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 110.003 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.31 117.18 7.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 63.009999999999998 111.517 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.35 149.31 11.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.097 -0.705 . . . . 74.129999999999995 109.097 175.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 202' ' ' ARG . 29.0 m-85 -120.2 147.41 44.77 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.744 -0.207 . . . . 75.430000000000007 110.852 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.835 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.4 Cg_endo -63.67 -64.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.527 2.151 . . . . 72.310000000000002 112.025 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.73 26.55 4.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.215 0.531 . . . . 60.119999999999997 109.985 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.51 ' OD1' ' HD3' ' A' ' 202' ' ' ARG . 78.3 m-20 70.08 6.55 5.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.225 -0.898 . . . . 74.109999999999999 112.05 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.9 ptm -54.24 -34.28 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 64.040000000000006 112.198 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.96 10.91 71.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.358 -0.925 . . . . 72.319999999999993 113.222 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.51 ' HD3' ' OD1' ' A' ' 199' ' ' ASP . 4.7 ptm180 -127.21 -39.59 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.138 0.469 . . . . 75.540000000000006 110.501 176.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 203' ' ' LYS . 1.2 ptmm? . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.853 -0.594 . . . . 64.109999999999999 110.124 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.859 0.361 . . . . 74.409999999999997 110.265 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.15 91.8 7.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.103 0.478 . . . . 63.140000000000001 110.444 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.18 -36.24 14.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.656 -0.702 . . . . 35.039999999999999 110.273 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 77' ' ' ILE . 31.3 mm -129.7 126.76 22.77 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.171 -0.922 . . . . 64.340000000000003 109.805 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 32.5 Cg_endo -64.41 140.09 68.16 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.565 2.176 . . . . 62.439999999999998 112.303 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 19.0 Cg_exo -66.73 166.23 22.99 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.62 2.213 . . . . 74.329999999999998 111.774 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -53.22 104.43 0.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.11 0.481 . . . . 71.030000000000001 110.91 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -129.61 -156.55 0.76 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.572 -0.74 . . . . 63.299999999999997 109.525 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -83.6 90.82 7.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.078 0.942 . . . . 61.130000000000003 110.629 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.424 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 2.4 mp0 -100.6 135.47 20.13 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 114.138 -1.392 . . . . 70.400000000000006 109.031 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' CB ' ' HB2' ' A' ' 164' ' ' PRO . 82.2 Cg_exo -46.92 123.03 6.8 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.253 2.635 . . . . 61.219999999999999 113.061 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.75 -24.72 15.35 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.972 2.448 . . . . 74.239999999999995 113.279 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.796 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 1.6 t30 -131.87 146.66 52.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.574 -0.528 . . . . 64.109999999999999 109.574 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.688 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.0 m -131.72 144.17 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.311 0.577 . . . . 73.140000000000001 111.157 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 77.0 m-85 -97.71 120.41 38.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.632 -0.713 . . . . 73.230000000000004 110.701 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -107.57 103.81 13.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.043 -0.354 . . . . 63.210000000000001 110.043 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 22' ' ' ILE . 29.6 mt-10 -92.18 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.491 -0.559 . . . . 73.420000000000002 109.491 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -103.5 179.26 4.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.162 0.506 . . . . 72.109999999999999 111.534 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.436 ' HB3' HD11 ' A' ' 160' ' ' ILE . 11.5 p -73.62 -18.35 61.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 62.450000000000003 111.176 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.7 mmm -98.65 -35.86 10.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 73.319999999999993 111.201 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -172.4 -133.94 1.72 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.691 . . . . 63.210000000000001 111.817 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -141.4 133.83 29.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.075 -0.713 . . . . 54.299999999999997 109.075 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -127.76 126.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.757 -0.656 . . . . 51.520000000000003 109.777 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 10.9 t -108.44 135.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.553 -0.536 . . . . 71.430000000000007 109.553 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.24 162.21 39.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.346 0.593 . . . . 75.409999999999997 110.621 175.68 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 131' ' ' ARG . 2.7 pt-20 -140.42 164.6 29.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.91 -1.041 . . . . 65.530000000000001 109.398 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.28 175.37 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.891 0.377 . . . . 74.129999999999995 110.826 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.3 m-85 -88.92 101.49 14.12 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.31 0.576 . . . . 62.310000000000002 111.052 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.563 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -82.21 -2.13 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.261 -0.881 . . . . 74.030000000000001 110.486 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -75.07 -67.5 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 74.519999999999996 111.24 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -117.51 13.08 14.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 73.409999999999997 110.782 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -136.91 62.2 39.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.824 0.345 . . . . 62.130000000000003 110.945 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 18.5 Cg_exo -65.99 -50.96 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.591 2.194 . . . . 75.040000000000006 112.091 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -74.02 -35.08 64.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.401 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.4 m -62.96 -37.6 87.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.714 -0.675 . . . . 72.209999999999994 110.08 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.563 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 25.2 t -63.85 -39.58 94.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.79 -0.641 . . . . 75.209999999999994 110.925 175.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mmpt? -63.73 -39.66 94.83 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.831 -0.433 . . . . 73.230000000000004 109.831 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -53.7 -57.51 10.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.698 -0.683 . . . . 72.25 110.133 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 14' ' ' VAL . 17.3 t80 -59.29 -49.71 76.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 72.219999999999999 110.754 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.99 75.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.391 -0.822 . . . . 62.310000000000002 112.357 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.658 ' OE2' ' HD3' ' A' ' 44' ' ' ARG . 25.9 mm-40 -63.27 -41.93 99.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.638 -0.255 . . . . 74.349999999999994 111.602 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.6 mm? -69.29 -27.36 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.254 -0.578 . . . . 75.530000000000001 110.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.0 65.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 72.450000000000003 110.802 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.658 ' HD3' ' OE2' ' A' ' 41' ' ' GLU . 2.9 ptm180 -75.05 -29.39 60.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 74.310000000000002 111.39 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 1.3 tmt_? -65.23 -37.31 86.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.35 0.595 . . . . 73.319999999999993 109.854 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.5 32.14 2.2 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.587 -0.816 . . . . 65.109999999999999 111.987 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 42' ' ' LEU . 85.0 t80 -85.91 -44.31 12.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.015 0.436 . . . . 64.340000000000003 110.259 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -78.71 -9.27 59.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 111.041 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -77.62 8.01 4.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 51.039999999999999 110.402 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.83 16.27 1.98 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.871 -0.604 . . . . 50.409999999999997 111.891 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.68 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -97.95 159.45 14.92 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.707 -0.29 . . . . 64.540000000000006 110.832 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -140.63 146.82 38.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.81 0.338 . . . . 34.32 111.544 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 65.4 m-85 -78.48 100.91 7.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.407 -0.961 . . . . 75.200000000000003 108.407 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -109.98 -14.56 14.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.471 -0.492 . . . . 74.340000000000003 111.671 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.948 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 12.7 mmm180 -110.03 112.92 25.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.092 -0.707 . . . . 53.229999999999997 109.092 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD13 HG23 ' A' ' 62' ' ' ILE . 19.7 mm -124.84 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.348 -0.612 . . . . 65.420000000000002 109.348 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 10.8 mt -102.0 115.49 43.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.652 -0.499 . . . . 65.340000000000003 109.652 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 146' ' ' GLU . 38.7 mtpt -57.13 129.27 41.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.127 0.267 . . . . 63.149999999999999 111.269 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.99 26.69 16.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.545 -0.752 . . . . 71.409999999999997 110.979 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -128.93 -81.71 0.57 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 74.319999999999993 109.976 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -161.04 159.71 29.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 73.310000000000002 110.325 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.581 HD11 ' HA3' ' A' ' 143' ' ' GLY . 62.4 mt -128.78 103.48 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 73.439999999999998 109.382 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.948 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 50.9 mt-30 -85.6 124.53 32.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.606 -0.725 . . . . 60.140000000000001 111.526 -176.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.02 139.16 10.74 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.754 -0.657 . . . . 43.119999999999997 112.487 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.68 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 142.96 -154.77 25.58 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.466 -0.873 . . . . 71.25 112.85 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 69' ' ' GLY . 34.1 t0 55.78 102.6 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.355 1.062 . . . . 72.219999999999999 112.714 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' CZ ' ' A' ' 47' ' ' TYR . 88.6 Cg_endo -79.77 -17.16 11.17 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.102 2.535 . . . . 75.120000000000005 111.515 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.9 p -90.3 -38.27 13.5 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.787 -0.642 . . . . 54.299999999999997 110.305 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 78.28 25.85 60.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 71.200000000000003 111.359 -176.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 76.1 p -97.96 -35.24 10.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 72.340000000000003 111.078 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.87 -20.85 6.71 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.668 -0.696 . . . . 41.25 112.274 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 7.2 ptm180 -93.57 -28.0 16.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 75.219999999999999 110.934 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.76 -179.52 53.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.7 -0.762 . . . . 51.240000000000002 111.831 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . -79.74 -87.52 0.54 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.861 -0.685 . . . . 63.310000000000002 112.371 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.44 27.07 4.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.845 0.831 . . . . 63.539999999999999 111.228 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -85.99 16.39 4.23 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.041 -0.981 . . . . 52.200000000000003 111.754 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.591 HG13 ' HD1' ' A' ' 78' ' ' TYR . 46.4 pt -81.85 -29.53 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.715 -0.394 . . . . 71.310000000000002 110.143 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG13 ' A' ' 77' ' ' ILE . 2.9 p90 -117.95 14.05 14.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.924 0.868 . . . . 74.510000000000005 110.521 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -77.06 1.81 Allowed Glycine 0 C--N 1.318 -0.441 0 CA-C-N 114.59 -1.186 . . . . 72.430000000000007 113.425 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -111.98 -163.85 0.88 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.272 -0.27 . . . . 70.530000000000001 110.272 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 5.0 pm0 -86.61 168.0 14.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.647 . . . . 73.129999999999995 109.252 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -98.88 -80.1 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.77 -0.372 . . . . 75.010000000000005 111.308 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.51 163.57 27.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.964 -0.754 . . . . 71.0 108.964 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.34 143.66 34.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 74.430000000000007 109.756 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 23.8 7.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.75 -0.659 . . . . 74.129999999999995 109.604 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 127' ' ' THR . 78.2 mt -54.51 100.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.52 -0.764 . . . . 71.200000000000003 111.648 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.61 91.33 0.43 Allowed Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.39 -0.823 . . . . 71.400000000000006 109.412 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' LEU . 19.2 Cg_endo -57.6 92.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.611 2.207 . . . . 44.420000000000002 111.071 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.28 23.3 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.145 0.974 . . . . 75.510000000000005 109.146 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -145.3 -176.88 5.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.361 -1.29 . . . . 73.439999999999998 108.625 -178.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HD3' HG22 ' A' ' 93' ' ' THR . 54.2 tttm -113.61 147.88 37.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.324 0.583 . . . . 62.439999999999998 110.938 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.24 79.99 4.67 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.091 0.948 . . . . 74.329999999999998 108.481 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.426 HG22 ' HD3' ' A' ' 91' ' ' LYS . 26.8 p -75.65 -41.95 52.69 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.612 -1.176 . . . . 74.319999999999993 111.838 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.795 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.83 -137.79 2.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.658 -0.782 . . . . 74.049999999999997 112.293 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.77 147.29 24.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.815 0.341 . . . . 40.210000000000001 110.891 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 106.41 21.95 8.08 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.446 -0.662 . . . . 75.109999999999999 111.446 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 mm -90.03 110.9 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.479 -0.563 . . . . 72.140000000000001 109.479 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -85.89 117.77 24.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.76 -0.654 . . . . 73.209999999999994 109.538 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.0 169.81 12.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.125 0.488 . . . . 52.030000000000001 111.854 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.845 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 14.0 tpt -90.45 135.4 33.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.412 -0.813 . . . . 75.239999999999995 109.983 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -97.86 149.33 22.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.522 -0.548 . . . . 74.200000000000003 109.522 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -163.11 159.26 22.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 73.109999999999999 110.7 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.39 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.627 0.727 . . . . 73.439999999999998 109.814 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -137.31 177.76 19.56 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.988 -1.645 . . . . 64.430000000000007 108.988 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 -51.84 9.72 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.021 2.481 . . . . 55.310000000000002 112.86 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.7 -4.83 29.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 71.140000000000001 111.59 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 2.2 m -88.81 49.68 1.83 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.327 0.584 . . . . 72.549999999999997 109.469 -175.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -74.27 -66.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.806 -1.088 . . . . 51.509999999999998 110.944 178.357 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 -100.77 2.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.625 -0.797 . . . . 71.25 112.343 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -152.87 35.94 0.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.012 0.434 . . . . 61.409999999999997 110.81 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 19.9 mt-30 -102.54 146.56 27.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 74.510000000000005 110.186 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -142.44 166.9 23.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.711 0.291 . . . . 61.229999999999997 110.795 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -158.59 153.23 24.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.926 0.393 . . . . 74.409999999999997 111.004 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 HD23 ' A' ' 98' ' ' LEU . 17.7 t -108.62 145.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 72.219999999999999 109.265 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -99.88 129.67 45.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.897 0.379 . . . . 54.439999999999998 110.452 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 62' ' ' ILE . 64.7 mt -84.79 -9.63 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 110.984 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.32 164.18 28.03 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.9 -0.591 . . . . 62.399999999999999 110.054 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 35.5 Cg_exo -60.98 114.52 2.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.454 2.103 . . . . 62.140000000000001 111.493 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.7 p -100.12 94.56 6.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.277 0.561 . . . . 74.549999999999997 111.189 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.11 14.56 27.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 72.109999999999999 110.104 -177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.59 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.6 p90 -118.29 -3.36 11.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.026 -0.988 . . . . 73.450000000000003 110.495 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.601 HD22 ' HD2' ' A' ' 126' ' ' HIS . 83.5 mt -105.06 8.82 34.44 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.792 -0.64 . . . . 74.209999999999994 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.1 -23.58 55.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.064 -1.425 . . . . 75.140000000000001 111.315 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.29 23.22 3.49 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 120.874 -0.679 . . . . 72.400000000000006 111.983 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.45 -32.95 3.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.936 0.398 . . . . 72.209999999999994 110.279 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.601 ' HD2' HD22 ' A' ' 122' ' ' LEU . 96.9 m-70 -141.24 139.53 33.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.322 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 86' ' ' LEU . 23.7 m -75.46 135.98 40.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.777 -0.453 . . . . 61.329999999999998 109.777 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -115.46 124.75 72.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 121.058 -0.257 . . . . 74.25 110.828 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.845 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 3.8 p90 -157.4 74.07 0.75 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.949 0.88 . . . . 65.209999999999994 110.932 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.83 152.39 22.55 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.01 -1.567 . . . . 74.120000000000005 113.841 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.631 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -138.62 110.2 7.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 74.549999999999997 109.726 174.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.9 p -79.93 139.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 44.439999999999998 111.264 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.633 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.1 t -142.47 151.71 42.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.096 -0.502 . . . . 51.219999999999999 109.892 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 42.42 60.07 2.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.258 0.623 . . . . 73.209999999999994 112.15 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.54 24.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.035 -1.079 . . . . 71.230000000000004 112.883 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -78.02 -32.51 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.109 -0.33 . . . . 73.549999999999997 110.109 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.46 -37.35 94.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.949 -0.644 . . . . 64.25 111.934 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.502 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 74.9 mmm -67.02 -51.1 59.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.511 -0.551 . . . . 53.420000000000002 109.511 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 62' ' ' ILE . 74.8 t -54.21 -32.92 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 64.099999999999994 110.586 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.8 t30 -71.29 -56.08 6.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 60.020000000000003 110.656 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.8 -13.8 61.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.463 -0.335 . . . . 70.349999999999994 111.307 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 145' ' ' VAL . 44.6 t -88.82 -36.62 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 63.25 110.505 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.581 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -83.52 -18.98 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 72.120000000000005 113.2 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 60.5 mtp -89.87 -8.76 51.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.2 0.444 . . . . 73.25 112.2 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.1 m -87.09 160.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.468 . . . . 52.240000000000002 110.737 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.666 ' HB3' ' HD2' ' A' ' 58' ' ' LYS . 15.2 pt-20 -141.93 -49.82 0.39 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.141 -0.481 . . . . 63.149999999999999 110.583 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 16.8 p -119.04 146.02 45.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.751 0.31 . . . . 64.010000000000005 111.156 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 154' ' ' VAL . 32.1 p-10 -92.56 -32.52 14.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.329 0.492 . . . . 65.340000000000003 112.329 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.6 m -147.06 -67.37 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.984 0.421 . . . . 72.450000000000003 110.226 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' A' ' 147' ' ' THR . 28.9 mm-40 -101.8 -157.01 0.58 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.892 -0.781 . . . . 64.120000000000005 108.892 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.6 59.7 2.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.077 0.942 . . . . 74.430000000000007 109.72 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.545 ' HG3' ' OD1' ' A' ' 148' ' ' ASN . 12.2 ptp180 -138.72 135.51 17.9 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.302 -1.317 . . . . 62.219999999999999 108.735 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 16.8 Cg_exo -65.4 149.03 88.53 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.643 2.229 . . . . 65.540000000000006 113.671 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 148' ' ' ASN . 40.7 t -65.63 151.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.433 -0.803 . . . . 73.310000000000002 110.191 175.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.64 137.59 48.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.302 -0.408 . . . . 54.229999999999997 110.014 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -71.74 145.85 48.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.54 -0.541 . . . . 61.329999999999998 109.54 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.99 125.93 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.057 -0.52 . . . . 61.299999999999997 110.644 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.95 159.37 19.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.265 0.555 . . . . 64.519999999999996 111.443 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.3 mp -87.74 102.4 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.644 -1.162 . . . . 50.439999999999998 108.494 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 19' ' ' SER . 30.7 mm -68.21 -56.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.537 -0.756 . . . . 74.409999999999997 110.009 -176.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 14.5 mptt -127.4 136.97 52.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 72.299999999999997 109.998 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.81 115.96 15.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.939 0.399 . . . . 70.230000000000004 110.385 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.62 116.3 26.59 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.64 . . . . 72.0 110.918 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 14' ' ' VAL . 56.8 Cg_endo -73.02 126.91 11.62 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.172 1.915 . . . . 73.409999999999997 111.413 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.7 m -158.86 -80.78 0.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 64.439999999999998 111.339 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.796 ' HA2' ' HB3' ' A' ' 13' ' ' ASN . . . 132.8 161.44 9.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.914 -0.66 . . . . 65.230000000000004 111.477 -175.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -149.09 -69.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.57 -0.824 . . . . 30.199999999999999 112.506 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.87 -83.03 0.94 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 60.119999999999997 112.388 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.85 152.86 8.7 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.698 . . . . 64.329999999999998 112.098 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -106.95 -35.16 6.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 55.350000000000001 110.166 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 103.78 -124.96 8.26 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.865 -0.607 . . . . 75.030000000000001 112.339 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 65.6 -131.51 34.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.019 -0.61 . . . . 71.430000000000007 112.032 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.56 -63.86 2.23 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.756 -0.735 . . . . 63.119999999999997 112.601 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.0 p 50.31 91.41 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.607 0.763 . . . . 74.310000000000002 112.058 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -149.32 134.01 4.72 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.852 -0.689 . . . . 55.210000000000001 112.006 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.32 123.87 6.32 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.796 -0.716 . . . . 74.319999999999993 111.678 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.46 -113.38 4.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 73.530000000000001 111.987 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 12.1 t -84.93 132.59 34.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.797 0.332 . . . . 74.340000000000003 110.168 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.08 145.78 38.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.67 -0.776 . . . . 70.010000000000005 111.996 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.73 153.88 22.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.837 -0.697 . . . . 74.120000000000005 111.898 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.82 -44.44 3.63 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.716 -0.754 . . . . 25.219999999999999 111.841 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.5 m 64.4 12.16 7.08 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.971 0.509 . . . . 64.129999999999995 111.871 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -165.04 171.91 40.55 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.111 -0.566 . . . . 51.240000000000002 112.082 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.93 -173.8 2.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.324 0.583 . . . . 74.319999999999993 111.454 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.24 145.53 4.36 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.118 -0.947 . . . . 62.340000000000003 111.188 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.49 -161.77 15.64 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.549 -0.834 . . . . 72.510000000000005 112.065 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.721 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.92 -177.12 6.58 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 110.326 -0.25 . . . . 40.399999999999999 110.326 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.86 91.96 28.27 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 109.648 -0.501 . . . . 64.230000000000004 109.648 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.6 Cg_exo -78.67 -12.18 15.18 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.899 2.4 . . . . 73.200000000000003 112.148 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.88 -36.51 70.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.95 -0.568 . . . . 71.349999999999994 109.997 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.2 pt -88.07 156.15 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.98 -0.748 . . . . 73.030000000000001 108.98 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -105.32 89.06 3.01 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.374 -0.53 . . . . 73.340000000000003 110.291 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 194' ' ' ALA . 9.7 p -163.92 170.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.83 -0.804 . . . . 71.310000000000002 108.83 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -94.9 115.72 27.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.865 0.364 . . . . 71.420000000000002 111.05 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.655 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -144.18 153.27 41.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.449 -0.945 . . . . 75.219999999999999 108.449 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.98 139.03 34.5 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.79 0.329 . . . . 75.349999999999994 111.034 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.8 Cg_endo -63.26 -54.13 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.713 2.275 . . . . 74.209999999999994 112.06 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.48 35.31 0.96 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.455 -0.339 . . . . 62.329999999999998 111.457 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.546 ' OD2' ' HD3' ' A' ' 202' ' ' ARG . 7.4 t70 75.77 -14.05 0.82 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.074 0.55 . . . . 64.400000000000006 111.66 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.5 ptm -46.1 -29.93 1.71 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.877 1.066 . . . . 72.200000000000003 113.877 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -111.09 10.72 29.23 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 72.340000000000003 113.254 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.546 ' HD3' ' OD2' ' A' ' 199' ' ' ASP . 44.0 mtp180 -72.43 -38.42 68.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 117.62 0.71 . . . . 70.239999999999995 111.91 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 203' ' ' LYS . 3.7 mppt? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.747 -0.645 . . . . 75.439999999999998 110.633 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.078 0.466 . . . . 72.230000000000004 110.022 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.14 160.77 14.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.976 -0.556 . . . . 50.299999999999997 110.354 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.81 55.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.17 -0.468 . . . . 74.150000000000006 110.672 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.455 HD13 HG12 ' A' ' 77' ' ' ILE . 71.7 mt 70.0 99.27 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 O-C-N 123.911 0.757 . . . . 65.219999999999999 111.296 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -89.34 132.03 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.041 2.494 . . . . 71.299999999999997 113.034 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' HG3' ' HD2' ' A' ' 37' ' ' LYS . 62.8 Cg_endo -78.38 -41.69 0.26 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.628 2.219 . . . . 74.140000000000001 112.528 176.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.09 -95.57 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.312 0.645 . . . . 73.420000000000002 112.653 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.1 m -76.89 -26.66 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 63.310000000000002 111.689 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' PRO . 1.8 t-105 -105.31 113.8 27.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.054 0.454 . . . . 75.129999999999995 110.506 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.8 93.64 4.81 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.658 -0.701 . . . . 62.340000000000003 110.743 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 4.2 Cg_endo -86.64 113.33 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.696 2.93 . . . . 53.210000000000001 113.068 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 6.2 Cg_exo -75.15 -44.85 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.811 2.341 . . . . 62.439999999999998 112.263 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -124.88 144.39 50.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 72.329999999999998 110.458 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.79 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.4 m -133.23 162.91 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 64.109999999999999 110.394 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -122.33 134.86 54.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.064 0.459 . . . . 74.310000000000002 110.376 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.4 mt -111.87 107.98 17.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 71.109999999999999 109.391 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -92.24 119.46 31.87 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.428 -0.582 . . . . 63.210000000000001 109.428 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.402 HG22 HG13 ' A' ' 159' ' ' ILE . 69.1 p -109.07 178.3 4.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.141 0.496 . . . . 71.25 110.986 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 t -67.27 -15.89 63.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 110.442 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.587 ' HG3' HG22 ' A' ' 142' ' ' VAL . 5.7 mmt -95.55 -34.62 11.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.007 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.18 -130.79 1.87 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.086 -0.806 . . . . 63.240000000000002 111.086 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.236 0.541 . . . . 64.230000000000004 110.486 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.96 114.13 37.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.429 -0.805 . . . . 65.230000000000004 109.767 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 41.3 t -96.4 141.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.839 -0.619 . . . . 75.230000000000004 109.374 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.1 163.79 36.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.137 0.494 . . . . 65.200000000000003 111.015 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.17 162.92 30.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.505 -0.77 . . . . 71.239999999999995 109.892 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 166.04 10.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.764 -0.653 . . . . 72.099999999999994 109.394 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 5.3 m-85 -85.75 93.5 8.88 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 74.010000000000005 111.702 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.845 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -79.47 -8.75 59.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.743 0.782 . . . . 70.209999999999994 109.343 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HE2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -70.34 -45.01 67.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.384 -1.28 . . . . 73.230000000000004 111.658 -173.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -137.86 8.61 2.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.807 0.299 . . . . 71.310000000000002 111.807 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.22 67.27 10.69 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.835 0.679 . . . . 60.399999999999999 112.835 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.49 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 21.3 Cg_exo -65.54 -27.4 53.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.025 1.817 . . . . 43.310000000000002 110.996 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -62.87 -59.48 4.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 64.310000000000002 110.892 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -62.67 -36.34 82.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.597 . . . . 75.319999999999993 110.208 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.845 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 39.5 t -53.73 -53.47 51.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.238 -0.892 . . . . 70.209999999999994 111.278 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.63 ' HD2' ' HG3' ' A' ' 6' ' ' PRO . 3.0 mtmp? -69.88 -27.28 64.68 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.789 -0.364 . . . . 74.420000000000002 111.666 -173.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' O ' HD23 ' A' ' 42' ' ' LEU . 59.8 t30 -59.48 -49.83 76.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.489 -0.56 . . . . 64.299999999999997 109.489 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.79 ' HE1' HG21 ' A' ' 14' ' ' VAL . 12.3 t80 -68.81 -51.33 41.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.852 176.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.54 -44.86 77.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 63.439999999999998 112.985 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 43.4 mt-10 -77.77 -26.59 49.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 121.126 -0.229 . . . . 72.109999999999999 111.572 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 38' ' ' ASN . 3.2 mm? -78.99 -20.88 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.788 -0.765 . . . . 72.030000000000001 110.428 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.38 -44.31 36.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 110.951 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.711 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -62.98 -36.76 84.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.629 -0.26 . . . . 71.349999999999994 111.314 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -72.77 -46.93 50.76 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.203 -0.599 . . . . 74.310000000000002 109.423 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.33 42.83 1.03 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.522 -0.847 . . . . 72.209999999999994 113.46 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HD1' ' HG3' ' A' ' 67' ' ' PRO . 1.2 m-85 -77.45 -15.95 59.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 73.319999999999993 110.405 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.82 0.27 51.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.761 -0.654 . . . . 62.439999999999998 111.001 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 48.7 m-80 -81.81 2.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 109.868 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -134.71 14.05 4.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.002 -0.618 . . . . 64.329999999999998 112.176 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.6 p -88.83 149.22 23.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.661 0.267 . . . . 54.210000000000001 110.46 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -138.65 128.42 25.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.553 -0.294 . . . . 71.239999999999995 110.556 -176.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 61.0 m-85 -67.07 110.74 3.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.97 -0.752 . . . . 75.400000000000006 108.97 175.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -111.86 -18.48 12.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.835 -0.346 . . . . 74.319999999999993 111.133 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.5 mmt85 -110.34 105.27 14.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.523 -0.547 . . . . 74.120000000000005 109.523 173.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.16 91.2 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.907 -0.775 . . . . 71.319999999999993 108.907 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.1 mt -102.8 119.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.739 -0.664 . . . . 73.439999999999998 109.262 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -52.02 139.25 23.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.446 0.466 . . . . 55.509999999999998 110.219 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 44.21 33.79 0.89 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.384 1.052 . . . . 75.340000000000003 112.6 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -131.54 -82.92 0.51 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.385 0.612 . . . . 71.0 110.213 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.539 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptm -159.76 156.59 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.804 . . . . 62.43 110.812 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 116' ' ' LEU . 43.1 mt -129.37 103.26 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.519 -0.764 . . . . 73.400000000000006 108.943 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 42.7 tt0 -87.93 124.61 33.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.764 -0.653 . . . . 74.219999999999999 111.835 -173.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.79 113.57 4.03 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.061 -0.815 . . . . 44.439999999999998 111.061 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.8 157.61 43.83 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.706 -0.283 . . . . 74.109999999999999 112.667 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.66 156.56 90.61 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 123.804 0.355 . . . . 72.209999999999994 111.492 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HG3' ' HD1' ' A' ' 47' ' ' TYR . 23.7 Cg_endo -58.71 -21.86 58.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.723 2.949 . . . . 70.120000000000005 113.521 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -86.66 -30.43 21.73 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.644 -0.502 . . . . 73.209999999999994 109.644 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.94 71.08 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.725 -0.75 . . . . 75.010000000000005 111.642 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.3 p -88.56 -32.14 18.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.56 0.695 . . . . 71.120000000000005 109.401 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.1 46.65 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.881 -1.054 . . . . 52.509999999999998 111.674 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -119.83 -2.97 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.761 0.282 . . . . 63.130000000000003 111.761 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.75 -155.3 11.68 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.607 -0.806 . . . . 74.099999999999994 112.557 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.4 167.65 42.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.337 -0.935 . . . . 74.439999999999998 111.639 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 55.2 -96.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.785 0.434 . . . . 71.150000000000006 110.925 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m 69.07 -31.79 0.21 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.86 0.864 . . . . 75.430000000000007 113.126 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.455 HG12 HD13 ' A' ' 4' ' ' ILE . 5.9 tt -55.84 -42.76 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.575 0.583 . . . . 64.120000000000005 112.575 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.571 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 13.8 p90 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.421 0.629 . . . . 75.140000000000001 110.774 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 112.3 -104.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 112.336 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 39.5 mtmt -125.68 -162.05 1.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.317 -0.623 . . . . 74.420000000000002 109.317 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -66.57 157.13 33.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.901 -0.778 . . . . 74.409999999999997 108.901 174.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -117.57 -54.24 2.37 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.646 -0.421 . . . . 73.310000000000002 111.417 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -166.61 -175.87 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.437 -0.579 . . . . 74.099999999999994 109.437 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -83.93 132.31 34.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 71.140000000000001 110.037 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB2' HG21 ' A' ' 127' ' ' THR . 35.2 mm-40 -96.93 8.76 43.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.787 -0.642 . . . . 63.009999999999998 109.671 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.21 105.63 0.52 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.84 -0.618 . . . . 72.319999999999993 111.893 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -163.2 80.97 1.58 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 71.109999999999999 109.571 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.05 88.32 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.012 1.808 . . . . 63.509999999999998 111.578 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.7 -18.69 37.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.112 0.958 . . . . 74.430000000000007 109.377 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.7 pp -101.18 -178.84 3.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.52 -1.218 . . . . 63.32 108.75 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -138.35 147.78 43.86 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.121 -0.632 . . . . 73.409999999999997 110.416 171.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 120' ' ' GLN . 1.2 p90 -62.8 109.38 1.42 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.801 0.81 . . . . 71.010000000000005 110.726 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -99.26 -44.99 6.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.228 -0.896 . . . . 52.43 110.428 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.66 -139.25 2.77 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.725 -0.75 . . . . 72.340000000000003 112.389 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.12 145.6 26.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.63 0.253 . . . . 63.200000000000003 110.687 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.66 22.26 7.45 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.648 -0.787 . . . . 71.340000000000003 111.618 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HG3' ' A' ' 189' ' ' PRO . 9.9 mm -84.76 109.68 18.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.214 -0.662 . . . . 74.299999999999997 109.214 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -84.87 115.18 22.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.006 -0.543 . . . . 73.109999999999999 109.569 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.79 176.84 7.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 70.310000000000002 110.855 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 26.7 ttt -104.19 142.07 35.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 72.409999999999997 111.145 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -97.97 141.89 30.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.471 . . . . 71.010000000000005 110.174 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -157.78 160.6 37.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.738 -0.665 . . . . 74.400000000000006 110.132 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.73 -9.02 25.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.613 0.721 . . . . 54.329999999999998 110.333 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.99 169.38 40.23 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.107 -1.597 . . . . 70.230000000000004 109.107 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.18 -42.49 46.59 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.098 2.532 . . . . 72.010000000000005 112.794 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -103.03 -5.45 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 64.409999999999997 111.806 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -84.94 48.4 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.432 0.634 . . . . 63.140000000000001 110.061 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -89.73 121.54 31.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.892 . . . . 73.109999999999999 109.712 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.01 -94.79 2.21 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.659 -0.781 . . . . 43.329999999999998 112.452 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 18.0 t -140.87 6.92 2.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.377 0.608 . . . . 74.409999999999997 109.999 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 19.4 mp0 -81.02 143.91 32.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.696 -0.684 . . . . 74.099999999999994 110.363 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 m-85 -144.24 162.32 36.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.369 -0.234 . . . . 74.239999999999995 110.369 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 41.9 p90 -154.02 157.21 38.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 70.099999999999994 111.148 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.693 HG22 HD23 ' A' ' 98' ' ' LEU . 18.2 t -112.11 145.88 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.928 -0.578 . . . . 71.310000000000002 109.444 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -99.52 130.38 45.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.952 0.406 . . . . 64.019999999999996 110.141 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 62' ' ' ILE . 59.5 mt -84.46 -7.1 59.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 51.229999999999997 110.775 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.39 163.35 24.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 34.32 109.929 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.25 113.12 2.75 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.602 2.201 . . . . 73.409999999999997 112.203 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.1 p -103.08 110.66 22.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 72.519999999999996 110.393 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -99.59 15.82 25.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.332 0.587 . . . . 75.430000000000007 110.82 -170.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.591 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.4 p90 -121.32 -2.65 9.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.467 -0.788 . . . . 74.129999999999995 110.89 -175.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.8 mt -102.97 7.93 39.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 43.539999999999999 110.475 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.89 -15.38 62.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.045 -0.98 . . . . 52.200000000000003 111.74 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.39 19.69 3.8 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.805 -0.712 . . . . 22.210000000000001 111.695 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -121.04 -28.8 4.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.266 0.555 . . . . 52.350000000000001 109.958 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.499 ' HD2' HD22 ' A' ' 122' ' ' LEU . 93.5 m-70 -138.64 144.55 39.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.489 -0.778 . . . . 73.409999999999997 109.376 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.407 HG21 ' HB2' ' A' ' 85' ' ' GLU . 14.5 t -85.37 145.19 27.61 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.398 -0.593 . . . . 75.140000000000001 109.398 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' A' ' 99' ' ' ALA . 31.4 mt -126.06 116.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.349 -0.387 . . . . 71.239999999999995 110.751 -176.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -154.41 74.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.456 0.472 . . . . 74.109999999999999 110.863 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.739 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.35 157.35 29.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.24 -0.981 . . . . 52.100000000000001 112.882 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 30.5 mtp180 -137.89 118.88 14.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.979 -0.378 . . . . 74.450000000000003 109.979 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.5 p -81.76 138.36 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 54.119999999999997 110.411 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.3 t -143.23 142.85 31.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.034 -0.53 . . . . 52.439999999999998 110.132 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.6 tt0 54.23 35.99 23.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.345 0.593 . . . . 61.140000000000001 112.035 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.12 29.41 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.236 -0.983 . . . . 75.109999999999999 112.565 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -83.39 -30.33 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 73.340000000000003 110.121 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.03 -31.65 81.59 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.659 . . . . 60.009999999999998 111.586 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.1 mmm -72.18 -49.35 36.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.486 -0.561 . . . . 72.319999999999993 109.486 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.476 HG13 HD12 ' A' ' 62' ' ' ILE . 61.8 t -55.0 -31.82 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.196 0.522 . . . . 75.310000000000002 110.508 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.04 -52.41 24.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.867 -0.606 . . . . 54.049999999999997 110.638 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -15.23 61.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.397 -0.365 . . . . 74.430000000000007 111.394 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.7 t -86.58 -38.82 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.31 -0.405 . . . . 74.530000000000001 110.555 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.83 -12.68 68.31 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.641 -0.79 . . . . 73.239999999999995 112.831 -176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.2 ptm -82.0 -17.17 47.79 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.622 -0.34 . . . . 73.409999999999997 110.806 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 142' ' ' VAL . 19.2 m -77.88 162.63 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.675 -0.41 . . . . 74.010000000000005 110.798 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.93 -61.73 0.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 72.209999999999994 111.041 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 17.2 p -130.68 147.35 52.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.11 0.481 . . . . 52.350000000000001 111.663 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -97.81 100.49 11.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.666 . . . . 71.409999999999997 110.869 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.3 t 69.36 -67.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.771 0.669 . . . . 63.130000000000003 111.41 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.527 ' O ' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -90.94 -177.13 4.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.932 -0.766 . . . . 52.109999999999999 108.932 176.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.14 53.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 75.340000000000003 110.516 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 152' ' ' ARG . 12.4 ptm85 -122.21 130.9 24.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.915 -1.039 . . . . 71.109999999999999 108.766 176.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.81 141.72 92.53 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.653 2.235 . . . . 74.019999999999996 112.219 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.0 t -61.39 150.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 71.510000000000005 109.671 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.24 173.99 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.33 0.586 . . . . 61.109999999999999 111.652 -174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.8 130.87 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 71.230000000000004 112.589 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.44 110.96 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.99 -1.115 . . . . 70.120000000000005 107.99 170.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.41 155.91 28.82 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.363 -0.535 . . . . 72.209999999999994 111.427 -168.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.4 mp -85.13 109.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.801 -1.091 . . . . 64.450000000000003 109.391 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.4 mm -71.49 -49.98 43.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.478 -0.783 . . . . 62.229999999999997 110.497 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.93 130.34 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.824 -0.625 . . . . 74.340000000000003 110.758 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.31 112.71 11.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.84 0.352 . . . . 21.510000000000002 110.537 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -142.15 152.35 61.14 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.64 -0.709 . . . . 64.25 110.032 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 30.9 Cg_endo -67.24 131.7 25.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.374 2.049 . . . . 64.219999999999999 111.984 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.4 ' H ' ' HA ' ' A' ' 14' ' ' VAL . 32.4 t -107.59 1.62 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.692 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.42 -78.35 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.747 -0.739 . . . . 13.41 111.829 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.76 -155.08 16.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.748 -0.739 . . . . 63.43 112.442 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.08 -106.92 3.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.012 -0.613 . . . . 64.200000000000003 111.885 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.31 176.49 15.17 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.892 -0.67 . . . . 25.309999999999999 112.091 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.0 t -156.21 104.44 2.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.868 -0.419 . . . . 74.400000000000006 109.868 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 145.64 -134.86 5.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.763 -0.732 . . . . 63.450000000000003 112.073 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.21 159.74 32.31 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.916 -0.659 . . . . 74.019999999999996 111.906 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.53 167.61 13.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.787 -0.721 . . . . 73.109999999999999 111.998 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.3 m -128.08 111.92 14.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.892 -0.41 . . . . 52.520000000000003 109.892 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.35 169.01 22.25 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.952 -0.642 . . . . 65.120000000000005 112.643 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.48 49.53 0.84 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.156 -0.545 . . . . 64.239999999999995 111.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -161.11 169.77 36.77 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 121.078 -0.582 . . . . 23.199999999999999 111.674 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -75.52 138.77 41.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.58 0.229 . . . . 62.420000000000002 110.679 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.78 -105.31 2.91 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.757 -0.735 . . . . 75.409999999999997 111.909 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.91 -86.75 1.35 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.038 -0.601 . . . . 74.420000000000002 111.872 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 179.38 69.21 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.772 -0.728 . . . . 72.030000000000001 112.269 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.9 t -107.99 107.75 18.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.853 -0.795 . . . . 71.409999999999997 108.853 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.95 6.39 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.746 -0.74 . . . . 54.240000000000002 112.309 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.7 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -100.19 178.0 4.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.329 0.585 . . . . 55.140000000000001 110.991 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 142.3 135.74 3.13 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.968 -1.014 . . . . 61.32 110.879 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.16 -176.7 51.42 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.265 -0.969 . . . . 70.299999999999997 111.775 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.809 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.44 145.52 47.55 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.691 -0.485 . . . . 64.230000000000004 109.691 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 98.3 m-85 -97.81 105.06 24.58 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-O 121.182 0.515 . . . . 61.350000000000001 110.368 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.71 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.6 Cg_endo -83.58 -7.44 10.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.215 2.61 . . . . 71.420000000000002 111.313 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.06 -35.05 20.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.105 -0.952 . . . . 71.329999999999998 110.789 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 193' ' ' VAL . 21.4 pt -74.63 -13.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 64.310000000000002 110.483 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 47.3 m170 61.59 54.96 2.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.835 -1.075 . . . . 54.43 111.236 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.561 HG12 HG13 ' A' ' 191' ' ' ILE . 9.9 p -150.16 141.15 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.512 . . . . 63.109999999999999 109.875 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.28 110.14 5.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 74.030000000000001 111.425 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.64 155.89 30.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.312 -0.625 . . . . 73.409999999999997 109.312 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.478 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 24.5 m-85 -118.44 154.11 52.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.651 -0.249 . . . . 71.120000000000005 111.266 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 44.4 Cg_endo -68.4 -75.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.413 2.075 . . . . 62.109999999999999 112.138 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 199' ' ' ASP . 1.4 pt? -127.66 32.07 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.726 -0.215 . . . . 74.299999999999997 110.982 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 198' ' ' LEU . 11.5 t70 77.01 -6.21 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.174 0.435 . . . . 44.130000000000003 112.174 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.8 ptm -49.5 -28.39 5.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.214 0.82 . . . . 50.140000000000001 113.214 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.04 2.82 35.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.186 -1.007 . . . . 60.520000000000003 113.331 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.478 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 44.5 mtp-105 -84.85 -63.34 1.35 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.759 0.79 . . . . 75.540000000000006 109.798 176.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 203' ' ' LYS . 18.1 mmmt . . . . . 0 C--O 1.246 0.891 0 CA-C-N 112.779 -2.01 . . . . 74.209999999999994 111.754 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.607 0.241 . . . . 64.5 110.755 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' HA ' ' HZ ' ' A' ' 82' ' ' PHE . . . -97.87 167.3 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 63.229999999999997 109.982 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.71 162.52 27.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.933 -0.121 . . . . 54.340000000000003 111.034 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.528 HD11 HG13 ' A' ' 77' ' ' ILE . 53.3 mt 73.03 115.11 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 O-C-N 124.127 0.892 . . . . 75.239999999999995 111.692 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 22.3 Cg_exo -65.98 149.12 86.36 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.84 2.36 . . . . 72.230000000000004 112.325 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 7.6 Cg_exo -74.81 38.13 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.582 2.855 . . . . 75.099999999999994 113.225 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' O ' ' HD1' ' A' ' 9' ' ' TRP . 35.3 m-20 -92.49 -9.27 42.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 75.439999999999998 110.6 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.521 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.0 p -69.3 99.04 1.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 73.439999999999998 111.061 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.462 ' HD1' ' O ' ' A' ' 7' ' ' ASP . 15.8 p-90 -117.7 4.24 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 75.439999999999998 110.199 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -51.93 142.76 25.02 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 114.995 -1.002 . . . . 70.519999999999996 112.25 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 11.9 Cg_exo -35.76 123.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.987 3.791 . . . . 74.349999999999994 114.26 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 86.3 Cg_endo -78.43 13.49 1.83 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.827 3.018 . . . . 71.349999999999994 113.608 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 165' ' ' SER . 4.9 t30 -133.36 138.94 46.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.741 -0.663 . . . . 74.010000000000005 109.899 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.3 m -138.92 156.73 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.708 0.29 . . . . 72.200000000000003 110.681 -177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.679 ' HD1' ' HB2' ' A' ' 165' ' ' SER . 27.8 p90 -123.99 141.13 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.074 0.464 . . . . 73.140000000000001 111.041 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.51 110.08 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.674 -0.694 . . . . 75.120000000000005 109.407 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.858 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 32.0 tt0 -88.83 113.25 24.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.492 -0.929 . . . . 71.310000000000002 108.492 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -103.13 -179.95 4.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.963 -0.562 . . . . 53.310000000000002 110.939 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -75.3 -15.74 60.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 74.340000000000003 110.649 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 92.5 mmm -97.1 -38.81 9.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.626 . . . . 73.25 110.664 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.49 -139.87 3.22 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.231 -0.748 . . . . 51.329999999999998 111.231 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -136.7 130.62 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.507 -0.553 . . . . 72.099999999999994 109.507 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG12 ' CG2' ' A' ' 139' ' ' VAL . 4.2 mp -124.85 130.49 73.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 71.540000000000006 110.467 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 15' ' ' TYR . 59.1 t -113.85 145.05 20.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.904 -0.406 . . . . 74.430000000000007 109.904 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.77 36.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.345 0.593 . . . . 63.43 110.725 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.466 ' HG3' ' HD3' ' A' ' 131' ' ' ARG . 9.4 pt-20 -134.1 162.15 32.91 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.211 -0.904 . . . . 54.210000000000001 108.999 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -97.44 175.5 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.6 -0.519 . . . . 75.310000000000002 109.6 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.576 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 3.9 m-30 -79.21 100.41 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 72.439999999999998 110.878 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.728 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 15.3 m0 -79.82 -7.06 58.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.956 -0.565 . . . . 73.120000000000005 110.45 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.52 -65.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.848 -0.614 . . . . 74.510000000000005 111.247 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.95 -16.06 20.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 73.230000000000004 110.813 -171.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -130.71 72.3 81.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.745 0.646 . . . . 73.400000000000006 112.745 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 14.0 Cg_exo -69.45 -20.88 35.72 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.392 2.061 . . . . 64.219999999999999 110.826 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -82.01 -45.55 15.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.057 -0.974 . . . . 74.430000000000007 110.836 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 12.1 m -65.92 -39.24 90.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.051 -0.522 . . . . 74.540000000000006 111.586 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 4.7 p -64.31 -39.78 94.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 70.400000000000006 111.699 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 8' ' ' SER . 9.5 mtmp? -91.14 -8.8 47.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.295 -0.562 . . . . 55.43 110.8 -178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 48.9 t30 -72.44 -55.54 6.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.657 -0.701 . . . . 71.049999999999997 109.349 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.28 -40.88 98.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.284 -0.416 . . . . 71.5 110.888 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.29 -42.8 61.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 62.520000000000003 111.312 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 10.0 mm-40 -56.84 -50.88 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.274 -0.421 . . . . 72.209999999999994 111.422 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 47' ' ' TYR . 2.7 mm? -62.77 -28.15 69.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.501 -0.318 . . . . 75.209999999999994 111.466 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -51.84 25.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 65.510000000000005 110.942 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -72.47 -29.65 63.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.310000000000002 111.472 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -68.02 -52.42 35.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.997 0.427 . . . . 65.340000000000003 109.954 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 131.13 43.45 0.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.057 -1.068 . . . . 54.020000000000003 113.233 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.576 ' CG ' HD12 ' A' ' 42' ' ' LEU . 18.7 m-85 -92.24 -33.49 14.64 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.465 -0.432 . . . . 74.109999999999999 111.395 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -82.06 -16.4 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 75.310000000000002 110.874 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.437 HD22 ' HA2' ' A' ' 46' ' ' GLY . 38.3 m-80 -70.78 -0.96 10.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.478 . . . . 74.219999999999999 111.028 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.05 34.52 2.07 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.518 -0.633 . . . . 75.400000000000006 111.518 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.531 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -104.21 149.62 25.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.979 0.418 . . . . 72.209999999999994 111.014 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -128.2 148.67 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 51.509999999999998 109.394 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 87.3 m-85 -80.08 122.5 26.86 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.499 -0.556 . . . . 74.5 109.499 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -106.61 -39.61 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.871 0.323 . . . . 72.230000000000004 111.871 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 39.3 mmt180 -108.91 105.42 14.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.923 -0.311 . . . . 63.509999999999998 110.23 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.712 HD13 ' HB2' ' A' ' 155' ' ' ASP . 4.8 mp -123.58 91.28 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.895 -0.779 . . . . 72.109999999999999 108.895 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.2 mt -96.28 130.48 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 109.237 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 1.005 ' HE2' ' HB3' ' A' ' 146' ' ' GLU . 43.8 mttt -54.97 108.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.928 0.767 . . . . 70.409999999999997 111.831 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 55.99 44.9 24.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.285 -0.87 . . . . 75.530000000000001 110.828 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 12.8 t80 -129.93 -75.99 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.269 -0.878 . . . . 63.439999999999998 109.12 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.516 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.75 154.63 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.215 -0.902 . . . . 61.149999999999999 109.884 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.601 HG23 HG13 ' A' ' 56' ' ' ILE . 46.8 mt -129.41 102.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.044 -0.525 . . . . 72.340000000000003 109.996 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 49.3 tt0 -86.02 122.51 30.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 74.409999999999997 110.526 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -125.17 142.7 14.02 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.886 -0.597 . . . . 72.349999999999994 112.011 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 149.66 -141.86 9.24 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.504 -0.855 . . . . 60.409999999999997 112.332 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.18 78.54 0.39 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.814 0.672 . . . . 74.200000000000003 112.814 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.78 -12.94 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 121.98 1.786 . . . . 62.200000000000003 110.442 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.8 p -103.23 -47.55 4.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.156 -0.929 . . . . 64.230000000000004 110.777 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.68 15.39 54.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.438 -0.665 . . . . 31.210000000000001 111.438 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -80.95 -41.54 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.29 0.567 . . . . 74.310000000000002 111.499 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -16.29 4.97 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.492 -0.776 . . . . 44.119999999999997 111.374 -174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -109.8 -30.33 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 65.219999999999999 110.903 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.6 -155.82 28.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.6 -0.809 . . . . 75.209999999999994 111.409 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.48 -105.48 0.24 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.624 -0.798 . . . . 60.030000000000001 112.282 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.98 36.4 21.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.609 0.719 . . . . 74.310000000000002 111.455 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -91.19 12.85 18.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.615 -0.72 . . . . 62.310000000000002 111.047 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.528 HG13 HD11 ' A' ' 4' ' ' ILE . 47.6 pt -74.23 -22.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.348 -0.387 . . . . 52.009999999999998 111.181 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 81' ' ' GLN . 6.8 p90 -110.81 3.38 18.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.498 0.666 . . . . 71.430000000000007 110.495 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 -115.55 4.83 Favored Glycine 0 C--O 1.237 0.295 0 CA-C-N 115.182 -0.917 . . . . 63.310000000000002 111.856 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -76.31 179.19 5.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.25 -1.018 . . . . 74.519999999999996 108.25 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.646 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -78.61 149.73 32.87 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.47 -0.937 . . . . 75.209999999999994 108.47 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' A' ' 2' ' ' ALA . 9.7 t80 -102.11 -85.66 0.43 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.329 0.862 . . . . 71.319999999999993 113.329 -156.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.65 157.65 43.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.841 0.353 . . . . 63.32 111.205 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.7 126.2 30.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.31 0.576 . . . . 74.430000000000007 110.2 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -105.99 18.7 21.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 109.496 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' A' ' 127' ' ' THR . 59.3 mt -62.01 104.63 0.48 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.952 -0.567 . . . . 70.219999999999999 110.891 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -169.88 80.45 0.63 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.413 -0.588 . . . . 73.319999999999993 109.413 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.21 100.39 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.464 2.109 . . . . 73.310000000000002 112.076 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.23 -3.59 52.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.228 1.013 . . . . 61.140000000000001 109.532 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -109.94 -171.39 1.83 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.315 -172.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -147.07 145.99 29.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.198 -1.038 . . . . 75.099999999999994 108.198 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 26.8 p90 -58.48 124.79 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.24 0.543 . . . . 75.010000000000005 110.066 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.4 p -121.98 -45.59 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.665 -0.698 . . . . 65.200000000000003 110.084 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -151.31 6.11 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.483 -0.78 . . . . 63.240000000000002 111.891 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.14 22.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.337 0.255 . . . . 71.230000000000004 110.704 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.69 22.7 7.21 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.476 -0.868 . . . . 74.219999999999999 111.835 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.4 mm -84.88 109.63 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.521 -0.548 . . . . 51.450000000000003 109.521 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -85.59 120.72 27.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.611 -0.514 . . . . 75.120000000000005 109.611 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.22 174.88 9.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.116 -0.493 . . . . 62.450000000000003 111.136 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.516 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 24.9 ttt -105.53 137.68 42.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 109.502 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.65 142.68 28.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.036 0.445 . . . . 54.210000000000001 110.171 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.81 161.34 42.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.528 -0.76 . . . . 73.230000000000004 110.348 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.31 -26.59 15.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.691 0.757 . . . . 74.230000000000004 109.559 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -150.03 178.16 27.68 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 109.2 -1.56 . . . . 74.319999999999993 109.2 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HA ' HD11 ' A' ' 86' ' ' LEU . 6.7 Cg_endo -48.45 -52.53 8.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.959 2.439 . . . . 63.329999999999998 112.479 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -101.42 -3.41 28.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 110.419 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.646 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -88.56 47.11 1.46 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.391 0.615 . . . . 63.219999999999999 109.608 -177.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' GLN . 5.4 p30 -94.75 130.08 41.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.056 -0.975 . . . . 74.219999999999999 109.989 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.79 -121.86 2.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.245 -0.978 . . . . 74.219999999999999 113.563 -173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 t -105.31 12.16 32.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 110.909 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 26.5 mt-30 -94.38 147.85 22.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 55.229999999999997 111.243 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.31 167.92 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.675 -0.861 . . . . 74.430000000000007 108.675 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 46.9 p90 -155.16 150.59 27.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 73.329999999999998 111.118 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 98' ' ' LEU . 14.2 t -112.97 140.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.012 -0.736 . . . . 70.439999999999998 109.012 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -94.44 127.08 40.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.094 0.473 . . . . 63.039999999999999 109.936 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 62.5 mt -83.51 -7.9 59.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.555 -0.748 . . . . 71.109999999999999 110.492 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -144.82 159.79 49.25 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 72.219999999999999 110.071 175.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 36.3 Cg_endo -66.14 112.06 2.19 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.51 2.14 . . . . 54.100000000000001 112.368 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.1 p -106.13 141.65 37.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.825 -0.625 . . . . 54.109999999999999 111.331 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.551 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -131.9 -0.25 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 73.420000000000002 110.646 175.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 2.52 55.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.47 -0.786 . . . . 75.409999999999997 112.489 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.15 6.65 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.23 0.826 . . . . 70.219999999999999 113.23 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.551 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 4.5 m-20 -64.65 -28.69 69.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.119 0.485 . . . . 74.540000000000006 111.042 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -102.57 13.11 56.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 63.130000000000003 111.448 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -116.61 -40.74 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 73.109999999999999 109.387 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.92 124.68 23.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.131 -0.941 . . . . 73.519999999999996 108.506 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.553 ' HB ' HD23 ' A' ' 86' ' ' LEU . 15.1 t -71.05 147.91 48.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.171 0.51 . . . . 72.430000000000007 110.768 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 99' ' ' ALA . 44.8 mt -121.58 123.32 69.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.853 -0.612 . . . . 74.409999999999997 110.523 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -159.31 75.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.32 0.581 . . . . 74.409999999999997 111.587 175.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.654 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.3 158.45 30.83 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.768 -0.729 . . . . 74.439999999999998 112.734 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.466 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -132.11 125.02 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.964 -0.754 . . . . 65.510000000000005 108.964 173.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.3 p -84.98 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.052 0.453 . . . . 74.310000000000002 110.291 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.514 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 34.5 t -141.2 147.69 38.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.43 -0.35 . . . . 74.239999999999995 111.016 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 42.62 35.27 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.379 1.072 . . . . 62.039999999999999 113.216 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.16 42.49 0.19 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.637 -0.792 . . . . 70.510000000000005 111.972 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -91.86 -33.83 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.796 0.332 . . . . 74.450000000000003 110.413 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -34.9 90.05 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.03 -0.605 . . . . 55.200000000000003 112.016 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.3 mmm -67.12 -51.25 56.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.797 -0.446 . . . . 74.510000000000005 109.797 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 62' ' ' ILE . 63.9 t -54.29 -30.68 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 74.120000000000005 110.954 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.78 -54.65 10.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 35.229999999999997 110.914 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.72 -16.38 60.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.187 -0.46 . . . . 52.130000000000003 111.418 -177.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 145' ' ' VAL . 64.5 t -86.21 -29.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 71.310000000000002 109.942 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.45 -7.56 79.08 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.691 -0.766 . . . . 71.310000000000002 112.607 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 16.6 ptp -96.58 -11.98 24.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.857 -0.337 . . . . 74.450000000000003 111.869 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 142' ' ' VAL . 23.9 m -74.93 136.67 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.207 -0.597 . . . . 72.450000000000003 110.637 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 1.005 ' HB3' ' HE2' ' A' ' 58' ' ' LYS . 4.6 pt-20 -117.51 -53.0 2.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.008 -0.542 . . . . 65.129999999999995 111.023 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.448 ' H ' ' HG3' ' A' ' 146' ' ' GLU . 4.6 p -132.42 162.21 31.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.083 -0.508 . . . . 63.420000000000002 110.253 -175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -93.91 -157.06 0.52 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.917 -0.771 . . . . 54.109999999999999 108.917 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.1 t -56.37 -35.75 68.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.282 0.492 . . . . 52.329999999999998 110.803 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.66 171.98 8.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 75.239999999999995 110.279 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.08 61.48 6.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.953 0.882 . . . . 60.0 109.995 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 18.3 ptp180 -146.72 145.42 22.92 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.779 -1.101 . . . . 74.5 108.999 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 24.4 Cg_exo -62.69 144.6 94.28 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.519 2.146 . . . . 74.230000000000004 112.982 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 145' ' ' VAL . 10.4 p -102.3 28.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 122.615 1.198 . . . . 71.019999999999996 108.468 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.712 ' HB2' HD13 ' A' ' 56' ' ' ILE . 7.1 p-10 -71.41 -13.59 61.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.01 -1.45 . . . . 75.030000000000001 112.332 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.493 ' OD1' ' HE2' ' A' ' 158' ' ' LYS . 8.1 t0 -72.82 78.68 1.13 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.165 0.507 . . . . 64.340000000000003 110.721 -176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.87 137.56 44.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 71.319999999999993 109.52 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HE2' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -123.55 155.14 38.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.922 0.391 . . . . 73.099999999999994 110.634 -172.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.8 mp -91.52 101.59 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.208 -1.034 . . . . 74.510000000000005 108.208 168.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 161' ' ' LYS . 32.2 mm -65.35 -48.63 82.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 64.219999999999999 110.918 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.858 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -143.9 138.52 28.62 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.488 -0.778 . . . . 61.43 110.071 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -141.5 118.89 11.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.142 -0.481 . . . . 73.420000000000002 110.414 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 161' ' ' LYS . 84.9 m-85 -141.83 158.37 62.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 109.803 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 14' ' ' VAL . 28.7 Cg_endo -64.35 137.99 58.47 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.175 1.917 . . . . 74.109999999999999 111.119 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.679 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 25.4 t -120.27 150.52 40.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.163 0.506 . . . . 61.130000000000003 111.283 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.69 -174.73 45.77 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.173 -0.771 . . . . 62.229999999999997 111.173 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -125.49 110.79 1.38 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.648 -0.787 . . . . 52.409999999999997 112.346 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -92.21 71.88 1.61 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.81 -0.71 . . . . 72.430000000000007 111.913 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -91.42 24.38 19.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.987 -0.625 . . . . 72.439999999999998 113.069 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -100.05 63.35 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.96 0.41 . . . . 74.239999999999995 110.286 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -99.5 -57.68 0.93 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.918 -0.658 . . . . 74.430000000000007 112.166 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.95 2.24 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.884 -0.674 . . . . 72.510000000000005 112.245 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -132.04 -17.43 1.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.881 -0.676 . . . . 74.019999999999996 112.508 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.1 t 54.16 61.44 3.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.343 0.592 . . . . 63.439999999999998 110.675 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.43 -50.14 3.53 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.734 -0.746 . . . . 75.340000000000003 112.08 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.47 55.1 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.856 -0.688 . . . . 63.409999999999997 112.406 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -82.62 124.53 6.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.693 -0.765 . . . . 51.100000000000001 112.02 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 m -85.86 71.03 10.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 62.43 110.831 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.13 176.42 33.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.768 -0.729 . . . . 71.209999999999994 112.012 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.79 64.79 4.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.95 -0.643 . . . . 43.43 112.156 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.6 90.23 1.22 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.987 -0.625 . . . . 54.039999999999999 112.16 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.7 t -97.7 -14.82 20.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 72.040000000000006 109.521 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 162.63 -80.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.404 -0.817 . . . . 44.009999999999998 111.608 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.52 -172.31 2.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.85 -0.426 . . . . 70.239999999999995 109.85 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.78 144.52 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.914 -0.585 . . . . 65.099999999999994 111.868 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.57 -168.64 45.06 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.542 -0.837 . . . . 44.310000000000002 111.828 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.834 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -84.27 152.09 24.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.238 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 191' ' ' ILE . 94.7 m-85 -98.67 112.29 62.26 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.406 -0.59 . . . . 75.450000000000003 109.406 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.601 ' HB3' HD12 ' A' ' 97' ' ' ILE . 54.2 Cg_endo -85.91 -5.44 8.78 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.511 2.141 . . . . 72.540000000000006 112.719 -177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.57 -19.83 32.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 110.801 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.8 pt -77.42 -16.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 62.130000000000003 111.266 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.38 31.09 10.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.85 -0.614 . . . . 72.209999999999994 111.69 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.32 149.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.968 -0.293 . . . . 54.030000000000001 110.971 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.48 124.07 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.214 0.531 . . . . 72.430000000000007 111.725 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.97 130.05 0.77 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.374 -0.83 . . . . 60.130000000000003 109.76 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 87.7 m-85 -115.86 146.71 37.54 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.452 -0.34 . . . . 72.030000000000001 110.426 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.0 Cg_endo -67.22 -62.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.383 2.055 . . . . 64.150000000000006 111.706 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 23.63 4.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 74.349999999999994 109.832 175.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 29.7 m-20 70.59 6.35 5.78 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.372 -0.831 . . . . 63.119999999999997 112.166 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 17.7 ptm -55.47 -32.14 62.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 74.310000000000002 112.292 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.69 4.6 85.04 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.534 -0.841 . . . . 73.099999999999994 113.503 -174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 11.1 ptm180 -116.51 -3.72 11.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.897 0.856 . . . . 71.340000000000003 110.089 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 203' ' ' LYS . 26.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-N 114.13 -1.396 . . . . 73.049999999999997 110.714 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.931 0.396 . . . . 63.329999999999998 110.186 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.62 -167.53 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.391 -0.368 . . . . 62.310000000000002 110.343 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.04 132.17 37.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.161 -0.311 . . . . 71.340000000000003 110.161 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm 67.63 109.19 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.922 0.764 . . . . 72.329999999999998 111.333 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.76 161.0 30.39 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.847 2.365 . . . . 74.430000000000007 112.485 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.91 138.95 78.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.728 2.285 . . . . 74.219999999999999 111.686 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -55.54 109.29 0.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.704 0.764 . . . . 74.319999999999993 112.223 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.511 ' HB2' HE22 ' A' ' 10' ' ' GLN . 6.2 m -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.615 -1.175 . . . . 74.310000000000002 107.901 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 46.6 p90 -79.3 -54.5 5.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.204 0.816 . . . . 63.509999999999998 113.204 -169.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.621 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 1.8 mp0 66.27 175.95 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 110.153 -0.314 . . . . 73.120000000000005 110.153 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 10' ' ' GLN . 73.1 Cg_exo -50.73 112.49 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.149 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.724 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 91.3 Cg_endo -88.22 7.97 4.27 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.457 2.772 . . . . 72.319999999999993 113.18 -173.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.469 HD22 ' HB3' ' A' ' 26' ' ' GLU . 21.2 t-20 -127.09 145.5 50.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.084 -0.962 . . . . 73.219999999999999 108.433 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 164' ' ' PRO . 29.1 m -136.15 157.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.853 0.358 . . . . 54.530000000000001 111.071 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.825 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 50.0 p90 -121.74 130.52 53.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.218 0.533 . . . . 70.019999999999996 110.382 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 16' ' ' LEU . 1.7 mm? -109.44 102.68 11.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.559 -0.746 . . . . 72.209999999999994 109.567 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -82.4 111.18 18.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.499 -0.926 . . . . 60.299999999999997 108.499 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -103.07 -179.74 4.04 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.116 0.484 . . . . 43.409999999999997 111.376 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 t -67.86 -24.57 65.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 75.230000000000004 109.929 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.486 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.1 mmt -86.63 -44.85 11.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 72.540000000000006 110.636 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.46 -126.92 0.98 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.804 -0.712 . . . . 65.010000000000005 111.554 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.26 137.09 46.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.924 0.362 . . . . 74.349999999999994 110.098 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -124.93 115.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.02 -0.536 . . . . 64.349999999999994 109.7 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 46.7 t -102.77 137.33 31.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.521 -0.472 . . . . 74.430000000000007 109.744 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.19 163.34 37.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.112 0.482 . . . . 52.43 110.809 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 13' ' ' ASN . 10.6 pt-20 -128.59 166.27 19.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.537 -0.756 . . . . 62.350000000000001 109.402 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -102.33 165.62 11.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.423 -0.955 . . . . 72.519999999999996 108.423 176.389 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 3.3 m-85 -89.64 90.38 8.22 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.612 -0.835 . . . . 74.310000000000002 111.345 177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.8 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -74.75 -11.89 60.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.266 1.032 . . . . 71.239999999999995 108.281 175.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.7 -35.57 77.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.2 -1.818 . . . . 75.540000000000006 110.95 -177.201 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -124.77 -20.89 4.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.792 -0.64 . . . . 72.019999999999996 110.721 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.539 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.09 85.13 50.99 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.129 0.418 . . . . 54.119999999999997 112.129 -169.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.57 -41.75 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 111.491 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.85 -43.23 36.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.661 -0.7 . . . . 73.409999999999997 111.053 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.557 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -63.2 -39.83 95.76 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.662 -0.699 . . . . 75.030000000000001 110.282 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.8 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 15.0 t -60.41 -46.08 91.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.844 -0.616 . . . . 53.25 110.101 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -59.59 -34.84 73.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 75.340000000000003 110.815 -178.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 35' ' ' THR . 38.2 t-20 -50.56 -61.36 2.24 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.584 -0.524 . . . . 75.420000000000002 109.584 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 112' ' ' PHE . 23.4 m-85 -67.97 -41.34 82.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.05 -0.523 . . . . 74.209999999999994 111.67 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 44' ' ' ARG . . . -56.54 -45.77 81.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 73.5 111.787 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG2' ' HE2' ' A' ' 37' ' ' LYS . 19.4 mm-40 -67.46 -42.27 83.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.096 -0.242 . . . . 52.109999999999999 111.198 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.5 mm? -66.11 -26.44 67.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.997 -0.281 . . . . 75.409999999999997 110.554 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.21 73.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.726 0.298 . . . . 71.25 110.628 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.597 ' HD3' ' HG2' ' A' ' 10' ' ' GLN . 29.9 mtm180 -66.31 -43.47 86.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.532 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.56 -43.61 98.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 72.420000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.14 64.12 0.53 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.834 -0.698 . . . . 41.520000000000003 111.502 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' HB2' HD12 ' A' ' 42' ' ' LEU . 73.1 t80 -86.0 -50.77 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.104 0.478 . . . . 70.129999999999995 110.154 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 7.0 m-85 -76.42 -10.82 59.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.368 -0.833 . . . . 71.409999999999997 111.796 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.73 -19.29 63.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 61.32 111.318 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.01 40.03 1.61 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.713 . . . . 41.350000000000001 111.996 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.626 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.6 p -118.28 156.62 28.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 70.319999999999993 111.153 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -141.98 163.05 33.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.103 -0.499 . . . . 55.049999999999997 110.735 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.9 m-85 -86.86 133.64 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.101 -0.499 . . . . 74.049999999999997 109.663 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -120.21 -28.96 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.254 -0.578 . . . . 63.43 111.457 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.2 mmt180 -112.6 109.59 19.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.121 -0.326 . . . . 74.109999999999999 110.121 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 53' ' ' PHE . 14.8 mm -121.51 88.6 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.04 -0.726 . . . . 74.540000000000006 109.04 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 18.3 mt -103.31 119.59 52.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.231 -0.587 . . . . 62.25 110.099 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -54.33 138.02 40.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.707 0.629 . . . . 64.319999999999993 110.759 178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p30 44.24 33.19 0.79 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.383 1.052 . . . . 71.019999999999996 112.68 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.35 -83.74 0.54 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.158 -0.473 . . . . 74.439999999999998 110.11 179.218 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -161.47 158.11 26.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.593 . . . . 65.510000000000005 110.389 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' HD21 ' A' ' 116' ' ' LEU . 59.8 mt -128.81 103.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.594 -0.73 . . . . 72.430000000000007 109.656 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -86.51 121.52 29.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.11 -0.495 . . . . 74.409999999999997 110.252 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.18 140.81 11.86 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.658 -0.782 . . . . 52.530000000000001 112.603 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.626 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 138.86 -151.77 21.86 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.653 -0.784 . . . . 44.25 112.302 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t0 58.3 95.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 123.756 0.823 . . . . 71.200000000000003 111.98 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 49.1 Cg_endo -71.31 -18.32 30.18 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.718 2.278 . . . . 75.409999999999997 112.359 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 70' ' ' THR . 81.8 p -91.65 -32.86 15.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.469 . . . . 63.329999999999998 110.887 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.77 22.88 71.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.817 -0.629 . . . . 64.430000000000007 112.284 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.581 HG22 ' OG1' ' A' ' 68' ' ' THR . 14.2 t -107.51 -20.94 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.649 0.24 . . . . 70.010000000000005 111.649 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.44 -13.96 6.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.316 -0.945 . . . . 74.0 113.506 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -0.82 7.08 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.107 0.78 . . . . 72.319999999999993 113.107 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 66.11 -164.9 39.58 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.882 -0.675 . . . . 42.409999999999997 113.337 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.18 -81.0 0.8 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 73.5 111.598 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . 59.31 34.47 22.94 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.696 0.76 . . . . 63.43 111.153 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.4 m -66.25 -25.93 67.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 40.219999999999999 112.718 -170.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.587 HG23 ' CD1' ' A' ' 78' ' ' TYR . 3.6 tt -65.78 -40.13 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.928 0.344 . . . . 71.099999999999994 111.928 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 13.3 p90 -107.01 -17.25 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.791 0.329 . . . . 72.040000000000006 111.333 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.94 -62.99 4.51 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.047 -0.597 . . . . 64.040000000000006 113.811 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 91.7 mttt -118.47 177.66 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.669 -0.312 . . . . 63.039999999999999 111.666 -175.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.422 ' NE2' HG23 ' A' ' 107' ' ' THR . 5.9 pm0 -71.46 164.68 25.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.93 -0.577 . . . . 73.540000000000006 110.441 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -110.53 -68.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.373 -0.376 . . . . 71.329999999999998 111.127 -172.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -168.02 156.69 9.15 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.129 -0.693 . . . . 73.129999999999995 109.129 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 9.4 p-10 -89.93 131.59 35.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 53.399999999999999 109.764 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 25.8 tt0 -105.53 8.01 33.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 75.430000000000007 110.262 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 mt -46.87 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.353 -0.84 . . . . 55.299999999999997 112.543 -170.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -179.56 87.0 0.2 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.404 -0.817 . . . . 73.230000000000004 109.23 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 30.9 Cg_endo -63.49 96.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.444 2.096 . . . . 71.230000000000004 111.828 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -11.38 59.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 64.430000000000007 109.46 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -105.02 170.56 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.598 -1.26 . . . . 73.010000000000005 107.598 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -126.0 150.83 47.77 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.926 -0.71 . . . . 75.25 110.79 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 35.7 p90 -65.5 121.83 15.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.169 -0.678 . . . . 74.439999999999998 109.169 173.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.5 p -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.963 -0.562 . . . . 71.549999999999997 110.61 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.26 -145.2 4.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.484 -0.78 . . . . 75.129999999999995 111.633 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.12 146.2 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.806 0.336 . . . . 74.120000000000005 111.048 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.67 26.18 5.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.754 -0.736 . . . . 74.540000000000006 111.98 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 189' ' ' PRO . 8.8 mm -90.07 111.51 23.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.583 -0.525 . . . . 75.329999999999998 109.583 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.91 117.73 24.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.866 -0.606 . . . . 74.420000000000002 109.673 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.78 176.92 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.404 . . . . 23.34 111.774 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.983 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 17.4 tpt -93.77 138.96 31.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 74.519999999999996 111.885 -173.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.21 132.89 43.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.198 -0.455 . . . . 65.329999999999998 110.315 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.4 162.07 36.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 110.596 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -82.54 -26.32 32.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.117 -0.492 . . . . 45.119999999999997 110.846 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 169.24 -134.38 3.18 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 121.0 -0.619 . . . . 74.439999999999998 112.16 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 25.8 Cg_endo -59.64 92.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.192 2.594 . . . . 71.310000000000002 111.713 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 2.2 p30 62.29 10.08 3.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.975 1.31 . . . . 72.019999999999996 112.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.4 m -82.17 57.85 3.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.475 0.655 . . . . 74.420000000000002 109.307 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.99 143.12 26.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.593 -0.731 . . . . 70.430000000000007 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.26 -98.96 2.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.746 -0.74 . . . . 72.129999999999995 111.966 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 42' ' ' LEU . 9.2 t -147.68 10.55 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.421 . . . . 55.119999999999997 110.536 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.54 159.04 17.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.688 0.28 . . . . 70.5 111.166 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 41.4 p90 -140.25 175.43 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 110.682 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -154.69 151.47 28.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 71.010000000000005 110.521 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 HD23 ' A' ' 98' ' ' LEU . 16.5 t -109.23 143.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.31 -0.626 . . . . 72.310000000000002 109.31 177.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -96.98 129.5 44.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.035 0.445 . . . . 73.519999999999996 110.402 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 62' ' ' ILE . 71.0 mt -85.5 -7.27 58.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.886 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.94 160.21 47.41 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.643 -0.708 . . . . 52.140000000000001 109.972 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 29.6 Cg_endo -64.06 111.79 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.492 2.128 . . . . 53.439999999999998 111.555 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.1 p -100.68 122.07 42.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 55.420000000000002 111.93 -172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.89 24.38 10.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.655 0.741 . . . . 75.200000000000003 109.815 174.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -115.45 -3.11 12.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.282 -0.872 . . . . 72.450000000000003 111.457 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.39 12.05 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 63.409999999999997 111.058 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.466 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 8.7 p-10 -63.14 -28.57 70.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 74.010000000000005 111.049 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.97 17.84 19.58 Favored Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.652 -0.785 . . . . 54.43 111.205 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -116.45 -34.6 4.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.254 0.549 . . . . 75.129999999999995 109.889 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.78 123.39 24.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.434 -0.95 . . . . 64.430000000000007 108.434 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 t -70.87 144.13 50.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.33 -0.548 . . . . 71.129999999999995 109.833 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.2 mt -113.49 124.38 70.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.832 -0.622 . . . . 73.219999999999999 111.28 -173.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.983 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 5.7 p90 -156.37 72.68 0.76 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.849 0.833 . . . . 74.120000000000005 110.468 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.59 157.47 29.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.616 -1.278 . . . . 41.409999999999997 113.53 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.614 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 38.5 mtp180 -139.63 121.88 15.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 70.219999999999999 110.002 173.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -86.37 137.11 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 75.0 110.306 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 48.5 t -149.56 147.82 28.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 109.954 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 8.9 tm0? 48.04 67.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 74.239999999999995 110.05 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 158.89 19.68 0.03 OUTLIER Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.269 -0.878 . . . . 70.219999999999999 113.267 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 184' ' ' ASP . 11.1 tp -80.73 -32.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.319 -0.623 . . . . 61.240000000000002 109.319 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.11 93.62 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.043 -0.823 . . . . 72.510000000000005 111.043 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.2 mmm -70.56 -48.94 52.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.768 -0.456 . . . . 50.030000000000001 109.768 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.4 t -56.28 -29.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.925 0.393 . . . . 73.099999999999994 110.8 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -70.59 -56.53 6.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.422 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.49 ' HE ' ' HB2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.87 -15.42 62.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.379 . . . . 75.450000000000003 111.085 -177.204 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 138' ' ' MET . 75.3 t -84.41 -39.6 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 53.109999999999999 110.154 174.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.15 -27.15 58.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.535 -0.84 . . . . 52.130000000000003 112.843 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.2 mmm -75.11 -13.27 60.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.859 0.318 . . . . 53.020000000000003 111.859 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.9 m -106.48 118.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.233 0.539 . . . . 64.010000000000005 110.834 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -106.28 -38.22 6.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.432 -0.507 . . . . 62.530000000000001 109.703 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.7 164.86 36.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.310000000000002 112.169 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -76.71 -175.0 3.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.317 -1.31 . . . . 75.140000000000001 109.077 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 t -61.58 -27.6 68.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.862 -0.792 . . . . 74.019999999999996 108.862 171.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.487 ' HB2' ' HG2' ' A' ' 152' ' ' ARG . 43.9 mt-30 -90.78 167.41 12.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.136 -0.938 . . . . 71.430000000000007 109.014 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.44 67.23 8.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.289 1.043 . . . . 74.409999999999997 109.104 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 14.8 ptp180 -148.4 144.29 18.44 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 113.664 -1.607 . . . . 74.510000000000005 108.63 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.32 130.35 37.22 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.419 1.412 . . . . 75.030000000000001 109.71 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -45.31 -53.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.529 0.518 . . . . 73.549999999999997 111.165 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -146.75 147.53 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.224 -0.658 . . . . 70.430000000000007 109.224 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -72.1 118.14 14.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.84 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.9 129.77 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.79 0.805 . . . . 64.129999999999995 111.478 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -154.16 173.03 16.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.998 -1.001 . . . . 62.539999999999999 109.42 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -89.74 114.43 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.27 -0.641 . . . . 72.219999999999999 109.27 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.8 mm -79.89 -58.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.686 -0.688 . . . . 51.109999999999999 110.53 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -125.07 137.01 54.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.108 -0.496 . . . . 72.25 109.786 176.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -141.39 122.71 14.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.63 -0.259 . . . . 62.119999999999997 110.857 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -145.04 154.12 54.21 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.99 -0.55 . . . . 71.230000000000004 109.867 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 14' ' ' VAL . 9.2 Cg_endo -57.13 138.96 88.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.181 1.921 . . . . 73.519999999999996 111.68 171.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.825 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 38.3 t -118.53 152.19 36.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.81 -0.632 . . . . 61.229999999999997 111.148 -172.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -125.42 57.83 0.68 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.006 -0.837 . . . . 43.32 111.006 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.42 162.7 47.91 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.954 -0.641 . . . . 70.510000000000005 112.595 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.95 -65.9 0.51 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.063 -0.589 . . . . 44.039999999999999 111.727 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.08 -132.95 21.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.793 -0.718 . . . . 73.530000000000001 112.058 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.0 p -86.17 -5.37 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.033 0.444 . . . . 62.520000000000003 110.665 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.37 -49.37 4.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.98 -0.628 . . . . 61.399999999999999 112.654 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.44 -119.97 5.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.896 -0.669 . . . . 52.020000000000003 111.812 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 111.59 149.16 11.27 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.624 -0.798 . . . . 71.319999999999993 112.306 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -153.75 109.92 3.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.85 0.357 . . . . 73.0 110.209 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -141.27 -141.4 3.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.842 -0.695 . . . . 65.109999999999999 112.191 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.76 -66.62 3.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.141 -0.552 . . . . 63.520000000000003 111.86 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -118.01 -70.38 0.38 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.367 -0.693 . . . . 52.329999999999998 111.367 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.8 m -130.89 158.73 39.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.303 -0.258 . . . . 71.430000000000007 110.303 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.29 -141.65 7.71 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.796 -0.716 . . . . 23.02 111.813 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.59 -173.49 25.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.138 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -96.19 112.01 4.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.862 -0.685 . . . . 50.100000000000001 112.01 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.9 t -82.22 146.58 29.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.898 0.38 . . . . 60.420000000000002 110.097 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 123.89 -135.28 9.66 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.341 -0.704 . . . . 40.409999999999997 111.341 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 136' ' ' ILE . 12.6 t0 -155.35 174.94 14.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.972 -0.751 . . . . 61.539999999999999 108.972 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 148.33 159.47 8.49 Favored Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.541 -0.838 . . . . 53.530000000000001 112.782 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.6 -166.63 39.11 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.887 -0.673 . . . . 64.200000000000003 112.321 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.7 173.31 12.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.804 0.335 . . . . 64.510000000000005 110.4 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.58 100.81 40.31 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.616 -0.265 . . . . 63.030000000000001 110.58 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.747 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.3 Cg_endo -80.34 -5.05 13.38 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.518 2.145 . . . . 74.430000000000007 111.734 176.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -77.15 -39.24 49.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.217 -0.902 . . . . 63.229999999999997 109.56 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.14 152.68 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.385 -0.969 . . . . 73.030000000000001 108.385 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -104.75 81.45 1.77 Allowed 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.223 -0.591 . . . . 73.310000000000002 110.808 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -156.93 146.87 11.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.998 -1.001 . . . . 75.450000000000003 109.111 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 110.847 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.479 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -153.52 150.24 28.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.878 -0.786 . . . . 64.200000000000003 108.878 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 199' ' ' ASP . 40.6 m-85 -122.7 142.27 37.22 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.688 -0.233 . . . . 64.230000000000004 110.479 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.764 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.9 -63.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.4 2.067 . . . . 73.409999999999997 111.488 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.1 pt? -122.44 16.71 10.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 55.149999999999999 109.844 174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 13.4 m-20 70.24 8.0 6.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.198 -0.91 . . . . 74.549999999999997 113.367 171.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -61.91 -21.42 64.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.766 0.284 . . . . 71.310000000000002 111.766 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.89 -5.39 83.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.831 -0.7 . . . . 54.219999999999999 112.958 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -82.68 -20.72 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.392 0.615 . . . . 70.049999999999997 110.462 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm . . . . . 0 C--O 1.245 0.849 0 CA-C-N 114.733 -1.121 . . . . 73.549999999999997 111.368 -175.237 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.236 -0.283 . . . . 74.310000000000002 110.236 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.22 18.54 18.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 54.420000000000002 110.773 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.15 -44.53 68.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.435 -0.802 . . . . 71.450000000000003 110.016 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.622 HG12 HG12 ' A' ' 77' ' ' ILE . 58.7 mt -129.76 103.7 17.4 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.894 -1.048 . . . . 71.319999999999993 109.115 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 31.9 Cg_endo -63.87 139.23 67.23 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.914 2.409 . . . . 54.409999999999997 112.791 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 52.1 Cg_exo -55.38 -39.09 92.9 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.922 2.414 . . . . 62.240000000000002 111.354 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.42 102.5 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.784 0.802 . . . . 70.200000000000003 109.047 174.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.782 ' HB3' HE22 ' A' ' 10' ' ' GLN . 31.9 m -121.34 122.02 38.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.537 -0.756 . . . . 73.200000000000003 111.602 -171.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.546 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 25.8 t90 -92.68 107.83 19.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.326 -0.62 . . . . 74.150000000000006 109.326 172.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.782 HE22 ' HB3' ' A' ' 8' ' ' SER . 1.5 mp0 -93.91 107.23 26.41 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.753 -0.658 . . . . 64.239999999999995 111.341 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 9.6 Cg_endo -90.31 116.86 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.556 2.838 . . . . 71.230000000000004 111.112 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.496 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 40.4 Cg_endo -67.73 -19.78 46.99 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.368 2.045 . . . . 73.310000000000002 112.45 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.516 HD22 ' CG1' ' A' ' 24' ' ' VAL . 5.0 t30 -139.42 145.96 39.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.605 -0.725 . . . . 74.019999999999996 110.149 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.6 m -133.85 145.16 33.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.399 0.618 . . . . 53.539999999999999 111.156 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.537 ' HE1' ' HB3' ' A' ' 165' ' ' SER . 84.3 m-85 -99.75 123.51 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.3 -0.864 . . . . 72.340000000000003 111.145 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.36 103.69 11.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 64.540000000000006 109.911 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.16 117.15 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.245 -0.65 . . . . 74.340000000000003 109.245 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 179.96 4.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.124 0.488 . . . . 74.150000000000006 111.739 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -64.33 -26.46 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.339 -0.846 . . . . 70.049999999999997 110.673 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 142' ' ' VAL . 7.1 mmt -91.54 -37.19 13.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.885 -0.598 . . . . 65.430000000000007 111.429 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.68 -128.9 1.26 Allowed Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.64 -0.791 . . . . 73.439999999999998 111.395 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.46 136.36 43.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.073 0.463 . . . . 75.439999999999998 110.039 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.4 120.79 57.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.603 -0.726 . . . . 73.129999999999995 109.14 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 6.9 t -101.4 141.59 17.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.688 -0.687 . . . . 74.219999999999999 109.179 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -147.76 161.59 40.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.272 -0.571 . . . . 64.409999999999997 111.16 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -132.27 163.76 27.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.144 -0.935 . . . . 72.349999999999994 110.429 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.71 168.09 10.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 73.25 109.901 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 m-85 -89.99 97.77 11.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 110.991 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.496 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 76.5 m95 -88.82 14.74 9.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.966 0.889 . . . . 72.340000000000003 109.003 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.52 -54.1 4.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.109 -1.405 . . . . 72.510000000000005 110.545 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.64 9.36 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 74.439999999999998 111.914 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.09 71.41 73.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.287 . . . . 62.229999999999997 110.887 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.15 -42.1 11.49 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.748 2.298 . . . . 70.409999999999997 112.987 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.45 -46.89 52.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 72.329999999999998 110.321 -177.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -41.23 86.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.21 -0.905 . . . . 75.420000000000002 110.93 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 129' ' ' PHE . 89.1 m -52.18 -51.0 60.74 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 111.425 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 4.5 mtmp? -73.14 -23.86 60.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.532 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -56.46 -47.86 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 74.439999999999998 109.411 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HZ ' ' HB3' ' A' ' 112' ' ' PHE . 3.8 m-85 -77.76 -42.31 34.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.478 -0.783 . . . . 55.329999999999998 111.069 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -55.89 -48.8 74.97 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.113 0.412 . . . . 74.400000000000006 112.113 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.669 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -59.72 -43.83 94.01 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.11 0.481 . . . . 62.039999999999999 110.769 178.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 75' ' ' ALA . 28.1 mt -67.36 -30.45 70.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.907 -0.588 . . . . 74.310000000000002 111.319 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.53 76.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.691 -0.686 . . . . 71.519999999999996 111.41 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' NH1' ' HA ' ' A' ' 8' ' ' SER . 17.7 ptt180 -81.16 -7.26 59.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.538 -0.465 . . . . 72.129999999999995 111.384 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -89.43 -49.38 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.792 -0.448 . . . . 53.020000000000003 109.792 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 41.03 0.54 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 115.819 -0.628 . . . . 51.109999999999999 112.005 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' HD22 ' A' ' 42' ' ' LEU . 50.5 t80 -71.4 -37.34 71.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.672 0.389 . . . . 65.540000000000006 111.672 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 45.2 m-85 -75.97 -16.41 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.46 . . . . 72.430000000000007 112.016 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -68.74 -7.7 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 74.140000000000001 111.585 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -127.36 16.09 6.34 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.578 -0.82 . . . . 54.119999999999997 112.472 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -101.53 150.06 23.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.322 . . . . 73.010000000000005 111.433 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 2.1 mptt -130.96 153.37 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.107 -177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 75.1 m-85 -90.04 108.41 19.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.475 -0.935 . . . . 74.239999999999995 108.475 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -110.63 -8.88 14.56 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.341 -0.544 . . . . 70.420000000000002 111.262 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.6 mmt180 -121.11 106.06 11.19 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.914 0.388 . . . . 73.299999999999997 110.278 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -122.17 89.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.86 -0.793 . . . . 61.310000000000002 108.86 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 39.1 mt -91.2 120.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.557 -0.905 . . . . 54.409999999999997 108.557 176.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 4.2 ptmm? -58.6 118.38 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.724 0.64 . . . . 60.409999999999997 111.438 -175.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' CG ' ' HZ3' ' A' ' 203' ' ' LYS . 41.9 m-20 61.72 40.49 13.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.868 -1.06 . . . . 61.25 111.182 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -136.69 -78.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 70.040000000000006 110.271 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.653 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 25.4 ptm -160.32 155.87 25.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.6 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.545 HD11 HD21 ' A' ' 116' ' ' LEU . 46.8 mt -128.17 102.92 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 73.430000000000007 109.454 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -81.07 127.2 32.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.01 -0.541 . . . . 64.510000000000005 110.486 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.84 139.72 11.18 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.811 -0.709 . . . . 40.219999999999999 112.145 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.27 -149.14 20.45 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.061 -1.066 . . . . 64.510000000000005 113.26 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 1.4 t70 48.14 86.42 0.15 Allowed Pre-proline 0 N--CA 1.461 0.117 0 C-N-CA 124.689 1.196 . . . . 65.230000000000004 112.617 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 82.3 Cg_endo -75.71 -18.13 17.49 Favored 'Trans proline' 0 CA--C 1.521 -0.165 0 C-N-CA 122.889 2.392 . . . . 71.439999999999998 110.679 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.6 p -84.3 -42.36 15.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.129 -1.396 . . . . 71.030000000000001 112.072 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 86.0 29.66 25.2 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 73.030000000000001 111.396 -174.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' OG1' ' A' ' 68' ' ' THR . 5.2 t -112.39 -33.68 6.11 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.974 0.361 . . . . 45.32 111.974 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.85 -0.66 11.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.127 -1.035 . . . . 50.420000000000002 113.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.26 -24.06 3.75 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.607 -0.349 . . . . 63.009999999999998 111.351 178.257 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 97.47 -171.09 26.2 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.563 -0.827 . . . . 45.539999999999999 112.818 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.58 -98.06 1.98 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.281 -0.485 . . . . 64.239999999999995 112.185 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . 59.31 33.77 22.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.698 0.761 . . . . 74.230000000000004 111.096 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -76.44 15.12 0.65 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.63 -1.168 . . . . 74.310000000000002 110.922 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 41' ' ' GLU . 6.8 tt -94.27 -38.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.871 -0.604 . . . . 63.43 111.091 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.66 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 34.7 p90 -106.11 -18.45 14.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.026 -0.67 . . . . 63.43 111.6 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.4 -103.62 2.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.316 -0.945 . . . . 74.140000000000001 113.449 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -125.61 174.94 7.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.984 0.421 . . . . 74.129999999999995 111.72 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 17.0 mp0 -87.0 -96.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.375 -0.829 . . . . 75.150000000000006 111.535 -171.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 13.2 m-30 78.17 14.88 1.45 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.086 0.555 . . . . 73.129999999999995 112.325 172.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.47 126.5 5.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.57 -0.741 . . . . 71.140000000000001 110.224 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.468 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . 5.4 p-10 -82.68 122.09 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.953 -0.758 . . . . 75.329999999999998 108.953 170.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -99.67 19.05 16.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.998 -0.742 . . . . 71.510000000000005 108.998 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 84' ' ' ASP . 28.1 mt -58.8 99.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.385 -1.28 . . . . 60.32 110.094 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -154.62 74.81 5.79 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 109.986 -0.376 . . . . 74.25 109.986 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.36 92.59 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.78 2.32 . . . . 65.25 112.238 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.0 -33.26 67.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 74.319999999999993 108.695 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -93.99 178.08 5.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.513 -1.221 . . . . 70.140000000000001 109.124 174.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -144.38 160.73 40.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.07 -0.344 . . . . 74.349999999999994 110.07 178.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.59 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 26.2 p90 -56.65 119.68 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.874 0.845 . . . . 53.020000000000003 111.053 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 33.8 p -116.62 -43.66 2.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.728 -0.669 . . . . 74.409999999999997 110.537 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.9 -155.18 7.82 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.363 -0.835 . . . . 74.329999999999998 111.339 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.37 141.15 31.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.776 0.322 . . . . 61.549999999999997 110.791 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.77 23.73 4.56 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.816 -0.706 . . . . 54.409999999999997 111.949 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -90.18 116.69 32.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 74.239999999999995 109.701 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.876 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -91.97 123.31 35.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.626 -0.715 . . . . 75.329999999999998 110.099 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.44 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -140.8 169.02 18.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 75.040000000000006 111.144 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.513 ' CG ' ' HE1' ' A' ' 129' ' ' PHE . 26.3 mtm -92.32 156.32 17.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.038 0.447 . . . . 73.120000000000005 110.495 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 166.86 10.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.821 -0.627 . . . . 51.25 109.709 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -120.42 179.06 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.742 0.306 . . . . 63.329999999999998 110.403 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.06 18.82 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.84 -0.618 . . . . 75.140000000000001 110.611 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.51 -142.92 14.17 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.748 -0.739 . . . . 71.150000000000006 112.846 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -58.77 92.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.645 2.897 . . . . 74.340000000000003 112.216 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.77 32.56 7.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.478 -1.237 . . . . 52.520000000000003 111.003 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.5 m -80.27 56.29 2.45 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.517 -1.219 . . . . 75.319999999999993 110.058 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 84' ' ' ASP . 15.8 m120 -72.57 100.62 2.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.027 -0.988 . . . . 73.230000000000004 109.633 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -116.32 -135.87 5.71 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.254 -0.974 . . . . 74.019999999999996 113.315 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 47.8 p -96.88 -4.78 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.404 -176.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -71.17 142.77 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.027 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.53 ' HB3' ' HZ ' ' A' ' 39' ' ' PHE . 52.3 p90 -143.5 169.38 17.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.828 0.347 . . . . 71.209999999999994 110.812 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.51 155.21 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 74.109999999999999 110.665 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.711 HG22 HD23 ' A' ' 98' ' ' LEU . 18.4 t -110.61 144.05 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.899 -0.591 . . . . 55.020000000000003 109.482 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.5 p -97.01 124.58 41.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.101 0.477 . . . . 62.530000000000001 110.538 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 62' ' ' ILE . 71.9 mt -83.66 -9.53 58.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.592 -0.731 . . . . 72.040000000000006 110.243 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.4 156.84 42.54 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.172 -0.922 . . . . 61.299999999999997 109.611 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 57.5 Cg_endo -72.28 113.34 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.262 1.975 . . . . 73.349999999999994 112.33 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.2 p -100.49 145.47 28.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 64.420000000000002 109.863 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.31 17.99 9.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 63.32 110.722 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.797 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 1.1 p90 -124.08 -1.72 8.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 72.140000000000001 111.33 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 86.9 mt -114.36 -6.1 12.92 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.975 0.417 . . . . 73.150000000000006 110.839 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.42 -19.19 64.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 72.25 111.249 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.53 12.52 10.24 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.52 -0.848 . . . . 34.539999999999999 111.841 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -120.14 -24.33 6.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 109.775 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 100' ' ' MET . 38.9 m80 -130.24 125.56 35.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.703 -0.681 . . . . 63.539999999999999 110.189 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.0 m -65.9 110.67 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 33.210000000000001 110.427 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 99' ' ' ALA . 32.5 mt -96.84 120.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.539 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 1.3 p90 -153.76 72.26 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.548 1.166 . . . . 73.230000000000004 109.742 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.876 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.63 153.1 23.58 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 118.269 -1.92 . . . . 33.039999999999999 113.857 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.4 mtp-105 -133.32 123.63 25.8 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.923 -0.769 . . . . 75.510000000000005 108.923 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.78 131.61 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.442 0.639 . . . . 54.509999999999998 109.901 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.644 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.6 m -134.36 139.1 45.39 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.507 -0.769 . . . . 50.130000000000003 110.263 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 47.09 46.38 16.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.325 0.491 . . . . 62.149999999999999 112.325 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.88 29.46 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.952 -1.118 . . . . 41.439999999999998 112.587 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -76.73 -33.52 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 70.25 110.435 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.32 -35.32 91.46 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.015 -0.612 . . . . 73.439999999999998 111.682 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 142' ' ' VAL . 68.4 mmm -69.37 -52.73 24.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.019 -0.363 . . . . 73.030000000000001 110.019 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.83 -30.97 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.135 0.493 . . . . 71.329999999999998 110.822 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.72 -53.62 14.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.762 -0.654 . . . . 75.340000000000003 110.612 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.38 -14.96 60.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 111.097 -177.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.4 t -85.66 -38.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.18 0.514 . . . . 62.219999999999999 110.049 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -82.01 -15.01 75.99 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.574 -0.822 . . . . 74.209999999999994 112.94 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.558 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.9 ptm -96.39 0.89 51.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.683 0.241 . . . . 73.140000000000001 111.155 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.2 m -57.84 152.71 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.6 0.714 . . . . 73.219999999999999 112.084 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' VAL . 7.3 pt-20 -97.81 -170.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.14 -0.936 . . . . 74.409999999999997 109.91 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 17.8 p -85.05 148.42 26.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.002 0.429 . . . . 65.010000000000005 111.737 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -73.49 -54.63 7.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.894 -0.593 . . . . 62.329999999999998 111.059 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.2 m -150.62 -52.66 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.712 -0.477 . . . . 73.299999999999997 109.712 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' O ' ' HB ' ' A' ' 147' ' ' THR . 40.0 mt-30 -81.9 -164.96 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.402 -0.592 . . . . 75.310000000000002 109.402 173.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.62 13.18 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.462 . . . . 70.140000000000001 110.752 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 2.0 ptm180 -94.11 121.37 64.1 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 70.409999999999997 109.751 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 40.1 Cg_exo -56.45 150.13 52.89 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.382 2.055 . . . . 75.439999999999998 110.308 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 146' ' ' GLU . 57.9 t -49.94 102.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.393 0.616 . . . . 73.329999999999998 110.564 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.57 93.96 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.194 -0.912 . . . . 63.299999999999997 110.56 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -152.07 14.01 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.627 -0.715 . . . . 74.219999999999999 110.217 175.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 142' ' ' VAL . 2.9 t -92.85 97.36 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.828 0.823 . . . . 75.040000000000006 110.561 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -120.43 165.95 14.24 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.719 -1.128 . . . . 70.420000000000002 108.824 176.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 48' ' ' TYR . 3.5 mp -88.92 103.3 13.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.451 -0.944 . . . . 74.340000000000003 108.451 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.429 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.8 mm -66.87 -59.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.368 -0.833 . . . . 64.019999999999996 110.233 -176.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 6.0 mptp? -128.63 132.93 48.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.659 . . . . 74.340000000000003 109.977 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.13 135.54 49.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.335 -0.393 . . . . 64.340000000000003 110.663 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -154.47 128.1 4.42 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.641 -0.709 . . . . 72.150000000000006 110.617 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.477 ' HG2' ' HZ3' ' A' ' 9' ' ' TRP . 91.7 Cg_endo -80.73 149.7 18.42 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.852 2.368 . . . . 75.420000000000002 112.817 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.537 ' HB3' ' HE1' ' A' ' 15' ' ' TYR . 21.4 t -152.44 -152.76 0.44 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 64.340000000000003 110.128 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.28 -45.57 0.11 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.003 -0.617 . . . . 61.340000000000003 111.996 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 128.94 -146.85 17.34 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.03 -0.605 . . . . 72.329999999999998 111.692 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.09 116.07 3.36 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.978 -0.629 . . . . 70.030000000000001 112.487 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 147.5 113.53 0.75 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.664 -0.779 . . . . 51.530000000000001 112.704 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.4 t -165.37 -169.5 1.62 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.668 -0.493 . . . . 64.230000000000004 109.668 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.86 -124.22 1.41 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 70.510000000000005 112.088 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.61 172.63 37.01 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.944 -0.646 . . . . 60.340000000000003 112.079 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.36 136.21 4.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.839 -0.696 . . . . 74.25 111.815 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 38.9 m 57.64 82.44 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 73.150000000000006 111.14 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -77.27 81.37 1.2 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.617 . . . . 33.299999999999997 112.176 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 143.42 -39.73 1.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.097 -0.573 . . . . 64.099999999999994 111.707 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -92.74 -149.02 24.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.865 -0.683 . . . . 24.420000000000002 112.212 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.4 m -95.88 109.0 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.843 0.354 . . . . 70.349999999999994 110.494 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 175.01 178.44 44.87 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.97 -0.633 . . . . 54.549999999999997 111.929 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.53 -45.87 0.38 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.86 -0.686 . . . . 72.200000000000003 111.804 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.52 80.93 1.22 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.782 -0.723 . . . . 25.309999999999999 111.803 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.0 m -94.95 -166.9 1.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 110.798 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.64 -172.2 39.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.884 -0.674 . . . . 72.430000000000007 111.579 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.85 -179.74 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.572 . . . . 45.140000000000001 111.014 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 156.95 145.98 4.35 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.021 -0.99 . . . . 70.209999999999994 111.117 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.62 -167.33 25.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.281 -0.961 . . . . 54.329999999999998 112.291 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.774 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.55 171.14 12.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.783 0.325 . . . . 62.049999999999997 110.485 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.71 94.38 8.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 110.022 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 90' ' ' LEU . 58.2 Cg_endo -77.83 -7.99 16.67 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.12 1.88 . . . . 72.439999999999998 112.802 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.508 ' OE2' ' HD2' ' A' ' 189' ' ' PRO . 1.3 mp0 -75.31 -35.01 61.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.104 0.478 . . . . 72.019999999999996 110.445 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 193' ' ' VAL . 14.7 pt -79.05 -13.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.929 -0.578 . . . . 70.200000000000003 111.509 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.0 m170 65.85 30.68 9.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.704 -0.68 . . . . 64.349999999999994 112.204 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 191' ' ' ILE . 4.6 p -123.49 149.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.142 -0.318 . . . . 71.340000000000003 110.142 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.52 119.0 18.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.162 -0.472 . . . . 71.540000000000006 111.601 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.41 HE21 ' HB ' ' A' ' 93' ' ' THR . 2.3 pp0? -164.97 156.7 15.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.477 -0.783 . . . . 75.230000000000004 109.589 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 10.8 m-85 -120.7 146.22 42.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.799 -0.36 . . . . 71.319999999999993 111.122 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.5 Cg_endo -62.15 -59.89 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.946 2.43 . . . . 63.130000000000003 111.968 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.7 21.17 5.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.901 0.381 . . . . 74.329999999999998 110.006 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 62.65 19.42 11.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.54 -0.755 . . . . 75.409999999999997 111.646 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 ptm -53.28 -53.51 49.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.524 -0.762 . . . . 75.340000000000003 112.289 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.78 -8.08 71.63 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.32 -0.467 . . . . 74.209999999999994 113.442 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.482 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 78.7 mtp180 -80.9 -42.78 20.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.888 0.375 . . . . 70.420000000000002 110.177 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 203' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-N 114.383 -1.28 . . . . 73.140000000000001 112.067 -174.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.76 0.314 . . . . 71.319999999999993 110.542 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.2 151.46 38.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 62.399999999999999 110.625 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -101.94 116.41 32.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.33 -0.395 . . . . 73.019999999999996 110.57 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 78' ' ' TYR . 79.1 mt 73.01 125.54 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.229 0 O-C-N 123.809 0.693 . . . . 64.340000000000003 111.09 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 44.8 Cg_endo -69.04 109.01 2.07 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.382 2.055 . . . . 71.109999999999999 111.751 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -82.04 2.84 8.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.885 2.39 . . . . 41.299999999999997 112.055 -176.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.0 89.4 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.41 0.624 . . . . 61.240000000000002 110.643 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 t -157.96 154.81 28.37 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.854 -1.165 . . . . 72.319999999999993 107.854 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -104.55 117.92 35.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.898 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' A' ' 44' ' ' ARG . 16.6 mp0 -111.04 142.12 25.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.771 . . . . 62.210000000000001 109.076 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 51.6 Cg_exo -57.91 116.95 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.77 1.647 . . . . 54.299999999999997 110.268 167.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.9 0.15 5.41 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.241 2.627 . . . . 62.210000000000001 113.276 -172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.7 129.13 32.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.35 -0.841 . . . . 75.140000000000001 108.799 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 39' ' ' PHE . 18.7 m -130.85 162.58 38.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.563 0.221 . . . . 63.030000000000001 110.493 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HB3' HG22 ' A' ' 24' ' ' VAL . 39.5 p90 -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.287 0.565 . . . . 72.430000000000007 112.096 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.23 116.39 28.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.005 -0.998 . . . . 73.5 109.423 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.36 112.64 20.51 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.903 -0.777 . . . . 75.540000000000006 108.903 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -105.31 177.98 4.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.926 0.393 . . . . 73.0 111.428 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' HD11 ' A' ' 160' ' ' ILE . 23.2 t -72.79 -11.44 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 61.43 110.557 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.647 ' HG3' HG22 ' A' ' 142' ' ' VAL . 8.7 mmt -100.39 -39.96 7.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 53.549999999999997 110.498 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.86 -127.0 0.99 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.789 -0.719 . . . . 62.530000000000001 111.505 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -145.82 130.79 12.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.28 -0.637 . . . . 75.049999999999997 109.28 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -126.43 129.19 71.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 75.409999999999997 110.399 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 15' ' ' TYR . 42.5 t -110.18 142.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.864 -0.421 . . . . 71.329999999999998 109.864 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.65 159.35 44.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.459 0.647 . . . . 72.450000000000003 111.002 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -132.74 163.5 28.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.484 -0.78 . . . . 71.099999999999994 110.005 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -98.4 166.99 11.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.445 -0.343 . . . . 75.219999999999999 110.158 -175.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.79 ' HE2' ' HB3' ' A' ' 190' ' ' GLU . 11.1 m-85 -87.73 99.34 12.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.374 0.607 . . . . 64.409999999999997 111.316 175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.715 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -81.45 0.1 39.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.283 -0.871 . . . . 73.439999999999998 109.37 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.58 -69.55 0.31 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.133 -0.94 . . . . 73.019999999999996 111.035 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.433 ' HD1' ' CG ' ' A' ' 89' ' ' ASP . 46.4 m80 -129.26 17.83 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.413 -0.358 . . . . 75.230000000000004 111.195 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.6 63.82 71.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.575 -0.284 . . . . 74.239999999999995 111.296 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.21 -44.0 2.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.643 2.229 . . . . 72.030000000000001 111.815 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -60.99 -47.15 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.757 0.789 . . . . 75.230000000000004 110.051 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -65.97 -41.28 91.37 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.56 -1.2 . . . . 73.299999999999997 110.965 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.715 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 41.8 t -57.43 -41.62 80.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 75.530000000000001 110.387 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 7.4 mmpt? -58.84 -45.45 90.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.925 -0.579 . . . . 62.520000000000003 110.897 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -53.49 -52.98 57.81 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.592 0.558 . . . . 53.409999999999997 110.511 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 27' ' ' LEU . 37.4 t80 -69.02 -44.06 73.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.284 -0.417 . . . . 74.25 110.692 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 44' ' ' ARG . . . -55.26 -53.01 61.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 43.43 112.004 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 41.8 mm-40 -66.35 -31.12 71.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 71.099999999999994 110.354 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -66.79 -36.87 83.4 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.056 -0.52 . . . . 72.120000000000005 110.292 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . . . -67.44 -35.73 79.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.579 -0.737 . . . . 75.329999999999998 110.085 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 15.2 mmm180 -61.57 -44.54 96.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.934 -0.575 . . . . 65.299999999999997 110.991 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -48.18 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 110.245 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.42 43.42 1.86 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.127 -1.035 . . . . 74.420000000000002 112.412 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.59 -18.92 56.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.077 0.465 . . . . 70.150000000000006 111.041 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.683 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.8 -6.01 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 74.0 111.738 -177.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.9 -8.82 47.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.182 -0.463 . . . . 75.549999999999997 111.242 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -136.9 26.32 3.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 112.153 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.2 p -98.76 148.05 24.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 64.140000000000001 111.437 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -135.72 161.65 34.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.332 -0.618 . . . . 50.130000000000003 109.332 177.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.6 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 74.2 m-85 -80.77 116.41 20.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 61.43 109.915 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -97.56 -22.16 16.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 65.140000000000001 110.451 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.774 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 33.5 mmt180 -125.27 116.31 21.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.540000000000006 110.151 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 62' ' ' ILE . 20.3 mm -124.42 88.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.108 -0.701 . . . . 71.150000000000006 109.108 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 13.7 mt -98.16 126.01 51.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.198 -0.667 . . . . 71.530000000000001 109.198 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.28 118.84 8.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.655 0.597 . . . . 73.310000000000002 110.656 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 57.81 40.63 25.95 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.894 0.747 . . . . 71.439999999999998 110.946 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.1 t80 -133.24 -81.02 0.48 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.221 0.534 . . . . 73.340000000000003 109.916 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.48 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.94 156.62 25.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.475 -0.784 . . . . 73.120000000000005 109.96 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.566 HD11 HD21 ' A' ' 116' ' ' LEU . 48.5 mt -126.92 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.405 -0.591 . . . . 72.510000000000005 109.405 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.774 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 18.3 mt-30 -85.6 124.65 32.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.31 -0.404 . . . . 72.409999999999997 110.93 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -119.57 141.24 15.46 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 52.119999999999997 111.93 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.8 -137.25 5.34 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.046 -0.597 . . . . 72.030000000000001 111.918 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 49.44 78.58 0.39 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.419 0.896 . . . . 61.520000000000003 113.419 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HG3' ' HA2' ' A' ' 74' ' ' GLY . 68.4 Cg_endo -76.56 -17.26 16.38 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.789 1.659 . . . . 71.409999999999997 110.395 168.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 70' ' ' THR . 33.9 p -96.61 -44.39 7.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.909 -1.041 . . . . 75.120000000000005 111.12 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.63 53.82 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 111.981 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' OG1' ' A' ' 68' ' ' THR . 10.3 t -98.95 -10.61 22.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.95 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.97 -15.4 58.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.863 -0.684 . . . . 64.319999999999993 112.939 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -144.35 18.4 1.71 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.956 0.354 . . . . 71.129999999999995 111.956 -175.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -84.74 -167.92 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.27 -0.967 . . . . 44.219999999999999 111.994 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 67' ' ' PRO . . . 113.7 -117.97 4.34 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.249 -0.977 . . . . 64.450000000000003 113.272 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.946 ' H ' ' HB2' ' A' ' 110' ' ' SER . . . -60.8 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.242 0.617 . . . . 75.010000000000005 112.497 -173.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -99.69 7.63 44.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.845 -0.798 . . . . 74.400000000000006 108.845 174.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.04 -38.65 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.869 -1.059 . . . . 64.129999999999995 111.132 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.87 ' HB2' ' HE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -98.89 -3.47 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 111.654 -178.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.86 -73.71 2.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.04 -0.6 . . . . 41.229999999999997 112.735 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -113.68 171.51 7.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.791 0.329 . . . . 71.109999999999999 110.703 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -76.24 161.32 28.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 61.039999999999999 110.467 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.87 ' HE2' ' HB2' ' A' ' 78' ' ' TYR . 71.1 m-85 -131.74 -169.15 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 73.25 110.351 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -46.47 139.21 5.14 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.836 0.71 . . . . 62.32 112.166 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -74.16 135.45 42.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.143 -0.688 . . . . 70.010000000000005 109.143 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 35' ' ' THR . 25.9 mm-40 -102.68 19.42 19.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.831 -0.622 . . . . 73.230000000000004 110.116 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.06 98.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.622 -0.717 . . . . 65.540000000000006 110.655 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -167.75 82.13 0.83 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.962 -0.563 . . . . 74.239999999999995 109.876 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.56 92.54 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.846 2.364 . . . . 62.130000000000003 112.372 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 15.3 t70 -71.31 -37.14 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.13 0.967 . . . . 75.209999999999994 109.079 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -84.3 179.04 7.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.543 -1.208 . . . . 53.420000000000002 108.985 172.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -139.59 169.1 18.36 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.479 -0.488 . . . . 64.319999999999993 109.881 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -63.49 123.12 17.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 60.409999999999997 109.539 171.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p -125.32 -40.99 2.08 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.567 0.699 . . . . 54.119999999999997 109.843 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.42 -143.4 3.69 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 114.934 -1.03 . . . . 64.519999999999996 111.179 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.6 150.83 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.704 0.287 . . . . 62.549999999999997 110.519 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.71 23.59 7.79 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.704 -0.76 . . . . 75.340000000000003 111.426 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.6 mm -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.33 -0.619 . . . . 52.299999999999997 109.33 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -83.38 122.88 29.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 109.883 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.79 171.94 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.154 0.502 . . . . 70.129999999999995 111.654 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.748 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 26.4 ttt -107.25 143.14 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.616 -0.72 . . . . 63.32 110.13 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -104.61 136.68 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.2 0.524 . . . . 45.340000000000003 110.64 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -139.43 166.23 25.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.583 -0.735 . . . . 62.039999999999999 109.766 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -85.88 -34.81 20.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.527 -0.306 . . . . 63.210000000000001 111.103 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.32 -123.05 1.07 Allowed Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.534 -0.841 . . . . 74.109999999999999 112.337 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.55 90.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.99 2.46 . . . . 71.219999999999999 112.201 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' PHE . 2.2 p30 59.87 11.08 2.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 74.25 112.373 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 m -81.48 61.18 4.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.69 0.757 . . . . 75.120000000000005 109.095 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.5 150.88 41.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.394 -1.276 . . . . 63.439999999999998 109.886 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.41 -139.82 3.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.632 -0.794 . . . . 53.130000000000003 111.958 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.946 ' HB2' ' H ' ' A' ' 75' ' ' ALA . 33.7 t -113.73 8.48 17.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.975 0.417 . . . . 71.129999999999995 110.359 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 9.2 mm-40 -82.47 138.81 34.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.386 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.88 167.29 21.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.111 -0.7 . . . . 72.219999999999999 109.111 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.768 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 51.5 p90 -157.12 153.87 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 72.530000000000001 112.059 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 98' ' ' LEU . 17.4 t -113.64 142.52 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.237 -0.892 . . . . 60.219999999999999 108.752 174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.9 p -96.04 129.38 43.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.123 0.487 . . . . 74.129999999999995 110.621 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 62' ' ' ILE . 74.3 mt -82.49 -10.5 58.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.432 -0.804 . . . . 44.549999999999997 110.78 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.56 164.12 24.32 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.414 -0.812 . . . . 61.310000000000002 110.022 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.554 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 23.9 Cg_exo -64.19 113.96 2.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.707 2.271 . . . . 64.209999999999994 112.134 177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.8 p -100.35 112.95 25.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.207 -0.451 . . . . 75.120000000000005 111.106 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.16 27.4 9.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.612 0.72 . . . . 54.420000000000002 109.756 -177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.74 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -129.83 3.52 4.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.153 -0.931 . . . . 73.310000000000002 110.983 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.74 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 94.4 mt -113.13 7.84 18.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.931 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 -27.28 56.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.913 -1.04 . . . . 62.399999999999999 111.917 -176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.3 25.43 4.85 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.088 -0.805 . . . . 65.120000000000005 111.088 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -116.86 -40.38 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.952 0.406 . . . . 60.420000000000002 110.067 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -142.3 137.12 30.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 63.020000000000003 111.11 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.1 m -68.75 121.77 17.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.658 -0.701 . . . . 54.149999999999999 110.796 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.9 mt -108.4 120.88 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.457 -0.201 . . . . 34.509999999999998 110.457 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.748 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.2 p90 -157.71 73.62 0.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.865 0.841 . . . . 72.310000000000002 110.81 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.868 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.96 150.94 20.43 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.274 -1.441 . . . . 63.219999999999999 113.433 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -127.54 119.63 26.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.862 -0.792 . . . . 73.329999999999998 108.862 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.403 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 9.2 p -79.66 132.08 32.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.338 0.589 . . . . 65.219999999999999 109.864 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' CYS . . . . . 0.578 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.1 m -133.55 141.21 47.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 61.219999999999999 110.916 -171.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.3 pt20 41.68 35.3 0.47 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.478 1.111 . . . . 71.109999999999999 113.842 176.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.32 37.6 0.23 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.585 -0.817 . . . . 64.430000000000007 112.211 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 197' ' ' PRO . 9.3 tp -85.33 -34.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.78 0.324 . . . . 73.409999999999997 110.542 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.59 -35.59 81.34 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.038 -0.601 . . . . 61.0 112.413 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 81.2 mmm -70.54 -51.32 29.45 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.336 -0.246 . . . . 71.340000000000003 110.336 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 62' ' ' ILE . 91.7 t -52.55 -32.12 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.001 0.429 . . . . 75.340000000000003 110.933 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.6 t30 -69.5 -53.8 17.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.84 -0.618 . . . . 73.510000000000005 110.559 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -15.43 61.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.055 -0.52 . . . . 73.200000000000003 110.975 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 20' ' ' MET . 45.1 t -84.0 -37.59 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.442 . . . . 73.200000000000003 110.315 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -74.78 -18.62 80.09 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.42 -0.895 . . . . 70.230000000000004 112.613 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 42.8 mtm -99.66 1.34 43.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.947 0.351 . . . . 42.509999999999998 111.947 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 142' ' ' VAL . 30.7 m -52.71 137.04 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.578 . . . . 75.310000000000002 111.903 -176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -117.98 -61.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.758 -0.656 . . . . 75.319999999999993 110.335 176.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 27.6 p -131.91 150.67 52.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.8 0.333 . . . . 65.420000000000002 111.365 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.62 ' OD1' ' HG3' ' A' ' 152' ' ' ARG . 35.0 p-10 -87.31 -12.6 46.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.201 0.524 . . . . 73.299999999999997 110.431 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.9 m -150.96 -72.25 0.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 70.129999999999995 109.707 174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.34 129.31 0.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 74.340000000000003 109.817 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.1 t70 64.13 13.28 7.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.59 0.71 . . . . 74.109999999999999 111.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.62 ' HG3' ' OD1' ' A' ' 148' ' ' ASN . 9.3 ptp180 -142.46 120.57 7.39 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.288 -0.634 . . . . 65.310000000000002 109.288 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 84.3 Cg_endo -81.24 163.77 19.69 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.239 2.626 . . . . 72.030000000000001 115.243 -165.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 148' ' ' ASN . 46.6 t -101.61 125.07 55.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.885 -1.052 . . . . 71.349999999999994 110.149 171.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -149.05 11.52 0.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.634 -0.506 . . . . 71.519999999999996 109.634 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 158' ' ' LYS . 6.6 p-10 -109.7 27.57 9.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.761 -0.654 . . . . 55.420000000000002 112.184 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.485 HG21 HG13 ' A' ' 142' ' ' VAL . 12.8 t -73.27 116.6 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.896 -0.779 . . . . 61.130000000000003 108.896 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.1 mttm -124.09 169.57 11.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.981 0.419 . . . . 73.219999999999999 111.207 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -93.45 99.81 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.838 -1.171 . . . . 71.439999999999998 107.838 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.592 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.4 mm -63.26 -61.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.62 -0.511 . . . . 34.109999999999999 109.62 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.592 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.2 mptp? -138.32 154.7 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.016 -0.735 . . . . 72.120000000000005 109.016 172.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -142.51 150.72 40.84 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.661 -0.496 . . . . 65.140000000000001 109.661 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 98.6 m-85 -156.05 145.62 15.37 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.339 -0.615 . . . . 74.120000000000005 109.339 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 5.4 Cg_exo -74.94 142.55 28.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.403 2.069 . . . . 73.409999999999997 111.954 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 11' ' ' PRO . 25.5 t -105.73 136.75 44.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 72.200000000000003 110.074 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.19 -38.44 72.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.885 -0.674 . . . . 50.130000000000003 112.835 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -127.22 168.99 19.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.721 -0.752 . . . . 70.209999999999994 112.423 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.78 156.69 19.45 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.467 -0.653 . . . . 34.340000000000003 111.467 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.68 143.94 6.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.698 -0.763 . . . . 63.130000000000003 112.004 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.2 p -81.51 -18.64 44.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 63.32 111.242 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 82.38 -69.8 3.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.747 -0.74 . . . . 73.439999999999998 112.603 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -150.73 -143.03 3.64 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.914 -0.66 . . . . 73.540000000000006 112.37 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.49 62.14 0.32 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.026 -0.606 . . . . 54.450000000000003 112.008 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 m -91.9 127.64 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 31.41 110.701 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 172.33 -88.32 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 71.109999999999999 111.602 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.45 46.44 1.09 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.031 -0.604 . . . . 64.230000000000004 112.114 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.4 -81.58 0.95 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.027 -0.606 . . . . 72.430000000000007 112.438 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.7 p -89.71 -11.74 41.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.148 0.499 . . . . 72.420000000000002 110.444 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.62 89.23 0.47 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.896 -0.669 . . . . 53.509999999999998 111.546 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.87 28.38 7.74 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.689 -0.767 . . . . 73.209999999999994 112.552 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.4 64.28 4.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.761 -0.733 . . . . 71.25 111.577 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -100.19 135.15 42.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.695 0.283 . . . . 73.120000000000005 110.401 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.71 167.26 22.56 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.928 -0.653 . . . . 55.310000000000002 112.292 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.4 m-20 -97.74 174.77 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.445 0.641 . . . . 54.439999999999998 110.836 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.51 145.87 4.29 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.173 -0.922 . . . . 73.120000000000005 110.811 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -79.3 -161.12 20.94 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.083 -1.055 . . . . 75.299999999999997 112.153 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.649 ' HB1' ' OE1' ' A' ' 195' ' ' GLN . . . -80.95 176.73 9.57 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.153 -0.314 . . . . 71.329999999999998 110.153 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' ILE . 76.7 m-85 -116.19 92.54 36.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.646 -0.502 . . . . 70.140000000000001 109.646 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 10.3 Cg_exo -70.48 -18.07 33.85 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.21 2.607 . . . . 72.329999999999998 113.279 -173.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.79 ' HB3' ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -78.14 -35.1 49.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.262 0.468 . . . . 62.520000000000003 112.262 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 188' ' ' PHE . 22.3 pt -73.03 -13.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 71.340000000000003 111.773 -171.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 63.8 m170 68.91 29.45 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.774 . . . . 72.129999999999995 111.926 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 191' ' ' ILE . 3.9 p -127.28 165.66 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.979 -0.748 . . . . 74.340000000000003 108.979 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.24 129.77 34.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 43.219999999999999 111.59 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.649 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -158.54 153.45 25.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.019 -0.734 . . . . 71.109999999999999 109.019 174.389 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 83.9 m-85 -122.07 138.19 28.5 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.726 -0.39 . . . . 72.109999999999999 111.038 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.0 Cg_endo -64.23 -51.5 2.06 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.622 2.215 . . . . 74.239999999999995 111.967 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -154.83 41.15 0.45 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.387 -0.37 . . . . 71.519999999999996 111.166 178.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 2.0 m-20 75.32 -12.82 0.92 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 112.257 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.573 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 23.0 ptm -50.64 -31.88 17.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.622 0.971 . . . . 72.319999999999993 113.622 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.86 2.7 55.65 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 119.803 -1.189 . . . . 72.120000000000005 113.677 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.498 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 31.8 ptt180 -118.98 1.89 11.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 117.565 0.682 . . . . 65.340000000000003 111.951 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 200' ' ' MET . 41.4 mtmt . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.116 -0.947 . . . . 70.310000000000002 110.831 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.864 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 24.5 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 N-CA-C 110.789 -0.504 . . . . 62.509999999999998 110.789 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 53.1 Cg_endo -69.55 -5.37 15.92 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.499 2.133 . . . . 72.109999999999999 112.116 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.69 HD21 HG12 ' A' ' 24' ' ' VAL . 4.7 t-20 -130.99 142.17 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.081 -0.963 . . . . 73.239999999999995 109.449 -175.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 164' ' ' PRO . 21.8 m -135.54 157.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.981 -0.377 . . . . 75.150000000000006 109.981 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.555 ' HB2' HD11 ' A' ' 22' ' ' ILE . 50.8 p90 -121.06 130.46 53.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.267 0.556 . . . . 74.519999999999996 110.754 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -111.15 102.17 10.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.501 -0.772 . . . . 64.129999999999995 109.806 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.86 110.65 17.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.22 -0.659 . . . . 74.530000000000001 109.22 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.499 HG21 ' HE2' ' A' ' 53' ' ' PHE . 72.1 p -99.81 -179.7 4.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.719 -175.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 p -69.27 -16.88 63.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.091 -0.504 . . . . 62.210000000000001 110.878 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.4 mmt -94.83 -41.05 9.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 70.129999999999995 111.019 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.78 -127.49 1.05 Allowed Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.639 -0.791 . . . . 43.439999999999998 111.717 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 15' ' ' TYR . 19.6 tt -135.7 137.94 48.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.888 0.375 . . . . 73.230000000000004 110.188 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -122.41 108.75 22.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.191 -0.67 . . . . 75.109999999999999 109.191 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.69 HG12 HD21 ' A' ' 13' ' ' ASN . 39.5 t -98.03 131.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.334 -0.617 . . . . 74.450000000000003 109.334 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 25' ' ' LEU . 4.6 pp -146.99 159.26 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.119 0.485 . . . . 73.340000000000003 110.793 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -125.61 164.12 21.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.698 -0.683 . . . . 71.230000000000004 110.604 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.34 159.29 17.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.275 -0.875 . . . . 70.439999999999998 109.128 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.2 m-85 -86.46 88.79 7.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.398 0.618 . . . . 75.299999999999997 111.536 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 34.0 m95 -79.91 -3.59 48.76 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.416 -0.957 . . . . 72.109999999999999 108.416 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.82 -41.2 26.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 74.310000000000002 111.135 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 12.0 t60 -132.2 -17.33 2.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.658 -0.417 . . . . 73.519999999999996 111.774 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.91 88.62 31.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.779 -0.368 . . . . 75.420000000000002 111.024 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' HIS . 11.1 Cg_exo -71.15 -17.17 31.62 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.83 2.353 . . . . 60.25 112.694 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 7.5 mptt -90.31 -54.75 3.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.084 0.469 . . . . 72.230000000000004 110.475 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.7 m -55.38 -44.11 75.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 74.530000000000001 111.646 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -64.48 -37.6 88.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.844 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.937 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -73.77 -38.92 64.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 74.530000000000001 110.53 -178.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.91 -58.71 7.38 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.386 0.429 . . . . 73.109999999999999 110.902 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 112' ' ' PHE . 65.6 m-85 -61.83 -43.79 98.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.076 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.08 93.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 73.209999999999994 111.393 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -59.44 -45.19 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.310000000000002 111.429 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.9 mm? -73.45 -23.34 60.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.736 0.303 . . . . 74.319999999999993 111.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.9 -48.71 52.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.386 . . . . 74.420000000000002 110.874 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -12.74 60.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.922 0.392 . . . . 64.310000000000002 111.022 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -52.35 9.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.839 -0.8 . . . . 74.209999999999994 108.839 172.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.92 45.84 0.93 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.675 -0.97 . . . . 64.439999999999998 110.675 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' HD12 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -88.86 -33.65 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.881 0.372 . . . . 62.509999999999998 111.368 -176.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 85.2 m-85 -71.94 -14.69 61.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.329 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -74.95 10.64 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 65.129999999999995 111.123 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.16 24.95 1.9 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.865 -0.607 . . . . 70.420000000000002 111.63 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.719 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 43.1 p -115.33 160.43 19.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.683 0.278 . . . . 72.319999999999993 111.082 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.9 ptpt -139.64 164.05 30.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.372 -0.377 . . . . 61.25 110.006 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.531 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.2 m-85 -82.24 117.68 22.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.831 -0.803 . . . . 72.209999999999994 108.831 173.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.83 -27.06 14.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.413 -0.358 . . . . 72.239999999999995 110.76 -169.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 30.5 mmt180 -132.02 116.68 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.517 -0.31 . . . . 73.310000000000002 110.564 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -127.28 94.25 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.007 -0.738 . . . . 62.229999999999997 109.007 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.8 mt -106.35 125.2 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.245 -0.434 . . . . 72.540000000000006 110.07 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.5 mtpt -60.27 130.79 48.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.223 0.327 . . . . 72.349999999999994 111.41 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 58.38 28.07 16.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.462 -0.79 . . . . 64.099999999999994 111.424 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -128.64 -87.52 0.55 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 65.25 109.86 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.731 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.7 ptt? -161.28 157.82 26.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 55.409999999999997 110.031 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 ' HA3' ' A' ' 143' ' ' GLY . 50.6 mt -128.62 102.07 7.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.613 -0.721 . . . . 73.420000000000002 109.682 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 23.5 tm0? -80.56 126.35 31.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 75.5 110.007 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.58 137.04 9.58 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.978 -0.63 . . . . 71.030000000000001 112.402 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.719 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 131.04 -137.47 9.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.071 -0.585 . . . . 53.119999999999997 112.12 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 4.5 t0 48.07 83.33 0.22 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 123.901 0.881 . . . . 73.129999999999995 112.241 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.26 -19.56 33.59 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.73 2.287 . . . . 71.030000000000001 111.498 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.571 ' OG1' HG22 ' A' ' 70' ' ' THR . 34.5 p -82.58 -34.55 27.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.144 -0.935 . . . . 71.109999999999999 111.534 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.0 60.92 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.102 -0.571 . . . . 74.219999999999999 111.835 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 72' ' ' ARG . 11.5 t -117.66 -17.48 9.91 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.101 0.408 . . . . 71.340000000000003 112.101 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.94 25.59 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 119.87 -1.157 . . . . 52.130000000000003 113.631 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.62 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.97 -7.36 6.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.336 0.568 . . . . 73.519999999999996 111.877 178.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 70.9 -163.87 53.64 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.182 -0.532 . . . . 72.209999999999994 113.342 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.12 -88.05 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.683 -0.567 . . . . 64.439999999999998 111.683 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 59.87 33.08 21.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.278 0.561 . . . . 74.030000000000001 111.934 173.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 t -78.83 0.66 26.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 70.510000000000005 111.686 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.8 pt -74.01 -29.76 26.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.722 -0.391 . . . . 65.420000000000002 111.254 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 23.1 p90 -108.05 1.73 22.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.3 0.572 . . . . 75.010000000000005 111.107 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -77.58 2.09 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.341 -0.845 . . . . 72.230000000000004 113.39 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -92.37 -170.39 2.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.851 0.358 . . . . 64.200000000000003 110.505 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -95.44 163.65 13.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.621 -0.511 . . . . 74.340000000000003 109.621 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 57.6 t80 -110.33 156.02 21.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.103 -0.239 . . . . 73.549999999999997 111.091 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.13 158.14 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.161 0.913 . . . . 73.219999999999999 112.16 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -75.22 106.76 6.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.299 -0.864 . . . . 73.040000000000006 110.838 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.5 21.37 9.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 62.149999999999999 109.354 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.413 HD23 ' OG1' ' A' ' 127' ' ' THR . 38.2 mt -59.32 97.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -0.999 . . . . 74.25 111.551 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -168.22 85.45 0.72 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 73.340000000000003 109.961 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.41 93.7 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.59 2.193 . . . . 61.130000000000003 111.947 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.61 -26.4 66.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.698 0.761 . . . . 63.539999999999999 109.65 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -83.12 177.75 8.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.899 -1.046 . . . . 70.239999999999995 108.808 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -133.8 159.86 39.34 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.907 -0.717 . . . . 72.230000000000004 110.541 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 118' ' ' PRO . 1.2 p90 -70.46 77.18 0.57 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.315 -0.857 . . . . 63.25 110.829 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -68.49 -40.59 80.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.945 -1.025 . . . . 75.299999999999997 111.421 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.66 -146.92 4.85 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.0 -0.619 . . . . 64.310000000000002 111.949 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.89 145.78 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.783 0.325 . . . . 43.009999999999998 110.751 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.09 24.3 6.34 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.67 -0.776 . . . . 74.230000000000004 111.535 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.2 mm -88.18 112.42 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.565 -0.532 . . . . 64.040000000000006 109.565 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.717 HD23 HG22 ' A' ' 114' ' ' VAL . 3.3 tm? -85.45 121.76 28.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.987 -0.551 . . . . 61.009999999999998 109.594 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -126.69 163.52 23.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.125 0.488 . . . . 75.340000000000003 111.186 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.753 ' HE2' ' HB3' ' A' ' 108' ' ' ASN . 28.1 ttt -91.62 134.16 34.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.483 -0.781 . . . . 73.450000000000003 109.939 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -96.5 151.24 19.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.132 0.492 . . . . 52.420000000000002 110.979 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.4 p-10 -155.84 159.38 39.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 73.400000000000006 110.581 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.62 -13.45 22.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.244 0.545 . . . . 73.319999999999993 110.808 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -162.58 -179.99 37.51 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.224 -1.55 . . . . 61.149999999999999 109.224 176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.63 -50.69 12.94 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.737 2.292 . . . . 72.0 112.063 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.89 19.56 15.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 72.140000000000001 110.367 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.3 m -101.08 51.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.317 -0.994 . . . . 71.239999999999995 108.317 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.753 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 42.3 m-80 -77.37 134.84 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.421 -1.263 . . . . 74.25 110.375 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.57 -157.21 10.09 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.745 -0.74 . . . . 71.010000000000005 112.506 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -95.7 8.99 41.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.162 0.506 . . . . 61.439999999999998 111.166 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 6.3 pt20 -90.8 158.6 16.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.871 -0.604 . . . . 72.299999999999997 111.328 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.477 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . 50.9 p90 -142.17 176.45 8.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.02 -0.536 . . . . 73.129999999999995 109.971 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 51.1 p90 -159.54 152.04 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 110.608 173.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.717 HG22 HD23 ' A' ' 98' ' ' LEU . 19.3 t -110.93 142.78 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.288 -0.634 . . . . 62.140000000000001 109.288 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.7 p -97.39 130.09 44.56 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.771 0.319 . . . . 72.450000000000003 110.154 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 62' ' ' ILE . 57.0 mt -86.22 -6.69 58.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.06 0.457 . . . . 72.450000000000003 110.957 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.19 166.88 14.33 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.805 -0.634 . . . . 52.100000000000001 109.794 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 92' ' ' PHE . 32.2 Cg_exo -59.41 106.63 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.591 2.194 . . . . 63.310000000000002 112.043 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.495 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.1 p -94.02 103.42 15.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.62 -0.718 . . . . 72.219999999999999 111.793 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.19 3.6 30.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.651 0.739 . . . . 73.299999999999997 110.255 176.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.495 ' CZ2' HG22 ' A' ' 119' ' ' THR . 1.2 p90 -93.71 -3.7 51.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.995 -1.002 . . . . 74.409999999999997 111.295 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.19 16.53 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.549 -0.296 . . . . 61.439999999999998 111.207 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.75 -38.9 57.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.281 -0.872 . . . . 75.299999999999997 111.552 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.12 22.48 10.39 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.608 -0.806 . . . . 64.019999999999996 112.083 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -118.4 -26.49 6.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.061 0.458 . . . . 73.010000000000005 110.135 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -137.34 128.09 27.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 51.030000000000001 110.486 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.413 ' OG1' HD23 ' A' ' 86' ' ' LEU . 21.5 m -68.73 120.71 15.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.433 . . . . 75.530000000000001 110.669 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 99' ' ' ALA . 47.8 mt -104.21 117.58 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.547 0.203 . . . . 73.430000000000007 111.547 -176.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 47.9 m-85 -158.77 77.04 0.75 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.511 0.507 . . . . 73.030000000000001 110.698 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.34 163.24 35.45 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.116 -0.564 . . . . 52.200000000000003 112.285 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 78.3 mtm180 -142.31 127.14 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.028 -0.36 . . . . 72.349999999999994 110.028 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -87.06 142.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 75.340000000000003 110.686 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 43.6 t -145.77 147.72 32.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 64.099999999999994 110.773 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.3 tt0 48.41 34.04 4.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.568 0.747 . . . . 75.340000000000003 112.567 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -163.45 16.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.061 -1.066 . . . . 72.099999999999994 112.407 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.0 tp -73.18 -31.74 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.159 -0.311 . . . . 62.530000000000001 110.159 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.93 95.49 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.982 -0.847 . . . . 71.109999999999999 110.982 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 81.8 mmm -68.61 -48.85 63.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.098 -0.334 . . . . 74.519999999999996 110.098 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.523 HG13 HD12 ' A' ' 62' ' ' ILE . 85.7 t -56.33 -30.23 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 71.340000000000003 110.532 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.72 -52.83 11.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.815 -0.63 . . . . 72.310000000000002 110.97 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -14.43 60.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.051 -0.522 . . . . 75.099999999999994 111.305 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.52 -33.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.077 0.465 . . . . 73.200000000000003 110.382 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.567 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -82.8 -22.03 58.6 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.595 -0.812 . . . . 61.109999999999999 113.0 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ptp -84.33 -13.26 52.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.853 -0.339 . . . . 72.129999999999995 111.659 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 54.310000000000002 111.256 -177.695 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.439 -0.578 . . . . 75.430000000000007 109.439 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -127.21 165.4 19.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.141 -0.481 . . . . 73.109999999999999 110.721 -175.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -86.76 105.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.617 -0.72 . . . . 73.230000000000004 109.102 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.1 mm -70.46 -56.37 11.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.562 -0.744 . . . . 73.140000000000001 110.673 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.5 mptm? -133.34 128.04 34.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 54.539999999999999 110.147 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -131.27 123.99 29.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.864 0.364 . . . . 71.239999999999995 110.672 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.22 143.24 32.84 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.89 -0.596 . . . . 63.530000000000001 109.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.864 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 74.4 Cg_endo -78.47 124.58 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.198 1.932 . . . . 62.119999999999997 112.241 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 115.522 -0.763 . . . . 73.329999999999998 109.234 -178.79 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.1 m-20 . . . . . 0 CA--C 1.516 -0.333 0 CA-C-O 121.32 0.581 . . . . 71.430000000000007 110.189 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.16 146.08 4.48 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.256 -0.884 . . . . 50.039999999999999 111.638 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.25 -167.38 39.86 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.359 -0.924 . . . . 55.039999999999999 111.864 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.702 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.38 167.21 21.18 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.605 -0.516 . . . . 74.430000000000007 109.605 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 191' ' ' ILE . 92.4 m-85 -114.06 103.62 55.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.142 0.496 . . . . 75.430000000000007 110.32 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.697 ' HB2' HD13 ' A' ' 90' ' ' LEU . 73.0 Cg_endo -79.87 -11.68 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.707 2.271 . . . . 74.319999999999993 112.069 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.69 -20.0 40.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.41 -0.814 . . . . 53.25 111.336 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 188' ' ' PHE . 18.4 pt -87.9 -13.6 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.969 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.1 m170 68.85 29.83 4.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.34 -0.846 . . . . 74.430000000000007 112.456 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 191' ' ' ILE . 4.2 p -130.81 148.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.803 -0.443 . . . . 71.340000000000003 109.803 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.48 124.53 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.953 0.406 . . . . 63.210000000000001 111.831 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -163.29 152.31 14.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 64.010000000000005 109.174 175.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 52.8 m-85 -117.67 146.01 37.75 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.624 0.25 . . . . 62.409999999999997 111.217 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.702 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.2 Cg_endo -66.0 -59.63 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.643 2.229 . . . . 75.120000000000005 112.191 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.2 pt? -143.98 38.87 1.33 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.769 0.285 . . . . 74.329999999999998 111.769 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.2 m-20 76.43 -19.23 0.43 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.75 1.019 . . . . 73.219999999999999 113.75 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -60.37 -23.09 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.728 0.64 . . . . 72.219999999999999 112.728 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 -13.37 60.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.241 -0.981 . . . . 63.130000000000003 112.955 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.419 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 24.8 ptt180 -110.71 -24.16 10.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.081 0.441 . . . . 75.439999999999998 111.261 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.362 -0.828 . . . . 52.310000000000002 110.394 176.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 31.0 Cg_endo . . . . . 0 N--CA 1.459 -0.554 0 N-CA-C 110.787 -0.505 . . . . 72.230000000000004 110.787 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 26.7 Cg_endo -63.27 -39.94 35.2 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.592 2.195 . . . . 74.329999999999998 112.67 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.452 HD21 HG23 ' A' ' 24' ' ' VAL . 26.2 t-20 -134.0 150.88 51.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 71.329999999999998 110.031 -173.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.55 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.0 m -129.23 141.65 46.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 75.140000000000001 110.498 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.511 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.1 m-85 -96.93 124.86 41.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 73.010000000000005 110.67 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD23 ' HB1' ' A' ' 162' ' ' ALA . 27.7 mt -112.22 100.56 8.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.564 -0.289 . . . . 73.510000000000005 110.23 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.848 ' HB2' ' HG2' ' A' ' 161' ' ' LYS . 35.8 mt-10 -82.48 110.76 17.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.233 -0.654 . . . . 72.329999999999998 109.233 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -105.57 177.76 4.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.185 0.516 . . . . 72.099999999999994 111.899 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 9.9 p -71.97 -19.26 61.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 74.219999999999999 110.611 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.43 ' HG3' HG22 ' A' ' 142' ' ' VAL . 5.1 mmt -92.4 -38.78 11.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.823 -0.626 . . . . 63.229999999999997 110.833 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.66 -126.51 1.01 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.909 -0.663 . . . . 63.130000000000003 111.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.03 137.2 38.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.796 -0.446 . . . . 50.210000000000001 109.796 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 139' ' ' VAL . 3.9 mp -139.02 130.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.721 -0.672 . . . . 72.519999999999996 109.227 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.2 m -118.94 151.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.019 -0.672 . . . . 74.129999999999995 110.664 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -145.96 161.45 40.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 74.099999999999994 110.22 176.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.0 pt-20 -129.77 164.19 24.59 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.149 -0.932 . . . . 62.520000000000003 109.439 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.03 162.97 12.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.025 -0.361 . . . . 71.299999999999997 110.025 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 131' ' ' ARG . 10.1 m-85 -86.39 101.75 13.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.325 0.583 . . . . 74.25 111.72 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.634 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -82.82 -1.68 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.223 -0.898 . . . . 72.540000000000006 110.184 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -68.87 -67.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.362 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.413 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 m170 -124.2 11.08 8.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 64.400000000000006 111.521 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.438 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.88 59.78 47.03 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.465 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 16.6 Cg_exo -67.53 -46.46 2.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.476 2.117 . . . . 55.130000000000003 111.975 -177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -63.91 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 65.439999999999998 110.307 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -67.13 -41.04 86.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.391 -0.822 . . . . 75.25 110.495 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 18.5 t -58.52 -48.19 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 72.540000000000006 110.533 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.38 -34.61 78.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 72.239999999999995 111.275 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.45 ' O ' HD23 ' A' ' 42' ' ' LEU . 6.7 t30 -54.69 -52.36 62.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 63.530000000000001 110.407 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HE1' HG21 ' A' ' 14' ' ' VAL . 27.4 t80 -67.71 -44.84 76.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.201 0.524 . . . . 70.239999999999995 109.911 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.52 -44.58 76.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.306 -0.861 . . . . 74.239999999999995 112.087 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.5 mt-10 -69.77 -38.78 76.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.11 -0.236 . . . . 75.109999999999999 111.19 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 38' ' ' ASN . 4.0 mm? -65.14 -26.92 68.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 73.310000000000002 110.395 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.93 -45.2 64.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.973 -0.558 . . . . 72.230000000000004 109.873 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.6 mtp180 -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 75.450000000000003 111.063 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 9.1 mpt_? -73.01 -40.46 65.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.012 -0.366 . . . . 53.210000000000001 110.012 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 30.03 6.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.655 -0.784 . . . . 61.240000000000002 112.479 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -76.88 -17.01 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 72.420000000000002 111.385 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -74.3 -17.22 60.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -71.19 -8.52 54.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.058 0.456 . . . . 73.209999999999994 110.606 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -122.69 31.21 4.87 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.942 -0.647 . . . . 64.430000000000007 111.951 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.811 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 73.4 p -112.11 154.3 25.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 61.0 111.155 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.82 157.46 43.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 109.948 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CD1' ' HA3' ' A' ' 64' ' ' GLY . 97.9 m-85 -89.59 121.58 31.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 71.099999999999994 109.642 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -104.89 -35.6 7.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.53 -0.304 . . . . 72.340000000000003 111.803 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -113.41 112.96 24.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.686 -0.405 . . . . 72.239999999999995 110.356 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -125.99 94.33 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.179 -0.674 . . . . 74.430000000000007 109.179 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.851 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 24.2 mt -96.47 122.05 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.742 -0.663 . . . . 41.240000000000002 109.408 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.4 mtpt -53.49 120.93 6.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.525 0.516 . . . . 74.340000000000003 111.554 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 54.9 41.14 32.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.385 -0.825 . . . . 65.049999999999997 111.329 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.851 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 8.5 t80 -133.23 -80.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.775 -0.648 . . . . 74.409999999999997 109.46 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.678 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.6 ptt? -161.23 157.49 25.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.395 -0.82 . . . . 70.25 110.085 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 HG13 ' A' ' 56' ' ' ILE . 49.8 mt -127.11 101.39 7.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.409 -0.589 . . . . 73.099999999999994 109.409 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 37.7 tt0 -83.84 121.38 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.839 -0.619 . . . . 65.150000000000006 110.139 -177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA3' ' CD1' ' A' ' 53' ' ' PHE . . . -142.93 151.35 23.09 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.519 -0.848 . . . . 15.050000000000001 112.719 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 135.14 -148.93 19.78 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.548 -0.834 . . . . 75.450000000000003 112.051 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 t70 59.67 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 O-C-N 124.376 0.692 . . . . 72.030000000000001 111.145 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.9 Cg_endo -64.53 -20.59 65.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.042 2.495 . . . . 54.240000000000002 112.445 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 70' ' ' THR . 9.9 p -82.52 -27.56 31.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 71.349999999999994 111.422 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.17 26.59 68.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.91 -0.662 . . . . 72.040000000000006 111.685 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 72' ' ' ARG . 14.7 t -118.54 -24.09 6.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.487 0.185 . . . . 62.009999999999998 111.215 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.79 9.35 43.38 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 64.239999999999995 113.253 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -150.38 21.77 0.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 62.350000000000001 110.718 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.503 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -103.7 -176.15 25.91 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.748 -0.739 . . . . 74.129999999999995 112.234 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 110' ' ' SER . . . 83.37 161.27 31.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.578 -0.82 . . . . 62.009999999999998 111.645 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' H ' HD11 ' A' ' 42' ' ' LEU . . . 58.98 16.3 4.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.094 0.473 . . . . 61.329999999999998 111.567 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -68.65 -12.55 61.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.552 . . . . 74.150000000000006 110.941 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.2 pt -64.55 -39.44 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.367 -0.378 . . . . 60.43 110.369 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.61 ' N ' HG13 ' A' ' 77' ' ' ILE . 95.5 m-85 -75.02 -32.93 61.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.662 -0.496 . . . . 73.239999999999995 109.662 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.37 8.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.548 -0.834 . . . . 73.420000000000002 112.93 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -171.2 2.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.982 -0.377 . . . . 60.109999999999999 109.982 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -70.93 164.27 25.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 64.319999999999993 110.577 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -99.22 143.0 29.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 72.340000000000003 109.642 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 106' ' ' ASP . 35.1 tt0 -58.87 147.26 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.634 0.584 . . . . 70.409999999999997 110.726 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.443 ' HA ' HD21 ' A' ' 108' ' ' ASN . 11.2 p-10 -67.33 125.3 25.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.741 0.781 . . . . 55.039999999999999 110.611 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.77 29.36 7.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.644 -1.162 . . . . 74.140000000000001 108.361 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -49.61 100.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.72 -1.127 . . . . 54.049999999999997 111.175 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.64 78.69 9.83 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.066 -0.516 . . . . 72.25 111.128 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.66 66.4 2.3 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.56 2.173 . . . . 74.010000000000005 111.638 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.99 -23.55 59.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.053 0.93 . . . . 63.340000000000003 109.436 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -89.13 166.42 13.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.462 -1.244 . . . . 74.530000000000001 108.879 174.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -113.71 141.58 47.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.278 -0.569 . . . . 63.329999999999998 110.836 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.96 70.42 0.76 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.968 . . . . 71.120000000000005 109.801 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 193' ' ' VAL . 37.1 p -62.7 -40.89 98.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.091 . . . . 62.43 111.765 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.81 -144.73 4.09 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.761 -0.733 . . . . 75.530000000000001 111.911 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.05 144.02 27.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.798 0.332 . . . . 44.32 110.523 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.65 22.08 6.19 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 111.706 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 mm -88.39 114.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -89.86 120.28 30.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 109.746 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.33 160.92 30.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.948 -0.569 . . . . 64.540000000000006 110.257 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 39.0 ttp -91.06 143.16 26.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.601 -0.518 . . . . 55.539999999999999 109.601 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.3 114.4 26.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.274 0.559 . . . . 33.229999999999997 110.975 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.463 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 2.9 p-10 -115.7 149.93 37.63 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.283 -0.871 . . . . 73.030000000000001 109.897 175.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.506 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -83.84 -28.01 28.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.258 -0.883 . . . . 64.450000000000003 111.285 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.37 -108.89 0.32 Allowed Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 120.912 -0.661 . . . . 43.450000000000003 112.147 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.06 89.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.892 2.395 . . . . 63.219999999999999 112.009 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 3.3 p30 48.1 31.11 2.35 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.878 -1.055 . . . . 64.25 111.898 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 103' ' ' ALA . 1.3 m -85.38 52.25 2.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.292 0.567 . . . . 41.340000000000003 109.996 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 19.0 m-80 -91.26 173.82 7.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.303 -0.862 . . . . 75.019999999999996 109.032 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.39 -96.71 0.13 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.353 -1.403 . . . . 75.540000000000006 114.234 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.536 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 46.9 t -126.87 12.19 7.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.391 0.615 . . . . 73.439999999999998 110.448 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 100' ' ' MET . 18.9 mp0 -101.14 147.04 26.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 74.400000000000006 109.474 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -147.21 176.09 10.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.809 0.338 . . . . 73.200000000000003 110.906 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.4 p90 -160.46 152.52 20.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.98 0.419 . . . . 63.530000000000001 110.202 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 98' ' ' LEU . 18.5 t -112.91 138.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.786 -0.643 . . . . 71.230000000000004 109.268 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.9 p -93.3 125.47 37.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.058 0.456 . . . . 54.329999999999998 109.999 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.4 mt -85.29 -6.46 59.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.357 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.41 161.14 34.78 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.338 -0.846 . . . . 71.349999999999994 109.997 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.43 113.7 2.38 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.644 2.229 . . . . 74.129999999999995 112.224 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.2 p -105.31 103.57 13.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.102 -0.499 . . . . 54.409999999999997 110.938 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -99.78 13.84 32.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.862 0.839 . . . . 64.140000000000001 109.479 -177.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.742 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -111.05 3.85 18.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.673 -1.149 . . . . 74.040000000000006 110.748 -178.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.742 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -113.29 6.4 17.34 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.272 -0.422 . . . . 71.519999999999996 111.642 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.05 -31.72 43.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.536 -0.757 . . . . 62.43 112.132 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -125.51 20.49 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.496 -0.859 . . . . 73.099999999999994 111.691 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.71 -31.25 5.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 74.129999999999995 110.656 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.463 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 35.1 m80 -142.27 141.14 32.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 64.099999999999994 111.04 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.1 m -78.32 111.08 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 55.0 110.277 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 90' ' ' LEU . 38.6 mt -98.99 122.82 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.299999999999997 110.71 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.5 p90 -159.71 73.31 0.55 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.689 0.757 . . . . 71.329999999999998 110.898 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.748 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.49 156.66 28.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.292 -1.432 . . . . 61.420000000000002 113.802 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.9 mtm180 -134.77 122.32 21.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.504 0.321 . . . . 75.129999999999995 110.282 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -83.64 138.69 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.036 0.446 . . . . 63.240000000000002 110.66 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 41.1 t -139.86 157.66 45.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 109.907 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.4 pt20 36.86 42.77 0.24 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.252 1.021 . . . . 64.430000000000007 113.18 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.76 17.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.455 -0.879 . . . . 74.420000000000002 112.509 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.536 ' H ' ' HB3' ' A' ' 184' ' ' ASP . 11.3 tp -74.34 -34.51 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.387 -0.227 . . . . 72.299999999999997 110.387 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.28 95.33 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.736 -0.745 . . . . 63.109999999999999 111.367 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -70.31 -50.79 35.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 110.114 -0.328 . . . . 75.140000000000001 110.114 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 23' ' ' ILE . 86.3 t -55.96 -30.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.043 0.449 . . . . 73.5 110.699 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.533 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.8 t30 -70.48 -53.32 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 110.521 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.39 61.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.35 -0.386 . . . . 71.319999999999993 111.225 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 20' ' ' MET . 50.6 t -83.47 -34.85 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.225 0.536 . . . . 55.340000000000003 109.733 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -79.53 -21.51 66.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.622 -0.799 . . . . 71.030000000000001 112.624 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 56.4 mtm -82.52 -23.96 34.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.944 0.35 . . . . 73.400000000000006 111.944 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.488 0.661 . . . . 61.420000000000002 110.196 178.647 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.688 0.756 . . . . 55.340000000000003 111.725 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -122.93 163.77 19.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.069 -0.969 . . . . 73.030000000000001 109.67 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -90.25 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.815 -1.18 . . . . 64.319999999999993 107.815 170.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 19' ' ' SER . 32.2 mm -67.07 -53.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.693 -0.685 . . . . 75.120000000000005 110.618 -173.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.848 ' HG2' ' HB2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -142.06 132.56 25.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.606 -0.724 . . . . 54.049999999999997 110.018 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -133.46 146.15 50.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.787 0.327 . . . . 74.349999999999994 110.625 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 161' ' ' LYS . 85.0 m-85 -148.37 140.7 14.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 75.010000000000005 109.822 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.452 ' HD3' ' OH ' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -78.15 132.49 11.54 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.186 1.924 . . . . 65.219999999999999 111.579 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 49.5 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 61.020000000000003 111.249 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.573 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 19.2 m-20 . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.523 0.678 . . . . 74.219999999999999 111.445 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 158.67 140.86 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.654 -1.157 . . . . 62.140000000000001 110.463 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.31 -169.81 40.57 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.233 -0.984 . . . . 71.519999999999996 111.97 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -75.34 166.67 23.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 110.153 -0.314 . . . . 71.239999999999995 110.153 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.97 100.03 11.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.482 -0.562 . . . . 70.310000000000002 109.482 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 5.5 Cg_exo -79.55 -9.75 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.666 2.244 . . . . 64.420000000000002 112.188 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.424 ' HB2' HH11 ' A' ' 131' ' ' ARG . 37.0 tt0 -74.17 -32.43 63.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.407 0.622 . . . . 75.209999999999994 109.63 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 pt -85.69 162.33 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.445 -0.946 . . . . 74.129999999999995 108.445 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -114.97 41.39 2.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 111.25 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.6 p -109.57 -174.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.318 -0.623 . . . . 53.439999999999998 109.318 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.738 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -115.84 114.38 24.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.646 0.26 . . . . 64.549999999999997 111.064 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.612 HE21 ' HB1' ' A' ' 187' ' ' ALA . 3.7 pm0 -155.12 152.97 30.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.46 -0.571 . . . . 70.409999999999997 109.46 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -121.39 139.82 30.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.545 -0.298 . . . . 72.010000000000005 110.402 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 19.7 Cg_endo -58.31 -57.9 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.937 2.424 . . . . 64.400000000000006 111.99 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.12 23.85 4.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 73.409999999999997 109.873 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 30.2 m-20 69.55 9.5 7.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.36 -0.836 . . . . 70.510000000000005 112.169 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.9 ptm -53.0 -40.33 63.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 72.439999999999998 112.002 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.38 61.95 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.855 -0.688 . . . . 72.099999999999994 113.318 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 19.6 mtp180 -94.84 -3.68 48.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 110.685 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 4.2 tppp? . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.604 -1.18 . . . . 62.100000000000001 112.142 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo . . . . . 0 N--CA 1.465 -0.199 0 CA-C-O 120.631 0.179 . . . . 72.129999999999995 111.931 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 32.1 Cg_endo -65.15 -22.48 61.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.928 2.419 . . . . 71.319999999999993 113.052 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -124.21 138.97 54.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.055 0.455 . . . . 75.030000000000001 110.936 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 164' ' ' PRO . 20.9 m -128.99 157.35 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.778 -0.646 . . . . 74.219999999999999 109.418 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' CB ' HG12 ' A' ' 24' ' ' VAL . 55.4 p90 -115.14 132.12 56.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.367 0.603 . . . . 75.120000000000005 111.551 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -110.32 109.13 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.086 -0.961 . . . . 62.420000000000002 110.25 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.13 112.39 23.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.19 -0.671 . . . . 74.019999999999996 109.19 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -104.68 178.89 4.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 110.682 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.482 ' HB3' HD11 ' A' ' 160' ' ' ILE . 12.9 p -80.44 -6.13 57.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.292 0.568 . . . . 75.239999999999995 110.463 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mmm -98.83 -41.58 7.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 60.240000000000002 109.565 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.01 -134.13 1.8 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.1 -0.8 . . . . 62.119999999999997 111.1 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.73 130.72 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.958 -0.756 . . . . 61.340000000000003 108.958 177.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 139' ' ' VAL . 4.8 mp -132.15 124.9 53.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.122 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CB ' ' A' ' 15' ' ' TYR . 3.2 m -106.48 146.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.272 -0.571 . . . . 65.109999999999999 109.767 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.47 162.01 37.62 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.982 0.42 . . . . 74.200000000000003 110.14 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -135.14 165.14 26.09 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.709 -0.678 . . . . 71.120000000000005 110.767 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.65 166.86 10.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.806 -0.634 . . . . 74.549999999999997 110.237 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -87.0 96.23 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.327 0.584 . . . . 71.439999999999998 111.635 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.402 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 42.0 m95 -88.82 1.9 54.49 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.256 -0.884 . . . . 72.209999999999994 109.511 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -74.11 -50.2 20.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 60.329999999999998 111.324 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -137.97 8.63 2.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 75.319999999999993 111.426 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.84 85.54 57.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 74.120000000000005 110.503 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.07 -11.58 21.35 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.184 2.59 . . . . 71.140000000000001 113.002 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.66 -48.88 3.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 73.230000000000004 111.55 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -35.93 73.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 65.200000000000003 111.194 -175.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -54.81 -53.22 58.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.816 -0.629 . . . . 75.239999999999995 111.609 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 6.0 mtmp? -81.81 -23.63 36.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.993 -0.549 . . . . 74.299999999999997 111.188 -172.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.499 ' O ' HD23 ' A' ' 42' ' ' LEU . 4.3 m-20 -52.06 -47.02 65.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.551 0.691 . . . . 70.25 109.221 171.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.513 ' HZ ' ' HB2' ' A' ' 100' ' ' MET . 19.2 m-85 -77.08 -49.57 15.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.378 -0.828 . . . . 74.319999999999993 110.834 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -57.25 -35.64 69.99 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.694 0.628 . . . . 63.5 112.694 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 49.0 mt-10 -88.0 -15.32 36.78 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.062 -0.399 . . . . 73.209999999999994 111.314 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.4 mm? -75.03 -20.87 59.4 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.031 -0.667 . . . . 73.310000000000002 109.299 164.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.521 ' HA ' ' HE1' ' A' ' 48' ' ' TYR . . . -74.52 -41.83 59.97 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.708 -0.678 . . . . 75.349999999999994 110.949 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 1.3 ptp180 -67.79 -27.36 66.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.754 0.311 . . . . 75.010000000000005 110.552 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.52 -39.17 77.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.687 -0.857 . . . . 73.019999999999996 108.687 172.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.89 15.42 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.633 -0.712 . . . . 74.239999999999995 111.477 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.6 ' HD2' ' HG3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -72.79 -20.08 61.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 53.32 110.512 -173.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 78.0 m-85 -62.53 -28.54 69.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.811 -0.632 . . . . 74.140000000000001 111.177 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 29.1 m-80 -72.73 91.0 1.44 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.963 0.887 . . . . 72.140000000000001 109.47 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.56 11.68 3.61 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 113.896 -1.502 . . . . 64.120000000000005 112.009 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.561 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 70.2 p -99.83 154.42 18.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 63.549999999999997 110.569 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -130.69 155.86 45.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.471 -0.331 . . . . 74.319999999999993 110.722 -176.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.8 m-85 -81.75 109.51 16.22 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.944 -0.762 . . . . 70.299999999999997 108.944 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 -37.96 12.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.106 -0.497 . . . . 73.439999999999998 111.676 -171.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 17.0 mmt180 -112.12 114.14 26.81 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 75.140000000000001 109.239 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 53' ' ' PHE . 4.0 mp -124.19 89.21 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.06 -0.718 . . . . 64.310000000000002 109.06 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -93.9 125.17 46.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.989 -0.745 . . . . 72.230000000000004 108.989 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 12.4 ptmm? -53.41 135.56 39.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.507 0.505 . . . . 75.340000000000003 110.946 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 42.68 37.01 0.91 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.213 0.946 . . . . 64.430000000000007 112.412 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.432 ' N ' ' HB2' ' A' ' 116' ' ' LEU . 2.7 m-85 -134.4 -80.44 0.45 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.066 -0.515 . . . . 31.309999999999999 111.398 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.46 155.83 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 65.129999999999995 111.065 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 116' ' ' LEU . 20.8 mt -132.3 106.36 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 75.430000000000007 110.004 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' OE1' ' HG2' ' A' ' 55' ' ' ARG . 44.4 tt0 -83.81 128.77 34.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.06 -0.348 . . . . 42.439999999999998 110.06 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.67 132.84 7.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.64 -0.79 . . . . 62.130000000000003 112.592 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 152.81 -112.79 0.55 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.55 -0.833 . . . . 21.329999999999998 113.452 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 31.09 73.14 0.5 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 74.430000000000007 113.364 -170.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.6 ' HG3' ' HD2' ' A' ' 47' ' ' TYR . 72.9 Cg_endo -78.84 -16.29 12.9 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.049 1.833 . . . . 71.129999999999995 111.543 174.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 p -105.18 -57.34 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.715 -0.675 . . . . 72.400000000000006 111.177 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.13 0.02 41.18 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.826 -0.702 . . . . 65.230000000000004 112.06 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 72' ' ' ARG . 1.9 t -80.95 -6.78 59.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 110.687 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.41 -25.51 26.72 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.624 -0.798 . . . . 65.329999999999998 112.55 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' CG ' HG23 ' A' ' 70' ' ' THR . 0.4 OUTLIER -94.21 -32.24 13.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 62.039999999999999 111.414 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -161.45 15.34 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.625 -0.797 . . . . 73.230000000000004 111.58 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.61 -84.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.02 -0.61 . . . . 44.509999999999998 112.101 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 60.73 39.37 17.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.225 0.536 . . . . 35.409999999999997 111.272 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m -55.78 -29.27 59.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.159 -0.928 . . . . 74.209999999999994 112.439 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG23 ' HD1' ' A' ' 78' ' ' TYR . 7.9 tt -73.95 -41.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.207 0.447 . . . . 63.340000000000003 112.207 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.484 ' HD1' HG23 ' A' ' 77' ' ' ILE . 43.8 p90 -108.02 -8.69 15.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.338 -0.545 . . . . 74.230000000000004 112.215 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.12 -101.14 1.43 Allowed Glycine 0 C--N 1.329 0.169 0 C-N-CA 121.138 -0.553 . . . . 74.109999999999999 113.254 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -69.12 163.78 24.04 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.518 -0.549 . . . . 55.43 109.518 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.652 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 1.6 mp0 -58.75 174.06 0.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.683 0.754 . . . . 74.099999999999994 112.257 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -116.88 155.73 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.088 -0.96 . . . . 73.120000000000005 109.424 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.55 159.42 8.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.522 0.514 . . . . 75.0 110.555 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HA ' HD21 ' A' ' 108' ' ' ASN . 6.6 p-10 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.688 -175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -91.48 13.41 17.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.078 -0.965 . . . . 73.400000000000006 109.788 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.12 106.32 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.738 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -164.92 71.01 1.45 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 73.200000000000003 109.882 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -76.29 81.44 2.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.395 2.063 . . . . 64.129999999999995 113.094 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.96 -18.13 41.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.686 0.755 . . . . 75.239999999999995 109.793 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 189' ' ' PRO . 2.9 pp -87.55 177.27 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.105 -0.952 . . . . 74.439999999999998 108.819 173.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.663 ' HD2' ' HA ' ' A' ' 192' ' ' HIS . 2.9 tmtm? -137.23 135.37 37.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.838 0.351 . . . . 74.030000000000001 110.425 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER -63.98 89.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.916 0.865 . . . . 72.409999999999997 109.977 173.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 193' ' ' VAL . 16.4 p -71.72 -51.01 25.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.602 -1.181 . . . . 74.150000000000006 111.083 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -147.85 -132.9 2.27 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.615 -0.802 . . . . 72.409999999999997 111.998 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.16 147.06 24.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.824 0.345 . . . . 41.340000000000003 110.852 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.2 20.98 8.3 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.751 -0.738 . . . . 34.520000000000003 111.582 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -87.05 111.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.387 -0.597 . . . . 63.5 109.387 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -88.15 118.74 27.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.721 -0.672 . . . . 64.230000000000004 109.809 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.515 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.63 173.83 9.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.005 -0.543 . . . . 54.340000000000003 111.512 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 39' ' ' PHE . 25.2 ttt -101.25 128.59 47.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.335 -0.848 . . . . 65.230000000000004 109.982 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -90.76 114.55 26.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.612 0.72 . . . . 71.329999999999998 110.991 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.531 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 3.9 p-10 -121.1 160.39 23.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.953 -1.021 . . . . 75.420000000000002 110.244 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.61 -25.31 16.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.152 -0.476 . . . . 31.210000000000001 110.832 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -152.75 -176.98 25.9 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.889 -1.285 . . . . 33.350000000000001 109.889 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.16 -53.72 5.98 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.338 2.692 . . . . 54.229999999999997 112.475 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.413 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 3.8 p30 -116.83 16.97 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.164 0.507 . . . . 73.329999999999998 110.671 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.468 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -92.73 53.55 2.06 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 71.230000000000004 108.261 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 84' ' ' ASP . 36.2 m-80 -87.04 107.81 18.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.641 -1.163 . . . . 74.219999999999999 110.281 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.88 -166.01 34.41 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.195 -0.762 . . . . 73.230000000000004 111.195 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m -100.22 67.12 1.35 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.908 -0.775 . . . . 70.049999999999997 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 69.2 mt-30 -124.83 147.76 48.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.111 -0.95 . . . . 53.329999999999998 110.174 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -120.4 155.81 32.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.427 -0.351 . . . . 71.239999999999995 110.919 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -153.76 141.74 20.26 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.111 -0.495 . . . . 75.230000000000004 110.37 168.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.732 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -110.94 142.43 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.602 -0.726 . . . . 72.230000000000004 109.424 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.58 127.04 41.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.382 . . . . 72.430000000000007 110.131 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 62' ' ' ILE . 65.3 mt -84.54 -9.03 58.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.773 -0.649 . . . . 55.43 109.859 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.0 157.7 31.96 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.107 -0.952 . . . . 71.510000000000005 109.556 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.421 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 27.5 Cg_exo -62.56 115.66 3.04 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.536 2.157 . . . . 52.530000000000001 112.264 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 p -105.77 106.92 17.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.006 0.431 . . . . 74.409999999999997 110.33 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp0? -97.34 20.71 11.13 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.381 0.61 . . . . 72.019999999999996 111.089 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.674 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -123.81 -1.77 8.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.314 -0.857 . . . . 75.310000000000002 110.337 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.674 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 97.9 mt -105.8 3.86 29.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.914 -0.584 . . . . 75.219999999999999 111.14 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.44 -23.68 67.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.455 -0.793 . . . . 74.420000000000002 111.134 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.29 18.4 7.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.686 -0.768 . . . . 63.450000000000003 111.504 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -115.49 -35.84 4.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.112 0.482 . . . . 71.109999999999999 109.708 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.531 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 54.0 m80 -141.59 132.66 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 72.109999999999999 109.093 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.7 t -74.78 147.14 41.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 110.302 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.515 HG23 ' HB2' ' A' ' 99' ' ' ALA . 43.3 mt -123.97 119.57 57.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.004 -0.544 . . . . 75.400000000000006 110.388 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -156.32 72.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.447 . . . . 71.299999999999997 110.198 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -166.17 165.6 38.27 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.249 -0.74 . . . . 54.140000000000001 111.249 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -152.97 132.01 12.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 74.030000000000001 111.084 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' GLY . 5.2 p -79.94 144.6 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.856 . . . . 45.219999999999999 110.716 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.594 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 42.7 t -139.23 151.99 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.175 -0.466 . . . . 42.399999999999999 109.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.4 tt0 45.42 42.15 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.59 0.556 . . . . 73.150000000000006 111.893 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 27.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.206 -0.997 . . . . 62.119999999999997 112.397 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.3 tp -81.92 -31.19 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.898 -0.408 . . . . 75.409999999999997 109.898 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.85 91.72 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.786 -0.721 . . . . 12.32 111.39 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 69.8 mmm -68.28 -49.58 59.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.233 -0.284 . . . . 63.229999999999997 110.233 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 23' ' ' ILE . 95.0 t -55.84 -30.53 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.251 0.548 . . . . 72.109999999999999 110.502 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.12 -52.62 22.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.717 -0.674 . . . . 72.019999999999996 110.709 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.3 OUTLIER -72.92 -14.73 61.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 74.450000000000003 111.481 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 145' ' ' VAL . 63.6 t -89.95 -35.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.98 0.419 . . . . 74.109999999999999 110.492 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -81.33 -11.83 82.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 63.299999999999997 112.867 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 ptp -95.67 0.65 52.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.573 0.225 . . . . 72.400000000000006 111.235 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.5 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.958 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 CA--C 1.517 -0.321 0 N-CA-C 107.618 -1.253 . . . . 64.319999999999993 107.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 2.3 mppt? -128.48 156.01 43.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.027 -0.669 . . . . 73.140000000000001 111.877 -166.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -86.33 104.23 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.694 -1.139 . . . . 75.510000000000005 108.199 168.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.684 HG22 ' HD3' ' A' ' 161' ' ' LYS . 32.2 mm -69.37 -58.36 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 73.510000000000005 110.6 -174.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.684 ' HD3' HG22 ' A' ' 160' ' ' ILE . 3.9 mppt? -132.13 139.4 48.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.73 -0.668 . . . . 71.239999999999995 110.131 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -138.92 127.3 22.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.69 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 161' ' ' LYS . 42.6 m-85 -140.22 155.06 70.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.7 Cg_exo -71.86 138.28 31.18 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.709 1.606 . . . . 72.319999999999993 110.364 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 73.019999999999996 111.152 -171.763 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER . . . . . 0 CA--C 1.503 -0.851 0 CA-C-O 122.008 0.908 . . . . 62.329999999999998 111.857 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 140.17 142.41 4.19 Favored Glycine 0 N--CA 1.426 -2.026 0 CA-C-N 113.82 -1.536 . . . . 61.100000000000001 111.263 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 172.06 54.1 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.691 -0.766 . . . . 63.409999999999997 111.656 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -66.36 148.59 51.64 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.848 -0.427 . . . . 62.030000000000001 109.848 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -80.1 107.18 6.29 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.372 -0.377 . . . . 73.319999999999993 110.185 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.632 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.3 Cg_exo -79.97 -5.84 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.762 2.308 . . . . 53.240000000000002 111.594 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.65 -22.29 60.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 71.400000000000006 110.446 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.426 HD12 HG12 ' A' ' 193' ' ' VAL . 8.0 pt -97.16 172.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.268 -0.641 . . . . 65.430000000000007 109.268 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . 0.663 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 63.9 m170 -121.24 27.4 8.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 72.540000000000006 111.111 -175.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.0 p -111.87 167.22 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.144 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.429 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -89.22 108.68 19.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.924 0.392 . . . . 61.32 111.375 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -152.2 150.11 29.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.241 -0.651 . . . . 71.019999999999996 109.241 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -127.08 151.68 74.65 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.678 -0.237 . . . . 73.310000000000002 110.955 -173.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.2 Cg_endo -66.38 -70.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.59 2.193 . . . . 75.140000000000001 111.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -114.99 16.41 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.033 0.444 . . . . 73.439999999999998 110.236 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 11.2 m-20 70.17 7.57 6.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.35 -0.841 . . . . 74.310000000000002 113.127 171.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.8 -31.18 71.38 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.884 0.327 . . . . 72.030000000000001 111.884 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.14 -1.14 87.6 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.808 -0.711 . . . . 50.119999999999997 112.907 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 69.8 mtp180 -80.98 -21.52 40.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 53.119999999999997 111.145 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.612 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.522 -0.763 . . . . 63.409999999999997 111.583 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 13.3 Cg_exo . . . . . 0 CA--C 1.531 0.348 0 CA-C-O 120.747 0.228 . . . . 73.329999999999998 112.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.5 -2.16 11.36 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.083 2.522 . . . . 45.329999999999998 112.886 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.576 HD21 HG12 ' A' ' 24' ' ' VAL . 24.5 t-20 -121.09 144.65 48.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 110.275 -175.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 32.1 m -135.32 150.88 29.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.431 . . . . 65.25 111.05 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 28.3 m-85 -103.28 119.71 39.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.832 -0.622 . . . . 74.430000000000007 111.018 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.67 105.03 14.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.063 0.459 . . . . 65.420000000000002 110.797 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' HG12 ' A' ' 22' ' ' ILE . 37.3 mt-10 -90.0 118.23 29.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.965 -0.754 . . . . 73.25 108.965 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -108.34 178.15 4.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 73.010000000000005 111.106 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 160' ' ' ILE . 33.2 t -79.55 6.67 9.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.98 -0.554 . . . . 73.349999999999994 110.431 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.602 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.8 mmt -113.56 -38.28 4.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.918 -0.583 . . . . 70.150000000000006 110.171 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.01 -132.69 1.74 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.268 -0.733 . . . . 74.540000000000006 111.268 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -139.64 131.34 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.17 -0.678 . . . . 64.120000000000005 109.17 177.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -123.47 124.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.584 -0.735 . . . . 71.310000000000002 110.095 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.576 HG12 HD21 ' A' ' 13' ' ' ASN . 20.7 t -99.42 133.6 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.171 -0.677 . . . . 62.240000000000002 109.171 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 3.9 pp -142.04 161.86 36.94 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.502 -0.479 . . . . 65.209999999999994 110.859 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.51 166.07 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.903 -0.59 . . . . 73.150000000000006 109.57 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -107.49 161.28 14.98 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.094 -0.706 . . . . 61.340000000000003 109.094 178.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 7.0 m-85 -84.62 97.04 9.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.668 0.747 . . . . 74.219999999999999 111.216 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 15.0 m95 -88.78 9.88 22.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.45 -1.315 . . . . 73.319999999999993 107.45 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.17 -55.0 5.42 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 113.413 -1.721 . . . . 74.129999999999995 110.603 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.85 1.75 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.177 0.436 . . . . 74.150000000000006 112.177 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.68 77.97 29.35 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.049 -0.26 . . . . 61.200000000000003 110.339 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 7.3 Cg_exo -73.8 -9.7 22.66 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.237 2.624 . . . . 51.149999999999999 113.164 -173.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -100.37 -51.99 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.31 0.576 . . . . 65.099999999999994 109.957 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.49 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -61.2 -39.77 91.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.95 -1.023 . . . . 74.549999999999997 111.574 -175.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 29' ' ' TRP . 26.0 p -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.325 -0.398 . . . . 75.239999999999995 110.767 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.4 mmmm -63.47 -41.07 98.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.626 -0.261 . . . . 72.239999999999995 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' HD23 ' A' ' 42' ' ' LEU . 65.5 t30 -60.25 -47.84 84.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.358 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 11.3 t80 -65.24 -52.21 55.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.131 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.17 81.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.294 -0.866 . . . . 65.450000000000003 112.181 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 44.3 mt-10 -77.53 -24.11 50.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.926 -0.309 . . . . 73.530000000000001 111.723 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.9 mm? -74.4 -27.54 60.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.168 0.508 . . . . 64.129999999999995 109.878 171.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.94 -41.27 71.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 72.140000000000001 110.573 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.678 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 8.4 ppt_? -79.7 -15.36 57.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 72.200000000000003 110.768 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -74.92 -32.93 61.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.045 -0.724 . . . . 71.140000000000001 109.045 172.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.19 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.817 -0.706 . . . . 74.010000000000005 111.791 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.627 ' HE1' ' HA3' ' A' ' 74' ' ' GLY . 6.2 t80 -76.63 -39.39 52.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.602 -0.299 . . . . 74.230000000000004 111.268 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -74.84 -15.51 60.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 112.162 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -76.3 90.65 3.19 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.725 0.774 . . . . 74.230000000000004 109.151 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.39 8.55 4.41 Favored Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.351 -1.295 . . . . 73.150000000000006 112.138 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -97.31 158.72 15.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.01 -0.367 . . . . 71.5 110.01 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -136.51 167.11 22.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.432 -0.507 . . . . 73.150000000000006 110.479 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 86.0 m-85 -83.35 118.87 23.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.943 -0.571 . . . . 71.209999999999994 109.548 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -92.3 -32.66 14.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.299999999999997 110.11 -172.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -121.72 120.86 35.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.961 -0.385 . . . . 72.109999999999999 109.961 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.512 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -131.82 95.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.083 -0.71 . . . . 61.119999999999997 109.083 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.6 mt -102.38 125.13 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 109.878 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -55.15 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.61 0.569 . . . . 61.329999999999998 110.945 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 41.15 44.16 2.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.4 1.062 . . . . 74.319999999999993 112.254 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -138.3 -81.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 72.150000000000006 110.056 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 ptp -160.96 156.9 25.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.688 -0.687 . . . . 61.409999999999997 110.307 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.512 HG23 HG13 ' A' ' 56' ' ' ILE . 37.4 mt -134.77 105.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 63.439999999999998 109.857 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.1 tm0? -84.48 128.71 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 74.519999999999996 110.181 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -124.97 147.88 16.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.13 -0.557 . . . . 63.039999999999999 112.61 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.27 -125.32 3.02 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.618 -0.593 . . . . 75.209999999999994 111.618 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.8 t0 42.15 84.08 0.19 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.947 0.899 . . . . 72.239999999999995 113.125 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 85.1 Cg_endo -79.17 -26.98 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.635 2.223 . . . . 72.340000000000003 111.729 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 20.1 p -84.11 -39.35 19.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.179 -0.919 . . . . 74.129999999999995 111.664 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.23 21.61 14.86 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.774 -0.931 . . . . 74.430000000000007 110.774 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.8 p -113.43 -24.88 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.534 . . . . 73.400000000000006 110.576 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.21 -13.46 65.78 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.659 -0.7 . . . . 75.450000000000003 111.832 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.31 15.51 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.18 0.514 . . . . 73.140000000000001 110.208 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.491 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -77.02 170.16 55.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.52 -0.763 . . . . 62.140000000000001 112.199 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.627 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . 69.43 -175.76 32.59 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.945 -0.645 . . . . 64.349999999999994 112.547 -175.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . 56.3 19.75 4.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.236 0.614 . . . . 70.329999999999998 112.354 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m -84.26 -1.36 55.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.64 -0.709 . . . . 71.120000000000005 110.746 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.6 tt -61.75 -37.84 79.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.743 -0.662 . . . . 73.230000000000004 111.358 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.617 ' HD1' HG23 ' A' ' 77' ' ' ILE . 21.6 p90 -103.22 4.16 36.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.217 0.532 . . . . 73.450000000000003 110.957 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.82 -108.99 2.84 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.342 -0.845 . . . . 72.150000000000006 112.467 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -89.97 -166.15 1.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.752 0.31 . . . . 71.140000000000001 110.233 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -60.62 161.06 8.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.616 . . . . 75.329999999999998 109.772 171.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -100.5 -71.53 0.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 73.209999999999994 111.179 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 14.0 tp10 -151.19 -168.31 3.06 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.802 -1.555 . . . . 65.239999999999995 106.802 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.827 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 0.9 OUTLIER -136.55 119.54 16.42 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.606 -0.887 . . . . 72.120000000000005 108.606 162.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -100.37 29.65 4.27 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.378 -1.283 . . . . 74.519999999999996 110.486 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 31.3 mt -48.89 99.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.376 -0.829 . . . . 33.350000000000001 111.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -170.69 83.63 0.54 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.61 -1.177 . . . . 75.439999999999998 108.839 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.9 84.13 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.284 1.99 . . . . 72.530000000000001 111.337 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.94 -18.15 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.329 1.061 . . . . 62.030000000000001 108.873 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -104.16 165.61 10.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.332 -1.304 . . . . 62.409999999999997 108.79 172.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -119.3 144.37 46.85 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.426 -0.352 . . . . 74.030000000000001 110.143 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.681 ' CZ ' ' HB3' ' A' ' 120' ' ' GLN . 51.4 p90 -71.33 115.31 10.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 72.019999999999996 108.197 174.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 189' ' ' PRO . 77.2 p -99.82 -30.83 11.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.832 -0.622 . . . . 71.329999999999998 110.104 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.42 -148.8 5.87 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.063 -0.971 . . . . 64.540000000000006 110.94 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.56 144.61 30.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.74 0.305 . . . . 61.420000000000002 111.02 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.58 22.93 5.87 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.812 -0.709 . . . . 71.430000000000007 111.993 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 7.9 mm -91.39 115.06 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.785 -0.366 . . . . 51.140000000000001 110.048 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.697 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 6.8 mt -83.1 124.78 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.233 -0.44 . . . . 74.400000000000006 111.115 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.82 171.73 13.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.103 0.478 . . . . 52.109999999999999 111.367 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.652 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 24.1 tpp -86.11 137.81 32.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.618 -0.719 . . . . 74.049999999999997 111.033 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -92.75 113.46 25.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.451 0.644 . . . . 75.0 110.346 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.6 -169.58 3.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.002 -0.999 . . . . 70.109999999999999 109.03 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.54 -41.58 4.78 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.846 -0.342 . . . . 70.310000000000002 111.026 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.3 -55.23 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.504 -0.855 . . . . 75.439999999999998 112.474 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 77.51 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.022 1.814 . . . . 45.109999999999999 112.099 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.827 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 3.5 p-10 44.93 48.26 9.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.685 0.615 . . . . 74.420000000000002 112.13 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.44 29.82 7.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 72.349999999999994 111.082 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.652 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 23.6 p30 -93.67 161.78 14.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.965 0.412 . . . . 64.129999999999995 110.915 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -165.08 -118.21 0.43 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 52.119999999999997 112.284 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 5.5 t -105.4 16.92 24.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.377 0.608 . . . . 64.519999999999996 109.944 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 72.2 mm-40 -93.87 145.28 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 61.210000000000001 109.375 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -145.44 170.88 15.51 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.102 -0.373 . . . . 71.409999999999997 110.394 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 28.6 p90 -157.05 152.76 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.955 0.407 . . . . 74.439999999999998 111.042 173.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.48 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.4 t -107.14 146.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 72.120000000000005 109.757 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.6 p -100.14 124.26 45.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.875 -0.417 . . . . 72.549999999999997 109.875 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.521 HD11 ' HA3' ' A' ' 143' ' ' GLY . 73.9 mt -85.58 -8.14 58.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.709 -0.678 . . . . 74.319999999999993 111.117 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.21 167.0 14.56 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.044 -0.526 . . . . 55.340000000000003 110.556 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.621 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 17.8 Cg_endo -60.35 113.08 1.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.804 2.336 . . . . 72.329999999999998 111.945 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.413 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 31.0 p -107.12 102.36 11.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 42.329999999999998 111.67 -175.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.698 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.8 OUTLIER -108.43 18.04 21.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 109.921 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -113.86 -3.5 13.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.049 -0.978 . . . . 72.540000000000006 111.515 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.7 pp -125.98 9.57 7.51 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.514 -0.474 . . . . 75.019999999999996 112.111 -175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.51 -32.61 51.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.456 0.646 . . . . 71.150000000000006 111.225 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.79 22.75 8.56 Favored Glycine 0 CA--C 1.509 -0.339 0 CA-C-N 115.423 -0.808 . . . . 60.100000000000001 111.68 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.8 mmtm -114.7 -38.71 3.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.306 0.574 . . . . 62.119999999999997 109.496 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -137.1 129.45 29.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.39 -0.823 . . . . 73.349999999999994 108.956 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -75.25 144.97 42.3 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.047 -0.661 . . . . 63.119999999999997 109.568 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.422 ' O ' HD21 ' A' ' 90' ' ' LEU . 44.2 mt -115.35 125.42 72.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.945 -171.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.3 p90 -154.18 72.83 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.964 0.888 . . . . 71.310000000000002 110.895 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.697 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -165.58 160.15 33.49 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.923 -1.608 . . . . 71.439999999999998 114.326 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.1 mtm180 -141.87 126.35 17.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.498 . . . . 72.200000000000003 109.748 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.0 p -91.42 136.13 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.274 0.559 . . . . 71.120000000000005 110.907 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.581 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 38.4 t -141.16 147.73 38.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.045 -0.525 . . . . 62.439999999999998 109.992 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.424 ' HA ' ' N ' ' A' ' 184' ' ' ASP . 12.5 tt0 52.42 35.41 17.41 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.124 0.488 . . . . 73.209999999999994 112.158 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.48 27.83 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.28 -0.962 . . . . 53.350000000000001 112.734 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -75.13 -38.71 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.721 -0.282 . . . . 75.120000000000005 110.299 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.66 -32.08 82.23 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.015 -0.612 . . . . 71.319999999999993 111.94 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.475 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.0 mmm -69.53 -52.0 30.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.962 -0.384 . . . . 73.010000000000005 109.962 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 23' ' ' ILE . 93.0 t -58.07 -29.69 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.143 0.497 . . . . 65.120000000000005 110.409 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.651 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -68.0 -55.61 11.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.882 -0.599 . . . . 73.120000000000005 109.975 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -14.92 61.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.176 -0.466 . . . . 65.209999999999994 111.288 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.725 HG13 HG21 ' A' ' 157' ' ' VAL . 30.4 t -78.61 -39.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.325 0.583 . . . . 75.349999999999994 109.544 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -80.49 -21.07 65.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.564 -0.827 . . . . 33.43 112.642 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 85.3 mtp -72.8 -17.03 61.61 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.945 0.35 . . . . 75.319999999999993 111.945 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 142' ' ' VAL . 34.4 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.63 . . . . 72.439999999999998 111.372 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.725 HG21 HG13 ' A' ' 142' ' ' VAL . 40.9 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 109.559 -0.534 . . . . 65.310000000000002 109.559 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -125.96 158.88 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 111.924 -176.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.1 mp -88.27 106.2 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.578 -1.192 . . . . 71.430000000000007 109.133 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 19' ' ' SER . 26.0 mm -71.67 -53.81 19.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.846 -0.616 . . . . 74.25 110.41 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.8 mptm? -129.9 137.98 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.726 -0.67 . . . . 71.219999999999999 109.843 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -146.06 110.23 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.019 0.437 . . . . 60.409999999999997 110.911 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.34 140.85 31.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.533 -0.758 . . . . 71.519999999999996 110.738 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.687 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 39.2 Cg_endo -67.8 135.24 34.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.604 2.203 . . . . 72.209999999999994 111.855 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.482 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 9.1 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 110.206 -0.294 . . . . 65.319999999999993 110.206 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.445 ' CG ' HG22 ' A' ' 136' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.73 -0.471 . . . . 70.549999999999997 109.73 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.55 140.95 3.0 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.859 -0.686 . . . . 50.340000000000003 112.518 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -83.5 -163.0 34.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.424 -0.893 . . . . 53.119999999999997 112.049 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.689 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.07 160.67 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.801 0.334 . . . . 55.030000000000001 110.474 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.482 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.9 m-85 -106.82 100.04 29.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.47 . . . . 74.109999999999999 110.144 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.673 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.8 Cg_exo -76.81 -6.37 16.76 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.155 2.57 . . . . 72.299999999999997 113.0 -173.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -81.87 -29.92 32.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.511 -0.313 . . . . 72.299999999999997 111.057 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.0 pt -76.52 -19.01 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.991 0.367 . . . . 64.129999999999995 111.991 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.4 m170 67.63 48.43 1.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 72.140000000000001 111.916 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 191' ' ' ILE . 7.3 p -152.34 141.33 14.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.494 -0.321 . . . . 74.099999999999994 110.267 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.64 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 44.409999999999997 111.704 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -163.37 136.5 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.737 -0.665 . . . . 74.239999999999995 109.339 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -109.1 146.84 34.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 75.329999999999998 111.292 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.0 Cg_endo -65.6 -62.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.806 2.337 . . . . 72.25 112.418 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.57 26.49 3.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.565 -0.289 . . . . 74.150000000000006 111.013 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 202' ' ' ARG . 71.5 m-20 68.31 12.58 8.8 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.266 -0.425 . . . . 71.530000000000001 111.708 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.6 ptm -60.5 -24.0 64.96 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.229 0.455 . . . . 72.140000000000001 112.229 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -114.45 18.15 18.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.593 -0.813 . . . . 72.430000000000007 112.327 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 29.0 mmt180 -66.56 -34.44 77.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 70.120000000000005 110.62 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.09 -0.957 . . . . 71.329999999999998 109.875 -177.197 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 79.1 Cg_exo . . . . . 0 CA--C 1.53 0.282 0 CA-C-O 121.076 0.365 . . . . 75.530000000000001 113.019 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 58.8 Cg_endo -70.99 -7.55 21.68 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.125 2.55 . . . . 63.130000000000003 113.289 -175.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.428 HD22 ' HB3' ' A' ' 26' ' ' GLU . 20.2 t-20 -124.34 147.62 48.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.396 -0.594 . . . . 73.109999999999999 109.396 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 27.9 m -129.09 146.82 33.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.056 -0.35 . . . . 75.019999999999996 110.056 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.79 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 46.2 p90 -107.29 128.23 54.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 74.349999999999994 110.374 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.13 99.43 8.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 73.310000000000002 109.993 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 36.8 tt0 -87.75 115.12 24.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.725 -0.843 . . . . 73.099999999999994 108.725 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 177.01 4.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.433 0.635 . . . . 74.120000000000005 112.036 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -71.68 -10.34 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.227 -0.897 . . . . 71.120000000000005 110.456 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -98.84 -41.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.922 -0.581 . . . . 65.340000000000003 110.535 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.48 -129.03 1.18 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.026 -0.83 . . . . 52.509999999999998 111.026 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -144.06 136.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.099 0.476 . . . . 75.439999999999998 110.188 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 139' ' ' VAL . 5.2 mp -134.83 122.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.454 -0.794 . . . . 74.299999999999997 109.032 176.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 133' ' ' CYS . 3.6 m -102.87 150.99 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.933 -0.707 . . . . 72.519999999999996 110.152 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.3 pp -143.99 161.07 39.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.782 -0.645 . . . . 73.420000000000002 109.757 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 29' ' ' TRP . 6.8 pt-20 -138.07 161.24 37.26 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.532 -0.758 . . . . 73.519999999999996 108.963 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 172.12 7.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 110.489 -172.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -91.61 96.2 10.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.407 0.622 . . . . 75.150000000000006 111.376 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -82.48 -5.25 58.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.056 -0.974 . . . . 73.329999999999998 110.439 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -68.31 -53.9 21.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.598 -0.728 . . . . 64.049999999999997 111.284 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -127.76 5.26 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 73.420000000000002 110.875 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.46 74.48 79.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.974 0.416 . . . . 52.439999999999998 110.699 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.19 -26.08 9.43 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.0 2.466 . . . . 75.310000000000002 112.737 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -89.51 -43.62 10.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.289 0.566 . . . . 74.409999999999997 109.908 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.502 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -59.79 -42.02 92.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 65.099999999999994 111.663 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.5 p -64.94 -33.34 75.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 72.150000000000006 111.538 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -31.07 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.83 -0.348 . . . . 75.129999999999995 111.499 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.44 -44.29 94.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 14' ' ' VAL . 18.0 t80 -63.97 -47.17 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.956 -0.565 . . . . 71.5 109.803 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.19 71.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 53.409999999999997 112.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.715 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 50.4 mm-40 -67.88 -29.3 68.38 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.696 0.284 . . . . 61.210000000000001 111.362 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 1.2 mm? -69.53 -37.41 77.08 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.185 0.517 . . . . 73.400000000000006 110.27 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.66 76.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 54.009999999999998 111.016 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 8.7 ptm180 -67.95 -30.07 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.372 -0.376 . . . . 73.010000000000005 111.375 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' HE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -67.18 -35.17 79.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.392 -0.596 . . . . 74.299999999999997 109.392 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 104.56 27.02 6.23 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.527 -0.844 . . . . 74.010000000000005 112.775 171.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 51' ' ' THR . 14.9 m-85 -82.09 -29.82 31.59 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.794 -0.239 . . . . 53.009999999999998 111.518 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.0 -17.13 60.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.99 0.424 . . . . 73.420000000000002 110.574 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 40.3 m-80 -69.47 -11.32 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.471 . . . . 72.510000000000005 110.403 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -119.52 16.25 10.53 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.84 -0.695 . . . . 73.109999999999999 112.059 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.639 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.4 p -97.32 159.95 14.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 44.119999999999997 110.992 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -142.56 155.83 45.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.152 -0.477 . . . . 74.319999999999993 109.953 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.4 m-85 -84.29 126.41 33.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.597 . . . . 61.450000000000003 109.387 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.83 -13.99 6.26 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.776 -0.369 . . . . 52.450000000000003 111.892 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 25.7 mmt85 -121.71 101.06 7.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.57 -0.53 . . . . 71.099999999999994 109.57 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -122.43 92.17 2.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.84 -0.8 . . . . 43.310000000000002 108.84 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.772 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.5 mt -100.11 121.52 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.868 -0.605 . . . . 73.540000000000006 109.422 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -49.95 132.03 22.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.941 0.776 . . . . 74.010000000000005 110.726 177.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 44.41 40.05 3.56 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.171 0.919 . . . . 72.439999999999998 112.328 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.772 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.7 t80 -134.64 -81.98 0.44 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 64.340000000000003 110.382 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.584 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 27.1 ptt? -161.19 155.09 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 71.430000000000007 110.679 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 116' ' ' LEU . 35.7 mt -125.16 101.66 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.916 -0.584 . . . . 71.439999999999998 109.973 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 21.1 mt-30 -86.05 123.04 30.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.014 -0.539 . . . . 71.450000000000003 111.296 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -129.97 137.61 9.65 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 65.510000000000005 112.111 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.639 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 157.63 -155.8 26.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.133 -1.032 . . . . 73.120000000000005 112.933 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 46.2 t0 56.4 89.81 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 112.234 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 41.8 Cg_endo -69.73 -17.6 37.61 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.01 2.473 . . . . 73.540000000000006 112.14 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -97.64 -39.51 9.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.012 -0.54 . . . . 74.319999999999993 112.25 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.71 25.03 33.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.582 -0.818 . . . . 72.310000000000002 111.605 -174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 60.9 p -101.11 -16.88 16.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 62.310000000000002 110.943 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 -17.93 42.63 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.068 -0.969 . . . . 75.420000000000002 112.126 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 1.5 ptp180 -106.55 -33.96 7.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 65.430000000000007 110.784 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.483 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 87.48 -159.05 30.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.673 -0.775 . . . . 61.210000000000001 112.346 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 -114.04 1.01 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.479 -0.649 . . . . 73.010000000000005 111.479 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . 57.59 39.31 27.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.015 0.436 . . . . 61.009999999999998 112.162 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.2 t -109.41 21.69 16.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 54.240000000000002 109.575 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.0 pt -72.11 -21.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.043 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 82' ' ' PHE . 5.2 p90 -106.77 5.45 28.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.512 0.672 . . . . 70.310000000000002 110.783 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.65 -117.51 4.66 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.272 -0.876 . . . . 42.030000000000001 111.738 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -88.56 -161.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.653 -0.869 . . . . 73.310000000000002 108.653 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -63.36 159.24 18.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 71.129999999999995 110.103 175.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 77.7 t80 -95.36 -67.67 0.84 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.061 -0.518 . . . . 74.310000000000002 111.253 -170.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -169.98 152.47 4.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 71.549999999999997 108.994 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.76 105.31 8.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.488 0.661 . . . . 73.349999999999994 109.245 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -101.68 21.96 13.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.808 -0.633 . . . . 64.140000000000001 109.586 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.68 97.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.987 . . . . 65.439999999999998 110.629 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -168.34 81.97 0.77 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 109.836 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 51.5 Cg_endo -68.22 106.97 1.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.29 1.994 . . . . 73.239999999999995 111.74 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.53 -28.1 65.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.152 -1.055 . . . . 74.510000000000005 108.152 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.7 pp -84.21 178.5 7.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.88 -1.509 . . . . 73.239999999999995 109.337 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -141.1 167.2 22.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.586 -0.446 . . . . 65.030000000000001 109.925 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -63.51 123.16 18.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.163 0.506 . . . . 61.350000000000001 109.65 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.0 p -122.62 -40.78 2.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 74.530000000000001 110.573 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.42 -148.05 5.92 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.418 -0.81 . . . . 51.450000000000003 111.363 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.01 136.8 33.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.732 0.301 . . . . 54.229999999999997 110.73 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 116.98 20.07 5.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.85 -0.69 . . . . 61.119999999999997 112.208 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.3 mm -86.64 111.66 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 51.409999999999997 109.37 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.704 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -87.85 122.89 32.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.148 0.499 . . . . 62.310000000000002 110.275 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.07 167.06 20.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.729 -0.669 . . . . 75.120000000000005 110.178 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 34.6 ttp -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.563 -0.532 . . . . 72.200000000000003 109.563 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.29 162.36 13.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.99 0.424 . . . . 63.219999999999999 110.664 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.789 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.5 p-10 -158.71 162.91 37.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.02 -0.536 . . . . 75.140000000000001 110.61 -171.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.08 -19.45 18.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.787 0.803 . . . . 51.399999999999999 109.601 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.76 172.37 33.79 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.208 -1.557 . . . . 64.140000000000001 109.208 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.98 -44.66 36.27 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.003 2.469 . . . . 52.340000000000003 112.421 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.44 -17.6 20.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 64.519999999999996 111.108 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -84.12 47.34 1.31 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.519 0.676 . . . . 62.310000000000002 110.056 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.789 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 36.6 m-80 -64.33 129.87 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.727 -1.124 . . . . 72.319999999999993 108.944 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.24 -146.39 6.43 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.823 -1.18 . . . . 71.420000000000002 114.244 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 35.6 t -99.06 27.65 4.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.231 0.539 . . . . 62.219999999999999 110.095 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 70.9 mt-30 -118.73 152.09 36.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.789 -0.641 . . . . 72.219999999999999 109.888 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.1 p90 -140.46 170.31 16.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.225 -0.657 . . . . 72.120000000000005 109.225 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 p90 -156.95 150.1 23.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.239 0.542 . . . . 74.010000000000005 111.173 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 HD23 ' A' ' 98' ' ' LEU . 16.1 t -113.34 141.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 40.210000000000001 109.338 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.8 p -94.83 125.93 39.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.896 0.379 . . . . 71.0 110.301 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 34.0 mt -85.56 -7.53 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 71.439999999999998 110.228 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.64 159.75 40.36 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.183 -0.917 . . . . 75.340000000000003 109.65 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 42.9 Cg_endo -69.32 114.62 3.69 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.389 2.06 . . . . 64.200000000000003 112.594 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -106.59 118.31 36.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.469 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.51 19.51 19.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 62.140000000000001 110.769 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.61 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -128.15 5.2 5.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.825 . . . . 72.329999999999998 111.015 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.61 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.2 mt -111.3 -1.81 15.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 75.140000000000001 111.461 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 10.2 p-10 -70.08 -10.13 57.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.113 0.482 . . . . 74.549999999999997 111.358 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.15 17.68 6.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 74.239999999999995 111.757 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -121.73 -28.0 4.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.032 0.444 . . . . 55.219999999999999 110.205 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.14 134.68 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 110.327 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -69.04 112.03 5.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.98 0.419 . . . . 63.329999999999998 110.272 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 99' ' ' ALA . 39.2 mt -98.79 119.46 46.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.5 110.368 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.6 p90 -156.88 74.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.503 0.668 . . . . 72.340000000000003 110.672 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.6 157.84 29.88 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 118.98 -1.581 . . . . 55.43 114.257 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 190' ' ' GLU . 4.5 mtt180 -125.82 125.53 43.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.583 -0.895 . . . . 64.319999999999993 108.583 173.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.433 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.1 p -88.04 132.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.196 -0.602 . . . . 71.099999999999994 110.159 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 47.8 t -139.94 152.03 46.03 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.287 -0.258 . . . . 43.32 111.095 -176.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.0 pt20 41.67 35.23 0.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.545 1.138 . . . . 74.430000000000007 113.11 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.36 15.75 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.559 -0.829 . . . . 71.540000000000006 112.343 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.1 tp -72.28 -33.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.619 0.247 . . . . 61.219999999999999 110.626 -174.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.49 -37.38 93.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.724 -0.751 . . . . 44.210000000000001 111.256 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 77.9 mmm -71.43 -49.46 41.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.285 -0.265 . . . . 72.049999999999997 110.285 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 23' ' ' ILE . 86.5 t -55.81 -30.59 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.998 0.428 . . . . 31.239999999999998 110.815 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.95 -51.14 27.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.014 -0.539 . . . . 72.340000000000003 110.566 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -76.29 -13.83 60.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.948 -0.569 . . . . 64.129999999999995 111.391 -177.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 145' ' ' VAL . 79.0 t -91.76 -27.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 71.140000000000001 109.895 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -93.35 -8.01 61.58 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.541 -0.838 . . . . 73.299999999999997 113.001 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 27.3 ptm -85.14 -11.14 55.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.798 0.333 . . . . 65.219999999999999 110.369 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 142' ' ' VAL . 28.9 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 64.349999999999994 110.77 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 22.2 t . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 108.019 -1.104 . . . . 73.140000000000001 108.019 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 2.6 mppt? -127.51 152.84 47.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.334 -0.546 . . . . 63.450000000000003 111.407 -167.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -89.78 109.85 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.45 -0.944 . . . . 62.140000000000001 108.45 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.431 HG22 ' CD ' ' A' ' 161' ' ' LYS . 28.5 mm -76.65 -51.87 18.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.102 -0.499 . . . . 71.340000000000003 110.679 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -131.73 129.84 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.739 . . . . 71.140000000000001 110.084 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -140.99 110.8 6.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.939 0.4 . . . . 60.109999999999999 110.792 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.59 155.14 53.09 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.543 -0.753 . . . . 71.319999999999993 109.708 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.673 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.77 137.68 39.12 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.295 1.997 . . . . 75.439999999999998 111.332 175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.79 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 5.8 t . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 120.961 0.41 . . . . 73.530000000000001 110.884 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.3 m-20 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.349 0.595 . . . . 64.219999999999999 110.41 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 155.38 144.18 3.85 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.072 -0.967 . . . . 64.120000000000005 110.963 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.433 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -80.36 -166.55 34.59 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.242 -0.98 . . . . 64.310000000000002 112.395 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.34 175.51 9.68 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.586 -0.524 . . . . 63.140000000000001 109.586 177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.37 102.45 53.13 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 110.511 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 97' ' ' ILE . 2.5 Cg_endo -79.69 -13.38 13.23 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.05 2.5 . . . . 74.140000000000001 111.065 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 131' ' ' ARG . 26.1 tt0 -70.85 -35.16 72.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.016 -0.993 . . . . 74.040000000000006 109.773 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.8 pt -92.15 156.45 3.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.144 -1.058 . . . . 64.109999999999999 108.144 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -106.39 74.77 1.04 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.996 -0.682 . . . . 74.109999999999999 110.921 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.7 149.1 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.393 -0.821 . . . . 63.109999999999999 108.977 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.33 118.49 24.9 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.811 -0.356 . . . . 61.219999999999999 110.863 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.591 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -152.08 153.23 33.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.543 -0.54 . . . . 72.439999999999998 109.543 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 202' ' ' ARG . 62.6 m-85 -120.65 137.74 26.7 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.453 -0.34 . . . . 53.049999999999997 111.126 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.85 -55.87 0.95 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.967 2.445 . . . . 63.409999999999997 112.289 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 15.12 2.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.641 -0.254 . . . . 75.329999999999998 111.458 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 202' ' ' ARG . 1.7 t70 61.91 80.84 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.472 1.13 . . . . 62.340000000000003 109.661 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 13.1 ptm -129.96 -10.13 4.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.271 -1.331 . . . . 70.129999999999995 110.541 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -142.19 14.97 2.55 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.375 -0.917 . . . . 64.0 112.801 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 3.1 ptt180 -98.15 -34.81 10.6 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 119.373 -0.931 . . . . 75.430000000000007 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.7 mmpt? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.517 -0.754 . . . . 73.430000000000007 110.084 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 N--CA 1.462 -0.374 0 N-CA-C 111.531 -0.219 . . . . 73.129999999999995 111.531 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 38.5 Cg_endo -67.57 -7.5 19.48 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.885 2.39 . . . . 75.409999999999997 113.268 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.659 HD21 HG12 ' A' ' 24' ' ' VAL . 18.0 t-20 -133.16 141.41 48.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 71.420000000000002 110.731 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.4 m -131.08 157.01 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.116 -0.493 . . . . 54.130000000000003 109.973 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 22' ' ' ILE . 23.7 p90 -121.03 138.82 53.99 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 74.030000000000001 110.638 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -114.77 103.68 11.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.627 -0.715 . . . . 61.409999999999997 109.754 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 22' ' ' ILE . 37.8 tt0 -88.13 114.65 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 159' ' ' ILE . 59.3 p -104.04 177.06 4.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.312 -0.404 . . . . 71.329999999999998 110.696 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.433 ' HB2' HD11 ' A' ' 160' ' ' ILE . 27.7 t -71.23 -20.41 62.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 73.030000000000001 110.994 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 142' ' ' VAL . 79.8 mtp -95.01 -33.94 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.26 . . . . 52.539999999999999 110.937 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.487 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -171.17 -138.6 2.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.454 -0.879 . . . . 61.539999999999999 112.153 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.98 129.99 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.068 -0.716 . . . . 63.140000000000001 109.068 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -124.14 123.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.487 -0.778 . . . . 74.540000000000006 110.316 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 13' ' ' ASN . 23.2 t -103.26 138.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.721 -0.474 . . . . 54.140000000000001 109.721 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.72 165.06 33.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 71.019999999999996 110.599 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 9.6 pt-20 -136.56 165.21 26.39 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.919 -0.582 . . . . 73.120000000000005 110.115 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.01 162.08 13.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.96 0.409 . . . . 61.340000000000003 110.504 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 4.0 m-85 -81.53 98.12 8.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 111.695 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 42.7 m95 -83.4 -3.72 57.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.117 -0.492 . . . . 65.129999999999995 110.594 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -78.84 -62.15 1.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 71.239999999999995 111.075 -175.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -125.5 18.76 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.571 -0.286 . . . . 73.329999999999998 111.76 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -142.0 71.69 23.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 45.399999999999999 111.14 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.35 -44.3 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.992 2.461 . . . . 73.349999999999994 113.052 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.9 tpmt? -73.66 -36.1 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 65.109999999999999 110.543 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.628 ' OG1' ' HB1' ' A' ' 32' ' ' ALA . 14.5 p -68.95 -43.34 75.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.16 -0.473 . . . . 71.209999999999994 110.616 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' CE2' ' A' ' 29' ' ' TRP . 25.0 t -53.88 -50.83 65.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.457 -0.792 . . . . 72.25 110.78 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.816 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.3 mmpt? -60.37 -37.01 79.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 72.519999999999996 111.114 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.554 HD22 ' HD1' ' A' ' 39' ' ' PHE . 9.7 t30 -62.17 -56.17 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 74.319999999999993 110.323 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HD1' HD22 ' A' ' 38' ' ' ASN . 3.2 m-30 -66.12 -40.05 90.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 71.420000000000002 111.565 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.35 94.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.61 -0.268 . . . . 73.299999999999997 111.0 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.81 -48.91 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 75.450000000000003 111.773 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -65.25 -25.79 67.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.395 -0.522 . . . . 74.319999999999993 111.008 -179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.79 -55.72 7.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.017 0.437 . . . . 74.120000000000005 110.778 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 44' ' ' ARG . 6.4 ppt_? -79.3 -28.3 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 74.120000000000005 112.24 -172.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -74.54 -52.9 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.875 0.369 . . . . 75.109999999999999 110.404 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.94 50.02 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.31 -0.948 . . . . 74.510000000000005 112.616 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB2' HD12 ' A' ' 42' ' ' LEU . 56.0 t80 -103.48 -51.44 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.793 -0.239 . . . . 75.019999999999996 111.091 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 51' ' ' THR . 76.0 m-85 -68.49 -18.99 64.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 121.146 -0.222 . . . . 74.0 111.316 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -74.34 84.48 1.93 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.63 -0.878 . . . . 75.400000000000006 108.63 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.53 24.41 1.13 Allowed Glycine 0 C--N 1.301 -1.384 0 CA-C-N 113.979 -1.464 . . . . 73.230000000000004 111.77 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 48' ' ' TYR . 34.3 p -108.91 158.67 17.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.928 -0.397 . . . . 54.030000000000001 109.928 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 12.2 ptpt -138.39 158.12 44.89 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.783 0.325 . . . . 63.140000000000001 111.168 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 78.9 m-85 -84.04 121.66 27.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.412 -0.588 . . . . 72.540000000000006 109.412 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -96.52 -40.62 8.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.467 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -123.71 114.65 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.343 -0.243 . . . . 61.310000000000002 110.343 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -119.64 89.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.698 -0.853 . . . . 75.329999999999998 108.698 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.0 mt -96.56 120.8 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.164 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -53.65 129.12 31.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.723 -0.671 . . . . 70.439999999999998 111.003 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 58.28 26.76 14.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.262 -0.881 . . . . 72.010000000000005 111.852 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.652 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 1.1 t80 -128.92 -83.45 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.201 0.524 . . . . 74.230000000000004 110.469 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.448 ' H ' ' HB3' ' A' ' 60' ' ' PHE . 27.3 ptt? -161.26 153.45 19.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.349 -0.841 . . . . 74.230000000000004 110.033 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 116' ' ' LEU . 23.4 mt -119.42 99.76 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.12 -0.696 . . . . 63.119999999999997 109.12 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.899 -0.591 . . . . 64.310000000000002 110.247 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.06 151.2 20.65 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.941 -0.647 . . . . 74.200000000000003 112.191 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.25 -77.93 0.2 Allowed Glycine 0 C--O 1.219 -0.797 0 C-N-CA 119.642 -1.266 . . . . 74.329999999999998 114.027 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -45.91 108.65 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 122.155 0.979 . . . . 72.530000000000001 113.205 -165.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 59.7 Cg_endo -74.46 -14.6 22.48 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.539 2.826 . . . . 44.25 111.891 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.5 p -84.63 -28.76 26.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.952 -1.022 . . . . 44.149999999999999 111.381 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 2.98 90.7 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.401 -0.68 . . . . 55.32 111.401 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.6 p -88.34 -24.61 23.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.319 0.581 . . . . 74.109999999999999 110.574 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.5 -16.35 48.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.287 -0.87 . . . . 63.310000000000002 112.096 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -82.0 -48.12 11.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 75.340000000000003 110.245 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.594 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 98.09 -174.57 28.9 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.592 -0.731 . . . . 65.430000000000007 112.525 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.29 -93.49 0.86 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.393 -0.683 . . . . 74.299999999999997 111.393 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 61.36 43.31 10.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.652 0.739 . . . . 62.219999999999999 111.97 172.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -86.35 24.65 1.33 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.528 -0.76 . . . . 71.5 111.157 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 pt -100.26 -17.7 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.809 -0.356 . . . . 63.219999999999999 111.487 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 30.2 p90 -121.3 -22.6 5.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.483 -0.487 . . . . 74.400000000000006 111.999 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.79 -99.65 1.15 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.563 -0.827 . . . . 44.310000000000002 111.467 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 23.6 mtpt -78.88 161.9 26.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.968 -0.382 . . . . 73.340000000000003 109.968 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 107' ' ' THR . 1.2 mp0 -66.08 172.07 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.248 0.547 . . . . 70.010000000000005 111.281 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -95.92 -71.96 0.65 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.52 -0.764 . . . . 74.409999999999997 109.067 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 5.8 tp10 -169.27 172.01 7.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.494 -1.299 . . . . 72.310000000000002 107.494 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 13.1 p-10 -77.87 107.86 10.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 54.310000000000002 109.263 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.42 18.35 5.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 71.040000000000006 109.483 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.5 mt -57.04 102.07 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.815 -1.084 . . . . 73.409999999999997 110.269 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -157.18 75.38 4.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.552 -0.536 . . . . 65.439999999999998 109.552 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 123' ' ' ASP . 37.0 Cg_endo -66.15 91.12 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.621 2.214 . . . . 61.200000000000003 112.221 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.28 -16.69 51.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.329 1.061 . . . . 74.439999999999998 108.917 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.5 pp -93.8 175.61 6.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.417 -1.265 . . . . 74.209999999999994 110.217 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -131.01 146.31 52.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 109.886 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.616 ' HE2' ' HB3' ' A' ' 123' ' ' ASP . 96.2 m-85 -69.77 94.15 0.79 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.276 -0.638 . . . . 72.239999999999995 109.276 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 195' ' ' GLN . 39.1 p -81.99 -41.71 20.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.945 -1.025 . . . . 61.299999999999997 110.434 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.5 -131.94 1.36 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 31.539999999999999 111.645 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.21 143.28 28.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.764 0.316 . . . . 71.430000000000007 110.782 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 25.0 5.57 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.741 -0.742 . . . . 70.400000000000006 112.128 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 189' ' ' PRO . 7.1 mm -86.45 110.0 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.237 -0.653 . . . . 74.450000000000003 109.237 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.738 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.8 tm? -87.19 113.01 22.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.202 -0.453 . . . . 61.43 110.058 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -127.12 171.23 11.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.923 -0.58 . . . . 75.420000000000002 110.589 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.503 ' SD ' ' HB ' ' A' ' 127' ' ' THR . 15.2 ptm -95.14 148.34 22.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.821 0.343 . . . . 65.040000000000006 110.146 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -94.92 124.82 39.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.028 0.442 . . . . 73.519999999999996 110.46 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.674 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -144.28 164.15 31.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 70.420000000000002 110.234 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -71.98 -44.87 62.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.99 -0.55 . . . . 55.329999999999998 110.53 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.28 -97.48 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.741 -0.742 . . . . 45.009999999999998 112.089 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.98 88.64 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.885 2.39 . . . . 72.129999999999995 112.145 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 53.51 12.54 0.38 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.688 1.195 . . . . 60.32 113.707 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.2 m -88.16 61.55 6.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.989 -0.745 . . . . 63.229999999999997 108.989 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.6 p30 -81.62 143.49 31.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.011 -0.995 . . . . 74.200000000000003 111.34 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -124.89 -172.27 13.47 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.519 -0.764 . . . . 61.43 112.033 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 75' ' ' ALA . 15.9 p -88.44 3.85 48.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 70.340000000000003 110.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 77.4 mt-30 -80.75 159.09 25.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 71.319999999999993 110.236 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -139.77 169.36 17.87 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.896 -0.409 . . . . 74.329999999999998 109.896 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.71 146.82 25.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.116 0.484 . . . . 72.120000000000005 110.127 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.668 HG22 HD23 ' A' ' 98' ' ' LEU . 13.1 t -110.44 134.24 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.508 -0.769 . . . . 64.239999999999995 109.36 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 p -91.69 125.58 36.46 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.024 0.44 . . . . 75.430000000000007 110.323 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 62' ' ' ILE . 47.1 mt -81.54 -9.7 59.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 73.340000000000003 110.683 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.24 159.54 32.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.585 -0.734 . . . . 74.129999999999995 110.201 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 34.9 Cg_exo -60.56 122.85 11.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.732 2.288 . . . . 62.520000000000003 111.939 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 3.5 p -127.76 89.15 2.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.227 0.537 . . . . 34.409999999999997 110.158 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.569 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.9 OUTLIER -93.22 24.19 3.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.875 0.845 . . . . 64.099999999999994 110.144 -166.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.671 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.3 p90 -116.56 -0.18 12.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.315 -1.311 . . . . 75.239999999999995 109.504 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.671 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 90.5 mt -108.19 1.05 21.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.368 -0.833 . . . . 72.010000000000005 110.796 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.616 ' HB3' ' HE2' ' A' ' 92' ' ' PHE . 16.9 p-10 -68.59 -15.87 63.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.374 -0.83 . . . . 75.239999999999995 111.276 -174.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 14.62 10.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.478 -0.868 . . . . 74.129999999999995 111.646 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -116.89 -37.24 3.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 65.129999999999995 110.546 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -133.27 130.28 38.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 65.450000000000003 110.088 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.503 ' HB ' ' SD ' ' A' ' 100' ' ' MET . 19.0 m -65.59 126.5 28.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 71.209999999999994 110.21 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 99' ' ' ALA . 22.6 mt -107.27 127.96 62.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.47 -0.332 . . . . 72.420000000000002 110.347 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.623 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 22.7 p90 -159.47 70.83 0.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.521 0.677 . . . . 73.0 110.816 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.66 155.16 26.39 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.903 -1.141 . . . . 73.120000000000005 113.296 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -136.2 120.57 18.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.34 137.28 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.149 0.5 . . . . 74.230000000000004 110.892 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.605 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 35.4 t -144.83 149.33 35.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.052 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.8 tt0 47.64 52.48 12.52 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.403 0.62 . . . . 74.439999999999998 111.585 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.83 25.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.379 -0.915 . . . . 74.150000000000006 112.05 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -79.49 -30.94 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.822 -0.436 . . . . 64.299999999999997 109.822 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.22 88.89 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.799 -0.715 . . . . 71.120000000000005 111.439 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.552 ' HE1' HH11 ' A' ' 141' ' ' ARG . 54.3 mmm -71.96 -52.44 17.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.936 -0.394 . . . . 63.350000000000001 109.936 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.86 -32.04 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.175 0.512 . . . . 53.32 110.926 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.418 ' HA ' ' SD ' ' A' ' 200' ' ' MET . 1.8 t30 -71.4 -50.86 27.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.794 -0.639 . . . . 74.239999999999995 110.878 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.552 HH11 ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -77.87 -12.36 59.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 64.120000000000005 111.29 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 145' ' ' VAL . 70.2 t -91.32 -32.32 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.096 0.474 . . . . 54.43 110.434 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.29 -17.37 60.85 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.554 -0.832 . . . . 60.109999999999999 113.11 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.2 ptp -88.36 -13.16 41.34 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.594 -0.442 . . . . 61.020000000000003 111.347 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 142' ' ' VAL . 27.5 m . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 121.307 0.575 . . . . 53.530000000000001 110.814 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.456 -0.138 0 N-CA-C 109.295 -0.632 . . . . 72.150000000000006 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -144.52 166.77 24.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.91 -0.586 . . . . 73.049999999999997 111.677 -168.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.7 mp -88.5 113.18 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.153 -0.93 . . . . 65.530000000000001 109.476 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.49 HG22 ' CD ' ' A' ' 161' ' ' LYS . 26.7 mm -75.56 -61.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.626 -0.716 . . . . 53.240000000000002 110.389 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 160' ' ' ILE . 2.1 mptm? -124.95 131.18 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 110.103 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -137.68 113.8 9.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.355 -0.384 . . . . 53.030000000000001 110.694 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -148.61 156.03 41.78 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 72.510000000000005 110.012 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 56.7 Cg_endo -70.33 134.62 27.18 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.19 1.927 . . . . 64.430000000000007 111.513 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 121.208 0.527 . . . . 74.430000000000007 110.731 -175.148 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.51 -0.571 0 CA-C-O 121.757 0.789 . . . . 63.229999999999997 110.842 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 141.31 148.05 5.0 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.3 -1.318 . . . . 61.409999999999997 111.458 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -84.67 -167.35 42.79 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.337 -0.935 . . . . 33.530000000000001 111.346 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.519 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -76.04 165.28 25.18 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.202 -0.666 . . . . 60.25 109.202 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.403 ' O ' HG21 ' A' ' 93' ' ' THR . 98.0 m-85 -106.84 93.4 8.81 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.637 0.256 . . . . 72.209999999999994 110.562 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.744 ' HB2' HD13 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -71.94 -11.85 27.83 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.522 2.148 . . . . 73.400000000000006 112.685 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.37 -38.36 71.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.399 0.618 . . . . 74.150000000000006 109.632 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.6 155.0 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.972 -1.121 . . . . 74.010000000000005 107.972 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.4 m170 -104.76 92.75 4.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.116 -0.634 . . . . 73.150000000000006 110.599 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.01 146.92 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.565 -0.743 . . . . 61.109999999999999 109.778 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.8 108.0 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.792 0.329 . . . . 24.210000000000001 111.171 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 93' ' ' THR . 19.4 pt20 -139.34 141.53 37.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 110.745 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.476 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 27.6 m-85 -112.6 135.53 21.52 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 120.715 0.293 . . . . 73.519999999999996 110.83 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.9 Cg_endo -62.26 -65.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.97 2.447 . . . . 74.430000000000007 112.253 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.3 pt? -125.44 19.5 8.09 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.158 0.504 . . . . 75.099999999999994 110.078 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 41.8 m-20 71.18 8.88 6.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.057 -0.974 . . . . 65.129999999999995 113.198 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' A' ' 140' ' ' ASN . 25.1 ptt? -63.89 -29.09 70.3 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.808 -0.357 . . . . 75.400000000000006 111.463 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.21 -2.47 90.49 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.822 -0.704 . . . . 50.240000000000002 112.35 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.476 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 14.3 mtp180 -87.24 -61.17 1.78 Allowed 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 110.132 -0.321 . . . . 74.439999999999998 110.132 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt . . . . . 0 C--O 1.249 1.043 0 O-C-N 125.123 1.514 . . . . 75.299999999999997 112.78 -172.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.851 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 19.2 Cg_endo . . . . . 0 CA--C 1.531 0.363 0 CA-C-O 121.0 0.333 . . . . 72.319999999999993 112.848 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.39 -11.75 9.38 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.194 2.596 . . . . 52.240000000000002 114.108 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.528 HD21 HG12 ' A' ' 24' ' ' VAL . 27.3 t-20 -131.22 148.49 52.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.639 0.257 . . . . 72.420000000000002 110.847 -171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 28.5 m -132.75 147.37 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.138 0.494 . . . . 64.010000000000005 111.021 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 39.1 m-85 -105.09 118.96 37.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.68 -0.691 . . . . 71.019999999999996 110.528 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 mt -106.02 98.24 7.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.447 -0.342 . . . . 60.119999999999997 110.118 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 6.0 tt0 -89.79 113.06 24.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.457 -0.571 . . . . 61.439999999999998 109.457 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -105.47 178.11 4.65 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.068 -0.515 . . . . 63.509999999999998 111.09 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -73.75 -15.06 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 73.420000000000002 111.049 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.408 ' HG3' HG22 ' A' ' 157' ' ' VAL . 89.7 mmm -99.23 -32.73 11.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 63.009999999999998 110.923 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.43 -134.16 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.015 -0.612 . . . . 62.299999999999997 111.741 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.29 130.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.184 -0.672 . . . . 72.140000000000001 109.184 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.9 mp -122.81 128.42 75.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.556 -0.747 . . . . 72.25 110.203 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.528 HG12 HD21 ' A' ' 13' ' ' ASN . 46.2 t -110.74 141.77 25.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.226 -0.443 . . . . 64.019999999999996 110.232 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.4 pp -155.49 166.6 33.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.878 0.37 . . . . 73.519999999999996 111.035 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.37 173.49 10.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.589 -0.732 . . . . 75.319999999999993 109.575 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -111.95 161.18 16.7 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.41 -0.589 . . . . 61.100000000000001 109.41 176.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.2 m-85 -80.23 102.16 9.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.548 0.689 . . . . 71.310000000000002 112.482 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -82.73 -3.5 56.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.931 -1.031 . . . . 75.329999999999998 109.68 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 30' ' ' LYS . 5.3 mptt -71.64 -57.37 4.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.329 -0.85 . . . . 73.400000000000006 111.176 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -136.9 21.49 3.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.055 0.391 . . . . 73.329999999999998 112.055 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -135.26 66.72 67.02 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 74.219999999999999 110.597 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.71 -51.27 4.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.883 2.389 . . . . 63.520000000000003 112.862 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -84.26 -25.63 29.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.741 -0.384 . . . . 75.209999999999994 110.243 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.7 -50.29 69.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.194 -0.669 . . . . 71.230000000000004 109.194 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 4.4 t -57.25 -43.99 83.46 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.427 -0.806 . . . . 61.399999999999999 110.28 172.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.628 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -59.95 -39.19 84.73 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.569 -0.741 . . . . 75.099999999999994 110.53 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -55.69 -50.49 70.15 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.899 0.381 . . . . 73.150000000000006 110.222 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.48 -42.75 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 74.540000000000006 111.164 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.44 86.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.011 0.434 . . . . 71.010000000000005 111.35 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -46.92 86.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 75.049999999999997 110.638 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.63 -30.48 68.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 61.439999999999998 111.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.64 67.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.95 -0.568 . . . . 74.329999999999998 111.084 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -74.95 -15.63 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.415 . . . . 72.349999999999994 110.346 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' HD12 ' A' ' 77' ' ' ILE . 23.5 tpt180 -77.67 -51.68 10.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.795 -0.639 . . . . 62.219999999999999 109.676 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.24 27.02 5.74 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.63 -0.714 . . . . 72.420000000000002 112.192 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.19 11.36 12.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 72.040000000000006 111.485 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.51 -14.75 18.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.751 0.31 . . . . 75.450000000000003 110.461 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 32.2 m-80 -80.64 99.28 8.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.94 0.876 . . . . 71.400000000000006 109.48 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.31 7.31 9.24 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 114.033 -1.439 . . . . 53.039999999999999 111.697 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.458 ' HB ' ' C ' ' A' ' 65' ' ' GLY . 81.9 p -88.84 165.4 14.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.555 0.217 . . . . 61.350000000000001 110.489 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -139.0 158.61 43.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 74.239999999999995 110.564 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 73.3 m-85 -80.6 133.65 35.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.4 0.619 . . . . 53.420000000000002 111.388 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.678 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 60.8 m80 -93.64 -56.75 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.966 -1.016 . . . . 74.040000000000006 110.507 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.3 mmm180 -114.88 112.72 23.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.852 -1.067 . . . . 73.329999999999998 109.805 -170.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 62' ' ' ILE . 4.4 mp -123.11 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.816 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 25.6 mt -103.58 127.32 57.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.022 -0.536 . . . . 73.140000000000001 109.714 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -59.83 130.75 48.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.413 0.446 . . . . 72.319999999999993 111.096 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 54.1 31.65 14.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 111.417 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -130.71 -82.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 110.301 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.658 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.7 ptm -160.5 155.83 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.54 -0.754 . . . . 75.310000000000002 110.603 -176.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 23.2 mt -132.97 101.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.765 -0.652 . . . . 54.109999999999999 109.742 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 50.4 tt0 -89.54 128.22 35.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.474 . . . . 75.0 110.986 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -131.14 160.16 23.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.87 -0.681 . . . . 64.329999999999998 112.613 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.458 ' C ' ' HB ' ' A' ' 51' ' ' THR . . . 137.77 -150.8 21.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 34.100000000000001 112.309 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.678 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 0.2 OUTLIER 68.08 96.02 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 112.954 0.724 . . . . 73.209999999999994 112.954 178.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.59 -17.56 11.17 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.244 1.962 . . . . 62.210000000000001 109.819 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.0 p -92.25 -48.32 6.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.131 -1.395 . . . . 52.539999999999999 112.154 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.1 13.42 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.526 -0.63 . . . . 71.409999999999997 111.526 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 68' ' ' THR . 4.0 t -112.39 -29.1 7.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 74.129999999999995 111.85 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.34 -21.86 9.82 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.372 -0.918 . . . . 70.319999999999993 112.839 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.435 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -103.33 -29.45 11.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 73.510000000000005 110.571 177.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.72 -169.04 15.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.55 -0.833 . . . . 53.409999999999997 113.361 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.33 36.9 2.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.332 -0.461 . . . . 70.140000000000001 112.725 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -76.26 59.5 1.39 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.545 0.688 . . . . 72.140000000000001 111.124 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -85.85 9.93 15.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.512 -0.767 . . . . 72.239999999999995 109.876 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 45' ' ' ARG . 3.0 tt -62.0 -38.6 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 70.310000000000002 110.117 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 13.04 22.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.723 0.773 . . . . 72.019999999999996 110.409 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -80.87 1.63 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.705 -1.134 . . . . 42.119999999999997 112.028 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -133.42 -179.85 5.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.968 0.413 . . . . 73.409999999999997 110.43 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.749 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -72.17 174.82 6.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.564 -0.744 . . . . 72.150000000000006 110.231 177.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.01 -64.4 1.31 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.391 0.615 . . . . 74.019999999999996 110.225 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -161.64 176.5 10.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.495 -1.298 . . . . 74.329999999999998 107.495 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.539 ' OD1' ' HG ' ' A' ' 86' ' ' LEU . 2.5 t0 -81.07 138.22 35.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.78 -0.768 . . . . 63.420000000000002 110.045 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -100.08 13.81 32.83 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.521 -0.763 . . . . 74.209999999999994 110.58 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 47.5 mt -51.54 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.694 0.621 . . . . 72.319999999999993 111.104 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -166.58 79.77 1.04 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.479 -0.782 . . . . 54.229999999999997 109.533 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.44 102.56 0.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.598 2.199 . . . . 61.229999999999997 112.078 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.94 -14.9 59.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.473 1.13 . . . . 71.299999999999997 108.917 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.3 pp -113.24 -174.92 2.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.251 -1.34 . . . . 64.140000000000001 109.545 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -141.28 166.38 24.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.963 -0.754 . . . . 54.420000000000002 108.963 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -63.9 123.37 18.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.441 0.639 . . . . 73.109999999999999 110.511 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 35.4 p -122.78 -44.81 2.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.528 -0.76 . . . . 74.019999999999996 110.005 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.75 -145.27 4.31 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.482 -0.781 . . . . 64.219999999999999 111.787 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.61 143.2 26.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.632 0.253 . . . . 71.040000000000006 110.923 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.77 22.0 6.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.589 -0.815 . . . . 74.439999999999998 111.894 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.4 mm -84.37 111.33 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.642 . . . . 74.310000000000002 109.268 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.6 124.44 32.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.668 -0.493 . . . . 61.140000000000001 109.668 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.42 171.32 14.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.048 -0.524 . . . . 41.340000000000003 111.383 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 25.4 ttt -107.54 132.36 53.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.693 -0.685 . . . . 72.209999999999994 109.805 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -96.29 163.19 13.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.411 . . . . 24.23 110.147 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -158.76 164.75 35.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 72.219999999999999 109.723 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.53 58.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 111.187 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 147.45 -136.54 6.13 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 120.858 -0.686 . . . . 71.099999999999994 111.875 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 18.2 Cg_endo -54.12 97.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 123.305 2.67 . . . . 55.219999999999999 111.811 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 3.2 p30 58.53 13.15 2.39 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.211 -1.359 . . . . 73.129999999999995 112.645 173.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.4 m -89.31 60.48 5.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.386 0.613 . . . . 74.540000000000006 109.369 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -85.1 151.95 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.598 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.94 -110.07 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.976 -0.556 . . . . 63.350000000000001 112.124 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 79.8 p -123.48 61.33 1.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.75 0.786 . . . . 64.340000000000003 110.568 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.609 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 69.8 mm-40 -126.91 146.0 50.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.586 -1.188 . . . . 61.340000000000003 109.716 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -148.93 164.91 33.13 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.581 -0.525 . . . . 73.239999999999995 109.581 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 48.6 p90 -158.36 152.12 23.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 74.239999999999995 111.302 175.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.688 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -113.27 143.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.329999999999998 109.115 175.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.7 p -98.79 130.55 45.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.28 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.3 mt -86.85 -5.5 59.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.721 -0.672 . . . . 70.299999999999997 110.651 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.95 163.52 25.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.697 -0.683 . . . . 51.219999999999999 110.135 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.503 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 21.5 Cg_exo -66.46 120.18 7.28 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.629 2.219 . . . . 74.409999999999997 112.074 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -104.68 156.56 17.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.617 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.95 12.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.256 0.551 . . . . 74.040000000000006 110.487 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -110.59 -11.03 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 74.129999999999995 112.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -129.85 -1.28 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.315 0.578 . . . . 75.040000000000006 111.149 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 -13.5 60.67 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.904 -1.044 . . . . 71.140000000000001 110.933 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.47 8.49 28.41 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.155 -0.778 . . . . 61.409999999999997 111.155 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -114.83 -23.4 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 71.299999999999997 109.159 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 100' ' ' MET . 86.0 m-70 -134.64 133.95 40.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.655 -1.157 . . . . 71.0 108.405 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -73.22 147.89 44.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.412 . . . . 63.100000000000001 110.52 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 99' ' ' ALA . 29.4 mt -125.16 122.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 73.329999999999998 110.62 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' A' ' 35' ' ' THR . 6.7 p90 -159.58 74.25 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.59 0.71 . . . . 75.010000000000005 110.925 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.7 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.45 157.16 29.25 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.574 -1.298 . . . . 71.420000000000002 113.177 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -132.58 120.07 21.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.902 -0.406 . . . . 75.549999999999997 109.902 173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.6 p -82.73 137.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 73.0 110.582 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 43.7 t -141.25 153.09 45.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.366 -0.379 . . . . 73.129999999999995 110.508 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 2.8 pt20 40.4 39.42 0.7 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.508 1.123 . . . . 54.5 113.221 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.24 31.96 0.12 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.825 -0.702 . . . . 45.549999999999997 112.124 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -83.79 -31.03 7.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 74.120000000000005 109.486 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.56 93.0 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.673 -0.694 . . . . 72.25 111.867 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.42 ' HE1' HH11 ' A' ' 141' ' ' ARG . 60.0 mmm -67.74 -50.63 56.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.641 -0.503 . . . . 73.129999999999995 109.641 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 62' ' ' ILE . 85.0 t -53.78 -32.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 63.009999999999998 110.833 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -72.82 -53.13 12.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.005 -0.543 . . . . 75.329999999999998 110.982 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.18 -14.1 60.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.113 -0.494 . . . . 73.420000000000002 111.186 -177.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 157' ' ' VAL . 51.4 t -88.73 -38.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.971 0.415 . . . . 63.009999999999998 110.294 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.53 -24.76 64.56 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.592 -0.813 . . . . 64.219999999999999 112.775 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.521 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.6 ptp -78.24 -16.91 57.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.824 -0.35 . . . . 70.109999999999999 111.539 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.643 0.735 . . . . 73.099999999999994 110.782 -179.68 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.474 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 t . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 114.068 1.136 . . . . 52.119999999999997 114.068 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.52 149.04 41.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.461 -1.245 . . . . 63.43 109.482 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.405 HD13 ' OG1' ' A' ' 51' ' ' THR . 3.9 mp -84.02 100.58 7.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.435 -0.95 . . . . 63.25 108.435 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.452 ' CG2' ' HD3' ' A' ' 161' ' ' LYS . 26.0 mm -70.9 -57.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.497 -0.774 . . . . 74.409999999999997 110.875 -174.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.793 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -136.24 126.65 26.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.358 0.599 . . . . 54.210000000000001 111.067 176.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -126.7 120.9 30.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.344 -0.844 . . . . 64.439999999999998 110.169 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -139.22 135.99 17.71 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.088 -0.506 . . . . 74.019999999999996 110.288 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.851 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 64.7 Cg_endo -75.83 131.93 13.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.503 2.136 . . . . 72.530000000000001 111.729 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.451 -0.341 . . . . 73.120000000000005 110.622 -177.498 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 134' ' ' GLN . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 109.7 -0.481 . . . . 72.530000000000001 109.7 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 139.56 151.76 5.74 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.86 -0.686 . . . . 72.230000000000004 112.089 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.22 -166.54 42.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.618 -0.801 . . . . 71.140000000000001 111.814 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.854 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.83 168.1 19.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.881 0.372 . . . . 62.520000000000003 110.216 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.38 98.49 46.66 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.111 0.482 . . . . 74.150000000000006 110.457 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.654 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 72.8 Cg_endo -78.84 -9.55 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.736 2.291 . . . . 60.020000000000003 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.08 -34.58 61.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.049 -0.978 . . . . 72.439999999999998 111.355 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 191' ' ' ILE . 10.5 pt -74.04 -19.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.106 -0.497 . . . . 64.329999999999998 111.273 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.8 m170 72.45 32.18 1.65 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.455 -0.793 . . . . 62.25 111.62 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.72 147.02 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.887 -0.597 . . . . 64.109999999999999 109.679 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.94 131.18 41.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.614 0.598 . . . . 52.310000000000002 112.614 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.66 157.52 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.933 -1.136 . . . . 74.150000000000006 107.933 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -121.18 150.01 52.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.766 -0.373 . . . . 72.329999999999998 111.404 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.854 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.7 Cg_endo -69.41 -76.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.597 2.198 . . . . 72.109999999999999 111.639 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.7 pt? -114.3 19.45 16.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 70.200000000000003 110.263 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 72.83 0.72 3.76 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.679 0.992 . . . . 74.129999999999995 113.679 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -61.41 -28.95 69.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.936 0.335 . . . . 71.129999999999995 111.402 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.85 -4.36 85.43 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.726 -0.75 . . . . 73.340000000000003 112.994 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -79.44 -35.29 40.69 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.902 0.382 . . . . 72.549999999999997 109.972 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-N 114.573 -1.194 . . . . 74.120000000000005 110.906 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HG3' ' HB3' ' A' ' 164' ' ' PRO . 32.4 Cg_endo . . . . . 0 C--O 1.233 0.24 0 CA-C-O 120.827 0.261 . . . . 70.239999999999995 112.536 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.12 -20.31 19.23 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 55.140000000000001 112.557 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.457 HD21 HG12 ' A' ' 24' ' ' VAL . 26.9 t-20 -139.12 146.13 40.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 74.420000000000002 109.578 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.8 m -139.9 163.53 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 74.140000000000001 111.716 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 165' ' ' SER . 34.9 m-85 -104.93 124.65 49.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.555 -0.748 . . . . 73.230000000000004 110.785 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.89 95.99 5.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.668 -0.493 . . . . 65.319999999999993 109.668 170.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -90.1 112.39 23.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.225 -0.657 . . . . 55.130000000000003 109.225 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -97.46 -179.72 4.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.011 0.434 . . . . 71.129999999999995 111.083 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -67.65 -29.74 69.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.775 -0.648 . . . . 62.399999999999999 110.545 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.662 ' SD ' HG22 ' A' ' 142' ' ' VAL . 93.9 mtp -88.12 -34.69 17.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.591 . . . . 71.120000000000005 111.358 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -173.82 -133.28 1.66 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.689 -0.767 . . . . 71.219999999999999 111.915 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.0 tt -140.75 137.43 35.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.116 0.484 . . . . 73.25 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 126.78 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.826 -0.625 . . . . 63.130000000000003 109.821 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 13.3 t -105.91 142.04 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 64.340000000000003 109.723 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.65 164.08 36.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 73.310000000000002 110.933 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 10.2 pt-20 -130.95 165.21 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.568 -0.742 . . . . 73.340000000000003 109.765 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.01 157.74 16.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 109.923 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -79.82 103.44 9.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 72.420000000000002 111.969 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -81.81 0.84 37.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 75.319999999999993 110.891 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -70.31 -66.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.033 -0.531 . . . . 72.430000000000007 111.274 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.421 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 t-160 -126.51 9.91 7.21 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.729 -0.388 . . . . 73.299999999999997 111.034 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.73 65.38 72.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 121.078 -0.249 . . . . 22.510000000000002 111.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 31' ' ' HIS . 13.2 Cg_exo -69.85 -45.56 1.5 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.647 2.231 . . . . 74.230000000000004 112.196 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.39 -35.1 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 109.972 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -65.52 -46.19 80.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.199 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -55.08 -48.93 72.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.952 -0.567 . . . . 74.430000000000007 110.496 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -36.0 78.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.806 -0.634 . . . . 70.5 110.935 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.35 -40.17 85.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 73.049999999999997 110.228 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.81 -47.56 58.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 74.420000000000002 109.792 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.51 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 63.310000000000002 111.78 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 51.2 mm-40 -60.35 -38.89 85.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 55.409999999999997 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 42' ' ' LEU . 30.7 mt -68.56 -30.46 69.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.889 0.376 . . . . 73.219999999999999 110.882 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.76 64.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 71.400000000000006 111.212 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -74.24 -29.1 61.54 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.775 -0.37 . . . . 75.530000000000001 111.244 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.4 -46.11 42.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.17 42.62 1.61 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.675 -0.774 . . . . 72.530000000000001 111.781 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -76.04 -27.91 57.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.249 0.547 . . . . 74.340000000000003 110.422 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.554 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.4 m-85 -78.2 -3.27 41.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.022 -0.535 . . . . 72.299999999999997 111.043 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -73.78 -0.64 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.098 0.475 . . . . 61.009999999999998 110.539 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.88 7.55 5.79 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.95 -0.568 . . . . 54.32 112.131 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 65' ' ' GLY . 35.3 p -88.02 149.45 23.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.353 . . . . 63.420000000000002 111.247 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 11.7 ptpt -139.39 157.41 45.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.197 -0.456 . . . . 64.010000000000005 110.59 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 80.9 m-85 -86.13 131.09 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.356 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -109.93 -38.91 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 72.140000000000001 110.992 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 26.4 mmm180 -115.37 117.37 30.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.076 -0.342 . . . . 70.310000000000002 110.076 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -131.23 94.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.94 -0.763 . . . . 72.239999999999995 108.94 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 36.9 mt -105.23 128.34 59.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.841 -0.618 . . . . 72.420000000000002 109.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.42 128.72 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.075 0.464 . . . . 73.540000000000006 111.13 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 54.12 35.43 22.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.848 -1.069 . . . . 64.019999999999996 111.512 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.786 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 4.2 t80 -132.44 -82.39 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.989 0.424 . . . . 73.310000000000002 110.279 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.478 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 22.7 ptp -159.74 158.63 31.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 110.573 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 116' ' ' LEU . 35.1 mt -130.22 100.28 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.622 -0.717 . . . . 70.299999999999997 109.419 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 50.1 tt0 -85.57 127.71 34.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.333 -0.394 . . . . 73.120000000000005 110.494 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -139.18 149.58 20.77 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.616 -0.802 . . . . 65.140000000000001 112.335 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 51' ' ' THR . . . 151.14 -71.76 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.926 -1.13 . . . . 61.509999999999998 113.524 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 32.0 t0 -42.86 105.91 0.45 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.899 0.703 . . . . 74.209999999999994 112.899 -168.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 97.6 Cg_endo -86.2 -18.52 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.315 2.676 . . . . 74.439999999999998 111.54 176.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 70' ' ' THR . 77.6 p -89.62 -32.7 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.309 -0.86 . . . . 74.340000000000003 111.371 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 31.64 59.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.832 -0.907 . . . . 74.329999999999998 110.832 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 64.3 p -102.88 -30.55 10.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 71.209999999999994 111.056 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.34 -3.31 23.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.299 -0.864 . . . . 63.210000000000001 112.085 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -119.12 -31.34 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.647 0.26 . . . . 61.420000000000002 111.277 178.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 95.39 -169.65 27.81 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.809 -0.71 . . . . 74.129999999999995 112.797 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.88 -105.52 2.29 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.26 -0.495 . . . . 32.420000000000002 112.246 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 44.77 48.96 8.98 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 65.109999999999999 112.645 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.44 12.71 2.83 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.021 -0.536 . . . . 54.219999999999999 110.919 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.6 -20.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.737 0.303 . . . . 53.420000000000002 110.611 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 16.0 p90 -101.2 -2.01 32.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.143 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.42 1.4 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 55.420000000000002 113.125 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.32 -168.05 1.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.841 0.353 . . . . 75.140000000000001 111.251 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.2 173.87 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 73.530000000000001 111.886 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 89.7 m-85 -139.67 -162.02 1.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.897 -1.047 . . . . 75.230000000000004 108.965 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.82 159.29 34.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.606 -0.516 . . . . 61.509999999999998 109.606 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -61.35 136.28 57.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.609 -0.515 . . . . 72.010000000000005 109.609 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.07 16.53 25.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 73.129999999999995 110.714 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.4 mt -71.8 96.81 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.147 0.499 . . . . 74.310000000000002 111.958 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.48 78.48 6.96 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.715 -0.675 . . . . 62.109999999999999 111.031 173.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 89.33 0.55 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.593 2.195 . . . . 74.019999999999996 112.428 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.22 10.76 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 71.299999999999997 110.544 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -122.98 -175.72 3.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.232 -0.895 . . . . 70.239999999999995 109.846 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -124.77 144.26 50.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.627 0.251 . . . . 53.530000000000001 110.827 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 68.34 0.63 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.637 0.732 . . . . 75.439999999999998 109.888 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.1 p -65.53 -39.39 91.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.159 -0.928 . . . . 74.319999999999993 112.066 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.609 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -170.42 -137.03 2.19 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.372 -0.918 . . . . 44.43 112.538 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.71 140.61 30.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.617 0.246 . . . . 60.520000000000003 110.741 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.25 24.32 5.73 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.774 -0.727 . . . . 61.109999999999999 111.775 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.434 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.8 mm -88.39 109.79 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.441 -0.577 . . . . 71.349999999999994 109.441 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.48 119.69 26.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.562 -0.532 . . . . 71.420000000000002 109.562 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.7 174.24 10.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 74.510000000000005 111.478 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.828 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 28.2 ttt -106.93 142.32 36.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.729 -0.669 . . . . 65.319999999999993 109.907 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -103.79 118.16 36.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.527 0.68 . . . . 70.120000000000005 111.095 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.667 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.8 p-10 -115.47 165.74 12.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.998 -1.001 . . . . 71.310000000000002 109.964 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.5 -37.38 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.862 0.839 . . . . 64.120000000000005 109.19 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -138.83 174.49 22.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 108.644 -1.782 . . . . 61.420000000000002 108.644 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.57 -49.61 11.73 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.073 2.515 . . . . 73.010000000000005 112.811 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.57 -11.1 19.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.521 -0.308 . . . . 72.530000000000001 111.275 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 3.1 m -86.14 55.46 3.55 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.667 -0.864 . . . . 54.32 108.667 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.667 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 38.6 m-80 -62.15 117.22 5.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.356 -1.293 . . . . 72.430000000000007 109.505 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' A' ' 102' ' ' ASN . . . -90.95 -168.16 41.82 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 63.0 112.672 -172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -99.46 20.27 14.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.42 0.628 . . . . 62.039999999999999 110.094 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 17.4 mt-30 -109.89 159.04 17.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.478 -0.783 . . . . 63.310000000000002 110.77 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -139.89 174.17 10.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.665 . . . . 74.0 109.203 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.2 p90 -160.08 154.69 24.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 54.329999999999998 111.692 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.22 145.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.274 -0.876 . . . . 74.209999999999994 109.23 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 p -100.94 131.1 46.97 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.062 0.458 . . . . 43.210000000000001 110.459 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 62' ' ' ILE . 59.8 mt -89.2 -5.39 57.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 62.329999999999998 110.994 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.39 164.22 21.9 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.849 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.609 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 38.9 Cg_exo -61.06 107.04 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.464 2.109 . . . . 61.210000000000001 111.887 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 23.4 p -96.37 96.89 9.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.81 -0.632 . . . . 63.219999999999999 111.02 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 120' ' ' GLN . 1.0 OUTLIER -100.02 9.9 42.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.57 0.7 . . . . 75.430000000000007 110.471 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.451 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -108.57 -12.42 14.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.77 -1.105 . . . . 74.420000000000002 111.591 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 3.3 pp -114.91 9.8 16.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 75.030000000000001 111.342 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.85 -34.37 65.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.465 -0.789 . . . . 62.149999999999999 110.885 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.39 15.36 30.03 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.524 -0.762 . . . . 73.310000000000002 112.033 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.59 -35.93 5.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.075 0.464 . . . . 72.319999999999993 110.078 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -140.82 139.4 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.796 -0.638 . . . . 73.400000000000006 109.671 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -77.68 148.71 34.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.156 0.503 . . . . 55.219999999999999 110.446 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 99' ' ' ALA . 45.1 mt -126.88 122.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.59 . . . . 75.430000000000007 110.555 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.828 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.4 p90 -153.93 72.94 0.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.685 0.755 . . . . 71.340000000000003 111.212 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.08 152.24 22.27 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.557 -1.306 . . . . 73.420000000000002 113.676 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.42 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 74.0 mtp180 -130.14 117.22 19.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.218 -0.66 . . . . 55.200000000000003 109.218 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.44 135.34 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.051 0.453 . . . . 64.0 110.385 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.64 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 51.3 t -143.65 145.01 32.14 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.26 -0.427 . . . . 73.530000000000001 110.096 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.692 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.7 tt0 50.92 40.69 25.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.354 0.597 . . . . 73.219999999999999 111.85 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -170.62 24.82 0.1 OUTLIER Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.143 -1.027 . . . . 62.039999999999999 112.152 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.5 tp -78.61 -32.32 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.088 -0.245 . . . . 75.230000000000004 110.478 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 141' ' ' ARG . . . -62.23 -37.35 94.4 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.155 -0.778 . . . . 72.420000000000002 111.155 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.58 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 72.1 mmm -68.09 -55.64 11.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.145 -0.317 . . . . 74.409999999999997 110.145 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 90.1 t -51.57 -31.25 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.218 0.532 . . . . 64.409999999999997 110.644 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.552 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.6 t30 -70.11 -56.79 5.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.713 -0.676 . . . . 72.310000000000002 110.538 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.532 ' HD2' ' HE3' ' A' ' 138' ' ' MET . 0.1 OUTLIER -72.62 -15.64 61.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.767 0.318 . . . . 71.140000000000001 111.261 -177.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG22 ' SD ' ' A' ' 20' ' ' MET . 75.3 t -79.73 -43.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.369 -0.604 . . . . 54.32 109.369 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -76.48 -25.86 64.64 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.417 -0.897 . . . . 63.43 112.549 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.552 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 77.7 mtp -73.53 -11.27 60.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.76 0.282 . . . . 65.400000000000006 111.76 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.561 0.696 . . . . 75.349999999999994 111.243 178.21 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 121.78 0.8 . . . . 72.519999999999996 111.697 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.67 172.97 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.165 -0.925 . . . . 65.219999999999999 109.276 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -89.52 105.01 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.728 -0.841 . . . . 75.049999999999997 108.728 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 22.7 mm -73.92 -48.22 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.364 -0.835 . . . . 55.43 110.989 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -131.86 126.08 33.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.944 -0.571 . . . . 62.530000000000001 110.828 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.16 122.82 30.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.0 0.429 . . . . 70.200000000000003 110.566 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -155.91 150.87 20.75 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.842 -0.617 . . . . 75.420000000000002 110.268 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 14' ' ' VAL . 54.7 Cg_endo -70.86 134.25 25.26 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.638 2.226 . . . . 74.530000000000001 112.887 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.53 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.6 p . . . . . 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 61.310000000000002 109.934 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.6 m-20 . . . . . 0 CA--C 1.515 -0.387 0 CA-C-O 121.275 0.559 . . . . 71.129999999999995 110.443 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.54 146.93 4.47 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.228 -0.896 . . . . 71.319999999999993 111.306 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -84.59 -166.61 41.55 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.373 -0.918 . . . . 51.43 111.929 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.641 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -74.9 170.86 15.1 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.741 0.305 . . . . 64.140000000000001 110.271 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.411 ' HD1' HH21 ' A' ' 131' ' ' ARG . 91.8 m-85 -111.14 93.17 17.21 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-O 121.153 0.501 . . . . 71.310000000000002 110.449 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 6.0 Cg_exo -76.36 -13.56 18.62 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.888 2.392 . . . . 73.129999999999995 111.715 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.24 -34.79 42.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.902 -1.045 . . . . 74.319999999999993 111.072 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 193' ' ' VAL . 31.3 pt -80.31 -11.7 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 71.239999999999995 111.428 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.04 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.416 -0.811 . . . . 72.019999999999996 111.321 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 191' ' ' ILE . 6.4 p -164.21 152.95 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.059 -0.349 . . . . 62.310000000000002 110.059 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.14 113.97 14.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.911 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -161.94 157.32 23.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 70.219999999999999 109.625 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -124.02 156.35 66.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.503 -0.317 . . . . 72.150000000000006 110.726 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 49.0 Cg_endo -69.34 -69.7 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.478 2.119 . . . . 50.409999999999997 112.272 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.6 pt? -120.25 23.57 10.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 72.400000000000006 109.95 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 68.56 13.92 9.0 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.226 -0.897 . . . . 72.340000000000003 111.846 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.6 ptm -52.24 -46.04 65.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 70.230000000000004 112.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 -2.15 90.11 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.745 -0.74 . . . . 72.109999999999999 113.141 -175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -80.02 -26.5 39.77 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.374 0.607 . . . . 60.409999999999997 110.206 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.632 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-N 114.9 -1.045 . . . . 72.439999999999998 109.927 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 164' ' ' PRO . 4.7 Cg_endo . . . . . 0 CA--C 1.529 0.24 0 N-CA-C 113.146 0.402 . . . . 73.019999999999996 113.146 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.1 Cg_exo -78.82 -31.51 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.894 2.396 . . . . 74.420000000000002 111.304 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 14.8 t-20 -143.23 139.84 30.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.144 -0.935 . . . . 63.340000000000003 109.329 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG21 ' HE1' ' A' ' 39' ' ' PHE . 24.6 m -135.89 165.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.539 -0.3 . . . . 53.439999999999998 110.617 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD11 ' A' ' 22' ' ' ILE . 38.5 p90 -124.13 134.11 53.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.167 0.508 . . . . 73.219999999999999 110.61 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.16 111.12 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 72.230000000000004 110.451 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 7.1 tp10 -85.67 112.09 20.69 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.383 -0.969 . . . . 71.030000000000001 108.383 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -105.0 -179.8 4.05 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.066 0.46 . . . . 55.340000000000003 111.263 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -1.48 42.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 62.32 111.035 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.608 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.0 mmt -108.32 -44.89 4.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 73.439999999999998 109.95 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.6 -140.9 3.19 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.592 -1.003 . . . . 60.310000000000002 110.592 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -133.08 131.47 58.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.529 -0.545 . . . . 74.230000000000004 109.529 -178.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.478 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -125.96 128.37 71.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.759 -0.655 . . . . 63.32 110.947 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 85.1 t -111.52 143.71 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.82 -0.437 . . . . 74.519999999999996 109.82 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.12 161.24 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.215 0.531 . . . . 73.25 110.852 176.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' HD22 ' A' ' 13' ' ' ASN . 5.8 pt-20 -125.72 168.81 13.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.366 -0.834 . . . . 72.219999999999999 109.823 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 ' CG ' ' A' ' 39' ' ' PHE . 1.1 mm? -108.54 163.05 13.57 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.198 -0.667 . . . . 64.409999999999997 109.198 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 2.9 m-85 -83.35 89.82 7.07 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.253 -0.579 . . . . 74.400000000000006 111.993 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -7.19 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.453 -1.314 . . . . 62.420000000000002 107.453 170.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -66.79 -43.06 84.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.426 -1.715 . . . . 53.329999999999998 110.746 -176.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -140.06 -1.61 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 75.439999999999998 111.584 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.6 88.97 18.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.742 -0.383 . . . . 21.100000000000001 111.435 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.23 -6.11 17.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.895 2.396 . . . . 75.010000000000005 112.626 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 15.4 mtpt -100.1 -53.8 3.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.399 -0.364 . . . . 74.109999999999999 111.101 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.416 HG23 ' SD ' ' A' ' 100' ' ' MET . 8.8 m -53.93 -35.86 62.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 70.310000000000002 111.977 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.629 ' SG ' ' HE2' ' A' ' 37' ' ' LYS . 6.1 p -66.89 -28.43 68.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 70.120000000000005 111.517 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HE2' ' SG ' ' A' ' 36' ' ' CYS . 36.8 mmtt -79.93 -34.83 38.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.347 -0.388 . . . . 73.129999999999995 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -57.04 -53.2 60.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.557 -0.747 . . . . 73.430000000000007 110.531 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HE1' HG21 ' A' ' 14' ' ' VAL . 23.4 t80 -61.55 -50.68 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 64.239999999999995 109.838 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -42.19 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.961 -1.018 . . . . 72.230000000000004 111.49 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.07 -48.92 70.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 61.43 110.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD12 ' CB ' ' A' ' 47' ' ' TYR . 2.6 mm? -74.78 -29.12 61.02 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.582 -0.447 . . . . 72.340000000000003 111.695 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.1 65.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.691 -0.231 . . . . 63.229999999999997 111.521 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -77.14 -21.54 53.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 65.099999999999994 110.423 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' C ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.65 -45.69 24.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.018 -0.734 . . . . 64.219999999999999 109.018 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.09 2.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.697 -0.763 . . . . 44.25 111.62 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -71.15 -30.77 66.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.139 0.495 . . . . 72.219999999999999 110.265 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -78.18 -7.72 57.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.598 -0.728 . . . . 70.329999999999998 111.502 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.78 -8.1 53.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 72.319999999999993 111.168 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.49 31.69 2.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.71 . . . . 72.349999999999994 112.252 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.715 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 20.3 p -107.46 150.63 26.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.041 0.448 . . . . 73.439999999999998 111.863 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 1.4 mmtp -120.17 169.93 9.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 63.100000000000001 109.169 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -88.08 118.49 27.68 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 63.210000000000001 109.329 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -93.31 -28.77 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 110.413 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 41.1 mmt180 -137.67 109.74 7.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 44.439999999999998 110.134 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 56' ' ' ILE . 4.1 mp -115.07 79.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.395 -0.595 . . . . 71.299999999999997 109.395 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.09 134.47 27.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.051 -0.522 . . . . 73.329999999999998 109.639 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 2.4 mptp? -74.62 128.76 36.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.443 -0.344 . . . . 72.219999999999999 110.388 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.8 32.28 21.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.005 0.815 . . . . 54.409999999999997 110.923 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.86 -83.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 74.200000000000003 111.144 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptm -160.63 155.15 23.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.822 -0.626 . . . . 64.219999999999999 110.718 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.508 HD12 HG13 ' A' ' 139' ' ' VAL . 36.1 mt -130.58 103.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.629 -0.714 . . . . 73.200000000000003 109.723 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.433 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.8 tt0 -80.14 126.6 31.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.9 -0.591 . . . . 72.219999999999999 110.447 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.28 129.38 7.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.836 -0.697 . . . . 70.310000000000002 111.646 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.715 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 134.81 -148.12 19.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.458 -0.877 . . . . 72.239999999999995 112.859 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.8 t0 53.21 81.75 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 123.892 0.877 . . . . 75.299999999999997 111.534 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD3' ' CE1' ' A' ' 47' ' ' TYR . 54.7 Cg_endo -72.32 -24.02 20.05 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.792 2.328 . . . . 42.109999999999999 111.159 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 5.6 p -81.9 -46.32 14.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.256 -0.884 . . . . 71.239999999999995 111.751 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.32 26.55 10.0 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.578 -0.82 . . . . 74.239999999999995 111.412 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 72' ' ' ARG . 6.6 t -128.81 -19.31 3.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.775 0.321 . . . . 73.019999999999996 111.121 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.88 -18.57 55.69 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.524 -0.846 . . . . 64.230000000000004 113.313 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -110.9 5.22 20.33 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.429 -0.453 . . . . 73.540000000000006 111.152 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -86.85 176.85 47.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 64.230000000000004 112.647 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 85.18 -45.26 3.48 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.034 -0.603 . . . . 62.439999999999998 112.533 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . -76.32 25.25 0.13 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.834 0.454 . . . . 60.299999999999997 111.702 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 74' ' ' GLY . 7.4 m -59.5 -24.35 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 62.530000000000001 111.06 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.591 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.4 tt -56.22 -48.36 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.717 -0.674 . . . . 74.219999999999999 111.284 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG23 ' A' ' 77' ' ' ILE . 30.2 p90 -108.97 -6.09 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.657 0.265 . . . . 62.450000000000003 111.593 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.58 -95.95 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.622 -0.799 . . . . 63.030000000000001 113.524 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -112.06 -174.33 2.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.744 0.783 . . . . 72.299999999999997 112.16 -173.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.551 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -85.91 175.18 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.388 -1.278 . . . . 74.129999999999995 108.751 170.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -132.98 -60.47 0.86 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.293 -0.563 . . . . 72.299999999999997 111.717 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.72 177.87 8.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.437 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.67 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -103.95 149.49 25.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.789 -0.449 . . . . 72.450000000000003 109.789 174.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -121.79 23.87 9.93 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' A' ' 127' ' ' THR . 55.8 mt -59.53 102.86 0.16 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.425 -0.807 . . . . 73.129999999999995 111.062 -174.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -161.84 82.09 1.84 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.923 0.392 . . . . 60.539999999999999 110.377 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.78 81.25 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.44 2.093 . . . . 72.540000000000006 111.296 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.76 -4.41 59.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.054 0.93 . . . . 64.510000000000005 109.403 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -94.72 -153.29 0.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.37 -1.286 . . . . 72.530000000000001 108.611 173.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -152.43 142.04 21.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.588 -0.445 . . . . 74.420000000000002 110.946 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 34.8 p90 -59.83 123.63 17.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.529 -0.76 . . . . 74.129999999999995 109.398 170.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.0 p -116.2 -40.13 3.31 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.253 -0.43 . . . . 63.340000000000003 110.995 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.36 -143.54 3.73 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.034 -0.603 . . . . 64.329999999999998 112.274 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 151.3 19.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.686 0.279 . . . . 62.420000000000002 110.626 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 103.35 23.73 8.28 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.52 -0.848 . . . . 51.350000000000001 111.319 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.1 mm -89.04 111.36 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.643 -0.502 . . . . 73.519999999999996 109.643 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -86.72 120.16 27.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 109.719 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 128' ' ' ILE . . . -134.42 172.86 12.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.151 -0.477 . . . . 73.5 111.319 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.57 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 64.7 mtp -90.52 141.78 28.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 72.150000000000006 110.411 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.22 156.66 18.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.136 -0.484 . . . . 64.209999999999994 109.754 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.7 p-10 -159.75 163.25 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.386 -0.37 . . . . 74.310000000000002 110.712 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.1 -38.7 15.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.68 . . . . 72.400000000000006 110.303 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.16 -80.67 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.522 -0.847 . . . . 32.0 112.65 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.13 85.3 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.976 2.451 . . . . 61.399999999999999 112.934 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 52.32 33.08 12.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.392 -0.822 . . . . 71.519999999999996 112.136 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -76.26 39.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.212 0.449 . . . . 75.109999999999999 112.212 -174.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.67 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 14.7 m-80 -84.66 139.58 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.377 -0.601 . . . . 73.140000000000001 109.377 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.15 -68.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.85 -1.167 . . . . 40.340000000000003 113.533 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 33.8 t -109.13 -24.24 11.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.573 0.582 . . . . 70.120000000000005 112.573 -169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -91.37 137.47 32.34 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.487 -0.485 . . . . 54.32 110.051 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 87.9 m-85 -141.12 167.5 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.653 0.263 . . . . 72.219999999999999 110.679 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 34.1 p90 -159.4 158.27 31.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.753 0.311 . . . . 72.450000000000003 110.719 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -112.14 146.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 61.439999999999998 109.686 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -98.55 131.84 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 70.430000000000007 110.232 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.9 mt -85.76 -7.71 58.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 111.024 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.96 158.41 33.89 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.797 -0.638 . . . . 61.140000000000001 110.106 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.684 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 56.2 Cg_endo -71.76 123.91 9.77 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.362 2.042 . . . . 72.5 112.04 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.4 HG21 HD21 ' A' ' 122' ' ' LEU . 41.0 p -108.81 158.57 17.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 110.937 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 21.67 2.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.105 0.479 . . . . 62.530000000000001 111.005 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.32 -3.98 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.064 -0.516 . . . . 75.040000000000006 112.113 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 4.3 pp -130.4 3.94 4.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.497 -0.481 . . . . 74.230000000000004 111.617 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.64 -28.36 69.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 73.219999999999999 110.493 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.28 13.07 55.18 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.29 -0.724 . . . . 62.100000000000001 111.29 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 25.1 mmmt -116.22 -22.94 8.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.119 -0.697 . . . . 71.219999999999999 109.119 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 100' ' ' MET . 85.4 m-70 -134.67 134.68 41.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.37 -0.832 . . . . 70.340000000000003 110.042 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 86' ' ' LEU . 18.9 m -72.81 121.4 19.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.06 -0.348 . . . . 72.450000000000003 110.06 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 99' ' ' ALA . 45.1 mt -108.71 114.65 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.92 -0.312 . . . . 64.319999999999993 111.768 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.5 m-85 -156.59 76.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 72.439999999999998 110.399 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.86 157.11 29.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.582 -0.818 . . . . 72.340000000000003 112.871 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.67 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 55.9 mtm180 -134.98 125.89 27.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.976 -0.379 . . . . 72.310000000000002 109.976 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.1 p -80.49 139.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.037 0.446 . . . . 64.420000000000002 110.41 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 41.3 t -139.24 143.58 38.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.551 -174.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.6 pt20 41.21 40.14 1.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.246 1.018 . . . . 73.540000000000006 113.239 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.47 41.41 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 44.310000000000002 111.901 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.2 tp -88.82 -36.35 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.672 0.272 . . . . 73.230000000000004 110.636 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -36.36 92.05 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.903 -0.665 . . . . 51.109999999999999 111.681 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.0 mmm -67.83 -51.66 45.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.26 -0.274 . . . . 64.420000000000002 110.26 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 62' ' ' ILE . 91.9 t -54.31 -32.66 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.131 0.491 . . . . 53.43 110.668 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -70.39 -51.87 26.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 74.019999999999996 110.45 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -76.81 -10.14 59.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.966 -0.561 . . . . 74.450000000000003 111.355 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.8 t -87.11 -38.9 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.277 0.561 . . . . 72.450000000000003 109.792 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.467 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.31 -33.96 38.08 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.574 -0.822 . . . . 50.030000000000001 112.87 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 22.1 ptm -78.93 -18.91 53.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.08 0.4 . . . . 72.540000000000006 112.08 -173.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.234 0.239 0 C-N-CA 119.962 -0.695 . . . . 61.299999999999997 110.095 -179.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 158' ' ' LYS . 3.6 t . . . . . 0 CA--C 1.518 -0.274 0 CA-C-O 121.847 0.832 . . . . 65.239999999999995 112.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 158' ' ' LYS . 2.0 mppt? -139.65 170.95 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.691 -1.14 . . . . 64.420000000000002 109.301 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.7 mp -90.52 106.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.734 -0.839 . . . . 64.040000000000006 108.734 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.552 HG22 ' HD2' ' A' ' 161' ' ' LYS . 26.0 mm -73.62 -52.3 21.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 110.251 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HD2' HG22 ' A' ' 160' ' ' ILE . 4.9 mptp? -130.73 143.42 50.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.542 -0.754 . . . . 71.319999999999993 109.298 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.94 127.22 13.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.944 -0.391 . . . . 63.32 109.944 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 95.3 m-85 -148.23 155.23 43.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.569 -0.53 . . . . 74.010000000000005 109.569 -174.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 7.8 Cg_endo -85.07 131.62 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.431 2.087 . . . . 73.109999999999999 112.117 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 116.047 -0.524 . . . . 73.430000000000007 110.688 -179.098 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.504 0.669 . . . . 73.310000000000002 111.172 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.525 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 152.3 137.6 2.6 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 114.742 -1.117 . . . . 23.239999999999998 110.922 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.66 -160.89 14.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.395 -0.907 . . . . 74.010000000000005 112.564 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.833 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.2 172.5 12.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.667 0.27 . . . . 53.030000000000001 110.395 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.2 98.48 22.7 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.868 -0.419 . . . . 75.530000000000001 109.868 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 1.4 Cg_endo -82.54 -8.52 11.46 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.766 2.31 . . . . 61.420000000000002 111.773 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.83 -26.76 36.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.974 -0.557 . . . . 73.420000000000002 110.301 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.3 pt -94.23 152.12 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.181 -1.044 . . . . 63.210000000000001 108.181 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -102.88 64.2 0.85 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.215 -0.594 . . . . 64.239999999999995 111.091 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.61 135.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.478 . . . . 74.340000000000003 110.477 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.61 110.33 3.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 75.540000000000006 111.027 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.37 149.25 29.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.911 -0.774 . . . . 70.140000000000001 108.911 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 70.6 m-85 -119.03 144.59 36.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.91 0.337 . . . . 60.329999999999998 111.91 -170.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.833 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.6 Cg_endo -64.35 -59.6 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.728 2.285 . . . . 64.129999999999995 112.093 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.0 OUTLIER -143.79 37.51 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.462 -0.335 . . . . 64.019999999999996 111.402 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.3 m-20 74.37 -14.61 0.69 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.817 0.673 . . . . 64.120000000000005 112.817 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptm -49.18 -33.35 12.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.291 0.849 . . . . 72.239999999999995 113.291 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.73 -1.56 63.58 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.371 -0.918 . . . . 75.209999999999994 113.315 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 36.4 ptt180 -120.32 -6.77 9.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.214 0.507 . . . . 71.120000000000005 110.95 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.247 0.929 0 CA-C-N 114.89 -1.05 . . . . 74.340000000000003 110.519 178.686 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 CA--C 1.529 0.255 0 N-CA-C 112.984 0.34 . . . . 74.329999999999998 112.984 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 -22.42 7.36 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.916 2.411 . . . . 71.030000000000001 112.521 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 24.8 t-20 -142.32 147.48 36.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.996 -0.742 . . . . 74.319999999999993 108.996 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.4 m -137.67 152.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.215 0.531 . . . . 72.549999999999997 111.782 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.73 122.53 42.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.155 -0.93 . . . . 72.420000000000002 110.566 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 mt -114.98 98.02 6.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.774 0.321 . . . . 73.209999999999994 110.41 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.35 124.98 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.021 -0.733 . . . . 70.540000000000006 109.021 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 159' ' ' ILE . 74.8 p -111.84 178.74 4.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.173 0.511 . . . . 50.43 111.274 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -76.4 -6.19 50.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 111.027 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.9 mmt -102.52 -43.38 5.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.926 -0.579 . . . . 25.510000000000002 109.867 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.56 -130.75 1.27 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.494 -0.642 . . . . 73.420000000000002 111.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 23' ' ' ILE . 19.4 tt -132.7 137.99 52.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.029 0.443 . . . . 74.420000000000002 110.0 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.493 HD12 HG23 ' A' ' 139' ' ' VAL . 20.1 mm -129.13 117.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.174 -0.676 . . . . 74.420000000000002 109.174 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.9 m -113.56 147.04 17.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 119.147 -1.021 . . . . 73.109999999999999 110.152 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.34 163.94 36.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.941 -0.572 . . . . 74.439999999999998 110.611 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.7 pt-20 -129.65 166.73 19.19 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.043 -0.98 . . . . 75.420000000000002 109.662 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -104.16 163.89 12.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.623 -0.51 . . . . 73.519999999999996 109.623 179.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 4.5 m-85 -82.58 98.95 9.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.177 0.513 . . . . 64.109999999999999 111.385 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.92 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -83.47 -0.56 50.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.551 -0.75 . . . . 65.140000000000001 110.014 -179.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -79.38 -53.88 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 75.319999999999993 111.466 -176.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.0 15.43 4.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.925 0.342 . . . . 74.239999999999995 111.925 -175.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.66 67.15 77.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.896 0.379 . . . . 71.040000000000006 110.108 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 16.8 Cg_exo -66.98 -43.98 5.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.798 2.332 . . . . 60.43 112.401 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -76.03 -45.42 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 75.040000000000006 110.034 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.5 m -63.02 -32.84 74.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 64.400000000000006 111.221 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.92 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 33.4 t -59.74 -43.09 94.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.593 -0.276 . . . . 52.32 110.758 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 45.6 mmtt -70.04 -32.44 70.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.974 -0.38 . . . . 73.219999999999999 109.974 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.61 -58.47 7.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 75.230000000000004 109.746 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD2' HD11 ' A' ' 27' ' ' LEU . 1.8 t80 -67.45 -37.05 82.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.75 . . . . 64.219999999999999 110.349 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.65 -43.06 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 70.219999999999999 111.457 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.689 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 10.5 tp10 -61.53 -42.94 99.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.932 0.396 . . . . 72.120000000000005 111.29 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.597 ' HG ' ' HB2' ' A' ' 110' ' ' SER . 4.3 mm? -66.37 -24.14 66.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 54.399999999999999 110.54 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.472 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -80.85 -31.07 35.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.099 -0.5 . . . . 73.219999999999999 110.129 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 38.6 mtp85 -61.95 -46.24 90.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.205 -0.907 . . . . 72.230000000000004 110.841 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -74.73 -49.35 21.4 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.831 -0.347 . . . . 75.340000000000003 110.83 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.65 49.76 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 61.130000000000003 111.941 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.62 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 23.6 t80 -70.99 -29.93 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.116 0.484 . . . . 73.450000000000003 111.235 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 32.2 m-85 -81.15 -5.88 58.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.642 . . . . 74.25 112.121 -169.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -75.57 -6.1 48.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 71.219999999999999 110.547 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.22 14.66 6.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 54.520000000000003 111.829 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 45.2 p -93.17 143.22 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.477 . . . . 71.510000000000005 111.015 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -140.2 147.09 39.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.794 -0.639 . . . . 72.200000000000003 110.054 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 63.9 m-85 -80.97 124.4 29.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.533 -0.543 . . . . 73.239999999999995 109.533 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -118.57 -19.83 8.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.563 -0.289 . . . . 64.319999999999993 111.366 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 34.5 mmt180 -122.82 105.5 10.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.805 -0.443 . . . . 74.450000000000003 109.805 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.401 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -122.02 81.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.297 0.57 . . . . 73.150000000000006 110.033 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.831 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 17.5 mt -89.91 132.82 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.226 -0.657 . . . . 74.219999999999999 109.226 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.582 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 2.3 mptp? -70.88 133.41 46.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.413 . . . . 72.430000000000007 110.008 -173.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 42.33 42.47 2.61 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.459 1.1 . . . . 63.530000000000001 111.716 -172.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.831 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.0 t80 -131.52 -84.34 0.51 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.628 -0.715 . . . . 72.340000000000003 109.705 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.674 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptt? -161.19 157.16 25.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.328 -0.851 . . . . 74.310000000000002 110.165 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 116' ' ' LEU . 44.6 mt -124.5 100.07 7.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.727 -0.67 . . . . 54.509999999999998 109.469 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 46.5 mt-30 -84.83 119.81 25.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.656 -0.702 . . . . 73.420000000000002 110.866 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -138.48 140.56 11.18 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.715 -0.675 . . . . 54.509999999999998 111.775 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 164.04 -91.81 0.11 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.409 -1.376 . . . . 64.409999999999997 114.081 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -28.44 104.58 0.19 Allowed Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.003 1.112 . . . . 74.450000000000003 114.003 -163.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 91.1 Cg_endo -81.96 -12.5 10.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.852 3.035 . . . . 72.329999999999998 112.47 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 70' ' ' THR . 64.3 p -103.36 -32.33 9.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 71.219999999999999 111.882 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 27.95 62.1 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.293 -0.723 . . . . 62.119999999999997 111.293 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.595 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 72.2 p -103.81 -34.85 8.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 111.222 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.98 -30.59 4.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 111.663 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 4.7 ptm180 -81.21 -37.42 28.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.043 0.449 . . . . 73.299999999999997 110.045 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 65.38 79.36 0.19 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.945 -0.57 . . . . 61.109999999999999 113.029 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.62 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 66.9 -130.97 30.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.022 -0.609 . . . . 55.109999999999999 112.745 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 55.55 22.19 4.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.105 0.562 . . . . 62.350000000000001 111.521 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -72.79 -12.6 61.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.712 -0.676 . . . . 53.049999999999997 110.868 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.418 HD12 ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -71.18 -51.96 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.389 -0.369 . . . . 72.319999999999993 110.424 178.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.426 ' HB3' ' HZ ' ' A' ' 82' ' ' PHE . 97.7 m-85 -77.64 -34.16 53.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.795 0.807 . . . . 74.109999999999999 109.105 175.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.12 -78.84 0.24 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.606 -1.179 . . . . 71.109999999999999 112.104 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -135.99 -168.57 2.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.786 0.327 . . . . 64.230000000000004 110.977 -175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.543 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -76.41 166.43 23.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 71.239999999999995 111.532 -177.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' HZ ' ' HB3' ' A' ' 78' ' ' TYR . 73.9 m-85 -132.38 -44.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.814 -0.63 . . . . 74.319999999999993 110.398 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -163.47 156.33 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.679 -0.859 . . . . 63.310000000000002 108.679 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ASP . 2.4 p-10 -74.81 125.11 28.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.352 -0.61 . . . . 74.329999999999998 109.352 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -98.36 20.79 12.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.048 0.451 . . . . 73.200000000000003 110.31 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -68.75 100.93 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.696 . . . . 74.109999999999999 110.952 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -156.45 77.04 4.36 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.981 -0.554 . . . . 74.310000000000002 109.926 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.39 93.59 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.552 2.168 . . . . 42.240000000000002 112.077 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.41 -10.19 58.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.248 1.023 . . . . 65.439999999999998 109.195 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.6 OUTLIER -108.16 174.17 5.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.597 -1.183 . . . . 73.019999999999996 109.306 178.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 93' ' ' THR . 32.6 ttpt -131.28 145.1 51.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.067 -0.346 . . . . 74.510000000000005 110.067 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -55.59 126.44 25.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.36 0.6 . . . . 74.349999999999994 109.571 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LYS . 20.7 p -127.04 -45.46 1.56 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.539 -0.755 . . . . 64.329999999999998 110.262 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.32 -144.75 4.07 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.344 -0.844 . . . . 42.039999999999999 111.304 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.92 145.47 25.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 110.77 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.63 21.83 6.64 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.732 -0.747 . . . . 64.439999999999998 111.906 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.3 mm -86.8 111.21 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.487 -0.561 . . . . 70.349999999999994 109.487 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.777 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.92 122.03 30.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 72.349999999999994 109.824 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.23 170.65 14.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.84 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.829 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 39.5 ttp -103.64 144.15 31.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.916 0.389 . . . . 73.209999999999994 110.063 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -98.74 151.74 20.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.127 0.489 . . . . 75.239999999999995 110.547 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -161.0 169.79 21.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 74.319999999999993 109.61 -172.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.13 -27.48 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.418 0.627 . . . . 51.310000000000002 110.545 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.85 174.82 32.33 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 109.594 -1.402 . . . . 42.439999999999998 109.594 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.48 -46.85 19.29 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.303 2.669 . . . . 71.109999999999999 112.692 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 8.4 p-10 -100.88 -12.95 18.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.385 -0.37 . . . . 64.420000000000002 111.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 1.3 m -83.17 50.31 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.499 0.666 . . . . 73.319999999999993 109.411 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.693 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 47.1 m-80 -70.94 141.29 51.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.893 -1.049 . . . . 74.239999999999995 110.9 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.17 -169.78 12.69 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.127 -0.789 . . . . 41.130000000000003 111.127 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.597 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . 24.4 p -94.53 6.69 48.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.367 0.584 . . . . 75.030000000000001 111.469 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 73.2 mt-30 -72.79 161.59 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 64.430000000000007 109.68 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -141.75 171.35 14.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.666 -0.414 . . . . 74.230000000000004 111.268 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.17 150.87 18.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.04 -0.527 . . . . 65.140000000000001 110.195 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.661 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.73 141.78 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.462 -0.57 . . . . 61.130000000000003 109.462 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -95.37 129.08 42.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.166 0.508 . . . . 72.439999999999998 110.318 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 62' ' ' ILE . 61.6 mt -87.14 -3.2 59.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 72.439999999999998 110.662 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.33 163.37 24.37 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.763 -0.653 . . . . 75.150000000000006 110.062 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.31 125.42 15.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.595 2.197 . . . . 73.219999999999999 111.845 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.3 p -114.5 140.87 48.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.394 -0.367 . . . . 74.209999999999994 111.247 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -137.01 24.47 3.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 111.003 174.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -120.72 -8.87 9.42 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.374 0.509 . . . . 63.439999999999998 112.374 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.5 pp -127.72 4.42 6.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.745 -0.382 . . . . 73.400000000000006 111.745 -173.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 1.4 m-20 -71.51 -22.45 61.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.823 -0.626 . . . . 60.43 110.334 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.81 7.87 55.7 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.928 -0.869 . . . . 73.540000000000006 110.928 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.7 mmtm -112.16 -33.2 6.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 72.319999999999993 109.426 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.462 ' ND1' ' HA ' ' A' ' 101' ' ' ALA . 58.4 m-70 -135.57 137.54 42.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.29 -0.868 . . . . 73.230000000000004 109.418 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.3 t -78.54 146.54 34.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.39 -0.524 . . . . 75.349999999999994 110.255 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 99' ' ' ALA . 51.8 mt -122.28 124.86 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.9 -0.591 . . . . 72.239999999999995 110.279 -175.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.829 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.9 p90 -159.23 73.2 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.633 0.73 . . . . 74.349999999999994 110.725 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.777 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.37 157.27 29.56 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.177 -1.487 . . . . 72.010000000000005 113.732 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.45 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 24.4 mtm180 -137.06 123.69 21.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.34 . . . . 75.340000000000003 110.132 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.66 140.95 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 53.329999999999998 110.906 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 45.1 t -137.34 152.24 49.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.026 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.5 pt20 41.13 31.09 0.13 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.534 1.134 . . . . 74.340000000000003 113.506 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.72 12.71 0.48 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.478 -0.867 . . . . 34.329999999999998 112.426 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -71.5 -34.25 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.799 -0.236 . . . . 54.530000000000001 110.92 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.57 91.76 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.484 -0.865 . . . . 41.350000000000001 111.387 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.5 mmm -71.2 -46.36 61.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.095 -0.335 . . . . 72.439999999999998 110.095 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.493 HG23 HD12 ' A' ' 23' ' ' ILE . 79.9 t -57.07 -31.82 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.236 0.541 . . . . 72.129999999999995 110.4 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -68.39 -52.72 29.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.72 -0.673 . . . . 74.430000000000007 109.901 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.605 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.97 -8.57 56.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 72.510000000000005 111.023 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 20' ' ' MET . 56.0 t -87.99 -43.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.265 0.555 . . . . 71.010000000000005 109.808 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -77.9 -37.54 29.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.608 -0.806 . . . . 75.349999999999994 112.78 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 24.0 ptm -73.86 -27.52 61.12 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.597 0.221 . . . . 62.240000000000002 111.597 -173.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.516 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.140000000000001 111.077 -175.504 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 53' ' ' PHE . 6.1 p . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 122.123 0.963 . . . . 63.229999999999997 109.876 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.76 168.46 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.859 -1.064 . . . . 64.329999999999998 110.524 -172.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.473 HG13 HG22 ' A' ' 18' ' ' THR . 3.4 mp -87.14 115.59 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.983 -0.747 . . . . 71.25 108.983 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 161' ' ' LYS . 31.0 mm -75.56 -62.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.368 -0.833 . . . . 73.420000000000002 110.973 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.655 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -129.68 135.64 48.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.811 0.339 . . . . 71.319999999999993 110.266 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -131.92 133.87 45.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 62.240000000000002 111.023 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 21.8 p90 -152.93 147.49 19.13 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 72.140000000000001 110.673 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 15.0 Cg_exo -70.16 152.27 67.16 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.128 2.552 . . . . 72.040000000000006 113.119 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 64.319999999999993 109.89 175.812 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.2 m-20 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.304 0.573 . . . . 45.409999999999997 111.237 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 165.92 143.65 3.81 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.311 -0.859 . . . . 45.229999999999997 111.205 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.2 -171.53 41.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.579 -0.82 . . . . 60.030000000000001 111.954 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.815 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.26 167.02 22.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.033 -0.358 . . . . 51.439999999999998 110.033 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.515 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.2 m-85 -110.81 97.15 32.26 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 71.549999999999997 111.218 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 90' ' ' LEU . 57.7 Cg_endo -75.03 -4.78 15.91 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.61 2.207 . . . . 62.43 112.791 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.18 -31.61 58.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 64.310000000000002 110.782 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 188' ' ' PHE . 13.3 pt -79.89 -17.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.040000000000006 111.929 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 17.2 m170 67.99 33.22 4.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 111.892 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 191' ' ' ILE . 4.9 p -136.57 149.85 27.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.658 0.266 . . . . 75.140000000000001 110.797 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 115.82 9.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.272 0.558 . . . . 65.25 112.155 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -156.57 159.34 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.504 -0.924 . . . . 72.0 108.504 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -132.23 145.24 56.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 120.547 -0.461 . . . . 74.219999999999999 111.585 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -67.4 -68.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.402 2.068 . . . . 73.239999999999995 111.693 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -126.24 24.88 6.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 110.621 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 75.39 -10.0 1.31 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.914 1.079 . . . . 74.319999999999993 113.914 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -55.42 -27.74 49.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.322 0.49 . . . . 71.519999999999996 112.322 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.81 -0.23 89.72 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.843 -0.694 . . . . 62.43 112.879 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.46 -33.47 48.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 111.135 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.3 -0.857 . . . . 74.340000000000003 110.183 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 18.0 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 CA-C-O 120.851 0.271 . . . . 71.310000000000002 112.012 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -4.87 16.17 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.999 2.466 . . . . 62.039999999999999 113.744 -175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.527 HD21 HG12 ' A' ' 24' ' ' VAL . 21.9 t-20 -128.98 144.2 51.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.885 0.374 . . . . 74.439999999999998 110.577 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 34.4 m -137.48 147.38 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.092 0.472 . . . . 74.430000000000007 110.854 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CD1' ' HB3' ' A' ' 165' ' ' SER . 13.3 m-85 -103.45 132.18 49.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.777 -0.647 . . . . 74.409999999999997 110.831 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD12 HG21 ' A' ' 159' ' ' ILE . 3.4 mm? -114.58 104.81 12.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.041 -0.527 . . . . 54.549999999999997 109.749 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.28 115.46 28.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.278 -0.638 . . . . 74.329999999999998 109.278 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -107.12 178.92 4.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 75.109999999999999 111.738 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.4 p -75.25 -10.08 59.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.724 -0.671 . . . . 44.109999999999999 110.798 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.5 mmt -94.46 -42.11 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.654 . . . . 53.119999999999997 109.932 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.83 -116.51 0.51 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.474 -0.785 . . . . 73.030000000000001 111.336 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -150.54 138.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.063 0.459 . . . . 63.130000000000003 110.477 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -132.28 127.52 57.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.686 -0.688 . . . . 74.099999999999994 109.571 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 8.5 t -113.62 147.45 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.855 -0.424 . . . . 62.219999999999999 109.855 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.37 163.5 39.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.984 0.421 . . . . 62.219999999999999 110.652 174.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 131' ' ' ARG . 1.8 pt-20 -129.76 163.0 27.16 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.653 -0.703 . . . . 73.450000000000003 110.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.23 161.92 13.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 71.439999999999998 110.509 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.478 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 2.7 m-85 -88.32 100.26 12.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 74.510000000000005 111.635 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -85.89 7.06 25.58 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.002 -0.74 . . . . 73.230000000000004 109.002 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 4.4 mptp? -78.01 -57.34 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.753 -1.112 . . . . 73.530000000000001 111.54 -176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -132.31 14.96 4.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.423 -0.353 . . . . 72.420000000000002 111.81 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.53 80.42 71.95 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.787 -0.449 . . . . 55.439999999999998 109.787 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.606 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 59.4 Cg_endo -73.19 -25.18 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.445 2.096 . . . . 71.109999999999999 113.729 -171.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -100.66 -33.69 10.18 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.126 -0.63 . . . . 74.439999999999998 111.637 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.65 95.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.177 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -57.62 -51.62 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 63.140000000000001 111.017 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 67.6 mttt -66.73 -41.71 87.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.829 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.03 -47.86 74.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.819 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.417 ' HE1' HG21 ' A' ' 14' ' ' VAL . 32.7 t80 -67.64 -50.96 55.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.246 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.36 80.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.32 -0.855 . . . . 52.539999999999999 111.663 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.63 -47.66 82.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.891 -0.595 . . . . 72.319999999999993 110.32 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 3.5 mm? -66.33 -27.55 67.99 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.113 -0.494 . . . . 73.030000000000001 111.07 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.55 52.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.84 -0.618 . . . . 60.130000000000003 110.91 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -73.74 -26.09 60.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.903 -0.406 . . . . 75.430000000000007 109.903 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -60.46 -47.6 85.43 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.83 -0.623 . . . . 75.430000000000007 109.587 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.51 20.51 6.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.486 -0.864 . . . . 62.229999999999997 113.575 170.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -79.58 -11.2 59.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.201 0.501 . . . . 75.140000000000001 111.359 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HA ' HG23 ' A' ' 51' ' ' THR . 95.6 m-85 -85.11 -4.84 59.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.893 0.378 . . . . 64.530000000000001 110.967 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 38.6 m-80 -77.9 4.95 10.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.269 0.557 . . . . 71.439999999999998 110.046 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.77 21.22 2.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.707 -0.679 . . . . 53.420000000000002 111.698 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.945 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 28.8 p -96.0 152.61 18.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.555 0.217 . . . . 64.239999999999995 110.702 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 3.7 mtmt -134.94 155.94 49.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.522 -0.308 . . . . 74.420000000000002 110.512 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' A' ' 157' ' ' VAL . 97.5 m-85 -92.43 113.79 26.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 72.049999999999997 109.0 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -112.83 -24.01 9.81 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.519 -0.473 . . . . 75.549999999999997 112.257 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 27.2 mmm180 -114.49 106.21 14.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.248 -0.581 . . . . 52.140000000000001 110.148 177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -124.57 92.86 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.102 -0.703 . . . . 34.32 109.102 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.4 mt -98.32 122.18 49.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 42.1 mtpt -56.94 127.71 33.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.297 0.373 . . . . 72.140000000000001 111.635 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 56.17 32.89 21.03 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.123 -0.944 . . . . 73.109999999999999 111.373 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.3 t80 -130.97 -82.67 0.53 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.267 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.9 ptt? -161.64 157.61 24.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.702 -0.681 . . . . 74.129999999999995 110.205 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.637 HG23 HG13 ' A' ' 56' ' ' ILE . 29.0 mt -131.99 108.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 60.030000000000001 109.79 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.2 tt0 -79.5 124.16 28.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.314 -0.403 . . . . 54.439999999999998 110.074 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -133.96 127.78 4.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.437 -0.665 . . . . 63.399999999999999 111.437 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.945 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 139.17 -155.45 23.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.07 -1.062 . . . . 64.329999999999998 112.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 111' ' ' GLN . 22.3 t0 53.74 96.15 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.741 0.817 . . . . 73.409999999999997 112.324 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.11 -16.49 44.75 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.334 2.023 . . . . 72.209999999999994 112.606 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 70' ' ' THR . 48.5 p -93.6 -36.07 12.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 64.329999999999998 110.683 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 18.8 75.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.095 -0.574 . . . . 72.140000000000001 112.696 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 68' ' ' THR . 9.9 t -111.64 -10.32 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 75.230000000000004 111.563 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.73 35.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.2 -1.0 . . . . 41.030000000000001 112.986 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -86.46 -47.63 9.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 61.130000000000003 111.02 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.51 173.41 32.32 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.42 -0.809 . . . . 63.43 111.421 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.0 -10.68 58.44 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 120.719 -0.753 . . . . 52.020000000000003 112.181 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -55.92 -77.36 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.971 -0.615 . . . . 73.519999999999996 112.074 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 m 59.27 15.39 4.24 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.186 -0.461 . . . . 64.010000000000005 111.497 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 pt -68.4 -17.21 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.592 0.71 . . . . 74.140000000000001 110.445 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.2 -12.33 26.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.727 -1.124 . . . . 73.510000000000005 111.147 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.58 -76.77 1.3 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.241 -0.505 . . . . 50.240000000000002 112.464 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -87.47 -156.17 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.576 -0.527 . . . . 74.200000000000003 109.576 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.78 174.38 1.44 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 73.040000000000006 110.559 172.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 106' ' ' ASP . 26.2 t80 -118.17 -175.09 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.271 -0.422 . . . . 74.299999999999997 110.218 -172.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -76.48 121.36 23.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 74.329999999999998 110.645 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 7.8 p-10 -76.77 86.44 3.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.869 0.842 . . . . 74.349999999999994 109.066 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.48 39.53 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.313 -0.858 . . . . 74.230000000000004 109.555 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.484 HD23 ' HB ' ' A' ' 127' ' ' THR . 15.5 mt -69.26 98.98 1.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.381 -1.281 . . . . 71.439999999999998 110.63 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -162.07 83.47 1.69 Allowed Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.725 -0.67 . . . . 73.129999999999995 109.867 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.891 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 28.6 Cg_endo -62.28 82.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 123.154 2.57 . . . . 73.209999999999994 112.209 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.45 -25.83 54.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.409 -0.814 . . . . 72.349999999999994 109.682 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.6 pp -85.17 -179.96 7.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 72.150000000000006 109.796 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -124.42 141.23 52.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.46 -0.496 . . . . 65.209999999999994 110.672 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.66 72.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.664 0.745 . . . . 71.019999999999996 110.006 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -66.4 -37.86 86.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.773 -1.103 . . . . 73.329999999999998 112.575 -171.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' H ' HD11 ' A' ' 97' ' ' ILE . . . -166.42 -140.93 3.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.361 -0.923 . . . . 51.450000000000003 112.758 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' SD ' ' A' ' 200' ' ' MET . . . -91.1 137.49 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.751 0.31 . . . . 74.409999999999997 110.686 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.48 23.35 5.74 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.669 -0.777 . . . . 41.43 111.852 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 94' ' ' GLY . 11.0 mm -85.41 109.6 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.346 -0.612 . . . . 72.319999999999993 109.346 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -86.3 118.41 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.212 0.529 . . . . 62.340000000000003 109.774 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -125.04 168.12 13.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.053 -0.521 . . . . 62.200000000000003 110.847 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.6 ttt -91.71 132.77 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.191 -0.459 . . . . 75.450000000000003 109.805 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 111' ' ' GLN . . . -96.26 141.08 30.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.01 -0.367 . . . . 63.119999999999997 110.01 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -150.38 165.35 33.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.147 -0.479 . . . . 72.450000000000003 110.792 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -69.55 -46.66 65.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.845 -0.616 . . . . 73.299999999999997 110.296 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.94 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.472 -0.87 . . . . 71.400000000000006 112.715 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.28 89.43 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.918 2.412 . . . . 54.210000000000001 112.193 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 p30 50.13 29.37 3.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.317 -0.856 . . . . 74.200000000000003 111.571 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 m -96.58 55.51 1.43 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.113 -1.069 . . . . 65.030000000000001 108.113 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -92.85 137.15 32.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.995 -1.457 . . . . 71.030000000000001 110.096 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.21 -107.8 0.76 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.231 -0.985 . . . . 73.310000000000002 113.616 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.8 p -127.28 56.43 1.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.546 0.688 . . . . 64.319999999999993 110.601 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 66' ' ' ASP . 18.8 mp0 -130.32 147.3 52.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.18 -0.918 . . . . 64.209999999999994 110.136 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -139.78 169.3 17.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.769 -0.456 . . . . 73.409999999999997 109.769 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -155.79 147.87 23.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.87 0.367 . . . . 63.549999999999997 110.296 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.8 t -111.54 140.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.885 -0.598 . . . . 50.439999999999998 109.391 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -94.86 128.81 41.89 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.853 0.359 . . . . 62.329999999999998 110.14 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD11 ' HA3' ' A' ' 143' ' ' GLY . 67.6 mt -83.62 -8.71 59.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.764 -0.653 . . . . 70.010000000000005 110.168 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.42 156.58 34.91 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.164 -0.926 . . . . 61.399999999999999 109.679 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.35 124.58 14.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.503 2.135 . . . . 52.32 112.236 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 p -123.99 122.12 37.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.405 . . . . 61.340000000000003 110.234 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 5.18 31.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.716 0.293 . . . . 73.319999999999993 111.373 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.611 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -108.39 -3.1 18.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.611 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.9 mt -102.04 3.74 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 111.371 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.891 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 p-10 -70.67 -15.2 62.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.68 -0.691 . . . . 73.409999999999997 111.155 -172.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.86 15.96 9.53 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.329 -0.709 . . . . 65.420000000000002 111.329 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.66 -41.31 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.271 0.558 . . . . 72.209999999999994 110.109 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -142.31 126.1 17.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.005 -1.109 . . . . 75.030000000000001 108.005 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.484 ' HB ' HD23 ' A' ' 86' ' ' LEU . 11.3 t -72.22 143.11 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.669 -0.812 . . . . 72.340000000000003 110.459 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' ALA . 40.4 mt -114.87 119.94 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.57 -0.741 . . . . 71.450000000000003 110.54 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.3 m-85 -157.23 75.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.318 0.387 . . . . 75.299999999999997 110.138 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.66 158.24 30.38 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.585 -0.817 . . . . 75.120000000000005 112.611 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 11.4 mtp180 -135.12 114.98 12.91 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.719 -0.475 . . . . 75.209999999999994 109.719 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 96' ' ' GLY . 14.3 p -79.86 130.6 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.37 0.605 . . . . 73.420000000000002 110.068 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.662 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 87.7 m -140.5 140.12 35.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.765 -0.652 . . . . 62.450000000000003 110.576 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 54.67 42.33 31.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.124 0.488 . . . . 64.5 111.764 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 41.58 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.43 -0.89 . . . . 54.130000000000003 111.99 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.0 tp -90.77 -34.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.59 0.233 . . . . 65.120000000000005 111.011 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.92 -35.87 91.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.807 -0.711 . . . . 64.519999999999996 111.624 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -68.34 -51.2 47.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 54.32 110.337 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.505 HG13 HD12 ' A' ' 62' ' ' ILE . 98.5 t -55.03 -31.12 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.296 0.57 . . . . 75.439999999999998 110.789 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.93 -55.01 10.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.819 -0.628 . . . . 61.219999999999999 110.681 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -17.66 62.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.367 -0.379 . . . . 72.439999999999998 111.213 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 145' ' ' VAL . 55.0 t -84.3 -37.75 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.1 0.476 . . . . 74.319999999999993 109.934 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -83.38 -7.5 86.44 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.775 -0.726 . . . . 74.0 113.002 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.33 -1.06 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.755 -0.378 . . . . 71.209999999999994 111.294 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 142' ' ' VAL . 33.0 m . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.971 0.415 . . . . 72.340000000000003 111.242 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.139 0.495 . . . . 62.140000000000001 111.374 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -121.94 162.88 20.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 60.439999999999998 109.533 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.626 HG21 HD12 ' A' ' 16' ' ' LEU . 3.5 mp -88.9 103.27 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.445 -0.946 . . . . 73.109999999999999 108.445 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 161' ' ' LYS . 32.1 mm -66.81 -56.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.479 -0.782 . . . . 74.519999999999996 110.636 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 3.5 mptp? -128.92 137.25 51.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 64.019999999999996 110.374 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.19 27.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.209 -0.451 . . . . 62.140000000000001 110.242 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -148.22 135.36 10.46 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.767 -0.651 . . . . 72.200000000000003 110.723 -173.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.68 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 59.8 Cg_endo -72.78 139.38 30.5 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.706 2.271 . . . . 71.519999999999996 112.044 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.544 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 16.9 t . . . . . 0 C--N 1.326 -0.456 0 N-CA-C 109.6 -0.518 . . . . 70.430000000000007 109.6 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.515 -0.381 0 CA-C-O 121.732 0.777 . . . . 74.0 110.913 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 144.67 144.05 4.11 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.574 -1.194 . . . . 72.310000000000002 110.863 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.59 -167.9 44.2 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.27 -0.967 . . . . 62.32 111.659 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 189' ' ' PRO . . . -75.43 163.54 27.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.228 -0.656 . . . . 65.409999999999997 109.228 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -102.24 103.29 29.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.19 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 6.0 Cg_exo -77.43 -18.46 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.776 2.318 . . . . 64.239999999999995 111.298 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.87 -33.59 62.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 75.030000000000001 110.238 -172.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -89.22 157.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -106.82 89.68 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.057 -0.657 . . . . 74.150000000000006 110.638 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 194' ' ' ALA . 6.1 p -158.08 -171.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.626 -0.879 . . . . 71.120000000000005 108.626 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.745 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -123.45 117.61 25.54 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 122.188 -0.32 . . . . 72.310000000000002 110.669 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -156.45 155.27 31.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.864 -0.421 . . . . 62.109999999999999 109.864 177.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -117.31 149.24 44.23 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.458 -0.337 . . . . 73.519999999999996 110.546 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.533 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.8 Cg_endo -67.31 -65.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.408 2.072 . . . . 63.119999999999997 112.108 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.9 27.54 4.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.635 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 72.59 5.02 5.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.52 -0.764 . . . . 65.439999999999998 112.687 173.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 201' ' ' GLY . 2.0 ppp? -63.58 -50.4 69.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.102 0.408 . . . . 60.25 112.102 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.487 ' N ' ' SD ' ' A' ' 200' ' ' MET . . . -75.75 15.34 4.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.263 -0.494 . . . . 71.409999999999997 114.148 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -81.78 -17.05 48.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 72.140000000000001 110.464 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.252 1.204 0 CA-C-N 114.872 -1.058 . . . . 73.129999999999995 110.945 178.524 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 34.4 Cg_exo . . . . . 0 C--O 1.233 0.252 0 CA-C-O 120.809 0.254 . . . . 52.399999999999999 112.023 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 56.6 Cg_endo -71.55 -16.98 30.4 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.84 2.36 . . . . 73.310000000000002 113.534 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.505 HD21 HG12 ' A' ' 24' ' ' VAL . 22.2 t-20 -132.51 147.8 52.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.252 -0.431 . . . . 63.240000000000002 110.092 -174.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.9 m -139.04 152.02 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.257 0.551 . . . . 65.420000000000002 111.438 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HD1' HG22 ' A' ' 24' ' ' VAL . 97.4 m-85 -102.94 121.31 42.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.079 -0.964 . . . . 72.25 110.743 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -108.09 103.07 12.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.805 0.336 . . . . 73.420000000000002 110.307 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -85.15 122.45 29.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.228 -0.656 . . . . 64.319999999999993 109.228 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -114.97 176.61 4.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.212 0.529 . . . . 71.439999999999998 112.041 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 160' ' ' ILE . 32.7 t -75.51 -1.6 25.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.606 -0.725 . . . . 71.430000000000007 110.565 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mmt -107.2 -39.7 5.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.814 -0.63 . . . . 74.329999999999998 110.274 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.64 -126.41 0.98 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.232 -0.747 . . . . 63.219999999999999 111.232 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -139.84 137.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.035 0.445 . . . . 74.140000000000001 109.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -120.93 118.03 54.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.77 -0.65 . . . . 73.400000000000006 109.677 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 15' ' ' TYR . 46.5 t -106.16 131.18 56.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.82 -0.437 . . . . 75.010000000000005 109.82 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.66 164.57 33.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.997 0.427 . . . . 73.349999999999994 110.414 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 12.2 pt-20 -135.5 166.56 22.91 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.774 -0.648 . . . . 72.219999999999999 109.876 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -103.52 160.03 15.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.495 -0.557 . . . . 64.5 109.495 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -83.89 91.58 7.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 72.319999999999993 111.962 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.653 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 78.9 m95 -84.22 6.48 22.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.607 -0.724 . . . . 72.430000000000007 110.314 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -73.6 -63.03 1.29 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.609 -0.723 . . . . 71.219999999999999 110.495 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.419 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 37.6 m80 -131.07 16.2 5.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.083 0.401 . . . . 73.310000000000002 112.083 -176.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -133.83 56.95 21.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.024 -0.27 . . . . 74.219999999999999 110.983 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 14.0 Cg_exo -68.82 -25.9 32.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.442 2.094 . . . . 73.299999999999997 112.023 -175.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -66.44 -54.23 26.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 53.350000000000001 110.176 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.651 ' HB ' ' CE2' ' A' ' 129' ' ' PHE . 1.6 p -64.16 -40.23 95.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.182 -0.917 . . . . 63.399999999999999 110.988 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 86.3 m -58.31 -46.78 85.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.079 -0.964 . . . . 62.539999999999999 111.02 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -59.49 -41.39 89.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.422 -0.354 . . . . 63.439999999999998 110.189 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.72 -56.54 20.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 52.130000000000003 110.326 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HE2' ' HB3' ' A' ' 112' ' ' PHE . 3.4 m-85 -66.74 -42.29 86.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.759 -0.655 . . . . 63.149999999999999 111.492 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.93 -41.81 97.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.455 -0.339 . . . . 54.25 111.571 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.39 -43.67 98.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.024 0.44 . . . . 75.219999999999999 110.198 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.541 ' CD1' ' HB3' ' A' ' 110' ' ' SER . 35.3 mt -70.59 -24.46 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.873 -0.603 . . . . 71.209999999999994 111.97 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.75 86.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.005 -0.543 . . . . 73.329999999999998 110.313 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -75.56 -34.28 60.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 74.519999999999996 109.927 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 14.3 tpp180 -64.83 -46.75 80.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 75.439999999999998 110.273 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.38 28.87 5.0 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.926 -0.654 . . . . 50.329999999999998 113.075 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.76 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 5.2 m-85 -87.15 -2.92 58.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 111.674 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -76.42 -12.69 60.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 75.349999999999994 110.303 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 49' ' ' ASN . 0.8 OUTLIER -79.45 3.16 19.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.22 0.533 . . . . 75.019999999999996 109.91 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -131.69 15.4 5.18 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.694 -0.684 . . . . 74.030000000000001 112.253 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.559 HG22 ' HD3' ' A' ' 67' ' ' PRO . 13.6 p -98.63 138.03 36.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.837 0.318 . . . . 61.149999999999999 110.497 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' CG ' ' HG3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -128.71 124.5 35.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.418 -0.355 . . . . 75.109999999999999 110.427 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 96.2 m-85 -70.06 103.34 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.412 -0.588 . . . . 74.25 109.412 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -114.25 -15.43 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.031 -0.668 . . . . 64.25 112.06 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 11.3 mmt180 -105.42 101.61 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.982 -0.687 . . . . 74.329999999999998 109.597 175.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG13 HG23 ' A' ' 62' ' ' ILE . 4.2 mp -125.87 95.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.018 -0.734 . . . . 63.049999999999997 109.018 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 44.0 mt -91.88 127.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 109.184 -0.673 . . . . 62.030000000000001 109.184 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -48.72 111.41 0.46 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.99 0.806 . . . . 72.299999999999997 112.133 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' HD2' ' A' ' 203' ' ' LYS . 43.2 m-20 56.4 39.66 29.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.112 -0.949 . . . . 65.450000000000003 111.307 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.84 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 9.7 t80 -128.59 -76.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.813 -0.631 . . . . 73.219999999999999 109.987 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.401 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.4 ptt? -160.59 155.59 24.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 72.519999999999996 110.673 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 56' ' ' ILE . 49.0 mt -128.41 105.28 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 73.230000000000004 109.48 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 39.6 tt0 -85.49 127.2 34.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.739 -0.664 . . . . 74.040000000000006 111.893 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.39 117.38 4.62 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.454 -1.058 . . . . 31.440000000000001 110.454 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.24 146.59 33.43 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 114.423 0.529 . . . . 53.43 114.423 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 64.9 t0 -46.0 126.73 7.07 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 124.792 1.237 . . . . 74.340000000000003 111.837 174.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD3' HG22 ' A' ' 51' ' ' THR . 29.3 Cg_endo -64.46 -30.77 62.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.177 2.584 . . . . 72.25 112.763 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 70' ' ' THR . 62.7 p -84.1 -32.86 24.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 74.099999999999994 110.061 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.83 70.84 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.51 -0.768 . . . . 71.409999999999997 113.01 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 72' ' ' ARG . 8.8 t -105.52 -26.02 12.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.121 0.46 . . . . 43.420000000000002 111.536 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.97 -5.34 10.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.476 -0.869 . . . . 30.039999999999999 113.223 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.512 ' HG2' HG23 ' A' ' 70' ' ' THR . 8.5 ptm180 -100.85 -23.75 14.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.076 0.438 . . . . 71.5 111.101 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 85.47 175.11 50.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.827 -0.702 . . . . 73.510000000000005 112.098 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.76 ' HA3' ' HD2' ' A' ' 47' ' ' TYR . . . -86.93 28.79 5.33 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.525 0.514 . . . . 70.420000000000002 112.28 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . -93.1 25.13 3.4 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.74 0.781 . . . . 35.200000000000003 110.883 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 55.4 m -75.65 -5.69 46.77 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.089 -0.96 . . . . 62.240000000000002 110.583 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.1 tt -55.62 -40.17 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.562 -0.745 . . . . 74.349999999999994 110.96 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.508 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 34.8 p90 -102.12 -9.14 20.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 63.43 111.276 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 76' ' ' SER . . . 126.74 -119.27 3.28 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.24 -0.744 . . . . 74.010000000000005 111.24 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -137.91 146.45 43.33 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.049 0.452 . . . . 64.209999999999994 111.726 176.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.437 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 1.7 mp0 38.1 -166.55 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 O-C-N 125.692 1.87 . . . . 64.25 115.294 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB2' ' OD1' ' A' ' 108' ' ' ASN . 20.8 m-85 -154.41 -165.74 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.531 -1.213 . . . . 74.010000000000005 108.446 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.78 160.05 26.31 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.172 -1.048 . . . . 51.5 108.172 171.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.27 123.54 23.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 75.109999999999999 109.993 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.06 31.31 6.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.421 -0.585 . . . . 53.450000000000003 109.421 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' A' ' 127' ' ' THR . 47.9 mt -66.11 98.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.716 . . . . 75.439999999999998 110.319 -176.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -166.06 89.96 0.86 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.898 -0.592 . . . . 71.109999999999999 109.85 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.98 95.36 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.779 2.319 . . . . 54.130000000000003 111.61 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.42 -17.58 61.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.403 1.096 . . . . 74.409999999999997 108.7 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.653 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -106.5 170.83 7.7 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.875 -1.511 . . . . 51.32 108.797 175.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 93' ' ' THR . 38.6 ttpt -128.16 142.88 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.843 -0.343 . . . . 71.450000000000003 110.165 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -56.16 122.69 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.433 0.635 . . . . 65.239999999999995 109.369 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -119.48 -45.9 2.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.556 -0.747 . . . . 70.409999999999997 109.771 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.607 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -155.96 -139.27 2.72 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.054 -0.975 . . . . 44.049999999999997 111.389 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.67 144.65 25.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 73.400000000000006 110.844 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.18 24.32 5.47 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.786 -0.721 . . . . 73.040000000000006 112.13 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.403 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.0 mm -86.87 110.79 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.355 -0.609 . . . . 70.040000000000006 109.355 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -86.52 117.4 25.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.731 -0.668 . . . . 74.310000000000002 109.889 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.2 173.32 11.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 54.140000000000001 111.056 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.541 ' HG2' ' N ' ' A' ' 101' ' ' ALA . 28.1 ttm -94.36 148.19 22.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 70.209999999999994 111.281 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' N ' ' HG2' ' A' ' 100' ' ' MET . . . -99.52 122.09 42.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.699 -0.682 . . . . 71.040000000000006 109.222 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.58 165.88 24.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 110.221 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.12 -28.67 14.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.32 0.581 . . . . 53.240000000000002 110.422 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.412 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.23 180.0 29.17 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.651 -1.38 . . . . 61.109999999999999 109.651 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.7 -50.54 12.88 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 64.239999999999995 112.786 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -102.77 -1.83 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.57 -0.286 . . . . 52.420000000000002 111.092 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 81' ' ' GLN . 7.9 m -88.34 53.85 2.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.865 0.84 . . . . 74.25 109.114 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 82' ' ' PHE . 3.7 p30 -82.88 158.46 22.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.289 -1.323 . . . . 63.020000000000003 109.8 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.89 -129.51 1.04 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.445 -0.883 . . . . 24.129999999999999 112.965 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 3.3 p -114.07 -1.09 13.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.002 0.371 . . . . 53.439999999999998 112.002 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 71.9 mt-30 -79.32 150.31 31.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.729 -0.471 . . . . 63.539999999999999 109.729 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' HB3' ' HE2' ' A' ' 39' ' ' PHE . 29.8 p90 -148.11 164.98 32.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.857 -0.337 . . . . 70.209999999999994 110.468 -176.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.2 151.49 29.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.889 0.376 . . . . 75.209999999999994 110.321 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.73 HG22 HD23 ' A' ' 98' ' ' LEU . 15.1 t -110.15 141.42 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.814 -0.63 . . . . 72.510000000000005 109.352 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.3 p -95.14 124.92 39.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.115 0.483 . . . . 63.530000000000001 110.318 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.2 mt -81.83 -8.98 59.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.631 -0.713 . . . . 70.430000000000007 110.569 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.23 42.3 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.386 -0.825 . . . . 35.43 109.801 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.607 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 18.8 Cg_exo -65.98 120.24 7.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.714 2.276 . . . . 53.0 111.934 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -108.43 116.23 31.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 110.476 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -104.44 11.41 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.106 0.479 . . . . 74.120000000000005 110.903 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.527 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -118.42 0.27 11.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.679 -0.691 . . . . 62.210000000000001 111.138 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 91.2 mt -104.01 10.24 36.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.107 -0.497 . . . . 73.030000000000001 110.511 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -62.73 -22.18 66.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.196 -0.911 . . . . 73.409999999999997 111.496 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.91 21.51 4.66 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.713 -0.756 . . . . 62.340000000000003 111.727 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -117.08 -32.1 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 62.399999999999999 110.23 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.65 131.31 27.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.863 -0.608 . . . . 75.219999999999999 110.319 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.433 ' OG1' HD23 ' A' ' 86' ' ' LEU . 46.1 m -68.31 119.42 12.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.982 0.42 . . . . 71.310000000000002 109.932 171.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 99' ' ' ALA . 46.2 mt -102.47 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.029 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.651 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 15.0 p90 -160.3 71.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 75.420000000000002 111.264 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.83 154.02 24.7 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.611 -1.281 . . . . 42.130000000000003 114.053 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -131.75 118.64 20.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.461 -0.57 . . . . 74.120000000000005 109.461 170.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.06 139.03 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 72.319999999999993 110.459 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 46.0 t -141.51 150.02 41.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.453 -0.339 . . . . 64.519999999999996 110.956 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.9 pt20 39.02 40.02 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.807 1.243 . . . . 73.140000000000001 113.474 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.57 23.07 0.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.874 -0.679 . . . . 44.020000000000003 111.834 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 tp -76.63 -32.88 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.717 0.294 . . . . 73.239999999999995 110.233 -175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.09 87.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.818 -0.706 . . . . 44.140000000000001 111.672 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 78.6 mmm -72.23 -50.07 30.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.414 -0.217 . . . . 74.230000000000004 110.414 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 62' ' ' ILE . 86.6 t -57.77 -28.71 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 71.25 110.565 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.627 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -72.14 -55.29 7.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 51.240000000000002 110.572 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -70.69 -17.3 62.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.128 -0.487 . . . . 70.430000000000007 111.015 -176.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.1 t -87.48 -33.32 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.258 0.552 . . . . 74.439999999999998 109.666 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.77 -13.36 82.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.787 -0.721 . . . . 51.229999999999997 112.687 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.627 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 67.9 mtp -85.17 -2.2 57.75 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.871 -0.194 . . . . 75.140000000000001 111.382 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 142' ' ' VAL . 6.1 m . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.294 0.568 . . . . 73.420000000000002 110.489 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.6 p . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 121.292 0.567 . . . . 73.010000000000005 110.308 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.435 ' HG3' ' CG ' ' A' ' 52' ' ' LYS . 10.2 mptt -111.36 151.34 28.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.634 . . . . 70.450000000000003 110.86 -172.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.53 99.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.287 -1.005 . . . . 74.409999999999997 108.287 169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.534 HG22 ' HD3' ' A' ' 161' ' ' LYS . 36.4 mm -62.9 -50.78 78.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 73.549999999999997 110.218 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.596 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -143.16 152.44 41.79 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.555 -0.748 . . . . 72.329999999999998 109.992 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.95 132.95 37.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.472 . . . . 62.049999999999997 109.875 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 43.4 m-85 -134.31 125.65 17.94 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.582 . . . . 64.400000000000006 109.957 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . 19.5 Cg_endo -62.21 136.15 58.52 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.81 1.673 . . . . 62.210000000000001 111.139 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.504 ' HA ' ' HE2' ' A' ' 15' ' ' TYR . 8.6 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.999 0.428 . . . . 74.420000000000002 110.679 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.511 -0.539 0 CA-C-O 121.571 0.7 . . . . 65.200000000000003 110.26 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 156.17 146.39 4.45 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.926 -1.034 . . . . 63.520000000000003 110.998 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.9 -178.18 52.15 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.282 -0.961 . . . . 55.130000000000003 111.397 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.893 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.5 141.69 53.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.43 -0.582 . . . . 75.25 109.43 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 61.4 m-85 -88.96 104.44 7.6 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 53.520000000000003 110.277 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.653 ' HB2' HD12 ' A' ' 90' ' ' LEU . 1.1 Cg_endo -82.47 -5.55 11.77 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.804 2.336 . . . . 72.439999999999998 111.301 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.66 -34.34 46.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 64.129999999999995 110.438 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 193' ' ' VAL . 17.7 pt -79.59 -13.6 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.497 -0.774 . . . . 70.219999999999999 111.555 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 58.9 m170 64.92 40.29 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.501 -0.772 . . . . 71.420000000000002 111.971 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 HG13 ' A' ' 191' ' ' ILE . 9.8 p -144.19 145.47 21.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 110.758 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.32 122.11 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.853 -0.612 . . . . 55.030000000000001 112.339 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.421 HE22 ' N ' ' A' ' 188' ' ' PHE . 2.8 pp0? -166.93 158.46 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.031 -0.986 . . . . 71.200000000000003 108.967 175.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 25.6 m-85 -126.11 148.45 63.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.939 -0.305 . . . . 65.140000000000001 110.587 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.893 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -66.38 -59.37 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.52 2.147 . . . . 63.119999999999997 111.786 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.7 33.15 1.81 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.882 0.372 . . . . 72.530000000000001 110.647 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.42 3.55 3.82 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.811 -0.632 . . . . 61.229999999999997 112.683 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.2 ptm -56.73 -30.54 63.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.936 0.347 . . . . 75.140000000000001 111.936 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.3 -1.78 89.34 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.675 -0.774 . . . . 74.329999999999998 112.514 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 85.3 mtt180 -101.19 -12.19 18.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.578 . . . . 61.210000000000001 110.234 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . 21.1 ttmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.616 -1.175 . . . . 74.010000000000005 111.433 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.862 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 27.1 Cg_exo . . . . . 0 N--CA 1.464 -0.25 0 N-CA-C 110.564 -0.591 . . . . 73.340000000000003 110.564 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 72.7 Cg_endo -75.28 -18.22 18.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 62.039999999999999 113.395 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.532 HD21 HG12 ' A' ' 24' ' ' VAL . 23.1 t-20 -140.42 152.22 45.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.503 -0.555 . . . . 74.140000000000001 109.503 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.734 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.2 m -136.8 144.87 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.382 0.61 . . . . 64.299999999999997 111.29 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.84 123.53 43.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.207 -0.906 . . . . 63.32 111.004 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 16' ' ' LEU . 3.0 mm? -108.0 102.78 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.435 -0.348 . . . . 71.209999999999994 110.571 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -91.05 108.19 19.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.232 -0.655 . . . . 73.349999999999994 109.232 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -101.55 -179.95 4.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.228 0.537 . . . . 45.530000000000001 112.09 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB2' HD11 ' A' ' 160' ' ' ILE . 22.9 t -72.48 -11.01 60.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 75.319999999999993 110.948 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.4 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.7 mmt -102.89 -41.05 6.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.197 -0.456 . . . . 72.219999999999999 110.623 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.45 -129.39 1.2 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.419 -0.672 . . . . 71.019999999999996 111.419 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -139.69 138.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.923 -0.399 . . . . 74.219999999999999 109.923 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.63 129.99 64.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.843 -0.617 . . . . 72.420000000000002 109.647 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 21.6 t -105.59 134.34 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.361 -0.607 . . . . 75.239999999999995 109.361 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.774 ' HB2' HD11 ' A' ' 98' ' ' LEU . 3.8 pp -144.17 160.76 40.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.406 -0.517 . . . . 63.329999999999998 111.127 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HB3' HD22 ' A' ' 13' ' ' ASN . 7.5 pt-20 -146.26 170.04 17.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 73.030000000000001 110.631 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.66 169.76 8.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.932 -0.576 . . . . 72.299999999999997 110.624 -173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.606 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -87.72 105.18 17.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.04 0.447 . . . . 71.409999999999997 110.851 176.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 1.4 m0 -85.88 0.06 54.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.005 -0.543 . . . . 53.409999999999997 109.854 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -72.62 -68.82 0.45 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.744 -0.662 . . . . 72.140000000000001 111.024 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -124.15 11.65 8.85 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.695 -0.402 . . . . 72.340000000000003 110.992 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB2' ' CG ' ' A' ' 129' ' ' PHE . . . -129.6 69.19 81.31 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.275 -0.57 . . . . 33.409999999999997 112.278 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.553 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 18.8 Cg_exo -65.73 -33.36 44.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.493 1.462 . . . . 70.010000000000005 109.706 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -57.0 -56.78 17.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.299 -0.864 . . . . 54.030000000000001 110.725 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 m -61.59 -36.22 80.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 70.340000000000003 110.823 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 54.0 t -63.63 -48.64 76.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 70.510000000000005 111.022 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.36 -37.25 77.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.659 0.266 . . . . 73.129999999999995 110.405 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 55.4 t-20 -55.58 -62.05 1.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.926 -0.579 . . . . 63.509999999999998 110.476 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HE1' HG21 ' A' ' 14' ' ' VAL . 5.0 t80 -65.01 -44.7 88.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.696 -0.684 . . . . 71.0 110.767 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -57.59 -48.77 78.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.451 -0.795 . . . . 52.43 112.198 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.28 -39.27 92.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.927 0.394 . . . . 63.509999999999998 111.159 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 3.6 mm? -69.15 -24.32 64.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.548 -0.296 . . . . 61.020000000000003 111.056 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.14 36.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.244 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.5 -29.03 70.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.178 0.513 . . . . 75.519999999999996 110.184 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 49.1 mtt180 -79.07 -50.55 10.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 74.519999999999996 109.86 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.03 52.82 0.68 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.809 . . . . 74.310000000000002 113.036 171.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.66 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 3.9 p90 -76.09 -25.97 56.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.343 0.592 . . . . 74.019999999999996 110.481 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.679 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.5 -7.95 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.479 -0.782 . . . . 64.109999999999999 112.844 -173.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -71.75 -5.73 36.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.499 . . . . 74.439999999999998 110.47 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.29 33.87 2.71 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.756 -0.656 . . . . 52.240000000000002 111.508 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.833 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.1 p -114.61 153.8 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.858 0.361 . . . . 53.310000000000002 111.119 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -146.13 161.61 39.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 109.889 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.638 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 97.9 m-85 -87.22 124.06 32.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.616 -0.513 . . . . 64.019999999999996 109.616 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -105.49 -32.77 8.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.996 -0.282 . . . . 73.120000000000005 111.13 -172.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -118.44 107.58 13.99 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.841 -0.343 . . . . 74.010000000000005 110.383 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.622 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -120.22 91.43 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.691 -0.855 . . . . 72.340000000000003 108.691 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.3 mt -93.24 128.91 44.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.98 -0.554 . . . . 73.109999999999999 110.116 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -52.2 109.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.341 1.026 . . . . 75.319999999999993 111.539 -176.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.564 ' OD2' ' HA2' ' A' ' 201' ' ' GLY . 6.6 t70 53.1 50.35 18.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.765 0.793 . . . . 71.310000000000002 110.703 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 7.1 t80 -137.55 -77.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.332 -0.849 . . . . 71.319999999999993 109.117 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.637 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.4 ptt? -162.29 154.9 19.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.939 -1.028 . . . . 73.530000000000001 109.739 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.622 HG23 HG13 ' A' ' 56' ' ' ILE . 36.1 mt -128.54 101.59 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.124 -0.489 . . . . 73.5 109.817 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.4 tm0? -82.26 126.38 32.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.394 -0.821 . . . . 74.099999999999994 109.833 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -142.69 145.68 15.93 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.176 -1.011 . . . . 71.430000000000007 113.569 -176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.833 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 130.33 -138.58 10.3 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.735 -0.745 . . . . 31.109999999999999 112.37 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.896 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 23.1 t0 44.85 89.09 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 124.49 1.116 . . . . 74.430000000000007 113.249 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 72.6 Cg_endo -75.21 -13.5 20.97 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.863 2.375 . . . . 63.25 111.878 172.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -95.94 -34.9 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 65.140000000000001 112.058 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.47 21.92 71.41 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.127 -0.558 . . . . 53.299999999999997 112.37 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -120.09 2.24 10.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 72.019999999999996 111.159 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.59 -5.08 66.94 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.559 -0.829 . . . . 63.5 112.755 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -88.52 -46.75 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.335 0.588 . . . . 75.319999999999993 109.97 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.896 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 72.87 67.98 1.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.468 -0.787 . . . . 63.229999999999997 112.451 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.66 -105.05 1.57 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.859 -0.686 . . . . 73.230000000000004 111.59 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 53.62 35.85 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.962 0.448 . . . . 73.329999999999998 111.353 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 m -56.16 -32.24 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 73.120000000000005 111.779 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -70.53 -56.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.367 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.462 ' CD1' HG23 ' A' ' 77' ' ' ILE . 90.9 m-85 -69.86 -40.13 75.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.324 0.583 . . . . 53.119999999999997 110.465 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 -67.7 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.264 -0.88 . . . . 75.129999999999995 112.556 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -113.14 -178.65 3.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.156 0.503 . . . . 64.120000000000005 112.001 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.423 ' OE1' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -104.01 162.1 13.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.451 -0.795 . . . . 74.549999999999997 109.092 177.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -130.3 -67.86 0.72 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.41 -0.516 . . . . 70.239999999999995 111.108 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.8 -179.46 5.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.466 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HA ' HD21 ' A' ' 108' ' ' ASN . 6.1 p-10 -91.53 136.44 33.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.607 -0.724 . . . . 74.549999999999997 109.612 174.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -100.24 15.66 26.84 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 54.32 109.147 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.93 104.58 2.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.438 -0.801 . . . . 73.329999999999998 111.697 -173.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -173.37 81.69 0.4 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 75.349999999999994 109.906 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.11 93.0 0.46 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.562 2.175 . . . . 74.430000000000007 112.342 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.39 -38.56 84.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.365 0.602 . . . . 73.450000000000003 110.123 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -81.16 -176.54 6.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.263 -0.881 . . . . 75.109999999999999 110.769 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -122.99 144.11 49.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.758 -0.46 . . . . 64.099999999999994 109.758 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.45 76.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.021 0.915 . . . . 53.420000000000002 109.677 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.7 p -61.52 -46.7 88.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.474 -1.239 . . . . 64.120000000000005 111.768 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.2 -140.21 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.62 -0.8 . . . . 53.240000000000002 112.27 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 137.7 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.661 0.267 . . . . 55.229999999999997 110.743 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 113.01 20.74 6.23 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.737 -0.744 . . . . 73.430000000000007 111.788 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.5 mm -87.41 114.7 26.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.238 -0.653 . . . . 72.049999999999997 109.238 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 25' ' ' LEU . 8.5 mt -85.47 127.07 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.264 0.554 . . . . 72.019999999999996 111.467 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 163.81 26.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 110.105 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.421 ' CE ' ' HB3' ' A' ' 108' ' ' ASN . 40.7 ttp -97.24 140.26 31.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.637 -0.505 . . . . 50.329999999999998 109.637 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -90.96 137.73 32.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 61.43 110.587 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -137.42 159.1 42.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.569 -0.741 . . . . 61.020000000000003 110.304 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.48 -2.11 36.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.605 0.717 . . . . 73.040000000000006 110.021 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.504 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -174.21 172.69 45.54 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.884 -1.686 . . . . 72.420000000000002 108.884 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 -44.91 34.68 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.659 2.24 . . . . 63.549999999999997 112.321 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.29 -3.7 18.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 54.119999999999997 110.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.504 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.6 m -85.8 52.44 2.47 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.735 0.779 . . . . 64.019999999999996 109.099 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.495 HD21 ' HA ' ' A' ' 84' ' ' ASP . 44.9 m-80 -79.68 130.58 35.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.773 -1.103 . . . . 63.329999999999998 110.332 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.27 -138.95 6.46 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.708 -0.758 . . . . 43.340000000000003 112.46 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -119.53 14.13 12.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.777 0.322 . . . . 72.420000000000002 111.349 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 pt20 -92.81 168.02 11.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.703 -0.226 . . . . 71.510000000000005 110.446 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -145.88 177.49 8.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.802 0.335 . . . . 74.150000000000006 111.127 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 45.6 p90 -160.29 151.87 19.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.319 173.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.0 t -106.61 146.84 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 71.209999999999994 109.56 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.2 p -102.01 126.95 49.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.058 -0.349 . . . . 64.239999999999995 110.058 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 68.2 mt -87.62 -7.71 57.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.317 0.58 . . . . 73.430000000000007 110.55 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -150.89 165.14 18.01 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.397 -0.82 . . . . 64.409999999999997 109.809 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.3 Cg_endo -58.59 113.85 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.631 2.221 . . . . 73.319999999999993 111.652 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.404 HG22 ' HE1' ' A' ' 121' ' ' TRP . 16.6 p -100.06 88.44 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.231 0.538 . . . . 74.239999999999995 111.492 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.726 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -96.9 19.64 12.37 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.916 0.865 . . . . 64.219999999999999 108.845 -178.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.963 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -121.19 1.39 10.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.308 -1.314 . . . . 73.299999999999997 109.891 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.963 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 63.6 mt -121.71 6.37 9.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.485 -0.779 . . . . 72.129999999999995 110.41 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.01 -17.29 64.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 71.099999999999994 111.448 -172.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.11 18.58 5.01 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.507 -0.854 . . . . 72.310000000000002 111.298 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -120.91 -30.13 4.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.119 0.485 . . . . 73.329999999999998 110.249 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -139.67 141.2 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.165 -0.68 . . . . 62.420000000000002 109.165 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -78.16 144.55 36.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.978 0.418 . . . . 75.219999999999999 110.129 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.434 ' O ' HD21 ' A' ' 90' ' ' LEU . 49.3 mt -122.72 112.96 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.14 -0.482 . . . . 63.420000000000002 110.928 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.0 m-85 -155.82 77.31 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.608 0.568 . . . . 75.219999999999999 110.763 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.478 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -163.27 164.49 36.12 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.623 -0.799 . . . . 72.530000000000001 112.553 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -141.76 126.04 17.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.067 -0.346 . . . . 62.409999999999997 110.067 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.9 p -92.56 138.06 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.149 0.499 . . . . 74.040000000000006 110.911 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 47.9 t -144.23 146.0 32.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.1 -0.5 . . . . 71.329999999999998 110.204 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.712 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 7.9 tt0 50.25 40.49 22.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.254 0.55 . . . . 72.409999999999997 111.991 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.66 17.47 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.151 -1.023 . . . . 75.329999999999998 112.512 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.2 tp -74.27 -33.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.061 -0.256 . . . . 73.319999999999993 110.617 -174.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.47 -38.31 96.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.543 -0.837 . . . . 73.540000000000006 111.243 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 142' ' ' VAL . 76.1 mmm -69.33 -51.82 33.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.0 -0.37 . . . . 73.310000000000002 110.0 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.462 HG13 HD12 ' A' ' 62' ' ' ILE . 89.7 t -54.89 -31.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.054 0.454 . . . . 74.519999999999996 110.922 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.75 -53.73 12.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 74.230000000000004 110.587 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -73.48 -13.92 61.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.556 -0.747 . . . . 74.140000000000001 111.078 -176.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 138' ' ' MET . 53.4 t -88.51 -40.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 64.140000000000001 110.104 174.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.6 -9.41 86.89 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.708 -0.678 . . . . 74.049999999999997 112.735 -177.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.541 ' HG3' HG13 ' A' ' 145' ' ' VAL . 14.6 ptp -96.18 -13.62 23.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.669 0.271 . . . . 74.219999999999999 111.21 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 144' ' ' MET . 32.2 m . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.272 0.558 . . . . 62.409999999999997 111.635 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 53' ' ' PHE . 5.7 p . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 122.629 1.204 . . . . 73.349999999999994 111.187 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -133.49 159.63 39.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.085 -1.416 . . . . 72.319999999999993 109.784 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.8 mp -81.37 103.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.815 -0.809 . . . . 75.129999999999995 108.815 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.3 mm -67.59 -65.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 71.219999999999999 109.951 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 mptm? -133.08 135.84 45.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.394 -0.821 . . . . 72.430000000000007 109.098 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.679 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -130.96 143.21 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.938 0.399 . . . . 61.219999999999999 110.089 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 17.0 m-85 -133.7 128.94 20.16 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.781 -0.645 . . . . 61.229999999999997 109.74 -171.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.16 129.11 7.62 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.816 1.677 . . . . 64.540000000000006 111.529 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 74.219999999999999 109.956 -179.531 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.8 m-20 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.424 0.63 . . . . 72.530000000000001 110.715 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.46 144.01 3.87 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.15 -0.932 . . . . 63.140000000000001 111.164 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.88 -174.24 48.34 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.275 -0.964 . . . . 54.200000000000003 112.135 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.95 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.42 149.43 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.532 -0.544 . . . . 75.310000000000002 109.532 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -89.92 103.47 6.42 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.309 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 90.3 Cg_endo -80.61 -6.69 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.218 1.945 . . . . 71.329999999999998 111.066 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.73 -27.48 55.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.666 -1.152 . . . . 73.340000000000003 110.764 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 193' ' ' VAL . 15.8 pt -89.0 -12.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.976 -0.556 . . . . 62.140000000000001 111.703 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 90' ' ' LEU . 12.0 m170 58.27 45.31 17.38 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.801 -0.636 . . . . 71.540000000000006 111.588 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 191' ' ' ILE . 7.0 p -141.91 147.99 21.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.342 -0.39 . . . . 52.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.21 107.81 2.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 112.202 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -158.38 157.48 32.42 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.873 -0.788 . . . . 71.25 108.873 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 202' ' ' ARG . 46.8 m-85 -128.01 151.65 76.22 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.895 -0.322 . . . . 71.439999999999998 110.949 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.95 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.6 Cg_endo -67.57 -57.55 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 111.711 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -126.52 15.85 7.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.122 -0.49 . . . . 65.450000000000003 110.13 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 1.2 m-20 64.18 22.98 13.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.583 0.957 . . . . 60.130000000000003 113.583 171.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.77 -46.87 51.09 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.886 -0.325 . . . . 60.310000000000002 111.494 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.564 ' HA2' ' OD2' ' A' ' 59' ' ' ASP . . . -79.09 0.5 79.01 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.053 -0.594 . . . . 63.340000000000003 113.593 -172.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 15.9 ptm180 -96.33 -18.01 20.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.157 0.503 . . . . 45.420000000000002 111.168 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.493 -0.776 . . . . 64.530000000000001 109.904 -175.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 50.9 Cg_exo . . . . . 0 C--O 1.232 0.213 0 CA-C-O 120.876 0.282 . . . . 55.450000000000003 112.701 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 29' ' ' TRP . 71.8 Cg_endo -78.98 -13.51 14.11 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.813 2.342 . . . . 72.409999999999997 112.575 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.675 HD21 HG12 ' A' ' 24' ' ' VAL . 4.0 t-20 -151.72 142.01 22.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 72.299999999999997 109.666 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.6 149.33 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.823 0.344 . . . . 71.540000000000006 110.952 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.698 ' CD1' ' HB2' ' A' ' 165' ' ' SER . 7.0 m-85 -107.89 132.57 53.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.02 -0.536 . . . . 63.420000000000002 110.789 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' HD22 ' A' ' 16' ' ' LEU . 2.4 mm? -118.88 102.5 8.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.498 -0.774 . . . . 60.439999999999998 109.917 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.36 109.58 17.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.088 -0.708 . . . . 71.420000000000002 109.088 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -98.28 178.2 5.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.939 0.4 . . . . 74.409999999999997 110.769 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 160' ' ' ILE . 6.9 p -70.96 -28.14 64.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.961 -0.563 . . . . 63.200000000000003 111.365 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.541 ' SD ' HG22 ' A' ' 142' ' ' VAL . 83.3 mtp -91.05 -41.58 10.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.55 -0.296 . . . . 73.439999999999998 111.118 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 -143.08 3.59 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.858 -0.687 . . . . 33.340000000000003 111.396 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 23' ' ' ILE . 20.4 tt -128.11 138.92 53.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 117.026 0.413 . . . . 71.430000000000007 109.895 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 22' ' ' ILE . 10.8 mm -125.53 132.27 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.617 -0.512 . . . . 51.299999999999997 109.617 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 18.3 t -120.0 139.86 45.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 110.14 -0.319 . . . . 75.349999999999994 110.14 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 161.37 42.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 73.319999999999993 110.449 174.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 14.6 pt-20 -130.87 167.68 18.53 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.015 -0.539 . . . . 71.299999999999997 110.167 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.28 157.9 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.416 -0.356 . . . . 64.219999999999999 110.688 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 4.9 m-85 -80.07 102.49 9.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 72.219999999999999 111.499 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 12' ' ' PRO . 11.5 m0 -80.58 -6.27 58.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.887 -0.597 . . . . 73.209999999999994 110.453 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -73.83 -53.35 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 74.549999999999997 111.732 -172.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.62 6.09 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.925 0.342 . . . . 73.420000000000002 111.925 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.19 79.01 67.46 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.996 0.426 . . . . 54.340000000000003 111.52 -176.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.8 Cg_exo -71.84 -41.03 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.371 2.047 . . . . 73.530000000000001 111.573 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -77.33 -43.31 33.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.933 -0.576 . . . . 73.5 110.143 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 2.1 m -57.23 -42.38 81.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.349999999999994 110.334 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.7 t -60.77 -47.96 83.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 110.651 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -62.95 -35.53 80.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.202 -0.453 . . . . 60.439999999999998 111.153 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.22 -53.31 59.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 71.219999999999999 110.76 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HZ ' ' HG3' ' A' ' 100' ' ' MET . 76.9 m-85 -67.96 -44.42 76.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 111.164 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -61.84 -35.96 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 60.32 112.13 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -66.35 -44.71 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.422 0.63 . . . . 61.140000000000001 109.948 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.744 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . 30.4 mt -67.64 -22.12 65.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 111.128 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.0 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 72.310000000000002 110.362 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 32.4 mmt180 -63.84 -49.6 72.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.311 0.576 . . . . 64.340000000000003 110.073 174.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -74.9 -51.97 12.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.378 -0.828 . . . . 71.120000000000005 110.802 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.9 44.86 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 74.420000000000002 112.129 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.744 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -70.6 -26.53 63.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.042 0.449 . . . . 74.140000000000001 110.714 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.503 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.3 m-85 -76.67 -16.49 59.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 62.32 111.572 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -74.52 2.33 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 73.299999999999997 110.942 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.32 11.7 5.26 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.921 -0.657 . . . . 53.420000000000002 111.907 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.4 p -90.45 137.93 31.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 74.219999999999999 110.951 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 2.0 mtmt -129.49 150.75 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.388 -0.597 . . . . 73.010000000000005 109.388 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 72.4 m-85 -78.05 122.37 25.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.851 -0.425 . . . . 70.409999999999997 109.851 177.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -107.36 -30.46 8.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.55 -0.295 . . . . 60.340000000000003 111.064 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 25.5 mmt180 -119.04 110.58 17.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.907 -0.405 . . . . 73.099999999999994 109.907 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.426 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -127.15 93.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 71.540000000000006 109.082 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 35.2 mt -104.1 125.48 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 109.94 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -50.42 129.39 21.84 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.65 0.594 . . . . 75.319999999999993 111.62 177.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' HE3' ' A' ' 58' ' ' LYS . 3.4 p30 42.22 43.74 3.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.231 0.957 . . . . 75.5 112.418 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.743 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -135.67 -77.54 0.43 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 72.310000000000002 110.291 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.7 ptp -160.05 156.05 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 64.140000000000001 110.634 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' A' ' 116' ' ' LEU . 40.6 mt -131.58 101.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.736 -0.666 . . . . 61.520000000000003 109.417 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 24.6 tm0? -88.42 128.92 35.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.647 -0.706 . . . . 73.200000000000003 109.802 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -137.17 144.24 15.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.708 -0.758 . . . . 71.329999999999998 112.369 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 147.14 -143.3 11.17 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.658 -0.782 . . . . 60.109999999999999 112.578 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HA ' HE22 ' A' ' 111' ' ' GLN . 44.5 t0 46.86 77.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 124.16 0.984 . . . . 70.430000000000007 112.71 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.72 -12.08 22.09 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.495 2.13 . . . . 73.010000000000005 111.587 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.0 p -91.81 -42.83 9.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.458 -0.792 . . . . 74.25 111.961 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.22 32.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.602 -0.809 . . . . 70.530000000000001 112.001 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.45 -2.65 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 52.140000000000001 111.038 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.69 -35.7 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.381 -0.914 . . . . 73.409999999999997 113.316 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.711 ' HG2' HG23 ' A' ' 70' ' ' THR . 14.3 ptm180 -78.67 -28.88 45.38 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.219 0.509 . . . . 72.519999999999996 110.888 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.04 -162.65 54.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.023 -0.608 . . . . 15.529999999999999 113.179 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.97 6.79 61.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.294 -0.479 . . . . 72.549999999999997 112.386 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -87.35 22.59 2.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.34 1.067 . . . . 71.409999999999997 110.723 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -85.51 5.8 29.76 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.318 -1.31 . . . . 51.109999999999999 109.805 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.49 -28.51 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.342 -0.845 . . . . 70.400000000000006 111.213 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 p90 -100.18 10.86 40.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.512 0.672 . . . . 75.209999999999994 110.788 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.41 -110.26 3.96 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.11 -0.95 . . . . 61.340000000000003 112.417 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -95.88 -169.02 1.86 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.426 0.291 . . . . 54.530000000000001 110.275 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.477 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -65.97 159.26 26.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 63.509999999999998 109.826 176.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -102.47 -85.18 0.44 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.836 0.35 . . . . 74.530000000000001 110.944 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -162.02 157.19 23.19 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.459 -0.941 . . . . 74.319999999999993 108.459 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.31 110.95 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.533 0.682 . . . . 64.450000000000003 110.438 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.43 28.83 3.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.841 -0.618 . . . . 72.109999999999999 109.377 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.38 100.31 0.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 71.319999999999993 110.502 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -159.92 72.74 3.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.798 -0.637 . . . . 75.140000000000001 109.827 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.21 98.21 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.206 1.938 . . . . 73.299999999999997 112.642 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.56 24.39 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.489 0.662 . . . . 73.340000000000003 110.318 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.8 pp -137.24 -169.06 2.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.501 -0.772 . . . . 73.209999999999994 110.278 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -140.6 151.06 44.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.033 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -72.43 69.5 0.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.713 0.768 . . . . 70.099999999999994 110.668 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.9 p -68.7 -39.94 80.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.174 -0.921 . . . . 63.25 111.824 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 -142.43 3.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.504 -0.855 . . . . 73.140000000000001 112.913 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 141.62 28.43 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.302 0.241 . . . . 60.32 111.018 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.41 22.2 6.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.793 -0.718 . . . . 52.140000000000001 111.917 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.1 mm -87.52 111.25 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.684 -0.487 . . . . 55.100000000000001 109.684 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -88.44 118.9 28.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.139 0.495 . . . . 73.409999999999997 109.715 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.3 173.4 10.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.063 -0.517 . . . . 52.420000000000002 110.817 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.479 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 12.3 ttp -104.02 137.04 42.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.139 -0.482 . . . . 65.430000000000007 110.141 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -89.21 144.46 26.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 63.350000000000001 110.73 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.2 p-10 -153.12 158.77 42.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 71.150000000000006 110.593 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.19 -16.56 20.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.74 0.781 . . . . 64.540000000000006 109.794 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -157.05 174.07 34.65 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.698 -1.761 . . . . 71.109999999999999 108.698 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.03 -47.73 22.52 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.844 2.363 . . . . 41.350000000000001 112.082 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -104.31 -5.07 22.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 64.209999999999994 110.986 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.409 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -87.61 49.33 1.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.767 0.794 . . . . 63.009999999999998 108.865 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 5.7 p30 -94.37 145.08 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 65.140000000000001 111.386 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -129.79 -167.26 12.04 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.013 -1.235 . . . . 64.540000000000006 110.013 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 19.5 t -87.47 14.88 7.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.94 0.87 . . . . 65.409999999999997 110.016 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 10.1 mm-40 -67.53 145.99 54.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.056 -1.09 . . . . 72.409999999999997 108.056 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.72 166.32 24.25 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.191 -0.603 . . . . 71.239999999999995 111.433 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.51 151.38 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.777 -0.647 . . . . 73.329999999999998 110.128 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -110.39 143.65 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.221 -0.659 . . . . 75.109999999999999 109.221 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -98.99 126.38 44.67 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.048 0.451 . . . . 63.509999999999998 110.159 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 62' ' ' ILE . 69.3 mt -83.99 -5.87 59.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.721 -0.672 . . . . 65.430000000000007 110.629 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -146.5 162.01 36.01 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.706 -0.679 . . . . 43.109999999999999 109.829 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 21.6 Cg_endo -61.8 112.91 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.018 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.418 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.2 p -97.51 102.72 14.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.397 0.618 . . . . 73.530000000000001 111.163 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.52 17.71 23.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.424 0.631 . . . . 72.349999999999994 110.355 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.29 -3.38 9.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 64.010000000000005 111.673 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.1 pp -133.07 8.17 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 74.430000000000007 112.443 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -62.74 -27.48 69.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.007 0.432 . . . . 65.099999999999994 111.021 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.34 11.35 36.53 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.751 . . . . 44.310000000000002 112.05 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -117.18 -27.46 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.489 0.661 . . . . 71.310000000000002 109.56 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.38 130.46 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 74.530000000000001 108.68 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.0 t -75.37 143.95 42.55 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.198 -0.601 . . . . 71.239999999999995 110.109 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.4 mt -122.95 116.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 73.439999999999998 110.501 -173.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.6 m-85 -151.96 74.13 1.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.998 0.427 . . . . 72.0 110.459 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.664 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.74 155.81 27.27 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.719 -0.753 . . . . 71.140000000000001 112.179 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.432 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 14.3 mtp180 -135.07 118.91 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.621 -0.511 . . . . 73.400000000000006 109.621 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.432 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.0 p -79.96 136.94 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.405 0.622 . . . . 63.210000000000001 110.55 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.676 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 44.1 t -141.8 145.76 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.674 -0.694 . . . . 72.219999999999999 109.693 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.5 tt0 42.75 48.75 4.92 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.483 0.658 . . . . 73.049999999999997 112.363 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 184' ' ' ASP . . . -172.12 13.58 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.833 -1.175 . . . . 54.43 112.988 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -73.54 -31.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.874 0.337 . . . . 53.530000000000001 110.238 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -37.38 94.75 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.701 -0.762 . . . . 53.140000000000001 111.203 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 142' ' ' VAL . 69.8 mmm -72.47 -50.66 24.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.85 -0.426 . . . . 72.420000000000002 109.85 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 62' ' ' ILE . 90.1 t -53.91 -30.65 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 64.209999999999994 110.83 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -69.91 -52.47 24.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.962 -0.563 . . . . 74.430000000000007 110.612 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.523 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.23 -17.07 60.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.447 -0.342 . . . . 74.230000000000004 111.402 -179.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 138' ' ' MET . 83.9 t -83.47 -34.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 109.957 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -91.01 -3.74 69.87 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.864 -0.684 . . . . 72.519999999999996 112.619 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.523 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.6 ptm -95.89 -12.2 25.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.728 0.299 . . . . 51.219999999999999 110.954 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 142' ' ' VAL . 21.4 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.668 . . . . 75.450000000000003 110.397 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 53' ' ' PHE . 3.6 p . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.739 0.781 . . . . 71.400000000000006 109.326 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -155.88 176.42 12.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.251 -0.886 . . . . 55.039999999999999 110.486 -171.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -90.17 109.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.456 -0.572 . . . . 74.109999999999999 109.456 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.709 HG22 ' HD3' ' A' ' 161' ' ' LYS . 27.6 mm -75.48 -49.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.628 -0.715 . . . . 74.430000000000007 110.871 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.709 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.78 140.55 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 109.92 178.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.503 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -144.01 134.91 25.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.846 0.355 . . . . 74.400000000000006 111.574 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -160.64 151.77 15.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 74.120000000000005 110.375 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 10.3 Cg_exo -70.73 142.23 43.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.832 2.355 . . . . 70.209999999999994 112.483 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.698 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 46.7 m . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.383 -0.599 . . . . 62.100000000000001 109.383 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 136' ' ' ILE . 4.2 m-20 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.123 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 170.08 142.95 3.74 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.719 -0.753 . . . . 61.229999999999997 111.515 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -82.44 -164.62 35.09 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.261 -0.971 . . . . 75.219999999999999 111.992 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.835 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.32 166.95 22.5 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.112 -0.329 . . . . 32.130000000000003 110.112 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.31 95.19 41.92 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-O 121.153 0.502 . . . . 73.0 110.336 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.683 ' HB2' HD13 ' A' ' 90' ' ' LEU . 55.6 Cg_endo -70.77 -19.37 31.41 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.914 2.409 . . . . 71.319999999999993 111.651 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.09 -37.53 66.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.903 -1.044 . . . . 72.099999999999994 111.522 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.518 HG13 HG12 ' A' ' 193' ' ' VAL . 30.4 pt -75.14 -13.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.175 -0.466 . . . . 63.130000000000003 111.75 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 59.8 m170 63.02 70.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 73.540000000000006 111.231 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 191' ' ' ILE . 9.3 p -170.8 140.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 110.003 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.31 117.18 7.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 63.009999999999998 111.517 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.35 149.31 11.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.097 -0.705 . . . . 74.129999999999995 109.097 175.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 202' ' ' ARG . 29.0 m-85 -120.2 147.41 44.77 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.744 -0.207 . . . . 75.430000000000007 110.852 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.835 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.4 Cg_endo -63.67 -64.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.527 2.151 . . . . 72.310000000000002 112.025 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.73 26.55 4.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.215 0.531 . . . . 60.119999999999997 109.985 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.51 ' OD1' ' HD3' ' A' ' 202' ' ' ARG . 78.3 m-20 70.08 6.55 5.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.225 -0.898 . . . . 74.109999999999999 112.05 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.9 ptm -54.24 -34.28 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 64.040000000000006 112.198 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.96 10.91 71.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.358 -0.925 . . . . 72.319999999999993 113.222 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.51 ' HD3' ' OD1' ' A' ' 199' ' ' ASP . 4.7 ptm180 -127.21 -39.59 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.138 0.469 . . . . 75.540000000000006 110.501 176.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 203' ' ' LYS . 1.2 ptmm? . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.853 -0.594 . . . . 64.109999999999999 110.124 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' CB ' ' HB2' ' A' ' 164' ' ' PRO . 82.2 Cg_exo . . . . . 0 CA--C 1.529 0.244 0 CA-C-O 121.125 0.385 . . . . 61.219999999999999 113.061 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.75 -24.72 15.35 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.972 2.448 . . . . 74.239999999999995 113.279 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.72 HD21 HG12 ' A' ' 24' ' ' VAL . 11.1 t-20 -131.87 146.66 52.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.574 -0.528 . . . . 64.109999999999999 109.574 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.688 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.0 m -131.72 144.17 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.311 0.577 . . . . 73.140000000000001 111.157 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 77.0 m-85 -97.71 120.41 38.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.632 -0.713 . . . . 73.230000000000004 110.701 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -107.57 103.81 13.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.043 -0.354 . . . . 63.210000000000001 110.043 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 22' ' ' ILE . 29.6 mt-10 -92.18 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.491 -0.559 . . . . 73.420000000000002 109.491 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -103.5 179.26 4.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.162 0.506 . . . . 72.109999999999999 111.534 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.436 ' HB3' HD11 ' A' ' 160' ' ' ILE . 11.5 p -73.62 -18.35 61.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 62.450000000000003 111.176 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.7 mmm -98.65 -35.86 10.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 73.319999999999993 111.201 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -172.4 -133.94 1.72 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.691 . . . . 63.210000000000001 111.817 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -141.4 133.83 29.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.075 -0.713 . . . . 54.299999999999997 109.075 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -127.76 126.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.757 -0.656 . . . . 51.520000000000003 109.777 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.72 HG12 HD21 ' A' ' 13' ' ' ASN . 10.9 t -108.44 135.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.553 -0.536 . . . . 71.430000000000007 109.553 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.24 162.21 39.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.346 0.593 . . . . 75.409999999999997 110.621 175.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 131' ' ' ARG . 2.7 pt-20 -140.42 164.6 29.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.91 -1.041 . . . . 65.530000000000001 109.398 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.28 175.37 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.891 0.377 . . . . 74.129999999999995 110.826 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.3 m-85 -88.92 101.49 14.12 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.31 0.576 . . . . 62.310000000000002 111.052 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.563 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -82.21 -2.13 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.261 -0.881 . . . . 74.030000000000001 110.486 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -75.07 -67.5 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 74.519999999999996 111.24 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -117.51 13.08 14.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 73.409999999999997 110.782 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -136.91 62.2 39.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.824 0.345 . . . . 62.130000000000003 110.945 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 18.5 Cg_exo -65.99 -50.96 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.591 2.194 . . . . 75.040000000000006 112.091 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -74.02 -35.08 64.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.401 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.4 m -62.96 -37.6 87.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.714 -0.675 . . . . 72.209999999999994 110.08 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.563 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 25.2 t -63.85 -39.58 94.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.79 -0.641 . . . . 75.209999999999994 110.925 175.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mmpt? -63.73 -39.66 94.83 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.831 -0.433 . . . . 73.230000000000004 109.831 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -53.7 -57.51 10.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.698 -0.683 . . . . 72.25 110.133 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 14' ' ' VAL . 17.3 t80 -59.29 -49.71 76.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 72.219999999999999 110.754 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.99 75.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.391 -0.822 . . . . 62.310000000000002 112.357 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.658 ' OE2' ' HD3' ' A' ' 44' ' ' ARG . 25.9 mm-40 -63.27 -41.93 99.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.638 -0.255 . . . . 74.349999999999994 111.602 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.6 mm? -69.29 -27.36 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.254 -0.578 . . . . 75.530000000000001 110.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.0 65.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 72.450000000000003 110.802 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.658 ' HD3' ' OE2' ' A' ' 41' ' ' GLU . 2.9 ptm180 -75.05 -29.39 60.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 74.310000000000002 111.39 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 1.3 tmt_? -65.23 -37.31 86.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.35 0.595 . . . . 73.319999999999993 109.854 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.5 32.14 2.2 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.587 -0.816 . . . . 65.109999999999999 111.987 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 42' ' ' LEU . 85.0 t80 -85.91 -44.31 12.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.015 0.436 . . . . 64.340000000000003 110.259 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -78.71 -9.27 59.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 111.041 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -77.62 8.01 4.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 51.039999999999999 110.402 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.83 16.27 1.98 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.871 -0.604 . . . . 50.409999999999997 111.891 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.68 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -97.95 159.45 14.92 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.707 -0.29 . . . . 64.540000000000006 110.832 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -140.63 146.82 38.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.81 0.338 . . . . 34.32 111.544 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 65.4 m-85 -78.48 100.91 7.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.407 -0.961 . . . . 75.200000000000003 108.407 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -109.98 -14.56 14.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.471 -0.492 . . . . 74.340000000000003 111.671 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.948 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 12.7 mmm180 -110.03 112.92 25.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.092 -0.707 . . . . 53.229999999999997 109.092 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD13 HG23 ' A' ' 62' ' ' ILE . 19.7 mm -124.84 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.348 -0.612 . . . . 65.420000000000002 109.348 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 10.8 mt -102.0 115.49 43.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.652 -0.499 . . . . 65.340000000000003 109.652 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 38.7 mtpt -57.13 129.27 41.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.127 0.267 . . . . 63.149999999999999 111.269 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.99 26.69 16.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.545 -0.752 . . . . 71.409999999999997 110.979 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -128.93 -81.71 0.57 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 74.319999999999993 109.976 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -161.04 159.71 29.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 73.310000000000002 110.325 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.581 HD11 ' HA3' ' A' ' 143' ' ' GLY . 62.4 mt -128.78 103.48 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 73.439999999999998 109.382 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.948 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 50.9 mt-30 -85.6 124.53 32.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.606 -0.725 . . . . 60.140000000000001 111.526 -176.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.02 139.16 10.74 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.754 -0.657 . . . . 43.119999999999997 112.487 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.68 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 142.96 -154.77 25.58 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.466 -0.873 . . . . 71.25 112.85 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 69' ' ' GLY . 34.1 t0 55.78 102.6 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.355 1.062 . . . . 72.219999999999999 112.714 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' CZ ' ' A' ' 47' ' ' TYR . 88.6 Cg_endo -79.77 -17.16 11.17 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.102 2.535 . . . . 75.120000000000005 111.515 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.9 p -90.3 -38.27 13.5 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.787 -0.642 . . . . 54.299999999999997 110.305 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 78.28 25.85 60.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 71.200000000000003 111.359 -176.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 76.1 p -97.96 -35.24 10.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 72.340000000000003 111.078 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.87 -20.85 6.71 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.668 -0.696 . . . . 41.25 112.274 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.444 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 7.2 ptm180 -93.57 -28.0 16.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 75.219999999999999 110.934 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.76 -179.52 53.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.7 -0.762 . . . . 51.240000000000002 111.831 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . -79.74 -87.52 0.54 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.861 -0.685 . . . . 63.310000000000002 112.371 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.44 27.07 4.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.845 0.831 . . . . 63.539999999999999 111.228 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -85.99 16.39 4.23 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.041 -0.981 . . . . 52.200000000000003 111.754 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.591 HG13 ' HD1' ' A' ' 78' ' ' TYR . 46.4 pt -81.85 -29.53 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.715 -0.394 . . . . 71.310000000000002 110.143 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG13 ' A' ' 77' ' ' ILE . 2.9 p90 -117.95 14.05 14.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.924 0.868 . . . . 74.510000000000005 110.521 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -77.06 1.81 Allowed Glycine 0 C--N 1.318 -0.441 0 CA-C-N 114.59 -1.186 . . . . 72.430000000000007 113.425 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -111.98 -163.85 0.88 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.272 -0.27 . . . . 70.530000000000001 110.272 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -86.61 168.0 14.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.647 . . . . 73.129999999999995 109.252 173.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -98.88 -80.1 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.77 -0.372 . . . . 75.010000000000005 111.308 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.51 163.57 27.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.964 -0.754 . . . . 71.0 108.964 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.34 143.66 34.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 74.430000000000007 109.756 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 23.8 7.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.75 -0.659 . . . . 74.129999999999995 109.604 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 127' ' ' THR . 78.2 mt -54.51 100.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.52 -0.764 . . . . 71.200000000000003 111.648 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.61 91.33 0.43 Allowed Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.39 -0.823 . . . . 71.400000000000006 109.412 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' LEU . 19.2 Cg_endo -57.6 92.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.611 2.207 . . . . 44.420000000000002 111.071 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.28 23.3 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.145 0.974 . . . . 75.510000000000005 109.146 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -145.3 -176.88 5.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.361 -1.29 . . . . 73.439999999999998 108.625 -178.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HD3' HG22 ' A' ' 93' ' ' THR . 54.2 tttm -113.61 147.88 37.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.324 0.583 . . . . 62.439999999999998 110.938 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.24 79.99 4.67 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.091 0.948 . . . . 74.329999999999998 108.481 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.426 HG22 ' HD3' ' A' ' 91' ' ' LYS . 26.8 p -75.65 -41.95 52.69 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.612 -1.176 . . . . 74.319999999999993 111.838 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.795 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.83 -137.79 2.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.658 -0.782 . . . . 74.049999999999997 112.293 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.77 147.29 24.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.815 0.341 . . . . 40.210000000000001 110.891 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 106.41 21.95 8.08 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.446 -0.662 . . . . 75.109999999999999 111.446 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 mm -90.03 110.9 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.479 -0.563 . . . . 72.140000000000001 109.479 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -85.89 117.77 24.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.76 -0.654 . . . . 73.209999999999994 109.538 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.0 169.81 12.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.125 0.488 . . . . 52.030000000000001 111.854 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.845 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 14.0 tpt -90.45 135.4 33.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.412 -0.813 . . . . 75.239999999999995 109.983 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -97.86 149.33 22.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.522 -0.548 . . . . 74.200000000000003 109.522 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -163.11 159.26 22.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 73.109999999999999 110.7 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.39 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.627 0.727 . . . . 73.439999999999998 109.814 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -137.31 177.76 19.56 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.988 -1.645 . . . . 64.430000000000007 108.988 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 -51.84 9.72 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.021 2.481 . . . . 55.310000000000002 112.86 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.7 -4.83 29.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 71.140000000000001 111.59 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 2.2 m -88.81 49.68 1.83 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.327 0.584 . . . . 72.549999999999997 109.469 -175.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -74.27 -66.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.806 -1.088 . . . . 51.509999999999998 110.944 178.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 -100.77 2.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.625 -0.797 . . . . 71.25 112.343 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -152.87 35.94 0.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.012 0.434 . . . . 61.409999999999997 110.81 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 19.9 mt-30 -102.54 146.56 27.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 74.510000000000005 110.186 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -142.44 166.9 23.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.711 0.291 . . . . 61.229999999999997 110.795 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -158.59 153.23 24.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.926 0.393 . . . . 74.409999999999997 111.004 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 HD23 ' A' ' 98' ' ' LEU . 17.7 t -108.62 145.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 72.219999999999999 109.265 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -99.88 129.67 45.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.897 0.379 . . . . 54.439999999999998 110.452 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 62' ' ' ILE . 64.7 mt -84.79 -9.63 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 110.984 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.32 164.18 28.03 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.9 -0.591 . . . . 62.399999999999999 110.054 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 35.5 Cg_exo -60.98 114.52 2.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.454 2.103 . . . . 62.140000000000001 111.493 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.7 p -100.12 94.56 6.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.277 0.561 . . . . 74.549999999999997 111.189 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -98.11 14.56 27.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 72.109999999999999 110.104 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.59 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.6 p90 -118.29 -3.36 11.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.026 -0.988 . . . . 73.450000000000003 110.495 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.601 HD22 ' HD2' ' A' ' 126' ' ' HIS . 83.5 mt -105.06 8.82 34.44 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.792 -0.64 . . . . 74.209999999999994 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.1 -23.58 55.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.064 -1.425 . . . . 75.140000000000001 111.315 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.29 23.22 3.49 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 120.874 -0.679 . . . . 72.400000000000006 111.983 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.45 -32.95 3.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.936 0.398 . . . . 72.209999999999994 110.279 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.601 ' HD2' HD22 ' A' ' 122' ' ' LEU . 96.9 m-70 -141.24 139.53 33.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.322 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 86' ' ' LEU . 23.7 m -75.46 135.98 40.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.777 -0.453 . . . . 61.329999999999998 109.777 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -115.46 124.75 72.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 121.058 -0.257 . . . . 74.25 110.828 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.845 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 3.8 p90 -157.4 74.07 0.75 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.949 0.88 . . . . 65.209999999999994 110.932 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.83 152.39 22.55 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.01 -1.567 . . . . 74.120000000000005 113.841 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.631 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -138.62 110.2 7.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 74.549999999999997 109.726 174.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.9 p -79.93 139.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 44.439999999999998 111.264 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.633 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.1 t -142.47 151.71 42.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.096 -0.502 . . . . 51.219999999999999 109.892 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 42.42 60.07 2.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.258 0.623 . . . . 73.209999999999994 112.15 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.54 24.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.035 -1.079 . . . . 71.230000000000004 112.883 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -78.02 -32.51 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.109 -0.33 . . . . 73.549999999999997 110.109 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.46 -37.35 94.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.949 -0.644 . . . . 64.25 111.934 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.502 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 74.9 mmm -67.02 -51.1 59.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.511 -0.551 . . . . 53.420000000000002 109.511 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 62' ' ' ILE . 74.8 t -54.21 -32.92 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 64.099999999999994 110.586 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.8 t30 -71.29 -56.08 6.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 60.020000000000003 110.656 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.8 -13.8 61.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.463 -0.335 . . . . 70.349999999999994 111.307 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 145' ' ' VAL . 44.6 t -88.82 -36.62 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 63.25 110.505 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.581 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -83.52 -18.98 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 72.120000000000005 113.2 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 60.5 mtp -89.87 -8.76 51.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.2 0.444 . . . . 73.25 112.2 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.1 m . . . . . 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.468 . . . . 52.240000000000002 110.737 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 120.534 0.207 . . . . 61.299999999999997 110.644 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.95 159.37 19.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.265 0.555 . . . . 64.519999999999996 111.443 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.3 mp -87.74 102.4 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.644 -1.162 . . . . 50.439999999999998 108.494 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 19' ' ' SER . 30.7 mm -68.21 -56.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.537 -0.756 . . . . 74.409999999999997 110.009 -176.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 14.5 mptt -127.4 136.97 52.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 72.299999999999997 109.998 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.81 115.96 15.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.939 0.399 . . . . 70.230000000000004 110.385 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.62 116.3 26.59 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.64 . . . . 72.0 110.918 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 14' ' ' VAL . 56.8 Cg_endo -73.02 126.91 11.62 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.172 1.915 . . . . 73.409999999999997 111.413 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.7 m . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 64.439999999999998 111.339 -176.346 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.324 0.583 . . . . 74.319999999999993 111.454 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.24 145.53 4.36 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.118 -0.947 . . . . 62.340000000000003 111.188 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.49 -161.77 15.64 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.549 -0.834 . . . . 72.510000000000005 112.065 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.721 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.92 -177.12 6.58 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 110.326 -0.25 . . . . 40.399999999999999 110.326 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.86 91.96 28.27 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 109.648 -0.501 . . . . 64.230000000000004 109.648 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.6 Cg_exo -78.67 -12.18 15.18 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.899 2.4 . . . . 73.200000000000003 112.148 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.88 -36.51 70.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.95 -0.568 . . . . 71.349999999999994 109.997 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.2 pt -88.07 156.15 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.98 -0.748 . . . . 73.030000000000001 108.98 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -105.32 89.06 3.01 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.374 -0.53 . . . . 73.340000000000003 110.291 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 194' ' ' ALA . 9.7 p -163.92 170.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.83 -0.804 . . . . 71.310000000000002 108.83 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -94.9 115.72 27.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.865 0.364 . . . . 71.420000000000002 111.05 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.655 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -144.18 153.27 41.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.449 -0.945 . . . . 75.219999999999999 108.449 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.98 139.03 34.5 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.79 0.329 . . . . 75.349999999999994 111.034 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.8 Cg_endo -63.26 -54.13 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.713 2.275 . . . . 74.209999999999994 112.06 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.48 35.31 0.96 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.455 -0.339 . . . . 62.329999999999998 111.457 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.546 ' OD2' ' HD3' ' A' ' 202' ' ' ARG . 7.4 t70 75.77 -14.05 0.82 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.074 0.55 . . . . 64.400000000000006 111.66 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.5 ptm -46.1 -29.93 1.71 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.877 1.066 . . . . 72.200000000000003 113.877 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -111.09 10.72 29.23 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 72.340000000000003 113.254 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.546 ' HD3' ' OD2' ' A' ' 199' ' ' ASP . 44.0 mtp180 -72.43 -38.42 68.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 117.62 0.71 . . . . 70.239999999999995 111.91 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 203' ' ' LYS . 3.7 mppt? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.747 -0.645 . . . . 75.439999999999998 110.633 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 4.2 Cg_endo . . . . . 0 N--CA 1.457 -0.647 0 N-CA-C 113.068 0.372 . . . . 53.210000000000001 113.068 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 6.2 Cg_exo -75.15 -44.85 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.811 2.341 . . . . 62.439999999999998 112.263 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.543 HD21 HG12 ' A' ' 24' ' ' VAL . 11.6 t-20 -124.88 144.39 50.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 72.329999999999998 110.458 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.79 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.4 m -133.23 162.91 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 64.109999999999999 110.394 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -122.33 134.86 54.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.064 0.459 . . . . 74.310000000000002 110.376 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.4 mt -111.87 107.98 17.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 71.109999999999999 109.391 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -92.24 119.46 31.87 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.428 -0.582 . . . . 63.210000000000001 109.428 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.402 HG22 HG13 ' A' ' 159' ' ' ILE . 69.1 p -109.07 178.3 4.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.141 0.496 . . . . 71.25 110.986 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 t -67.27 -15.89 63.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 110.442 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.587 ' HG3' HG22 ' A' ' 142' ' ' VAL . 5.7 mmt -95.55 -34.62 11.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.007 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.18 -130.79 1.87 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.086 -0.806 . . . . 63.240000000000002 111.086 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.236 0.541 . . . . 64.230000000000004 110.486 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.96 114.13 37.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.429 -0.805 . . . . 65.230000000000004 109.767 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 41.3 t -96.4 141.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.839 -0.619 . . . . 75.230000000000004 109.374 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.1 163.79 36.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.137 0.494 . . . . 65.200000000000003 111.015 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HB3' HD22 ' A' ' 13' ' ' ASN . 11.2 pt-20 -134.17 162.92 30.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.505 -0.77 . . . . 71.239999999999995 109.892 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 166.04 10.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.764 -0.653 . . . . 72.099999999999994 109.394 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 5.3 m-85 -85.75 93.5 8.88 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 74.010000000000005 111.702 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.845 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -79.47 -8.75 59.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.743 0.782 . . . . 70.209999999999994 109.343 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HE2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -70.34 -45.01 67.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.384 -1.28 . . . . 73.230000000000004 111.658 -173.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -137.86 8.61 2.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.807 0.299 . . . . 71.310000000000002 111.807 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.22 67.27 10.69 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.835 0.679 . . . . 60.399999999999999 112.835 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.49 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 21.3 Cg_exo -65.54 -27.4 53.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.025 1.817 . . . . 43.310000000000002 110.996 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -62.87 -59.48 4.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 64.310000000000002 110.892 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -62.67 -36.34 82.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.597 . . . . 75.319999999999993 110.208 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.845 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 39.5 t -53.73 -53.47 51.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.238 -0.892 . . . . 70.209999999999994 111.278 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 3.0 mtmp? -69.88 -27.28 64.68 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.789 -0.364 . . . . 74.420000000000002 111.666 -173.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' O ' HD23 ' A' ' 42' ' ' LEU . 59.8 t30 -59.48 -49.83 76.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.489 -0.56 . . . . 64.299999999999997 109.489 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.79 ' HE1' HG21 ' A' ' 14' ' ' VAL . 12.3 t80 -68.81 -51.33 41.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.852 176.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.54 -44.86 77.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 63.439999999999998 112.985 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 43.4 mt-10 -77.77 -26.59 49.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 121.126 -0.229 . . . . 72.109999999999999 111.572 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 38' ' ' ASN . 3.2 mm? -78.99 -20.88 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.788 -0.765 . . . . 72.030000000000001 110.428 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.38 -44.31 36.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 110.951 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.711 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -62.98 -36.76 84.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.629 -0.26 . . . . 71.349999999999994 111.314 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -72.77 -46.93 50.76 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.203 -0.599 . . . . 74.310000000000002 109.423 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.33 42.83 1.03 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.522 -0.847 . . . . 72.209999999999994 113.46 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HD1' ' HG3' ' A' ' 67' ' ' PRO . 1.2 m-85 -77.45 -15.95 59.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 73.319999999999993 110.405 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.82 0.27 51.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.761 -0.654 . . . . 62.439999999999998 111.001 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 48.7 m-80 -81.81 2.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 109.868 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -134.71 14.05 4.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.002 -0.618 . . . . 64.329999999999998 112.176 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.6 p -88.83 149.22 23.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.661 0.267 . . . . 54.210000000000001 110.46 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -138.65 128.42 25.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.553 -0.294 . . . . 71.239999999999995 110.556 -176.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 61.0 m-85 -67.07 110.74 3.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.97 -0.752 . . . . 75.400000000000006 108.97 175.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -111.86 -18.48 12.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.835 -0.346 . . . . 74.319999999999993 111.133 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.5 mmt85 -110.34 105.27 14.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.523 -0.547 . . . . 74.120000000000005 109.523 173.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.16 91.2 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.907 -0.775 . . . . 71.319999999999993 108.907 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.1 mt -102.8 119.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.739 -0.664 . . . . 73.439999999999998 109.262 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -52.02 139.25 23.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.446 0.466 . . . . 55.509999999999998 110.219 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 44.21 33.79 0.89 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.384 1.052 . . . . 75.340000000000003 112.6 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -131.54 -82.92 0.51 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.385 0.612 . . . . 71.0 110.213 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.539 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptm -159.76 156.59 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.804 . . . . 62.43 110.812 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 116' ' ' LEU . 43.1 mt -129.37 103.26 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.519 -0.764 . . . . 73.400000000000006 108.943 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 42.7 tt0 -87.93 124.61 33.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.764 -0.653 . . . . 74.219999999999999 111.835 -173.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.79 113.57 4.03 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.061 -0.815 . . . . 44.439999999999998 111.061 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.8 157.61 43.83 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.706 -0.283 . . . . 74.109999999999999 112.667 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.66 156.56 90.61 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 123.804 0.355 . . . . 72.209999999999994 111.492 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HG3' ' HD1' ' A' ' 47' ' ' TYR . 23.7 Cg_endo -58.71 -21.86 58.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.723 2.949 . . . . 70.120000000000005 113.521 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -86.66 -30.43 21.73 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.644 -0.502 . . . . 73.209999999999994 109.644 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.94 71.08 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.725 -0.75 . . . . 75.010000000000005 111.642 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.3 p -88.56 -32.14 18.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.56 0.695 . . . . 71.120000000000005 109.401 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.1 46.65 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.881 -1.054 . . . . 52.509999999999998 111.674 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -119.83 -2.97 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.761 0.282 . . . . 63.130000000000003 111.761 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.75 -155.3 11.68 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.607 -0.806 . . . . 74.099999999999994 112.557 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.4 167.65 42.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.337 -0.935 . . . . 74.439999999999998 111.639 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 55.2 -96.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.785 0.434 . . . . 71.150000000000006 110.925 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m 69.07 -31.79 0.21 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.86 0.864 . . . . 75.430000000000007 113.126 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.426 ' H ' ' C ' ' A' ' 75' ' ' ALA . 5.9 tt -55.84 -42.76 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.575 0.583 . . . . 64.120000000000005 112.575 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.571 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 13.8 p90 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.421 0.629 . . . . 75.140000000000001 110.774 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 112.3 -104.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 112.336 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 39.5 mtmt -125.68 -162.05 1.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.317 -0.623 . . . . 74.420000000000002 109.317 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -66.57 157.13 33.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.901 -0.778 . . . . 74.409999999999997 108.901 174.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -117.57 -54.24 2.37 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.646 -0.421 . . . . 73.310000000000002 111.417 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -166.61 -175.87 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.437 -0.579 . . . . 74.099999999999994 109.437 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -83.93 132.31 34.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 71.140000000000001 110.037 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB2' HG21 ' A' ' 127' ' ' THR . 35.2 mm-40 -96.93 8.76 43.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.787 -0.642 . . . . 63.009999999999998 109.671 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.21 105.63 0.52 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.84 -0.618 . . . . 72.319999999999993 111.893 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -163.2 80.97 1.58 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 71.109999999999999 109.571 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.05 88.32 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.012 1.808 . . . . 63.509999999999998 111.578 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.7 -18.69 37.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.112 0.958 . . . . 74.430000000000007 109.377 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.7 pp -101.18 -178.84 3.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.52 -1.218 . . . . 63.32 108.75 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -138.35 147.78 43.86 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.121 -0.632 . . . . 73.409999999999997 110.416 171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 120' ' ' GLN . 1.2 p90 -62.8 109.38 1.42 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.801 0.81 . . . . 71.010000000000005 110.726 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -99.26 -44.99 6.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.228 -0.896 . . . . 52.43 110.428 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.66 -139.25 2.77 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.725 -0.75 . . . . 72.340000000000003 112.389 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.12 145.6 26.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.63 0.253 . . . . 63.200000000000003 110.687 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.66 22.26 7.45 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.648 -0.787 . . . . 71.340000000000003 111.618 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HG3' ' A' ' 189' ' ' PRO . 9.9 mm -84.76 109.68 18.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.214 -0.662 . . . . 74.299999999999997 109.214 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -84.87 115.18 22.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.006 -0.543 . . . . 73.109999999999999 109.569 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.79 176.84 7.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 70.310000000000002 110.855 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 26.7 ttt -104.19 142.07 35.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 72.409999999999997 111.145 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -97.97 141.89 30.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.471 . . . . 71.010000000000005 110.174 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -157.78 160.6 37.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.738 -0.665 . . . . 74.400000000000006 110.132 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.73 -9.02 25.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.613 0.721 . . . . 54.329999999999998 110.333 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.99 169.38 40.23 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.107 -1.597 . . . . 70.230000000000004 109.107 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.18 -42.49 46.59 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.098 2.532 . . . . 72.010000000000005 112.794 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -103.03 -5.45 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 64.409999999999997 111.806 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -84.94 48.4 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.432 0.634 . . . . 63.140000000000001 110.061 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -89.73 121.54 31.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.892 . . . . 73.109999999999999 109.712 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.01 -94.79 2.21 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.659 -0.781 . . . . 43.329999999999998 112.452 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 18.0 t -140.87 6.92 2.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.377 0.608 . . . . 74.409999999999997 109.999 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.412 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 19.4 mp0 -81.02 143.91 32.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.696 -0.684 . . . . 74.099999999999994 110.363 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 m-85 -144.24 162.32 36.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.369 -0.234 . . . . 74.239999999999995 110.369 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 41.9 p90 -154.02 157.21 38.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 70.099999999999994 111.148 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.693 HG22 HD23 ' A' ' 98' ' ' LEU . 18.2 t -112.11 145.88 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.928 -0.578 . . . . 71.310000000000002 109.444 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -99.52 130.38 45.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.952 0.406 . . . . 64.019999999999996 110.141 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 62' ' ' ILE . 59.5 mt -84.46 -7.1 59.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 51.229999999999997 110.775 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.39 163.35 24.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 34.32 109.929 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.25 113.12 2.75 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.602 2.201 . . . . 73.409999999999997 112.203 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.1 p -103.08 110.66 22.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 72.519999999999996 110.393 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 1.1 pp0? -99.59 15.82 25.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.332 0.587 . . . . 75.430000000000007 110.82 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.591 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.4 p90 -121.32 -2.65 9.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.467 -0.788 . . . . 74.129999999999995 110.89 -175.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.8 mt -102.97 7.93 39.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 43.539999999999999 110.475 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.89 -15.38 62.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.045 -0.98 . . . . 52.200000000000003 111.74 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.39 19.69 3.8 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.805 -0.712 . . . . 22.210000000000001 111.695 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -121.04 -28.8 4.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.266 0.555 . . . . 52.350000000000001 109.958 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.499 ' HD2' HD22 ' A' ' 122' ' ' LEU . 93.5 m-70 -138.64 144.55 39.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.489 -0.778 . . . . 73.409999999999997 109.376 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.407 HG21 ' HB2' ' A' ' 85' ' ' GLU . 14.5 t -85.37 145.19 27.61 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.398 -0.593 . . . . 75.140000000000001 109.398 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' A' ' 99' ' ' ALA . 31.4 mt -126.06 116.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.349 -0.387 . . . . 71.239999999999995 110.751 -176.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -154.41 74.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.456 0.472 . . . . 74.109999999999999 110.863 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.739 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.35 157.35 29.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.24 -0.981 . . . . 52.100000000000001 112.882 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 30.5 mtp180 -137.89 118.88 14.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.979 -0.378 . . . . 74.450000000000003 109.979 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.5 p -81.76 138.36 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 54.119999999999997 110.411 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.3 t -143.23 142.85 31.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.034 -0.53 . . . . 52.439999999999998 110.132 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.6 tt0 54.23 35.99 23.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.345 0.593 . . . . 61.140000000000001 112.035 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.12 29.41 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.236 -0.983 . . . . 75.109999999999999 112.565 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -83.39 -30.33 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 73.340000000000003 110.121 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.03 -31.65 81.59 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.659 . . . . 60.009999999999998 111.586 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.1 mmm -72.18 -49.35 36.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.486 -0.561 . . . . 72.319999999999993 109.486 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.476 HG13 HD12 ' A' ' 62' ' ' ILE . 61.8 t -55.0 -31.82 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.196 0.522 . . . . 75.310000000000002 110.508 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.04 -52.41 24.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.867 -0.606 . . . . 54.049999999999997 110.638 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -15.23 61.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.397 -0.365 . . . . 74.430000000000007 111.394 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.7 t -86.58 -38.82 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.31 -0.405 . . . . 74.530000000000001 110.555 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.83 -12.68 68.31 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.641 -0.79 . . . . 73.239999999999995 112.831 -176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.2 ptm -82.0 -17.17 47.79 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.622 -0.34 . . . . 73.409999999999997 110.806 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 142' ' ' VAL . 19.2 m . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.675 -0.41 . . . . 74.010000000000005 110.798 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 C--O 1.221 -0.447 0 N-CA-C 107.99 -1.115 . . . . 70.120000000000005 107.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.41 155.91 28.82 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.363 -0.535 . . . . 72.209999999999994 111.427 -168.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.4 mp -85.13 109.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.801 -1.091 . . . . 64.450000000000003 109.391 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.4 mm -71.49 -49.98 43.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.478 -0.783 . . . . 62.229999999999997 110.497 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.93 130.34 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.824 -0.625 . . . . 74.340000000000003 110.758 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.31 112.71 11.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.84 0.352 . . . . 21.510000000000002 110.537 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -142.15 152.35 61.14 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.64 -0.709 . . . . 64.25 110.032 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 30.9 Cg_endo -67.24 131.7 25.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.374 2.049 . . . . 64.219999999999999 111.984 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.4 ' H ' ' HA ' ' A' ' 14' ' ' VAL . 32.4 t . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.692 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.7 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.329 0.585 . . . . 55.140000000000001 110.991 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 142.3 135.74 3.13 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.968 -1.014 . . . . 61.32 110.879 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.16 -176.7 51.42 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.265 -0.969 . . . . 70.299999999999997 111.775 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.809 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.44 145.52 47.55 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.691 -0.485 . . . . 64.230000000000004 109.691 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 98.3 m-85 -97.81 105.06 24.58 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-O 121.182 0.515 . . . . 61.350000000000001 110.368 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.71 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.6 Cg_endo -83.58 -7.44 10.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.215 2.61 . . . . 71.420000000000002 111.313 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.06 -35.05 20.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.105 -0.952 . . . . 71.329999999999998 110.789 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 193' ' ' VAL . 21.4 pt -74.63 -13.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 64.310000000000002 110.483 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 47.3 m170 61.59 54.96 2.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.835 -1.075 . . . . 54.43 111.236 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.561 HG12 HG13 ' A' ' 191' ' ' ILE . 9.9 p -150.16 141.15 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.512 . . . . 63.109999999999999 109.875 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.28 110.14 5.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 74.030000000000001 111.425 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.64 155.89 30.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.312 -0.625 . . . . 73.409999999999997 109.312 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.478 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 24.5 m-85 -118.44 154.11 52.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.651 -0.249 . . . . 71.120000000000005 111.266 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 44.4 Cg_endo -68.4 -75.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.413 2.075 . . . . 62.109999999999999 112.138 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 199' ' ' ASP . 1.4 pt? -127.66 32.07 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.726 -0.215 . . . . 74.299999999999997 110.982 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 198' ' ' LEU . 11.5 t70 77.01 -6.21 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.174 0.435 . . . . 44.130000000000003 112.174 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.8 ptm -49.5 -28.39 5.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.214 0.82 . . . . 50.140000000000001 113.214 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.04 2.82 35.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.186 -1.007 . . . . 60.520000000000003 113.331 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.478 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 44.5 mtp-105 -84.85 -63.34 1.35 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.759 0.79 . . . . 75.540000000000006 109.798 176.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 203' ' ' LYS . 18.1 mmmt . . . . . 0 C--O 1.246 0.891 0 CA-C-N 112.779 -2.01 . . . . 74.209999999999994 111.754 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 11.9 Cg_exo . . . . . 0 CA--C 1.53 0.304 0 N-CA-C 114.26 0.831 . . . . 74.349999999999994 114.26 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 86.3 Cg_endo -78.43 13.49 1.83 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.827 3.018 . . . . 71.349999999999994 113.608 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.471 HD22 ' HB3' ' A' ' 26' ' ' GLU . 20.4 t-20 -133.36 138.94 46.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.741 -0.663 . . . . 74.010000000000005 109.899 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.3 m -138.92 156.73 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.708 0.29 . . . . 72.200000000000003 110.681 -177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.679 ' HD1' ' HB2' ' A' ' 165' ' ' SER . 27.8 p90 -123.99 141.13 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.074 0.464 . . . . 73.140000000000001 111.041 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.51 110.08 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.674 -0.694 . . . . 75.120000000000005 109.407 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.858 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 32.0 tt0 -88.83 113.25 24.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.492 -0.929 . . . . 71.310000000000002 108.492 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -103.13 -179.95 4.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.963 -0.562 . . . . 53.310000000000002 110.939 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -75.3 -15.74 60.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 74.340000000000003 110.649 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 92.5 mmm -97.1 -38.81 9.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.626 . . . . 73.25 110.664 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.49 -139.87 3.22 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.231 -0.748 . . . . 51.329999999999998 111.231 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -136.7 130.62 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.507 -0.553 . . . . 72.099999999999994 109.507 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG12 ' CG2' ' A' ' 139' ' ' VAL . 4.2 mp -124.85 130.49 73.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 71.540000000000006 110.467 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 15' ' ' TYR . 59.1 t -113.85 145.05 20.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.904 -0.406 . . . . 74.430000000000007 109.904 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.77 36.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.345 0.593 . . . . 63.43 110.725 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB3' HD22 ' A' ' 13' ' ' ASN . 9.4 pt-20 -134.1 162.15 32.91 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.211 -0.904 . . . . 54.210000000000001 108.999 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -97.44 175.5 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.6 -0.519 . . . . 75.310000000000002 109.6 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.576 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 3.9 m-30 -79.21 100.41 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 72.439999999999998 110.878 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.728 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 15.3 m0 -79.82 -7.06 58.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.956 -0.565 . . . . 73.120000000000005 110.45 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.52 -65.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.848 -0.614 . . . . 74.510000000000005 111.247 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.95 -16.06 20.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 73.230000000000004 110.813 -171.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -130.71 72.3 81.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.745 0.646 . . . . 73.400000000000006 112.745 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 14.0 Cg_exo -69.45 -20.88 35.72 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.392 2.061 . . . . 64.219999999999999 110.826 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -82.01 -45.55 15.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.057 -0.974 . . . . 74.430000000000007 110.836 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 12.1 m -65.92 -39.24 90.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.051 -0.522 . . . . 74.540000000000006 111.586 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 4.7 p -64.31 -39.78 94.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 70.400000000000006 111.699 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 9.5 mtmp? -91.14 -8.8 47.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.295 -0.562 . . . . 55.43 110.8 -178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 48.9 t30 -72.44 -55.54 6.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.657 -0.701 . . . . 71.049999999999997 109.349 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.28 -40.88 98.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.284 -0.416 . . . . 71.5 110.888 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.29 -42.8 61.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 62.520000000000003 111.312 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 10.0 mm-40 -56.84 -50.88 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.274 -0.421 . . . . 72.209999999999994 111.422 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 47' ' ' TYR . 2.7 mm? -62.77 -28.15 69.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.501 -0.318 . . . . 75.209999999999994 111.466 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -51.84 25.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 65.510000000000005 110.942 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -72.47 -29.65 63.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.310000000000002 111.472 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -68.02 -52.42 35.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.997 0.427 . . . . 65.340000000000003 109.954 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 131.13 43.45 0.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.057 -1.068 . . . . 54.020000000000003 113.233 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.576 ' CG ' HD12 ' A' ' 42' ' ' LEU . 18.7 m-85 -92.24 -33.49 14.64 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.465 -0.432 . . . . 74.109999999999999 111.395 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -82.06 -16.4 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 75.310000000000002 110.874 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.437 HD22 ' HA2' ' A' ' 46' ' ' GLY . 38.3 m-80 -70.78 -0.96 10.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.478 . . . . 74.219999999999999 111.028 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.05 34.52 2.07 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.518 -0.633 . . . . 75.400000000000006 111.518 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.531 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -104.21 149.62 25.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.979 0.418 . . . . 72.209999999999994 111.014 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -128.2 148.67 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 51.509999999999998 109.394 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 87.3 m-85 -80.08 122.5 26.86 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.499 -0.556 . . . . 74.5 109.499 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -106.61 -39.61 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.871 0.323 . . . . 72.230000000000004 111.871 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 39.3 mmt180 -108.91 105.42 14.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.923 -0.311 . . . . 63.509999999999998 110.23 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.601 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -123.58 91.28 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.895 -0.779 . . . . 72.109999999999999 108.895 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.2 mt -96.28 130.48 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 109.237 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 43.8 mttt -54.97 108.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.928 0.767 . . . . 70.409999999999997 111.831 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 55.99 44.9 24.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.285 -0.87 . . . . 75.530000000000001 110.828 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 12.8 t80 -129.93 -75.99 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.269 -0.878 . . . . 63.439999999999998 109.12 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.516 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.75 154.63 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.215 -0.902 . . . . 61.149999999999999 109.884 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.601 HG23 HG13 ' A' ' 56' ' ' ILE . 46.8 mt -129.41 102.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.044 -0.525 . . . . 72.340000000000003 109.996 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 49.3 tt0 -86.02 122.51 30.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 74.409999999999997 110.526 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -125.17 142.7 14.02 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.886 -0.597 . . . . 72.349999999999994 112.011 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 149.66 -141.86 9.24 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.504 -0.855 . . . . 60.409999999999997 112.332 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.18 78.54 0.39 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.814 0.672 . . . . 74.200000000000003 112.814 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.78 -12.94 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 121.98 1.786 . . . . 62.200000000000003 110.442 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.8 p -103.23 -47.55 4.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.156 -0.929 . . . . 64.230000000000004 110.777 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.68 15.39 54.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.438 -0.665 . . . . 31.210000000000001 111.438 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -80.95 -41.54 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.29 0.567 . . . . 74.310000000000002 111.499 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -16.29 4.97 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.492 -0.776 . . . . 44.119999999999997 111.374 -174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -109.8 -30.33 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 65.219999999999999 110.903 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.6 -155.82 28.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.6 -0.809 . . . . 75.209999999999994 111.409 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.48 -105.48 0.24 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.624 -0.798 . . . . 60.030000000000001 112.282 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.98 36.4 21.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.609 0.719 . . . . 74.310000000000002 111.455 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -91.19 12.85 18.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.615 -0.72 . . . . 62.310000000000002 111.047 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.461 HG13 ' HD1' ' A' ' 78' ' ' TYR . 47.6 pt -74.23 -22.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.348 -0.387 . . . . 52.009999999999998 111.181 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 81' ' ' GLN . 6.8 p90 -110.81 3.38 18.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.498 0.666 . . . . 71.430000000000007 110.495 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 -115.55 4.83 Favored Glycine 0 C--O 1.237 0.295 0 CA-C-N 115.182 -0.917 . . . . 63.310000000000002 111.856 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -76.31 179.19 5.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.25 -1.018 . . . . 74.519999999999996 108.25 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.646 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -78.61 149.73 32.87 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.47 -0.937 . . . . 75.209999999999994 108.47 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -102.11 -85.66 0.43 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.329 0.862 . . . . 71.319999999999993 113.329 -156.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.65 157.65 43.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.841 0.353 . . . . 63.32 111.205 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.7 126.2 30.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.31 0.576 . . . . 74.430000000000007 110.2 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -105.99 18.7 21.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 109.496 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' A' ' 127' ' ' THR . 59.3 mt -62.01 104.63 0.48 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.952 -0.567 . . . . 70.219999999999999 110.891 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -169.88 80.45 0.63 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.413 -0.588 . . . . 73.319999999999993 109.413 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.21 100.39 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.464 2.109 . . . . 73.310000000000002 112.076 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.23 -3.59 52.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.228 1.013 . . . . 61.140000000000001 109.532 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -109.94 -171.39 1.83 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.315 -172.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -147.07 145.99 29.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.198 -1.038 . . . . 75.099999999999994 108.198 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 26.8 p90 -58.48 124.79 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.24 0.543 . . . . 75.010000000000005 110.066 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.4 p -121.98 -45.59 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.665 -0.698 . . . . 65.200000000000003 110.084 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -151.31 6.11 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.483 -0.78 . . . . 63.240000000000002 111.891 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.14 22.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.337 0.255 . . . . 71.230000000000004 110.704 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.69 22.7 7.21 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.476 -0.868 . . . . 74.219999999999999 111.835 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.4 mm -84.88 109.63 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.521 -0.548 . . . . 51.450000000000003 109.521 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -85.59 120.72 27.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.611 -0.514 . . . . 75.120000000000005 109.611 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.22 174.88 9.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.116 -0.493 . . . . 62.450000000000003 111.136 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.516 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 24.9 ttt -105.53 137.68 42.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 109.502 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.65 142.68 28.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.036 0.445 . . . . 54.210000000000001 110.171 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.81 161.34 42.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.528 -0.76 . . . . 73.230000000000004 110.348 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.31 -26.59 15.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.691 0.757 . . . . 74.230000000000004 109.559 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -150.03 178.16 27.68 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 109.2 -1.56 . . . . 74.319999999999993 109.2 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HA ' HD11 ' A' ' 86' ' ' LEU . 6.7 Cg_endo -48.45 -52.53 8.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.959 2.439 . . . . 63.329999999999998 112.479 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -101.42 -3.41 28.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 110.419 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.646 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -88.56 47.11 1.46 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.391 0.615 . . . . 63.219999999999999 109.608 -177.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' GLN . 5.4 p30 -94.75 130.08 41.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.056 -0.975 . . . . 74.219999999999999 109.989 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.79 -121.86 2.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.245 -0.978 . . . . 74.219999999999999 113.563 -173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 t -105.31 12.16 32.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 110.909 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 26.5 mt-30 -94.38 147.85 22.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 55.229999999999997 111.243 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.31 167.92 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.675 -0.861 . . . . 74.430000000000007 108.675 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 46.9 p90 -155.16 150.59 27.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 73.329999999999998 111.118 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 98' ' ' LEU . 14.2 t -112.97 140.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.012 -0.736 . . . . 70.439999999999998 109.012 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -94.44 127.08 40.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.094 0.473 . . . . 63.039999999999999 109.936 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 62.5 mt -83.51 -7.9 59.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.555 -0.748 . . . . 71.109999999999999 110.492 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -144.82 159.79 49.25 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 72.219999999999999 110.071 175.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 36.3 Cg_endo -66.14 112.06 2.19 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.51 2.14 . . . . 54.100000000000001 112.368 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.1 p -106.13 141.65 37.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.825 -0.625 . . . . 54.109999999999999 111.331 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.551 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -131.9 -0.25 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 73.420000000000002 110.646 175.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 2.52 55.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.47 -0.786 . . . . 75.409999999999997 112.489 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.15 6.65 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.23 0.826 . . . . 70.219999999999999 113.23 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.551 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 4.5 m-20 -64.65 -28.69 69.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.119 0.485 . . . . 74.540000000000006 111.042 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -102.57 13.11 56.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 63.130000000000003 111.448 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -116.61 -40.74 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 73.109999999999999 109.387 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -135.92 124.68 23.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.131 -0.941 . . . . 73.519999999999996 108.506 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.553 ' HB ' HD23 ' A' ' 86' ' ' LEU . 15.1 t -71.05 147.91 48.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.171 0.51 . . . . 72.430000000000007 110.768 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 99' ' ' ALA . 44.8 mt -121.58 123.32 69.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.853 -0.612 . . . . 74.409999999999997 110.523 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -159.31 75.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.32 0.581 . . . . 74.409999999999997 111.587 175.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.654 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.3 158.45 30.83 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.768 -0.729 . . . . 74.439999999999998 112.734 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.466 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -132.11 125.02 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.964 -0.754 . . . . 65.510000000000005 108.964 173.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.3 p -84.98 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.052 0.453 . . . . 74.310000000000002 110.291 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.514 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 34.5 t -141.2 147.69 38.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.43 -0.35 . . . . 74.239999999999995 111.016 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 42.62 35.27 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.379 1.072 . . . . 62.039999999999999 113.216 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.16 42.49 0.19 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.637 -0.792 . . . . 70.510000000000005 111.972 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -91.86 -33.83 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.796 0.332 . . . . 74.450000000000003 110.413 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -34.9 90.05 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.03 -0.605 . . . . 55.200000000000003 112.016 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.3 mmm -67.12 -51.25 56.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.797 -0.446 . . . . 74.510000000000005 109.797 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 62' ' ' ILE . 63.9 t -54.29 -30.68 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 74.120000000000005 110.954 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.78 -54.65 10.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 35.229999999999997 110.914 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.72 -16.38 60.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.187 -0.46 . . . . 52.130000000000003 111.418 -177.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 145' ' ' VAL . 64.5 t -86.21 -29.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 71.310000000000002 109.942 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.45 -7.56 79.08 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.691 -0.766 . . . . 71.310000000000002 112.607 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 16.6 ptp -96.58 -11.98 24.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.857 -0.337 . . . . 74.450000000000003 111.869 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 142' ' ' VAL . 23.9 m . . . . . 0 C--N 1.332 -0.193 0 C-N-CA 120.207 -0.597 . . . . 72.450000000000003 110.637 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.52 -0.548 . . . . 71.319999999999993 109.52 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -123.55 155.14 38.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.922 0.391 . . . . 73.099999999999994 110.634 -172.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.8 mp -91.52 101.59 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.208 -1.034 . . . . 74.510000000000005 108.208 168.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 161' ' ' LYS . 32.2 mm -65.35 -48.63 82.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 64.219999999999999 110.918 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.858 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -143.9 138.52 28.62 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.488 -0.778 . . . . 61.43 110.071 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -141.5 118.89 11.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.142 -0.481 . . . . 73.420000000000002 110.414 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 161' ' ' LYS . 84.9 m-85 -141.83 158.37 62.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 109.803 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 14' ' ' VAL . 28.7 Cg_endo -64.35 137.99 58.47 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.175 1.917 . . . . 74.109999999999999 111.119 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.679 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 25.4 t . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.163 0.506 . . . . 61.130000000000003 111.283 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 109.85 -0.426 . . . . 70.239999999999995 109.85 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.78 144.52 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.914 -0.585 . . . . 65.099999999999994 111.868 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.57 -168.64 45.06 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.542 -0.837 . . . . 44.310000000000002 111.828 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.834 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -84.27 152.09 24.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.238 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 191' ' ' ILE . 94.7 m-85 -98.67 112.29 62.26 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.406 -0.59 . . . . 75.450000000000003 109.406 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.601 ' HB3' HD12 ' A' ' 97' ' ' ILE . 54.2 Cg_endo -85.91 -5.44 8.78 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.511 2.141 . . . . 72.540000000000006 112.719 -177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.57 -19.83 32.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 110.801 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.8 pt -77.42 -16.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 62.130000000000003 111.266 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.38 31.09 10.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.85 -0.614 . . . . 72.209999999999994 111.69 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.32 149.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.968 -0.293 . . . . 54.030000000000001 110.971 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.48 124.07 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.214 0.531 . . . . 72.430000000000007 111.725 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.97 130.05 0.77 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.374 -0.83 . . . . 60.130000000000003 109.76 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 87.7 m-85 -115.86 146.71 37.54 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.452 -0.34 . . . . 72.030000000000001 110.426 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.0 Cg_endo -67.22 -62.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.383 2.055 . . . . 64.150000000000006 111.706 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 23.63 4.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 74.349999999999994 109.832 175.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 29.7 m-20 70.59 6.35 5.78 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.372 -0.831 . . . . 63.119999999999997 112.166 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 17.7 ptm -55.47 -32.14 62.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 74.310000000000002 112.292 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.69 4.6 85.04 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.534 -0.841 . . . . 73.099999999999994 113.503 -174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 11.1 ptm180 -116.51 -3.72 11.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.897 0.856 . . . . 71.340000000000003 110.089 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 203' ' ' LYS . 26.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-N 114.13 -1.396 . . . . 73.049999999999997 110.714 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 CA--C 1.529 0.251 0 CA-C-O 120.948 0.312 . . . . 75.340000000000003 112.149 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.724 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 91.3 Cg_endo -88.22 7.97 4.27 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.457 2.772 . . . . 72.319999999999993 113.18 -173.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.469 HD22 ' HB3' ' A' ' 26' ' ' GLU . 21.2 t-20 -127.09 145.5 50.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.084 -0.962 . . . . 73.219999999999999 108.433 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 164' ' ' PRO . 29.1 m -136.15 157.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.853 0.358 . . . . 54.530000000000001 111.071 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.825 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 50.0 p90 -121.74 130.52 53.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.218 0.533 . . . . 70.019999999999996 110.382 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 16' ' ' LEU . 1.7 mm? -109.44 102.68 11.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.559 -0.746 . . . . 72.209999999999994 109.567 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -82.4 111.18 18.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.499 -0.926 . . . . 60.299999999999997 108.499 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -103.07 -179.74 4.04 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.116 0.484 . . . . 43.409999999999997 111.376 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 t -67.86 -24.57 65.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 75.230000000000004 109.929 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.486 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.1 mmt -86.63 -44.85 11.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 72.540000000000006 110.636 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.46 -126.92 0.98 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.804 -0.712 . . . . 65.010000000000005 111.554 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.26 137.09 46.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.924 0.362 . . . . 74.349999999999994 110.098 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -124.93 115.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.02 -0.536 . . . . 64.349999999999994 109.7 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 46.7 t -102.77 137.33 31.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.521 -0.472 . . . . 74.430000000000007 109.744 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.19 163.34 37.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.112 0.482 . . . . 52.43 110.809 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 13' ' ' ASN . 10.6 pt-20 -128.59 166.27 19.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.537 -0.756 . . . . 62.350000000000001 109.402 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -102.33 165.62 11.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.423 -0.955 . . . . 72.519999999999996 108.423 176.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 3.3 m-85 -89.64 90.38 8.22 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.612 -0.835 . . . . 74.310000000000002 111.345 177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.8 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -74.75 -11.89 60.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.266 1.032 . . . . 71.239999999999995 108.281 175.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.7 -35.57 77.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.2 -1.818 . . . . 75.540000000000006 110.95 -177.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -124.77 -20.89 4.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.792 -0.64 . . . . 72.019999999999996 110.721 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.539 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.09 85.13 50.99 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.129 0.418 . . . . 54.119999999999997 112.129 -169.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.57 -41.75 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 111.491 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.85 -43.23 36.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.661 -0.7 . . . . 73.409999999999997 111.053 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.557 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -63.2 -39.83 95.76 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.662 -0.699 . . . . 75.030000000000001 110.282 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.8 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 15.0 t -60.41 -46.08 91.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.844 -0.616 . . . . 53.25 110.101 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -59.59 -34.84 73.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 75.340000000000003 110.815 -178.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 35' ' ' THR . 38.2 t-20 -50.56 -61.36 2.24 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.584 -0.524 . . . . 75.420000000000002 109.584 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 112' ' ' PHE . 23.4 m-85 -67.97 -41.34 82.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.05 -0.523 . . . . 74.209999999999994 111.67 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 44' ' ' ARG . . . -56.54 -45.77 81.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 73.5 111.787 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG2' ' HE2' ' A' ' 37' ' ' LYS . 19.4 mm-40 -67.46 -42.27 83.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.096 -0.242 . . . . 52.109999999999999 111.198 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.5 mm? -66.11 -26.44 67.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.997 -0.281 . . . . 75.409999999999997 110.554 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.21 73.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.726 0.298 . . . . 71.25 110.628 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 29.9 mtm180 -66.31 -43.47 86.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.532 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.56 -43.61 98.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 72.420000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.14 64.12 0.53 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.834 -0.698 . . . . 41.520000000000003 111.502 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' HB2' HD12 ' A' ' 42' ' ' LEU . 73.1 t80 -86.0 -50.77 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.104 0.478 . . . . 70.129999999999995 110.154 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 7.0 m-85 -76.42 -10.82 59.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.368 -0.833 . . . . 71.409999999999997 111.796 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.73 -19.29 63.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 61.32 111.318 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.01 40.03 1.61 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.713 . . . . 41.350000000000001 111.996 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.626 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.6 p -118.28 156.62 28.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 70.319999999999993 111.153 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -141.98 163.05 33.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.103 -0.499 . . . . 55.049999999999997 110.735 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.9 m-85 -86.86 133.64 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.101 -0.499 . . . . 74.049999999999997 109.663 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -120.21 -28.96 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.254 -0.578 . . . . 63.43 111.457 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.2 mmt180 -112.6 109.59 19.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.121 -0.326 . . . . 74.109999999999999 110.121 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 53' ' ' PHE . 14.8 mm -121.51 88.6 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.04 -0.726 . . . . 74.540000000000006 109.04 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 18.3 mt -103.31 119.59 52.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.231 -0.587 . . . . 62.25 110.099 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -54.33 138.02 40.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.707 0.629 . . . . 64.319999999999993 110.759 178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p30 44.24 33.19 0.79 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.383 1.052 . . . . 71.019999999999996 112.68 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.35 -83.74 0.54 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.158 -0.473 . . . . 74.439999999999998 110.11 179.218 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -161.47 158.11 26.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.593 . . . . 65.510000000000005 110.389 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' HD21 ' A' ' 116' ' ' LEU . 59.8 mt -128.81 103.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.594 -0.73 . . . . 72.430000000000007 109.656 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -86.51 121.52 29.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.11 -0.495 . . . . 74.409999999999997 110.252 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.18 140.81 11.86 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.658 -0.782 . . . . 52.530000000000001 112.603 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.626 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 138.86 -151.77 21.86 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.653 -0.784 . . . . 44.25 112.302 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t0 58.3 95.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 123.756 0.823 . . . . 71.200000000000003 111.98 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 49.1 Cg_endo -71.31 -18.32 30.18 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.718 2.278 . . . . 75.409999999999997 112.359 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 70' ' ' THR . 81.8 p -91.65 -32.86 15.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.469 . . . . 63.329999999999998 110.887 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.77 22.88 71.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.817 -0.629 . . . . 64.430000000000007 112.284 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.581 HG22 ' OG1' ' A' ' 68' ' ' THR . 14.2 t -107.51 -20.94 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.649 0.24 . . . . 70.010000000000005 111.649 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.44 -13.96 6.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.316 -0.945 . . . . 74.0 113.506 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -0.82 7.08 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.107 0.78 . . . . 72.319999999999993 113.107 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.415 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 66.11 -164.9 39.58 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.882 -0.675 . . . . 42.409999999999997 113.337 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.18 -81.0 0.8 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 73.5 111.598 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . 59.31 34.47 22.94 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.696 0.76 . . . . 63.43 111.153 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.4 m -66.25 -25.93 67.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 40.219999999999999 112.718 -170.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.587 HG23 ' CD1' ' A' ' 78' ' ' TYR . 3.6 tt -65.78 -40.13 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.928 0.344 . . . . 71.099999999999994 111.928 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 13.3 p90 -107.01 -17.25 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.791 0.329 . . . . 72.040000000000006 111.333 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.94 -62.99 4.51 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.047 -0.597 . . . . 64.040000000000006 113.811 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 91.7 mttt -118.47 177.66 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.669 -0.312 . . . . 63.039999999999999 111.666 -175.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 164.68 25.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.93 -0.577 . . . . 73.540000000000006 110.441 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -110.53 -68.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.373 -0.376 . . . . 71.329999999999998 111.127 -172.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -168.02 156.69 9.15 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.129 -0.693 . . . . 73.129999999999995 109.129 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 9.4 p-10 -89.93 131.59 35.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 53.399999999999999 109.764 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 25.8 tt0 -105.53 8.01 33.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 75.430000000000007 110.262 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 mt -46.87 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.353 -0.84 . . . . 55.299999999999997 112.543 -170.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -179.56 87.0 0.2 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.404 -0.817 . . . . 73.230000000000004 109.23 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 30.9 Cg_endo -63.49 96.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.444 2.096 . . . . 71.230000000000004 111.828 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -11.38 59.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 64.430000000000007 109.46 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -105.02 170.56 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.598 -1.26 . . . . 73.010000000000005 107.598 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -126.0 150.83 47.77 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.926 -0.71 . . . . 75.25 110.79 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 35.7 p90 -65.5 121.83 15.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.169 -0.678 . . . . 74.439999999999998 109.169 173.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.5 p -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.963 -0.562 . . . . 71.549999999999997 110.61 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.26 -145.2 4.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.484 -0.78 . . . . 75.129999999999995 111.633 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.12 146.2 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.806 0.336 . . . . 74.120000000000005 111.048 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.67 26.18 5.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.754 -0.736 . . . . 74.540000000000006 111.98 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 189' ' ' PRO . 8.8 mm -90.07 111.51 23.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.583 -0.525 . . . . 75.329999999999998 109.583 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.91 117.73 24.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.866 -0.606 . . . . 74.420000000000002 109.673 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.78 176.92 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.404 . . . . 23.34 111.774 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.983 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 17.4 tpt -93.77 138.96 31.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 74.519999999999996 111.885 -173.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.21 132.89 43.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.198 -0.455 . . . . 65.329999999999998 110.315 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.4 162.07 36.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 110.596 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -82.54 -26.32 32.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.117 -0.492 . . . . 45.119999999999997 110.846 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 169.24 -134.38 3.18 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 121.0 -0.619 . . . . 74.439999999999998 112.16 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 25.8 Cg_endo -59.64 92.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.192 2.594 . . . . 71.310000000000002 111.713 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 2.2 p30 62.29 10.08 3.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.975 1.31 . . . . 72.019999999999996 112.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.4 m -82.17 57.85 3.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.475 0.655 . . . . 74.420000000000002 109.307 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.99 143.12 26.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.593 -0.731 . . . . 70.430000000000007 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.26 -98.96 2.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.746 -0.74 . . . . 72.129999999999995 111.966 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 42' ' ' LEU . 9.2 t -147.68 10.55 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.421 . . . . 55.119999999999997 110.536 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.54 159.04 17.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.688 0.28 . . . . 70.5 111.166 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 41.4 p90 -140.25 175.43 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 110.682 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -154.69 151.47 28.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 71.010000000000005 110.521 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 HD23 ' A' ' 98' ' ' LEU . 16.5 t -109.23 143.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.31 -0.626 . . . . 72.310000000000002 109.31 177.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -96.98 129.5 44.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.035 0.445 . . . . 73.519999999999996 110.402 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 62' ' ' ILE . 71.0 mt -85.5 -7.27 58.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.886 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.94 160.21 47.41 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.643 -0.708 . . . . 52.140000000000001 109.972 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 29.6 Cg_endo -64.06 111.79 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.492 2.128 . . . . 53.439999999999998 111.555 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.1 p -100.68 122.07 42.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 55.420000000000002 111.93 -172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.515 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 1.1 pm0 -120.89 24.38 10.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.655 0.741 . . . . 75.200000000000003 109.815 174.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -115.45 -3.11 12.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.282 -0.872 . . . . 72.450000000000003 111.457 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.39 12.05 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 63.409999999999997 111.058 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.466 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 8.7 p-10 -63.14 -28.57 70.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 74.010000000000005 111.049 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.97 17.84 19.58 Favored Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.652 -0.785 . . . . 54.43 111.205 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -116.45 -34.6 4.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.254 0.549 . . . . 75.129999999999995 109.889 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.78 123.39 24.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.434 -0.95 . . . . 64.430000000000007 108.434 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 t -70.87 144.13 50.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.33 -0.548 . . . . 71.129999999999995 109.833 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.2 mt -113.49 124.38 70.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.832 -0.622 . . . . 73.219999999999999 111.28 -173.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.983 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 5.7 p90 -156.37 72.68 0.76 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.849 0.833 . . . . 74.120000000000005 110.468 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.59 157.47 29.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.616 -1.278 . . . . 41.409999999999997 113.53 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.614 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 38.5 mtp180 -139.63 121.88 15.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 70.219999999999999 110.002 173.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -86.37 137.11 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 75.0 110.306 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 48.5 t -149.56 147.82 28.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 109.954 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER 48.04 67.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 74.239999999999995 110.05 -175.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 158.89 19.68 0.03 OUTLIER Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.269 -0.878 . . . . 70.219999999999999 113.267 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 184' ' ' ASP . 11.1 tp -80.73 -32.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.319 -0.623 . . . . 61.240000000000002 109.319 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.11 93.62 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.043 -0.823 . . . . 72.510000000000005 111.043 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.2 mmm -70.56 -48.94 52.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.768 -0.456 . . . . 50.030000000000001 109.768 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.4 t -56.28 -29.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.925 0.393 . . . . 73.099999999999994 110.8 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -70.59 -56.53 6.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.422 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.49 ' HE ' ' HB2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.87 -15.42 62.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.379 . . . . 75.450000000000003 111.085 -177.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 138' ' ' MET . 75.3 t -84.41 -39.6 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 53.109999999999999 110.154 174.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.15 -27.15 58.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.535 -0.84 . . . . 52.130000000000003 112.843 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.2 mmm -75.11 -13.27 60.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.859 0.318 . . . . 53.020000000000003 111.859 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 121.233 0.539 . . . . 64.010000000000005 110.834 178.82 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.79 0.805 . . . . 64.129999999999995 111.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -154.16 173.03 16.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.998 -1.001 . . . . 62.539999999999999 109.42 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -89.74 114.43 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.27 -0.641 . . . . 72.219999999999999 109.27 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.8 mm -79.89 -58.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.686 -0.688 . . . . 51.109999999999999 110.53 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -125.07 137.01 54.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.108 -0.496 . . . . 72.25 109.786 176.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -141.39 122.71 14.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.63 -0.259 . . . . 62.119999999999997 110.857 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -145.04 154.12 54.21 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.99 -0.55 . . . . 71.230000000000004 109.867 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 14' ' ' VAL . 9.2 Cg_endo -57.13 138.96 88.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.181 1.921 . . . . 73.519999999999996 111.68 171.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.825 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 38.3 t . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 115.81 -0.632 . . . . 61.229999999999997 111.148 -172.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 136' ' ' ILE . 12.6 t0 . . . . . 0 CA--C 1.512 -0.505 0 N-CA-C 108.972 -0.751 . . . . 61.539999999999999 108.972 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 148.33 159.47 8.49 Favored Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.541 -0.838 . . . . 53.530000000000001 112.782 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.6 -166.63 39.11 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.887 -0.673 . . . . 64.200000000000003 112.321 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.7 173.31 12.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.804 0.335 . . . . 64.510000000000005 110.4 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.58 100.81 40.31 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.616 -0.265 . . . . 63.030000000000001 110.58 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.747 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.3 Cg_endo -80.34 -5.05 13.38 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.518 2.145 . . . . 74.430000000000007 111.734 176.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -77.15 -39.24 49.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.217 -0.902 . . . . 63.229999999999997 109.56 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.14 152.68 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.385 -0.969 . . . . 73.030000000000001 108.385 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -104.75 81.45 1.77 Allowed 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.223 -0.591 . . . . 73.310000000000002 110.808 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -156.93 146.87 11.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.998 -1.001 . . . . 75.450000000000003 109.111 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 110.847 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.479 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -153.52 150.24 28.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.878 -0.786 . . . . 64.200000000000003 108.878 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 199' ' ' ASP . 40.6 m-85 -122.7 142.27 37.22 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.688 -0.233 . . . . 64.230000000000004 110.479 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.764 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.9 -63.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.4 2.067 . . . . 73.409999999999997 111.488 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.1 pt? -122.44 16.71 10.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 55.149999999999999 109.844 174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 13.4 m-20 70.24 8.0 6.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.198 -0.91 . . . . 74.549999999999997 113.367 171.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -61.91 -21.42 64.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.766 0.284 . . . . 71.310000000000002 111.766 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.89 -5.39 83.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.831 -0.7 . . . . 54.219999999999999 112.958 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -82.68 -20.72 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.392 0.615 . . . . 70.049999999999997 110.462 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm . . . . . 0 C--O 1.245 0.849 0 CA-C-N 114.733 -1.121 . . . . 73.549999999999997 111.368 -175.237 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 9.6 Cg_endo . . . . . 0 N--CA 1.45 -1.074 0 N-CA-C 111.112 -0.38 . . . . 71.230000000000004 111.112 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.496 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 40.4 Cg_endo -67.73 -19.78 46.99 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.368 2.045 . . . . 73.310000000000002 112.45 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.687 HD21 HG12 ' A' ' 24' ' ' VAL . 22.5 t-20 -139.42 145.96 39.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.605 -0.725 . . . . 74.019999999999996 110.149 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.6 m -133.85 145.16 33.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.399 0.618 . . . . 53.539999999999999 111.156 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.537 ' HE1' ' HB3' ' A' ' 165' ' ' SER . 84.3 m-85 -99.75 123.51 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.3 -0.864 . . . . 72.340000000000003 111.145 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.36 103.69 11.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 64.540000000000006 109.911 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.16 117.15 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.245 -0.65 . . . . 74.340000000000003 109.245 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 179.96 4.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.124 0.488 . . . . 74.150000000000006 111.739 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -64.33 -26.46 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.339 -0.846 . . . . 70.049999999999997 110.673 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 142' ' ' VAL . 7.1 mmt -91.54 -37.19 13.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.885 -0.598 . . . . 65.430000000000007 111.429 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.68 -128.9 1.26 Allowed Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.64 -0.791 . . . . 73.439999999999998 111.395 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.46 136.36 43.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.073 0.463 . . . . 75.439999999999998 110.039 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.4 120.79 57.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.603 -0.726 . . . . 73.129999999999995 109.14 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.687 HG12 HD21 ' A' ' 13' ' ' ASN . 6.9 t -101.4 141.59 17.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.688 -0.687 . . . . 74.219999999999999 109.179 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -147.76 161.59 40.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.272 -0.571 . . . . 64.409999999999997 111.16 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -132.27 163.76 27.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.144 -0.935 . . . . 72.349999999999994 110.429 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.71 168.09 10.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 73.25 109.901 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 m-85 -89.99 97.77 11.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 110.991 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.496 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 76.5 m95 -88.82 14.74 9.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.966 0.889 . . . . 72.340000000000003 109.003 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.52 -54.1 4.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.109 -1.405 . . . . 72.510000000000005 110.545 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.64 9.36 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 74.439999999999998 111.914 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.09 71.41 73.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.287 . . . . 62.229999999999997 110.887 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.15 -42.1 11.49 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.748 2.298 . . . . 70.409999999999997 112.987 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.45 -46.89 52.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 72.329999999999998 110.321 -177.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -41.23 86.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.21 -0.905 . . . . 75.420000000000002 110.93 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 129' ' ' PHE . 89.1 m -52.18 -51.0 60.74 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 111.425 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 4.5 mtmp? -73.14 -23.86 60.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.532 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -56.46 -47.86 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 74.439999999999998 109.411 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HZ ' ' HB3' ' A' ' 112' ' ' PHE . 3.8 m-85 -77.76 -42.31 34.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.478 -0.783 . . . . 55.329999999999998 111.069 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -55.89 -48.8 74.97 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.113 0.412 . . . . 74.400000000000006 112.113 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.669 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -59.72 -43.83 94.01 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.11 0.481 . . . . 62.039999999999999 110.769 178.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 75' ' ' ALA . 28.1 mt -67.36 -30.45 70.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.907 -0.588 . . . . 74.310000000000002 111.319 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.53 76.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.691 -0.686 . . . . 71.519999999999996 111.41 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 41' ' ' GLU . 17.7 ptt180 -81.16 -7.26 59.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.538 -0.465 . . . . 72.129999999999995 111.384 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -89.43 -49.38 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.792 -0.448 . . . . 53.020000000000003 109.792 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 41.03 0.54 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 115.819 -0.628 . . . . 51.109999999999999 112.005 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' HD22 ' A' ' 42' ' ' LEU . 50.5 t80 -71.4 -37.34 71.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.672 0.389 . . . . 65.540000000000006 111.672 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 45.2 m-85 -75.97 -16.41 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.46 . . . . 72.430000000000007 112.016 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -68.74 -7.7 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 74.140000000000001 111.585 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -127.36 16.09 6.34 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.578 -0.82 . . . . 54.119999999999997 112.472 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -101.53 150.06 23.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.322 . . . . 73.010000000000005 111.433 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 2.1 mptt -130.96 153.37 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.107 -177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 75.1 m-85 -90.04 108.41 19.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.475 -0.935 . . . . 74.239999999999995 108.475 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -110.63 -8.88 14.56 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.341 -0.544 . . . . 70.420000000000002 111.262 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.6 mmt180 -121.11 106.06 11.19 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.914 0.388 . . . . 73.299999999999997 110.278 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -122.17 89.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.86 -0.793 . . . . 61.310000000000002 108.86 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 39.1 mt -91.2 120.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.557 -0.905 . . . . 54.409999999999997 108.557 176.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 4.2 ptmm? -58.6 118.38 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.724 0.64 . . . . 60.409999999999997 111.438 -175.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' CG ' ' HZ3' ' A' ' 203' ' ' LYS . 41.9 m-20 61.72 40.49 13.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.868 -1.06 . . . . 61.25 111.182 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -136.69 -78.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 70.040000000000006 110.271 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.653 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 25.4 ptm -160.32 155.87 25.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.6 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.545 HD11 HD21 ' A' ' 116' ' ' LEU . 46.8 mt -128.17 102.92 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 73.430000000000007 109.454 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -81.07 127.2 32.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.01 -0.541 . . . . 64.510000000000005 110.486 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.84 139.72 11.18 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.811 -0.709 . . . . 40.219999999999999 112.145 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.27 -149.14 20.45 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.061 -1.066 . . . . 64.510000000000005 113.26 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 1.4 t70 48.14 86.42 0.15 Allowed Pre-proline 0 N--CA 1.461 0.117 0 C-N-CA 124.689 1.196 . . . . 65.230000000000004 112.617 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 82.3 Cg_endo -75.71 -18.13 17.49 Favored 'Trans proline' 0 CA--C 1.521 -0.165 0 C-N-CA 122.889 2.392 . . . . 71.439999999999998 110.679 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.6 p -84.3 -42.36 15.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.129 -1.396 . . . . 71.030000000000001 112.072 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 86.0 29.66 25.2 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 73.030000000000001 111.396 -174.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' OG1' ' A' ' 68' ' ' THR . 5.2 t -112.39 -33.68 6.11 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.974 0.361 . . . . 45.32 111.974 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.85 -0.66 11.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.127 -1.035 . . . . 50.420000000000002 113.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.26 -24.06 3.75 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.607 -0.349 . . . . 63.009999999999998 111.351 178.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 97.47 -171.09 26.2 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.563 -0.827 . . . . 45.539999999999999 112.818 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.58 -98.06 1.98 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.281 -0.485 . . . . 64.239999999999995 112.185 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . 59.31 33.77 22.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.698 0.761 . . . . 74.230000000000004 111.096 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -76.44 15.12 0.65 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.63 -1.168 . . . . 74.310000000000002 110.922 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 41' ' ' GLU . 6.8 tt -94.27 -38.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.871 -0.604 . . . . 63.43 111.091 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.66 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 34.7 p90 -106.11 -18.45 14.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.026 -0.67 . . . . 63.43 111.6 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.4 -103.62 2.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.316 -0.945 . . . . 74.140000000000001 113.449 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -125.61 174.94 7.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.984 0.421 . . . . 74.129999999999995 111.72 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -87.0 -96.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.375 -0.829 . . . . 75.150000000000006 111.535 -171.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 13.2 m-30 78.17 14.88 1.45 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.086 0.555 . . . . 73.129999999999995 112.325 172.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.47 126.5 5.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.57 -0.741 . . . . 71.140000000000001 110.224 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.618 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 5.4 p-10 -82.68 122.09 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.953 -0.758 . . . . 75.329999999999998 108.953 170.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -99.67 19.05 16.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.998 -0.742 . . . . 71.510000000000005 108.998 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 84' ' ' ASP . 28.1 mt -58.8 99.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.385 -1.28 . . . . 60.32 110.094 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -154.62 74.81 5.79 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 109.986 -0.376 . . . . 74.25 109.986 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.36 92.59 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.78 2.32 . . . . 65.25 112.238 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.0 -33.26 67.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 74.319999999999993 108.695 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -93.99 178.08 5.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.513 -1.221 . . . . 70.140000000000001 109.124 174.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -144.38 160.73 40.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.07 -0.344 . . . . 74.349999999999994 110.07 178.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.59 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 26.2 p90 -56.65 119.68 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.874 0.845 . . . . 53.020000000000003 111.053 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 33.8 p -116.62 -43.66 2.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.728 -0.669 . . . . 74.409999999999997 110.537 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.9 -155.18 7.82 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.363 -0.835 . . . . 74.329999999999998 111.339 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.37 141.15 31.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.776 0.322 . . . . 61.549999999999997 110.791 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.77 23.73 4.56 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.816 -0.706 . . . . 54.409999999999997 111.949 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -90.18 116.69 32.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 74.239999999999995 109.701 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.876 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -91.97 123.31 35.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.626 -0.715 . . . . 75.329999999999998 110.099 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.44 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -140.8 169.02 18.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 75.040000000000006 111.144 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.513 ' CG ' ' HE1' ' A' ' 129' ' ' PHE . 26.3 mtm -92.32 156.32 17.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.038 0.447 . . . . 73.120000000000005 110.495 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 166.86 10.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.821 -0.627 . . . . 51.25 109.709 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -120.42 179.06 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.742 0.306 . . . . 63.329999999999998 110.403 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.06 18.82 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.84 -0.618 . . . . 75.140000000000001 110.611 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.51 -142.92 14.17 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.748 -0.739 . . . . 71.150000000000006 112.846 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -58.77 92.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.645 2.897 . . . . 74.340000000000003 112.216 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.77 32.56 7.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.478 -1.237 . . . . 52.520000000000003 111.003 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.5 m -80.27 56.29 2.45 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.517 -1.219 . . . . 75.319999999999993 110.058 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 m-80 -72.57 100.62 2.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.027 -0.988 . . . . 73.230000000000004 109.633 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -116.32 -135.87 5.71 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.254 -0.974 . . . . 74.019999999999996 113.315 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 47.8 p -96.88 -4.78 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.404 -176.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -71.17 142.77 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.027 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.53 ' HB3' ' HZ ' ' A' ' 39' ' ' PHE . 52.3 p90 -143.5 169.38 17.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.828 0.347 . . . . 71.209999999999994 110.812 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.51 155.21 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 74.109999999999999 110.665 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.711 HG22 HD23 ' A' ' 98' ' ' LEU . 18.4 t -110.61 144.05 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.899 -0.591 . . . . 55.020000000000003 109.482 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.5 p -97.01 124.58 41.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.101 0.477 . . . . 62.530000000000001 110.538 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 62' ' ' ILE . 71.9 mt -83.66 -9.53 58.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.592 -0.731 . . . . 72.040000000000006 110.243 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.4 156.84 42.54 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.172 -0.922 . . . . 61.299999999999997 109.611 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 57.5 Cg_endo -72.28 113.34 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.262 1.975 . . . . 73.349999999999994 112.33 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.2 p -100.49 145.47 28.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 64.420000000000002 109.863 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -123.31 17.99 9.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 63.32 110.722 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.797 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 1.1 p90 -124.08 -1.72 8.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 72.140000000000001 111.33 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 86.9 mt -114.36 -6.1 12.92 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.975 0.417 . . . . 73.150000000000006 110.839 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.42 -19.19 64.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 72.25 111.249 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.53 12.52 10.24 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.52 -0.848 . . . . 34.539999999999999 111.841 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -120.14 -24.33 6.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 109.775 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 100' ' ' MET . 38.9 m80 -130.24 125.56 35.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.703 -0.681 . . . . 63.539999999999999 110.189 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.0 m -65.9 110.67 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 33.210000000000001 110.427 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 99' ' ' ALA . 32.5 mt -96.84 120.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.539 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 1.3 p90 -153.76 72.26 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.548 1.166 . . . . 73.230000000000004 109.742 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.876 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.63 153.1 23.58 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 118.269 -1.92 . . . . 33.039999999999999 113.857 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.4 mtp-105 -133.32 123.63 25.8 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.923 -0.769 . . . . 75.510000000000005 108.923 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.78 131.61 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.442 0.639 . . . . 54.509999999999998 109.901 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.644 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.6 m -134.36 139.1 45.39 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.507 -0.769 . . . . 50.130000000000003 110.263 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 47.09 46.38 16.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.325 0.491 . . . . 62.149999999999999 112.325 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.88 29.46 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.952 -1.118 . . . . 41.439999999999998 112.587 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -76.73 -33.52 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 70.25 110.435 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.32 -35.32 91.46 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.015 -0.612 . . . . 73.439999999999998 111.682 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 142' ' ' VAL . 68.4 mmm -69.37 -52.73 24.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.019 -0.363 . . . . 73.030000000000001 110.019 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.83 -30.97 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.135 0.493 . . . . 71.329999999999998 110.822 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.72 -53.62 14.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.762 -0.654 . . . . 75.340000000000003 110.612 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.38 -14.96 60.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 111.097 -177.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.4 t -85.66 -38.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.18 0.514 . . . . 62.219999999999999 110.049 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -82.01 -15.01 75.99 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.574 -0.822 . . . . 74.209999999999994 112.94 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.558 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.9 ptm -96.39 0.89 51.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.683 0.241 . . . . 73.140000000000001 111.155 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--N 1.326 -0.415 0 CA-C-O 121.6 0.714 . . . . 73.219999999999999 112.084 -177.14 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 142' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.828 0.823 . . . . 75.040000000000006 110.561 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -120.43 165.95 14.24 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.719 -1.128 . . . . 70.420000000000002 108.824 176.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 48' ' ' TYR . 3.5 mp -88.92 103.3 13.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.451 -0.944 . . . . 74.340000000000003 108.451 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.429 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.8 mm -66.87 -59.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.368 -0.833 . . . . 64.019999999999996 110.233 -176.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 6.0 mptp? -128.63 132.93 48.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.659 . . . . 74.340000000000003 109.977 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.13 135.54 49.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.335 -0.393 . . . . 64.340000000000003 110.663 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -154.47 128.1 4.42 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.641 -0.709 . . . . 72.150000000000006 110.617 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 91.7 Cg_endo -80.73 149.7 18.42 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.852 2.368 . . . . 75.420000000000002 112.817 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.537 ' HB3' ' HE1' ' A' ' 15' ' ' TYR . 21.4 t . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 64.340000000000003 110.128 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.3 0.572 . . . . 45.140000000000001 111.014 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 156.95 145.98 4.35 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.021 -0.99 . . . . 70.209999999999994 111.117 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.62 -167.33 25.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.281 -0.961 . . . . 54.329999999999998 112.291 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.774 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.55 171.14 12.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.783 0.325 . . . . 62.049999999999997 110.485 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.71 94.38 8.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 110.022 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 90' ' ' LEU . 58.2 Cg_endo -77.83 -7.99 16.67 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.12 1.88 . . . . 72.439999999999998 112.802 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.508 ' OE2' ' HD2' ' A' ' 189' ' ' PRO . 1.3 mp0 -75.31 -35.01 61.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.104 0.478 . . . . 72.019999999999996 110.445 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 193' ' ' VAL . 14.7 pt -79.05 -13.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.929 -0.578 . . . . 70.200000000000003 111.509 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.0 m170 65.85 30.68 9.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.704 -0.68 . . . . 64.349999999999994 112.204 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 191' ' ' ILE . 4.6 p -123.49 149.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.142 -0.318 . . . . 71.340000000000003 110.142 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.52 119.0 18.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.162 -0.472 . . . . 71.540000000000006 111.601 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.41 HE21 ' HB ' ' A' ' 93' ' ' THR . 2.3 pp0? -164.97 156.7 15.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.477 -0.783 . . . . 75.230000000000004 109.589 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 10.8 m-85 -120.7 146.22 42.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.799 -0.36 . . . . 71.319999999999993 111.122 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.5 Cg_endo -62.15 -59.89 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.946 2.43 . . . . 63.130000000000003 111.968 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.7 21.17 5.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.901 0.381 . . . . 74.329999999999998 110.006 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 62.65 19.42 11.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.54 -0.755 . . . . 75.409999999999997 111.646 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 ptm -53.28 -53.51 49.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.524 -0.762 . . . . 75.340000000000003 112.289 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.78 -8.08 71.63 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.32 -0.467 . . . . 74.209999999999994 113.442 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.482 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 78.7 mtp180 -80.9 -42.78 20.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.888 0.375 . . . . 70.420000000000002 110.177 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 203' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-N 114.383 -1.28 . . . . 73.140000000000001 112.067 -174.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 51.6 Cg_exo . . . . . 0 N--CA 1.457 -0.675 0 N-CA-C 110.268 -0.705 . . . . 54.299999999999997 110.268 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.9 0.15 5.41 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.241 2.627 . . . . 62.210000000000001 113.276 -172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.581 HD21 HG12 ' A' ' 24' ' ' VAL . 3.1 t-20 -135.7 129.13 32.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.35 -0.841 . . . . 75.140000000000001 108.799 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 39' ' ' PHE . 18.7 m -130.85 162.58 38.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.563 0.221 . . . . 63.030000000000001 110.493 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HB3' HG22 ' A' ' 24' ' ' VAL . 39.5 p90 -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.287 0.565 . . . . 72.430000000000007 112.096 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.23 116.39 28.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.005 -0.998 . . . . 73.5 109.423 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.36 112.64 20.51 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.903 -0.777 . . . . 75.540000000000006 108.903 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -105.31 177.98 4.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.926 0.393 . . . . 73.0 111.428 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' HD11 ' A' ' 160' ' ' ILE . 23.2 t -72.79 -11.44 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 61.43 110.557 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.647 ' HG3' HG22 ' A' ' 142' ' ' VAL . 8.7 mmt -100.39 -39.96 7.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 53.549999999999997 110.498 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.86 -127.0 0.99 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.789 -0.719 . . . . 62.530000000000001 111.505 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -145.82 130.79 12.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.28 -0.637 . . . . 75.049999999999997 109.28 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -126.43 129.19 71.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 75.409999999999997 110.399 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 15' ' ' TYR . 42.5 t -110.18 142.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.864 -0.421 . . . . 71.329999999999998 109.864 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.65 159.35 44.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.459 0.647 . . . . 72.450000000000003 111.002 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -132.74 163.5 28.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.484 -0.78 . . . . 71.099999999999994 110.005 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -98.4 166.99 11.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.445 -0.343 . . . . 75.219999999999999 110.158 -175.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.79 ' HE2' ' HB3' ' A' ' 190' ' ' GLU . 11.1 m-85 -87.73 99.34 12.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.374 0.607 . . . . 64.409999999999997 111.316 175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.715 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -81.45 0.1 39.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.283 -0.871 . . . . 73.439999999999998 109.37 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.58 -69.55 0.31 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.133 -0.94 . . . . 73.019999999999996 111.035 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.433 ' HD1' ' CG ' ' A' ' 89' ' ' ASP . 46.4 m80 -129.26 17.83 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.413 -0.358 . . . . 75.230000000000004 111.195 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.6 63.82 71.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.575 -0.284 . . . . 74.239999999999995 111.296 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.21 -44.0 2.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.643 2.229 . . . . 72.030000000000001 111.815 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -60.99 -47.15 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.757 0.789 . . . . 75.230000000000004 110.051 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -65.97 -41.28 91.37 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.56 -1.2 . . . . 73.299999999999997 110.965 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.715 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 41.8 t -57.43 -41.62 80.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 75.530000000000001 110.387 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 7.4 mmpt? -58.84 -45.45 90.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.925 -0.579 . . . . 62.520000000000003 110.897 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -53.49 -52.98 57.81 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.592 0.558 . . . . 53.409999999999997 110.511 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 27' ' ' LEU . 37.4 t80 -69.02 -44.06 73.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.284 -0.417 . . . . 74.25 110.692 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 44' ' ' ARG . . . -55.26 -53.01 61.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 43.43 112.004 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 41.8 mm-40 -66.35 -31.12 71.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 71.099999999999994 110.354 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -66.79 -36.87 83.4 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.056 -0.52 . . . . 72.120000000000005 110.292 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . . . -67.44 -35.73 79.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.579 -0.737 . . . . 75.329999999999998 110.085 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 15.2 mmm180 -61.57 -44.54 96.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.934 -0.575 . . . . 65.299999999999997 110.991 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -48.18 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 110.245 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.42 43.42 1.86 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.127 -1.035 . . . . 74.420000000000002 112.412 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.59 -18.92 56.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.077 0.465 . . . . 70.150000000000006 111.041 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.683 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.8 -6.01 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 74.0 111.738 -177.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.9 -8.82 47.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.182 -0.463 . . . . 75.549999999999997 111.242 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -136.9 26.32 3.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 112.153 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.2 p -98.76 148.05 24.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 64.140000000000001 111.437 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -135.72 161.65 34.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.332 -0.618 . . . . 50.130000000000003 109.332 177.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.6 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 74.2 m-85 -80.77 116.41 20.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 61.43 109.915 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -97.56 -22.16 16.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 65.140000000000001 110.451 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.774 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 33.5 mmt180 -125.27 116.31 21.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.540000000000006 110.151 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 62' ' ' ILE . 20.3 mm -124.42 88.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.108 -0.701 . . . . 71.150000000000006 109.108 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 13.7 mt -98.16 126.01 51.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.198 -0.667 . . . . 71.530000000000001 109.198 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.28 118.84 8.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.655 0.597 . . . . 73.310000000000002 110.656 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 57.81 40.63 25.95 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.894 0.747 . . . . 71.439999999999998 110.946 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.1 t80 -133.24 -81.02 0.48 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.221 0.534 . . . . 73.340000000000003 109.916 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.48 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.94 156.62 25.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.475 -0.784 . . . . 73.120000000000005 109.96 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.566 HD11 HD21 ' A' ' 116' ' ' LEU . 48.5 mt -126.92 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.405 -0.591 . . . . 72.510000000000005 109.405 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.774 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 18.3 mt-30 -85.6 124.65 32.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.31 -0.404 . . . . 72.409999999999997 110.93 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -119.57 141.24 15.46 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 52.119999999999997 111.93 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.8 -137.25 5.34 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.046 -0.597 . . . . 72.030000000000001 111.918 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 49.44 78.58 0.39 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.419 0.896 . . . . 61.520000000000003 113.419 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HG3' ' HA2' ' A' ' 74' ' ' GLY . 68.4 Cg_endo -76.56 -17.26 16.38 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.789 1.659 . . . . 71.409999999999997 110.395 168.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 70' ' ' THR . 33.9 p -96.61 -44.39 7.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.909 -1.041 . . . . 75.120000000000005 111.12 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.63 53.82 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 111.981 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' OG1' ' A' ' 68' ' ' THR . 10.3 t -98.95 -10.61 22.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.95 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.97 -15.4 58.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.863 -0.684 . . . . 64.319999999999993 112.939 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -144.35 18.4 1.71 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.956 0.354 . . . . 71.129999999999995 111.956 -175.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -84.74 -167.92 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.27 -0.967 . . . . 44.219999999999999 111.994 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 67' ' ' PRO . . . 113.7 -117.97 4.34 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.249 -0.977 . . . . 64.450000000000003 113.272 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.946 ' H ' ' HB2' ' A' ' 110' ' ' SER . . . -60.8 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.242 0.617 . . . . 75.010000000000005 112.497 -173.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -99.69 7.63 44.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.845 -0.798 . . . . 74.400000000000006 108.845 174.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.04 -38.65 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.869 -1.059 . . . . 64.129999999999995 111.132 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.87 ' HB2' ' HE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -98.89 -3.47 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 111.654 -178.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.86 -73.71 2.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.04 -0.6 . . . . 41.229999999999997 112.735 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -113.68 171.51 7.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.791 0.329 . . . . 71.109999999999999 110.703 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 161.32 28.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 61.039999999999999 110.467 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.87 ' HE2' ' HB2' ' A' ' 78' ' ' TYR . 71.1 m-85 -131.74 -169.15 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 73.25 110.351 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -46.47 139.21 5.14 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.836 0.71 . . . . 62.32 112.166 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HA ' HD21 ' A' ' 108' ' ' ASN . 7.9 p-10 -74.16 135.45 42.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.143 -0.688 . . . . 70.010000000000005 109.143 174.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 35' ' ' THR . 25.9 mm-40 -102.68 19.42 19.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.831 -0.622 . . . . 73.230000000000004 110.116 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.06 98.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.622 -0.717 . . . . 65.540000000000006 110.655 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -167.75 82.13 0.83 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.962 -0.563 . . . . 74.239999999999995 109.876 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.56 92.54 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.846 2.364 . . . . 62.130000000000003 112.372 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 15.3 t70 -71.31 -37.14 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.13 0.967 . . . . 75.209999999999994 109.079 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -84.3 179.04 7.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.543 -1.208 . . . . 53.420000000000002 108.985 172.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -139.59 169.1 18.36 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.479 -0.488 . . . . 64.319999999999993 109.881 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -63.49 123.12 17.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 60.409999999999997 109.539 171.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p -125.32 -40.99 2.08 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.567 0.699 . . . . 54.119999999999997 109.843 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.42 -143.4 3.69 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 114.934 -1.03 . . . . 64.519999999999996 111.179 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.6 150.83 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.704 0.287 . . . . 62.549999999999997 110.519 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.71 23.59 7.79 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.704 -0.76 . . . . 75.340000000000003 111.426 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.6 mm -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.33 -0.619 . . . . 52.299999999999997 109.33 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -83.38 122.88 29.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 109.883 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.79 171.94 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.154 0.502 . . . . 70.129999999999995 111.654 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.748 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 26.4 ttt -107.25 143.14 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.616 -0.72 . . . . 63.32 110.13 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -104.61 136.68 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.2 0.524 . . . . 45.340000000000003 110.64 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -139.43 166.23 25.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.583 -0.735 . . . . 62.039999999999999 109.766 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -85.88 -34.81 20.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.527 -0.306 . . . . 63.210000000000001 111.103 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.32 -123.05 1.07 Allowed Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.534 -0.841 . . . . 74.109999999999999 112.337 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.55 90.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.99 2.46 . . . . 71.219999999999999 112.201 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' PHE . 2.2 p30 59.87 11.08 2.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 74.25 112.373 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 m -81.48 61.18 4.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.69 0.757 . . . . 75.120000000000005 109.095 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 84' ' ' ASP . 31.0 m-80 -73.5 150.88 41.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.394 -1.276 . . . . 63.439999999999998 109.886 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.41 -139.82 3.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.632 -0.794 . . . . 53.130000000000003 111.958 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.946 ' HB2' ' H ' ' A' ' 75' ' ' ALA . 33.7 t -113.73 8.48 17.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.975 0.417 . . . . 71.129999999999995 110.359 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 9.2 mm-40 -82.47 138.81 34.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.386 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.88 167.29 21.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.111 -0.7 . . . . 72.219999999999999 109.111 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.768 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 51.5 p90 -157.12 153.87 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 72.530000000000001 112.059 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 98' ' ' LEU . 17.4 t -113.64 142.52 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.237 -0.892 . . . . 60.219999999999999 108.752 174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.9 p -96.04 129.38 43.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.123 0.487 . . . . 74.129999999999995 110.621 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 62' ' ' ILE . 74.3 mt -82.49 -10.5 58.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.432 -0.804 . . . . 44.549999999999997 110.78 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.56 164.12 24.32 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.414 -0.812 . . . . 61.310000000000002 110.022 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.554 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 23.9 Cg_exo -64.19 113.96 2.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.707 2.271 . . . . 64.209999999999994 112.134 177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.8 p -100.35 112.95 25.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.207 -0.451 . . . . 75.120000000000005 111.106 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.717 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -114.16 27.4 9.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.612 0.72 . . . . 54.420000000000002 109.756 -177.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.74 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -129.83 3.52 4.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.153 -0.931 . . . . 73.310000000000002 110.983 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.74 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 94.4 mt -113.13 7.84 18.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.931 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 -27.28 56.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.913 -1.04 . . . . 62.399999999999999 111.917 -176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.3 25.43 4.85 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.088 -0.805 . . . . 65.120000000000005 111.088 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -116.86 -40.38 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.952 0.406 . . . . 60.420000000000002 110.067 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -142.3 137.12 30.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 63.020000000000003 111.11 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.1 m -68.75 121.77 17.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.658 -0.701 . . . . 54.149999999999999 110.796 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.9 mt -108.4 120.88 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.457 -0.201 . . . . 34.509999999999998 110.457 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.748 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.2 p90 -157.71 73.62 0.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.865 0.841 . . . . 72.310000000000002 110.81 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.868 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.96 150.94 20.43 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.274 -1.441 . . . . 63.219999999999999 113.433 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -127.54 119.63 26.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.862 -0.792 . . . . 73.329999999999998 108.862 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.403 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 9.2 p -79.66 132.08 32.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.338 0.589 . . . . 65.219999999999999 109.864 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . 0.578 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.1 m -133.55 141.21 47.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 61.219999999999999 110.916 -171.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.3 pt20 41.68 35.3 0.47 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.478 1.111 . . . . 71.109999999999999 113.842 176.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.32 37.6 0.23 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.585 -0.817 . . . . 64.430000000000007 112.211 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 197' ' ' PRO . 9.3 tp -85.33 -34.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.78 0.324 . . . . 73.409999999999997 110.542 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.59 -35.59 81.34 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.038 -0.601 . . . . 61.0 112.413 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 81.2 mmm -70.54 -51.32 29.45 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.336 -0.246 . . . . 71.340000000000003 110.336 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 62' ' ' ILE . 91.7 t -52.55 -32.12 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.001 0.429 . . . . 75.340000000000003 110.933 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.6 t30 -69.5 -53.8 17.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.84 -0.618 . . . . 73.510000000000005 110.559 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -15.43 61.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.055 -0.52 . . . . 73.200000000000003 110.975 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 20' ' ' MET . 45.1 t -84.0 -37.59 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.442 . . . . 73.200000000000003 110.315 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -74.78 -18.62 80.09 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.42 -0.895 . . . . 70.230000000000004 112.613 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 42.8 mtm -99.66 1.34 43.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.947 0.351 . . . . 42.509999999999998 111.947 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 142' ' ' VAL . 30.7 m . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.578 . . . . 75.310000000000002 111.903 -176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.485 HG21 HG13 ' A' ' 142' ' ' VAL . 12.8 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 108.896 -0.779 . . . . 61.130000000000003 108.896 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.1 mttm -124.09 169.57 11.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.981 0.419 . . . . 73.219999999999999 111.207 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -93.45 99.81 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.838 -1.171 . . . . 71.439999999999998 107.838 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.592 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.4 mm -63.26 -61.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.62 -0.511 . . . . 34.109999999999999 109.62 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.592 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.2 mptp? -138.32 154.7 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.016 -0.735 . . . . 72.120000000000005 109.016 172.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -142.51 150.72 40.84 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.661 -0.496 . . . . 65.140000000000001 109.661 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 98.6 m-85 -156.05 145.62 15.37 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.339 -0.615 . . . . 74.120000000000005 109.339 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 5.4 Cg_exo -74.94 142.55 28.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.403 2.069 . . . . 73.409999999999997 111.954 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 11' ' ' PRO . 25.5 t . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 72.200000000000003 110.074 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.4 m-20 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.445 0.641 . . . . 54.439999999999998 110.836 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.51 145.87 4.29 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.173 -0.922 . . . . 73.120000000000005 110.811 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -79.3 -161.12 20.94 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.083 -1.055 . . . . 75.299999999999997 112.153 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.649 ' HB1' ' OE1' ' A' ' 195' ' ' GLN . . . -80.95 176.73 9.57 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.153 -0.314 . . . . 71.329999999999998 110.153 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' ILE . 76.7 m-85 -116.19 92.54 36.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.646 -0.502 . . . . 70.140000000000001 109.646 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 10.3 Cg_exo -70.48 -18.07 33.85 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.21 2.607 . . . . 72.329999999999998 113.279 -173.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.79 ' HB3' ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -78.14 -35.1 49.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.262 0.468 . . . . 62.520000000000003 112.262 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 188' ' ' PHE . 22.3 pt -73.03 -13.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 71.340000000000003 111.773 -171.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 63.8 m170 68.91 29.45 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.774 . . . . 72.129999999999995 111.926 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 191' ' ' ILE . 3.9 p -127.28 165.66 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.979 -0.748 . . . . 74.340000000000003 108.979 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.24 129.77 34.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 43.219999999999999 111.59 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.649 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -158.54 153.45 25.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.019 -0.734 . . . . 71.109999999999999 109.019 174.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 83.9 m-85 -122.07 138.19 28.5 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.726 -0.39 . . . . 72.109999999999999 111.038 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.0 Cg_endo -64.23 -51.5 2.06 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.622 2.215 . . . . 74.239999999999995 111.967 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -154.83 41.15 0.45 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.387 -0.37 . . . . 71.519999999999996 111.166 178.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 2.0 m-20 75.32 -12.82 0.92 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 112.257 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.573 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 23.0 ptm -50.64 -31.88 17.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.622 0.971 . . . . 72.319999999999993 113.622 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.86 2.7 55.65 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 119.803 -1.189 . . . . 72.120000000000005 113.677 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.498 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 31.8 ptt180 -118.98 1.89 11.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 117.565 0.682 . . . . 65.340000000000003 111.951 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 200' ' ' MET . 41.4 mtmt . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.116 -0.947 . . . . 70.310000000000002 110.831 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 121.005 0.431 . . . . 65.120000000000005 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.92 117.59 26.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.362 -0.381 . . . . 72.109999999999999 111.39 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.66 -38.67 19.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.26 0.552 . . . . 30.210000000000001 110.26 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 78' ' ' TYR . 78.4 mt -129.01 112.65 18.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.443 -0.798 . . . . 71.329999999999998 110.107 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 2.9 Cg_exo -76.26 113.79 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.882 2.388 . . . . 71.129999999999995 111.911 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.07 -48.38 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.711 2.274 . . . . 62.549999999999997 111.51 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.64 67.94 0.59 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.34 -0.845 . . . . 75.109999999999999 112.038 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 p 176.49 -173.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.641 -1.163 . . . . 70.049999999999997 108.469 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -104.19 119.96 40.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.275 -0.269 . . . . 61.420000000000002 110.275 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.444 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.3 mp0 -109.45 99.42 36.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.117 -0.327 . . . . 75.010000000000005 110.117 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.864 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 24.5 Cg_exo -63.68 145.87 91.72 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.021 1.814 . . . . 62.509999999999998 110.789 172.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 53.1 Cg_endo -69.55 -5.37 15.92 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.499 2.133 . . . . 72.109999999999999 112.116 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.69 HD21 HG12 ' A' ' 24' ' ' VAL . 4.7 t-20 -130.99 142.17 50.32 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.081 -0.963 . . . . 73.239999999999995 109.449 -175.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 164' ' ' PRO . 21.8 m -135.54 157.2 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.981 -0.377 . . . . 75.150000000000006 109.981 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.555 ' HB2' HD11 ' A' ' 22' ' ' ILE . 50.8 p90 -121.06 130.46 53.78 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.267 0.556 . . . . 74.519999999999996 110.754 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -111.15 102.17 10.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.501 -0.772 . . . . 64.129999999999995 109.806 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.86 110.65 17.35 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.22 -0.659 . . . . 74.530000000000001 109.22 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.499 HG21 ' HE2' ' A' ' 53' ' ' PHE . 72.1 p -99.81 -179.7 4.26 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.149 -0.478 . . . . 74.340000000000003 110.719 -175.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 p -69.27 -16.88 63.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.091 -0.504 . . . . 62.210000000000001 110.878 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.4 mmt -94.83 -41.05 9.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.584 . . . . 70.129999999999995 111.019 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.78 -127.49 1.05 Allowed Glycine 0 C--O 1.226 -0.394 0 C-N-CA 120.639 -0.791 . . . . 43.439999999999998 111.717 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 15' ' ' TYR . 19.6 tt -135.7 137.94 48.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.888 0.375 . . . . 73.230000000000004 110.188 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -122.41 108.75 22.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.191 -0.67 . . . . 75.109999999999999 109.191 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG12 HD21 ' A' ' 13' ' ' ASN . 39.5 t -98.03 131.5 44.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.334 -0.617 . . . . 74.450000000000003 109.334 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 25' ' ' LEU . 4.6 pp -146.99 159.26 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.119 0.485 . . . . 73.340000000000003 110.793 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -125.61 164.12 21.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.698 -0.683 . . . . 71.230000000000004 110.604 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.34 159.29 17.57 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.275 -0.875 . . . . 70.439999999999998 109.128 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.695 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 3.2 m-85 -86.46 88.79 7.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.398 0.618 . . . . 75.299999999999997 111.536 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 34.0 m95 -79.91 -3.59 48.76 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.416 -0.957 . . . . 72.109999999999999 108.416 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.82 -41.2 26.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 74.310000000000002 111.135 -176.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 12.0 t60 -132.2 -17.33 2.7 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.658 -0.417 . . . . 73.519999999999996 111.774 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.91 88.62 31.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.779 -0.368 . . . . 75.420000000000002 111.024 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' HIS . 11.1 Cg_exo -71.15 -17.17 31.62 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.83 2.353 . . . . 60.25 112.694 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 7.5 mptt -90.31 -54.75 3.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.084 0.469 . . . . 72.230000000000004 110.475 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.7 m -55.38 -44.11 75.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 74.530000000000001 111.646 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -64.48 -37.6 88.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.371 . . . . 54.030000000000001 110.844 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.937 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -73.77 -38.92 64.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 74.530000000000001 110.53 -178.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.91 -58.71 7.38 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.386 0.429 . . . . 73.109999999999999 110.902 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.477 ' CE1' ' HB3' ' A' ' 112' ' ' PHE . 65.6 m-85 -61.83 -43.79 98.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.076 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 10' ' ' GLN . . . -59.57 -44.08 93.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 73.209999999999994 111.393 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -59.44 -45.19 92.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.744 0.307 . . . . 72.310000000000002 111.429 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.9 mm? -73.45 -23.34 60.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.736 0.303 . . . . 74.319999999999993 111.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.9 -48.71 52.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.386 . . . . 74.420000000000002 110.874 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -12.74 60.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.922 0.392 . . . . 64.310000000000002 111.022 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -52.35 9.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.839 -0.8 . . . . 74.209999999999994 108.839 172.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.92 45.84 0.93 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.675 -0.97 . . . . 64.439999999999998 110.675 -174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HB2' HD12 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -88.86 -33.65 17.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.881 0.372 . . . . 62.509999999999998 111.368 -176.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 85.2 m-85 -71.94 -14.69 61.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.329 -175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -74.95 10.64 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.241 0.543 . . . . 65.129999999999995 111.123 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.16 24.95 1.9 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.865 -0.607 . . . . 70.420000000000002 111.63 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.719 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 43.1 p -115.33 160.43 19.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.683 0.278 . . . . 72.319999999999993 111.082 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 9.9 ptpt -139.64 164.05 30.96 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.372 -0.377 . . . . 61.25 110.006 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.531 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.2 m-85 -82.24 117.68 22.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.831 -0.803 . . . . 72.209999999999994 108.831 173.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.83 -27.06 14.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.413 -0.358 . . . . 72.239999999999995 110.76 -169.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 30.5 mmt180 -132.02 116.68 17.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.517 -0.31 . . . . 73.310000000000002 110.564 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -127.28 94.25 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.007 -0.738 . . . . 62.229999999999997 109.007 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.791 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.8 mt -106.35 125.2 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.245 -0.434 . . . . 72.540000000000006 110.07 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 39.5 mtpt -60.27 130.79 48.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.223 0.327 . . . . 72.349999999999994 111.41 -178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 58.38 28.07 16.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.462 -0.79 . . . . 64.099999999999994 111.424 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.791 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -128.64 -87.52 0.55 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 65.25 109.86 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.731 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.7 ptt? -161.28 157.82 26.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 55.409999999999997 110.031 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.567 HD11 ' HA3' ' A' ' 143' ' ' GLY . 50.6 mt -128.62 102.07 7.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.613 -0.721 . . . . 73.420000000000002 109.682 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 23.5 tm0? -80.56 126.35 31.13 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 75.5 110.007 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.58 137.04 9.58 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.978 -0.63 . . . . 71.030000000000001 112.402 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.719 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 131.04 -137.47 9.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.071 -0.585 . . . . 53.119999999999997 112.12 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.487 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 4.5 t0 48.07 83.33 0.22 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 123.901 0.881 . . . . 73.129999999999995 112.241 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.26 -19.56 33.59 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.73 2.287 . . . . 71.030000000000001 111.498 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.571 ' OG1' HG22 ' A' ' 70' ' ' THR . 34.5 p -82.58 -34.55 27.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.144 -0.935 . . . . 71.109999999999999 111.534 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.0 60.92 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.102 -0.571 . . . . 74.219999999999999 111.835 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 72' ' ' ARG . 11.5 t -117.66 -17.48 9.91 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.101 0.408 . . . . 71.340000000000003 112.101 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.04 -1.94 25.59 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 119.87 -1.157 . . . . 52.130000000000003 113.631 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.62 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.97 -7.36 6.04 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.336 0.568 . . . . 73.519999999999996 111.877 178.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 70.9 -163.87 53.64 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 121.182 -0.532 . . . . 72.209999999999994 113.342 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.12 -88.05 1.23 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.683 -0.567 . . . . 64.439999999999998 111.683 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 59.87 33.08 21.54 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.278 0.561 . . . . 74.030000000000001 111.934 173.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.7 t -78.83 0.66 26.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.019 -0.537 . . . . 70.510000000000005 111.686 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.8 pt -74.01 -29.76 26.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.722 -0.391 . . . . 65.420000000000002 111.254 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' HB3' HD11 ' A' ' 4' ' ' ILE . 23.1 p90 -108.05 1.73 22.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.3 0.572 . . . . 75.010000000000005 111.107 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -77.58 2.09 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.341 -0.845 . . . . 72.230000000000004 113.39 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -92.37 -170.39 2.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.851 0.358 . . . . 64.200000000000003 110.505 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -95.44 163.65 13.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.621 -0.511 . . . . 74.340000000000003 109.621 176.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CZ ' ' HG2' ' A' ' 34' ' ' LYS . 57.6 t80 -110.33 156.02 21.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.103 -0.239 . . . . 73.549999999999997 111.091 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -53.13 158.14 1.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 124.161 0.913 . . . . 73.219999999999999 112.16 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -75.22 106.76 6.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.299 -0.864 . . . . 73.040000000000006 110.838 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.5 21.37 9.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.716 -0.674 . . . . 62.149999999999999 109.354 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.413 HD23 ' OG1' ' A' ' 127' ' ' THR . 38.2 mt -59.32 97.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.001 -0.999 . . . . 74.25 111.551 -173.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -168.22 85.45 0.72 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 73.340000000000003 109.961 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.41 93.7 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.59 2.193 . . . . 61.130000000000003 111.947 173.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.61 -26.4 66.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.698 0.761 . . . . 63.539999999999999 109.65 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -83.12 177.75 8.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.899 -1.046 . . . . 70.239999999999995 108.808 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -133.8 159.86 39.34 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.907 -0.717 . . . . 72.230000000000004 110.541 174.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.454 ' HB2' ' HA ' ' A' ' 118' ' ' PRO . 1.2 p90 -70.46 77.18 0.57 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.315 -0.857 . . . . 63.25 110.829 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.2 p -68.49 -40.59 80.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.945 -1.025 . . . . 75.299999999999997 111.421 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.66 -146.92 4.85 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.0 -0.619 . . . . 64.310000000000002 111.949 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.89 145.78 24.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.783 0.325 . . . . 43.009999999999998 110.751 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.09 24.3 6.34 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.67 -0.776 . . . . 74.230000000000004 111.535 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.2 mm -88.18 112.42 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 109.565 -0.532 . . . . 64.040000000000006 109.565 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.717 HD23 HG22 ' A' ' 114' ' ' VAL . 3.3 tm? -85.45 121.76 28.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.987 -0.551 . . . . 61.009999999999998 109.594 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -126.69 163.52 23.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.125 0.488 . . . . 75.340000000000003 111.186 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.753 ' HE2' ' HB3' ' A' ' 108' ' ' ASN . 28.1 ttt -91.62 134.16 34.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.483 -0.781 . . . . 73.450000000000003 109.939 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -96.5 151.24 19.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.132 0.492 . . . . 52.420000000000002 110.979 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.4 p-10 -155.84 159.38 39.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 73.400000000000006 110.581 -174.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.62 -13.45 22.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.244 0.545 . . . . 73.319999999999993 110.808 -177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -162.58 -179.99 37.51 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.224 -1.55 . . . . 61.149999999999999 109.224 176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.63 -50.69 12.94 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.737 2.292 . . . . 72.0 112.063 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -115.89 19.56 15.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 72.140000000000001 110.367 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.3 m -101.08 51.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.317 -0.994 . . . . 71.239999999999995 108.317 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.753 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 42.3 m-80 -77.37 134.84 38.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.421 -1.263 . . . . 74.25 110.375 -178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.57 -157.21 10.09 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.745 -0.74 . . . . 71.010000000000005 112.506 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.8 p -95.7 8.99 41.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.162 0.506 . . . . 61.439999999999998 111.166 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 6.3 pt20 -90.8 158.6 16.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.871 -0.604 . . . . 72.299999999999997 111.328 -176.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.477 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . 50.9 p90 -142.17 176.45 8.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.02 -0.536 . . . . 73.129999999999995 109.971 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 51.1 p90 -159.54 152.04 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 110.608 173.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.717 HG22 HD23 ' A' ' 98' ' ' LEU . 19.3 t -110.93 142.78 22.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.288 -0.634 . . . . 62.140000000000001 109.288 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.7 p -97.39 130.09 44.56 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.771 0.319 . . . . 72.450000000000003 110.154 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 62' ' ' ILE . 57.0 mt -86.22 -6.69 58.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.06 0.457 . . . . 72.450000000000003 110.957 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.19 166.88 14.33 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.805 -0.634 . . . . 52.100000000000001 109.794 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 92' ' ' PHE . 32.2 Cg_exo -59.41 106.63 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.591 2.194 . . . . 63.310000000000002 112.043 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.495 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 26.1 p -94.02 103.42 15.5 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.62 -0.718 . . . . 72.219999999999999 111.793 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -105.19 3.6 30.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.651 0.739 . . . . 73.299999999999997 110.255 176.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.495 ' CZ2' HG22 ' A' ' 119' ' ' THR . 1.2 p90 -93.71 -3.7 51.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.995 -1.002 . . . . 74.409999999999997 111.295 -177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 pp -134.19 16.53 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.549 -0.296 . . . . 61.439999999999998 111.207 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -51.75 -38.9 57.34 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.281 -0.872 . . . . 75.299999999999997 111.552 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -117.12 22.48 10.39 Favored Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 120.608 -0.806 . . . . 64.019999999999996 112.083 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -118.4 -26.49 6.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.061 0.458 . . . . 73.010000000000005 110.135 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -137.34 128.09 27.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 51.030000000000001 110.486 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.413 ' OG1' HD23 ' A' ' 86' ' ' LEU . 21.5 m -68.73 120.71 15.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.246 -0.433 . . . . 75.530000000000001 110.669 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 99' ' ' ALA . 47.8 mt -104.21 117.58 50.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.547 0.203 . . . . 73.430000000000007 111.547 -176.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 47.9 m-85 -158.77 77.04 0.75 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.511 0.507 . . . . 73.030000000000001 110.698 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.66 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.34 163.24 35.45 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.116 -0.564 . . . . 52.200000000000003 112.285 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.695 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 78.3 mtm180 -142.31 127.14 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.028 -0.36 . . . . 72.349999999999994 110.028 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -87.06 142.73 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 75.340000000000003 110.686 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.616 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 43.6 t -145.77 147.72 32.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 64.099999999999994 110.773 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.3 tt0 48.41 34.04 4.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.568 0.747 . . . . 75.340000000000003 112.567 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -163.45 16.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.061 -1.066 . . . . 72.099999999999994 112.407 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.0 tp -73.18 -31.74 35.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.159 -0.311 . . . . 62.530000000000001 110.159 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.93 95.49 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.982 -0.847 . . . . 71.109999999999999 110.982 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 81.8 mmm -68.61 -48.85 63.06 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.098 -0.334 . . . . 74.519999999999996 110.098 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.523 HG13 HD12 ' A' ' 62' ' ' ILE . 85.7 t -56.33 -30.23 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 71.340000000000003 110.532 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.72 -52.83 11.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.815 -0.63 . . . . 72.310000000000002 110.97 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -14.43 60.93 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.051 -0.522 . . . . 75.099999999999994 111.305 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.4 t -93.52 -33.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.077 0.465 . . . . 73.200000000000003 110.382 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.567 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -82.8 -22.03 58.6 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.595 -0.812 . . . . 61.109999999999999 113.0 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ptp -84.33 -13.26 52.87 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.853 -0.339 . . . . 72.129999999999995 111.659 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 154' ' ' VAL . 31.4 m -93.31 137.74 21.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.982 0.42 . . . . 54.310000000000002 111.256 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 147' ' ' THR . 0.0 OUTLIER -116.71 -46.91 2.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.453 . . . . 65.120000000000005 110.642 175.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 1.9 p -119.91 146.34 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.074 0.464 . . . . 73.329999999999998 111.418 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.65 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 46.9 t30 -93.44 -33.6 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.785 -0.643 . . . . 72.030000000000001 109.362 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 24.7 t -168.2 176.0 6.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.287 -0.869 . . . . 62.229999999999997 108.986 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 18.67 -97.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.197 1.184 . . . . 75.299999999999997 114.197 -175.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -129.43 26.47 5.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.122 0.963 . . . . 75.209999999999994 109.624 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -103.63 116.49 61.82 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.297 -0.865 . . . . 62.009999999999998 109.661 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 46.3 Cg_exo -56.58 154.9 28.43 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.576 2.184 . . . . 74.099999999999994 111.098 176.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.65 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 76.7 t -55.99 118.11 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.318 -0.623 . . . . 71.340000000000003 109.318 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -45.89 133.95 8.22 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 124.224 0.952 . . . . 74.439999999999998 111.715 -175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -45.36 126.71 6.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.616 -1.175 . . . . 62.009999999999998 112.785 -171.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p -97.17 128.73 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.609 -1.178 . . . . 75.430000000000007 109.439 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -127.21 165.4 19.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.141 -0.481 . . . . 73.109999999999999 110.721 -175.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -86.76 105.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.617 -0.72 . . . . 73.230000000000004 109.102 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.1 mm -70.46 -56.37 11.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.562 -0.744 . . . . 73.140000000000001 110.673 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.578 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.5 mptm? -133.34 128.04 34.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 54.539999999999999 110.147 176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -131.27 123.99 29.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.864 0.364 . . . . 71.239999999999995 110.672 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -140.22 143.24 32.84 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.89 -0.596 . . . . 63.530000000000001 109.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.864 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 74.4 Cg_endo -78.47 124.58 6.49 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.198 1.932 . . . . 62.119999999999997 112.241 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.5 m -163.57 137.92 5.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.522 -0.763 . . . . 73.329999999999998 109.234 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 13' ' ' ASN . . . -86.76 110.27 3.51 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.759 -0.734 . . . . 62.340000000000003 112.879 -174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.27 105.93 3.19 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.979 -0.848 . . . . 71.540000000000006 110.979 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.15 -64.01 2.08 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.875 -0.679 . . . . 63.32 112.653 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.29 150.06 26.38 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.676 -0.773 . . . . 61.420000000000002 111.978 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.1 t -153.09 140.35 19.51 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.833 -0.432 . . . . 73.25 109.833 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.73 -160.08 11.32 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.873 -0.679 . . . . 71.230000000000004 111.869 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 169.94 153.35 8.54 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.672 -0.775 . . . . 70.120000000000005 112.388 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -172.88 56.47 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.159 -0.776 . . . . 64.519999999999996 111.159 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -77.05 105.59 8.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.026 0.441 . . . . 64.150000000000006 110.863 -174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 113.71 -25.56 10.87 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.89 -0.671 . . . . 73.439999999999998 111.61 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -174.47 79.12 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.681 -0.771 . . . . 33.030000000000001 112.412 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -89.46 53.67 3.81 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.899 -0.667 . . . . 71.450000000000003 111.777 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 m -64.68 -33.29 75.59 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.662 0.385 . . . . 71.129999999999995 111.211 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.09 -94.0 0.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.966 -0.635 . . . . 53.420000000000002 112.121 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.68 132.89 7.48 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.7 -0.762 . . . . 72.109999999999999 111.884 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.33 61.37 1.19 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.259 -0.736 . . . . 65.340000000000003 111.259 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.4 m -74.43 100.82 3.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 71.239999999999995 110.694 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 124.58 -150.01 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.292 -0.723 . . . . 63.240000000000002 111.292 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.734 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.1 m-20 -121.13 169.29 10.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.32 0.581 . . . . 71.430000000000007 110.189 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.16 146.08 4.48 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.256 -0.884 . . . . 50.039999999999999 111.638 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -82.25 -167.38 39.86 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.359 -0.924 . . . . 55.039999999999999 111.864 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.702 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.38 167.21 21.18 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.605 -0.516 . . . . 74.430000000000007 109.605 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 191' ' ' ILE . 92.4 m-85 -114.06 103.62 55.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 121.142 0.496 . . . . 75.430000000000007 110.32 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.697 ' HB2' HD13 ' A' ' 90' ' ' LEU . 73.0 Cg_endo -79.87 -11.68 13.72 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.707 2.271 . . . . 74.319999999999993 112.069 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -81.69 -20.0 40.41 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.41 -0.814 . . . . 53.25 111.336 -173.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 188' ' ' PHE . 18.4 pt -87.9 -13.6 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.969 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 44.1 m170 68.85 29.83 4.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.34 -0.846 . . . . 74.430000000000007 112.456 173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 191' ' ' ILE . 4.2 p -130.81 148.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.803 -0.443 . . . . 71.340000000000003 109.803 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.48 124.53 27.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.953 0.406 . . . . 63.210000000000001 111.831 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.627 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -163.29 152.31 14.53 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.174 -0.676 . . . . 64.010000000000005 109.174 175.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 52.8 m-85 -117.67 146.01 37.75 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.624 0.25 . . . . 62.409999999999997 111.217 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.702 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.2 Cg_endo -66.0 -59.63 0.13 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.643 2.229 . . . . 75.120000000000005 112.191 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.2 pt? -143.98 38.87 1.33 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 111.769 0.285 . . . . 74.329999999999998 111.769 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.2 m-20 76.43 -19.23 0.43 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.75 1.019 . . . . 73.219999999999999 113.75 170.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -60.37 -23.09 64.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.728 0.64 . . . . 72.219999999999999 112.728 -169.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.36 -13.37 60.14 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.241 -0.981 . . . . 63.130000000000003 112.955 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.419 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 24.8 ptt180 -110.71 -24.16 10.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.081 0.441 . . . . 75.439999999999998 111.261 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.362 -0.828 . . . . 52.310000000000002 110.394 176.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.923 0.392 . . . . 63.229999999999997 110.585 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.64 -174.52 4.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.992 -0.549 . . . . 75.200000000000003 109.528 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -66.43 132.63 48.72 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.191 -0.204 . . . . 75.510000000000005 110.526 177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.689 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 86.3 mt 74.88 98.06 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.146 0 O-C-N 123.849 0.718 . . . . 52.149999999999999 111.709 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 17.0 Cg_endo -92.06 106.14 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.245 2.63 . . . . 72.329999999999998 110.796 169.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD2' ' HA ' ' A' ' 5' ' ' PRO . 17.5 Cg_endo -57.95 138.59 86.76 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.953 2.436 . . . . 73.030000000000001 111.858 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.89 144.85 37.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.13 -0.486 . . . . 70.25 110.024 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -88.24 -8.61 55.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.516 -0.311 . . . . 72.140000000000001 111.546 -173.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -105.5 119.14 38.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.486 -0.561 . . . . 75.299999999999997 109.486 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -97.24 109.98 52.2 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.734 -0.666 . . . . 73.439999999999998 110.869 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 31.0 Cg_endo -66.91 113.46 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.311 2.007 . . . . 72.230000000000004 110.787 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 26.7 Cg_endo -63.27 -39.94 35.2 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.592 2.195 . . . . 74.329999999999998 112.67 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.452 HD21 HG23 ' A' ' 24' ' ' VAL . 26.2 t-20 -134.0 150.88 51.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.829 -0.623 . . . . 71.329999999999998 110.031 -173.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.55 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.0 m -129.23 141.65 46.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 75.140000000000001 110.498 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.511 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.1 m-85 -96.93 124.86 41.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 73.010000000000005 110.67 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD23 ' HB1' ' A' ' 162' ' ' ALA . 27.7 mt -112.22 100.56 8.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.564 -0.289 . . . . 73.510000000000005 110.23 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.848 ' HB2' ' HG2' ' A' ' 161' ' ' LYS . 35.8 mt-10 -82.48 110.76 17.89 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.233 -0.654 . . . . 72.329999999999998 109.233 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -105.57 177.76 4.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.185 0.516 . . . . 72.099999999999994 111.899 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 157' ' ' VAL . 9.9 p -71.97 -19.26 61.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 74.219999999999999 110.611 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.441 ' HE3' HG22 ' A' ' 142' ' ' VAL . 5.1 mmt -92.4 -38.78 11.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.823 -0.626 . . . . 63.229999999999997 110.833 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.66 -126.51 1.01 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.909 -0.663 . . . . 63.130000000000003 111.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -140.03 137.2 38.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.796 -0.446 . . . . 50.210000000000001 109.796 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.631 HG12 HG23 ' A' ' 139' ' ' VAL . 3.9 mp -139.02 130.54 35.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.721 -0.672 . . . . 72.519999999999996 109.227 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.2 m -118.94 151.14 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.019 -0.672 . . . . 74.129999999999995 110.664 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -145.96 161.45 40.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 74.099999999999994 110.22 176.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.0 pt-20 -129.77 164.19 24.59 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.149 -0.932 . . . . 62.520000000000003 109.439 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.03 162.97 12.51 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.025 -0.361 . . . . 71.299999999999997 110.025 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 131' ' ' ARG . 10.1 m-85 -86.39 101.75 13.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.325 0.583 . . . . 74.25 111.72 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.634 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -82.82 -1.68 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.223 -0.898 . . . . 72.540000000000006 110.184 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -68.87 -67.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 64.099999999999994 111.362 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.413 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 27.6 m170 -124.2 11.08 8.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 64.400000000000006 111.521 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.438 ' N ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.88 59.78 47.03 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 111.465 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 16.6 Cg_exo -67.53 -46.46 2.72 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.476 2.117 . . . . 55.130000000000003 111.975 -177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -63.91 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 65.439999999999998 110.307 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.498 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -67.13 -41.04 86.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.391 -0.822 . . . . 75.25 110.495 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.634 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 18.5 t -58.52 -48.19 81.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 72.540000000000006 110.533 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -64.38 -34.61 78.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 72.239999999999995 111.275 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.45 ' O ' HD23 ' A' ' 42' ' ' LEU . 6.7 t30 -54.69 -52.36 62.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.021 0.439 . . . . 63.530000000000001 110.407 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HE1' HG21 ' A' ' 14' ' ' VAL . 27.4 t80 -67.71 -44.84 76.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.201 0.524 . . . . 70.239999999999995 109.911 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.52 -44.58 76.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.306 -0.861 . . . . 74.239999999999995 112.087 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.611 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.5 mt-10 -69.77 -38.78 76.86 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.11 -0.236 . . . . 75.109999999999999 111.19 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 38' ' ' ASN . 4.0 mm? -65.14 -26.92 68.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.82 0.343 . . . . 73.310000000000002 110.395 176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.93 -45.2 64.63 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.973 -0.558 . . . . 72.230000000000004 109.873 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.6 mtp180 -64.79 -31.24 72.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.987 -0.552 . . . . 75.450000000000003 111.063 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HD3' ' O ' ' A' ' 41' ' ' GLU . 9.1 mpt_? -73.01 -40.46 65.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.012 -0.366 . . . . 53.210000000000001 110.012 175.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.68 30.03 6.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.655 -0.784 . . . . 61.240000000000002 112.479 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -76.88 -17.01 59.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 72.420000000000002 111.385 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -74.3 -17.22 60.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -71.19 -8.52 54.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.058 0.456 . . . . 73.209999999999994 110.606 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -122.69 31.21 4.87 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.942 -0.647 . . . . 64.430000000000007 111.951 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.811 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 73.4 p -112.11 154.3 25.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 61.0 111.155 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.82 157.46 43.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 109.948 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CD1' ' HA3' ' A' ' 64' ' ' GLY . 97.9 m-85 -89.59 121.58 31.93 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 71.099999999999994 109.642 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -104.89 -35.6 7.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.53 -0.304 . . . . 72.340000000000003 111.803 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -113.41 112.96 24.51 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.686 -0.405 . . . . 72.239999999999995 110.356 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.65 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -125.99 94.33 2.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.179 -0.674 . . . . 74.430000000000007 109.179 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.851 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 24.2 mt -96.47 122.05 47.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.742 -0.663 . . . . 41.240000000000002 109.408 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 1.038 ' HD2' ' HB3' ' A' ' 146' ' ' GLU . 39.4 mtpt -53.49 120.93 6.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.525 0.516 . . . . 74.340000000000003 111.554 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 54.9 41.14 32.14 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.385 -0.825 . . . . 65.049999999999997 111.329 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.851 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 8.5 t80 -133.23 -80.59 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.775 -0.648 . . . . 74.409999999999997 109.46 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.678 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.6 ptt? -161.23 157.49 25.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.395 -0.82 . . . . 70.25 110.085 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 HG13 ' A' ' 56' ' ' ILE . 49.8 mt -127.11 101.39 7.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.409 -0.589 . . . . 73.099999999999994 109.409 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 37.7 tt0 -83.84 121.38 27.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.839 -0.619 . . . . 65.150000000000006 110.139 -177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA3' ' CD1' ' A' ' 53' ' ' PHE . . . -142.93 151.35 23.09 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.519 -0.848 . . . . 15.050000000000001 112.719 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.811 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 135.14 -148.93 19.78 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.548 -0.834 . . . . 75.450000000000003 112.051 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 t70 59.67 92.6 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 O-C-N 124.376 0.692 . . . . 72.030000000000001 111.145 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.9 Cg_endo -64.53 -20.59 65.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.042 2.495 . . . . 54.240000000000002 112.445 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 70' ' ' THR . 9.9 p -82.52 -27.56 31.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 71.349999999999994 111.422 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.17 26.59 68.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.91 -0.662 . . . . 72.040000000000006 111.685 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 72' ' ' ARG . 14.7 t -118.54 -24.09 6.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.487 0.185 . . . . 62.009999999999998 111.215 -177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.79 9.35 43.38 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 64.239999999999995 113.253 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 70' ' ' THR . 0.1 OUTLIER -150.38 21.77 0.83 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.99 0.424 . . . . 62.350000000000001 110.718 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.503 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -103.7 -176.15 25.91 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.748 -0.739 . . . . 74.129999999999995 112.234 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 110' ' ' SER . . . 83.37 161.27 31.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.578 -0.82 . . . . 62.009999999999998 111.645 -175.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' H ' HD11 ' A' ' 42' ' ' LEU . . . 58.98 16.3 4.56 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.094 0.473 . . . . 61.329999999999998 111.567 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.3 t -68.65 -12.55 61.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.987 -0.552 . . . . 74.150000000000006 110.941 -175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG13 ' N ' ' A' ' 78' ' ' TYR . 8.2 pt -64.55 -39.44 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 116.367 -0.378 . . . . 60.43 110.369 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.689 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 95.5 m-85 -75.02 -32.93 61.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.662 -0.496 . . . . 73.239999999999995 109.662 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.21 -17.37 8.0 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.548 -0.834 . . . . 73.420000000000002 112.93 173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -171.2 2.52 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.982 -0.377 . . . . 60.109999999999999 109.982 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -70.93 164.27 25.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 64.319999999999993 110.577 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -99.22 143.0 29.99 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 72.340000000000003 109.642 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 106' ' ' ASP . 35.1 tt0 -58.87 147.26 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.634 0.584 . . . . 70.409999999999997 110.726 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.443 ' HA ' HD21 ' A' ' 108' ' ' ASN . 11.2 p-10 -67.33 125.3 25.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.741 0.781 . . . . 55.039999999999999 110.611 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -117.77 29.36 7.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.644 -1.162 . . . . 74.140000000000001 108.361 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.9 mt -49.61 100.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.72 -1.127 . . . . 54.049999999999997 111.175 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.64 78.69 9.83 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.066 -0.516 . . . . 72.25 111.128 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.66 66.4 2.3 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.56 2.173 . . . . 74.010000000000005 111.638 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.99 -23.55 59.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.053 0.93 . . . . 63.340000000000003 109.436 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -89.13 166.42 13.85 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.462 -1.244 . . . . 74.530000000000001 108.879 174.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -113.71 141.58 47.08 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.278 -0.569 . . . . 63.329999999999998 110.836 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.96 70.42 0.76 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.968 . . . . 71.120000000000005 109.801 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 193' ' ' VAL . 37.1 p -62.7 -40.89 98.57 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.799 -1.091 . . . . 62.43 111.765 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.81 -144.73 4.09 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.761 -0.733 . . . . 75.530000000000001 111.911 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.05 144.02 27.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.798 0.332 . . . . 44.32 110.523 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.65 22.08 6.19 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.829 -0.7 . . . . 73.200000000000003 111.706 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.6 mm -88.39 114.03 26.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -89.86 120.28 30.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 109.746 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.33 160.92 30.67 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.948 -0.569 . . . . 64.540000000000006 110.257 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 111' ' ' GLN . 39.0 ttp -91.06 143.16 26.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.601 -0.518 . . . . 55.539999999999999 109.601 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.3 114.4 26.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.274 0.559 . . . . 33.229999999999997 110.975 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.463 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 2.9 p-10 -115.7 149.93 37.63 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.283 -0.871 . . . . 73.030000000000001 109.897 175.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.506 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -83.84 -28.01 28.32 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.258 -0.883 . . . . 64.450000000000003 111.285 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.37 -108.89 0.32 Allowed Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 120.912 -0.661 . . . . 43.450000000000003 112.147 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.06 89.93 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.892 2.395 . . . . 63.219999999999999 112.009 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 3.3 p30 48.1 31.11 2.35 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.878 -1.055 . . . . 64.25 111.898 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.506 ' HB ' ' H ' ' A' ' 103' ' ' ALA . 1.3 m -85.38 52.25 2.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.292 0.567 . . . . 41.340000000000003 109.996 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 19.0 m-80 -91.26 173.82 7.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.303 -0.862 . . . . 75.019999999999996 109.032 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.39 -96.71 0.13 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.353 -1.403 . . . . 75.540000000000006 114.234 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.536 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 46.9 t -126.87 12.19 7.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.391 0.615 . . . . 73.439999999999998 110.448 -170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 100' ' ' MET . 18.9 mp0 -101.14 147.04 26.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 74.400000000000006 109.474 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -147.21 176.09 10.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.809 0.338 . . . . 73.200000000000003 110.906 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.4 p90 -160.46 152.52 20.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.98 0.419 . . . . 63.530000000000001 110.202 174.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 98' ' ' LEU . 18.5 t -112.91 138.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.786 -0.643 . . . . 71.230000000000004 109.268 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.9 p -93.3 125.47 37.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.058 0.456 . . . . 54.329999999999998 109.999 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.4 mt -85.29 -6.46 59.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.59 -0.732 . . . . 71.230000000000004 110.357 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.41 161.14 34.78 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.338 -0.846 . . . . 71.349999999999994 109.997 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.43 113.7 2.38 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.644 2.229 . . . . 74.129999999999995 112.224 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 41.2 p -105.31 103.57 13.13 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.102 -0.499 . . . . 54.409999999999997 110.938 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -99.78 13.84 32.33 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.862 0.839 . . . . 64.140000000000001 109.479 -177.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.742 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -111.05 3.85 18.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.673 -1.149 . . . . 74.040000000000006 110.748 -178.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.742 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 95.2 mt -113.29 6.4 17.34 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.272 -0.422 . . . . 71.519999999999996 111.642 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.05 -31.72 43.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.536 -0.757 . . . . 62.43 112.132 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -125.51 20.49 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.496 -0.859 . . . . 73.099999999999994 111.691 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -116.71 -31.25 5.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.716 0.293 . . . . 74.129999999999995 110.656 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.463 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 35.1 m80 -142.27 141.14 32.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.314 . . . . 64.099999999999994 111.04 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.1 m -78.32 111.08 13.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 55.0 110.277 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 90' ' ' LEU . 38.6 mt -98.99 122.82 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.299999999999997 110.71 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.5 p90 -159.71 73.31 0.55 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.689 0.757 . . . . 71.329999999999998 110.898 176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.748 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.49 156.66 28.56 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.292 -1.432 . . . . 61.420000000000002 113.802 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.9 mtm180 -134.77 122.32 21.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.504 0.321 . . . . 75.129999999999995 110.282 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.7 p -83.64 138.69 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.036 0.446 . . . . 63.240000000000002 110.66 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.568 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 41.1 t -139.86 157.66 45.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 109.907 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.4 pt20 36.86 42.77 0.24 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.252 1.021 . . . . 64.430000000000007 113.18 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.76 17.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.455 -0.879 . . . . 74.420000000000002 112.509 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.536 ' H ' ' HB3' ' A' ' 184' ' ' ASP . 11.3 tp -74.34 -34.51 36.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.387 -0.227 . . . . 72.299999999999997 110.387 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.28 95.33 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.736 -0.745 . . . . 63.109999999999999 111.367 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -70.31 -50.79 35.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 110.114 -0.328 . . . . 75.140000000000001 110.114 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 23' ' ' ILE . 86.3 t -55.96 -30.58 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.043 0.449 . . . . 73.5 110.699 176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.533 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.8 t30 -70.48 -53.32 16.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.991 -0.55 . . . . 74.209999999999994 110.521 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.39 61.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.35 -0.386 . . . . 71.319999999999993 111.225 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.441 HG22 ' HE3' ' A' ' 20' ' ' MET . 50.6 t -83.47 -34.85 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.225 0.536 . . . . 55.340000000000003 109.733 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -79.53 -21.51 66.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.622 -0.799 . . . . 71.030000000000001 112.624 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.533 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 56.4 mtm -82.52 -23.96 34.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.944 0.35 . . . . 73.400000000000006 111.944 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.3 m -78.47 122.97 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.488 0.661 . . . . 61.420000000000002 110.196 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.038 ' HB3' ' HD2' ' A' ' 58' ' ' LYS . 8.4 pt-20 -90.42 -165.4 1.34 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.553 -0.749 . . . . 72.439999999999998 111.493 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 28.3 p -84.07 150.09 25.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.881 -0.6 . . . . 63.340000000000003 111.36 -178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 45.6 t30 -65.72 -30.9 71.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.674 0.749 . . . . 75.150000000000006 109.501 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 37.6 t -142.64 -80.67 0.21 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.98 -1.009 . . . . 74.129999999999995 108.91 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.404 ' C ' ' H ' ' A' ' 152' ' ' ARG . 9.4 pt20 -147.15 125.11 11.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.789 -0.642 . . . . 72.299999999999997 109.974 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 69.87 -13.26 0.42 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.326 0.65 . . . . 63.219999999999999 112.715 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 150' ' ' GLN . 2.7 ptm180 -107.76 108.07 61.06 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.461 -0.57 . . . . 71.540000000000006 109.461 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 23.4 Cg_endo -61.37 145.39 98.28 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.659 2.239 . . . . 74.239999999999995 112.284 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 146' ' ' GLU . 65.2 t -59.17 -54.0 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.189 0.518 . . . . 71.140000000000001 109.928 177.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -119.52 117.76 29.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.986 -0.746 . . . . 75.439999999999998 108.986 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -83.57 136.58 34.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.836 0.351 . . . . 74.340000000000003 110.298 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.3 p -122.82 126.51 73.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.688 0.756 . . . . 55.340000000000003 111.725 -175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -122.93 163.77 19.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.069 -0.969 . . . . 73.030000000000001 109.67 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -90.25 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.815 -1.18 . . . . 64.319999999999993 107.815 170.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.411 HD11 ' HB3' ' A' ' 19' ' ' SER . 32.2 mm -67.07 -53.5 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.693 -0.685 . . . . 75.120000000000005 110.618 -173.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.848 ' HG2' ' HB2' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -142.06 132.56 25.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.606 -0.724 . . . . 54.049999999999997 110.018 176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -133.46 146.15 50.88 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.787 0.327 . . . . 74.349999999999994 110.625 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 161' ' ' LYS . 85.0 m-85 -148.37 140.7 14.73 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.51 . . . . 75.010000000000005 109.822 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.452 ' HD3' ' OH ' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -78.15 132.49 11.54 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.186 1.924 . . . . 65.219999999999999 111.579 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.46 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 49.5 m -151.52 -163.9 1.86 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 61.020000000000003 111.249 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.46 137.13 4.41 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 121.015 -0.612 . . . . 70.230000000000004 111.682 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -115.6 141.76 17.14 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.898 -0.668 . . . . 54.420000000000002 111.751 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.27 123.25 4.91 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.618 -0.801 . . . . 72.019999999999996 111.948 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -85.03 111.48 3.52 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.536 -0.84 . . . . 62.420000000000002 111.472 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.8 m -59.72 101.36 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 64.219999999999999 110.862 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.02 -40.18 2.1 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.98 -0.555 . . . . 75.129999999999995 112.772 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 107.77 -5.31 34.72 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.253 -0.739 . . . . 72.129999999999995 111.253 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.21 -131.63 2.89 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.179 -0.768 . . . . 21.140000000000001 111.179 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.2 t -158.14 -68.0 0.09 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.765 -0.457 . . . . 43.450000000000003 109.765 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 166.83 -176.43 41.89 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.439 -0.664 . . . . 53.020000000000003 111.439 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.19 -55.02 4.55 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.884 -0.674 . . . . 34.43 112.485 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -128.97 -169.49 12.59 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.124 -0.56 . . . . 52.030000000000001 111.953 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.1 m -80.81 -27.64 36.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.863 0.363 . . . . 71.120000000000005 111.016 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 111.41 163.3 17.68 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.835 -0.698 . . . . 44.240000000000002 111.877 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.53 7.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.788 . . . . 71.430000000000007 112.412 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.4 52.78 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.045 -0.598 . . . . 60.130000000000003 112.385 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 m -150.13 93.03 1.95 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.37 . . . . 63.109999999999999 110.247 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -72.63 -63.07 3.0 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.726 -0.749 . . . . 74.450000000000003 112.156 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.573 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 19.2 m-20 -125.07 167.51 14.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.523 0.678 . . . . 74.219999999999999 111.445 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 158.67 140.86 3.01 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.654 -1.157 . . . . 62.140000000000001 110.463 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.31 -169.81 40.57 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.233 -0.984 . . . . 71.519999999999996 111.97 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -75.34 166.67 23.24 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 110.153 -0.314 . . . . 71.239999999999995 110.153 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.97 100.03 11.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.482 -0.562 . . . . 70.310000000000002 109.482 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 5.5 Cg_exo -79.55 -9.75 14.7 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.666 2.244 . . . . 64.420000000000002 112.188 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.424 ' HB2' HH11 ' A' ' 131' ' ' ARG . 37.0 tt0 -74.17 -32.43 63.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.407 0.622 . . . . 75.209999999999994 109.63 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.8 pt -85.69 162.33 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.445 -0.946 . . . . 74.129999999999995 108.445 173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -114.97 41.39 2.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.89 0.376 . . . . 74.319999999999993 111.25 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.6 p -109.57 -174.26 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.318 -0.623 . . . . 53.439999999999998 109.318 176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.738 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -115.84 114.38 24.66 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.646 0.26 . . . . 64.549999999999997 111.064 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.612 HE21 ' HB1' ' A' ' 187' ' ' ALA . 3.7 pm0 -155.12 152.97 30.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.46 -0.571 . . . . 70.409999999999997 109.46 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -121.39 139.82 30.34 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.545 -0.298 . . . . 72.010000000000005 110.402 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 19.7 Cg_endo -58.31 -57.9 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.937 2.424 . . . . 64.400000000000006 111.99 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -132.12 23.85 4.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 73.409999999999997 109.873 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 30.2 m-20 69.55 9.5 7.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.36 -0.836 . . . . 70.510000000000005 112.169 174.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.9 ptm -53.0 -40.33 63.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 72.439999999999998 112.002 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.38 61.95 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.855 -0.688 . . . . 72.099999999999994 113.318 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 19.6 mtp180 -94.84 -3.68 48.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.827 0.346 . . . . 75.409999999999997 110.685 177.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 203' ' ' LYS . 4.2 tppp? . . . . . 0 C--O 1.249 1.027 0 CA-C-N 114.604 -1.18 . . . . 62.100000000000001 112.142 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ppp? . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 120.845 0.355 . . . . 75.530000000000001 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.91 179.9 7.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.939 -0.573 . . . . 55.039999999999999 109.839 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -82.44 146.91 29.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.124 -0.324 . . . . 64.200000000000003 110.124 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 78' ' ' TYR . 51.8 mm 76.58 107.19 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.214 0 O-C-N 123.845 0.716 . . . . 73.340000000000003 110.368 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 2.8 Cg_endo -79.93 109.92 2.47 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.361 2.707 . . . . 71.120000000000005 112.936 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -86.02 87.87 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.134 2.556 . . . . 74.239999999999995 112.025 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -74.45 -44.19 52.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 110.582 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 m -125.27 -179.36 4.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.856 -0.611 . . . . 73.140000000000001 110.012 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -88.18 -23.76 23.51 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.23 -0.285 . . . . 71.150000000000006 110.23 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 2.1 mp0 72.25 130.12 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.1 0.875 . . . . 71.319999999999993 112.059 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 10' ' ' GLN . 31.0 Cg_exo -63.1 136.85 58.5 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.92 2.413 . . . . 72.129999999999995 111.931 176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 32.1 Cg_endo -65.15 -22.48 61.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.928 2.419 . . . . 71.319999999999993 113.052 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -124.21 138.97 54.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.055 0.455 . . . . 75.030000000000001 110.936 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 164' ' ' PRO . 20.9 m -128.99 157.35 41.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.778 -0.646 . . . . 74.219999999999999 109.418 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' CB ' HG12 ' A' ' 24' ' ' VAL . 55.4 p90 -115.14 132.12 56.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.367 0.603 . . . . 75.120000000000005 111.551 -178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.5 mt -110.32 109.13 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.086 -0.961 . . . . 62.420000000000002 110.25 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.13 112.39 23.85 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.19 -0.671 . . . . 74.019999999999996 109.19 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -104.68 178.89 4.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 110.682 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.482 ' HB3' HD11 ' A' ' 160' ' ' ILE . 12.9 p -80.44 -6.13 57.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.292 0.568 . . . . 75.239999999999995 110.463 176.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mmm -98.83 -41.58 7.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 60.240000000000002 109.565 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.01 -134.13 1.8 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.1 -0.8 . . . . 62.119999999999997 111.1 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -141.73 130.72 23.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.958 -0.756 . . . . 61.340000000000003 108.958 177.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 HG23 ' A' ' 139' ' ' VAL . 4.8 mp -132.15 124.9 53.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.841 -0.618 . . . . 74.329999999999998 110.122 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.612 HG12 ' CB ' ' A' ' 15' ' ' TYR . 3.2 m -106.48 146.85 12.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 120.272 -0.571 . . . . 65.109999999999999 109.767 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.47 162.01 37.62 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.982 0.42 . . . . 74.200000000000003 110.14 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -135.14 165.14 26.09 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.709 -0.678 . . . . 71.120000000000005 110.767 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.65 166.86 10.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.806 -0.634 . . . . 74.549999999999997 110.237 -174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -87.0 96.23 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.327 0.584 . . . . 71.439999999999998 111.635 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.402 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 42.0 m95 -88.82 1.9 54.49 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.256 -0.884 . . . . 72.209999999999994 109.511 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -74.11 -50.2 20.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 60.329999999999998 111.324 -177.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -137.97 8.63 2.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.494 -0.321 . . . . 75.319999999999993 111.426 -173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.84 85.54 57.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 74.120000000000005 110.503 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.07 -11.58 21.35 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.184 2.59 . . . . 71.140000000000001 113.002 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.66 -48.88 3.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 73.230000000000004 111.55 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.85 -35.93 73.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.836 -0.62 . . . . 65.200000000000003 111.194 -175.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 p -54.81 -53.22 58.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.816 -0.629 . . . . 75.239999999999995 111.609 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 6.0 mtmp? -81.81 -23.63 36.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.993 -0.549 . . . . 74.299999999999997 111.188 -172.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.499 ' O ' HD23 ' A' ' 42' ' ' LEU . 4.3 m-20 -52.06 -47.02 65.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.551 0.691 . . . . 70.25 109.221 171.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.513 ' HZ ' ' HB2' ' A' ' 100' ' ' MET . 19.2 m-85 -77.08 -49.57 15.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.378 -0.828 . . . . 74.319999999999993 110.834 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -57.25 -35.64 69.99 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.694 0.628 . . . . 63.5 112.694 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.852 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 49.0 mt-10 -88.0 -15.32 36.78 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.062 -0.399 . . . . 73.209999999999994 111.314 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.4 mm? -75.03 -20.87 59.4 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.031 -0.667 . . . . 73.310000000000002 109.299 164.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.521 ' HA ' ' HE1' ' A' ' 48' ' ' TYR . . . -74.52 -41.83 59.97 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.708 -0.678 . . . . 75.349999999999994 110.949 176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 1.3 ptp180 -67.79 -27.36 66.68 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.754 0.311 . . . . 75.010000000000005 110.552 176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.52 -39.17 77.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.687 -0.857 . . . . 73.019999999999996 108.687 172.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.89 15.42 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.633 -0.712 . . . . 74.239999999999995 111.477 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.6 ' HD2' ' HG3' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -72.79 -20.08 61.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 53.32 110.512 -173.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 78.0 m-85 -62.53 -28.54 69.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.811 -0.632 . . . . 74.140000000000001 111.177 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 29.1 m-80 -72.73 91.0 1.44 Allowed 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.963 0.887 . . . . 72.140000000000001 109.47 -177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 126.56 11.68 3.61 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 113.896 -1.502 . . . . 64.120000000000005 112.009 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.561 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 70.2 p -99.83 154.42 18.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.605 0.24 . . . . 63.549999999999997 110.569 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -130.69 155.86 45.89 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.471 -0.331 . . . . 74.319999999999993 110.722 -176.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.8 m-85 -81.75 109.51 16.22 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.944 -0.762 . . . . 70.299999999999997 108.944 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.02 -37.96 12.51 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.106 -0.497 . . . . 73.439999999999998 111.676 -171.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 17.0 mmt180 -112.12 114.14 26.81 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.239 -0.652 . . . . 75.140000000000001 109.239 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 53' ' ' PHE . 4.0 mp -124.19 89.21 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.06 -0.718 . . . . 64.310000000000002 109.06 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.3 mt -93.9 125.17 46.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.989 -0.745 . . . . 72.230000000000004 108.989 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 12.4 ptmm? -53.41 135.56 39.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 O-C-N 123.507 0.505 . . . . 75.340000000000003 110.946 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 42.68 37.01 0.91 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 124.213 0.946 . . . . 64.430000000000007 112.412 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.432 ' N ' ' HB2' ' A' ' 116' ' ' LEU . 2.7 m-85 -134.4 -80.44 0.45 Allowed 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 116.066 -0.515 . . . . 31.309999999999999 111.398 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.46 155.83 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.744 0.307 . . . . 65.129999999999995 111.065 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 116' ' ' LEU . 20.8 mt -132.3 106.36 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 75.430000000000007 110.004 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' OE1' ' HG2' ' A' ' 55' ' ' ARG . 44.4 tt0 -83.81 128.77 34.77 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.06 -0.348 . . . . 42.439999999999998 110.06 177.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -127.67 132.84 7.62 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.64 -0.79 . . . . 62.130000000000003 112.592 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 152.81 -112.79 0.55 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.55 -0.833 . . . . 21.329999999999998 113.452 176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 31.09 73.14 0.5 Allowed Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 74.430000000000007 113.364 -170.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.6 ' HG3' ' HD2' ' A' ' 47' ' ' TYR . 72.9 Cg_endo -78.84 -16.29 12.9 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.049 1.833 . . . . 71.129999999999995 111.543 174.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 p -105.18 -57.34 2.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.715 -0.675 . . . . 72.400000000000006 111.177 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.13 0.02 41.18 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.826 -0.702 . . . . 65.230000000000004 112.06 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 72' ' ' ARG . 1.9 t -80.95 -6.78 59.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 110.687 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.41 -25.51 26.72 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.624 -0.798 . . . . 65.329999999999998 112.55 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' CG ' HG23 ' A' ' 70' ' ' THR . 0.4 OUTLIER -94.21 -32.24 13.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.972 0.415 . . . . 62.039999999999999 111.414 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -161.45 15.34 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.625 -0.797 . . . . 73.230000000000004 111.58 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.61 -84.87 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.02 -0.61 . . . . 44.509999999999998 112.101 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 60.73 39.37 17.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.225 0.536 . . . . 35.409999999999997 111.272 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.4 m -55.78 -29.27 59.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.159 -0.928 . . . . 74.209999999999994 112.439 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.514 HG12 HD12 ' A' ' 4' ' ' ILE . 7.9 tt -73.95 -41.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.207 0.447 . . . . 63.340000000000003 112.207 -173.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.533 ' HB3' HD11 ' A' ' 4' ' ' ILE . 43.8 p90 -108.02 -8.69 15.8 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.338 -0.545 . . . . 74.230000000000004 112.215 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.12 -101.14 1.43 Allowed Glycine 0 C--N 1.329 0.169 0 C-N-CA 121.138 -0.553 . . . . 74.109999999999999 113.254 173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -69.12 163.78 24.04 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.518 -0.549 . . . . 55.43 109.518 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.652 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 1.6 mp0 -58.75 174.06 0.37 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.683 0.754 . . . . 74.099999999999994 112.257 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -116.88 155.73 28.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.088 -0.96 . . . . 73.120000000000005 109.424 -174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.55 159.42 8.36 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.522 0.514 . . . . 75.0 110.555 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HA ' HD21 ' A' ' 108' ' ' ASN . 6.6 p-10 -63.14 113.82 3.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.688 -175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -91.48 13.41 17.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.078 -0.965 . . . . 73.400000000000006 109.788 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.12 106.32 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.644 -0.707 . . . . 72.230000000000004 110.738 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -164.92 71.01 1.45 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.713 -0.676 . . . . 73.200000000000003 109.882 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -76.29 81.44 2.47 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.395 2.063 . . . . 64.129999999999995 113.094 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.96 -18.13 41.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.686 0.755 . . . . 75.239999999999995 109.793 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 189' ' ' PRO . 2.9 pp -87.55 177.27 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.105 -0.952 . . . . 74.439999999999998 108.819 173.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.663 ' HD2' ' HA ' ' A' ' 192' ' ' HIS . 2.9 tmtm? -137.23 135.37 37.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.838 0.351 . . . . 74.030000000000001 110.425 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' A' ' 120' ' ' GLN . 0.3 OUTLIER -63.98 89.56 0.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.916 0.865 . . . . 72.409999999999997 109.977 173.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 193' ' ' VAL . 16.4 p -71.72 -51.01 25.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.602 -1.181 . . . . 74.150000000000006 111.083 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -147.85 -132.9 2.27 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.615 -0.802 . . . . 72.409999999999997 111.998 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.16 147.06 24.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.824 0.345 . . . . 41.340000000000003 110.852 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.2 20.98 8.3 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.751 -0.738 . . . . 34.520000000000003 111.582 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -87.05 111.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.387 -0.597 . . . . 63.5 109.387 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -88.15 118.74 27.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.721 -0.672 . . . . 64.230000000000004 109.809 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.515 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.63 173.83 9.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.005 -0.543 . . . . 54.340000000000003 111.512 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.513 ' HB2' ' HZ ' ' A' ' 39' ' ' PHE . 25.2 ttt -101.25 128.59 47.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.335 -0.848 . . . . 65.230000000000004 109.982 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -90.76 114.55 26.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.612 0.72 . . . . 71.329999999999998 110.991 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.531 ' H ' ' HD2' ' A' ' 126' ' ' HIS . 3.9 p-10 -121.1 160.39 23.78 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.953 -1.021 . . . . 75.420000000000002 110.244 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.61 -25.31 16.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.152 -0.476 . . . . 31.210000000000001 110.832 -177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -152.75 -176.98 25.9 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.889 -1.285 . . . . 33.350000000000001 109.889 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.16 -53.72 5.98 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.338 2.692 . . . . 54.229999999999997 112.475 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.413 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 3.8 p30 -116.83 16.97 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.164 0.507 . . . . 73.329999999999998 110.671 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.468 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -92.73 53.55 2.06 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.261 -1.015 . . . . 71.230000000000004 108.261 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.416 HD21 ' HA ' ' A' ' 84' ' ' ASP . 36.2 m-80 -87.04 107.81 18.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.641 -1.163 . . . . 74.219999999999999 110.281 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -95.88 -166.01 34.41 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.195 -0.762 . . . . 73.230000000000004 111.195 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.2 m -100.22 67.12 1.35 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.908 -0.775 . . . . 70.049999999999997 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 69.2 mt-30 -124.83 147.76 48.58 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.111 -0.95 . . . . 53.329999999999998 110.174 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -120.4 155.81 32.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.427 -0.351 . . . . 71.239999999999995 110.919 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -153.76 141.74 20.26 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.111 -0.495 . . . . 75.230000000000004 110.37 168.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.732 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -110.94 142.43 23.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.602 -0.726 . . . . 72.230000000000004 109.424 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.58 127.04 41.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.903 0.382 . . . . 72.430000000000007 110.131 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 62' ' ' ILE . 65.3 mt -84.54 -9.03 58.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.773 -0.649 . . . . 55.43 109.859 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.0 157.7 31.96 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.107 -0.952 . . . . 71.510000000000005 109.556 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.421 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 27.5 Cg_exo -62.56 115.66 3.04 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.536 2.157 . . . . 52.530000000000001 112.264 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 p -105.77 106.92 17.65 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.006 0.431 . . . . 74.409999999999997 110.33 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp0? -97.34 20.71 11.13 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.381 0.61 . . . . 72.019999999999996 111.089 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.674 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -123.81 -1.77 8.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.314 -0.857 . . . . 75.310000000000002 110.337 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.674 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 97.9 mt -105.8 3.86 29.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.914 -0.584 . . . . 75.219999999999999 111.14 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.44 -23.68 67.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.455 -0.793 . . . . 74.420000000000002 111.134 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.29 18.4 7.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.686 -0.768 . . . . 63.450000000000003 111.504 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -115.49 -35.84 4.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.112 0.482 . . . . 71.109999999999999 109.708 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.531 ' HD2' ' H ' ' A' ' 102' ' ' ASN . 54.0 m80 -141.59 132.66 26.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.636 -0.711 . . . . 72.109999999999999 109.093 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.7 t -74.78 147.14 41.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 110.302 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.515 HG23 ' HB2' ' A' ' 99' ' ' ALA . 43.3 mt -123.97 119.57 57.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.004 -0.544 . . . . 75.400000000000006 110.388 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -156.32 72.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.447 . . . . 71.299999999999997 110.198 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -166.17 165.6 38.27 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.249 -0.74 . . . . 54.140000000000001 111.249 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -152.97 132.01 12.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 74.030000000000001 111.084 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' GLY . 5.2 p -79.94 144.6 10.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.316 -0.856 . . . . 45.219999999999999 110.716 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.594 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 42.7 t -139.23 151.99 46.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.175 -0.466 . . . . 42.399999999999999 109.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.4 tt0 45.42 42.15 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.59 0.556 . . . . 73.150000000000006 111.893 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 27.39 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.206 -0.997 . . . . 62.119999999999997 112.397 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.465 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.3 tp -81.92 -31.19 10.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.898 -0.408 . . . . 75.409999999999997 109.898 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.85 91.72 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.786 -0.721 . . . . 12.32 111.39 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 69.8 mmm -68.28 -49.58 59.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.233 -0.284 . . . . 63.229999999999997 110.233 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.437 HG23 HG12 ' A' ' 23' ' ' ILE . 95.0 t -55.84 -30.53 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.251 0.548 . . . . 72.109999999999999 110.502 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -70.12 -52.62 22.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.717 -0.674 . . . . 72.019999999999996 110.709 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.3 OUTLIER -72.92 -14.73 61.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 74.450000000000003 111.481 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 145' ' ' VAL . 63.6 t -89.95 -35.23 7.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.98 0.419 . . . . 74.109999999999999 110.492 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -81.33 -11.83 82.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 63.299999999999997 112.867 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 ptp -95.67 0.65 52.91 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.573 0.225 . . . . 72.400000000000006 111.235 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.5 m -65.24 144.27 14.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.478 0.656 . . . . 73.420000000000002 111.958 -177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.79 -169.84 1.69 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.525 -0.761 . . . . 73.25 109.439 175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.1 p -60.29 143.27 53.21 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.691 0.281 . . . . 70.319999999999993 110.97 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -66.94 -59.47 3.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.17 0.509 . . . . 61.350000000000001 110.512 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 24.5 m -157.39 158.94 36.84 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.691 -0.855 . . . . 62.340000000000003 108.691 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 52.05 25.6 3.29 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.235 0.457 . . . . 75.340000000000003 112.235 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.47 29.91 19.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.062 0.545 . . . . 70.439999999999998 111.891 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 149' ' ' SER . 5.5 ptm180 -98.79 130.66 27.23 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.073 -1.084 . . . . 73.209999999999994 108.073 171.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.83 144.96 75.07 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.397 2.065 . . . . 65.230000000000004 111.325 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.36 -61.53 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 110.279 -0.267 . . . . 73.319999999999993 110.279 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.3 t70 69.47 -43.08 0.52 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.007 0.817 . . . . 74.109999999999999 112.523 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -78.88 64.45 3.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.601 0.715 . . . . 64.310000000000002 111.305 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.1 t -121.9 115.5 46.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.618 -1.253 . . . . 64.319999999999993 107.618 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 2.3 mppt? -128.48 156.01 43.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.027 -0.669 . . . . 73.140000000000001 111.877 -166.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -86.33 104.23 13.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.694 -1.139 . . . . 75.510000000000005 108.199 168.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.684 HG22 ' HD3' ' A' ' 161' ' ' LYS . 32.2 mm -69.37 -58.36 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.909 -0.587 . . . . 73.510000000000005 110.6 -174.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.684 ' HD3' HG22 ' A' ' 160' ' ' ILE . 3.9 mppt? -132.13 139.4 48.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.73 -0.668 . . . . 71.239999999999995 110.131 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . . . -138.92 127.3 22.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.291 -0.413 . . . . 75.239999999999995 110.69 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 161' ' ' LYS . 42.6 m-85 -140.22 155.06 70.52 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.7 Cg_exo -71.86 138.28 31.18 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.709 1.606 . . . . 72.319999999999993 110.364 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.2 t -76.48 -40.42 50.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 73.019999999999996 111.152 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.73 -106.26 2.69 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.59 -0.814 . . . . 63.149999999999999 111.5 -177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -78.47 -55.8 3.84 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.663 -0.779 . . . . 73.409999999999997 111.771 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.93 102.92 2.48 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.943 -0.646 . . . . 70.230000000000004 111.773 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.0 72.27 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.852 -0.69 . . . . 62.100000000000001 111.876 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.9 t -111.45 -170.89 1.73 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.685 0.278 . . . . 73.129999999999995 110.259 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 115.68 98.38 2.14 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.013 -0.613 . . . . 74.239999999999995 112.021 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -94.06 73.87 1.12 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.815 -0.707 . . . . 43.450000000000003 111.784 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -85.47 47.65 3.86 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 121.132 -0.556 . . . . 71.340000000000003 112.663 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.9 m -107.0 103.4 12.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.816 -0.438 . . . . 74.519999999999996 109.816 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 136.08 -172.63 22.27 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.484 -0.647 . . . . 74.530000000000001 111.484 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.16 -72.25 1.4 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.288 -0.482 . . . . 44.32 112.667 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 166.93 -89.37 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.608 -0.597 . . . . 75.519999999999996 111.608 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.3 m -96.41 -36.19 10.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.213 0.53 . . . . 61.020000000000003 109.741 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 167.98 -170.51 41.96 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.058 -0.817 . . . . 64.219999999999999 111.058 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.82 47.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.267 -0.968 . . . . 53.109999999999999 112.712 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -162.35 178.05 38.29 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.753 -0.737 . . . . 72.310000000000002 111.823 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.5 m -117.12 -5.16 11.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.953 0.406 . . . . 71.200000000000003 110.426 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.74 97.7 0.21 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.306 -1.118 . . . . 64.400000000000006 110.306 -174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -77.17 169.88 17.53 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.008 0.908 . . . . 62.329999999999998 111.857 -171.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 140.17 142.41 4.19 Favored Glycine 0 N--CA 1.426 -2.026 0 CA-C-N 113.82 -1.536 . . . . 61.100000000000001 111.263 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.94 172.06 54.1 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.691 -0.766 . . . . 63.409999999999997 111.656 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.786 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -66.36 148.59 51.64 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.848 -0.427 . . . . 62.030000000000001 109.848 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -80.1 107.18 6.29 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.372 -0.377 . . . . 73.319999999999993 110.185 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.632 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.3 Cg_exo -79.97 -5.84 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.762 2.308 . . . . 53.240000000000002 111.594 -178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.65 -22.29 60.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 71.400000000000006 110.446 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.426 HD12 HG12 ' A' ' 193' ' ' VAL . 8.0 pt -97.16 172.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.268 -0.641 . . . . 65.430000000000007 109.268 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . 0.663 ' HA ' ' HD2' ' A' ' 91' ' ' LYS . 63.9 m170 -121.24 27.4 8.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.054 0.454 . . . . 72.540000000000006 111.111 -175.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 194' ' ' ALA . 4.0 p -111.87 167.22 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.144 -176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.429 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -89.22 108.68 19.75 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.924 0.392 . . . . 61.32 111.375 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -152.2 150.11 29.48 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.241 -0.651 . . . . 71.019999999999996 109.241 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -127.08 151.68 74.65 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.678 -0.237 . . . . 73.310000000000002 110.955 -173.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.2 Cg_endo -66.38 -70.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.59 2.193 . . . . 75.140000000000001 111.864 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -114.99 16.41 17.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.033 0.444 . . . . 73.439999999999998 110.236 175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 202' ' ' ARG . 11.2 m-20 70.17 7.57 6.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.35 -0.841 . . . . 74.310000000000002 113.127 171.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.8 -31.18 71.38 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.884 0.327 . . . . 72.030000000000001 111.884 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.14 -1.14 87.6 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.808 -0.711 . . . . 50.119999999999997 112.907 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 199' ' ' ASP . 69.8 mtp180 -80.98 -21.52 40.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 53.119999999999997 111.145 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.612 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.522 -0.763 . . . . 63.409999999999997 111.583 -176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.744 0.307 . . . . 73.239999999999995 110.707 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.91 137.61 54.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.677 -0.49 . . . . 54.030000000000001 109.677 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.57 84.26 6.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.686 -0.234 . . . . 61.350000000000001 111.528 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt 66.3 102.66 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 O-C-N 123.907 0.754 . . . . 61.030000000000001 112.364 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.02 116.48 4.41 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.223 1.949 . . . . 73.230000000000004 111.422 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.11 31.41 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.037 2.491 . . . . 73.219999999999999 112.125 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -77.67 108.03 10.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.724 . . . . 74.329999999999998 109.641 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.5 p -142.75 128.96 19.84 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.563 -0.29 . . . . 71.340000000000003 111.441 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -95.65 -1.61 49.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.015 -0.539 . . . . 74.420000000000002 110.265 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG2' ' HB3' ' A' ' 44' ' ' ARG . 2.6 mp0 -59.26 147.62 74.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.43 -0.804 . . . . 72.450000000000003 111.343 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 13.3 Cg_exo -70.52 155.21 63.91 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.072 2.514 . . . . 73.329999999999998 112.161 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.5 -2.16 11.36 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.083 2.522 . . . . 45.329999999999998 112.886 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.576 HD21 HG12 ' A' ' 24' ' ' VAL . 24.5 t-20 -121.09 144.65 48.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 110.275 -175.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 32.1 m -135.32 150.88 29.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.431 . . . . 65.25 111.05 -177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 28.3 m-85 -103.28 119.71 39.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.832 -0.622 . . . . 74.430000000000007 111.018 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.67 105.03 14.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.063 0.459 . . . . 65.420000000000002 110.797 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' HG12 ' A' ' 22' ' ' ILE . 37.3 mt-10 -90.0 118.23 29.4 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.965 -0.754 . . . . 73.25 108.965 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -108.34 178.15 4.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 73.010000000000005 111.106 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 160' ' ' ILE . 33.2 t -79.55 6.67 9.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.98 -0.554 . . . . 73.349999999999994 110.431 176.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.602 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.8 mmt -113.56 -38.28 4.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.918 -0.583 . . . . 70.150000000000006 110.171 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.01 -132.69 1.74 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.268 -0.733 . . . . 74.540000000000006 111.268 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -139.64 131.34 33.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.17 -0.678 . . . . 64.120000000000005 109.17 177.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -123.47 124.19 69.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.584 -0.735 . . . . 71.310000000000002 110.095 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.576 HG12 HD21 ' A' ' 13' ' ' ASN . 20.7 t -99.42 133.6 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.171 -0.677 . . . . 62.240000000000002 109.171 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 3.9 pp -142.04 161.86 36.94 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.502 -0.479 . . . . 65.209999999999994 110.859 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.51 166.07 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.903 -0.59 . . . . 73.150000000000006 109.57 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -107.49 161.28 14.98 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.094 -0.706 . . . . 61.340000000000003 109.094 178.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 7.0 m-85 -84.62 97.04 9.39 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.668 0.747 . . . . 74.219999999999999 111.216 176.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 36' ' ' CYS . 15.0 m95 -88.78 9.88 22.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.45 -1.315 . . . . 73.319999999999993 107.45 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.17 -55.0 5.42 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 113.413 -1.721 . . . . 74.129999999999995 110.603 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -132.85 1.75 3.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.177 0.436 . . . . 74.150000000000006 112.177 -178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.68 77.97 29.35 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.049 -0.26 . . . . 61.200000000000003 110.339 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 7.3 Cg_exo -73.8 -9.7 22.66 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.237 2.624 . . . . 51.149999999999999 113.164 -173.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -100.37 -51.99 3.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.31 0.576 . . . . 65.099999999999994 109.957 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.49 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -61.2 -39.77 91.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.95 -1.023 . . . . 74.549999999999997 111.574 -175.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 29' ' ' TRP . 26.0 p -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.325 -0.398 . . . . 75.239999999999995 110.767 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.4 mmmm -63.47 -41.07 98.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.626 -0.261 . . . . 72.239999999999995 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' O ' HD23 ' A' ' 42' ' ' LEU . 65.5 t30 -60.25 -47.84 84.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.358 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 11.3 t80 -65.24 -52.21 55.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.205 0.526 . . . . 74.329999999999998 110.131 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.17 81.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.294 -0.866 . . . . 65.450000000000003 112.181 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 44.3 mt-10 -77.53 -24.11 50.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.926 -0.309 . . . . 73.530000000000001 111.723 -176.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 38' ' ' ASN . 2.9 mm? -74.4 -27.54 60.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.168 0.508 . . . . 64.129999999999995 109.878 171.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.94 -41.27 71.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.809 -0.632 . . . . 72.140000000000001 110.573 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.678 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 8.4 ppt_? -79.7 -15.36 57.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 72.200000000000003 110.768 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -74.92 -32.93 61.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.045 -0.724 . . . . 71.140000000000001 109.045 172.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.97 31.19 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.817 -0.706 . . . . 74.010000000000005 111.791 177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.627 ' HE1' ' HA3' ' A' ' 74' ' ' GLY . 6.2 t80 -76.63 -39.39 52.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.602 -0.299 . . . . 74.230000000000004 111.268 -175.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -74.84 -15.51 60.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 112.162 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -76.3 90.65 3.19 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.725 0.774 . . . . 74.230000000000004 109.151 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 127.39 8.55 4.41 Favored Glycine 0 C--N 1.301 -1.414 0 CA-C-N 114.351 -1.295 . . . . 73.150000000000006 112.138 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.3 p -97.31 158.72 15.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.01 -0.367 . . . . 71.5 110.01 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -136.51 167.11 22.0 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.432 -0.507 . . . . 73.150000000000006 110.479 -177.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 86.0 m-85 -83.35 118.87 23.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.943 -0.571 . . . . 71.209999999999994 109.548 175.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -92.3 -32.66 14.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.034 -0.53 . . . . 74.299999999999997 110.11 -172.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -121.72 120.86 35.89 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.961 -0.385 . . . . 72.109999999999999 109.961 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -131.82 95.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.083 -0.71 . . . . 61.119999999999997 109.083 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.6 mt -102.38 125.13 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 116.167 -0.469 . . . . 74.200000000000003 109.878 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.4 OUTLIER -55.15 134.51 49.54 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.61 0.569 . . . . 61.329999999999998 110.945 178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 41.15 44.16 2.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.4 1.062 . . . . 74.319999999999993 112.254 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -138.3 -81.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.735 -0.666 . . . . 72.150000000000006 110.056 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 ptp -160.96 156.9 25.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.688 -0.687 . . . . 61.409999999999997 110.307 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.512 HG23 HG13 ' A' ' 56' ' ' ILE . 37.4 mt -134.77 105.67 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 63.439999999999998 109.857 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.1 tm0? -84.48 128.71 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 74.519999999999996 110.181 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -124.97 147.88 16.6 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.13 -0.557 . . . . 63.039999999999999 112.61 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.27 -125.32 3.02 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 111.618 -0.593 . . . . 75.209999999999994 111.618 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.8 t0 42.15 84.08 0.19 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.947 0.899 . . . . 72.239999999999995 113.125 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.614 ' HG3' ' CE1' ' A' ' 47' ' ' TYR . 85.1 Cg_endo -79.17 -26.98 4.75 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.635 2.223 . . . . 72.340000000000003 111.729 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 20.1 p -84.11 -39.35 19.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.179 -0.919 . . . . 74.129999999999995 111.664 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.23 21.61 14.86 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.774 -0.931 . . . . 74.430000000000007 110.774 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.8 p -113.43 -24.88 9.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.534 . . . . 73.400000000000006 110.576 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.21 -13.46 65.78 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.659 -0.7 . . . . 75.450000000000003 111.832 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.31 15.51 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.18 0.514 . . . . 73.140000000000001 110.208 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.491 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -77.02 170.16 55.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.52 -0.763 . . . . 62.140000000000001 112.199 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.627 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . 69.43 -175.76 32.59 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.945 -0.645 . . . . 64.349999999999994 112.547 -175.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . 56.3 19.75 4.17 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.236 0.614 . . . . 70.329999999999998 112.354 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m -84.26 -1.36 55.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.64 -0.709 . . . . 71.120000000000005 110.746 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.6 tt -61.75 -37.84 79.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.743 -0.662 . . . . 73.230000000000004 111.358 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.617 ' HD1' HG23 ' A' ' 77' ' ' ILE . 21.6 p90 -103.22 4.16 36.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.217 0.532 . . . . 73.450000000000003 110.957 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.82 -108.99 2.84 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.342 -0.845 . . . . 72.150000000000006 112.467 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -89.97 -166.15 1.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.752 0.31 . . . . 71.140000000000001 110.233 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -60.62 161.06 8.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.844 -0.616 . . . . 75.329999999999998 109.772 171.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -100.5 -71.53 0.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.177 0.513 . . . . 73.209999999999994 111.179 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 14.0 tp10 -151.19 -168.31 3.06 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.802 -1.555 . . . . 65.239999999999995 106.802 -176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.827 ' HB2' ' HA ' ' A' ' 106' ' ' ASP . 0.9 OUTLIER -136.55 119.54 16.42 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.606 -0.887 . . . . 72.120000000000005 108.606 162.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -100.37 29.65 4.27 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.378 -1.283 . . . . 74.519999999999996 110.486 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 31.3 mt -48.89 99.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.376 -0.829 . . . . 33.350000000000001 111.823 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -170.69 83.63 0.54 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.61 -1.177 . . . . 75.439999999999998 108.839 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.9 84.13 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.284 1.99 . . . . 72.530000000000001 111.337 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.94 -18.15 59.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.329 1.061 . . . . 62.030000000000001 108.873 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.673 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -104.16 165.61 10.94 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.332 -1.304 . . . . 62.409999999999997 108.79 172.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -119.3 144.37 46.85 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.426 -0.352 . . . . 74.030000000000001 110.143 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.681 ' CZ ' ' HB3' ' A' ' 120' ' ' GLN . 51.4 p90 -71.33 115.31 10.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.197 -1.038 . . . . 72.019999999999996 108.197 174.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 189' ' ' PRO . 77.2 p -99.82 -30.83 11.83 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.832 -0.622 . . . . 71.329999999999998 110.104 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.42 -148.8 5.87 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.063 -0.971 . . . . 64.540000000000006 110.94 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.56 144.61 30.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.74 0.305 . . . . 61.420000000000002 111.02 175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.58 22.93 5.87 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.812 -0.709 . . . . 71.430000000000007 111.993 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 7.9 mm -91.39 115.06 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.785 -0.366 . . . . 51.140000000000001 110.048 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.697 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 6.8 mt -83.1 124.78 30.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.233 -0.44 . . . . 74.400000000000006 111.115 176.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.82 171.73 13.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.103 0.478 . . . . 52.109999999999999 111.367 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.652 ' SD ' ' HB2' ' A' ' 108' ' ' ASN . 24.1 tpp -86.11 137.81 32.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.618 -0.719 . . . . 74.049999999999997 111.033 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -92.75 113.46 25.75 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.451 0.644 . . . . 75.0 110.346 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -147.6 -169.58 3.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.002 -0.999 . . . . 70.109999999999999 109.03 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.54 -41.58 4.78 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.846 -0.342 . . . . 70.310000000000002 111.026 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.3 -55.23 0.49 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.504 -0.855 . . . . 75.439999999999998 112.474 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.37 77.51 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.022 1.814 . . . . 45.109999999999999 112.099 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.827 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 3.5 p-10 44.93 48.26 9.31 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.685 0.615 . . . . 74.420000000000002 112.13 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.44 29.82 7.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.943 -0.571 . . . . 72.349999999999994 111.082 -174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.652 ' HB2' ' SD ' ' A' ' 100' ' ' MET . 23.6 p30 -93.67 161.78 14.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.965 0.412 . . . . 64.129999999999995 110.915 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -165.08 -118.21 0.43 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 52.119999999999997 112.284 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 5.5 t -105.4 16.92 24.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.377 0.608 . . . . 64.519999999999996 109.944 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.444 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 72.2 mm-40 -93.87 145.28 24.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 61.210000000000001 109.375 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -145.44 170.88 15.51 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.102 -0.373 . . . . 71.409999999999997 110.394 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 28.6 p90 -157.05 152.76 26.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.955 0.407 . . . . 74.439999999999998 111.042 173.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.48 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.4 t -107.14 146.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 72.120000000000005 109.757 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.6 p -100.14 124.26 45.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.875 -0.417 . . . . 72.549999999999997 109.875 177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.521 HD11 ' HA3' ' A' ' 143' ' ' GLY . 73.9 mt -85.58 -8.14 58.45 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.709 -0.678 . . . . 74.319999999999993 111.117 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.621 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.21 167.0 14.56 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.044 -0.526 . . . . 55.340000000000003 110.556 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.621 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 17.8 Cg_endo -60.35 113.08 1.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.804 2.336 . . . . 72.329999999999998 111.945 175.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.413 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 31.0 p -107.12 102.36 11.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.037 -0.529 . . . . 42.329999999999998 111.67 -175.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.698 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.8 OUTLIER -108.43 18.04 21.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.695 0.76 . . . . 75.420000000000002 109.921 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -113.86 -3.5 13.43 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.049 -0.978 . . . . 72.540000000000006 111.515 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.7 pp -125.98 9.57 7.51 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.514 -0.474 . . . . 75.019999999999996 112.111 -175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.51 -32.61 51.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.456 0.646 . . . . 71.150000000000006 111.225 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -119.79 22.75 8.56 Favored Glycine 0 CA--C 1.509 -0.339 0 CA-C-N 115.423 -0.808 . . . . 60.100000000000001 111.68 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.8 mmtm -114.7 -38.71 3.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.306 0.574 . . . . 62.119999999999997 109.496 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -137.1 129.45 29.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.39 -0.823 . . . . 73.349999999999994 108.956 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -75.25 144.97 42.3 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.047 -0.661 . . . . 63.119999999999997 109.568 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.422 ' O ' HD21 ' A' ' 90' ' ' LEU . 44.2 mt -115.35 125.42 72.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.172 -0.467 . . . . 71.200000000000003 110.945 -171.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.3 p90 -154.18 72.83 0.9 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.964 0.888 . . . . 71.310000000000002 110.895 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.697 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -165.58 160.15 33.49 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.923 -1.608 . . . . 71.439999999999998 114.326 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 28' ' ' TYR . 26.1 mtm180 -141.87 126.35 17.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.498 . . . . 72.200000000000003 109.748 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.0 p -91.42 136.13 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.274 0.559 . . . . 71.120000000000005 110.907 177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.581 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 38.4 t -141.16 147.73 38.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.045 -0.525 . . . . 62.439999999999998 109.992 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.618 ' HG3' ' HA3' ' A' ' 183' ' ' GLY . 12.5 tt0 52.42 35.41 17.41 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.124 0.488 . . . . 73.209999999999994 112.158 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -174.48 27.83 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.28 -0.962 . . . . 53.350000000000001 112.734 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -75.13 -38.71 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.721 -0.282 . . . . 75.120000000000005 110.299 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.66 -32.08 82.23 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.015 -0.612 . . . . 71.319999999999993 111.94 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.475 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.0 mmm -69.53 -52.0 30.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.962 -0.384 . . . . 73.010000000000005 109.962 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 23' ' ' ILE . 93.0 t -58.07 -29.69 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.143 0.497 . . . . 65.120000000000005 110.409 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.651 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -68.0 -55.61 11.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.882 -0.599 . . . . 73.120000000000005 109.975 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -14.92 61.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.176 -0.466 . . . . 65.209999999999994 111.288 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.725 HG13 HG21 ' A' ' 157' ' ' VAL . 30.4 t -78.61 -39.24 22.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.325 0.583 . . . . 75.349999999999994 109.544 173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -80.49 -21.07 65.09 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.564 -0.827 . . . . 33.43 112.642 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 85.3 mtp -72.8 -17.03 61.61 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.945 0.35 . . . . 75.319999999999993 111.945 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.562 ' HB ' HG21 ' A' ' 154' ' ' VAL . 34.4 m -92.96 128.36 44.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.424 0.63 . . . . 72.439999999999998 111.372 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 4.1 pt-20 -111.46 -60.07 1.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.529 -0.76 . . . . 74.510000000000005 110.873 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 2.9 p -122.78 153.83 39.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 75.140000000000001 111.536 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.955 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 54.8 t30 -75.66 -48.32 22.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.552 -0.749 . . . . 75.209999999999994 110.449 -176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.6 t -166.9 -57.47 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.183 -0.917 . . . . 64.209999999999994 109.14 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -90.85 -155.61 0.4 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.621 -0.718 . . . . 75.019999999999996 110.234 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -76.7 29.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.159 0.584 . . . . 75.329999999999998 112.482 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 2.1 ptp180 -135.55 142.61 41.74 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.733 0.301 . . . . 74.310000000000002 110.867 -176.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 46.1 Cg_exo -57.44 152.24 48.33 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.753 2.302 . . . . 73.439999999999998 111.677 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.955 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 45.5 t -50.23 -69.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 123.577 0.548 . . . . 75.209999999999994 111.687 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -169.25 150.68 4.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.368 -0.975 . . . . 62.030000000000001 108.368 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.588 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 11.3 p-10 -77.12 114.38 15.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.922 -0.77 . . . . 74.239999999999995 108.922 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.725 HG21 HG13 ' A' ' 142' ' ' VAL . 40.9 t -74.13 126.26 34.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.559 -0.534 . . . . 65.310000000000002 109.559 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -125.96 158.88 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.278 0.561 . . . . 72.319999999999993 111.924 -176.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.1 mp -88.27 106.2 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.578 -1.192 . . . . 71.430000000000007 109.133 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 19' ' ' SER . 26.0 mm -71.67 -53.81 19.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.846 -0.616 . . . . 74.25 110.41 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.8 mptm? -129.9 137.98 50.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.726 -0.67 . . . . 71.219999999999999 109.843 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -146.06 110.23 4.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.019 0.437 . . . . 60.409999999999997 110.911 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.34 140.85 31.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.533 -0.758 . . . . 71.519999999999996 110.738 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.687 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 39.2 Cg_endo -67.8 135.24 34.85 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.604 2.203 . . . . 72.209999999999994 111.855 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.482 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 9.1 t -164.34 -173.1 2.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.206 -0.294 . . . . 65.319999999999993 110.206 -177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -92.62 98.73 2.44 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.918 -0.658 . . . . 71.349999999999994 112.489 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 15' ' ' TYR . . . -97.59 109.29 3.8 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.852 -0.689 . . . . 62.340000000000003 112.154 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -152.63 166.09 31.18 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.95 -0.643 . . . . 70.319999999999993 112.224 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 182' ' ' SER . . . -123.75 142.08 14.03 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.847 -0.692 . . . . 62.020000000000003 111.978 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.8 m -87.49 110.06 20.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.954 0.406 . . . . 64.120000000000005 110.57 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.94 -144.99 18.17 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.869 -0.682 . . . . 31.34 111.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 163.58 -134.74 3.5 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.595 -0.812 . . . . 63.350000000000001 112.082 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -71.28 105.15 1.57 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.957 -0.639 . . . . 64.120000000000005 112.595 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.0 t -54.3 -49.64 69.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.739 0.304 . . . . 75.030000000000001 110.775 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.21 -88.41 0.14 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.575 -0.821 . . . . 41.229999999999997 112.559 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -116.15 28.13 7.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.04 -0.6 . . . . 74.340000000000003 111.849 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -165.75 166.98 38.86 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.44 -0.664 . . . . 32.100000000000001 111.44 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.5 p -78.16 129.31 35.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.96 0.41 . . . . 74.200000000000003 110.45 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.08 147.52 5.07 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.406 -0.677 . . . . 55.420000000000002 111.406 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.67 165.27 39.37 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.781 -0.723 . . . . 54.109999999999999 112.359 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 96.11 -165.43 24.09 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.613 -0.803 . . . . 72.430000000000007 111.711 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.404 ' HB2' ' HA2' ' A' ' 169' ' ' GLY . 36.9 m -154.47 121.5 5.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.92 0.39 . . . . 23.539999999999999 110.635 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.618 ' HA3' ' HG3' ' A' ' 134' ' ' GLN . . . 78.6 -91.79 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.915 -0.659 . . . . 64.420000000000002 113.4 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.445 ' CG ' HG22 ' A' ' 136' ' ' ILE . 0.6 OUTLIER -166.29 -163.43 0.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.73 -0.471 . . . . 70.549999999999997 109.73 -171.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 160.55 140.95 3.0 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.859 -0.686 . . . . 50.340000000000003 112.518 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -83.5 -163.0 34.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.424 -0.893 . . . . 53.119999999999997 112.049 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.689 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.07 160.67 27.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.801 0.334 . . . . 55.030000000000001 110.474 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.482 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.9 m-85 -106.82 100.04 29.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 121.088 0.47 . . . . 74.109999999999999 110.144 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.673 ' HB2' HD12 ' A' ' 90' ' ' LEU . 4.8 Cg_exo -76.81 -6.37 16.76 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.155 2.57 . . . . 72.299999999999997 113.0 -173.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -81.87 -29.92 32.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.511 -0.313 . . . . 72.299999999999997 111.057 -174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.0 pt -76.52 -19.01 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.991 0.367 . . . . 64.129999999999995 111.991 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.4 m170 67.63 48.43 1.08 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 72.140000000000001 111.916 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.462 HG12 HG13 ' A' ' 191' ' ' ILE . 7.3 p -152.34 141.33 14.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.494 -0.321 . . . . 74.099999999999994 110.267 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.64 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 44.409999999999997 111.704 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.439 ' NE2' HD11 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -163.37 136.5 5.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.737 -0.665 . . . . 74.239999999999995 109.339 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -109.1 146.84 34.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.345 -0.389 . . . . 75.329999999999998 111.292 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 36.0 Cg_endo -65.6 -62.58 0.08 OUTLIER 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 122.806 2.337 . . . . 72.25 112.418 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -134.57 26.49 3.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.565 -0.289 . . . . 74.150000000000006 111.013 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 202' ' ' ARG . 71.5 m-20 68.31 12.58 8.8 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.266 -0.425 . . . . 71.530000000000001 111.708 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.6 ptm -60.5 -24.0 64.96 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.229 0.455 . . . . 72.140000000000001 112.229 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -114.45 18.15 18.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.593 -0.813 . . . . 72.430000000000007 112.327 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 29.0 mmt180 -66.56 -34.44 77.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.443 . . . . 70.120000000000005 110.62 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.09 -0.957 . . . . 71.329999999999998 109.875 -177.197 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.978 -0.378 . . . . 74.540000000000006 109.978 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.01 -59.24 2.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 110.649 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.57 155.56 34.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 42.310000000000002 109.648 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.489 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 58.0 mt 67.16 101.76 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 123.774 0.671 . . . . 74.120000000000005 110.683 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.07 131.02 12.69 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.73 2.286 . . . . 70.120000000000005 113.378 -172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.89 168.5 22.84 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.621 2.214 . . . . 75.230000000000004 111.145 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.69 35.1 22.25 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.669 -0.493 . . . . 72.010000000000005 109.669 -173.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.826 ' HB2' ' HD2' ' A' ' 37' ' ' LYS . 1.4 m -54.83 115.37 2.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.374 -0.83 . . . . 72.219999999999999 110.805 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -82.55 9.23 9.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.454 -0.794 . . . . 75.120000000000005 112.76 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.476 ' CD ' ' HD2' ' A' ' 44' ' ' ARG . 2.2 mp0 -64.78 124.77 87.33 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.096 -0.502 . . . . 74.239999999999995 110.561 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HD2' ' HB2' ' A' ' 164' ' ' PRO . 79.1 Cg_exo -50.0 149.29 11.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.418 2.745 . . . . 75.530000000000001 113.019 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 58.8 Cg_endo -70.99 -7.55 21.68 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.125 2.55 . . . . 63.130000000000003 113.289 -175.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.428 HD22 ' HB3' ' A' ' 26' ' ' GLU . 20.2 t-20 -124.34 147.62 48.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.396 -0.594 . . . . 73.109999999999999 109.396 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 27.9 m -129.09 146.82 33.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.056 -0.35 . . . . 75.019999999999996 110.056 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.79 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 46.2 p90 -107.29 128.23 54.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.006 0.431 . . . . 74.349999999999994 110.374 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.13 99.43 8.98 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 73.310000000000002 109.993 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 36.8 tt0 -87.75 115.12 24.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.725 -0.843 . . . . 73.099999999999994 108.725 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 177.01 4.85 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.433 0.635 . . . . 74.120000000000005 112.036 -172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 t -71.68 -10.34 59.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.227 -0.897 . . . . 71.120000000000005 110.456 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mmt -98.84 -41.92 7.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.922 -0.581 . . . . 65.340000000000003 110.535 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.48 -129.03 1.18 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.026 -0.83 . . . . 52.509999999999998 111.026 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -144.06 136.06 22.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.099 0.476 . . . . 75.439999999999998 110.188 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 HG12 HG23 ' A' ' 139' ' ' VAL . 5.2 mp -134.83 122.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.454 -0.794 . . . . 74.299999999999997 109.032 176.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 133' ' ' CYS . 3.6 m -102.87 150.99 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.933 -0.707 . . . . 72.519999999999996 110.152 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.3 pp -143.99 161.07 39.7 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.782 -0.645 . . . . 73.420000000000002 109.757 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' HZ2' ' A' ' 29' ' ' TRP . 6.8 pt-20 -138.07 161.24 37.26 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.532 -0.758 . . . . 73.519999999999996 108.963 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.1 172.12 7.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 110.489 -172.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -91.61 96.2 10.34 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.407 0.622 . . . . 75.150000000000006 111.376 173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.537 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -82.48 -5.25 58.59 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.056 -0.974 . . . . 73.329999999999998 110.439 -179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -68.31 -53.9 21.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.598 -0.728 . . . . 64.049999999999997 111.284 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -127.76 5.26 6.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.465 -0.334 . . . . 73.420000000000002 110.875 -174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.46 74.48 79.97 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.974 0.416 . . . . 52.439999999999998 110.699 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.19 -26.08 9.43 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.0 2.466 . . . . 75.310000000000002 112.737 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -89.51 -43.62 10.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.289 0.566 . . . . 74.409999999999997 109.908 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.502 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -59.79 -42.02 92.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.099 -0.955 . . . . 65.099999999999994 111.663 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.5 p -64.94 -33.34 75.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 72.150000000000006 111.538 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.826 ' HD2' ' HB2' ' A' ' 8' ' ' SER . 0.2 OUTLIER -78.14 -31.07 49.62 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.83 -0.348 . . . . 75.129999999999995 111.499 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.44 -44.29 94.97 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.799 -0.445 . . . . 74.230000000000004 109.799 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 14' ' ' VAL . 18.0 t80 -63.97 -47.17 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.956 -0.565 . . . . 71.5 109.803 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -50.19 71.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.611 -0.722 . . . . 53.409999999999997 112.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.715 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 50.4 mm-40 -67.88 -29.3 68.38 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.696 0.284 . . . . 61.210000000000001 111.362 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 1.2 mm? -69.53 -37.41 77.08 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.185 0.517 . . . . 73.400000000000006 110.27 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.66 76.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 54.009999999999998 111.016 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 8.7 ptm180 -67.95 -30.07 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.372 -0.376 . . . . 73.010000000000005 111.375 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' HE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -67.18 -35.17 79.08 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.392 -0.596 . . . . 74.299999999999997 109.392 178.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 104.56 27.02 6.23 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.527 -0.844 . . . . 74.010000000000005 112.775 171.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 51' ' ' THR . 14.9 m-85 -82.09 -29.82 31.59 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.794 -0.239 . . . . 53.009999999999998 111.518 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -75.0 -17.13 60.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.99 0.424 . . . . 73.420000000000002 110.574 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 40.3 m-80 -69.47 -11.32 60.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.471 . . . . 72.510000000000005 110.403 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -119.52 16.25 10.53 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.84 -0.695 . . . . 73.109999999999999 112.059 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.639 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.4 p -97.32 159.95 14.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 44.119999999999997 110.992 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -142.56 155.83 45.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.152 -0.477 . . . . 74.319999999999993 109.953 -176.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.608 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 93.4 m-85 -84.29 126.41 33.15 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.597 . . . . 61.450000000000003 109.387 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.83 -13.99 6.26 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.776 -0.369 . . . . 52.450000000000003 111.892 -174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 25.7 mmt85 -121.71 101.06 7.35 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.57 -0.53 . . . . 71.099999999999994 109.57 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -122.43 92.17 2.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.84 -0.8 . . . . 43.310000000000002 108.84 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.772 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.5 mt -100.11 121.52 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.868 -0.605 . . . . 73.540000000000006 109.422 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -49.95 132.03 22.77 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.941 0.776 . . . . 74.010000000000005 110.726 177.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 44.41 40.05 3.56 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.171 0.919 . . . . 72.439999999999998 112.328 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.772 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.7 t80 -134.64 -81.98 0.44 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 64.340000000000003 110.382 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.584 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 27.1 ptt? -161.19 155.09 22.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 71.430000000000007 110.679 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 116' ' ' LEU . 35.7 mt -125.16 101.66 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.916 -0.584 . . . . 71.439999999999998 109.973 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 21.1 mt-30 -86.05 123.04 30.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.014 -0.539 . . . . 71.450000000000003 111.296 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -129.97 137.61 9.65 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.397 -0.819 . . . . 65.510000000000005 112.111 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.639 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 157.63 -155.8 26.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.133 -1.032 . . . . 73.120000000000005 112.933 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.483 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 46.2 t0 56.4 89.81 0.1 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 124.082 0.953 . . . . 73.230000000000004 112.234 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 41.8 Cg_endo -69.73 -17.6 37.61 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.01 2.473 . . . . 73.540000000000006 112.14 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -97.64 -39.51 9.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.012 -0.54 . . . . 74.319999999999993 112.25 -171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 87.71 25.03 33.72 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.582 -0.818 . . . . 72.310000000000002 111.605 -174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.511 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 60.9 p -101.11 -16.88 16.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.607 0.718 . . . . 62.310000000000002 110.943 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 -17.93 42.63 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.068 -0.969 . . . . 75.420000000000002 112.126 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 1.5 ptp180 -106.55 -33.96 7.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.181 0.515 . . . . 65.430000000000007 110.784 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.483 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 87.48 -159.05 30.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.673 -0.775 . . . . 61.210000000000001 112.346 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.26 -114.04 1.01 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.479 -0.649 . . . . 73.010000000000005 111.479 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . 57.59 39.31 27.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.015 0.436 . . . . 61.009999999999998 112.162 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.2 t -109.41 21.69 16.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.378 0.609 . . . . 54.240000000000002 109.575 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.0 pt -72.11 -21.9 20.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.042 -0.526 . . . . 73.319999999999993 111.043 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 4' ' ' ILE . 5.2 p90 -106.77 5.45 28.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.512 0.672 . . . . 70.310000000000002 110.783 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 110.65 -117.51 4.66 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.272 -0.876 . . . . 42.030000000000001 111.738 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -88.56 -161.79 0.78 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.653 -0.869 . . . . 73.310000000000002 108.653 172.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -63.36 159.24 18.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 71.129999999999995 110.103 175.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HB2' ' CE2' ' A' ' 78' ' ' TYR . 77.7 t80 -95.36 -67.67 0.84 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.061 -0.518 . . . . 74.310000000000002 111.253 -170.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -169.98 152.47 4.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.994 -0.743 . . . . 71.549999999999997 108.994 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.76 105.31 8.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.488 0.661 . . . . 73.349999999999994 109.245 171.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -101.68 21.96 13.59 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.808 -0.633 . . . . 64.140000000000001 109.586 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.68 97.24 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.03 -0.987 . . . . 65.439999999999998 110.629 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -168.34 81.97 0.77 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-O 121.018 0.437 . . . . 74.140000000000001 109.836 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 51.5 Cg_endo -68.22 106.97 1.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.29 1.994 . . . . 73.239999999999995 111.74 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.53 -28.1 65.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.152 -1.055 . . . . 74.510000000000005 108.152 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.7 pp -84.21 178.5 7.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.88 -1.509 . . . . 73.239999999999995 109.337 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -141.1 167.2 22.76 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.586 -0.446 . . . . 65.030000000000001 109.925 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -63.51 123.16 18.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.163 0.506 . . . . 61.350000000000001 109.65 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 37.0 p -122.62 -40.78 2.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 74.530000000000001 110.573 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.42 -148.05 5.92 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.418 -0.81 . . . . 51.450000000000003 111.363 175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.01 136.8 33.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.732 0.301 . . . . 54.229999999999997 110.73 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 116.98 20.07 5.0 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.85 -0.69 . . . . 61.119999999999997 112.208 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.3 mm -86.64 111.66 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 51.409999999999997 109.37 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.704 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -87.85 122.89 32.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.148 0.499 . . . . 62.310000000000002 110.275 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.07 167.06 20.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.729 -0.669 . . . . 75.120000000000005 110.178 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 34.6 ttp -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.563 -0.532 . . . . 72.200000000000003 109.563 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.29 162.36 13.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.99 0.424 . . . . 63.219999999999999 110.664 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.789 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.5 p-10 -158.71 162.91 37.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.02 -0.536 . . . . 75.140000000000001 110.61 -171.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.08 -19.45 18.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.787 0.803 . . . . 51.399999999999999 109.601 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.76 172.37 33.79 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.208 -1.557 . . . . 64.140000000000001 109.208 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.98 -44.66 36.27 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.003 2.469 . . . . 52.340000000000003 112.421 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -96.44 -17.6 20.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.907 -0.588 . . . . 64.519999999999996 111.108 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.8 m -84.12 47.34 1.31 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.519 0.676 . . . . 62.310000000000002 110.056 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.789 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 36.6 m-80 -64.33 129.87 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.727 -1.124 . . . . 72.319999999999993 108.944 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.24 -146.39 6.43 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.823 -1.18 . . . . 71.420000000000002 114.244 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 35.6 t -99.06 27.65 4.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.231 0.539 . . . . 62.219999999999999 110.095 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 70.9 mt-30 -118.73 152.09 36.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.789 -0.641 . . . . 72.219999999999999 109.888 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 53.1 p90 -140.46 170.31 16.03 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.225 -0.657 . . . . 72.120000000000005 109.225 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 42.6 p90 -156.95 150.1 23.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.239 0.542 . . . . 74.010000000000005 111.173 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.704 HG22 HD23 ' A' ' 98' ' ' LEU . 16.1 t -113.34 141.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.36 -0.836 . . . . 40.210000000000001 109.338 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.8 p -94.83 125.93 39.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.896 0.379 . . . . 71.0 110.301 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 34.0 mt -85.56 -7.53 58.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.512 -0.767 . . . . 71.439999999999998 110.228 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -147.64 159.75 40.36 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.183 -0.917 . . . . 75.340000000000003 109.65 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 42.9 Cg_endo -69.32 114.62 3.69 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.389 2.06 . . . . 64.200000000000003 112.594 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -106.59 118.31 36.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 74.310000000000002 110.469 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.51 19.51 19.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.222 0.534 . . . . 62.140000000000001 110.769 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.61 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -128.15 5.2 5.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.386 -0.825 . . . . 72.329999999999998 111.015 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.61 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 96.2 mt -111.3 -1.81 15.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 75.140000000000001 111.461 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.487 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 10.2 p-10 -70.08 -10.13 57.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.113 0.482 . . . . 74.549999999999997 111.358 -175.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -126.15 17.68 6.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 74.239999999999995 111.757 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -121.73 -28.0 4.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.032 0.444 . . . . 55.219999999999999 110.205 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.14 134.68 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 74.340000000000003 110.327 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -69.04 112.03 5.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.98 0.419 . . . . 63.329999999999998 110.272 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 99' ' ' ALA . 39.2 mt -98.79 119.46 46.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.5 110.368 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' CZ ' HG22 ' A' ' 35' ' ' THR . 5.6 p90 -156.88 74.33 0.79 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.503 0.668 . . . . 72.340000000000003 110.672 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.682 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.6 157.84 29.88 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 118.98 -1.581 . . . . 55.43 114.257 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 190' ' ' GLU . 4.5 mtt180 -125.82 125.53 43.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.583 -0.895 . . . . 64.319999999999993 108.583 173.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.433 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.1 p -88.04 132.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.196 -0.602 . . . . 71.099999999999994 110.159 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.553 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 47.8 t -139.94 152.03 46.03 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.287 -0.258 . . . . 43.32 111.095 -176.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.778 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 8.0 pt20 41.67 35.23 0.47 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.545 1.138 . . . . 74.430000000000007 113.11 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.36 15.75 0.23 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.559 -0.829 . . . . 71.540000000000006 112.343 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.1 tp -72.28 -33.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.619 0.247 . . . . 61.219999999999999 110.626 -174.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.49 -37.38 93.19 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.724 -0.751 . . . . 44.210000000000001 111.256 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 77.9 mmm -71.43 -49.46 41.47 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.285 -0.265 . . . . 72.049999999999997 110.285 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.49 HG23 HG12 ' A' ' 23' ' ' ILE . 86.5 t -55.81 -30.59 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.998 0.428 . . . . 31.239999999999998 110.815 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.95 -51.14 27.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.014 -0.539 . . . . 72.340000000000003 110.566 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.1 OUTLIER -76.29 -13.83 60.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.948 -0.569 . . . . 64.129999999999995 111.391 -177.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 145' ' ' VAL . 79.0 t -91.76 -27.01 4.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 71.140000000000001 109.895 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -93.35 -8.01 61.58 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.541 -0.838 . . . . 73.299999999999997 113.001 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 27.3 ptm -85.14 -11.14 55.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.798 0.333 . . . . 65.219999999999999 110.369 178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 142' ' ' VAL . 28.9 m -80.17 162.33 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 64.349999999999994 110.77 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 14.2 pt-20 -142.63 -40.38 0.33 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.669 -0.696 . . . . 74.5 110.032 175.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 10.2 p -123.03 138.78 54.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 111.024 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 154' ' ' VAL . 25.9 p-10 -99.38 4.42 46.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.669 . . . . 73.129999999999995 109.549 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.591 ' HB3' ' CG ' ' A' ' 152' ' ' ARG . 35.4 t -163.68 -156.92 0.38 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.751 -1.113 . . . . 74.549999999999997 108.278 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 151' ' ' ASP . 7.6 pt20 -45.26 -62.98 1.04 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.428 0.899 . . . . 63.140000000000001 113.428 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 150' ' ' GLN . 2.9 p30 -142.8 11.78 1.84 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.922 0.391 . . . . 74.519999999999996 111.182 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.591 ' CG ' ' HB3' ' A' ' 149' ' ' SER . 12.6 ptm180 -97.9 133.76 22.96 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.282 -0.417 . . . . 74.230000000000004 110.418 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 20.4 Cg_endo -60.46 146.94 95.86 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.998 2.465 . . . . 50.329999999999998 112.539 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.522 ' HA ' ' HB3' ' A' ' 148' ' ' ASN . 66.5 t -61.25 109.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 73.209999999999994 110.67 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -110.9 -22.8 11.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.643 -0.708 . . . . 62.009999999999998 110.804 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.12 84.36 2.11 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.3 0.572 . . . . 72.349999999999994 112.361 -172.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 53' ' ' PHE . 22.2 t -139.15 122.91 19.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.019 -1.104 . . . . 73.140000000000001 108.019 169.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 2.6 mppt? -127.51 152.84 47.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.334 -0.546 . . . . 63.450000000000003 111.407 -167.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.0 mp -89.78 109.85 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.45 -0.944 . . . . 62.140000000000001 108.45 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.431 HG22 ' CD ' ' A' ' 161' ' ' LYS . 28.5 mm -76.65 -51.87 18.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.102 -0.499 . . . . 71.340000000000003 110.679 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -131.73 129.84 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.575 -0.739 . . . . 71.140000000000001 110.084 177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -140.99 110.8 6.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.939 0.4 . . . . 60.109999999999999 110.792 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.59 155.14 53.09 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.543 -0.753 . . . . 71.319999999999993 109.708 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.673 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.77 137.68 39.12 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.295 1.997 . . . . 75.439999999999998 111.332 175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.79 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 5.8 t -136.42 149.96 48.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.961 0.41 . . . . 73.530000000000001 110.884 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.41 154.52 20.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.872 -0.68 . . . . 44.219999999999999 111.711 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -146.02 95.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.804 -0.713 . . . . 53.310000000000002 112.012 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.3 137.25 14.85 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.728 -0.749 . . . . 71.129999999999995 112.142 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -101.51 150.99 18.58 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.776 -0.726 . . . . 42.030000000000001 112.005 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.4 t -149.86 129.72 13.36 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.826 -0.435 . . . . 72.099999999999994 109.826 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 143.32 141.21 3.79 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.874 -0.679 . . . . 72.540000000000006 112.091 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -137.26 88.09 0.22 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 64.549999999999997 112.309 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.44 144.19 13.73 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.888 -0.672 . . . . 11.25 112.292 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.2 t -74.97 -31.34 61.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.09 0.472 . . . . 63.329999999999998 109.764 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.41 -105.63 3.17 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.066 -0.588 . . . . 61.409999999999997 112.212 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -86.25 61.55 4.44 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.825 -0.703 . . . . 75.439999999999998 111.907 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.45 -176.4 29.9 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.187 -0.53 . . . . 74.109999999999999 111.983 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 22.5 m -139.34 155.92 47.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.696 0.284 . . . . 71.420000000000002 110.415 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.01 -121.73 7.05 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.748 -0.739 . . . . 72.019999999999996 112.333 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 102.49 -66.7 0.38 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.948 -0.644 . . . . 72.450000000000003 111.794 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.15 163.11 19.07 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.832 -0.699 . . . . 75.0 112.358 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.2 m -120.45 17.95 12.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.006 0.432 . . . . 52.329999999999998 110.361 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.77 -92.72 1.34 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.89 -0.672 . . . . 51.43 111.819 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.3 m-20 -126.93 172.57 10.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.349 0.595 . . . . 64.219999999999999 110.41 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 155.38 144.18 3.85 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.072 -0.967 . . . . 64.120000000000005 110.963 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.433 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -80.36 -166.55 34.59 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.242 -0.98 . . . . 64.310000000000002 112.395 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.613 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.34 175.51 9.68 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.586 -0.524 . . . . 63.140000000000001 109.586 177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -111.37 102.45 53.13 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 110.511 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' A' ' 97' ' ' ILE . 2.5 Cg_endo -79.69 -13.38 13.23 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.05 2.5 . . . . 74.140000000000001 111.065 178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 131' ' ' ARG . 26.1 tt0 -70.85 -35.16 72.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.016 -0.993 . . . . 74.040000000000006 109.773 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.8 pt -92.15 156.45 3.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.144 -1.058 . . . . 64.109999999999999 108.144 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -106.39 74.77 1.04 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.996 -0.682 . . . . 74.109999999999999 110.921 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.7 149.1 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.393 -0.821 . . . . 63.109999999999999 108.977 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.33 118.49 24.9 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.811 -0.356 . . . . 61.219999999999999 110.863 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.591 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -152.08 153.23 33.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.543 -0.54 . . . . 72.439999999999998 109.543 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.439 ' CD2' ' HB3' ' A' ' 202' ' ' ARG . 62.6 m-85 -120.65 137.74 26.7 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 116.453 -0.34 . . . . 53.049999999999997 111.126 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.85 -55.87 0.95 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.967 2.445 . . . . 63.409999999999997 112.289 -175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.79 15.12 2.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.641 -0.254 . . . . 75.329999999999998 111.458 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 202' ' ' ARG . 1.7 t70 61.91 80.84 0.21 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 122.472 1.13 . . . . 62.340000000000003 109.661 -170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 13.1 ptm -129.96 -10.13 4.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.271 -1.331 . . . . 70.129999999999995 110.541 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -142.19 14.97 2.55 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.375 -0.917 . . . . 64.0 112.801 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.439 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 3.1 ptt180 -98.15 -34.81 10.6 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 119.373 -0.931 . . . . 75.430000000000007 110.816 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 5.7 mmpt? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.517 -0.754 . . . . 73.430000000000007 110.084 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.869 0.366 . . . . 72.129999999999995 110.636 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.52 105.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 73.120000000000005 109.715 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.9 153.66 22.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.424 -0.353 . . . . 73.129999999999995 110.736 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.825 HD11 ' HB3' ' A' ' 78' ' ' TYR . 16.3 mm 63.79 85.89 0.15 Allowed Pre-proline 0 C--N 1.33 -0.279 0 O-C-N 124.043 0.839 . . . . 74.030000000000001 111.777 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -96.09 93.96 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 123.72 2.946 . . . . 74.510000000000005 110.944 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' HG2' ' HD3' ' A' ' 37' ' ' LYS . 14.1 Cg_exo -69.71 -46.06 1.39 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.957 2.438 . . . . 52.149999999999999 112.874 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.0 t70 63.47 20.42 12.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.034 0.921 . . . . 74.340000000000003 110.081 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.8 m -144.67 124.0 13.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.094 -0.957 . . . . 54.130000000000003 109.812 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.5 t-105 -72.01 -59.26 2.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.144 -0.48 . . . . 72.230000000000004 110.262 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 73.03 151.58 0.14 Allowed Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 124.023 0.827 . . . . 65.140000000000001 111.995 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.3 145.34 98.14 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.564 2.176 . . . . 73.129999999999995 111.531 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 38.5 Cg_endo -67.57 -7.5 19.48 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.885 2.39 . . . . 75.409999999999997 113.268 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.659 HD21 HG12 ' A' ' 24' ' ' VAL . 18.0 t-20 -133.16 141.41 48.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 71.420000000000002 110.731 -172.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.4 m -131.08 157.01 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.116 -0.493 . . . . 54.130000000000003 109.973 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.543 ' HB2' HD11 ' A' ' 22' ' ' ILE . 23.7 p90 -121.03 138.82 53.99 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 74.030000000000001 110.638 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.5 mt -114.77 103.68 11.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.627 -0.715 . . . . 61.409999999999997 109.754 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.455 ' HA ' HG12 ' A' ' 22' ' ' ILE . 37.8 tt0 -88.13 114.65 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.304 -0.628 . . . . 74.129999999999995 109.304 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 159' ' ' ILE . 59.3 p -104.04 177.06 4.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.312 -0.404 . . . . 71.329999999999998 110.696 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.433 ' HB2' HD11 ' A' ' 160' ' ' ILE . 27.7 t -71.23 -20.41 62.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.201 -0.454 . . . . 73.030000000000001 110.994 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 142' ' ' VAL . 79.8 mtp -95.01 -33.94 12.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.26 . . . . 52.539999999999999 110.937 -178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.487 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -171.17 -138.6 2.56 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.454 -0.879 . . . . 61.539999999999999 112.153 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -143.98 129.99 15.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.068 -0.716 . . . . 63.140000000000001 109.068 178.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -124.14 123.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.487 -0.778 . . . . 74.540000000000006 110.316 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG12 HD21 ' A' ' 13' ' ' ASN . 23.2 t -103.26 138.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.721 -0.474 . . . . 54.140000000000001 109.721 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.72 165.06 33.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 71.019999999999996 110.599 178.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 9.6 pt-20 -136.56 165.21 26.39 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.919 -0.582 . . . . 73.120000000000005 110.115 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.01 162.08 13.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.96 0.409 . . . . 61.340000000000003 110.504 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 4.0 m-85 -81.53 98.12 8.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 111.695 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 42.7 m95 -83.4 -3.72 57.8 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.117 -0.492 . . . . 65.129999999999995 110.594 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -78.84 -62.15 1.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.896 -0.593 . . . . 71.239999999999995 111.075 -175.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -125.5 18.76 8.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.571 -0.286 . . . . 73.329999999999998 111.76 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -142.0 71.69 23.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.076 0.465 . . . . 45.399999999999999 111.14 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.35 -44.3 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.992 2.461 . . . . 73.349999999999994 113.052 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 1.9 tpmt? -73.66 -36.1 65.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.761 0.315 . . . . 65.109999999999999 110.543 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.628 ' OG1' ' HB1' ' A' ' 32' ' ' ALA . 14.5 p -68.95 -43.34 75.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.16 -0.473 . . . . 71.209999999999994 110.616 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' SG ' ' CE2' ' A' ' 29' ' ' TRP . 25.0 t -53.88 -50.83 65.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.457 -0.792 . . . . 72.25 110.78 175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.816 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 10.3 mmpt? -60.37 -37.01 79.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.305 -0.407 . . . . 72.519999999999996 111.114 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.554 HD22 ' HD1' ' A' ' 39' ' ' PHE . 9.7 t30 -62.17 -56.17 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 74.319999999999993 110.323 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.554 ' HD1' HD22 ' A' ' 38' ' ' ASN . 3.2 m-30 -66.12 -40.05 90.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.436 -0.347 . . . . 71.420000000000002 111.565 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.35 94.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.61 -0.268 . . . . 73.299999999999997 111.0 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.81 -48.91 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.403 -0.362 . . . . 75.450000000000003 111.773 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.535 HD12 ' HB2' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -65.25 -25.79 67.82 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.395 -0.522 . . . . 74.319999999999993 111.008 -179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.79 -55.72 7.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.017 0.437 . . . . 74.120000000000005 110.778 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 44' ' ' ARG . 6.4 ppt_? -79.3 -28.3 42.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.852 -0.613 . . . . 74.120000000000005 112.24 -172.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -74.54 -52.9 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.875 0.369 . . . . 75.109999999999999 110.404 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.94 50.02 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.31 -0.948 . . . . 74.510000000000005 112.616 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB2' HD12 ' A' ' 42' ' ' LEU . 56.0 t80 -103.48 -51.44 3.21 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 122.793 -0.239 . . . . 75.019999999999996 111.091 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 51' ' ' THR . 76.0 m-85 -68.49 -18.99 64.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 121.146 -0.222 . . . . 74.0 111.316 -175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -74.34 84.48 1.93 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.63 -0.878 . . . . 75.400000000000006 108.63 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.53 24.41 1.13 Allowed Glycine 0 C--N 1.301 -1.384 0 CA-C-N 113.979 -1.464 . . . . 73.230000000000004 111.77 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 48' ' ' TYR . 34.3 p -108.91 158.67 17.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.928 -0.397 . . . . 54.030000000000001 109.928 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 12.2 ptpt -138.39 158.12 44.89 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.783 0.325 . . . . 63.140000000000001 111.168 -175.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 78.9 m-85 -84.04 121.66 27.72 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.412 -0.588 . . . . 72.540000000000006 109.412 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -96.52 -40.62 8.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 110.467 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -123.71 114.65 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.343 -0.243 . . . . 61.310000000000002 110.343 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -119.64 89.8 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.698 -0.853 . . . . 75.329999999999998 108.698 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.0 mt -96.56 120.8 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.164 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -53.65 129.12 31.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.723 -0.671 . . . . 70.439999999999998 111.003 177.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 58.28 26.76 14.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.262 -0.881 . . . . 72.010000000000005 111.852 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.652 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 1.1 t80 -128.92 -83.45 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.201 0.524 . . . . 74.230000000000004 110.469 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.448 ' H ' ' HB3' ' A' ' 60' ' ' PHE . 27.3 ptt? -161.26 153.45 19.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.349 -0.841 . . . . 74.230000000000004 110.033 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 116' ' ' LEU . 23.4 mt -119.42 99.76 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.12 -0.696 . . . . 63.119999999999997 109.12 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -84.05 123.66 30.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.899 -0.591 . . . . 64.310000000000002 110.247 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.06 151.2 20.65 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.941 -0.647 . . . . 74.200000000000003 112.191 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.25 -77.93 0.2 Allowed Glycine 0 C--O 1.219 -0.797 0 C-N-CA 119.642 -1.266 . . . . 74.329999999999998 114.027 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -45.91 108.65 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 122.155 0.979 . . . . 72.530000000000001 113.205 -165.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 59.7 Cg_endo -74.46 -14.6 22.48 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.539 2.826 . . . . 44.25 111.891 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.5 p -84.63 -28.76 26.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.952 -1.022 . . . . 44.149999999999999 111.381 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.47 2.98 90.7 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.401 -0.68 . . . . 55.32 111.401 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.6 p -88.34 -24.61 23.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.319 0.581 . . . . 74.109999999999999 110.574 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.5 -16.35 48.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.287 -0.87 . . . . 63.310000000000002 112.096 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -82.0 -48.12 11.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.267 0.556 . . . . 75.340000000000003 110.245 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.594 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 98.09 -174.57 28.9 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.592 -0.731 . . . . 65.430000000000007 112.525 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.29 -93.49 0.86 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.393 -0.683 . . . . 74.299999999999997 111.393 175.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.6 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . 61.36 43.31 10.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.652 0.739 . . . . 62.219999999999999 111.97 172.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -86.35 24.65 1.33 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.528 -0.76 . . . . 71.5 111.157 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 pt -100.26 -17.7 6.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.809 -0.356 . . . . 63.219999999999999 111.487 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.825 ' HB3' HD11 ' A' ' 4' ' ' ILE . 30.2 p90 -121.3 -22.6 5.96 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.483 -0.487 . . . . 74.400000000000006 111.999 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.79 -99.65 1.15 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.563 -0.827 . . . . 44.310000000000002 111.467 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 23.6 mtpt -78.88 161.9 26.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.968 -0.382 . . . . 73.340000000000003 109.968 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 107' ' ' THR . 1.2 mp0 -66.08 172.07 4.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.248 0.547 . . . . 70.010000000000005 111.281 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -95.92 -71.96 0.65 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.52 -0.764 . . . . 74.409999999999997 109.067 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 84' ' ' ASP . 5.8 tp10 -169.27 172.01 7.56 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.494 -1.299 . . . . 72.310000000000002 107.494 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 13.1 p-10 -77.87 107.86 10.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.263 -0.643 . . . . 54.310000000000002 109.263 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.42 18.35 5.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 71.040000000000006 109.483 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.5 mt -57.04 102.07 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.815 -1.084 . . . . 73.409999999999997 110.269 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -157.18 75.38 4.25 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.552 -0.536 . . . . 65.439999999999998 109.552 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 123' ' ' ASP . 37.0 Cg_endo -66.15 91.12 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.621 2.214 . . . . 61.200000000000003 112.221 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -81.28 -16.69 51.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.329 1.061 . . . . 74.439999999999998 108.917 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.5 pp -93.8 175.61 6.66 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.417 -1.265 . . . . 74.209999999999994 110.217 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -131.01 146.31 52.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 109.886 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.616 ' HE2' ' HB3' ' A' ' 123' ' ' ASP . 96.2 m-85 -69.77 94.15 0.79 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.276 -0.638 . . . . 72.239999999999995 109.276 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.602 ' HB ' ' HG2' ' A' ' 195' ' ' GLN . 39.1 p -81.99 -41.71 20.36 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.945 -1.025 . . . . 61.299999999999997 110.434 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.5 -131.94 1.36 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.425 -0.807 . . . . 31.539999999999999 111.645 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.21 143.28 28.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.764 0.316 . . . . 71.430000000000007 110.782 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 25.0 5.57 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.741 -0.742 . . . . 70.400000000000006 112.128 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 189' ' ' PRO . 7.1 mm -86.45 110.0 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.237 -0.653 . . . . 74.450000000000003 109.237 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.738 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.8 tm? -87.19 113.01 22.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.202 -0.453 . . . . 61.43 110.058 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -127.12 171.23 11.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.923 -0.58 . . . . 75.420000000000002 110.589 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.503 ' SD ' ' HB ' ' A' ' 127' ' ' THR . 15.2 ptm -95.14 148.34 22.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.821 0.343 . . . . 65.040000000000006 110.146 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -94.92 124.82 39.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.028 0.442 . . . . 73.519999999999996 110.46 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.674 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -144.28 164.15 31.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.802 -0.636 . . . . 70.420000000000002 110.234 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -71.98 -44.87 62.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.99 -0.55 . . . . 55.329999999999998 110.53 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.28 -97.48 0.16 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.741 -0.742 . . . . 45.009999999999998 112.089 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.98 88.64 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.885 2.39 . . . . 72.129999999999995 112.145 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 53.51 12.54 0.38 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.688 1.195 . . . . 60.32 113.707 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.2 m -88.16 61.55 6.32 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.989 -0.745 . . . . 63.229999999999997 108.989 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.6 p30 -81.62 143.49 31.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.011 -0.995 . . . . 74.200000000000003 111.34 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -124.89 -172.27 13.47 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.519 -0.764 . . . . 61.43 112.033 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 75' ' ' ALA . 15.9 p -88.44 3.85 48.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 70.340000000000003 110.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 77.4 mt-30 -80.75 159.09 25.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.748 . . . . 71.319999999999993 110.236 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -139.77 169.36 17.87 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.896 -0.409 . . . . 74.329999999999998 109.896 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.71 146.82 25.43 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.116 0.484 . . . . 72.120000000000005 110.127 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.668 HG22 HD23 ' A' ' 98' ' ' LEU . 13.1 t -110.44 134.24 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.508 -0.769 . . . . 64.239999999999995 109.36 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 p -91.69 125.58 36.46 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.024 0.44 . . . . 75.430000000000007 110.323 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 62' ' ' ILE . 47.1 mt -81.54 -9.7 59.63 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 73.340000000000003 110.683 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.24 159.54 32.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.585 -0.734 . . . . 74.129999999999995 110.201 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 34.9 Cg_exo -60.56 122.85 11.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.732 2.288 . . . . 62.520000000000003 111.939 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 3.5 p -127.76 89.15 2.89 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.227 0.537 . . . . 34.409999999999997 110.158 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.569 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.9 OUTLIER -93.22 24.19 3.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.875 0.845 . . . . 64.099999999999994 110.144 -166.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.671 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.3 p90 -116.56 -0.18 12.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.315 -1.311 . . . . 75.239999999999995 109.504 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.671 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 90.5 mt -108.19 1.05 21.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.368 -0.833 . . . . 72.010000000000005 110.796 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.616 ' HB3' ' HE2' ' A' ' 92' ' ' PHE . 16.9 p-10 -68.59 -15.87 63.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.374 -0.83 . . . . 75.239999999999995 111.276 -174.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 14.62 10.22 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.478 -0.868 . . . . 74.129999999999995 111.646 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -116.89 -37.24 3.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.754 0.312 . . . . 65.129999999999995 110.546 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -133.27 130.28 38.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.387 -0.369 . . . . 65.450000000000003 110.088 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.503 ' HB ' ' SD ' ' A' ' 100' ' ' MET . 19.0 m -65.59 126.5 28.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.852 0.358 . . . . 71.209999999999994 110.21 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' A' ' 99' ' ' ALA . 22.6 mt -107.27 127.96 62.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.47 -0.332 . . . . 72.420000000000002 110.347 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.623 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 22.7 p90 -159.47 70.83 0.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.521 0.677 . . . . 73.0 110.816 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.66 155.16 26.39 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.903 -1.141 . . . . 73.120000000000005 113.296 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.0 mtm180 -136.2 120.57 18.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.34 137.28 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.149 0.5 . . . . 74.230000000000004 110.892 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.605 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 35.4 t -144.83 149.33 35.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.052 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.8 tt0 47.64 52.48 12.52 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.403 0.62 . . . . 74.439999999999998 111.585 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 175.83 25.74 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.379 -0.915 . . . . 74.150000000000006 112.05 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.451 ' CG2' ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -79.49 -30.94 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.822 -0.436 . . . . 64.299999999999997 109.822 -175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.58 -34.22 88.89 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.799 -0.715 . . . . 71.120000000000005 111.439 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.552 ' HE1' HH11 ' A' ' 141' ' ' ARG . 54.3 mmm -71.96 -52.44 17.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.936 -0.394 . . . . 63.350000000000001 109.936 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.86 -32.04 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.175 0.512 . . . . 53.32 110.926 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.418 ' HA ' ' SD ' ' A' ' 200' ' ' MET . 1.8 t30 -71.4 -50.86 27.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.794 -0.639 . . . . 74.239999999999995 110.878 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.552 HH11 ' HE1' ' A' ' 138' ' ' MET . 0.1 OUTLIER -77.87 -12.36 59.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 64.120000000000005 111.29 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 145' ' ' VAL . 70.2 t -91.32 -32.32 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.096 0.474 . . . . 54.43 110.434 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.29 -17.37 60.85 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.554 -0.832 . . . . 60.109999999999999 113.11 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.2 ptp -88.36 -13.16 41.34 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.594 -0.442 . . . . 61.020000000000003 111.347 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 142' ' ' VAL . 27.5 m -73.84 140.24 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.307 0.575 . . . . 53.530000000000001 110.814 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 7.6 pt-20 -128.45 -40.25 1.62 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.37 -0.832 . . . . 63.310000000000002 109.894 176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 15.6 p -137.89 152.1 48.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.758 -0.655 . . . . 62.229999999999997 110.636 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -76.75 -67.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.883 0.327 . . . . 61.43 111.883 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 27.9 t -141.04 -8.32 1.03 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.064 0.459 . . . . 74.340000000000003 110.309 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.603 ' O ' ' HB ' ' A' ' 147' ' ' THR . 23.0 mm-40 -130.07 -166.88 1.73 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.994 -0.743 . . . . 70.420000000000002 108.994 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 19.61 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.672 0.749 . . . . 63.530000000000001 110.272 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 5.8 ptm180 -106.13 131.97 21.28 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 74.140000000000001 109.767 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 43.5 Cg_exo -57.02 154.02 35.32 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.134 2.556 . . . . 63.219999999999999 112.985 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 17.3 t -64.02 157.58 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 72.219999999999999 110.358 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 156' ' ' ASP . 7.7 t70 -76.64 -166.27 0.64 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.759 0.314 . . . . 73.510000000000005 110.862 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.459 ' H ' ' CG ' ' A' ' 155' ' ' ASP . 31.2 t70 -73.43 113.28 10.35 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.949 0.499 . . . . 74.299999999999997 111.953 -173.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.85 133.36 43.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.295 -0.632 . . . . 72.150000000000006 109.295 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -144.52 166.77 24.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.91 -0.586 . . . . 73.049999999999997 111.677 -168.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.7 mp -88.5 113.18 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.153 -0.93 . . . . 65.530000000000001 109.476 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.49 HG22 ' CD ' ' A' ' 161' ' ' LYS . 26.7 mm -75.56 -61.42 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.626 -0.716 . . . . 53.240000000000002 110.389 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 160' ' ' ILE . 2.1 mptm? -124.95 131.18 53.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 110.103 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -137.68 113.8 9.98 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.355 -0.384 . . . . 53.030000000000001 110.694 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -148.61 156.03 41.78 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.864 -0.607 . . . . 72.510000000000005 110.012 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 56.7 Cg_endo -70.33 134.62 27.18 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.19 1.927 . . . . 64.430000000000007 111.513 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 29.0 t -87.33 129.13 35.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.208 0.527 . . . . 74.430000000000007 110.731 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.07 11.68 29.17 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.439 -0.8 . . . . 65.420000000000002 112.151 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -142.02 -172.76 13.7 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.871 -0.681 . . . . 52.439999999999998 111.902 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -163.4 -109.14 0.23 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.988 -0.625 . . . . 75.430000000000007 112.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -169.37 137.76 4.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.872 -0.68 . . . . 50.109999999999999 112.191 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.5 m -75.19 -35.43 61.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.091 0.472 . . . . 70.049999999999997 110.639 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.49 157.45 28.61 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.118 -0.793 . . . . 74.549999999999997 111.118 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -167.51 175.39 42.53 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.476 -0.869 . . . . 70.510000000000005 112.309 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 86.12 -138.24 15.82 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.925 -0.655 . . . . 72.040000000000006 111.8 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 25.1 t -106.59 -32.33 8.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.683 -0.488 . . . . 64.519999999999996 109.683 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.97 -148.2 22.3 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.783 -0.723 . . . . 63.039999999999999 112.526 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.91 -34.55 5.48 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.01 -0.614 . . . . 53.240000000000002 111.864 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 177.54 -128.09 1.27 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.481 -0.648 . . . . 70.209999999999994 111.481 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 38.1 m -87.39 120.85 29.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.812 0.339 . . . . 63.140000000000001 110.109 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 128.63 61.75 0.11 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.709 -0.758 . . . . 73.340000000000003 112.051 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.6 145.43 11.88 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.885 -0.674 . . . . 61.009999999999998 112.041 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.72 -15.87 26.38 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.817 -0.706 . . . . 52.43 111.939 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 p -111.9 108.19 17.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.808 0.337 . . . . 74.129999999999995 110.647 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -116.44 -58.42 0.32 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.049 -0.596 . . . . 64.450000000000003 111.615 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.565 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -102.14 173.08 6.54 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.757 0.789 . . . . 63.229999999999997 110.842 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 141.31 148.05 5.0 Favored Glycine 0 N--CA 1.437 -1.3 0 CA-C-N 114.3 -1.318 . . . . 61.409999999999997 111.458 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -84.67 -167.35 42.79 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.337 -0.935 . . . . 33.530000000000001 111.346 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.519 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -76.04 165.28 25.18 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.202 -0.666 . . . . 60.25 109.202 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.403 ' O ' HG21 ' A' ' 93' ' ' THR . 98.0 m-85 -106.84 93.4 8.81 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 120.637 0.256 . . . . 72.209999999999994 110.562 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.744 ' HB2' HD13 ' A' ' 90' ' ' LEU . 53.8 Cg_endo -71.94 -11.85 27.83 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.522 2.148 . . . . 73.400000000000006 112.685 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -71.37 -38.36 71.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.399 0.618 . . . . 74.150000000000006 109.632 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.7 pt -88.6 155.0 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.972 -1.121 . . . . 74.010000000000005 107.972 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 55.4 m170 -104.76 92.75 4.4 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.116 -0.634 . . . . 73.150000000000006 110.599 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.01 146.92 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.565 -0.743 . . . . 61.109999999999999 109.778 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.8 108.0 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.792 0.329 . . . . 24.210000000000001 111.171 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.602 ' HG2' ' HB ' ' A' ' 93' ' ' THR . 19.4 pt20 -139.34 141.53 37.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 110.745 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.476 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 27.6 m-85 -112.6 135.53 21.52 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 120.715 0.293 . . . . 73.519999999999996 110.83 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.9 Cg_endo -62.26 -65.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.97 2.447 . . . . 74.430000000000007 112.253 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.3 pt? -125.44 19.5 8.09 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.158 0.504 . . . . 75.099999999999994 110.078 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 41.8 m-20 71.18 8.88 6.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.057 -0.974 . . . . 65.129999999999995 113.198 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' A' ' 140' ' ' ASN . 25.1 ptt? -63.89 -29.09 70.3 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.808 -0.357 . . . . 75.400000000000006 111.463 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -81.21 -2.47 90.49 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.822 -0.704 . . . . 50.240000000000002 112.35 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.476 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 14.3 mtp180 -87.24 -61.17 1.78 Allowed 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 110.132 -0.321 . . . . 74.439999999999998 110.132 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt . . . . . 0 C--O 1.249 1.043 0 O-C-N 125.123 1.514 . . . . 75.299999999999997 112.78 -172.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.105 -0.331 . . . . 61.030000000000001 110.105 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 -31.05 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.341 0.591 . . . . 41.43 110.231 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.91 147.66 35.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.247 -0.888 . . . . 71.319999999999993 109.617 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 51.1 mm 68.57 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.482 0.658 . . . . 55.350000000000001 110.736 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 4' ' ' ILE . 43.8 Cg_endo -68.59 140.11 46.48 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.647 2.231 . . . . 74.129999999999995 112.37 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.65 58.32 2.55 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.148 2.565 . . . . 34.409999999999997 112.2 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.59 -49.01 79.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.195 -0.911 . . . . 75.439999999999998 111.646 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.8 m -142.3 179.85 6.68 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.181 -0.463 . . . . 62.200000000000003 109.902 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 43.3 p90 -87.68 -22.87 24.41 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.155 -0.218 . . . . 74.140000000000001 110.475 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.619 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.9 mp0 72.69 132.7 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 123.62 0.768 . . . . 62.210000000000001 111.585 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.851 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 19.2 Cg_endo -59.64 151.61 68.59 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.236 2.624 . . . . 72.319999999999993 112.848 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.39 -11.75 9.38 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.194 2.596 . . . . 52.240000000000002 114.108 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.528 HD21 HG12 ' A' ' 24' ' ' VAL . 27.3 t-20 -131.22 148.49 52.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.639 0.257 . . . . 72.420000000000002 110.847 -171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 28.5 m -132.75 147.37 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.138 0.494 . . . . 64.010000000000005 111.021 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 39.1 m-85 -105.09 118.96 37.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.68 -0.691 . . . . 71.019999999999996 110.528 176.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.2 mt -106.02 98.24 7.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.447 -0.342 . . . . 60.119999999999997 110.118 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 6.0 tt0 -89.79 113.06 24.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.457 -0.571 . . . . 61.439999999999998 109.457 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -105.47 178.11 4.65 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.068 -0.515 . . . . 63.509999999999998 111.09 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -73.75 -15.06 61.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 73.420000000000002 111.049 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.408 ' HG3' HG22 ' A' ' 157' ' ' VAL . 89.7 mmm -99.23 -32.73 11.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.08 -0.509 . . . . 63.009999999999998 110.923 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.43 -134.16 2.04 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.015 -0.612 . . . . 62.299999999999997 111.741 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -144.29 130.86 16.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.184 -0.672 . . . . 72.140000000000001 109.184 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 22' ' ' ILE . 3.9 mp -122.81 128.42 75.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.556 -0.747 . . . . 72.25 110.203 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.528 HG12 HD21 ' A' ' 13' ' ' ASN . 46.2 t -110.74 141.77 25.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.226 -0.443 . . . . 64.019999999999996 110.232 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.4 pp -155.49 166.6 33.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.878 0.37 . . . . 73.519999999999996 111.035 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.37 173.49 10.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.589 -0.732 . . . . 75.319999999999993 109.575 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -111.95 161.18 16.7 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.41 -0.589 . . . . 61.100000000000001 109.41 176.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.2 m-85 -80.23 102.16 9.3 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.548 0.689 . . . . 71.310000000000002 112.482 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -82.73 -3.5 56.57 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.931 -1.031 . . . . 75.329999999999998 109.68 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 30' ' ' LYS . 5.3 mptt -71.64 -57.37 4.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.329 -0.85 . . . . 73.400000000000006 111.176 -172.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -136.9 21.49 3.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.055 0.391 . . . . 73.329999999999998 112.055 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.544 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -135.26 66.72 67.02 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 74.219999999999999 110.597 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.71 -51.27 4.18 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.883 2.389 . . . . 63.520000000000003 112.862 -173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -84.26 -25.63 29.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.741 -0.384 . . . . 75.209999999999994 110.243 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -63.7 -50.29 69.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.194 -0.669 . . . . 71.230000000000004 109.194 175.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 4.4 t -57.25 -43.99 83.46 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.427 -0.806 . . . . 61.399999999999999 110.28 172.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.628 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -59.95 -39.19 84.73 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.569 -0.741 . . . . 75.099999999999994 110.53 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -55.69 -50.49 70.15 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.899 0.381 . . . . 73.150000000000006 110.222 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.48 -42.75 91.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.413 . . . . 74.540000000000006 111.164 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.619 ' HB1' ' HB3' ' A' ' 10' ' ' GLN . . . -58.02 -43.44 86.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.011 0.434 . . . . 71.010000000000005 111.35 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -58.84 -46.92 86.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 75.049999999999997 110.638 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.63 -30.48 68.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.265 -0.425 . . . . 61.439999999999998 111.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.64 67.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.95 -0.568 . . . . 74.329999999999998 111.084 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -74.95 -15.63 60.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.973 0.415 . . . . 72.349999999999994 110.346 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' HD12 ' A' ' 77' ' ' ILE . 23.5 tpt180 -77.67 -51.68 10.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.795 -0.639 . . . . 62.219999999999999 109.676 175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.24 27.02 5.74 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.63 -0.714 . . . . 72.420000000000002 112.192 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -86.19 11.36 12.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.549 0.214 . . . . 72.040000000000006 111.485 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -100.51 -14.75 18.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.751 0.31 . . . . 75.450000000000003 110.461 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.414 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 32.2 m-80 -80.64 99.28 8.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.94 0.876 . . . . 71.400000000000006 109.48 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 120.31 7.31 9.24 Favored Glycine 0 C--N 1.299 -1.525 0 CA-C-N 114.033 -1.439 . . . . 53.039999999999999 111.697 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.458 ' HB ' ' C ' ' A' ' 65' ' ' GLY . 81.9 p -88.84 165.4 14.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.555 0.217 . . . . 61.350000000000001 110.489 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -139.0 158.61 43.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.848 0.356 . . . . 74.239999999999995 110.564 -176.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 73.3 m-85 -80.6 133.65 35.79 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.4 0.619 . . . . 53.420000000000002 111.388 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.678 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 60.8 m80 -93.64 -56.75 2.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.966 -1.016 . . . . 74.040000000000006 110.507 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.3 mmm180 -114.88 112.72 23.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.852 -1.067 . . . . 73.329999999999998 109.805 -170.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 62' ' ' ILE . 4.4 mp -123.11 89.47 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.756 -0.831 . . . . 64.120000000000005 108.756 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.816 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 25.6 mt -103.58 127.32 57.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.022 -0.536 . . . . 73.140000000000001 109.714 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -59.83 130.75 48.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.413 0.446 . . . . 72.319999999999993 111.096 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 54.1 31.65 14.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.282 -0.872 . . . . 71.420000000000002 111.417 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.816 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -130.71 -82.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 110.301 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.658 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.7 ptm -160.5 155.83 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.54 -0.754 . . . . 75.310000000000002 110.603 -176.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 55' ' ' ARG . 23.2 mt -132.97 101.88 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.765 -0.652 . . . . 54.109999999999999 109.742 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 50.4 tt0 -89.54 128.22 35.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.474 . . . . 75.0 110.986 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.619 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -131.14 160.16 23.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.87 -0.681 . . . . 64.329999999999998 112.613 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.458 ' C ' ' HB ' ' A' ' 51' ' ' THR . . . 137.77 -150.8 21.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.759 -0.734 . . . . 34.100000000000001 112.309 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.678 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 0.2 OUTLIER 68.08 96.02 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 112.954 0.724 . . . . 73.209999999999994 112.954 178.087 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.59 -17.56 11.17 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.244 1.962 . . . . 62.210000000000001 109.819 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.0 p -92.25 -48.32 6.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.131 -1.395 . . . . 52.539999999999999 112.154 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.57 28.1 13.42 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.526 -0.63 . . . . 71.409999999999997 111.526 -174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' OG1' ' A' ' 68' ' ' THR . 4.0 t -112.39 -29.1 7.64 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.85 0.315 . . . . 74.129999999999995 111.85 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.34 -21.86 9.82 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.372 -0.918 . . . . 70.319999999999993 112.839 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.435 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -103.33 -29.45 11.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.796 0.331 . . . . 73.510000000000005 110.571 177.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.72 -169.04 15.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.55 -0.833 . . . . 53.409999999999997 113.361 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.33 36.9 2.29 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.332 -0.461 . . . . 70.140000000000001 112.725 -174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -76.26 59.5 1.39 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.545 0.688 . . . . 72.140000000000001 111.124 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -85.85 9.93 15.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.512 -0.767 . . . . 72.239999999999995 109.876 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.529 HD12 ' HB2' ' A' ' 45' ' ' ARG . 3.0 tt -62.0 -38.6 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.22 -0.9 . . . . 70.310000000000002 110.117 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 13.04 22.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.723 0.773 . . . . 72.019999999999996 110.409 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.92 -80.87 1.63 Allowed Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 114.705 -1.134 . . . . 42.119999999999997 112.028 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -133.42 -179.85 5.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.968 0.413 . . . . 73.409999999999997 110.43 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.749 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -72.17 174.82 6.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.564 -0.744 . . . . 72.150000000000006 110.231 177.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.01 -64.4 1.31 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.391 0.615 . . . . 74.019999999999996 110.225 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -161.64 176.5 10.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.495 -1.298 . . . . 74.329999999999998 107.495 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.539 ' OD1' ' HG ' ' A' ' 86' ' ' LEU . 2.5 t0 -81.07 138.22 35.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.78 -0.768 . . . . 63.420000000000002 110.045 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -100.08 13.81 32.83 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.521 -0.763 . . . . 74.209999999999994 110.58 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 84' ' ' ASP . 47.5 mt -51.54 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.694 0.621 . . . . 72.319999999999993 111.104 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -166.58 79.77 1.04 Allowed Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.479 -0.782 . . . . 54.229999999999997 109.533 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.44 102.56 0.71 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.598 2.199 . . . . 61.229999999999997 112.078 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -76.94 -14.9 59.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.473 1.13 . . . . 71.299999999999997 108.917 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.3 pp -113.24 -174.92 2.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.251 -1.34 . . . . 64.140000000000001 109.545 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -141.28 166.38 24.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.963 -0.754 . . . . 54.420000000000002 108.963 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -63.9 123.37 18.77 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.441 0.639 . . . . 73.109999999999999 110.511 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 35.4 p -122.78 -44.81 2.19 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.528 -0.76 . . . . 74.019999999999996 110.005 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.75 -145.27 4.31 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.482 -0.781 . . . . 64.219999999999999 111.787 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.61 143.2 26.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.632 0.253 . . . . 71.040000000000006 110.923 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.77 22.0 6.18 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.589 -0.815 . . . . 74.439999999999998 111.894 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 189' ' ' PRO . 12.4 mm -84.37 111.33 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.268 -0.642 . . . . 74.310000000000002 109.268 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.6 124.44 32.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.668 -0.493 . . . . 61.140000000000001 109.668 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.42 171.32 14.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.048 -0.524 . . . . 41.340000000000003 111.383 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 126' ' ' HIS . 25.4 ttt -107.54 132.36 53.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.693 -0.685 . . . . 72.209999999999994 109.805 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -96.29 163.19 13.18 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.297 -0.411 . . . . 24.23 110.147 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -158.76 164.75 35.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 72.219999999999999 109.723 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.5 -9.53 58.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.118 0.485 . . . . 73.239999999999995 111.187 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 147.45 -136.54 6.13 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 120.858 -0.686 . . . . 71.099999999999994 111.875 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 18.2 Cg_endo -54.12 97.16 0.05 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.328 0 C-N-CA 123.305 2.67 . . . . 55.219999999999999 111.811 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 3.2 p30 58.53 13.15 2.39 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.211 -1.359 . . . . 73.129999999999995 112.645 173.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.4 m -89.31 60.48 5.29 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.386 0.613 . . . . 74.540000000000006 109.369 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -85.1 151.95 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.598 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -154.94 -110.07 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.976 -0.556 . . . . 63.350000000000001 112.124 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 79.8 p -123.48 61.33 1.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.75 0.786 . . . . 64.340000000000003 110.568 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.609 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 69.8 mm-40 -126.91 146.0 50.46 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.586 -1.188 . . . . 61.340000000000003 109.716 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -148.93 164.91 33.13 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.581 -0.525 . . . . 73.239999999999995 109.581 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 48.6 p90 -158.36 152.12 23.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.092 0.472 . . . . 74.239999999999995 111.302 175.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.688 HG22 HD23 ' A' ' 98' ' ' LEU . 15.9 t -113.27 143.42 22.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.329999999999998 109.115 175.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.7 p -98.79 130.55 45.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.966 0.412 . . . . 75.120000000000005 110.28 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.3 mt -86.85 -5.5 59.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.721 -0.672 . . . . 70.299999999999997 110.651 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.95 163.52 25.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.697 -0.683 . . . . 51.219999999999999 110.135 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.503 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 21.5 Cg_exo -66.46 120.18 7.28 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.629 2.219 . . . . 74.409999999999997 112.074 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.7 p -104.68 156.56 17.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.617 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.95 12.85 0.44 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.256 0.551 . . . . 74.040000000000006 110.487 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -110.59 -11.03 14.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 74.129999999999995 112.516 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -129.85 -1.28 4.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.315 0.578 . . . . 75.040000000000006 111.149 -176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 -13.5 60.67 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.904 -1.044 . . . . 71.140000000000001 110.933 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -111.47 8.49 28.41 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.155 -0.778 . . . . 61.409999999999997 111.155 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -114.83 -23.4 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.624 0.726 . . . . 71.299999999999997 109.159 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 100' ' ' MET . 86.0 m-70 -134.64 133.95 40.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.655 -1.157 . . . . 71.0 108.405 172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.6 t -73.22 147.89 44.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.412 . . . . 63.100000000000001 110.52 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 99' ' ' ALA . 29.4 mt -125.16 122.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.243 -0.435 . . . . 73.329999999999998 110.62 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' A' ' 35' ' ' THR . 6.7 p90 -159.58 74.25 0.6 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.59 0.71 . . . . 75.010000000000005 110.925 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.7 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.45 157.16 29.25 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 119.574 -1.298 . . . . 71.420000000000002 113.177 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -132.58 120.07 21.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.902 -0.406 . . . . 75.549999999999997 109.902 173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.6 p -82.73 137.51 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.029 0.442 . . . . 73.0 110.582 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.56 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 43.7 t -141.25 153.09 45.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.366 -0.379 . . . . 73.129999999999995 110.508 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.457 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 2.8 pt20 40.4 39.42 0.7 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.508 1.123 . . . . 54.5 113.221 177.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.24 31.96 0.12 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.825 -0.702 . . . . 45.549999999999997 112.124 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -83.79 -31.03 7.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.486 -0.561 . . . . 74.120000000000005 109.486 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.56 93.0 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.673 -0.694 . . . . 72.25 111.867 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.42 ' HE1' HH11 ' A' ' 141' ' ' ARG . 60.0 mmm -67.74 -50.63 56.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.641 -0.503 . . . . 73.129999999999995 109.641 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 62' ' ' ILE . 85.0 t -53.78 -32.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 63.009999999999998 110.833 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -72.82 -53.13 12.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.005 -0.543 . . . . 75.329999999999998 110.982 -177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.18 -14.1 60.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.113 -0.494 . . . . 73.420000000000002 111.186 -177.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.474 HG13 HG21 ' A' ' 157' ' ' VAL . 51.4 t -88.73 -38.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.971 0.415 . . . . 63.009999999999998 110.294 175.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.53 -24.76 64.56 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.592 -0.813 . . . . 64.219999999999999 112.775 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.521 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 14.6 ptp -78.24 -16.91 57.36 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.824 -0.35 . . . . 70.109999999999999 111.539 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.1 m -95.28 114.71 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.643 0.735 . . . . 73.099999999999994 110.782 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -112.19 -53.74 2.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.37 -0.832 . . . . 73.349999999999994 110.063 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 6.6 p -130.83 145.41 51.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.642 -0.708 . . . . 24.210000000000001 109.996 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.531 ' OD1' ' HG3' ' A' ' 152' ' ' ARG . 25.2 p-10 -89.77 -12.32 39.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.592 -0.521 . . . . 73.409999999999997 109.592 177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.747 ' HB3' ' HD2' ' A' ' 152' ' ' ARG . 9.8 t -170.01 -163.76 0.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.451 -0.795 . . . . 71.540000000000006 108.991 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.7 110.37 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.389 0.514 . . . . 74.349999999999994 112.389 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 48.92 49.19 19.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.287 -0.87 . . . . 73.099999999999994 112.69 176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.747 ' HD2' ' HB3' ' A' ' 149' ' ' SER . 9.9 ptp180 -148.13 112.7 3.84 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.476 -0.784 . . . . 72.530000000000001 109.141 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 71.8 Cg_endo -78.76 160.83 27.71 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.886 2.391 . . . . 73.519999999999996 113.74 -170.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.2 31.29 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.32 -0.855 . . . . 74.25 108.924 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.29 137.27 56.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.519 -0.764 . . . . 75.030000000000001 110.705 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 158' ' ' LYS . 18.9 t70 -174.87 -63.41 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.358 -0.837 . . . . 73.340000000000003 110.646 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.474 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 t -21.46 112.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 O-C-N 126.136 2.148 . . . . 52.119999999999997 114.068 -166.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.52 149.04 41.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.461 -1.245 . . . . 63.43 109.482 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.405 HD13 ' OG1' ' A' ' 51' ' ' THR . 3.9 mp -84.02 100.58 7.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.435 -0.95 . . . . 63.25 108.435 172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.452 ' CG2' ' HD3' ' A' ' 161' ' ' LYS . 26.0 mm -70.9 -57.42 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.497 -0.774 . . . . 74.409999999999997 110.875 -174.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.793 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -136.24 126.65 26.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.358 0.599 . . . . 54.210000000000001 111.067 176.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . . . -126.7 120.9 30.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.344 -0.844 . . . . 64.439999999999998 110.169 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -139.22 135.99 17.71 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.088 -0.506 . . . . 74.019999999999996 110.288 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.851 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 64.7 Cg_endo -75.83 131.93 13.85 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.503 2.136 . . . . 72.530000000000001 111.729 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 46.3 m -150.75 -174.75 4.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.451 -0.341 . . . . 73.120000000000005 110.622 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.76 130.3 10.11 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.789 -0.719 . . . . 64.010000000000005 112.039 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -167.88 -164.25 23.23 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.781 -0.723 . . . . 74.219999999999999 111.782 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.96 -143.78 15.9 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.878 -0.677 . . . . 60.420000000000002 111.736 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.96 169.32 42.36 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.557 -0.617 . . . . 73.310000000000002 111.557 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 23.3 m -144.78 151.4 38.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.836 0.318 . . . . 51.219999999999999 110.518 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -153.94 -119.54 0.73 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.713 -0.555 . . . . 74.439999999999998 111.713 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 132.47 -132.6 6.7 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.805 -0.712 . . . . 74.200000000000003 112.048 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -84.29 83.18 1.63 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.788 -0.72 . . . . 73.019999999999996 111.808 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.0 m -149.85 129.98 13.58 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.782 0.325 . . . . 75.420000000000002 110.24 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.97 -106.05 3.25 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.901 -0.666 . . . . 53.409999999999997 112.144 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -164.04 -84.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.848 -0.691 . . . . 71.409999999999997 112.085 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -89.53 -57.42 1.75 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.846 -0.692 . . . . 62.43 112.221 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.3 t -107.56 109.6 21.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.917 0.389 . . . . 72.030000000000001 110.053 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -145.69 127.79 2.92 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.033 -0.603 . . . . 62.420000000000002 111.724 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.56 154.04 7.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.849 -0.691 . . . . 63.149999999999999 112.085 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.76 63.15 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.084 -0.579 . . . . 35.5 112.812 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.5 t -140.82 151.23 44.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.6 -0.519 . . . . 53.509999999999998 109.6 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -91.26 -68.13 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.692 -0.766 . . . . 74.230000000000004 111.607 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -101.32 -171.23 1.95 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 72.530000000000001 109.7 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 139.56 151.76 5.74 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.86 -0.686 . . . . 72.230000000000004 112.089 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -86.22 -166.54 42.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.618 -0.801 . . . . 71.140000000000001 111.814 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.854 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.83 168.1 19.72 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.881 0.372 . . . . 62.520000000000003 110.216 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -113.38 98.49 46.66 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-O 121.111 0.482 . . . . 74.150000000000006 110.457 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.654 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 72.8 Cg_endo -78.84 -9.55 15.65 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.736 2.291 . . . . 60.020000000000003 111.787 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -75.08 -34.58 61.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.049 -0.978 . . . . 72.439999999999998 111.355 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.405 ' H ' HG12 ' A' ' 191' ' ' ILE . 10.5 pt -74.04 -19.47 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.106 -0.497 . . . . 64.329999999999998 111.273 -177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 64.8 m170 72.45 32.18 1.65 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.455 -0.793 . . . . 62.25 111.62 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.6 p -139.72 147.02 24.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.887 -0.597 . . . . 64.109999999999999 109.679 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.94 131.18 41.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.614 0.598 . . . . 52.310000000000002 112.614 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.66 157.52 8.6 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.933 -1.136 . . . . 74.150000000000006 107.933 171.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -121.18 150.01 52.87 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.766 -0.373 . . . . 72.329999999999998 111.404 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.854 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.7 Cg_endo -69.41 -76.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.597 2.198 . . . . 72.109999999999999 111.639 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.7 pt? -114.3 19.45 16.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 70.200000000000003 110.263 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 72.83 0.72 3.76 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.679 0.992 . . . . 74.129999999999995 113.679 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -61.41 -28.95 69.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.936 0.335 . . . . 71.129999999999995 111.402 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -77.85 -4.36 85.43 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.726 -0.75 . . . . 73.340000000000003 112.994 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -79.44 -35.29 40.69 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 120.902 0.382 . . . . 72.549999999999997 109.972 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-N 114.573 -1.194 . . . . 74.120000000000005 110.906 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.035 0.445 . . . . 62.32 110.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.84 94.92 6.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.01 0.433 . . . . 73.430000000000007 111.504 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.57 -46.73 45.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 70.25 109.905 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.9 mt -131.01 88.23 46.22 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.395 -0.82 . . . . 53.350000000000001 109.667 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -90.23 159.8 4.69 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.131 2.554 . . . . 65.340000000000003 112.643 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.45 96.02 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.238 1.959 . . . . 72.310000000000002 112.436 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.17 -74.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.859 -0.61 . . . . 63.100000000000001 110.174 176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 m -99.03 -152.75 0.42 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.794 -0.817 . . . . 60.439999999999998 108.794 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 43.5 p90 -84.56 -20.91 30.75 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 121.019 -0.272 . . . . 75.340000000000003 110.643 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.617 ' HB2' ' HE2' ' A' ' 37' ' ' LYS . 2.8 mp0 65.49 143.55 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.485 0 CA-C-N 115.583 -0.735 . . . . 63.549999999999997 111.824 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.462 ' HG3' ' HB3' ' A' ' 164' ' ' PRO . 32.4 Cg_endo -63.29 127.19 19.43 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.816 2.344 . . . . 70.239999999999995 112.536 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.12 -20.31 19.23 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 55.140000000000001 112.557 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.457 HD21 HG12 ' A' ' 24' ' ' VAL . 26.9 t-20 -139.12 146.13 40.29 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.653 -0.703 . . . . 74.420000000000002 109.578 -175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.8 m -139.9 163.53 24.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 74.140000000000001 111.716 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 165' ' ' SER . 34.9 m-85 -104.93 124.65 49.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.555 -0.748 . . . . 73.230000000000004 110.785 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.89 95.99 5.8 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.668 -0.493 . . . . 65.319999999999993 109.668 170.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -90.1 112.39 23.83 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.225 -0.657 . . . . 55.130000000000003 109.225 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -97.46 -179.72 4.58 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.011 0.434 . . . . 71.129999999999995 111.083 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 160' ' ' ILE . 0.7 OUTLIER -67.65 -29.74 69.12 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.775 -0.648 . . . . 62.399999999999999 110.545 178.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.662 ' SD ' HG22 ' A' ' 142' ' ' VAL . 93.9 mtp -88.12 -34.69 17.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.899 -0.591 . . . . 71.120000000000005 111.358 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.58 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -173.82 -133.28 1.66 Allowed Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.689 -0.767 . . . . 71.219999999999999 111.915 177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.0 tt -140.75 137.43 35.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.116 0.484 . . . . 73.25 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.44 126.78 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.826 -0.625 . . . . 63.130000000000003 109.821 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 13.3 t -105.91 142.04 19.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.146 -0.479 . . . . 64.340000000000003 109.723 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.65 164.08 36.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.974 0.416 . . . . 73.310000000000002 110.933 178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 10.2 pt-20 -130.95 165.21 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.568 -0.742 . . . . 73.340000000000003 109.765 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.01 157.74 16.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 109.923 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -79.82 103.44 9.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 72.420000000000002 111.969 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -81.81 0.84 37.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.584 -0.735 . . . . 75.319999999999993 110.891 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -70.31 -66.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.033 -0.531 . . . . 72.430000000000007 111.274 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.421 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 6.4 t-160 -126.51 9.91 7.21 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.729 -0.388 . . . . 73.299999999999997 111.034 -174.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -128.73 65.38 72.36 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 121.078 -0.249 . . . . 22.510000000000002 111.306 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 31' ' ' HIS . 13.2 Cg_exo -69.85 -45.56 1.5 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.647 2.231 . . . . 74.230000000000004 112.196 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.39 -35.1 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 109.972 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -65.52 -46.19 80.57 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.673 -0.694 . . . . 72.450000000000003 110.199 177.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -55.08 -48.93 72.87 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.952 -0.567 . . . . 74.430000000000007 110.496 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HE2' ' HB2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -61.11 -36.0 78.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.806 -0.634 . . . . 70.5 110.935 -178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.35 -40.17 85.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.024 0.44 . . . . 73.049999999999997 110.228 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.81 -47.56 58.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.858 -0.61 . . . . 74.420000000000002 109.792 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.37 -47.51 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 63.310000000000002 111.78 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 51.2 mm-40 -60.35 -38.89 85.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 55.409999999999997 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 42' ' ' LEU . 30.7 mt -68.56 -30.46 69.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.889 0.376 . . . . 73.219999999999999 110.882 177.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.76 64.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.579 -0.737 . . . . 71.400000000000006 111.212 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' ' HA ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -74.24 -29.1 61.54 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.775 -0.37 . . . . 75.530000000000001 111.244 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -74.4 -46.11 42.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.625 -0.509 . . . . 74.239999999999995 109.625 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.17 42.62 1.61 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.675 -0.774 . . . . 72.530000000000001 111.781 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -76.04 -27.91 57.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.249 0.547 . . . . 74.340000000000003 110.422 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.554 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.4 m-85 -78.2 -3.27 41.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.022 -0.535 . . . . 72.299999999999997 111.043 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -73.78 -0.64 16.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.098 0.475 . . . . 61.009999999999998 110.539 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.88 7.55 5.79 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.95 -0.568 . . . . 54.32 112.131 176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 65' ' ' GLY . 35.3 p -88.02 149.45 23.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.353 . . . . 63.420000000000002 111.247 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 52' ' ' LYS . 11.7 ptpt -139.39 157.41 45.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.197 -0.456 . . . . 64.010000000000005 110.59 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 80.9 m-85 -86.13 131.09 34.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.356 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -109.93 -38.91 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 72.140000000000001 110.992 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 26.4 mmm180 -115.37 117.37 30.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.076 -0.342 . . . . 70.310000000000002 110.076 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -131.23 94.8 2.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.94 -0.763 . . . . 72.239999999999995 108.94 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 36.9 mt -105.23 128.34 59.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.841 -0.618 . . . . 72.420000000000002 109.796 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.42 128.72 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.075 0.464 . . . . 73.540000000000006 111.13 -177.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 54.12 35.43 22.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.848 -1.069 . . . . 64.019999999999996 111.512 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.786 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 4.2 t80 -132.44 -82.39 0.49 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.989 0.424 . . . . 73.310000000000002 110.279 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.478 ' HG2' ' HD2' ' A' ' 60' ' ' PHE . 22.7 ptp -159.74 158.63 31.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 110.573 -178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 HD21 ' A' ' 116' ' ' LEU . 35.1 mt -130.22 100.28 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.622 -0.717 . . . . 70.299999999999997 109.419 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 50.1 tt0 -85.57 127.71 34.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.333 -0.394 . . . . 73.120000000000005 110.494 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -139.18 149.58 20.77 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.616 -0.802 . . . . 65.140000000000001 112.335 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 51' ' ' THR . . . 151.14 -71.76 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.926 -1.13 . . . . 61.509999999999998 113.524 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . 32.0 t0 -42.86 105.91 0.45 Allowed Pre-proline 0 N--CA 1.47 0.542 0 N-CA-C 112.899 0.703 . . . . 74.209999999999994 112.899 -168.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 97.6 Cg_endo -86.2 -18.52 3.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.315 2.676 . . . . 74.439999999999998 111.54 176.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.41 ' HB ' HG23 ' A' ' 70' ' ' THR . 77.6 p -89.62 -32.7 16.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.309 -0.86 . . . . 74.340000000000003 111.371 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 31.64 59.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.832 -0.907 . . . . 74.329999999999998 110.832 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' HG3' ' A' ' 72' ' ' ARG . 64.3 p -102.88 -30.55 10.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.309 0.576 . . . . 71.209999999999994 111.056 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.34 -3.31 23.65 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.299 -0.864 . . . . 63.210000000000001 112.085 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HG3' ' OG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -119.12 -31.34 4.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.647 0.26 . . . . 61.420000000000002 111.277 178.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 95.39 -169.65 27.81 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.809 -0.71 . . . . 74.129999999999995 112.797 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.88 -105.52 2.29 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.26 -0.495 . . . . 32.420000000000002 112.246 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 44.77 48.96 8.98 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.45 0.7 . . . . 65.109999999999999 112.645 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.2 t -80.44 12.71 2.83 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.021 -0.536 . . . . 54.219999999999999 110.919 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.6 -20.88 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.737 0.303 . . . . 53.420000000000002 110.611 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.421 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 16.0 p90 -101.2 -2.01 32.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.143 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.42 1.4 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.942 -0.647 . . . . 55.420000000000002 113.125 175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -121.32 -168.05 1.61 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.841 0.353 . . . . 75.140000000000001 111.251 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -68.2 173.87 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 73.530000000000001 111.886 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 89.7 m-85 -139.67 -162.02 1.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.897 -1.047 . . . . 75.230000000000004 108.965 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.82 159.29 34.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.606 -0.516 . . . . 61.509999999999998 109.606 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -61.35 136.28 57.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.609 -0.515 . . . . 72.010000000000005 109.609 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -101.07 16.53 25.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 73.129999999999995 110.714 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.4 mt -71.8 96.81 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.147 0.499 . . . . 74.310000000000002 111.958 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.48 78.48 6.96 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.715 -0.675 . . . . 62.109999999999999 111.031 173.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 89.33 0.55 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.593 2.195 . . . . 74.019999999999996 112.428 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -86.22 10.76 13.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.659 0.742 . . . . 71.299999999999997 110.544 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -122.98 -175.72 3.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.232 -0.895 . . . . 70.239999999999995 109.846 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -124.77 144.26 50.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.627 0.251 . . . . 53.530000000000001 110.827 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 68.34 0.63 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.637 0.732 . . . . 75.439999999999998 109.888 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.1 p -65.53 -39.39 91.72 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.159 -0.928 . . . . 74.319999999999993 112.066 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.609 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -170.42 -137.03 2.19 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.372 -0.918 . . . . 44.43 112.538 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.71 140.61 30.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.617 0.246 . . . . 60.520000000000003 110.741 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.25 24.32 5.73 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.774 -0.727 . . . . 61.109999999999999 111.775 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.434 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.8 mm -88.39 109.79 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.441 -0.577 . . . . 71.349999999999994 109.441 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.836 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.48 119.69 26.11 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.562 -0.532 . . . . 71.420000000000002 109.562 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.7 174.24 10.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.023 0.44 . . . . 74.510000000000005 111.478 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.828 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 28.2 ttt -106.93 142.32 36.75 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.729 -0.669 . . . . 65.319999999999993 109.907 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -103.79 118.16 36.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.527 0.68 . . . . 70.120000000000005 111.095 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.667 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.8 p-10 -115.47 165.74 12.66 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.998 -1.001 . . . . 71.310000000000002 109.964 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.5 -37.38 11.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.862 0.839 . . . . 64.120000000000005 109.19 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -138.83 174.49 22.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 108.644 -1.782 . . . . 61.420000000000002 108.644 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.57 -49.61 11.73 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.073 2.515 . . . . 73.010000000000005 112.811 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -101.57 -11.1 19.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.521 -0.308 . . . . 72.530000000000001 111.275 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 3.1 m -86.14 55.46 3.55 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.667 -0.864 . . . . 54.32 108.667 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.667 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 38.6 m-80 -62.15 117.22 5.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.356 -1.293 . . . . 72.430000000000007 109.505 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' A' ' 102' ' ' ASN . . . -90.95 -168.16 41.82 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.703 -0.76 . . . . 63.0 112.672 -172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 m -99.46 20.27 14.12 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.42 0.628 . . . . 62.039999999999999 110.094 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.668 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 17.4 mt-30 -109.89 159.04 17.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.478 -0.783 . . . . 63.310000000000002 110.77 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -139.89 174.17 10.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.203 -0.665 . . . . 74.0 109.203 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 49.2 p90 -160.08 154.69 24.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.305 0.574 . . . . 54.329999999999998 111.692 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.669 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.22 145.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.274 -0.876 . . . . 74.209999999999994 109.23 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.5 p -100.94 131.1 46.97 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.062 0.458 . . . . 43.210000000000001 110.459 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 62' ' ' ILE . 59.8 mt -89.2 -5.39 57.72 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.698 -0.683 . . . . 62.329999999999998 110.994 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.39 164.22 21.9 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.849 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.609 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 38.9 Cg_exo -61.06 107.04 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.464 2.109 . . . . 61.210000000000001 111.887 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.523 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 23.4 p -96.37 96.89 9.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.81 -0.632 . . . . 63.219999999999999 111.02 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 120' ' ' GLN . 1.0 OUTLIER -100.02 9.9 42.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.57 0.7 . . . . 75.430000000000007 110.471 -176.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.451 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -108.57 -12.42 14.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.77 -1.105 . . . . 74.420000000000002 111.591 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.523 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 3.3 pp -114.91 9.8 16.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.737 0.303 . . . . 75.030000000000001 111.342 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.85 -34.37 65.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.465 -0.789 . . . . 62.149999999999999 110.885 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.39 15.36 30.03 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.524 -0.762 . . . . 73.310000000000002 112.033 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.59 -35.93 5.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.075 0.464 . . . . 72.319999999999993 110.078 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -140.82 139.4 34.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.796 -0.638 . . . . 73.400000000000006 109.671 -177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -77.68 148.71 34.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.156 0.503 . . . . 55.219999999999999 110.446 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.52 HG23 ' HB2' ' A' ' 99' ' ' ALA . 45.1 mt -126.88 122.65 60.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.903 -0.59 . . . . 75.430000000000007 110.555 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.828 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.4 p90 -153.93 72.94 0.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.685 0.755 . . . . 71.340000000000003 111.212 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.08 152.24 22.27 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 119.557 -1.306 . . . . 73.420000000000002 113.676 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.42 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 74.0 mtp180 -130.14 117.22 19.6 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.218 -0.66 . . . . 55.200000000000003 109.218 172.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.44 135.34 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.051 0.453 . . . . 64.0 110.385 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.64 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 51.3 t -143.65 145.01 32.14 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.26 -0.427 . . . . 73.530000000000001 110.096 -176.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.692 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.7 tt0 50.92 40.69 25.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.354 0.597 . . . . 73.219999999999999 111.85 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 139' ' ' VAL . . . -170.62 24.82 0.1 OUTLIER Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.143 -1.027 . . . . 62.039999999999999 112.152 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.5 tp -78.61 -32.32 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.088 -0.245 . . . . 75.230000000000004 110.478 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 141' ' ' ARG . . . -62.23 -37.35 94.4 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.155 -0.778 . . . . 72.420000000000002 111.155 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.58 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 72.1 mmm -68.09 -55.64 11.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 110.145 -0.317 . . . . 74.409999999999997 110.145 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 135' ' ' GLY . 90.1 t -51.57 -31.25 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.218 0.532 . . . . 64.409999999999997 110.644 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.552 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.6 t30 -70.11 -56.79 5.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.713 -0.676 . . . . 72.310000000000002 110.538 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.532 ' HD2' ' HE3' ' A' ' 138' ' ' MET . 0.1 OUTLIER -72.62 -15.64 61.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.767 0.318 . . . . 71.140000000000001 111.261 -177.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG22 ' SD ' ' A' ' 20' ' ' MET . 75.3 t -79.73 -43.25 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.369 -0.604 . . . . 54.32 109.369 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -76.48 -25.86 64.64 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.417 -0.897 . . . . 63.43 112.549 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.552 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 77.7 mtp -73.53 -11.27 60.39 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.76 0.282 . . . . 65.400000000000006 111.76 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.66 117.02 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.561 0.696 . . . . 75.349999999999994 111.243 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.51 -92.3 0.43 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.605 -0.725 . . . . 71.340000000000003 110.282 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.0 p -117.01 149.37 40.37 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.93 -0.577 . . . . 73.340000000000003 109.691 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -83.75 -147.04 0.09 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 110.261 -0.274 . . . . 53.43 110.261 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.5 t -60.67 -32.97 72.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 51.219999999999999 110.234 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -97.14 171.93 8.14 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.311 -0.626 . . . . 74.140000000000001 109.311 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.36 63.59 7.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.053 0.93 . . . . 72.450000000000003 109.718 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -137.91 143.51 40.2 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 114.528 -1.215 . . . . 64.340000000000003 109.05 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.39 129.56 33.31 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.289 1.993 . . . . 72.540000000000006 111.497 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.3 t -53.85 -45.01 62.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.06 -0.518 . . . . 73.420000000000002 110.599 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -139.65 128.7 23.68 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.485 -0.561 . . . . 75.409999999999997 109.485 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.17 88.15 6.03 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.067 0.46 . . . . 72.5 109.941 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.52 126.97 41.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.78 0.8 . . . . 72.519999999999996 111.697 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.67 172.97 11.36 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.165 -0.925 . . . . 65.219999999999999 109.276 173.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -89.52 105.01 15.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 108.728 -0.841 . . . . 75.049999999999997 108.728 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 22.7 mm -73.92 -48.22 39.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.364 -0.835 . . . . 55.43 110.989 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -131.86 126.08 33.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.944 -0.571 . . . . 62.530000000000001 110.828 178.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.16 122.82 30.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.0 0.429 . . . . 70.200000000000003 110.566 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -155.91 150.87 20.75 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.842 -0.617 . . . . 75.420000000000002 110.268 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.484 ' HA ' HG12 ' A' ' 14' ' ' VAL . 54.7 Cg_endo -70.86 134.25 25.26 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.638 2.226 . . . . 74.530000000000001 112.887 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.53 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.6 p -81.93 -46.47 13.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 61.310000000000002 109.934 175.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.16 -76.92 1.0 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.544 -0.753 . . . . 73.019999999999996 111.774 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -98.32 57.56 1.02 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.76 -0.733 . . . . 70.040000000000006 112.634 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.2 24.11 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.099 -0.801 . . . . 65.319999999999993 111.099 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.51 157.72 25.45 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.024 -1.084 . . . . 72.439999999999998 112.891 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 25.5 t -155.81 140.43 16.95 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.294 -0.632 . . . . 63.329999999999998 109.294 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.62 135.7 2.59 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.647 -0.787 . . . . 65.019999999999996 112.001 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 118.59 -146.2 18.42 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.91 -0.662 . . . . 75.319999999999993 111.909 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.749 ' HA3' ' HA3' ' A' ' 181' ' ' GLY . . . 82.33 47.05 6.23 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.977 -0.63 . . . . 53.32 112.651 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.4 m -82.34 90.93 6.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.976 -0.379 . . . . 72.239999999999995 109.976 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -137.83 103.09 0.4 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.651 -0.785 . . . . 72.209999999999994 112.722 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 75.13 -156.36 48.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.079 -0.581 . . . . 54.450000000000003 112.915 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -106.18 1.8 37.81 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.011 -0.614 . . . . 52.219999999999999 112.197 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.2 t -158.15 154.84 28.06 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.827 -0.434 . . . . 61.329999999999998 109.827 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.16 -71.14 0.2 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.931 -0.652 . . . . 54.109999999999999 111.594 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.56 -161.16 46.19 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.888 -0.672 . . . . 44.340000000000003 112.528 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.749 ' HA3' ' HA3' ' A' ' 173' ' ' GLY . . . -144.86 51.24 0.62 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.862 -0.685 . . . . 62.149999999999999 111.855 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 33.8 t -131.95 111.74 11.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.931 -0.396 . . . . 70.420000000000002 109.931 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.67 -80.78 0.29 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.82 -0.705 . . . . 35.310000000000002 111.663 178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.6 m-20 -126.18 170.65 11.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.275 0.559 . . . . 71.129999999999995 110.443 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.54 146.93 4.47 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.228 -0.896 . . . . 71.319999999999993 111.306 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -84.59 -166.61 41.55 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.373 -0.918 . . . . 51.43 111.929 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.641 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -74.9 170.86 15.1 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.741 0.305 . . . . 64.140000000000001 110.271 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.411 ' HD1' HH21 ' A' ' 131' ' ' ARG . 91.8 m-85 -111.14 93.17 17.21 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-O 121.153 0.501 . . . . 71.310000000000002 110.449 -175.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 6.0 Cg_exo -76.36 -13.56 18.62 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.888 2.392 . . . . 73.129999999999995 111.715 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.24 -34.79 42.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.902 -1.045 . . . . 74.319999999999993 111.072 -173.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 193' ' ' VAL . 31.3 pt -80.31 -11.7 12.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 71.239999999999995 111.428 -172.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.04 67.51 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.416 -0.811 . . . . 72.019999999999996 111.321 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 191' ' ' ILE . 6.4 p -164.21 152.95 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.059 -0.349 . . . . 62.310000000000002 110.059 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.14 113.97 14.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.911 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -161.94 157.32 23.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 70.219999999999999 109.625 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -124.02 156.35 66.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.503 -0.317 . . . . 72.150000000000006 110.726 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 49.0 Cg_endo -69.34 -69.7 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.478 2.119 . . . . 50.409999999999997 112.272 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' A' ' 197' ' ' PRO . 1.6 pt? -120.25 23.57 10.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 72.400000000000006 109.95 174.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 68.56 13.92 9.0 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.226 -0.897 . . . . 72.340000000000003 111.846 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 18.6 ptm -52.24 -46.04 65.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.034 -0.53 . . . . 70.230000000000004 112.25 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -80.9 -2.15 90.11 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.745 -0.74 . . . . 72.109999999999999 113.141 -175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -80.02 -26.5 39.77 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.374 0.607 . . . . 60.409999999999997 110.206 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.632 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.87 0 CA-C-N 114.9 -1.045 . . . . 72.439999999999998 109.927 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.556 0.217 . . . . 70.219999999999999 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.17 129.71 5.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.637 0.256 . . . . 74.420000000000002 111.062 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.88 -59.09 2.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.007 0.432 . . . . 44.520000000000003 110.353 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 78' ' ' TYR . 74.6 mt -134.65 102.34 11.49 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.702 -0.681 . . . . 73.420000000000002 110.556 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -87.04 113.91 1.04 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.03 2.487 . . . . 75.129999999999995 111.366 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.92 142.26 46.75 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.501 2.134 . . . . 74.239999999999995 112.255 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -87.62 10.99 16.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.256 -0.429 . . . . 64.540000000000006 111.283 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.0 p 61.61 -68.75 0.05 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.82 1.248 . . . . 65.0 112.417 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -65.69 119.81 11.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.832 0.348 . . . . 74.040000000000006 110.377 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.92 109.0 56.81 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 109.173 -0.677 . . . . 71.439999999999998 109.173 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 164' ' ' PRO . 4.7 Cg_endo -49.24 112.04 0.59 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.442 2.762 . . . . 73.019999999999996 113.146 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.1 Cg_exo -78.82 -31.51 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.894 2.396 . . . . 74.420000000000002 111.304 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 14.8 t-20 -143.23 139.84 30.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.144 -0.935 . . . . 63.340000000000003 109.329 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.483 HG21 ' HE1' ' A' ' 39' ' ' PHE . 24.6 m -135.89 165.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.539 -0.3 . . . . 53.439999999999998 110.617 -176.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HB2' HD11 ' A' ' 22' ' ' ILE . 38.5 p90 -124.13 134.11 53.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.167 0.508 . . . . 73.219999999999999 110.61 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.16 111.12 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 72.230000000000004 110.451 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 161' ' ' LYS . 7.1 tp10 -85.67 112.09 20.69 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.383 -0.969 . . . . 71.030000000000001 108.383 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.1 p -105.0 -179.8 4.05 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.066 0.46 . . . . 55.340000000000003 111.263 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -1.48 42.07 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 62.32 111.035 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.608 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.0 mmt -108.32 -44.89 4.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 73.439999999999998 109.95 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.6 -140.9 3.19 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 110.592 -1.003 . . . . 60.310000000000002 110.592 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -133.08 131.47 58.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.529 -0.545 . . . . 74.230000000000004 109.529 -178.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -125.96 128.37 71.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.759 -0.655 . . . . 63.32 110.947 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 85.1 t -111.52 143.71 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.82 -0.437 . . . . 74.519999999999996 109.82 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.12 161.24 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.215 0.531 . . . . 73.25 110.852 176.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' HD22 ' A' ' 13' ' ' ASN . 5.8 pt-20 -125.72 168.81 13.25 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.366 -0.834 . . . . 72.219999999999999 109.823 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD11 ' CG ' ' A' ' 39' ' ' PHE . 1.1 mm? -108.54 163.05 13.57 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.198 -0.667 . . . . 64.409999999999997 109.198 177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 2.9 m-85 -83.35 89.82 7.07 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.253 -0.579 . . . . 74.400000000000006 111.993 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -7.19 58.87 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.453 -1.314 . . . . 62.420000000000002 107.453 170.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -66.79 -43.06 84.9 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.426 -1.715 . . . . 53.329999999999998 110.746 -176.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -140.06 -1.61 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.981 -0.554 . . . . 75.439999999999998 111.584 -173.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.6 88.97 18.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.742 -0.383 . . . . 21.100000000000001 111.435 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.23 -6.11 17.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.895 2.396 . . . . 75.010000000000005 112.626 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 15.4 mtpt -100.1 -53.8 3.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.399 -0.364 . . . . 74.109999999999999 111.101 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.416 HG23 ' SD ' ' A' ' 100' ' ' MET . 8.8 m -53.93 -35.86 62.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 70.310000000000002 111.977 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.629 ' SG ' ' HE2' ' A' ' 37' ' ' LYS . 6.1 p -66.89 -28.43 68.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.373 -0.376 . . . . 70.120000000000005 111.517 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HE2' ' SG ' ' A' ' 36' ' ' CYS . 36.8 mmtt -79.93 -34.83 38.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.347 -0.388 . . . . 73.129999999999995 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -57.04 -53.2 60.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.557 -0.747 . . . . 73.430000000000007 110.531 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' HE1' HG21 ' A' ' 14' ' ' VAL . 23.4 t80 -61.55 -50.68 71.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 64.239999999999995 109.838 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -42.19 66.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.961 -1.018 . . . . 72.230000000000004 111.49 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -54.07 -48.92 70.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 61.43 110.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD12 ' CB ' ' A' ' 47' ' ' TYR . 2.6 mm? -74.78 -29.12 61.02 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.582 -0.447 . . . . 72.340000000000003 111.695 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.5 -38.1 65.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.691 -0.231 . . . . 63.229999999999997 111.521 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 7' ' ' ASP . 3.7 ppt_? -77.14 -21.54 53.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.996 0.427 . . . . 65.099999999999994 110.423 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' C ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.65 -45.69 24.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.018 -0.734 . . . . 64.219999999999999 109.018 176.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.67 36.09 2.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.697 -0.763 . . . . 44.25 111.62 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.543 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 0.2 OUTLIER -71.15 -30.77 66.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.139 0.495 . . . . 72.219999999999999 110.265 -177.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -78.18 -7.72 57.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.598 -0.728 . . . . 70.329999999999998 111.502 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.78 -8.1 53.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 72.319999999999993 111.168 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.49 31.69 2.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.808 -0.71 . . . . 72.349999999999994 112.252 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.715 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 20.3 p -107.46 150.63 26.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.041 0.448 . . . . 73.439999999999998 111.863 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 1.4 mmtp -120.17 169.93 9.79 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.169 -0.678 . . . . 63.100000000000001 109.169 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -88.08 118.49 27.68 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 63.210000000000001 109.329 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -93.31 -28.77 16.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 110.413 -170.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 41.1 mmt180 -137.67 109.74 7.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.283 -0.417 . . . . 44.439999999999998 110.134 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 56' ' ' ILE . 4.1 mp -115.07 79.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.395 -0.595 . . . . 71.299999999999997 109.395 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.09 134.47 27.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.051 -0.522 . . . . 73.329999999999998 109.639 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.988 ' HE3' ' HA ' ' A' ' 146' ' ' GLU . 2.4 mptp? -74.62 128.76 36.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.443 -0.344 . . . . 72.219999999999999 110.388 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.8 32.28 21.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.005 0.815 . . . . 54.409999999999997 110.923 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -133.86 -83.2 0.45 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.024 0.44 . . . . 74.200000000000003 111.144 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptm -160.63 155.15 23.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.822 -0.626 . . . . 64.219999999999999 110.718 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.508 HD12 HG13 ' A' ' 139' ' ' VAL . 36.1 mt -130.58 103.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.629 -0.714 . . . . 73.200000000000003 109.723 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.433 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.8 tt0 -80.14 126.6 31.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.9 -0.591 . . . . 72.219999999999999 110.447 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.28 129.38 7.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.836 -0.697 . . . . 70.310000000000002 111.646 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.715 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 134.81 -148.12 19.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.458 -0.877 . . . . 72.239999999999995 112.859 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 49.8 t0 53.21 81.75 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 123.892 0.877 . . . . 75.299999999999997 111.534 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD3' ' CE1' ' A' ' 47' ' ' TYR . 54.7 Cg_endo -72.32 -24.02 20.05 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.792 2.328 . . . . 42.109999999999999 111.159 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 73' ' ' GLY . 5.6 p -81.9 -46.32 14.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.256 -0.884 . . . . 71.239999999999995 111.751 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.32 26.55 10.0 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.578 -0.82 . . . . 74.239999999999995 111.412 -173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 72' ' ' ARG . 6.6 t -128.81 -19.31 3.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.775 0.321 . . . . 73.019999999999996 111.121 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.88 -18.57 55.69 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.524 -0.846 . . . . 64.230000000000004 113.313 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HD3' ' C ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -110.9 5.22 20.33 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.429 -0.453 . . . . 73.540000000000006 111.152 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -86.85 176.85 47.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.623 -0.799 . . . . 64.230000000000004 112.647 -177.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 85.18 -45.26 3.48 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.034 -0.603 . . . . 62.439999999999998 112.533 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.587 ' HB2' ' HB2' ' A' ' 110' ' ' SER . . . -76.32 25.25 0.13 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.834 0.454 . . . . 60.299999999999997 111.702 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 74' ' ' GLY . 7.4 m -59.5 -24.35 63.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.349 -0.841 . . . . 62.530000000000001 111.06 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.591 HG23 ' HD1' ' A' ' 78' ' ' TYR . 3.4 tt -56.22 -48.36 79.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 115.717 -0.674 . . . . 74.219999999999999 111.284 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG23 ' A' ' 77' ' ' ILE . 30.2 p90 -108.97 -6.09 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.657 0.265 . . . . 62.450000000000003 111.593 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.58 -95.95 1.13 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.622 -0.799 . . . . 63.030000000000001 113.524 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -112.06 -174.33 2.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.744 0.783 . . . . 72.299999999999997 112.16 -173.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.551 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -85.91 175.18 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.388 -1.278 . . . . 74.129999999999995 108.751 170.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -132.98 -60.47 0.86 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.293 -0.563 . . . . 72.299999999999997 111.717 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.72 177.87 8.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.437 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.67 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -103.95 149.49 25.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.789 -0.449 . . . . 72.450000000000003 109.789 174.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -121.79 23.87 9.93 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 HD23 ' OG1' ' A' ' 127' ' ' THR . 55.8 mt -59.53 102.86 0.16 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.425 -0.807 . . . . 73.129999999999995 111.062 -174.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -161.84 82.09 1.84 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.923 0.392 . . . . 60.539999999999999 110.377 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.78 81.25 0.46 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.44 2.093 . . . . 72.540000000000006 111.296 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.76 -4.41 59.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.054 0.93 . . . . 64.510000000000005 109.403 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -94.72 -153.29 0.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.37 -1.286 . . . . 72.530000000000001 108.611 173.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -152.43 142.04 21.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.588 -0.445 . . . . 74.420000000000002 110.946 174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.684 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 34.8 p90 -59.83 123.63 17.6 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.529 -0.76 . . . . 74.129999999999995 109.398 170.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.0 p -116.2 -40.13 3.31 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.253 -0.43 . . . . 63.340000000000003 110.995 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.36 -143.54 3.73 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.034 -0.603 . . . . 64.329999999999998 112.274 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 151.3 19.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.686 0.279 . . . . 62.420000000000002 110.626 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.408 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 103.35 23.73 8.28 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.52 -0.848 . . . . 51.350000000000001 111.319 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.406 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.1 mm -89.04 111.36 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.643 -0.502 . . . . 73.519999999999996 109.643 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.1 tm? -86.72 120.16 27.73 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.749 -0.66 . . . . 74.310000000000002 109.719 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 128' ' ' ILE . . . -134.42 172.86 12.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.151 -0.477 . . . . 73.5 111.319 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.57 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 64.7 mtp -90.52 141.78 28.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.588 . . . . 72.150000000000006 110.411 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.22 156.66 18.24 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.136 -0.484 . . . . 64.209999999999994 109.754 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.599 ' HB2' ' HB ' ' A' ' 107' ' ' THR . 3.7 p-10 -159.75 163.25 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.386 -0.37 . . . . 74.310000000000002 110.712 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.1 -38.7 15.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.705 -0.68 . . . . 72.400000000000006 110.303 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.16 -80.67 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.522 -0.847 . . . . 32.0 112.65 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.13 85.3 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.976 2.451 . . . . 61.399999999999999 112.934 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 52.32 33.08 12.07 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.392 -0.822 . . . . 71.519999999999996 112.136 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -76.26 39.22 0.19 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.212 0.449 . . . . 75.109999999999999 112.212 -174.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.67 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 14.7 m-80 -84.66 139.58 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.377 -0.601 . . . . 73.140000000000001 109.377 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.15 -68.42 0.28 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.85 -1.167 . . . . 40.340000000000003 113.533 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 33.8 t -109.13 -24.24 11.25 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.573 0.582 . . . . 70.120000000000005 112.573 -169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -91.37 137.47 32.34 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.487 -0.485 . . . . 54.32 110.051 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 87.9 m-85 -141.12 167.5 22.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.653 0.263 . . . . 72.219999999999999 110.679 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 34.1 p90 -159.4 158.27 31.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.753 0.311 . . . . 72.450000000000003 110.719 178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -112.14 146.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 61.439999999999998 109.686 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -98.55 131.84 44.45 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.967 0.413 . . . . 70.430000000000007 110.232 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 62' ' ' ILE . 55.9 mt -85.76 -7.71 58.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 111.024 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.96 158.41 33.89 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.797 -0.638 . . . . 61.140000000000001 110.106 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.684 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 56.2 Cg_endo -71.76 123.91 9.77 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.362 2.042 . . . . 72.5 112.04 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.4 HG21 HD21 ' A' ' 122' ' ' LEU . 41.0 p -108.81 158.57 17.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 110.937 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 21.67 2.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.105 0.479 . . . . 62.530000000000001 111.005 174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.32 -3.98 6.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.064 -0.516 . . . . 75.040000000000006 112.113 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 4.3 pp -130.4 3.94 4.69 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.497 -0.481 . . . . 74.230000000000004 111.617 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.64 -28.36 69.04 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.895 -0.593 . . . . 73.219999999999999 110.493 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.28 13.07 55.18 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.29 -0.724 . . . . 62.100000000000001 111.29 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 25.1 mmmt -116.22 -22.94 8.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.119 -0.697 . . . . 71.219999999999999 109.119 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 100' ' ' MET . 85.4 m-70 -134.67 134.68 41.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.37 -0.832 . . . . 70.340000000000003 110.042 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.402 ' OG1' HD23 ' A' ' 86' ' ' LEU . 18.9 m -72.81 121.4 19.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.06 -0.348 . . . . 72.450000000000003 110.06 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' A' ' 99' ' ' ALA . 45.1 mt -108.71 114.65 47.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.92 -0.312 . . . . 64.319999999999993 111.768 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.746 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.5 m-85 -156.59 76.1 0.87 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 72.439999999999998 110.399 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.86 157.11 29.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.582 -0.818 . . . . 72.340000000000003 112.871 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.67 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 55.9 mtm180 -134.98 125.89 27.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.976 -0.379 . . . . 72.310000000000002 109.976 174.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.1 p -80.49 139.0 18.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.037 0.446 . . . . 64.420000000000002 110.41 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 41.3 t -139.24 143.58 38.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.236 -0.438 . . . . 73.010000000000005 110.551 -174.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.6 pt20 41.21 40.14 1.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.246 1.018 . . . . 73.540000000000006 113.239 178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.47 41.41 0.17 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.832 -0.699 . . . . 44.310000000000002 111.901 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.2 tp -88.82 -36.35 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.672 0.272 . . . . 73.230000000000004 110.636 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.95 -36.36 92.05 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.903 -0.665 . . . . 51.109999999999999 111.681 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.0 mmm -67.83 -51.66 45.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 110.26 -0.274 . . . . 64.420000000000002 110.26 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.508 HG13 HD12 ' A' ' 62' ' ' ILE . 91.9 t -54.31 -32.66 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.131 0.491 . . . . 53.43 110.668 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -70.39 -51.87 26.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.846 -0.615 . . . . 74.019999999999996 110.45 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -76.81 -10.14 59.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.966 -0.561 . . . . 74.450000000000003 111.355 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.8 t -87.11 -38.9 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.277 0.561 . . . . 72.450000000000003 109.792 173.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.467 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.31 -33.96 38.08 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.574 -0.822 . . . . 50.030000000000001 112.87 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 22.1 ptm -78.93 -18.91 53.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.08 0.4 . . . . 72.540000000000006 112.08 -173.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.37 126.32 37.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 119.962 -0.695 . . . . 61.299999999999997 110.095 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.988 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 11.0 pt-20 -78.82 -174.36 3.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.864 -0.607 . . . . 70.439999999999998 111.5 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.8 p -84.89 161.21 19.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.713 -0.676 . . . . 73.310000000000002 110.654 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -73.86 -38.87 64.31 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.103 -1.073 . . . . 65.230000000000004 108.103 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.834 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 30.6 t -158.26 139.94 13.72 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.093 -1.412 . . . . 71.129999999999995 108.361 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 42.48 -94.75 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 O-C-N 124.076 0.86 . . . . 54.310000000000002 113.155 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.52 10.52 9.14 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.02 0.378 . . . . 73.319999999999993 112.02 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.834 ' HD3' ' HB3' ' A' ' 149' ' ' SER . 3.1 ptm180 -95.43 111.37 55.07 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.33 -0.618 . . . . 73.340000000000003 109.33 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.16 146.39 90.52 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.713 2.275 . . . . 75.019999999999996 112.939 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 146' ' ' GLU . 61.0 t -62.47 -54.47 33.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.351 0.596 . . . . 71.329999999999998 109.586 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -102.47 133.22 47.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.684 -0.689 . . . . 72.019999999999996 109.794 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' OD2' ' HD2' ' A' ' 158' ' ' LYS . 32.0 t70 -86.62 100.22 12.28 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.926 -0.579 . . . . 71.230000000000004 109.609 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 158' ' ' LYS . 3.6 t -104.47 123.08 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.847 0.832 . . . . 65.239999999999995 112.478 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 158' ' ' LYS . 2.0 mppt? -139.65 170.95 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.691 -1.14 . . . . 64.420000000000002 109.301 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.7 mp -90.52 106.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.734 -0.839 . . . . 64.040000000000006 108.734 175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.552 HG22 ' HD2' ' A' ' 161' ' ' LYS . 26.0 mm -73.62 -52.3 21.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 110.251 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.552 ' HD2' HG22 ' A' ' 160' ' ' ILE . 4.9 mptp? -130.73 143.42 50.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.542 -0.754 . . . . 71.319999999999993 109.298 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.94 127.22 13.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.944 -0.391 . . . . 63.32 109.944 175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 95.3 m-85 -148.23 155.23 43.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.569 -0.53 . . . . 74.010000000000005 109.569 -174.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.956 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 7.8 Cg_endo -85.07 131.62 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.431 2.087 . . . . 73.109999999999999 112.117 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.3 p -109.18 -27.79 9.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.047 -0.524 . . . . 73.430000000000007 110.688 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.04 -37.39 3.78 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.834 -0.698 . . . . 33.219999999999999 112.092 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -179.81 70.37 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.65 -0.786 . . . . 72.530000000000001 112.404 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.5 118.16 4.81 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.853 -0.689 . . . . 45.219999999999999 111.736 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.47 ' HA3' ' SG ' ' A' ' 133' ' ' CYS . . . 106.24 162.42 22.71 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.702 -0.761 . . . . 50.439999999999998 111.967 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.1 p -141.37 154.73 45.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.524 0.202 . . . . 72.530000000000001 110.523 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.1 53.29 0.64 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.504 -0.855 . . . . 63.240000000000002 112.32 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.17 93.1 0.78 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.802 -0.713 . . . . 62.43 111.971 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.17 165.35 24.41 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.992 -0.623 . . . . 60.310000000000002 112.237 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -159.47 103.46 1.59 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.105 -0.332 . . . . 72.030000000000001 110.105 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 153.74 -154.77 25.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.932 -0.651 . . . . 61.520000000000003 111.597 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.49 -56.41 4.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.941 -0.647 . . . . 61.130000000000003 112.484 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 87.87 -67.82 3.13 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.08 -0.581 . . . . 63.130000000000003 111.852 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 26.9 m -137.11 19.13 2.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.297 0.57 . . . . 75.230000000000004 110.139 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.36 -176.42 35.33 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.506 -0.77 . . . . 73.200000000000003 111.444 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 124.34 0.22 8.74 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.943 -0.646 . . . . 74.140000000000001 111.987 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.68 37.91 4.34 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.884 -0.674 . . . . 73.049999999999997 111.427 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 14.9 m -88.48 120.77 30.17 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.692 0.282 . . . . 64.340000000000003 110.932 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -77.55 -102.97 0.17 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.675 -0.774 . . . . 74.430000000000007 111.547 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.506 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -130.37 171.6 12.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.504 0.669 . . . . 73.310000000000002 111.172 178.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.525 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 152.3 137.6 2.6 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 114.742 -1.117 . . . . 23.239999999999998 110.922 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.66 -160.89 14.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.395 -0.907 . . . . 74.010000000000005 112.564 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.833 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.2 172.5 12.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.667 0.27 . . . . 53.030000000000001 110.395 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.2 98.48 22.7 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.868 -0.419 . . . . 75.530000000000001 109.868 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 1.4 Cg_endo -82.54 -8.52 11.46 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.766 2.31 . . . . 61.420000000000002 111.773 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -80.83 -26.76 36.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.974 -0.557 . . . . 73.420000000000002 110.301 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.3 pt -94.23 152.12 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.181 -1.044 . . . . 63.210000000000001 108.181 171.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -102.88 64.2 0.85 Allowed 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.215 -0.594 . . . . 64.239999999999995 111.091 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.61 135.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.478 . . . . 74.340000000000003 110.477 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.61 110.33 3.65 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 75.540000000000006 111.027 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.37 149.25 29.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.911 -0.774 . . . . 70.140000000000001 108.911 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD1' ' HD3' ' A' ' 202' ' ' ARG . 70.6 m-85 -119.03 144.59 36.2 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.91 0.337 . . . . 60.329999999999998 111.91 -170.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.833 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.6 Cg_endo -64.35 -59.6 0.18 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.728 2.285 . . . . 64.129999999999995 112.093 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 199' ' ' ASP . 1.0 OUTLIER -143.79 37.51 1.31 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.462 -0.335 . . . . 64.019999999999996 111.402 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 1.3 m-20 74.37 -14.61 0.69 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.817 0.673 . . . . 64.120000000000005 112.817 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptm -49.18 -33.35 12.12 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.291 0.849 . . . . 72.239999999999995 113.291 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -94.73 -1.56 63.58 Favored Glycine 0 C--O 1.228 -0.281 0 C-N-CA 120.371 -0.918 . . . . 75.209999999999994 113.315 -175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 196' ' ' TYR . 36.4 ptt180 -120.32 -6.77 9.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.214 0.507 . . . . 71.120000000000005 110.95 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.247 0.929 0 CA-C-N 114.89 -1.05 . . . . 74.340000000000003 110.519 178.686 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 tpt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.35 -0.611 . . . . 71.219999999999999 109.35 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.56 -11.29 19.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.358 0.503 . . . . 55.409999999999997 112.358 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.92 154.74 24.43 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.29 -0.164 . . . . 74.450000000000003 111.216 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.521 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 41.1 mm 74.37 123.88 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 O-C-N 124.026 0.829 . . . . 73.120000000000005 111.522 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 10.1 Cg_endo -89.81 104.64 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.338 2.692 . . . . 75.519999999999996 112.512 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 4' ' ' ILE . 1.3 Cg_endo -83.01 106.42 1.42 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.065 2.51 . . . . 74.310000000000002 111.726 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -80.29 178.95 7.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.397 -0.594 . . . . 75.540000000000006 109.397 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -105.46 -17.87 14.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.526 0.203 . . . . 50.140000000000001 111.158 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -118.46 102.05 8.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.591 0.71 . . . . 61.039999999999999 111.091 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -106.07 120.2 49.68 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.864 -1.062 . . . . 63.200000000000003 110.095 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.78 124.65 16.76 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.385 2.724 . . . . 74.329999999999998 112.984 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.02 -22.42 7.36 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.916 2.411 . . . . 71.030000000000001 112.521 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 26' ' ' GLU . 24.8 t-20 -142.32 147.48 36.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.996 -0.742 . . . . 74.319999999999993 108.996 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.4 m -137.67 152.22 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.215 0.531 . . . . 72.549999999999997 111.782 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.73 122.53 42.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.155 -0.93 . . . . 72.420000000000002 110.566 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 mt -114.98 98.02 6.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.774 0.321 . . . . 73.209999999999994 110.41 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -80.35 124.98 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.021 -0.733 . . . . 70.540000000000006 109.021 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.473 HG22 HG13 ' A' ' 159' ' ' ILE . 74.8 p -111.84 178.74 4.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.173 0.511 . . . . 50.43 111.274 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -76.4 -6.19 50.57 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.676 -0.693 . . . . 74.319999999999993 111.027 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.813 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.9 mmt -102.52 -43.38 5.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.926 -0.579 . . . . 25.510000000000002 109.867 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -171.56 -130.75 1.27 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.494 -0.642 . . . . 73.420000000000002 111.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 23' ' ' ILE . 19.4 tt -132.7 137.99 52.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.029 0.443 . . . . 74.420000000000002 110.0 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.493 HD12 HG23 ' A' ' 139' ' ' VAL . 20.1 mm -129.13 117.26 43.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.174 -0.676 . . . . 74.420000000000002 109.174 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 133' ' ' CYS . 2.9 m -113.56 147.04 17.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 C-N-CA 119.147 -1.021 . . . . 73.109999999999999 110.152 175.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.34 163.94 36.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.941 -0.572 . . . . 74.439999999999998 110.611 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 10.7 pt-20 -129.65 166.73 19.19 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.043 -0.98 . . . . 75.420000000000002 109.662 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -104.16 163.89 12.09 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.623 -0.51 . . . . 73.519999999999996 109.623 179.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 4.5 m-85 -82.58 98.95 9.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.177 0.513 . . . . 64.109999999999999 111.385 176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.92 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -83.47 -0.56 50.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.551 -0.75 . . . . 65.140000000000001 110.014 -179.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -79.38 -53.88 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.721 -0.672 . . . . 75.319999999999993 111.466 -176.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.0 15.43 4.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.925 0.342 . . . . 74.239999999999995 111.925 -175.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.66 67.15 77.98 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.896 0.379 . . . . 71.040000000000006 110.108 174.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 16.8 Cg_exo -66.98 -43.98 5.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.798 2.332 . . . . 60.43 112.401 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -76.03 -45.42 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.118 0.485 . . . . 75.040000000000006 110.034 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.534 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.5 m -63.02 -32.84 74.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.256 -0.884 . . . . 64.400000000000006 111.221 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.92 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 33.4 t -59.74 -43.09 94.39 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.593 -0.276 . . . . 52.32 110.758 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 45.6 mmtt -70.04 -32.44 70.58 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.974 -0.38 . . . . 73.219999999999999 109.974 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.61 -58.47 7.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.359 -0.837 . . . . 75.230000000000004 109.746 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' CD2' HD11 ' A' ' 27' ' ' LEU . 1.8 t80 -67.45 -37.05 82.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.75 . . . . 64.219999999999999 110.349 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.65 -43.06 98.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 70.219999999999999 111.457 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.689 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 10.5 tp10 -61.53 -42.94 99.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.932 0.396 . . . . 72.120000000000005 111.29 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.597 ' HG ' ' HB2' ' A' ' 110' ' ' SER . 4.3 mm? -66.37 -24.14 66.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 54.399999999999999 110.54 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.472 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -80.85 -31.07 35.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.099 -0.5 . . . . 73.219999999999999 110.129 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 38.6 mtp85 -61.95 -46.24 90.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.205 -0.907 . . . . 72.230000000000004 110.841 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -74.73 -49.35 21.4 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.831 -0.347 . . . . 75.340000000000003 110.83 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.65 49.76 0.31 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.744 -0.741 . . . . 61.130000000000003 111.941 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.62 ' CE1' ' HA3' ' A' ' 74' ' ' GLY . 23.6 t80 -70.99 -29.93 66.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.116 0.484 . . . . 73.450000000000003 111.235 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 32.2 m-85 -81.15 -5.88 58.2 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.642 . . . . 74.25 112.121 -169.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -75.57 -6.1 48.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.968 0.413 . . . . 71.219999999999999 110.547 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.22 14.66 6.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 54.520000000000003 111.829 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 45.2 p -93.17 143.22 26.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.477 . . . . 71.510000000000005 111.015 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -140.2 147.09 39.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.794 -0.639 . . . . 72.200000000000003 110.054 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 63.9 m-85 -80.97 124.4 29.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.533 -0.543 . . . . 73.239999999999995 109.533 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -118.57 -19.83 8.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.563 -0.289 . . . . 64.319999999999993 111.366 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.879 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 34.5 mmt180 -122.82 105.5 10.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.805 -0.443 . . . . 74.450000000000003 109.805 175.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.401 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -122.02 81.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.297 0.57 . . . . 73.150000000000006 110.033 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.831 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 17.5 mt -89.91 132.82 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 109.226 -0.657 . . . . 74.219999999999999 109.226 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.788 ' HE3' ' HA ' ' A' ' 146' ' ' GLU . 2.3 mptp? -70.88 133.41 46.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.29 -0.413 . . . . 72.430000000000007 110.008 -173.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 p30 42.33 42.47 2.61 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.459 1.1 . . . . 63.530000000000001 111.716 -172.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.831 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.0 t80 -131.52 -84.34 0.51 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.628 -0.715 . . . . 72.340000000000003 109.705 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.674 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptt? -161.19 157.16 25.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.328 -0.851 . . . . 74.310000000000002 110.165 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.53 HD11 HD21 ' A' ' 116' ' ' LEU . 44.6 mt -124.5 100.07 7.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.727 -0.67 . . . . 54.509999999999998 109.469 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.879 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 46.5 mt-30 -84.83 119.81 25.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.656 -0.702 . . . . 73.420000000000002 110.866 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -138.48 140.56 11.18 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.715 -0.675 . . . . 54.509999999999998 111.775 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . . . 164.04 -91.81 0.11 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.409 -1.376 . . . . 64.409999999999997 114.081 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -28.44 104.58 0.19 Allowed Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 114.003 1.112 . . . . 74.450000000000003 114.003 -163.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 91.1 Cg_endo -81.96 -12.5 10.78 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.852 3.035 . . . . 72.329999999999998 112.47 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 70' ' ' THR . 64.3 p -103.36 -32.33 9.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 71.219999999999999 111.882 -173.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 27.95 62.1 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.293 -0.723 . . . . 62.119999999999997 111.293 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.595 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 72.2 p -103.81 -34.85 8.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 111.222 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.98 -30.59 4.33 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.49 -0.777 . . . . 64.409999999999997 111.663 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 4.7 ptm180 -81.21 -37.42 28.68 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.043 0.449 . . . . 73.299999999999997 110.045 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 65.38 79.36 0.19 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.945 -0.57 . . . . 61.109999999999999 113.029 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.62 ' HA3' ' CE1' ' A' ' 47' ' ' TYR . . . 66.9 -130.97 30.83 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.022 -0.609 . . . . 55.109999999999999 112.745 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 55.55 22.19 4.99 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.105 0.562 . . . . 62.350000000000001 111.521 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.8 t -72.79 -12.6 61.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.712 -0.676 . . . . 53.049999999999997 110.868 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.418 HD12 ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -71.18 -51.96 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.389 -0.369 . . . . 72.319999999999993 110.424 178.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.521 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 97.7 m-85 -77.64 -34.16 53.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.795 0.807 . . . . 74.109999999999999 109.105 175.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 109.12 -78.84 0.24 Allowed Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.606 -1.179 . . . . 71.109999999999999 112.104 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -135.99 -168.57 2.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.786 0.327 . . . . 64.230000000000004 110.977 -175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.543 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -76.41 166.43 23.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 71.239999999999995 111.532 -177.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' HZ ' ' HB3' ' A' ' 78' ' ' TYR . 73.9 m-85 -132.38 -44.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.814 -0.63 . . . . 74.319999999999993 110.398 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -163.47 156.33 18.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.679 -0.859 . . . . 63.310000000000002 108.679 -174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 106' ' ' ASP . 2.4 p-10 -74.81 125.11 28.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.352 -0.61 . . . . 74.329999999999998 109.352 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -98.36 20.79 12.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.048 0.451 . . . . 73.200000000000003 110.31 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -68.75 100.93 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.696 . . . . 74.109999999999999 110.952 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -156.45 77.04 4.36 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.981 -0.554 . . . . 74.310000000000002 109.926 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.39 93.59 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.552 2.168 . . . . 42.240000000000002 112.077 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.41 -10.19 58.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.248 1.023 . . . . 65.439999999999998 109.195 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.6 OUTLIER -108.16 174.17 5.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.597 -1.183 . . . . 73.019999999999996 109.306 178.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 93' ' ' THR . 32.6 ttpt -131.28 145.1 51.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.067 -0.346 . . . . 74.510000000000005 110.067 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -55.59 126.44 25.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.36 0.6 . . . . 74.349999999999994 109.571 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LYS . 20.7 p -127.04 -45.46 1.56 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.539 -0.755 . . . . 64.329999999999998 110.262 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -160.32 -144.75 4.07 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.344 -0.844 . . . . 42.039999999999999 111.304 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.92 145.47 25.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.734 0.302 . . . . 64.219999999999999 110.77 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.63 21.83 6.64 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.732 -0.747 . . . . 64.439999999999998 111.906 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.3 mm -86.8 111.21 21.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.487 -0.561 . . . . 70.349999999999994 109.487 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.777 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -86.92 122.03 30.21 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.986 -0.552 . . . . 72.349999999999994 109.824 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.487 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -131.23 170.65 14.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.84 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.829 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 39.5 ttp -103.64 144.15 31.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.916 0.389 . . . . 73.209999999999994 110.063 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -98.74 151.74 20.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.127 0.489 . . . . 75.239999999999995 110.547 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -161.0 169.79 21.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.731 -0.668 . . . . 74.319999999999993 109.61 -172.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.13 -27.48 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.418 0.627 . . . . 51.310000000000002 110.545 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.85 174.82 32.33 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 109.594 -1.402 . . . . 42.439999999999998 109.594 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.48 -46.85 19.29 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.303 2.669 . . . . 71.109999999999999 112.692 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 8.4 p-10 -100.88 -12.95 18.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.385 -0.37 . . . . 64.420000000000002 111.461 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 1.3 m -83.17 50.31 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.499 0.666 . . . . 73.319999999999993 109.411 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.693 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 47.1 m-80 -70.94 141.29 51.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.893 -1.049 . . . . 74.239999999999995 110.9 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.17 -169.78 12.69 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.127 -0.789 . . . . 41.130000000000003 111.127 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.597 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . 24.4 p -94.53 6.69 48.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.367 0.584 . . . . 75.030000000000001 111.469 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 73.2 mt-30 -72.79 161.59 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.68 -0.489 . . . . 64.430000000000007 109.68 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -141.75 171.35 14.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.666 -0.414 . . . . 74.230000000000004 111.268 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -160.17 150.87 18.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.04 -0.527 . . . . 65.140000000000001 110.195 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.661 HG22 HD23 ' A' ' 98' ' ' LEU . 16.0 t -113.73 141.78 28.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.462 -0.57 . . . . 61.130000000000003 109.462 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.8 p -95.37 129.08 42.65 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.166 0.508 . . . . 72.439999999999998 110.318 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 62' ' ' ILE . 61.6 mt -87.14 -3.2 59.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.608 -0.724 . . . . 72.439999999999998 110.662 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.33 163.37 24.37 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.763 -0.653 . . . . 75.150000000000006 110.062 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.31 125.42 15.67 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.595 2.197 . . . . 73.219999999999999 111.845 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.3 p -114.5 140.87 48.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.394 -0.367 . . . . 74.209999999999994 111.247 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -137.01 24.47 3.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 111.003 174.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -120.72 -8.87 9.42 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.374 0.509 . . . . 63.439999999999998 112.374 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 3.5 pp -127.72 4.42 6.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.745 -0.382 . . . . 73.400000000000006 111.745 -173.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 1.4 m-20 -71.51 -22.45 61.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.823 -0.626 . . . . 60.43 110.334 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.81 7.87 55.7 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.928 -0.869 . . . . 73.540000000000006 110.928 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 122' ' ' LEU . 39.7 mmtm -112.16 -33.2 6.31 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 72.319999999999993 109.426 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.462 ' ND1' ' HA ' ' A' ' 101' ' ' ALA . 58.4 m-70 -135.57 137.54 42.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.29 -0.868 . . . . 73.230000000000004 109.418 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.3 t -78.54 146.54 34.23 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.39 -0.524 . . . . 75.349999999999994 110.255 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.487 HG23 ' HB2' ' A' ' 99' ' ' ALA . 51.8 mt -122.28 124.86 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.9 -0.591 . . . . 72.239999999999995 110.279 -175.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.829 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 2.9 p90 -159.23 73.2 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.633 0.73 . . . . 74.349999999999994 110.725 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.777 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.37 157.27 29.56 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 119.177 -1.487 . . . . 72.010000000000005 113.732 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.45 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 24.4 mtm180 -137.06 123.69 21.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.52 -0.34 . . . . 75.340000000000003 110.132 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.66 140.95 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.096 0.474 . . . . 53.329999999999998 110.906 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 45.1 t -137.34 152.24 49.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.026 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 5.5 pt20 41.13 31.09 0.13 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.534 1.134 . . . . 74.340000000000003 113.506 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -154.72 12.71 0.48 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.478 -0.867 . . . . 34.329999999999998 112.426 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -71.5 -34.25 52.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.799 -0.236 . . . . 54.530000000000001 110.92 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.23 -35.57 91.76 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.484 -0.865 . . . . 41.350000000000001 111.387 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.517 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.5 mmm -71.2 -46.36 61.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.095 -0.335 . . . . 72.439999999999998 110.095 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.493 HG23 HD12 ' A' ' 23' ' ' ILE . 79.9 t -57.07 -31.82 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.236 0.541 . . . . 72.129999999999995 110.4 174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -68.39 -52.72 29.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.72 -0.673 . . . . 74.430000000000007 109.901 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.605 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.97 -8.57 56.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.866 -0.606 . . . . 72.510000000000005 111.023 -176.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 20' ' ' MET . 56.0 t -87.99 -43.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.265 0.555 . . . . 71.010000000000005 109.808 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -77.9 -37.54 29.32 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.608 -0.806 . . . . 75.349999999999994 112.78 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.605 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 24.0 ptm -73.86 -27.52 61.12 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.597 0.221 . . . . 62.240000000000002 111.597 -173.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.9 m -71.01 117.41 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-O 121.562 0.696 . . . . 74.140000000000001 111.077 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.788 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 1.1 mp0 -87.39 -72.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.011 -0.995 . . . . 71.409999999999997 109.933 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 11.0 p -122.38 151.04 41.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.121 -0.945 . . . . 71.129999999999995 110.602 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -74.25 -43.6 56.31 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.919 -0.312 . . . . 72.329999999999998 111.204 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.8 m -158.63 -52.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.38 0.61 . . . . 73.340000000000003 110.0 -179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -92.65 -173.44 3.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.486 -0.779 . . . . 74.349999999999994 109.945 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.39 56.38 1.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.03 0.919 . . . . 72.299999999999997 109.875 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.43 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 0.9 OUTLIER -141.95 118.51 7.2 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 114.87 -1.059 . . . . 74.340000000000003 109.143 175.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 32.7 Cg_exo -62.33 153.71 68.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.655 2.237 . . . . 70.120000000000005 112.389 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -68.83 90.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.639 -0.875 . . . . 65.239999999999995 108.639 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.52 21.48 4.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.594 -0.73 . . . . 71.239999999999995 112.827 -166.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -137.09 109.4 7.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.792 0.806 . . . . 43.140000000000001 111.497 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 53' ' ' PHE . 6.1 p -159.62 117.8 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.123 0.963 . . . . 63.229999999999997 109.876 171.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.76 168.46 20.69 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.859 -1.064 . . . . 64.329999999999998 110.524 -172.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.473 HG13 HG22 ' A' ' 18' ' ' THR . 3.4 mp -87.14 115.59 28.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.983 -0.747 . . . . 71.25 108.983 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.655 HG22 ' HD3' ' A' ' 161' ' ' LYS . 31.0 mm -75.56 -62.22 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.368 -0.833 . . . . 73.420000000000002 110.973 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.655 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -129.68 135.64 48.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.811 0.339 . . . . 71.319999999999993 110.266 175.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -131.92 133.87 45.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.127 -0.488 . . . . 62.240000000000002 111.023 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 21.8 p90 -152.93 147.49 19.13 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 72.140000000000001 110.673 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 15.0 Cg_exo -70.16 152.27 67.16 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.128 2.552 . . . . 72.040000000000006 113.119 -176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.5 t -87.89 151.78 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.731 -0.668 . . . . 64.319999999999993 109.89 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -93.1 53.52 2.52 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.843 -0.694 . . . . 53.210000000000001 112.934 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.41 -116.68 3.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.713 -0.755 . . . . 63.210000000000001 112.355 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -158.44 -178.64 32.66 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.956 -0.64 . . . . 33.509999999999998 111.963 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.11 102.98 2.99 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.697 . . . . 74.099999999999994 112.239 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.3 t -93.98 92.31 7.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.052 0.453 . . . . 71.329999999999998 110.156 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -89.07 -83.99 1.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.707 -0.758 . . . . 73.310000000000002 111.753 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.93 -146.89 20.73 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.695 -0.764 . . . . 64.120000000000005 112.273 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 76.76 -154.18 43.21 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.867 -0.682 . . . . 71.510000000000005 111.856 -177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.0 t -130.69 121.82 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.389 . . . . 51.329999999999998 110.345 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -119.48 18.68 10.04 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.05 -0.595 . . . . 72.109999999999999 111.62 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.5 -92.24 0.42 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.89 -0.672 . . . . 42.140000000000001 112.007 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.0 27.34 0.63 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.131 -0.557 . . . . 62.409999999999997 111.881 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 62.9 m -158.13 154.6 27.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.118 -0.327 . . . . 53.140000000000001 110.118 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 132.47 133.91 3.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.716 -0.754 . . . . 72.129999999999995 112.174 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -178.69 56.44 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.093 -0.575 . . . . 65.510000000000005 111.711 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 61.1 4.7 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.095 -0.574 . . . . 33.509999999999998 112.945 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.3 p -95.28 -15.88 22.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.135 0.493 . . . . 74.549999999999997 110.255 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.03 -104.0 2.18 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.658 -0.701 . . . . 63.399999999999999 111.943 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.2 m-20 -99.86 178.13 4.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.304 0.573 . . . . 45.409999999999997 111.237 -178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 165.92 143.65 3.81 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.311 -0.859 . . . . 45.229999999999997 111.205 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.2 -171.53 41.05 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.579 -0.82 . . . . 60.030000000000001 111.954 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.815 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -78.26 167.02 22.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 110.033 -0.358 . . . . 51.439999999999998 110.033 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.515 ' O ' HG12 ' A' ' 191' ' ' ILE . 97.2 m-85 -110.81 97.15 32.26 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.098 0.475 . . . . 71.549999999999997 111.218 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.561 ' HB2' HD12 ' A' ' 90' ' ' LEU . 57.7 Cg_endo -75.03 -4.78 15.91 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.61 2.207 . . . . 62.43 112.791 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.18 -31.61 58.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 64.310000000000002 110.782 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 188' ' ' PHE . 13.3 pt -79.89 -17.97 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.267 -0.424 . . . . 73.040000000000006 111.929 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 17.2 m170 67.99 33.22 4.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 111.892 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 191' ' ' ILE . 4.9 p -136.57 149.85 27.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.658 0.266 . . . . 75.140000000000001 110.797 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.6 115.82 9.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.272 0.558 . . . . 65.25 112.155 -175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -156.57 159.34 38.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.504 -0.924 . . . . 72.0 108.504 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -132.23 145.24 56.48 Favored Pre-proline 0 C--N 1.319 -0.743 0 C-N-CA 120.547 -0.461 . . . . 74.219999999999999 111.585 -174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -67.4 -68.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.402 2.068 . . . . 73.239999999999995 111.693 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -126.24 24.88 6.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 110.621 177.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 75.39 -10.0 1.31 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.914 1.079 . . . . 74.319999999999993 113.914 170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -55.42 -27.74 49.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.322 0.49 . . . . 71.519999999999996 112.322 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.81 -0.23 89.72 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.843 -0.694 . . . . 62.43 112.879 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -78.46 -33.47 48.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 111.135 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.515 ' NZ ' ' HB3' ' A' ' 203' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.3 -0.857 . . . . 74.340000000000003 110.183 -174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.304 0.097 . . . . 74.230000000000004 111.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.37 78.13 0.3 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.21 0.529 . . . . 62.020000000000003 110.903 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.22 -57.14 2.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.593 -0.731 . . . . 51.509999999999998 110.451 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.591 HD11 ' HA ' ' A' ' 78' ' ' TYR . 54.0 mt -113.3 116.17 46.79 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.831 . . . . 73.099999999999994 109.313 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 4' ' ' ILE . 40.2 Cg_exo -57.13 119.73 7.18 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.494 2.796 . . . . 74.200000000000003 113.823 -170.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.1 Cg_exo -79.7 -24.99 5.68 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.913 2.408 . . . . 74.129999999999995 111.41 171.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.91 35.84 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.712 -0.676 . . . . 74.540000000000006 110.95 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -55.32 111.8 0.95 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.008 0.432 . . . . 74.019999999999996 110.833 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -90.36 9.33 29.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.891 -0.595 . . . . 72.400000000000006 111.117 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' HG2' ' A' ' 44' ' ' ARG . 2.3 mp0 -60.84 141.84 92.7 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 114.938 -1.028 . . . . 74.230000000000004 111.092 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 18.0 Cg_endo -61.97 150.75 85.09 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.554 2.17 . . . . 71.310000000000002 112.012 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -4.87 16.17 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.999 2.466 . . . . 62.039999999999999 113.744 -175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.527 HD21 HG12 ' A' ' 24' ' ' VAL . 21.9 t-20 -128.98 144.2 51.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.885 0.374 . . . . 74.439999999999998 110.577 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 34.4 m -137.48 147.38 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.092 0.472 . . . . 74.430000000000007 110.854 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CD1' ' HB3' ' A' ' 165' ' ' SER . 13.3 m-85 -103.45 132.18 49.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.777 -0.647 . . . . 74.409999999999997 110.831 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD12 HG21 ' A' ' 159' ' ' ILE . 3.4 mm? -114.58 104.81 12.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.041 -0.527 . . . . 54.549999999999997 109.749 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -92.28 115.46 28.1 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.278 -0.638 . . . . 74.329999999999998 109.278 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -107.12 178.92 4.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.936 0.398 . . . . 75.109999999999999 111.738 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.4 p -75.25 -10.08 59.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.724 -0.671 . . . . 44.109999999999999 110.798 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.5 mmt -94.46 -42.11 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.654 . . . . 53.119999999999997 109.932 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.83 -116.51 0.51 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.474 -0.785 . . . . 73.030000000000001 111.336 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -150.54 138.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.063 0.459 . . . . 63.130000000000003 110.477 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 139' ' ' VAL . 4.1 mp -132.28 127.52 57.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.686 -0.688 . . . . 74.099999999999994 109.571 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 8.5 t -113.62 147.45 17.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.855 -0.424 . . . . 62.219999999999999 109.855 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.37 163.5 39.81 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.984 0.421 . . . . 62.219999999999999 110.652 174.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 131' ' ' ARG . 1.8 pt-20 -129.76 163.0 27.16 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.653 -0.703 . . . . 73.450000000000003 110.531 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -105.23 161.92 13.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 71.439999999999998 110.509 -174.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.478 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 2.7 m-85 -88.32 100.26 12.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.125 0.488 . . . . 74.510000000000005 111.635 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -85.89 7.06 25.58 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.002 -0.74 . . . . 73.230000000000004 109.002 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 4.4 mptp? -78.01 -57.34 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.753 -1.112 . . . . 73.530000000000001 111.54 -176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -132.31 14.96 4.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.423 -0.353 . . . . 72.420000000000002 111.81 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.53 80.42 71.95 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.787 -0.449 . . . . 55.439999999999998 109.787 175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.606 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 59.4 Cg_endo -73.19 -25.18 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.445 2.096 . . . . 71.109999999999999 113.729 -171.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -100.66 -33.69 10.18 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.126 -0.63 . . . . 74.439999999999998 111.637 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -43.65 95.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 75.319999999999993 111.177 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -57.62 -51.62 68.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 63.140000000000001 111.017 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.606 ' HE3' ' O ' ' A' ' 33' ' ' PRO . 67.6 mttt -66.73 -41.71 87.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.829 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.03 -47.86 74.18 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.195 -0.457 . . . . 74.030000000000001 110.819 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.417 ' HE1' HG21 ' A' ' 14' ' ' VAL . 32.7 t80 -67.64 -50.96 55.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 110.246 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.36 80.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.32 -0.855 . . . . 52.539999999999999 111.663 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.63 -47.66 82.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.891 -0.595 . . . . 72.319999999999993 110.32 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 75' ' ' ALA . 3.5 mm? -66.33 -27.55 67.99 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.113 -0.494 . . . . 73.030000000000001 111.07 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.55 52.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.84 -0.618 . . . . 60.130000000000003 110.91 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HG2' ' HG3' ' A' ' 10' ' ' GLN . 6.6 ppt_? -73.74 -26.09 60.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.903 -0.406 . . . . 75.430000000000007 109.903 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -60.46 -47.6 85.43 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.83 -0.623 . . . . 75.430000000000007 109.587 173.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.51 20.51 6.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.486 -0.864 . . . . 62.229999999999997 113.575 170.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -79.58 -11.2 59.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.201 0.501 . . . . 75.140000000000001 111.359 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HA ' HG23 ' A' ' 51' ' ' THR . 95.6 m-85 -85.11 -4.84 59.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.893 0.378 . . . . 64.530000000000001 110.967 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 38.6 m-80 -77.9 4.95 10.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.269 0.557 . . . . 71.439999999999998 110.046 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.77 21.22 2.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.707 -0.679 . . . . 53.420000000000002 111.698 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.945 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 28.8 p -96.0 152.61 18.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.555 0.217 . . . . 64.239999999999995 110.702 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 3.7 mtmt -134.94 155.94 49.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.522 -0.308 . . . . 74.420000000000002 110.512 -173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' HB2' HG13 ' A' ' 157' ' ' VAL . 97.5 m-85 -92.43 113.79 26.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 72.049999999999997 109.0 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -112.83 -24.01 9.81 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.519 -0.473 . . . . 75.549999999999997 112.257 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 27.2 mmm180 -114.49 106.21 14.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.248 -0.581 . . . . 52.140000000000001 110.148 177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 62' ' ' ILE . 4.8 mp -124.57 92.86 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.102 -0.703 . . . . 34.32 109.102 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.795 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 22.4 mt -98.32 122.18 49.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 109.231 -0.655 . . . . 73.329999999999998 109.231 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 42.1 mtpt -56.94 127.71 33.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.297 0.373 . . . . 72.140000000000001 111.635 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 56.17 32.89 21.03 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.123 -0.944 . . . . 73.109999999999999 111.373 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.795 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.3 t80 -130.97 -82.67 0.53 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 110.267 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.651 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.9 ptt? -161.64 157.61 24.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.702 -0.681 . . . . 74.129999999999995 110.205 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.637 HG23 HG13 ' A' ' 56' ' ' ILE . 29.0 mt -131.99 108.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.971 -0.559 . . . . 60.030000000000001 109.79 -178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 57.2 tt0 -79.5 124.16 28.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.314 -0.403 . . . . 54.439999999999998 110.074 177.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -133.96 127.78 4.71 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.437 -0.665 . . . . 63.399999999999999 111.437 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.945 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 139.17 -155.45 23.94 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.07 -1.062 . . . . 64.329999999999998 112.343 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 111' ' ' GLN . 22.3 t0 53.74 96.15 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.741 0.817 . . . . 73.409999999999997 112.324 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.11 -16.49 44.75 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.334 2.023 . . . . 72.209999999999994 112.606 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 70' ' ' THR . 48.5 p -93.6 -36.07 12.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.96 0.409 . . . . 64.329999999999998 110.683 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.13 18.8 75.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.095 -0.574 . . . . 72.140000000000001 112.696 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 HG22 ' OG1' ' A' ' 68' ' ' THR . 9.9 t -111.64 -10.32 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.944 -0.302 . . . . 75.230000000000004 111.563 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.73 35.47 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.2 -1.0 . . . . 41.030000000000001 112.986 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -86.46 -47.63 9.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.141 0.496 . . . . 61.130000000000003 111.02 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.51 173.41 32.32 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.42 -0.809 . . . . 63.43 111.421 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.0 -10.68 58.44 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 120.719 -0.753 . . . . 52.020000000000003 112.181 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -55.92 -77.36 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.971 -0.615 . . . . 73.519999999999996 112.074 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.2 m 59.27 15.39 4.24 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.186 -0.461 . . . . 64.010000000000005 111.497 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 pt -68.4 -17.21 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.592 0.71 . . . . 74.140000000000001 110.445 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HA ' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -95.2 -12.33 26.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.727 -1.124 . . . . 73.510000000000005 111.147 -177.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.58 -76.77 1.3 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.241 -0.505 . . . . 50.240000000000002 112.464 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -87.47 -156.17 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.576 -0.527 . . . . 74.200000000000003 109.576 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.78 174.38 1.44 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.037 0.446 . . . . 73.040000000000006 110.559 172.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' A' ' 106' ' ' ASP . 26.2 t80 -118.17 -175.09 2.79 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.271 -0.422 . . . . 74.299999999999997 110.218 -172.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -76.48 121.36 23.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.375 -0.375 . . . . 74.329999999999998 110.645 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 7.8 p-10 -76.77 86.44 3.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.869 0.842 . . . . 74.349999999999994 109.066 171.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.48 39.53 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.313 -0.858 . . . . 74.230000000000004 109.555 -174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.484 HD23 ' HB ' ' A' ' 127' ' ' THR . 15.5 mt -69.26 98.98 1.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.381 -1.281 . . . . 71.439999999999998 110.63 -176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -162.07 83.47 1.69 Allowed Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.725 -0.67 . . . . 73.129999999999995 109.867 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.891 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 28.6 Cg_endo -62.28 82.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 123.154 2.57 . . . . 73.209999999999994 112.209 176.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.45 -25.83 54.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.409 -0.814 . . . . 72.349999999999994 109.682 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 3.6 pp -85.17 -179.96 7.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 72.150000000000006 109.796 175.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -124.42 141.23 52.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.46 -0.496 . . . . 65.209999999999994 110.672 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.66 72.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.664 0.745 . . . . 71.019999999999996 110.006 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.6 p -66.4 -37.86 86.19 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.773 -1.103 . . . . 73.329999999999998 112.575 -171.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' H ' HD11 ' A' ' 97' ' ' ILE . . . -166.42 -140.93 3.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.361 -0.923 . . . . 51.450000000000003 112.758 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' SD ' ' A' ' 200' ' ' MET . . . -91.1 137.49 32.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.751 0.31 . . . . 74.409999999999997 110.686 177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 111.48 23.35 5.74 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.669 -0.777 . . . . 41.43 111.852 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 94' ' ' GLY . 11.0 mm -85.41 109.6 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.346 -0.612 . . . . 72.319999999999993 109.346 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.72 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -86.3 118.41 25.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.212 0.529 . . . . 62.340000000000003 109.774 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -125.04 168.12 13.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.053 -0.521 . . . . 62.200000000000003 110.847 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.6 ttt -91.71 132.77 36.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.191 -0.459 . . . . 75.450000000000003 109.805 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 111' ' ' GLN . . . -96.26 141.08 30.03 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.01 -0.367 . . . . 63.119999999999997 110.01 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -150.38 165.35 33.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.147 -0.479 . . . . 72.450000000000003 110.792 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -69.55 -46.66 65.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.845 -0.616 . . . . 73.299999999999997 110.296 178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.52 -104.94 0.21 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.472 -0.87 . . . . 71.400000000000006 112.715 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.28 89.43 0.13 Allowed 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.918 2.412 . . . . 54.210000000000001 112.193 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 p30 50.13 29.37 3.55 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.317 -0.856 . . . . 74.200000000000003 111.571 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 m -96.58 55.51 1.43 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.113 -1.069 . . . . 65.030000000000001 108.113 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -92.85 137.15 32.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.995 -1.457 . . . . 71.030000000000001 110.096 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.21 -107.8 0.76 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.231 -0.985 . . . . 73.310000000000002 113.616 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.8 p -127.28 56.43 1.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.546 0.688 . . . . 64.319999999999993 110.601 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.496 ' CG ' ' HB2' ' A' ' 66' ' ' ASP . 18.8 mp0 -130.32 147.3 52.02 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.18 -0.918 . . . . 64.209999999999994 110.136 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -139.78 169.3 17.97 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.769 -0.456 . . . . 73.409999999999997 109.769 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 42.9 p90 -155.79 147.87 23.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.87 0.367 . . . . 63.549999999999997 110.296 173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.72 HG22 HD23 ' A' ' 98' ' ' LEU . 17.8 t -111.54 140.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.885 -0.598 . . . . 50.439999999999998 109.391 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.6 p -94.86 128.81 41.89 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.853 0.359 . . . . 62.329999999999998 110.14 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD11 ' HA3' ' A' ' 143' ' ' GLY . 67.6 mt -83.62 -8.71 59.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.764 -0.653 . . . . 70.010000000000005 110.168 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -151.42 156.58 34.91 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.164 -0.926 . . . . 61.399999999999999 109.679 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.35 124.58 14.06 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.503 2.135 . . . . 52.32 112.236 178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 p -123.99 122.12 37.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.308 -0.405 . . . . 61.340000000000003 110.234 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.28 5.18 31.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.716 0.293 . . . . 73.319999999999993 111.373 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.611 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -108.39 -3.1 18.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.611 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.9 mt -102.04 3.74 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 111.371 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.891 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 12.4 p-10 -70.67 -15.2 62.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.68 -0.691 . . . . 73.409999999999997 111.155 -172.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.86 15.96 9.53 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.329 -0.709 . . . . 65.420000000000002 111.329 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.66 -41.31 2.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.271 0.558 . . . . 72.209999999999994 110.109 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -142.31 126.1 17.05 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.005 -1.109 . . . . 75.030000000000001 108.005 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.484 ' HB ' HD23 ' A' ' 86' ' ' LEU . 11.3 t -72.22 143.11 48.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 119.669 -0.812 . . . . 72.340000000000003 110.459 -177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 99' ' ' ALA . 40.4 mt -114.87 119.94 63.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.57 -0.741 . . . . 71.450000000000003 110.54 -173.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.3 m-85 -157.23 75.69 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.318 0.387 . . . . 75.299999999999997 110.138 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.66 158.24 30.38 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.585 -0.817 . . . . 75.120000000000005 112.611 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.509 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 11.4 mtp180 -135.12 114.98 12.91 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.719 -0.475 . . . . 75.209999999999994 109.719 177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 96' ' ' GLY . 14.3 p -79.86 130.6 35.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.37 0.605 . . . . 73.420000000000002 110.068 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.662 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 87.7 m -140.5 140.12 35.22 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.765 -0.652 . . . . 62.450000000000003 110.576 -172.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 54.67 42.33 31.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.124 0.488 . . . . 64.5 111.764 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 41.58 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.43 -0.89 . . . . 54.130000000000003 111.99 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.0 tp -90.77 -34.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.59 0.233 . . . . 65.120000000000005 111.011 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.92 -35.87 91.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.807 -0.711 . . . . 64.519999999999996 111.624 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.445 ' O ' HG23 ' A' ' 142' ' ' VAL . 75.6 mmm -68.34 -51.2 47.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 54.32 110.337 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.505 HG13 HD12 ' A' ' 62' ' ' ILE . 98.5 t -55.03 -31.12 24.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.296 0.57 . . . . 75.439999999999998 110.789 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.93 -55.01 10.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.819 -0.628 . . . . 61.219999999999999 110.681 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -17.66 62.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.367 -0.379 . . . . 72.439999999999998 111.213 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 145' ' ' VAL . 55.0 t -84.3 -37.75 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.1 0.476 . . . . 74.319999999999993 109.934 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -83.38 -7.5 86.44 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.775 -0.726 . . . . 74.0 113.002 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.33 -1.06 37.11 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.755 -0.378 . . . . 71.209999999999994 111.294 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 142' ' ' VAL . 33.0 m -63.39 154.72 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.971 0.415 . . . . 72.340000000000003 111.242 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -90.43 -159.66 0.63 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.503 0.668 . . . . 71.140000000000001 110.34 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.8 p -107.57 131.87 53.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.189 -0.914 . . . . 64.540000000000006 110.783 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 1.078 ' HB2' ' HA ' ' A' ' 154' ' ' VAL . 46.2 t30 -69.23 -73.6 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.492 -0.776 . . . . 75.239999999999995 110.851 -173.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.2 m -87.72 -75.4 0.41 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 74.510000000000005 110.668 -177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -124.03 -81.77 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.114 0.483 . . . . 71.0 110.978 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -111.67 7.65 20.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.383 -0.826 . . . . 73.439999999999998 109.785 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -105.02 139.79 20.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.436 -0.802 . . . . 65.129999999999995 110.19 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.7 149.56 82.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.926 2.417 . . . . 73.099999999999994 112.023 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.078 ' HA ' ' HB2' ' A' ' 148' ' ' ASN . 70.4 t -57.35 -61.33 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.226 -0.443 . . . . 63.200000000000003 111.919 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -106.87 113.37 26.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.947 0.403 . . . . 54.100000000000001 111.504 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -79.47 103.31 9.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.805 -0.634 . . . . 74.310000000000002 109.38 174.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 53' ' ' PHE . 2.5 p -96.16 139.95 18.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.139 0.495 . . . . 62.140000000000001 111.374 -176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -121.94 162.88 20.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.736 -0.665 . . . . 60.439999999999998 109.533 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.626 HG21 HD12 ' A' ' 16' ' ' LEU . 3.5 mp -88.9 103.27 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.445 -0.946 . . . . 73.109999999999999 108.445 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' A' ' 161' ' ' LYS . 32.1 mm -66.81 -56.43 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.479 -0.782 . . . . 74.519999999999996 110.636 -176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 49' ' ' ASN . 3.5 mptp? -128.92 137.25 51.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 64.019999999999996 110.374 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.14 124.19 27.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.209 -0.451 . . . . 62.140000000000001 110.242 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -148.22 135.36 10.46 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.767 -0.651 . . . . 72.200000000000003 110.723 -173.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.68 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 59.8 Cg_endo -72.78 139.38 30.5 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.706 2.271 . . . . 71.519999999999996 112.044 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.544 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 16.9 t -169.7 -157.31 0.16 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.6 -0.518 . . . . 70.430000000000007 109.6 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 165.51 71.46 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.992 -0.623 . . . . 64.310000000000002 112.049 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -131.61 29.77 3.37 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.418 -0.896 . . . . 61.299999999999997 112.515 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.75 122.42 5.71 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 64.239999999999995 112.316 -178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.24 151.39 17.93 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.907 -0.663 . . . . 74.299999999999997 111.823 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.766 ' HB3' ' HA ' ' A' ' 182' ' ' SER . 64.2 m -139.46 31.97 2.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.842 0.321 . . . . 62.039999999999999 110.86 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -78.2 63.95 3.52 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.825 -0.702 . . . . 60.130000000000003 112.695 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.34 156.35 15.66 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.448 -0.661 . . . . 52.200000000000003 111.448 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.96 110.0 1.23 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.306 -0.95 . . . . 43.020000000000003 113.114 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.5 p -117.59 98.58 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.144 0.497 . . . . 64.340000000000003 110.123 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.12 -158.09 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.984 -0.627 . . . . 72.209999999999994 112.477 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.5 -66.35 3.92 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.25 -0.5 . . . . 74.549999999999997 112.024 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -155.31 -92.09 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.174 -0.536 . . . . 43.049999999999997 111.83 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 52.4 m -98.6 152.42 19.62 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.983 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -179.86 -121.81 0.75 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.082 -0.58 . . . . 55.25 111.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -157.73 -69.72 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.805 -0.712 . . . . 44.43 112.107 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.26 8.53 85.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.917 -0.659 . . . . 74.409999999999997 112.078 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.766 ' HA ' ' HB3' ' A' ' 170' ' ' SER . 56.3 m -155.86 167.31 30.82 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.838 -0.43 . . . . 51.240000000000002 109.838 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.46 -124.53 5.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.734 -0.745 . . . . 65.530000000000001 111.875 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.29 174.27 6.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.732 0.777 . . . . 74.0 110.913 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.497 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 144.67 144.05 4.11 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 114.574 -1.194 . . . . 72.310000000000002 110.863 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.59 -167.9 44.2 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.27 -0.967 . . . . 62.32 111.659 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 189' ' ' PRO . . . -75.43 163.54 27.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.228 -0.656 . . . . 65.409999999999997 109.228 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -102.24 103.29 29.72 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.806 0.336 . . . . 74.549999999999997 110.19 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 6.0 Cg_exo -77.43 -18.46 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.776 2.318 . . . . 64.239999999999995 111.298 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.87 -33.59 62.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.346 -0.843 . . . . 75.030000000000001 110.238 -172.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -89.22 157.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.763 -0.829 . . . . 70.25 108.763 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -106.82 89.68 3.08 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.057 -0.657 . . . . 74.150000000000006 110.638 -177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 194' ' ' ALA . 6.1 p -158.08 -171.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.626 -0.879 . . . . 71.120000000000005 108.626 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.745 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -123.45 117.61 25.54 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 122.188 -0.32 . . . . 72.310000000000002 110.669 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 187' ' ' ALA . 0.1 OUTLIER -156.45 155.27 31.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.864 -0.421 . . . . 62.109999999999999 109.864 177.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -117.31 149.24 44.23 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.458 -0.337 . . . . 73.519999999999996 110.546 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.533 ' HB3' ' HA2' ' A' ' 186' ' ' GLY . 42.8 Cg_endo -67.31 -65.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.408 2.072 . . . . 63.119999999999997 112.108 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.9 27.54 4.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.942 0.401 . . . . 61.509999999999998 110.635 176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 72.59 5.02 5.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.52 -0.764 . . . . 65.439999999999998 112.687 173.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 201' ' ' GLY . 2.0 ppp? -63.58 -50.4 69.59 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.102 0.408 . . . . 60.25 112.102 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.487 ' N ' ' SD ' ' A' ' 200' ' ' MET . . . -75.75 15.34 4.97 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.263 -0.494 . . . . 71.409999999999997 114.148 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -81.78 -17.05 48.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 72.140000000000001 110.464 173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.252 1.204 0 CA-C-N 114.872 -1.058 . . . . 73.129999999999995 110.945 178.524 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.931 -0.396 . . . . 74.439999999999998 109.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.76 168.59 19.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.834 -0.432 . . . . 72.530000000000001 109.834 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.31 -57.16 9.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.732 0.301 . . . . 65.430000000000007 110.758 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 78' ' ' TYR . 60.1 mt -122.76 131.63 24.35 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.833 -0.621 . . . . 61.219999999999999 110.643 -175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.65 127.25 17.58 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.733 2.289 . . . . 64.400000000000006 112.023 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 -36.5 85.56 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.766 2.31 . . . . 73.030000000000001 112.063 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.96 136.64 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.929 -0.578 . . . . 73.450000000000003 109.957 176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 t -179.84 159.41 0.83 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.852 -0.613 . . . . 74.239999999999995 109.488 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -97.32 -29.51 13.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.306 -0.406 . . . . 71.140000000000001 110.552 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.488 ' HG3' ' HD2' ' A' ' 44' ' ' ARG . 1.2 mp0 67.72 135.88 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.584 0 O-C-N 123.653 0.596 . . . . 74.540000000000006 112.151 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 34.4 Cg_exo -60.17 132.43 44.19 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.718 2.279 . . . . 52.399999999999999 112.023 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.653 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 56.6 Cg_endo -71.55 -16.98 30.4 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.84 2.36 . . . . 73.310000000000002 113.534 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.505 HD21 HG12 ' A' ' 24' ' ' VAL . 22.2 t-20 -132.51 147.8 52.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.252 -0.431 . . . . 63.240000000000002 110.092 -174.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 164' ' ' PRO . 26.9 m -139.04 152.02 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.257 0.551 . . . . 65.420000000000002 111.438 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HD1' HG22 ' A' ' 24' ' ' VAL . 97.4 m-85 -102.94 121.31 42.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.079 -0.964 . . . . 72.25 110.743 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.3 mt -108.09 103.07 12.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.805 0.336 . . . . 73.420000000000002 110.307 175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -85.15 122.45 29.37 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.228 -0.656 . . . . 64.319999999999993 109.228 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -114.97 176.61 4.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.212 0.529 . . . . 71.439999999999998 112.041 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' HD11 ' A' ' 160' ' ' ILE . 32.7 t -75.51 -1.6 25.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.606 -0.725 . . . . 71.430000000000007 110.565 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mmt -107.2 -39.7 5.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.814 -0.63 . . . . 74.329999999999998 110.274 177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.64 -126.41 0.98 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.232 -0.747 . . . . 63.219999999999999 111.232 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -139.84 137.34 39.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.035 0.445 . . . . 74.140000000000001 109.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -120.93 118.03 54.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.77 -0.65 . . . . 73.400000000000006 109.677 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG22 ' HD1' ' A' ' 15' ' ' TYR . 46.5 t -106.16 131.18 56.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.82 -0.437 . . . . 75.010000000000005 109.82 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.66 164.57 33.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.997 0.427 . . . . 73.349999999999994 110.414 178.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 12.2 pt-20 -135.5 166.56 22.91 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.774 -0.648 . . . . 72.219999999999999 109.876 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.9 OUTLIER -103.52 160.03 15.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.495 -0.557 . . . . 64.5 109.495 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -83.89 91.58 7.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.164 0.507 . . . . 72.319999999999993 111.962 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.653 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 78.9 m95 -84.22 6.48 22.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.607 -0.724 . . . . 72.430000000000007 110.314 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -73.6 -63.03 1.29 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.609 -0.723 . . . . 71.219999999999999 110.495 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.419 ' C ' ' HD3' ' A' ' 33' ' ' PRO . 37.6 m80 -131.07 16.2 5.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.083 0.401 . . . . 73.310000000000002 112.083 -176.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' OG1' ' A' ' 35' ' ' THR . . . -133.83 56.95 21.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.024 -0.27 . . . . 74.219999999999999 110.983 176.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 32' ' ' ALA . 14.0 Cg_exo -68.82 -25.9 32.76 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.442 2.094 . . . . 73.299999999999997 112.023 -175.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -66.44 -54.23 26.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.661 -0.7 . . . . 53.350000000000001 110.176 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.651 ' HB ' ' CE2' ' A' ' 129' ' ' PHE . 1.6 p -64.16 -40.23 95.7 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.182 -0.917 . . . . 63.399999999999999 110.988 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 86.3 m -58.31 -46.78 85.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.079 -0.964 . . . . 62.539999999999999 111.02 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -59.49 -41.39 89.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.422 -0.354 . . . . 63.439999999999998 110.189 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -60.72 -56.54 20.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 52.130000000000003 110.326 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HE2' ' HB3' ' A' ' 112' ' ' PHE . 3.4 m-85 -66.74 -42.29 86.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.759 -0.655 . . . . 63.149999999999999 111.492 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 10' ' ' GLN . . . -63.93 -41.81 97.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.455 -0.339 . . . . 54.25 111.571 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' OE1' HG23 ' A' ' 4' ' ' ILE . 33.5 tt0 -61.39 -43.67 98.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.024 0.44 . . . . 75.219999999999999 110.198 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.541 ' CD1' ' HB3' ' A' ' 110' ' ' SER . 35.3 mt -70.59 -24.46 62.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.873 -0.603 . . . . 71.209999999999994 111.97 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.13 -39.75 86.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.005 -0.543 . . . . 73.329999999999998 110.313 174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.488 ' HD2' ' HG3' ' A' ' 10' ' ' GLN . 74.5 mtp180 -75.56 -34.28 60.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 74.519999999999996 109.927 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.583 ' HG3' ' CD1' ' A' ' 47' ' ' TYR . 14.3 tpp180 -64.83 -46.75 80.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.585 -0.734 . . . . 75.439999999999998 110.273 176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.38 28.87 5.0 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.926 -0.654 . . . . 50.329999999999998 113.075 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.76 ' HD2' ' HA3' ' A' ' 74' ' ' GLY . 5.2 m-85 -87.15 -2.92 58.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.94 0.4 . . . . 75.010000000000005 111.674 -176.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -76.42 -12.69 60.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 75.349999999999994 110.303 172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 49' ' ' ASN . 0.8 OUTLIER -79.45 3.16 19.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.22 0.533 . . . . 75.019999999999996 109.91 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -131.69 15.4 5.18 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.694 -0.684 . . . . 74.030000000000001 112.253 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.559 HG22 ' HD3' ' A' ' 67' ' ' PRO . 13.6 p -98.63 138.03 36.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.837 0.318 . . . . 61.149999999999999 110.497 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' CG ' ' HG3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -128.71 124.5 35.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.418 -0.355 . . . . 75.109999999999999 110.427 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 96.2 m-85 -70.06 103.34 2.26 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.412 -0.588 . . . . 74.25 109.412 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -114.25 -15.43 12.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.031 -0.668 . . . . 64.25 112.06 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HB2' ' CB ' ' A' ' 63' ' ' GLN . 11.3 mmt180 -105.42 101.61 11.13 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.982 -0.687 . . . . 74.329999999999998 109.597 175.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG13 HG23 ' A' ' 62' ' ' ILE . 4.2 mp -125.87 95.13 2.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.018 -0.734 . . . . 63.049999999999997 109.018 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 44.0 mt -91.88 127.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 109.184 -0.673 . . . . 62.030000000000001 109.184 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -48.72 111.41 0.46 Allowed 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.99 0.806 . . . . 72.299999999999997 112.133 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' OD2' ' HD2' ' A' ' 203' ' ' LYS . 43.2 m-20 56.4 39.66 29.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.112 -0.949 . . . . 65.450000000000003 111.307 177.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.84 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 9.7 t80 -128.59 -76.09 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.813 -0.631 . . . . 73.219999999999999 109.987 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.401 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.4 ptt? -160.59 155.59 24.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 72.519999999999996 110.673 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 56' ' ' ILE . 49.0 mt -128.41 105.28 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.829 -0.623 . . . . 73.230000000000004 109.48 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.553 ' CB ' ' HB2' ' A' ' 55' ' ' ARG . 39.6 tt0 -85.49 127.2 34.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.739 -0.664 . . . . 74.040000000000006 111.893 -175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.39 117.38 4.62 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.454 -1.058 . . . . 31.440000000000001 110.454 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.24 146.59 33.43 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 114.423 0.529 . . . . 53.43 114.423 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.468 ' OD1' ' HA2' ' A' ' 73' ' ' GLY . 64.9 t0 -46.0 126.73 7.07 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 124.792 1.237 . . . . 74.340000000000003 111.837 174.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.559 ' HD3' HG22 ' A' ' 51' ' ' THR . 29.3 Cg_endo -64.46 -30.77 62.04 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.177 2.584 . . . . 72.25 112.763 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.485 ' OG1' HG22 ' A' ' 70' ' ' THR . 62.7 p -84.1 -32.86 24.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 74.099999999999994 110.061 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.24 15.83 70.84 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.51 -0.768 . . . . 71.409999999999997 113.01 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.512 HG23 ' HG2' ' A' ' 72' ' ' ARG . 8.8 t -105.52 -26.02 12.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.121 0.46 . . . . 43.420000000000002 111.536 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.97 -5.34 10.47 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.476 -0.869 . . . . 30.039999999999999 113.223 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.512 ' HG2' HG23 ' A' ' 70' ' ' THR . 8.5 ptm180 -100.85 -23.75 14.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.076 0.438 . . . . 71.5 111.101 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 66' ' ' ASP . . . 85.47 175.11 50.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.827 -0.702 . . . . 73.510000000000005 112.098 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.76 ' HA3' ' HD2' ' A' ' 47' ' ' TYR . . . -86.93 28.79 5.33 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.525 0.514 . . . . 70.420000000000002 112.28 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . -93.1 25.13 3.4 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.74 0.781 . . . . 35.200000000000003 110.883 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 79' ' ' GLY . 55.4 m -75.65 -5.69 46.77 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.089 -0.96 . . . . 62.240000000000002 110.583 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.1 tt -55.62 -40.17 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.562 -0.745 . . . . 74.349999999999994 110.96 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.534 ' HA ' HD11 ' A' ' 4' ' ' ILE . 34.8 p90 -102.12 -9.14 20.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 63.43 111.276 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 76' ' ' SER . . . 126.74 -119.27 3.28 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.24 -0.744 . . . . 74.010000000000005 111.24 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -137.91 146.45 43.33 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.049 0.452 . . . . 64.209999999999994 111.726 176.34 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.437 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 1.7 mp0 38.1 -166.55 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 O-C-N 125.692 1.87 . . . . 64.25 115.294 173.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB2' ' OD1' ' A' ' 108' ' ' ASN . 20.8 m-85 -154.41 -165.74 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.531 -1.213 . . . . 74.010000000000005 108.446 173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.78 160.05 26.31 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.172 -1.048 . . . . 51.5 108.172 171.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.27 123.54 23.19 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 75.109999999999999 109.993 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -114.06 31.31 6.65 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.421 -0.585 . . . . 53.450000000000003 109.421 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 HD23 ' OG1' ' A' ' 127' ' ' THR . 47.9 mt -66.11 98.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.716 . . . . 75.439999999999998 110.319 -176.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -166.06 89.96 0.86 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.898 -0.592 . . . . 71.109999999999999 109.85 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.98 95.36 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.779 2.319 . . . . 54.130000000000003 111.61 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -73.42 -17.58 61.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.403 1.096 . . . . 74.409999999999997 108.7 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -106.5 170.83 7.7 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 113.875 -1.511 . . . . 51.32 108.797 175.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' O ' HG23 ' A' ' 93' ' ' THR . 38.6 ttpt -128.16 142.88 51.05 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.843 -0.343 . . . . 71.450000000000003 110.165 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -56.16 122.69 12.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.433 0.635 . . . . 65.239999999999995 109.369 173.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 91' ' ' LYS . 25.2 p -119.48 -45.9 2.5 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.556 -0.747 . . . . 70.409999999999997 109.771 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.607 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -155.96 -139.27 2.72 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.054 -0.975 . . . . 44.049999999999997 111.389 174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.67 144.65 25.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.592 0.234 . . . . 73.400000000000006 110.844 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.18 24.32 5.47 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.786 -0.721 . . . . 73.040000000000006 112.13 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.403 ' CD1' ' HG3' ' A' ' 189' ' ' PRO . 8.0 mm -86.87 110.79 20.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.355 -0.609 . . . . 70.040000000000006 109.355 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.881 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -86.52 117.4 25.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.731 -0.668 . . . . 74.310000000000002 109.889 -177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.482 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -132.2 173.32 11.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 54.140000000000001 111.056 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.541 ' HG2' ' N ' ' A' ' 101' ' ' ALA . 28.1 ttm -94.36 148.19 22.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.213 0.53 . . . . 70.209999999999994 111.281 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' N ' ' HG2' ' A' ' 100' ' ' MET . . . -99.52 122.09 42.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.699 -0.682 . . . . 71.040000000000006 109.222 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -134.58 165.88 24.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 110.221 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.12 -28.67 14.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.32 0.581 . . . . 53.240000000000002 110.422 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.412 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -153.23 180.0 29.17 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.651 -1.38 . . . . 61.109999999999999 109.651 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.7 -50.54 12.88 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.233 2.622 . . . . 64.239999999999995 112.786 -178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -102.77 -1.83 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.57 -0.286 . . . . 52.420000000000002 111.092 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.437 ' HA ' ' CG ' ' A' ' 81' ' ' GLN . 7.9 m -88.34 53.85 2.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.865 0.84 . . . . 74.25 109.114 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 82' ' ' PHE . 3.7 p30 -82.88 158.46 22.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.289 -1.323 . . . . 63.020000000000003 109.8 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.89 -129.51 1.04 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.445 -0.883 . . . . 24.129999999999999 112.965 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.541 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 3.3 p -114.07 -1.09 13.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.002 0.371 . . . . 53.439999999999998 112.002 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 71.9 mt-30 -79.32 150.31 31.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.729 -0.471 . . . . 63.539999999999999 109.729 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' HB3' ' HE2' ' A' ' 39' ' ' PHE . 29.8 p90 -148.11 164.98 32.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.857 -0.337 . . . . 70.209999999999994 110.468 -176.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -154.2 151.49 29.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.889 0.376 . . . . 75.209999999999994 110.321 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.73 HG22 HD23 ' A' ' 98' ' ' LEU . 15.1 t -110.15 141.42 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.814 -0.63 . . . . 72.510000000000005 109.352 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 37.3 p -95.14 124.92 39.44 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.115 0.483 . . . . 63.530000000000001 110.318 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' A' ' 62' ' ' ILE . 54.2 mt -81.83 -8.98 59.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.631 -0.713 . . . . 70.430000000000007 110.569 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -146.52 160.23 42.3 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.386 -0.825 . . . . 35.43 109.801 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.607 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 18.8 Cg_exo -65.98 120.24 7.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.714 2.276 . . . . 53.0 111.934 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -108.43 116.23 31.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.206 -0.452 . . . . 55.210000000000001 110.476 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -104.44 11.41 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.106 0.479 . . . . 74.120000000000005 110.903 -174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.527 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.2 p90 -118.42 0.27 11.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.679 -0.691 . . . . 62.210000000000001 111.138 -174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.527 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 91.2 mt -104.01 10.24 36.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.107 -0.497 . . . . 73.030000000000001 110.511 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -62.73 -22.18 66.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.196 -0.911 . . . . 73.409999999999997 111.496 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.91 21.51 4.66 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.713 -0.756 . . . . 62.340000000000003 111.727 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -117.08 -32.1 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.108 0.48 . . . . 62.399999999999999 110.23 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -139.65 131.31 27.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.863 -0.608 . . . . 75.219999999999999 110.319 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.433 ' OG1' HD23 ' A' ' 86' ' ' LEU . 46.1 m -68.31 119.42 12.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 120.982 0.42 . . . . 71.310000000000002 109.932 171.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 99' ' ' ALA . 46.2 mt -102.47 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 72.230000000000004 110.029 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.651 ' CE2' ' HB ' ' A' ' 35' ' ' THR . 15.0 p90 -160.3 71.54 0.45 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 75.420000000000002 111.264 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.881 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.83 154.02 24.7 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.611 -1.281 . . . . 42.130000000000003 114.053 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -131.75 118.64 20.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.461 -0.57 . . . . 74.120000000000005 109.461 170.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.06 139.03 18.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 72.319999999999993 110.459 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 46.0 t -141.51 150.02 41.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.453 -0.339 . . . . 64.519999999999996 110.956 -175.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 2.9 pt20 39.02 40.02 0.43 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.807 1.243 . . . . 73.140000000000001 113.474 177.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.57 23.07 0.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.874 -0.679 . . . . 44.020000000000003 111.834 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 tp -76.63 -32.88 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.717 0.294 . . . . 73.239999999999995 110.233 -175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.48 -36.09 87.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.818 -0.706 . . . . 44.140000000000001 111.672 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 78.6 mmm -72.23 -50.07 30.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.414 -0.217 . . . . 74.230000000000004 110.414 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 62' ' ' ILE . 86.6 t -57.77 -28.71 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.202 0.525 . . . . 71.25 110.565 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.627 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.4 t30 -72.14 -55.29 7.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 51.240000000000002 110.572 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -70.69 -17.3 62.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.128 -0.487 . . . . 70.430000000000007 111.015 -176.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.1 t -87.48 -33.32 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.258 0.552 . . . . 74.439999999999998 109.666 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.77 -13.36 82.44 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.787 -0.721 . . . . 51.229999999999997 112.687 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.627 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 67.9 mtp -85.17 -2.2 57.75 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.871 -0.194 . . . . 75.140000000000001 111.382 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.624 ' HB ' HG21 ' A' ' 154' ' ' VAL . 6.1 m -80.81 135.67 24.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.294 0.568 . . . . 73.420000000000002 110.489 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.423 ' HG3' ' H ' ' A' ' 147' ' ' THR . 13.0 pt-20 -129.75 -56.53 1.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.576 . . . . 74.25 109.956 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 146' ' ' GLU . 2.9 p -128.78 141.52 51.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.045 0.45 . . . . 70.340000000000003 110.432 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.659 ' HB3' ' HG3' ' A' ' 152' ' ' ARG . 11.7 t-20 -52.32 -60.94 2.62 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.888 -1.051 . . . . 62.43 112.168 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 75.1 m -163.45 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.344 -0.984 . . . . 50.539999999999999 108.344 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -93.78 -167.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.758 -1.11 . . . . 61.520000000000003 108.441 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.88 59.42 2.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.855 0.836 . . . . 74.420000000000002 109.571 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.659 ' HG3' ' HB3' ' A' ' 148' ' ' ASN . 6.4 ptp180 -134.31 133.18 21.47 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 114.993 -1.003 . . . . 72.109999999999999 109.489 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.59 139.37 69.59 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.347 2.031 . . . . 70.409999999999997 111.469 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 ' HB ' ' A' ' 145' ' ' VAL . 14.9 t -62.49 152.03 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.936 -0.574 . . . . 71.299999999999997 111.368 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.89 138.7 57.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 74.010000000000005 110.115 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' A' ' 158' ' ' LYS . 8.9 p-10 -68.43 153.56 43.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.96 -0.564 . . . . 65.530000000000001 111.673 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 53' ' ' PHE . 3.6 p -103.54 135.96 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.57 . . . . 73.010000000000005 110.308 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' A' ' 156' ' ' ASP . 10.2 mptt -111.36 151.34 28.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.806 -0.634 . . . . 70.450000000000003 110.86 -172.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.53 99.99 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.287 -1.005 . . . . 74.409999999999997 108.287 169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.534 HG22 ' HD3' ' A' ' 161' ' ' LYS . 36.4 mm -62.9 -50.78 78.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 73.549999999999997 110.218 -176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.596 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -143.16 152.44 41.79 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.555 -0.748 . . . . 72.329999999999998 109.992 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -135.95 132.95 37.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.472 . . . . 62.049999999999997 109.875 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 43.4 m-85 -134.31 125.65 17.94 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.582 . . . . 64.400000000000006 109.957 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . 19.5 Cg_endo -62.21 136.15 58.52 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.81 1.673 . . . . 62.210000000000001 111.139 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.504 ' HA ' ' HE2' ' A' ' 15' ' ' TYR . 8.6 t -62.11 142.7 57.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.999 0.428 . . . . 74.420000000000002 110.679 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 110.66 5.33 27.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.768 -0.729 . . . . 60.210000000000001 111.723 -176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -171.03 38.65 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.118 -0.563 . . . . 52.509999999999998 111.857 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -75.97 -48.07 10.5 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.78 -0.724 . . . . 72.099999999999994 112.206 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 164.82 172.79 32.72 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.463 -0.655 . . . . 63.420000000000002 111.463 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 50.3 m -124.03 -31.01 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.698 0.285 . . . . 42.119999999999997 111.137 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 133.2 -161.26 24.15 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.729 -0.748 . . . . 75.150000000000006 111.742 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.33 59.2 0.5 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.675 -0.774 . . . . 62.350000000000001 112.184 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 127.35 137.1 4.43 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.791 -0.718 . . . . 34.549999999999997 111.908 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.3 m -106.7 103.43 12.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.701 0.286 . . . . 51.340000000000003 110.383 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -121.58 -153.27 8.92 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.776 -0.726 . . . . 54.119999999999997 112.256 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -102.05 22.13 39.22 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.902 -0.666 . . . . 64.319999999999993 111.76 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -91.24 98.77 2.48 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.038 -0.601 . . . . 42.210000000000001 111.936 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 19.0 m -107.75 85.85 2.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.159 0.504 . . . . 73.129999999999995 110.096 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -100.94 126.59 8.97 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.725 -0.67 . . . . 42.43 111.923 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -147.19 102.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.88 -0.676 . . . . 73.430000000000007 111.625 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.67 -164.5 26.38 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.809 -0.71 . . . . 74.129999999999995 111.999 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.0 m -71.15 141.94 50.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.346 -0.242 . . . . 72.420000000000002 110.346 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.8 111.14 3.2 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.516 -0.85 . . . . 61.119999999999997 111.894 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -77.29 174.01 11.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.571 0.7 . . . . 65.200000000000003 110.26 179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 156.17 146.39 4.45 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.926 -1.034 . . . . 63.520000000000003 110.998 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.9 -178.18 52.15 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.282 -0.961 . . . . 55.130000000000003 111.397 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.893 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.5 141.69 53.87 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.43 -0.582 . . . . 75.25 109.43 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 61.4 m-85 -88.96 104.44 7.6 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 120.973 0.416 . . . . 53.520000000000003 110.277 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.653 ' HB2' HD12 ' A' ' 90' ' ' LEU . 1.1 Cg_endo -82.47 -5.55 11.77 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.804 2.336 . . . . 72.439999999999998 111.301 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.66 -34.34 46.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 64.129999999999995 110.438 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 193' ' ' VAL . 17.7 pt -79.59 -13.6 13.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.497 -0.774 . . . . 70.219999999999999 111.555 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 58.9 m170 64.92 40.29 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.501 -0.772 . . . . 71.420000000000002 111.971 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.537 HG12 HG13 ' A' ' 191' ' ' ILE . 9.8 p -144.19 145.47 21.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 110.758 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.32 122.11 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.853 -0.612 . . . . 55.030000000000001 112.339 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.421 HE22 ' N ' ' A' ' 188' ' ' PHE . 2.8 pp0? -166.93 158.46 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.031 -0.986 . . . . 71.200000000000003 108.967 175.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.445 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 25.6 m-85 -126.11 148.45 63.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.939 -0.305 . . . . 65.140000000000001 110.587 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.893 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 37.5 Cg_endo -66.38 -59.37 0.13 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.52 2.147 . . . . 63.119999999999997 111.786 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.7 33.15 1.81 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.882 0.372 . . . . 72.530000000000001 110.647 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.42 3.55 3.82 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.811 -0.632 . . . . 61.229999999999997 112.683 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 22.2 ptm -56.73 -30.54 63.64 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.936 0.347 . . . . 75.140000000000001 111.936 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -84.3 -1.78 89.34 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.675 -0.774 . . . . 74.329999999999998 112.514 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.445 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 85.3 mtt180 -101.19 -12.19 18.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.578 . . . . 61.210000000000001 110.234 177.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.516 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . 21.1 ttmt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.616 -1.175 . . . . 74.010000000000005 111.433 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.716 0.293 . . . . 71.530000000000001 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.67 85.36 6.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.29 0.567 . . . . 72.340000000000003 110.394 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.59 -67.73 0.83 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 61.530000000000001 111.004 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 48.6 mm -121.03 97.31 48.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.243 -0.435 . . . . 40.450000000000003 111.137 -174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -97.53 121.95 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.446 2.764 . . . . 74.25 112.603 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.36 142.93 87.54 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.447 2.098 . . . . 53.439999999999998 111.09 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.58 -64.24 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.234 0.54 . . . . 74.030000000000001 111.143 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.419 ' HB2' ' H ' ' A' ' 9' ' ' TRP . 2.5 p -135.02 -147.09 0.26 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.6 -0.727 . . . . 74.329999999999998 109.075 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.419 ' H ' ' HB2' ' A' ' 8' ' ' SER . 36.5 p90 -76.85 165.8 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.191 -0.67 . . . . 74.519999999999996 109.191 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' A' ' 37' ' ' LYS . 3.0 mp0 -104.18 133.38 20.26 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.658 -0.246 . . . . 74.340000000000003 111.521 -170.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.862 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 27.1 Cg_exo -63.36 116.23 3.49 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.552 2.168 . . . . 73.340000000000003 110.564 168.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 29' ' ' TRP . 72.7 Cg_endo -75.28 -18.22 18.31 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.678 2.252 . . . . 62.039999999999999 113.395 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.532 HD21 HG12 ' A' ' 24' ' ' VAL . 23.1 t-20 -140.42 152.22 45.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.503 -0.555 . . . . 74.140000000000001 109.503 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.734 HG21 ' HE1' ' A' ' 39' ' ' PHE . 33.2 m -136.8 144.87 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.382 0.61 . . . . 64.299999999999997 111.29 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.84 123.53 43.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.207 -0.906 . . . . 63.32 111.004 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 16' ' ' LEU . 3.0 mm? -108.0 102.78 11.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.435 -0.348 . . . . 71.209999999999994 110.571 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -91.05 108.19 19.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.232 -0.655 . . . . 73.349999999999994 109.232 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -101.55 -179.95 4.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.228 0.537 . . . . 45.530000000000001 112.09 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB2' HD11 ' A' ' 160' ' ' ILE . 22.9 t -72.48 -11.01 60.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.316 -0.856 . . . . 75.319999999999993 110.948 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.4 ' HG3' HG22 ' A' ' 142' ' ' VAL . 4.7 mmt -102.89 -41.05 6.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.197 -0.456 . . . . 72.219999999999999 110.623 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.45 -129.39 1.2 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.419 -0.672 . . . . 71.019999999999996 111.419 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -139.69 138.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.923 -0.399 . . . . 74.219999999999999 109.923 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mp -130.63 129.99 64.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.843 -0.617 . . . . 72.420000000000002 109.647 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 21.6 t -105.59 134.34 47.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.361 -0.607 . . . . 75.239999999999995 109.361 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.774 ' HB2' HD11 ' A' ' 98' ' ' LEU . 3.8 pp -144.17 160.76 40.4 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.406 -0.517 . . . . 63.329999999999998 111.127 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HB3' HD22 ' A' ' 13' ' ' ASN . 7.5 pt-20 -146.26 170.04 17.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.728 -0.669 . . . . 73.030000000000001 110.631 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.66 169.76 8.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.932 -0.576 . . . . 72.299999999999997 110.624 -173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.606 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -87.72 105.18 17.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.04 0.447 . . . . 71.409999999999997 110.851 176.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.5 ' CZ2' ' HB2' ' A' ' 12' ' ' PRO . 1.4 m0 -85.88 0.06 54.08 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.005 -0.543 . . . . 53.409999999999997 109.854 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -72.62 -68.82 0.45 Allowed 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.744 -0.662 . . . . 72.140000000000001 111.024 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -124.15 11.65 8.85 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.695 -0.402 . . . . 72.340000000000003 110.992 -173.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB2' ' CG ' ' A' ' 129' ' ' PHE . . . -129.6 69.19 81.31 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.275 -0.57 . . . . 33.409999999999997 112.278 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.553 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 18.8 Cg_exo -65.73 -33.36 44.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.493 1.462 . . . . 70.010000000000005 109.706 174.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -57.0 -56.78 17.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.299 -0.864 . . . . 54.030000000000001 110.725 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 m -61.59 -36.22 80.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.096 -0.502 . . . . 70.340000000000003 110.823 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 54.0 t -63.63 -48.64 76.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 70.510000000000005 111.022 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.36 -37.25 77.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.659 0.266 . . . . 73.129999999999995 110.405 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' O ' HD23 ' A' ' 42' ' ' LEU . 55.4 t-20 -55.58 -62.05 1.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.926 -0.579 . . . . 63.509999999999998 110.476 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.734 ' HE1' HG21 ' A' ' 14' ' ' VAL . 5.0 t80 -65.01 -44.7 88.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.696 -0.684 . . . . 71.0 110.767 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -57.59 -48.77 78.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.451 -0.795 . . . . 52.43 112.198 -177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -65.28 -39.27 92.35 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.927 0.394 . . . . 63.509999999999998 111.159 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 47' ' ' TYR . 3.6 mm? -69.15 -24.32 64.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.548 -0.296 . . . . 61.020000000000003 111.056 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.14 36.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.178 -0.464 . . . . 73.430000000000007 111.244 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -63.5 -29.03 70.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.178 0.513 . . . . 75.519999999999996 110.184 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 49.1 mtt180 -79.07 -50.55 10.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 74.519999999999996 109.86 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.03 52.82 0.68 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.602 -0.809 . . . . 74.310000000000002 113.036 171.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.66 ' CD1' ' HB3' ' A' ' 42' ' ' LEU . 3.9 p90 -76.09 -25.97 56.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.343 0.592 . . . . 74.019999999999996 110.481 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.679 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.5 -7.95 56.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.479 -0.782 . . . . 64.109999999999999 112.844 -173.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -71.75 -5.73 36.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.147 0.499 . . . . 74.439999999999998 110.47 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.29 33.87 2.71 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.756 -0.656 . . . . 52.240000000000002 111.508 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.833 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 75.1 p -114.61 153.8 29.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.858 0.361 . . . . 53.310000000000002 111.119 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' N ' ' HE2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -146.13 161.61 39.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 109.889 -178.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.638 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 97.9 m-85 -87.22 124.06 32.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.616 -0.513 . . . . 64.019999999999996 109.616 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -105.49 -32.77 8.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.996 -0.282 . . . . 73.120000000000005 111.13 -172.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -118.44 107.58 13.99 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.841 -0.343 . . . . 74.010000000000005 110.383 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.622 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -120.22 91.43 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.691 -0.855 . . . . 72.340000000000003 108.691 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.3 mt -93.24 128.91 44.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.98 -0.554 . . . . 73.109999999999999 110.116 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.423 ' CD ' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -52.2 109.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.341 1.026 . . . . 75.319999999999993 111.539 -176.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.564 ' OD2' ' HA2' ' A' ' 201' ' ' GLY . 6.6 t70 53.1 50.35 18.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.765 0.793 . . . . 71.310000000000002 110.703 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 7.1 t80 -137.55 -77.92 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.332 -0.849 . . . . 71.319999999999993 109.117 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.637 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 26.4 ptt? -162.29 154.9 19.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.939 -1.028 . . . . 73.530000000000001 109.739 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.622 HG23 HG13 ' A' ' 56' ' ' ILE . 36.1 mt -128.54 101.59 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.124 -0.489 . . . . 73.5 109.817 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 113' ' ' PHE . 25.4 tm0? -82.26 126.38 32.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.394 -0.821 . . . . 74.099999999999994 109.833 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -142.69 145.68 15.93 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.176 -1.011 . . . . 71.430000000000007 113.569 -176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.833 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 130.33 -138.58 10.3 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.735 -0.745 . . . . 31.109999999999999 112.37 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.896 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 23.1 t0 44.85 89.09 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 124.49 1.116 . . . . 74.430000000000007 113.249 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 72.6 Cg_endo -75.21 -13.5 20.97 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.863 2.375 . . . . 63.25 111.878 172.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.5 p -95.94 -34.9 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.933 -0.576 . . . . 65.140000000000001 112.058 -173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.47 21.92 71.41 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.127 -0.558 . . . . 53.299999999999997 112.37 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -120.09 2.24 10.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.142 0.496 . . . . 72.019999999999996 111.159 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.59 -5.08 66.94 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.559 -0.829 . . . . 63.5 112.755 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -88.52 -46.75 8.85 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.335 0.588 . . . . 75.319999999999993 109.97 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.896 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 72.87 67.98 1.69 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.468 -0.787 . . . . 63.229999999999997 112.451 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.66 -105.05 1.57 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.859 -0.686 . . . . 73.230000000000004 111.59 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 53.62 35.85 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.962 0.448 . . . . 73.329999999999998 111.353 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 m -56.16 -32.24 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.894 -0.594 . . . . 73.120000000000005 111.779 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -70.53 -56.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.367 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' HA ' ' CD1' ' A' ' 4' ' ' ILE . 90.9 m-85 -69.86 -40.13 75.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.324 0.583 . . . . 53.119999999999997 110.465 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.62 -67.7 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.264 -0.88 . . . . 75.129999999999995 112.556 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -113.14 -178.65 3.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.156 0.503 . . . . 64.120000000000005 112.001 -174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' OE1' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -104.01 162.1 13.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.451 -0.795 . . . . 74.549999999999997 109.092 177.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -130.3 -67.86 0.72 Allowed 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.41 -0.516 . . . . 70.239999999999995 111.108 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -131.8 -179.46 5.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.949 0.404 . . . . 74.150000000000006 110.466 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HA ' HD21 ' A' ' 108' ' ' ASN . 6.1 p-10 -91.53 136.44 33.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.607 -0.724 . . . . 74.549999999999997 109.612 174.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -100.24 15.66 26.84 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.147 -0.686 . . . . 54.32 109.147 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.93 104.58 2.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.438 -0.801 . . . . 73.329999999999998 111.697 -173.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -173.37 81.69 0.4 Allowed Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 75.349999999999994 109.906 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.11 93.0 0.46 Allowed 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.562 2.175 . . . . 74.430000000000007 112.342 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.39 -38.56 84.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.365 0.602 . . . . 73.450000000000003 110.123 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' CD1' ' HB2' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -81.16 -176.54 6.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.263 -0.881 . . . . 75.109999999999999 110.769 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -122.99 144.11 49.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.758 -0.46 . . . . 64.099999999999994 109.758 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.45 76.2 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.021 0.915 . . . . 53.420000000000002 109.677 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.7 p -61.52 -46.7 88.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.474 -1.239 . . . . 64.120000000000005 111.768 -173.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.2 -140.21 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.62 -0.8 . . . . 53.240000000000002 112.27 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.84 137.7 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.661 0.267 . . . . 55.229999999999997 110.743 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 113.01 20.74 6.23 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.737 -0.744 . . . . 73.430000000000007 111.788 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.5 mm -87.41 114.7 26.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.238 -0.653 . . . . 72.049999999999997 109.238 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.774 HD11 ' HB2' ' A' ' 25' ' ' LEU . 8.5 mt -85.47 127.07 34.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.264 0.554 . . . . 72.019999999999996 111.467 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.62 163.81 26.34 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.316 -0.856 . . . . 71.409999999999997 110.105 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.421 ' CE ' ' HB3' ' A' ' 108' ' ' ASN . 40.7 ttp -97.24 140.26 31.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.637 -0.505 . . . . 50.329999999999998 109.637 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB3' ' HG3' ' A' ' 111' ' ' GLN . . . -90.96 137.73 32.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 61.43 110.587 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -137.42 159.1 42.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.569 -0.741 . . . . 61.020000000000003 110.304 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -99.48 -2.11 36.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.605 0.717 . . . . 73.040000000000006 110.021 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.504 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -174.21 172.69 45.54 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 108.884 -1.686 . . . . 72.420000000000002 108.884 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 -44.91 34.68 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.659 2.24 . . . . 63.549999999999997 112.321 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -108.29 -3.7 18.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 54.119999999999997 110.899 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.504 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 4.6 m -85.8 52.44 2.47 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.735 0.779 . . . . 64.019999999999996 109.099 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.495 HD21 ' HA ' ' A' ' 84' ' ' ASP . 44.9 m-80 -79.68 130.58 35.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.773 -1.103 . . . . 63.329999999999998 110.332 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.27 -138.95 6.46 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.708 -0.758 . . . . 43.340000000000003 112.46 -178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -119.53 14.13 12.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.777 0.322 . . . . 72.420000000000002 111.349 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.531 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 5.8 pt20 -92.81 168.02 11.46 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.703 -0.226 . . . . 71.510000000000005 110.446 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -145.88 177.49 8.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.802 0.335 . . . . 74.150000000000006 111.127 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 45.6 p90 -160.29 151.87 19.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.233 -0.44 . . . . 75.25 110.319 173.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 98' ' ' LEU . 15.0 t -106.61 146.84 12.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.93 -0.577 . . . . 71.209999999999994 109.56 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.2 p -102.01 126.95 49.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.058 -0.349 . . . . 64.239999999999995 110.058 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 68.2 mt -87.62 -7.71 57.14 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.317 0.58 . . . . 73.430000000000007 110.55 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -150.89 165.14 18.01 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.397 -0.82 . . . . 64.409999999999997 109.809 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.3 Cg_endo -58.59 113.85 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.631 2.221 . . . . 73.319999999999993 111.652 175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.404 HG22 ' HE1' ' A' ' 121' ' ' TRP . 16.6 p -100.06 88.44 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.231 0.538 . . . . 74.239999999999995 111.492 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.726 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -96.9 19.64 12.37 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.916 0.865 . . . . 64.219999999999999 108.845 -178.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.963 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -121.19 1.39 10.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.308 -1.314 . . . . 73.299999999999997 109.891 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.963 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 63.6 mt -121.71 6.37 9.97 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.485 -0.779 . . . . 72.129999999999995 110.41 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.01 -17.29 64.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.164 -0.925 . . . . 71.099999999999994 111.448 -172.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.11 18.58 5.01 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.507 -0.854 . . . . 72.310000000000002 111.298 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -120.91 -30.13 4.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.119 0.485 . . . . 73.329999999999998 110.249 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -139.67 141.2 37.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.165 -0.68 . . . . 62.420000000000002 109.165 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.0 t -78.16 144.55 36.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.978 0.418 . . . . 75.219999999999999 110.129 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.434 ' O ' HD21 ' A' ' 90' ' ' LEU . 49.3 mt -122.72 112.96 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.14 -0.482 . . . . 63.420000000000002 110.928 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.606 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.0 m-85 -155.82 77.31 0.96 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.608 0.568 . . . . 75.219999999999999 110.763 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.478 ' C ' ' HB2' ' A' ' 98' ' ' LEU . . . -163.27 164.49 36.12 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.623 -0.799 . . . . 72.530000000000001 112.553 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -141.76 126.04 17.55 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.067 -0.346 . . . . 62.409999999999997 110.067 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 96' ' ' GLY . 11.9 p -92.56 138.06 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.149 0.499 . . . . 74.040000000000006 110.911 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.55 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 47.9 t -144.23 146.0 32.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.1 -0.5 . . . . 71.329999999999998 110.204 -176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.712 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 7.9 tt0 50.25 40.49 22.41 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.254 0.55 . . . . 72.409999999999997 111.991 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.66 17.47 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.151 -1.023 . . . . 75.329999999999998 112.512 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 185' ' ' GLY . 11.2 tp -74.27 -33.7 35.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.061 -0.256 . . . . 73.319999999999993 110.617 -174.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.47 -38.31 96.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.543 -0.837 . . . . 73.540000000000006 111.243 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.416 ' O ' HG23 ' A' ' 142' ' ' VAL . 76.1 mmm -69.33 -51.82 33.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.0 -0.37 . . . . 73.310000000000002 110.0 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.462 HG13 HD12 ' A' ' 62' ' ' ILE . 89.7 t -54.89 -31.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.054 0.454 . . . . 74.519999999999996 110.922 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -71.75 -53.73 12.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.296 0.57 . . . . 74.230000000000004 110.587 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -73.48 -13.92 61.14 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.556 -0.747 . . . . 74.140000000000001 111.078 -176.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 138' ' ' MET . 53.4 t -88.51 -40.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.219 0.533 . . . . 64.140000000000001 110.104 174.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -77.6 -9.41 86.89 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.708 -0.678 . . . . 74.049999999999997 112.735 -177.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.541 ' HG3' HG13 ' A' ' 145' ' ' VAL . 14.6 ptp -96.18 -13.62 23.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.669 0.271 . . . . 74.219999999999999 111.21 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.541 HG13 ' HG3' ' A' ' 144' ' ' MET . 32.2 m -109.94 126.82 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.272 0.558 . . . . 62.409999999999997 111.635 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 1.3 pt-20 -124.46 -45.1 1.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.129 0.49 . . . . 74.230000000000004 109.752 168.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 12.5 p -140.57 152.52 45.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.746 -0.661 . . . . 72.150000000000006 110.121 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' HB3' HG22 ' A' ' 154' ' ' VAL . 11.8 p30 -94.06 -144.33 0.24 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.715 -0.22 . . . . 62.450000000000003 110.7 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.5 m -62.7 -25.72 68.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.195 0.521 . . . . 64.409999999999997 109.961 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.692 ' HB2' ' HG2' ' A' ' 152' ' ' ARG . 35.0 mt-30 -97.46 169.9 9.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.438 -0.801 . . . . 74.109999999999999 108.863 175.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -85.5 22.8 1.48 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.726 0.774 . . . . 73.340000000000003 109.859 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.692 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 1.4 ptm180 -102.31 147.95 34.72 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.437 -0.801 . . . . 63.340000000000003 110.09 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 31.6 Cg_exo -59.21 134.62 60.43 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.702 2.268 . . . . 62.049999999999997 112.33 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 148' ' ' ASN . 34.0 t -64.34 -69.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.398 0.618 . . . . 72.219999999999999 110.001 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -136.4 147.6 47.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.191 -0.913 . . . . 72.400000000000006 109.148 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.85 179.85 6.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.547 -0.538 . . . . 65.109999999999999 109.547 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 53' ' ' PHE . 5.7 p -156.13 108.38 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 122.629 1.204 . . . . 73.349999999999994 111.187 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -133.49 159.63 39.8 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.085 -1.416 . . . . 72.319999999999993 109.784 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.8 mp -81.37 103.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.815 -0.809 . . . . 75.129999999999995 108.815 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.3 mm -67.59 -65.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.688 -0.687 . . . . 71.219999999999999 109.951 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 163' ' ' TYR . 2.5 mptm? -133.08 135.84 45.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.394 -0.821 . . . . 72.430000000000007 109.098 176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.679 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -130.96 143.21 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.938 0.399 . . . . 61.219999999999999 110.089 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 161' ' ' LYS . 17.0 m-85 -133.7 128.94 20.16 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.781 -0.645 . . . . 61.229999999999997 109.74 -171.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.16 129.11 7.62 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.816 1.677 . . . . 64.540000000000006 111.529 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p -75.17 113.22 12.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.977 0.418 . . . . 74.219999999999999 109.956 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -139.94 -80.48 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.83 -0.7 . . . . 71.019999999999996 112.317 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.63 -2.39 90.63 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 73.140000000000001 113.41 -176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.03 -27.89 9.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.676 -0.773 . . . . 65.129999999999995 112.323 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 138.91 -94.13 0.2 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.6 -0.6 . . . . 72.120000000000005 111.6 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 73.1 m -154.44 132.4 11.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.079 -0.341 . . . . 65.430000000000007 110.079 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -86.01 54.74 4.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.869 -0.681 . . . . 74.010000000000005 112.236 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.84 -170.61 25.68 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.112 -0.566 . . . . 71.400000000000006 111.826 -177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 75.52 -78.0 1.19 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.156 -0.545 . . . . 61.420000000000002 112.205 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.7 m -152.24 121.19 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.904 -0.406 . . . . 74.219999999999999 109.904 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -74.19 75.36 1.15 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.834 -0.698 . . . . 24.219999999999999 112.18 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -110.19 119.7 5.43 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.698 -0.561 . . . . 53.140000000000001 111.698 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 174.62 82.46 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.865 -0.683 . . . . 62.219999999999999 111.567 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 50.2 m -133.66 31.92 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.234 0.54 . . . . 74.150000000000006 110.223 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -80.41 162.8 46.05 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.663 -0.699 . . . . 73.400000000000006 112.031 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -156.53 86.0 0.13 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.667 -0.777 . . . . 44.549999999999997 112.311 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 156.01 158.82 9.02 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.937 -0.649 . . . . 74.219999999999999 112.02 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 3.0 p -104.65 -52.54 2.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 72.209999999999994 110.632 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 95.59 -69.06 1.05 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.979 -0.629 . . . . 72.120000000000005 112.114 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.8 m-20 -100.04 171.68 7.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 72.530000000000001 110.715 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.46 144.01 3.87 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.15 -0.932 . . . . 63.140000000000001 111.164 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.88 -174.24 48.34 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.275 -0.964 . . . . 54.200000000000003 112.135 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.95 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -69.42 149.43 48.34 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.532 -0.544 . . . . 75.310000000000002 109.532 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -89.92 103.47 6.42 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.127 -0.488 . . . . 75.409999999999997 110.309 -176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 187' ' ' ALA . 90.3 Cg_endo -80.61 -6.69 13.56 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.218 1.945 . . . . 71.329999999999998 111.066 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.73 -27.48 55.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.666 -1.152 . . . . 73.340000000000003 110.764 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 193' ' ' VAL . 15.8 pt -89.0 -12.85 9.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.976 -0.556 . . . . 62.140000000000001 111.703 -176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 90' ' ' LEU . 12.0 m170 58.27 45.31 17.38 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.801 -0.636 . . . . 71.540000000000006 111.588 174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 191' ' ' ILE . 7.0 p -141.91 147.99 21.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.342 -0.39 . . . . 52.0 110.31 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.21 107.81 2.48 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 112.202 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -158.38 157.48 32.42 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.873 -0.788 . . . . 71.25 108.873 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 202' ' ' ARG . 46.8 m-85 -128.01 151.65 76.22 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.895 -0.322 . . . . 71.439999999999998 110.949 -175.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.95 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 40.6 Cg_endo -67.57 -57.55 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 111.711 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 197' ' ' PRO . 1.7 pt? -126.52 15.85 7.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.122 -0.49 . . . . 65.450000000000003 110.13 175.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 1.2 m-20 64.18 22.98 13.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.583 0.957 . . . . 60.130000000000003 113.583 171.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.77 -46.87 51.09 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.886 -0.325 . . . . 60.310000000000002 111.494 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.564 ' HA2' ' OD2' ' A' ' 59' ' ' ASP . . . -79.09 0.5 79.01 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.053 -0.594 . . . . 63.340000000000003 113.593 -172.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 15.9 ptm180 -96.33 -18.01 20.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.157 0.503 . . . . 45.420000000000002 111.168 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.493 -0.776 . . . . 64.530000000000001 109.904 -175.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.973 -0.38 . . . . 74.010000000000005 109.973 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.89 99.47 3.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.378 0.609 . . . . 73.540000000000006 111.16 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.31 -61.08 0.83 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.322 -0.854 . . . . 62.32 108.772 173.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.7 mm -128.57 123.34 22.17 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.053 -0.976 . . . . 72.200000000000003 109.109 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 73.4 Cg_exo -51.54 147.88 21.98 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.802 2.334 . . . . 75.409999999999997 112.445 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 50.8 Cg_exo -54.23 150.45 32.6 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.91 2.407 . . . . 75.140000000000001 112.421 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 2.0 m-20 -75.91 55.12 0.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 72.340000000000003 110.747 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.663 ' HB2' HE22 ' A' ' 10' ' ' GLN . 6.7 m -78.64 -162.48 0.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.685 -0.689 . . . . 74.129999999999995 109.868 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.427 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 9.4 p-90 -57.3 -65.92 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.849 0.314 . . . . 75.409999999999997 111.849 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 8' ' ' SER . 2.3 mp0 69.34 159.39 0.15 Allowed Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 122.892 0.477 . . . . 54.450000000000003 111.564 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 50.9 Cg_exo -55.29 119.33 6.35 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.742 2.295 . . . . 55.450000000000003 112.701 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 29' ' ' TRP . 71.8 Cg_endo -78.98 -13.51 14.11 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.813 2.342 . . . . 72.409999999999997 112.575 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.675 HD21 HG12 ' A' ' 24' ' ' VAL . 4.0 t-20 -151.72 142.01 22.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 72.299999999999997 109.666 -173.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.6 149.33 29.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.823 0.344 . . . . 71.540000000000006 110.952 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.698 ' CD1' ' HB2' ' A' ' 165' ' ' SER . 7.0 m-85 -107.89 132.57 53.32 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.02 -0.536 . . . . 63.420000000000002 110.789 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' N ' HD22 ' A' ' 16' ' ' LEU . 2.4 mm? -118.88 102.5 8.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.498 -0.774 . . . . 60.439999999999998 109.917 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.36 109.58 17.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.088 -0.708 . . . . 71.420000000000002 109.088 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -98.28 178.2 5.13 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.939 0.4 . . . . 74.409999999999997 110.769 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 160' ' ' ILE . 6.9 p -70.96 -28.14 64.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.961 -0.563 . . . . 63.200000000000003 111.365 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.541 ' SD ' HG22 ' A' ' 142' ' ' VAL . 83.3 mtp -91.05 -41.58 10.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.55 -0.296 . . . . 73.439999999999998 111.118 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 -143.08 3.59 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.858 -0.687 . . . . 33.340000000000003 111.396 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 23' ' ' ILE . 20.4 tt -128.11 138.92 53.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 117.026 0.413 . . . . 71.430000000000007 109.895 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 22' ' ' ILE . 10.8 mm -125.53 132.27 71.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.617 -0.512 . . . . 51.299999999999997 109.617 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 18.3 t -120.0 139.86 45.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 110.14 -0.319 . . . . 75.349999999999994 110.14 174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 161.37 42.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.824 0.345 . . . . 73.319999999999993 110.449 174.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ARG . 14.6 pt-20 -130.87 167.68 18.53 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.015 -0.539 . . . . 71.299999999999997 110.167 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.28 157.9 17.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.416 -0.356 . . . . 64.219999999999999 110.688 -175.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 4.9 m-85 -80.07 102.49 9.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 72.219999999999999 111.499 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 12' ' ' PRO . 11.5 m0 -80.58 -6.27 58.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.887 -0.597 . . . . 73.209999999999994 110.453 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -73.83 -53.35 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.468 -0.787 . . . . 74.549999999999997 111.732 -172.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.62 6.09 5.63 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.925 0.342 . . . . 73.420000000000002 111.925 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.19 79.01 67.46 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.996 0.426 . . . . 54.340000000000003 111.52 -176.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.8 Cg_exo -71.84 -41.03 2.33 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.371 2.047 . . . . 73.530000000000001 111.573 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -77.33 -43.31 33.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.933 -0.576 . . . . 73.5 110.143 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.513 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 2.1 m -57.23 -42.38 81.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 64.349999999999994 110.334 177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 30.7 t -60.77 -47.96 83.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.024 -0.534 . . . . 75.120000000000005 110.651 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HE2' ' HB2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -62.95 -35.53 80.45 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.202 -0.453 . . . . 60.439999999999998 111.153 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -57.22 -53.31 59.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 71.219999999999999 110.76 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.479 ' HZ ' ' HG3' ' A' ' 100' ' ' MET . 76.9 m-85 -67.96 -44.42 76.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.186 -0.461 . . . . 61.310000000000002 111.164 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -61.84 -35.96 79.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 60.32 112.13 -178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -66.35 -44.71 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.422 0.63 . . . . 61.140000000000001 109.948 179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.744 ' HB3' ' HB3' ' A' ' 47' ' ' TYR . 30.4 mt -67.64 -22.12 65.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 111.128 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.0 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.649 -0.705 . . . . 72.310000000000002 110.362 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 32.4 mmt180 -63.84 -49.6 72.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.311 0.576 . . . . 64.340000000000003 110.073 174.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.6 mtt-85 -74.9 -51.97 12.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.378 -0.828 . . . . 71.120000000000005 110.802 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.9 44.86 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.698 -0.763 . . . . 74.420000000000002 112.129 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.744 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -70.6 -26.53 63.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.042 0.449 . . . . 74.140000000000001 110.714 -175.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 67.3 m-85 -76.67 -16.49 59.52 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.767 -0.651 . . . . 62.32 111.572 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -74.52 2.33 9.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.034 0.445 . . . . 73.299999999999997 110.942 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.32 11.7 5.26 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.921 -0.657 . . . . 53.420000000000002 111.907 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.566 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.4 p -90.45 137.93 31.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 74.219999999999999 110.951 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 2.0 mtmt -129.49 150.75 50.7 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.388 -0.597 . . . . 73.010000000000005 109.388 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 72.4 m-85 -78.05 122.37 25.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.851 -0.425 . . . . 70.409999999999997 109.851 177.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -107.36 -30.46 8.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.55 -0.295 . . . . 60.340000000000003 111.064 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 25.5 mmt180 -119.04 110.58 17.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.907 -0.405 . . . . 73.099999999999994 109.907 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.426 HG13 HG23 ' A' ' 62' ' ' ILE . 4.5 mp -127.15 93.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 71.540000000000006 109.082 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.743 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 35.2 mt -104.1 125.48 58.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.028 -0.533 . . . . 72.040000000000006 109.94 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -50.42 129.39 21.84 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.65 0.594 . . . . 75.319999999999993 111.62 177.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' OD1' ' HE3' ' A' ' 58' ' ' LYS . 3.4 p30 42.22 43.74 3.0 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.231 0.957 . . . . 75.5 112.418 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.743 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -135.67 -77.54 0.43 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 72.310000000000002 110.291 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.7 ptp -160.05 156.05 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 64.140000000000001 110.634 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' A' ' 116' ' ' LEU . 40.6 mt -131.58 101.43 5.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.736 -0.666 . . . . 61.520000000000003 109.417 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 24.6 tm0? -88.42 128.92 35.53 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.647 -0.706 . . . . 73.200000000000003 109.802 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -137.17 144.24 15.72 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.708 -0.758 . . . . 71.329999999999998 112.369 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 147.14 -143.3 11.17 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.658 -0.782 . . . . 60.109999999999999 112.578 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HA ' HE22 ' A' ' 111' ' ' GLN . 44.5 t0 46.86 77.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 124.16 0.984 . . . . 70.430000000000007 112.71 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.72 -12.08 22.09 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.495 2.13 . . . . 73.010000000000005 111.587 174.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.0 p -91.81 -42.83 9.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.458 -0.792 . . . . 74.25 111.961 -176.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.22 32.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.602 -0.809 . . . . 70.530000000000001 112.001 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.711 HG23 ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.45 -2.65 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.846 0.355 . . . . 52.140000000000001 111.038 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.69 -35.7 4.57 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.381 -0.914 . . . . 73.409999999999997 113.316 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.711 ' HG2' HG23 ' A' ' 70' ' ' THR . 14.3 ptm180 -78.67 -28.88 45.38 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.219 0.509 . . . . 72.519999999999996 110.888 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.04 -162.65 54.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.023 -0.608 . . . . 15.529999999999999 113.179 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.97 6.79 61.43 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.294 -0.479 . . . . 72.549999999999997 112.386 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . -87.35 22.59 2.1 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.34 1.067 . . . . 71.409999999999997 110.723 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.9 m -85.51 5.8 29.76 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.318 -1.31 . . . . 51.109999999999999 109.805 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 pt -63.49 -28.51 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.342 -0.845 . . . . 70.400000000000006 111.213 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 p90 -100.18 10.86 40.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.512 0.672 . . . . 75.209999999999994 110.788 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.41 -110.26 3.96 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.11 -0.95 . . . . 61.340000000000003 112.417 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -95.88 -169.02 1.86 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.426 0.291 . . . . 54.530000000000001 110.275 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.477 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -65.97 159.26 26.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.201 -0.454 . . . . 63.509999999999998 109.826 176.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -102.47 -85.18 0.44 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.836 0.35 . . . . 74.530000000000001 110.944 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -162.02 157.19 23.19 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.459 -0.941 . . . . 74.319999999999993 108.459 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -70.31 110.95 5.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.533 0.682 . . . . 64.450000000000003 110.438 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.43 28.83 3.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.841 -0.618 . . . . 72.109999999999999 109.377 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.38 100.31 0.47 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.11 -0.95 . . . . 71.319999999999993 110.502 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -159.92 72.74 3.16 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.798 -0.637 . . . . 75.140000000000001 109.827 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.21 98.21 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.206 1.938 . . . . 73.299999999999997 112.642 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.56 24.39 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.489 0.662 . . . . 73.340000000000003 110.318 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' A' ' 189' ' ' PRO . 1.8 pp -137.24 -169.06 2.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.501 -0.772 . . . . 73.209999999999994 110.278 -174.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -140.6 151.06 44.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.148 -0.478 . . . . 73.239999999999995 110.033 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -72.43 69.5 0.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.713 0.768 . . . . 70.099999999999994 110.668 174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.9 p -68.7 -39.94 80.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.174 -0.921 . . . . 63.25 111.824 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 -142.43 3.83 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.504 -0.855 . . . . 73.140000000000001 112.913 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 141.62 28.43 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.302 0.241 . . . . 60.32 111.018 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.41 22.2 6.22 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.793 -0.718 . . . . 52.140000000000001 111.917 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 189' ' ' PRO . 9.1 mm -87.52 111.25 21.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.684 -0.487 . . . . 55.100000000000001 109.684 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.712 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -88.44 118.9 28.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.139 0.495 . . . . 73.409999999999997 109.715 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.3 173.4 10.55 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.063 -0.517 . . . . 52.420000000000002 110.817 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.479 ' HG3' ' HZ ' ' A' ' 39' ' ' PHE . 12.3 ttp -104.02 137.04 42.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.139 -0.482 . . . . 65.430000000000007 110.141 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -89.21 144.46 26.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 63.350000000000001 110.73 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 2.2 p-10 -153.12 158.77 42.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.987 -0.551 . . . . 71.150000000000006 110.593 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.19 -16.56 20.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.74 0.781 . . . . 64.540000000000006 109.794 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' N ' ' HB ' ' A' ' 107' ' ' THR . . . -157.05 174.07 34.65 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.698 -1.761 . . . . 71.109999999999999 108.698 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.03 -47.73 22.52 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.844 2.363 . . . . 41.350000000000001 112.082 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -104.31 -5.07 22.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.565 . . . . 64.209999999999994 110.986 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.409 ' HB ' ' N ' ' A' ' 104' ' ' GLY . 3.8 m -87.61 49.33 1.79 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.767 0.794 . . . . 63.009999999999998 108.865 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 5.7 p30 -94.37 145.08 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 65.140000000000001 111.386 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -129.79 -167.26 12.04 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.013 -1.235 . . . . 64.540000000000006 110.013 175.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 19.5 t -87.47 14.88 7.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 117.94 0.87 . . . . 65.409999999999997 110.016 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 10.1 mm-40 -67.53 145.99 54.37 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.056 -1.09 . . . . 72.409999999999997 108.056 173.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -137.72 166.32 24.25 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.191 -0.603 . . . . 71.239999999999995 111.433 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.51 151.38 28.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.777 -0.647 . . . . 73.329999999999998 110.128 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.712 HG22 HD23 ' A' ' 98' ' ' LEU . 17.5 t -110.39 143.65 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.221 -0.659 . . . . 75.109999999999999 109.221 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.3 p -98.99 126.38 44.67 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.048 0.451 . . . . 63.509999999999998 110.159 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.506 HD21 ' CD1' ' A' ' 62' ' ' ILE . 69.3 mt -83.99 -5.87 59.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.721 -0.672 . . . . 65.430000000000007 110.629 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -146.5 162.01 36.01 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.706 -0.679 . . . . 43.109999999999999 109.829 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 21.6 Cg_endo -61.8 112.91 1.62 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.653 2.235 . . . . 72.140000000000001 112.018 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.418 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.2 p -97.51 102.72 14.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.397 0.618 . . . . 73.530000000000001 111.163 -176.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.52 17.71 23.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.424 0.631 . . . . 72.349999999999994 110.355 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.29 -3.38 9.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 64.010000000000005 111.673 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.1 pp -133.07 8.17 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 74.430000000000007 112.443 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -62.74 -27.48 69.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.007 0.432 . . . . 65.099999999999994 111.021 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -108.34 11.35 36.53 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.723 -0.751 . . . . 44.310000000000002 112.05 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -117.18 -27.46 6.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.489 0.661 . . . . 71.310000000000002 109.56 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.38 130.46 34.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.266 -0.879 . . . . 74.530000000000001 108.68 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.0 t -75.37 143.95 42.55 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.198 -0.601 . . . . 71.239999999999995 110.109 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.506 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.4 mt -122.95 116.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.77 -0.65 . . . . 73.439999999999998 110.501 -173.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' TYR . 59.6 m-85 -151.96 74.13 1.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.998 0.427 . . . . 72.0 110.459 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.664 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.74 155.81 27.27 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.719 -0.753 . . . . 71.140000000000001 112.179 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.432 ' HB2' ' CG ' ' A' ' 26' ' ' GLU . 14.3 mtp180 -135.07 118.91 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.621 -0.511 . . . . 73.400000000000006 109.621 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.432 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 12.0 p -79.96 136.94 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.405 0.622 . . . . 63.210000000000001 110.55 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.676 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 44.1 t -141.8 145.76 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.674 -0.694 . . . . 72.219999999999999 109.693 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.5 tt0 42.75 48.75 4.92 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.483 0.658 . . . . 73.049999999999997 112.363 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' ' HB2' ' A' ' 184' ' ' ASP . . . -172.12 13.58 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.833 -1.175 . . . . 54.43 112.988 175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 184' ' ' ASP . 11.0 tp -73.54 -31.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.874 0.337 . . . . 53.530000000000001 110.238 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.79 -37.38 94.75 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.701 -0.762 . . . . 53.140000000000001 111.203 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.577 ' O ' HG23 ' A' ' 142' ' ' VAL . 69.8 mmm -72.47 -50.66 24.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.85 -0.426 . . . . 72.420000000000002 109.85 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 62' ' ' ILE . 90.1 t -53.91 -30.65 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.054 0.454 . . . . 64.209999999999994 110.83 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -69.91 -52.47 24.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.962 -0.563 . . . . 74.430000000000007 110.612 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.523 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.23 -17.07 60.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.447 -0.342 . . . . 74.230000000000004 111.402 -179.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 138' ' ' MET . 83.9 t -83.47 -34.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 109.957 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.707 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -91.01 -3.74 69.87 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.864 -0.684 . . . . 72.519999999999996 112.619 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.523 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.6 ptm -95.89 -12.2 25.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.728 0.299 . . . . 51.219999999999999 110.954 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 142' ' ' VAL . 21.4 m -83.28 116.39 27.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.504 0.668 . . . . 75.450000000000003 110.397 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.06 -61.76 1.65 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.543 -0.753 . . . . 73.25 111.397 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.1 p -143.68 163.45 33.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.232 0.539 . . . . 53.420000000000002 111.736 -178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -89.42 168.92 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.433 -0.951 . . . . 54.240000000000002 108.433 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.2 m -57.88 -19.11 27.01 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.201 0.815 . . . . 73.200000000000003 113.201 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -84.77 13.55 5.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.956 0.354 . . . . 73.219999999999999 111.956 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 63.52 36.94 10.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.56 0.695 . . . . 75.030000000000001 110.748 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 152.7 75.46 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 72.299999999999997 108.833 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.36 145.3 21.64 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.351 2.034 . . . . 72.0 111.528 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.16 -25.41 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.828 0.347 . . . . 75.319999999999993 110.84 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 81.24 -80.95 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.195 0.813 . . . . 74.540000000000006 113.195 163.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.54 91.38 5.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.013 0.911 . . . . 74.409999999999997 112.652 -170.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 53' ' ' PHE . 3.6 p -145.73 120.07 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.105 -0.952 . . . . 71.400000000000006 109.326 167.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -155.88 176.42 12.65 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.251 -0.886 . . . . 55.039999999999999 110.486 -171.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.3 mp -90.17 109.72 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.456 -0.572 . . . . 74.109999999999999 109.456 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.709 HG22 ' HD3' ' A' ' 161' ' ' LYS . 27.6 mm -75.48 -49.68 26.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.628 -0.715 . . . . 74.430000000000007 110.871 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.709 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.78 140.55 48.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 109.92 178.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.503 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -144.01 134.91 25.28 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.846 0.355 . . . . 74.400000000000006 111.574 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -160.64 151.77 15.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 74.120000000000005 110.375 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 10.3 Cg_exo -70.73 142.23 43.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.832 2.355 . . . . 70.209999999999994 112.483 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.698 ' HB2' ' CD1' ' A' ' 15' ' ' TYR . 46.7 m -160.58 -162.4 0.95 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.383 -0.599 . . . . 62.100000000000001 109.383 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.02 38.96 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.565 -0.826 . . . . 72.349999999999994 112.412 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.37 103.93 2.1 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.676 -0.773 . . . . 75.129999999999995 111.791 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -59.9 129.34 48.03 Favored Glycine 0 C--O 1.236 0.262 0 C-N-CA 121.329 -0.462 . . . . 71.420000000000002 112.473 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -159.41 162.84 33.12 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.922 -0.656 . . . . 61.32 112.045 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.4 m -90.57 -48.44 7.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.922 0.391 . . . . 73.230000000000004 110.204 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 78.3 -64.87 3.43 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.898 -0.592 . . . . 72.510000000000005 112.408 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 105.78 -90.01 0.65 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.171 -0.772 . . . . 74.430000000000007 111.171 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 95.37 163.35 34.42 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.887 -0.673 . . . . 54.140000000000001 112.608 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.6 p -73.46 -36.72 65.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.922 0.391 . . . . 73.549999999999997 111.209 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -135.66 71.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 52.240000000000002 111.897 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.73 -158.77 12.95 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.643 -0.789 . . . . 42.439999999999998 112.413 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.09 -7.95 67.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.122 -0.561 . . . . 50.140000000000001 112.046 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.4 p -80.67 169.06 18.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.62 0.247 . . . . 75.540000000000006 110.982 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.98 135.8 21.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.048 -0.596 . . . . 72.549999999999997 112.483 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.77 60.41 0.26 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.228 -0.51 . . . . 44.049999999999997 111.889 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -116.03 24.63 9.93 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.362 -0.695 . . . . 53.219999999999999 111.362 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.9 m -84.93 139.22 31.99 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.808 0.337 . . . . 52.219999999999999 110.547 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -173.07 142.12 6.53 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.865 -0.684 . . . . 61.509999999999998 112.0 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 136' ' ' ILE . 4.2 m-20 -85.38 -175.25 5.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.123 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 170.08 142.95 3.74 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.719 -0.753 . . . . 61.229999999999997 111.515 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.432 ' HA3' ' CG1' ' A' ' 132' ' ' VAL . . . -82.44 -164.62 35.09 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.261 -0.971 . . . . 75.219999999999999 111.992 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.835 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -77.32 166.95 22.5 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.112 -0.329 . . . . 32.130000000000003 110.112 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.31 95.19 41.92 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-O 121.153 0.502 . . . . 73.0 110.336 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.683 ' HB2' HD13 ' A' ' 90' ' ' LEU . 55.6 Cg_endo -70.77 -19.37 31.41 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.914 2.409 . . . . 71.319999999999993 111.651 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.09 -37.53 66.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.903 -1.044 . . . . 72.099999999999994 111.522 -172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.518 HG13 HG12 ' A' ' 193' ' ' VAL . 30.4 pt -75.14 -13.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.175 -0.466 . . . . 63.130000000000003 111.75 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 90' ' ' LEU . 59.8 m170 63.02 70.29 0.55 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.797 -0.638 . . . . 73.540000000000006 111.231 175.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 191' ' ' ILE . 9.3 p -170.8 140.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 110.003 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.31 117.18 7.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.889 0.376 . . . . 63.009999999999998 111.517 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.35 149.31 11.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.097 -0.705 . . . . 74.129999999999995 109.097 175.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 202' ' ' ARG . 29.0 m-85 -120.2 147.41 44.77 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.744 -0.207 . . . . 75.430000000000007 110.852 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.835 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.4 Cg_endo -63.67 -64.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.527 2.151 . . . . 72.310000000000002 112.025 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.73 26.55 4.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.215 0.531 . . . . 60.119999999999997 109.985 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.51 ' OD1' ' HD3' ' A' ' 202' ' ' ARG . 78.3 m-20 70.08 6.55 5.81 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.225 -0.898 . . . . 74.109999999999999 112.05 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 21.9 ptm -54.24 -34.28 60.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 64.040000000000006 112.198 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -93.96 10.91 71.62 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.358 -0.925 . . . . 72.319999999999993 113.222 -174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.51 ' HD3' ' OD1' ' A' ' 199' ' ' ASP . 4.7 ptm180 -127.21 -39.59 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.138 0.469 . . . . 75.540000000000006 110.501 176.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 203' ' ' LYS . 1.2 ptmm? . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.853 -0.594 . . . . 64.109999999999999 110.124 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 tpp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.859 0.361 . . . . 74.409999999999997 110.265 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.15 91.8 7.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.103 0.478 . . . . 63.140000000000001 110.444 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.18 -36.24 14.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.656 -0.702 . . . . 35.039999999999999 110.273 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 77' ' ' ILE . 31.3 mm -129.7 126.76 22.77 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.171 -0.922 . . . . 64.340000000000003 109.805 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 32.5 Cg_endo -64.41 140.09 68.16 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.565 2.176 . . . . 62.439999999999998 112.303 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 19.0 Cg_exo -66.73 166.23 22.99 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.62 2.213 . . . . 74.329999999999998 111.774 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -53.22 104.43 0.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.11 0.481 . . . . 71.030000000000001 110.91 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.3 m -129.61 -156.55 0.76 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.572 -0.74 . . . . 63.299999999999997 109.525 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -83.6 90.82 7.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.078 0.942 . . . . 61.130000000000003 110.629 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.424 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 2.4 mp0 -100.6 135.47 20.13 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 114.138 -1.392 . . . . 70.400000000000006 109.031 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' CB ' ' HB2' ' A' ' 164' ' ' PRO . 82.2 Cg_exo -46.92 123.03 6.8 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.253 2.635 . . . . 61.219999999999999 113.061 -176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.75 -24.72 15.35 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.972 2.448 . . . . 74.239999999999995 113.279 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.796 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 11.1 t-20 -131.87 146.66 52.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.574 -0.528 . . . . 64.109999999999999 109.574 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.688 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.0 m -131.72 144.17 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.311 0.577 . . . . 73.140000000000001 111.157 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 162' ' ' ALA . 77.0 m-85 -97.71 120.41 38.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.632 -0.713 . . . . 73.230000000000004 110.701 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.7 mt -107.57 103.81 13.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.043 -0.354 . . . . 63.210000000000001 110.043 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 22' ' ' ILE . 29.6 mt-10 -92.18 113.38 25.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.491 -0.559 . . . . 73.420000000000002 109.491 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -103.5 179.26 4.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.162 0.506 . . . . 72.109999999999999 111.534 -172.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.436 ' HB3' HD11 ' A' ' 160' ' ' ILE . 11.5 p -73.62 -18.35 61.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 62.450000000000003 111.176 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.7 mmm -98.65 -35.86 10.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.078 -0.51 . . . . 73.319999999999993 111.201 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA3' ' HE2' ' A' ' 138' ' ' MET . . . -172.4 -133.94 1.72 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.85 -0.691 . . . . 63.210000000000001 111.817 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -141.4 133.83 29.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.075 -0.713 . . . . 54.299999999999997 109.075 178.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -127.76 126.9 67.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.757 -0.656 . . . . 51.520000000000003 109.777 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.72 HG12 HD21 ' A' ' 13' ' ' ASN . 10.9 t -108.44 135.08 48.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.553 -0.536 . . . . 71.430000000000007 109.553 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.24 162.21 39.93 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.346 0.593 . . . . 75.409999999999997 110.621 175.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' HG3' ' HG3' ' A' ' 131' ' ' ARG . 2.7 pt-20 -140.42 164.6 29.68 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.91 -1.041 . . . . 65.530000000000001 109.398 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -100.28 175.37 5.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.891 0.377 . . . . 74.129999999999995 110.826 -171.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 5.3 m-85 -88.92 101.49 14.12 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.31 0.576 . . . . 62.310000000000002 111.052 174.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.563 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.8 OUTLIER -82.21 -2.13 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.261 -0.881 . . . . 74.030000000000001 110.486 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -75.07 -67.5 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 74.519999999999996 111.24 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -117.51 13.08 14.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.961 0.41 . . . . 73.409999999999997 110.782 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -136.91 62.2 39.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.824 0.345 . . . . 62.130000000000003 110.945 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 18.5 Cg_exo -65.99 -50.96 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.591 2.194 . . . . 75.040000000000006 112.091 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -74.02 -35.08 64.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.153 -0.476 . . . . 72.219999999999999 110.401 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.543 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 2.4 m -62.96 -37.6 87.75 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.714 -0.675 . . . . 72.209999999999994 110.08 177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.563 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 25.2 t -63.85 -39.58 94.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.79 -0.641 . . . . 75.209999999999994 110.925 175.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 10.8 mmpt? -63.73 -39.66 94.83 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.831 -0.433 . . . . 73.230000000000004 109.831 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -53.7 -57.51 10.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.698 -0.683 . . . . 72.25 110.133 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.688 ' HE1' HG21 ' A' ' 14' ' ' VAL . 17.3 t80 -59.29 -49.71 76.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 72.219999999999999 110.754 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.99 75.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.391 -0.822 . . . . 62.310000000000002 112.357 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.658 ' OE2' ' HD3' ' A' ' 44' ' ' ARG . 25.9 mm-40 -63.27 -41.93 99.07 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.638 -0.255 . . . . 74.349999999999994 111.602 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.6 mm? -69.29 -27.36 65.34 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.254 -0.578 . . . . 75.530000000000001 110.645 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.0 65.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 72.450000000000003 110.802 177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.658 ' HD3' ' OE2' ' A' ' 41' ' ' GLU . 2.9 ptm180 -75.05 -29.39 60.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.033 -0.531 . . . . 74.310000000000002 111.39 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 1.3 tmt_? -65.23 -37.31 86.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.35 0.595 . . . . 73.319999999999993 109.854 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.5 32.14 2.2 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.587 -0.816 . . . . 65.109999999999999 111.987 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 42' ' ' LEU . 85.0 t80 -85.91 -44.31 12.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.015 0.436 . . . . 64.340000000000003 110.259 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -78.71 -9.27 59.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.057 -0.52 . . . . 75.120000000000005 111.041 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -77.62 8.01 4.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 51.039999999999999 110.402 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.83 16.27 1.98 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.871 -0.604 . . . . 50.409999999999997 111.891 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.68 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -97.95 159.45 14.92 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.707 -0.29 . . . . 64.540000000000006 110.832 -178.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -140.63 146.82 38.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.81 0.338 . . . . 34.32 111.544 -177.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.567 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 65.4 m-85 -78.48 100.91 7.07 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.407 -0.961 . . . . 75.200000000000003 108.407 171.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -109.98 -14.56 14.23 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.471 -0.492 . . . . 74.340000000000003 111.671 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.948 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 12.7 mmm180 -110.03 112.92 25.23 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.092 -0.707 . . . . 53.229999999999997 109.092 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD13 HG23 ' A' ' 62' ' ' ILE . 19.7 mm -124.84 92.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.348 -0.612 . . . . 65.420000000000002 109.348 -171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 10.8 mt -102.0 115.49 43.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 109.652 -0.499 . . . . 65.340000000000003 109.652 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 146' ' ' GLU . 38.7 mtpt -57.13 129.27 41.02 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 123.127 0.267 . . . . 63.149999999999999 111.269 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.99 26.69 16.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.545 -0.752 . . . . 71.409999999999997 110.979 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -128.93 -81.71 0.57 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.086 0.469 . . . . 74.319999999999993 109.976 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -161.04 159.71 29.64 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.66 -0.7 . . . . 73.310000000000002 110.325 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.581 HD11 ' HA3' ' A' ' 143' ' ' GLY . 62.4 mt -128.78 103.48 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 73.439999999999998 109.382 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.948 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 50.9 mt-30 -85.6 124.53 32.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.606 -0.725 . . . . 60.140000000000001 111.526 -176.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.02 139.16 10.74 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.754 -0.657 . . . . 43.119999999999997 112.487 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.68 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 142.96 -154.77 25.58 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.466 -0.873 . . . . 71.25 112.85 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 69' ' ' GLY . 34.1 t0 55.78 102.6 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 C-N-CA 124.355 1.062 . . . . 72.219999999999999 112.714 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' CZ ' ' A' ' 47' ' ' TYR . 88.6 Cg_endo -79.77 -17.16 11.17 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 123.102 2.535 . . . . 75.120000000000005 111.515 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.9 p -90.3 -38.27 13.5 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.787 -0.642 . . . . 54.299999999999997 110.305 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 66' ' ' ASP . . . 78.28 25.85 60.72 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 71.200000000000003 111.359 -176.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.444 ' OG1' ' HG2' ' A' ' 72' ' ' ARG . 76.1 p -97.96 -35.24 10.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.204 0.526 . . . . 72.340000000000003 111.078 -178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.87 -20.85 6.71 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.668 -0.696 . . . . 41.25 112.274 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 7.2 ptm180 -93.57 -28.0 16.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.028 0.442 . . . . 75.219999999999999 110.934 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.76 -179.52 53.01 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.7 -0.762 . . . . 51.240000000000002 111.831 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' HA3' ' HE1' ' A' ' 47' ' ' TYR . . . -79.74 -87.52 0.54 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.861 -0.685 . . . . 63.310000000000002 112.371 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.44 27.07 4.61 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.845 0.831 . . . . 63.539999999999999 111.228 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -85.99 16.39 4.23 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.041 -0.981 . . . . 52.200000000000003 111.754 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.591 HG13 ' HD1' ' A' ' 78' ' ' TYR . 46.4 pt -81.85 -29.53 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.715 -0.394 . . . . 71.310000000000002 110.143 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.591 ' HD1' HG13 ' A' ' 77' ' ' ILE . 2.9 p90 -117.95 14.05 14.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.924 0.868 . . . . 74.510000000000005 110.521 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -77.06 1.81 Allowed Glycine 0 C--N 1.318 -0.441 0 CA-C-N 114.59 -1.186 . . . . 72.430000000000007 113.425 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -111.98 -163.85 0.88 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.272 -0.27 . . . . 70.530000000000001 110.272 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' H ' ' CD ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -86.61 168.0 14.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.647 . . . . 73.129999999999995 109.252 173.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -98.88 -80.1 0.47 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.77 -0.372 . . . . 75.010000000000005 111.308 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.51 163.57 27.38 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.964 -0.754 . . . . 71.0 108.964 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.34 143.66 34.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.093 0.473 . . . . 74.430000000000007 109.756 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 23.8 7.13 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.75 -0.659 . . . . 74.129999999999995 109.604 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.401 HD23 ' OG1' ' A' ' 127' ' ' THR . 78.2 mt -54.51 100.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.52 -0.764 . . . . 71.200000000000003 111.648 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -171.61 91.33 0.43 Allowed Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.39 -0.823 . . . . 71.400000000000006 109.412 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' C ' ' H ' ' A' ' 90' ' ' LEU . 19.2 Cg_endo -57.6 92.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.611 2.207 . . . . 44.420000000000002 111.071 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -86.28 23.3 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.145 0.974 . . . . 75.510000000000005 109.146 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -145.3 -176.88 5.28 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.361 -1.29 . . . . 73.439999999999998 108.625 -178.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.426 ' HD3' HG22 ' A' ' 93' ' ' THR . 54.2 tttm -113.61 147.88 37.24 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.324 0.583 . . . . 62.439999999999998 110.938 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.24 79.99 4.67 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.091 0.948 . . . . 74.329999999999998 108.481 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.426 HG22 ' HD3' ' A' ' 91' ' ' LYS . 26.8 p -75.65 -41.95 52.69 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.612 -1.176 . . . . 74.319999999999993 111.838 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.795 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -168.83 -137.79 2.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.658 -0.782 . . . . 74.049999999999997 112.293 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.77 147.29 24.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.815 0.341 . . . . 40.210000000000001 110.891 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 106.41 21.95 8.08 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.446 -0.662 . . . . 75.109999999999999 111.446 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 mm -90.03 110.9 22.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.479 -0.563 . . . . 72.140000000000001 109.479 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.964 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -85.89 117.77 24.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.76 -0.654 . . . . 73.209999999999994 109.538 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.0 169.81 12.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.125 0.488 . . . . 52.030000000000001 111.854 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.845 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 14.0 tpt -90.45 135.4 33.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.412 -0.813 . . . . 75.239999999999995 109.983 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -97.86 149.33 22.49 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.522 -0.548 . . . . 74.200000000000003 109.522 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 3.1 p-10 -163.11 159.26 22.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.231 -0.44 . . . . 73.109999999999999 110.7 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.74 -34.39 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.627 0.727 . . . . 73.439999999999998 109.814 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -137.31 177.76 19.56 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 108.988 -1.645 . . . . 64.430000000000007 108.988 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 -51.84 9.72 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.021 2.481 . . . . 55.310000000000002 112.86 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.7 -4.83 29.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 71.140000000000001 111.59 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 104' ' ' GLY . 2.2 m -88.81 49.68 1.83 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.327 0.584 . . . . 72.549999999999997 109.469 -175.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.676 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -74.27 -66.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.806 -1.088 . . . . 51.509999999999998 110.944 178.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.12 -100.77 2.14 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.625 -0.797 . . . . 71.25 112.343 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -152.87 35.94 0.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.012 0.434 . . . . 61.409999999999997 110.81 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 19.9 mt-30 -102.54 146.56 27.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 74.510000000000005 110.186 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -142.44 166.9 23.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.711 0.291 . . . . 61.229999999999997 110.795 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -158.59 153.23 24.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.926 0.393 . . . . 74.409999999999997 111.004 175.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.718 HG22 HD23 ' A' ' 98' ' ' LEU . 17.7 t -108.62 145.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.265 -0.642 . . . . 72.219999999999999 109.265 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.6 p -99.88 129.67 45.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.897 0.379 . . . . 54.439999999999998 110.452 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD21 ' CD1' ' A' ' 62' ' ' ILE . 64.7 mt -84.79 -9.63 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.644 -0.707 . . . . 74.120000000000005 110.984 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.32 164.18 28.03 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.9 -0.591 . . . . 62.399999999999999 110.054 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.795 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 35.5 Cg_exo -60.98 114.52 2.2 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.454 2.103 . . . . 62.140000000000001 111.493 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.7 p -100.12 94.56 6.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.277 0.561 . . . . 74.549999999999997 111.189 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -98.11 14.56 27.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.645 0.736 . . . . 72.109999999999999 110.104 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.59 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 2.6 p90 -118.29 -3.36 11.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.026 -0.988 . . . . 73.450000000000003 110.495 -175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.601 HD22 ' HD2' ' A' ' 126' ' ' HIS . 83.5 mt -105.06 8.82 34.44 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.792 -0.64 . . . . 74.209999999999994 109.608 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.1 -23.58 55.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.064 -1.425 . . . . 75.140000000000001 111.315 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.29 23.22 3.49 Favored Glycine 0 CA--C 1.508 -0.398 0 C-N-CA 120.874 -0.679 . . . . 72.400000000000006 111.983 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.45 -32.95 3.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.936 0.398 . . . . 72.209999999999994 110.279 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.601 ' HD2' HD22 ' A' ' 122' ' ' LEU . 96.9 m-70 -141.24 139.53 33.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 110.322 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 86' ' ' LEU . 23.7 m -75.46 135.98 40.68 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.777 -0.453 . . . . 61.329999999999998 109.777 175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.8 mt -115.46 124.75 72.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 121.058 -0.257 . . . . 74.25 110.828 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.845 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 3.8 p90 -157.4 74.07 0.75 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.949 0.88 . . . . 65.209999999999994 110.932 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.964 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.83 152.39 22.55 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.01 -1.567 . . . . 74.120000000000005 113.841 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.631 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -138.62 110.2 7.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.133 0.492 . . . . 74.549999999999997 109.726 174.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.9 p -79.93 139.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.497 -0.774 . . . . 44.439999999999998 111.264 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.633 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.1 t -142.47 151.71 42.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.096 -0.502 . . . . 51.219999999999999 109.892 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 42.42 60.07 2.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.258 0.623 . . . . 73.209999999999994 112.15 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.54 24.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.035 -1.079 . . . . 71.230000000000004 112.883 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -78.02 -32.51 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 110.109 -0.33 . . . . 73.549999999999997 110.109 -176.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.46 -37.35 94.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.949 -0.644 . . . . 64.25 111.934 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.502 ' HE2' ' HA3' ' A' ' 21' ' ' GLY . 74.9 mmm -67.02 -51.1 59.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.511 -0.551 . . . . 53.420000000000002 109.511 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 62' ' ' ILE . 74.8 t -54.21 -32.92 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.241 0.543 . . . . 64.099999999999994 110.586 175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 144' ' ' MET . 2.8 t30 -71.29 -56.08 6.75 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.733 -0.667 . . . . 60.020000000000003 110.656 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.8 -13.8 61.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.463 -0.335 . . . . 70.349999999999994 111.307 -176.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 145' ' ' VAL . 44.6 t -88.82 -36.62 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 63.25 110.505 175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.581 ' HA3' HD11 ' A' ' 62' ' ' ILE . . . -83.52 -18.98 62.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 72.120000000000005 113.2 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 60.5 mtp -89.87 -8.76 51.19 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.2 0.444 . . . . 73.25 112.2 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.1 m -87.09 160.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.529 -0.468 . . . . 52.240000000000002 110.737 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.666 ' HB3' ' HD2' ' A' ' 58' ' ' LYS . 15.2 pt-20 -141.93 -49.82 0.39 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.141 -0.481 . . . . 63.149999999999999 110.583 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 16.8 p -119.04 146.02 45.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.751 0.31 . . . . 64.010000000000005 111.156 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 154' ' ' VAL . 32.1 p-10 -92.56 -32.52 14.79 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.329 0.492 . . . . 65.340000000000003 112.329 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 26.6 m -147.06 -67.37 0.26 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.984 0.421 . . . . 72.450000000000003 110.226 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' A' ' 147' ' ' THR . 28.9 mm-40 -101.8 -157.01 0.58 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.892 -0.781 . . . . 64.120000000000005 108.892 174.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.6 59.7 2.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.077 0.942 . . . . 74.430000000000007 109.72 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.545 ' HG3' ' OD1' ' A' ' 148' ' ' ASN . 12.2 ptp180 -138.72 135.51 17.9 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 114.302 -1.317 . . . . 62.219999999999999 108.735 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.6 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 16.8 Cg_exo -65.4 149.03 88.53 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.643 2.229 . . . . 65.540000000000006 113.671 -171.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 148' ' ' ASN . 40.7 t -65.63 151.47 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.433 -0.803 . . . . 73.310000000000002 110.191 175.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.64 137.59 48.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.302 -0.408 . . . . 54.229999999999997 110.014 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -71.74 145.85 48.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.54 -0.541 . . . . 61.329999999999998 109.54 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -96.99 125.93 49.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.057 -0.52 . . . . 61.299999999999997 110.644 -173.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.74 ' HB3' ' HB3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -113.95 159.37 19.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.265 0.555 . . . . 64.519999999999996 111.443 -177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 162' ' ' ALA . 4.3 mp -87.74 102.4 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.644 -1.162 . . . . 50.439999999999998 108.494 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 19' ' ' SER . 30.7 mm -68.21 -56.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.537 -0.756 . . . . 74.409999999999997 110.009 -176.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 14.5 mptt -127.4 136.97 52.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.875 -0.602 . . . . 72.299999999999997 109.998 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.425 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.81 115.96 15.12 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.939 0.399 . . . . 70.230000000000004 110.385 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.62 116.3 26.59 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.791 -0.64 . . . . 72.0 110.918 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 14' ' ' VAL . 56.8 Cg_endo -73.02 126.91 11.62 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.172 1.915 . . . . 73.409999999999997 111.413 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.7 m -158.86 -80.78 0.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 64.439999999999998 111.339 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.796 ' HA2' ' HB3' ' A' ' 13' ' ' ASN . . . 132.8 161.44 9.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.914 -0.66 . . . . 65.230000000000004 111.477 -175.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -149.09 -69.79 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.57 -0.824 . . . . 30.199999999999999 112.506 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.87 -83.03 0.94 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.694 -0.765 . . . . 60.119999999999997 112.388 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 171.85 152.86 8.7 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.698 . . . . 64.329999999999998 112.098 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.2 m -106.95 -35.16 6.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 55.350000000000001 110.166 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 103.78 -124.96 8.26 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.865 -0.607 . . . . 75.030000000000001 112.339 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 65.6 -131.51 34.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 121.019 -0.61 . . . . 71.430000000000007 112.032 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.56 -63.86 2.23 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.756 -0.735 . . . . 63.119999999999997 112.601 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.0 p 50.31 91.41 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.607 0.763 . . . . 74.310000000000002 112.058 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -149.32 134.01 4.72 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.852 -0.689 . . . . 55.210000000000001 112.006 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.32 123.87 6.32 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.796 -0.716 . . . . 74.319999999999993 111.678 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 103.46 -113.38 4.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.898 -0.668 . . . . 73.530000000000001 111.987 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 12.1 t -84.93 132.59 34.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.797 0.332 . . . . 74.340000000000003 110.168 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.08 145.78 38.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.67 -0.776 . . . . 70.010000000000005 111.996 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.73 153.88 22.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.837 -0.697 . . . . 74.120000000000005 111.898 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.82 -44.44 3.63 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.716 -0.754 . . . . 25.219999999999999 111.841 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.5 m 64.4 12.16 7.08 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.971 0.509 . . . . 64.129999999999995 111.871 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -165.04 171.91 40.55 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.111 -0.566 . . . . 51.240000000000002 112.082 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.93 -173.8 2.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.324 0.583 . . . . 74.319999999999993 111.454 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 162.24 145.53 4.36 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.118 -0.947 . . . . 62.340000000000003 111.188 178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -77.49 -161.77 15.64 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.549 -0.834 . . . . 72.510000000000005 112.065 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.721 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -83.92 -177.12 6.58 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 110.326 -0.25 . . . . 40.399999999999999 110.326 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.86 91.96 28.27 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 109.648 -0.501 . . . . 64.230000000000004 109.648 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.6 Cg_exo -78.67 -12.18 15.18 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.899 2.4 . . . . 73.200000000000003 112.148 -175.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.88 -36.51 70.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.95 -0.568 . . . . 71.349999999999994 109.997 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.2 pt -88.07 156.15 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.98 -0.748 . . . . 73.030000000000001 108.98 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -105.32 89.06 3.01 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.374 -0.53 . . . . 73.340000000000003 110.291 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 194' ' ' ALA . 9.7 p -163.92 170.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.83 -0.804 . . . . 71.310000000000002 108.83 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 193' ' ' VAL . . . -94.9 115.72 27.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.865 0.364 . . . . 71.420000000000002 111.05 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.655 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -144.18 153.27 41.93 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.449 -0.945 . . . . 75.219999999999999 108.449 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -128.98 139.03 34.5 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.79 0.329 . . . . 75.349999999999994 111.034 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 31.8 Cg_endo -63.26 -54.13 1.19 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.713 2.275 . . . . 74.209999999999994 112.06 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.48 35.31 0.96 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.455 -0.339 . . . . 62.329999999999998 111.457 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.546 ' OD2' ' HD3' ' A' ' 202' ' ' ARG . 7.4 t70 75.77 -14.05 0.82 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.074 0.55 . . . . 64.400000000000006 111.66 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.5 ptm -46.1 -29.93 1.71 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.877 1.066 . . . . 72.200000000000003 113.877 -172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -111.09 10.72 29.23 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.095 -1.05 . . . . 72.340000000000003 113.254 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.546 ' HD3' ' OD2' ' A' ' 199' ' ' ASP . 44.0 mtp180 -72.43 -38.42 68.34 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 117.62 0.71 . . . . 70.239999999999995 111.91 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 203' ' ' LYS . 3.7 mppt? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.747 -0.645 . . . . 75.439999999999998 110.633 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.078 0.466 . . . . 72.230000000000004 110.022 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.14 160.77 14.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.976 -0.556 . . . . 50.299999999999997 110.354 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.04 131.81 55.2 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.17 -0.468 . . . . 74.150000000000006 110.672 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.455 HD13 HG12 ' A' ' 77' ' ' ILE . 71.7 mt 70.0 99.27 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 O-C-N 123.911 0.757 . . . . 65.219999999999999 111.296 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -89.34 132.03 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.041 2.494 . . . . 71.299999999999997 113.034 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' HG3' ' HD2' ' A' ' 37' ' ' LYS . 62.8 Cg_endo -78.38 -41.69 0.26 Allowed 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.628 2.219 . . . . 74.140000000000001 112.528 176.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 57.09 -95.57 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.312 0.645 . . . . 73.420000000000002 112.653 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.1 m -76.89 -26.66 54.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 63.310000000000002 111.689 -173.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.473 ' O ' ' HB2' ' A' ' 6' ' ' PRO . 1.8 t-105 -105.31 113.8 27.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.054 0.454 . . . . 75.129999999999995 110.506 -176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.8 93.64 4.81 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.658 -0.701 . . . . 62.340000000000003 110.743 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 4.2 Cg_endo -86.64 113.33 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.696 2.93 . . . . 53.210000000000001 113.068 -177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 6.2 Cg_exo -75.15 -44.85 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.811 2.341 . . . . 62.439999999999998 112.263 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.543 HD21 HG12 ' A' ' 24' ' ' VAL . 11.6 t-20 -124.88 144.39 50.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 72.329999999999998 110.458 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.79 HG21 ' HE1' ' A' ' 39' ' ' PHE . 22.4 m -133.23 162.91 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.391 -0.368 . . . . 64.109999999999999 110.394 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -122.33 134.86 54.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.064 0.459 . . . . 74.310000000000002 110.376 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.4 mt -111.87 107.98 17.2 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 71.109999999999999 109.391 176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -92.24 119.46 31.87 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.428 -0.582 . . . . 63.210000000000001 109.428 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.402 HG22 HG13 ' A' ' 159' ' ' ILE . 69.1 p -109.07 178.3 4.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.141 0.496 . . . . 71.25 110.986 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 t -67.27 -15.89 63.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 73.340000000000003 110.442 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.587 ' HG3' HG22 ' A' ' 142' ' ' VAL . 5.7 mmt -95.55 -34.62 11.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.007 -178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.18 -130.79 1.87 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.086 -0.806 . . . . 63.240000000000002 111.086 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.72 136.51 45.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.236 0.541 . . . . 64.230000000000004 110.486 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.96 114.13 37.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.429 -0.805 . . . . 65.230000000000004 109.767 176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 41.3 t -96.4 141.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.839 -0.619 . . . . 75.230000000000004 109.374 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.1 163.79 36.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.137 0.494 . . . . 65.200000000000003 111.015 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HB3' HD22 ' A' ' 13' ' ' ASN . 11.2 pt-20 -134.17 162.92 30.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.505 -0.77 . . . . 71.239999999999995 109.892 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.38 166.04 10.67 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.764 -0.653 . . . . 72.099999999999994 109.394 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HE1' ' HG3' ' A' ' 131' ' ' ARG . 5.3 m-85 -85.75 93.5 8.88 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 74.010000000000005 111.702 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.845 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -79.47 -8.75 59.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.743 0.782 . . . . 70.209999999999994 109.343 177.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HE2' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -70.34 -45.01 67.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.384 -1.28 . . . . 73.230000000000004 111.658 -173.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -137.86 8.61 2.79 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.807 0.299 . . . . 71.310000000000002 111.807 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.22 67.27 10.69 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.835 0.679 . . . . 60.399999999999999 112.835 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.49 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 21.3 Cg_exo -65.54 -27.4 53.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.025 1.817 . . . . 43.310000000000002 110.996 173.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 tttm -62.87 -59.48 4.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 64.310000000000002 110.892 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -62.67 -36.34 82.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.888 -0.597 . . . . 75.319999999999993 110.208 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.845 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 39.5 t -53.73 -53.47 51.71 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.238 -0.892 . . . . 70.209999999999994 111.278 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.63 ' HD2' ' HG3' ' A' ' 6' ' ' PRO . 3.0 mtmp? -69.88 -27.28 64.68 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.789 -0.364 . . . . 74.420000000000002 111.666 -173.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' O ' HD23 ' A' ' 42' ' ' LEU . 59.8 t30 -59.48 -49.83 76.29 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.489 -0.56 . . . . 64.299999999999997 109.489 177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.79 ' HE1' HG21 ' A' ' 14' ' ' VAL . 12.3 t80 -68.81 -51.33 41.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.037 0.446 . . . . 75.230000000000004 109.852 176.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -55.54 -44.86 77.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.741 . . . . 63.439999999999998 112.985 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 43.4 mt-10 -77.77 -26.59 49.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 121.126 -0.229 . . . . 72.109999999999999 111.572 -175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 38' ' ' ASN . 3.2 mm? -78.99 -20.88 47.99 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.788 -0.765 . . . . 72.030000000000001 110.428 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.38 -44.31 36.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 110.951 176.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.711 ' HG2' ' HA ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -62.98 -36.76 84.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.629 -0.26 . . . . 71.349999999999994 111.314 179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.2 ttt85 -72.77 -46.93 50.76 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.203 -0.599 . . . . 74.310000000000002 109.423 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.33 42.83 1.03 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.522 -0.847 . . . . 72.209999999999994 113.46 171.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HD1' ' HG3' ' A' ' 67' ' ' PRO . 1.2 m-85 -77.45 -15.95 59.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.119 0.485 . . . . 73.319999999999993 110.405 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -84.82 0.27 51.44 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.761 -0.654 . . . . 62.439999999999998 111.001 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' A' ' 161' ' ' LYS . 48.7 m-80 -81.81 2.95 27.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 109.868 175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -134.71 14.05 4.45 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.002 -0.618 . . . . 64.329999999999998 112.176 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.6 p -88.83 149.22 23.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.661 0.267 . . . . 54.210000000000001 110.46 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -138.65 128.42 25.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.553 -0.294 . . . . 71.239999999999995 110.556 -176.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 61.0 m-85 -67.07 110.74 3.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.97 -0.752 . . . . 75.400000000000006 108.97 175.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -111.86 -18.48 12.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.835 -0.346 . . . . 74.319999999999993 111.133 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.5 mmt85 -110.34 105.27 14.22 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.523 -0.547 . . . . 74.120000000000005 109.523 173.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.16 91.2 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.907 -0.775 . . . . 71.319999999999993 108.907 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 21.1 mt -102.8 119.34 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.739 -0.664 . . . . 73.439999999999998 109.262 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -52.02 139.25 23.24 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 123.446 0.466 . . . . 55.509999999999998 110.219 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 44.21 33.79 0.89 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.384 1.052 . . . . 75.340000000000003 112.6 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 2.2 t80 -131.54 -82.92 0.51 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.385 0.612 . . . . 71.0 110.213 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.539 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.2 ptm -159.76 156.59 27.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.43 -0.804 . . . . 62.43 110.812 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.543 ' CD1' HD21 ' A' ' 116' ' ' LEU . 43.1 mt -129.37 103.26 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.519 -0.764 . . . . 73.400000000000006 108.943 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 42.7 tt0 -87.93 124.61 33.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.764 -0.653 . . . . 74.219999999999999 111.835 -173.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -87.79 113.57 4.03 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.061 -0.815 . . . . 44.439999999999998 111.061 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.8 157.61 43.83 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.706 -0.283 . . . . 74.109999999999999 112.667 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.66 156.56 90.61 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 123.804 0.355 . . . . 72.209999999999994 111.492 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.692 ' HG3' ' HD1' ' A' ' 47' ' ' TYR . 23.7 Cg_endo -58.71 -21.86 58.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.723 2.949 . . . . 70.120000000000005 113.521 -175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -86.66 -30.43 21.73 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.644 -0.502 . . . . 73.209999999999994 109.644 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.03 15.94 71.08 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.725 -0.75 . . . . 75.010000000000005 111.642 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.3 p -88.56 -32.14 18.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.56 0.695 . . . . 71.120000000000005 109.401 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.1 46.65 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.881 -1.054 . . . . 52.509999999999998 111.674 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -119.83 -2.97 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.761 0.282 . . . . 63.130000000000003 111.761 -177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.75 -155.3 11.68 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.607 -0.806 . . . . 74.099999999999994 112.557 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.4 167.65 42.99 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.337 -0.935 . . . . 74.439999999999998 111.639 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HB1' ' HE1' ' A' ' 78' ' ' TYR . . . 55.2 -96.46 0.06 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.785 0.434 . . . . 71.150000000000006 110.925 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.4 m 69.07 -31.79 0.21 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.86 0.864 . . . . 75.430000000000007 113.126 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.455 HG12 HD13 ' A' ' 4' ' ' ILE . 5.9 tt -55.84 -42.76 71.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.575 0.583 . . . . 64.120000000000005 112.575 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.571 ' HE1' ' HB1' ' A' ' 75' ' ' ALA . 13.8 p90 -95.97 10.59 36.86 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.421 0.629 . . . . 75.140000000000001 110.774 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 112.3 -104.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 112.336 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.484 ' HB2' ' HE3' ' A' ' 80' ' ' LYS . 39.5 mtmt -125.68 -162.05 1.09 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.317 -0.623 . . . . 74.420000000000002 109.317 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -66.57 157.13 33.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.901 -0.778 . . . . 74.409999999999997 108.901 174.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -117.57 -54.24 2.37 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.646 -0.421 . . . . 73.310000000000002 111.417 -169.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -166.61 -175.87 3.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.437 -0.579 . . . . 74.099999999999994 109.437 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -83.93 132.31 34.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.007 0.432 . . . . 71.140000000000001 110.037 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB2' HG21 ' A' ' 127' ' ' THR . 35.2 mm-40 -96.93 8.76 43.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.787 -0.642 . . . . 63.009999999999998 109.671 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.6 mt -61.21 105.63 0.52 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.84 -0.618 . . . . 72.319999999999993 111.893 -171.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -163.2 80.97 1.58 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 71.109999999999999 109.571 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.05 88.32 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.012 1.808 . . . . 63.509999999999998 111.578 174.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.7 -18.69 37.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.112 0.958 . . . . 74.430000000000007 109.377 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 189' ' ' PRO . 3.7 pp -101.18 -178.84 3.86 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.52 -1.218 . . . . 63.32 108.75 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -138.35 147.78 43.86 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.121 -0.632 . . . . 73.409999999999997 110.416 171.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 120' ' ' GLN . 1.2 p90 -62.8 109.38 1.42 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.801 0.81 . . . . 71.010000000000005 110.726 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -99.26 -44.99 6.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.228 -0.896 . . . . 52.43 110.428 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.66 -139.25 2.77 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.725 -0.75 . . . . 72.340000000000003 112.389 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.12 145.6 26.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.63 0.253 . . . . 63.200000000000003 110.687 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.66 22.26 7.45 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.648 -0.787 . . . . 71.340000000000003 111.618 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HG3' ' A' ' 189' ' ' PRO . 9.9 mm -84.76 109.68 18.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.214 -0.662 . . . . 74.299999999999997 109.214 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.1 tm? -84.87 115.18 22.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.006 -0.543 . . . . 73.109999999999999 109.569 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -128.79 176.84 7.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.976 -0.556 . . . . 70.310000000000002 110.855 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.402 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 26.7 ttt -104.19 142.07 35.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 72.409999999999997 111.145 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB3' ' CB ' ' A' ' 111' ' ' GLN . . . -97.97 141.89 30.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.09 0.471 . . . . 71.010000000000005 110.174 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -157.78 160.6 37.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.738 -0.665 . . . . 74.400000000000006 110.132 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.73 -9.02 25.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.613 0.721 . . . . 54.329999999999998 110.333 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -165.99 169.38 40.23 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 109.107 -1.597 . . . . 70.230000000000004 109.107 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.18 -42.49 46.59 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.098 2.532 . . . . 72.010000000000005 112.794 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -103.03 -5.45 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 64.409999999999997 111.806 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -84.94 48.4 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.432 0.634 . . . . 63.140000000000001 110.061 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -89.73 121.54 31.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.892 . . . . 73.109999999999999 109.712 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -112.01 -94.79 2.21 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.659 -0.781 . . . . 43.329999999999998 112.452 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 18.0 t -140.87 6.92 2.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.377 0.608 . . . . 74.409999999999997 109.999 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 19.4 mp0 -81.02 143.91 32.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.696 -0.684 . . . . 74.099999999999994 110.363 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 36.6 m-85 -144.24 162.32 36.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.369 -0.234 . . . . 74.239999999999995 110.369 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 63' ' ' GLN . 41.9 p90 -154.02 157.21 38.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 70.099999999999994 111.148 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.693 HG22 HD23 ' A' ' 98' ' ' LEU . 18.2 t -112.11 145.88 17.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.928 -0.578 . . . . 71.310000000000002 109.444 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 p -99.52 130.38 45.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.952 0.406 . . . . 64.019999999999996 110.141 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.543 HD21 ' CD1' ' A' ' 62' ' ' ILE . 59.5 mt -84.46 -7.1 59.39 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 51.229999999999997 110.775 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -154.39 163.35 24.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.572 -0.74 . . . . 34.32 109.929 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.25 113.12 2.75 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.602 2.201 . . . . 73.409999999999997 112.203 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.1 p -103.08 110.66 22.67 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 72.519999999999996 110.393 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' CE2' ' A' ' 92' ' ' PHE . 1.1 pp0? -99.59 15.82 25.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.332 0.587 . . . . 75.430000000000007 110.82 -170.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.591 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 1.4 p90 -121.32 -2.65 9.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.467 -0.788 . . . . 74.129999999999995 110.89 -175.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.591 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 94.8 mt -102.97 7.93 39.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 43.539999999999999 110.475 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -65.89 -15.38 62.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.045 -0.98 . . . . 52.200000000000003 111.74 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.39 19.69 3.8 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.805 -0.712 . . . . 22.210000000000001 111.695 178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -121.04 -28.8 4.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.266 0.555 . . . . 52.350000000000001 109.958 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.499 ' HD2' HD22 ' A' ' 122' ' ' LEU . 93.5 m-70 -138.64 144.55 39.75 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.489 -0.778 . . . . 73.409999999999997 109.376 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.407 HG21 ' HB2' ' A' ' 85' ' ' GLU . 14.5 t -85.37 145.19 27.61 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.398 -0.593 . . . . 75.140000000000001 109.398 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' A' ' 99' ' ' ALA . 31.4 mt -126.06 116.14 44.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.349 -0.387 . . . . 71.239999999999995 110.751 -176.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -154.41 74.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.456 0.472 . . . . 74.109999999999999 110.863 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.739 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.35 157.35 29.23 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.24 -0.981 . . . . 52.100000000000001 112.882 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.483 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 30.5 mtp180 -137.89 118.88 14.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.979 -0.378 . . . . 74.450000000000003 109.979 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 96' ' ' GLY . 7.5 p -81.76 138.36 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 54.119999999999997 110.411 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.603 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 49.3 t -143.23 142.85 31.52 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.034 -0.53 . . . . 52.439999999999998 110.132 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.7 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 6.6 tt0 54.23 35.99 23.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.345 0.593 . . . . 61.140000000000001 112.035 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.12 29.41 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.236 -0.983 . . . . 75.109999999999999 112.565 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.7 tp -83.39 -30.33 8.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.05 0.452 . . . . 73.340000000000003 110.121 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.03 -31.65 81.59 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.917 -0.659 . . . . 60.009999999999998 111.586 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.439 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.1 mmm -72.18 -49.35 36.29 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.486 -0.561 . . . . 72.319999999999993 109.486 178.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.476 HG13 HD12 ' A' ' 62' ' ' ILE . 61.8 t -55.0 -31.82 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.196 0.522 . . . . 75.310000000000002 110.508 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.04 -52.41 24.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.867 -0.606 . . . . 54.049999999999997 110.638 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -15.23 61.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.397 -0.365 . . . . 74.430000000000007 111.394 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 145' ' ' VAL . 53.7 t -86.58 -38.82 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.31 -0.405 . . . . 74.530000000000001 110.555 174.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.83 -12.68 68.31 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.641 -0.79 . . . . 73.239999999999995 112.831 -176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.2 ptm -82.0 -17.17 47.79 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.622 -0.34 . . . . 73.409999999999997 110.806 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 142' ' ' VAL . 19.2 m -77.88 162.63 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.675 -0.41 . . . . 74.010000000000005 110.798 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.93 -61.73 0.46 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.088 -0.506 . . . . 72.209999999999994 111.041 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 150' ' ' GLN . 17.2 p -130.68 147.35 52.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.11 0.481 . . . . 52.350000000000001 111.663 -176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -97.81 100.49 11.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.734 -0.666 . . . . 71.409999999999997 110.869 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 48.3 t 69.36 -67.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.771 0.669 . . . . 63.130000000000003 111.41 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.527 ' O ' ' HB ' ' A' ' 147' ' ' THR . 0.1 OUTLIER -90.94 -177.13 4.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.932 -0.766 . . . . 52.109999999999999 108.932 176.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.14 53.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.577 0.703 . . . . 75.340000000000003 110.516 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 152' ' ' ARG . 12.4 ptm85 -122.21 130.9 24.51 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 114.915 -1.039 . . . . 71.109999999999999 108.766 176.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.81 141.72 92.53 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.653 2.235 . . . . 74.019999999999996 112.219 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.0 t -61.39 150.23 7.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 71.510000000000005 109.671 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.24 173.99 10.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.33 0.586 . . . . 61.109999999999999 111.652 -174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.8 130.87 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 71.230000000000004 112.589 -172.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.44 110.96 28.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.99 -1.115 . . . . 70.120000000000005 107.99 170.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -117.41 155.91 28.82 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.363 -0.535 . . . . 72.209999999999994 111.427 -168.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.4 mp -85.13 109.52 18.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.801 -1.091 . . . . 64.450000000000003 109.391 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.535 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.4 mm -71.49 -49.98 43.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.478 -0.783 . . . . 62.229999999999997 110.497 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.535 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -132.93 130.34 39.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.824 -0.625 . . . . 74.340000000000003 110.758 178.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.541 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -133.31 112.71 11.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.84 0.352 . . . . 21.510000000000002 110.537 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -142.15 152.35 61.14 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.64 -0.709 . . . . 64.25 110.032 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 14' ' ' VAL . 30.9 Cg_endo -67.24 131.7 25.74 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.374 2.049 . . . . 64.219999999999999 111.984 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.4 ' H ' ' HA ' ' A' ' 14' ' ' VAL . 32.4 t -107.59 1.62 23.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.973 0.416 . . . . 72.140000000000001 110.692 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.42 -78.35 2.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.747 -0.739 . . . . 13.41 111.829 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.76 -155.08 16.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.748 -0.739 . . . . 63.43 112.442 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.08 -106.92 3.27 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.012 -0.613 . . . . 64.200000000000003 111.885 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.31 176.49 15.17 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.892 -0.67 . . . . 25.309999999999999 112.091 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.0 t -156.21 104.44 2.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.868 -0.419 . . . . 74.400000000000006 109.868 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 145.64 -134.86 5.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.763 -0.732 . . . . 63.450000000000003 112.073 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 96.21 159.74 32.31 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.916 -0.659 . . . . 74.019999999999996 111.906 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.53 167.61 13.4 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.787 -0.721 . . . . 73.109999999999999 111.998 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.3 m -128.08 111.92 14.02 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.892 -0.41 . . . . 52.520000000000003 109.892 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.35 169.01 22.25 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.952 -0.642 . . . . 65.120000000000005 112.643 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.48 49.53 0.84 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.156 -0.545 . . . . 64.239999999999995 111.878 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -161.11 169.77 36.77 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 121.078 -0.582 . . . . 23.199999999999999 111.674 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.2 p -75.52 138.77 41.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.58 0.229 . . . . 62.420000000000002 110.679 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.78 -105.31 2.91 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.757 -0.735 . . . . 75.409999999999997 111.909 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 80.91 -86.75 1.35 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.038 -0.601 . . . . 74.420000000000002 111.872 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 179.38 69.21 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.772 -0.728 . . . . 72.030000000000001 112.269 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.9 t -107.99 107.75 18.57 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.853 -0.795 . . . . 71.409999999999997 108.853 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -99.4 -128.95 6.39 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.746 -0.74 . . . . 54.240000000000002 112.309 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.7 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -100.19 178.0 4.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.329 0.585 . . . . 55.140000000000001 110.991 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 142.3 135.74 3.13 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 114.968 -1.014 . . . . 61.32 110.879 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.16 -176.7 51.42 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 120.265 -0.969 . . . . 70.299999999999997 111.775 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.809 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.44 145.52 47.55 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.691 -0.485 . . . . 64.230000000000004 109.691 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 189' ' ' PRO . 98.3 m-85 -97.81 105.06 24.58 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-O 121.182 0.515 . . . . 61.350000000000001 110.368 -174.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.71 ' HB2' HD13 ' A' ' 90' ' ' LEU . 5.6 Cg_endo -83.58 -7.44 10.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.215 2.61 . . . . 71.420000000000002 111.313 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.06 -35.05 20.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.105 -0.952 . . . . 71.329999999999998 110.789 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 193' ' ' VAL . 21.4 pt -74.63 -13.25 15.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.8 -0.636 . . . . 64.310000000000002 110.483 -178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 47.3 m170 61.59 54.96 2.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.835 -1.075 . . . . 54.43 111.236 173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.561 HG12 HG13 ' A' ' 191' ' ' ILE . 9.9 p -150.16 141.15 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.075 -0.512 . . . . 63.109999999999999 109.875 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.28 110.14 5.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 74.030000000000001 111.425 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.64 155.89 30.85 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.312 -0.625 . . . . 73.409999999999997 109.312 176.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.478 ' CD2' ' HG3' ' A' ' 202' ' ' ARG . 24.5 m-85 -118.44 154.11 52.1 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.651 -0.249 . . . . 71.120000000000005 111.266 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 44.4 Cg_endo -68.4 -75.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.413 2.075 . . . . 62.109999999999999 112.138 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 199' ' ' ASP . 1.4 pt? -127.66 32.07 5.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.726 -0.215 . . . . 74.299999999999997 110.982 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 198' ' ' LEU . 11.5 t70 77.01 -6.21 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.174 0.435 . . . . 44.130000000000003 112.174 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 23.8 ptm -49.5 -28.39 5.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.214 0.82 . . . . 50.140000000000001 113.214 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.04 2.82 35.4 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.186 -1.007 . . . . 60.520000000000003 113.331 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.478 ' HG3' ' CD2' ' A' ' 196' ' ' TYR . 44.5 mtp-105 -84.85 -63.34 1.35 Allowed 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.759 0.79 . . . . 75.540000000000006 109.798 176.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 203' ' ' LYS . 18.1 mmmt . . . . . 0 C--O 1.246 0.891 0 CA-C-N 112.779 -2.01 . . . . 74.209999999999994 111.754 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.607 0.241 . . . . 64.5 110.755 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' HA ' ' HZ ' ' A' ' 82' ' ' PHE . . . -97.87 167.3 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 63.229999999999997 109.982 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.71 162.52 27.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.933 -0.121 . . . . 54.340000000000003 111.034 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.528 HD11 HG13 ' A' ' 77' ' ' ILE . 53.3 mt 73.03 115.11 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 O-C-N 124.127 0.892 . . . . 75.239999999999995 111.692 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 22.3 Cg_exo -65.98 149.12 86.36 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.84 2.36 . . . . 72.230000000000004 112.325 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 7.6 Cg_exo -74.81 38.13 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.582 2.855 . . . . 75.099999999999994 113.225 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' O ' ' HD1' ' A' ' 9' ' ' TRP . 35.3 m-20 -92.49 -9.27 42.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 75.439999999999998 110.6 178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.521 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 8.0 p -69.3 99.04 1.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 73.439999999999998 111.061 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.462 ' HD1' ' O ' ' A' ' 7' ' ' ASP . 15.8 p-90 -117.7 4.24 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.896 -0.593 . . . . 75.439999999999998 110.199 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -51.93 142.76 25.02 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 114.995 -1.002 . . . . 70.519999999999996 112.25 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 11.9 Cg_exo -35.76 123.83 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.987 3.791 . . . . 74.349999999999994 114.26 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.728 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 86.3 Cg_endo -78.43 13.49 1.83 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.827 3.018 . . . . 71.349999999999994 113.608 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.471 HD22 ' HB3' ' A' ' 26' ' ' GLU . 20.4 t-20 -133.36 138.94 46.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.741 -0.663 . . . . 74.010000000000005 109.899 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 164' ' ' PRO . 33.3 m -138.92 156.73 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.708 0.29 . . . . 72.200000000000003 110.681 -177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.679 ' HD1' ' HB2' ' A' ' 165' ' ' SER . 27.8 p90 -123.99 141.13 52.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.074 0.464 . . . . 73.140000000000001 111.041 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.51 110.08 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.674 -0.694 . . . . 75.120000000000005 109.407 177.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.858 ' HB3' ' HG2' ' A' ' 161' ' ' LYS . 32.0 tt0 -88.83 113.25 24.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.492 -0.929 . . . . 71.310000000000002 108.492 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -103.13 -179.95 4.1 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.963 -0.562 . . . . 53.310000000000002 110.939 -174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 p -75.3 -15.74 60.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 74.340000000000003 110.649 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 92.5 mmm -97.1 -38.81 9.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.626 . . . . 73.25 110.664 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.49 -139.87 3.22 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.231 -0.748 . . . . 51.329999999999998 111.231 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -136.7 130.62 46.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 109.507 -0.553 . . . . 72.099999999999994 109.507 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG12 ' CG2' ' A' ' 139' ' ' VAL . 4.2 mp -124.85 130.49 73.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 71.540000000000006 110.467 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 15' ' ' TYR . 59.1 t -113.85 145.05 20.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.904 -0.406 . . . . 74.430000000000007 109.904 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.77 36.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.345 0.593 . . . . 63.43 110.725 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB3' HD22 ' A' ' 13' ' ' ASN . 9.4 pt-20 -134.1 162.15 32.91 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.211 -0.904 . . . . 54.210000000000001 108.999 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 36' ' ' CYS . 1.0 OUTLIER -97.44 175.5 6.21 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.6 -0.519 . . . . 75.310000000000002 109.6 -176.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.576 ' OH ' ' HG2' ' A' ' 189' ' ' PRO . 3.9 m-30 -79.21 100.41 7.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 72.439999999999998 110.878 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.728 ' NE1' ' HB2' ' A' ' 12' ' ' PRO . 15.3 m0 -79.82 -7.06 58.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.956 -0.565 . . . . 73.120000000000005 110.45 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -75.52 -65.29 0.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.848 -0.614 . . . . 74.510000000000005 111.247 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -96.95 -16.06 20.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 73.230000000000004 110.813 -171.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -130.71 72.3 81.94 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 112.745 0.646 . . . . 73.400000000000006 112.745 -169.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 14.0 Cg_exo -69.45 -20.88 35.72 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.392 2.061 . . . . 64.219999999999999 110.826 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -82.01 -45.55 15.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.057 -0.974 . . . . 74.430000000000007 110.836 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 12.1 m -65.92 -39.24 90.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.051 -0.522 . . . . 74.540000000000006 111.586 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 4.7 p -64.31 -39.78 94.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.583 -0.28 . . . . 70.400000000000006 111.699 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 8' ' ' SER . 9.5 mtmp? -91.14 -8.8 47.69 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.295 -0.562 . . . . 55.43 110.8 -178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 48.9 t30 -72.44 -55.54 6.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.657 -0.701 . . . . 71.049999999999997 109.349 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.28 -40.88 98.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.284 -0.416 . . . . 71.5 110.888 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.29 -42.8 61.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.963 -0.562 . . . . 62.520000000000003 111.312 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 38' ' ' ASN . 10.0 mm-40 -56.84 -50.88 71.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.274 -0.421 . . . . 72.209999999999994 111.422 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' CG ' ' A' ' 47' ' ' TYR . 2.7 mm? -62.77 -28.15 69.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.501 -0.318 . . . . 75.209999999999994 111.466 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -51.84 25.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 65.510000000000005 110.942 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptt85 -72.47 -29.65 63.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.310000000000002 111.472 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -68.02 -52.42 35.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.997 0.427 . . . . 65.340000000000003 109.954 178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' HD22 ' A' ' 49' ' ' ASN . . . 131.13 43.45 0.18 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.057 -1.068 . . . . 54.020000000000003 113.233 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.576 ' CG ' HD12 ' A' ' 42' ' ' LEU . 18.7 m-85 -92.24 -33.49 14.64 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.465 -0.432 . . . . 74.109999999999999 111.395 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -82.06 -16.4 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 75.310000000000002 110.874 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.437 HD22 ' HA2' ' A' ' 46' ' ' GLY . 38.3 m-80 -70.78 -0.96 10.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.105 0.478 . . . . 74.219999999999999 111.028 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.05 34.52 2.07 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.518 -0.633 . . . . 75.400000000000006 111.518 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.531 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 26.8 p -104.21 149.62 25.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.979 0.418 . . . . 72.209999999999994 111.014 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -128.2 148.67 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.394 -0.595 . . . . 51.509999999999998 109.394 -178.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 87.3 m-85 -80.08 122.5 26.86 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.499 -0.556 . . . . 74.5 109.499 175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -106.61 -39.61 5.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.871 0.323 . . . . 72.230000000000004 111.871 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 39.3 mmt180 -108.91 105.42 14.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.923 -0.311 . . . . 63.509999999999998 110.23 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.712 HD13 ' HB2' ' A' ' 155' ' ' ASP . 4.8 mp -123.58 91.28 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.895 -0.779 . . . . 72.109999999999999 108.895 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.9 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 27.2 mt -96.28 130.48 44.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.71 -0.677 . . . . 63.409999999999997 109.237 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 1.005 ' HE2' ' HB3' ' A' ' 146' ' ' GLU . 43.8 mttt -54.97 108.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.928 0.767 . . . . 70.409999999999997 111.831 -173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 55.99 44.9 24.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.285 -0.87 . . . . 75.530000000000001 110.828 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.9 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 12.8 t80 -129.93 -75.99 0.54 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.269 -0.878 . . . . 63.439999999999998 109.12 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.516 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.75 154.63 22.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.215 -0.902 . . . . 61.149999999999999 109.884 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.601 HG23 HG13 ' A' ' 56' ' ' ILE . 46.8 mt -129.41 102.18 7.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.044 -0.525 . . . . 72.340000000000003 109.996 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 113' ' ' PHE . 49.3 tt0 -86.02 122.51 30.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 74.409999999999997 110.526 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -125.17 142.7 14.02 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.886 -0.597 . . . . 72.349999999999994 112.011 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 149.66 -141.86 9.24 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.504 -0.855 . . . . 60.409999999999997 112.332 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 52.18 78.54 0.39 Allowed Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.814 0.672 . . . . 74.200000000000003 112.814 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -72.78 -12.94 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 121.98 1.786 . . . . 62.200000000000003 110.442 169.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 75.8 p -103.23 -47.55 4.28 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.156 -0.929 . . . . 64.230000000000004 110.777 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.68 15.39 54.91 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.438 -0.665 . . . . 31.210000000000001 111.438 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.7 p -80.95 -41.54 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.29 0.567 . . . . 74.310000000000002 111.499 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.14 -16.29 4.97 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.492 -0.776 . . . . 44.119999999999997 111.374 -174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -109.8 -30.33 7.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.15 0.5 . . . . 65.219999999999999 110.903 173.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.6 -155.82 28.44 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.6 -0.809 . . . . 75.209999999999994 111.409 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.48 -105.48 0.24 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.624 -0.798 . . . . 60.030000000000001 112.282 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 52.98 36.4 21.87 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.609 0.719 . . . . 74.310000000000002 111.455 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -91.19 12.85 18.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.615 -0.72 . . . . 62.310000000000002 111.047 -175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.528 HG13 HD11 ' A' ' 4' ' ' ILE . 47.6 pt -74.23 -22.24 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.348 -0.387 . . . . 52.009999999999998 111.181 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 81' ' ' GLN . 6.8 p90 -110.81 3.38 18.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.498 0.666 . . . . 71.430000000000007 110.495 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 106.09 -115.55 4.83 Favored Glycine 0 C--O 1.237 0.295 0 CA-C-N 115.182 -0.917 . . . . 63.310000000000002 111.856 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -76.31 179.19 5.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.25 -1.018 . . . . 74.519999999999996 108.25 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.646 ' HG3' ' HA ' ' A' ' 107' ' ' THR . 0.8 OUTLIER -78.61 149.73 32.87 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.47 -0.937 . . . . 75.209999999999994 108.47 172.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' A' ' 2' ' ' ALA . 9.7 t80 -102.11 -85.66 0.43 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.329 0.862 . . . . 71.319999999999993 113.329 -156.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.65 157.65 43.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.841 0.353 . . . . 63.32 111.205 -168.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.7 126.2 30.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.31 0.576 . . . . 74.430000000000007 110.2 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -105.99 18.7 21.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.793 -0.639 . . . . 74.340000000000003 109.496 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' A' ' 127' ' ' THR . 59.3 mt -62.01 104.63 0.48 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.952 -0.567 . . . . 70.219999999999999 110.891 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -169.88 80.45 0.63 Allowed Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.413 -0.588 . . . . 73.319999999999993 109.413 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.21 100.39 0.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.464 2.109 . . . . 73.310000000000002 112.076 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.23 -3.59 52.85 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.228 1.013 . . . . 61.140000000000001 109.532 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.7 OUTLIER -109.94 -171.39 1.83 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.239 -1.346 . . . . 74.439999999999998 111.315 -172.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -147.07 145.99 29.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.198 -1.038 . . . . 75.099999999999994 108.198 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 26.8 p90 -58.48 124.79 20.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.24 0.543 . . . . 75.010000000000005 110.066 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.4 p -121.98 -45.59 2.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.665 -0.698 . . . . 65.200000000000003 110.084 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -151.31 6.11 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.483 -0.78 . . . . 63.240000000000002 111.891 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.11 150.14 22.17 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 122.337 0.255 . . . . 71.230000000000004 110.704 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 107.69 22.7 7.21 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.476 -0.868 . . . . 74.219999999999999 111.835 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.601 HD12 ' HB3' ' A' ' 189' ' ' PRO . 10.4 mm -84.88 109.63 18.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.521 -0.548 . . . . 51.450000000000003 109.521 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 3.2 tm? -85.59 120.72 27.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.611 -0.514 . . . . 75.120000000000005 109.611 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -129.22 174.88 9.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.116 -0.493 . . . . 62.450000000000003 111.136 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.516 ' HB2' ' CE1' ' A' ' 129' ' ' PHE . 24.9 ttt -105.53 137.68 42.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.908 -0.587 . . . . 71.239999999999995 109.502 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -96.65 142.68 28.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.036 0.445 . . . . 54.210000000000001 110.171 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.81 161.34 42.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.528 -0.76 . . . . 73.230000000000004 110.348 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.31 -26.59 15.86 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.691 0.757 . . . . 74.230000000000004 109.559 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 107' ' ' THR . . . -150.03 178.16 27.68 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 109.2 -1.56 . . . . 74.319999999999993 109.2 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HA ' HD11 ' A' ' 86' ' ' LEU . 6.7 Cg_endo -48.45 -52.53 8.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.959 2.439 . . . . 63.329999999999998 112.479 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -101.42 -3.41 28.73 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.034 -0.53 . . . . 73.200000000000003 110.419 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.646 ' HA ' ' HG3' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -88.56 47.11 1.46 Allowed 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.391 0.615 . . . . 63.219999999999999 109.608 -177.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 81' ' ' GLN . 5.4 p30 -94.75 130.08 41.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.056 -0.975 . . . . 74.219999999999999 109.989 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.79 -121.86 2.88 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.245 -0.978 . . . . 74.219999999999999 113.563 -173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.0 t -105.31 12.16 32.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 110.909 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 26.5 mt-30 -94.38 147.85 22.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 55.229999999999997 111.243 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -141.31 167.92 21.02 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.675 -0.861 . . . . 74.430000000000007 108.675 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' GLN . 46.9 p90 -155.16 150.59 27.26 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 73.329999999999998 111.118 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.745 HG22 HD23 ' A' ' 98' ' ' LEU . 14.2 t -112.97 140.27 33.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.012 -0.736 . . . . 70.439999999999998 109.012 176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -94.44 127.08 40.12 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.094 0.473 . . . . 63.039999999999999 109.936 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB2' ' N ' ' A' ' 60' ' ' PHE . 62.5 mt -83.51 -7.9 59.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.555 -0.748 . . . . 71.109999999999999 110.492 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -144.82 159.79 49.25 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.538 -0.755 . . . . 72.219999999999999 110.071 175.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 36.3 Cg_endo -66.14 112.06 2.19 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.51 2.14 . . . . 54.100000000000001 112.368 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.1 p -106.13 141.65 37.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.825 -0.625 . . . . 54.109999999999999 111.331 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.551 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -131.9 -0.25 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 73.420000000000002 110.646 175.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 2.52 55.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.47 -0.786 . . . . 75.409999999999997 112.489 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.15 6.65 3.9 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.23 0.826 . . . . 70.219999999999999 113.23 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.551 ' OD1' ' HA ' ' A' ' 120' ' ' GLN . 4.5 m-20 -64.65 -28.69 69.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.119 0.485 . . . . 74.540000000000006 111.042 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -102.57 13.11 56.73 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 63.130000000000003 111.448 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -116.61 -40.74 3.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 73.109999999999999 109.387 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -135.92 124.68 23.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.131 -0.941 . . . . 73.519999999999996 108.506 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.553 ' HB ' HD23 ' A' ' 86' ' ' LEU . 15.1 t -71.05 147.91 48.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.171 0.51 . . . . 72.430000000000007 110.768 -175.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' A' ' 99' ' ' ALA . 44.8 mt -121.58 123.32 69.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.853 -0.612 . . . . 74.409999999999997 110.523 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -159.31 75.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.32 0.581 . . . . 74.409999999999997 111.587 175.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.654 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -163.3 158.45 30.83 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.768 -0.729 . . . . 74.439999999999998 112.734 177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.466 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -132.11 125.02 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.964 -0.754 . . . . 65.510000000000005 108.964 173.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' GLY . 10.3 p -84.98 137.17 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.052 0.453 . . . . 74.310000000000002 110.291 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.514 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . 34.5 t -141.2 147.69 38.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.43 -0.35 . . . . 74.239999999999995 111.016 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 42.62 35.27 0.65 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.379 1.072 . . . . 62.039999999999999 113.216 177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.16 42.49 0.19 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.637 -0.792 . . . . 70.510000000000005 111.972 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 9.7 tp -91.86 -33.83 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.796 0.332 . . . . 74.450000000000003 110.413 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -34.9 90.05 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.03 -0.605 . . . . 55.200000000000003 112.016 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 142' ' ' VAL . 70.3 mmm -67.12 -51.25 56.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.797 -0.446 . . . . 74.510000000000005 109.797 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 62' ' ' ILE . 63.9 t -54.29 -30.68 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.01 0.433 . . . . 74.120000000000005 110.954 177.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -70.78 -54.65 10.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 35.229999999999997 110.914 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.608 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.72 -16.38 60.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.187 -0.46 . . . . 52.130000000000003 111.418 -177.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 145' ' ' VAL . 64.5 t -86.21 -29.69 6.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 71.310000000000002 109.942 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -86.45 -7.56 79.08 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.691 -0.766 . . . . 71.310000000000002 112.607 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.608 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 16.6 ptp -96.58 -11.98 24.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.857 -0.337 . . . . 74.450000000000003 111.869 178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 142' ' ' VAL . 23.9 m -74.93 136.67 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.207 -0.597 . . . . 72.450000000000003 110.637 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 1.005 ' HB3' ' HE2' ' A' ' 58' ' ' LYS . 4.6 pt-20 -117.51 -53.0 2.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.008 -0.542 . . . . 65.129999999999995 111.023 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.448 ' H ' ' HG3' ' A' ' 146' ' ' GLU . 4.6 p -132.42 162.21 31.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.083 -0.508 . . . . 63.420000000000002 110.253 -175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -93.91 -157.06 0.52 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.917 -0.771 . . . . 54.109999999999999 108.917 176.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 31.1 t -56.37 -35.75 68.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.282 0.492 . . . . 52.329999999999998 110.803 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -92.66 171.98 8.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.464 -0.335 . . . . 75.239999999999995 110.279 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.08 61.48 6.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.953 0.882 . . . . 60.0 109.995 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 153' ' ' PRO . 18.3 ptp180 -146.72 145.42 22.92 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 114.779 -1.101 . . . . 74.5 108.999 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 146' ' ' GLU . 24.4 Cg_exo -62.69 144.6 94.28 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.519 2.146 . . . . 74.230000000000004 112.982 -174.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.471 ' CG1' ' HB ' ' A' ' 145' ' ' VAL . 10.4 p -102.3 28.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 122.615 1.198 . . . . 71.019999999999996 108.468 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.712 ' HB2' HD13 ' A' ' 56' ' ' ILE . 7.1 p-10 -71.41 -13.59 61.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.01 -1.45 . . . . 75.030000000000001 112.332 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.493 ' OD1' ' HE2' ' A' ' 158' ' ' LYS . 8.1 t0 -72.82 78.68 1.13 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.165 0.507 . . . . 64.340000000000003 110.721 -176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.2 t -111.87 137.56 44.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.668 -0.696 . . . . 71.319999999999993 109.52 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.493 ' HE2' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -123.55 155.14 38.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.922 0.391 . . . . 73.099999999999994 110.634 -172.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.427 HG21 ' HB2' ' A' ' 162' ' ' ALA . 3.8 mp -91.52 101.59 12.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.208 -1.034 . . . . 74.510000000000005 108.208 168.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 161' ' ' LYS . 32.2 mm -65.35 -48.63 82.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 64.219999999999999 110.918 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.858 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -143.9 138.52 28.62 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.488 -0.778 . . . . 61.43 110.071 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 159' ' ' ILE . . . -141.5 118.89 11.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.142 -0.481 . . . . 73.420000000000002 110.414 -176.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 161' ' ' LYS . 84.9 m-85 -141.83 158.37 62.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.839 -0.618 . . . . 63.340000000000003 109.803 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.503 ' HA ' HG12 ' A' ' 14' ' ' VAL . 28.7 Cg_endo -64.35 137.99 58.47 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.175 1.917 . . . . 74.109999999999999 111.119 173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.679 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 25.4 t -120.27 150.52 40.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.163 0.506 . . . . 61.130000000000003 111.283 -174.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.69 -174.73 45.77 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.173 -0.771 . . . . 62.229999999999997 111.173 173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -125.49 110.79 1.38 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.648 -0.787 . . . . 52.409999999999997 112.346 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -92.21 71.88 1.61 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.81 -0.71 . . . . 72.430000000000007 111.913 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -91.42 24.38 19.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.987 -0.625 . . . . 72.439999999999998 113.069 -176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.2 m -100.05 63.35 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.96 0.41 . . . . 74.239999999999995 110.286 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -99.5 -57.68 0.93 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.918 -0.658 . . . . 74.430000000000007 112.166 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.95 2.24 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.884 -0.674 . . . . 72.510000000000005 112.245 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -132.04 -17.43 1.3 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.881 -0.676 . . . . 74.019999999999996 112.508 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.1 t 54.16 61.44 3.04 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.343 0.592 . . . . 63.439999999999998 110.675 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.43 -50.14 3.53 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.734 -0.746 . . . . 75.340000000000003 112.08 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 153.47 55.1 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.856 -0.688 . . . . 63.409999999999997 112.406 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -82.62 124.53 6.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.693 -0.765 . . . . 51.100000000000001 112.02 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 54.3 m -85.86 71.03 10.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 62.43 110.831 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.13 176.42 33.22 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.768 -0.729 . . . . 71.209999999999994 112.012 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.79 64.79 4.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.95 -0.643 . . . . 43.43 112.156 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -95.6 90.23 1.22 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.987 -0.625 . . . . 54.039999999999999 112.16 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.7 t -97.7 -14.82 20.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.521 -0.548 . . . . 72.040000000000006 109.521 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 162.63 -80.49 0.14 Allowed Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.404 -0.817 . . . . 44.009999999999998 111.608 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.52 -172.31 2.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.85 -0.426 . . . . 70.239999999999995 109.85 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 152.78 144.52 3.93 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.914 -0.585 . . . . 65.099999999999994 111.868 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -86.57 -168.64 45.06 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.542 -0.837 . . . . 44.310000000000002 111.828 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.834 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -84.27 152.09 24.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.856 0.36 . . . . 75.219999999999999 110.238 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 191' ' ' ILE . 94.7 m-85 -98.67 112.29 62.26 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 109.406 -0.59 . . . . 75.450000000000003 109.406 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.601 ' HB3' HD12 ' A' ' 97' ' ' ILE . 54.2 Cg_endo -85.91 -5.44 8.78 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.511 2.141 . . . . 72.540000000000006 112.719 -177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.57 -19.83 32.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 110.801 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 188' ' ' PHE . 21.8 pt -77.42 -16.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 62.130000000000003 111.266 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 42.6 m170 65.38 31.09 10.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.85 -0.614 . . . . 72.209999999999994 111.69 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.32 149.63 19.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.968 -0.293 . . . . 54.030000000000001 110.971 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.48 124.07 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.214 0.531 . . . . 72.430000000000007 111.725 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.97 130.05 0.77 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.374 -0.83 . . . . 60.130000000000003 109.76 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 87.7 m-85 -115.86 146.71 37.54 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.452 -0.34 . . . . 72.030000000000001 110.426 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 38.0 Cg_endo -67.22 -62.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.383 2.055 . . . . 64.150000000000006 111.706 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.79 23.63 4.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.767 -0.651 . . . . 74.349999999999994 109.832 175.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 202' ' ' ARG . 29.7 m-20 70.59 6.35 5.78 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.372 -0.831 . . . . 63.119999999999997 112.166 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 17.7 ptm -55.47 -32.14 62.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 74.310000000000002 112.292 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.69 4.6 85.04 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.534 -0.841 . . . . 73.099999999999994 113.503 -174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 199' ' ' ASP . 11.1 ptm180 -116.51 -3.72 11.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.897 0.856 . . . . 71.340000000000003 110.089 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 203' ' ' LYS . 26.2 ttpt . . . . . 0 C--O 1.248 1.002 0 CA-C-N 114.13 -1.396 . . . . 73.049999999999997 110.714 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 120.931 0.396 . . . . 63.329999999999998 110.186 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.62 -167.53 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.391 -0.368 . . . . 62.310000000000002 110.343 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.04 132.17 37.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.161 -0.311 . . . . 71.340000000000003 110.161 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 78' ' ' TYR . 47.3 mm 67.63 109.19 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 123.922 0.764 . . . . 72.329999999999998 111.333 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.76 161.0 30.39 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.847 2.365 . . . . 74.430000000000007 112.485 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.91 138.95 78.74 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.728 2.285 . . . . 74.219999999999999 111.686 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -55.54 109.29 0.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.704 0.764 . . . . 74.319999999999993 112.223 -173.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.543 ' HB3' HE22 ' A' ' 10' ' ' GLN . 6.2 m -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.615 -1.175 . . . . 74.310000000000002 107.901 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 46.6 p90 -79.3 -54.5 5.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.204 0.816 . . . . 63.509999999999998 113.204 -169.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.621 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.2 mp0 66.27 175.95 0.06 OUTLIER Pre-proline 0 N--CA 1.47 0.526 0 N-CA-C 110.153 -0.314 . . . . 73.120000000000005 110.153 -173.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 10' ' ' GLN . 73.1 Cg_exo -50.73 112.49 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.119 1.879 . . . . 75.340000000000003 112.149 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.724 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 91.3 Cg_endo -88.22 7.97 4.27 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.457 2.772 . . . . 72.319999999999993 113.18 -173.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.469 HD22 ' HB3' ' A' ' 26' ' ' GLU . 21.2 t-20 -127.09 145.5 50.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.084 -0.962 . . . . 73.219999999999999 108.433 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 164' ' ' PRO . 29.1 m -136.15 157.31 37.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.853 0.358 . . . . 54.530000000000001 111.071 -177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.825 ' HD2' ' HB2' ' A' ' 165' ' ' SER . 50.0 p90 -121.74 130.52 53.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.218 0.533 . . . . 70.019999999999996 110.382 175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 16' ' ' LEU . 1.7 mm? -109.44 102.68 11.54 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.559 -0.746 . . . . 72.209999999999994 109.567 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -82.4 111.18 18.2 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.499 -0.926 . . . . 60.299999999999997 108.499 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p -103.07 -179.74 4.04 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.116 0.484 . . . . 43.409999999999997 111.376 -172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.4 t -67.86 -24.57 65.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.617 -0.72 . . . . 75.230000000000004 109.929 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.486 ' HG3' HG22 ' A' ' 142' ' ' VAL . 6.1 mmt -86.63 -44.85 11.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.589 -0.732 . . . . 72.540000000000006 110.636 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.46 -126.92 0.98 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.804 -0.712 . . . . 65.010000000000005 111.554 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 tt -137.26 137.09 46.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.924 0.362 . . . . 74.349999999999994 110.098 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.7 mm -124.93 115.63 44.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.02 -0.536 . . . . 64.349999999999994 109.7 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.67 ' HB ' ' O ' ' A' ' 133' ' ' CYS . 46.7 t -102.77 137.33 31.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.521 -0.472 . . . . 74.430000000000007 109.744 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.19 163.34 37.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.112 0.482 . . . . 52.43 110.809 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 13' ' ' ASN . 10.6 pt-20 -128.59 166.27 19.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.537 -0.756 . . . . 62.350000000000001 109.402 176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.9 OUTLIER -102.33 165.62 11.02 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.423 -0.955 . . . . 72.519999999999996 108.423 176.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 3.3 m-85 -89.64 90.38 8.22 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.612 -0.835 . . . . 74.310000000000002 111.345 177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.8 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -74.75 -11.89 60.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.266 1.032 . . . . 71.239999999999995 108.281 175.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.7 -35.57 77.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.2 -1.818 . . . . 75.540000000000006 110.95 -177.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -124.77 -20.89 4.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.792 -0.64 . . . . 72.019999999999996 110.721 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.539 ' HB1' ' HB ' ' A' ' 35' ' ' THR . . . -132.09 85.13 50.99 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.129 0.418 . . . . 54.119999999999997 112.129 -169.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.57 -41.75 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.322 2.015 . . . . 74.409999999999997 111.491 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.85 -43.23 36.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.661 -0.7 . . . . 73.409999999999997 111.053 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.557 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -63.2 -39.83 95.76 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.662 -0.699 . . . . 75.030000000000001 110.282 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.8 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 15.0 t -60.41 -46.08 91.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.844 -0.616 . . . . 53.25 110.101 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HA ' ' HE3' ' A' ' 37' ' ' LYS . 0.8 OUTLIER -59.59 -34.84 73.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.941 -0.572 . . . . 75.340000000000003 110.815 -178.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 35' ' ' THR . 38.2 t-20 -50.56 -61.36 2.24 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.584 -0.524 . . . . 75.420000000000002 109.584 173.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 112' ' ' PHE . 23.4 m-85 -67.97 -41.34 82.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.05 -0.523 . . . . 74.209999999999994 111.67 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 44' ' ' ARG . . . -56.54 -45.77 81.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.259 -0.428 . . . . 73.5 111.787 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' HG2' ' HE2' ' A' ' 37' ' ' LYS . 19.4 mm-40 -67.46 -42.27 83.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 121.096 -0.242 . . . . 52.109999999999999 111.198 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 47' ' ' TYR . 3.5 mm? -66.11 -26.44 67.46 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.997 -0.281 . . . . 75.409999999999997 110.554 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.27 -45.21 73.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.726 0.298 . . . . 71.25 110.628 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.597 ' HD3' ' HG2' ' A' ' 10' ' ' GLN . 29.9 mtm180 -66.31 -43.47 86.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 110.532 177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -62.56 -43.61 98.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.546 -0.752 . . . . 72.420000000000002 110.853 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.14 64.12 0.53 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.834 -0.698 . . . . 41.520000000000003 111.502 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' HB2' HD12 ' A' ' 42' ' ' LEU . 73.1 t80 -86.0 -50.77 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.104 0.478 . . . . 70.129999999999995 110.154 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.588 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 7.0 m-85 -76.42 -10.82 59.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.368 -0.833 . . . . 71.409999999999997 111.796 -169.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.73 -19.29 63.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 61.32 111.318 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.01 40.03 1.61 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.802 -0.713 . . . . 41.350000000000001 111.996 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.626 ' HB ' ' HA2' ' A' ' 65' ' ' GLY . 40.6 p -118.28 156.62 28.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 70.319999999999993 111.153 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -141.98 163.05 33.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.103 -0.499 . . . . 55.049999999999997 110.735 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.571 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 84.9 m-85 -86.86 133.64 33.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.101 -0.499 . . . . 74.049999999999997 109.663 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -120.21 -28.96 4.96 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.254 -0.578 . . . . 63.43 111.457 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.2 mmt180 -112.6 109.59 19.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.121 -0.326 . . . . 74.109999999999999 110.121 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 53' ' ' PHE . 14.8 mm -121.51 88.6 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.04 -0.726 . . . . 74.540000000000006 109.04 -178.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 18.3 mt -103.31 119.59 52.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.231 -0.587 . . . . 62.25 110.099 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -54.33 138.02 40.35 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.707 0.629 . . . . 64.319999999999993 110.759 178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 p30 44.24 33.19 0.79 Allowed 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.383 1.052 . . . . 71.019999999999996 112.68 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.35 -83.74 0.54 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.158 -0.473 . . . . 74.439999999999998 110.11 179.218 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -161.47 158.11 26.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.593 . . . . 65.510000000000005 110.389 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' HD21 ' A' ' 116' ' ' LEU . 59.8 mt -128.81 103.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.594 -0.73 . . . . 72.430000000000007 109.656 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -86.51 121.52 29.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.11 -0.495 . . . . 74.409999999999997 110.252 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -136.18 140.81 11.86 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.658 -0.782 . . . . 52.530000000000001 112.603 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.626 ' HA2' ' HB ' ' A' ' 51' ' ' THR . . . 138.86 -151.77 21.86 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.653 -0.784 . . . . 44.25 112.302 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t0 58.3 95.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 123.756 0.823 . . . . 71.200000000000003 111.98 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' HA2' ' A' ' 73' ' ' GLY . 49.1 Cg_endo -71.31 -18.32 30.18 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.718 2.278 . . . . 75.409999999999997 112.359 177.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.581 ' OG1' HG22 ' A' ' 70' ' ' THR . 81.8 p -91.65 -32.86 15.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.469 . . . . 63.329999999999998 110.887 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.77 22.88 71.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.817 -0.629 . . . . 64.430000000000007 112.284 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.581 HG22 ' OG1' ' A' ' 68' ' ' THR . 14.2 t -107.51 -20.94 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.649 0.24 . . . . 70.010000000000005 111.649 -176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.44 -13.96 6.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.316 -0.945 . . . . 74.0 113.506 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -0.82 7.08 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.107 0.78 . . . . 72.319999999999993 113.107 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' HA2' ' HD2' ' A' ' 67' ' ' PRO . . . 66.11 -164.9 39.58 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.882 -0.675 . . . . 42.409999999999997 113.337 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.18 -81.0 0.8 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 73.5 111.598 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 78' ' ' TYR . . . 59.31 34.47 22.94 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.696 0.76 . . . . 63.43 111.153 175.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.4 m -66.25 -25.93 67.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 40.219999999999999 112.718 -170.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.587 HG23 ' CD1' ' A' ' 78' ' ' TYR . 3.6 tt -65.78 -40.13 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.928 0.344 . . . . 71.099999999999994 111.928 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 13.3 p90 -107.01 -17.25 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.791 0.329 . . . . 72.040000000000006 111.333 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.94 -62.99 4.51 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.047 -0.597 . . . . 64.040000000000006 113.811 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 78' ' ' TYR . 91.7 mttt -118.47 177.66 4.74 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.669 -0.312 . . . . 63.039999999999999 111.666 -175.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.46 164.68 25.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.93 -0.577 . . . . 73.540000000000006 110.441 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -110.53 -68.98 0.89 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.373 -0.376 . . . . 71.329999999999998 111.127 -172.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -168.02 156.69 9.15 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.129 -0.693 . . . . 73.129999999999995 109.129 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 9.4 p-10 -89.93 131.59 35.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.327 0.584 . . . . 53.399999999999999 109.764 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 25.8 tt0 -105.53 8.01 33.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 75.430000000000007 110.262 -173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.6 mt -46.87 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.353 -0.84 . . . . 55.299999999999997 112.543 -170.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -179.56 87.0 0.2 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.404 -0.817 . . . . 73.230000000000004 109.23 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.466 ' HG3' ' HB2' ' A' ' 123' ' ' ASP . 30.9 Cg_endo -63.49 96.96 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.444 2.096 . . . . 71.230000000000004 111.828 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.87 -11.38 59.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 64.430000000000007 109.46 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 189' ' ' PRO . 0.8 OUTLIER -105.02 170.56 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.598 -1.26 . . . . 73.010000000000005 107.598 170.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -126.0 150.83 47.77 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.926 -0.71 . . . . 75.25 110.79 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.466 ' HD2' ' HB2' ' A' ' 118' ' ' PRO . 35.7 p90 -65.5 121.83 15.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.169 -0.678 . . . . 74.439999999999998 109.169 173.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.5 p -115.28 -38.88 3.71 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.963 -0.562 . . . . 71.549999999999997 110.61 -176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.26 -145.2 4.3 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.484 -0.78 . . . . 75.129999999999995 111.633 175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.12 146.2 24.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.806 0.336 . . . . 74.120000000000005 111.048 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 132' ' ' VAL . . . 108.67 26.18 5.43 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.754 -0.736 . . . . 74.540000000000006 111.98 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 189' ' ' PRO . 8.8 mm -90.07 111.51 23.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.583 -0.525 . . . . 75.329999999999998 109.583 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.879 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -85.91 117.73 24.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.866 -0.606 . . . . 74.420000000000002 109.673 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.78 176.92 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.947 0.404 . . . . 23.34 111.774 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.983 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 17.4 tpt -93.77 138.96 31.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 74.519999999999996 111.885 -173.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.21 132.89 43.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.198 -0.455 . . . . 65.329999999999998 110.315 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.4 162.07 36.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 110.596 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -82.54 -26.32 32.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.117 -0.492 . . . . 45.119999999999997 110.846 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 169.24 -134.38 3.18 Favored Glycine 0 CA--C 1.501 -0.787 0 C-N-CA 121.0 -0.619 . . . . 74.439999999999998 112.16 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 25.8 Cg_endo -59.64 92.76 0.08 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.293 0 C-N-CA 123.192 2.594 . . . . 71.310000000000002 111.713 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 84' ' ' ASP . 2.2 p30 62.29 10.08 3.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.975 1.31 . . . . 72.019999999999996 112.465 175.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 1.4 m -82.17 57.85 3.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.475 0.655 . . . . 74.420000000000002 109.307 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.99 143.12 26.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.593 -0.731 . . . . 70.430000000000007 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.26 -98.96 2.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.746 -0.74 . . . . 72.129999999999995 111.966 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.425 ' OG ' ' HG ' ' A' ' 42' ' ' LEU . 9.2 t -147.68 10.55 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.985 0.421 . . . . 55.119999999999997 110.536 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.54 159.04 17.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.688 0.28 . . . . 70.5 111.166 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.406 ' HB3' ' CE2' ' A' ' 39' ' ' PHE . 41.4 p90 -140.25 175.43 9.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 110.682 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -154.69 151.47 28.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 71.010000000000005 110.521 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.754 HG22 HD23 ' A' ' 98' ' ' LEU . 16.5 t -109.23 143.79 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.31 -0.626 . . . . 72.310000000000002 109.31 177.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.3 p -96.98 129.5 44.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.035 0.445 . . . . 73.519999999999996 110.402 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 62' ' ' ILE . 71.0 mt -85.5 -7.27 58.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.886 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -144.94 160.21 47.41 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.643 -0.708 . . . . 52.140000000000001 109.972 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.466 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 29.6 Cg_endo -64.06 111.79 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.492 2.128 . . . . 53.439999999999998 111.555 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.1 p -100.68 122.07 42.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 55.420000000000002 111.93 -172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.515 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 1.1 pm0 -120.89 24.38 10.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.655 0.741 . . . . 75.200000000000003 109.815 174.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -115.45 -3.11 12.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.282 -0.872 . . . . 72.450000000000003 111.457 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 pp -136.39 12.05 3.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 63.409999999999997 111.058 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.466 ' HB2' ' HG3' ' A' ' 88' ' ' PRO . 8.7 p-10 -63.14 -28.57 70.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 74.010000000000005 111.049 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.97 17.84 19.58 Favored Glycine 0 CA--C 1.506 -0.488 0 C-N-CA 120.652 -0.785 . . . . 54.43 111.205 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -116.45 -34.6 4.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.254 0.549 . . . . 75.129999999999995 109.889 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -133.78 123.39 24.77 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.434 -0.95 . . . . 64.430000000000007 108.434 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.5 t -70.87 144.13 50.79 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.33 -0.548 . . . . 71.129999999999995 109.833 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.2 mt -113.49 124.38 70.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.832 -0.622 . . . . 73.219999999999999 111.28 -173.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.983 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 5.7 p90 -156.37 72.68 0.76 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.849 0.833 . . . . 74.120000000000005 110.468 177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -164.59 157.47 29.86 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.616 -1.278 . . . . 41.409999999999997 113.53 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.614 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 38.5 mtp180 -139.63 121.88 15.92 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.002 -0.37 . . . . 70.219999999999999 110.002 173.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 96' ' ' GLY . 8.7 p -86.37 137.11 21.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.915 0.388 . . . . 75.0 110.306 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 48.5 t -149.56 147.82 28.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 109.954 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 184' ' ' ASP . 0.0 OUTLIER 48.04 67.63 0.8 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.458 0.647 . . . . 74.239999999999995 110.05 -175.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 158.89 19.68 0.03 OUTLIER Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.269 -0.878 . . . . 70.219999999999999 113.267 178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.608 HG22 ' CG ' ' A' ' 184' ' ' ASP . 11.1 tp -80.73 -32.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.319 -0.623 . . . . 61.240000000000002 109.319 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.11 93.62 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.043 -0.823 . . . . 72.510000000000005 111.043 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.506 ' O ' HG23 ' A' ' 142' ' ' VAL . 79.2 mmm -70.56 -48.94 52.9 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.768 -0.456 . . . . 50.030000000000001 109.768 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.4 t -56.28 -29.13 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.925 0.393 . . . . 73.099999999999994 110.8 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -70.59 -56.53 6.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.422 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.49 ' HE ' ' HB2' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.87 -15.42 62.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.365 -0.379 . . . . 75.450000000000003 111.085 -177.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 138' ' ' MET . 75.3 t -84.41 -39.6 14.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 53.109999999999999 110.154 174.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.448 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -78.15 -27.15 58.57 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.535 -0.84 . . . . 52.130000000000003 112.843 -177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 89.2 mmm -75.11 -13.27 60.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.859 0.318 . . . . 53.020000000000003 111.859 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.9 m -106.48 118.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-O 121.233 0.539 . . . . 64.010000000000005 110.834 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -106.28 -38.22 6.3 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.432 -0.507 . . . . 62.530000000000001 109.703 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.7 164.86 36.92 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.310000000000002 112.169 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -76.71 -175.0 3.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.317 -1.31 . . . . 75.140000000000001 109.077 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 17.0 t -61.58 -27.6 68.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.862 -0.792 . . . . 74.019999999999996 108.862 171.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.487 ' HB2' ' HG2' ' A' ' 152' ' ' ARG . 43.9 mt-30 -90.78 167.41 12.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.136 -0.938 . . . . 71.430000000000007 109.014 172.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.44 67.23 8.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.289 1.043 . . . . 74.409999999999997 109.104 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 14.8 ptp180 -148.4 144.29 18.44 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 113.664 -1.607 . . . . 74.510000000000005 108.63 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.32 130.35 37.22 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.419 1.412 . . . . 75.030000000000001 109.71 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -45.31 -53.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 123.529 0.518 . . . . 73.549999999999997 111.165 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -146.75 147.53 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.224 -0.658 . . . . 70.430000000000007 109.224 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -72.1 118.14 14.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.84 -175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.9 129.77 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.79 0.805 . . . . 64.129999999999995 111.478 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -154.16 173.03 16.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.998 -1.001 . . . . 62.539999999999999 109.42 -178.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 159' ' ' ILE . 3.6 mp -89.74 114.43 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.27 -0.641 . . . . 72.219999999999999 109.27 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.572 HG22 ' HD3' ' A' ' 161' ' ' LYS . 26.8 mm -79.89 -58.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.686 -0.688 . . . . 51.109999999999999 110.53 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.572 ' HD3' HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -125.07 137.01 54.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.108 -0.496 . . . . 72.25 109.786 176.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -141.39 122.71 14.87 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.63 -0.259 . . . . 62.119999999999997 110.857 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -145.04 154.12 54.21 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.99 -0.55 . . . . 71.230000000000004 109.867 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.525 ' HA ' HG12 ' A' ' 14' ' ' VAL . 9.2 Cg_endo -57.13 138.96 88.61 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.181 1.921 . . . . 73.519999999999996 111.68 171.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.825 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 38.3 t -118.53 152.19 36.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.81 -0.632 . . . . 61.229999999999997 111.148 -172.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -125.42 57.83 0.68 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.006 -0.837 . . . . 43.32 111.006 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -79.42 162.7 47.91 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.954 -0.641 . . . . 70.510000000000005 112.595 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.95 -65.9 0.51 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.063 -0.589 . . . . 44.039999999999999 111.727 -178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.08 -132.95 21.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.793 -0.718 . . . . 73.530000000000001 112.058 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.0 p -86.17 -5.37 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.033 0.444 . . . . 62.520000000000003 110.665 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.37 -49.37 4.22 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.98 -0.628 . . . . 61.399999999999999 112.654 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.44 -119.97 5.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.896 -0.669 . . . . 52.020000000000003 111.812 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 111.59 149.16 11.27 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.624 -0.798 . . . . 71.319999999999993 112.306 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.1 p -153.75 109.92 3.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.85 0.357 . . . . 73.0 110.209 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -141.27 -141.4 3.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.842 -0.695 . . . . 65.109999999999999 112.191 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.76 -66.62 3.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.141 -0.552 . . . . 63.520000000000003 111.86 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -118.01 -70.38 0.38 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.367 -0.693 . . . . 52.329999999999998 111.367 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 20.8 m -130.89 158.73 39.42 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.303 -0.258 . . . . 71.430000000000007 110.303 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.29 -141.65 7.71 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.796 -0.716 . . . . 23.02 111.813 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.59 -173.49 25.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.919 -0.658 . . . . 72.219999999999999 112.138 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -96.19 112.01 4.35 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.862 -0.685 . . . . 50.100000000000001 112.01 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 17.9 t -82.22 146.58 29.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.898 0.38 . . . . 60.420000000000002 110.097 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 123.89 -135.28 9.66 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.341 -0.704 . . . . 40.409999999999997 111.341 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.608 ' CG ' HG22 ' A' ' 136' ' ' ILE . 12.6 t0 -155.35 174.94 14.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.972 -0.751 . . . . 61.539999999999999 108.972 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 133' ' ' CYS . . . 148.33 159.47 8.49 Favored Glycine 0 C--N 1.309 -0.96 0 C-N-CA 120.541 -0.838 . . . . 53.530000000000001 112.782 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -82.6 -166.63 39.11 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.887 -0.673 . . . . 64.200000000000003 112.321 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.764 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -79.7 173.31 12.71 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.804 0.335 . . . . 64.510000000000005 110.4 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -108.58 100.81 40.31 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.616 -0.265 . . . . 63.030000000000001 110.58 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.747 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.3 Cg_endo -80.34 -5.05 13.38 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.518 2.145 . . . . 74.430000000000007 111.734 176.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -77.15 -39.24 49.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.217 -0.902 . . . . 63.229999999999997 109.56 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.14 152.68 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.385 -0.969 . . . . 73.030000000000001 108.385 171.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -104.75 81.45 1.77 Allowed 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.223 -0.591 . . . . 73.310000000000002 110.808 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 9.0 p -156.93 146.87 11.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 114.998 -1.001 . . . . 75.450000000000003 109.111 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.94 116.79 17.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.888 0.375 . . . . 73.030000000000001 110.847 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.479 HE21 ' N ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -153.52 150.24 28.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.878 -0.786 . . . . 64.200000000000003 108.878 175.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.536 ' HB3' ' HA ' ' A' ' 199' ' ' ASP . 40.6 m-85 -122.7 142.27 37.22 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 116.688 -0.233 . . . . 64.230000000000004 110.479 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.764 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 29.1 Cg_endo -61.9 -63.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.4 2.067 . . . . 73.409999999999997 111.488 -178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.1 pt? -122.44 16.71 10.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.105 -0.498 . . . . 55.149999999999999 109.844 174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 196' ' ' TYR . 13.4 m-20 70.24 8.0 6.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.198 -0.91 . . . . 74.549999999999997 113.367 171.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -61.91 -21.42 64.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.766 0.284 . . . . 71.310000000000002 111.766 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.89 -5.39 83.76 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.831 -0.7 . . . . 54.219999999999999 112.958 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -82.68 -20.72 35.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.392 0.615 . . . . 70.049999999999997 110.462 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm . . . . . 0 C--O 1.245 0.849 0 CA-C-N 114.733 -1.121 . . . . 73.549999999999997 111.368 -175.237 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 110.236 -0.283 . . . . 74.310000000000002 110.236 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.22 18.54 18.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 54.420000000000002 110.773 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.15 -44.53 68.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.435 -0.802 . . . . 71.450000000000003 110.016 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.622 HG12 HG12 ' A' ' 77' ' ' ILE . 58.7 mt -129.76 103.7 17.4 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.894 -1.048 . . . . 71.319999999999993 109.115 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 31.9 Cg_endo -63.87 139.23 67.23 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.914 2.409 . . . . 54.409999999999997 112.791 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 52.1 Cg_exo -55.38 -39.09 92.9 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.922 2.414 . . . . 62.240000000000002 111.354 176.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.42 102.5 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.784 0.802 . . . . 70.200000000000003 109.047 174.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.782 ' HB3' HE22 ' A' ' 10' ' ' GLN . 31.9 m -121.34 122.02 38.93 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.537 -0.756 . . . . 73.200000000000003 111.602 -171.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.546 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 25.8 t90 -92.68 107.83 19.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.326 -0.62 . . . . 74.150000000000006 109.326 172.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.782 HE22 ' HB3' ' A' ' 8' ' ' SER . 1.5 mp0 -93.91 107.23 26.41 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.753 -0.658 . . . . 64.239999999999995 111.341 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 9.6 Cg_endo -90.31 116.86 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.556 2.838 . . . . 71.230000000000004 111.112 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.496 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 40.4 Cg_endo -67.73 -19.78 46.99 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.368 2.045 . . . . 73.310000000000002 112.45 -177.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.687 HD21 HG12 ' A' ' 24' ' ' VAL . 22.5 t-20 -139.42 145.96 39.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.605 -0.725 . . . . 74.019999999999996 110.149 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 29.6 m -133.85 145.16 33.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.399 0.618 . . . . 53.539999999999999 111.156 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.537 ' HE1' ' HB3' ' A' ' 165' ' ' SER . 84.3 m-85 -99.75 123.51 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.3 -0.864 . . . . 72.340000000000003 111.145 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.36 103.69 11.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 64.540000000000006 109.911 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.16 117.15 28.7 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.245 -0.65 . . . . 74.340000000000003 109.245 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 179.96 4.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.124 0.488 . . . . 74.150000000000006 111.739 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -64.33 -26.46 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.339 -0.846 . . . . 70.049999999999997 110.673 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.697 ' HG3' HG22 ' A' ' 142' ' ' VAL . 7.1 mmt -91.54 -37.19 13.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.885 -0.598 . . . . 65.430000000000007 111.429 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.68 -128.9 1.26 Allowed Glycine 0 CA--C 1.504 -0.599 0 C-N-CA 120.64 -0.791 . . . . 73.439999999999998 111.395 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.46 136.36 43.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.073 0.463 . . . . 75.439999999999998 110.039 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.4 120.79 57.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.603 -0.726 . . . . 73.129999999999995 109.14 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.687 HG12 HD21 ' A' ' 13' ' ' ASN . 6.9 t -101.4 141.59 17.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.688 -0.687 . . . . 74.219999999999999 109.179 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 pp -147.76 161.59 40.92 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.272 -0.571 . . . . 64.409999999999997 111.16 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -132.27 163.76 27.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.144 -0.935 . . . . 72.349999999999994 110.429 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.71 168.09 10.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 73.25 109.901 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 6.3 m-85 -89.99 97.77 11.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.875 0.369 . . . . 72.140000000000001 110.991 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.496 ' NE1' ' HA ' ' A' ' 12' ' ' PRO . 76.5 m95 -88.82 14.74 9.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.966 0.889 . . . . 72.340000000000003 109.003 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -91.52 -54.1 4.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.109 -1.405 . . . . 72.510000000000005 110.545 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -131.64 9.36 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 74.439999999999998 111.914 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.09 71.41 73.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.287 . . . . 62.229999999999997 110.887 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.15 -42.1 11.49 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.748 2.298 . . . . 70.409999999999997 112.987 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -72.45 -46.89 52.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 72.329999999999998 110.321 -177.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.77 -41.23 86.1 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.21 -0.905 . . . . 75.420000000000002 110.93 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 129' ' ' PHE . 89.1 m -52.18 -51.0 60.74 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.921 -0.581 . . . . 75.219999999999999 111.425 176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.655 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 4.5 mtmp? -73.14 -23.86 60.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.096 -0.502 . . . . 74.430000000000007 111.532 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -56.46 -47.86 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.406 0.622 . . . . 74.439999999999998 109.411 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HZ ' ' HB3' ' A' ' 112' ' ' PHE . 3.8 m-85 -77.76 -42.31 34.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.478 -0.783 . . . . 55.329999999999998 111.069 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 37' ' ' LYS . . . -55.89 -48.8 74.97 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.113 0.412 . . . . 74.400000000000006 112.113 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.669 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -59.72 -43.83 94.01 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.11 0.481 . . . . 62.039999999999999 110.769 178.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 75' ' ' ALA . 28.1 mt -67.36 -30.45 70.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.907 -0.588 . . . . 74.310000000000002 111.319 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.53 76.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.691 -0.686 . . . . 71.519999999999996 111.41 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' NH1' ' HA ' ' A' ' 8' ' ' SER . 17.7 ptt180 -81.16 -7.26 59.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.538 -0.465 . . . . 72.129999999999995 111.384 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -89.43 -49.38 6.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.792 -0.448 . . . . 53.020000000000003 109.792 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 41.03 0.54 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 115.819 -0.628 . . . . 51.109999999999999 112.005 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' HB2' HD22 ' A' ' 42' ' ' LEU . 50.5 t80 -71.4 -37.34 71.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.672 0.389 . . . . 65.540000000000006 111.672 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' HB2' ' CB ' ' A' ' 162' ' ' ALA . 45.2 m-85 -75.97 -16.41 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.46 . . . . 72.430000000000007 112.016 -169.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -68.74 -7.7 36.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.843 0.354 . . . . 74.140000000000001 111.585 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -127.36 16.09 6.34 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.578 -0.82 . . . . 54.119999999999997 112.472 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -101.53 150.06 23.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.775 0.322 . . . . 73.010000000000005 111.433 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 2.1 mptt -130.96 153.37 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.107 -177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 75.1 m-85 -90.04 108.41 19.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.475 -0.935 . . . . 74.239999999999995 108.475 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -110.63 -8.88 14.56 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.341 -0.544 . . . . 70.420000000000002 111.262 -171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 26.6 mmt180 -121.11 106.06 11.19 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.914 0.388 . . . . 73.299999999999997 110.278 172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 62' ' ' ILE . 4.6 mp -122.17 89.72 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.86 -0.793 . . . . 61.310000000000002 108.86 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.752 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 39.1 mt -91.2 120.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 108.557 -0.905 . . . . 54.409999999999997 108.557 176.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 4.2 ptmm? -58.6 118.38 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 123.724 0.64 . . . . 60.409999999999997 111.438 -175.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' CG ' ' HZ3' ' A' ' 203' ' ' LYS . 41.9 m-20 61.72 40.49 13.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.868 -1.06 . . . . 61.25 111.182 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.752 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 3.5 t80 -136.69 -78.12 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 70.040000000000006 110.271 177.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.653 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 25.4 ptm -160.32 155.87 25.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.6 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.545 HD11 HD21 ' A' ' 116' ' ' LEU . 46.8 mt -128.17 102.92 9.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 73.430000000000007 109.454 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 55' ' ' ARG . 45.0 tt0 -81.07 127.2 32.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.01 -0.541 . . . . 64.510000000000005 110.486 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -130.84 139.72 11.18 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.811 -0.709 . . . . 40.219999999999999 112.145 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 154.27 -149.14 20.45 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.061 -1.066 . . . . 64.510000000000005 113.26 176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.513 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 1.4 t70 48.14 86.42 0.15 Allowed Pre-proline 0 N--CA 1.461 0.117 0 C-N-CA 124.689 1.196 . . . . 65.230000000000004 112.617 -177.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 82.3 Cg_endo -75.71 -18.13 17.49 Favored 'Trans proline' 0 CA--C 1.521 -0.165 0 C-N-CA 122.889 2.392 . . . . 71.439999999999998 110.679 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 70' ' ' THR . 3.6 p -84.3 -42.36 15.89 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.129 -1.396 . . . . 71.030000000000001 112.072 -172.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 66' ' ' ASP . . . 86.0 29.66 25.2 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 73.030000000000001 111.396 -174.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' OG1' ' A' ' 68' ' ' THR . 5.2 t -112.39 -33.68 6.11 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.974 0.361 . . . . 45.32 111.974 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.85 -0.66 11.99 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.127 -1.035 . . . . 50.420000000000002 113.006 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -126.26 -24.06 3.75 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 122.607 -0.349 . . . . 63.009999999999998 111.351 178.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 66' ' ' ASP . . . 97.47 -171.09 26.2 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.563 -0.827 . . . . 45.539999999999999 112.818 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.58 -98.06 1.98 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.281 -0.485 . . . . 64.239999999999995 112.185 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 110' ' ' SER . . . 59.31 33.77 22.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.698 0.761 . . . . 74.230000000000004 111.096 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -76.44 15.12 0.65 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.63 -1.168 . . . . 74.310000000000002 110.922 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 41' ' ' GLU . 6.8 tt -94.27 -38.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 115.871 -0.604 . . . . 63.43 111.091 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.66 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 34.7 p90 -106.11 -18.45 14.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.026 -0.67 . . . . 63.43 111.6 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.4 -103.62 2.19 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.316 -0.945 . . . . 74.140000000000001 113.449 175.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -125.61 174.94 7.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.984 0.421 . . . . 74.129999999999995 111.72 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -87.0 -96.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.375 -0.829 . . . . 75.150000000000006 111.535 -171.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 13.2 m-30 78.17 14.88 1.45 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.086 0.555 . . . . 73.129999999999995 112.325 172.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.47 126.5 5.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.57 -0.741 . . . . 71.140000000000001 110.224 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.618 ' HA ' ' ND2' ' A' ' 108' ' ' ASN . 5.4 p-10 -82.68 122.09 27.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.953 -0.758 . . . . 75.329999999999998 108.953 170.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -99.67 19.05 16.59 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.998 -0.742 . . . . 71.510000000000005 108.998 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 84' ' ' ASP . 28.1 mt -58.8 99.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.385 -1.28 . . . . 60.32 110.094 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -154.62 74.81 5.79 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 109.986 -0.376 . . . . 74.25 109.986 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.36 92.59 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.78 2.32 . . . . 65.25 112.238 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.0 -33.26 67.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.695 -0.854 . . . . 74.319999999999993 108.695 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -93.99 178.08 5.77 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.513 -1.221 . . . . 70.140000000000001 109.124 174.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -144.38 160.73 40.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.07 -0.344 . . . . 74.349999999999994 110.07 178.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.59 ' O ' ' HD2' ' A' ' 91' ' ' LYS . 26.2 p90 -56.65 119.68 6.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.874 0.845 . . . . 53.020000000000003 111.053 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 189' ' ' PRO . 33.8 p -116.62 -43.66 2.9 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.728 -0.669 . . . . 74.409999999999997 110.537 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.9 -155.18 7.82 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.363 -0.835 . . . . 74.329999999999998 111.339 174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.37 141.15 31.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.776 0.322 . . . . 61.549999999999997 110.791 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.77 23.73 4.56 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.816 -0.706 . . . . 54.409999999999997 111.949 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.1 mm -90.18 116.69 32.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 74.239999999999995 109.701 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.876 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.2 tm? -91.97 123.31 35.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.626 -0.715 . . . . 75.329999999999998 110.099 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.44 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -140.8 169.02 18.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 75.040000000000006 111.144 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.513 ' CG ' ' HE1' ' A' ' 129' ' ' PHE . 26.3 mtm -92.32 156.32 17.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.038 0.447 . . . . 73.120000000000005 110.495 176.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 166.86 10.28 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.821 -0.627 . . . . 51.25 109.709 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -120.42 179.06 4.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.742 0.306 . . . . 63.329999999999998 110.403 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -146.06 18.82 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.84 -0.618 . . . . 75.140000000000001 110.611 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.51 -142.92 14.17 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.748 -0.739 . . . . 71.150000000000006 112.846 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -58.77 92.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.645 2.897 . . . . 74.340000000000003 112.216 -175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.77 32.56 7.25 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.478 -1.237 . . . . 52.520000000000003 111.003 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.5 m -80.27 56.29 2.45 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.517 -1.219 . . . . 75.319999999999993 110.058 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' A' ' 84' ' ' ASP . 28.7 m-80 -72.57 100.62 2.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.027 -0.988 . . . . 73.230000000000004 109.633 174.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA2' ' OH ' ' A' ' 78' ' ' TYR . . . -116.32 -135.87 5.71 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.254 -0.974 . . . . 74.019999999999996 113.315 -173.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 47.8 p -96.88 -4.78 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.404 -176.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -71.17 142.77 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.027 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.53 ' HB3' ' HZ ' ' A' ' 39' ' ' PHE . 52.3 p90 -143.5 169.38 17.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.828 0.347 . . . . 71.209999999999994 110.812 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -157.51 155.21 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.944 0.402 . . . . 74.109999999999999 110.665 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.711 HG22 HD23 ' A' ' 98' ' ' LEU . 18.4 t -110.61 144.05 19.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.899 -0.591 . . . . 55.020000000000003 109.482 174.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 42.5 p -97.01 124.58 41.03 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.101 0.477 . . . . 62.530000000000001 110.538 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 62' ' ' ILE . 71.9 mt -83.66 -9.53 58.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.592 -0.731 . . . . 72.040000000000006 110.243 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -148.4 156.84 42.54 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 115.172 -0.922 . . . . 61.299999999999997 109.611 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HB2' ' HD2' ' A' ' 92' ' ' PHE . 57.5 Cg_endo -72.28 113.34 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.262 1.975 . . . . 73.349999999999994 112.33 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 57.2 p -100.49 145.47 28.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 64.420000000000002 109.863 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -123.31 17.99 9.82 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.374 0.607 . . . . 63.32 110.722 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.797 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 1.1 p90 -124.08 -1.72 8.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.563 -0.744 . . . . 72.140000000000001 111.33 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.797 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 86.9 mt -114.36 -6.1 12.92 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.975 0.417 . . . . 73.150000000000006 110.839 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.42 -19.19 64.49 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 72.25 111.249 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.53 12.52 10.24 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.52 -0.848 . . . . 34.539999999999999 111.841 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -120.14 -24.33 6.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 74.349999999999994 109.775 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 100' ' ' MET . 38.9 m80 -130.24 125.56 35.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.703 -0.681 . . . . 63.539999999999999 110.189 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.0 m -65.9 110.67 2.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.206 -0.452 . . . . 33.210000000000001 110.427 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 99' ' ' ALA . 32.5 mt -96.84 120.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 110.539 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 1.3 p90 -153.76 72.26 0.9 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.548 1.166 . . . . 73.230000000000004 109.742 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.876 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.63 153.1 23.58 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 118.269 -1.92 . . . . 33.039999999999999 113.857 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.4 mtp-105 -133.32 123.63 25.8 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.923 -0.769 . . . . 75.510000000000005 108.923 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.78 131.61 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.442 0.639 . . . . 54.509999999999998 109.901 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.644 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.6 m -134.36 139.1 45.39 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.507 -0.769 . . . . 50.130000000000003 110.263 -172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 47.09 46.38 16.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.325 0.491 . . . . 62.149999999999999 112.325 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.88 29.46 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.952 -1.118 . . . . 41.439999999999998 112.587 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 185' ' ' GLY . 10.4 tp -76.73 -33.52 21.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 70.25 110.435 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.32 -35.32 91.46 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.015 -0.612 . . . . 73.439999999999998 111.682 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.464 ' O ' HG23 ' A' ' 142' ' ' VAL . 68.4 mmm -69.37 -52.73 24.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.019 -0.363 . . . . 73.030000000000001 110.019 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 80.7 t -53.83 -30.97 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.135 0.493 . . . . 71.329999999999998 110.822 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -70.72 -53.62 14.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.762 -0.654 . . . . 75.340000000000003 110.612 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.558 ' HA ' ' HG2' ' A' ' 144' ' ' MET . 0.0 OUTLIER -74.38 -14.96 60.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 111.097 -177.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 20' ' ' MET . 54.4 t -85.66 -38.17 12.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.18 0.514 . . . . 62.219999999999999 110.049 175.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 58' ' ' LYS . . . -82.01 -15.01 75.99 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.574 -0.822 . . . . 74.209999999999994 112.94 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.558 ' HG2' ' HA ' ' A' ' 141' ' ' ARG . 25.9 ptm -96.39 0.89 51.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.683 0.241 . . . . 73.140000000000001 111.155 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.2 m -57.84 152.71 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.6 0.714 . . . . 73.219999999999999 112.084 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' O ' HG23 ' A' ' 154' ' ' VAL . 7.3 pt-20 -97.81 -170.46 1.99 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.14 -0.936 . . . . 74.409999999999997 109.91 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 17.8 p -85.05 148.42 26.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.002 0.429 . . . . 65.010000000000005 111.737 -177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -73.49 -54.63 7.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.894 -0.593 . . . . 62.329999999999998 111.059 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.2 m -150.62 -52.66 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.712 -0.477 . . . . 73.299999999999997 109.712 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.416 ' O ' ' HB ' ' A' ' 147' ' ' THR . 40.0 mt-30 -81.9 -164.96 0.88 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.402 -0.592 . . . . 75.310000000000002 109.402 173.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.62 13.18 1.05 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.071 0.462 . . . . 70.140000000000001 110.752 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 150' ' ' GLN . 2.0 ptm180 -94.11 121.37 64.1 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.751 -0.463 . . . . 70.409999999999997 109.751 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 40.1 Cg_exo -56.45 150.13 52.89 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.382 2.055 . . . . 75.439999999999998 110.308 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 146' ' ' GLU . 57.9 t -49.94 102.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.393 0.616 . . . . 73.329999999999998 110.564 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.57 93.96 4.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.194 -0.912 . . . . 63.299999999999997 110.56 -172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -152.07 14.01 0.61 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.627 -0.715 . . . . 74.219999999999999 110.217 175.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 142' ' ' VAL . 2.9 t -92.85 97.36 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 121.828 0.823 . . . . 75.040000000000006 110.561 -176.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -120.43 165.95 14.24 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.719 -1.128 . . . . 70.420000000000002 108.824 176.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 48' ' ' TYR . 3.5 mp -88.92 103.3 13.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.451 -0.944 . . . . 74.340000000000003 108.451 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.429 ' O ' ' HD2' ' A' ' 161' ' ' LYS . 34.8 mm -66.87 -59.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.368 -0.833 . . . . 64.019999999999996 110.233 -176.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 160' ' ' ILE . 6.0 mptp? -128.63 132.93 48.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.659 . . . . 74.340000000000003 109.977 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' TYR . . . -129.13 135.54 49.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.335 -0.393 . . . . 64.340000000000003 110.663 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -154.47 128.1 4.42 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.641 -0.709 . . . . 72.150000000000006 110.617 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.477 ' HG2' ' HZ3' ' A' ' 9' ' ' TRP . 91.7 Cg_endo -80.73 149.7 18.42 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.852 2.368 . . . . 75.420000000000002 112.817 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.537 ' HB3' ' HE1' ' A' ' 15' ' ' TYR . 21.4 t -152.44 -152.76 0.44 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 64.340000000000003 110.128 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.28 -45.57 0.11 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.003 -0.617 . . . . 61.340000000000003 111.996 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 128.94 -146.85 17.34 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.03 -0.605 . . . . 72.329999999999998 111.692 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.09 116.07 3.36 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.978 -0.629 . . . . 70.030000000000001 112.487 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 147.5 113.53 0.75 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.664 -0.779 . . . . 51.530000000000001 112.704 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.4 t -165.37 -169.5 1.62 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.668 -0.493 . . . . 64.230000000000004 109.668 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 156.86 -124.22 1.41 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.868 -0.682 . . . . 70.510000000000005 112.088 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.61 172.63 37.01 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.944 -0.646 . . . . 60.340000000000003 112.079 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -162.36 136.21 4.24 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.839 -0.696 . . . . 74.25 111.815 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 38.9 m 57.64 82.44 0.13 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.207 0.527 . . . . 73.150000000000006 111.14 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -77.27 81.37 1.2 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.003 -0.617 . . . . 33.299999999999997 112.176 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 143.42 -39.73 1.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.097 -0.573 . . . . 64.099999999999994 111.707 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -92.74 -149.02 24.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.865 -0.683 . . . . 24.420000000000002 112.212 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 15.4 m -95.88 109.0 21.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.843 0.354 . . . . 70.349999999999994 110.494 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 175.01 178.44 44.87 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.97 -0.633 . . . . 54.549999999999997 111.929 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.53 -45.87 0.38 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.86 -0.686 . . . . 72.200000000000003 111.804 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.52 80.93 1.22 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.782 -0.723 . . . . 25.309999999999999 111.803 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.0 m -94.95 -166.9 1.54 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 64.329999999999998 110.798 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.64 -172.2 39.49 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.884 -0.674 . . . . 72.430000000000007 111.579 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.85 -179.74 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.572 . . . . 45.140000000000001 111.014 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 136' ' ' ILE . . . 156.95 145.98 4.35 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.021 -0.99 . . . . 70.209999999999994 111.117 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.62 -167.33 25.85 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.281 -0.961 . . . . 54.329999999999998 112.291 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.774 ' HB2' ' HD3' ' A' ' 197' ' ' PRO . . . -72.55 171.14 12.95 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.783 0.325 . . . . 62.049999999999997 110.485 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -105.71 94.38 8.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 110.022 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 90' ' ' LEU . 58.2 Cg_endo -77.83 -7.99 16.67 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.12 1.88 . . . . 72.439999999999998 112.802 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.508 ' OE2' ' HD2' ' A' ' 189' ' ' PRO . 1.3 mp0 -75.31 -35.01 61.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.104 0.478 . . . . 72.019999999999996 110.445 -177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 193' ' ' VAL . 14.7 pt -79.05 -13.32 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.929 -0.578 . . . . 70.200000000000003 111.509 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.0 m170 65.85 30.68 9.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.704 -0.68 . . . . 64.349999999999994 112.204 173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 191' ' ' ILE . 4.6 p -123.49 149.53 27.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.142 -0.318 . . . . 71.340000000000003 110.142 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.52 119.0 18.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.162 -0.472 . . . . 71.540000000000006 111.601 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.41 HE21 ' HB ' ' A' ' 93' ' ' THR . 2.3 pp0? -164.97 156.7 15.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.477 -0.783 . . . . 75.230000000000004 109.589 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 202' ' ' ARG . 10.8 m-85 -120.7 146.22 42.94 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 120.799 -0.36 . . . . 71.319999999999993 111.122 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 28.5 Cg_endo -62.15 -59.89 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.946 2.43 . . . . 63.130000000000003 111.968 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.7 21.17 5.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.901 0.381 . . . . 74.329999999999998 110.006 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 62.65 19.42 11.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.54 -0.755 . . . . 75.409999999999997 111.646 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . . . . . . . . . 14.0 ptm -53.28 -53.51 49.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.524 -0.762 . . . . 75.340000000000003 112.289 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -72.78 -8.08 71.63 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.32 -0.467 . . . . 74.209999999999994 113.442 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.482 ' HG3' ' CE2' ' A' ' 196' ' ' TYR . 78.7 mtp180 -80.9 -42.78 20.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.888 0.375 . . . . 70.420000000000002 110.177 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.521 ' NZ ' ' HB2' ' A' ' 203' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-N 114.383 -1.28 . . . . 73.140000000000001 112.067 -174.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.76 0.314 . . . . 71.319999999999993 110.542 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.2 151.46 38.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 62.399999999999999 110.625 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' A' ' 4' ' ' ILE . . . -101.94 116.41 32.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.33 -0.395 . . . . 73.019999999999996 110.57 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 78' ' ' TYR . 79.1 mt 73.01 125.54 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.229 0 O-C-N 123.809 0.693 . . . . 64.340000000000003 111.09 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 44.8 Cg_endo -69.04 109.01 2.07 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.382 2.055 . . . . 71.109999999999999 111.751 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 1.3 Cg_endo -82.04 2.84 8.26 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.885 2.39 . . . . 41.299999999999997 112.055 -176.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.0 89.4 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.41 0.624 . . . . 61.240000000000002 110.643 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 t -157.96 154.81 28.37 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.854 -1.165 . . . . 72.319999999999993 107.854 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -104.55 117.92 35.31 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 110.898 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' A' ' 44' ' ' ARG . 16.6 mp0 -111.04 142.12 25.62 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.503 -0.771 . . . . 62.210000000000001 109.076 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 164' ' ' PRO . 51.6 Cg_exo -57.91 116.95 3.6 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.77 1.647 . . . . 54.299999999999997 110.268 167.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.9 0.15 5.41 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.241 2.627 . . . . 62.210000000000001 113.276 -172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.581 HD21 HG12 ' A' ' 24' ' ' VAL . 3.1 t-20 -135.7 129.13 32.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.35 -0.841 . . . . 75.140000000000001 108.799 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 39' ' ' PHE . 18.7 m -130.85 162.58 38.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.563 0.221 . . . . 63.030000000000001 110.493 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HB3' HG22 ' A' ' 24' ' ' VAL . 39.5 p90 -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.287 0.565 . . . . 72.430000000000007 112.096 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.23 116.39 28.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.005 -0.998 . . . . 73.5 109.423 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.36 112.64 20.51 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.903 -0.777 . . . . 75.540000000000006 108.903 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -105.31 177.98 4.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.926 0.393 . . . . 73.0 111.428 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' HD11 ' A' ' 160' ' ' ILE . 23.2 t -72.79 -11.44 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 61.43 110.557 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.647 ' HG3' HG22 ' A' ' 142' ' ' VAL . 8.7 mmt -100.39 -39.96 7.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.236 -0.438 . . . . 53.549999999999997 110.498 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.86 -127.0 0.99 Allowed Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.789 -0.719 . . . . 62.530000000000001 111.505 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -145.82 130.79 12.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.28 -0.637 . . . . 75.049999999999997 109.28 -179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.1 mp -126.43 129.19 71.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 75.409999999999997 110.399 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 15' ' ' TYR . 42.5 t -110.18 142.0 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.864 -0.421 . . . . 71.329999999999998 109.864 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD22 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -148.65 159.35 44.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.459 0.647 . . . . 72.450000000000003 111.002 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -132.74 163.5 28.86 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.484 -0.78 . . . . 71.099999999999994 110.005 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -98.4 166.99 11.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.445 -0.343 . . . . 75.219999999999999 110.158 -175.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.79 ' HE2' ' HB3' ' A' ' 190' ' ' GLU . 11.1 m-85 -87.73 99.34 12.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.374 0.607 . . . . 64.409999999999997 111.316 175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.715 ' HD1' ' HG ' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -81.45 0.1 39.2 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.283 -0.871 . . . . 73.439999999999998 109.37 177.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.58 -69.55 0.31 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.133 -0.94 . . . . 73.019999999999996 111.035 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.433 ' HD1' ' CG ' ' A' ' 89' ' ' ASP . 46.4 m80 -129.26 17.83 5.99 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.413 -0.358 . . . . 75.230000000000004 111.195 -177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.6 63.82 71.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.575 -0.284 . . . . 74.239999999999995 111.296 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.21 -44.0 2.74 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.643 2.229 . . . . 72.030000000000001 111.815 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -60.99 -47.15 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.757 0.789 . . . . 75.230000000000004 110.051 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.422 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -65.97 -41.28 91.37 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.56 -1.2 . . . . 73.299999999999997 110.965 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.715 ' HG ' ' HD1' ' A' ' 29' ' ' TRP . 41.8 t -57.43 -41.62 80.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 75.530000000000001 110.387 175.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.665 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 7.4 mmpt? -58.84 -45.45 90.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.925 -0.579 . . . . 62.520000000000003 110.897 177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -53.49 -52.98 57.81 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.592 0.558 . . . . 53.409999999999997 110.511 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 27' ' ' LEU . 37.4 t80 -69.02 -44.06 73.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.284 -0.417 . . . . 74.25 110.692 -178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 44' ' ' ARG . . . -55.26 -53.01 61.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.652 -0.704 . . . . 43.43 112.004 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 37' ' ' LYS . 41.8 mm-40 -66.35 -31.12 71.7 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 71.099999999999994 110.354 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -66.79 -36.87 83.4 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.056 -0.52 . . . . 72.120000000000005 110.292 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . . . -67.44 -35.73 79.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.579 -0.737 . . . . 75.329999999999998 110.085 174.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 15.2 mmm180 -61.57 -44.54 96.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.934 -0.575 . . . . 65.299999999999997 110.991 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -48.18 46.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 110.245 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.42 43.42 1.86 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.127 -1.035 . . . . 74.420000000000002 112.412 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -77.59 -18.92 56.38 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.077 0.465 . . . . 70.150000000000006 111.041 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.683 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -76.8 -6.01 50.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 74.0 111.738 -177.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.9 -8.82 47.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.182 -0.463 . . . . 75.549999999999997 111.242 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -136.9 26.32 3.01 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.828 -0.701 . . . . 71.219999999999999 112.153 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.2 p -98.76 148.05 24.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.907 0.384 . . . . 64.140000000000001 111.437 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -135.72 161.65 34.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.332 -0.618 . . . . 50.130000000000003 109.332 177.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.6 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 74.2 m-85 -80.77 116.41 20.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 61.43 109.915 178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -97.56 -22.16 16.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.867 -0.606 . . . . 65.140000000000001 110.451 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.774 ' HB2' ' HB2' ' A' ' 63' ' ' GLN . 33.5 mmt180 -125.27 116.31 21.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.540000000000006 110.151 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 62' ' ' ILE . 20.3 mm -124.42 88.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.108 -0.701 . . . . 71.150000000000006 109.108 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.865 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 13.7 mt -98.16 126.01 51.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.198 -0.667 . . . . 71.530000000000001 109.198 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.28 118.84 8.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.655 0.597 . . . . 73.310000000000002 110.656 -172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 57.81 40.63 25.95 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.894 0.747 . . . . 71.439999999999998 110.946 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HB3' ' HB ' ' A' ' 57' ' ' ILE . 5.1 t80 -133.24 -81.02 0.48 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.221 0.534 . . . . 73.340000000000003 109.916 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.48 ' HG2' ' HD1' ' A' ' 60' ' ' PHE . 27.6 ptt? -160.94 156.62 25.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.475 -0.784 . . . . 73.120000000000005 109.96 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.566 HD11 HD21 ' A' ' 116' ' ' LEU . 48.5 mt -126.92 103.82 11.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.405 -0.591 . . . . 72.510000000000005 109.405 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.774 ' HB2' ' HB2' ' A' ' 55' ' ' ARG . 18.3 mt-30 -85.6 124.65 32.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.31 -0.404 . . . . 72.409999999999997 110.93 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -119.57 141.24 15.46 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.876 -0.602 . . . . 52.119999999999997 111.93 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 156.8 -137.25 5.34 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.046 -0.597 . . . . 72.030000000000001 111.918 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 49.44 78.58 0.39 Allowed Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 113.419 0.896 . . . . 61.520000000000003 113.419 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HG3' ' HA2' ' A' ' 74' ' ' GLY . 68.4 Cg_endo -76.56 -17.26 16.38 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.789 1.659 . . . . 71.409999999999997 110.395 168.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.533 ' OG1' HG22 ' A' ' 70' ' ' THR . 33.9 p -96.61 -44.39 7.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.909 -1.041 . . . . 75.120000000000005 111.12 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.24 11.63 53.82 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.773 -0.727 . . . . 74.519999999999996 111.981 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' OG1' ' A' ' 68' ' ' THR . 10.3 t -98.95 -10.61 22.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 64.140000000000001 110.95 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.97 -15.4 58.14 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.863 -0.684 . . . . 64.319999999999993 112.939 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' H ' HG23 ' A' ' 70' ' ' THR . 0.0 OUTLIER -144.35 18.4 1.71 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.956 0.354 . . . . 71.129999999999995 111.956 -175.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' ' OG1' ' A' ' 68' ' ' THR . . . -84.74 -167.92 43.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.27 -0.967 . . . . 44.219999999999999 111.994 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' HA2' ' HG3' ' A' ' 67' ' ' PRO . . . 113.7 -117.97 4.34 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.249 -0.977 . . . . 64.450000000000003 113.272 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.946 ' H ' ' HB2' ' A' ' 110' ' ' SER . . . -60.8 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.242 0.617 . . . . 75.010000000000005 112.497 -173.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -99.69 7.63 44.99 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.845 -0.798 . . . . 74.400000000000006 108.845 174.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.04 -38.65 82.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.869 -1.059 . . . . 64.129999999999995 111.132 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.87 ' HB2' ' HE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -98.89 -3.47 35.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 111.654 -178.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.86 -73.71 2.52 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.04 -0.6 . . . . 41.229999999999997 112.735 177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm -113.68 171.51 7.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.791 0.329 . . . . 71.109999999999999 110.703 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.24 161.32 28.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.935 -0.575 . . . . 61.039999999999999 110.467 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.87 ' HE2' ' HB2' ' A' ' 78' ' ' TYR . 71.1 m-85 -131.74 -169.15 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 73.25 110.351 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -46.47 139.21 5.14 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.836 0.71 . . . . 62.32 112.166 -176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HA ' HD21 ' A' ' 108' ' ' ASN . 7.9 p-10 -74.16 135.45 42.83 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.143 -0.688 . . . . 70.010000000000005 109.143 174.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.422 ' HG3' HG23 ' A' ' 35' ' ' THR . 25.9 mm-40 -102.68 19.42 19.19 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.831 -0.622 . . . . 73.230000000000004 110.116 -175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.06 98.84 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.622 -0.717 . . . . 65.540000000000006 110.655 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -167.75 82.13 0.83 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.962 -0.563 . . . . 74.239999999999995 109.876 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.56 92.54 0.24 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.846 2.364 . . . . 62.130000000000003 112.372 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 15.3 t70 -71.31 -37.14 71.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.13 0.967 . . . . 75.209999999999994 109.079 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 189' ' ' PRO . 3.5 pp -84.3 179.04 7.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.543 -1.208 . . . . 53.420000000000002 108.985 172.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -139.59 169.1 18.36 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 120.479 -0.488 . . . . 64.319999999999993 109.881 172.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -63.49 123.12 17.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.539 -0.541 . . . . 60.409999999999997 109.539 171.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 39.9 p -125.32 -40.99 2.08 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.567 0.699 . . . . 54.119999999999997 109.843 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.554 ' HA2' ' HG3' ' A' ' 118' ' ' PRO . . . -163.42 -143.4 3.69 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 114.934 -1.03 . . . . 64.519999999999996 111.179 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.6 150.83 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.704 0.287 . . . . 62.549999999999997 110.519 176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.71 23.59 7.79 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.704 -0.76 . . . . 75.340000000000003 111.426 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 189' ' ' PRO . 8.6 mm -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.33 -0.619 . . . . 52.299999999999997 109.33 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.868 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 3.3 tm? -83.38 122.88 29.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 109.883 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 128' ' ' ILE . . . -133.79 171.94 13.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.154 0.502 . . . . 70.129999999999995 111.654 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.748 ' HB2' ' HE1' ' A' ' 129' ' ' PHE . 26.4 ttt -107.25 143.14 35.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.616 -0.72 . . . . 63.32 110.13 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 111' ' ' GLN . . . -104.61 136.68 43.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.2 0.524 . . . . 45.340000000000003 110.64 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -139.43 166.23 25.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.583 -0.735 . . . . 62.039999999999999 109.766 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -85.88 -34.81 20.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.527 -0.306 . . . . 63.210000000000001 111.103 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.32 -123.05 1.07 Allowed Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.534 -0.841 . . . . 74.109999999999999 112.337 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.55 90.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.99 2.46 . . . . 71.219999999999999 112.201 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' PHE . 2.2 p30 59.87 11.08 2.38 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.688 1.195 . . . . 74.25 112.373 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.9 m -81.48 61.18 4.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.69 0.757 . . . . 75.120000000000005 109.095 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 84' ' ' ASP . 31.0 m-80 -73.5 150.88 41.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.394 -1.276 . . . . 63.439999999999998 109.886 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.41 -139.82 3.96 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.632 -0.794 . . . . 53.130000000000003 111.958 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.946 ' HB2' ' H ' ' A' ' 75' ' ' ALA . 33.7 t -113.73 8.48 17.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.975 0.417 . . . . 71.129999999999995 110.359 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 101' ' ' ALA . 9.2 mm-40 -82.47 138.81 34.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 110.386 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.88 167.29 21.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.111 -0.7 . . . . 72.219999999999999 109.111 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.768 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 51.5 p90 -157.12 153.87 28.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 72.530000000000001 112.059 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 98' ' ' LEU . 17.4 t -113.64 142.52 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.237 -0.892 . . . . 60.219999999999999 108.752 174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.9 p -96.04 129.38 43.33 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.123 0.487 . . . . 74.129999999999995 110.621 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 62' ' ' ILE . 74.3 mt -82.49 -10.5 58.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.432 -0.804 . . . . 44.549999999999997 110.78 178.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -147.56 164.12 24.32 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.414 -0.812 . . . . 61.310000000000002 110.022 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.554 ' HG3' ' HA2' ' A' ' 94' ' ' GLY . 23.9 Cg_exo -64.19 113.96 2.45 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.707 2.271 . . . . 64.209999999999994 112.134 177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.8 p -100.35 112.95 25.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.207 -0.451 . . . . 75.120000000000005 111.106 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.717 ' H ' ' NE2' ' A' ' 120' ' ' GLN . 0.7 OUTLIER -114.16 27.4 9.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.612 0.72 . . . . 54.420000000000002 109.756 -177.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.74 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -129.83 3.52 4.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.153 -0.931 . . . . 73.310000000000002 110.983 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.74 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 94.4 mt -113.13 7.84 18.08 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.931 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 -27.28 56.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.913 -1.04 . . . . 62.399999999999999 111.917 -176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.3 25.43 4.85 Favored Glycine 0 CA--C 1.504 -0.606 0 N-CA-C 111.088 -0.805 . . . . 65.120000000000005 111.088 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -116.86 -40.38 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.952 0.406 . . . . 60.420000000000002 110.067 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -142.3 137.12 30.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 63.020000000000003 111.11 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.1 m -68.75 121.77 17.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.658 -0.701 . . . . 54.149999999999999 110.796 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 99' ' ' ALA . 42.9 mt -108.4 120.88 60.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.457 -0.201 . . . . 34.509999999999998 110.457 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.748 ' HE1' ' HB2' ' A' ' 100' ' ' MET . 4.2 p90 -157.71 73.62 0.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.865 0.841 . . . . 72.310000000000002 110.81 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.868 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -162.96 150.94 20.43 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.274 -1.441 . . . . 63.219999999999999 113.433 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 mtp180 -127.54 119.63 26.44 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.862 -0.792 . . . . 73.329999999999998 108.862 175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.403 ' CG1' ' HA3' ' A' ' 186' ' ' GLY . 9.2 p -79.66 132.08 32.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.338 0.589 . . . . 65.219999999999999 109.864 175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . 0.578 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 73.1 m -133.55 141.21 47.61 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.698 -0.683 . . . . 61.219999999999999 110.916 -171.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 184' ' ' ASP . 3.3 pt20 41.68 35.3 0.47 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.478 1.111 . . . . 71.109999999999999 113.842 176.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.32 37.6 0.23 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.585 -0.817 . . . . 64.430000000000007 112.211 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 197' ' ' PRO . 9.3 tp -85.33 -34.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.78 0.324 . . . . 73.409999999999997 110.542 -175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.59 -35.59 81.34 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.038 -0.601 . . . . 61.0 112.413 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.427 ' O ' HG23 ' A' ' 142' ' ' VAL . 81.2 mmm -70.54 -51.32 29.45 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.336 -0.246 . . . . 71.340000000000003 110.336 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 62' ' ' ILE . 91.7 t -52.55 -32.12 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.001 0.429 . . . . 75.340000000000003 110.933 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.448 ' O ' ' HG3' ' A' ' 144' ' ' MET . 1.6 t30 -69.5 -53.8 17.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.84 -0.618 . . . . 73.510000000000005 110.559 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -15.43 61.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.055 -0.52 . . . . 73.200000000000003 110.975 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.647 HG22 ' HG3' ' A' ' 20' ' ' MET . 45.1 t -84.0 -37.59 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.029 0.442 . . . . 73.200000000000003 110.315 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 116' ' ' LEU . . . -74.78 -18.62 80.09 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.42 -0.895 . . . . 70.230000000000004 112.613 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 140' ' ' ASN . 42.8 mtm -99.66 1.34 43.41 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.947 0.351 . . . . 42.509999999999998 111.947 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 142' ' ' VAL . 30.7 m -52.71 137.04 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.313 0.578 . . . . 75.310000000000002 111.903 -176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -117.98 -61.35 1.69 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.758 -0.656 . . . . 75.319999999999993 110.335 176.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 153' ' ' PRO . 27.6 p -131.91 150.67 52.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.8 0.333 . . . . 65.420000000000002 111.365 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.62 ' OD1' ' HG3' ' A' ' 152' ' ' ARG . 35.0 p-10 -87.31 -12.6 46.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.201 0.524 . . . . 73.299999999999997 110.431 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 41.9 m -150.96 -72.25 0.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.629 -0.714 . . . . 70.129999999999995 109.707 174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.34 129.31 0.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 74.340000000000003 109.817 177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.1 t70 64.13 13.28 7.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.59 0.71 . . . . 74.109999999999999 111.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.62 ' HG3' ' OD1' ' A' ' 148' ' ' ASN . 9.3 ptp180 -142.46 120.57 7.39 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.288 -0.634 . . . . 65.310000000000002 109.288 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 147' ' ' THR . 84.3 Cg_endo -81.24 163.77 19.69 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.239 2.626 . . . . 72.030000000000001 115.243 -165.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 148' ' ' ASN . 46.6 t -101.61 125.07 55.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.885 -1.052 . . . . 71.349999999999994 110.149 171.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -149.05 11.52 0.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.634 -0.506 . . . . 71.519999999999996 109.634 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 158' ' ' LYS . 6.6 p-10 -109.7 27.57 9.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.761 -0.654 . . . . 55.420000000000002 112.184 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.485 HG21 HG13 ' A' ' 142' ' ' VAL . 12.8 t -73.27 116.6 15.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.896 -0.779 . . . . 61.130000000000003 108.896 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.1 mttm -124.09 169.57 11.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.981 0.419 . . . . 73.219999999999999 111.207 -175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -93.45 99.81 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.838 -1.171 . . . . 71.439999999999998 107.838 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.592 HG22 ' HD2' ' A' ' 161' ' ' LYS . 25.4 mm -63.26 -61.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.62 -0.511 . . . . 34.109999999999999 109.62 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.592 ' HD2' HG22 ' A' ' 160' ' ' ILE . 2.2 mptp? -138.32 154.7 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.016 -0.735 . . . . 72.120000000000005 109.016 172.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . . . -142.51 150.72 40.84 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.661 -0.496 . . . . 65.140000000000001 109.661 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 15' ' ' TYR . 98.6 m-85 -156.05 145.62 15.37 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.339 -0.615 . . . . 74.120000000000005 109.339 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.62 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 5.4 Cg_exo -74.94 142.55 28.19 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.403 2.069 . . . . 73.409999999999997 111.954 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 11' ' ' PRO . 25.5 t -105.73 136.75 44.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 72.200000000000003 110.074 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.19 -38.44 72.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.885 -0.674 . . . . 50.130000000000003 112.835 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -127.22 168.99 19.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.721 -0.752 . . . . 70.209999999999994 112.423 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.78 156.69 19.45 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.467 -0.653 . . . . 34.340000000000003 111.467 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 121.68 143.94 6.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.698 -0.763 . . . . 63.130000000000003 112.004 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.2 p -81.51 -18.64 44.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 63.32 111.242 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 82.38 -69.8 3.27 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.747 -0.74 . . . . 73.439999999999998 112.603 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -150.73 -143.03 3.64 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.914 -0.66 . . . . 73.540000000000006 112.37 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -113.49 62.14 0.32 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.026 -0.606 . . . . 54.450000000000003 112.008 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.7 m -91.9 127.64 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.787 0.327 . . . . 31.41 110.701 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 172.33 -88.32 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.602 -0.599 . . . . 71.109999999999999 111.602 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.45 46.44 1.09 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.031 -0.604 . . . . 64.230000000000004 112.114 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 75.4 -81.58 0.95 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.027 -0.606 . . . . 72.430000000000007 112.438 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.7 p -89.71 -11.74 41.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.148 0.499 . . . . 72.420000000000002 110.444 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -117.62 89.23 0.47 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.896 -0.669 . . . . 53.509999999999998 111.546 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -115.87 28.38 7.74 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.689 -0.767 . . . . 73.209999999999994 112.552 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -86.4 64.28 4.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.761 -0.733 . . . . 71.25 111.577 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -100.19 135.15 42.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.695 0.283 . . . . 73.120000000000005 110.401 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.71 167.26 22.56 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.928 -0.653 . . . . 55.310000000000002 112.292 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 134' ' ' GLN . 1.4 m-20 -97.74 174.77 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.445 0.641 . . . . 54.439999999999998 110.836 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.51 145.87 4.29 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.173 -0.922 . . . . 73.120000000000005 110.811 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 197' ' ' PRO . . . -79.3 -161.12 20.94 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.083 -1.055 . . . . 75.299999999999997 112.153 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.649 ' HB1' ' OE1' ' A' ' 195' ' ' GLN . . . -80.95 176.73 9.57 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 110.153 -0.314 . . . . 71.329999999999998 110.153 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 191' ' ' ILE . 76.7 m-85 -116.19 92.54 36.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.646 -0.502 . . . . 70.140000000000001 109.646 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 90' ' ' LEU . 10.3 Cg_exo -70.48 -18.07 33.85 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.21 2.607 . . . . 72.329999999999998 113.279 -173.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.79 ' HB3' ' HE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -78.14 -35.1 49.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.262 0.468 . . . . 62.520000000000003 112.262 -172.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 188' ' ' PHE . 22.3 pt -73.03 -13.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.904 0.383 . . . . 71.340000000000003 111.773 -171.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 63.8 m170 68.91 29.45 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.496 -0.774 . . . . 72.129999999999995 111.926 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 191' ' ' ILE . 3.9 p -127.28 165.66 25.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.979 -0.748 . . . . 74.340000000000003 108.979 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -86.24 129.77 34.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 43.219999999999999 111.59 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.649 ' OE1' ' HB1' ' A' ' 187' ' ' ALA . 0.0 OUTLIER -158.54 153.45 25.06 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.019 -0.734 . . . . 71.109999999999999 109.019 174.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 202' ' ' ARG . 83.9 m-85 -122.07 138.19 28.5 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.726 -0.39 . . . . 72.109999999999999 111.038 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 187' ' ' ALA . 33.0 Cg_endo -64.23 -51.5 2.06 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.622 2.215 . . . . 74.239999999999995 111.967 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 197' ' ' PRO . 1.0 OUTLIER -154.83 41.15 0.45 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.387 -0.37 . . . . 71.519999999999996 111.166 178.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 198' ' ' LEU . 2.0 m-20 75.32 -12.82 0.92 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 112.257 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.573 ' O ' ' HE2' ' A' ' 203' ' ' LYS . 23.0 ptm -50.64 -31.88 17.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.622 0.971 . . . . 72.319999999999993 113.622 -173.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -100.86 2.7 55.65 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 119.803 -1.189 . . . . 72.120000000000005 113.677 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.498 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 31.8 ptt180 -118.98 1.89 11.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 117.565 0.682 . . . . 65.340000000000003 111.951 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 200' ' ' MET . 41.4 mtmt . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.116 -0.947 . . . . 70.310000000000002 110.831 175.223 . . . . . . . . 1 1 . 1 stop_ save_